accession,name,description,Parent study,Study Disease/Focus,Study Design,Study Markerset,Study Molecular Data Type,Study Content,Ancestry (computed),NIH Institute,Study Consent,Release Date,Embargo Release Date,Related Terms,Collections
"phs004382.v1.p1","The Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora    Populations","African Americans have one of the highest rates of type 2 diabetes in the United States, and often have other medical problems related to obesity and cardiovascular disease. These conditions  have various risk factors, including high blood sugar levels, high cholesterol levels, and insulin resistance. However, these risk factors need","Not Applicable","Obesity","Cross-Sectional","custom_markerset","SNP Genotypes (NGS)","4 phenotype datasets, 19 variables, 1 molecular datasets, 534 subjects, 534 samples","","NHGRI","GRU-IRB --- General Research Use (IRB)","2026-01-12","2026-01-12","Cardiovascular Diseases; Insulin Resistance; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs004087.v1.p1","Identifying and Understanding Drivers of Chemoresistance in Small Cell    Lung Cancer","Using a patient derived model of small cell lung cancer, the KEAP1 gene was deleted using lentiviral expression of a vector expressing CAS9 and single guide RNA (sgRNA) targeting KEAP1.  A control vector expressing model was also generated. RNA-Seq analysis was performed to compare gene expression in tumors growing in vivo, comparing","Not Applicable","Kelch-Like ECH-Associated Protein 1","Xenograft","Not Provided","RNA-Seq","3 phenotype datasets, 12 variables, 23 samples sequenced, 1 subjects, 23 samples","","NCI","GRU --- General Research Use","2026-01-12","2026-01-12","Not Provided",""
"phs003273.v1.p1","Genetic and Clinical Determinants of Telomere Length","Numerous studies have established connections between leukocyte telomere length (LTL) and genetics and health. However, these studies have concentrated on specific diseases or GWAS analyses. We sought to explore the  interplay between LTL, genomics, and human health by examining two vast patient populations obtained from the Vanderbilt University and Marshfield","Not Applicable","Telomere","Case-Control","MEGAEx_BioVU_15075710_A1, custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 24 variables, 2 molecular datasets, 61182 subjects, 61182 samples","European (60932), African (1), East Asian (20), African American (16), Hispanic1 (22), Hispanic2 (146), Other Asian or Pacific Islander (20), South Asian (10), Other (15)","NIGMS","GRU --- General Research Use","2026-01-12","2026-01-12","Aging; Aging, Biological; Biological Aging",""
"phs001478.v2.p1","Exploration of the Biologic Basis for Underperformance of Oral Polio and    Rotavirus Vaccines in Bangladesh","Oral polio and rotavirus vaccines are significantly less effective in children living in the developing world. Environmental enteropathy, which is associated with intestinal inflammation, decreased absorption and increased permeability, may  contribute substantially to oral vaccine failure in developing country settings. The primary objective of the study was to determine the association","Not Applicable","Intestinal Diseases","Prospective Longitudinal Cohort","MEGA_Consortium_Array","SNP/CNV (Array)","13 phenotype datasets, 172 variables, 1 molecular datasets, 640 subjects, 635 samples","","NIAID","DS-TENT-IRB-PUB-NPU-MDS-GSO-RD --- Disease-Specific (Tropical Enteropathy, IRB, PUB, NPU, MDS, GSO, RD)","2026-01-12","2026-01-12","Communicable Diseases; Inflammation; Malnutrition; Communicable Disease; Disease, Communicable; Disease, Infectious",""
"phs000954.v5.p2","NHLBI TOPMed: The Cleveland Family Study (CFS)","The Cleveland Family Study (CFS) is one cohort involved in the WGS project. The CFS was designed to provide fundamental epidemiological data on genetic and non-genetic risk factors for sleep  disordered breathing (SDB). In brief, the CFS is a family-based study that enrolled a total of 2284 individuals from 361 families between 1990 and","Not Applicable","Sleep Apnea Syndromes","Prospective Longitudinal Cohort","WGS_markerset_grc38, SV_STR_grc38","SNP/CNV Genotypes (NGS), De-novo Mutations (NGS), CNV (NGS), WGS","3 phenotype datasets, 15 variables, 2 documents, 3 molecular datasets, 1293 samples sequenced, 1293 subjects, 1293 samples","European (613), African (9), East Asian (1), African American (655), Hispanic1 (9), Hispanic2 (1), Other Asian or Pacific Islander (1), Other (3)","NHLBI","DS-HLBS-IRB-NPU --- Disease-Specific (Heart, Lung, Blood, and Sleep Disorders, IRB, NPU)","2026-01-12","2026-01-12","Diabetes Mellitus; Hypertension; Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High",""
"phs004343.v1.p1","Interagency Registry for Mechanically Assisted Circulatory Support    (Intermacs-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Available Data  Data available for request include Intermacs and Pedimacs data, as well as data from the Medical Arm of Mechanical Circulatory Support (MedaMACS)","Not Applicable","Cardiovascular Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 23028 subjects, 23028 samples","","NHLBI","GRU --- General Research Use","2026-01-09","2026-01-09","Congestive Heart Failure; Heart Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs004230.v1.p1","REDIAL RNASeq Study","We seek to characterize the genomics of acute lymphoblastic leukemia (ALL) in children of Hispanic ethnicity. We hypothesize that certain molecular subtypes of ALL are over- or under-represented in Hispanics  compared to patients of other genetic ancestries. Utilizing the REDIAL Study cohort, we performed genomic profiling (e.g., RNAseq) to determine","Not Applicable","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 11 variables, 292 samples sequenced, 292 subjects, 292 samples","","NCI","HMB --- Health/Medical/Biomedical","2026-01-09","2026-01-09","ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic; Leukemia, Lymphoblastic, Acute, L1",""
"phs002371.v9.p2","Human Tumor Atlas Network (HTAN)","An NCI-funded Cancer Moonshot initiative to construct 3-dimensional atlases of the dynamic cellular, morphological, and molecular features of human cancers as they evolve from precancerous lesions to advanced disease. Note:  All data, including raw sequencing and imaging files, biospecimen data, clinical data and downstream analysis files related to this study are","Not Applicable","Neoplasms","Collection","Not Provided","Not Provided","2 phenotype datasets, 6 variables, 1894 subjects, 6178 samples","","NCI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2026-01-09","2022-05-27","Adenomatous Polyposis Coli; Lung Neoplasms; Skin Neoplasms; ADENOMATOUS POLYPOSIS OF THE COLON; APC; APC - Adenomatous Polyposis Coli","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001652.v1.p1","Real-Time Genomic Characterization of Advanced Pancreatic Cancer to    Enable Precision Medicine","Clinically relevant subtypes exist for pancreatic ductal adenocarcinoma (PDAC), but molecular characterization is not yet standard in clinical care. We implemented a biopsy protocol to perform time-sensitive whole exome sequencing  (WES) and RNA-sequencing (RNA-Seq) for patients with advanced PDAC. Therapeutically relevant genomic alterations were identified in 48% (34/71) and","Not Applicable","Carcinoma, Pancreatic Ductal","Case Set","other","RNA-Seq, SNV (.MAF), WXS","4 phenotype datasets, 21 variables, 1 molecular datasets, 71 samples sequenced,  SRA, 79 subjects, 71 samples","","NCI","GRU --- General Research Use","2026-01-09","2026-01-09","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs004337.v1.p1","Studies of Atopic Dermatitis through Single-Cell Transcriptomics and    Immune Repertoires","In atopic dermatitis (AD) patients, the homeostatic processes maintaining barrier integrity and immune regulation in the skin break down, resulting in chronic inflammation. To understand the tissue changes occurring during  disease, we profiled skin from AD, scleroderma, and healthy patients using single-cell transcriptomics (scRNA-Seq) and immune repertoire profiling of","Not Applicable","Dermatitis, Atopic","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 24 variables, 63 samples sequenced, 16 subjects, 63 samples","","NIAID","HMB-MDS --- Health/Medical/Biomedical (MDS)","2026-01-08","2026-01-08","AD - Atopic dermatitis; ATOD; Allergic eczema; Atopic Eczema; Atopic Neurodermatitis; Atopic dermatitis, chronic",""
"phs004253.v1.p1","Distinct Phenotypes and Repertoires of Bronchoalveolar and Airway Mucosal    T Cells in Health and Allergic Asthma","T cells play a central role in host protection against respiratory pathogens, but maladaptive T cell responses can lead to pulmonary diseases. Defining the biology of protective versus pathogenic T  cell responses in the lungs of humans will be critical to nominate novel approaches to improve respiratory health. Previous studies have examined T","Not Applicable","Asthma","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 22 samples sequenced, 6 subjects, 22 samples","","NIAID","GRU --- General Research Use","2026-01-08","2026-01-08","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003671.v1.p1","FORCE Trial: Resistance Training Intervention Among Colon Cancer Patients","Our study population was composed of participants of the FORCE clinical trial, which was a randomized resistance training intervention study for Stage II and III colon cancer patients undergoing chemotherapy.  Patients were recruited from Kaiser Permanente of Northern California, the Penn State Cancer Institute, and the Dana Farber Cancer Institute and were","Not Applicable","Colonic Neoplasms","Clinical Trial","MethylationEPIC","Methylation (CpG)","4 phenotype datasets, 21 variables, 1 molecular datasets, 171 subjects, 318 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2026-01-08","2026-01-08","COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic; Cancers, Colon",""
"phs003325.v2.p1","DNA-Sequencing of Baseline and Progression Plasma from the Phase III    Alliance A031201 Trial","Circulating tumor DNA (ctDNA) in plasma cell free DNA (cfDNA) of cancer patients is associated with poor prognosis, but is challenging to detect from low plasma volumes. In metastatic castration-resistant  prostate cancer (mCRPC), ctDNA assays are needed to prognosticate outcomes of patients treated with androgen receptor (AR) inhibitors. We developed a","Not Applicable","Prostatic Neoplasms","Clinical Trial","Not Provided","Targeted-Capture","4 phenotype datasets, 14 variables, 1207 samples sequenced, 873 subjects, 1207 samples","","NCI","DS-PC-IRB-NPU --- Disease-Specific (Prostate Cancer, IRB, NPU)","2026-01-08","2024-10-23","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs002187.v2.p1","Gabriella Miller Kids First Pediatric Research Program in Germline and    Somatic Variants in Myeloid Malignancies in Children","This project aims to sequence an unparalleled number of cases of de novo Acute Myeloid Leukemia (AML) and Down Syndrome AML (DS-AML), to establish a database comprised of genomic and  transcriptome information which can be interrogated for both somatic and germline variants. Identification of the somatic variants will provide","Not Applicable","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 6 variables, 1441 subjects, 3712 samples","","NCI","GRU --- General Research Use","2026-01-08","2021-09-17","Leukemia, Promyelocytic, Acute; AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult",""
"phs000964.v6.p2","NHLBI TOPMed: The Jackson Heart Study (JHS)","Since there is a greater prevalence of cardiovascular disease among African Americans, the purpose of the Jackson Heart Study (JHS) is to explore the reasons for this disparity and to  uncover new approaches to reduce it. The JHS is a large, community-based, observational study whose 5306 participants were recruited from among the","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38, SV_STR_grc38, MethylationEPIC","Methylation (CpG), SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 30 variables, 3 documents, 3 molecular datasets, 3403 samples sequenced, 3403 subjects, 5092 samples","African (75), East Asian (1), African American (3315), Hispanic1 (14), Other (1)","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2026-01-08","2026-01-08","Diabetes Mellitus; Hypertension; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs003411.v1.p1","Transcriptome of Human Merkel Cell Carcinoma","Merkel Cell Carcinoma (MCC) is a rare and aggressive skin cancer with poorly understood molecular characteristics. In this study, we conducted RNA sequencing (RNA-Seq) on tumor samples from 9 human  MCC patients to unravel the intricate transcriptional landscape of MCC. Data available in dbGaP include bulk RNA sequencing of 9 tumor samples.","Not Applicable","Carcinoma, Merkel Cell","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 9 samples sequenced, 9 subjects, 9 samples","","NIAMS","GRU --- General Research Use","2026-01-07","2026-01-07","Anaplastic carcinoma of the skin; Cancer, Merkel Cell; Cell Cancer, Merkel; Cutaneous APUDoma; MCC; Merkel Cell Cancer","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001591.v3.p2","Center for Oral Health Research in Appalachia (COHRA) Genomic Studies of    Oral Health and Disease","The purpose of this project is to identify the genetic factors contributing to dental caries in children and adults. The datasets come from the Center for Oral Health Research in  Appalachia (COHRA), which has the long-term goal of determining the sources of oral health disparities in a high risk, Northern Appalachian","Not Applicable","Dental Caries","Family/Twin/Trios","HumanCoreExome-24, Multi-Ethnic_Global, imputation_panel","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","5 phenotype datasets, 148 variables, 3 molecular datasets, 5210 subjects, 5361 samples","European (2579), African (5), East Asian (6), African American (387), Hispanic1 (79), Hispanic2 (25), Other Asian or Pacific Islander (4), South Asian (3), Other (11)","NIDCR","DS-DOH-MDS --- Disease-Specific (Dental and Oral Health, MDS), HMB --- Health/Medical/Biomedical","2026-01-07","2026-01-07","Caries; Caries, Dental; Cariosity of teeth; Carious Lesion; Carious Lesions; Cavities, Dental",""
"phs001203.v5.p1","Stockholm-Tartu Atherosclerosis Reverse Network Engineering Task    (STARNET)","STARNET is a genetics of RNA expression study of multiple disease-relevant tissues obtained from living patients with cardiovascular disease. Tissue samples are obtained from blood, atherosclerotic-lesion-free internal mammary artery (MAM)  and atherosclerotic aortic root (AOR), subcutaneous fat (SF), visceral abdominal fat (VAF), skeletal muscle (SKLM), and liver (LIV) during open","Not Applicable","Coronary Artery Disease","Case Set","RNAseq_gene_transcripts, HumanOmniExpressExome-8","SNP Genotypes (Array), RNA-Seq, RNA Seq (NGS)","7 phenotype datasets, 38 variables, 3 molecular datasets, 7173 samples sequenced, 1290 subjects, 9876 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2026-01-07","2026-01-07","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs003768.v3.p2","NIH RECOVER: A Multi-Site Pathology Study of Post-Acute Sequelae of    SARS-CoV-2 Infection","The RECOVER tissue pathology study is a cross-sectional study designed to define and characterize the epidemiology, natural history, clinical spectrum, and underlying mechanisms of post-acute effects of SARS-CoV-2 infection in  a diverse population representative of the general COVID-19 population in the US. The autopsy study will characterize the pathology of PASC in","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2 documents, 245 subjects, 245 samples","","NHLBI","GRU --- General Research Use","2026-01-06","2025-02-07","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000424.v11.p2","Common Fund (CF) Genotype-Tissue Expression Project (GTEx)","Lay Description The aim of the Genotype-Tissue Expression (GTEx) Project is to increase our understanding of how changes in our genes affect human health and disease with the ultimate goal  of improving health care for future generations. GTEx will create a database that researchers can use to study how inherited changes in genes lead to","Not Applicable","Reference Values","Cross-Sectional","RNAseq_probe_set_grc37, Affymetrix_expression_array, imputation_panel, RNAseq_probe_set_grc38, HumanOmni5-4, HumanExome-12, WES_markerset_grc37, HumanOmni2.5-8, WGS_markerset_grc37, WGS_markerset_grc38","Allele-Specific Expression, Allele-Specific Expression, SNP Genotypes (Array), mRNA Expression (Array), SNP Genotypes (imputed), RNA-Seq, CNV Genotypes, SNP/CNV Genotypes (NGS), RNA Seq (NGS), MAF (NGS), WGS, WXS","4 phenotype datasets, 324 variables, 1 documents, 12 molecular datasets, 14116 samples sequenced, 983 subjects, 48236 samples","European (153), East Asian (2), African American (25), Hispanic1 (3), Hispanic2 (2)","NHGRI","GRU --- General Research Use","2026-01-06","2022-10-20","Not Provided",""
"phs003431.v1.p1","CIDR-Whole Genome Sequencing: Prospective Birth Cohort to Elucidate    Etiology of ADHD in US Minority Children","Attention Deficit Hyperactivity Disorder (ADHD) is the most common pediatric developmental disability, affecting at least 6 million U.S. children; children from minority racial and ethnic populations, such as Black children,  are at even higher risk. A major challenge in preventing and treating ADHD is that the causes remain unclear. Available data suggest that both","Not Applicable","Attention Deficit Disorder with Hyperactivity","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 51 variables, 1 molecular datasets, 491 samples sequenced, 489 subjects, 491 samples","","NHGRI","DS-ADHD --- Disease-Specific (Attention deficit hyperactive disorder)","2026-01-05","2026-01-05","ADD; ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorders with Hyperactivity; Attention Deficit Hyperactivity Disorder",""
"phs004182.v1.p1","Characterization of Taste Genetics and Oral Microbiome in Early Childhood    Caries","This study included 538 participants under the age of 72 months, recruited between December 2017 and July 2022 from various community clinics across Winnipeg, Manitoba. Samples were collected from buccal  swabs to sequence the taste-related genes. For the sequencing, 55 candidate genes were selected based on their roles in taste signal transduction,","Not Applicable","Dental Caries","Case-Control","target_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 538 subjects, 538 samples","","NIDCR","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2026-01-02","2026-01-02","Caries; Caries, Dental; Cariosity of teeth; Carious Lesion; Carious Lesions; Cavities, Dental",""
"phs003988.v1.p1","SCORCH: Single Nuclei Transcriptome Profiling in Addiction Circuitry of    the HIV+ Brain","The HIV pandemic continues to pose a global health burden, despite considerable advances in treatment and prevention. Although a large fraction of people with HIV (PWH) are receiving life-saving antiretroviral  therapy (ART), treatment does not eradicate the virus. An important co-morbidity relevant to HIV neurologic disease is substance use disorder (SUD),","Not Applicable","HIV","Case-Control","Global_Screening_Array-24","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 47 variables, 1 molecular datasets, 50 samples sequenced, 156 subjects, 246 samples","","NIDA","HMB-IRB-PUB --- Health/Medical/Biomedical (IRB, PUB)","2025-12-23","2025-12-23","Opioid-Related Disorders; Substance-Related Disorders; Addiction, Opiate; Dependence, Opiate; Opiate Addiction; Opiate Dependence",""
"phs003966.v1.p1","Whole-Exome Sequencing of Acute Myeloid Leukemia","The Fanconi anemia (FA) pathway is a tumor-suppressive network comprised of at least 22 genes. We demonstrate that the FA pathway disruption sensitizes Acute Myeloid Leukemia (AML) cells to PLK1  inhibition (iPLK1). We obtained cryopreserved mononuclear cells (MNCs) derived from the bone marrow of 16 adult AML patients from the Indiana","Not Applicable","Leukemia, Myeloid, Acute","Case Set","Not Provided","WXS","4 phenotype datasets, 17 variables, 16 samples sequenced, 16 subjects, 16 samples","","NCI","HMB --- Health/Medical/Biomedical, DS-HM --- Disease-Specific (Hematological Malignancies)","2025-12-22","2025-12-22","Anemia, Fanconi; Anemia, Fanconi's; Anemias, Fanconi; FA; Fanconi Anemias; Fanconi Hypoplastic Anemia",""
"phs002554.v3.p1","Gene Expression and Epigenetic Analyses of Human Myocytes from Different    Muscles","The study contains expression, DNA methylation data and genomic data of in vitro cultured primary myoblasts, immortalized control myoblast, and mutant myoblasts. The primary myoblasts were derived from biopsies of  control, facioscapulohumeral dystrophy 1 (FSHD1) and FSHD2 patients from the tibialis anterior, quadricep, bicep and deltoid. FSHD is linked to DUX4","Not Applicable","Muscular Dystrophy, Facioscapulohumeral","Case-Control","RNAseq_gene_transcripts","Bisulfite-Seq, OTHER, RNA-Seq, SNP/CNV Genotypes (NGS)","5 phenotype datasets, 26 variables, 1 molecular datasets, 176 samples sequenced, 11 subjects, 176 samples","","NIAMS","GRU --- General Research Use","2025-12-22","2025-12-22","Atrophies, Facioscapulohumeral; Atrophy, Facioscapulohumeral; Dystrophies, Facioscapulohumeral Muscular; Dystrophies, Landouzy-Dejerine; Dystrophy, Facioscapulohumeral Muscular; Dystrophy, Landouzy-Dejerine","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs004268.v1.p1","Cetuximab and Nivolumab in Recurrent/Metastatic Head and Neck Cancer","A multi-center, non-randomized, open label, phase I/II study was conducted at Moffitt Cancer Center, Ohio State University and Emory University. Early results of the clinical trial in recurrent and/or metastatic  (R/M) head and neck squamous cell carcinoma (HNSCC) has been previously published, showing that the combination of cetuximab and nivolumab has","Not Applicable","Head and Neck Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 19 variables, 158 samples sequenced, 41 subjects, 158 samples","","NCI","GRU --- General Research Use","2025-12-19","2025-12-19","Head Neoplasm; Head Neoplasms; Neoplasm, Head; Neoplasms, Head",""
"phs001601.v3.p2","NHLBI TOPMed - NHGRI CCDG: Penn Medicine BioBank Early Onset Atrial    Fibrillation Study","Cases with early-onset atrial fibrillation were selected from the Penn Biobank based on an age of atrial fibrillation onset prior to 61 years of age, and in the absence of  a myocardial infarction, heart failure or severe valvular disease. Principal Investigators: Daniel J. Rader, MD, University of Pennsylvania,","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 25 variables, 2 documents, 2 molecular datasets, 480 samples sequenced, 2210 subjects, 2253 samples","European (443), African (74), African American (1627), Hispanic1 (36), Hispanic2 (4), Other Asian or Pacific Islander (1), Other (8)","NHLBI","HMB-IRB-PUB --- Health/Medical/Biomedical (IRB, PUB)","2025-12-19","2025-12-19","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs001600.v3.p2","NHLBI TOPMed - NHGRI CCDG: Early-onset Atrial Fibrillation in the    CATHeterization GENetics (CATHGEN) Cohort","The CATHeterization GENetics (CATHGEN) biorepository collected biospecimens and clinical data on individuals age &#x02265;18 undergoing cardiac catheterization for concern of ischemic heart disease at a single center (Duke University Medical  Center) from 2000-2010; a total of N 9334 individuals were collected. Samples were matched at the individual level to clinical data collected at the","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 24 variables, 2 documents, 2 molecular datasets, 246 samples sequenced, 1271 subjects, 1411 samples","","NHLBI","DS-CVD-IRB --- Disease-Specific (Cardiovascular Disease, IRB)","2025-12-19","2025-12-19","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs004388.v1.p1","SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with    Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors    (MPNST)","Combined mTOR and MEK inhibition, critical components of the RAS effector pathway underlying the pathogenesis of NF1-related tumors, caused regression in a malignant peripheral nerve sheath tumors (MPNST) transgenic mouse  model. The primary objective of this multi-institutional open label Simon 2 stage phase 2 study of the MEK inhibitor selumetinib and the mTOR","Not Applicable","Neurofibrosarcoma","Clinical Trial","Not Provided","WGS","4 phenotype datasets, 28 variables, 55 samples sequenced, 41 subjects, 55 samples","","NCI","GRU --- General Research Use","2025-12-18","2025-12-18","MPNST; Malignant peripheral nerve sheath tumor; Malignant peripheral nerve sheath tumour; Malignant schwannoma; NEUROFIBROSARCOMA; Neurogenic Sarcoma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003792.v1.p1","Genetic Factors Associated with Anthracycline-Induced Cardiomyopathy    (COG-ALTE03N1)","We investigated the genetic mechanisms underlying anthracycline-induced cardiomyopathy, a serious long-term complication among childhood cancer survivors. We focused on the role of DNA damage response and repair (DDR) genes, which  had not been previously studied in this context. A gene-based and pathway-based approach was applied to assess both the main effects and","Not Applicable","Cardiomyopathies","Case-Control","custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 339 subjects, 339 samples","","NCI","DS-CCA --- Disease-Specific (Childhood Cancers)","2025-12-18","2025-12-18","Cardiomyopathies, Primary; Cardiomyopathy, Primary; Disease, Primary Myocardial; Diseases, Primary Myocardial; Myocardial Disease, Primary; Myocardial Diseases, Primary",""
"phs002387.v2.p1","Ghana Breast Health Study","The Ghana Breast Health Study (GBHS) was a multi-disciplinary, population-based case-control study conducted in Accra and Kumasi, Ghana that was designed to investigate breast cancer etiology especially for more aggressive  breast cancers which are more prevalent in African ancestry women. The study enrolled 2,202 women with lesions suspicious for breast cancer of which","Not Applicable","Breast Neoplasms","Case-Control","Global_Screening_Array-24","SNP/CNV (Array), WGS","4 phenotype datasets, 34 variables, 1 molecular datasets, 30 samples sequenced, 2544 subjects, 2559 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-12-18","2021-05-20","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002844.v1.p1","Phenotype Genotype Biomarkers (PGB)","The Phenotype-Genotype-Biomarker (PGB, or PGB1) study (NCT02327845) of the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium was a natural history and biomarker study of patients  with amyotrophic lateral sclerosis (ALS) or a related disorder, including but not limited to ALS-frontotemporal dementia (ALS-FTD), progressive","Not Applicable","Amyotrophic Lateral Sclerosis","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 21 variables, 1 molecular datasets, 705 subjects, 705 samples","European (583), African (2), East Asian (3), African American (22), Hispanic1 (16), Hispanic2 (37), Other Asian or Pacific Islander (3), South Asian (7), Other (32)","NINDS","GRU --- General Research Use","2025-12-17","2025-12-17","Spastic Paraplegia, Hereditary; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease",""
"phs004345.v1.p1","Host-Specific Effects on Bacterial Modulation of Respiratory Epithelial    Gene Expression and Alternative Splicing","Given the extensive variability inherent to humans and how variable microbiome composition is between individuals, we wanted to investigate inter-individual differences in host response to microbial colonization. Using primary normal  human bronchial epithelial cells from six different adult donors (including both males and females and spanning in age from mid-20s to mid-50s), we","Not Applicable","Respiratory Mucosa","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 267 samples sequenced, 6 subjects, 267 samples","","NIAID","HMB --- Health/Medical/Biomedical","2025-12-16","2025-12-16","Not Provided",""
"phs001434.v3.p1","NHLBI TOPMed: Defining the Time-Dependent Genetic and Transcriptomic    Responses to Cardiac Injury Among Patients with Arrhythmias","The UMMS miRhythm Study is an ongoing study of adult patients undergoing an elective electrophysiology study or arrhythmia ablation procedure for a supraventricular or ventricular arrhythmia, including atrial fibrillation (AF).  Atrial fibrillation is a major clinical and public health problem that is related to atrial pathologic remodeling. Few tools are available to","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS)","4 phenotype datasets, 31 variables, 2 documents, 2 molecular datasets, 65 subjects, 65 samples","","NHLBI","GRU --- General Research Use","2025-12-16","2025-12-16","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001228.v3.p2","Gabriella Miller Kids First (GMKF) Pediatric Research Program in    Susceptibility to Ewing Sarcoma Based on Germline Risk and Familial    History of Cancer","Ewing sarcoma (EWS) is a deadly bone cancer that occurs in children and adolescents. Mounting evidence suggests that a genetic predisposition exists for this pediatric cancer, although the specific genetic  contribution has yet to be identified. EWS has never been linked to a specific cancer predisposition syndrome, although several case reports have","Not Applicable","Sarcoma, Ewing","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1332 subjects, 1505 samples","","NCI","GRU --- General Research Use","2025-12-16","2018-06-18","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000280.v9.p3","Atherosclerosis Risk in Communities (ARIC) Cohort","The Atherosclerosis Risk in Communities (ARIC) Study, sponsored by the National Heart, Lung and Blood Institute (NHLBI), is a prospective epidemiologic study conducted in four U.S. communities. The four communities  are Forsyth County, NC; Jackson, MS; the northwest suburbs of Minneapolis, MN; and Washington County, MD. ARIC is designed to investigate the","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Affymetrix_WG_Array, CVDSNP55, imputation_panel, WES_markerset_grc37, Cardio-Metabo_Chip, WES_markerset_grc36, other, target_markerset_grc37, Illumina_Exome_Array, WGS_markerset_grc37, WGS_markerset_grc38, SomaScan","Not Provided","398 phenotype datasets, 31705 variables, 357 documents, 11750 samples sequenced, 15687 subjects, 57266 samples, 9 substudies","","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-12-16","2025-12-16","Atherosclerosis; Diabetes Mellitus; Heart Diseases; Heart Failure, Congestive; Hypertension; Myocardial Infarction",""
"phs003946.v1.p3","Atherosclerosis Risk in Communities - Imaging","The Atherosclerosis Risk in Communities (ARIC) Study, sponsored by the National Heart, Lung and Blood Institute (NHLBI), is a prospective epidemiologic study conducted in four U.S. communities. The four communities  are Forsyth County, NC; Jackson, MS; the northwest suburbs of Minneapolis, MN; and Washington County, MD. ARIC is designed to investigate the","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v9.p3)","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","15277 samples","","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-12-16","2025-12-16","Atherosclerosis; Diabetes Mellitus; Heart Diseases; Heart Failure, Congestive; Hypertension; Myocardial Infarction",""
"phs003388.v1.p3","Proteomic Longitudinal ARIC Study: SOMAscan of Multiple Visits","This substudy phs003388 ARIC SomaScan contains selected phenotype of subjects available from the phs003388 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants can be viewed at the  top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study and substudy are","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v9.p3)","Proteomics","Prospective Longitudinal Cohort","SomaScan","Proteomics","1 phenotype datasets, 4 variables, 1 molecular datasets, 15636 subjects, 15636 samples","","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-12-16","2025-12-16","Not Provided",""
"phs001536.v4.p3","Center for Common Disease Genomics: Atherosclerosis Risk in Communities    (ARIC) Study","This sub-study phs001536 CCDG_ARIC contains genotype, sequence data, and selected phenotype of subjects available from the phs001536 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants can be  viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study and","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v9.p3)","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP Genotypes (NGS)","2 phenotype datasets, 9 variables, 1 molecular datasets, 2630 subjects, 2630 samples","European (2298), African (13), African American (437), Hispanic1 (4), Hispanic2 (1)","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-12-16","2025-12-16","Cerebrovascular Disorders; Heart Diseases; Heart Failure; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs000860.v7.p3","MIchigan-CORnell-TEXas (MICORTEX) - Estimating the Contribution of the    Network of DNA Sequence Variations to the Prediction of CHD and    Diabetes","This sub-study phs000860 MICORTEX contains genotype and selected phenotype of subjects available from the phs000860 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants can be viewed at  the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study and sub-study","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v9.p3)","Coronary Disease","Prospective Longitudinal Cohort","other","Legacy Genotypes","1 phenotype datasets, 4 variables, 1 molecular datasets, 6876 subjects, 6876 samples","","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-12-16","2025-12-16","Diabetes Mellitus; CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary",""
"phs000668.v7.p3","Building on GWAS: the U.S. CHARGE consortium - Sequencing (CHARGE-S):    ARIC","This sub-study phs000668 CHARGE-S Atherosclerosis Risk in Communities (ARIC) contains whole genome, whole exome, and targeted sequencing data, and exome SNP array data, produced as part of NHLBI's CHARGE-S project  for subjects available from the phs000668 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants can be viewed at the top-level","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v9.p3)","Atherosclerosis","Case Set","target_markerset_grc37, Illumina_Exome_Array, WGS_markerset_grc37, WES_markerset_grc37","SNP Genotypes (Array), SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WGS, WXS","6 phenotype datasets, 72 variables, 4 molecular datasets, 10944 samples sequenced, 14202 subjects, 14202 samples","European (1696), African (57), African American (1806), Hispanic1 (14), Hispanic2 (4), Other (3)","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-12-16","2025-12-16","Atrial Fibrillation; Cardiovascular Diseases; Heart Failure; Hypertension; Osteoporosis; Pulmonary Disease, Chronic Obstructive",""
"phs000557.v8.p3","NHLBI Atherosclerosis Risk in Communities (ARIC) Candidate Gene    Association Resource (CARe)","This sub-study phs000557 ARIC_CARe contains genotype derived from sequence data and selected phenotype of subjects available from the phs000557 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants  can be viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v9.p3)","Atherosclerosis","Case-Control","CVDSNP55","SNP Genotypes (Array)","2 phenotype datasets, 97 variables, 1 molecular datasets, 13856 subjects, 13908 samples","","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-12-16","2025-12-16","Diabetes Mellitus; Heart Diseases; Heart Failure, Congestive; Hypertension; Myocardial Infarction; Risk Factors",""
"phs000398.v9.p3","National Heart Lung and Blood Institute (NHLBI) GO-ESP: Heart Cohorts    Component of the Exome Sequencing Project (ARIC)","This sub-study phs000398 HeartGO_ARIC contains genotype derived from sequence data and selected phenotype of subjects available from the phs000398 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants  can be viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v9.p3)","Cardiovascular Diseases","Case-Control","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS, SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 127 variables, 3 molecular datasets, 806 samples sequenced, 806 subjects, 806 samples","","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-12-16","2025-12-16","Brain Ischemia; Myocardial Infarction; Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies",""
"phs000223.v9.p3","Population Architecture using Genomics and Epidemiology (PAGE): Causal    Variants Across the Life Course (CALiCo): Atherosclerosis Risk in    Communities (ARIC)","This sub-study phs000223 PAGE CALiCo ARIC contains genotype data and selected phenotype of subjects available from the phs000223. Summary level phenotypes for the NHLBI ARIC Cohort study participants can be  viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study and","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v9.p3)","Cardiovascular Diseases","Prospective Longitudinal Cohort","Cardio-Metabo_Chip","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 4 analyses, 1 molecular datasets, 3122 subjects, 3212 samples","","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-12-16","2025-12-16","Coronary Disease; Gout; Myocardial Infarction; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs000090.v9.p3","GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study","This sub-study phs000090 GENEVA ARIC contains genotype data and selected phenotype of subjects available from the phs000090 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants can be  viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study and","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v9.p3)","Cardiovascular Diseases","Case-Control","Affymetrix_WG_Array, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed), SNP Genotypes (Array), SNP Genotypes (imputed)","2 phenotype datasets, 366 variables, 166 documents, 3 molecular datasets, 12220 subjects, 12540 samples","European (9590), African (112), East Asian (1), African American (3003), Hispanic1 (34), Hispanic2 (20), Other Asian or Pacific Islander (1), South Asian (2), Other (8)","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-12-16","2025-12-16","Atherosclerosis; Diabetes Mellitus; Heart Diseases; Heart Failure, Congestive; Hypertension; Myocardial Infarction",""
"phs000997.v6.p3","NHLBI TOPMed - NHGRI CCDG: The Vanderbilt AF Ablation Registry","The Vanderbilt Atrial Fibrillation Ablation Registry (VAFAR) was founded in 2011. Patients with AF referred for AF ablation are prospectively enrolled. A detailed clinical history is recorded, along with imaging  data (cardiac MRI or CT). Blood samples are obtained for DNA extraction at the time of ablation. Details of the ablation procedure are recorded.","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 31 variables, 2 documents, 2 molecular datasets, 171 samples sequenced, 171 subjects, 171 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-12-12","2025-12-12","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs000179.v7.p2","Genetic Epidemiology of COPD (COPDGene) Funded by the National Heart,    Lung, and Blood Institute","Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States and the only leading cause of death that is steadily increasing in frequency. This  project will establish a racially diverse cohort that is sufficiently large and appropriately designed for genome-wide association analysis of COPD.","Not Applicable","Pulmonary Disease, Chronic Obstructive","Case-Control","HumanOmni1-Quad, WES_markerset_grc37","Not Provided","5 phenotype datasets, 1026 variables, 16 documents, 4 analyses, 12103 images, 823 samples sequenced, 10719 subjects, 34979 samples, 3 substudies","","NHLBI","HMB --- Health/Medical/Biomedical, DS-CS --- Disease-Specific (COPD and Smoking)","2025-12-12","2025-12-12","Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs004023.v1.p2","Genetic Epidemiology of COPD (COPDGene) Imaging Data","This study contains CT imaging files, obtained at each of the on-site visits. Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States and  the only leading cause of death that is steadily increasing in frequency. This project established a racially diverse cohort that is sufficiently","Genetic Epidemiology of COPD (COPDGene) Funded by the National Heart, Lung, and Blood Institute (phs000179.v7.p2)","Pulmonary Disease, Chronic Obstructive","Case-Control","Not Provided","Not Provided","19422 samples","","NHLBI","HMB --- Health/Medical/Biomedical, DS-CS --- Disease-Specific (COPD and Smoking)","2025-12-12","2025-12-12","Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD",""
"phs000765.v4.p2","Genetic Epidemiology of COPD (COPDGene) Genetic Analysis","This sub-study phs000765 COPDGene_Geno contains genotype of subjects available from the phs000765 study. Summary level phenotypes for the NHLBI COPDGene Cohort study participants can be viewed at the top-level study  page phs000179 COPDGene_v5 Cohort. Individual level phenotype data and molecular data for all COPDGene Cohort top-level study and sub-study are","Genetic Epidemiology of COPD (COPDGene) Funded by the National Heart, Lung, and Blood Institute (phs000179.v7.p2)","Pulmonary Disease, Chronic Obstructive","Case-Control","HumanOmni1-Quad, WES_markerset_grc37","SNP Genotypes (Array), RNA-Seq, SNP Genotypes (NGS)","1 phenotype datasets, 6 variables, 2 analyses, 3 molecular datasets, 534 samples sequenced, 10274 subjects, 15557 samples","European (6641), African (96), African American (3176), Hispanic1 (36), Hispanic2 (15), Other Asian or Pacific Islander (2), Other (18)","NHLBI","HMB --- Health/Medical/Biomedical, DS-CS --- Disease-Specific (COPD and Smoking)","2025-12-12","2025-12-12","Pulmonary Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD",""
"phs000296.v6.p2","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (COPDGene)","This sub-study phs000296 ESP LungGO COPDGene contains genotype derived from sequence data and selected phenotype of subjects available from the phs000179 COPDGene_v6 study. Summary level phenotypes for the NHLBI COPDGene  Cohort study participants can be viewed at the top-level study page. Individual level phenotype data and molecular data for all COPDGene Cohort","Genetic Epidemiology of COPD (COPDGene) Funded by the National Heart, Lung, and Blood Institute (phs000179.v7.p2)","Pulmonary Disease, Chronic Obstructive","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS), WXS","2 phenotype datasets, 20 variables, 2 molecular datasets, 289 samples sequenced, 289 subjects, 289 samples","","NHLBI","HMB --- Health/Medical/Biomedical, DS-CS --- Disease-Specific (COPD and Smoking)","2025-12-12","2025-12-12","Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD",""
"phs004294.v1.p1","Comparison of Oral Collection Methods for 16S rRNA Gene and Shotgun    Metagenomic Sequencing","We investigated how different sample collection methods affect oral microbiome studies by comparing unpreserved saliva, saliva preserved in glycerol, and mouthwash samples. We assessed their stability at room temperature and  their intraindividual stability over six months. Samples were collected from 20 healthy participants at two time points six months apart; saliva","Not Applicable","Microbiota","Methods","Not Provided","WGS","4 phenotype datasets, 21 variables, 180 samples sequenced, 20 subjects, 180 samples","","NCI","GRU --- General Research Use","2025-12-10","2025-12-10","Not Provided",""
"phs003889.v1.p1","Pursuing Molecular Biomarkers to Guide Adjuvant Therapy for HPV+ Head and    Neck Cancers After Transoral Robotic Surgery","Human papillomavirus-positive oropharyngeal squamous cell carcinomas (HPV+ OPSCCs) represent a distinct subset of head and neck cancers that are rapidly increasing in incidence. Despite the generally favorable prognosis of HPV+  OPSCCs, compared to HPV-negative counterparts, due to higher treatment responsiveness and improved survival, a subset of patients experiences disease","Not Applicable","Oropharyngeal Neoplasms","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 99 samples sequenced, 99 subjects, 99 samples","","NCI","GRU --- General Research Use","2025-12-10","2025-12-10","Recurrence; Neoplasm of Oropharynx; Neoplasm of the Oropharynx; Neoplasm, Oropharyngeal; Neoplasm, Oropharynx; Neoplasms, Oropharyngeal",""
"phs003715.v1.p1","Mutation Patterns Predict Drug Response in Acute Myeloid Leukemia","As part of a study correlating co-occurring mutations in Acute Myeloid Leukemia (AML) with drug sensitivity, we performed single cell mutation analysis to document the subclonal composition for 8 patient  samples (blood or marrow mononuclear cells) of the 99 patients studied. We utilized the Tapestri Single Cell DNA plus Protein Sequencing Kit","Not Applicable","Leukemia, Myeloid, Acute","Case Set","Not Provided","AMPLICON, OTHER","4 phenotype datasets, 21 variables, 8 samples sequenced, 8 subjects, 8 samples","","NCI","DS-LEU-IRB --- Disease-Specific (Leukemia, IRB)","2025-12-10","2025-12-10","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs004195.v1.p1","Nanobioreactor Detection of Space-Associated Hematopoietic Stem and    Progenitor Cell Aging","This study examined the effects of exposure to low-Earth orbit (LEO) on hematopoietic stem and progenitor cell function, gene expression, telomere length, mutation burden, and ADAR1 isoform expression, evaluated 32-45  days post-spaceflight compared to ground control in 3D nanobioreactors. Enriched CD34+ hematopoietic stem and progenitor cells (HSPCs) derived from","Not Applicable","Hematopoietic Stem Cells","Case-Control","target_markerset_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 15 variables, 1 molecular datasets, 36 samples sequenced, 13 subjects, 36 samples","","NCI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-12-09","2025-12-09","Not Provided",""
"phs003107.v1.p1","Testicular Cancer Consortium WES","We have leveraged our previous collaborative research to better understand the genetic underpinnings of testicular germ cell tumor (TGCT), and have completed whole exome sequencing on the DNA of patients  at high risk for TGCT. Specifically, we conducted a study of high-risk individuals using data from Penn Medicine and the NCI. We collected germline","Not Applicable","Testicular Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 22 variables, 327 samples sequenced, 327 subjects, 327 samples","","NCI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2025-12-09","2025-12-09","Neoplasm of Testis; Neoplasm of the Testis; Neoplasm, Testicular; Neoplasm, Testis; Neoplasms, Testicular; Neoplasms, Testis",""
"phs004095.v1.p1","A Phase Ib Study of Sapacitabine and Olaparib in Patients With    BRCA1/2-Mutated (BRCA1/2m) Metastatic Breast Cancer","PARP inhibitors significantly extend progression-free survival (PFS), compared to chemotherapy in patients with germline BRCA1/2 (gBRCA1/2)-mutated HER2-negative metastatic breast cancer, but responses are not durable. Preclinical studies suggest that sapacitabine,  an oral nucleoside analog, is synergistic with PARP inhibition in cell lines harboring homologous recombination repair (HRR) defects. To translate","Not Applicable","Breast Neoplasms","Case Set","custom_markerset","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 23 variables, 1 molecular datasets, 10 subjects, 35 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-12-08","2025-12-08","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs004123.v1.p1","SWOG S1512: A Phase II Study of PD-1 Blockade with Pembrolizumab In    Patients with Locally Advanced and Metastatic Desmoplastic Melanoma","SWOG S1512 (NCT02775851) was a phase II trial designed to evaluate how well pembrolizumab works in treating patients with desmoplastic melanoma (DM) that can be removed by surgery (resectable; Cohort  A) or cannot be removed by surgery (unresectable; Cohort B). Biopsies were collected before (baseline) and during (on-therapy) treatment, as well as","Not Applicable","Melanoma","Clinical Trial","Not Provided","WXS","4 phenotype datasets, 17 variables, 51 samples sequenced, 20 subjects, 51 samples","","NCI","GRU --- General Research Use","2025-12-04","2025-12-04","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002465.v2.p1","The Human Pancreas Analysis Program (HPAP)","The past decade has seen a dramatic improvement in our ability to phenotype and molecularly profile human tissues with unprecedented resolution at the genomic, epigenomic, protein, and functional levels. The  Human Pancreas Analysis Program (HPAP), part of the Human Islet Research Network and supported by the National Institute of Diabetes and Digestive","Not Applicable","Diabetes Mellitus","Case-Control","other, WGS_markerset_grc38","Bisulfite-Seq, OTHER, SNP/CNV Genotypes (NGS), SNV (.MAF), WGS","4 phenotype datasets, 30 variables, 2 molecular datasets, 326 samples sequenced, 164 subjects, 406 samples","","NIDDK","GRU --- General Research Use","2025-12-04","2025-12-04","Diabetes Mellitus, Type 1; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001798.v3.p2","A New Reference Panel to Boost African American Genotype Imputation","Modern genetic studies have been conducted predominantly in cohorts of individuals of European ancestry. By 2010, there were approximately ten times as many published genome wide association studies (GWAS) in  people of European ancestry than studies in people of all other ancestries combined. This research disparity has led to an uneven understanding of","Not Applicable","Black or African American","Cross-Sectional","WGS_markerset_grc38, imputation_panel","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 6 variables, 1 molecular datasets, 2294 samples sequenced, 2294 subjects, 2294 samples","","NHGRI","HGV-IRB-PUB-NPU --- Human Genetic Variation Research (IRB, PUB, NPU)","2025-12-03","2021-07-29","Not Provided",""
"phs004279.v1.p1","African American Cardiovascular Pharmacogenomics Consortium (ACCOuNT)","The African American Cardiovascular Pharmacogenomics Consortium (ACCOuNT) assembled an observational cohort to characterize genetic and clinical determinants of inter&#x02011;individual variability in warfarin dose requirements among participants of African ancestry receiving  anticoagulation care. The submission includes individual&#x02011;level genotypes in PLINK format (.bed/.bim/.fam) and a harmonized phenotype file","Not Applicable","Warfarin","Cross-Sectional","Multi-Ethnic_Global","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 309 subjects, 309 samples","","NIMHD","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2025-12-02","2025-12-02","Not Provided",""
"phs004176.v1.p1","Enabling Whole Genome Sequencing Analysis from FFPE Specimens in Clinical    Oncology","This study includes whole genome sequencing from 44 pediatric patients at Memorial Sloan Kettering derived from formalin-fixed paraffin-embedded (FFPE) tissue. This dataset was used to train and validate a classification  strategy called FFPErase for detecting artifact mutations from FFPE damage. First Author Investigator: Dylan Domenico, Memorial Sloan Kettering","Not Applicable","Whole Genome Sequencing","Case Set","Not Provided","WGS","3 phenotype datasets, 9 variables, 79 samples sequenced, 44 subjects, 79 samples","","NCI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2025-12-02","2025-12-02","Not Provided",""
"phs004037.v1.p1","Genome-Wide Association Study for Glucocorticoid-Induced Ocular    Hypertension","We aim to identify genetic variants associated with glucocorticoid (GC)-induced intraocular pressure (IOP) change utilizing genome-wide association study (GWAS) and whole exome sequencing (WES) analyses. The primary outcome was IOP  change from baseline to the maximum IOP measurement within 6 months of GC treatment. Study participants were derived from two cohorts: the","Not Applicable","Genome-Wide Association Study","Case-Control","WES_markerset_grc38, Global_Screening_Array-24","SNP/CNV Genotypes (imputed), SNP/CNV Genotypes (NGS), Targeted-Capture","5 phenotype datasets, 71 variables, 1 molecular datasets, 1135 samples sequenced, 1142 subjects, 2270 samples","","NEI","GRU --- General Research Use, DS-ED --- Disease-Specific (Eye Disease)","2025-12-02","2025-12-02","Ocular Hypertension; Glaucoma, Suspect; Glaucomas, Suspect; Suspect Glaucoma; Suspect Glaucomas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002621.v2.p1","CIDR: NINDS High Throughput Genotyping Resource Access for Structural    Hindbrain Disorders","Recessive forms for many structural brain disorders (SBDs), including cerebellar hypoplasia (CBH), corpus callosum hypoplasia (CCH), cobblestone lissencephaly (COB), classical lissencephaly (LIS), microcephaly (MIC), and pontocerebellar hypoplasia (PCH), have been  described. Patients usually present to the clinic with neurodevelopmental disorders (NDDs), including autism, epilepsy, intellectual disability, and","Not Applicable","Brain Diseases","Case-Control","HumanCoreExome-24, WGS_markerset_grc38","SNP/CNV (Array), SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 21 variables, 2 molecular datasets, 93 samples sequenced, 593 subjects, 603 samples","","NINDS","GRU --- General Research Use","2025-12-02","2025-12-02","Classical Lissencephaly; Cobblestone Lissencephaly; Meningomyelocele; Microcephaly; Brain Disease; Brain Disorders",""
"phs003955.v1.p1","Transcriptomic Profiling of Lung Adenocarcinoma From Never-Smokers","Lung adenocarcinoma in people who have never smoked (NS-LUAD) has a high mortality rate. Knowing NS-LUAD phenotypic plasticity and cell composition can provide guidance for prognosis and treatment. This study  comprises large RNA-seq data set from 684 tumor samples from NS-LUAD, including 610 from the Sherlock-Lung Study and 74 downloaded from the public","Not Applicable","Adenocarcinoma of Lung","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 610 samples sequenced, 610 subjects, 610 samples","","NCI","GRU --- General Research Use, GRU-IRB --- General Research Use (IRB), HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-NPU --- Health/Medical/Biomedical (NPU), DS-LC --- Disease-Specific (Lung Cancer), DS-LC-IRB-NPU --- Disease-Specific (Lung Cancer, IRB, NPU), DS-LC-NPU --- Disease-Specific (Lung Cancer, NPU)","2025-11-26","2025-11-26","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs001003.v4.p1","Prospective Procurement of Solid Tumor Tissue to Identify Novel    Therapeutic Targets","Recent advances and insights into the molecular pathogenesis of cancer have led to the development of novel molecular and biologic targeted therapies for the treatment of advanced cancer patients. A  critical challenge in extending these studies involves the identification and validation of new therapeutic targets for future cancer therapies. In","Not Applicable","Melanoma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WGS, WXS","5 phenotype datasets, 15 variables, 1161 samples sequenced, 219 subjects, 1163 samples","","NCI","GRU --- General Research Use","2025-11-25","2020-12-23","Esophageal Neoplasms; Paraneoplastic Syndromes, Ocular; Rectal Neoplasms; Bile duct cancer; CC; CCA","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003759.v1.p1","Dysregulation of Alternative Splicing Is a Transcriptomic Feature of    Patient Derived Fibroblasts From CAG Repeat Expansion Spinocerebellar    Ataxias","The aim of this study was to characterize transcriptomic changes in patient-derived cell lines of CAG repeat expansion spinocerebellar ataxias (SCAs), using RNA-sequencing (RNA-Seq), to help us better understand disease  pathogenesis. The data consists of two SCA1, two SCA3, and one SCA7 cell lines with 5 unaffected controls. Widespread alternative splicing","Not Applicable","Spinocerebellar Ataxias","Case-Control","Not Provided","RNA-Seq","5 phenotype datasets, 20 variables, 11 samples sequenced, 11 subjects, 11 samples","","NINDS","HMB-NPU --- Health/Medical/Biomedical (NPU)","2025-11-24","2025-11-24","Ataxias, Spinocerebellar; Atrophies, Spinocerebellar; Atrophy, Spinocerebellar; Spinocerebellar Atrophies; Spinocerebellar Atrophy; Spinocerebellar Degeneration",""
"phs003751.v1.p1","Dynamic Evolution of Fibroblasts Revealed by Single Cell RNA Sequencing    of Human Pancreatic Cancer","Understanding the constituents of the pancreatic ductal adenocarcinoma (PDAC) microenvironment may illuminate more efficacious targets for treating this aggressive malignancy. However, the compositional changes occurring in untreated and treated PDAC  relative to both normal and inflamed pancreas have not been well characterized. To provide a more comprehensive understanding of the PDAC tumor","Not Applicable","Pancreatic Neoplasms","Collection","Not Provided","RNA-Seq, ssRNA-seq","4 phenotype datasets, 14 variables, 36 samples sequenced, 19 subjects, 36 samples","","NCI","GRU --- General Research Use, DS-PAD --- Disease-Specific (Pancreatic Disease)","2025-11-24","2025-11-24","Pancreatitis; Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas",""
"phs002988.v2.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R):    Atherosclerosis Risk in Communities Study (ARIC)","Cohort Description The Atherosclerosis Risk in Communities (ARIC) study began in the mid-1980s with the initial aims being to describe the presence of subclinical atherosclerosis, the progression of atherosclerosis to  clinical cardiovascular disease (CVD), and the association of novel risk factors with CVD. ARIC recruited its cohort of men and women aged 45-64 in","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 6523 subjects, 6523 samples","","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2025-11-21","2023-11-06","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003970.v1.p1","A Therapeutic Vaccine for Fibrolamellar Hepatocellular Carcinoma","Fibrolamellar hepatocellular carcinoma (FLC) is a rare form of liver cancer affecting 33 children and young adults that is driven by a chimeric protein, DNAJ-PKAc. We conducted a phase 1  clinical trial of a therapeutic vaccine targeting DNAJ-PKAc 38 (FLC-Vac), in combination with nivolumab and ipilimumab, in children and adults with","Not Applicable","Receptors, Antigen, T-Cell","Clinical Trial","Not Provided","AMPLICON, RNA-Seq","4 phenotype datasets, 20 variables, 57 samples sequenced, 12 subjects, 57 samples","","NCI","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2025-11-20","2025-11-20","Not Provided",""
"phs003821.v1.p1","OurHealth - Cardiovascular Disease in South Asians","The OurHealth Study aims to build a biobank comprised of South Asian samples from participants residing in the United States. Primary objectives are to (1) identify genetic and non-genetic drivers  of cardiometabolic disease in South Asians, (2) engage participants and researchers in scientific advances and research opportunities to accelerate","Not Applicable","Coronary Disease","Cross-Sectional","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 621 subjects, 621 samples","","NHGRI","GRU --- General Research Use","2025-11-20","2025-11-20","Risk Factors; CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary",""
"phs004310.v1.p1","Women's Ischemia Syndrome Evaluation (WISE-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: This  is a National Heart, Lung and Blood Institute sponsored, four-center study designed to: 1) optimize symptom evaluation and diagnostic testing for","Not Applicable","Angina Pectoris","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1024 subjects, 1024 samples","","NHLBI","GRU --- General Research Use","2025-11-19","2025-11-19","Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia; AP - Angina pectoris; Angina",""
"phs004276.v1.p1","A Case Controlled Etiologic Study of Sarcoidosis (ACCESS-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Access to  Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from (ACCESS)","Not Applicable","Lung Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1404 subjects, 1404 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-11-19","2025-11-19","Sarcoidosis; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders",""
"phs004102.v1.p1","Genomic Copy-Number Variants Drive Apoptotic Resistance and Relapses on    Immune Checkpoint Inhibitors","We investigated the genomic mechanisms underlying acquired resistance (AR) to immune checkpoint inhibitors (ICIs) across tumor types, specifically by examining how copy number variant (CNV)-driven subclonal evolution contributes to clinical  relapses in melanoma patients. We analyzed longitudinal clinical melanoma samples from patients who experienced relapses on ICI therapy, complemented","Not Applicable","Melanoma","Case-Control","Not Provided","WGS","4 phenotype datasets, 18 variables, 7 samples sequenced, 3 subjects, 7 samples","","NCI","GRU --- General Research Use","2025-11-19","2025-11-19","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs003921.v1.p1","Molecular Correlatives from SU2C-SARC032","SU2C-SARC032 was a phase II international, randomized trial for patients with localized, high-risk undifferentiated pleomorphic sarcoma or dedifferentiated or pleomorphic liposarcoma of the extremity and limb girdle. On the trial,  the addition of perioperative pembrolizumab to preoperative radiotherapy and surgery improved disease-free survival compared to preoperative","Not Applicable","Sarcoma","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 189 samples sequenced, 119 subjects, 189 samples","","NCI","GRU --- General Research Use","2025-11-19","2025-11-19","Sarcoma, Spindle Cell; Sarcomas, Spindle Cell; Spindle Cell Sarcomas; spindle cell sarcoma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003463.v5.p4","NIH RECOVER: A Multi-Site Observational Study of Post-Acute Sequelae of    SARS-CoV-2 Infection in Adults","The NIH Researching COVID to Enhance Recovery (RECOVER) initiative comprises a set of three combined retrospective and prospective, longitudinal, observational meta-cohort studies with nested case-control studies designed to define and  characterize the epidemiology, natural history, clinical spectrum, and underlying mechanisms of post-acute effects of SARS-CoV-2 infection (PASC or","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2 documents, 15156 subjects, 15156 samples","","NHLBI","GRU --- General Research Use","2025-11-19","2024-04-05","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003461.v3.p3","NIH RECOVER-Pediatric: Understanding the Long-Term Impact of COVID on    Children and Families","The NIH Researching COVID to Enhance Recovery (RECOVER) initiative comprises a set of three combined retrospective and prospective, longitudinal and observational meta-cohort studies with nested case-control studies designed to define  and characterize the epidemiology, natural history, clinical spectrum, and underlying mechanisms of post-acute effects of SARS-CoV-2 infection (PASC","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 4 documents, 25155 subjects, 25155 samples","","NHLBI","GRU --- General Research Use","2025-11-19","2024-10-16","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs004254.v1.p1","Heart Failure Network - Imaging from Nitrate's Effect on Activity    Tolerance in Heart Failure with Preserved Ejection Fraction (HFN    NEAT-Imaging)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  determine the effect of isosorbide mononitrate on daily activity in patients with heart failure and preserved ejection fraction. Background: Nitrates","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 110 subjects, 110 samples","","NHLBI","GRU --- General Research Use","2025-11-18","2025-11-18","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac",""
"phs002440.v3.p1","Parallel CRISPR Editing of Familial ALS Mutations","Induced pluripotent stem cells (iPSCs) provide a modeling system for human disease within the critical context of the human genome. CRISPR editing of iPSCs allows the construction of isogenic pairs  where the cells have nearly identical genomes except for the desired edited change. Here, we used CRISPR editing on a healthy control line to","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","Not Provided","OTHER, RNA-Seq, WXS","4 phenotype datasets, 16 variables, 94 samples sequenced, 3 subjects, 94 samples","","NINDS","HMB --- Health/Medical/Biomedical","2025-11-18","2021-06-17","ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease; Disease, Lou-Gehrigs",""
"phs001215.v5.p2","NHLBI TOPMed: San Antonio Family Heart Study (SAFHS)","The San Antonio Family Heart Study (SAFHS) is a complex pedigree-based mixed longitudinal study designed to identify low frequency or rare variants influencing susceptibility to cardiovascular disease, using whole genome  sequence (WGS) information from 2,590 individuals in large Mexican American pedigrees from San Antonio, Texas. The major objectives of this study are","Not Applicable","Cardiovascular Diseases","Family/Twin/Trios","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","5 phenotype datasets, 47 variables, 2 documents, 2 molecular datasets, 1829 samples sequenced, 2594 subjects, 2682 samples","European (12), East Asian (1), Hispanic1 (1), Hispanic2 (1755), Other (9)","NHLBI","DS-DHD-IRB-PUB-MDS-RD --- Disease-Specific (Diabetes and Heart Disease, IRB, PUB, MDS, RD)","2025-11-18","2025-11-18","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs004203.v1.p1","Sickle Cell Disease Implementation Consortium Registry (SCDIC    Registry-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  understand the barriers to care and other factors related to reduced healthcare utilization after the transition from pediatric to adult SCD care","Not Applicable","Anemia, Sickle Cell","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2445 subjects, 2445 samples","","NHLBI","GRU --- General Research Use","2025-11-17","2025-11-17","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S",""
"phs004183.v1.p1","Psychophysiological Investigation of Myocardial Ischemia (PIMI-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  investigate psychophysiological factors related to both symptomatic and asymptomatic cardiac ischemia. Background: An important hypothesis has been","Not Applicable","Myocardial Ischemia","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 196 subjects, 196 samples","","NHLBI","GRU --- General Research Use","2025-11-17","2025-11-17","Cardiac ischemia; Disease, Ischemic Heart; Diseases, Ischemic Heart; Heart Disease, Ischemic; Heart Diseases, Ischemic; IHD",""
"phs004178.v1.p1","NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural    History Study","NCCAPS is a longitudinal prospective cohort study designed to assess patient, disease and treatment factors associated with short- and long-term outcomes in patients with cancer who develop COVID-19. We also  aimed to describe COVID-19 symptoms and treatments, and to describe disruptions in cancer treatment due to COVID-19. The study enrolled patients with","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 1572 subjects, 1572 samples","","NCI","GRU --- General Research Use","2025-11-17","2025-11-17","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs001287.v22.p7","CPTAC Proteogenomic Study","Recently, significant progress has been made in characterizing and sequencing the genomic alterations in statistically robust numbers of samples from several types of cancer. For example, The Cancer Genome Atlas  (TCGA), International Cancer Genome Consortium (ICGC) and other similar efforts are identifying genomic alterations associated with specific cancers","Not Applicable","Neoplasms","Case Set","Not Provided","Not Provided","3 phenotype datasets, 11 variables, 7239 subjects, 7239 samples","","NCI","GRU --- General Research Use","2025-11-17","2023-06-29","Lung Neoplasms; Sarcoma; Uterine Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs004314.v1.p1","Study of Clinical Efficacy of Antimicrobial Therapy Strategy Using    Pragmatic Design in Idiopathic Pulmonary Fibrosis (CleanUP    IPF-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives To  investigate whether the addition of antimicrobial treatments improves outcomes compared to usual care alone among patients with idiopathic pulmonary","Not Applicable","Idiopathic Pulmonary Fibrosis","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 513 subjects, 513 samples","","NHLBI","GRU --- General Research Use","2025-09-30","2025-09-30","Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary; FIBROCYSTIC PULMONARY DYSPLASIA; FIBROSING ALVEOLITIS, CRYPTOGENIC; Fibrocystic Pulmonary Dysplasias",""
"phs004269.v1.p1","Single-Cell Multiomics of the Immune Microenvironment in T-Cell Acute    Lymphoblastic Leukemia","We present single-cell transcriptome and surface protein expression (CITE-seq) data from four healthy donors and fifteen pediatric T cell acute lymphoblastic leukemia (T-ALL) patients at diagnosis and at different treatment  timepoints (days 1 &#x02013; 6 and at time of remission). Mononuclear cells from peripheral blood (PB; longitudinal) or bone marrow (BM; diagnosis","Not Applicable","Leukemia, T-Cell","Case-Control","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 17 variables, 66 samples sequenced, 35 subjects, 66 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-09-30","2025-09-30","Leukemia, Lymphocytic, T Cell; Leukemia, Lymphocytic, T-Cell; Leukemia, T Cell; Leukemia, T Lymphocytic; Leukemia, T-Cell Lymphocytic; Leukemia, T-Lymphocytic",""
"phs004267.v1.p1","Space Associated Stem Cell Hallmarks of Aging in Astronauts","This study examined the effects of the stress of space, specifically low earth orbit, on hematopoietic stem and progenitor cells (HSPCs) that maintain lifelong hematopoiesis and immune responses. Enriched CD34+  HSPCs were derived from 7 astronauts before, during and after 10 and 21-day ISS missions on the International Space Station. The samples were used as","Not Applicable","Hematopoietic Stem Cells","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 91 samples sequenced, 7 subjects, 91 samples","","NCI","HMB-IRB-COL-NPU --- Health/Medical/Biomedical (IRB, COL, NPU)","2025-09-30","2025-09-30","Aging; Aging, Biological; Biological Aging",""
"phs004223.v1.p1","The Adhesion GPCR ADGRL2 Engages Galpha13 to Enable Epidermal    Differentiation","We sought to determine the role of ADGRL2 in epidermal homeostasis. Primary neonatal foreskin keratinocytes were obtained from discarded surgical samples at a California hospital. Samples were anonymous and not  selected. ADGRL2, working through GNA13, was found to promote epidermal differentiation through the ADGRL2 intracellular loop 3 (ICL3) loop, using","Not Applicable","Epidermis","Collection","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 17 variables, 49 samples sequenced, 6 subjects, 49 samples","","NIAMS","GRU --- General Research Use","2025-09-30","2025-09-30","Not Provided",""
"phs003892.v1.p1","Multiomic Landscape of Multiple Myeloma Precursor and Relapsed Disease","Multiple myeloma (MM) is a treatable, though incurable, plasma cell malignancy. The molecular mechanisms driving disease onset and the emergence of drug resistance remain elusive. To better characterize the mutational,  transcriptional, and epigenetic alterations that accompany MM disease evolution, we accessed molecular data from MM patients treated at Moffitt","Not Applicable","Multiple Myeloma","Clinical Trial","Not Provided","ATAC-seq, OTHER, RNA-Seq","4 phenotype datasets, 24 variables, 88 samples sequenced, 41 subjects, 88 samples","","NCI","GRU --- General Research Use","2025-09-30","2025-09-30","Monoclonal Gammopathy of Undetermined Significance; Smoldering Multiple Myeloma; Asymptomatic monoclonal gammopathy; Benign Monoclonal Gammapathies; Benign Monoclonal Gammapathy; Benign Monoclonal Gammopathies",""
"phs003659.v2.p2","Exome Sequencing of Alcohol-Associated Hepatitis","Alcoholic hepatitis (AH) is a clinically severe, acute disease that only afflicts a fraction of patients with alcohol use disorder (AUD). Although recent genomic studies of alcoholic cirrhosis (AC) and  steatosis have revealed that several genes of large effect are shared between these disorders, the genetic and environmental sources of variation","Not Applicable","Hepatitis, Alcoholic","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 24 variables, 1213 samples sequenced, 1213 subjects, 1213 samples","","NIAAA","GRU --- General Research Use","2025-09-30","2025-09-30","Alcoholic Hepatitis; AH - Alcoholic hepatitis; acute alcoholic Hepatitis; acute alcoholic liver disease",""
"phs001732.v3.p1","NHLBI TOPMed: TReating Children to Prevent EXacerbations of Asthma    (TREXA)","TREXA is a 44-week randomized, double-blind, double-masked, four-treatment, parallel trial that will evaluate the weaning strategy that provides the best protection against the development of exacerbations in children whose asthma  is acceptably controlled on a low dose of ICS (per NAEPP guidelines). Following the 4 weeks of the run-in period on a 1x dose of ICS (100 &#x000b5;g","Not Applicable","Asthma","Prospective Longitudinal Cohort","WGS_markerset_grc38, SV_STR_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 24 variables, 2 documents, 2 molecular datasets, 67 samples sequenced, 89 subjects, 89 samples","","NHLBI","DS-ASTHMA-IRB-COL --- Disease-Specific (Asthma, IRB, COL)","2025-09-30","2025-09-30","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs003979.v1.p1","Identification of a Type 1 Diabetes-Associated T Cell Receptor Repertoire    Signature from the Human Peripheral Blood","Type 1 Diabetes (T1D) is a T-cell mediated disease with a strong immunogenetic HLA dependence. HLA allelic influence on the T cell receptor (TCR) repertoire shapes thymic selection and controls  activation of diabetogenic clones, yet remains largely unresolved in T1D. We sequenced the circulating TCR&#x003b2; chain repertoire from 2250","Not Applicable","Diabetes Mellitus, Type 1","Cross-Sectional","custom_markerset","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 774 subjects, 774 samples","European (607), African American (46), Hispanic1 (59), Hispanic2 (29), Other Asian or Pacific Islander (2), South Asian (10), Other (21)","NIAID","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2025-09-26","2025-09-26","Type 1 Diabetes; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset",""
"phs002267.v3.p1","HuBMAP: A Spatially Resolved Molecular Atlas of Human Endothelium","The human circulatory system plays a vital role in the proper functioning of every organ in the human body. Because vascular related diseases, such as atherosclerosis, do not occur homogeneously  throughout the vascular tree, differences in the endothelium of various organs must exist. There is even evidence of heterogeneity of adjacent","Not Applicable","Endothelium","Case Set","Not Provided","ATAC-seq, RNA-Seq","3 phenotype datasets, 9 variables, 44 samples sequenced, 12 subjects, 44 samples","","NHGRI","GRU --- General Research Use","2025-09-26","2022-01-19","Not Provided",""
"phs004313.v1.p1","Losartan Effects on Emphysema Progression (LEEP-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives To  evaluate the efficacy of losartan, an angiotensin receptor blocker, to reduce emphysema progression in patients with COPD and mild to moderate","Not Applicable","Pulmonary Disease, Chronic Obstructive","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 220 subjects, 220 samples","","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2025-09-25","2025-09-25","COPD; Pulmonary Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease",""
"phs004000.v1.p1","Assessment of Complex Chromosomal Changes in De-Identified Cell Lines","In this study, we obtained DNA from the Coriell Repository from individuals with complex chromosomal changes. The database (""Chromosome Abnormalities"") of these de-identified samples contains 1,366 individuals as per https://www.coriell.org/1/NIGMS.  We started with 16 individuals in this pilot study that we will hopefully expand out in a potential large NIH grant using information derived in this","Not Applicable","Chromosome 9p Deletion Syndrome","Case Set","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use","2025-09-25","","9p deletion; 9p deletion syndrome; 9p monosomy; 9p syndrome; 9p- syndrome; Alfi syndrome",""
"phs003790.v1.p1","Chicago Infant Mortality Study","The Chicago Infant Mortality Study (CIMS) was a population-based, prospective, case-control study conducted in metropolitan Chicago, Cook County, Illinois, to examine the risk factors for sudden infant death syndrome (SIDS)  among a primarily Black population. Eligible case infants were aged birth to one year where the cause of death was determined to be SIDS while","Not Applicable","Sudden Infant Death","Case-Control","WES_markerset_grc38, MethylationEPIC, RNAseq_probe_set_grc38","Methylation (CpG), Metabolomics, SNP/CNV Genotypes (NGS), RNA Seq (NGS)","4 phenotype datasets, 55 variables, 4 molecular datasets, 407 subjects, 488 samples","","NICHD","HMB-NPU-GSO --- Health/Medical/Biomedical (NPU, GSO)","2025-09-25","2025-09-25","CAV3-Related Sudden Infant Death Syndrome; Cot Death; Cot Deaths; Crib Death; Death, Cot; Death, Crib",""
"phs003609.v1.p1","Virginia PrIMeD Study","The goal of this study was to determine whether screening children (2-16 yrs) in pediatric waiting rooms for genetic risk of type 1 diabetes (T1D) could be applied to diverse  (by geography, genetic ancestry) communities, and for those at ""high genetic risk,"" if barriers prevent subsequent screening for presence of islet","Not Applicable","Diabetes Mellitus, Type 1","Prospective Longitudinal Cohort","custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 23 variables, 1 molecular datasets, 3818 subjects, 3818 samples","","NIDDK","DS-T1DR-IRB --- Disease-Specific (Type 1 diabetes, its complications and other autoimmune diseases, IRB)","2025-09-25","2025-09-25","DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes Mellitus, Sudden Onset",""
"phs001801.v1.p1","Center for Cancer Genomics (CCG) Cancers of Unknown Primary Project    (CUPP)","The Cancers of Unknown Primary Project (CUPP) aims to characterize difficult tumor types with the goal of determining future best treatment practices. NCI will utilize whole exome sequencing, copy-number variation,  DNA methylation in conjunction with transcriptome sequencing to provide a comprehensive genomic landscape of Cancers of Unknown Primary (CUP). The","Not Applicable","Neoplasms, Unknown Primary","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 791 subjects, 791 samples","","NCI","GRU --- General Research Use","2025-09-25","2025-09-25","Cancer - unknown origin; Cancer of Unknown Primary; Cancer of Unknown Primary Site; Malignant tumor - unknown primary; Malignant tumor of unknown origin; Metastasis - unknown primary",""
"phs003341.v1.p1","Single-Cell TCR/BCR Sequencing for Korean COVID-19 Vaccinated and Patient    Samples","We conducted longitudinal single-cell TCR/BCR sequencing for COVID-19 vaccinated cases (297 samples from 112 cases) and COVID-19 infected cases classified as Asymptomatic (26 samples from 12 cases), Mild (82 samples  from 37 cases), Moderate (123 samples from 50 cases), Severe (216 samples from 58 cases), and Critical (142 samples from 41 cases) according to the","Not Applicable","COVID-19 Vaccines","Prospective Longitudinal Cohort","custom_markerset","RNA Seq (NGS)","4 phenotype datasets, 47 variables, 1 molecular datasets, 310 subjects, 886 samples","","NIAID","DS-COV-IRB-NPU --- Disease-Specific (COVID-19, IRB, NPU)","2025-09-23","2025-09-23","COVID-19; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus",""
"phs004275.v1.p1","Patient Registry for Primary Pulmonary Hypertension (PPH    Registry-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives Establish  a patient registry to evaluate the natural history, etiology, pathogenesis and treatment of primary pulmonary hypertension. Specific aims included","Not Applicable","Lung Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 317 subjects, 317 samples","","NHLBI","GRU --- General Research Use","2025-09-22","2025-09-22","Hypertension, Pulmonary; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders",""
"phs003994.v1.p1","The Oral Mycobiome and Risk of Pancreatic Cancer","The purpose of our study was to assess the influence of oral microbiota on the development of pancreatic cancer. Our preliminary case-control studies showed that oral carriage of a periodontal  pathogen is related to increased risk for pancreatic cancer. We hypothesize that the oral bacteria and fungi are associated with risk of pancreatic","Not Applicable","Pancreatic Neoplasms","Case-Control","Not Provided","AMPLICON, WGS","4 phenotype datasets, 22 variables, 890 samples sequenced, 890 subjects, 890 samples","","NCI","GRU --- General Research Use","2025-09-22","2025-09-22","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic",""
"phs001048.v4.p1","The Finland-United States Investigation of NIDDM Genetics (FUSION) Tissue    Biopsy Study","The Finland-United States Investigation of NIDDM Genetics (FUSION) study is a long-term effort to identify genetic variants that predispose to type 2 diabetes (T2D) or that impact the variability of  T2D-related quantitative traits (QTs). Most of the variants associated with T2D and related traits (glucose and insulin, anthropometrics, lipids)","Not Applicable","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37, MethylationEPIC, HumanOmni2.5-4, HumanOmni2.5-8, imputation_panel, RNAseq_probe_set_grc38, target_markerset_grc38, RNAseq_gene_transcripts","ATAC-seq, Methylation (CpG), SNP Genotypes (Array), Bisulfite-Seq, SNP Genotypes (imputed), SNP/CNV Genotypes (imputed), RNA-Seq, Chromatin (NGS), RNA Seq (NGS), RNA Seq (NGS), WGS, miRNA-Seq","4 phenotype datasets, 88 variables, 2 documents, 7 molecular datasets, 1480 samples sequenced, 317 subjects, 403212 samples","","NHGRI","GRU --- General Research Use","2025-09-22","2025-04-25","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003662.v1.p1","Kids First: The Genomic Architecture of Hirschsprung Disease (HSCR)","Hirschsprung disease (HSCR) is a male biased developmental disorder associated with a lack of innervation of the gastrointestinal tract. Genetic studies have been instrumental in understanding its multifactorial inheritance, high  heritability, syndromic associations, and genetic heterogeneity with variable penetrance and expressivity. At least 24 genes and 9 loci with","Not Applicable","Hirschsprung Disease","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2130 subjects, 2130 samples","","NICHD","GRU --- General Research Use","2025-09-19","2025-09-19","Aganglionic Megacolon; Aganglionosis; Colonic aganglionosis; Congenital Megacolon; Congenital intestinal aganglionosis; Disease, Hirschsprung","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002038.v1.p1","NHLBI TOPMed: Trans-Omics Analysis for Congestive Heart Failure (TOPCHeF)","Heart failure (HF) is a serious, common, morbid condition that has a huge public health impact. In 2012 alone, there were 1M hospital discharges and 1.7M outpatient visits where HF  was the principal diagnosis. HF is the most common hospital discharge diagnosis of the elderly and led to costs in excess of $30B in 2012.","Not Applicable","Heart Failure","Case-Control","WGS_markerset_grc38, RNAseq_gene_transcripts","SNP/CNV Genotypes (NGS), RNA Seq (NGS), WGS","5 phenotype datasets, 32 variables, 1 documents, 2 molecular datasets, 833 samples sequenced, 943 subjects, 1614 samples","","NHLBI","GRU --- General Research Use","2025-09-19","2025-09-19","Congestive Heart Failure; Myocardial Ischemia; Cardiomyopathies, Primary; Cardiomyopathy, Primary; Disease, Primary Myocardial; Diseases, Primary Myocardial","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs003895.v1.p1","Response&#x0200b; to Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm","Tagraxofusp is a CD123-targeted therapy comprised of a recombinant human interleukin-3 (IL-3) fused to a truncated diphtheria toxin (DT) payload. It is the first approved treatment specifically for patients with  Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). In order to identify biomarkers of response, bone marrow samples from 12 BPDCN patients who","Not Applicable","Blastic Plasmacytoid Dendritic Cell Neoplasm","Clinical Trial","Not Provided","RNA-Seq, Targeted-Capture","4 phenotype datasets, 19 variables, 53 samples sequenced, 12 subjects, 53 samples","","NCI","GRU --- General Research Use","2025-09-18","2025-09-18","Agranular CD4+ CD56+ Hematodermic Neoplasm Tumor; Agranular CD4+ CD56+ Hematodermic Neoplasm-Tumor; Agranular CD4+ CD56+ Hematodermic Neoplasm/Tumor; Agranular CD4+ Natural Killer Cell Leukemia; BPDCN; BPDCNs",""
"phs001207.v4.p1","NHLBI TOPMed: African American Sarcoidosis Genetics Resource","This study aims to comprehensively interrogate the genomes of African American sarcoidosis families. Sarcoidosis is characterized by a hyperimmune response resulting in granuloma formation in multiple organs. It affects African  Americans (AAs) more frequently and more severely than whites. While previous linkage, admixture, candidate gene and genome-wide association (GWA)","Not Applicable","Sarcoidosis","Family/Twin/Trios","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","5 phenotype datasets, 30 variables, 2 documents, 2 molecular datasets, 1333 samples sequenced, 1335 subjects, 1334 samples","","NHLBI","DS-SAR-IRB --- Disease-Specific (Sarcoidosis, IRB)","2025-09-18","2025-09-18","Benign lymphogranulomatosis of Schaumann; Besnier Boeck Disease; Besnier Boeck Schaumann Syndrome; Besnier-Boeck Disease; Besnier-Boeck-Schaumann Syndrome; Besnier-Boeck-Schaumann disease",""
"phs004185.v1.p1","Establishment and Genomic Validation of Novel Patient-Derived Xenograft    Models for Drug Discovery in Gastrointestinal Stromal Tumor","This dataset contains targeted next-generation sequencing data generated with the Illumina TruSight Oncology 500 (TSO500) assay from six gastrointestinal stromal tumors (GIST) and matched patient-derived xenograft (PDX) models established at  Fox Chase Cancer Center (Philadelphia, PA). GIST are most commonly driven by activating mutations in KIT or PDGFRA, and this study focused on","Not Applicable","Gastrointestinal Stromal Tumors","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 18 variables, 23 samples sequenced, 23 subjects, 23 samples","","NCI","GRU --- General Research Use","2025-09-16","2025-09-16","GANT; GI stroma tumor; GI stroma tumour; GIST; GIST - Gastrointestinal stromal tumor; Gastrointestinal Stromal Neoplasm",""
"phs001821.v1.p1","Evaluation of Local Response of Prostate Cancer to Irradiation Using    Multiparametric MRI and MR-Guided Biopsies","The purpose of this study was to determine the rate of local recurrence in patients with intermediate and high risk prostate cancer treated with radiotherapy. In this study, multiparametric MRI  was first performed, and biopsy tissue was acquired from cancerous regions detected on MRI. Blood samples were also taken. DNA and RNA were extracted","Not Applicable","Prostatic Neoplasms","Case Set","Affymetrix_expression_array","SNP Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets, 114 samples sequenced,  SRA, 29 subjects, 174 samples","","NCI","GRU-IRB-PUB-NPU --- General Research Use (IRB, PUB, NPU)","2025-09-15","2025-09-15","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs004065.v1.p1","Health Information National Trends Survey-SEER (HINTS-SEER)","HINTS-SEER is a cross-sectional survey that sampled cancer survivors from three different SEER cancer registries. Sampling frames of survivors from each registry were stratified by time since diagnosis and race/ethnicity,  with non-malignant tumors and non-melanoma skin cancers excluded. Respondents who consented completed a self-administered questionnaire sent through","Not Applicable","Health Communication","Cross-Sectional","Not Provided","Not Provided","1 phenotype datasets, 2 variables, 1234 subjects","","NCI","GRU --- General Research Use","2025-09-12","2025-09-12","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs003982.v1.p1","Research in Adaptive Interests, Skills, and Environment","The Research on Adaptive Interest, Skills, and Environments (RAISE) project is a coordinated set of pilot studies funded and otherwise supported by the Center for the Study of Adolescent Risk  and Resilience (C-StARR) at Duke University. The initial data collection effort (Adolescent T1; 2015; NAHDAP 100737) was conducted by telephone and","Not Applicable","Substance-Related Disorders","Prospective Longitudinal Cohort","Global_Diversity_Array-8","SNP Genotypes (Array)","4 phenotype datasets, 31 variables, 1 documents, 1 molecular datasets, 436 subjects, 436 samples","European (269), African (4), East Asian (1), African American (83), Hispanic1 (22), Hispanic2 (42), Other Asian or Pacific Islander (6), South Asian (3), Other (7)","NIDA","GRU-IRB --- General Research Use (IRB)","2025-09-12","2025-09-12","Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced",""
"phs003944.v1.p1","Systemic Inflammation and Lymphocyte Activation Precede Rheumatoid    Arthritis","The Allen Institute for Immunology-University of California, San Diego-University of Colorado Transition to Rheumatoid Arthritis (ALTRA) project is a prospective longitudinal cohort study to understand the pre-clinical development of rheumatoid  arthritis (RA). We performed cross-sectional and longitudinal multi-omics analyses of peripheral immunity in the anti-citrullinated protein","Not Applicable","Arthritis, Rheumatoid","Prospective Longitudinal Cohort","Not Provided","ATAC-seq, OTHER, RNA-Seq, Targeted-Capture","5 phenotype datasets, 23 variables, 81 samples sequenced, 223 subjects, 344 samples","","NIAID","GRU --- General Research Use, DS-IHD --- Disease-Specific (Immune Health and Disease)","2025-09-12","2025-09-12","Rheumatoid Arthritis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003215.v1.p1","Childhood Cancer Data Initiative (CCDI): Texas Pediatric Patient Derived    Xenograft&#x000a0;","The DNA/RNA samples of patients for which PDX models were developed were from a population of children, adolescents, and young adults from South Texas. Consent was obtained for collection of  malignant and non-malignant tissue samples for genetic analysis and for the development of models to study new ways to treat cancer. For additional","Not Applicable","Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","Xenograft","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 51 subjects, 362 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-09-12","2025-09-12","Hepatoblastoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002733.v2.p2","Colon Cancer Family Registry (Colon CFR)","The Colon Cancer Family Registry Cohort (CCFRC www.coloncfr.org) is a cohort of families recruited through six study sites located in the USA, Canada, Australia, and New Zealand. The CCFRC was  formed as a resource to support studies on the etiology, prevention, and clinical management of colorectal cancer. Recruitment protocols fall broadly","Not Applicable","Colorectal Neoplasms","Case-Control","Not Provided","Not Provided","7 phenotype datasets, 1363 variables, 38362 subjects","","NCI","HMB --- Health/Medical/Biomedical, HMB-IRB-COL --- Health/Medical/Biomedical (IRB, COL), DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-CA-PUB-MDS --- Disease-Specific (Cancer, PUB, MDS), DS-CA-IRB-PUB-NPU-MDS --- Disease-Specific (Cancer, IRB, PUB, NPU, MDS), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), DS-COC-IRB-COL --- Disease-Specific (Colon Cancer, IRB, COL)","2025-09-12","2022-08-15","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002501.v1.p1","Diabetic Retinopathy Genomics Study (DRGen) - Genetic Biomarkers of    Diabetic Retinopathy","Using a well-defined, clinically supported phenotypic strategy, we seek to better understand the role of common and rare genetic variants in the progression of diabetic retinopathy (DR). Whole exome/whole genome  sequencing (WES/WGS) was used to systematically search the human genome to detect DR susceptibility genes or genes that protect people from","Not Applicable","Diabetic Retinopathy","Case-Control","WES_markerset_grc38, WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS, WXS","4 phenotype datasets, 50 variables, 2 molecular datasets, 361 samples sequenced, 361 subjects, 361 samples","European (30), African American (2), Hispanic2 (31), Other Asian or Pacific Islander (1), Other (3)","NEI","GRU --- General Research Use","2025-09-12","2025-09-12","Diabetic Angiopathies; Macular Edema; Retinal Diseases; Angiopathies, Diabetic; Angiopathy, Diabetic; Diabetic Angiopathy","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003945.v1.p1","Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study","Study population The WECARE Study is an international multicenter population-based case-control study of cases with asynchronous contralateral breast cancer (CBC) and individually matched controls with unilateral breast cancer (UBC). Recruitment  and data collection for the WECARE Study were conducted in two phases, herein referred to as WECARE I (2001&#x02013;2004) and WECARE II","Not Applicable","Breast Neoplasms","Case Set","Axiom_PMRA","SNP Genotypes (Array)","4 phenotype datasets, 34 variables, 1 analyses, 1 molecular datasets, 2355 subjects, 2085 samples","European (1667), African (5), East Asian (71), African American (112), Hispanic1 (13), Hispanic2 (155), Other Asian or Pacific Islander (42), South Asian (10), Other (14)","NCI","HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-BRCA-NPU-MDS --- Disease-Specific (Breast Cancer, NPU, MDS), DS-BRCA-NPU --- Disease-Specific (Breast Cancer, NPU), HMB-NPU --- Health/Medical/Biomedical (NPU), DS-BRCA-IRB-NPU --- Disease-Specific (Breast Cancer, IRB, NPU)","2025-09-11","2025-09-11","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002276.v4.p1","Gabriella Miller Kids First Pediatric Research Program in Pediatric    T-Cell Acute Lymphoblastic Leukemia","The outcome for patients with relapsed T-ALL is dismal with 3-year event free survival of 15%. Thus, the primary goal in the treatment of T-ALL is to prevent relapse, which  requires accurate risk stratification. Unfortunately, no genetic alterations have been identified to date that are reproducibly prognostic","Not Applicable","Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 7 variables, 1358 subjects, 5065 samples","","NICHD","GRU --- General Research Use","2025-09-11","2021-11-10","Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases; Blood and Lymphatic System Disorders; Hematopoietic and Lymphoid System Disorder; Blastoma; CA",""
"phs001545.v3.p1","NHLBI TOPMed - NHGRI CCDG: Intermountain INSPIRE Registry","The INtermountain Healthcare Biological Samples Collection Project and Investigational REgistry for the On-going Study of Disease Origin, Progression and Treatment (Intermountain INSPIRE Registry) purpose is to collect biological samples, clinical  information and laboratory data from Intermountain Healthcare patients. The registry originally collected samples in patients undergoing a coronary","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 18 variables, 2 documents, 2 molecular datasets, 10 samples sequenced, 476 subjects, 475 samples","","NHLBI","DS-MULTIPLE_DISEASES-MDS --- Disease-Specific (Cardiovascular, metabolic disease and associated risk factors, MDS)","2025-09-11","2025-09-11","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs003841.v1.p1","Longitudinal Multi-Omic Immune Resource Reveals Dynamic Responses in    Healthy Human Aging","The generation and maintenance of protective immunity is a dynamic interplay between host and environment that is impacted by age. Understanding fundamental changes in the healthy immune system that occur  over a lifespan is critical in developing interventions for age-related susceptibility to infections and diseases. Here, we use multi-omic profiling","Not Applicable","Immunity","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, Targeted-Capture","5 phenotype datasets, 23 variables, 57 samples sequenced, 239 subjects, 1011 samples","","NIA","GRU --- General Research Use","2025-09-10","2025-09-10","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002790.v9.p3","Childhood Cancer Data Initiative (CCDI): Molecular Characterization    Initiative","The National Cancer Institute's (NCI) Childhood Cancer Data Initiative (CCDI) focuses on the critical need to collect, analyze, and share data to address the burden of cancer in children, adolescents,  and young adults (AYAs). The Molecular Characterization Initiative (MCI) will further the CCDI's goals by providing access to better diagnostic tests","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","Not Provided","OTHER, RNA-Seq, WXS","2 phenotype datasets, 5 variables, 7356 samples sequenced, 5516 subjects, 15622 samples","","NCI","GRU --- General Research Use","2025-09-10","2022-11-03","Sarcoma; Blastoma; CA; CA - Cancer; Cancer; MT",""
"phs004173.v1.p1","Bogalusa Heart Study (BHS-BioLINCC)","Objectives: To investigate the early natural history of cardiovascular disease in a cohort of children and young adults in a biracial, semirural community. Background: The Bogalusa Heart Study has been  a long-term epidemiologic study. The investigators have identified and followed black and white participants for nearly 40 years, and have described","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 11816 subjects, 11816 samples","","NHLBI","GRU --- General Research Use","2025-09-09","2025-09-09","Arterial Occlusive Diseases; Atherosclerosis; Coronary Disease; Heart Diseases; Myocardial Ischemia; Vascular Diseases",""
"phs004115.v1.p1","B Cell Lymphocytosis and Reprogramming due to a CARD11 Bi-Allelic    Gain-of-Function Mutation","This is a single-cell RNA sequencing (scRNA-seq) study using peripheral blood mononuclear cells (PBMC) from 2 healthy donors and 2 patients with B cell Expansion with NF-&#x003ba;B and T cell  Anergy (BENTA). Samples were not hashed or multiplexed. The 10X Genomics Platform was used for sequencing. Principal findings include transcriptome","Not Applicable","Single-Cell Gene Expression Analysis","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 11 variables, 4 samples sequenced, 4 subjects, 4 samples","","NIGMS","HMB --- Health/Medical/Biomedical","2025-09-09","2025-09-09","Not Provided",""
"phs003688.v1.p1","MP2PRT: Evaluation of an Inflammation Polygenic Risk Score (iPRS) to    Predict Cancer Related Cognitive Impairment and Fatigue in Patients    Receiving Chemotherapy for Non-Metastatic Breast Cancer in URCC0701    and URCC10055","This study is a secondary analysis of cancer related cognitive impairment (CRCI) and cancer related fatigue (CRF) among participants in URCC0701 and URCC10055 from the University of Rochester NCI Community  Oncology Research Program (NCORP) Research Base. CRCI and CRF are common, troublesome, and dose-limiting toxicities reported by patients undergoing","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","custom_markerset","SNP/CNV (Array)","4 phenotype datasets, 25 variables, 1 molecular datasets, 799 subjects, 799 samples","","NCI","GRU --- General Research Use","2025-09-09","2025-09-09","Cognitive Symptoms; Fatigue; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor",""
"phs001672.v13.p1","Veterans Administration (VA) Million Veteran Program (MVP) Summary    Results from Omics Studies","MVP is an ongoing prospective cohort study and mega-biobank in the Department of Veterans Affairs Healthcare System designed to study genetic influences on health and disease among veterans. Eligible subjects  must be active users of the Veteran Health Administration (with available electronic health record) and willing to provide informed consent.","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","335 analyses","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-09-09","2025-12-16","Arthritis; COVID-19; Diabetes Mellitus; Eye Diseases; Kidney Diseases; Lung Neoplasms","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs000743.v4.p1","METSIM (METabolic Syndrome In Men) Study","The METSIM Study includes 10,197 men, aged from 45 to 73 years, randomly selected from the population register of the town of Kuopio, Eastern Finland, and examined in 2005-2010. The  aim of the study is to investigate genetic and non-genetic factors associated with the risk of type 2 diabetes (T2D), cardiovascular disease (CVD),","Not Applicable","Metabolic Syndrome","Prospective Longitudinal Cohort","HumanOmniExpress-12, HumanExome-12, WES_markerset_grc37, RNAseq_gene_transcripts","Not Provided","5 phenotype datasets, 70 variables, 11887 samples sequenced, 10197 subjects, 32012 samples, 8 substudies","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-09-08","2025-09-08","Cardiovascular Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs004033.v1.p1","METSIM (METabolic Syndrome In Men) Study Metabolomics","We performed untargeted metabolomic profiling in METSIM baseline plasma samples after an overnight fast of at least 10 hours for 10,188 participants using Metabolon's DiscoveryHD4 mass spectrometry platform (Durham, North  Carolina, USA). Principal Investigator: Markku Laakso, MD, PhD, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland","METSIM (METabolic Syndrome In Men) Study (phs000743.v4.p1)","Metabolic Syndrome","Cross-Sectional","","Metabolomics","1 phenotype datasets, 5 variables, 1 molecular datasets, 10188 subjects, 10188 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-09-08","2025-09-08","Cardiovascular Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs003387.v2.p1","METSIM Subcutaneous Adipose Surgical Biopsy RNA-Seq","This subcutaneous adipose RNA-Seq dataset derived from small surgical biopsies is part of the third release of the METabolic Syndrome In Men (METSIM) study (phs000743). These data were generated to  evaluate relationships between adipose gene expression levels, genotypes, and cardiometabolic trait data included in dbGaP in the METSIM study. Two","METSIM (METabolic Syndrome In Men) Study (phs000743.v4.p1)","Subcutaneous Fat, Abdominal","Prospective Longitudinal Cohort","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","2 phenotype datasets, 34 variables, 1 molecular datasets, 496 samples sequenced, 483 subjects, 496 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-09-08","2025-09-08","Not Provided",""
"phs003386.v2.p1","METSIM Subcutaneous Adipose Needle Biopsy ATAC-Seq","This subcutaneous adipose ATAC-Seq dataset derived from small needle or surgical biopsies is part of the third release of the METabolic Syndrome In Men (METSIM) study (phs000743). These data were  generated to identify open chromatin regions in adipose tissue. The tissue donors are a subset of the initial 10,197 participants in the METSIM","METSIM (METabolic Syndrome In Men) Study (phs000743.v4.p1)","Subcutaneous Fat, Abdominal","Prospective Longitudinal Cohort","Not Provided","ATAC-seq","1 phenotype datasets, 26 variables, 19 samples sequenced, 17 subjects, 19 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-09-08","2025-09-08","Not Provided",""
"phs003385.v2.p1","METSIM Subcutaneous Adipose Needle Biopsy RNA-Seq","This subcutaneous adipose RNA-seq dataset derived from small needle biopsies is part of the third release of the METabolic Syndrome In Men (METSIM) study (phs000743). These data were generated to  evaluate relationships between adipose gene expression levels, genotypes, and cardiometabolic trait data included in dbGaP in the METSIM study. Two","METSIM (METabolic Syndrome In Men) Study (phs000743.v4.p1)","Subcutaneous Fat, Abdominal","Prospective Longitudinal Cohort","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 30 variables, 1 molecular datasets, 434 samples sequenced, 434 subjects, 434 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-09-08","2025-09-08","Not Provided",""
"phs001579.v1.p1","Center for Common Disease Genomics (CCDG)-Cardiovascular: METSIM    (METabolic Syndrome In Men) Study","The National Human Genome Research Institute (NHGRI) has funded the Centers for Common Disease Genomics (CCDG), a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants  contributing to multiple common disease phenotypes and to better understand the general principles of genomic architecture underlying common, complex","METSIM (METabolic Syndrome In Men) Study (phs000743.v4.p1)","Cardiovascular Diseases","Case-Control","Not Provided","Not Provided","1219 subjects, 9928 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-09-08","2025-09-08","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs001100.v4.p1","Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in    Multi-Ethnic Samples (T2D-GENES) Project 1: Metabolic Syndrome in Men    Study (METSIM)","This substudy contains molecular data and selected phenotypes of subjects available from the ""Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Metabolic Syndrome in  Men Study (METSIM)"" project. Summary-level phenotypes for the METSIM Study participants can be viewed at the top-level study phs000743.","METSIM (METabolic Syndrome In Men) Study (phs000743.v4.p1)","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","1 phenotype datasets, 5 variables, 1 molecular datasets, 982 samples sequenced, 982 subjects, 982 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-09-08","2025-09-08","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000919.v3.p1","METSIM (METabolic Syndrome In Men) Study GWAS and Exome Chip","This substudy contains genotypes and selected phenotypes of subjects available from the ""METSIM (METabolic Syndrome In Men) Study GWAS and Exome Chip"" project. Summary-level phenotypes for the METSIM Study participants  can be viewed at the top-level study page phs000743. Individual-level phenotype data and molecular data for all METSIM top-level study and","METSIM (METabolic Syndrome In Men) Study (phs000743.v4.p1)","Metabolic Syndrome","Prospective Longitudinal Cohort","HumanOmniExpress-12, HumanExome-12","SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 1 molecular datasets, 10108 subjects, 10108 samples","European (10012), African (1), Hispanic1 (2), Hispanic2 (1), South Asian (2), Other (48)","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-09-08","2025-09-08","Cardiovascular Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs000752.v3.p1","METSIM (METabolic Syndrome In Men) Study: FinMetSeq Exome Sequencing","This substudy contains molecular data and selected phenotypes of subjects available from the ""METSIM (METabolic Syndrome In Men) Study: FinMetSeq Exome Sequencing"" project. Summary-level phenotypes for the METSIM Study participants  can be viewed at the top-level study page phs000743. Individual-level phenotype data and molecular data for all METSIM top-level study and","METSIM (METabolic Syndrome In Men) Study (phs000743.v4.p1)","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","WXS","1 phenotype datasets, 3 variables, 9956 samples sequenced, 9956 subjects, 9956 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-09-08","2025-09-08","Diabetes Mellitus; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs004168.v1.p1","Acute Respiratory Distress Network Early Versus Delayed Enteral Feeding    to Treat People with Acute Lung Injury or Acute Respiratory Distress    Syndrome (ARDSNet EDEN-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Biospecimens: Access  to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from ARDSNet-EDEN","Not Applicable","Respiratory Distress Syndrome","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1000 subjects, 1000 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-09-05","2025-09-05","Lung Diseases; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders",""
"phs004103.v1.p1","Single Cell Transcriptional Analysis of Human Adenoids Identifies    Molecular Features of Airway Microfold Cells","We aimed to characterize the cellular composition and molecular features of the human adenoid, a mucosa-associated lymphoid tissue located in the upper airway, with a focus on epithelial populations involved  in immune surveillance. To this end, we performed single-nucleus RNA sequencing (snRNA-seq) on adenoid tissue obtained from 6 human donors (age 2","Not Applicable","Adenoids","Control Set","Not Provided","OTHER","3 phenotype datasets, 19 variables, 2 samples sequenced, 8 subjects, 8 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2025-09-05","2025-09-05","Not Provided",""
"phs002590.v2.p1","Kids First: Whole Genome Sequencing in Recessive Structural Brain Defects","Almost 5% of all live births in the US (1:20 births) display an inborn defect, including both structural and functional/metabolic abnormalities. These are among the most common causes of Infant  mortality in the developed world and underlie nearly half of hospitalizations in the first 3 years of life. Of the 35 major defects observable at","Not Applicable","Brain","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1146 subjects, 1150 samples","","NICHD","GRU --- General Research Use","2025-09-05","2023-08-28","Band Heterotopia of Brain; Cerebellar Hypoplasia; Polymicrogyria; Congenital cerebellar hypoplasia; Congenital hypoplasia of cerebellum; Congenital small cerebellum",""
"phs004165.v1.p1","Acute Respiratory Distress Syndrome Clinical Network: Fluid and Catheter    Treatment Trial (ARDSNet FACTT-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Biospecimens: Access  to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from","Not Applicable","Acute Lung Injury","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1000 subjects, 1000 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-09-04","2025-09-04","Lung Diseases; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders",""
"phs004091.v1.p1","An Ultrasensitive Method for Detection of Cell-Free RNA","Our study describes the development of a novel method for cell free RNA (cfRNA) analysis called RARE-Seq (Random priming & Affinity capture of cell-free RNA fragments for Enrichment analysis by  Sequencing). We find RARE-Seq improves the limit of detection for tumor-na&#x000ef;ve cancer detection while maintaining high specificity. We explore","Not Applicable","Carcinoma, Non-Small-Cell Lung","Case-Control","Not Provided","Targeted-Capture","4 phenotype datasets, 25 variables, 222 samples sequenced, 172 subjects, 222 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-09-04","2025-09-04","COVID-19; Respiratory Distress Syndrome; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection",""
"phs004041.v1.p1","Cellular Profiling Identifies Targetable T Cell Phenotypes in Lymphocytic    Variant Hypereosinophilic Syndrome","Lymphocytic variant hypereosinophilic syndrome (LHES) is driven by aberrant Th2&#x02011;skewed lymphocyte clones that promote tissue eosinophilia. We performed multimodal single&#x02011;cell RNA&#x02011;sequencing (scRNA&#x02011;seq), cell&#x02011;surface protein (ADT) profiling, and paired &#x003b1;&#x003b2;&#x02011;TCR sequencing  on peripheral&#x02011;blood mononuclear cells (PBMCs) from two clinically characterized LHES patients and one idiopathic HES control. One LHES","Not Applicable","Hypereosinophilic Syndrome","Case-Control","Not Provided","AMPLICON, OTHER, RNA-Seq","4 phenotype datasets, 14 variables, 2 documents, 4 samples sequenced, 3 subjects, 4 samples","","NIAID","GRU --- General Research Use","2025-09-04","2025-09-04","Hypereosinophilic Syndromes; Endocarditis, Loeffler; Endocarditis, Loeffler's; Endocarditis, Loefflers; Eosinophilic endocarditis; Loeffler Endocarditis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003425.v1.p1","Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined with Nivolumab    and Ipilimumab for Patients with Resected MMR-p Colorectal and    Pancreatic Cancer","We developed INtraCEllular Reverse Transcription with Sorting and sequencing (INCERTS), an approach to combine molecular indexing of receptor repertoires within intact cells and fluorescence-activated cell sorting (FACS). We demonstrate that  INCERTS enables efficient processing of millions of cells from pooled human peripheral blood mononuclear cell (PBMC) samples while retaining robust","Not Applicable","Single-Cell Analysis","Clinical Trial","Not Provided","AMPLICON, RNA-Seq","4 phenotype datasets, 14 variables, 32 samples sequenced, 7 subjects, 32 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2025-09-04","2025-09-04","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs004098.v1.p1","INCLUDE: Down Syndrome Early Post-Natal Brain Multiome","Neurodevelopmental deficiencies and neuronal dysfunction contribute to cognitive impairment in individuals with Down syndrome, but what molecular pathways underlie the defects that lead to intellectual disability remain unclear. Human brain  development is precisely choreographed through tightly regulated transcriptional programs. Proper regulation of these transcriptional programs is","Not Applicable","Down Syndrome","Case-Control","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 8 subjects, 36 samples","","NICHD","GRU --- General Research Use","2025-09-03","2025-09-03","47,XX,+21; 47,XY,+21; DS; Down syndrome chromosome region; Down syndrome critical region; Down syndrome, Isolated cases",""
"phs004081.v1.p1","Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome","Study ID: Children's Oncology Group (COG) - AAML1531 NCT Number: NCT02521493 Trial Title: Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome Submitted in collaboration with the NCTN/NCORP Data Archive  Data presented in the following publication(s): 34320162 Disease type(s): Hematopoietic Neoplasm/Leukemia - Acute Myeloid Leukemia; Hematopoietic","Not Applicable","Leukemia, Myeloid, Acute","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 103 variables, 2 documents, 201 subjects","","NCI","GRU --- General Research Use","2025-09-03","2025-09-03","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs003941.v1.p1","ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of    Repurposed Medications","This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within healthcare systems and in community settings where it  can be integrated into routine COVID-19 testing programs and subsequent treatment plans. This platform protocol will enroll participants in an","Not Applicable","COVID-19","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 10488 subjects, 10488 samples","","NHLBI","GRU --- General Research Use","2025-09-03","2025-09-03","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003775.v1.p1","WGS of Five Pancreatic Cancer Patients-Tumor and Normal","We performed whole genome sequence on tumor-derived and normal cell lines from patients who had terminal pancreatic cancer and consented for rapid autopsy upon their death. The 5 samples are  from Dr. Christine Iacobuzio-Donahue's rapid autopsy program as reported in Boland et al. (PLOSOne, 2024, In Press, PMID 38352348). Inclusion:","Not Applicable","Pancreatic Neoplasms","Tumor vs. Matched-Normal","Not Provided","WGS","4 phenotype datasets, 16 variables, 14 samples sequenced, 5 subjects, 14 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2025-09-03","2025-09-03","Metastases; Metastase; Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize",""
"phs000763.v2.p1","The Collaborative Study on the Genetics of Alcoholism (COGA)","COGA is a family study of alcoholism, in which the subjects have been drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), a large, ongoing family-based study that  includes subjects from seven sites around the US. COGA has gathered detailed, standardized data on study participants, including diagnostic and","Not Applicable","Alcoholism","Family/Twin/Trios","HumanOmniExpress-12, imputation_panel, WGS_markerset_grc38, WES_markerset_grc38","SNP Genotypes (Array), SNP Genotypes (imputed), SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), CNV (NGS)","6 phenotype datasets, 98 variables, 1 documents, 1 analyses, 4 molecular datasets, 3557 subjects, 2629 samples","European (2014), African American (7), Hispanic1 (18), Hispanic2 (15), Other Asian or Pacific Islander (1), Other (3)","NIAAA","DS-ALC-IRB-RD --- Disease-Specific (Alcoholism, IRB, RD)","2025-09-03","2025-09-03","ALCOHOL DEPENDENCE, PROTECTION AGAINST; Addiction, Alcohol; Addictive alcohol use; Alcohol Addiction; Alcohol Dependence; Alcohol dependence syndrome",""
"phs002591.v2.p1","Kids First: Whole Genome Sequencing in Structural Defects of the Neural    Tube","Myelomeningocele (aka meningomyelocele, MM) is the most severe form of spina bifida, a neural tube defect (NTD) in humans and the most common CNS birth defect. MM is considered a  genetically complex disease, and occurs in 3.72/10,000 live US birth, and is partly preventable with prenatal folate, but the genetic basis and the","Not Applicable","Meningomyelocele","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1164 subjects, 1167 samples","","NICHD","GRU --- General Research Use","2025-08-29","2023-06-20","Hydromeningomyelocele; Hydromyelomeningocele; Meningomyeloceles; Myelomeningocele; Myelomeningoceles; Spina Bifida Cystica",""
"phs004187.v1.p1","Alpha1-Antitrypsin Deficiency Registry (AADR-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  characterize the clinical and laboratory course of patients with severe alpha 1-antitrypsin deficiency whether or not the patient is undergoing","Not Applicable","alpha 1-Antitrypsin Deficiency","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1129 subjects, 1129 samples","","NHLBI","GRU --- General Research Use","2025-08-27","2025-08-27","alpha 1 Antitrypsin Deficiency; Chronic Obstructive Pulmonary Disease; Lung Diseases; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD",""
"phs003252.v1.p1","Genomic Landscape of Apical Periodontitis","We undertook the first genome-wide association (GWAS) study of apical periodontitis, enrolling 932 patients with deep carious lesions at UTHealth School of Dentistry and the University of Pittsburgh School of  Dental Medicine. We used a case-control design to compare those with apical periodontitis to those without. Genotype data was generated for all","Not Applicable","Periapical Periodontitis","Case-Control","Multi-Ethnic_Global","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 889 subjects, 888 samples","European (367), African (6), East Asian (55), African American (111), Hispanic1 (112), Hispanic2 (156), Other Asian or Pacific Islander (19), South Asian (23), Other (39)","NIDCR","HMB-IRB-PUB-NPU --- Health/Medical/Biomedical (IRB, PUB, NPU)","2025-08-27","2025-08-27","Apical Periodontitides; Apical Periodontitis; Periapical Periodontitides; Periodontitides, Apical; Periodontitides, Periapical; Periodontitis, Apical",""
"phs003593.v2.p1","Framingham Heart Study-Cohort (FHS-Cohort) - Imaging","The Framingham Heart Study (FHS) is a population-based, observational cohort study initiated in 1948 to prospectively investigate the determinants of cardiovascular disease to guide public health prevention. The FHS began  by recruiting an Original Cohort of 5,209 men and women between the ages of 30 and 62 from the town of Framingham, Massachusetts, who had not yet","Not Applicable","Longitudinal Studies","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 15448 subjects, 42958 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-08-26","2024-05-13","Not Provided",""
"phs003936.v1.p1","Studying Glioblastoma in a Human Organoid Tumor Transplantation Model","This study comprises two complementary investigations that leverage innovative human model systems and cutting-edge molecular profiling to dissect glioblastoma (GBM) heterogeneity and tumor-microenvironment interactions. The first study uses a novel  Human Organoid Tumor Transplantation (HOTT) model, in which freshly dissociated GBM tumor cells from five patients were transplanted into human","Not Applicable","Glioblastoma","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 170 samples sequenced, 27 subjects, 170 samples","","NCI","DS-BT-PUB-NPU --- Disease-Specific (Brain Tumors, PUB, NPU)","2025-08-25","2025-08-25","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs001395.v3.p2","NHLBI TOPMed - NHGRI CCDG: Hispanic Community Health Study/Study of    Latinos (HCHS/SOL)","This study contains whole genome sequence data. A case-control sample of individuals from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), a multicenter prospective cohort study of 16,415 persons of  Cuban, Dominican, Mexican, Puerto Rican, Central American, and South American background (phs000810), was selected for whole genome sequencing,","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38, RNAseq_gene_transcripts","SNP/CNV Genotypes (NGS), CNV (NGS), RNA Seq (NGS), WGS","4 phenotype datasets, 23 variables, 2 documents, 3 molecular datasets, 3877 samples sequenced, 8091 subjects, 17980 samples","European (1158), African (1), East Asian (1), African American (992), Hispanic1 (2555), Hispanic2 (2423), Other Asian or Pacific Islander (5), Other (600)","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU), HMB --- Health/Medical/Biomedical","2025-08-25","2025-08-25","Asthma; Coronary Disease; Myocardial Infarction; Pulmonary Disease, Chronic Obstructive; Airway hyperreactivity; Asthma, Bronchial","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1); Collection: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) (phs003650.v1.p1)"
"phs004076.v1.p1","Single Cell RNA Sequencing of Tendon Scar Tissue (Tenolysis)","This human tenolysis sample was collected as a control (non-diabetic sample) as part of larger study described below. The purpose of the larger study is to define the cellular and  molecular environment in tendons, pulleys, synovial sheath, tendon scar tissue, and palmar fascia samples. The samples are isolated from discarded","Not Applicable","Tendons","Collection","Not Provided","RNA-Seq","3 phenotype datasets, 10 variables, 1 samples sequenced, 1 subjects, 1 samples","","NIAMS","HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS)","2025-08-22","2025-08-22","Not Provided",""
"phs004009.v1.p1","Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance    and Progression of Fusion-Positive Rhabdomyosarcoma","In our previous work, we used a myoblast model of fusion-positive rhabdomyosarcoma (FP-RMS) to demonstrate that FGF8, a target of the PAX3-FOXO1 (P3F) transcription factor, is essential for tumorigenicity driven  by P3F. When aberrantly expressed, FGF8 can also sustain tumorigenicity in recurrent tumors that are independent of P3F. In this study, we report","Not Applicable","Rhabdomyosarcoma","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 10 samples sequenced, 10 subjects, 10 samples","","NCI","GRU --- General Research Use","2025-08-22","2025-08-22","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs004031.v1.p1","Genome-Wide Association Study of the Taste and Hedonic Ratings of the    Low-Calorie Sweetener Acesulfame Potassium","Acesulfame potassium (Ace-K) is a low-calorie sweetener (LCS) widely used as an additive in foods and beverages and an excipient in pediatric medicines. Because genetic variants play a role in  individual variation in the taste of Ace-K, we sought to identify genetic contributions to its taste using a genome-wide association study (GWAS).","Not Applicable","Taste Perception","Clinical Trial","GSA-24v3-0-A1","SNP Genotypes (Array)","4 phenotype datasets, 25 variables, 3 analyses, 1 molecular datasets, 141 subjects, 141 samples","European (52), East Asian (5), African American (63), Hispanic1 (4), Hispanic2 (2), Other Asian or Pacific Islander (2), South Asian (12), Other (1)","NIDCD","HMB-NPU --- Health/Medical/Biomedical (NPU)","2025-08-21","2025-08-21","Not Provided",""
"phs003637.v2.p1","Sleep Heart Health Study (SHHS-BioLINCC-NSRR)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Related Studies  Parent cohort phenotype data can be accessed through ARIC-BioLINCC, Framingham-BioLINCC, and CHS-BioLINCC. Objectives To determine the cardiovascular","Not Applicable","Sleep Apnea, Obstructive","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 5839 subjects, 5839 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-08-21","2024-06-25","Cardiovascular Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs004171.v1.p1","Heart Failure Network: Entresto(TM) in Advanced Heart Failure    (HFN-LIFE-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  compare treatment with sacubitril/valsartan versus valsartan alone in patients with advanced heart failure with a reduced ejection fraction and","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 365 subjects, 365 samples","","NHLBI","GRU --- General Research Use","2025-08-20","2025-08-20","Heart Diseases; Cardiac Disease; Cardiac Diseases; Cardiac Disorder; Cardiac Disorders; Cardiopathy",""
"phs003926.v1.p1","The PRIME-AIR Study: Positive End-Expiratory Pressure, Recruitment,    Incentive Spirometry, Muscle Relaxant Optimization, Preoperative    Education, Postoperative Early Ambulation, Individualized, and    Reinforced","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. The PRIME-AIR  study (""Positive end-expiratory pressure, Recruitment, Incentive spirometry, Muscle relaxant optimization, preoperative Education, postoperative","Not Applicable","Postoperative Complications","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 735 subjects, 735 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-08-20","2025-08-20","Complication, Postoperative; Complications, Postoperative; Postoperative Complication; Postoperative problem",""
"phs004130.v1.p1","Prevention and Early Treatment of Acute Lung Injury (PETAL) Network -    Functional, Imaging, and Respiratory Evaluation in CORAL (PETAL FIRE    CORAL-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Biospecimens: Access  to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from PETAL FIRE","Not Applicable","SARS-CoV-2","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 99 subjects, 99 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-08-19","2025-08-19","COVID-19; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus",""
"phs004117.v1.p1","Prematurity and Respiratory Outcomes Program (PROP) Core Database    Protocol (PROP-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: The  Prematurity and Respiratory Outcomes Program (PROP) was performed to identify suitable predictors of respiratory outcomes that may serve as surrogate","Not Applicable","Pregnancy Complications","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 835 subjects, 835 samples","","NHLBI","GRU --- General Research Use","2025-08-19","2025-08-19","Premature Birth; Respiration Disorders; Adverse Birth Outcome; Adverse Birth Outcomes; Birth Outcome, Adverse; Outcome, Adverse Birth",""
"phs004078.v1.p1","Singapore Adult Metabolism Study - Phase 2 (SAMS2)","Singapore Adult Metabolism Study - Phase 2 (SAMS2) was an interventional study where hundreds of donors aged 21-45 were recruited to participate in a 16-week weight loss program. Study individuals  selected (see below for more detailed selection standards) were sedentary (exercise 1 or fewer times a week), obese or overweight with a body fat","Not Applicable","Body Weight","Interventional","imputation_panel","SNP Genotypes (imputed)","5 phenotype datasets, 55 variables, 1 molecular datasets, 54 subjects, 108 samples","","NHGRI","GRU --- General Research Use","2025-08-19","2025-08-19","Insulin Resistance","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003920.v1.p1","The Formation and Propagation of Human Robertsonian Chromosomes","Robertsonian chromosomes are a type of variant chromosome found commonly in nature. Present in one in 800 humans, these chromosomes can underlie infertility, trisomies, and increased cancer incidence. Recognized cytogenetically  for more than a century, their origins have remained mysterious. Recent advances in genomics have allowed us to assemble three human Robertsonian","Not Applicable","Translocation, Genetic","Collection","Not Provided","Hi-C, WGA, WGS","4 phenotype datasets, 16 variables, 3 samples sequenced, 3 subjects, 3 samples","","NCI","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2025-08-19","2025-08-19","Chromosomal Translocation; Chromosomal Translocations; Chromosome Translocation; Genetic Translocation; Genetic Translocations; Translocation",""
"phs000976.v3.p1","Study on the Genetics of Alcoholism (COGA): African American Family GWAS","COGA is a family study of alcoholism, in which the subjects have been drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), a large, ongoing family-based study that  includes subjects from seven sites around the US. COGA has gathered detailed, standardized data on study participants, including diagnostic and","Not Applicable","Alcoholism","Family/Twin/Trios","HumanOmni2.5-8, WES_markerset_grc38, WGS_markerset_grc38","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), CNV (NGS)","6 phenotype datasets, 103 variables, 3 molecular datasets, 4166 subjects, 3823 samples","European (58), African (59), African American (2882), Hispanic1 (153), Hispanic2 (11), Other (54)","NIAAA","DS-ALC-IRB-RD --- Disease-Specific (Alcoholism, IRB, RD)","2025-08-19","2025-08-19","ALCOHOL DEPENDENCE, PROTECTION AGAINST; Addiction, Alcohol; Addictive alcohol use; Alcohol Addiction; Alcohol Dependence; Alcohol dependence syndrome",""
"phs003742.v1.p1","Single Cell RNA-Sequencing of BCG Naive and Recurrent Non-Muscle Invasive    Bladder Cancer Reveals a CD6/ALCAM-Mediated Immune-Suppressive Pathway","Non-muscle invasive bladder cancer (NMIBC) represents 70&#x02013;80% patients with newly diagnosed bladder cancer, and Bacillus Calmette-Guerin (BCG) remains a cornerstone treatment for intermediate- and high-risk NMIBC to prevent disease recurrence  and progression. However, a significant number of patients experience recurrence after their first course of BCG, posing significant challenges in","Not Applicable","Urinary Bladder Neoplasms","Clinical Genetic Testing","Not Provided","RNA-Seq, WXS","3 phenotype datasets, 15 variables, 82 samples sequenced, 43 subjects, 82 samples","","NCI","GRU --- General Research Use","2025-08-15","2025-08-15","Bladder Cancer; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder; Cancer, Urinary Bladder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001489.v4.p2","Center for Common Disease Genomics [CCDG] - Neuropsychiatric: Epilepsy:    Epi25 Consortium","Epilepsy genetics research is at an exciting stage where it is now feasible, with the power of a large cohort, to understand the more complex genetic components of epilepsy. The  driving principle behind the Epi25 Consortium is collaboration and synergy - it is only possible to achieve this type of research by working","Not Applicable","Epilepsy","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets, 12850 samples sequenced, 12890 subjects, 12890 samples","","NHGRI","DS-EPSBAID-MDS-RD --- Disease-Specific (Epilepsy, Structural Brain Abnormalities, Intellectual Disability, MDS, RD), DS-EP --- Disease-Specific (Epilepsy), HMB-MDS --- Health/Medical/Biomedical (MDS), GRU-IRB --- General Research Use (IRB), GRU --- General Research Use, DS-CARNEU-MDS --- Disease-Specific (Cardiology, Neurology, MDS), DS-SEIZD --- Disease-Specific (Seizure Disorders), DS-EP-MDS --- Disease-Specific (Epilepsy, MDS), DS-EP-NPU --- Disease-Specific (Epilepsy, NPU), HMB --- Health/Medical/Biomedical, DS-EPSBA-MDS-RD --- Disease-Specific (Epilepsy, Structural Brain Abnormalities, MDS, RD), DS-EPI-ADULT-NPU-MDS --- Disease-Specific (Epilepsy - Adults, NPU, MDS), GRU-NPU --- General Research Use (NPU), DS-EAED-MDS --- Disease-Specific (Epilepsy and Anti-epileptic Drugs, MDS), DS-NEUROLOGY-MDS --- Disease-Specific (Neurology, MDS), DS-EARET-MDS --- Disease-Specific (Epilepsy causes and Responses to Antiepileptic Tx, MDS), DS-NPD-IRB-NPU --- Disease-Specific (Neuropsychiatric Disorders, IRB, NPU), DS-NEUROLOGY-ADULTS-NPU --- Disease-Specific (Neurology - Adults, NPU), HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-GSO --- Health/Medical/Biomedical (GSO), DS-NSD-NPU-MDS --- Disease-Specific (Nervous System Diseases, NPU, MDS), DS-EPSBACID-MDS-RD --- Disease-Specific (Epilepsy, Structural Brain Abnormalities, Convulsions, Intellectual Disability, MDS, RD), DS-NSD-ADULTS-NPU-MDS --- Disease-Specific (Nervous System Diseases-Adults, NPU, MDS), DS-NEURO-EP-MDS --- Disease-Specific (Neurology, Epilepsy, MDS), DS-MBND-NPU-MDS --- Disease-Specific (Mental, Behavioral and Neurodevelopmental Disorders, NPU, MDS), DS-EAED-IRB-NPU-MDS --- Disease-Specific (Epilepsy and Anti-epileptic Drugs, IRB, NPU, MDS), DS-EPCOM-MDS-RD --- Disease-Specific (Epilepsy and Epilepsy Comorbidities, MDS, RD), DS-EPSBACID-NPU-MDS-RD --- Disease-Specific (Epilepsy, Structural Brain Abnormalities, Convulsions, Intellectual Disability, NPU, MDS, RD), DS-EPI-MULTI-MDS --- Disease-Specific (Epilepsy Multiple Disorders, MDS), DS-EPASM-MDS --- Disease-Specific (Epilepsy, Antiseizure Medicines, MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-EPASM-MDS-RD --- Disease-Specific (Epilepsy, Antiseizure Medicines, MDS, RD)","2025-08-13","2021-03-26","Epilepsies; Seizure Disorder; Seizure Disorders; epilepsy",""
"phs004100.v1.p1","Single-Cell RNA-Seq Profiling of Peripheral Immune Responses to Severe    Infection in Uganda","We conducted a prospective observational study (RESERVE-U-2-TOR) of adults admitted to Tororo General Hospital in eastern Uganda with severe, undifferentiated infection (i.e., suspected sepsis). Peripheral blood mononuclear cells (PBMCs) were  isolated from freshly collected heparinized whole-blood samples (4 - 5 mL) using a standard density-gradient protocol (STEMCELL Technologies). PBMCs","Not Applicable","Sepsis","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 8 samples sequenced, 8 subjects, 8 samples","","NIAID","GRU-IRB-COL --- General Research Use (IRB, COL)","2025-08-12","2025-08-12","Pyaemia; Pyaemias; Pyemia; Pyemias; Pyohemia; Pyohemias",""
"phs001952.v2.p1","National Cancer Institute (NCI) Early Onset Malignancies Initiative    (EOMI): Molecular profiling of Breast, Colon, Kidney, Liver, Multiple    Myeloma, and Prostate among Racially and Ethnically Diverse    Populations","The Early Onset Malignancies Initiative (EOMI) is focused on collecting specimens from racially and ethnically diverse population groups with six different types of cancer (breast, prostate, colon, liver, kidney, and  multiple myeloma). This initiative is a partnership between the Center for Research Strategy, the Center for Cancer Genomics and the Division of","Not Applicable","Neoplasms","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 222 subjects, 222 samples","","NCI","GRU --- General Research Use","2025-08-08","2025-04-28","Kidney Neoplasms; Liver Neoplasms; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor",""
"phs000829.v1.p1","A Translational, Pharmacodynamic and Pharmacokinetic Phase IB Clinical    Study of Everolimus in Resectable Non-Small Cell Lung Cancer","This phase IB clinical trial studied the pharmacodynamic changes induced by everolimus in patients with previously untreated, resectable non small cell lung cancer. Using a combination of in vivo and  ex vivo assessments with FDG PET, immunohistochemistry and genomic assays, evidence of mTOR pathway perturbation was assessed in patients treated","Not Applicable","Lung Neoplasms","Clinical Trial","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 33 subjects, 28 samples","","NCI","GRU-PUB-MDS --- General Research Use (PUB, MDS)","2025-08-08","2025-08-08","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs004043.v1.p1","Activation-Induced Marker (AIM) Sequencing of Healthy Human T Cells","T cells from five healthy human donors were stimulated with a peptide pool (CEFX, JPT) and anti-CD28/CD49d co-stimulation. Cells were then sorted based on activation (OX40 and PD-L1 for CD4s,  CD137 for CD8s) and labeled with corresponding hashing antibodies prior to sequencing. In total, this dataset encompasses 42,370 cells (12,743","Not Applicable","Antigens, Differentiation, T-Lymphocyte","Methods","imputation_panel","SNP Genotypes (imputed), OTHER, RNA-Seq","4 phenotype datasets, 12 variables, 1 molecular datasets, 12 samples sequenced, 7 subjects, 17 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2025-08-07","2025-08-07","Not Provided",""
"phs003855.v1.p1","Single-Cell RNA-Sequencing of Bone Marrow and Circulating Tumor Cells    from Patients with Multiple Myeloma and its Precursor Conditions","We performed single-cell RNA and V(D)J-sequencing of tumor cells from bone marrow and peripheral blood specimens and patients with Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), and  Multiple Myeloma (MM), as well as healthy donors. In this study we aimed to shed light on the mechanisms underlying tumor cell circulatory capacity","Not Applicable","Multiple Myeloma","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 22 variables, 215 samples sequenced, 97 subjects, 215 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-08-07","2025-08-07","Monoclonal Gammopathy of Undetermined Significance; Smoldering Multiple Myeloma; Asymptomatic monoclonal gammopathy; Benign Monoclonal Gammapathies; Benign Monoclonal Gammapathy; Benign Monoclonal Gammopathies",""
"phs002454.v1.p1","A Prospective Study of the Oral Microbiome and Pancreatic Cancer","Two prospective cohort studies - the Black Women's Health Study and the Southern Community Cohort Study - were used to investigate the oral microbiome in relation to pancreatic cancer risk.  Using a nested case-control study design, 148 cases and 510 matched controls were included (122 Black American pancreatic cancer cases and 409","Not Applicable","Pancreatic Neoplasms","Case-Control","Not Provided","WGS","4 phenotype datasets, 20 variables, 757 samples sequenced, 674 subjects, 757 samples","","NCI","HMB-COL-NPU-GSO --- Health/Medical/Biomedical (COL, NPU, GSO), DS-PACA-PUB-NPU --- Disease-Specific (Pancreatic Cancer, PUB, NPU)","2025-08-07","2025-08-07","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic",""
"phs004124.v1.p1","Human Epilepsy Genetics: Mosaic Mutations in Focal Epilepsy","This study investigates the role of somatic mosaic mutations in human focal epilepsies, including focal cortical dysplasia (FCD) and mesial temporal lobe epilepsy (mTLE). It leverages genomic and single-cell transcriptomic  data from surgically resected brain tissue to identify pathogenic variants and characterize their effects on specific cell types and molecular","Not Applicable","Epilepsies, Partial","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 16 variables, 33 samples sequenced, 25 subjects, 33 samples","","NINDS","HMB --- Health/Medical/Biomedical, DS-NDR --- Disease-Specific (Neurological Disorders Research)","2025-08-06","2025-08-06","Epilepsy, Temporal Lobe; Disorders, Focal Seizure; Disorders, Partial Seizure; Epilepsies, Focal; Epilepsies, Localization-Related; Epilepsy, Focal",""
"phs001891.v1.p1","The Bangladesh Environmental Enteric Dysfunction (BEED) Study","Environmental enteric dysfunction (EED), a sub-acute inflammatory condition of the small intestinal mucosa of unclear etiology, has been associated with a variety of environmental exposures and host factors and is  implicated in growth faltering. Linear growth faltering usually occurs within the first two years of life and in most of the cases is irreversible","Not Applicable","Environment","Case-Control","Not Provided","AMPLICON, RNA-Seq","6 phenotype datasets, 28 variables, 385 samples sequenced,  SRA, 227 subjects, 385 samples","","NIAID","DS-TENT-IRB-PUB-NPU-MDS-GSO-RD --- Disease-Specific (Tropical Enteropathy, IRB, PUB, NPU, MDS, GSO, RD)","2025-08-06","2025-08-06","growth and development; Inflammation; Intestinal Diseases; Malnutrition; growth; Inflammatory Response, Innate",""
"phs004166.v1.p1","Profiling Genome-Wide Circulating ncRNAs for the Early Detection of Lung    Cancer","Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all cases. Although imaging techniques such as low-dose computed  tomography (LDCT), combined with tissue biopsies, have improved early detection rates, current diagnostic approaches are often limited by high","Not Applicable","Lung Neoplasms","Case-Control","Not Provided","miRNA-Seq","4 phenotype datasets, 17 variables, 233 samples sequenced, 233 subjects, 233 samples","","NCI","GRU --- General Research Use","2025-08-05","2025-08-05","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell",""
"phs004112.v1.p1","Collagen Proteostasis in Health and Disease","This study uses human iPSC-derived cartilage to investigate the effects of the p.Arg719Cys mutation in the COL2A1 gene, which is linked to precocious osteoarthritis. Using a CRISPR-edited isogenic cell line  pair, we compared wild-type and mutant cartilage for matrix defects and cellular stress responses. We performed RNA-sequencing and quantitative","Not Applicable","Osteoarthritis","Methods","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 18 samples sequenced, 1 subjects, 18 samples","","NIAMS","GRU --- General Research Use","2025-08-05","2025-08-05","Osteochondrodysplasias; Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides; Degenerative Arthritis",""
"phs004180.v1.p1","National Institute on Aging Genetics of Alzheimer's Disease Data Storage    Site (NIAGADS)","NIAGADS is an NIH controlled-access data repository that collaborates with researchers around the world to facilitate data access and sharing for genomic and associated omics data related to Alzheimer's Disease  (AD), Alzheimer's Disease Related Dementias (ADRD), as well as healthy aging. Serving as the data coordinating center for the Alzheimer's Disease","Not Applicable","Alzheimer Disease","Collection","Not Provided","Not Provided","Not Provided","","NIA","","2025-08-01","","Aging; Amyotrophic Lateral Sclerosis; Cognitive Dysfunction; Dementia; Frontotemporal Dementia; Lewy Body Disease",""
"phs003812.v1.p1","APOBEC Mutagenesis, Kataegis, Chromothripsis in EGFR-Mutant    Osimertinib-Resistant Lung Adenocarcinomas","Expanding on studies investigating apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC) mutagenesis in histological transformation of epidermal growth factor receptor (EGFR)-mutant lung cancers, it has been hypothesized that mutational signature  analysis may help better understand acquired resistance to targeted therapies. Using mutational signature analysis in Receptor Tyrosine Kinase (RTK)","Not Applicable","Transcriptome","Case Set","Not Provided","WGS","4 phenotype datasets, 16 variables, 64 samples sequenced, 27 subjects, 64 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-08-01","2025-08-01","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs003445.v1.p1","Single-Cell Genomic and Transcriptomic Analysis of the Aging Human Brain","We studied human brain aging using single-cell whole genome sequencing and single-nucleus RNA sequencing of the pre-frontal cortex from 19 donors ranging in age from 0.4 years to 104 years.  All donors were free of neuropathology and none received a clinical neurological diagnosis prior to death. snRNA-seq libraries were prepared in","Not Applicable","Aging","Control Set","custom_probe_set","RNA Seq (NGS), WGA, WGS, ssRNA-seq","4 phenotype datasets, 15 variables, 1 molecular datasets, 116 samples sequenced, 19 subjects, 136 samples","","NIA","GRU-IRB --- General Research Use (IRB)","2025-07-31","2025-07-31","DNA Damage; Aging, Biological; Biological Aging; DNA Injuries; DNA Injury; DNA Lesion",""
"phs004172.v1.p1","Genetics and Pathobiology of Disorders of Keratinization","The goal of this study was to identify potential drivers of disorders of keratinization in human. Individuals diagnosed with disorders of keratinization were recruited with no exclusion criteria. Saliva or  blood samples were taken from consented patients or family members and DNA harvested immediately. Whole exome sequencing was performed (150-bp paired","Not Applicable","Erythrokeratodermia Variabilis","Mendelian","Not Provided","WXS","4 phenotype datasets, 14 variables, 2 samples sequenced, 2 subjects, 2 samples","","NIAMS","DS-GSD-GSO --- Disease-Specific (Genetic Skin Disease, GSO)","2025-07-28","2025-07-28","Congenital poikiloderma; Darier-Gottron disease; EKV; EKVP; ERYTHROKERATODERMIA FIGURATA, CONGENITAL FAMILIAL, IN PLAQUES; ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA",""
"phs004109.v1.p1","Copy Number Abnormalities of Chr1 in Multiple Myeloma at the Single Cell    Level","Single-cell whole genome sequencing (scWGS) provides a tool to gain deeper insights into the clonal relationships of Chr1 copy number changes. Here, we study Chr1 copy number alteration (CNA) using  Direct library preparation plus (DLP+), a scalable scWGS platform implemented by image-based object recognition, and open-source computational","Not Applicable","Multiple Myeloma","Case Set","Not Provided","OTHER","4 phenotype datasets, 21 variables, 5 samples sequenced, 5 subjects, 5 samples","","NCI","DS-MM --- Disease-Specific (Multiple Myeloma)","2025-07-28","2025-07-28","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease",""
"phs004044.v1.p1","Single-Cell Atlas of Human Liver and Blood Immune Cells Across Fatty    Liver Disease Stages","The goal of the study was to investigate immunological correlates of human fatty liver disease progression. We generated a single-cell RNA-seq (scRNA-seq) atlas of immune cells from liver fine needle  aspirates (FNAs) and paired peripheral blood mononuclear cells (PBMCs) from a full-spectrum Metabolic Dysfunction-Associated Steatotic Liver Disease","Not Applicable","Non-alcoholic Fatty Liver Disease","Cross-Sectional","Not Provided","RNA-Seq","4 phenotype datasets, 39 variables, 50 samples sequenced, 25 subjects, 50 samples","","NIDDK","HMB --- Health/Medical/Biomedical","2025-07-28","2025-07-28","Fibrosis; Inflammation; Inflammatory Response, Innate; Innate Inflammatory Response; Innate Inflammatory Responses; Fatty Liver, Nonalcoholic",""
"phs003977.v1.p1","Disease-Linked Regulatory DNA Variants and Homeostatic Transcription    Factors in Epidermis","The role of non-coding variants in polygenic skin disease and their connection to homeostatic transcription factors (TFs) in epidermis was investigated. Homeostatic TFs were identified by perturb-seq in differentiating keratinocytes,  using either 10x or split-pool approaches to sequencing, with follow-up validation by siRNA and RNA-seq. TF binding events were profiled by","Not Applicable","Keratinocytes","Collection","Not Provided","OTHER, RNA-Seq","3 phenotype datasets, 18 variables, 475 samples sequenced, 25 subjects, 475 samples","","NHGRI","GRU --- General Research Use","2025-07-28","2025-07-28","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs004075.v1.p1","RNA Transcriptomic and DNA Methylation Landscape in FTLD-TDP and Controls","Frontotemporal lobar degeneration (FTLD) is one of the leading causes of dementia in individuals younger than 65 years, with the aggregation of TDP-43 as one of the most common forms  of FTLD. FTLD-TDP is clinically, genetically and pathologically heterogeneous, with GRN and C9orf72 as the most common genetic forms (although more","Not Applicable","Frontotemporal Lobar Degeneration","Case-Control","Not Provided","Bisulfite-Seq, RNA-Seq","4 phenotype datasets, 18 variables, 458 samples sequenced, 183 subjects, 458 samples","","NINDS","GRU --- General Research Use","2025-07-25","2025-07-25","Frontotemporal Dementia; Complex, Disinhibition-Dementia-Parkinsonism-Amyotrophy; Complex, Disinhibition-Dementia-Parkinsonism-Amytrophy; Complices, Disinhibition-Dementia-Parkinsonism-Amyotrophy; Complices, Disinhibition-Dementia-Parkinsonism-Amytrophy; DDPAC","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003204.v1.p1","Single Cell DNA Methylation Analysis for Forensic Epigenetics","As part of the Epigenetic CHaracterization and Observation (ECHO) program, the Genomic Analysis Laboratory at the Salk Institute generated the DNA methylation profiles of certain PBMC cell types to determine  the change in methylation levels before, during or after exposure to certain biological or chemical agents. Samples from individuals who either","Not Applicable","HIV","Case-Control","Not Provided","Bisulfite-Seq","4 phenotype datasets, 14 variables, 61682 samples sequenced, 105 subjects, 61683 samples","","NIAID","GRU-IRB-COL --- General Research Use (IRB, COL)","2025-07-25","2025-07-25","Anthrax; Influenza; Bacillus anthracis Infection; Bacillus anthracis Infections; Bacillus anthracis caused disease or disorder; Bacillus anthracis disease or disorder",""
"phs001665.v2.p1","Field studies of Cryptosporidiosis and Enteropathogens in Bangladesh","Cryptosporidiosis causes severe diarrhea in infants in the developing world. There is no vaccine to prevent it, and little in the way of treatment. This study on Bangladeshi urban slum  children aims to support the design of a vaccine, both by determining how the immune system protects from infection and by identifying the genotypes","Not Applicable","Environment","Clinical Trial","Not Provided","RNA-Seq","12 phenotype datasets, 89 variables, 6 samples sequenced,  SRA, 519 subjects, 392 samples","","NIAID","DS-TENT-IRB-PUB-NPU-MDS-GSO-RD --- Disease-Specific (Tropical Enteropathy, IRB, PUB, NPU, MDS, GSO, RD)","2025-07-25","2025-07-25","Communicable Diseases; Inflammation; Malnutrition; Communicable Disease; Disease, Communicable; Disease, Infectious",""
"phs000007.v35.p16","Framingham Cohort","Startup of Framingham Heart Study. Cardiovascular disease (CVD) is the leading cause of death and serious illness in the United States. In 1948, the Framingham Heart Study (FHS) -- under  the direction of the National Heart Institute (now known as the National Heart, Lung, and Blood Institute, NHLBI) -- embarked on a novel and","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Affymetrix_expression_array, custom_probe_set, Affymetrix_50K, Affymetrix_100K, Affymetrix_WG_Array, other, imputation_panel, CVDSNP55, WES_markerset_grc37, HumanOmni5-4, target_markerset_grc36, SNP-PCR, HumanMethylation450, WES_markerset_grc36, WGS_markerset_grc36, Axiom_Array, HumanExome-12_plus, WGS_markerset_grc37, custom_PCR_marker_set, Global_Screening_Array-24, WES_markerset_grc38, RNAseq_probe_set_grc38, target_markerset_grc38, proteome","Not Provided","541 phenotype datasets, 91702 variables, 2038 documents, 3029 analyses, 6989 samples sequenced, 15089 subjects, 57930 samples, 13 substudies","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Dementia; Diabetes Mellitus; Heart Diseases; Heart Failure, Congestive; Hypertension; Intermittent Claudication",""
"phs002938.v3.p16","Framingham Heart Study NCBI Molecular QTL Resource","Framingham Heart Study NCBI Molecular QTL Resource Exclusions: no whole genome sequencing, no RNA sequencing, no DNA methylation data (as appropriate); withdrawal of consent. Principal Investigator: Daniel Levy, Population Sciences  Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Framingham, MA, USA Co-Investigators: Roby Joehanes,","Framingham Cohort (phs000007.v35.p16)","Quantitative Trait Loci","Cross-Sectional","Not Provided","Not Provided","Not Provided","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Not Provided",""
"phs002611.v3.p16","Framingham Heart Study RNA Sequencing in Postmortem Brain Tissue","The biology of obesity is complex, involving both environmental and genetic factors and affecting metabolic and endocrine mechanisms in tissues of the gut, adipose, and brain. This study was conducted  to identify transcripts in postmortem human brain tissue associated with obesity status. We conducted both large and small RNA sequencing of","Framingham Cohort (phs000007.v35.p16)","Obesity","Case-Control","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS), miRNA-Seq","1 phenotype datasets, 5 variables, 1 molecular datasets, 166 samples sequenced, 117 subjects, 166 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Not Provided",""
"phs002560.v3.p16","Clinical and Genetic Correlates of the Gut Microbiome and Relation to    Cardiometabolic Risk","The human gut harbors trillions of microbes that play dynamic roles in health. While the microbiome contributes to many cardiometabolic traits by modulating host inflammation and metabolism, there is an  incomplete understanding regarding the extent and mechanisms by which individual microbes impact risk and development of cardiovascular disease","Framingham Cohort (phs000007.v35.p16)","Metagenome","Prospective Longitudinal Cohort","Not Provided","AMPLICON, WGS","2 phenotype datasets, 6 variables, 1277 samples sequenced, 1420 subjects, 2750 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Not Provided",""
"phs002559.v3.p16","Framingham BRain Imaging, cognition, Dementia and next generation    GEnomics (BRIDGET)","The BRIDGET study population comprises six large, richly phenotyped and genotyped prospective cohort studies of middle-aged and older community-dwelling persons: Austrian Stroke Prevention Study [ASPS], Rotterdam Study, Study of Health  in Pomerania [SHIP], 3C-Dijon Study, Lothian Birth Cohort 1936 [LBC1936], and Framingham Heart Study (FHS). The FHS is an external partner","Framingham Cohort (phs000007.v35.p16)","Alzheimer Disease","Prospective Longitudinal Cohort","target_markerset_grc38","OTHER, Methylome sequencing, SNP/CNV Genotypes (NGS)","1 phenotype datasets, 4 variables, 2 molecular datasets, 197 samples sequenced, 197 subjects, 197 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases",""
"phs002558.v3.p16","Framingham CHARGE Alzheimer's Disease Sequencing Project (ADSP)","To identify novel genetic variation influencing AD risk and protection, the Alzheimer's Disease Sequencing Project (ADSP) was implemented as a collaborative effort of the National Institutes on Aging, the National  Human Genome Research Institute, and the Alzheimer disease research community. Study design and sample selection were conducted to address issues of","Framingham Cohort (phs000007.v35.p16)","Alzheimer Disease","Case Set","WES_markerset_grc38","SNP Genotypes (NGS)","1 phenotype datasets, 4 variables, 1 molecular datasets, 581 subjects, 581 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases",""
"phs001610.v6.p16","Type 2 Diabetes Genetic Exploration by Next Generation Sequencing in    Multi-Ethnic Samples (T2D-GENES) Follow-up Study: Framingham Heart    Study","This substudy phs001610 Framingham T2D-GENES contains next-generation sequencing in multi-ethnic samples. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study page phs000007 Framingham  Cohort. Individual level phenotype data and molecular data for all Framingham top-level study and substudies are available by requesting Authorized","Framingham Cohort (phs000007.v35.p16)","Diabetes Mellitus, Type 2","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 14 variables, 1 molecular datasets, 986 samples sequenced, 989 subjects, 989 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000724.v12.p16","Framingham Offspring Exam 8 and Generation 3 Exam 2 450K Array DNA    Methylation Study","This substudy phs000724 Framingham DNA Methylation contains raw 450K offspring DNA methylation data as well as processed DNA methylation in both offspring and generation3 (Gen3) participants. 850K array DNA methylation  data in both offspring and Gen3 can be found under the FHS substudy phs000974 NHLBI TOPMed: The Framingham Heart Study. Summary level phenotypes for","Framingham Cohort (phs000007.v35.p16)","Epigenomics","Prospective Longitudinal Cohort","HumanMethylation450","Methylation (CpG)","2 phenotype datasets, 38 variables, 2 molecular datasets, 4208 subjects, 6829 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Cardiovascular Diseases; Heart Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs000651.v15.p16","Building on GWAS: the U.S. CHARGE Consortium - Sequencing (CHARGE-S): FHS","This substudy phs000651 Framingham CHARGE-S contains whole genome, whole exome, and targeted sequence data, produced as part of NHLBI's CHARGE-S project. Summary level phenotypes for the Framingham Cohort study participants  can be viewed at the top-level study page phs000007 Framingham Cohort. Individual level phenotype data and molecular data for all Framingham","Framingham Cohort (phs000007.v35.p16)","Cardiovascular Diseases","Prospective Longitudinal Cohort","target_markerset_grc36, WES_markerset_grc36, WGS_markerset_grc36, WGS_markerset_grc37, WES_markerset_grc37","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WGS, WXS","5 phenotype datasets, 40 variables, 7 molecular datasets, 2512 samples sequenced, 2515 subjects, 2515 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Atherosclerosis; Atrial Fibrillation; Heart Failure, Congestive; Hypertension; Osteoporosis; Pulmonary Disease, Chronic Obstructive",""
"phs000401.v18.p16","National Heart Lung and Blood Institute (NHLBI) GO-ESP: Heart Cohorts    Component of the Exome Sequencing Project (FHS)","This substudy phs000401 Framingham ESP Heart-GO contains exome sequence data and harmonized phenotype variables, produced as part of NHLBI's GO-ESP project. Summary level phenotypes for the Framingham Cohort study participants  can be viewed at the top-level study page phs000007 Framingham Cohort. Individual level phenotype data and molecular data for all Framingham","Framingham Cohort (phs000007.v35.p16)","Cardiovascular Diseases","Prospective Longitudinal Cohort","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 110 variables, 2 molecular datasets, 459 samples sequenced, 459 subjects, 715 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Brain Ischemia; Myocardial Infarction; Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies",""
"phs000363.v22.p16","SABRe CVD","This substudy phs000363 Framingham SABRe contains immunoassays, gene expression profiling, and microRNA data. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study page  phs000007 Framingham Cohort. Individual level phenotype data and molecular data for all Framingham top-level study and substudies are available by","Framingham Cohort (phs000007.v35.p16)","Cardiovascular Diseases","Prospective Longitudinal Cohort","Affymetrix_expression_array, custom_probe_set, HumanMethylation450","miRNA Expression (Array), mRNA Expression (Array)","21 phenotype datasets, 1404 variables, 73 documents, 4 molecular datasets, 7496 subjects, 11222 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Myocardial Infarction; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs000342.v23.p16","NHLBI Framingham SNP Health Association Resource (SHARe)","This substudy phs000342 Framingham SHARe contains a large number of historical and contemporary FHS genotypes. These include 100K, 550K, HumanOmni5M-4v1, HumanExome BeadChip v1.0, Affymetrix Axiom Genome-Wide BioBank, and Illumina Global  Screening array sets; three different imputed data sets; focused genotype sets including apoE, genotypes of rare type 2 diabetes (T2D) associated","Framingham Cohort (phs000007.v35.p16)","Cardiovascular Diseases","Prospective Longitudinal Cohort","Affymetrix_50K, Affymetrix_100K, Affymetrix_WG_Array, other, imputation_panel, HumanOmni5-4, SNP-PCR, Axiom_Array, HumanExome-12_plus, custom_PCR_marker_set, Global_Screening_Array-24, proteome","SNP Genotypes (Array), SNP/CNV (Array), SNP Genotypes (imputed), Legacy Genotypes, Metabolomics, SNP Genotypes (PCR), Proteomics","7 phenotype datasets, 28 variables, 2812 analyses, 13 molecular datasets, 11038 subjects, 34739 samples","European (4616), African (3), East Asian (105), African American (269), Hispanic1 (134), Hispanic2 (158), Other Asian or Pacific Islander (22), South Asian (84), Other (62)","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Dementia; Diabetes Mellitus; Heart Diseases; Heart Failure, Congestive; Hypertension; Intermittent Claudication",""
"phs000307.v20.p16","Framingham Heart Study Allelic Spectrum Project","This substudy phs000307 Framingham Allelic Spectrum Project includes the generation of deep coverage targeted re-sequencing and variant identification for 216 genes in the Framingham Heart Study (FHS) sample collection, produced  as part of NHLBI's Medical Resequencing projects. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the","Framingham Cohort (phs000007.v35.p16)","Cardiovascular Diseases","Prospective Longitudinal Cohort","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","1 phenotype datasets, 4 variables, 1 molecular datasets, 1623 samples sequenced, 1623 subjects, 1623 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs000282.v24.p16","NHLBI Framingham Candidate Gene Association Resource (CARe)","This substudy phs000282 Framingham CARe contains 50K genotypes from 2,100 candidate genes across a range of cardiovascular, metabolic, and inflammatory syndromes, produced as part of NHLBI's Candidate Gene Association Resource  (CARe) project. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study page phs000007 Framingham","Framingham Cohort (phs000007.v35.p16)","Cardiovascular Diseases","Prospective Longitudinal Cohort","CVDSNP55","SNP Genotypes (Array)","1 molecular datasets, 8490 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-07-25","2025-07-25","Dementia; Diabetes Mellitus; Heart Diseases; Heart Failure, Congestive; Hypertension; Intermittent Claudication",""
"phs003397.v2.p1","Studies of L1-mediated Pseudogene Formation in Human HeLa Cells","Alu elements mobilize from one genomic location to another by a ""copy-and-paste"" mechanism known as retrotransposition, which requires the human Long INterspersed Element-1 (LINE-1 or L1) ORF2-encoded protein (ORF2p); however,  little is known about other cellular factors required for Alu retrotransposition. Isolates of HeLa cells differ in their ability to support Alu","Not Applicable","HeLa Cells","Collection","Not Provided","WGS","3 phenotype datasets, 14 variables, 4 samples sequenced, 1 subjects, 4 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs003396.v2.p1","Intratumoral Heterogeneity and Clonal Evolution Induced by HPV    Integration","The human papillomavirus (HPV) genome is integrated into host DNA in most HPV-positive cancers, but the consequences for chromosomal integrity are unknown. We used continuous long-read sequencing of oropharyngeal cancers  and cervical cancer cell lines to resolve structural variation induced by HPV. We discovered a previously undescribed form of structural variation,","Not Applicable","Human Papillomavirus Viruses","Case Set","Not Provided","WGS","3 phenotype datasets, 15 variables, 3 samples sequenced, 1 subjects, 3 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs002099.v3.p1","Systematic Analysis of Transcription Program Regulation by Transcription    Factor EB (TFEB)","In order to evaluate the effects of TFEB, a master regulator of autophagy and lysosomal biogenesis, CRISPR-Cas9 TFEB knock out cell lines were generated and reconstituted with wild-type TFEB (TFEB-WT),  a vector control (TFEB-KO) or TFEB engineered to remain localized to the cytosol (TFEB-cyto) or to the nucleus (TFEB-nuc). RNA sequencing was","Not Applicable","TFEB protein, human","Metagenomics","Not Provided","RNA-Seq","3 phenotype datasets, 14 variables, 162 samples sequenced, 1 subjects, 162 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Bacterial Infections; Bacteria caused disease or disorder; Bacteria disease or disorder; Bacteria infectious disease; Bacterial Disease; Bacterial Diseases","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs002014.v4.p1","High Resolution Analysis of Spatial Interactions of Hundreds of Promoters    in HeLa Cells","In this study we developed a new hybridisation-based promoter Capture-C protocol that makes use of biotinylated dsDNA probes and allows high-resolution promoter interactome description. Experiments aimed to describe spatial interactions  of set of 861 promoters were performed in HeLa cells. We have found that enrichment efficiency and quality of final libraries in our study is on a","Not Applicable","Promoter Regions, Genetic","Case Set","Not Provided","WGS","3 phenotype datasets, 10 variables, 4 samples sequenced, 1 subjects, 4 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs001974.v8.p1","NHLBI TOPMed: Genomic Summary Results for the Trans-Omics for Precision    Medicine Program","The NHLBI Trans-Omics for Precision Medicine (TOPMed) program aims to identify the genetic basis of variation in biomedical phenotypes, with emphasis on those related to heart, lung, blood and sleep  disorders, as part of a broader Precision Medicine Initiative. The TOPMed program has provided whole genome sequencing (WGS) to over 80 different","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Provided","2910 analyses, 1 molecular datasets","","NHLBI","GRU --- General Research Use","2025-07-24","2021-02-10","Hematologic Diseases; Respiratory Tract Diseases; Sleep Wake Disorders; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs001944.v5.p1","Characterization of a New Case of XMLV (Bxv1) Contamination in the Human    Cell Line Hep2 (Clone 2B) Using High-Throughput DNA- and RNA-Seq","We have sequenced DNA and RNA from the Hep2 (clone 2B) cell line (Sigma-Aldrich catalog number: 85011412-1VL) using short read Illumina sequencing. We show that this cell line is indistinguishable  from the HeLa cell line (as mentioned on the Sigma-Aldrich website) by mapping integrations of the human papillomavirus 18. We also show that the","Not Applicable","HeLa Cells","Case Set","Not Provided","RNA-Seq, WGS","3 phenotype datasets, 15 variables, 2 samples sequenced, 1 subjects, 2 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs001671.v6.p1","RNA Ligation Precedes U6 snRNA/LINE-1 Retrotransposition","Long Interspersed Element-1 (L1) retrotransposons make up approximately 17% of the human genome. L1 moves throughout the genome via a copy-and-paste mechanism termed retrotransposition. L1 retrotransposition also mobilizes other cellular  RNAs such as SINES, U6 snRNA and, mRNA, which for the latter results in the formation of processed pseudogenes. In this study we demonstrate that the","Not Applicable","Retroelements","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 12 variables, 3 samples sequenced, 1 subjects, 3 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs001669.v6.p1","Examination of Engineered LINE-1 Integration Events in HeLa Cells","Long Interspsesed Element-1 (LINE1 or L1) encodes two proteins (ORF1p and ORF2p) required for its mobilization (i.e. retrotransposition) in the human genome. Human ORF2p, a 150kDa protein, has endonuclease (EN)  and reverse transcriptase (RT) activities. L1 EN is classified as apurinic/apyrimidin-like endonuclease (APE) and is responsible for initiating","Not Applicable","Long Interspersed Nucleotide Elements","Case Set","Not Provided","OTHER, Tn-Seq","3 phenotype datasets, 13 variables, 9 samples sequenced, 1 subjects, 9 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs001520.v6.p1","Bacterial Artificial Chromosomes Establish Replication Timing and    Sub-Nuclear Compartment De Novo as Extra-Chromosomal Vectors","The role of DNA sequence in determining replication timing (RT) and chromatin higher order organization remains elusive. To address this question, we have developed an extra-chromosomal replication system consisting of  200kb human bacteria artificial chromosomes (BACs) modified with Epstein-Barr virus (EBV) replication origin elements (E-BACs). E-BACs were stably","Not Applicable","DNA Replication Timing","Methods","Not Provided","ChIP-Seq, OTHER","3 phenotype datasets, 12 variables, 38 samples sequenced, 1 subjects, 38 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs001450.v7.p1","Identification of G-Quadruplex Clusters by High-Throughput Sequencing of    Whole-Genome Amplified Products with a G-Quadruplex Ligand","G-quadruplex (G4) is a non-canonical DNA structure that has been found in the genome. To identify clusters of G4-forming sequences in the genome, we performed whole genome amplification (WGA) in  the presence or absence of a G4 ligand that inhibits DNA polymerase activity on the G4 forming regions, followed by high-throughput sequencing of the","Not Applicable","Uterine Cervical Neoplasms","Case Set","Not Provided","WGA","3 phenotype datasets, 14 variables, 2 samples sequenced, 1 subjects, 2 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs001269.v8.p1","Massively Multiplex Single-Cell Hi-C of HeLa Cells","In this study, we developed a massively multiplexed, single-cell Hi-C protocol to study the chromosomal architecture of single HeLa cells. HeLa studies can be requested individually by study accession (phs######.v#.p#)  or by applying to the HeLa Collection using phs000640, which will provide access to all HeLa studies in dbGaP. Approved users of these data should","Not Applicable","Uterine Cervical Neoplasms","Case Set","Not Provided","OTHER","3 phenotype datasets, 19 variables, 6 samples sequenced, 1 subjects, 6 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs001268.v8.p1","Construction of Thousands of Single Cell Genome Sequencing Libraries    Using Combinatorial Indexing","Single-cell genome sequencing has proven valuable for the detection of somatic variation, particularly in the context of tumor evolution. Current technologies suffer from high library construction costs which restrict the  number of cells that can be assessed and thus impose limitations on the ability to measure heterogeneity within a tissue. Here, we present Single","Not Applicable","Uterine Cervical Neoplasms","Case Set","Not Provided","WGS","3 phenotype datasets, 19 variables, 1 samples sequenced, 1 subjects, 1 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs001029.v10.p1","The Heterogeneity Study of HeLa S3 Cells Based on Full-Length Single-Cell    RNA-Seq","In this study, we produced full-length RNA-seq data of 45 single HeLa S3 cells, 8 replicates of 10 pg total RNA and one 5 ng total RNA from HeLa S3  cell population. Using this data, we investigated the heterogeneity of HeLa S3 cells in gene expression, alternative splicing, fusion and HPV-host","Not Applicable","Uterine Cervical Neoplasms","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 15 variables, 60 samples sequenced, 1 subjects, 60 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Papillomavirus Infections; HPV; HPV (human papillomavirus) disease; HPV (human papillomavirus) infection; HPV Infection; HPV Infections","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs001010.v9.p1","High Resolution Maps of the HeLa 3D Genome Using Hi-C","We use in situ Hi-C to probe the three-dimensional architecture of genomes, constructing haploid and diploid maps of nine cell types (including HeLa). The densest, in human lymphoblastoid cells, contains  4.9 billion contacts, achieving 1-kilobase resolution. We find that genomes are partitioned into contact domains (median length, 185kb), which are","Not Applicable","Uterine Cervical Neoplasms","Case Set","Not Provided","OTHER","3 phenotype datasets, 14 variables, 4 samples sequenced, 1 subjects, 4 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs000665.v11.p1","HeLa S3 (CCL-2.2) HiC Sequencing","HiC chromatin conformation sequencing was performed for the purpose of chromosome fusion and structural rearrangement identification. HeLa studies can be requested individually by study accession (phs######.v#.p#) or by applying to  the HeLa Collection using phs000640, which will provide access to all HeLa studies in dbGaP. Approved users of these data should include the","Not Applicable","Uterine Cervical Neoplasms","Case Set","Not Provided","OTHER","5 phenotype datasets, 19 variables, 1 samples sequenced, 1 subjects, 1 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs000643.v12.p1","The Genomic and Transcriptomic Landscape of a HeLa Cell Line","HeLa is the most widely used model cell line for studying human cellular and molecular biology. To date, no genomic reference for this cell line has been released, and experiments  have relied on the human reference genome. Effective design and interpretation of molecular genetic studies performed using HeLa cells require","Not Applicable","Uterine Cervical Neoplasms","Case Set","WGS_markerset_grc37","RNA-Seq, SNP Genotypes (NGS), WGS","3 phenotype datasets, 10 variables, 1 molecular datasets, 1 samples sequenced, 1 subjects, 1 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs000642.v12.p1","The Haplotype-Resolved Genome and Epigenome of the Aneuploid HeLa Cancer    Cell Line","The genomic architecture of HeLa remains largely unexplored beyond its karyotype, partly because like many cancers, its extensive aneuploidy renders such analyses challenging. We carried out haplotype-resolved whole-genome sequencing of  the HeLa CCL-2 strain, examined point- and indel-mutation variations, mapped copy-number variations and loss of heterozygosity regions, and phased","Not Applicable","Uterine Cervical Neoplasms","Case Set","WGS_markerset_grc37","CLONEEND, OTHER, POOLCLONE, RNA-Seq, SNP Genotypes (NGS), WGS","3 phenotype datasets, 10 variables, 1 molecular datasets, 10 samples sequenced, 1 subjects, 12 samples","","OD","HMB --- Health/Medical/Biomedical","2025-07-24","2025-07-24","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms","HeLa Cell Genome Sequencing Studies (phs000640.v12.p1)"
"phs004114.v1.p1","Pyoderma Gangrenosum Caused by Molecular Uncoupling of OTULIN Catalytic    Activity and LUBAC Binding","This is a single-cell RNA sequencing (scRNA-seq) study using peripheral blood mononuclear cells (PBMC) from 3 healthy donors and 2 patients with OTULIN-related Pyoderma Gangrenosum (ORP). Samples were not hashed  or multiplexed. The 10X Genomics Platform was used for sequencing. Principal findings include transcriptome changes due to a mutation in OTULIN that","Not Applicable","Single-Cell Gene Expression Analysis","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 11 variables, 5 samples sequenced, 5 subjects, 5 samples","","NIGMS","HMB --- Health/Medical/Biomedical","2025-07-23","2025-07-23","Not Provided",""
"phs003863.v1.p1","Symptom Clusters in Oncology Patients Receiving Chemotherapy","The parent longitudinal study evaluated the symptom experience of oncology outpatients receiving chemotherapy. Patients completed questionnaires in their homes a total of six times (assessments 1 through 6). The questionnaires  were timed to evaluate symptoms associated with the receipt of two cycles of chemotherapy that were administered approximately a month apart.","Not Applicable","Symptom Assessment","Prospective Longitudinal Cohort","RNAseq_gene_transcripts, MethylationEPIC","Methylation (CpG), RNA Seq (NGS)","5 phenotype datasets, 101 variables, 1 molecular datasets, 1170 subjects, 1843 samples","","NCI","HMB-IRB-PUB-NPU --- Health/Medical/Biomedical (IRB, PUB, NPU)","2025-07-23","2025-07-23","Fatigue; Risk Factors; Blastoma; CA; CA - Cancer; Cancer",""
"phs004063.v1.p1","DNA Repair Capacity for Lung Disease Risk Assessment","A focus of this work was to address the extent to which susceptibility for lung cancer varies by gene-environment-phenotype interactions involving DNA repair capacity and differences in risk from environmental  stressors. GWAS from a subset of subjects from the Lovelace Smokers Cohort and New Mexico Lung Cancer cohort were used to derive polygenic risk","Not Applicable","Lung Neoplasms","Case-Control","custom_markerset","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 15 variables, 1 molecular datasets, 441 subjects, 441 samples","","NCI","DS-LC-NPU --- Disease-Specific (Lung Cancer, NPU)","2025-07-21","2025-07-21","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs003472.v1.p1","Impact of Genomic Variation on Function (IGVF) Consortium","The IGVF (Impact of Genomic Variation on Function) Consortium aims to understand how genomic variation affects genome function, which in turn impacts phenotype. The NHGRI is funding this collaborative program  that brings together teams of investigators who will use state-of-the-art experimental and computational approaches to model, predict, characterize","Not Applicable","Genomic Structural Variation","Collection","Not Provided","Not Provided","Not Provided","","NHGRI","GRU-PUB-NPU --- General Research Use (PUB, NPU), GRU --- General Research Use, HMB --- Health/Medical/Biomedical, HMB-MDS --- Health/Medical/Biomedical (MDS), GRU-PUB --- General Research Use (PUB)","2025-07-21","","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001662.v4.p2","NHLBI TOPMed: Lung Tissue Research Consortium (LTRC)","Chronic obstructive pulmonary disease (COPD), a disease state characterized by airflow limitation that is not fully reversible, is the third leading cause of death in the U.S. COPD is a  heterogeneous syndrome, with affected individuals demonstrating marked differences in lung structure (emphysema vs. airway disease); physiology","Not Applicable","Pulmonary Disease, Chronic Obstructive","Case-Control","WGS_markerset_grc38, MethylationEPIC, proteome, RNAseq_probe_set_grc38","Methylation (CpG), Metabolomics, Proteomics, RNA-Seq, SNP/CNV Genotypes (NGS), CNV (NGS), RNA Seq (NGS), WGS","27 phenotype datasets, 1577 variables, 3 documents, 6 molecular datasets, 2952 samples sequenced, 1609 subjects, 8675 samples","European (1386), African (2), East Asian (1), African American (86), Hispanic1 (12), Hispanic2 (21), Other Asian or Pacific Islander (1), South Asian (5), Other (3)","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-07-18","2025-07-18","Lung Diseases, Interstitial; Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary; FIBROCYSTIC PULMONARY DYSPLASIA; FIBROSING ALVEOLITIS, CRYPTOGENIC","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs004085.v1.p1","Idiopathic Pulmonary Fibrosis Network (IPFNet) Sildenafil Trial of    Exercise Performance in Idiopathic Pulmonary Fibrosis    (IPFNet-STEP-IPF-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: The  STEP-IPF study sought to evaluate whether treatment with sildenafil would improve walk distance, dyspnea, and quality of life in participants with","Not Applicable","Idiopathic Pulmonary Fibrosis","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 180 subjects, 180 samples","","NHLBI","GRU --- General Research Use","2025-07-17","2025-07-17","Lung Diseases; Pulmonary Fibrosis; Respiratory Tract Diseases; Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary",""
"phs003929.v1.p1","Re-Evaluation of Systemic Early Neuromuscular Blockade","This study of the ROSE trial data explored two distinct molecular subtypes of ARDS (Acute Respiratory Distress Syndrome) to better understand the disease's complexity and potential for personalized treatment. Previous  studies had identified different inflammatory profiles in ARDS patients, with this research addressing three key questions: 1. Can these molecular","Not Applicable","Sequence Analysis, RNA","Case-Control","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 128 subjects, 221 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2025-07-17","2025-07-17","Respiratory Distress Syndrome; Distress Syndrome, Respiratory; Distress Syndromes, Respiratory; Lung, Shock; Respiratory Distress Syndromes; Shock Lung",""
"phs003868.v1.p1","Genomic Analysis of Relapsed/Refractory DLBCL","Molecular phenotyping techniques have established a landscape of genomic variants in diagnostic Diffuse Large B Cell Lymphoma (DLBCL), however these have not yet been applied in large scale studies of  relapsed/refractory DLBCL resulting in incomplete characterization of mechanisms driving tumor progression and treatment resistance. Here, we","Not Applicable","Lymphoma, Non-Hodgkin","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 19 variables, 220 samples sequenced, 87 subjects, 220 samples","","NCI","GRU --- General Research Use","2025-07-17","2025-07-17","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum Cell Sarcomas; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003641.v1.p1","Collagen XVII Promotes Pancreatic Cancer Through Regulation of PIK3R5","Pancreatic ductal adenocarcinoma (PDAC) contains a desmoplastic stroma that promotes the aggressive biology of this disease. While the varied mechanisms by which fibrillar collagens contribute to PDAC have been defined,  little is known about the contribution of transmembrane collagens. Among this class of collagens, Collagen XVII uniquely contains an extensive","Not Applicable","Pancreatic Neoplasms","Xenograft","Not Provided","RNA-Seq","3 phenotype datasets, 17 variables, 10 samples sequenced, 1 subjects, 10 samples","","NCI","DS-PAD --- Disease-Specific (Pancreatic Disease)","2025-07-17","2025-07-17","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic",""
"phs003045.v2.p2","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Coronary    Artery Risk Development in Young Adults Study (CARDIA)","Cohort Description The Coronary Artery Risk Development in Young Adults (CARDIA) study is a study examining the development and determinants of clinical and subclinical cardiovascular disease and their risk factors.  It began in 1985-6 with a group of 5115 black and white men and women aged 18-30 years. The participants were selected so that there would be","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2714 subjects, 2714 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2025-07-17","2024-10-11","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs001408.v1.p1","Ultrasensitive Detection of Aberrant Cells in Remission Causing AML    Relapse","Acute myelogenous leukemia (AML) is a hematological malignancy that often responds well to initial treatment in which patients achieve a complete remission (CR). Nevertheless, most patients will relapse after achieving  a CR, which is often fatal. This minimal residual disease (MRD) that remains after CR is likely the source of relapse and so improved measurement and","Not Applicable","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 16 variables, 38 samples sequenced, 19 subjects, 38 samples","","NCI","DS-AML-IRB-NPU-MDS --- Disease-Specific (Acute Myelogenous Leukemia, IRB, NPU, MDS)","2025-07-17","2025-07-17","Neoplasm, Residual; Recurrence; AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia",""
"phs001300.v5.p1","NABEC: North American Brain Expression Consortium","This study utilized neurologically normal control samples deposited in North American Brain Expression Consortium (NABEC). This top-level study, phs001300, makes available all phenotype data of the NABEC study participants. In  addition, molecular data from the substudies, listed above, are available. Neurologically normal control individuals only. Note: Raw sequencing data,","Not Applicable","Gene Expression Profiling","Control Set","HumanHap550, Human610-Quad, Human660W-Quad, WES_markerset_grc37, Neuro_Consortium_Array, WGS_markerset_grc38","Not Provided","3 phenotype datasets, 10 variables, 1858 samples sequenced, 432 subjects, 2280 samples, 8 substudies","","NIA","GRU --- General Research Use","2025-07-16","2022-03-17","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs001158.v4.p2","Human Dorsal Root Ganglion RNA Landscape Profiling for Neuropathic and    Chronic Pain","Bulk and spatial RNA sequencing were performed on human Dorsal Root Ganglia (DRGs), peripheral sensory nerves and nodose ganglia and relative gene abundances were calculated. Various analyses were performed: 1.  Human DRG gene expression profiles were contrasted with a panel of gene expression profiles of relevant tissues in human and mouse (integrating,","Not Applicable","Chronic Pain","Case-Control","Not Provided","RNA-Seq, miRNA-Seq","4 phenotype datasets, 36 variables, 186 samples sequenced, 111 subjects, 186 samples","","NINDS","GRU --- General Research Use","2025-07-16","2017-07-28","Diabetic Neuropathies; Neuralgia; Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003181.v2.p1","NABEC Long-Read Whole-Genome Sequencing","The North American Brain Expression Consortium (NABEC) provides a richly phenotyped collection of neuropathologically normal post-mortem brain samples that has underpinned more than a decade of genomic and transcriptomic research.  Previous NABEC data releases include bulk RNA-seq, array genotypes, short-read whole-genome sequencing (WGS), and Cap Analysis of Gene Expression","NABEC: North American Brain Expression Consortium (phs001300.v5.p1)","Brain","Control Set","Not Provided","Not Provided","Not Provided","","NIA","GRU --- General Research Use","2025-07-16","2022-03-17","Not Provided",""
"phs002636.v4.p1","NABEC Whole-Genome Sequencing","NABEC whole-genome DNA sequencing was done in 354 neurologically normal control samples deposited in North American Brain Expression Consortium (NABEC). The DNA comes from brain tissue. The whole-genome sequencing data  was generated and provided by the laboratory of Neurogenetics, NIA, NIH. Principal Investigator: Andrew B. Singleton, PhD, Center for","NABEC: North American Brain Expression Consortium (phs001300.v5.p1)","Nervous System Diseases","Control Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","1 phenotype datasets, 4 variables, 2 molecular datasets, 354 samples sequenced, 354 subjects, 354 samples","European (346), African American (2), Hispanic1 (2), Hispanic2 (2), Other Asian or Pacific Islander (1), Other (1)","NIA","GRU --- General Research Use","2025-07-16","2022-03-17","Disease, Nervous System; Diseases, Nervous System; Disorder, Nervous System; Disorder, Neurologic; Disorder, Neurological; Disorders, Nervous System",""
"phs001462.v5.p1","NABEC: NeuroChip Genotyping","This study describes the design, application and implementation of the NeuroChip genotyping platform. The NeuroChip (Illumina) is an affordable, high-throughput genotyping array that contains a tagging variant backbone (n 300,000  variants) as well as manually curated custom variant content. These custom variants have been previously reported in diverse neurological diseases.","NABEC: North American Brain Expression Consortium (phs001300.v5.p1)","Molecular Probe Techniques","Control Set","Neuro_Consortium_Array","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 1 molecular datasets, 270 subjects, 270 samples","","NIA","GRU --- General Research Use","2025-07-16","2022-03-17","Not Provided",""
"phs001354.v5.p1","NABEC: Total RNA Sequencing of Human Cerebral Frontal Cortex","TotalRNA Sequencing was performed in 276 neurologically normal control samples deposited in North American Brain Expression Consortium (NABEC). The DNA comes from cerebral frontal cortex. The total RNA sequencing data  was generated and provided by the laboratory of Neurogenetics, NIA, NIH. Principal Investigators: Mark R. Cookson, PhD, Laboratory of Neurogenetics,","NABEC: North American Brain Expression Consortium (phs001300.v5.p1)","Healthy Volunteers","Control Set","Not Provided","RNA-Seq, RNA-Seq","1 phenotype datasets, 4 variables, 483 samples sequenced, 276 subjects, 483 samples","","NIA","GRU --- General Research Use","2025-07-16","2022-03-17","Not Provided",""
"phs001353.v5.p1","NABEC: mRNA Sequencing of Human Cerebral Frontal Cortex","mRNA Sequencing was performed in 69 neurologically normal control samples deposited in North American Brain Expression Consortium (NABEC). The DNA comes from cerebral frontal cortex. The mRNA sequencing data was  generated and provided by the laboratory of Neurogenetics, NIA, NIH. Inclusion Criterion: Neurologically normal control individuals only. Principal","NABEC: North American Brain Expression Consortium (phs001300.v5.p1)","Healthy Volunteers","Control Set","Not Provided","RNA-Seq, RNA-Seq","1 phenotype datasets, 4 variables, 69 samples sequenced, 69 subjects, 69 samples","","NIA","GRU --- General Research Use","2025-07-16","2022-03-17","Not Provided",""
"phs001302.v5.p1","NABEC: Comprehensive Promoter Level Expression Quantitative Trait Loci    Analysis of the Human Frontal Lobe","In this paper (Blauwendraat et al., 2016, PMID: 27287230) we describe a comprehensive promoter level expression quantitative trait loci analysis of the human frontal lobe. Correlations are made between common  genetic variability across the human genome and gene expression values obtained from neurologically normal human frontal cortex brain. Genotypes were","NABEC: North American Brain Expression Consortium (phs001300.v5.p1)","Not Provided","Control Set","Not Provided","RNA-Seq, RNA-Seq","1 phenotype datasets, 4 variables, 142 samples sequenced, 142 subjects, 142 samples","","NIA","GRU --- General Research Use","2025-07-16","2022-03-17","",""
"phs001301.v5.p1","NABEC: Exome Sequencing of North American Brain Expression Consortium    (NABEC) Subjects","Genome wide exome DNA sequencing was done in 343 neurologically normal control samples deposited in North American Brain Expression Consortium (NABEC). The DNA comes from cerebral frontal cortex. The exome  sequencing data was generated and provided by the laboratory of Neurogenetics, NIA, NIH. Neurologically normal control individuals only. Principal","NABEC: North American Brain Expression Consortium (phs001300.v5.p1)","Not Provided","Control Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","1 phenotype datasets, 4 variables, 1 molecular datasets, 492 samples sequenced, 343 subjects, 835 samples","","NIA","GRU --- General Research Use","2025-07-16","2022-03-17","",""
"phs000249.v7.p1","NABEC: Genome-Wide Genotyping","This sub-study contains genotypes for 382 neurologically healthy control samples deposited from the North American Brain Expression Consortium (NABEC). Here, we release the raw genotype data of these control individuals  where the genotypes were assayed on Illumina genome-wide genotyping arrays. Previous Study Name: Abundant Quantitative Trait Loci Exist for DNA","NABEC: North American Brain Expression Consortium (phs001300.v5.p1)","Healthy Volunteers","Control Set","HumanHap550, Human610-Quad, Human660W-Quad, WES_markerset_grc37","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 9 variables, 4 molecular datasets, 318 samples sequenced, 382 subjects, 1013 samples","","NIA","GRU --- General Research Use","2025-07-16","2022-03-17","DNA Methylation",""
"phs004080.v1.p1","Prevention and Early Treatment of Acute Lung Injury (PETAL) Crystalloid    Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) (PETAL    CLOVERS-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Access to  Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from PETAL CLOVERS","Not Applicable","Shock, Septic","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1563 subjects, 1563 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-07-15","2025-07-15","Endotoxin Shock; Endotoxin Shocks; Gram-negative septic shock; Gram-negative shock; Shock, Endotoxic; Shock, Endotoxin",""
"phs004018.v1.p1","The Oral Microbiome and Head and Neck Cancer","Oral microbiota may influence head and neck squamous cell carcinoma (HNSCC) development, potentially related to carcinogen metabolism. The human oral cavity hosts a diverse microbiota, including bacteria and fungi. We  performed shotgun sequencing and ITS1 sequencing on 236 HNSCC case participants who developed HNSCC during a mean follow-up of 5.1 years and 458","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Case-Control","Not Provided","AMPLICON, WGS","4 phenotype datasets, 25 variables, 694 samples sequenced, 694 subjects, 694 samples","","NCI","HMB-IRB-COL --- Health/Medical/Biomedical (IRB, COL), HMB-IRB --- Health/Medical/Biomedical (IRB)","2025-07-15","2025-07-15","Head Neoplasm; Head Neoplasms; Neoplasm, Head; Neoplasms, Head; Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx",""
"phs003897.v1.p1","Oncogenome of Kaposi Sarcoma","Kaposi Sarcoma (KS) is an aggressive cancer caused by the Kaposi Sarcoma Herpesvirus (KSHV/HHV-8). Individuals with immunodeficiencies, exemplified by HIV, have an elevated risk of developing KS. However, understanding of  the genetic factors contributing to KS progression is still limited. To explore potential genetic alterations in KS that could offer biological or","Not Applicable","Sarcoma, Kaposi","Tumor vs. Matched-Normal","Not Provided","WXS","4 phenotype datasets, 30 variables, 137 samples sequenced, 59 subjects, 137 samples","","NCI","GRU --- General Research Use","2025-07-15","2025-07-15","Kaposi Sarcoma; African lymphadenopathic Kaposi's sarcoma; HHV8; KS; KS - Kaposi's sarcoma; KSHV",""
"phs004036.v1.p1","Omic Studies in Children's Respiratory and Environmental Workgroup (CREW)    Cohorts","Children's Respiratory Research Workgroup (CREW) is an NIH-funded project consisting of multiple individual U.S. cohorts and three scientific centers working together to identify phenotypes and causes of childhood asthma. CREW  will include data from a large number of children and their families, with broad diversity in terms of ethnicity, family characteristics,","Not Applicable","Asthma","Prospective Longitudinal Cohort","MethylationEPIC, Global_Diversity_Array-8","Methylation (CpG), SNP Genotypes (imputed)","6 phenotype datasets, 49 variables, 1 molecular datasets, 1524 subjects, 2563 samples","","NIAID","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2025-07-14","2025-07-14","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003985.v1.p1","PE-CGS: Optimizing Engagement of Hispanic Colorectal Cancer Patients in    Cancer Genomic Characterization Studies","Colorectal Cancer (CRC) is the second leading cause of cancer death in the US. Hispanic/Latinos (H/L) are the largest and fasting growing ethnic group in the US, and cancer is  the leading cause of death among H/L in the US. Therefore, we need to fully understand the full complexity of the molecular etiology of cancer in","Not Applicable","Colorectal Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 67 subjects, 201 samples","","NCI","GRU --- General Research Use","2025-07-14","2025-07-14","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000979.v4.p2","HBCC Postmortem Psychiatric Molecular Studies","This postmortem study examines molecular, genetic and epigenetic signatures in the brains of hundreds of subjects with or without mental disorders conducted by the DIRP NIMH Human Brain Collection Core  (HBCC). The brain tissues are obtained under protocols approved by the CNS IRB (NCT00001260), with the permission of the next-of-kin (NOK) through","Not Applicable","Schizophrenia","Case-Control","Not Provided","Not Provided","Not Provided","European (169), African (11), East Asian (5), African American (149), Hispanic1 (2), Hispanic2 (10), Other Asian or Pacific Islander (4), South Asian (2), Other (2)","NIMH","GRU --- General Research Use","2025-07-14","","Anxiety Disorders; Bipolar Disorder; Depressive Disorder, Major; Feeding and Eating Disorders; Obsessive-Compulsive Disorder; Tic Disorders","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs004105.v1.p1","Somatic Mutation in Normal Bladder Study","Adult human somatic tissues are landscapes of mutant clones, but little is known about how these landscapes are shaped by known cancer risk factors. The goal of this study was  to determine how the main bladder cancer risk factors (sex and smoking) change the mutational landscape of the normal urothelium. We collected normal","Not Applicable","Urinary Bladder","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 19 variables, 82 samples sequenced, 48 subjects, 82 samples","","NCI","GRU --- General Research Use","2025-07-11","2025-07-11","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs004012.v1.p1","Identifying the Genetic Basis of Variably Protease-Sensitive Prionopathy    (VPSPr)","Design: Sequencing of cases only Molecular technologies: Exome sequencing and custom targeted sequencing of PRNP Aims: Identify modestly penetrant, high odds ratio variants conferring risk of variably protease-sensitive prionopathy (VPSPr)  Population: n 67 autopsy-confirmed VPSPr cases, United States, 1997-2021 Principal findings: Association to PRNP M129V replicated, no other causal","Not Applicable","Prion Diseases","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 67 samples sequenced, 67 subjects, 67 samples","","NINDS","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS)","2025-07-11","2025-07-11","Dementia, Transmissible; Dementias, Transmissible; Disorder, Prion-Induced; Disorders, Prion-Induced; Encephalopathies, Spongiform, Transmissible; Encephalopathies, Transmissible Spongiform",""
"phs003919.v1.p1","Enhanced Adjuvanticity of a Personal Neoantigen Vaccine Generates Potent    Neoantigen-Specific Immunity","Personalized neoantigen-targeting vaccines can induce durable and diverse T cell responses and have been associated with improved outcomes. To augment immunogenicity, we tested a synthetic long peptide vaccine formulated with  the adjuvants Montanide and poly-ICLC in 10 patients with melanoma. The vaccines, co-administered locally with ipilimumab and systemically with","Not Applicable","Cancer Vaccines","Clinical Trial","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 21 variables, 150 samples sequenced, 9 subjects, 150 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-07-11","2025-07-11","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma; Melanoma, Malignant",""
"phs003476.v1.p1","Impact of Chemotherapy on the Somatic Mutation Burden of Sperm and Other    Tissues","We applied high-fidelity duplex sequencing to 94 samples from 36 individuals exposed to diverse chemotherapies along with 32 controls. We found that in many of the sperm samples from men  exposed to chemotherapy, the somatic mutation burden was elevated compared to controls as well as the expected burden based on trio studies. We then","Not Applicable","Mutation","Case Set","Not Provided","OTHER","4 phenotype datasets, 16 variables, 141 samples sequenced, 60 subjects, 141 samples","","NCI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2025-07-11","2025-07-11","Not Provided",""
"phs004024.v1.p1","Genome Sequencing and Variant Calling of HCM Patients with MYH7 Variants","To investigate potential genetic causes of cardiomyopathy we recruited 48 patients harboring rare MYH7 variants identified from panel-based testing and with a clinical manifestation of cardiomyopathy. Genome sequencing was performed  to identify other potential causative variants and genetic modifiers of the cardiomyopathy phenotype, which varied among patients. Inclusion Crteria:","Not Applicable","Cardiomyopathy, Hypertrophic","Case Set","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 25 variables, 1 molecular datasets, 48 subjects, 48 samples","European (35), East Asian (3), African American (5), Hispanic1 (2), Hispanic2 (1), Other (2)","NHLBI","DS-CMP-IRB --- Disease-Specific (Cardiomyopathy, IRB)","2025-07-10","2025-07-10","Cardiomyopathies, Primary; Cardiomyopathy, Primary; Disease, Primary Myocardial; Diseases, Primary Myocardial; Myocardial Disease, Primary; Myocardial Diseases, Primary",""
"phs003009.v2.p1","Genomic Characterization of Duke Melanoma Brain Metastases","Previous work has shown that melanoma brain metastases (MBM) have a unique molecular profile compared to extracranial metastases (ECM). Description of the biology of MBM and associations between biological features  and clinical outcomes will facilitate the design of rational therapies for patients with MBM. To better characterize the molecular profile of MBM, we","Not Applicable","Brain Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 32 variables, 43 samples sequenced, 14 subjects, 43 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2025-07-09","2023-11-21","Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain; Neoplasm of the Brain",""
"phs004053.v1.p1","Uncovering Gene Regulatory Differences between Human and Chimpanzee    Neural Cells","A major challenge in human evolutionary biology is to pinpoint the genetic differences that underlie phenotypic changes in the human lineage, such as increased neuron number and a prolonged period  of neuronal maturation. Here, we used human-chimpanzee tetraploid cells to distinguish changes in gene expression due to cis-acting sequence variants","Not Applicable","Evolution, Molecular","Methods","Not Provided","ATAC-seq, OTHER, RNA-Seq","3 phenotype datasets, 24 variables, 359 samples sequenced, 3 subjects, 359 samples","","NIMH","GRU --- General Research Use","2025-07-08","2025-07-08","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003729.v2.p1","Epigenetic Control of Topoisomerase 1 by MacroH2A1.1","DNA transactions introduce torsional constraints that pose an inherent risk to genome integrity. While topoisomerase 1 (TOP1) activity is essential for removing DNA supercoiling, aberrant stabilization of TOP1:DNA cleavage complexes  (TOP1ccs) can result in cytotoxic single-stranded DNA lesions (SSLs). What protects the genome from aberrant TOP1 activity remains unknown. Using a","Not Applicable","DNA Topoisomerases, Type I","Collection","Not Provided","ChIP-Seq","3 phenotype datasets, 17 variables, 31 samples sequenced, 1 subjects, 31 samples","","NCI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2025-07-08","2024-10-24","Not Provided",""
"phs003530.v1.p1","Somatic Mosaicism in Amyotrophic Lateral Sclerosis and Frontotemporal    Dementia","The study was designed to investigate the role of somatic mosaic mutations in the pathogenesis of sporadic amyotrophic lateral sclerosis (sALS) and frontotemporal dementia (sFTD). A panel of molecular inversion  probes (MIP) were used to target the exons and exon-intron junctions of 88 neurodegeneration-related genes. The panel included 34 ALS/FTD genes, 10","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","Not Provided","Targeted-Capture","4 phenotype datasets, 15 variables, 1787 samples sequenced, 543 subjects, 1787 samples","","NINDS","HMB --- Health/Medical/Biomedical, DS-NSD --- Disease-Specific (Nervous System Diseases), DS-NDR --- Disease-Specific (Neurological Disorders Research)","2025-07-08","2025-07-08","Frontotemporal Dementia; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease",""
"phs004077.v1.p1","National Emphysema Treatment Trial (NETT-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Available Data:  The current release of the NETT study dataset includes follow-up data through May of 2013. Objectives: To compare lung-volume-reduction surgery with","Not Applicable","Pulmonary Disease, Chronic Obstructive","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 3775 subjects, 3775 samples","","NHLBI","GRU --- General Research Use","2025-07-07","2025-07-07","Chronic Obstructive Pulmonary Disease; Lung Diseases; Lung Diseases, Obstructive; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD",""
"phs001954.v2.p1","International Cancer Proteogenome Consortium (ICPC): Proteogenomics of    Early Stage Lung Adenocarcinoma in Taiwan","Lung cancer in East Asia is characterized by a high percentage of never-smokers with early-onset adenocarcinoma, predominantly with EGFR mutations. To provide an insight into the molecular phenotype of this  demographically distinct disease, we have performed a proteogenomics study on a prospectively collected cohort representing early stage lung","Not Applicable","Adenocarcinoma of Lung","Case Set","Not Provided","RNA-Seq, WGS, WXS","4 phenotype datasets, 18 variables, 1704 samples sequenced, 213 subjects, 1704 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2025-07-03","2020-05-19","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs004072.v1.p1","Genetic and Epigenetic Screens in Primary Human T Cells Link Candidate    Causal Autoimmune Variants to T Cell Networks","We aimed to define the target genes and pathways in which autoimmune disease-associated genetic variants operate. We performed single cell-CRISPR-interference screens in primary human T cells and bulk RNA-seq on  T cells containing CRISPRi and single gRNAs to assess how T cell regulatory regions containing autoimmune-associated genetic variants affect nearby","Not Applicable","Autoimmune Diseases","Case-Control","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 16 variables, 1 molecular datasets, 27 samples sequenced, 4 subjects, 27 samples","","NIAID","GRU --- General Research Use","2025-07-02","2025-07-02","","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs004002.v1.p1","Virtual Growing Child 5-Dimensional Functional Models for Treating    Respiratory Anomalies (dMRI-VGC)","Objectives We are sharing a database of dynamic magnetic resonance imaging (dMRI) scans of normal children, which can serve as a reference standard to quantify regional respiratory abnormalities in young  patients with various respiratory conditions and facilitate treatment planning and response assessment. The database can also be useful to advance","Not Applicable","Magnetic Resonance Imaging","Collection","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 200 subjects, 200 samples","","NHLBI","GRU --- General Research Use","2025-06-27","2025-06-27","Not Provided",""
"phs003798.v1.p1","A Phase II Study: CRS207/GVAX Plus Anti-PD1 and Anti-CTLA4 Recruits    Mesothelin- and KRAS-Specific T cells into PDAC","This study examined immunologic correlatives from a phase II study evaluating CRS207/GVAX vaccines in combination with anti-PD1 and anti-CTLA4 in metastatic pancreatic cancer (NCT03190265). Arm A received CRS207/GVAX with anti-PD1  and anti-CTLA4 therapy; Arm B received CRS207 with anti-PD1 and anti-CTLA4 therapy. Patients undergoing treatment in this trial had peripheral blood","Not Applicable","Pancreatic Neoplasms","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 35 variables, 40 samples sequenced, 61 subjects, 40 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2025-06-27","2025-06-27","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic",""
"phs003673.v1.p1","Genomic and Immune Profiling of Breast Cancer Brain Metastases","Previous work has shown that breast cancer brain metastases (BCBrM) can have unique molecular profiles compared to extracranial tumors (ECTs), resulting in some patients demonstrating subtype switching between primary/extracranial tumors  and brain metastases. Description of the biology of BCBrM and associations between biological features and clinical outcomes, particularly between","Not Applicable","Brain Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 37 variables, 180 samples sequenced, 42 subjects, 180 samples","","NCI","GRU-IRB-COL-NPU --- General Research Use (IRB, COL, NPU)","2025-06-27","2025-06-27","Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain; Neoplasm of the Brain",""
"phs003383.v1.p1","SUDC Registry and Research Collaborative","The Sudden Unexplained Death in Childhood Registry and Research Collaborative (SUDCRRC), created at NYU Langone Health in 2014, connects academic investigators, forensic pathologists, and medical examiner and coroner partner offices  to study sudden unexpected pediatric deaths, aged 1 month to 18 years, whose death is unexplained or unclear at the end of the public mandated","Not Applicable","Death, Sudden","Case Set","Not Provided","WXS","5 phenotype datasets, 19 variables, 260 samples sequenced, 261 subjects, 261 samples","","NHGRI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2025-06-27","2025-06-27","Sudden Unexplained Nocturnal Death Syndrome; Bangungut; Brugada Syndrome; Brugada type idiopathic ventricular fibrillation; Idiopathic ventricular fibrillation, Brugada type; Pokkuri death syndrome",""
"phs002883.v1.p1","Childhood Cancer Data Initiative (CCDI): NCI-COG Pediatric MATCH    Precision Medicine Clinical Trial","The National Cancer Institute-Children's Oncology Group (NCI-COG) Pediatric Molecular Analysis for Therapy Choice (MATCH) trial provides a framework for biomarker-driven early phase trials of targeted therapies in pediatric and young  adult cancer patients across the United States. Pediatric MATCH enrolled more than 1,300 patients with treatment-refractory cancers, offering access","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 9 variables, 1239 subjects, 6219 samples","","NCI","GRU --- General Research Use","2025-06-27","2025-06-27","Sarcoma; Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003976.v1.p1","A Perioperative Study of Safusidenib in Patients with IDH1-Mutated Glioma","10 participants with a radiological or pathological diagnosis of WHO Grade 2 lower-grade glioma (LGG) were recruited at a single center starting in December, 2022. Eligibility criteria permitted participants who  had undergone prior surgery for WHO Grade 2 LGG, but excluded those with a history of prior radiation or chemotherapy. In Part A of the study,","Not Applicable","Glioma","Clinical Trial","MethylationEPIC, Metabolome, RNAseq_gene_transcripts","Methylation (CpG), Metabolomics, OTHER, RNA Seq (NGS), WGS","4 phenotype datasets, 16 variables, 2 molecular datasets, 20 samples sequenced, 10 subjects, 20 samples","","NCI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2025-06-25","2025-06-25","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia",""
"phs003959.v1.p1","Epigenomics of Neurocognitive Function in Breast Cancer","This study harnessed the data and biospecimens from the Exercise Program in Cancer and Cognition (EPICC) study (parent study) that collected data on cognitive function, demographics, other symptoms and biospecimens  at two time points (T1: enrollment, T2: six months later) within the context of a six-month randomized controlled trial of a moderate intensity","Not Applicable","Breast Neoplasms","Clinical Trial","MethylationEPIC","Methylation (CpG)","5 phenotype datasets, 62 variables, 1 molecular datasets, 125 subjects, 275 samples","","NCI","DS-BRCA-GSO --- Disease-Specific (Breast Cancer, GSO)","2025-06-25","2025-06-25","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003938.v1.p1","Transcriptomic Profiling after B-Cell Depletion Reveals Central and    Peripheral Immune Cell Changes in Multiple Sclerosis","We investigated the immunological effects of B cell depletion therapy using ocrelizumab in treatment-na&#x000ef;ve relapsing-remitting multiple sclerosis (RRMS) patients. Our primary aim was to delineate transcriptomic alterations in immune cell  populations in peripheral blood before and after therapy, using single-cell RNA sequencing (scRNAseq). This study included 18 newly diagnosed,","Not Applicable","Multiple Sclerosis","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 42 samples sequenced, 23 subjects, 42 samples","","NIAID","HMB --- Health/Medical/Biomedical","2025-06-25","2025-06-25","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple",""
"phs003860.v1.p1","Genetic and Hormonal Contributions to Gene Expression in Immune Cells","The origins of sex differences in human disease are elusive, in part because of difficulties in separating the effects of sex hormones and sex chromosomes. To isolate the effects of  testosterone, estradiol, and sex chromosome complement (XX or XY) in humans, we implemented a four-state, cross-sectional study design of trans- and","Not Applicable","Transgender Persons","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 69 samples sequenced, 69 subjects, 69 samples","","NICHD","GRU --- General Research Use","2025-06-25","2025-06-25","Not Provided",""
"phs003454.v1.p1","Estimating the Efficacy of Pharmacogenomics Over a Lifetime","The goal was to evaluate the potential impact of pharmacogenomic testing on drug prescribing over a lifetime. To address this goal, 300 random patients enrolled in Marshfield Clinic's PMRP biobank  with life-long medical records were whole genome sequenced and evaluated for known clinically actionable pharmacogenomic variants as defined by CPIC","Not Applicable","Pharmacogenetics","Cross-Sectional","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 300 subjects, 300 samples","","NIGMS","GRU-NPU --- General Research Use (NPU)","2025-06-25","2025-06-25","Not Provided",""
"phs002857.v3.p1","MSK SPECTRUM - SPatiotemporal Evolution of Cancer Traced Using    Multimodalities","MSK SPECTRUM is a multi-modal, interdisciplinary prospective study of spatiotemporal determinants of high-grade serous ovarian cancer (HGSOC) evolution, treatment and response. Accounting for 80% of ovarian cancers, HGSOC is the  most lethal gynecological malignancy and is a cancer of major unmet clinical need. Challenges in disease management relate to several unresolved","Not Applicable","Ovarian Neoplasms","Prospective Longitudinal Cohort","Not Provided","Targeted-Capture, WGS","5 phenotype datasets, 16 variables, 333 samples sequenced, 52 subjects, 333 samples","","NCI","GRU --- General Research Use","2025-06-25","2023-01-20","Genomic Instability; Genome Instabilities; Genome Instability; Genomic Instabilities; Instabilities, Genome; Instabilities, Genomic",""
"phs003745.v1.p1","Identifying and Reducing Disparities in Patient-Reported Outcomes Among    African American Prostate Cancer Survivors","This research study aimed to identify disparities in prostate cancer symptom burden and their contributors among African American, Hispanic, and non-Hispanic White prostate cancer survivors. We collected patient-reported outcomes data,  focusing on various aspects of the survivors' health and well-being, clinical data, demographics data, and germline genomic data. Inclusion Criteria:","Not Applicable","Prostatic Neoplasms","Case Set","custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 88 variables, 1 molecular datasets, 625 subjects, 526 samples","European (228), African (26), African American (216), Hispanic1 (28), Hispanic2 (16), Other (12)","NCI","DS-CA-NPU --- Disease-Specific (Cancer, NPU)","2025-06-24","2025-06-24","Anxiety; Depression; Sleep Wake Disorders; Urinary Incontinence; Angst; Anxiety disease",""
"phs002555.v1.p1","Parallel Genomic Alterations of Antigen and Payload Targets Mediate    Polyclonal Acquired Clinical Resistance to the Antibody Drug Conjugate    Sacituzumab Govitecan","Sacituzumab Govitecan (SG), a novel antibody drug conjugate (ADC) incorporating the anti-TROP2 antibody hRS7 conjugated to a topoisomerase-1 inhibitor (SN-38) payload, is the first ADC to be approved for advanced  triple negative breast cancer (TNBC). However, mechanisms governing therapeutic resistance to SG are not known. We sought to identify mechanisms of","Not Applicable","Breast Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 26 samples sequenced, 3 subjects, 26 samples","","NCI","GRU --- General Research Use","2025-06-24","2025-06-24","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs004071.v1.p1","Idiopathic Pulmonary Fibrosis Network (IPFnet) Prednisone, Azathioprine,    and N-Acetylcysteine: A Study That Evaluates Response in Idiopathic    Pulmonary Fibrosis (IPFNet-Panther-IPF-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: The  initial objective of the PANTHER-IPF study was to evaluate the effectiveness of a drug combination of prednisone, azathioprine, and N-acetylcysteine","Not Applicable","Idiopathic Pulmonary Fibrosis","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 264 subjects, 264 samples","","NHLBI","GRU --- General Research Use","2025-06-18","2025-06-18","Lung Diseases, Interstitial; Pathologic Processes; Pulmonary Fibrosis; Respiratory Tract Diseases; Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis",""
"phs004070.v1.p1","Idiopathic Pulmonary Fibrosis Network AntiCoagulant Effectiveness in    Idiopathic Pulmonary Fibrosis (IPFNet-ACE-IPF-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: The  ACE-IPF trial tested the hypothesis that treatment with warfarin at recognized therapeutic doses would reduce rates of mortality, hospitalization,","Not Applicable","Idiopathic Pulmonary Fibrosis","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 145 subjects, 145 samples","","NHLBI","GRU --- General Research Use","2025-06-18","2025-06-18","Lung Diseases, Interstitial; Pathologic Processes; Pulmonary Fibrosis; Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary",""
"phs004011.v1.p1","INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and    Decompensated Heart Failure (INVESTED)","INVESTED was planned as a large, adequately powered, multicenter trial to assess the cardiopulmonary benefit of high- compared with standard-dose influenza vaccine in a high-risk cardiovascular population. In contrast to  more complex interventions in patients with cardiac disease, the major potential benefits of this intervention are a) the ease of administration, b)","Not Applicable","Influenza Vaccines","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 5260 subjects, 5260 samples","","NHLBI","GRU --- General Research Use","2025-06-18","2025-06-18","Heart Failure; Myocardial Infarction; Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart",""
"phs001126.v1.p1","Targeted Mutational Analysis of Intestinal T-cell Lymphomas, Using a    Customized Targeted Amplicon Panel on the Ion Torrent PGM","Intestinal T-cell lymphomas (ITCL) are rare, aggressive T-cell lymphomas that are composed primarily of enteropathy-associated lymphomas Type 1 and type 2, and a small fraction of cases not classifiable as  EATL that are classified as peripheral T-cell lymphoma, not otherwise classifiable. The molecular pathogenesis of these rare lymphomas is largely","Not Applicable","Enteropathy-Associated T-Cell Lymphoma","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 34 subjects, 34 samples","","NCI","GRU --- General Research Use","2025-06-18","2025-06-18","",""
"phs004052.v1.p1","Stress and Treatment Response in Puerto Rican and African American    Children with Asthma (STAR)","The Stress and Treatment Response in Puerto Rican and African American Children with Asthma Study (STAR) was a 6-week study of response to inhaled corticosteroids (ICS) in youth aged 8-20  years recruited at the University of Puerto Rico Medical Center and UPMC Children's Hospital of Pittsburgh from June 5, 2018 to May 16, 2022. At a","Not Applicable","Asthma","Case Set","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 156 subjects, 156 samples","","NHLBI","DS-ASTHMA --- Disease-Specific (Asthma)","2025-06-17","2025-06-17","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs004051.v1.p1","Vitamin-D-Kids Asthma","The Vitamin D Kids Asthma Study (VDKA) was a 48-week multicenter randomized, double-blinded, placebo-controlled trial of vitamin D3 for severe asthma exacerbations in children 6-16 years old, recruited from February  28, 2016 to September 20, 2019. An ancillary study for nasal sampling was conducted at the Pittsburgh site. Prior to randomization, participants","Not Applicable","Asthma","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 66 subjects, 66 samples","","NHLBI","DS-ASTHMA --- Disease-Specific (Asthma)","2025-06-17","2025-06-17","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs004042.v1.p1","Single-Cell Sequencing of Genomic DNA, RNA, and ADT in CRISPR-Edited    Cells","CRAFTseq data containing multi-modal single-cell genomic DNA amplicon, cDNA and surface-protein from various primary cell types and cell lines, including human CD4 T cells, Jurkat cells, HH cells, Daudi cells  and HEK293T cells. Cells were edited with CRISPR HDR or base editing. Also contains bulk RNA-seq data for edited human primary CD4 T cells and Daudi","Not Applicable","T-Lymphocytes","Methods","Not Provided","OTHER","4 phenotype datasets, 11 variables, 48 samples sequenced, 49 subjects, 48 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2025-06-17","2025-06-17","Not Provided",""
"phs004049.v1.p1","Proteogenomic Characterization Unveils Biomarkers Associated With    Chemoresistance in Muscle Invasive Bladder Cancer","Cisplatin-based neoadjuvant chemotherapy (NAC) combined with radical cystectomy has been used as a standard of care for patients with clinically non-metastatic muscle invasive urothelial bladder cancer, but 40-50% patients will  benefit from the treatment. Molecular subtypes of muscle invasive bladder cancer (MIBC) provide a possible biomarker roadmap that may help identify","Not Applicable","Urinary Bladder Neoplasms","Collection","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 20 variables, 126 samples sequenced, 53 subjects, 126 samples","","NCI","GRU --- General Research Use","2025-06-16","2025-06-16","Bladder Cancer; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder; Cancer, Urinary Bladder",""
"phs004067.v1.p1","Effectiveness and Safety of Intermittent Antimicrobial Therapy for the    Treatment of New Onset Pseudomonas Aeruginosa Airway Infection in    Young Patients With Cystic Fibrosis (EPIC-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  investigate the efficacy and safety of 4 antipseudomonal treatments in children with cystic fibrosis (CF) with recently acquired Pseudomonas","Not Applicable","Pulmonary Disease, Chronic Obstructive","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 304 subjects, 304 samples","","NHLBI","GRU --- General Research Use","2025-06-13","2025-06-13","Chronic Obstructive Pulmonary Disease; Cystic Fibrosis; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease",""
"phs004046.v1.p1","Perceptions, Prevalence, and Patterns of Cannabis Use among Cancer    Patients in NCI-Designated Cancer Centers","This study aimed to better understand the evolving landscape of cannabis use among patients undergoing cancer treatment across diverse geographic regions. It sought to characterize patterns of use, patient perceptions,  and contextual influences such as legal status and provider engagement that affect cannabis use. Given the shifting legal environment, this study","Not Applicable","Neoplasms","Cross-Sectional","Not Provided","Not Provided","2 phenotype datasets, 246 variables, 1 documents, 8264 subjects","","NCI","GRU --- General Research Use, GRU-PUB-NPU --- General Research Use (PUB, NPU), DS-CA --- Disease-Specific (Cancer)","2025-06-13","2025-06-13","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs003291.v1.p1","Immune Checkpoint Blockade for Relapsed Hematologic Malignancy Post-HSCT","Relapse after allogeneic hematopoietic stem cell transplantation (HSCT) is characterized by poor outcomes and novel therapeutic options are urgently needed. Immune checkpoint blockade using CTLA-4 and PD-1 blocking antibodies are  a potential concept for reinstating a dormant graft-versus-leukemia (Gvl) effect. This study investigated transcriptomic changes in biopsies obtained","Not Applicable","CTLA-4 Antigen","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 36 subjects, 78 samples","","NCI","GRU --- General Research Use","2025-06-13","2025-06-13","Relapse; HEMOLYMPHORETICULAR tumor, malignant; Hematopoietic Malignancies; Hematopoietic Malignancy; Hematopoietic Neoplasm; Hematopoietic Neoplasms Including Lymphomas",""
"phs001208.v3.p1","Study on the Genetics of Alcoholism (COGA): Smoke Screen and Exome    Sequencing","This is a family study of alcoholism, in which the subjects have been drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), a large, ongoing family-based study that  includes subjects from seven sites around the US. COGA has gathered detailed, standardized data on study participants, including diagnostic and","Not Applicable","Alcoholism","Family/Twin/Trios","Axiom_Smokesc, WES_markerset_grc38, WGS_markerset_grc38","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), CNV (NGS)","5 phenotype datasets, 65 variables, 3 molecular datasets, 7148 subjects, 6064 samples","European (4715), African (1), East Asian (12), African American (113), Hispanic1 (133), Hispanic2 (292), Other Asian or Pacific Islander (47), South Asian (18), Other (84)","NIDA","DS-ADX-IRB --- Disease-Specific (Addictive Disorders, IRB)","2025-06-13","2025-06-13","ALCOHOL DEPENDENCE, PROTECTION AGAINST; Addiction, Alcohol; Addictive alcohol use; Alcohol Addiction; Alcohol Dependence; Alcohol dependence syndrome",""
"phs000804.v2.p1","Genomic Sequencing of Ewing Sarcoma","Pediatric Ewing sarcoma is a pediatric cancer that primarily arises from the bone. It is characterized by chimeric fusions of the EWS gene and an ETS family transcription factor. In  this study, we performed massively parallel sequencing of a larger collection of Ewing sarcoma tumors to define the genomic landscape of this","Not Applicable","Sarcoma, Ewing","Tumor vs. Matched-Normal","Affymetrix_WG_Array","SNP Genotypes (Array), RNA-Seq, WGS, WXS","4 phenotype datasets, 18 variables, 1 molecular datasets, 132 samples sequenced,  SRA, 102 subjects, 132 samples","","NCI","GRU --- General Research Use, DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2025-06-13","2016-12-13","ES; Ewing Sarcoma; Ewing Tumor; Ewing tumour; Ewing's Sarcoma; Ewing's Tumor","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs004019.v1.p1","Stressors and Health Study","Objectives The objectives of the Stressors and Health Study were to: (1) examine the prevalence of stressors and health outcomes and (2) assess differences in the associations between multi-level stressors  and health outcomes, and (3) explore the protective and adaptive factors in the associations between multi-level stressors and health outcomes.","Not Applicable","Chronic Disease","Cross-Sectional","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 5500 subjects, 5500 samples","","NHLBI","HMB-PUB-COL --- Health/Medical/Biomedical (PUB, COL)","2025-06-12","2025-06-12","Chronic Diseases; Chronic Illness; Chronic Illnesses; Disease, Chronic; Illness, Chronic",""
"phs004032.v1.p1","High Frequency Ventilation in Premature Infants (HIFI-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  evaluate the hypothesis that high frequency oscillatory ventilation in preterm infants would reduce the incidence of mortality and pulmonary","Not Applicable","Bronchopulmonary Dysplasia","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2272 subjects, 2272 samples","","NHLBI","GRU --- General Research Use","2025-06-11","2025-06-11","Lung Diseases; Respiratory Distress Syndrome; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary",""
"phs003963.v1.p1","Imaging: Hispanic Community Health Study/Study of Latinos (HCHS/SOL)","The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) is a multi-center epidemiologic study in Hispanic/Latino populations to determine the role of acculturation in the prevalence and development of disease, and  to identify risk factors playing a protective or harmful role in Hispanics/Latinos. The study is sponsored by the National Heart, Lung, and Blood","Not Applicable","Hispanic or Latino","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 13175 subjects, 13175 samples","","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU), HMB --- Health/Medical/Biomedical","2025-06-11","2025-06-11","Not Provided","Collection: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) (phs003650.v1.p1)"
"phs003962.v1.p1","Somatic Mutations and Their Etiological Determinants for Breast Cancer in    African American Women (B-CAUSE Study)","The breast cancer health disparity between women of African ancestry (AA) and European ancestry (EA) remains a major public health challenge in the United States. AA women are afflicted by  higher rate of triple-negative breast cancer (TNBC) and bear the highest mortality rate of all populations from the disease. Even within TNBC, some","Not Applicable","Breast Neoplasms","Case Set","WES_markerset_grc37","CNV Genotypes, SNV (.MAF), WXS","4 phenotype datasets, 31 variables, 1 molecular datasets, 924 samples sequenced, 462 subjects, 924 samples","","NCI","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), HMB-COL-NPU-GSO --- Health/Medical/Biomedical (COL, NPU, GSO)","2025-06-11","2025-06-11","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002322.v2.p1","Kids First: Genetics of Pediatric Germ Cell Tumors","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by the  NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella Miller","Not Applicable","Neoplasms, Germ Cell and Embryonal","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 761 subjects, 863 samples","","NICHD","GRU --- General Research Use","2025-06-11","2023-05-12","Germ Cell and Embryonal Neoplasms; Germ Cell and Embryonic Neoplasms; Neoplasms, Germ Cell and Embryonic",""
"phs003925.v1.p1","Genomic Characterization of HPV+ Oropharyngeal Tumors","Archived surgical samples from HPV positive oropharynx patients were identified and sequenced through the UNC/UTHSC NCTN Integrated Translational Science Center. DNA targeted panel sequencing data will be available through dbGaP.  Patients with sample available for sequencing Principal Investigator: Cherie-Ann Nathan, MD, FACS, LSU Health Shreveport, Shreveport, LA, USA","Not Applicable","Oropharyngeal Neoplasms","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 13 variables, 30 samples sequenced, 30 subjects, 30 samples","","NCI","DS-HNC --- Disease-Specific (Head and Neck Cancer)","2025-06-10","2025-06-10","Neoplasm of Oropharynx; Neoplasm of the Oropharynx; Neoplasm, Oropharyngeal; Neoplasm, Oropharynx; Neoplasms, Oropharyngeal; Neoplasms, Oropharynx",""
"phs003680.v1.p1","Genetic Modifiers of Duchenne Muscular Dystrophy","The primary determinant of disease severity in patients with severe Duchenne muscular dystrophy (DMD) or milder Becker muscular dystrophy (BMD) is whether their dystrophin gene (DMD) mutation disrupts the mRNA  reading frame or permits the expression of a partially functional protein. However, even in the complete absence of dystrophin, variability in","Not Applicable","Muscular Dystrophy, Duchenne","Case Set","HumanOmni2.5Exome-8","SNP Genotypes (Array)","5 phenotype datasets, 19 variables, 2 documents, 1 analyses, 1 molecular datasets, 419 subjects, 419 samples","","NINDS","GRU-PUB --- General Research Use (PUB)","2025-06-10","2025-06-10","Benign Duchenne muscular dystrophy; Cardiomyopathy, Dilated, 3B; Cardiomyopathy, Dilated, X-Linked; Childhood Muscular Dystrophy, Pseudohypertrophic; Childhood Pseudohypertrophic Muscular Dystrophy; DMD",""
"phs001995.v3.p1","Capturing the Genetic Diversity of the Himba Population","The Himba people are a semi-nomadic, Bantu-speaking pastoralist group from the northwestern Kunene region of Namibia. Because of their limited population size, restricted geographic distribution, and endogamy, founder populations represent  an ideal system for genetic analyses due to reduction of the confounding environmental and cultural variables. The original study used genotype data","Not Applicable","Sex","Prospective Longitudinal Cohort","MEGAEx_Immunov2_0_Psych, H3Africa_Array, MethylationEPIC, target_markerset_grc38","Methylation (CpG), SNP Genotypes (Array), Custom targeted DNA sequencing","5 phenotype datasets, 17 variables, 3 molecular datasets, 678 subjects, 678 samples","","NIGMS","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2025-06-06","2025-06-06","Not Provided",""
"phs004055.v1.p1","Cardiovascular Cell Therapy Research Network (CCTRN): A Phase II, RCT of    Mesenchymal Stem Cells & Cardiac Stem Cells in Subjects With Ischemic    HF (CONCERT HF-BioLINCC)","Data Access Note: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives To  assess the feasibility, safety, and efficacy of autologous mesenchymal stromal cells (MSCs) and c-kit positive cardiac cells (CPCs), alone or in","Not Applicable","Cardiomyopathies","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 125 subjects, 125 samples","","NHLBI","GRU --- General Research Use","2025-06-04","2025-06-04","Cardiomyopathies, Primary; Cardiomyopathy, Primary; Disease, Primary Myocardial; Diseases, Primary Myocardial; Myocardial Disease, Primary; Myocardial Diseases, Primary",""
"phs003778.v1.p1","10x Multiome from Human Fetal Heart","We hope to uncover the genetic basis of congenital heart disease by examining how genetic variants, especially those in non-coding regions, influence heart development. To achieve this goal, our research  team created a single-cell atlas of human fetal heart development. The study population consists of 41 structurally normal fetal hearts spanning 6 to","Not Applicable","Fetal Heart","Collection","Not Provided","OTHER","3 phenotype datasets, 11 variables, 110 samples sequenced, 64 subjects, 110 samples","","NICHD","GRU --- General Research Use","2025-06-04","2025-06-04","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003235.v1.p1","Leukemia Relapse via Genetic Immune Escape after Allogeneic Hematopoietic    Cell Transplantation","Graft-versus-leukemia (GvL) reactions are responsible for the effectiveness of allogeneic hematopoietic cell transplantation as a treatment modality for myeloid neoplasia, whereby donor T- effector cells recognize leukemia neoantigens. However, a  substantial fraction of patients experience relapses because of the failure of the immunological responses to control leukemic outgrowth. Here we","Not Applicable","Leukemia, Myeloid, Acute","Cross-Sectional","Not Provided","AMPLICON","3 phenotype datasets, 13 variables, 85 samples sequenced, 47 subjects, 85 samples","","NHLBI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2025-06-04","2025-06-04","Tumor Escape; AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult",""
"phs000653.v4.p1","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes","The Epi4K project began in 2011 as an international, multi-center study that seeks to identify and characterize the genetic bases of complex epilepsies. The Center without Walls Epi4K project includes  three cores and four scientific projects, as well as a steering committee comprised of the primary study investigators and representatives from the","Not Applicable","Epilepsy","Family/Twin/Trios","WES_markerset_grc37","Not Provided","3 phenotype datasets, 15 variables, 2642 samples sequenced, 2642 subjects, 2642 samples, 3 substudies","","NINDS","GRU --- General Research Use, DS-ESD-GSO --- Disease-Specific (Epilepsy and seizure disorders, GSO)","2025-06-04","2025-06-04","Epilepsy, Absence; Epilepsy, Cryptogenic, Partial Complex; Epilepsy, Idiopathic Generalized; Epileptic encephalopathy, Lennox-Gastaut type; Myoclonic Epilepsy, Juvenile; Spasms, Infantile",""
"phs001558.v2.p1","Epi4K: Genetic Analyses in Multiplex Families and Sibling Pairs","Project 2 of the Epi4K: Gene Discovery in 4,000 Epilepsy Genomes project is designed to study the genetic bases of familial epilepsies, in particular genetic generalized and non-acquried (non-lesional) focal  epilepsy. This exome-sequencing study consists of two parts: (1) a co-segregation analyses to identify genetic epilepsy syndromes within and across","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes (phs000653.v4.p1)","Epilepsy","Family/Twin/Trios","Not Provided","WXS","1 phenotype datasets, 3 variables, 1172 samples sequenced, 1172 subjects, 1172 samples","","NINDS","GRU --- General Research Use, DS-ESD-GSO --- Disease-Specific (Epilepsy and seizure disorders, GSO)","2025-06-04","2025-06-04","Epilepsy, Generalized; Disorders, Focal Seizure; Disorders, Partial Seizure; Epilepsies, Focal; Epilepsies, Localization-Related; Epilepsy, Focal",""
"phs001183.v2.p1","Study of Malformations of Cortical Development","This study features individuals with either polymicrogyria (PMG) or periventricular nodular heterotopia (PVNH) and their parents, recruited through the Epilepsy Phenome/Genome Project (EPGP). We performed phenotyping and whole exome or  whole genome sequencing, trio analysis, and gene-level collapsing analysis to identify pathogenic de novo and inherited variants present in","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes (phs000653.v4.p1)","Periventricular Nodular Heterotopia","Family/Twin/Trios","Not Provided","WXS","2 phenotype datasets, 8 variables, 459 samples sequenced, 459 subjects, 459 samples","","NINDS","GRU --- General Research Use, DS-ESD-GSO --- Disease-Specific (Epilepsy and seizure disorders, GSO)","2025-06-04","2025-06-04","Polymicrogyria; BPNH; Familial Nodular Heterotopia; Familial Nodular Heterotopias; HETEROTOPIA, FAMILIAL NODULAR; HETEROTOPIA, PERIVENTRICULAR NODULAR, 1",""
"phs000654.v4.p1","Epi4K: Genetic Analyses in Epileptic Encephalopathies","Project 1 of the Epi4K: Gene Discovery in 4,000 Epilepsy Genomes project is designed to study the genetics of sporadic epileptic encephalopathies, which are a group of severe childhood epilepsy  disorders for which the cause is often unknown. The study focuses on two of the more common types: infantile spasms (IS) and Lennox-Gastaut syndrome","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes (phs000653.v4.p1)","Epileptic encephalopathy, Lennox-Gastaut type","Family/Twin/Trios","WES_markerset_grc37","SNP Genotypes (NGS), WXS, SNP Genotypes (NGS), WXS","1 phenotype datasets, 3 variables, 2 molecular datasets, 1011 samples sequenced, 1011 subjects, 1011 samples","European (168), East Asian (2), African American (9), Hispanic1 (12), Hispanic2 (7), Other Asian or Pacific Islander (5), South Asian (6), Other (10)","NINDS","GRU --- General Research Use, DS-ESD-GSO --- Disease-Specific (Epilepsy and seizure disorders, GSO)","2025-06-04","2025-06-04","Spasms, Infantile; Childhood Epileptic Encephalopathy with Diffuse Slow Spikes and Waves; Attack, Lightning; Attacks, Lightning; IESS; Infantile Spasm",""
"phs003721.v1.p1","HuBMAP: High Resolution 3D Mapping of Cellular Heterogeneity Within    Multiple Types of Mineralized Tissues","The overall goal of the study was to generate 3D single cell maps of healthy human knee cartilage. Articular cartilage from the weightbearing and non-weightbearing regions of the femoral condyles  in healthy knees from young donors (n 12) was analyzed by bulk RNA-sequencing (RNA-Seq), single nuclei RNA (snRNA-seq) and ATAC-sequencing and by","Not Applicable","Knee Joint","Collection","Not Provided","RNA-Seq","5 phenotype datasets, 16 variables, 13 samples sequenced, 6 subjects, 13 samples","","NIAMS","GRU --- General Research Use","2025-05-30","2025-05-30","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs004008.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Eliminating COVID-19 Disparities in Arizona in Partnership with    Vulnerable / Underserved Communities","The COVID-19 pandemic significantly affects the entire State of Arizona but impacts communities along the border with Mexico disproportionally. Majority Latinx and American Indian communities along this border have higher  infection rates and less access to testing and vaccination. This proposed supplement aims to increase access to testing and related services for","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs004007.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Community - Engaged Approaches to Testing in Community and Healthcare    Settings for Underserved Populations (CATCH-UP)","The pandemic caused by the novel coronavirus SARS-CoV-2 has resulted in substantial global morbidity and mortality, including in Oklahoma, and caused unprecedented interruptions in nearly all aspects of life. COVID-19  has demonstrated considerable disparities based on age and certain chronic illnesses as well as other social determinants of health. The population","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs004006.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Leveraging Bio-Cultural Mechanisms to Maximize the Impact of    Multi-Level Preventable Disease Interventions with Southwest    Populations","Arizona has one of the highest COVID-19 positivity test rates (approximately 19%) in the U.S. Positivity rates are disproportionately higher among Arizona's Latinx, American Indian and African American communities. The  proposed community driven and culturally congruent intervention aims to increase access to testing by identifying and decreasing barriers to testing","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs004003.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Oklahoma Shared Clinical and Translational Resources","COVID-19 has demonstrated considerable disparities based on age and certain chronic illnesses as well as other social determinants of health. The population of the state of Oklahoma is at particular  risk to SARS-CoV-2 due to its large rural population, strained healthcare system, and poor overall health. This study is an extension of the Oklahoma","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003915.v1.p1","JAK Inhibitor Withdrawal Causes a Transient Proinflammatory Cascade: A    Potential Mechanism for Major Adverse Cardiac Events","This is a study of mesenchymal stromal cells (MSCs) from salivary glands. The salivary glands were derived from participants who had dry eye or dry mouth symptoms but did not  have evidence of systemic autoimmune disease (sicca controls). The aim of the study was to determine the effects of Type I and Type II Janus kinase","Not Applicable","Xerostomia","Control Set","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 12 samples sequenced, 3 subjects, 12 samples","","NIDCR","HMB --- Health/Medical/Biomedical","2025-05-29","2025-05-29","Absent salivary secretion; Aptyalia; Aptyalism; Asialia; Asialias; Clinical xerostomia",""
"phs003864.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): An    Adaptive Intervention Trial of Home Testing with Behavioral Nudges for    Improving COVID-19 Testing and Prevention among People Affected by    Diabetes","This multi-institution team (Emory University, Morehouse School of Medicine, Georgia Institute of Technology), anchored by the Georgia Center for Diabetes Translation Research (P30DK111024) partnership, proposes to leverage and expand on  the on-going, RADx-UP funded Project PEACH (P30DK111024), to design and evaluate a home-based COVID-19 testing program with behavioral nudges","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003757.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Evaluating a Community-Led COVID-19 Testing Intervention to Address    Mistrust","The goal of this study is to address community concerns with self-administering COVID-19 testing through a community-led intervention co-developed with our partner Housing Collaborative Community Advisory Board (HC CAB). Our  HC CAB partners report that our relationships with them helped overcome mistrust common in their communities. They described the nature of our","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003687.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Addressing COVID-19 Testing Disparities in Vulnerable Populations    Using a Community JITAI (Just in Time Adaptive Intervention) Approach:    RADxUP Phase III","Vulnerable populations including those with medical comorbidities, people living in rural settings and minorities experience significant COVID-19 disparities. Additionally, Hispanics and Blacks are significantly more likely to be infected and  hospitalized when compared to White, Non-Hispanics. The proposed study builds on RADx-UP Phases I & Phase II work reaching these populations in three","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003686.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid    Evaluation And TEsting Experiences","Cases of COVID-19 infection in San Diego have persistently remained high in the county's central and southern communities near the US/Mexico border, home to primarily Latino residents who have been  one of the ethnic minority communities most impacted by COVID-19. To address this, our Phase I RADx-UP project partnered with San Ysidro Health","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU-IRB --- General Research Use (IRB)","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003595.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Faithful Response II: COVID-19 Rapid Test-to-Treat with African    American Churches","Many multilayered barriers increase risk for COVID-19 among AA including poverty, essential jobs with increased virus exposure, cultural norms (e.g., risk denial, medical/contact tracing mistrust), chronic health conditions, and limited  access to healthcare and other services/resources. These barriers highlight the need for accessible, trusted COVID-19 testing and linkage to","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003544.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Increasing COVID-19 vaccine uptake through a patient navigation    intervention among underserved populations","The novel SARS-CoV-2 continues to spread in the United States, with almost 5 million confirmed cases of and over 150,000 deaths. Given observed disparities in morbidity, hospitalization, and mortality across  race, ethnicity, and socioeconomic status, there is a great need to increase testing access and uptake with rapid return of test results. We propose","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003377.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Community Activation to TrAnsform Local sYSTems (CATALYST)","Community health workers (CHWs) played an essential role in addressing multi-level, community barriers to accessing COVID-19 information, testing, risk mitigation, and vaccination; however, little is known about how CHWs managed  their roles in light of enormous social, community, and political challenges. In May 2020 the Orange County Health Equity COVID-19 Community-","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003366.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    You & Me: Test and Treat","This proposal will evaluate a systematic and scalable community-engaged test and treat protocol that provides rapid access to COVID-19 at-home tests for self-administration, ""next steps"" guidance and education, and information  on local resources to facilitate treatment in underserved populations. The protocol will be designed and implemented in two communities, Pitt County,","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2025-05-29","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003160.v1.p1","Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing    Program &#x02013;Sarcoma, Kidney, and Liver Cancers","The goal was to complete whole exome sequencing (WES) and RNA sequencing (RNA-Seq) on patient derived xenograft samples. Cancer in children is rare with approximately 15,700 new cases diagnosed annually  in children 21 years or younger in the U.S. Through use of multimodality therapy (surgery, radiation therapy, and aggressive chemotherapy), 70% of","Not Applicable","Pediatric cancer","Xenograft","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 53 subjects, 370 samples","","NCI","GRU --- General Research Use","2025-05-27","2025-05-27","Chordoma; Hepatoblastoma; Rhabdoid Tumor; Cellular Ependymoma; Clear Cell Ependymoma; Astrocytoma, Grade IV",""
"phs003888.v1.p1","The Study of Somatic LINE1 Activity in Cancers","This study focuses exclusively on the quantification of LINE1 mobilization. We analyzed a recent whole genome sequencing data release from multiple Cancer Genome Atlas (TCGA) sub-projects. In addition to the  somatic LINE1 insertions (present in tumor and having no support in the matched normal) there are ""pseudo-germline"" non-reference LINE1 elements","Not Applicable","Neoplasms","Case-Control","target_markerset_grc38","CNV (NGS)","4 phenotype datasets, 15 variables, 1 molecular datasets, 4667 subjects, 9334 samples","","NCI","GRU --- General Research Use","2025-05-21","2025-05-21","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001523.v2.p1","Multi-Omic Microbiome Study-Pregnancy Initiative (MOMS-PI)","The Vaginal Microbiome Consortium team at Virginia Commonwealth University has conducted the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) in collaboration with the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)  to better understand how microbiome and host profiles change throughout pregnancy and influence the establishment of the nascent microbiome in","Not Applicable","Pregnancy","Prospective Longitudinal Cohort","Not Provided","OTHER","10 phenotype datasets, 265 variables, 1375 samples sequenced, 597 subjects, 10580 samples","","NICHD","DS-PREG-COM-IRB-PUB-MDS --- Disease-Specific (Pregnancy Complications, IRB, PUB, MDS)","2025-05-20","2025-05-20","Premature Birth; Gestation; Pregnancy, function; Birth, Premature; Birth, Preterm; Births, Premature",""
"phs001286.v4.p2","The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)","The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial is a large population-based randomized trial designed and sponsored by the National Cancer Institute (NCI) to determine the effects of  screening on cancer-related mortality and secondary endpoints in over 150,000 men and women aged 55 to 74. The screening component of the trial was","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","OncoArray, HumanOmni5-4, HumanOmni2.5-8, Global_Screening_Array-24, HumanOmniExpress-24, MethylationEPIC","Methylation (CpG), SNP/CNV (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 15 variables, 3 molecular datasets, 110559 subjects, 113630 samples","European (100737), African (154), East Asian (2749), African American (4481), Hispanic1 (225), Hispanic2 (1379), Other Asian or Pacific Islander (783), South Asian (160), Other (242)","NCI","CADM --- Research relating to adults diseases and methods","2025-05-20","2025-05-20","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs000710.v2.p1","1000 Genomes Used for Cloud Testing","WARNING: This is a test data set. The phenotype data was not checked to match 1000 Genomes project. Use with caution. This study provides public access to a demonstration subset  of 1000 genomes sequence data in dbGaP. It is intended to be used by software developers who design, implement and validate pipelines for dbGaP data.","Not Applicable","Test study for cloud access","Cross-Sectional","custom_markerset","SNP Genotypes (Array), RNA-Seq, WGS","5 phenotype datasets, 16 variables, 1 molecular datasets, 108 samples sequenced, 2508 subjects, 2508 samples","","NLM","","2025-05-19","2025-05-19","Not Provided",""
"phs003981.v1.p1","Immediate Postoperative Minimal Residual Disease Detection with MAESTRO    Predicts Recurrence and Survival in Head and Neck Cancer Patients    Treated with Surgery","We selected 24 patients with locally advanced head and neck squamous cell carcinoma (HNSCC) who were surgically treated. MAESTRO, our ultrasensitive, tumor-informed, mutation enrichment sequencing assay, was applied in a  pooled format (MAESTRO-Pool) to plasma samples collected from these patients at baseline (pre-op) and postoperatively. We show that detection of","Not Applicable","Neoplasms","Case Set","Not Provided","WGS","4 phenotype datasets, 13 variables, 48 samples sequenced, 24 subjects, 48 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-05-16","2025-05-16","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001110.v4.p1","Kids First: Pediatric Research Project on the Genomic Analysis of    Congenital Diaphragmatic Hernia","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by the  NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella Miller","Not Applicable","Hernias, Diaphragmatic, Congenital","Family/Twin/Trios","WGS_markerset_grc37","CNV Genotypes, SNP Genotypes (NGS), WGS","5 phenotype datasets, 27 variables, 1 molecular datasets, 594 samples sequenced, 3968 subjects, 4470 samples","","NCI","GRU --- General Research Use","2025-05-16","2017-05-25","Agenesis of Hemidiaphragm; CDH; CDH - Congenital diaphragmatic hernia; Congenital Diaphragmatic Defect; Congenital Diaphragmatic Defects; Congenital Diaphragmatic Hernia","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003999.v1.p1","Synovial Fibroblast Gene Expression in Response to Fibronectin Fragment","Osteoarthritis (OA) is a prevalent joint disease characterized by the progressive degradation of articular cartilage, hypertrophy of neighboring bone, and varying degrees of synovial inflammation. Recent research has highlighted the  potential role of synovial fibroblasts in the pathogenesis of OA, particularly their inflammatory properties that disrupt cartilage homeostasis.","Not Applicable","Osteoarthritis","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 10 samples sequenced, 5 subjects, 10 samples","","NIAMS","GRU-NPU --- General Research Use (NPU)","2025-05-15","2025-05-15","Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides; Degenerative Arthritis; Degenerative arthropathy",""
"phs003933.v1.p1","Long-Term Oxygen Treatment Trial (LOTT-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  evaluate the efficacy of long-term treatment with supplemental oxygen in people with stable chronic obstructive pulmonary disease (COPD) and resting","Not Applicable","Pulmonary Disease, Chronic Obstructive","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1759 subjects, 1759 samples","","NHLBI","GRU --- General Research Use","2025-05-15","2025-05-15","CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD; COLD - Chronic obstructive lung disease",""
"phs003839.v1.p1","Health Effects of Arsenic Longitudinal Study","The Health Effects of Arsenic Longitudinal Study (HEALS), a multidisciplinary and large prospective cohort study in Araihazar, Bangladesh, was established to evaluate the effects of full-dose range arsenic (As) exposure  on various health outcomes. We applied array-based genotyping technologies to baseline DNA samples from a subset of the HEALS study and linked those","Not Applicable","Arsenic","Prospective Longitudinal Cohort","MethylationEPIC, custom_markerset","Methylation (CpG), SNP/CNV (Array)","3 phenotype datasets, 14 variables, 1 molecular datasets, 3526 subjects, 3526 samples","","NIEHS","HMB-COL --- Health/Medical/Biomedical (COL)","2025-05-15","2025-05-15","Not Provided",""
"phs003906.v1.p1","Targeting EGFR in NF1 Mutant Melanoma","Our study focused on melanoma patients with driver mutations in the neurofibromin 1 (NF1) tumor suppressor gene, a subset of melanoma patients that have not benefitted from recent treatment advances.  We have leveraged patient-derived short-term cultures (STCs) and multiomics approaches to identify molecular features that could be developed into","Not Applicable","Melanoma","Tumor vs. Matched-Normal","Not Provided","WXS","3 phenotype datasets, 11 variables, 56 samples sequenced, 30 subjects, 56 samples","","NCI","DS-M-IRB-COL-NPU-GSO --- Disease-Specific (Melanoma, IRB, COL, NPU, GSO)","2025-05-14","2025-05-14","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs003558.v1.p1","Genomics of Substance Use Disorders in Latin American Populations","This is a subsample of the National Survey of Drug, Alcohol, and Tobacco Use, administered in 2016 between August and October to participants aged 12-65 in urban and rural Mexican  households, named Mexican Genomic Database for Addiction Research (MxGDAR). The objective of the survey was to evaluate the patterns of use of","Not Applicable","Substance-Related Disorders","Cross-Sectional","Global_Diversity_Array-8","SNP/CNV (Array)","5 phenotype datasets, 40 variables, 1 molecular datasets, 1816 subjects, 1731 samples","","NIDA","GRU-IRB --- General Research Use (IRB)","2025-05-14","2025-05-14","Illness, Mental; Mental Disorder; Mental Disorders; Mental Dysfunction; Mental Illness; Mental Illnesses",""
"phs002367.v2.p1","Longitudinal Study of Vaginal Flora","This prospective observational study aims to advance our knowledge of the natural history and abnormal alteration in vaginal microbial flora, and to identify risk factors that are associated with these  changes. A total of 5500 healthy, non-pregnant women of reproductive age will be enrolled and followed up in Birmingham, Alabama, for one year","Not Applicable","Female Urogenital Diseases and Pregnancy Complications","Prospective Longitudinal Cohort","Not Provided","AMPLICON, WGS","4 phenotype datasets, 15 variables, 1465 samples sequenced, 844 subjects, 1465 samples","","NIAID","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2025-05-14","2022-07-20","Sexually Transmitted Diseases; Vaginosis, Bacterial; Disease with a predominantly sexual mode of transmission; Disease, Sexually Transmitted; Disease, Venereal; Diseases, Sexually Transmitted",""
"phs002183.v2.p1","The Multiethnic Cohort (MEC) Study","The Multiethnic Cohort (MEC) study of over 215,000 men and women in Hawaii and California is unique in that it is population-based and includes large representations of older adults (45-75  years at baseline) for five US racial/ethnic groups (Japanese Americans, African Americans, European Americans, Latinos and Native Hawaiians) at","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","Global_Diversity_Array-8, imputation_panel","SNP/CNV (Array), SNP/CNV Genotypes (imputed)","9 phenotype datasets, 210 variables, 2 molecular datasets, 204142 subjects, 120985 samples","","NCI","DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2025-05-14","2025-05-14","Risk Factors; Blastoma; CA; CA - Cancer; Cancer; MT",""
"phs001661.v4.p1","NHLBI TOPMed: Genetic Causes of Complex Pediatric Disorders - Asthma    (GCPD-A)","The Center for Applied Genomics (CAG) at the Children's Hospital of Philadelphia (CHOP) is focused on addressing the roles of both single nucleotide variants and structural copy number variants, and  their functional impact, together with gene-environment interactions and their influence on asthma drug response. A clinical team of full-time nurses","Not Applicable","Asthma","Case-Control","WGS_markerset_grc38, RNAseq_gene_transcripts, SV_STR_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), RNA Seq (NGS), WGS","5 phenotype datasets, 35 variables, 2 documents, 3 molecular datasets, 4444 samples sequenced, 5464 subjects, 5612 samples","European (53), African (90), East Asian (1), African American (3960), Hispanic1 (202), Hispanic2 (57), Other Asian or Pacific Islander (3), South Asian (5), Other (57)","NHLBI","DS-ASTHMA-GSO --- Disease-Specific (Asthma, GSO)","2025-05-14","2025-05-14","Allergies; Hypersensitivity; Allergic disorders; Allergy; Hypersensitive; Hypersensitivities",""
"phs001605.v3.p1","NHLBI TOPMed: Chicago Initiative to Raise Asthma Health Equity (CHIRAH)","The CHIRAH project was a community-based study of the factors associated with asthma morbidity in the African American population. CHIRAH evaluated the role of various variables (biologic/environmental, psychologic/behavioral, and socioeconomic)  on asthma morbidity and the function of changes in these variables on asthma morbidity in a longitudinal fashion. This involved collection of a","Not Applicable","Asthma","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 23 variables, 2 documents, 2 molecular datasets, 279 samples sequenced, 292 subjects, 296 samples","African (3), African American (266), Hispanic1 (3), Hispanic2 (2), Other (2)","NHLBI","DS-ASTHMA-IRB-COL --- Disease-Specific (Asthma, IRB, COL)","2025-05-14","2025-05-14","Hypersensitivity; Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma",""
"phs004022.v1.p1","Broccoli Sprouts Extracts Trial (BEST-COPD-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  establish a safe and tolerable dose of sulforaphane that effects in vivo antioxidants via Nrf2 for development as a potential novel treatment for","Not Applicable","Pulmonary Disease, Chronic Obstructive","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 89 subjects, 89 samples","","NHLBI","GRU --- General Research Use","2025-05-13","2025-05-13","Chronic Obstructive Pulmonary Disease; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD",""
"phs003873.v1.p1","Precision High Intensity Training Through Epigenetics (PHITE)","Exercising regularly promotes health, but these benefits are complicated by acute inflammation induced by exercise. A potential source of exercise-induced inflammation is cell-free DNA (cfDNA), yet the cellular origins, molecular  causes, and immune system interactions of exercise-induced cfDNA are unclear. To study these, 10 healthy individuals were randomized to a 12-week","Not Applicable","Exercise","Clinical Trial","proteome","Bisulfite-Seq, OTHER, Proteomics","4 phenotype datasets, 22 variables, 1 molecular datasets, 54 samples sequenced, 11 subjects, 90 samples","","NIAID","GRU --- General Research Use","2025-05-13","2025-05-13","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs004021.v1.p1","Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack    Trial (ALLHAT-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives Hypertension  Study: To determine whether treatment with a calcium channel blocker or an angiotensin-converting enzyme inhibitor lowers the incidence of coronary","Not Applicable","Hypertension","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 42418 subjects, 42418 samples","","NHLBI","GRU --- General Research Use","2025-05-12","2025-05-12","Congestive Heart Failure; Coronary Heart Disease; Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Heart Failure",""
"phs004020.v1.p1","Prospective Investigation of Pulmonary Embolism Diagnosis    (PIOPED-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  determine the sensitivities and specificities of ventillation/perfusion (V/Q) lung scans for acute pulmonary embolism (PE). Participants: A total of","Not Applicable","Lung Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1487 subjects, 1487 samples","","NHLBI","GRU --- General Research Use","2025-05-12","2025-05-12","Pulmonary Embolism; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders",""
"phs004013.v1.p1","Lung Health Study (LHS-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  determine the effects of Special Care, compared to Usual Care, on rate of decline in pulmonary function in a group of cigarette smokers identified as","Not Applicable","Pulmonary Disease, Chronic Obstructive","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 5887 subjects, 5887 samples","","NHLBI","GRU --- General Research Use","2025-05-12","2025-05-12","Lung Diseases; Lung Diseases, Obstructive; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary",""
"phs004010.v1.p1","Clinical Study of Intermittent Positive Pressure Breathing    (IPPB-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  evaluate the efficacy of long-term intermittent positive pressure breathing (IPPB) treatment when used as an adjunct to the overall care of","Not Applicable","Pulmonary Disease, Chronic Obstructive","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 3218 subjects, 3218 samples","","NHLBI","GRU --- General Research Use","2025-05-12","2025-05-12","Lung Diseases; Lung Diseases, Obstructive; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary",""
"phs003995.v1.p1","Lipid Research Clinics - Prevalence Study (LRC-PS-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: The  LRC Program began in 1971 under the sponsorship of the National Heart, Lung, and Blood Institute, National Institutes of Health. Part of this program","Not Applicable","Cardiovascular Diseases","Cross-Sectional","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 60495 subjects, 60495 samples","","NHLBI","GRU --- General Research Use","2025-05-12","2025-05-12","Coronary Disease; Heart Diseases; Myocardial Ischemia; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs003968.v1.p1","Weighing Risks and Benefits of Laparoscopic Anti-Reflux Surgery in    Patients With Idiopathic Pulmonary Fibrosis (WRAP-IPF-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  determine if the reduction of abnormal gastro-esophageal reflux (GER) with laparoscopic anti-reflux surgery will slow the progression of idiopathic","Not Applicable","Idiopathic Pulmonary Fibrosis","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 58 subjects, 58 samples","","NHLBI","GRU --- General Research Use","2025-05-12","2025-05-12","Gastroesophageal Reflux; Acid Reflux, Gastric; Esophageal Reflux; GASTROESOPHAGEAL REFLUX DISEASE; GASTROESOPHAGEAL REFLUX, PEDIATRIC; GER",""
"phs003930.v1.p1","Puerto Rico Heart Health Program (PRHHP-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  investigate morbidity and mortality from Coronary Heart Disease (CHD) in Puerto Rican rural and urban men. The objectives of the study were: (1) to","Not Applicable","Coronary Disease","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 9824 subjects, 9824 samples","","NHLBI","GRU --- General Research Use","2025-05-12","2025-05-12","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart",""
"phs003870.v1.p1","Fgl2 Regulates Fc&#x003b3;RIIB+ CD8+ T Cell Responses during Infection","While the inhibitory receptor Fc&#x003b3;RIIB has been shown to be upregulated on activated CD8+ T cells in both mice and humans, its impact on T cell fate during infection has  not been fully elucidated. We identified an increase in Fc&#x003b3;RIIB-expressing CD8+ T cells in COVID patients relative to healthy controls, and","Not Applicable","COVID-19","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 11 variables, 33 samples sequenced, 20 subjects, 33 samples","","NIAID","GRU --- General Research Use","2025-05-10","2025-05-10","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003949.v1.p1","Single-Cell Mitochondrial Mutation Lineage Tracing of Non-Dysplastic and    Dysplastic Barrett's Esophagus","This study addresses a critical knowledge gap in understanding Barrett's esophagus (BE), a common metaplastic condition and precursor to esophageal adenocarcinoma, by identifying lineage connections and cell states underlying its  development and malignant transformation. We collected biopsies from 13 Barrett's esophagus patients undergoing routine surveillance endoscopy,","Not Applicable","Barrett Esophagus","Case Set","WES_markerset_grc38","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 3 samples sequenced, 1 subjects, 6 samples","","NIDDK","HMB-NPU --- Health/Medical/Biomedical (NPU)","2025-05-09","2025-05-09","BARRETT METAPLASIA; BE; Barret syndrome; Barrett Metaplasias; Barrett Syndrome; Barrett esophagus/esophageal adenocarcinoma",""
"phs003948.v1.p1","Pomalidomide for the Treatment of Bleeding in HHT (PATH-HHT)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  determine efficacy (reduction in severity of epistaxis), tolerability, and improvement in quality of life of pomalidomide compared to placebo after","Not Applicable","Telangiectasia, Hereditary Hemorrhagic","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 144 subjects, 144 samples","","NHLBI","DS-HHT-IRB-PUB-COL --- Disease-Specific (Hereditary Hemorrhagic Telangiectasia, IRB, PUB, COL)","2025-05-09","2025-05-09","Epistaxis; Bleeding, Nasal; Bleedings, Nasal; Bloody nose; Finding of bleeding of nose; Frequent nosebleeds",""
"phs003932.v1.p1","Biomarkers for Noise-Induced Sleep Disruption","This project aims to investigate gene expression biomarkers for noise-induced sleep disruption and cognitive changes. The project is a sub-study, part of the larger ASCENT COE project 86 designed to  test the ability of broadband pink noise to serve as a countermeasure for sleep loss from simulated aircraft noise. Gene expression research was","Not Applicable","Noise","Interventional","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 14 variables, 1 documents, 1 molecular datasets, 150 samples sequenced, 26 subjects, 150 samples","","NHGRI","GRU --- General Research Use","2025-05-09","2025-05-09","Sleep; Nighttime Sleep","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003725.v2.p1","Carolina Breast Cancer Study (CBCS)","The Carolina Breast Cancer Study (CBCS), phase III, is a population-based study aiming to understand the social and molecular correlates of breast cancer outcomes, particularly among Black and young women.  CBCS recruited first primary breast cancer cases from 44 North Carolina counties between 2008-2013. All cases were between age 20 and 74 and","Not Applicable","Breast Neoplasms","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 15 variables, 836 samples sequenced, 439 subjects, 836 samples","","NCI","DS-BRCA-COL --- Disease-Specific (Breast Cancer, COL)","2025-05-09","2024-10-29","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003997.v1.p1","Functional Variant rs9344 at 11q13.3 Regulates CCND1 Expression in    Multiple Myeloma with t(11;14)","Multiple myeloma (MM) is a plasma cell (PC) malignancy characterized by cytogenetic abnormalities, such as t(11;14)(q13;q32), resulting in CCND1 overexpression. The rs9344 G allele within CCND1 is the most significant  susceptibility allele for t(11;14). We have found the G risk allele is enriched in both healthy individuals of African ancestry and African American","Not Applicable","Multiple Myeloma","Case Set","Not Provided","ATAC-seq, ChIP-Seq","4 phenotype datasets, 16 variables, 60 samples sequenced, 26 subjects, 60 samples","","NCI","DS-MG-IRB --- Disease-Specific (Monoclonal Gammopathies, IRB)","2025-05-08","2025-05-08","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease",""
"phs003924.v1.p1","Comparison Across Multiple Types of Sleep Deprivation","This study is designed to assess neurobehavioral performance, as well as molecular and physiological changes associated with variations in timing and quantity of sleep. Gene expression changes associated with neurobehavioral  (cognitive) performance were assessed in a time-series among individuals randomly assigned to four separate sleep conditions during a 10-day","Not Applicable","Sleep Deprivation","Interventional","T2T-CHM13v2","RNA-Seq, RNA Seq (NGS)","7 phenotype datasets, 130 variables, 1 documents, 1 molecular datasets, 1572 samples sequenced, 59 subjects, 1572 samples","","NHGRI","GRU --- General Research Use","2025-05-08","2025-05-08","Insufficient Sleep Syndrome; Insufficient Sleep Syndromes; Syndrome, Insufficient Sleep","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002981.v2.p1","INCLUDE: Human Trisome Project","The INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project is an NIH-wide collaboration that seeks to improve health and quality-of-life for people with Down syndrome.  The INCLUDE Project Data Coordinating Center and partners created the INCLUDE Data Hub, a centralized data resource that allows access to large-scale","Not Applicable","Down Syndrome","Case Set","Not Provided","Not Provided","2 phenotype datasets, 6 variables, 807 subjects, 1154 samples","","NICHD","GRU --- General Research Use","2025-05-07","2023-11-22","47,XX,+21; 47,XY,+21; DS; Down syndrome chromosome region; Down syndrome critical region; Down syndrome, Isolated cases",""
"phs003869.v1.p1","Characteristics and Inflammatory Markers in Children with Eosinophilic    Esophagitis (EoE)","The overall protocol for the samples used in this study collects medical information, blood, and biopsy samples from children with eosinophilic esophagitis (EoE) over time to understand clinical characteristics and  disease pathogenesis. Our patient population has confirmed EoE and symptoms of esophageal dysfunction characteristic endoscopic findings of EoE.","Not Applicable","Eosinophilic Esophagitis","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 4 samples sequenced, 4 subjects, 4 samples","","NIAID","GRU-PUB-COL-NPU --- General Research Use (PUB, COL, NPU)","2025-05-06","2025-05-06","Esophagitis, Eosinophilic; Chronic Esophagitides, Eosinophilic; Chronic Esophagitis, Eosinophilic; EE; EoE; Eosinophilic Chronic Esophagitides",""
"phs003357.v1.p1","Evolution of Structural Rearrangements in Prostate Cancer Intracranial    Metastases","Intracranial metastases in prostate cancer are uncommon but clinically aggressive. We sought to characterize prostate cancer intracranial metastases in order to improve our understanding of their pathogenesis and to promote  the search for new treatment strategies. We evaluated the clinical and molecular characteristics of 36 patients with metastatic prostate cancer to","Not Applicable","Prostatic Neoplasms","Tumor vs. Matched-Normal","custom_markerset","SNV (.MAF), WGS","4 phenotype datasets, 23 variables, 1 molecular datasets, 64 samples sequenced, 21 subjects, 64 samples","","NCI","GRU-IRB --- General Research Use (IRB)","2025-05-06","2025-05-06","Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain",""
"phs003280.v1.p1","Genetic Markers of Caries Risk in Diverse Underserved Children: CIDR","The study Predicting Caries Risk In Underserved Children, From Toddlers To The School-age Years In Primary Healthcare Settings, is a renewal of an initial project designed to develop a dental  caries risk tool for use in primary medical and dental healthcare settings to identify high dental caries risk children, expanding from the toddler","Not Applicable","Dental Caries","Prospective Longitudinal Cohort","Global_Diversity_Array-8, imputation_panel","SNP/CNV (Array), SNP Genotypes (imputed)","5 phenotype datasets, 111 variables, 2 molecular datasets, 1059 subjects, 1073 samples","","NIDCR","HMB --- Health/Medical/Biomedical","2025-05-06","2025-05-06","Caries; Caries, Dental; Cariosity of teeth; Carious Lesion; Carious Lesions; Cavities, Dental",""
"phs001476.v2.p1","Field Studies of Human Immunity to Amebiasis in Bangladesh","Amebiasis is a common cause of diarrhea and is associated with malnutrition in grade-school aged children in an urban slum of Dhaka, Bangladesh. Field Studies of Human Immunity to Amebiasis  in Bangladesh was designed to determine the contribution of amebiasis to illness in the first 2 years of life when most deaths due to diarrhea occur,","Not Applicable","Intestinal Diseases","Prospective Longitudinal Cohort","Human1M-Duo, HumanOmni2.5-8, HumanOmni1-Quad","SNP Genotypes (Array)","13 phenotype datasets, 183 variables, 1 molecular datasets, 447 subjects, 447 samples","","NIAID","DS-TENT-IRB-PUB-NPU-MDS-GSO-RD --- Disease-Specific (Tropical Enteropathy, IRB, PUB, NPU, MDS, GSO, RD)","2025-05-06","2025-05-06","Communicable Diseases; Inflammation; Malnutrition; Communicable Disease; Disease, Communicable; Disease, Infectious",""
"phs003961.v1.p1","P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer    Organoids","Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy defined by extensive invasion into the local tumor microenvironment and systemic metastasis. PDAC develops in a hypoxic microenvironment and adapts to survive  under low oxygen conditions, including the activation of processes that may enhance the ability of cancer cells to invade locally or metastasize.","Not Applicable","Carcinoma, Pancreatic Ductal","Case Set","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 15 variables, 1 molecular datasets, 6 samples sequenced, 3 subjects, 6 samples","","NCI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2025-05-05","2025-05-05","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas",""
"phs003898.v1.p1","Human Cancer-Targeted Immunity via Transgenic Hematopoietic Stem Cell    Progeny","Analysis of a patient biopsy from the clinical trial (NCT03240861), a first-in-human study of transgenic NY-ESO-1 TCR- T cells and NY-ESO-1 TCR+ sr39tk autologous hematopoietic stem cells tandem therapy for  solid tumors after myeloablative conditioning chemotherapy with busulfan and fludarabine. Single-cell RNAseq and single-cell ATACseq analysis from","Not Applicable","Sarcoma, Synovial","Clinical Trial","Not Provided","ATAC-seq, RNA-Seq","4 phenotype datasets, 18 variables, 2 samples sequenced, 1 subjects, 2 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2025-05-05","2025-05-05","Synovial Sarcoma; Malignant synovioma; Sarcomas, Synovial; Synovial Sarcomas; Synovialosarcoma; Synovioma",""
"phs003853.v1.p1","Stanford Acute Myeloid Leukemia Single-Cell DNA Sequencing","These are single-cell DNA sequencing data from acute myeloid leukemia samples from Stanford University. They were used in multiple publications to understand clonal evolution in AML. Longitudinal bone marrow and  blood samples were taken from each subject with acute myeloid leukemia at diagnosis, relapse, or remission. All subjects were over the age of 18.","Not Applicable","Leukemia, Myeloid, Acute","Case Set","Not Provided","Bisulfite-Seq, Targeted-Capture","4 phenotype datasets, 25 variables, 46 samples sequenced, 17 subjects, 46 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-05-05","2025-05-05","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs003707.v2.p1","MP2PRT-MNG: Identifying Novel Molecular Markers of Response to    Radiotherapy in Meningiomas Using Samples from the RTOG-0539    (NCT00895622)","The Molecular Profiling to Predict Response to Treatment (MP2PRT) program is part of the NCI's Cancer Moonshot Initiative. The aim of this program is the retrospective characterization and analysis of  biospecimens collected from completed NCI-sponsored trials of the National Clinical Trials Network and the NCI Community Oncology Research Program.","Not Applicable","Meningioma","Clinical Trial","MethylationEPIC","Methylation (CpG), RNA-Seq, WXS","3 phenotype datasets, 16 variables, 2 molecular datasets, 253 samples sequenced, 100 subjects, 352 samples","","NCI","GRU-COL --- General Research Use (COL)","2025-05-05","2025-05-05","Diffuse meningiomatosis; Meningioma, Multiple; Meningiomas, Multiple; Meningiomatoses; Meningiomatosis; Multifocal meningiomata",""
"phs000693.v7.p3","University of Washington Center for Mendelian Genomics (UW-CMG)","The Centers for Mendelian Genomics project uses next-generation sequencing and computational approaches to discover the genes and variants that underlie Mendelian conditions. By discovering genes that cause Mendelian conditions, we  will expand our understanding of their biology to facilitate diagnosis and new treatments. Note: Raw sequencing data, metadata, vcf and phenotype","Not Applicable","Rare Diseases","Mendelian","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use, DS-EP --- Disease-Specific (Epilepsy), DS-HFA --- Disease-Specific (Head and Face), DS-NBIA --- Disease-Specific (Neurodegeneration with Brain Iron Accumulation), HMB-IRB --- Health/Medical/Biomedical (IRB), GRU-IRB --- General Research Use (IRB), DS-BDIS --- Disease-Specific (Brain Disorders), DS-CHDEF --- Disease-Specific (Congenital Heart Defects), DS-BAV-IRB-PUB-RD --- Disease-Specific (Bicuspid Aortic Valve, IRB, PUB, RD), HMB --- Health/Medical/Biomedical","2025-04-30","","Acrofacial dysostosis, Nager type; Agenesis of Corpus Callosum; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Arthritis; Attention Deficit Disorder with Hyperactivity","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002624.v4.p1","Clonal Lineage Tracing of Primary Human Cortical Progenitors, Cell Type    Profiles in the Brain Vasculature and Genotyping Data for 22q11DS and    Control iPS Lines","We sought to characterize the cell types produced by individual human cortical progenitors and describe their lineage relationships. We labeled individual human cortical cells with a massively complex lentivirus library  encoding a GFP reporter gene and a molecular barcode that could be captured by standard 3' scRNA-seq methodologies. We then cultured the labeled","Not Applicable","Neural Stem Cells","Prospective Longitudinal Cohort","RNAseq_gene_transcripts","SNP/CNV (Array), RNA-Seq","4 phenotype datasets, 12 variables, 1 molecular datasets, 30 samples sequenced, 38 subjects, 38 samples","","NIMH","GRU --- General Research Use","2025-04-29","2024-03-06","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs001927.v2.p2","NHLBI TOPMed: SubPopulations and InteRmediate Outcome Measures In COPD    Study (SPIROMICS)","Subpopulations and Intermediate Outcome Measures in COPD Study Description Subpopulations and intermediate outcome measures in COPD study (SPIROMICS) supports the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and  clinical data from subjects with COPD for the purpose of identifying subpopulations and intermediate outcome measures. It is funded by the National","Not Applicable","Pulmonary Disease, Chronic Obstructive","Prospective Longitudinal Cohort","WGS_markerset_grc38, Metabolome, RNAseq_probe_set_grc38","Metabolomics, RNA-Seq, SNP/CNV Genotypes (NGS), CNV (NGS), RNA Seq (NGS), WGS","5 phenotype datasets, 52 variables, 2 documents, 3 molecular datasets, 4153 samples sequenced, 2423 subjects, 8321 samples","European (155), African (1), East Asian (2), African American (32), Other Asian or Pacific Islander (1), Other (2)","NHLBI","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU), DS-COPD --- Disease-Specific (Chronic Obstructive Pulmonary Disease), DS-COPD-NPU --- Disease-Specific (Chronic Obstructive Pulmonary Disease, NPU), GRU-COL --- General Research Use (COL), GRU-COL-NPU --- General Research Use (COL, NPU), DS-COPD-COL --- Disease-Specific (Chronic Obstructive Pulmonary Disease, COL), DS-COPD-COL-NPU --- Disease-Specific (Chronic Obstructive Pulmonary Disease, COL, NPU)","2025-04-29","2025-04-29","Bronchitis, Chronic; Pulmonary Emphysema; Chronic Bronchitis; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs003161.v1.p1","Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing    Program &#x02013; Sarcomas and other Solid Tumors","The primary goal of this project involves the comprehensive molecular profiling of patient-derived xenograft (PDX) mouse tumor models. Molecular profiling of each PDX model will include whole exome sequencing (WES),  RNAseq, MethylEPIC arrays, CytoSNP array, and DNA fingerprint for quality control. Limited clinical demographic data (e.g. diagnosis, disease site,","Not Applicable","Heterografts","Xenograft","Not Provided","AMPLICON","2 phenotype datasets, 5 variables, 185 samples sequenced, 175 subjects, 883 samples","","NCI","GRU --- General Research Use","2025-04-25","2025-04-25","Desmoplastic Small Round Cell Tumor; Hepatoblastoma; Pleuropulmonary blastoma; Rhabdoid Tumor; Sarcoma; Synovial Sarcoma",""
"phs002655.v1.p1","COVID-19-Induced Immune Alterations in Infants","Although previous studies have described some overlap between COVID-19-induced immune alterations in adults and children, no systematic immune profiling studies have been reported in infants. We applied a multidimensional approach  to decipher the immune responses to SARS-CoV-2 infected infants (n 26; 10 mild, 11 moderate and 5 severe) and healthy matched controls (n 14).","Not Applicable","Immunity","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 36 variables, 40 samples sequenced, 40 subjects, 40 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2025-04-25","2025-04-25","COVID-19; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus",""
"phs003908.v1.p1","Multiple Myeloma Clinical Targeted Sequencing of Patient Samples","Purpose: Molecular diagnostics for the risk stratification of patients with multiple myeloma (MM) have languished in the area of cytogenetics and fluorescence in situ hybidization (FISH). However, here we present  the case for next generation sequencing of MM patient samples to not only identify high-risk markers, but also mutations and deletions relating to","Not Applicable","Multiple Myeloma","Tumor vs. Matched-Normal","Not Provided","Targeted-Capture","4 phenotype datasets, 24 variables, 268 samples sequenced, 130 subjects, 268 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2025-04-24","2025-04-24","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease",""
"phs003793.v1.p1","Platinum Pedigree Consortium Long-Read Sequencing","Platinum Pedigree Consortium includes whole genome sequencing of blood-derived DNA using five technologies on a 4-generation family. This is the CEPH-Utah (CEU) family 1463 and includes 4 grandparents from 1st  generation, 2 parents from 2nd generation, 5 children from 3rd generation, 9 individuals from the 4th generation representing 2 branches of the 3rd","Not Applicable","Genetic Variation","Control Set","Not Provided","WGS","4 phenotype datasets, 15 variables, 8 samples sequenced, 5 subjects, 8 samples","","NHGRI","GRU --- General Research Use","2025-04-24","2025-04-24","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003913.v1.p1","Lung Tissue Research Consortium (LTRC-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Biospecimens: Access  to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from LTRC include","Not Applicable","Pulmonary Disease, Chronic Obstructive","Cross-Sectional","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 4486 subjects, 4486 samples","","NHLBI","DS-LD-MDS --- Disease-Specific (Lung Diseases, MDS)","2025-04-22","2025-04-22","Chronic Obstructive Pulmonary Disease; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD",""
"phs003825.v2.p2","Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using    an Impedance Valve and Early Versus Delayed Analysis (PRIMED)    (ROC-PRIMED-BioLINCC)","Accessing Data: Please refer to &#x0201c;Authorized Access&#x0201d; below regarding accessing data through the BioData Catalyst ecosystem. The data from this accession is not available for download through dbGaP. Objective: The  purpose of this study was to examine two different treatments during a cardiac arrest that occurs outside of the hospital and whether either or both","Not Applicable","Heart Arrest","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 34622 subjects, 34622 samples","","NHLBI","GRU --- General Research Use","2025-04-22","2025-02-26","Arrest, Cardiac; Arrest, Heart; Asystole; Asystoles; Cardiac standstill; Heart stops beating",""
"phs003799.v1.p1","Skin Microbiome of Monogenic Skin Disorder","Ichthyosis introduces multiple sources of disturbance to the skin, including the direct biochemical consequences of the genotype, the phenotypic changes in skin physiology, and an altered skin microbiome. The association  between changes in the skin microbiome and the disease's genotypic and phenotypic effects are historically obscured. Here we characterize the skin","Not Applicable","Ichthyosis","Case-Control","Not Provided","WGS","4 phenotype datasets, 21 variables, 466 samples sequenced, 48 subjects, 466 samples","","NIAMS","GRU --- General Research Use","2025-04-22","2025-04-22","",""
"phs003419.v2.p1","BLUE CORAL: Biology and Longitudinal Epidemiology of PETAL COVID-19    Observational Study","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Available Data:  Long Term Follow-up data has been added with version 2. Biospecimens: Access to Biospecimens is through the NHLBI Biologic Specimen and Data","Not Applicable","epidemiology","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1376 subjects, 1376 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2025-04-22","2024-12-09","COVID-19; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus",""
"phs003947.v1.p1","Integrating Circulating Tumor DNA Analysis and Radiomics for Dynamic Risk    Assessment in Localized Lung Cancer","DNA was isolated from pre-treatment and mid-treatment plasma samples and matched germline samples from patients undergoing chemoradiation therapy for stage IIB-IIIB non-small cell lung cancer. Sequencing libraries were hybrid captured  using custom selector pools designed to target genes frequently mutated in non-small cell lung cancer prior to ultra-deep next generation sequencing.","Not Applicable","Carcinoma, Non-Small-Cell Lung","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 20 variables, 120 samples sequenced, 40 subjects, 120 samples","","NCI","GRU --- General Research Use","2025-04-16","2025-04-16","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER",""
"phs000892.v7.p1","Clinical Proteomic Tumor Analysis Consortium (CPTAC) Proteogenomic    Confirmatory Study of Breast, Colon, Lung, and Ovarian Tumors","Recently, significant progress has been made in characterizing and sequencing the genomic alterations in statistically robust numbers of samples from several types of cancer. For example, The Cancer Genome Atlas  (TCGA), International Cancer Genome Consortium (ICGC) and other similar efforts are identifying genomic alterations associated with specific cancers","Not Applicable","Neoplasms","Case Set","Not Provided","RNA-Seq, WXS, miRNA-Seq","6 phenotype datasets, 284 variables, 1044 samples sequenced,  SRA, 348 subjects, 1087 samples","European (94), East Asian (24), African American (9), Hispanic1 (3), Hispanic2 (6), Other Asian or Pacific Islander (1), Other (1)","NCI","GRU --- General Research Use","2025-04-16","2017-01-22","Carcinoma, Ductal, Breast; Carcinoma, Lobular; Lung Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung",""
"phs003691.v1.p1","Somatic Mutations in 3,929 HPV-Positive Exfoliated Cervical Cell Samples","We investigated the detection, timing, and HPV type specificity of cervical somatic hotspot mutations (i.e., previously reported cancer driver mutations) in 3,929 HPV-positive exfoliated cervical cell samples from individuals undergoing  routine cervical screening in the U.S. using deep-targeted sequencing of 20 candidate genes. Our study included samples from 3,351 women with the","Not Applicable","Uterine Cervical Neoplasms","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 15 variables, 3928 samples sequenced, 3351 subjects, 3928 samples","","NCI","GRU --- General Research Use","2025-04-14","2025-04-14","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms",""
"phs002992.v1.p1","Multi-Omics Study of Lung Cancer in Smokers From EAGLE","EAGLE (Environment And Genetics in Lung cancer Etiology) is a population-based case-control study examining the full spectrum of lung cancer etiology from smoking initiation, smoking dependency to lung cancer development  and outcome. It combines a traditional molecular epidemiology design with more integrative approaches by examining epidemiological, molecular, and","Not Applicable","Lung Neoplasms","Tumor vs. Matched-Normal","custom_markerset","Methylome sequencing, WGS","4 phenotype datasets, 15 variables, 1 molecular datasets, 442 samples sequenced, 221 subjects, 702 samples","","NCI","DS-LDS-MDS --- Disease-Specific (Lung disease or smoking, MDS)","2025-04-14","2025-04-14","Respiratory Tract Diseases; Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung",""
"phs003655.v1.p1","Efficacy and Immune Effects of Anakinra Prophylaxis for Neurologic    Toxicity and Cytokine Release Syndrome in Patients with Lymphoma    Receiving Axicabtagene Ciloleucel","Chimeric antigen receptor T cells have transformed the treatment of multiple hematologic malignancies, but are limited in application due to treatment-related toxicities. Cytokine release syndrome (CRS) and neurotoxicity (NT) are  the primary toxicities associated with these therapies and are thought to be mediated by broad immune activation due to robust T-cell expansion.","Not Applicable","Interleukin 1 Receptor Antagonist Protein","Case Set","Not Provided","OTHER","4 phenotype datasets, 18 variables, 18 samples sequenced, 17 subjects, 18 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-04-11","2025-04-11","Not Provided",""
"phs003459.v1.p1","Heterogeneity in Lysosomal Storage Disorders","Gaucher disease (GD) is an inherited lysosomal storage disorder caused by biallelic pathogenic variants in GBA1, which encodes glucocerebrosidase. Additionally, GBA1 variants are a well-established genetic risk factor for Parkinson's  disease (PD), leading some PD research centers to incorporate GBA1 screening to identify patients who may benefit from targeted therapeutics.","Not Applicable","Gaucher Disease","Case Set","Not Provided","WGS","3 phenotype datasets, 8 variables, 91 samples sequenced, 91 subjects, 91 samples","","NHGRI","GRU --- General Research Use, DS-GDGRD --- Disease-Specific (Gaucher Disease and GBA1-related Disorders)","2025-04-11","2025-04-11","Acid beta-Glucosidase Deficiency; Acid beta-Glucosidase Deficiency Disease; Acute cerebral Gaucher disease; Adult Gaucher disease; Cerebroside Lipidoses, Glucosyl; Cerebroside Lipidosis Syndrome","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003193.v1.p1","Fetal Genomics Consortium (FGC)","Many of the congenital anomalies and associated genomic variants identified during prenatal care are rare, requiring aggregation and harmonization to assure their appropriate clinical interpretation and to support the expanding  utility of genomics in perinatal medicine. The primary step in accomplishing this is the creation of interoperability allowing collection,","Not Applicable","Congenital Abnormalities","Clinical Genetic Testing","Not Provided","Not Provided","Not Provided","","NICHD","GRU --- General Research Use","2025-04-11","","Abnormalities, Congenital; Abnormality, Congenital; Birth Defect; Birth Defects; CM - Congenital malformation; Congenital Anatomic Abnormality",""
"phs001232.v7.p3","Clinical and Genetic Evaluation of Individuals with Undiagnosed Disorders    through the Undiagnosed Diseases Network (UDN)","The National Human Genome Research Institute and the NIH Clinical Center established the intramural Undiagnosed Diseases Program (UDP) in 2008 to make progress in uncovering, understanding, and treating rare disorders.  Based on the success of the UDP, the NIH Common Fund established the Undiagnosed Diseases Network (UDN) in FY 2013 (Phase I, 9/16/2015-8/31/2018) to","Not Applicable","Rare Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc37, WGS_markerset_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), WGS, WXS","6 phenotype datasets, 24 variables, 7 molecular datasets, 8428 samples sequenced, 7187 subjects, 8431 samples","","NINDS","GRU --- General Research Use","2025-04-11","2025-04-11","Disease, Rare; Rare Disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001194.v4.p3","National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet    Program: The Pediatric Cardiac Genetics Consortium (PCGC) Study","Multi-center, prospective observational cohort study of individuals with congenital heart defects (CHD). Phenotypic data and source DNA derived from 10,000 probands, parents, and families of interest are being collected to  investigate relationships between genetic factors and phenotypic and clinical outcomes in patients with CHD. Phenotype data will be stored at dbGaP,","Not Applicable","Heart Defects, Congenital","Prospective Longitudinal Cohort","Not Provided","Not Provided","19 phenotype datasets, 429 variables, 12091 samples sequenced, 21963 subjects, 43400 samples, 2 substudies","","NHLBI","HMB --- Health/Medical/Biomedical, DS-CHD --- Disease-Specific (Congenital Heart Disease)","2025-04-11","2021-08-31","Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Abnormally shaped heart; Cardiac abnormalities","NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs000450.v6.p1","Whole Exome Sequencing of Diffuse Large B-Cell Lymphoma","We performed massively parallel whole exome sequencing of 55 primary tumor samples from patients with diffuse large B cell lymphoma (DLBCL) and matched normal tissue. We identified recurrent mutations in  genes that are well known to be functionally relevant in DLBCL, as well as in genes for which a functional role in DLBCL has not been previously","Not Applicable","Lymphoma, Large B-Cell, Diffuse","Case Set","WGS_markerset_grc36","SNP Genotypes (NGS), WXS","6 phenotype datasets, 25 variables, 1 molecular datasets, 545 samples sequenced, 389 subjects, 545 samples","","NCI","GRU-NPU-MDS --- General Research Use (NPU, MDS), DS-BLD-MDS --- Disease-Specific (Blood and Lymph Disorders, MDS), DS-CA-MDS --- Disease-Specific (Cancer, MDS), HMB --- Health/Medical/Biomedical","2025-04-11","2025-04-11","Centroblastic diffuse large B-cell malignant lymphoma; Centroblastic diffuse malignant lymphoma; Centroblastic malignant lymphoma; DLBCL; DLBCL - diffuse large B cell lymphoma; Diffuse Histiocytic Lymphoma","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001843.v2.p3","Pediatric Cardiac Genomics Consortium (PCGC) Study - Centers for    Mendelian Genomics Collaboration","This substudy phs001843 PCGC Study - CMG Collaboration contains whole genome sequences. Summary level phenotypes for the PCGC Cohort study participants can be viewed at the top-level study page phs001194  PCGC Cohort. Individual level phenotype data and molecular data for all PCGC top-level study and substudies are available by requesting Authorized","National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet Program: The Pediatric Cardiac Genetics Consortium (PCGC) Study (phs001194.v4.p3)","Heart Defects, Congenital","Family/Twin/Trios","Not Provided","Not Provided","1 phenotype datasets, 5 variables, 130 subjects, 130 samples","","NHLBI","HMB --- Health/Medical/Biomedical, DS-CHD --- Disease-Specific (Congenital Heart Disease)","2025-04-11","2021-08-31","Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Abnormally shaped heart; Cardiac abnormalities",""
"phs000571.v7.p3","National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet    Program: The Pediatric Cardiac Genetics Consortium (PCGC)","This substudy phs000571 PCGC contains whole exome sequences, targeted sequences, and SNP array data. Summary level phenotypes for the PCGC Cohort study participants can be viewed at the top-level study  page phs001194 PCGC Cohort. Individual level phenotype data and molecular data for all PCGC top-level study and substudies are available by","National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet Program: The Pediatric Cardiac Genetics Consortium (PCGC) Study (phs001194.v4.p3)","Heart Defects, Congenital","Prospective Longitudinal Cohort","Not Provided","AMPLICON, OTHER, RNA-Seq, WGS, WXS","1 phenotype datasets, 5 variables, 12091 samples sequenced, 20529 subjects, 43270 samples","European (1443), African (6), East Asian (22), African American (145), Hispanic1 (121), Hispanic2 (135), Other Asian or Pacific Islander (29), South Asian (70), Other (48)","NHLBI","HMB --- Health/Medical/Biomedical, DS-CHD --- Disease-Specific (Congenital Heart Disease)","2025-04-11","2021-08-31","Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Abnormally shaped heart; Cardiac abnormalities",""
"phs003846.v1.p1","Genomic Landscape of Multiple Myeloma and of its Precursor Conditions,    and its Clinical Implications","Reliable strategies to capture patients at risk of progression from precursor stages of multiple myeloma (MM) to overt disease are still missing. In this study, we generated whole-genome sequencing (WGS)  data from matched tumor and normal samples from 98 individuals from the PCROWD study (Precursor Crowd, NCT02269592). These individuals have either a","Not Applicable","Multiple Myeloma","Tumor vs. Matched-Normal","Not Provided","WGS","4 phenotype datasets, 20 variables, 196 samples sequenced, 98 subjects, 196 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-04-10","2025-04-10","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease",""
"phs003814.v1.p1","RNA Sequencing Analysis of Patient-Derived Xenograft Tissue PIM-084    Treated with L-NMMA+Alpelisib vs Vehicle Control","This dataset contains RNA-seq analysis of vehicle control compared to L-NMMA+alpelisib treated metaplastic breast cancer PDX PIM084 tumors (RNA sequencing and analysis performed by Novogene). The submitted data contains the  gene ID, gene name, normalized read counts from all samples from control group and combination treatment group, log2-fold change derived from DESeq2","Not Applicable","Breast Neoplasms","Xenograft","RNAseq_gene_transcripts","RNA Seq (NGS)","3 phenotype datasets, 13 variables, 1 molecular datasets, 6 subjects, 6 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-04-10","2025-04-10","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002504.v3.p2","UCSF Database for the Advancement of JMML - Integration of Metadata with    Omic Data","Juvenile myelomonocytic leukemia (JMML) is a rare and frequently fatal myeloproliferative/myelodysplastic disorder of early childhood with an estimated incidence of 1.2 cases per million. It is associated with a spectrum  of diverse outcomes ranging from spontaneous resolution in rare patients to transformation to acute myeloid leukemia in others. The overwhelming","Not Applicable","Leukemia, Myelomonocytic, Juvenile","Collection","Not Provided","AMPLICON, Bisulfite-Seq, RNA-Seq, WGA, WXS","2 phenotype datasets, 5 variables, 283 samples sequenced, 220 subjects, 438 samples","","NCI","GRU --- General Research Use","2025-04-10","2022-08-05","Neurofibromatosis 1; JCML; JCML - Juvenile chronic myeloid leukemia; JMML; Juvenile Chronic Myelogenous Leukemia; Juvenile Myelomonocytic Leukemias",""
"phs002262.v3.p1","Characterization of High-Grade Serous Ovarian Cancer Subtypes via    Single-Cell and Spatial-Transcriptomics Profiling","We measured gene expression in single-cell RNA sequencing samples from patients with high-grade serous ovarian cancer (HGSOC), for a study on improving HGSOC subtype definition by taking into account varying  cell type proportions within tumors. The initial dataset (added October, 2020) contains 3 samples (3 individuals). The next dataset (added November,","Not Applicable","Carcinoma, Ovarian Epithelial","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 12 variables, 43 samples sequenced, 18 subjects, 43 samples","","NCI","GRU --- General Research Use","2025-04-10","2020-11-10","Cancer, Epithelial Ovarian; Cancer, Ovarian Epithelial; Carcinoma of Ovary; Carcinoma of the Ovary; Carcinoma, Epithelial Ovarian; Epithelial Cancer, Ovarian","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003876.v1.p1","Single-Cell Transcriptomic Characterization of Microscopic Colitis","Patients with microscopic colitis (MC), chronic diarrhea without histological signs of MC, or unaffected controls were profiled using single-cell RNA sequencing (scRNA-seq; inDrops and 10X Genomics were used). One profiled  patient without clinical symptoms was found to have histological signs of MC (asymptomatic MC). Some of the subjects from dbGaP study phs003418 are","Not Applicable","Colitis, Microscopic","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 82 samples sequenced, 45 subjects, 82 samples","","NCI","GRU --- General Research Use","2025-04-07","2025-04-07","",""
"phs002812.v2.p1","Multiplexed scRNA-Seq Reveals Cellular and Genetic Correlates of SLE","Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease. Knowledge of circulating immune cell types and cell states associated with SLE remains incomplete. We profiled over 1.2 million PBMCs (160  cases, 98 controls) with multiplexed single-cell RNA-seq (mux-seq). Cases exhibited prominent expression of type-1 interferon-stimulated genes (ISG)","Not Applicable","Lupus Erythematosus, Systemic","Case-Control","Axiom_Exome_Plus","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 258 subjects, 258 samples","","NIAMS","GRU --- General Research Use","2025-04-07","2022-05-03","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003884.v1.p1","Defining Cutaneous Gene Expression Signatures in Juvenile Dermatomyositis","Skin inflammation in juvenile dermatomyositis (JDM) can signal disease onset or flare up and prevent complete disease remission. Our objective was to evaluate JDM cutaneous expression signatures through tape stripping  in both lesional and non-lesional skin and as compared to paired blood. A total of 28 JDM and 20 control (CTL) patients participated in the study.","Not Applicable","Dermatomyositis","Cross-Sectional","Not Provided","RNA-Seq","4 phenotype datasets, 12 variables, 148 samples sequenced, 49 subjects, 148 samples","","NIAMS","GRU --- General Research Use","2025-04-04","2025-04-04","Juvenile Dermatomyositis; Adult dermatomyositis; Amyopathic dermatomyositis; DM; DM - Dermatomyositis; Dermatopolymyositis",""
"phs003747.v1.p1","Jackson Heart Study - Images","The Jackson Heart Study (JHS) is a large, community-based, observational study that recruited 5,306 African American adults from three counties (Hinds, Madison and Rankin) in the Jackson, MS area. Participants  age 35-84 years at baseline were enrolled from each of 4 recruitment pools: (1) random, 17%, (2) volunteer, 30%, (3) currently enrolled in the","Not Applicable","Cardiovascular Diseases","Collection","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 3883 subjects, 3883 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), DS-CVD-NPU-MDS --- Disease-Specific (Cardiovascular Disease, NPU, MDS)","2025-04-04","2025-04-04","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs002529.v2.p1","Childhood Cancer Data Initiative (CCDI): Comprehensive Genomic Sequencing    of Pediatric Cancer Cases (CMRI/KUCC)","This study provides paired tumor normal genomic sequencing data from 200 children with cancer, including both solid tumors and leukemias, done by the Children's Mercy Research Institute (CMRI) and University  of Kansas Cancer Center (KUCC). These data include whole genome sequencing (generally, 20x), whole exome sequencing (generally, 300x), bulk RNA","Not Applicable","Whole Genome Sequencing","Tumor vs. Matched-Normal","Not Provided","ATAC-seq, RNA-Seq, WGS, WXS","2 phenotype datasets, 5 variables, 372 samples sequenced, 200 subjects, 392 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2025-04-04","2023-02-28","Blood (Leukemia); Blood cancer; Leucocythaemia; Leucocythaemias; Leucocythemia; Leucocythemias",""
"phs003954.v1.p1","Proteomic Biomarkers of Progressive Fibrosing Interstitial Lung Disease:    a Multicentre Cohort Analysis (PF-ILD Proteomics-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  identify novel plasma biomarkers of progressive fibrosing interstitial lung disease and develop a proteomic signature to predict this phenotype.","Not Applicable","Lung Diseases, Interstitial","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 589 subjects, 589 samples","","NHLBI","GRU --- General Research Use","2025-04-03","2025-04-03","Interstitial Lung Disease; Interstitial Pneumonias; Interstitial Pneumonitides; Interstitial Pneumonitis; Pneumonias, Interstitial; Pneumonitides, Interstitial",""
"phs003958.v1.p1","EASI-Genomics GM21886 Cell Line High Molecular Weight DNA Sequencing","An interlaboratory study was performed with GM21886 cells to evaluate methods for high molecular weight (HMW) genomic DNA extraction and compare sample and sequencing QC metrics, and pipelines for structural  variant (SV) calling. Four laboratories prepared HMW genomic DNA using four alternative extraction methods FireMonkey (Revolugen), Genomic Tip","Not Applicable","Chromosome 18 ring","Methods","Not Provided","WGS","3 phenotype datasets, 11 variables, 14 samples sequenced, 1 subjects, 14 samples","","NIGMS","GRU --- General Research Use","2025-04-02","2025-04-02","Ring Chromosome 18","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003309.v1.p1","Whole Genome Sequencing Consortium on Frontotemporal Dementia With    Underlying TDP-43 Pathology","Frontotemporal lobar degeneration (FTLD) is one of the leading causes of dementia in individuals younger than 65 years. The FTLD symptoms of most patients are not yet explained by mutations  in the known FTLD genes (C9orf72, GRN, MAPT). Identifying genetic risk associated with the disease is key for developing disease models and new","Not Applicable","Frontotemporal Lobar Degeneration","Case-Control","WES_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 16 variables, 1 molecular datasets, 577 samples sequenced, 577 subjects, 577 samples","European (516), African (1), East Asian (20), African American (10), Hispanic1 (9), Hispanic2 (10), Other Asian or Pacific Islander (2), South Asian (11)","NINDS","GRU --- General Research Use, DS-ND --- Disease-Specific (Neurodegenerative Disorders), HMB --- Health/Medical/Biomedical","2025-04-02","2025-04-02","Frontotemporal Dementia; Complex, Disinhibition-Dementia-Parkinsonism-Amyotrophy; Complex, Disinhibition-Dementia-Parkinsonism-Amytrophy; Complices, Disinhibition-Dementia-Parkinsonism-Amyotrophy; Complices, Disinhibition-Dementia-Parkinsonism-Amytrophy; DDPAC",""
"phs003980.v1.p1","Is the Gut Important in Multiple Joint Osteoarthritis? A Multimodal    Investigation in Humans and Pet Dogs","The Gut Health in Multiple Joint Osteoarthritis (MJOA) Study leverages data from parallel community-based cohorts in humans and in pet dogs to elucidate the role of altered microbiota in MJOA.  One hundred Johnston County Health Study human participants were 35 to 70 years of age at enrollment (2022-2023), self-identified as Hispanic, White,","Not Applicable","Microbiota","Cross-Sectional","Not Provided","AMPLICON","4 phenotype datasets, 15 variables, 100 samples sequenced, 100 subjects, 100 samples","","NIAMS","GRU-NPU --- General Research Use (NPU)","2025-04-01","2025-04-01","Osteoarthritis; Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides; Degenerative Arthritis",""
"phs003943.v1.p1","Single Cell and Spatial Transcriptomics Studies of Fibrosis in    Prospective Registry in IBD Study at MGH and GI Disease and Endoscopy    Registry","Stricturing disease or fibrosis is a common complication of inflammatory bowel disease (IBD), often requiring surgical intervention. This process is caused by the abnormal deposition of extracellular matrix in the  context of inflammation, and thus involves crosstalk between multiple cell types including fibroblasts and immune cells. To understand the cellular","Not Applicable","Crohn Disease","Case-Control","Not Provided","RNA-Seq","5 phenotype datasets, 36 variables, 122 samples sequenced, 34 subjects, 122 samples","","NIDDK","HMB-MDS --- Health/Medical/Biomedical (MDS), DS-DSDIA-MDS --- Disease-Specific (Digestive System Diseases in Adults 18 and over, MDS)","2025-04-01","2025-04-01","CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's disease of colon; Crohn's disease of large bowel",""
"phs003820.v1.p1","Transcriptomics of PPD and Control LCLs Exposed to Steroid Hormones","Lymphoblastoid cell lines (LCLs) were derived from women with (n 11) and without (n 9) past postpartum depression (PPD) and compared transcriptomically in two studies. Data provided represents: 1) normalized  RNA-seq expression (CPM) or 2) Ampliseq-RNA Expression (CPM). The two studies are described below. 1) The first examined estradiol (E2) and","Not Applicable","Depression, Postpartum","Case-Control","WES_markerset_grc37","RNA Seq (NGS)","4 phenotype datasets, 15 variables, 1 molecular datasets, 20 subjects, 98 samples","","NIMH","GRU --- General Research Use","2025-04-01","2025-04-01","Depression, Post-Natal; Depression, Post-Partum; Depression, Postnatal; Post Natal Depression; Post Partum Depression; Post-Natal Depression","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003760.v1.p1","DirectHRD Enables Sensitive Scar-Based Classification of Homologous    Recombination Deficiency (HRD)","Homologous recombination deficiency (HRD)-induced genomic scars are an FDA-approved biomarker for identifying cancers likely to respond to PARP inhibitors. However, detecting HRD scars from blood biopsies has been challenging due  to the low tumor content in blood samples. To address this limitation, we developed DirectHRD, a genomic scar-based HRD classifier leveraging","Not Applicable","Neoplasms","Case-Control","Not Provided","WGS","3 phenotype datasets, 11 variables, 67 samples sequenced, 33 subjects, 67 samples","","NCI","GRU --- General Research Use, HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-PUB --- Health/Medical/Biomedical (PUB)","2025-04-01","2025-04-01","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003508.v1.p1","Healthy and FPD Bone Marrow Single Cell Sequencing","Familial platelet disorder (FPD) is caused by germline RUNX1 mutations. Families inheriting the disease suffer from platelet dysfunction and consequently various bleeding disorders. The life long risk of developing leukemia  increases in FPD individuals by 40% and the onset is at 29 years old. In order to understand the mechanism behind disease transformation, we","Not Applicable","Hematologic Diseases","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 30 samples sequenced, 14 subjects, 30 samples","","NHGRI","GRU --- General Research Use","2025-04-01","2025-04-01","Blood Disease; Blood Diseases; Blood Disorder; Blood dyscrasia; Disease of blood AND/OR blood forming organ; Disease, Blood",""
"phs003041.v2.p1","Mayo Clinic Adult Diffuse Glioma Illumina OncoArray SNP Data","These data are from adult diffuse glioma subjects genotyped on the Illumina OncoArray. Data from this study were used for case control association studies and developing polygenic risk scores. Variants  in D2HGDH and near FAM20C were identified that were associated with glioma subtypes (PMID: 32386320). Mutation and copy number data are included for","Not Applicable","Glioma","Case Set","OncoArray","SNP Genotypes (Array)","5 phenotype datasets, 42 variables, 1 molecular datasets, 794 subjects, 794 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-04-01","2025-04-01","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia",""
"phs003965.v1.p1","Sequencing of 3D Organoids Derived From Colorectal Cancer Patients","This study focuses on the whole-exome sequencing (WES) of patient-derived organoids (PDOs) established from colorectal cancer (CRC) tumors collected at Columbia University. CRC remains a major cause of cancer-related mortality  due to its metastatic progression and resistance to therapy. To model CRC at the patient level, we generated 3D organoid cultures from primary and","Not Applicable","Colorectal Neoplasms","Case Set","target_markerset_grc38","MAF (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets, 10 samples sequenced, 9 subjects, 10 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2025-03-31","2025-03-31","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs003109.v1.p1","Oral Immunotherapy for Induction of Tolerance and Desensitization in    Peanut-Allergic Children (IMPACT)","Brief Summary: This is a randomized, double-blind, placebo-controlled, multi-center study comparing peanut oral immunotherapy (OIT) to placebo in the induction of tolerance and desensitization in peanut-allergic children. Eligible participants with  peanut allergy will be randomly assigned to receive either peanut OIT or placebo for 134 weeks followed by peanut avoidance for 26 weeks. Detailed","Not Applicable","Peanut Hypersensitivity","Clinical Trial","WGS_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 17 variables, 1 molecular datasets, 126 subjects, 126 samples","European (83), East Asian (11), African American (4), Hispanic1 (3), Hispanic2 (1), Other Asian or Pacific Islander (17), South Asian (2), Other (5)","NIAID","GRU --- General Research Use, GRU-IRB --- General Research Use (IRB)","2025-03-31","2025-03-31","Allergies, Peanut; Allergy, Peanut; Groundnut Hypersensitivity; Hypersensitivity, Groundnut; Hypersensitivity, Peanut; Peanut Allergies","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001870.v2.p1","Genomic Changes in Breast Cancer Among Chinese Women in Hong Kong","Recently, tumor sequencing and profiling analyses have improved molecular classification and refined existing breast cancer subtypes. However, epidemiologic data are absent in most somatic profiling studies even in extensively studied  Western populations. The expansion of genomic studies to understudied populations with the integration of etiologic factors will allow the capture of","Not Applicable","Breast Neoplasms","Case Set","MethylationEPIC","AMPLICON, Methylation (CpG), RNA-Seq, WGS, WXS","4 phenotype datasets, 13 variables, 2 molecular datasets, 900 samples sequenced, 247 subjects, 1198 samples","","NCI","DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS)","2025-03-31","2025-03-31","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003295.v1.p1","Durvalumab Plus Tremelimumab Alone or in Combination with Low-Dose or    Hypofractionated Radiotherapy in Metastatic Non-Small-Cell Lung Cancer    Refractory to Previous PD(L)-1 Therapy: an Open-Label, Multicentre,    Randomised, Phase 2 Trial","Brief Summary This randomized phase II trial studies the side effects of durvalumab and tremelimumab and to see how well they work with or without high or low-dose radiation therapy  in treating patients with colorectal or non-small cell lung cancer that has spread to other parts of the body (metastatic). Immunotherapy with","Not Applicable","Immunotherapy","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 11 variables, 76 subjects, 579 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2025-03-28","2025-03-28","Not Provided",""
"phs003294.v1.p1","A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted    Low-Dose or Hypofractionated Radiation for Patients with Metastatic    Colorectal Cancer","Brief Summary This randomized phase II trial studies the side effects of durvalumab and tremelimumab to see how well they work with or without high or low-dose radiation therapy in  treating patients with colorectal (CRC) or non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic). Immunotherapy","Not Applicable","Immunotherapy","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 11 variables, 19 subjects, 133 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2025-03-28","2025-03-28","Not Provided",""
"phs002626.v1.p1","Kids First: Whole Genome Sequencing Studies of Multiplex Nonsyndromic    Cleft Lip/Palate Families","Nonsyndromic cleft lip with or without cleft palate (NSCLP) is a common birth defect that affects approximately 135,000 newborns worldwide, and imposes significant medical, psychosocial and financial burdens to affected  individuals and their families. Genetic variation in numerous genes has been associated with NSCLP, however the exact mechanisms by which they","Not Applicable","Orofacial Cleft 1","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 828 subjects, 829 samples","","NICHD","GRU --- General Research Use","2025-03-28","2025-03-28","Cleft Lip; Cleft Palate; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips",""
"phs003883.v1.p1","Next Generation Sequencing to Predict Risk of Events from Coronary Artery    Disease","Coronary artery disease (CAD) and myocardial infarction (MI) remain the leading cause of death worldwide and in the US. In recent years, clinical studies that considered intermediate phenotypes (phenotypic or  genomic data isolated between DNA and the main disease phenotype) have greatly enhanced our understanding of complex traits like CAD by enabling","Not Applicable","Coronary Artery Disease","Case-Control","RNAseq_gene_transcripts","RNA Seq (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 115 subjects, 115 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2025-03-27","2025-03-27","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery",""
"phs003801.v1.p1","Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin    +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by    Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast    Cancer: DNA Sequencing","This randomized phase II trial studies how well paclitaxel with or without carboplatin and/or bevacizumab followed by doxorubicin and cyclophosphamide works in treating patients with breast cancer that can be  removed by surgery. Drugs used in chemotherapy, such as paclitaxel, carboplatin, doxorubicin, and cyclophosphamide, work in different ways to stop","Not Applicable","Breast Neoplasms","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 27 variables, 536 samples sequenced, 268 subjects, 536 samples","","NCI","DS-CA-COL --- Disease-Specific (Cancer, COL)","2025-03-27","2025-03-27","Breast Diseases; Neoplasms by Site; Skin Diseases; Triple Negative Breast Neoplasms; Breast Disease, Endocrine; Breast Diseases, Endocrine",""
"phs003827.v1.p1","Depth of Response Correlates with Improved Outcomes for Early    Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial    Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone","Early treatment of patients with high-risk smoldering myeloma (HRSMM) has been shown to delay progression to multiple myeloma (MM), but not all patients respond well. Identifying biological predictors of response  and resistance to treatment can help optimize treatment selection for patients and improve outcomes. Here, we investigate tumor and immune biomarkers","Not Applicable","Multiple Myeloma","Case Set","RNAseq_probe_set_grc38, target_markerset_grc38","OTHER, RNA-Seq, Custom targeted DNA/RNA sequencing, RNA Seq (NGS)","4 phenotype datasets, 21 variables, 1 molecular datasets, 54 samples sequenced, 20 subjects, 54 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-03-26","2025-03-26","Smoldering Multiple Myeloma; Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma",""
"phs003724.v1.p1","Whole Blood Transcriptomics of Patients With Melioidosis","Melioidosis is a neglected tropical infection caused by the Gram negative bacterium Burkholderia pseudomallei that is associated with high mortality rates in southeast Asia. The goal of this study was  to a) identify human blood leukocyte transcriptomic features and pathways specific to melioidosis (vs other etiologies of infection), b) identify","Not Applicable","Melioidosis","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 284 samples sequenced, 284 subjects, 284 samples","","NIAID","GRU --- General Research Use, DS-INF-IRB --- Disease-Specific (Infection, IRB)","2025-03-26","2025-03-26","Infections; Sepsis; Infection and Infestation; Infections and Infestations; Infestation and Infection; Infestations and Infections","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003576.v1.p1","Proteogenomic Analysis of CALGB40601 (ALLIANCE) a Neoadjuvant Phase III    HER2-Positive Breast Cancer Trial","80 frozen core needle biopsies from 54 HER2+ breast cancer patients from the CALGB 40601 trial (NCT00770809) were processed for proteogenomic analysis to identify genes, proteins, and phosphosites associated with  pathological complete response to neodjuvant anti-HER2 therapies. The final set included 22 patients treated with trastuzumab plus lapatinib in","Not Applicable","Breast Neoplasms","Clinical Trial","Not Provided","RNA-Seq, WXS","3 phenotype datasets, 12 variables, 171 samples sequenced, 53 subjects, 171 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2025-03-26","2025-03-26","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003922.v1.p1","Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with    Urothelial Cancer: a Phase 1 Trial","This is a phase 1 single center clinical trial evaluating a multi-peptide personalized neoantigen vaccine, PGV001, in combination with atezolizumab for patients with urothelial cancer. Patients were enrolled in either  the adjuvant or metastatic setting. Those in the adjuvant setting included patients considered high risk of recurrence (pathological stage ypT2-T4 or","Not Applicable","Cancer Vaccines","Clinical Trial","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 29 samples sequenced, 9 subjects, 29 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-03-25","2025-03-25","Kidney Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Kidney Tumor; Kidney cancer",""
"phs003610.v1.p1","Circulating, Cell-Free DNA Methylation Patterns Indicate Cellular Sources    of Allograft Injury after Liver Transplant","Post-transplant complications reduce allograft and recipient survival. Current approaches for detecting allograft injury non-invasively are limited and do not differentiate between cellular mechanisms. Here, we monitor cellular damages after liver  transplants from cell-free DNA (cfDNA) fragments released from dying cells into the circulation. We analyzed longitudinal blood samples collected","Not Applicable","DNA Methylation","Prospective Longitudinal Cohort","Not Provided","ATAC-seq, Bisulfite-Seq, ChIP-Seq, RNA-Seq","3 phenotype datasets, 13 variables, 160 samples sequenced, 62 subjects, 160 samples","","NCI","GRU-IRB-PUB-COL --- General Research Use (IRB, PUB, COL)","2025-03-25","2025-03-25","",""
"phs003516.v1.p1","DNA Methylation in Prostate Tumor and Paired Benign Tissue for African    and European Ancestry Men","We recruited prostate cancer (PCa) patients undergoing robotic-assisted laparoscopic radical prostatectomy at the University of Chicago Medical Center Urology Clinic between 2011 and 2017. Our study includes 76 African American  (AA) and 75 European American (EA) men with PCa of Gleason Score (GS) &#x02265;7, recruited by the Epidemiology Research Recruitment Core at the","Not Applicable","Prostatic Neoplasms","Case Set","imputation_panel, MethylationEPIC","Methylation (CpG), SNP Genotypes (imputed)","4 phenotype datasets, 25 variables, 2 molecular datasets, 151 subjects, 300 samples","","NCI","GRU --- General Research Use","2025-03-25","2025-03-25","DNA Methylation; NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003914.v1.p1","Multidimensional and Longitudinal Immune Profiling of Sepsis in Uganda","We conducted a prospective, observational cohort study of adults (RESERVE-U-2-TOR) admitted to Tororo General Hospital in eastern Uganda with severe, undifferentiated infection (i.e., suspected sepsis). Briefly, whole-blood samples were collected  in PAXgene blood RNA tubes (PreAnalytiX, Qiagen, Germantown, MD, USA), from which RNA was extracted using PAXgene Blood RNA Kits (cat. no. 762164)","Not Applicable","Sepsis","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 274 samples sequenced, 274 subjects, 274 samples","","NIAID","GRU-IRB-COL --- General Research Use (IRB, COL)","2025-03-19","2025-03-19","Pyaemia; Pyaemias; Pyemia; Pyemias; Pyohemia; Pyohemias",""
"phs003871.v1.p1","Cryptococcosis in Previously Healthy Adults","Cryptococcus is a fungus that causes infections most commonly in immunocompromised patients, such as those with AIDS and solid organ transplant recipients and is currently responsible for an estimated 15%  of all AIDS-related deaths globally. However, in developed countries, approximately one-third of cases fall outside these groups such that","Not Applicable","Cryptococcosis","Prospective Longitudinal Cohort","nCounter_GeneExpressionAssay, RNAseq_probe_set_grc38","mRNA Expression (Array), OTHER, RNA Seq (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 1 samples sequenced, 8 subjects, 9 samples","","NIAID","GRU --- General Research Use","2025-03-17","2025-03-17","Busse-Buschke disease; Busse-Buschke's disease; C neoformans Infection; C neoformans Infections; C. neoformans Infection; C. neoformans Infections","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003618.v1.p1","Immune Determinants of Resistance to PD-1 Blockade in Renal Cell    Carcinoma","We performed an integrated bulk and single-cell transcriptomic analysis of tumors from 102 advanced renal cell carcinoma patients enrolled in a phase II clinical trial of frontline nivolumab (NCT03117309) to  investigate determinants of response to anti-PD1 monotherapy. The present study includes 112 archival or pre-treatment tumors of clear cell and","Not Applicable","Carcinoma, Renal Cell","Case Set","Not Provided","OTHER, RNA-Seq, WXS","4 phenotype datasets, 18 variables, 285 samples sequenced, 102 subjects, 285 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-03-17","2025-03-17","Kidney Neoplasms; ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell",""
"phs003917.v1.p1","Precision Diagnosis of Neurodevelopmental Disorders in Middle Eastern    Populations","We constructed de novo genome assemblies for six family trios from diverse Middle Eastern ancestries (Sudan, Jordan, Syria, Qatar, and Afghanistan), involving probands with various unresolved neurodevelopmental conditions. We generated  high-quality, nearly complete genome assemblies for trios, revealing extended novel sequence impacting known genes, novel HLA/KIR alleles, and strong","Not Applicable","Rare Diseases","Family/Twin/Trios","custom_markerset","SRA Metadata, WGS","5 phenotype datasets, 17 variables, 1 molecular datasets, 36 samples sequenced, 18 subjects, 36 samples","","NHGRI","GRU --- General Research Use","2025-03-14","2025-03-14","Rare Disease; Child Mental Disorder; Child Mental Disorders; Disorder, Child Mental; Disorder, Neurodevelopmental; Mental Disorder, Child","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003804.v1.p1","Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure    with Preserved Ejection Fraction (INDIE-HFpEF): Heart Failure Network    (HFN INDIE-Imaging)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objective: To  determine the effect of inhaled, nebulized inorganic nitrite on exercise capacity in patients with heart failure with preserved ejection fraction.","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 100 subjects, 199 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2025-03-13","2025-03-13","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac",""
"phs003344.v1.p1","Investigating Delayed-Onset Drug Hypersensitivity Reactions Prospectively","Delayed-type drug hypersensitivity reactions (dtDHR) are significant causes of morbidity and mortality, but the origin, phenotype and function of pathogenic T cells across the spectrum of severity are unknown. Research  has been hampered by several barriers. We leveraged recent technical advancements to study skin-resident memory T cells (TRM) versus recruited T cell","Not Applicable","Drug-Related Side Effects and Adverse Reactions","Prospective Longitudinal Cohort","Not Provided","OTHER","4 phenotype datasets, 15 variables, 3 samples sequenced, 14 subjects, 20 samples","","NIAID","HMB --- Health/Medical/Biomedical","2025-03-13","2025-03-13","ADR; ADR - Adverse drug reaction; Adverse Drug Event; Adverse Drug Events; Adverse Drug Experience; Adverse Drug Reaction",""
"phs003779.v1.p1","Resolution of Ring Chromosomes, Robertsonian Translocations, and Complex    Structural Variants from Long-Read Sequencing and Telomere-to-Telomere    Assembly","These data were generated to test the hypothesis that long-read whole genome sequencing and optical genome mapping could resolve clinically relevant human structural genomic variation involving complex and/or repetitive portions  of the genome. The study included individuals with structural genomic variation involving complex and/or repetitive portions of the genome, and their","Not Applicable","Genomic Structural Variation","Case Set","WGS_markerset_grc37","SNP Genotypes (NGS), WGS","3 phenotype datasets, 13 variables, 1 molecular datasets, 10 samples sequenced, 10 subjects, 19 samples","","NIMH","GRU --- General Research Use","2025-03-12","2025-03-12","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003727.v1.p1","Aerobiology, Immunology, and Mycobacterium Tuberculosis Transmission","We submit data from the TB Aerobiology, Immunology and Transmission (TBAIT) study examining clinical and transcriptomic characteristics associated with Tuberculosis cough aerosolization. From a prospective longitudinal cohort of 142 participants  with previously untreated pulmonary Mycobacterium tuberculosis (Mtb) infection, we assessed presence of culturable Mtb aerosols using a cough aerosol","Not Applicable","Mycobacterium tuberculosis","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 58 samples sequenced, 58 subjects, 58 samples","","NIAID","GRU --- General Research Use","2025-03-12","2025-03-12","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003581.v2.p1","Genetic and Genomic Analysis of Primary Human Chondrocytes","Osteoarthritis (OA) is a common, degenerative joint disease characterized by the gradual breakdown of the cartilage in the joints. Despite osteoarthritis affecting over 500 million individuals, the lack of a  comprehensive mechanistic understanding of the disease has greatly hindered the development of adequate treatment options. To address this, we","Not Applicable","Osteoarthritis","Case-Control","target_markerset_grc38, ATAC_DNAseq_probe_set, RNAseq_probe_set_grc38, Global_Diversity_Array-8, WGS_markerset_grc38","ATAC-seq, SNP/CNV (Array), Hi-C, RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 15 variables, 3 molecular datasets, 249 samples sequenced, 125 subjects, 350 samples","European (75), East Asian (2), African American (26), Hispanic1 (2), Hispanic2 (10), Other Asian or Pacific Islander (1), South Asian (1)","NIAMS","GRU-NPU --- General Research Use (NPU)","2025-03-12","2025-03-12","Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides; Degenerative Arthritis; Degenerative arthropathy",""
"phs003251.v1.p1","Genetic Studies of Homologous Recombination Deficiency in Hispanic    Gastric Cancer","Approximately 10% of gastric cancer cases show familial clustering and a hereditary cause is likely, however, only 1-3% cases result from known hereditary syndromes &#x02013; which are predominantly associated with  CDH1 and CTNNA1 genes. Hispanics are 2 times more likely to be diagnosed and to die from gastric cancer compared to non-Hispanic whites. Not only","Not Applicable","Stomach Neoplasms","Case Set","WES_markerset_grc38","SNP/CNV Genotypes (NGS), WGS, WXS","4 phenotype datasets, 13 variables, 1 molecular datasets, 536 samples sequenced, 536 subjects, 536 samples","","NCI","GRU-NPU --- General Research Use (NPU), GRU --- General Research Use","2025-03-12","2025-03-12","Ca lesser curvature - stomach; Cancer of Stomach; Cancer of the Stomach; Cancer, Gastric; Cancer, Stomach; Cancers, Gastric",""
"phs002686.v3.p2","Immunophenotyping in a COVID-19 Cohort (IMPACC) Transcriptomics and    Genotyping Assays","IMPACC (IMmunoPhenotyping Assessment in a COVID-19 Cohort) is a prospective longitudinal cohort study (NCT04378777) launched in May 2020 in response to the worldwide pandemic caused by the severe acute respiratory  syndrome coronavirus 2 (SARS-CoV-2). It was funded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Multi-Ethnic_Global, WGS_markerset_grc38","SNP Genotypes (Array), RNA-Seq, SNP/CNV Genotypes (NGS)","5 phenotype datasets, 24 variables, 2 molecular datasets, 9162 samples sequenced, 1169 subjects, 10254 samples","European (129), African (8), East Asian (16), African American (104), Hispanic1 (16), Hispanic2 (151), Other Asian or Pacific Islander (14), South Asian (7), Other (8)","NIAID","DS-COV --- Disease-Specific (COVID-19)","2025-03-12","2025-03-12","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002192.v5.p2","Cancer Moonshot Biobank","The National Cancer Institute initiated the Cancer Moonshot Biobank to accelerate research through the collection and distribution of biospecimens for key research efforts. The Biobank will engage with over one  thousand cancer patients, being treated with standard-of-care therapies, for longitudinal biospecimen and data collection. Cancer patients will be","Not Applicable","Neoplasms","Case Set","custom_markerset","SNP/CNV Genotypes (NGS)","33 phenotype datasets, 420 variables, 2 documents, 2 molecular datasets, 503 subjects, 2305 samples","","NCI","GRU --- General Research Use","2025-03-12","2025-01-08","Lung Neoplasms; AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult",""
"phs003770.v1.p1","Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-Based Cohorts    (LEANORA)","Underrepresented populations' participation in clinical trials remains limited, and the potential impact of genomic variants on drug metabolism remains elusive. This study aimed to assess the pharmacokinetics (PK) and pharmacogenomics  (PGx) of ribociclib in self-identified Black women with hormone receptor positive (HR+)/human epidermal growth factor receptor 2-negative (HER2)","Not Applicable","ribociclib","Prospective Longitudinal Cohort","custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 61 variables, 1 molecular datasets, 14 subjects, 14 samples","","NCI","GRU --- General Research Use","2025-03-11","2025-03-11","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003438.v1.p1","Integrated Somatic and Germline Molecular Properties Dictating Biological    and Clinical Phenotypes in Cancer","We performed single-nuclei matched RNA- and ATAC-sequencing of frozen biopsies from normal adjacent tissue, primary and metastatic esophageal adenocarcinoma specimens. The data was then further stratified into a tumor microenvironment  and malignant compartment and was computationally analyzed to reveal cancer cell subtypes and programs driving malignancy. Principal Investigator:","Not Applicable","Neoplasms","Case-Control","Not Provided","ATAC-seq, RNA-Seq","4 phenotype datasets, 19 variables, 20 samples sequenced, 10 subjects, 20 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-03-11","2025-03-11","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs003284.v2.p1","Immune-Related Adverse Events after Immune Checkpoint Blockade-Based    Therapy are Associated with Improved Survival in Advanced Sarcoma","Immune activation after immune checkpoint blockade (ICB) can lead to a unique group of adverse events (AEs), which have been associated with improved outcome in many carcinomas. The association between  immune-related AEs (irAEs) and outcome in patients with sarcoma is not well studied. This study has two components: (1) a retrospective clinical","Not Applicable","Sarcoma","Clinical Trial","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 21 variables, 1 molecular datasets, 108 samples sequenced, 64 subjects, 108 samples","","NCI","DS-SARC --- Disease-Specific (Sarcoma)","2025-03-11","2025-03-11","Drug-Related Side Effects and Adverse Reactions; ADR; ADR - Adverse drug reaction; Adverse Drug Event; Adverse Drug Events; Adverse Drug Experience",""
"phs003837.v1.p1","Addiction of Primary Cutaneous Gamma-Delta T-cell Lymphomas to JAK-STAT    Signaling","Primary cutaneous &#x003b3;&#x003b4; T-cell lymphoma (PCGDTL) is a mature T-cell lymphoma (TCL) of the skin with a median survival of 31 months and no effective therapies. PCGDTLs frequently possess mutations  in the JAK/STAT pathway, including in JAK1, JAK3, STAT3, STAT5B, and SOCS1. We hypothesized that single-agent JAK inhibition may be effective in","Not Applicable","Lymphoma, T-Cell, Cutaneous","Case Set","Not Provided","RNA-Seq, WGS","3 phenotype datasets, 14 variables, 8 samples sequenced, 2 subjects, 8 samples","","NCI","HMB-IRB-PUB-GSO --- Health/Medical/Biomedical (IRB, PUB, GSO)","2025-03-10","2025-03-10","Lymphoma, T-Cell, Peripheral; Granulomatous Slack Skin; Slack Skin, Granulomatous",""
"phs003594.v1.p1","Framingham Heart Study-Cohort (FHS-Cohort) - BioLINCC","Data Access NOTE Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Related Studies  Other Framingham data available include: Imaging studies (Framingham Heart Study-Cohort (FHS-Cohort)-Imaging, phs003593), Genetics and genomics","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 15447 subjects, 15447 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2025-03-10","2025-03-10","Atherosclerosis; Atherogeneses; Atherogenesis; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs002614.v2.p1","Multi-Omic Investigation of Beckwith-Wiedemann Syndrome Hepatoblastoma","Hepatoblastoma (HB) is the most common malignant liver tumor diagnosed in children under 5 years of age. One of the most common HB predisposition syndromes is Beckwith-Wiedemann Syndrome (BWS, OMIM  130650), which affects approximately 1/10,000 live births. In this study, we perform Whole Exome Sequencing (WES), DNA methylation array, messenger","Not Applicable","Beckwith-Wiedemann Syndrome","Tumor vs. Matched-Normal","RNAseq_probe_set_grc37, MethylationEPIC, WES_markerset_grc38, target_markerset_grc38","Methylation (CpG), Chromatin (NGS), RNA Seq (NGS), RNA Seq (NGS), WGS, WXS","4 phenotype datasets, 10 variables, 1 documents, 3 molecular datasets, 95 samples sequenced, 96 subjects, 112 samples","","NCI","GRU-PUB-COL-NPU --- General Research Use (PUB, COL, NPU)","2025-03-10","2025-03-10","Hepatoblastoma; BWS; Beckwith Wiedemann Syndrome; Beckwith's syndrome; Beckwith-Wiedemann syndrome chromosome region; EMG SYNDROME",""
"phs003314.v1.p1","Xenodiagnosis of Lyme Disease","Ixodes scapularis ticks are an important vector for at least six tick-borne human pathogens, including the predominant North American Lyme disease spirochete Borrelia burgdorferi. The ability for these ticks to  survive in nature is credited, in part, to their ability to feed on a variety of hosts without excessive activation of the proinflammatory branch of","Not Applicable","Lyme Disease","Clinical Trial","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 29 samples sequenced, 17 subjects, 29 samples","","NIAID","DS-LYME --- Disease-Specific (Lyme Disease and Related Conditions)","2025-03-07","2025-03-07","B. burgdorferi Infection; B. burgdorferi Infections; Bannwarth syndrome; Bannworth's syndrome; Borrelia; Borrelia burgdorferi Infection",""
"phs003275.v2.p1","Prediction of Resistance and Sensitivity to HER2 Targeted Therapy in the    Neoadjuvant Setting","Women with breast cancers that overexpress HER2 are at greater risk for disease progression and death than women whose tumors do not overexpress HER2. Trastuzumab, a recombinant humanized monoclonal antibody  against the extracellular domain of the HER2 protein blocks downstream signaling of HER2 and substantially improves the efficacy of chemotherapy in","Not Applicable","Breast Neoplasms","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 26 variables, 272 samples sequenced, 245 subjects, 272 samples","","NCI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2025-03-07","2024-04-17","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002918.v1.p1","California Teachers Study (CTS): Whole Genome Sequences From    Under-Represented Populations","The California Teachers Study (CTS) is a prospective observational cohort of N 133,477 adult women who have been followed since 1995. Participants completed up to six surveys and have been  linked with cancer, hospitalization, and mortality data. In 2013-2016, over 14,000 CTS participants donated blood samples for future research. For","Not Applicable","Women's Health","Cross-Sectional","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 67 variables, 1 molecular datasets, 1750 samples sequenced, 1750 subjects, 1750 samples","","NHGRI","GRU-IRB --- General Research Use (IRB)","2025-03-07","2025-03-07","Life Style; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors",""
"phs001682.v3.p1","NHLBI TOPMed: Pulmonary Hypertension and the Hypoxic Response in SCD    (PUSH)","During Visit One, the PUSH Study will perform echocardiography on 600 children and adolescent with patients with sickle cell disease (SCD) and 100 control children and adolescents at three Field  Centers, namely Howard University, Children's National Medical Center and University of Michigan. Patients or their parents will be approached and","Not Applicable","Anemia, Sickle Cell","Case-Control","SV_STR_grc38, WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 84 variables, 2 documents, 1 molecular datasets, 371 samples sequenced, 432 subjects, 424 samples","European (2), African (81), African American (280), Hispanic1 (2), Hispanic2 (1), Other (4)","NHLBI","DS-SCD-IRB-PUB-COL --- Disease-Specific (Sickle Cell Disease, IRB, PUB, COL)","2025-03-07","2025-03-07","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S",""
"phs003378.v2.p1","A Phase I Study of the Treatment of Recurrent Malignant Glioma with    CAN-3110 (AKA rQNestin34.5v.2), a Genetically Engineered HSV-1 Virus","This study is a ""first-in-human"" phase 1 trial of recurrent, IDH wild-type glioblastoma (rGBM) patients treated with CAN-3110 (aka rQNestin34.5v.2), a genetically modified oncolytic herpes simplex virus 1 (HSV-1). The  study was a 3+3 dose-escalation study starting at a single intra-tumoral injection of 106 PFU CAN-3110 going up to 1010 PFU in half-log increments","Not Applicable","Glioblastoma","Clinical Trial","custom_markerset, RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS), RNA Seq (NGS), WGS","4 phenotype datasets, 49 variables, 2 molecular datasets, 45 samples sequenced, 22 subjects, 129 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-03-06","2023-10-17","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs003786.v1.p1","Mind Body Study: A Sub-Study on Psychosocial Factors and Microbiomes of    Nurses in the Nurse's Health Study II","The Mind-Body Study is a sub-study of the Nurses' Health Study II (NHSII) which investigated associations between biomarkers and psychosocial factors. The prevalences of clinically meaningful depressive symptoms, mild-to-severe anxiety  symptoms, experiencing major-life discrimination, and food addiction were 19%, 21%, 30%, and 5% respectively. These participants were more likely to","Not Applicable","Gastrointestinal Microbiome","Collection","Not Provided","WGS","5 phenotype datasets, 41 variables, 818 samples sequenced, 213 subjects, 818 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-03-05","2025-03-05","Not Provided",""
"phs003407.v1.p1","FluOMICS","The FluOMICS project is to generate predictive models of influenza virus pathogenesis, leveraging previous collaborations that generated global datasets and models that predict the severity of disease caused by three  influenza virus strains with different levels of virulence. This case-control study of patients diagnosed with severe and mild influenza virus","Not Applicable","Influenza, Human","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 16 variables, 1 molecular datasets, 495 subjects, 495 samples","","NIAID","GRU --- General Research Use","2025-03-05","2025-03-05","Flu; Flu, Human; Grippe; Human Flu; Human Influenza; Human Influenzas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003907.v1.p1","Honolulu Heart Program (HHP-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Access to  Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from HHP include","Not Applicable","Heart Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 8006 subjects, 8006 samples","","NHLBI","GRU --- General Research Use","2025-03-04","2025-03-04","Asthma; COPD; Cardiovascular Disease; Chronic Obstructive Pulmonary Disease; Congestive Heart Failure; Coronary Disease",""
"phs003887.v1.p1","Cancer-Restricted Cryptic Antigens Are Targets for T Cell Recognition","Subjects included patients with pancreatic cancer, at least 18 years of age, who were recruited from outpatient clinics and inpatient units at Dana-Farber Cancer Institute and Brigham and Women's Hospital.  Bulk and single-cell transcriptomic profiling of human pancreatic cancer patient samples (direct from tumor or profiling of patient-derived","Not Applicable","Carcinoma, Pancreatic Ductal","Case Set","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 20 variables, 38 samples sequenced, 17 subjects, 38 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-03-04","2025-03-04","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas",""
"phs003886.v1.p1","Developing Targeted Therapy for Patients with Multiple Myeloma and Gain    or Amplification of Chr1q (1q+)","Multiple myeloma (MM) frequently presents with gain or amplification of chr1q (1q+), which is associated with inferior response to treatment and poor outcomes. To develop targeted therapy for MM with  1q+, we leveraged external and in-house dependency screens and drug screens, along with single-cell sequencing of patient tumors with subclonal 1q+.","Not Applicable","Multiple Myeloma","Case Set","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 19 variables, 21 samples sequenced, 7 subjects, 21 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-03-04","2025-03-04","Monoclonal Gammopathy of Undetermined Significance; Smoldering Multiple Myeloma; Asymptomatic monoclonal gammopathy; Benign Monoclonal Gammapathies; Benign Monoclonal Gammapathy; Benign Monoclonal Gammopathies",""
"phs003789.v1.p1","Understanding Determinants of Racial Disparities in Lung Cancer Incidence","This is a nested case-control study designed to evaluate the association between common genetic variants and the risk of lung cancer. The study included 1258 cases and 1252 controls selected  from the Southern Community Cohort Study (SCCS), a large, prospective observational cohort. Cases were identified from cancer registries across the","Not Applicable","Lung Neoplasms","Case-Control","custom_markerset","SNP/CNV (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 2510 subjects, 2510 samples","","NCI","DS-LC-PUB-NPU-MDS --- Disease-Specific (Lung Cancer, PUB, NPU, MDS)","2025-03-04","2025-03-04","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs003787.v1.p1","Single-Cell RNA-Sequencing of Tumor and Immune Cells from Patients with    Asymptomatic Waldenstrom's Macroglobulinemia","We performed single-cell RNA-seq on tumor and immune cells from 30 patients with IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS), Smoldering Waldenstrom's Macroglobulinemia (SWM), and overt Waldenstrom's Macroglobulinemia (WM)  to identify tumor-intrinsic and immune biomarkers of disease progression in patients with asymptomatic WM. We identified subtypes within MYD88-mutant","Not Applicable","Waldenstrom Macroglobulinemia","Case-Control","Not Provided","RNA-Seq","6 phenotype datasets, 32 variables, 99 samples sequenced, 36 subjects, 99 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-03-04","2025-03-04","Lymphoma, Lymphocytic, Plasmacytoid; Lymphoma, Lymphoplasmacytoid; Lymphomas, Lymphoplasmacytoid; Lymphoplasmacytoid Lymphoma; Lymphoplasmacytoid Lymphomas; Macroglobulinaemia, Waldenstrom's",""
"phs003739.v1.p1","Coronary Artery Risk Development in Young Adults (CARDIA-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Related Studies:  Other CARDIA data available include: phs000236.v2.p2 PAGE: CALiCo: Coronary Artery Risk Development in Young Adults(CARDIA) phs000309.v3.p2 The","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 4544 subjects, 4544 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS)","2025-03-04","2025-03-04","Atherosclerosis; Coronary Disease; Hypertension; Atherogeneses; Atherogenesis; Adverse Cardiac Event",""
"phs003723.v1.p1","Contextual and Health Behavior Effects on Epigenetic Aging Among Africans    in the Family and Community Health Studies","The Family and Community Health Studies (FACHS) is a longitudinal examination of health and health related behaviors in African American families. The original study cohort consisted of 867 African American  parent-child dyads from Georgia and Iowa who were ascertained in cooperation with local school districts. The key inclusion criteria for","Not Applicable","Substance-Related Disorders","Prospective Longitudinal Cohort","MethylationEPIC, MEGA_Consortium_Array","Methylation (CpG), SNP Genotypes (Array)","4 phenotype datasets, 64 variables, 2 molecular datasets, 309 subjects, 309 samples","","NCI","GRU --- General Research Use","2025-03-04","2025-03-04","Depression; Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced",""
"phs003902.v1.p1","Resuscitation Outcomes Consortium Pragmatic Trial of Airway Management in    out-of-Hospital Cardiac Arrest (ROC PART-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  determine the effect of an initial airway management strategy using laryngeal tube (LT) insertion, compared with endotracheal intubation (ETI), on","Not Applicable","Heart Arrest","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 3004 subjects, 3004 samples","","NHLBI","GRU --- General Research Use","2025-03-03","2025-03-03","Arrest, Cardiac; Arrest, Heart; Asystole; Asystoles; Cardiac standstill; Heart stops beating",""
"phs003901.v1.p1","Resuscitation Outcomes Consortium Trial of Continuous Compressions Versus    Standard CPR in Patients With out-of-Hospital Cardiac Arrest (ROC    CCC-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  compare the rate of survival to hospital discharge after continuous chest compressions versus standard American Heart Association recommended","Not Applicable","Heart Arrest","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 26148 subjects, 26148 samples","","NHLBI","GRU --- General Research Use","2025-03-03","2025-03-03","Arrest, Cardiac; Arrest, Heart; Asystole; Asystoles; Cardiac standstill; Heart stops beating",""
"phs003900.v1.p1","Prevention and Early Treatment of Acute Lung Injury (PETAL) Acetaminophen    in Sepsis: Targeted Therapy to Enhance Recovery (ASTER) (PETAL    ASTER-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Access to  Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from PETAL ASTER","Not Applicable","Respiratory Distress Syndrome","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 487 subjects, 487 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-03-03","2025-03-03","Critical Illness; Lung Diseases; Critical Illnesses; Critically Ill; Illness, Critical; Illnesses, Critical",""
"phs003899.v1.p1","Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia: A    Study in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide    (TOLSURF-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: To  assess whether late surfactant treatment in extremely low gestational age newborn (ELGAN, &#x02264;28 week gestation) infants requiring ventilation","Not Applicable","Bronchopulmonary Dysplasia","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 511 subjects, 511 samples","","NHLBI","GRU --- General Research Use","2025-03-03","2025-03-03","",""
"phs003835.v1.p1","DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve    Sheath Tumors with Divergent Molecular Signatures","Study Design and Aims We aimed to investigate the molecular mechanisms underlying the malignant transformation of pre-existing neurofibromas (PNST) to malignant peripheral nerve sheath tumors (MPNST) in individuals with neurofibromatosis  type 1 (NF1). Our primary focus was on the role of DLK1 in this transformation process and its potential as a biomarker for diagnosis, risk","Not Applicable","Nerve Sheath Neoplasms","Case Set","RNAseq_gene_transcripts","OTHER, RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), RNA Seq (NGS), WXS","4 phenotype datasets, 17 variables, 2 molecular datasets, 16 samples sequenced, 17 subjects, 17 samples","","NINDS","GRU --- General Research Use","2025-03-03","2025-03-03","Neurofibromatosis 1; Neoplasm of Nerve Sheath; Neoplasm of the Nerve Sheath; Neoplasm, Nerve Sheath; Neoplasms, Nerve Sheath; Nerve Sheath Neoplasm","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003591.v1.p1","Genomics Analysis Reveals Molecular Patterns of Tumorigenesis in    HPV-Associated and HPV-Independent Sinonasal Squamous Cell Carcinoma","The goal of this study was to identify molecular mechanisms of tumorigenesis in HPV-associated and HPV-independent sinonasal carcinoma using high-throughput sequencing approaches. Whole genome sequencing was performed for HPV-associated samples  and whole exome sequencing for HPV-independent samples. Ultimately, we identified distinct molecular patterns of tumorigenesis between HPV-associated","Not Applicable","Neoplasms","Case Set","Not Provided","WGS, WXS","4 phenotype datasets, 26 variables, 27 samples sequenced, 14 subjects, 27 samples","","NCI","GRU --- General Research Use","2025-03-03","2025-03-03","Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinoma, Squamous Cell; Carcinomas, Epidermoid; Carcinomas, Planocellular","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002213.v1.p1","Role of Microglia Somatic Mutations in Neurodegenerative Diseases","Somatic genetic heterogeneity resulting from post-zygotic DNA mutations is widespread in human tissues and can cause diseases, however few studies have investigated its role in neurodegenerative processes such as Alzheimer's  Disease (AD). Here we report the selective enrichment of microglia clones carrying pathogenic variants, that are not present in neuronal,","Not Applicable","Alzheimer Disease","Case-Control","Not Provided","Targeted-Capture","4 phenotype datasets, 17 variables, 588 samples sequenced, 73 subjects, 588 samples","","NINDS","GRU --- General Research Use, HMB-PUB-COL-MDS --- Health/Medical/Biomedical (PUB, COL, MDS)","2025-03-03","2025-03-03","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003648.v1.p1","Precision Interception of Gastric Cancer Precursors Through Molecular and    Cellular Risk Stratification","The GAstric Precancerous conditions Study (GAPS, NCT04191551) is a cross-sectional study of patients undergoing endoscopy who are at increased risk of gastric cancer. Enrolled patients are administered a standardized questionnaire,  undergo clinical biopsy collection using the Sydney system, and consent for the collection of saliva, blood, and additional gastric tissue. All","Not Applicable","Metaplasia","Cross-Sectional","Not Provided","RNA-Seq","5 phenotype datasets, 31 variables, 4 images, 311 samples sequenced, 168 subjects, 311 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-02-28","2025-02-28","Precancerous Conditions; Condition, Preneoplastic; Conditions, Preneoplastic; Preneoplastic Condition; Preneoplastic Conditions; Ca lesser curvature - stomach",""
"phs003553.v1.p1","Harnessing the Electronic Health Record to Predict Risk of Cardiovascular    Disease: Sangre Por Salud (SPS) Biobank GWAS Data","These data are from subjects in the Sangre Por Salud (SPS) Biobank, a Latino population from the Southwest United States. Subjects were genotyped in 2 batches on the Illumina Multi-ethnic  Global Array. Data from this study were used for testing a new cardiovascular risk score and evaluating polygenic risk scores. SPS biobank GWAS data","Not Applicable","Genome-Wide Association Study","Control Set","MEGA_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 1 molecular datasets, 3699 subjects, 3699 samples","European (10), African American (4), Hispanic1 (14), Hispanic2 (3588), Other Asian or Pacific Islander (8), Other (76)","NHLBI","HMB --- Health/Medical/Biomedical","2025-02-28","2025-02-28","Not Provided",""
"phs003479.v1.p1","CEBP-Beta/IL-1-Beta/ TNF-alpha Feedback Loop Drives Drug Resistance to    BCL2 and MDM2 Inhibitors in Monocytic Leukemia Cells","To uncover the mechanisms of MDM2 inhibitor resistance that are mediated by IL-1, we performed RNAseq on three primary AML patient cells treated with idasanutlin in the presence or absence  of IL-1&#x003b2;. These three leukemia samples were chosen because they exhibit high blast counts and are protected by IL-1&#x003b2; when treated","Not Applicable","Drug Resistance, Neoplasm","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 20 samples sequenced, 3 subjects, 20 samples","","NCI","DS-LEU --- Disease-Specific (Leukemia)","2025-02-28","2025-02-28","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs002962.v2.p1","Germline Genetics of Myelodysplastic Syndromes (MDS) and Acute Myeloid    Leukemia (AML)","Myelodysplastic syndromes (MDS) are part of a heterogeneous and overlapping group of clonal diseases that arise in the hematopoietic stem or progenitor cells and also include acute myeloid leukemia (AML),  myeloproliferative neoplasms (MPN), and the hybrid MDS/MPN entities. Individuals with MDS have a high risk of progressing to leukemia, with","Not Applicable","Myelodysplastic Syndromes","Case-Control","Global_Diversity_Array-8","SNP Genotypes (Array)","5 phenotype datasets, 36 variables, 2 molecular datasets, 2003 subjects, 2003 samples","European (1858), African (1), East Asian (14), African American (44), Hispanic1 (11), Hispanic2 (50), Other Asian or Pacific Islander (9), South Asian (5), Other (11)","NCI","GRU-PUB --- General Research Use (PUB), GRU --- General Research Use","2025-02-28","2025-02-28","Hematopoetic Myelodysplasia; Hematopoetic Myelodysplasias; Myelodysplasia, Hematopoetic; Myelodysplasias, Hematopoetic",""
"phs003490.v1.p1","Impact of Genetic Variation on Response to GO Therapy in COG-AML Trials    AAML03P1 and AAML0531","The 340 de novo Acute Myeloid Leukemia (AML) patients (ages 1 month to 21 years) were enrolled in COG-AAML03P1 (NCT00070174). Everyone received standard chemotherapy regimen of ara-C, daunorubicin and etoposide  (ADE) with addition of one 3 mg/m2 dose of Gemtuzumab Ozogamicin (GO) in induction 1 as well as in intensification II phase. The 1022 de novo AML","Not Applicable","Precision Medicine","Clinical Trial","custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 1225 subjects, 1225 samples","","NCI","GRU --- General Research Use","2025-02-27","2025-02-27","Not Provided",""
"phs002915.v2.p1","Integrative Single-Cell Analysis of Transcriptome, Epigenome, and Lineage    in HIV Latency and Activation","With the development of triple combination antiretroviral therapy, routine HIV treatment eliminates nearly all actively infected cells. Nevertheless, the small reservoir of latently infected cells, which can remain dormant for  long periods of time before becoming active and producing new virus particles, represents a crucial barrier to completely curing the disease.","Not Applicable","Hematopoietic Stem Cells","Case-Control","Not Provided","ATAC-seq, RNA-Seq","5 phenotype datasets, 17 variables, 4 samples sequenced, 2 subjects, 4 samples","","NIAID","HMB --- Health/Medical/Biomedical","2025-02-27","2022-08-18","Not Provided",""
"phs003862.v1.p1","Spatial Transcriptomics of Vaccine Therapy With or Without    Cyclophosphamide in Treating Patients Undergoing Chemotherapy and    Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can    Be Removed by Surgery","Pancreatic ductal adenocarcinoma (PDAC) is a rapidly progressing cancer that responds poorly to immunotherapies. Intratumoral tertiary lymphoid structures (TLS) have been associated with rare long-term PDAC survivors, but the role  of TLS in PDAC and their spatial relationships within the context of the broader tumor microenvironment remain unknown. Here, spatial transcriptomics","Not Applicable","Pancreatic Neoplasms","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 17 variables, 16 samples sequenced, 16 subjects, 16 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2025-02-26","2025-02-26","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic",""
"phs003826.v1.p1","Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation on    Helicopter Study (PROHS) (ROC-PROHS-BioLINCC)","Accessing Data: Please refer to the ""Authorized Access"" section below regarding accessing data through the BioData Catalyst ecosystem. The data from this accession is not available for download through dbGaP.  Objective: To observe if patients with severe traumatic injuries evacuated to level 1 trauma centers on air ambulances who received prehospital red","Not Applicable","Resuscitation","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2341 subjects, 2341 samples","","NHLBI","GRU --- General Research Use","2025-02-26","2025-02-26","Not Provided",""
"phs003879.v1.p1","Prevention and Early Treatment of Acute Lung Injury Network - Vitamin D    to Improve Outcomes by Leveraging Early Treatment (PETAL    VIOLET-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below regarding accessing data through the BioData Catalyst ecosystem. The data from this accession is not available for download through  dbGaP. Biospecimens: Access to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC).","Not Applicable","Respiratory Distress Syndrome","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1358 subjects, 1358 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-02-25","2025-02-25","Critical Illness; Respiration Disorders; Vitamin D Deficiency; Critical Illnesses; Critically Ill; Illness, Critical",""
"phs003878.v1.p1","Prevention and Early Treatment of Acute Lung Injury Network -    Reevaluation of Systemic Early Neuromuscular Blockade (PETAL    ROSE-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below regarding accessing data through the BioData Catalyst ecosystem. The data from this accession is not available for download through  dbGaP. Available Data: The data available for request now include Long Term Outcome data. Biospecimens: Access to Biospecimens is through the NHLBI","Not Applicable","Respiratory Distress Syndrome","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1006 subjects, 1006 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-02-25","2025-02-25","Acute Respiratory Distress Syndrome; Distress Syndrome, Respiratory; Distress Syndromes, Respiratory; Lung, Shock; Respiratory Distress Syndromes; Respiratory distress syndrome",""
"phs003818.v1.p1","Resuscitation Outcomes Consortium (ROC) Controlled Study of the Clinical    Effectiveness of Automated Real-Time Feedback on CPR Process Conducted    at a Subset of ROC Sites (CPR) (ROC-CPR-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: A  substudy of the ROC PRIMED trial, the ROC CPR trial sought to investigate whether real-time audio and visual feedback during cardiopulmonary","Not Applicable","Heart Arrest","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1818 subjects, 1818 samples","","NHLBI","GRU --- General Research Use","2025-02-25","2025-02-25","Arrest, Cardiac; Arrest, Heart; Asystole; Asystoles; Cardiac standstill; Heart stops beating",""
"phs003406.v1.p1","Immunogenetics of BCG Vaccination and Pediatric Tuberculosis","We examined genetic variation associated with BCG-induced innate immune responses and susceptibility to pediatric tuberculosis (TB) disease. South African study participants were enrolled at the South African Tuberculosis Vaccine Initiative  (SATVI) as part of a larger BCG vaccination study. This area has one of the highest rates of TB incidence in the world. Infants were vaccinated with","Not Applicable","Tuberculosis","Case-Control","imputation_panel, MEGA_Consortium_Array","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 19 variables, 2 molecular datasets, 680 subjects, 680 samples","","NIAID","GRU --- General Research Use","2025-02-25","2025-02-25","Infection, Mycobacterium tuberculosis; Infections, Mycobacterium tuberculosis; Koch Disease; Koch's Disease; Kochs Disease; Mycobacterium tuberculosis Infection",""
"phs002293.v1.p1","MP2PRT: Genomic and Molecular Characterization of Biomarkers Associated    with Tumor Angiogenesis, DNA Repair, and Immunologic Tolerance using    Samples from the NRG Oncology Phase 3 Randomized Trial, GOG-0240    (NCT00803062)","The Molecular Profiling to Predict Response to Treatment (MP2PRT) program is part of the NCI's Cancer Moonshot Initiative. The aim of this program is the retrospective characterization and analysis of  biospecimens collected from completed NCI-sponsored trials of the National Clinical Trials Network and the NCI Community Oncology Research Program.","Not Applicable","Uterine Cervical Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 182 subjects, 481 samples","","NCI","GRU-COL --- General Research Use (COL)","2025-02-25","2025-02-25","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms",""
"phs002480.v5.p4","Genomics of Glomerular Disorders","The purpose of the ""Genomics of Glomerular Disorders"" study is to identify genetic contributions to primary glomerulopathies. This repository includes a total of N 4,238 patients with a kidney biopsy  diagnosis of a primary glomerular disorder across the following categories: focal segmental glomerulosclerosis (FSGS, N 583),","Not Applicable","Glomerulonephritis","Case Set","WES_markerset_grc37, WGS_markerset_grc37, RNAseq_gene_transcripts","RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), WGS","5 phenotype datasets, 21 variables, 3 molecular datasets, 6085 samples sequenced, 4238 subjects, 6087 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2025-02-24","2025-02-24","GN - Glomerulonephritis; Glomerular nephritis; Glomerulonephritides; Glomerulonephritis (disease); Kidney Scarring; Scarring, Kidney",""
"phs001325.v6.p1","NextGen Consortium: The iPSCORE (iPSC Collection for Omic Research)    Resource for Studying the Impact of Genetic Variation on Molecular and    Physiological Phenotypes - Whole Genome Sequence","The iPSC Collection for Omic Research (iPSCORE) Resource was created as part of the Next-Gen Consortium funded by NHLBI. The overarching purpose of the resource is to provide a large  collection of human induced pluripotent stem cells (iPSCs) for use in studying the impact of genetic variation on molecular and physiological","Not Applicable","Healthy Volunteers","Control Set","WGS_markerset_grc37, RNAseq_probe_set_grc37, WGS_markerset_grc38","CNV Segments (NGS), SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 37 variables, 20 analyses, 5 molecular datasets, 291 samples sequenced, 273 subjects, 295 samples","European (187), African (1), East Asian (21), African American (5), Hispanic1 (4), Hispanic2 (12), Other Asian or Pacific Islander (21), South Asian (6), Other (16)","NHLBI","GRU-NPU --- General Research Use (NPU), DS-CMP-NPU-MDS --- Disease-Specific (Cardiomyopathy, NPU, MDS), DS-CMP-MD-NPU-MDS --- Disease-Specific (Cardiomyopathy and Mitochondrial Disease, NPU, MDS)","2025-02-24","2025-02-24","Cardiovascular Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs000930.v11.p1","CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology)    Consortium Summary Results from Genomic Studies","GWAS have successfully identified genetic loci associated with a variety of conditions such as type 2 diabetes and coronary disease. The large number of statistical tests required in GWAS has  posed a special challenge because few studies that have DNA and high-quality phenotype data are sufficiently large to provide adequate statistical","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","HumanMethylation450","Not Provided","493 analyses, 1 molecular datasets","","NHLBI","GRU --- General Research Use","2025-02-24","2017-03-17","Cerebrovascular Disorders; Risk Factors; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs003824.v1.p1","Women's Health Initiative Clinical Trial and Observational Study -    Imaging","Objectives: The clinical trial assessed the safety and efficacy of three interventions. Specifically, it evaluated (1) the major health benefits and risks of estrogen plus progestin and estrogen alone, (2)  the effects of a low-fat eating pattern on risk of colorectal cancer, and (3) the efficacy of calcium with vitamin D supplementation for preventing","Not Applicable","Electrocardiography","Clinical Trial","Not Provided","Not Provided","1 phenotype datasets, 2 variables, 67979 subjects","","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2025-02-21","2025-02-21","Not Provided",""
"phs003529.v2.p2","Sickle Cell Disease Natural History Data Resource (SCD NHDR)","Data Access NOTE Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Background The  NHLBI initiated the Sickle Cell Disease Natural History Data Resource (SCD NHDR) to leverage existing SCD studies to build a data resource to provide","Not Applicable","Anemia, Sickle Cell","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1792 subjects, 1792 samples","","NHLBI","GRU --- General Research Use","2025-02-21","2024-02-12","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S",""
"phs001783.v8.p1","Exome Recapture and Sequencing of Prospectively Characterized Clinical    Specimens From Cancer Patients","The study cohort comprises samples from patients whose tumors have been prospectively characterized as part of their care at Memorial Sloan Kettering Cancer Center. This includes a variety of distinct  tumor type and molecular subtypes. DNA samples from tumor tissue were from patients at Memorial Sloan Kettering Cancer Center. Tumor and normal","Not Applicable","Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 20 variables, 3862 samples sequenced, 1783 subjects, 3862 samples","","NCI","DS-CA-PUB-MDS --- Disease-Specific (Cancer, PUB, MDS)","2025-02-21","2019-07-10","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001709.v2.p2","Count Me In (CMI): The Metastatic Breast Cancer (MBC) Project    (CMI-MBCproject)","Count Me In - The Metastatic Breast Cancer Project: A Patient-Driven Research Initiative to Accelerate Metastatic Breast Cancer Research The Metastatic Breast Cancer Project is a research study that directly  engages patients with metastatic breast cancer via social media and advocacy groups and empowers them to accelerate cancer research by sharing their","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 11 variables, 1275 samples sequenced, 549 subjects, 1275 samples","","NCI","GRU --- General Research Use","2025-02-21","2019-10-04","Neoplasm Metastasis; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003872.v1.p1","Digitalis Investigation Group (DIG-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives To  determine the effect of increasing age on mortality, hospitalizations, and digoxin side effects in patients with heart failure (HF), and to determine","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 7788 subjects, 7788 samples","","NHLBI","GRU --- General Research Use","2025-02-20","2025-02-20","Arrhythmia; Cardiovascular Diseases; Heart Diseases; Abnormal heart rate; Arrhythmia, Cardiac; Arrhythmias",""
"phs003858.v1.p1","Public Access Defibrillation Community Trial (PAD)(PAD-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives The  Public Access Defibrillation (PAD) Community Trial sought to evaluate broad implementation of Public Access Defibrillators (PAD) in urban community","Not Applicable","Arrhythmias, Cardiac","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 3951 subjects, 3951 samples","","NHLBI","GRU --- General Research Use","2025-02-20","2025-02-20","Arrhythmia; Heart Arrest; Heart Diseases; Myocardial Infarction; Abnormal heart rate; Arrhythmia, Cardiac",""
"phs003845.v1.p1","Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors","This phase Ib/II single-arm study evaluated atezolizumab + bevacizumab for patients with treatment-refractory metastatic HPV+ anal cancer. The primary endpoint was best overall response, and secondary endpoints included progression-free survival,  overall survival, and safety/tolerability. Paired tissue biopsies were collected in patients before treatment and at the time of first restaging and","Not Applicable","Anus Neoplasms","Clinical Trial","WES_markerset_grc38, RNAseq_probe_set_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), WXS","4 phenotype datasets, 17 variables, 1 molecular datasets, 2 samples sequenced, 1 subjects, 2 samples","","NCI","GRU --- General Research Use","2025-02-20","2025-02-20","Anal Cancer; Anal Neoplasms; Anal Neoplasms, Benign and Malignant; Anal Tumor; Anal Tumors; Anus Neoplasm",""
"phs003782.v1.p1","Evaluation Study of Congestive Heart Failure and Pulmonary Artery    Catheterization Effectiveness (ESCAPE-BioLINCC)","Accessing Data Please refer to &#x0201c;Authorized Access&#x0201d; below regarding accessing data through the BioData Catalyst ecosystem. The data from this accession is not available for download through dbGaP. Objectives To  test whether pulmonary artery catheter use was safe and could improve clinical outcomes in participants hospitalized with recurrent heart failure.","Not Applicable","Heart Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 872 subjects, 872 samples","","NHLBI","GRU --- General Research Use","2025-02-20","2025-02-20","Heart Failure; Cardiac Disease; Cardiac Diseases; Cardiac Disorder; Cardiac Disorders; Cardiopathy","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003738.v1.p1","Atherosclerosis Risk in Communities Study (ARIC-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. At present,  the ARIC sIRB has determined that ARIC data cannot be shared with for-profit entities. Related Studies Other ARIC data available include: Imaging","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 15277 subjects, 15277 samples","","NHLBI","HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS)","2025-02-20","2025-02-20","Atherosclerosis; Atherogeneses; Atherogenesis; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs003737.v1.p1","Incentives and Case Management to Improve Cardiac Care: Healthy Lifestyle    Program (HeLP)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this study. Objectives: The HeLP study assessed how early case  management, financial incentives contingent on cardiac-rehabilitation attendance, or both impacted adherence to cardiac rehabilitation among patients","Not Applicable","Cardiovascular Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 192 subjects, 192 samples","","NHLBI","GRU --- General Research Use","2025-02-20","2025-02-20","Congestive Heart Failure; Heart Diseases; Myocardial Infarction; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs003694.v1.p1","Blood Group Genotypes and Phenotypes in Omani Blood Donors and Its Links    With Susceptibility to Malaria","The Omani population experienced endemic malaria prior to eradication in the late 1990's. Since malaria is known to be a strong selective pressure on the human genome, particularly at blood  group associated loci, we aimed to understand how selective pressures from malaria may be affecting genetic variation at blood group loci. Blood","Not Applicable","genetics","Collection","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 32 variables, 1 molecular datasets, 100 samples sequenced, 100 subjects, 100 samples","","NIGMS","GRU-COL --- General Research Use (COL)","2025-02-20","2025-02-20","Not Provided",""
"phs003163.v1.p1","Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing    Program - Neuroblastoma","The goal of NCI's Pediatric In Vivo Testing Consortium (PIVOT) is to advance the development of effective treatments for pediatric cancers through preclinical in vivo testing of novel therapeutic agents.  To design impactful experiments that can be rapidly translated to the clinic, PIVOT investigators require comprehensive genomic characterization of","Not Applicable","Neuroblastoma","Xenograft","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 36 subjects, 250 samples","","NCI","GRU --- General Research Use","2025-02-19","2025-02-19","Not Provided",""
"phs001498.v3.p2","INSIGHT (Intervention Nurses Start Infants Growing on Healthy    Trajectories) Cohort","This is a study of the biological risk factors for children enrolled in the INSIGHT (Intervention Nurses Start Infants Growing on Healthy Trajectories) study. INSIGHT is a randomized, controlled trial  testing a responsive parenting intervention designed for the primary prevention of childhood obesity against a safety control. These first-born","Not Applicable","Pediatric Obesity","Prospective Longitudinal Cohort","MethylationEPIC","Methylation (CpG), SNP/CNV (Array)","6 phenotype datasets, 107 variables, 2 molecular datasets, 505 subjects, 930 samples","European (189), East Asian (2), African American (10), Hispanic1 (5), Other Asian or Pacific Islander (2), South Asian (2), Other (10)","NIDDK","GRU-GSO --- General Research Use (GSO)","2025-02-18","2025-02-18","Child Obesity; Childhood Obesity; Childhood Onset Obesity; Childhood obesity BMI 95-100 percentile; Obesity in Childhood; Obesity, Child",""
"phs003833.v1.p1","NRG-GY017: Atezolizumab before and/or with Chemoradiotherapy in Immune    System Activation in Patients with Node Positive Stage IB2, II, IIIB,    or IVA Cervical Cancer","Locally advanced cervical cancer remains an area of high therapeutic unmet need, with 50% of patients developing disease recurrence despite treatment with chemotherapy combined with radiation. Combination of immune checkpoint  blockade with chemoradiation has been explored in this setting, but optimal sequencing of these modalities is unknown. To address this question, we","Not Applicable","Uterine Cervical Neoplasms","Clinical Trial","RNAseq_gene_transcripts","RNA Seq (NGS)","4 phenotype datasets, 18 variables, 1 molecular datasets, 36 subjects, 114 samples","","NCI","GRU-COL --- General Research Use (COL)","2025-02-14","2025-02-14","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms",""
"phs003627.v1.p1","Modulation of Lung Immune Responses to Viral Infection-Microbiome    Interactions with Respiratory Organoids","Here, we colonized bronchial epithelial air-liquid interface tissue cultures with 58 different individual microbes. Following 18 and 48 hours of colonization, we performed bulk RNA-seq of the host epithelial cells  (n 3). Overall, we found significant microbial species-level and strain-level variation in host gene expression changes for innate immunity and","Not Applicable","Microbiota","Control Set","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 409 samples sequenced, 1 subjects, 409 samples","","NIAID","HMB --- Health/Medical/Biomedical","2025-02-14","2025-02-14","Not Provided",""
"phs001199.v2.p1","TIGER-LC High-Throughput Sequencing","Intrahepatic cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC) are clinically disparate primary liver cancers with etiological and biological heterogeneity. We performed sequencing on multiple data levels of Thai CCA and HCC  among the Thailand Initiative in Genomics and Expression Research for Liver Cancer (TIGER-LC) cohort using targeted OncoVar platform, whole exome,","Not Applicable","Carcinoma, Hepatocellular","Case Set","Not Provided","RNA-Seq, WXS","5 phenotype datasets, 19 variables, 652 samples sequenced, 249 subjects, 652 samples","","NCI","GRU --- General Research Use","2025-02-14","2025-02-14","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells",""
"phs003885.v1.p1","Rapid Early Action for Coronary Treatment (REACT-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: This  multicenter controlled community study developed and evaluated the impact of a community educational intervention program on participant delay time","Not Applicable","Cardiovascular Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 92404 subjects, 92404 samples","","NHLBI","GRU --- General Research Use","2025-02-13","2025-02-13","Coronary Disease; Heart Disease; Myocardial Infarction; Myocardial Ischemia; Adverse Cardiac Event; Adverse Cardiac Events",""
"phs003740.v1.p1","Jackson Heart Study (JHS-BioLINCC)","Accessing Data: Please refer to &#x0201c;Authorized Access&#x0201d; below regarding accessing data through the BioData Catalyst ecosystem. The data from this accession is not available for download through dbGaP. Related Studies:  Other Jackson Heart Study data available include: Imaging studies (JHS-Imaging), Genetics and genomics (The Jackson Heart Study, phs000286.v7.p2),","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 3883 subjects, 3883 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), DS-CVD-NPU-MDS --- Disease-Specific (Cardiovascular Disease, NPU, MDS)","2025-02-13","2025-02-13","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs003716.v1.p1","Measurement of the Male Germline Mutation Rate Using Sequential Sperm    Samples","We recalled 23 sperm donors with prior banked samples to provide a new sperm sample. The old and new sequential sperm samples were then profiled by high-fidelity duplex sequencing to  measure individual-specific mutation rates and patterns. We also performed deep whole-genome sequencing of sequential sperm samples from two","Not Applicable","Mutation","Case Set","Not Provided","OTHER, Targeted-Capture, WGS","3 phenotype datasets, 9 variables, 104 samples sequenced, 23 subjects, 104 samples","","NICHD","GRU-IRB --- General Research Use (IRB)","2025-02-13","2025-02-13","Not Provided",""
"phs003848.v1.p1","Asian Immune Diversity Atlas (AIDA) sQTL","Current efforts within the Human Cell Atlas (HCA) are largely focused on defining reference human cell types using a relatively small number of samples of predominantly European origin. However, the  next phase of the HCA is likely to address the topic of human diversity by comprehensively characterizing variation in cell states across age, sex,","Not Applicable","blood","Collection","Global_Diversity_Array-8","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 16 variables, 1 molecular datasets, 306 subjects, 306 samples","","NHGRI","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2025-02-12","2025-02-12","Not Provided",""
"phs003816.v1.p1","CD4 T Cell Subsets in Human Metastatic Melanoma","We used single-cell RNA-sequencing (scRNA-seq) to define CD4+ T-cell subsets in melanoma tumors from patients undergoing tumor resection. All patients received immune checkpoint blockade prior to surgery. We identified multiple  subsets in the tumor with transcriptional features of suppressive function, including TR1 cells and FOXP3+ Treg cells. Based on transcriptional","Not Applicable","Melanoma","Case Set","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 16 variables, 11 samples sequenced, 6 subjects, 11 samples","","NCI","GRU --- General Research Use","2025-02-12","2025-02-12","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs003505.v1.p1","National Cancer Institute Multi-Ancestry Genome-Wide Association Study of    Kidney Cancer (NCI-3)","The National Cancer Institute (NCI) multi-ancestral genome-wide association study (GWAS) of kidney cancer (""NCI-3"") was performed by NCI to further investigate common genetic variants associated with risk of kidney cancer  and its two major subtypes across individuals of different ancestries (European, African, East Asian, Latin American). The NCI-3 GWAS includes 12,315","Not Applicable","Kidney Neoplasms","Case-Control","Global_Diversity_Array-8, WGS_markerset_grc38","SNP/CNV (Array), SNP/CNV Genotypes (NGS)","4 phenotype datasets, 39 variables, 31 analyses, 2 molecular datasets, 89808 subjects, 89808 samples","European (82769), African (121), East Asian (550), African American (3439), Hispanic1 (1173), Hispanic2 (1019), Other Asian or Pacific Islander (122), South Asian (1), Other (614)","NCI","DS-RCC-IRB-PUB-NPU-GSO --- Disease-Specific (Kidney Cancer, IRB, PUB, NPU, GSO)","2025-02-12","2025-02-12","Kidney Tumor; Kidney cancer; Kidney neoplasm; Neoplasia of the kidneys; Neoplasm of Kidney; Neoplasm of the Kidney",""
"phs003456.v1.p1","Assessing Individual Head and Neck Squamous Cell Carcinoma Patient    Response to Therapy Through Integration of Functional and Genomic Data","This study combines RNA sequencing (RNASeq), whole exome sequencing (WES), reverse phase protein array (RPPA) and copy number variation (CNV) data, along with a custom high throughput inhibitor assay to  characterize tumor cells from patients with head and neck squamous cell carcinoma (HNSCC), in order to identify potential therapy targets on an","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Case Set","Cytogenetic_Arrays, custom_probe_set","CNV Genotypes, Proteomics, RNA-Seq, WXS","4 phenotype datasets, 20 variables, 1 molecular datasets, 75 samples sequenced, 20 subjects, 112 samples","","NCI","DS-SHNO-CA --- Disease-Specific (Skin, Head and Neck or Oral diseases)","2025-02-12","2025-02-12","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx",""
"phs003880.v1.p1","Metabolic Biomarkers in Thoracic Cancers","Here we present RNA sequencing (RNA-Seq) of non-small cell lung cancer (NSCLC) and adjacent lung tissue. These samples were acquired from primarily untreated, surgically resected primary tumors. The first analysis  published with this data was to determine the metabolic signatures between primary tumors and adjacent lung tissue. The associated clinical trial","Not Applicable","Carcinoma, Non-Small-Cell Lung","Tumor vs. Matched-Normal","Not Provided","RNA-Seq","4 phenotype datasets, 30 variables, 89 samples sequenced, 37 subjects, 89 samples","","NCI","GRU --- General Research Use","2025-02-11","2025-02-11","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER",""
"phs003710.v1.p1","A Personalized Neoantigen Vaccine Generates Anti-Tumor Immunity in    High-Risk Renal Cell Carcinoma","Personalized cancer vaccines (PCVs) can generate circulating immune responses against predicted neoantigens. However, whether such responses can target cancer driver mutations, lead to immune recognition of a patient's tumor, and  result in clinical activity are largely unknown, particularly in patients with lower mutation burden tumors. We conducted a phase I trial testing a","Not Applicable","Cancer Vaccines","Clinical Trial","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 20 variables, 157 samples sequenced, 9 subjects, 157 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-02-11","2025-02-11","ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal Cell",""
"phs003292.v1.p1","Ipilimumab plus Decitabine for Patients with MDS or AML in    Post-Transplant or Transplant Na&#x000ef;ve Settings","Design and Aims This study was a phase 1 clinical trial investigating the combination of ipilimumab (IPI), a CTLA-4 checkpoint inhibitor, and decitabine (DEC), a hypomethylating agent, for treating relapsed/refractory  (R/R) myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The goal was to determine whether DEC could enhance the immune response to","Not Applicable","Immunotherapy","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 48 subjects, 687 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-02-11","2025-02-11","Not Provided",""
"phs003253.v1.p1","Single-Cell ATAC and RNA Sequencing of Human Breast Cancer Reveals    Salient Cancer-Specific Enhancers","Matched single-cell chromatin accessibility sequencing (scATAC-seq) and single-cell transcriptomic sequencing (scRNA-seq) were performed for 12 human breast tumor samples, 4 normal human mammary reduction samples, and 4 human breast cancer  cell lines (HCC1143, SUM149PT, MCF7, and T47D). Both scATAC-seq and scRNA-seq assays resolved the underlying cellular heterogeneity in chromatin","Not Applicable","Breast Neoplasms","Case Set","Not Provided","ATAC-seq, RNA-Seq","5 phenotype datasets, 23 variables, 40 samples sequenced, 19 subjects, 40 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-02-11","2025-02-11","Triple Negative Breast Neoplasms; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors",""
"phs001570.v4.p1","CALGB 40601: Randomized Phase III Trial of Paclitaxel Combined With    Trastuzumab, Lapatinib, or Both As Neoadjuvant Treatment of    HER2-Positive Primary Breast Cancer","This randomized phase III trial studies paclitaxel and trastuzumab with or without lapatinib to see how well they work in treating patients with stage II or stage III breast cancer  that can be removed by surgery. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by","Not Applicable","Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 45 variables, 943 samples sequenced, 277 subjects, 943 samples","","NCI","HMB-COL --- Health/Medical/Biomedical (COL)","2025-02-11","2018-09-06","Breast Diseases; Breast Neoplasms, Male; Molecular Mechanisms of Pharmacological Action; Neoplasms by Site; Skin Diseases; Breast Disease, Endocrine",""
"phs003865.v1.p1","Multi-Modal Single-Cell, Spatial, and Genomic Analyses of Human Non-Small    Cell Lung Cancer Brain Metastases","We performed single nuclei RNA-sequencing (snRNA-seq) with matched T cell receptor sequencing (TCR-seq), and pool matched low pass whole genome sequencing (WGS) of 12 treatment-naive non-small cell lung cancer (NSCLC)  primary tumors (PTs) and 31 treatment-naive NSCLC brain metastases (BMs). In total, we recovered 277,206 cell transcriptomes in 43 samples.","Not Applicable","Single-Cell Gene Expression Analysis","Case Set","Not Provided","OTHER, WGS","3 phenotype datasets, 12 variables, 42 samples sequenced, 42 subjects, 42 samples","","NCI","GRU --- General Research Use","2025-02-10","2025-02-10","Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain",""
"phs003844.v1.p1","Best Endovascular vs. Best Surgical Therapy in Patients With Critical    Limb Ischemia (BEST CLI-BioLINCC)","Data Access NOTE Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives To  compare the effectiveness of surgical treatment to the effectiveness of endovascular treatment in adults with chronic limb-threatening ischemia who","Not Applicable","Peripheral Arterial Disease","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1830 subjects, 1830 samples","","NHLBI","GRU --- General Research Use","2025-02-10","2025-02-10","Peripheral Artery Disease; Arterial Disease, Peripheral; Arterial Diseases, Peripheral; Artery Disease, Peripheral; Artery Diseases, Peripheral; Disease, Peripheral Arterial",""
"phs003762.v1.p1","A Clone's Genomic Stability as a Biomarker of Its DNA-Damage Resilience","A main problem in the treatment of advanced cancers, including gastric cancers and glioblastoma, is the incertitude at which we predict how individual patients will respond to DNA-damaging agents, especially  on the long run. Knowing the mechanism behind a patient's response, or the lack thereof, will help us depart from the oversimplified","Not Applicable","Glioblastoma","Case Set","Not Provided","WGS","4 phenotype datasets, 18 variables, 9 samples sequenced, 2 subjects, 9 samples","","NCI","GRU --- General Research Use","2025-02-10","2025-02-10","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytoma (excluding glioblastoma); Astrocytomas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003758.v2.p1","Transcriptional Response to Hypoxia in iPSC-Derived Endothelial Cells    from a High Altitude Adapted Population","We established lymphoblastoid cell lines from 10 adult individuals of Tibetan ancestry living in the Chicago area. These lines were reprogrammed to induced pluripotent stem cells (iPSC). We validated genetic  ancestry by genome-wide SNP array genotyping and population genetic analyses. After being subjected to standard quality control testing iPSCs were","Not Applicable","Transcriptome","Case Set","RNAseq_gene_transcripts, WGS_markerset_grc37","RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS)","3 phenotype datasets, 13 variables, 1 molecular datasets, 37 samples sequenced, 17 subjects, 57 samples","","NHLBI","GRU-IRB --- General Research Use (IRB), HYP-TIBETANS-IRB --- Adaptations to Hypoxia among Tibetans (IRB)","2025-02-10","2024-11-18","Not Provided",""
"phs002813.v1.p1","Transcriptome-Wide Association Study (TWAS) to Identify Susceptibility    Genes for Colorectal Cancer","This study included genotype data from 420 study participants of East Asian descent, along with RNA-seq (n 300) and small RNA seq data (n 400) generated from their colorectal tissue  samples. We used the transcriptome data and genotype data from these individuals to build a prediction model for each coding gene and long non-coding","Not Applicable","Colorectal Neoplasms","Case Set","MEGAEx_BioVU_15075710_A1","SNP Genotypes (Array), RNA-Seq, miRNA-Seq","4 phenotype datasets, 14 variables, 1 molecular datasets, 700 samples sequenced, 420 subjects, 1120 samples","","NCI","HMB-IRB-PUB-COL --- Health/Medical/Biomedical (IRB, PUB, COL)","2025-02-10","2025-02-10","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001507.v2.p2","Columbia-Yale-Bilkent Study: Genetics Study of Essential Tremor","This is a research development/planning grant application to initiate collaborative studies with investigators at Bilkent University in Turkey to study the genetics of Essential Tremor (ET). ET is one of  the most common neurological diseases, with an estimated 7 million affected individuals in the United States. The most characteristic clinical","Not Applicable","Essential Tremor","Family/Twin/Trios","WGS_markerset_grc38","SNP Genotypes (NGS), WGS","5 phenotype datasets, 92 variables, 1 molecular datasets, 12 samples sequenced, 12 subjects, 12 samples","","NINDS","DS-ET-IRB-PUB-NPU --- Disease-Specific (Essential Tremor, IRB, PUB, NPU)","2025-02-10","2021-04-15","Hereditary Essential Tremor; Tremor, Familial; Benign Essential Tremor; Benign Essential Tremors; Essential Tremor, Benign; Essential Tremors",""
"phs003630.v1.p1","Elucidating Mechanisms of the Graft versus Leukemia Effect of    Hematopoietic Stem Cell Transplant for Acute Myeloid Leukemia","Donor lymphocyte infusion (DLI) is an established mode of adoptive cellular therapy for treatment of relapsed disease after allogeneic hematopoietic stem cell transplantation (HSCT). For patients with acute myeloid leukemia  (AML), the response rate to DLI is only 20%. Here we use next generation sequencing technologies to understand the transcriptomic and immunologic","Not Applicable","Leukemia, Myeloid, Acute","Case Set","Not Provided","OTHER, WXS","4 phenotype datasets, 17 variables, 34 samples sequenced, 25 subjects, 93 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-02-07","2025-02-07","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs003464.v1.p1","Genomic Landscape of Colorectal Cancer in a Multi-Ancestry Cohort","Elucidating the tumor mutational landscape of colorectal cancer (CRC) in admixed and ancestrally diverse populations is essential to enable precision medicine advancements that benefit individuals of all backgrounds. This study  draws from the Latino Colorectal Cancer Consortium (LC3) and other prior initiatives to characterize and examine the somatic mutational patterns of","Not Applicable","Colorectal Neoplasms","Tumor vs. Matched-Normal","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 24 variables, 1 molecular datasets, 598 samples sequenced, 718 subjects, 1436 samples","","NCI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2025-02-07","2025-02-07","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs003444.v2.p1","The Cancer Dependency Map (DepMap)","The Cancer Dependency Map (DepMap) aims to accelerate precision cancer medicine by creating a comprehensive map of tumor vulnerabilities. The DepMap project genomically profiles a wide range of cancer models  and characterizes them for their sensitivity to genetic and compound perturbations. The data is computationally analyzed to create a systematic","Not Applicable","Whole Genome Sequencing","Collection","Not Provided","Not Provided","Not Provided","","NHGRI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-02-07","","Not Provided",""
"phs003164.v2.p1","Childhood Cancer Data Initiative (CCDI): CCDI Pediatric In Vivo Testing    Program - Leukemia","The goal of this study is to molecularly characterize a large panel of pediatric acute lymphoblastic leukemia (ALL) patient-derived xenografts (PDXs) previously established in immune-deficient mice. These PDXs are utilized  as part of the NCI-funded Pediatric Preclinical In vivo Testing (PIVOT) program to identify novel agents and combinations. Biospecimen data include","Not Applicable","Pediatrics","Xenograft","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 40 subjects, 158 samples","","NCI","GRU --- General Research Use","2025-02-07","2024-05-21","Leukemia, Biphenotypic, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Acute Biphenotypic Leukemia; Acute Biphenotypic Leukemias; Acute Leukemia, Biphenotypic; Acute Leukemia, Hybrid",""
"phs002580.v1.p1","International Cancer Proteogenome Consortium (ICPC): Proteogenomics of    Oral Squamous Cell Carcinoma in Taiwan","Oral cavity squamous cell carcinoma (OSCC) is the major subtype ( 90%) of oral cancer, which is leading cancer with high mortality worldwide. The environmental risk factors associated with OSCC  are quite different in Taiwan as compared to other populations. In most non-Taiwanese populations, OSCC is often associated with tobacco chewing,","Not Applicable","Carcinoma, Squamous Cell","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 19 variables, 448 samples sequenced, 112 subjects, 448 samples","","NCI","GRU --- General Research Use","2025-02-07","2025-02-07","Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinomas, Epidermoid; Carcinomas, Planocellular; Carcinomas, Squamous",""
"phs003750.v1.p1","The Genetic Landscape of Familial Pulmonary Fibrosis","This dataset was collected from a study that was designed to identify disease-causing rare genetic variants in individuals with Familial Interstitial Pneumonia (FIP). Subjects were identified from our ongoing FIP  Registry (IRB #020343), where FIP is defined as idiopathic interstitial lung disease (ILD) in two or more family members with at least one affected","Not Applicable","Pulmonary Fibrosis","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 585 samples sequenced, 585 subjects, 585 samples","","NHLBI","HMB-COL --- Health/Medical/Biomedical (COL)","2025-01-22","2025-01-22","Genetic Predisposition to Disease; Lung Diseases, Interstitial; Genetic Predisposition; Genetic Predispositions; Genetic Susceptibilities; Genetic Susceptibility",""
"phs003772.v1.p1","Identification of Novel Immunotherapy Targets in Myeloma","RNA sequencing (RNA-Seq) was performed on 94 multiple myeloma (MM) patient samples. We used genomic subgroup and high-risk markers to identify therapeutic targets, including TNFRSF17, GPRC5D, ITGA4, and LAX1, with  low predicted toxicity and high specificity to MM and genomic subgroups such as those with TP53 alterations. Samples were taken from the Indiana","Not Applicable","Multiple Myeloma","Cross-Sectional","Not Provided","RNA-Seq","4 phenotype datasets, 21 variables, 94 samples sequenced, 89 subjects, 94 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2025-01-21","2025-01-21","Chromosomal Translocation; Chromosomal Translocations; Chromosome Translocation; Genetic Translocation; Genetic Translocations; Translocation",""
"phs001961.v3.p1","LungMAP: Molecular Atlas of Lung Development - Human Lung Tissue","Mammalian fetal lung development is a complex biological process. Despite considerable progress, a comprehensive understanding of the dynamic regulatory networks that govern postnatal alveolar lung development is still lacking. The  purpose of this study as part of the LungMAP consortium (www.lungmap.net) is to understand the transcriptional changes in the process of mammalian","Not Applicable","Lung","Control Set","Not Provided","ATAC-seq, RNA-Seq","5 phenotype datasets, 30 variables, 10 samples sequenced, 54 subjects, 91 samples","","NHLBI","GRU --- General Research Use","2025-01-17","2021-06-08","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs001569.v1.p1","NHLBI TOPMed - NHGRI CCDG: Pakistan Risk of Myocardial Infarction Study    (PROMIS)","The Pakistan Risk of Myocardial Infarction (PROMIS) study is a retrospective multicenter case-control cohort study of individuals with and without coronary heart disease from Pakistan. Multiple biological samples have been  collected from the participants including DNA, plasma, serum, and whole blood. The goal of the study is to recruit 20,000 cases and 20,000 controls","Not Applicable","Myocardial Infarction","Case-Control","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 22 variables, 1 documents, 2 molecular datasets, 8070 samples sequenced,  SRA, 26061 subjects, 26061 samples","","NHLBI","GRU --- General Research Use","2025-01-17","2025-01-17","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000452.v5.p2","Melanoma Genome Sequencing Project","Melanoma is the most prevalent cause of skin cancer morbidity and mortality. In order to characterize the full range of somatic mutations that may drive the growth of melanoma, we  are sequencing tumor and normal DNA from a set of roughly 150 melanomas. For the majority of samples (approximately 90% of the cases), mutations in","Not Applicable","Melanoma","Case Set","other, Affymetrix_WG_Array","SNP Genotypes (Array), RNA-Seq, SNV Aggregate (.MAF), WGS, WXS","4 phenotype datasets, 28 variables, 2 molecular datasets, 1012 samples sequenced, 444 subjects, 1205 samples","","NHGRI","GRU --- General Research Use, DS-M --- Disease-Specific (Melanoma)","2025-01-17","2016-01-08","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002970.v1.p1","LCL RNA-Seq from African Ancestry Samples in the 1000 Genomes Project","This dataset contains mRNA-seq of RNA extracted from lymphoblastoid cell lines (LCLs) derived from individuals of African ancestry. On its own this is a resource for studying gene expression in  individuals of African ancestry. Combined with the variants derived from WGS of these same individuals it enables the study of genetics of gene","Not Applicable","Gene Expression","Collection","Not Provided","Not Provided","659 subjects, 659 samples","","NHGRI","","2025-01-15","","Not Provided",""
"phs003769.v1.p1","Acute Respiratory Distress Network (ARDSNet) Study 02 Late Steroid Rescue    Study (LaSRS) (ARDSNet-LaSRS-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Biospecimens: Access  to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from","Not Applicable","Respiratory Distress Syndrome","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 180 subjects, 180 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2025-01-15","2025-01-15","Lung Diseases; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders",""
"phs002969.v1.p1","Black Representation in Genomic Research Whole Blood eQTL Study","This dataset contains whole genome sequencing (WGS) results, as well as mRNA-seq of RNA extracted from a venous blood sample, from 23andMe research participants of African ancestry. This dataset facilitates  the study of gene expression, genetic variation and the genetic architecture of gene expression in individuals of African ancestry. Unrelated","Not Applicable","Gene Expression","Collection","RNAseq_probe_set_grc38, WGS_markerset_grc38","RNA-Seq, SNP Genotypes (NGS), RNA Seq (NGS), WGS","5 phenotype datasets, 21 variables, 2 molecular datasets, 2148 samples sequenced, 1002 subjects, 2148 samples","","NHGRI","GRU --- General Research Use","2025-01-15","2025-01-15","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003851.v1.p1","Uncovering Principles of Adaptive Regulation in Cancer Resistance Through    Deep Evolutionary Profiling","A comprehensive understanding of the emergence of therapy resistance in cancer requires new approaches capable of generating and characterizing drug resistant cell lines at scale. Here, we present the EVolution  Of Lineages in Vitro (EVOLV) platform, a high-throughput approach for generating diverse libraries of viable, drug-resistant cell lines from a common","Not Applicable","Drug Resistance","Case-Control","WGS_markerset_grc37","RNA-Seq, SNV (.MAF), WGS","4 phenotype datasets, 17 variables, 1 molecular datasets, 286 samples sequenced, 2 subjects, 286 samples","","NCI","GRU --- General Research Use","2025-01-13","2025-01-13","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003545.v1.p1","The Innate Immune Response as a Therapeutic Target for Cutaneous    Leishmaniasis","The overall goal of the proposed project is to identify innate host functions that contribute to cure or failure during antileishmanial drug therapy, and their related biomarkers. Results from this  project enabled the identification of host-specific predictive and prognostic signatures of therapeutic responsiveness, and the bases for rational","Not Applicable","Host-Pathogen Interactions","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 33 variables, 209 samples sequenced, 40 subjects, 209 samples","","NIAID","GRU-COL --- General Research Use (COL)","2025-01-13","2025-01-13","Not Provided",""
"phs001725.v3.p1","NHLBI TOPMed - NHGRI CCDG: Groningen Genetics of Atrial Fibrillation    (GGAF) Study","Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. The Groningen Genetics  of Atrial Fibrillation (GGAF) cohort is a cohort composed from 5 different sources of individuals with atrial fibrillation (AF) and age and","Not Applicable","Atrial Fibrillation","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","3 phenotype datasets, 14 variables, 2 documents, 2 molecular datasets, 640 samples sequenced, 640 subjects, 640 samples","","NHLBI","GRU --- General Research Use","2025-01-13","2025-01-13","Arrhythmia, Cardiac; Heart Diseases; Abnormal heart rate; Arrhythmia; Arrhythmias; Arrhythmias, Cardiac","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs003830.v1.p1","Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma    Development and Radiotherapy Response","To study tumor evolution during tumorigenesis and in response to radiotherapy, we performed whole exome sequencing of 120 spatially distinct tumor regions and matched germline DNA from 20 patients with  undifferentiated pleomorphic sarcoma. This data was utilized to generate personalized capture probes for targeted resequencing of the tumor and","Not Applicable","Sarcoma","Tumor vs. Matched-Normal","Not Provided","Targeted-Capture","3 phenotype datasets, 14 variables, 157 samples sequenced, 20 subjects, 157 samples","","NCI","GRU --- General Research Use","2025-01-10","2025-01-10","Sarcoma, Spindle Cell; Sarcomas, Spindle Cell; Spindle Cell Sarcomas; spindle cell sarcoma",""
"phs003784.v1.p1","Resuscitation Outcomes Consortium (ROC) Amiodarone, Lidocaine or Neither    for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or    Ventricular Tachycardia (ALPS)(ROC-ALPS-BioLINCC)","Accessing Data Please refer to &#x0201c;Authorized Access&#x0201d; below regarding accessing data through the BioData Catalyst ecosystem. The data from this accession is not available for download through dbGaP. Objective To  compare the effects of amiodarone, lidocaine, and placebo on survival to hospital discharge after out-of-hospital cardiac arrest due to","Not Applicable","Heart Arrest","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 4653 subjects, 4653 samples","","NHLBI","GRU --- General Research Use","2025-01-10","2025-01-10","Cardiac Arrest; Arrest, Cardiac; Arrest, Heart; Asystole; Asystoles; Cardiac standstill",""
"phs003632.v1.p1","Whole Exome Sequencing and RNA Sequencing of High Grade Serous Ovarian    Cancer in Black and White Patients","In this study, we generated new RNA and whole exome sequencing data from high-grade serous ovarian cancer tumor samples of self-identified Black and White individuals. Our RNA-Seq analysis revealed that,  while the prevalence of subtypes varied across racial groups, the cluster-specific gene expression patterns were consistent. Despite these","Not Applicable","Ovarian Neoplasms","Collection","Not Provided","RNA-Seq, WXS","5 phenotype datasets, 45 variables, 1717 samples sequenced, 657 subjects, 1717 samples","","NCI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2025-01-10","2025-01-10","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian",""
"phs003281.v1.p1","Spatiotemporal Charting of Human Esophageal Development for Epidermolysis    Bullosa Cell Therapy","Human fetal esophageal development is not well understood. We present a spatio-temporal single-cell multi-omics atlas to close such a long-standing knowledge gap. With such an atlas, we describe the cellular  heterogeneity and lineage transitions of esophageal epithelium and stroma. We delineate the cellular dynamics of both epithelial and stromal","Not Applicable","Single-Cell Analysis","Control Set","Not Provided","OTHER, RNA-Seq","3 phenotype datasets, 12 variables, 50 samples sequenced, 22 subjects, 50 samples","","NCI","GRU --- General Research Use","2025-01-10","2025-01-10","Acantholysis Bullosa; Acanthosis bullosa; Bullous recurrent eruption; Dermatitis bullosa hereditaria; EB; EB - Epidermolysis bullosa",""
"phs003116.v1.p1","Detroit Research on Cancer Survivors (ROCS) and Disparities and Cancer    Epidemiology - Colorectal Cancer (DANCE)","The goals for this study were as follows: 1. Enroll a total of 5,060 African Americans newly diagnosed with cancer into the Detroit Research on Cancer Survivors (Detroit ROCS) Cohort.  These population-based cases will be ascertained through the Detroit Metropolitan Detroit Cancer Surveillance System (MDCSS), a founding member of","Not Applicable","Breast Neoplasms","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 47 variables, 1 molecular datasets, 2191 samples sequenced, 2166 subjects, 2191 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2025-01-10","2025-01-10","Lung Neoplasms; Uterine Neoplasms; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs003748.v1.p1","Genomic and Phenotypic Profile of Sickle Cell Disease in Human Population    in Cameroon","Sickle cell disease (SCD) is caused by a biallelic single nucleotide substitution in the beta-globin gene (HBB), resulting in an amino acid substitution, Glu7Val, formerly known as Glu6Val. An estimated  300,000 babies with SCD are born worldwide each year, with nearly 75% of these births being in sub-Saharan Africa. In Africa, at least 30-50% of","Not Applicable","Anemia, Sickle Cell","Cross-Sectional","H3Africa_Array","SNP/CNV (Array)","4 phenotype datasets, 39 variables, 1 documents, 1 molecular datasets, 879 subjects, 879 samples","","NHLBI","GRU-PUB-COL-NPU --- General Research Use (PUB, COL, NPU)","2025-01-08","2025-01-08","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S",""
"phs003709.v1.p1","Chronic Renal Insufficiency Cohort (CRIC) Study Metabolomics and    Proteomics","The Chronic Renal Insufficiency Cohort (CRIC study) was established in 2001 by the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to improve the understanding of the relationship between  chronic kidney disease and cardiovascular disease. The goals of the CRIC Study are to examine risk factors for progression of chronic kidney disease","Not Applicable","Renal Insufficiency, Chronic","Prospective Longitudinal Cohort","proteome, Metabolome","Metabolomics, Proteomics","4 phenotype datasets, 165 variables, 1 molecular datasets, 3414 subjects, 5213 samples","","NIDDK","DS-KHBV-NPU --- Disease-Specific (kidney, heart and blood vessels, NPU)","2025-01-08","2025-01-08","Chronic Renal Insufficiency; Chronic Kidney Insufficiencies; Chronic Renal Insufficiencies; Chronic renal impairment; Kidney Insufficiencies, Chronic; Kidney Insufficiency, Chronic",""
"phs003556.v1.p1","Risk Factors for Asymptomatic Diverticulosis","Data for this analysis came from a prospective study of colonic diverticulosis at the University of North Carolina Hospital in Chapel Hill, North Carolina (NIH R01DK094738). This is a case-control  genetic and transcriptomic study to identify the genetic and cellular determinants underlying colonic diverticulosis and the relationship with other","Not Applicable","Diverticulosis, Colonic","Cross-Sectional","WGS_markerset_grc38","RNA-Seq, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 16 variables, 1 molecular datasets, 404 samples sequenced, 404 subjects, 404 samples","","NIDDK","GRU --- General Research Use","2025-01-08","2025-01-08","Colon diverticula; Colonic Diverticulosis; Symptomatic diverticulosis of colon","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001818.v5.p1","Single-Cell Genomic Analysis of Gastrointestinal Cancer","Our study aimed to define the heterogeneity of gastrointestinal cancers at a single-cell resolution. We subjected single-cell suspensions derived from surgical resections of gastrointestinal cancer tissue, paired normal tissue, peripheral  blood mononuclear cells (PBMCs) or their ex vivo cultures to high-throughput microfluidics based single-cell RNA and DNA sequencing. We analyzed the","Not Applicable","Stomach Neoplasms","Case Set","Not Provided","OTHER, WGS","4 phenotype datasets, 21 variables, 140 samples sequenced, 41 subjects, 140 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-01-08","2019-10-04","Appendiceal Neoplasms; Metaplasia; Appendiceal Neoplasm; Appendiceal tumor; Appendix Tumor; Neoplasm of Appendix","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002289.v2.p1","Yale SPORE in Skin Cancer Project 2","Understanding the relationship between tumor and peripheral immune environments could allow longitudinal immune monitoring in cancer. Here, we examined whether T cells that share the same TCRab and are found  in both tumor and blood can be interrogated to gain insight into the ongoing tumor T cell response. Paired transcriptome and TCRab repertoire of","Not Applicable","Single-Cell Analysis","Case Set","RNAseq_probe_set_grc38, RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS), RNA Seq (NGS)","5 phenotype datasets, 28 variables, 2 molecular datasets, 58 samples sequenced, 29 subjects, 240040 samples","","NCI","HMB --- Health/Medical/Biomedical","2025-01-07","2025-01-07","Not Provided","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs003806.v1.p1","Genotyping Data From Subjects With Brain Lesions","These data are from subjects with adult diffuse glioma (IDH wildtype, IDH mutant/1p19q intact, and IDH mutant/1p19q co-deleted), brain lesions, tumefactive multiple sclerosis, brain metastases, central nervous system lymphoma and  controls genotyped on the Affymetrix Axiom Precision Medicine array. Data from this study were used for case/control association studies and","Not Applicable","Glioma","Case-Control","Axiom_PMRA","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 1783 subjects, 1783 samples","","NINDS","HMB --- Health/Medical/Biomedical","2025-01-06","2025-01-06","Central Nervous System Diseases; Multiple Sclerosis; Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm",""
"phs003002.v2.p1","A Platform Study of Combination Immunotherapy for the Neoadjuvant and    Adjuvant Treatment of Patients with Surgically Resectable    Adenocarcinoma of the Pancreas","This is a single-institutional, randomized, open label platform clinical trial testing various immunotherapy combinations. Patients with newly diagnosed and surgically resectable pancreatic ductal adenocarcinoma (PDA) and scheduled to undergo the  Whipple procedure at Johns Hopkins Hospital were eligible to participate in this study. Criteria for determining resectability strictly followed","Not Applicable","Pancreatic Neoplasms","Clinical Trial","WES_markerset_grc37, RNAseq_gene_transcripts","RNA-Seq, SNP Genotypes (NGS), RNA Seq (NGS)","5 phenotype datasets, 25 variables, 2 molecular datasets, 121 samples sequenced, 35 subjects, 170 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2025-01-06","2025-01-06","Carcinoma, Pancreatic Ductal; Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas",""
"phs003409.v1.p1","Tracking Therapy-Resistant Alterations in Childhood Acute Lymphoblastic    Leukemia","Relapse is currently the major cause of death in children with B-ALL. The goal of this study is to uncover the genetic underpinnings of relapsed B-ALL in the AALL1331 cohort  (PMID: 33651090) via whole genome and transcriptome sequencing of matched diagnosis, relapse, and remission specimens. We aim to discover genetic","Not Applicable","Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","Tumor vs. Matched-Normal","Not Provided","Targeted-Capture","4 phenotype datasets, 16 variables, 89 samples sequenced, 72 subjects, 89 samples","","NCI","GRU --- General Research Use","2024-12-20","2024-12-20","Leukemia, Pre B Cell; Leukemia, Pre-B-Cell; Leukemias, Pre-B-Cell; Pre B ALL; Pre B Cell Leukemia; Pre B-ALL","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003382.v1.p1","PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research","SELECT study: SELECT was a phase III, double-blind, placebo-controlled 4-arm study of selenium, vitamin E, selenium and vitamin E together, and placebo designed to assess the effect of these supplements  on the incidence of prostate cancer. Funded by the National Cancer Institute and conducted by SWOG, the study opened in August 2001 and quickly","Not Applicable","Genome-Wide Association Study","Case-Control","Global_Screening_Array-24","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 molecular datasets, 32521 subjects, 32521 samples","European (27570), African (91), East Asian (260), African American (2765), Hispanic1 (694), Hispanic2 (704), Other Asian or Pacific Islander (108), South Asian (70), Other (258)","NCI","GRU --- General Research Use","2024-12-20","2024-12-20","Not Provided",""
"phs003638.v1.p1","Long-Read Sequencing to Identify Inherited Mutations Predisposing to    Breast Cancer","We aimed to detect deeply intronic mutations within genes linked to breast/ovarian cancer that are potentially under-reported in clinical testing due to technical limitations. Current DNA and RNA tests typically  exclude these regions, which harbor many variants within complex repetitive sequences that short-read sequencing cannot align. By employing targeted","Not Applicable","Breast Neoplasms","Case Set","Not Provided","Targeted-Capture","3 phenotype datasets, 12 variables, 7 samples sequenced, 7 subjects, 7 samples","","NCI","DS-BRCA-COL --- Disease-Specific (Breast Cancer, COL)","2024-12-19","2024-12-19","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000159.v15.p5","Genomics of Acute Myeloid Leukemia","Sequence data from the Genomics of AML PPG program at Washington University since 2009 is made available. This repository contains data from tumors (bone marrow or peripheral blood) from Acute  Myeloid Leukemia (AML) and several other related disorders - myelodysplastic syndromes (MDS), secondary AML (sAML) and therapy-related AML (tAML). It","Not Applicable","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","custom_PCR_marker_set, WGS_markerset_grc36, Affymetrix_WG_Array, target_markerset_grc37, WGS_markerset_grc37","AMPLICON, ATAC-seq, SNP Genotypes (Array), Bisulfite-Seq, ChIP-Seq, OTHER, RNA-Seq, SNP Genotypes (NGS), SNP Genotypes (NGS), Targeted-Capture, WGS, WXS, miRNA-Seq","4 phenotype datasets, 16 variables, 6 molecular datasets, 4056 samples sequenced, 1013 subjects, 4087 samples","","NHGRI","GRU --- General Research Use, DS-HEM --- Disease-Specific (Hematologic Disease)","2024-12-18","2016-08-01","Myelodysplastic-Myeloproliferative Diseases; AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003683.v2.p1","Somatic Mutations in Individual Skin Cells","Ultraviolet (UV) radiation is the primary cause of melanoma through the acquisition of driver mutations in melanocytes. It also plays a significant role in oncogenesis in other skin cells, such  as keratinocytes. However, the mutational profiles vary widely among different skin cancers, and the early mutational processes in different cell","Not Applicable","Carcinoma, Squamous Cell","Cross-Sectional","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 15 variables, 471 samples sequenced, 23 subjects, 471 samples","","NCI","GRU --- General Research Use","2024-12-16","2024-08-22","Skin Neoplasms; Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinomas, Epidermoid; Carcinomas, Planocellular",""
"phs003660.v1.p1","Methylation-Based Immune Deconvolution in Prostate Cancer Patients Before    and After Radical Prostatectomy","To explore whether surgical treatment for prostate cancer leads to long-term immune changes, we conducted a pilot study of n 11 prostate cancer patients treated with radical prostatectomy. We also  included n 8 patients managed with active surveillance as a comparison group. We examined intra-individual changes in circulating immune cell subsets","Not Applicable","Prostatic Neoplasms","Case Set","MethylationEPIC","Methylation (CpG)","4 phenotype datasets, 15 variables, 1 molecular datasets, 19 subjects, 38 samples","","NCI","GRU --- General Research Use","2024-12-16","2024-12-16","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001204.v1.p1","Mayo Clinic - Fecal Microbiota and Adenomas","Background: Adenomatous polyps are the most common precursor to colorectal cancer (CRC), the second leading cause of cancer death in the United States. We sought to learn more about early  events of carcinogenesis by investigating shifts in the gut microbiota of patients with adenomas. Methods: We analyzed 16S rRNA gene sequences from","Not Applicable","Adenoma","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 13 variables, 752 samples sequenced, 819 subjects, 819 samples","","NCI","GRU --- General Research Use, GRU-COL --- General Research Use (COL)","2024-12-16","2024-12-16","Adenoma, Microcystic; Adenomas, Microcystic; Microcystic Adenomas; microcystic adenoma; microcystic adenoma (morphologic abnormality); CRC","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003067.v2.p2","Using NGS to Sequence Whole Genomes to Identify Genes Underlying ALS","Our ALS Consortium - a partnership of clinicians, basic scientists, geneticists, and computational biologists from 48 institutions (4 of which are industry partners) across 5 countries - establishes a framework  to apply whole genome sequencing (WGS) and functional genomics to the study of amyotrophic lateral sclerosis (ALS). Because ALS-causing mutations","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","Not Provided","Not Provided","4 phenotype datasets, 14 variables, 4420 subjects, 4424 samples","","NHGRI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2024-12-12","2024-03-18","Frontotemporal Dementia; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); ALS Compute (phs003184.v1.p1)"
"phs002907.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Jackson    Heart Study (JHS)","Note for data in BioData Catalyst: Instructions for requesting individual-level data are available on BioData Catalyst at https://biodatacatalyst.nhlbi.nih.gov/resources/data/. Apply for data access in dbGaP. Upon approval, users may begin  accessing requested data in BioData Catalyst. For questions about availability, you may contact the BioData Catalyst team at","Not Applicable","genetics","Collection","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 3883 subjects, 3883 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2024-12-12","2024-12-12","Not Provided",""
"phs003807.v1.p1","Gene-Specific RNA Sequencing in PLCG2-Associated Immune Dysregulation    with Cold Urticaria","This study utilized gene-specific RNA-sequencing of PLCG2 to screen for disease causing in-frame exon-skipping transcripts of PLCG2 in a collection of 9 subjects with cold urticaria, 2 subjects with known  PLCG2-associated antibody deficiency and immune dysregulation (PLAID)-causing deletions of PLCG2 (positive controls) and 3 healthy subjects (negative","Not Applicable","Cryopyrin-Associated Periodic Syndromes","Case Set","Not Provided","Targeted-Capture, WGS","5 phenotype datasets, 19 variables, 19 samples sequenced, 17 subjects, 19 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2024-12-11","2024-12-11","Amyloid nephropathy with deafness and urticaria; CAPS2; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; MUCKLE-WELLS SYNDROME; MWS; Muckle Wells Syndrome",""
"phs003780.v1.p1","Rearrangements of Viral and Human Genomes at Human Papillomavirus    Integration Events and Their Allele-Specific Impacts on Cancer Genome    Regulation","We discovered genomic and epigenomic dysregulation originating at sites of human papillomavirus (HPV) integration following the Oxford Nanopore long-read analysis of 72 cervical cancer genomes. The integration events had allele-specific  effects on the genome, methylome, and transcriptome, which sometimes resulted in the activation of cancer genes. We also examined the 72 samples","Not Applicable","Uterine Cervical Neoplasms","Case Set","WGS_markerset_grc38, target_markerset_grc38","Methylome sequencing, SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 13 variables, 2 molecular datasets, 72 samples sequenced, 72 subjects, 72 samples","","NCI","GRU --- General Research Use","2024-12-11","2024-12-11","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms",""
"phs003756.v1.p1","Programs, Origins, and Immunomodulatory Functions of Myeloid Cells in    Gliomas","Gliomas are challenging malignancies characterized by an immunosuppressive microenvironment filled with myeloid cells, whose roles in immune modulation are not fully understood. In this study, we utilized single-cell RNA sequencing  (scRNA-seq) data from 85 primary human glioma tumors, related blood samples, and brain tumor organoid models. We found that nearly all","Not Applicable","Glioma","Prospective Longitudinal Cohort","Not Provided","OTHER, RNA-Seq","3 phenotype datasets, 18 variables, 106 samples sequenced, 48 subjects, 109 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-12-11","2024-12-11","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia",""
"phs002770.v1.p1","MUSIC: Long-TerM OUtcomes after the Multisystem Inflammatory Syndrome In    Children","This study is an observational cohort study that will use routinely-collected clinical and cardiac (EKG, echocardiogram, CMR, exercise testing) data to assess the association between MIS-C (multisystem inflammatory syndrome in  children) and cardiac outcomes within the first year after hospital discharge. Research funding will be available for EKGs, echocardiograms and MRIs","Not Applicable","pediatric multisystem inflammatory disease, COVID-19 related","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1114 subjects, 1114 samples","","NHLBI","GRU --- General Research Use","2024-12-10","2024-12-10","MIS-C associated with COVID-19; MIS-C multisystem inflammatory syndrome in children; multisystem inflammatory syndrome in children; pediatric inflammatory multisystem syndrome","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002182.v4.p1","Asthma in the Lives of Families Today (ALOFT)","Social interactions and the overall psychosocial environment have a demonstrated impact on health, particularly for people living in disadvantaged urban areas. Here we investigated the effect of psychosocial experiences on  gene expression in peripheral blood immune cells of 251 children with asthma in Metro Detroit. Participants were included from an ongoing","Not Applicable","Asthma","Prospective Longitudinal Cohort","WGS_markerset_grc37","OTHER, RNA-Seq, SNP/CNV Genotypes (NGS)","7 phenotype datasets, 62 variables, 1 molecular datasets, 515 samples sequenced, 259 subjects, 766 samples","European (39), African American (199), Hispanic1 (7), Hispanic2 (4), Other (2)","NHLBI","GRU --- General Research Use","2024-12-10","2024-12-10","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs003560.v1.p1","The Role of E2F4 in Controlling Resistance to Irinotecan (CPT-11) in    Human Colon Cancer","This study reports the results of RNA sequencing (RNA-seq) experiments performed on three isogenic clones of the human HT29 colon cancer cell line, genetically engineered to achieve the selective inactivation  of the adenovirus early 2 (E2) gene transcription factor 4 (E2F4) protein, a key functional component of the multimeric transcriptional repression","Not Applicable","Colonic Neoplasms","Interventional","Not Provided","RNA-Seq","3 phenotype datasets, 22 variables, 12 samples sequenced, 1 subjects, 12 samples","","NCI","GRU --- General Research Use","2024-12-06","2024-12-06","COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic; Cancers, Colon",""
"phs003230.v2.p1","Temporal Evolution Reveals Bifurcated Lineages in Aggressive    Neuroendocrine Small Cell Prostate Cancer Trans-Differentiation","Trans-differentiation from adenocarcinoma to small cell neuroendocrine (SCN) cancer is an adverse consequence of treatment escape in various cancers, including prostate, lung, and bladder cancers (Balanis and Sheu et al.,  PMID 31287989). Expression of dominant negative p53 (TP53DN), myrAkt1, RB1-shRNA, c-Myc, and Bcl2(PARCB forward transformation) using human","Not Applicable","Carcinoma, Neuroendocrine","Xenograft","RNAseq_gene_transcripts","ATAC-seq, ChIP-Seq, OTHER, RNA-Seq, RNA Seq (NGS), RNA Seq (NGS)","4 phenotype datasets, 17 variables, 1 molecular datasets, 74 samples sequenced, 12 subjects, 74 samples","","NCI","GRU --- General Research Use","2024-12-06","2023-11-27","Carcinoma, Small Cell; Carcinoma, Oat Cell; Carcinomas, Oat Cell; Carcinomas, Small Cell; Oat Cell Carcinoma; Oat Cell Carcinomas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003018.v1.p1","A Comprehensive Binding and Functional Map of Human RNA-binding Proteins","The objective of the ENCORE (Encyclopedia of RNA Elements) project is to develop a foundational, functional map of protein-RNA interactions of RNA binding proteins (RBPs) encoded in the human genome,  and the RNA elements they bind to across the transcriptome. These RNA elements, when expressed, form the basis of co- and post-transcriptional","Not Applicable","RNA-Binding Proteins","Case-Control","Not Provided","Not Provided","Not Provided","","NHGRI","","2024-12-05","","Not Provided",""
"phs003749.v1.p1","Developing Allelic Imbalance Analysis from Single-Nucleus RNA-Seq Data","Single-cell RNA-seq (scRNA-seq) is emerging as a powerful tool for understanding gene function across diverse cells. Recently, this has included the use of allele-specific expression (ASE) analysis to better understand  how variation in the human genome affects RNA expression at the single-cell level. We reasoned that, because intronic reads are more prevalent in","Not Applicable","Brain","Control Set","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 9 variables, 1 molecular datasets, 22 samples sequenced, 2 subjects, 22 samples","","NIMH","GRU --- General Research Use","2024-12-04","2024-12-04","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002391.v2.p1","De Novo Mutation Rates at the Single-Mutation Resolution in the Human    Genome","Mutation Enrichment followed by upscaled Maximum Depth Sequencing (MEMDS) is a highly accurate method for detection of rare DNA variants in large samples that has sufficiently high accuracy, yield and  sequencing depth to measure the de novo origination rates of target individual natural point mutations and indels at target base positions in","Not Applicable","Mutation Rate","Collection","Not Provided","AMPLICON","4 phenotype datasets, 20 variables, 52 samples sequenced, 28 subjects, 56 samples","","NHGRI","GRU --- General Research Use","2024-12-03","2022-01-24","Anemia, Sickle Cell; Malaria; Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003822.v1.p1","Genomic Alterations in Normal Breast Tissues Preceding Breast Cancer    Diagnosis (GANPBC)","This study was designed to examine the genomic alterations in histologically normal breast tissues of women who subsequently developed breast cancer and compare it to breast tissues from women who  did not. Breast core needle biopsy tissues from 160 healthy women at the Susan G. Komen Tissue Bank were requested for this study and sequenced using","Not Applicable","Breast Neoplasms","Case-Control","Not Provided","WXS","4 phenotype datasets, 21 variables, 160 samples sequenced, 160 subjects, 160 samples","","NCI","GRU --- General Research Use","2024-11-27","2024-11-27","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003771.v1.p1","Single Chromatin Fiber Profiling in the Human Brain","We developed a human postmortem brain-applicable &#x02018;Fiber-seq' protocol for genome-scale, PCR-free single molecule sequencing of on average 8-10kb long chromatin fibers, to map nucleosome positioning and nucleosome-depleted regions which include,  for example, active promoters and enhancers. We generated two Fiber-seq reference sets, one from sorted non-neuronal NeuN- prefrontal cortex (PFC)","Not Applicable","Chromatin","Control Set","Not Provided","OTHER","3 phenotype datasets, 14 variables, 7 samples sequenced, 3 subjects, 7 samples","","NIDA","HMB-PUB --- Health/Medical/Biomedical (PUB)","2024-11-27","2024-11-27","Not Provided",""
"phs000524.v2.p2","Chronic Renal Insufficiency Cohort (CRIC) - GWAS","The Chronic Renal Insufficiency Cohort (CRIC study) was established in 2001 by the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to improve the understanding of the relationship between  chronic kidney disease and cardiovascular disease. The goals of the CRIC Study are to examine risk factors for progression of chronic kidney disease","Not Applicable","Renal Insufficiency, Chronic","Case Set","HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 165 variables, 121 documents, 1 molecular datasets, 3596 subjects, 3596 samples","European (1600), African (45), East Asian (43), African American (1458), Hispanic1 (72), Hispanic2 (309), Other Asian or Pacific Islander (24), South Asian (25), Other (22)","NIDDK","HMB --- Health/Medical/Biomedical, DS-KHBV --- Disease-Specific (kidney, heart and blood vessels)","2024-11-27","2013-01-04","Chronic Renal Insufficiency; Chronic Kidney Insufficiencies; Chronic Renal Insufficiencies; Chronic renal impairment; Kidney Insufficiencies, Chronic; Kidney Insufficiency, Chronic",""
"phs001510.v1.p1","CIDR NICHD Genetic Basis of Recessive Pediatric Brain Disease - Group 3","The purpose of this study is to identify new genetic causes of recessive forms of pediatric neurodevelopmental disorders (NDDs) including Cerebellar hypoplasia (CBH), Lissencephaly (LIS), Microcephaly (MIC), Corpus callosum hypoplasia  (CCH), Pontocerebellar hypoplasia (PCH), Pontine tegmental cap dysplasia (PTCD), and Aicardi syndrome among many others. Using whole exome sequencing","Not Applicable","Cerebellar Hypoplasia","Prospective Longitudinal Cohort","HumanCoreExome-24","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 757 subjects, 791 samples","","NICHD","GRU --- General Research Use","2024-11-26","2024-11-26","Agenesis of Corpus Callosum; Microcephaly; ACC; ACC - Agenesis of corpus callosum; Absence of Corpus Callosum; Absence of the corpus callosum",""
"phs002787.v2.p1","Personalized Breast Cancer Vaccines Based on Genome Sequencing","This study is from a phase I clinical trial of neoantigen DNA vaccines in triple negative breast cancer patients with persistent disease following neoadjuvant chemotherapy. The exome and RNA sequences  used to identify somatic mutations, predict neoantigens, and design vaccines is within. Principal Investigator: William Gillanders, MD, Washington","Not Applicable","Triple Negative Breast Neoplasms","Case Set","Not Provided","AMPLICON, RNA-Seq, WXS","4 phenotype datasets, 16 variables, 84 samples sequenced, 18 subjects, 84 samples","","NCI","GRU --- General Research Use","2024-11-22","2022-05-13","Breast Cancer, Triple-Negative; Breast Cancers, Triple-Negative; Breast Neoplasm, Triple-Negative; Breast Neoplasms, Triple-Negative; ER Negative PR Negative HER2 Negative Breast Cancer; ER Negative PR Negative HER2 Negative Breast Neoplasms","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002419.v2.p1","Integrative Molecular Characterization of Breast Cancer","Version 1: We have performed integrative analyses of breast cancer tumors, including whole exome sequencing (WES) of tumor and normal pairs, whole transcriptome sequencing, and single-cell RNA sequencing (scRNA-seq) or  single-nucleus RNA sequencing (snRNA-seq), to determine molecular correlates of response to novel and immune therapies. We have focused on dissecting","Not Applicable","Breast Neoplasms","Case Set","Not Provided","ATAC-seq, RNA-Seq, WXS","4 phenotype datasets, 23 variables, 355 samples sequenced, 86 subjects, 355 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-11-22","2021-08-18","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs003482.v2.p1","Epigenomics of Prostate Cancer from Cell Free Plasma","We sought to perform epigenomic characterization of prostate cancers by profiling circulating nucleosomes isolated from patient plasma using cell free chromatin immunoprecipitation followed by sequencing (cfChIP-seq). Our major findings include  identification of prostate-cancer specific regulatory elements using a novel statistical method accounting for variable tumor DNA fraction in plasma,","Not Applicable","Prostatic Neoplasms","Case-Control","Not Provided","ChIP-Seq, Targeted-Capture","4 phenotype datasets, 20 variables, 78 samples sequenced, 46 subjects, 78 samples","","NCI","DS-CA-NPU --- Disease-Specific (Cancer, NPU), GRU --- General Research Use","2024-11-21","2024-10-16","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003649.v1.p1","Establishment of an iPSC Repository Derived from Healthy Volunteers","Understanding the interaction between genetic variation and epigenetic variation remains a challenge due to the confounding role of environmental factors. We propose that human induced pluripotent stem cells (iPSCs) are  an excellent model to study the relationship between genetic variation and epigenetic variation while controlling for consistent environmental","Not Applicable","Gene Expression","Collection","WGS_markerset_grc38","ATAC-seq, Bisulfite-Seq, RNA-Seq, SNP/CNV Genotypes (NGS), CNV (NGS), WGS","5 phenotype datasets, 18 variables, 1 molecular datasets, 24 samples sequenced, 3 subjects, 24 samples","","NHGRI","GRU --- General Research Use","2024-11-20","2024-11-20","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001822.v1.p1","CIDR NICHD Genetic Basis of Recessive Pediatric Brain Diseases - Group 4","The purpose of this study is to identify new genetic causes of recessive forms of pediatric neurodevelopmental disorders (NDDs) including Cerebellar hypoplasia (CBH), Lissencephaly (LIS), Microcephaly (MIC), Corpus callosum hypoplasia  (CCH), Pontocerebellar hypoplasia (PCH), Pontine tegmental cap dysplasia (PTCD), and Aicardi syndrome among many others. Using whole exome sequencing","Not Applicable","Cerebellar Hypoplasia","Prospective Longitudinal Cohort","HumanCoreExome-24","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 774 subjects, 809 samples","","NICHD","GRU --- General Research Use","2024-11-20","2024-11-20","Agenesis of Corpus Callosum; Microcephaly; ACC; ACC - Agenesis of corpus callosum; Absence of Corpus Callosum; Absence of the corpus callosum","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001060.v1.p1","CIDR/NICHD Genetic Basis of Recessive Pediatric Brain Diseases","The purpose of this study is to identify new genetic causes of recessive forms of pediatric neurodevelopmental disorders (NDDs) including cerebellar hypoplasia (CBH), lissencephaly (LIS), microcephaly (MIC), corpus callosum hypoplasia  (CCH), pontocerebellar hypoplasia (PCH), pontine tegmental cap dysplasia (PTCD), and Aicardi syndrome among many others. Using whole exome sequencing","Not Applicable","Cerebellar Diseases","Prospective Longitudinal Cohort","HumanCoreExome-24","SNP Genotypes (Array)","5 phenotype datasets, 20 variables, 1 molecular datasets, 353 subjects, 365 samples","","NICHD","GRU --- General Research Use","2024-11-20","2024-11-20","Microcephaly; Cerebellar Disease; Cerebellar Disorder; Cerebellar Disorders; Cerebellar Dysfunction; Cerebellar Dysfunctions",""
"phs003369.v3.p1","The Melbourne Urological Research Alliance (MURAL) Collection of    Patient-Derived Models of Prostate Cancer","1. Low-Dose Carboplatin Modifies the Tumor Microenvironment to Augment CAR T Cell Efficacy in Human Prostate Cancer Models. Single-cell RNA sequencing (scRNA-seq) was performed to analyze the transcriptional modifications in  the tumor microenvironment of prostate cancer patient-derived xenografts (PDX). The analyzed PDX tumor was PDX-287R from the MURAL collection of PDXs","Not Applicable","Prostatic Neoplasms","Xenograft","Not Provided","ChIP-Seq, RNA-Seq, Targeted-Capture","4 phenotype datasets, 21 variables, 511 samples sequenced, 75 subjects, 511 samples","","NCI","GRU --- General Research Use","2024-11-19","2023-10-18","Adenocarcinoma; Neuroendocrine Tumors; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant",""
"phs003800.v1.p1","Single-Cell Transcriptomic Analysis of Kaposi Sarcoma","Summary: Single-cell transcriptome analysis of skin and blood samples from individuals with Kaposi's sarcoma Aims: Elucidate the cellular composition and gene expression profiles of Kaposi sarcoma herpesvirus (KSHV) infected cells  and non-infected tumor infiltrating cells, and peripheral blood samples from the same individuals, with or without specific therapies, such as","Not Applicable","Sarcoma, Kaposi","Case Set","Not Provided","OTHER","4 phenotype datasets, 22 variables, 25 samples sequenced, 16 subjects, 25 samples","","NCI","GRU --- General Research Use","2024-11-18","2024-11-18","African lymphadenopathic Kaposi's sarcoma; HHV8; KS; KS - Kaposi's sarcoma; KSHV; Kaposi sarcoma",""
"phs002173.v2.p2","Gabriella Miller Kids First Pediatric Research Program in Bladder    Exstrophy, Epispadias, Complex (BEEC)","Urogenital anomalies account for 20-30% of prenatally detected structural defects. Bladder Exstrophy Epispadias Complex (BEEC) describes a subset of anomalies with a spectrum of developmental defects ranging from a mild  form of epispadias, to classic bladder exstrophy, to omphalocele, exstrophy, imperforate anus, spinal anomalies (OEIS) complex. Patients with BEEC","Not Applicable","Bladder Exstrophy","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 391 subjects, 400 samples","","NICHD","HMB-NPU --- Health/Medical/Biomedical (NPU)","2024-11-18","2022-08-25","Omphalocele Exstrophy Imperforate Anus; Bladder Exstrophies; Bladder Exstrophy-Epispadias-Cloacal Exstrophy Complex; Bladder Extrophies; Bladder Extrophy; Classic exstrophy of the bladder",""
"phs001987.v3.p1","Gabriella Miller Kids First Pediatric Research Program in    Enchondromatoses and Related Malignant Tumors","Chondrosarcoma is a malignant tumor that originates from cartilaginous cells. It is the third most common primary malignancy of bone after myeloma and osteosarcoma. It accounts for about 20% of  bone tumors and is diagnosed in approximately 600 patients each year in the United States. Up to 40% of the chondrosarcomas arise from an","Not Applicable","Enchondromatosis","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 211 subjects, 218 samples","","NICHD","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2024-11-18","2020-04-10","Chondrosarcoma; Vascular Malformations; Congenital enchondromatosis; DYSCHONDROPLASIA; Disease, Ollier; Disease, Ollier's",""
"phs003766.v1.p1","DDX50 Cooperates With STAU1 to Effect Stabilization of    Pro-Differentiation RNAs","This study was undertaken to determine the role of DDX50 in epidermal homeostasis. Primary neonatal foreskin keratinocytes were obtained from discarded surgical samples at a California hospital. Samples were anonymous  and not selected. DDX50, which was associated with STAU1, was found to promote epidermal differentiation and transcript stability using the methods","Not Applicable","Epidermis","Collection","Not Provided","OTHER, RIP-Seq, RNA-Seq","3 phenotype datasets, 16 variables, 110 samples sequenced, 17 subjects, 110 samples","","NIAMS","GRU --- General Research Use","2024-11-15","2024-11-15","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002502.v3.p1","Center for Common Disease Genomics [CCDG] Neuropsychiatric: Autism    Spectrum Disorder (ASD) &#x02013; Whole Exomes","The National Human Genome Research Institute (NHGRI) has funded a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing to multiple common disease phenotypes. Called  the Centers for Common Disease Genomics (CCDG), this initiative will explore a range of diseases with the ultimate goal of 1) undertaking variant","Not Applicable","Autistic Disorder","Family/Twin/Trios","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use, DS-ASD-RD --- Disease-Specific (Autism Spectrum Disorder, RD), DS-RARED --- Disease-Specific (Rare Disease), DS-NDEVRD --- Disease-Specific (Neurodevelopmental and related disorders), DS-MLHLTH-IRB-NPU-MDS --- Disease-Specific (Mental Health, IRB, NPU, MDS), DS-MBND-MDS --- Disease-Specific (Mental, Behavioral, and Neurodevelopmental Disorders, MDS), DS-ASD --- Disease-Specific (Autism Spectrum Disorder), HMB-MDS --- Health/Medical/Biomedical (MDS), GRU-NPU --- General Research Use (NPU), HMB-NPU --- Health/Medical/Biomedical (NPU), DS-ASD-NPU --- Disease-Specific (Autism Spectrum Disorder, NPU), DS-ASD-NPU-MDS --- Disease-Specific (Autism Spectrum Disorder, NPU, MDS), DS-ASD-MDS --- Disease-Specific (Autism Spectrum Disorder, MDS), DS-MHNR-NPU-MDS --- Disease-Specific (Mental Health and Neurology Research, NPU, MDS)","2024-11-15","","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003803.v1.p1","Resuscitation Outcomes Consortium (ROC) Cardiac Epidemiologic Registry    (Cardiac Epistry) Versions 1 and 2 (ROC-Cardiac Epistry 1 and    2-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Available Data:  The ROC Cardiac Epistry versions 1 and 2 include all cardiac arrest cases entered into the ROC database from December 1, 2005 to April 1, 2011. ROC","Not Applicable","Heart Arrest","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 109326 subjects, 109326 samples","","NHLBI","GRU --- General Research Use","2024-11-14","2024-11-14","Arrest, Cardiac; Arrest, Heart; Asystole; Asystoles; Cardiac standstill; Heart stops beating",""
"phs003791.v1.p1","Prevention and Early Treatment of Acute Lung Injury (PETAL) - Low Tidal    Volume Universal Support Feasibility of Recruitment for Interventional    Trial (LOTUS FRUIT) (PETAL-LOTUS FRUIT-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives: The  two main goals of PETAL-LOTUS FRUIT were to conduct a prospective, observational study within all PETAL Network sites to determine the frequency of","Not Applicable","Respiratory Insufficiency","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2848 subjects, 2848 samples","","NHLBI","GRU --- General Research Use","2024-11-14","2024-11-14","Decreased lung function; Decreased pulmonary function; Decreased respiration; Depressions, Ventilatory; Respiratory Depression; Ventilatory Depression",""
"phs003777.v1.p1","Resuscitation Outcomes Consortium (ROC) Hypertonic Saline (HS) Trial    Shock Study and Traumatic Brain Injury Study (TBI)    (ROC-HS/TBI-BioLINCC)","Data Access NOTE Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession. Access differs from many other dbGaP accessions. Objectives  Shock: To determine if prehospital administration of 7.5% hypertonic saline with 6% Dextran-70 (HSD) or 7.5% hypertonic saline alone (HS), compared","Not Applicable","Brain Injuries","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2220 subjects, 2220 samples","","NHLBI","GRU --- General Research Use","2024-11-14","2024-11-14","Not Provided",""
"phs003754.v1.p1","Single Cell and Spatial Transcriptomic Profiling of Haemophilus ducreyi    Infection","We investigated the immune response in end-point pustules formed by Haemophilus ducreyi in volunteers using an experimental infection model. Six volunteers were infected in the skin of the upper arm  at three sites with 41-85 CFU of H. ducreyi loaded on an allergy testing device; a sham-inoculated (e.g., wound) site was also performed. Five","Not Applicable","Haemophilus ducreyi","Case Set","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 18 samples sequenced, 5 subjects, 18 samples","","NIAID","HMB --- Health/Medical/Biomedical","2024-11-14","2024-11-14","Skin Diseases, Infectious",""
"phs003705.v1.p1","Genetic Basis of Early Onset Bicuspid Aortic Valve Disease","The study protocol was approved by the Committee for the Protection of Human Subjects at the University of Texas Health Science Center at Houston (HSC-MS-11-0185). Study recruitment began on July  1, 2017, and concluded on March 30, 2022. After written informed consent, we enrolled probands with early onset BAV disease (EBAV), which we defined","Not Applicable","Bicuspid Aortic Valve Disease","Case-Control","Global_Screening and Omni-Express","SNP Genotypes (Array)","5 phenotype datasets, 23 variables, 1 molecular datasets, 542 subjects, 541 samples","","NHLBI","DS-BAV-IRB-PUB-RD --- Disease-Specific (Bicuspid Aortic Valve, IRB, PUB, RD)","2024-11-14","2024-11-14","AORTIC VALVE, BICUSPID; Aortic valve has two leaflets rather than three; BAV; BICUSPID AORTIC VALVE; Bicommissural Aortic Valve; Bicuspid Aortic Valves",""
"phs003274.v1.p1","Association of Oxidative Stress Pathway Alterations with Risk of    Treatment Failure in RTOG9512: A Randomized Trial of    Hyperfractionation Versus Conventional Fractionation in T2 Squamous    Cell Carcinoma of the Vocal Cord","Based on the growing body of retrospectively collected and heterogeneously treated clinical cohorts and preclinical models, we investigated the clinical importance of NRF2 pathway alteration in an independent set of  patients treated uniformly in the large prospective phase III trial RTOG 9512. We tested the hypothesis that patients with T2 glottic squamous cell","Not Applicable","Laryngeal Neoplasms","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 15 variables, 153 samples sequenced, 153 subjects, 153 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-11-13","2024-11-13","Cancer of Larynx; Cancer of the Larynx; Cancer, Laryngeal; Cancer, Larynx; Cancers, Laryngeal; Cancers, Larynx",""
"phs001710.v2.p1","Transplant Outcomes in Aplastic Anemia (TOAA): GWAS and Whole Exome    Sequence Data","The TOAA study is a research collaboration between the National Cancer Institute and the Center for International Blood and Marrow Transplant Research. The study aims to identify molecular predictors of  outcomes after hematopoietic cell transplant in patients with severe aplastic anemia. Principal Investigator: Shahinaz Gadalla, MD, PhD, National","Not Applicable","Anemia, Aplastic","Prospective Longitudinal Cohort","HumanOmniExpress-24","SNP/CNV (Array), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 641 samples sequenced, 683 subjects, 1318 samples","","NCI","DS-HCTCT-IRB --- Disease-Specific (Hematopoietic Cell Transplantation and Cell Therapy, IRB)","2024-11-12","2024-11-12","Aplastic Anemia",""
"phs000974.v6.p5","NHLBI TOPMed: Genomic Activities such as Whole Genome Sequencing and    Related Phenotypes in the Framingham Heart Study","The Framingham Heart Study (FHS) is a prospective cohort study of 3 generations of subjects who have been followed up to 65 years to evaluate risk factors for cardiovascular disease.  Its large sample of 15,000 men and women who have been extensively phenotyped with repeated examinations make it ideal for the study of genetic","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38, RNAseq_gene_transcripts, MethylationEPIC, SV_STR_grc38","Methylation (CpG), Metabolomics, RNA-Seq, SNP/CNV Genotypes (NGS), De-novo Mutations (NGS), CNV (NGS), RNA Seq (NGS), WGS","8 phenotype datasets, 1399 variables, 6 documents, 6 molecular datasets, 9684 samples sequenced, 7304 subjects, 18714 samples","European (4163), Hispanic1 (2), Hispanic2 (1), Other Asian or Pacific Islander (2), Other (4)","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2024-11-08","2024-11-08","Atherosclerosis; Atrial Fibrillation; Heart Failure; Hypertension; Osteoporosis; Pulmonary Disease, Chronic Obstructive",""
"phs001905.v2.p2","CIDR: Molecular Pathological Epidemiology of Colorectal Cancer","Colorectal cancer, the second most commonly diagnosed cancer is a biologically heterogeneous disease. To characterize the molecular attributes of colorectal tumors, we conducted targeted sequencing at the Center for Inherited  Disease Research (CIDR) on 4,518 tumor and matched normal DNA samples from the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) and","Not Applicable","Colorectal Neoplasms","Case Set","WES_markerset_grc37","CNV Genotypes, Targeted-Capture","4 phenotype datasets, 55 variables, 1 molecular datasets, 8416 samples sequenced, 4341 subjects, 8416 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB), GRU --- General Research Use, CADM --- Cancer in all age groups, other diseases in adults only, and methods, DS-CA-MDS --- Disease-Specific (Cancer, MDS), HMB --- Health/Medical/Biomedical, HMB-IRB-NPU-GSO --- Health/Medical/Biomedical (IRB, NPU, GSO), DS-COC-MDS --- Disease-Specific (Colon Cancer, MDS)","2024-11-07","2024-11-07","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001844.v2.p1","Genome-Wide Association of Type 2 Diabetes in Africans: The AADM Study","The Africa America Diabetes Mellitus (AADM) study is a genetic epidemiological study of type 2 diabetes in Sub-Saharan Africa. Study participants were enrolled through university medical centers in Nigeria, Ghana,  and Kenya. Ethical approval for the study was obtained from the Institutional Review Board (IRB) of each participating institution. All subjects","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","Not Provided","Not Provided","8 phenotype datasets, 3102 variables, 3 documents, 1 analyses, 580 subjects, 580 samples","","NHGRI","HMB --- Health/Medical/Biomedical","2024-11-06","2024-11-06","Diabetes Mellitus; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset",""
"phs003776.v1.p1","Genetic Analysis of Epidermal Inclusion Cysts","The goal of this study was to identify a potential driver of epidermal inclusion cysts, or epidermoid cysts, (EICs) in human skin. Individuals were recruited at EIC excision appointments made  a priori, with no exclusion criteria. Fresh biopsies and saliva were taken from consented patients, and DNA harvested immediately. Whole exome","Not Applicable","Epidermal Cyst","Case Set","Not Provided","WXS","4 phenotype datasets, 15 variables, 27 samples sequenced, 13 subjects, 27 samples","","NIAMS","DS-CMD-GSO --- Disease-Specific (cutaneous mosaic disorders, GSO)","2024-11-05","2024-11-05","Epidermoid Cyst; Central punctum opening in cyst; Cyst, Epidermal; Cyst, Epidermoid; Cyst, Sebaceous; Cysts, Epidermal",""
"phs003767.v1.p1","Glucose Binds and Activates NSUN2 to Promote Translation and Epidermal    Differentiation","This study was undertaken to determine the role of NSUN2 in epidermal homeostasis. Primary neonatal foreskin keratinocytes were obtained from discarded surgical samples at a California hospital. Samples were anonymous  and not selected. NSUN2 was found to promote epidermal differentiation and alter translation using the methods of RNA-seq, CLIP-seq and Ribo-seq.","Not Applicable","Epidermis","Collection","Not Provided","OTHER, RIP-Seq, RNA-Seq","3 phenotype datasets, 16 variables, 55 samples sequenced, 6 subjects, 55 samples","","NIAMS","GRU --- General Research Use","2024-11-05","2024-11-05","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002296.v1.p1","Normal Pressure Hydrocephalus","Idiopathic normal pressure hydrocephalus (iNPH) is a neurological disorder of aging that is characterized by enlarged cerebral ventricles, gait difficulty, incontinence and dementia. It is a common disorder that occurs  almost exclusively after the age of 60. About 1.3% of patients over the age of 65 and 9-14% of nursing home residents are thought to have iNPH.","Not Applicable","Hydrocephalus, Normal Pressure","Case Set","Not Provided","WXS","4 phenotype datasets, 12 variables, 44 samples sequenced, 53 subjects, 44 samples","","NINDS","DS-NPH-IRB-NPU-GSO --- Disease-Specific (Normal Pressure Hydrocephalus, IRB, NPU, GSO)","2024-11-01","2024-11-01","Chronic adult hydrocephalus; Hakim Syndrome; Hakim Syndromes; Hakim's Syndrome; Hakim's Syndromes; Hakims Syndrome",""
"phs003603.v1.p1","Exome Sequencing in an Ancestrally Diverse Autism Cohort","Autism spectrum disorder (ASD) is a collection of neurodevelopmental disorders manifested by impaired social communication, repetitive behaviors, and restricted interests. We performed whole exome sequencing (WES) on a total of  754 individuals from 195 families, including 222 probands with ASD, from diverse ancestral backgrounds. We identified potentially pathogenic variants","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","WES_markerset_grc38","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 19 variables, 1 documents, 1 molecular datasets, 754 subjects, 754 samples","","NICHD","DS-ASD --- Disease-Specific (Autism Spectrum Disorder)","2024-10-31","2024-10-31","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs002801.v1.p1","KDM6A Loss Triggers an Epigenetic Switch that Disrupts Urothelial    Identity and Drives Cell Proliferation in Bladder Cancer","Disruption of KDM6A, a histone lysine demethylase, is one of the most common somatic alternations in bladder cancer. How mutations of this chromatin modifier impact the epigenetic landscape to promote  carcinogenesis is poorly understood. Here, we demonstrate that KDM6A loss triggers an epigenomic switch that disrupts urothelial identity and induces","Not Applicable","Urinary Bladder Neoplasms","Case Set","Not Provided","ATAC-seq, ChIP-Seq, OTHER, RNA-Seq, WXS","3 phenotype datasets, 16 variables, 72 samples sequenced, 72 subjects, 72 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2024-10-31","2024-10-31","Bladder Cancer; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder; Cancer, Urinary Bladder",""
"phs001416.v4.p1","NHLBI TOPMed: MESA and MESA Family AA-CAC","The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (disease detected non-invasively before it has produced clinical signs and symptoms) and the risk  factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease. MESA researchers study a","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38, RNAseq_probe_set_grc38, MethylationEPIC, Metabolome, proteome","Methylation (CpG), Metabolomics, Proteomics, RNA-Seq, SNP/CNV Genotypes (NGS), CNV (NGS), RNA Seq (NGS), WGS","7 phenotype datasets, 97 variables, 2 documents, 5 molecular datasets, 10799 samples sequenced, 7888 subjects, 28429 samples","European (1890), African (93), East Asian (604), African American (1870), Hispanic1 (215), Hispanic2 (635), Other Asian or Pacific Islander (10), South Asian (1), Other (61)","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2024-10-31","2024-10-31","Cardiovascular Risk Factors; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs003809.v1.p1","Resuscitation Outcomes Consortium (ROC) Trauma Epidemiologic Registry    (Trauma Epistry) (ROC-Trauma Epistry-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Available Data:  This dataset only includes traumatic injury participants. For ROC cardiac arrest Epistry data please see: ROC-Cardiac Epistry 1 and 2 and ROC-Cardiac","Not Applicable","mortality","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 13730 subjects, 13730 samples","","NHLBI","GRU --- General Research Use","2024-10-29","2024-10-29","Not Provided",""
"phs003783.v1.p1","Randomized Evaluation of Sedation Titration for Respiratory Failure    (RESTORE-BioLINCC)","Data Access NOTE Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives The  primary aim of the RESTORE clinical trial was to determine whether critically ill children managed with a nurse-implemented, goal-directed sedation","Not Applicable","Respiratory Insufficiency","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2449 subjects, 2449 samples","","NHLBI","GRU --- General Research Use","2024-10-29","2024-10-29","Lung Diseases; Respiratory Distress Syndrome; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary",""
"phs003744.v1.p1","ARDSNet 07-08: Randomized, Blinded, Placebo-Controlled, Multi-Center    Trial of Omega-3 Fatty Acid, Gamma-Linolenic Acid, and Antioxidants in    Acute Lung Injury or ARDS (OMEGA) (ARDSNet-Omega-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Biospecimens: Access  to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from","Not Applicable","Acute Lung Injury","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 272 subjects, 272 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2024-10-29","2024-10-29","Lung Diseases; Respiratory Distress Syndrome; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary",""
"phs003720.v1.p1","TARGET Trial Study Cohort","In a randomized controlled clinical trial, investigators will compare the effects on [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) from two treatment regimens in rheumatoid arthritis (RA) patients deemed methotrexate  inadequate responders (MTX-IRs). Two common RA treatments will be compared: triple therapy (sulfasalazine, methotrexate, and hydroxychloroquine)","Not Applicable","Arthritis, Rheumatoid","Clinical Trial","Not Provided","Not Provided","5 phenotype datasets, 85 variables, 24 documents, 159 subjects","","NIAMS","DS-RA --- Disease-Specific (Rheumatoid Arthritis)","2024-10-25","2024-10-25","Arthritis; Autoimmune Diseases; Immune System Diseases; Joint Diseases; Molecular Mechanisms of Pharmacological Action; Musculoskeletal Diseases",""
"phs002999.v4.p1","Uncovering Inversion Formation in the Human Genome and its Impact to    Disease","The relevance of inversions for disease causation, speciation and adaptation is broadly recognized, although the prevalence of inversions is unknown. In humans, de novo inversions are associated with congenital anomalies  in approximately 9.6% of patients. Yet, despite the biological relevance of inversions, their molecular features, formation mechanism, impact to the","Not Applicable","Genetic Diseases, Inborn","Case Set","WGS_markerset_grc37","RNA-Seq, CNV (NGS), WGS","5 phenotype datasets, 20 variables, 1 molecular datasets, 259 samples sequenced, 172 subjects, 260 samples","","NIGMS","GRU --- General Research Use","2024-10-24","2023-07-18","Genetic Diseases, X-Linked; Disease, Genetic; Disease, Hereditary; Diseases, Genetic; Diseases, Hereditary; Disorder, Genetic","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001928.v2.p2","A Comprehensive Genomic Study of Pediatric Malignancy","Malignancy remains the leading cause of disease-related death in children. DNA sequencing studies have shown a paucity of actionable genomic alterations and a low mutation burden across pediatric cancers at  diagnosis. We perform a comprehensive genomic and epigenomic analysis of pediatric tumor and normal tissues using next-generation sequencing to","Not Applicable","Neuroblastoma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 400 samples sequenced, 267 subjects, 401 samples","","NCI","GRU --- General Research Use","2024-10-24","2021-11-18","Desmoplastic Small Round Cell Tumor; Endodermal Sinus Tumor; Hepatoblastoma; Sarcoma; Sarcoma, Alveolar Soft Part; Sarcoma, Clear Cell","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001879.v2.p1","Microbiota and Complications in Kidney Transplant Recipients","In this study, we investigated the role of the gut microbiota on the development of complications in kidney transplant recipients. We collected serial fecal specimens from 168 kidney transplant recipients  within the first 3 months after transplantation. We performed 16S rRNA gene sequencing of the V4-V5 hypervariable region and examined whether the","Not Applicable","Urinary Tract Infections","Prospective Longitudinal Cohort","Not Provided","AMPLICON, WGS","4 phenotype datasets, 159 variables, 552 samples sequenced, 174 subjects, 552 samples","","NIAID","GRU-IRB --- General Research Use (IRB), HMB-IRB --- Health/Medical/Biomedical (IRB)","2024-10-24","2019-12-11","",""
"phs003394.v1.p1","Systematic Identification of Minor Histocompatibility Antigens Informs    Outcomes after Allogeneic Stem Cell Transplantation","This study cohort is composed of 287 patients affected by myeloid disease (AML/MDS) who were subjected to allogeneic hematopoietic cell transplantation (allo-HCT) from an HLA-matched related donor. For each study  subject, we have collected genomic DNA from both donor and recipient (D-R). Resulting germline whole exome sequencing from D-R pairs has formed the","Not Applicable","Hematopoietic Stem Cell Transplantation","Case Set","Not Provided","WXS","4 phenotype datasets, 15 variables, 576 samples sequenced, 576 subjects, 576 samples","","NCI","DS-HM-MDS --- Disease-Specific (Hematological Malignancies, MDS), GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2024-10-23","2024-10-23","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs001414.v1.p1","Genetics of Eating Disorders","This genetic study examines Anorexia Nervosa, Bulimia Nervosa, and Binge Eating Disorder. We performed whole exome sequencing (WES) on 93 unrelated individuals with eating disorders (38 restricted-eating, 55 binge-eating) to  identify novel damaging variants. Using an unbiased, data-driven approach, we prioritized candidate genes with an excessive burden of predicted","Not Applicable","Anorexia Nervosa","Prospective Longitudinal Cohort","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 93 subjects, 93 samples","","NIMH","GRU --- General Research Use","2024-10-23","2024-10-23","Binge-Eating Disorder; Bulimia Nervosa; AN - Anorexia nervosa; Anorexia Nervosas; Nervosa, Anorexia; Nervosas, Anorexia","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs003692.v1.p1","BPH Tissues for Cell Culture and Analysis - A Patient-Derived Xenograft    Model Using Benign Prostatic Tissues","Our goal was to establish and characterize a patient-derived xenograft model for benign prostatic hyperplasia (BPH) using human benign prostatic tissues. Characterization of the model was done by histology, immunohistochemistry,  proteomics, and transcriptome analysis (RNAseq). The RNAseq data will be deposited in dbGaP. Subjects were undergoing prostatectomy for prostate or","Not Applicable","Prostatic Hyperplasia","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 31 samples sequenced, 6 subjects, 31 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2024-10-18","2024-10-18","BEP - Benign enlargement of prostate; BPH; BPH - benign prostatic hyperplasia; Benign Hyperplasia of Prostate; Benign Hyperplasia of the Prostate; Benign Prostate Hyperplasia",""
"phs003324.v1.p1","Whole Exome and RNA Sequencing of 22 Patient-Derived Xenografts from    Estrogen Receptor-Positive Breast Cancers","We performed RNA and whole exome sequencing on 22 patient-derived xenografts (PDX) from estrogen receptor-positive (ER+) breast cancers, in the presence and absence of estradiol (E2) supplementation. Exome coverage across  more than 3,500 clinically relevant genes that previously were covered below 20X ( 2.72Mb) was achieved. On average, 11.2Gb of unique sequence data","Not Applicable","Breast Neoplasms","Xenograft","WES_markerset_grc38, RNAseq_gene_transcripts","RNA-Seq, CNV Segments (NGS), RNA Seq (NGS), WXS","4 phenotype datasets, 19 variables, 1 documents, 1 molecular datasets, 84 samples sequenced, 20 subjects, 84 samples","","NCI","GRU --- General Research Use","2024-10-18","2024-10-18","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002722.v1.p1","Patient-Derived Breast Cancer Organoid Study","This study uses normal and tumor tissues from breast cancer patients to derive 3D cell culture models called organoids. Organoid technology is an innovative platform that can be used to  study a patient's tumor in a dish ex-vivo. As part of this study we have comprehensively characterized these models using next-generation sequencing","Not Applicable","Neoplasms","Collection","target_markerset_grc37","OTHER, RNA-Seq, SNP Genotypes (NGS), Targeted-Capture","4 phenotype datasets, 13 variables, 1 molecular datasets, 469 samples sequenced, 95 subjects, 622 samples","","NCI","GRU --- General Research Use","2024-10-18","2024-10-18","Triple Negative Breast Neoplasms; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors",""
"phs001486.v5.p4","NCI Cancer Model Development for the Human Cancer Model Initiative (HCMI)","The Cancer Model Development Center (CMDC) project is part of the Human Cancer Model Initiative (HCMI) and is managed by the Office of Cancer Genomics within the Center for Cancer  Genomics at the National Cancer Institute (NCI). The goal of the HCMI is to generate approximately 1000 novel human ""next generation"" tumor-derived","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 1153 subjects, 1153 samples","","NCI","GRU --- General Research Use","2024-10-18","2019-02-07","Esophageal Neoplasms; Liver Neoplasms; Lung Neoplasms; Neoplasms, Germ Cell and Embryonal; Sarcoma, Ewing; Breast Cancer","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003689.v1.p1","Genomic Alterations and Transcriptional Phenotypes in Circulating Tumor    DNA and Matched Metastatic Tumor","We analyzed a prospective cohort of 49 plasma samples obtained before, during, and after treatment from 20 patients with recurrent small cell lung cancer. We conducted cfDNA low-pass whole genome  sequencing (0.1X coverage) and exome sequencing (130X coverage) in comparison with time-point matched tumor characterized using whole-exome (130X)","Not Applicable","Small Cell Lung Carcinoma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WGS, WXS","4 phenotype datasets, 15 variables, 107 samples sequenced, 19 subjects, 107 samples","","NCI","GRU --- General Research Use","2024-10-17","2024-10-17","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001612.v3.p3","NHLBI TOPMed: Coronary Artery Risk Development in Young Adults (CARDIA)","CARDIA is a study examining the etiology and natural history of cardiovascular disease beginning in young adulthood. In 1985-1986, a cohort of 5115 healthy black and white men and women,  aged 18-30 years, were selected to have approximately the same number of people in subgroups of age (18-24 and 25-30), sex, race, and education (high","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38, SV_STR_grc38, MethylationEPIC, RNAseq_gene_transcripts, proteome","Methylation (CpG), Metabolomics, Proteomics, RNA-Seq, SNP/CNV Genotypes (NGS), CNV (NGS), RNA Seq (NGS), WGS","7 phenotype datasets, 71 variables, 2 documents, 6 molecular datasets, 8533 samples sequenced, 3598 subjects, 34866 samples","European (1787), African (25), East Asian (1), African American (1530), Hispanic1 (36), Hispanic2 (21), Other Asian or Pacific Islander (10), South Asian (1), Other (14)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2024-10-17","2024-10-17","Atherosclerosis; Diabetes Mellitus; Hypertension; Atherogeneses; Atherogenesis; Adverse Cardiac Event",""
"phs003743.v1.p1","Acute Respiratory Distress Network (ARDSNet) Studies 06 and 08    Prospective, Randomized, Multicenter Trial of Aerosolized Albuterol    Versus Placebo for the Treatment of Acute Lung Injury (ALTA)    (ARDSNet-ALTA-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Biospecimens Access  to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from ARDSNet-ALTA","Not Applicable","Acute Lung Injury","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 282 subjects, 282 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2024-10-16","2024-10-16","Lung Diseases; Respiratory Distress Syndrome; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary",""
"phs003736.v1.p1","Acute Respiratory Distress Network (ARDSNet) Studies 10 and 12 Statins    for Acutely Injured Lungs from Sepsis (SAILS) (ARDSNet-SAILS-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Biospecimens Access  to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from","Not Applicable","Acute Lung Injury","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 745 subjects, 745 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2024-10-16","2024-10-16","Acute Respiratory Distress Syndrome; Lung Diseases; Sepsis; Distress Syndrome, Respiratory; Distress Syndromes, Respiratory; Lung, Shock",""
"phs003670.v1.p1","Prostate Cancer Upgrading Reference Set","This study aimed to investigate clinical, demographic, and molecular features of men diagnosed with low-risk prostate cancer [ISUP Grade Group 1 (GG1)] at biopsy who underwent radical prostatectomy, and for  whom an increased tumor grade (ISUP Grade Group 2 or above) was subsequently detected in the resected prostate. This phenomenon is termed upgrading.","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 9 variables, 1 molecular datasets, 191 samples sequenced, 191 subjects, 191 samples","European (154), African (2), East Asian (2), African American (22), Hispanic1 (1), Hispanic2 (6), Other Asian or Pacific Islander (1), South Asian (3)","NCI","GRU --- General Research Use","2024-10-16","2024-10-16","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs003568.v1.p1","HuBMAP: Single-Cell Multiplex Chromatin and RNA Interactions in Aging    Human Brain","The study employs the Multi-Nucleic Acid Interaction Mapping in Single Cell (MUSIC) technique to concurrently profile multiplex chromatin interactions, gene expression, and RNA-chromatin associations within individual nuclei, revealing dynamically organized  chromatin complexes in human frontal cortex samples from elderly donors. The MUSIC technique allows for the exploration of chromatin architecture and","Not Applicable","Alzheimer Disease","Collection","Not Provided","OTHER","3 phenotype datasets, 9 variables, 14 samples sequenced, 14 subjects, 14 samples","","NIGMS","HMB --- Health/Medical/Biomedical","2024-10-16","2024-10-16","Aging; Aging, Biological; Biological Aging; AD; AD - Alzheimer's disease; ALZHEIMER DISEASE",""
"phs003548.v1.p1","Heart Failure Network - Nitrate's Effect on Activity Tolerance in Heart    Failure with Preserved Ejection Fraction (HFN NEAT-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Related Studies  Echo images are available with HFN-NEAT Imaging. Objectives To determine the effect of isosorbide mononitrate on daily activity in patients with","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 110 subjects, 110 samples","","NHLBI","GRU --- General Research Use","2024-10-16","2024-10-16","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003734.v1.p1","Acute Respiratory Distress Network (ARDSNet) Studies 01 and 03 Lower    Versus Higher Tidal Volume, Ketoconazole Treatment and Lisofylline    Treatment (ARMA/KARMA/LARMA) (ARDSNet-ARMA/KARMA/LARMA-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Biospecimens Access  to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from","Not Applicable","Acute Lung Injury","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 902 subjects, 902 samples","","NHLBI","GRU --- General Research Use","2024-10-15","2024-10-15","Lung Diseases; Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders",""
"phs003730.v1.p1","Beta-Blocker Evaluation in Survival Trial (BEST-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives The  Beta-Blocker Evaluation of Survival Trial was designed to determine whether bucindolol hydrochloride- a nonselective beta-adrenergic blocker and mild","Not Applicable","Cardiovascular Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2707 subjects, 2707 samples","","NHLBI","GRU --- General Research Use","2024-10-15","2024-10-15","Heart Diseases; Heart Failure; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs003726.v1.p1","Resuscitation Outcomes Consortium (ROC) Cardiac Epidemiologic Registry    (Cardiac Epistry) Version 3 (ROC-Cardiac Epistry 3-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Available Data  The ROC Cardiac Epistry version 3 include all cardiac arrest cases entered into the ROC database from April 1, 2011 to June 30, 2015. This is","Not Applicable","Heart Arrest","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 120306 subjects, 120306 samples","","NHLBI","GRU --- General Research Use","2024-10-15","2024-10-15","Arrest, Cardiac; Arrest, Heart; Asystole; Asystoles; Cardiac standstill; Heart stops beating",""
"phs003714.v1.p1","Acute Respiratory Distress Network (ARDSNet) Study 04 Assessment of Low    Tidal Volume and Elevated End-Expiratory Volume to Obviate Lung Injury    (ALVEOLI-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession differs from many other dbGaP accessions. Biospecimens Access  to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from","Not Applicable","Acute Lung Injury","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 550 subjects, 550 samples","","NHLBI","GRU --- General Research Use","2024-10-15","2024-10-15","Acute Respiratory Distress Syndrome; Lung Diseases; Respiratory Distress Syndrome; Distress Syndrome, Respiratory; Distress Syndromes, Respiratory; Lung, Shock",""
"phs003708.v1.p1","CONNECTS Master Protocol for Clinical Trials targeting Macro- and    Micro-Immuno-Thrombosis, Vascular Hyperinflammation, and    Hypercoagulability and Renin-Angiotensin-Aldosterone System (RAAS) in    Hospitalized Patients with COVID-19 (ACTIV-4 Host Tissue)","ACTIV 4 Host Tissue is a shared-placebo clinical trial platform evaluating therapies targeting the host response to COVID-19 in hospitalized patients. The overarching goal of the platform was to find  effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients hospitalized for COVID-19 include hastening","Not Applicable","COVID-19 Drug Treatment","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 899 subjects, 899 samples","","NHLBI","GRU --- General Research Use","2024-10-15","2024-10-15","Not Provided",""
"phs001237.v4.p2","NHLBI TOPMed: Women's Health Initiative (WHI)","This is Whole Genome Sequencing data from the TOPMed participation of the Women's Health Initiative. Approximately 11,100 subjects were involved in this study: approximately 1,100 cases of VTE, 4,000 cases  of ischemic stroke, 900 cases of hemorrhagic stroke, and 5,100 controls. Summary level phenotypes for the WHI Cohort study participants can be viewed","Not Applicable","Stroke","Prospective Longitudinal Cohort","WGS_markerset_grc38, MethylationEPIC, Metabolome, RNAseq_gene_transcripts","Methylation (CpG), Metabolomics, RNA-Seq, SNP/CNV Genotypes (NGS), CNV (NGS), RNA Seq (NGS), WGS","7 phenotype datasets, 98 variables, 2 documents, 4 molecular datasets, 12331 samples sequenced, 13107 subjects, 22908 samples","European (9069), African (52), East Asian (169), African American (1379), Hispanic1 (89), Hispanic2 (223), Other Asian or Pacific Islander (44), Other (21)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2024-10-15","2024-10-15","Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents; CEREBROVASCULAR ACCIDENT; CVA",""
"phs003755.v1.p1","Whole Exome Sequencing of Head and Neck Patients-Derived Tumor Organoids    and Formalin Fixed Paraffin Embedded Tumor Tissue","In this study, tissue specimens were procured from head and neck squamous cell carcinoma (HNSCC) patients undergoing routine diagnostic procedures as part of their standard of care. For surgical cases,  only excess tissue remaining after allocation for essential pathological diagnosis was utilized for research purposes. We aimed to validate the","Not Applicable","Head and Neck Neoplasms","Methods","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets, 8 samples sequenced, 4 subjects, 8 samples","","NCI","DS-HNC-IRB-PUB-NPU --- Disease-Specific (Head and Neck Cancer, IRB, PUB, NPU)","2024-10-11","2024-10-11","Head Neoplasm; Head Neoplasms; Neoplasm, Head; Neoplasms, Head",""
"phs003565.v1.p1","Heart Failure Network - Phosphodiesterase-5 Inhibition to Improve    Clinical Status and Exercise Capacity in Diastolic Heart Failure (HFN    RELAX-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Related Study  Echo images are available through HFN RELAX-Imaging Objectives The RELAX trial tested the hypothesis that chronic phosphodiesterase type-5 inhibitor","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 216 subjects, 216 samples","","NHLBI","GRU --- General Research Use","2024-10-11","2024-10-11","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003493.v1.p1","Surgical Treatment for Ischemic Heart Failure (STICH-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objective To  compare medical therapy with coronary bypass surgery and/or surgical ventricular reconstruction for patients with congestive heart failure and","Not Applicable","Cardiovascular Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2621 subjects, 2621 samples","","NHLBI","GRU --- General Research Use","2024-10-11","2024-10-11","Coronary Disease; Heart Diseases; Heart Failure, Congestive; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003121.v2.p1","Targeted Genomic Sequencing in Large Human Genes to Detect Induced    Structural Variants","Partial inhibition of DNA replication leads to de novo copy number variant (CNV) formation throughout the genome, especially at common fragile sites (CFSs). We previously showed that these hotspots for  genome instability reside in late-replicating domains associated with large, transcribed genes. In this study, we performed targeted, error-corrected","Not Applicable","Chromosome Fragile Sites","Methods","WGS_markerset_grc38","CNV (NGS), Targeted-Capture, WGS","3 phenotype datasets, 15 variables, 2 molecular datasets, 32 samples sequenced, 1 subjects, 32 samples","","NCI","GRU --- General Research Use","2024-10-11","2024-10-11","Genomic Instability; Genome Instabilities; Genome Instability; Genomic Instabilities; Instabilities, Genome; Instabilities, Genomic","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001188.v3.p1","The Finland-United States Investigation of NIDDM Genetics (FUSION) Study    - Islet Expression and Regulation by RNAseq and ATACseq","This study evaluates gene expression and its regulation in human pancreatic islets, a tissue relevant in the study of genetic risk factors contributing to diabetes. We obtained pancreatic tissue sections  and purified pancreatic islets from deceased donors and processed these biological samples to generate various data types. We generated spatial","Not Applicable","Diabetes Mellitus, Type 2","Control Set","RNAseq_probe_set_grc37, HumanOmni2.5-4, imputation_panel, MethylationEPIC","ATAC-seq, Methylation (CpG), SNP Genotypes (Array), Bisulfite-Seq, SNP Genotypes (imputed), QTL Results, RNA-Seq, RNA Seq (NGS), WGS, miRNA-Seq","5 phenotype datasets, 30 variables, 1 documents, 5 molecular datasets, 331 samples sequenced, 188 subjects, 574 samples","European (71), East Asian (1), African American (15), Hispanic1 (2), Hispanic2 (12), Other (2)","NHGRI","GRU --- General Research Use","2024-10-11","2024-10-11","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003718.v1.p1","Paired Analysis of Host and Pathogen Genomes Identifies Determinants of    Human Tuberculosis","The outcome of infectious diseases may depend on the interaction between human and pathogen genomic variations. This study was designed to explore and validate this relationship in tuberculosis (TB) by  conducting a genome-to-genome study of paired genomes from human hosts and the infectious agent Mycobacterium tuberculosis. Blood samples were","Not Applicable","Tuberculosis","Case Set","GSA-24v3-0-A1","SNP Genotypes (Array)","3 phenotype datasets, 10 variables, 1 molecular datasets, 699 subjects, 699 samples","","NIAID","DS-TB --- Disease-Specific (Tuberculosis)","2024-10-10","2024-10-10","Infection, Mycobacterium tuberculosis; Infections, Mycobacterium tuberculosis; Koch Disease; Koch's Disease; Kochs Disease; Mycobacterium tuberculosis Infection",""
"phs003226.v1.p1","Genomic Profiling of Pediatric B-cell Acute Lymphoblastic Leukemia","Pediatric leukemia is the most common type of childhood cancer and, despite tremendous progress in treatment, remains the second leading cause of cancer deaths in children. B-cell acute lymphoblastic leukemia  (B-ALL) is the most common type of pediatric leukemia. Recent studies using transcriptional profiling of large cohorts of pediatric B-ALL have shown","Not Applicable","Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","Case Set","ATAC_DNAseq_probe_set, target_markerset_grc38, RNAseq_probe_set_grc38","ATAC-seq, Hi-C, RNA-Seq, Chromatin (NGS), RNA Seq (NGS), RNA Seq (NGS)","4 phenotype datasets, 17 variables, 1 molecular datasets, 139 samples sequenced, 53 subjects, 139 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2024-10-10","2024-10-10","Leukemia, Pre B Cell; Leukemia, Pre-B-Cell; Leukemias, Pre-B-Cell; Pre B ALL; Pre B Cell Leukemia; Pre B-ALL",""
"phs003781.v1.p1","Transgenerational Transmission of Post-Zygotic Mutations Suggests    Symmetric Contribution of First Two Blastomeres to Human Germline","Skin and blood samples were collected from four phenotypically normal individuals (mother, father, and children) from a randomly selected family. Whole genomes of the samples from these individuals were sequenced  to a depth of 30X-200X. Sequencing data for the mother was previously analyzed and is available at NDA collection #2961. Sequenced reads from the","Not Applicable","Healthy Volunteers","Family/Twin/Trios","Not Provided","WGS","4 phenotype datasets, 16 variables, 3 samples sequenced, 4 subjects, 4 samples","","NINDS","GRU --- General Research Use","2024-10-09","2024-10-09","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002517.v4.p2","Childhood Cancer Data Initiative (CCDI): Molecular Characterization    across Pediatric Brain Tumors and Other Solid and Hematologic    Malignancies for Research, Diagnostic, and Precision Medicine","This study contains tumor and germline WGS, RNA-Seq, Clinical Panel Sequencing, and other omics and molecular data for patients with pediatric brain tumors and other solid and hematologic malignancies. This  data has been collected from multiple organizations including the multi-institute Children's Brain Tumor Network (CBTN), the Pacific Pediatric","Not Applicable","Brain Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, Targeted-Capture, WGS, WXS, miRNA-Seq","2 phenotype datasets, 5 variables, 8455 samples sequenced, 3960 subjects, 9082 samples","","NCI","GRU --- General Research Use","2024-10-07","2023-05-12","Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain; Neoplasm of the Brain",""
"phs001211.v5.p4","NHLBI TOPMed - NHGRI CCDG: Atherosclerosis Risk in Communities (ARIC)","Participants from the Atherosclerosis Risk in Communities (ARIC) Study, a large population-based longitudinal cohort study, have been included in this Project and whole genome sequencing will be performed to contribute  to analyses of early-onset atrial fibrillation and venous thromboembolism. Additional phenotype and genotype data are available for these individuals","Not Applicable","Cardiovascular Diseases","Case-Control","WGS_markerset_grc38, SV_STR_grc38, MethylationEPIC","Methylation (CpG), SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 32 variables, 2 documents, 3 molecular datasets, 3156 samples sequenced, 11585 subjects, 25689 samples","European (6397), African (66), East Asian (1), African American (2057), Hispanic1 (17), Hispanic2 (7), Other (2)","NHLBI","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2024-10-07","2024-10-07","Arrhythmias, Cardiac; Atrial Fibrillation; Thromboembolism; Abnormal heart rate; Arrhythmia; Arrhythmia, Cardiac",""
"phs000951.v6.p5","NHLBI TOPMed: Genetic Epidemiology of COPD (COPDGene)","Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, and the only leading cause of death that is steadily increasing in frequency. This  project established a racially diverse cohort that is sufficiently large and appropriately designed for genome-wide association analysis of COPD. A","Not Applicable","Pulmonary Disease, Chronic Obstructive","Case-Control","WGS_markerset_grc38, SV_STR_grc38, RNAseq_gene_transcripts, MethylationEPIC","Methylation (CpG), Metabolomics, RNA-Seq, SNP/CNV Genotypes (NGS), CNV (NGS), RNA Seq (NGS), WGS","6 phenotype datasets, 68 variables, 2 documents, 5 molecular datasets, 11248 samples sequenced, 10660 subjects, 34044 samples","European (6953), African (107), African American (3315), Hispanic1 (49), Hispanic2 (46), Other Asian or Pacific Islander (10), South Asian (2), Other (23)","NHLBI","HMB --- Health/Medical/Biomedical, DS-CS-RD --- Disease-Specific (COPD and Smoking, RD)","2024-10-07","2024-10-07","Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs003741.v1.p1","Single-Cell Analysis of the Multiple Myeloma Microenvironment after    Gamma-Secretase Inhibition and CAR T-Cell Therapy","We examined the effects of gamma-secretase inhibition (GSI) on the bone marrow microenvironment in multiple myeloma patients before anti-B-cell maturation antigen (BCMA) CAR T-cell therapy. Single-nuclei RNA and ATAC sequencing  revealed significant changes in gene expression and chromatin accessibility, especially in monocytes and tumor cells, following exposure to GSI. The","Not Applicable","Multiple Myeloma","Interventional","Not Provided","ATAC-seq, RNA-Seq","3 phenotype datasets, 11 variables, 32 samples sequenced, 16 subjects, 32 samples","","NCI","GRU --- General Research Use","2024-10-04","2024-10-04","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease",""
"phs003642.v1.p1","Wnt Activity Reveals Context-Dependent Genetic Effects on Gene Regulation    in Neural Progenitors","In this study we aimed to identify context-dependent regulatory functions of common genetic variation after stimulation of the canonical Wnt pathway. Fetal cortical tissue between 14 and 21 gestation weeks  was subjected to RNA-Sequencing (242 samples) and ATAC-Sequencing (222 samples) to profile expression and chromatin accessibility, respectively.","Not Applicable","Sequence Analysis, RNA","Collection","custom_markerset","ATAC-seq, SNP/CNV Genotypes (imputed), RNA-Seq","3 phenotype datasets, 13 variables, 1 molecular datasets, 464 samples sequenced, 83 subjects, 547 samples","","NIMH","GRU --- General Research Use","2024-10-02","2024-10-02","Not Provided",""
"phs000648.v2.p1","Pancreatic Cancer Case Control Association Study","Pancreatic cancer is the fourth leading cause of cancer death in the United States. This is in large part due to the rapidly fatal course of this disease, as the  vast majority of patients die within months of diagnosis and the five-year survival rate is less than 5. We have brought together over 8000","Not Applicable","Pancreatic Neoplasms","Case-Control","HumanOmniExpressExome-8","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 analyses, 1 molecular datasets, 8021 subjects, 8377 samples","European (7589), African (5), East Asian (91), African American (123), Hispanic1 (31), Hispanic2 (73), Other Asian or Pacific Islander (30), South Asian (39), Other (40)","NCI","DS-PACA --- Disease-Specific (Pancreatic Cancer)","2024-10-02","2015-06-22","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic",""
"phs003451.v2.p1","The Genetic Evolution of Acral Melanoma","Acral melanoma is a rare melanoma subtype arising on the sole, palm, or nail apparatus. We performed whole-exome sequencing (WES) for a cohort of 35 acral melanoma patients. For each  patient, we sequenced multiple tumor areas representing different tumor stages, including the in situ and invasive portions of the primary tumor and","Not Applicable","Melanoma","Tumor vs. Matched-Normal","Not Provided","Targeted-Capture, WGS, WXS","4 phenotype datasets, 22 variables, 208 samples sequenced, 35 subjects, 208 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-10-01","2024-05-08","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs002397.v1.p1","Trisomy 21 Dosage Compensation Map (T21DoCoMap)","Excess gene dosage from human chromosome 21 (HSA21), due to trisomy or translocation of HSA21 material, causes Down syndrome (DS). We derived trisomy 21 (T21) induced pluripotent stem cells (iPSCs)  alongside otherwise isogenic euploid controls from mosaic DS fibroblasts (GM00260, first described in Lubiniecki et al., PMID: 225951) of the NIGMS","Not Applicable","Down Syndrome","Collection","Cytogenetic_Arrays, MethylationEPIC","CNV Genotypes, Methylation (CpG), RNA-Seq, WGS","3 phenotype datasets, 17 variables, 1 molecular datasets, 94 samples sequenced, 1 subjects, 106 samples","","NIGMS","GRU --- General Research Use","2024-09-26","2024-09-26","47,XX,+21; 47,XY,+21; DS; Down syndrome chromosome region; Down syndrome critical region; Down syndrome, Isolated cases",""
"phs003658.v1.p1","Blood DNA Methylation in Post-Acute Sequelae of COVID-19 (PASC): a    Prospective Cohort Study","Background: DNA methylation integrates environmental signals with transcriptional programs. COVID-19 infection induces changes in the host methylome. While post-acute sequelae of COVID-19 (PASC) is a long-term complication of acute illness,  its association with DNA methylation is unknown. No universal blood marker of PASC, superseding single organ dysfunctions, has yet been identified.","Not Applicable","DNA Methylation","Cross-Sectional","Not Provided","WGS","4 phenotype datasets, 15 variables, 115 samples sequenced, 115 subjects, 115 samples","","NIAID","HMB-NPU --- Health/Medical/Biomedical (NPU)","2024-09-25","2024-09-25","",""
"phs003597.v1.p1","Ongoing Replication Stress Tolerance and Clonal T Cell Responses    Distinguish Liver and Lung Recurrence and Patient Outcomes in    Pancreatic Ductal Adenocarcinoma","Patients with metastatic pancreatic ductal adenocarcinoma (PDAC) survive longer when disease spreads to the lung but not to the liver. We generated overlapping, multi-omic datasets to identify molecular and cellular  features that distinguish patients whose disease develops liver metastasis (liver cohort) from those whose disease progression results in lung","Not Applicable","Pancreatic Neoplasms","Tumor vs. Matched-Normal","target_markerset_grc37","RNA-Seq, SNP/CNV Genotypes (NGS), Targeted-Capture","5 phenotype datasets, 74 variables, 1 molecular datasets, 525 samples sequenced, 278 subjects, 525 samples","","NCI","DS-PACA --- Disease-Specific (Pancreatic Cancer)","2024-09-24","2024-09-24","Neoplasm Metastasis; Metastase; Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize",""
"phs001134.v3.p1","Radiation-Related Genomic Profile of Papillary Thyroid Cancer after the    Chernobyl Accident","The April 26, 1986 accident at the Chernobyl nuclear power plant in northern Ukraine resulted in the release of radioactive contaminants, which were deposited in the surrounding areas in Ukraine,  Belarus, and Russia. The main radiation-related health effect resulting from these exposures is the increased occurrence of thyroid cancer among","Not Applicable","Thyroid Cancer, Papillary","Case Set","HumanOmniExpress-24, MethylationEPIC","Methylation (CpG), SNP Genotypes (Array)","5 phenotype datasets, 23 variables, 3 molecular datasets, 440 subjects, 4661 samples","","NCI","GRU --- General Research Use","2024-09-20","2024-09-20","Neoplasms, Radiation-Induced; Neoplasm, Radiation-Induced; Neoplasms, Radiation Induced; Radiation Induced Neoplasm; Radiation Induced Neoplasms; Radiation-Induced Neoplasm","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003746.v1.p1","The Contribution of De Novo Coding Mutations to Meningomyelocele","Meningomyelocele (MM) is considered a genetically complex disease resulting from the failure of the neural tube to close; a neural tube defect (NTD). Patients display neuromotor disability and frequent hydrocephalus  requiring ventricular shunting. A few genes have been proposed to contribute to disease susceptibility, but most risk remains unexplained. 851 MM","Not Applicable","Meningomyelocele","Family/Twin/Trios","Not Provided","WXS","5 phenotype datasets, 19 variables, 739 samples sequenced, 739 subjects, 739 samples","","NICHD","GRU --- General Research Use","2024-09-18","2024-09-18","Hydromeningomyelocele; Hydromyelomeningocele; Meningomyeloceles; Myelomeningocele; Myelomeningoceles; Spina Bifida Cystica",""
"phs000639.v3.p1","Human Autism Genetics","The goal of this study is to bring together the power of 1) whole exome sequencing, 2) homozygosity mapping in consanguineous families, and 3) transcriptional analysis in brain tissue to  identify genetic causes of autism spectrum disorders (ASD). Related Genes: FMR1 Principal Investigator: Christopher A. Walsh, PhD, Children's","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","WES_markerset_grc37","ATAC-seq, RNA-Seq, SNP Genotypes (NGS), WXS, ncRNA-Seq","5 phenotype datasets, 20 variables, 1 molecular datasets, 805 samples sequenced, 789 subjects, 806 samples","","NIMH","DS-ASD --- Disease-Specific (Autism Spectrum Disorder), DS-NDR --- Disease-Specific (Neurological Disorders Research), HMB --- Health/Medical/Biomedical","2024-09-18","2023-05-12","Fragile X-Associated Tremor Ataxia Syndrome; ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders",""
"phs003629.v1.p1","Pre-Existing Skin-Resident CD8 and &#x003b3;&#x003b4; T Cell Circuits Mediate Immune    Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy","Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer with a 50% response rate to immunotherapy. Here, we attempted to identify novel predictive biomarkers of response through extensive and  deep multi-omics interrogation of 186 samples from 116 patients. We collectively integrated bulk RNAseq, single-cell RNAseq, multiplex","Not Applicable","Carcinoma, Merkel Cell","Case Set","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 20 variables, 146 samples sequenced, 124 subjects, 146 samples","","NCI","GRU --- General Research Use","2024-09-16","2024-09-16","Anaplastic carcinoma of the skin; Cancer, Merkel Cell; Cell Cancer, Merkel; Cutaneous APUDoma; MCC; Merkel Cell Cancer",""
"phs003700.v1.p1","Analyzing Somatic Mutagenesis in Systemic Sclerosis","The study was undertaken with the aim of estimating differences in the mutational burden in lung tissues from healthy vs systemic sclerosis (SSc) patients. SSc is an auto-immune disease, with  patients often developing cancer. However, the etiology of this phenomenon is poorly understood. As such we sought to uncover potential molecular","Not Applicable","Genomic Instability","Case-Control","WGS_markerset_grc38","SNP Genotypes (NGS), WGS","4 phenotype datasets, 18 variables, 1 molecular datasets, 23 samples sequenced, 10 subjects, 23 samples","","NIAMS","GRU --- General Research Use","2024-09-13","2024-09-13","Inflammation; Scleroderma, Systemic; Genome Instabilities; Genome Instability; Genomic Instabilities; Instabilities, Genome","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003189.v1.p1","Genetics of Antinuclear Antibodies","Antinuclear antibodies (ANA) are antibodies that react against self-antigens in the cell. While it has been reported that 12 to 20% of the general population have a positive ANA test,  the genetics of ANA positivity is unknown. We performed a genome wide-association study for positive ANA tests among individuals without an ANA","Not Applicable","Antibodies, Antinuclear","Case-Control","Not Provided","Not Provided","4 phenotype datasets, 14 variables, 1 analyses, 5079 subjects, 5079 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2024-09-12","2024-09-12","Not Provided",""
"phs003713.v1.p1","Transcription Factor Analysis of SLE","Background: Systemic lupus erythematosus (SLE) is an autoimmune disease with protean manifestations. This study identifies two histone marks of activation and the binding of p300 genome-wide in three cell types  and three clinical subsets to better understand cell-specific effects and differences across clinical subsets. Results: We examined 20 patients with","Not Applicable","Lupus Erythematosus, Systemic","Case-Control","Not Provided","ChIP-Seq","4 phenotype datasets, 14 variables, 244 samples sequenced, 28 subjects, 244 samples","","NIAID","DS-SLE-COL-NPU --- Disease-Specific (Systemic lupus erythematosus, COL, NPU)","2024-09-11","2024-09-11","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus",""
"phs003600.v1.p1","Comprehensive Genomic Data Deposition for Pancreatic Cancer Precision    Medicine Studies: Clinical Trials NCT02451982 and NCT02648282","This submission includes specimens from 89 pancreatic cancer patients at Johns Hopkins Hospital, comprising 41 surgically resectable and 48 locally advanced pancreatic cancer (LAPC) cases. These samples originate from two  clinical studies, NCT02451982 and NCT02648282, following the Johns Hopkins Medical Institution Institutional Review Board-approved registry protocol","Not Applicable","Pancreatic Neoplasms","Clinical Trial","Not Provided","RNA-Seq, WGS, WXS","3 phenotype datasets, 12 variables, 288 samples sequenced, 75 subjects, 290 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2024-09-11","2024-09-11","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic",""
"phs002481.v5.p1","Gene Expression Study of Individuals with Sex Chromosome Aneuploidies","Males and females show dramatic differences in their vulnerability to the same diseases. For example, compared to men, lupus is six times more prevalent, thyroid cancer is three times more  prevalent, and unipolar depression is twice as prevalent in women. Diseases with a strong male bias include autism (5:1), dilated cardiomyopathy","Not Applicable","Aneuploidy","Case-Control","Not Provided","RNA-Seq","5 phenotype datasets, 30 variables, 4 documents, 502 samples sequenced, 220 subjects, 502 samples","","NHGRI","GRU --- General Research Use","2024-09-09","2021-08-30","Sex Chromosome Aberrations; Alteration of chromosome number; Aneuploid; Aneuploidies; Aneuploids; chromosome number anomaly",""
"phs003634.v1.p1","Genomic Analysis of Diffuse Large B Cell Lymphoma","Tumors from 383 newly diagnosed diffuse large B cell lymphoma were included in this study. Tumor DNA was extracted from formalin-fixed, paraffin embedded (FFPE) tissue sections, germline DNA was extracted  from blood, and whole exome sequencing (WES) of all samples (n 340 tumor normal pairs) was performed using the Agilent SureSelect All Exon V6 and","Not Applicable","Lymphoma, Large B-Cell, Diffuse","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 18 variables, 1001 samples sequenced, 383 subjects, 1001 samples","","NCI","GRU --- General Research Use","2024-09-06","2024-09-06","Centroblastic diffuse large B-cell malignant lymphoma; Centroblastic diffuse malignant lymphoma; Centroblastic malignant lymphoma; DLBCL; DLBCL - diffuse large B cell lymphoma; Diffuse Histiocytic Lymphoma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000920.v6.p4","NHLBI TOPMed - NHGRI CCDG: Genes-Environments and Admixture in Latino    Asthmatics (GALA II)","This is a case-only pharmacogenetic study of bronchodilator drug response among racially admixed Latino children with asthma. Each participant had two spirometry measurements using the KoKo PFT System. With the  first spirometry test, participant was administered with 4 puffs of HFA Albuterol. The second albuterol measurement was based on age, for","Not Applicable","Lung Diseases","Case Set","WGS_markerset_grc38, SV_STR_grc38, RNAseq_gene_transcripts","RNA-Seq, SNP/CNV Genotypes (NGS), CNV (NGS), RNA Seq (NGS), WGS","4 phenotype datasets, 24 variables, 2 documents, 3 molecular datasets, 5710 samples sequenced, 4860 subjects, 7060 samples","European (21), African American (244), Hispanic1 (2270), Hispanic2 (1952), Other (290)","NHLBI","DS-LD-IRB-COL --- Disease-Specific (Lung Diseases, IRB, COL)","2024-09-06","2024-09-06","Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders; Lung disorder",""
"phs003706.v1.p1","Clinical Outcomes and ctDNA Correlates for CAPOX BETR: A phase II trial    of Capecitabine, Oxaliplatin, Bevacizumab, Trastuzumab in Previously    Untreated Advanced HER2+ Gastroesophageal Adenocarcinoma","We performed circulating tumor DNA (ctDNA) analysis on plasma of patients with advanced HER2 positive gastroesophageal adenocarcinomas who were treated on a phase 2 clinical trial testing the addition of  bevacizumab to capecitabine, oxaliplatin, and trastuzumab. ctDNA was analyzed using panel based next generation sequencing assay (Predicine CARE),","Not Applicable","Esophageal Neoplasms","Clinical Trial","Not Provided","WGS","4 phenotype datasets, 14 variables, 58 samples sequenced, 30 subjects, 58 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-09-05","2024-09-05","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophageal neoplasm; Esophageal tumour; Esophagus Neoplasm",""
"phs003668.v1.p1","Studies of Left Ventricular Dysfunction (SOLVD-BioLINCC)","Data Access NOTE: Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession. Access differs from many other dbGaP accessions. Objectives  This study was initiated in 1986, primarily to evaluate the effects of enalapril, an ACE inhibitor, on long-term mortality and major morbidity in a","Not Applicable","Cardiovascular Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 11939 subjects, 11939 samples","","NHLBI","GRU --- General Research Use","2024-09-05","2024-09-05","Coronary Disease; Heart Diseases; Heart Failure; Hypertension; Myocardial Ischemia; Adverse Cardiac Event","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003667.v1.p1","Heart Failure Network: Inorganic Nitrite Delivery to Improve Exercise    Capacity in HFpEF (HFN INDIE-BioLINCC)","Data Access NOTE Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objective To  determine the effect of inhaled, nebulized inorganic nitrite on exercise capacity in patients with heart failure with preserved ejection fraction.","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 105 subjects, 105 samples","","NHLBI","GRU --- General Research Use","2024-09-05","2024-09-05","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003665.v1.p1","Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone    Antagonist (TOPCAT-BioLINCC)","Data Access NOTE Please refer to the ""Authorized Access"" section below for information about how access to the data from this accession. Access differs from many other dbGaP accessions. Biospecimens  Access to Biospecimens is through the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). Biospecimens from","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 3445 subjects, 3445 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2024-09-05","2024-09-05","Cardiovascular Diseases; Heart Diseases; Heart Failure, Congestive; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003654.v1.p1","Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT-BioLINCC)","Data Access NOTE: Please refer to the &#x0201c;Authorized Access&#x0201d; section below for information about how access to the data from this accession differs from many other dbGaP accessions. Objectives The  Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) was designed to evaluate the hypothesis that amiodarone or a conservatively programmed","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2521 subjects, 2521 samples","","NHLBI","GRU --- General Research Use","2024-09-05","2024-09-05","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003537.v1.p1","HudsonAlpha Long Read Sequencing Data of Individuals with Rare Suspected    Genetic Conditions","The data included in this project were generated from several IRB projects focused on the identification of the underlying genetic cause of undiagnosed rare conditions in infants, children and adults  enrolled across the southeastern United States. Long read genome sequencing was performed on DNA samples collected as part of an IRB-approved study","Not Applicable","Abnormalities, Multiple","Case Set","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use","2024-09-05","","Growth Disorders; Nervous System Diseases; Rare Disease; CONGENITAL ANOMALIES; MCA; Multiple Abnormalities","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002552.v2.p1","Genomic Analysis of Low Grade B-Cell Lymphoma","We included tumors from 64 newly diagnosed or untreated Low Grade B-Cell Lymphoma (LGBCL) patients, consisting of SMZL (n 48), NMZL (n 6), EMZL (n 2), LPL (n 5), and  B-NOS (n 3) in this study. Samples were selected from cases consented to the Molecular Epidemiology Resource (MER) of the University of Iowa and Mayo","Not Applicable","Lymphoma, Non-Hodgkin","Case Set","Not Provided","RNA-Seq, WXS","3 phenotype datasets, 14 variables, 183 samples sequenced, 64 subjects, 183 samples","","NCI","GRU --- General Research Use","2024-09-05","2023-05-25","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum Cell Sarcomas; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002329.v1.p1","Bacterial Vaginosis, Cervical Immune Cells and HIV Susceptibility","This was a cross-sectional study to characterize cervical immune cell composition and activation status in the presence versus absence of bacterial vaginosis (BV) using bulk messenger RNA sequencing (mRNA-Seq). Women  enrolled in a longitudinal, open cohort study and engaged in a sex work in Mombasa, Kenya, were eligible. On the day of enrollment, participants","Not Applicable","Genital Diseases, Female","Cross-Sectional","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 21 samples sequenced, 30 subjects, 21 samples","","NIAID","GRU --- General Research Use","2024-09-04","2024-09-04","HIV Infections; Vaginosis, Bacterial; Disease of female genital organ; Disease of female genital system; Diseases, Female Genital; Diseases, Gynecologic","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001474.v2.p1","Single Cell RNA-Seq Reveals Malignant and Stromal Programs Associated    with Metastasis in Head and Neck Cancer","This study of head and neck cancer aimed to profile individual malignant, stromal, and immune cells in treatment-naive oral cavity squamous cell carcinoma, with or without matched metastatic cervical lymph  nodes. Clinical and pathologic information was collected on all patients, in addition to a fresh biopsy sample from the primary tumor and/or","Not Applicable","Carcinoma, Squamous Cell","Prospective Longitudinal Cohort","Somatic_Variant","RNA-Seq, SNP Genotypes (NGS), WXS","4 phenotype datasets, 25 variables, 1 molecular datasets, 27 samples sequenced, 18 subjects, 27 samples","","NCI","GRU --- General Research Use","2024-09-04","2021-05-18","Neoplasm Metastasis; Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinomas, Epidermoid; Carcinomas, Planocellular","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002405.v2.p1","Gene Variants in Pheochromocytoma and Paraganglioma","Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors that arise from chromaffin cells in the adrenal medulla and in extra-adrenal locations, respectively. PPGL has the strongest hereditary risk of all  endocrine neoplasms with about 40% of cases harboring germline mutations and another 25-30% of cases arising from somatic mutations. To date, over 20","Not Applicable","Paraganglioma","Case Set","Not Provided","WXS","4 phenotype datasets, 20 variables, 31 samples sequenced, 20 subjects, 31 samples","","NICHD","GRU --- General Research Use","2024-09-03","2021-09-02","Pheochromocytoma; Carotid body tumor; Carotid body tumors; Carotid body tumours; Gangliocytic Paraganglioma; Gangliocytic Paragangliomas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003678.v1.p1","INCLUDE Data Hub: NDA GUIDs for Down Syndrome Research","The INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project is an NIH-wide collaboration that seeks to improve health and quality of life for people with  Down syndrome. The INCLUDE Project Data Coordinating Center (DCC) and partners created the INCLUDE Data Hub, a centralized data resource that allows","Not Applicable","Down Syndrome","Collection","Not Provided","Not Provided","Not Provided","","NICHD","GRU --- General Research Use","2024-08-30","","47,XX,+21; 47,XY,+21; DS; Down syndrome chromosome region; Down syndrome critical region; Down syndrome, Isolated cases",""
"phs001607.v4.p3","NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing","This is a set of cases diagnosed with idiopathic pulmonary fibrosis, a fatal interstitial lung disease. These cases were included in the TOPMed phase three studies. The planned study will  compare these cases to within-TOPMed controls for genome-wide association studies. Inclusion: Diagnosis of Idiopathic Pulmonary Fibrosis (IPF) and","Not Applicable","Idiopathic Pulmonary Fibrosis","Case Set","WGS_markerset_grc38, SV_STR_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 24 variables, 2 documents, 2 molecular datasets, 3668 samples sequenced, 3696 subjects, 3704 samples","European (2677), East Asian (13), African American (14), Hispanic1 (14), Hispanic2 (17), South Asian (12), Other (109)","NHLBI","DS-ILD-IRB-NPU --- Disease-Specific (Interstitial Lung Disease, IRB, NPU), DS-LD-IRB-NPU --- Disease-Specific (Lung Disease, IRB, NPU), DS-PFIB-IRB-NPU --- Disease-Specific (Pulmonary Fibrosis, IRB, NPU), DS-PUL-ILD-IRB-NPU --- Disease-Specific (Pulmonary, Interstitial Lung Disease, IRB, NPU), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-LD-IRB-COL-NPU --- Disease-Specific (Lung Diseases, IRB, COL, NPU)","2024-08-30","2024-08-30","Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary; FIBROCYSTIC PULMONARY DYSPLASIA; FIBROSING ALVEOLITIS, CRYPTOGENIC; Fibrocystic Pulmonary Dysplasias",""
"phs003615.v1.p1","Phase 2 Study of Nivolumab and Entinostat in Unresectable or Metastatic    Cholangiocarcinoma and Pancreatic Adenocarcinoma","The study was a single-center, open-label, phase II trial (registration no. NCT03250273) designed to evaluate the efficacy of entinostat in combination with nivolumab in patients with advanced pancreatic ductal adenocarcinoma  (PDAC). The aim was to assess the objective response rate using RECIST v1.1 criteria as the primary endpoint. A total of 27 patients with advanced","Not Applicable","Carcinoma, Pancreatic Ductal","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 55 variables, 46 samples sequenced, 30 subjects, 53 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2024-08-29","2024-08-29","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas",""
"phs003015.v2.p1","Ipilimumab and Decitabine in Treating Patients With Relapsed or    Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia","The NCI Experimental Therapeutics Clinical Trials Network (ETCTN)/Cancer Therapy Evaluation Program (CTEP) 10026 study (NCT02890329) tested combined ipilimumab and decitabine treatment in two cohorts: Arm A consisted of patients with  relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation. Arm B consisted of patients with advanced","Not Applicable","Leukemia, Myeloid, Acute","Clinical Trial","Not Provided","ATAC-seq, RNA-Seq, Targeted-Capture, WXS","5 phenotype datasets, 19 variables, 220 samples sequenced, 38 subjects, 220 samples","","NCI","HMB-COL --- Health/Medical/Biomedical (COL)","2024-08-29","2024-08-29","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs003348.v1.p1","A genotype-phenotype study of tumors from patients with inherited    mutations in DNA repair genes","This study investigated the genomic landscape of tumors from patients with inherited mutations in DNA repair genes. The aim of this study was to determine the relationship between locus-specific loss  of heterozygosity (LOH) and genomic signatures of homologous recombination-based DNA repair (HR) deficiency in tumors associated with pathogenic","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","Not Provided","WXS","4 phenotype datasets, 25 variables, 39 samples sequenced, 39 subjects, 39 samples","","NCI","GRU --- General Research Use","2024-08-28","2024-08-28","BRCA1- and BRCA2-associated hereditary breast and ovarian cancer; BRCA1- and BRCA2-associated hereditary breast and ovarian cancer (HBOC); Breast and ovarian cancer; Familial Breast and Ovarian Cancer Syndrome; Familial Breast/Ovarian Cancer (BRCA1, BRCA2); HBOC Syndrome",""
"phs000921.v5.p2","NHLBI TOPMed: Study of African Americans, Asthma, Genes and Environment    (SAGE)","This is a parallel case-control pharmacogenetic study of bronchodilator drug response among African American children with and without asthma. Each participant had spirometry measured using the KoKo PFT System. Asthmatic  participants were administered with 4 puffs of HFA Albuterol. Healthy participants were given a baseline spirometry test. The overall goal is to","Not Applicable","Lung Diseases","Case-Control","WGS_markerset_grc38, SV_STR_grc38, RNAseq_gene_transcripts","RNA-Seq, SNP/CNV Genotypes (NGS), CNV (NGS), RNA Seq (NGS), WGS","5 phenotype datasets, 33 variables, 3 documents, 3 molecular datasets, 2781 samples sequenced, 1964 subjects, 2868 samples","European (1), African (19), African American (1843), Hispanic1 (39), South Asian (2), Other (48)","NHLBI","DS-LD-IRB-COL --- Disease-Specific (Lung Diseases, IRB, COL)","2024-08-28","2024-08-28","Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders; Lung disorder",""
"phs003304.v1.p1","Adipocytes Regulate Fibroblast Function and Their Loss Contributes to    Fibroblast Dysfunction in Inflammatory Diseases","We profiled live synovial cells from 16 individuals with no diagnosed arthritis using single-cell RNA sequencing. Our study was designed to provide a reference single cell RNA sequencing dataset for  researchers interested in studying arthritic synovium, providing sequencing data on healthy synovial cells for comparison to cells from diseased","Not Applicable","Synovial Membrane","Collection","Not Provided","OTHER, RNA-Seq","7 phenotype datasets, 31 variables, 100 samples sequenced, 22 subjects, 100 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2024-08-27","2024-08-27","Not Provided",""
"phs003640.v1.p1","The Somatic Mutational Landscape of Thyroid Cancer in Patients with    Germline PTEN Mutations","PTEN hamartoma tumor syndrome (PHTS) is associated with a high rate of thyroid cancer and benign thyroid disease, yet nothing is known of the genomic landscape of PHTS-associated thyroid tumors.  In this study, exome sequencing was performed on 58 thyroid tumors (28 cancers, 30 benign nodules) from 19 patients with PHTS, sequenced in","Not Applicable","Hamartoma Syndrome, Multiple","Tumor vs. Matched-Normal","WES_markerset_grc37","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 68 samples sequenced, 16 subjects, 68 samples","","NCI","DS-CWDN-COL-NPU --- Disease-Specific (Cowden Syndrome or another condition within the PTEN Hamartoma Tumor Syndrome, COL, NPU), DS-CWDN --- Disease-Specific (Cowden Syndrome or another condition within the PTEN Hamartoma Tumor Syndrome)","2024-08-26","2024-08-26","BANNAYAN-RILEY-RUVALCABA SYNDROME; BANNAYAN-ZONANA SYNDROME; BBRS; BZS; CD; CS",""
"phs003458.v1.p1","Mapping Disease Pathways for Biliary Atresia","Biliary atresia (BA) is a poorly understood rare disease that causes jaundice and liver failure at birth due to underdeveloped bile ducts. Associated defects include poor development of the portal  vein and involvement of non-hepatic organs. After initial surgical drainage in all patients, the majority need liver transplantation because of","Not Applicable","Biliary Atresia","Case-Control","HumanOmni2.5, WGS_markerset_grc37","SNP/CNV (Array), RNA-Seq, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 18 variables, 1 molecular datasets, 68 samples sequenced, 771 subjects, 930 samples","European (85), African American (2), Hispanic1 (7), Hispanic2 (2), Other Asian or Pacific Islander (3), Other (1)","NIDDK","GRU --- General Research Use, DS-CHILDLIVD-IRB-NPU --- Disease-Specific (Children's Liver Disease, IRB, NPU), DS-CHILDCHOLLIVD-IRB-NPU --- Disease-Specific (Children's Cholestatic Liver Disease, IRB, NPU), HMB --- Health/Medical/Biomedical, DS-LIVD --- Disease-Specific (Liver Disease), DS-BA --- Disease-Specific (Biliary Atresia), DS-LIVD-PUB-NPU --- Disease-Specific (Liver Disease, PUB, NPU), DS-LIVD-GSO --- Disease-Specific (Liver Disease, GSO), DS-NEONATLIVD --- Disease-Specific (Neonatal Liver Disease)","2024-08-26","2024-08-26","Familial Extrahepatic Biliary Atresia","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003717.v1.p1","Molecular Analysis of Alliance A031201 Study","This is the first study examining the relationship between clonal hematopoiesis and clinical outcomes in prostate cancer patients. We used a targeted gene sequencing panel to identify patients in the  A031201 clinical trial with and without clonal hematopoiesis. We found that clonal hematopoiesis did not affect overall or progression free survival","Not Applicable","Prostatic Neoplasms","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 13 variables, 957 samples sequenced, 957 subjects, 957 samples","","NCI","DS-PC --- Disease-Specific (Prostate Cancer)","2024-08-23","2024-08-23","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs003704.v1.p1","Botensilimab, an Fc-enhanced Anti-CTLA-4 Antibody, is Effective Against    Tumors Poorly Responsive to Conventional Immunotherapy","This study explores the genomic landscape associated with a novel Fc-engineered anti-CTLA-4 antibody (botensilimab) in advanced solid tumors. We seek to understand if enhancing the Fc-region affinity of anti-CTLA-4 antibodies  can improve anti-tumor efficacy and expand clinical benefit to tumors poorly responsive to conventional immunotherapy. As part of an ongoing","Not Applicable","Immunotherapy","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 12 variables, 95 samples sequenced, 70 subjects, 95 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2024-08-23","2024-08-23","Sarcoma; CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine",""
"phs003701.v1.p1","A Collaborative Search for New Genes for Non-Syndromic Deafness","We seek to identify the DNA variants underlying sensorineural hearing loss. We obtain the DNA sequence of affected individuals and their family members. DNA variants are filtered to determine their  segregation in affected families. Inclusion Criteria 1. Sensorineural hearing loss diagnosed with audiometric tests 2. Hearing loss not caused by the","Not Applicable","Hearing Loss, Sensorineural","Family/Twin/Trios","Not Provided","WGS","5 phenotype datasets, 17 variables, 33 samples sequenced, 33 subjects, 33 samples","","NIDCD","DS-HL-D-PUB-COL --- Disease-Specific (Hearing Loss or Deafness, PUB, COL)","2024-08-23","2024-08-23","Deafness Neurosensory; Deafness, Neurosensory; Deafness, Sensoryneural; Deafness, sensorineural; Deafnesses, Neurosensory; Deafnesses, Sensoryneural",""
"phs003674.v1.p1","Integrative Gene Regulatory Network Analysis Discloses Key Driver Genes    of Fibromuscular Dysplasia","Fibromuscular dysplasia (FMD) is a poorly understood vascular disease that can lead to hypertension, stroke, myocardial infarction and even death. In 2013 we initiated the DEFINE study (ClinicalTrials.gov Identifier: NCT01967511),  which has now recruited 440 subjects and which aims to unravel the pathobiological mechanisms of this disease. Here, by integrating DNA genotype and","Not Applicable","Fibromuscular Dysplasia","Case-Control","RNAseq_gene_transcripts","RNA Seq (NGS)","5 phenotype datasets, 23 variables, 1 molecular datasets, 94 subjects, 116 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2024-08-23","2024-08-23","Arterial fibromuscular dysplasia; Arteries Fibromuscular Dysplasia; Arteries Fibromuscular Dysplasias; Dysplasia, Fibromuscular; FIBROMUSCULAR DYSPLASIA OF ARTERIES; FMDA",""
"phs003118.v1.p1","Cognitively Affected DMD Patients have Unique Methylation Signatures    Compared to Cognitively Normal DMD Patients","The overarching goal of this project was to identify changes in methylation patterns in Duchenne muscular dystrophy (DMD) patients with discordant symptoms using whole genome bisulfite sequencing (WGBS) from genomic  DNA isolated from whole serum. DMD siblings (biological brothers) had the same genetic mutation in the dystrophin gene but with discordance in","Not Applicable","Methylation","Case Set","Not Provided","Bisulfite-Seq","4 phenotype datasets, 15 variables, 13 samples sequenced, 15 subjects, 13 samples","","NINDS","GRU --- General Research Use","2024-08-23","2024-08-23","",""
"phs003676.v1.p1","Chromothripsis in Small Cell Lung Carcinoma Associated with Carcinoid    Transformation","Small cell lung carcinoma (SCLC) is typically associated with tobacco exposure and inactivation of RB1 and TP53 genes. We performed detailed clinicopathologic, genomic, and transcriptomic profiling of an atypical subset  of SCLC in never/light smokers that lacked RB1 and TP53 co-inactivation and found that most cases were associated with chromothripsis &#x02013;","Not Applicable","Carcinoma, Small Cell","Case Set","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 13 variables, 29 samples sequenced, 12 subjects, 29 samples","","NCI","GRU --- General Research Use","2024-08-22","2024-08-22","Carcinoid Tumor; Chromothripsis; Carcinoid; Carcinoid tumor (disease); Carcinoid tumors; Carcinoid tumour","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002922.v2.p1","Genomic and Transcriptomic Sequencing of CAR-T-Treated Patients","Chimeric Antigen Receptor (CAR)-T cell therapy has revolutionized the treatment of hematologic malignancies. Approximately half of patients with refractory large B-cell lymphomas achieve durable responses from CD19-targeting CAR-T treatment; however,  failure mechanisms are identified in only a fraction of cases. Here we use next-generation sequencing technologies to characterize the genomic and","Not Applicable","Lymphoma, B-Cell","Prospective Longitudinal Cohort","Not Provided","OTHER","4 phenotype datasets, 16 variables, 95 samples sequenced, 58 subjects, 155 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-08-22","2022-10-06","",""
"phs001946.v2.p1","Genetic Evaluation of Autoinflammatory Diseases","Many pediatric patients with early-onset autoinflammatory disease (AID) phenotypes are mutation-negative for genetically known AIDs. Recent data suggest a role for Type-I interferon (IFN) dysregulation in causing AID phenotypes with  clinical features that are distinct from those found in patients with IL-1 mediated AIDs. We screened patients for the presence of an IFN-response","Not Applicable","Hereditary Autoinflammatory Diseases","Cross-Sectional","Not Provided","WGS, WXS","4 phenotype datasets, 17 variables, 26 samples sequenced, 26 subjects, 26 samples","","NIAID","HMB-COL --- Health/Medical/Biomedical (COL)","2024-08-22","2023-03-15","Panniculitis; Autoinflammation Disease, Hereditary; Autoinflammation Diseases, Hereditary; Autoinflammatory Disease, Hereditary; Autoinflammatory Diseases, Hereditary; Disease, Hereditary Autoinflammation",""
"phs000924.v5.p2","NextGen Consortium: The iPSCORE (iPSC Collection for Omic Research)    Resource for Studying the Impact of Genetic Variation on Molecular    Phenotypes","The iPSC Collection for Omic Research (iPSCORE) Resource was created as part of the Next-Gen Consortium funded by NHLBI. The overarching purpose of the resource is to provide a large  collection of human induced pluripotent stem cells (iPSCs) for use in studying the impact of genetic variation on molecular and physiological","Not Applicable","Healthy Volunteers","Control Set","RNAseq_probe_set_grc37, RNAseq_gene_transcripts, HumanCoreExome-12, HumanCoreExome-24, HumanMethylation450, MEGA_Consortium_Array","ATAC-seq, Methylation (CpG), SNP Genotypes (Array), ChIP-Seq, Hi-C, RNA-Seq, RNA Seq (NGS)","5 phenotype datasets, 69 variables, 1 documents, 5 molecular datasets, 2270 samples sequenced, 307 subjects, 3039 samples","European (145), East Asian (21), African American (4), Hispanic1 (3), Hispanic2 (10), Other Asian or Pacific Islander (20), South Asian (6), Other (15)","NHLBI","GRU --- General Research Use, DS-CMP-MDS --- Disease-Specific (Cardiomyopathy, MDS), DS-CMP-MD-MDS --- Disease-Specific (Cardiomyopathy and Mitochondrial Disease, MDS)","2024-08-22","2019-03-06","Cardiovascular Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs003697.v1.p1","Evolving Cell States and Oncogenic Drivers during the Progression of    IDH-Mutant Gliomas","The study aims to understand the changes in cell states during the progression of IDH mutant gliomas. We generated scATAC-seq data from tumor samples of patients with IDH mutant gliomas,  ranging from grade 2 to grade 4, including both IDH mutant oligodendroglioma and IDH mutant astrocytoma samples. Additionally, we have generated","Not Applicable","Glioma","Methods","Not Provided","ATAC-seq, RNA-Seq","3 phenotype datasets, 12 variables, 15 samples sequenced, 11 subjects, 15 samples","","NCI","GRU --- General Research Use","2024-08-15","2024-08-15","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia",""
"phs001367.v2.p1","Add Health: Longitudinal Study of a Nationally Representative Sample of    Adolescents in Grades 7-12 in the United States during the 1994-95    School Year, Followed into Adulthood with Five Interviews/Surveys in    1995, 1996, 2001-02, 2008, and 2016-18","The National Longitudinal Study of Adolescent to Adult Health [Add Health] is an ongoing longitudinal study of a nationally representative U.S. cohort of more than 20,000 adolescents in grades 7-12  (aged 12-19 years) in 1994 followed into adulthood with five interviews/surveys in 1995, 1996, 2001-02, 2008, and 2016-18. Add Health was designed to","Not Applicable","Adolescent Health","Prospective Longitudinal Cohort","HumanOmni1-Quad, imputation_panel, RNAseq_gene_transcripts","SNP Genotypes (Array), RNA Seq (NGS)","5 phenotype datasets, 26 variables, 2 documents, 3 molecular datasets, 11572 subjects, 14517 samples","European (6031), African (40), East Asian (221), African American (2049), Hispanic1 (280), Hispanic2 (873), Other Asian or Pacific Islander (292), South Asian (16), Other (172)","NICHD","GRU-IRB-PUB-GSO --- General Research Use (IRB, PUB, GSO)","2024-08-14","2024-08-14","Depression; Educational Status; Employment; Health Status; Life Style; Risk Factors",""
"phs002366.v2.p2","Lung Cancer Genetic Study Among Asian Never Smokers","The Lung Cancer Genetic Study Among Asian Never Smokers includes data from four population-based studies conducted among Asian women: the Shanghai Women's Health Study (SWHS), the Hwasun Cancer Epidemiology Study  (HCES1 and HCES2), the Female Lung Cancer Consortium in Asia (FLCCA, including sFLCA), and the Guangzhou Lung Cancer Study (GLCS). Shanghai Women's","Not Applicable","Lung Neoplasms","Case-Control","WES_markerset_grc37, MEGA_Consortium_Array","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 17 variables, 2 molecular datasets, 1195 samples sequenced, 8310 subjects, 8369 samples","","NCI","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), HMB-PUB --- Health/Medical/Biomedical (PUB), DS-LC --- Disease-Specific (Lung Cancer), GRU-NPU --- General Research Use (NPU)","2024-08-13","2024-08-13","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs001524.v3.p2","The Genetic Basis of Aggressive Prostate Cancer, The Role of Rare    Variation","In this study, we will apply a multi-staged approach to reveal genes harboring rare variants that are associated with aggressive PCa. Whole-exome sequencing (Aim 1a) of 2,774 aggressive cases and  2,776 non-aggressive cases of European ancestry will be conducted followed by rare variant analysis of single sites and gene burden testing to","Not Applicable","Prostatic Neoplasms","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS), Targeted-Capture, WXS","4 phenotype datasets, 29 variables, 3 molecular datasets, 21898 samples sequenced, 21745 subjects, 21898 samples","","NCI","GRU --- General Research Use, DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS), CADM --- Cancer in all age groups, other diseases in adults only, and methods, DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB), DS-PC --- Disease-Specific (Prostate Cancer), MHNSI-MDS --- Men's Health and Nutrition in Serious Illnesses (MDS), DS-CA-NPU-GSO --- Disease-Specific (Cancer, NPU, GSO), DS-PC-NPU-MDS --- Disease-Specific (Prostate Cancer, NPU, MDS)","2024-08-12","2024-08-12","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs003620.v1.p1","Environmental Influences on Child Health Outcomes (ECHO) - PATHWAYS -    Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)","Pregnant women are exposed daily to multiple chemical and non-chemical stressors, including air pollutants, phthalates, and psychosocial stress. The Developmental Origins of Health and Disease model (DOHaD) states that exposure  to these stressors in pregnancy affects fetal development in a manner that impacts offspring health across the life course. Yet epidemiologic data in","Not Applicable","Gene Expression Profiling","Prospective Longitudinal Cohort","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 18 variables, 1 molecular datasets, 408 samples sequenced, 408 subjects, 408 samples","","OD","HMB --- Health/Medical/Biomedical","2024-08-09","2024-08-09","Not Provided",""
"phs003619.v1.p1","Environmental Influences on Child Health Outcomes (ECHO) - PATHWAYS -    Conditions Affecting Neurocognitive Development and Learning in Early    Childhood (CANDLE)","Pregnant women are exposed daily to multiple chemical and non-chemical stressors, including air pollutants, phthalates, and psychosocial stress. The Developmental Origins of Health and Disease model (DOHaD) states that exposure  to these stressors in pregnancy affects fetal development in a manner that impacts offspring health across the life course. Yet epidemiologic data in","Not Applicable","Gene Expression Profiling","Prospective Longitudinal Cohort","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 17 variables, 1 molecular datasets, 794 samples sequenced, 794 subjects, 794 samples","","OD","HMB --- Health/Medical/Biomedical","2024-08-09","2024-08-09","Not Provided",""
"phs003488.v1.p1","APOLLO-OV: Applied Proteogenomics of High Grade Serous Ovarian Carcinoma","APOLLO is a proteogenomic study seeking to describe the major genome, transcriptome, proteome and phosphoproteome alterations, subtypes, and molecular predictors of patient outcomes. This study includes 70 high grade serous  ovarian carcinoma tissues from the Gynecologic Cancer Center of Excellence","Not Applicable","Ovarian Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Provided","3 phenotype datasets, 13 variables, 70 subjects, 70 samples","","NCI","GRU --- General Research Use","2024-08-09","2024-08-09","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian",""
"phs003282.v2.p1","Genetic Analysis of Skin Cells","Cutaneous squamous cell carcinoma (cSCC) is a form of skin cancer originating from keratinocytes in the skin. They have high mutation burdens, primarily driven by UV-radiation-induced DNA damage. The order  in which mutations undergo selection during the evolution of cSCC is not known. A subset of cSCCs grow out of benign neoplasms called actinic","Not Applicable","DNA Copy Number Variations","Methods","Not Provided","RNA-Seq, Targeted-Capture","4 phenotype datasets, 13 variables, 54 samples sequenced, 16 subjects, 54 samples","","NCI","GRU --- General Research Use","2024-08-09","2023-08-18","Not Provided",""
"phs003563.v1.p1","Transfer Learning Associates CAFs with EMT and Inflammation in Tumor    Cells in Human Tumors and Organoid Co-Culture in Pancreatic Ductal    Adenocarcinoma","This study examined the transcriptional changes induced by cancer associated fibroblasts (CAFs) in pancreatic ductal adenocarcinoma patient-derived tumor organoids. We hypothesized that cancer associated fibroblasts impacted tumor cell transcription to  promote tumorigenic behavior. Using patient-matched cells from 3 patients, we compared the transcriptional profiles of patient-derived organoids in","Not Applicable","Pancreatic Neoplasms","Collection","Not Provided","RNA-Seq","3 phenotype datasets, 16 variables, 12 samples sequenced, 3 subjects, 12 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2024-08-08","2024-08-08","Inflammation; Inflammatory Response, Innate; Innate Inflammatory Response; Innate Inflammatory Responses; Cancer of the pancreas; Neoplasia of the pancreas",""
"phs003639.v1.p1","Cardiovascular Health Study (CHS) - Imaging","The Cardiovascular Health Study (CHS) is a prospective study of risk factors for development and progression of coronary heart disease (CHD) and stroke in people aged 65 years and older.  The 5,888 study participants were recruited from four U.S. communities and have undergone extensive clinic examinations for evaluation of markers of","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 5539 subjects, 5539 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), DS-CVD-NPU-MDS --- Disease-Specific (Cardiovascular Disease, NPU, MDS)","2024-08-07","2024-08-07","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs003579.v1.p1","Phase II Study of Cryoablation and Post-Progression Immune Checkpoint    Inhibition in Metastatic Melanoma","Percutaneous cryoablation guided by imaging is a well-established, minimally invasive treatment for oncological conditions. We posited that cryoablation could alter the immune microenvironment by directly influencing the tumor, potentially eliciting  an anti-tumor response in cases resistant to immune checkpoint inhibition (ICI). In this non-randomized phase II single-center study (NCT03290677),","Not Applicable","Melanoma","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 20 samples sequenced, 15 subjects, 20 samples","","NCI","DS-MSC-MDS --- Disease-Specific (Melanoma and Skin Cancer Research, MDS)","2024-08-05","2024-08-05","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs003286.v2.p1","Multi-Omic Profiling of Glioma Patient Tumors and Patient-Derived Model    Systems","We have created a resource of transcriptomic (RNAseq), genomic (whole-exome seq), and lipidomic (untargeted shotgun) profiling data from over 175 molecularly diverse glioma tumors and derivative models in orthotopic mouse  xenografts and gliomasphere cultures from over 110 unique patient tumor lines. Provided in this dataset are matched bulk RNA and whole-exome","Not Applicable","Glioblastoma","Collection","RNAseq_gene_transcripts, WES_markerset_grc38","RNA-Seq, CNV Segments (NGS), RNA Seq (NGS), WXS","5 phenotype datasets, 23 variables, 1 molecular datasets, 461 samples sequenced, 119 subjects, 461 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2024-08-05","2024-08-05","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs002750.v1.p1","Single Cell RNA Sequencing of Human Hematopoiesis","This study includes single cell RNA sequencing of human CD34+ hematopoietic stem and progenitor cells throughout human life spanning midgestation into mature adulthood. This study included otherwise healthy human blood  stem and progenitor cell donors. Principal Investigators: R. Grant Rowe, MD, PhD, Boston Children's Hospital, Boston, MA, USA Principal","Not Applicable","Hematopoiesis","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 26 samples sequenced, 26 subjects, 26 samples","","NIDDK","GRU --- General Research Use","2024-08-02","2024-08-02","Not Provided",""
"phs003703.v1.p1","Multi-Ethnic Study of Atherosclerosis (Electrocardiogram Tracing    Repository)","The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (disease detected non-invasively before it has produced clinical signs and symptoms) and the risk  factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease. MESA researchers study a","Not Applicable","Atherosclerosis","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 6814 subjects, 6814 samples","","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2024-08-01","2024-08-01","Cardiovascular Diseases; Atherogeneses; Atherogenesis; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs003702.v1.p1","Multi-Ethnic Study of Atherosclerosis (Echocardiogram Image Repository)","The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (disease detected non-invasively before it has produced clinical signs and symptoms) and the risk  factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease. MESA researchers study a","Not Applicable","Atherosclerosis","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 6814 subjects, 6814 samples","","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2024-08-01","2024-08-01","Cardiovascular Diseases; Heart Failure; Atherogeneses; Atherogenesis; Adverse Cardiac Event; Adverse Cardiac Events",""
"phs003657.v1.p1","The Effects of Long-Term Heavy Metal Exposure on Transcriptome Landscape    in Human Peripheral Blood Cells","The present study investigates the impact of long-term residence in a mining area on transcriptome changes induced by heavy metal exposure in human peripheral blood mononuclear cells (PBMCs) from 65  healthy subjects selected from the general population. This study includes the same participants which were recruited in our previous investigation","Not Applicable","Environmental Exposure","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 65 samples sequenced, 65 subjects, 65 samples","","NHGRI","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2024-08-01","2024-08-01","Not Provided",""
"phs000286.v7.p2","Jackson Heart Study (JHS) Cohort","The Jackson Heart Study (JHS) is a large, community-based, observational study whose participants were recruited from urban and rural areas of the three counties (Hinds, Madison and Rankin) that make  up the Jackson, MS metropolitan statistical area (MSA). Participants were enrolled from each of 4 recruitment pools: (1) random, 17%, (2) volunteer,","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","CVDSNP55, Affymetrix_WG_Array, Human1M-Duo, WES_markerset_grc37, WES_markerset_grc36, HumanExome-12","Not Provided","103 phenotype datasets, 4224 variables, 2 documents, 4481 samples sequenced, 3889 subjects, 17470 samples, 8 substudies","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2024-08-01","2024-08-01","Arrhythmias, Cardiac; Heart Failure; Hypertension; Kidney Failure, Chronic; Peripheral Vascular Diseases; Abnormal heart rate",""
"phs002369.v1.p2","Metabolomic Predictors of Insulin Resistance and Diabetes","Our lab has identified and validated novel metabolite profiles of those destined to develop overt T2D. These metabolites were elevated up to 12 years before the onset of T2D in  individuals who were initially glucose-tolerant; improved prediction of T2D beyond clinical risk factors and established biochemical markers; and","Jackson Heart Study (JHS) Cohort (phs000286.v7.p2)","Metabolomics","Prospective Longitudinal Cohort","Not Provided","Not Provided","1 phenotype datasets, 8 variables, 2706 subjects, 2706 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2024-08-01","2024-08-01","Not Provided",""
"phs002256.v1.p2","Aptamer Proteomics of Cardiometabolic and Renal Traits in African    Americans","This sub-study phs002256 Cardiometabolic Renal Proteomics study contains molecular data. Summary level phenotypes for the NHLBI JHS cohort participants can be viewed at the top-level study page phs000286 JHS Cohort.  Individual level phenotype data and molecular data for all JHS Cohort top-level study and substudies are available by requesting Authorized Access to","Jackson Heart Study (JHS) Cohort (phs000286.v7.p2)","Cardiometabolic Risk Factors","Case Set","Not Provided","Not Provided","1 phenotype datasets, 8 variables, 2101 subjects, 2101 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2024-08-01","2024-08-01","Cardiometabolic Risk Factor; Factor, Cardiometabolic Risk; Factors, Cardiometabolic Risk; Risk Factor, Cardiometabolic; Risk Factors, Cardiometabolic",""
"phs001356.v2.p2","Exome Chip Genotyping: The Jackson Heart Study","This sub-study phs001356 Exome Chip contains sequence data and selected phenotype of subjects available from the phs001356 study. Summary-level phenotype data for the NHLBI JHS participants can be viewed at  the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for all JHS Cohort top-level study and substudies","Jackson Heart Study (JHS) Cohort (phs000286.v7.p2)","Cardiovascular Diseases","Prospective Longitudinal Cohort","HumanExome-12","SNP Genotypes (Array)","1 phenotype datasets, 8 variables, 1 molecular datasets, 2788 subjects, 2788 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2024-08-01","2024-08-01","Diabetes Mellitus; Hypertension; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs001098.v3.p2","Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in    Multi-Ethnic Samples (T2D-GENES) Project 1: Jackson Heart Study","This sub-study phs001098 T2D GENES Exome Seq contains genotype derived from sequence data and selected phenotype of subjects available from the phs001098 study. Summary level phenotypes for the NHLBI JHS  Cohort study participants can be viewed at the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for all","Jackson Heart Study (JHS) Cohort (phs000286.v7.p2)","Diabetes Mellitus, Type 2","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 32 variables, 1 molecular datasets, 1030 samples sequenced,  SRA, 1029 subjects, 1030 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2024-08-01","2024-08-01","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001069.v2.p2","Myocardial Infarction Genetics Exome Sequencing Consortium: Jackson Heart    Study","This sub-study phs001069 MIGen JHS contains sample phenotype and sequence data of subjects available from the phs001069 study. Summary level phenotypes for the NHLBI JHS Cohort study participants can be  viewed at the top-level study page phs000286 JHS Cohort. Individual level data and sequence data for all JHS Cohort top-level study and substudies","Jackson Heart Study (JHS) Cohort (phs000286.v7.p2)","Cardiovascular Diseases","Control Set","Not Provided","WXS","1 phenotype datasets, 3 variables, 1065 samples sequenced,  SRA, 1065 subjects, 1065 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2024-08-01","2024-08-01","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs000499.v5.p2","NHLBI Jackson Heart Study Candidate Gene Association Resource (CARe)","This sub-study phs000499 JHS CARe contains genotype data of subjects available from the phs000499 study. Summary level phenotypes for the NHLBI JHS Cohort study participants can be viewed at the  top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for all JHS Cohort top-level study and substudies are","Jackson Heart Study (JHS) Cohort (phs000286.v7.p2)","Longitudinal Studies","Prospective Longitudinal Cohort","CVDSNP55, Affymetrix_WG_Array, Human1M-Duo","SNP Genotypes (Array)","2 phenotype datasets, 72 variables, 3 molecular datasets, 3352 subjects, 5460 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2024-08-01","2024-08-01","Not Provided",""
"phs000498.v5.p2","JHS Allelic Spectrum Project","This sub-study phs000498 JHS Allelic Spectrum Seq contains genotype derived from sequence data and selected phenotype of subjects available from the phs000498 study. Summary level phenotypes for the NHLBI JHS  Cohort study participants can be viewed at the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for all","Jackson Heart Study (JHS) Cohort (phs000286.v7.p2)","Cardiovascular Diseases","Prospective Longitudinal Cohort","WES_markerset_grc37","SNP Genotypes (NGS), WXS","1 phenotype datasets, 3 variables, 1 molecular datasets, 1983 samples sequenced,  SRA, 1983 subjects, 1983 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2024-08-01","2024-08-01","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs000402.v5.p2","National Heart Lung and Blood Institute (NHLBI) GO-ESP: Heart Cohorts    Component of the Exome Sequencing Project (JHS)","This sub-study phs000402 HeartGO JHS contains genotype derived from sequence data and selected phenotype of subjects available from the phs000402 study. Summary level phenotypes for the NHLBI JHS Cohort study  participants can be viewed at the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for all JHS Cohort","Jackson Heart Study (JHS) Cohort (phs000286.v7.p2)","Cardiovascular Diseases","Case-Control","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (NGS), WXS","2 phenotype datasets, 92 variables, 3 molecular datasets, 403 samples sequenced,  SRA, 402 subjects, 337 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2024-08-01","2024-08-01","Brain Ischemia; Myocardial Infarction; Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies",""
"phs003682.v1.p1","EWS-WT1 Fusion Isoforms Establish Oncogenic Programs and Therapeutic    Vulnerabilities in Desmoplastic Small Round Cell Tumors","Desmoplastic Small Round Cell Tumor (DSRCT) is an aggressive mesenchymal tumor driven by fusions between the disordered domain of the Ewing sarcoma RNA binding protein 1 (EWSR1) and the developmental  transcription factor Wilms tumor 1 (WT1). We used genome-wide chromatin profiling to identify EWSR1-WT1-dependent gene regulatory networks and target","Not Applicable","Sarcoma","Case Set","Not Provided","ChIP-Seq","3 phenotype datasets, 10 variables, 12 samples sequenced, 2 subjects, 12 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-07-31","2024-07-31","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs003480.v1.p1","Single-Cell RNA-Sequencing of Human Prostatectomy Tissue","The tissue microenvironment in prostate cancer is profoundly altered. How prostate cancer cells and their precursors mediate those changes is unclear, in part due to the inability to longitudinally study  the disease evolution in human tissues. To overcome this limitation, we performed extensive single-cell RNA-sequencing (scRNA-seq) to assess the","Not Applicable","Prostatic Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 12 samples sequenced, 7 subjects, 12 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2024-07-30","2024-07-30","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs003437.v1.p1","Basal-to-Inflammatory Transition Contributes to Basal Cell Carcinoma    Therapy Resistance via Crosstalk with a Pro-Inflammatory Stromal Niche","Overcoming tumor evolution and inducible resistance states remain the main challenge to creating successful anti-tumor therapies. The body's cancer-associated inflammatory response is a double-edged sword having ill-defined pro- and anti-tumor  properties. Our group previously identified a basal cell carcinoma (BCC) tumor-intrinsic resistance pathway called basal to squamous cell carcinoma","Not Applicable","Carcinoma, Basal Cell","Case Set","RNAseq_gene_transcripts, ATAC_DNAseq_probe_set","OTHER, Chromatin (NGS), RNA Seq (NGS)","4 phenotype datasets, 15 variables, 1 molecular datasets, 8 samples sequenced, 6 subjects, 8 samples","","NIAMS","GRU --- General Research Use","2024-07-30","2024-07-30","BCC - Basal cell carcinoma of skin; Basal Cell Cancer; Basal Cell Carcinoma; Basal Cell Carcinoma of Skin; Basal Cell Carcinoma of the Skin; Basal Cell Epithelioma",""
"phs003395.v1.p1","Efficacy of Ustekinumab Followed by Abatacept for the Treatment of    Psoriasis Vulgaris (PAUSE)","Psoriasis is a chronic immune disease of the skin and joints that affects about 2% of the population. The most common form of psoriasis is plaque psoriasis, also called psoriasis  vulgaris. A variety of drugs, including biologics, are available for treatment of moderate to severe psoriasis. When biologic agents are stopped,","Not Applicable","Psoriasis","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 24 variables, 5 documents, 403 samples sequenced, 90 subjects, 467 samples","European (56), East Asian (2), African American (5), Hispanic1 (2), Hispanic2 (6), Other Asian or Pacific Islander (2), South Asian (2), Other (1)","NIAID","GRU --- General Research Use","2024-07-26","2024-07-26","Acropustulosis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis; Palmoplantar Pustulosis",""
"phs003712.v1.p1","Early Detection of Malignant and Pre-Malignant Peripheral Nerve Tumors    Using Cell-Free DNA Fragmentomics","Early detection of neurofibromatosis type 1 (NF1) associated peripheral nerve sheath tumors (PNST) informs clinical decision-making, potentially averting deadly outcomes. Here, we describe a cell-free DNA (cfDNA) fragmentomic approach which  distinguishes non-malignant, pre-malignant and malignant forms of NF1 PNST. Using plasma samples from a novel cohort of 101 NF1 patients and 21","Not Applicable","Neurofibromatosis 1","Case-Control","Not Provided","WGS","3 phenotype datasets, 12 variables, 166 samples sequenced, 122 subjects, 166 samples","","NCI","GRU-IRB --- General Research Use (IRB)","2024-07-25","2024-07-25","Molluscum Fibrosum; Multiple non-ossifying fibromatosis; NEUROFIBROMATOSIS TYPE 1; NEUROFIBROMATOSIS, PERIPHERAL TYPE; NEUROFIBROMATOSIS, TYPE I; NEUROFIBROMATOSIS, TYPE I, SOMATIC",""
"phs003519.v1.p1","Childhood Cancer Data Initiative (CCDI): Single-Cell Atlas of NF1 Nerve    Sheath Tumors","The worst outcome of NF1 is the development of the aggressive and highly metastatic malignant peripheral nerve sheath tumors (MPNST), which transform from benign plexiform neurofibroma (PN) and lack effective  treatment. In this study, we performed single-cell RNA sequencing of 63 clinically annotated NF1-associated peripheral nerve sheath tumors, including","Not Applicable","Rare Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 29 subjects, 55 samples","","NCI","GRU --- General Research Use","2024-07-22","2024-07-22","Neurofibromatosis 1; Rare Disease; Blastoma; CA; CA - Cancer; Cancer",""
"phs002453.v1.p1","Million Veteran Program (MVP) Summary Results from Non-Sensitive Omics    Studies","MVP is an ongoing prospective cohort study and mega&#x02010;biobank in the Department of Veterans Affairs Healthcare System designed to study genetic influences on health and disease among veterans. This is  the accession to hold publicly available results. Results from sensitive phenotypes or MVP population subsets can be found at accession phs001672 and","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 documents, 6037 analyses","","NHLBI","","2024-07-19","","Arthritis; Diabetes Mellitus; Eye Diseases; Kidney Diseases; Lung Neoplasms; Persian Gulf Syndrome",""
"phs003578.v1.p1","REDS-IV-P Epidemiology, Surveillance and Preparedness of the Novel    SARS-CoV-2 Epidemic (RESPONSE)","Leveraging access to the blood supply and blood donors, the REDS-IV-P program began conducting the RESPONSE study (REDS-IV-P Epidemiology, Surveillance and Preparedness of the Novel SARS-CoV-2 Epidemic) in early 2020  in order to 1) evaluate if SARS-CoV-2 RNA was found in blood donations in the U.S. using an assay that could potentially be used to screen the blood","Not Applicable","SARS-CoV-2","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 4729 subjects, 4729 samples","","NHLBI","GRU --- General Research Use","2024-07-19","2024-07-19","Not Provided",""
"phs003008.v1.p1","Comprehensive Genomic Characterization of Translocation Renal Cell    Carcinoma","Xp11 translocation renal cell carcinoma (tRCC) is a rare, female-predominant cancer driven by a fusion between the TFE3 gene on chromosome Xp11.2 and a partner gene on either chrX or  an autosome. It remains unknown what types of rearrangements underlie TFE3 fusions, whether fusions can arise from both the active (chrXa) and","Not Applicable","Kidney","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 15 variables, 61 samples sequenced, 16 subjects, 61 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-07-19","2024-07-19","Not Provided",""
"phs001988.v2.p1","Molecular Characterization of Prostate Cancer Specimens by Bulk and    Single Cell Analysis","Version 1: We performed single-cell RNA-sequencing (scRNA-seq) of fresh biopsies from metastatic castration resistant prostate cancer. Additionally, where available, we performed matched bulk whole exome sequencing (WXS; tumor and normal  paired) and whole transcriptome sequencing for the same individuals. We also performed bulk whole exome (WXS) and RNA-sequencing (RNA-Seq) from FFPE","Not Applicable","Prostatic Neoplasms","Clinical Trial","Not Provided","RNA-Seq, WGS, WXS","4 phenotype datasets, 26 variables, 201 samples sequenced, 58 subjects, 201 samples","","NCI","GRU --- General Research Use, DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS)","2024-07-19","2021-04-27","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs003569.v1.p1","Aberrant Activation of Wound Healing Programs within the Metastatic Niche    Facilitates Lung Colonization by Osteosarcoma Cells","Lung metastasis is responsible for nearly all deaths caused by osteosarcoma, the most common pediatric bone tumor. How malignant bone cells coerce the lung microenvironment to support metastatic growth is  unclear. This study delineates how osteosarcoma cells educate the lung microenvironment during metastatic progression. Using single-cell","Not Applicable","Osteosarcoma","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 19 variables, 7 samples sequenced, 5 subjects, 7 samples","","NCI","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2024-07-18","2024-07-18","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteoblastic osteosarcoma; Osteoblastic sarcoma; Osteochondrosarcoma",""
"phs002338.v1.p1","NHLBI TOPMed: Stanford Cardiovascular Institute iPSC Biobank Study (SCVI)","The proposed Stanford Cardiovascular Institute (SCVI) Biorepository will curate and manage an expanded collection of human induced pluripotent stem cell (iPSC) lines and provide investigators with iPSC materials generated using  standardized protocols, with the overall objective of promoting the continued adoption and development of iPSC technology in cardiovascular research.","Not Applicable","Heart Diseases","Collection","WGS_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 documents, 1 molecular datasets, 1249 subjects, 1249 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2024-07-11","2024-07-11","Cardiac Disease; Cardiac Diseases; Cardiac Disorder; Cardiac Disorders; Cardiopathy; Disorder of heart",""
"phs002268.v1.p1","HuBMAP: A 3-D Tissue Map of the Human Lymphatic System","The major goal of the 3-D Tissue Map of the Human Lymphatic System is to use microscopic and biomolecular procedures to facilitate co-registration pipelines and common 3D reconstruction algorithms. Tissue  collected from human spleen, thymus and lymph node will be spatially resolved at the single cell level both within and across individuals. The","Not Applicable","Lymphoid Tissue","Collection","Not Provided","RNA-Seq","3 phenotype datasets, 9 variables, 26 samples sequenced, 7 subjects, 26 samples","","NHGRI","GRU --- General Research Use","2024-07-11","2024-07-11","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002174.v2.p1","Gabriella Miller Kids First Pediatric Research Project in Cornelia de    Lange Syndrome, Related Diagnosis and Structural Birth Defects","This study involves a cohort of 400 individuals and family members with Cornelia de Lange Syndrome (CdLS) and CdLS-like phenotypes for which a molecular etiology has not yet been established.  CdLS is a developmental disorder characterized by development delays, cognitive impairment, short stature, hearing loss, specific facial features,","Not Applicable","De Lange Syndrome","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 436 subjects, 562 samples","","NICHD","HMB-GSO --- Health/Medical/Biomedical (GSO)","2024-07-11","2022-09-07","Congenital Abnormalities; Abnormalities, Congenital; Abnormality, Congenital; Birth Defect; Birth Defects; CM - Congenital malformation",""
"phs003679.v1.p1","High-Fidelity, Large-Scale Targeted Profiling of Microsatellites","This study developed a novel method of targeted sequencing of microsatellites. We optimized every aspect of targeted hybridization capture geared towards minimizing artifacts that commonly occur in laboratory manipulation of  microsatellite-containing DNA. This achieved a higher fidelity for microsatellite sequencing than standard targeted DNA sequencing. In the","Not Applicable","Microsatellite Instability","Family/Twin/Trios","Not Provided","Targeted-Capture, WGS","4 phenotype datasets, 16 variables, 25 samples sequenced, 16 subjects, 25 samples","","OD","GRU --- General Research Use","2024-07-10","2024-07-10","Error Phenotype, Replication; Error Phenotypes, Replication; Phenotype, Replication Error; Phenotypes, Replication Error; Replication Error Phenotype; Replication Error Phenotypes",""
"phs003613.v1.p1","Chromatin Landscape of BET Inhibitor-Treated CD8+ T-cells from Chronic    Lymphocytic Leukemia Patients","The pan-BET (bromodomain and extra-terminal) inhibitor, OPN-51107 (OPN5) was found to alleviate features of T-cell exhaustion in models of chronic lymphocytic leukemia (CLL). To evaluate if OPN5 treatment could relieve  fixed chromatin states associated with terminal T-cell dysfunction, ATAC-sequencing was performed on CLL patient T-cells. Peripheral blood","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case Set","","ATAC-seq, SRA Metadata","3 phenotype datasets, 15 variables, 1 molecular datasets, 8 samples sequenced, 5 subjects, 10 samples","","NCI","GRU --- General Research Use","2024-07-10","2024-07-10","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs001726.v3.p1","NHLBI TOPMed: Childhood Asthma Management Program (CAMP)","The Childhood Asthma Management Program (CAMP) was designed to evaluate whether continuous, long-term treatment (over a period of four to six years) with either an inhaled corticosteroid (budesonide) or an  inhaled noncorticosteroid drug (nedocromil) safely produces an improvement in lung growth as compared with treatment for symptoms only (with","Not Applicable","Asthma","Family/Twin/Trios","WGS_markerset_grc38, MethylationEPIC","Methylation (CpG), Metabolomics, SNP/CNV Genotypes (NGS), CNV (NGS), WGS","7 phenotype datasets, 74 variables, 2 documents, 4 molecular datasets, 2031 samples sequenced, 2785 subjects, 4968 samples","European (1341), African (11), East Asian (16), African American (228), Hispanic1 (38), Hispanic2 (145), Other Asian or Pacific Islander (30), South Asian (1), Other (30)","NHLBI","DS-AST-COPD --- Disease-Specific (Asthma and Chronic Obstructive Pulmonary Disease)","2024-07-10","2024-07-10","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000988.v6.p1","NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica","This administrative supplement to the project, ""The Genetic Epidemiology of Asthma in Costa Rica"" (R37 HL066289) is in response to NOT-HL-14-029 to perform whole genome sequencing (WGS) on existing NHLBI  populations. We focus on asthma because of its public health significance. Asthma affects 26 million U.S. children and adults, remains a major cause","Not Applicable","Asthma","Family/Twin/Trios","WGS_markerset_grc38, MethylationEPIC","Methylation (CpG), Metabolomics, SNP/CNV Genotypes (NGS), De-novo Mutations (NGS), CNV (NGS), WGS","7 phenotype datasets, 78 variables, 2 documents, 5 molecular datasets, 4431 samples sequenced, 4283 subjects, 8130 samples","European (10), African American (1), Hispanic2 (3674), Other Asian or Pacific Islander (1), Other (192)","NHLBI","DS-ASTHMA-IRB-MDS-RD --- Disease-Specific (Asthma, IRB, MDS, RD)","2024-07-10","2024-07-10","Immunoglobulin E, Basic Level of, in Serum; Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma",""
"phs003633.v1.p1","Joint-Specific TF Regulation in RA","The mechanisms responsible for the distribution and severity of joint involvement in rheumatoid arthritis (RA) are not known. To explore whether site-specific fibroblast-like synoviocyte (FLS) biology might be associated with  location-specific synovitis and explain the predilection for hand (wrist/metacarpal phalangeal joints) involvement in RA, we generated bulk,","Not Applicable","Arthritis, Rheumatoid","Case Set","Not Provided","ATAC-seq, RNA-Seq","3 phenotype datasets, 13 variables, 120 samples sequenced, 30 subjects, 120 samples","","NIAMS","HMB-PUB --- Health/Medical/Biomedical (PUB)","2024-07-08","2024-07-08","",""
"phs003503.v1.p1","ILyAD (Indolent Lymphoma And vitamin D)","Indolent non-Hodgkin lymphomas are incurable diseases, and require intermittent and often morbid and expensive therapy during their prolonged natural history. Lower intensity and better-tolerated, cost-effective treatment strategies are needed for  these patients. Low vitamin D levels at diagnosis of indolent lymphomas are strongly associated with inferior outcomes to treatment. Standard therapy","Not Applicable","Lymphoma, Non-Hodgkin","Clinical Trial","WES_markerset_grc38","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 185 samples sequenced, 185 subjects, 185 samples","","NCI","GRU-IRB --- General Research Use (IRB)","2024-07-08","2024-07-08","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum Cell Sarcomas; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma",""
"phs003462.v1.p1","Tumor detection by analysis of both symmetric- and hemi-methylation of    plasma cell-free DNA","Aberrant DNA methylation plays a critical role in tumorigenesis. While DNA methylation has been used for cancer detection and classification, DNA hemi-methylation, a novel epigenetic mark has not been analyzed  extensively in cancer epigenomes. Here we report a strand-specific (ss) sequencing method (MeDIP-Seq) for plasma cell free (cf) DNA (sscf-MeDIP-Seq),","Not Applicable","Early Detection of Cancer","Case-Control","Not Provided","MeDIP-Seq","3 phenotype datasets, 13 variables, 271 samples sequenced, 271 subjects, 271 samples","","NCI","DS-HCC --- Disease-Specific (Hepatocellular Carcinoma), DS-BT --- Disease-Specific (Brain Tumors)","2024-07-08","2024-07-08","Liver Neoplasms; Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour",""
"phs003220.v2.p1","Identification of High-Risk PHF19 Expressing Cells in Myeloma Single-Cell    Multiomics","The aim of this study is to identify novel subsets of cells that are associated with progression and response to treatment. In this project, we study the tumor fraction from  49 myeloma patients across stages of progression. Samples were collected from 10 smoldering multiple myeloma (SMM), 22 newly diagnosed multiple","Not Applicable","Multiple Myeloma","Case Set","Not Provided","OTHER, WGS","4 phenotype datasets, 30 variables, 186 samples sequenced, 49 subjects, 186 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2024-07-08","2024-03-07","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease",""
"phs002180.v1.p1","Genomic Characterization CS-MATCH-0007 Arm Z1B","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 384 variables, 29 subjects, 29 samples","","NCI","GRU-COL --- General Research Use (COL)","2024-07-08","2024-07-08","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002177.v1.p1","Genomic Characterization CS-MATCH-0007 Arm C1","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 316 variables, 11 subjects, 11 samples","","NCI","GRU-COL --- General Research Use (COL)","2024-07-08","2024-07-08","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002152.v1.p1","Genomic Characterization CS-MATCH-0007 Arm P","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 297 variables, 28 subjects, 28 samples","","NCI","GRU-COL --- General Research Use (COL)","2024-07-08","2024-07-08","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs003582.v1.p1","Regulation of T Cell CXCL13 Production","This study evaluated the signals that regulate production of the B cell chemoattractant CXCL13 by human CD4 T cells. Single-cell and bulk RNA-seq datasets evaluated the gene expression changes induced  by TGF-beta and the aryl hydrocarbon receptor (AHR), two signals that regulate CXCL13 production. Bulk ATAC-seq data evaluated the epigenetic changes","Not Applicable","Lupus Erythematosus, Systemic","Case Set","Not Provided","ATAC-seq, RNA-Seq","8 phenotype datasets, 47 variables, 181 samples sequenced, 38 subjects, 243 samples","","NIAMS","HMB --- Health/Medical/Biomedical, DS-SLE --- Disease-Specific (Systemic lupus erythematosus)","2024-07-03","2024-07-03","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus",""
"phs003647.v1.p1","Genetic Investigations of Attention-Deficit/Hyperactivity Disorder","Design and Aims: We conducted whole-exome DNA sequencing on 152 parent-child trios (456 individuals total) that included a child meeting DSM-IV or DSM-5 criteria for ADHD along with both biological  parents to identify rare de novo damaging DNA variants associated with ADHD risk. Mutation rates were compared between 147 ADHD trios and 780","Not Applicable","Attention Deficit Disorder with Hyperactivity","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 18 variables, 1 molecular datasets, 2781 subjects, 2781 samples","","NIMH","GRU --- General Research Use","2024-06-28","2024-06-28","ADD; ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorders with Hyperactivity; Attention Deficit Hyperactivity Disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003455.v1.p1","Correlative Studies for Protocol #14-C-0059: T Cells Expressing an    Anti-GD2 Chimeric Antigen Receptor in Patients with GD2+ Solid Tumors,    a Collaboration with CIMAC-CIDC","This study is a retrospective correlative analysis of immune cell phenotypes in samples from a Phase I clinical trial (NCT02107963) of GD2 CAR-T cells (GD2-CAR.OX40.28.z.iC9) in children and young adults  with osteosarcoma and neuroblastoma. The study was a 3+3 dose-escalation study with four dose levels (1 x 10(5) transduced T cells/kg; 1 x 106","Not Applicable","Osteosarcoma","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 12 variables, 15 subjects, 103 samples","","NCI","GRU-PUB-COL --- General Research Use (PUB, COL)","2024-06-28","2024-06-28","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs003360.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): RADx Tech COVID-19    Viral Dynamics/COVID Detect","The COVID Detect/COVID-19 viral dynamics study was planned and performed to assess SARS-CoV-2 viral dynamics in early infection, accuracy/persistence of SARS-CoV-2 antigen/PCR testing, clinical aspects of mild COVID-19, and potential  SARS-CoV-2 transmission dynamics or risk factors. We performed a cohort study of adult students and employees of University of Illinois","Not Applicable","COVID-19","Control Set","Not Provided","Not Provided","Not Provided","","OD","DS-COV --- Disease-Specific (COVID-19), GRU --- General Research Use","2024-06-28","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003239.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Test Us At Home    Daily","Symptomatic or close-contact participants are enrolled and asked to perform daily tests for 10 days. Each participant performs a rapid antigen test (Quidel or Abbott) followed by home-based sample collection  and subsequent highly sensitive RT-qPCR assay (Roche, LOD 1,800 NDU/mL) performed in a CLIA-certified lab. Note for data in RADx: Instructions for","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2024-06-28","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003238.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Self-Testing for    Our Protection from COVID-19 (STOP COVID-19)","The study seeks to understand how and why people perform SARS-CoV-2 testing and report their results to the public health department. Participants participate in this study for three months and  receive home-delivery of rapid antigen and PCR-collection kits if they report to be at-risk for SARS-CoV-2 infection i.e. recently became symptomatic","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2024-06-28","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003237.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Test Us At Home","Objective: Evaluate performance of Ag-RDT for detection of SARS-CoV-2 in relation to onset of infection for symptomatic and asymptomatic participants. Design, Setting, and Participants: Prospective cohort study conducted from October  2021 to February 2022 among participants 2 years-old from across the US who enrolled using a smartphone app. During each testing encounter,","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2024-06-28","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003210.v1.p1","The Nephrotic Syndrome Study Network (NEPTUNE)","The Nephrotic Syndrome Study Network (NEPTUNE) is a collaborative investigational infrastructure of 40 North American sites for conducting clinical and translational research in Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy (MN),  and Minimal Change Disease (MCD). NEPTUNE provides prospective, un-blinded, standardized evaluation of clinical and molecular outcomes in two","Not Applicable","Nephrotic Syndrome","Prospective Longitudinal Cohort","WES_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 17 variables, 1 molecular datasets, 620 samples sequenced, 620 subjects, 620 samples","European (247), African (9), East Asian (18), African American (163), Hispanic1 (37), Hispanic2 (83), Other Asian or Pacific Islander (22), South Asian (23), Other (18)","NIDDK","HMB-IRB-PUB-MDS --- Health/Medical/Biomedical (IRB, PUB, MDS)","2024-06-28","2024-06-28","Glomerulonephritis; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Kidney Failure, Chronic; Nephrosis, Lipoid; Rare Diseases",""
"phs002681.v2.p1","Natural Killer Cell Therapies for Hematologic Malignancies","The ""Natural Killer Cell Therapies for Hematologic Malignancies"" study is an umbrella repository for data pertaining to multiple related clinical trials that aim to assess NK cell therapies as part  of treatment strategies for a range of hematologic malignancies. Here, data from two trials, NCT03068819 and NCT02782546, are presented. Cytokine","Not Applicable","Leukemia","Clinical Trial","Not Provided","OTHER","5 phenotype datasets, 19 variables, 81 samples sequenced, 25 subjects, 81 samples","","NCI","DS-HM --- Disease-Specific (Hematological Malignancies)","2024-06-28","2022-08-10","Blood (Leukemia); Blood cancer; Leucocythaemia; Leucocythaemias; Leucocythemia; Leucocythemias",""
"phs003460.v1.p1","Blood Transcriptome Profiling Following Seizures","The retrospective diagnosis or confirmation of a seizure, after the event, is very challenging. Many times clinicians can only use a patient's self-reported history. To further complicate the diagnosis, it  is known that 20-30% of patients reporting a seizure actually suffer from psychogenic non-epileptic seizure (PNES). The patient has the behavior of a","Not Applicable","Seizures","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 21 variables, 91 samples sequenced, 33 subjects, 91 samples","","NINDS","HMB-IRB --- Health/Medical/Biomedical (IRB)","2024-06-27","2024-06-27","Epilepsies; Seizure Disorder; Seizure Disorders; epilepsy; Clonic Seizure; Clonic Seizures",""
"phs003645.v1.p1","Single Cell Analysis of Healthy and Diseased Temporomandibular Joint    Synovial Fluid","Temporomandibular joint disorders (TMJDs) are a set of complex, poorly understood painful conditions that negatively affect many children and adults in the US. In this study, we establish a protocol  to utilize irrigation fluid from TMJ arthrocentesis to perform single-cell RNA sequencing on cells contained in TMJ synovial fluid. Our results","Not Applicable","Temporomandibular Joint Disorders","Methods","Not Provided","RNA-Seq","3 phenotype datasets, 10 variables, 1 samples sequenced, 1 subjects, 1 samples","","NIDCR","GRU --- General Research Use","2024-06-26","2024-06-26","Disease, TMJ; Disease, Temporomandibular Joint; Diseases, TMJ; Diseases, Temporomandibular Joint; Disorder, TMJ; Disorder, Temporomandibular",""
"phs003621.v1.p1","Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in    Heart Failure (GUIDE-IT-BioLINCC)","Accessing Data: Please refer to &#x0201c;Authorized Access&#x0201d; below regarding accessing data through the BioData Catalyst ecosystem. The data from this accession is not available for download through dbGaP. Objective: To  determine whether an amino-terminal pro-B-type natriuretic peptide (NT-pro-BNP)-guided treatment strategy improves clinical outcomes vs usual care in","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 894 subjects, 894 samples","","NHLBI","GRU --- General Research Use","2024-06-24","2024-06-24","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003599.v1.p1","Heart Failure: A Controlled Trial Investigating Outcomes of Exercise    Training (HF-ACTION-BioLINCC)","Accessing Data Please refer to &#x0201c;Authorized Access&#x0201d; below regarding accessing data through the BioData Catalyst ecosystem. The data from this accession is not available for download through dbGaP. Objectives The  HF-ACTION study examined whether exercise training reduces a composite endpoint of all-cause mortality or all-cause hospitalization for patients with","Not Applicable","Cardiovascular Diseases","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2130 subjects, 2130 samples","","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2024-06-24","2024-06-24","Heart Diseases; Heart Failure; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003601.v1.p1","Transcriptomic Profiling of Peripheral Immune Cells in a Trial of    Ruxolitinib with Nivolumab for Anti-PD1 Non-Responsive cHL","Treatment with checkpoint inhibitors is effective in multiple cancer types. However, even in cancers with high response rates such as Hodgkin lymphoma, some patients fail to respond or relapse following  an initial response to checkpoint inhibitors. In this study, we examined patients enrolled in a clinical trial of ruxolitinib with nivolumab in","Not Applicable","Hodgkin Disease","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 46 samples sequenced, 19 subjects, 46 samples","","NCATS","GRU --- General Research Use","2024-06-21","2024-06-21","CHL; Classic Hodgkin disease; Disease, Hodgkin; Disease, Hodgkin's; Disease, Hodgkins; Familial Hodgkin Disease",""
"phs003180.v1.p1","Eosinophil Activation and Function in Parasitic Infections and Other    Conditions with Increased Tissue or Peripheral Blood Eosinophilia in    Humans","Whole-genome sequencing of tumors and matched normal samples from 11 patients with PDGFR-rearranged hypereosinophilic syndrome reveals simple genomic alterations in this disease without recurrent somatic changes besides the known rearrangement.  Related Genes: PDGFRA, PDGFRB, UVRAG, IQGAP2, FIP1L1 Principal Investigator: Amy Klion, National Institute of Allergy and Infectious Diseases,","Not Applicable","Hypereosinophilic Syndrome","Tumor vs. Matched-Normal","custom_markerset","SNV Aggregate (.MAF), WGS","4 phenotype datasets, 15 variables, 1 molecular datasets, 22 samples sequenced, 11 subjects, 22 samples","","NIAID","GRU --- General Research Use","2024-06-20","2024-06-20","Endocarditis, Loeffler; Endocarditis, Loeffler's; Endocarditis, Loefflers; Eosinophilic endocarditis; Loeffler Endocarditis; Loeffler's Endocarditis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002184.v1.p1","Transcriptomic Analysis of Pluripotent Stem Cell-Based Model of Human    Amniogenesis","The amniotic epithelium is the innermost layer of the amniochorionic membrane that physically divides the maternal and fetal environments. Amniogenesis is initiated during implantation in humans. In implanting blastocysts, the  pluripotent epiblast cells undergo apical-basal polarization to form a cyst with a central lumen, the future amniotic cavity. This event is followed","Not Applicable","RNA-Seq","Collection","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 30 samples sequenced, 1 subjects, 30 samples","","NICHD","GRU --- General Research Use","2024-06-20","2024-06-20","Not Provided",""
"phs003644.v1.p1","Left Atrial Cardiomyocyte Transcriptomic Analysis of Postoperative Atrial    Fibrillation","After IRB approval and informed consent, cardiomyocytes were isolated from human left atrial tissue samples obtained along the standard atriotomy incision during mitral valve surgery. RNA was isolated from cardiomyocytes  and RNA libraries were prepared after rRNA depletion. RNA sequencing and whole transcriptome analysis were performed to identify differential gene","Not Applicable","Atrial Fibrillation","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 37 variables, 30 samples sequenced, 30 subjects, 30 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2024-06-13","2024-06-13","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs003623.v1.p1","BIRC5 Upregulation Enhances DNMT3A-Mutant T-ALL Cell Survival and    Pathogenesis","The goal of this study was to determine how patients with T-ALL who have DNA methyltransferase 3 alpha (DNMT3A) mutations develop resistance to therapy. Since DNMT3A is a methyltransferase, we  examined the effect of those mutations on epigenetic regulation using whole genome bisulfite sequencing (WGBS). We also assessed any changes in gene","Not Applicable","Leukemia-Lymphoma, Adult T-Cell","Case Set","Not Provided","Bisulfite-Seq, RNA-Seq","4 phenotype datasets, 12 variables, 10 samples sequenced, 10 subjects, 10 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2024-06-13","2024-06-13","ATLL; Adult T Cell Lymphoma/Leukemia; Adult T-Cell Leukemia; Adult T-Cell Leukemia-Lymphoma; Adult T-Cell Leukemia-Lymphomas; Adult T-Cell Leukemias","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002343.v1.p1","Structure of the Mucosal and Stool Microbiome in Lynch Syndrome","The gut microbiota has been associated with colorectal cancer (CRC), but causal alterations preceding CRC have not been elucidated. To prospectively assess microbiome changes prior to colorectal neoplasia, we investigated  samples from 100 Lynch syndrome patients using 16S rRNA gene sequencing of colon biopsies, coupled with metagenomic and metatranscriptomic sequencing","Not Applicable","Colorectal Neoplasms","Case Set","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 27 variables, 361 samples sequenced, 100 subjects, 361 samples","","NCI","GRU --- General Research Use","2024-06-13","2024-06-13","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs003432.v1.p1","Childhood Cancer Data Initiative (CCDI): Identification and Targeting of    Treatment Resistant Progenitor Populations in T-cell Acute    Lymphoblastic Leukemia","Our goal with this study was to identify the mechanisms of treatment resistance in T-cell acute lymphoblastic leukemia (ALL) using single-cell genomics. We profiled 40 T-ALL cases from the Children's  Oncology Group AALL0434 clinical trial using CITE-seq/snATAC-seq, capturing a breadth of immunophenotypes, including early T-cell precursor (ETP) and","Not Applicable","Pediatrics","Case Set","Not Provided","ATAC-seq, RNA-Seq","2 phenotype datasets, 5 variables, 43 samples sequenced, 43 subjects, 43 samples","","NCI","GRU --- General Research Use","2024-06-12","2024-06-12","Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Blastoma; CA; CA - Cancer; Cancer; MT",""
"phs003379.v1.p1","Germline Mutations and Developmental Mosaicism Underlying EGFR-Mutant    Lung Cancer","We designed this study to examine the etiology of multiple lung tumors in EGFR-mutant non-small cell lung cancer patients who undergo surgical resection. Participants were 52-85 years old never or  former smokers, who had at least 2 surgical lung tumor pathology specimens available in the Massachusetts General Hospital biobank, at least one of","Not Applicable","Carcinoma, Non-Small-Cell Lung","Case Set","Not Provided","WXS","4 phenotype datasets, 17 variables, 68 samples sequenced, 12 subjects, 68 samples","","NCI","GRU --- General Research Use","2024-06-12","2024-06-12","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER",""
"phs003113.v1.p1","Integrative Analysis for Multi-Omics Data in Non-Small-Cell Lung Cancer","We conducted epigenetic and transcriptomic mapping of primary non-small cell lung tumors and non-neoplastic tissues. 20 non-neoplastic lung tissues and 18 non-small cell lung tumors were obtained from Biorepository and  Tissue Technology Shared Resource at Moores Cancer Center, UC San Diego. All tumor samples were in pathological stages I and II. 8 pairs of samples","Not Applicable","Carcinoma, Non-Small-Cell Lung","Tumor vs. Matched-Normal","Not Provided","ChIP-Seq, RNA-Seq","3 phenotype datasets, 14 variables, 38 samples sequenced, 30 subjects, 38 samples","","NHGRI","GRU --- General Research Use","2024-06-10","2024-06-10","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003091.v2.p1","Single-Cell DNA Methylation Profiling with sciMETv2","In this study we developed a high-throughput single-cell DNA methylation analysis technology, sciMETv2. This technique is rapid, cost-effective, and robust, enabling large-scale single-cell methylome dataset generation. We demonstrate this technology  on human middle frontal gyrus, where we identified major cell types. We additionally performed target enrichment using sciMET-cap to enable a","Not Applicable","DNA Methylation","Methods","Not Provided","Bisulfite-Seq","3 phenotype datasets, 8 variables, 17 samples sequenced, 2 subjects, 17 samples","","NIMH","HMB --- Health/Medical/Biomedical","2024-06-10","2022-11-28","",""
"phs002908.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Hispanic    Community Health Study/Study of Latinos (HCHS/SOL)","Cohort Description Hispanic Community Health Study/Study of Latinos (HCHS/SOL) is an ongoing population-based prospective cohort study of 16,415 community dwelling Hispanic/Latino adults aged 18-74 years at baseline, recruited from four  urban field centers with large populations of Hispanics/ Latinos (Bronx, NY; Chicago, IL; Miami, FL; and San Diego, CA). The primary goals of the","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 11182 subjects, 11182 samples","","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU), HMB --- Health/Medical/Biomedical","2024-06-07","2024-06-07","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Collection: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) (phs003650.v1.p1)"
"phs002258.v2.p1","Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection    Reveals Unique Host Responses, Viral Diversification, and Drug    Interactions","In less than nine months, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has killed hundreds of thousands of people, including 23,000 in New York City (NYC) alone. The pandemic's  sudden emergence highlights the clinical need to detect infection, track strain evolution, and identify biomarkers of disease course. To address","Not Applicable","COVID-19","Metagenomics","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 900 samples sequenced, 729 subjects, 900 samples","","NIAID","GRU-IRB-PUB-COL --- General Research Use (IRB, PUB, COL)","2024-06-07","2021-01-15","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003468.v1.p1","The Role of GPD1L in the Pathogenesis of Brugada Syndrome","This study performed exome sequencing on a proband with Brugada Syndrome, as well as high-density SNP array data from the proband, affected family members, and unaffected family members. The principal  findings of this study were the identification of GPD1L-A280V as the only plausible variant present in a linkage region on chromosome 3, which","Not Applicable","Brugada Syndrome","Family/Twin/Trios","Global_Screening_Array-24","SNP Genotypes (Array), WXS","5 phenotype datasets, 17 variables, 1 molecular datasets, 1 samples sequenced, 15 subjects, 16 samples","","NHLBI","GRU --- General Research Use","2024-06-06","2024-06-06","Bangungut; Brugada type idiopathic ventricular fibrillation; Idiopathic ventricular fibrillation, Brugada type; Pokkuri death syndrome; RIGHT BUNDLE BRANCH BLOCK, ST SEGMENT ELEVATION, AND SUDDEN DEATH SYNDROME; SUDDEN UNEXPLAINED NOCTURNAL DEATH SYNDROME","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003219.v1.p1","Single-Cell Sequencing Reveals Distinct Microenvironment Cell Types    Associated with Response to High Dose Melphalan and Autologous Stem    Cell Transplant in Multiple Myeloma","The aim of this study is to understand the transcriptome of microenvironment cells in pre- and post- autologous stem cell transplantation (ASCT) samples between patients with complete response and partial  response to transplant. Here, we studied immune cells from 40 multiple myeloma patients who have undergone ASCT. Samples were collected from 40","Not Applicable","Multiple Myeloma","Cross-Sectional","Not Provided","OTHER","4 phenotype datasets, 17 variables, 136 samples sequenced, 40 subjects, 136 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2024-06-06","2024-06-06","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease",""
"phs002514.v1.p1","Identification of Modifiers of 22q11.2 Deletion Syndrome in Whole Genome    Sequence - CIDR","This project aims to identify genetic modifiers of congenital heart disease (CHD), which occurs among 22q11.2 deletion syndrome (22q11.2DS; also known as DiGeorge syndrome/velo-cardio-facial syndrome) patients. In contrast to the  prevalence of 0.8% in the general population, about 60%-70% of 22q11.2DS patients have CHD, of which most are conotruncal heart defects, making","Not Applicable","Heart Defects, Congenital","Case-Control","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 23 variables, 1 molecular datasets, 844 samples sequenced, 879 subjects, 844 samples","","NICHD","GRU --- General Research Use","2024-06-06","2024-06-06","Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Abnormally shaped heart; Cardiac abnormalities","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002211.v3.p1","Gynecology and Lubricant Effects (GALE) Study","The GALE study is a longitudinal study of the association between lubricant use and the vaginal microbiota in women receiving transvaginal ultrasound (TVUS) at the Diagnostic Radiology and Nuclear Medicine  Department at the University of Maryland School of Medicine. Participants undergo a clinical exam at enrollment (at least 5 days prior to TVUS) and","Not Applicable","Vaginosis, Bacterial","Prospective Longitudinal Cohort","Not Provided","AMPLICON","5 phenotype datasets, 159 variables, 2859 samples sequenced, 121 subjects, 2859 samples","","NIAID","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2024-06-06","2020-11-10","Bacterial Vaginosis; BV; BV - Bacterial vaginosis; Bacterial Vaginitides; Bacterial Vaginitis; Bacterial Vaginoses",""
"phs003590.v1.p1","FIGHT-207: Anonymized Genomic Alterations and Clinical Responses","Background: FIGHT-207 was a phase 2 study of the FGFR1-FGFR3 inhibitor pemigatinib in patients with previously treated, locally advanced/metastatic or unresectable solid tumor malignancies harboring activating fibroblast growth factor receptor  (FGFR) gene alterations. Population information: 107 patients were divided into 3 cohorts: A. FGFR1&#x02013;FGFR3 fusions/rearrangements; n 49 B.","Not Applicable","Antineoplastic Agents","Clinical Trial","custom_markerset","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 22 variables, 1 molecular datasets, 101 subjects, 262 samples","","NCI","HMB-COL --- Health/Medical/Biomedical (COL)","2024-06-05","2024-06-05","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001087.v4.p1","Common Deleterious Germline Variants Shape the Urothelial Cancer Genome","Our study used whole-exome, whole-genome, and RNA sequencing to analyze samples from primary tumors, locally recurrent or metastatic urothelial tumors collected over time, and matched normal urothelium. We described the  molecular landscape of mutational signatures and structural variants in chemotherapy-resistant urothelial cancer. Inclusion Criteria: Patients with","Not Applicable","Carcinoma, Transitional Cell","Case Set","target_markerset_grc37","AMPLICON, RNA-Seq, CNV Segments (NGS), SNV (.MAF), WGS, WXS","4 phenotype datasets, 20 variables, 1 molecular datasets, 504 samples sequenced, 174 subjects, 554 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2024-06-05","2018-04-09","Neoplasm Metastasis; Urinary Bladder Neoplasms; Metastase; Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002450.v2.p1","Genomic Basis of Phenotypic Variability of Complex Disorders","The 520-kbp deletion on chromosome 16p12.1 is associated with multiple neurodevelopmental outcomes, including intellectual disability/developmental delay (ID/DD), schizophrenia, autism, and epilepsy. This variant is inherited in 95% of cases from  carrier parents manifesting neuropsychiatric features, while affected children with the deletion were more likely to carry another large Copy Number","Not Applicable","DNA Copy Number Variations","Family/Twin/Trios","HumanOmniExpress-12, WGS_markerset_grc37, SV_STR_grc37, RNAseq_probe_set_grc37","SNP/CNV (Array), RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), WGS","6 phenotype datasets, 65 variables, 4 molecular datasets, 241 samples sequenced, 143 subjects, 339 samples","","NIGMS","GRU-NPU --- General Research Use (NPU)","2024-06-04","2024-06-04","Child Development Disorders, Pervasive; Congenital Abnormalities; Developmental Disabilities; Pervasive Child Development Disorders; Abnormalities, Congenital; Abnormality, Congenital",""
"phs003413.v1.p1","Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor","Immune checkpoint inhibitors (ICIs) are widely used in anti-cancer therapies, but they can cause morbid and potentially fatal immune-related adverse events (irAEs), such as ICI-related myocarditis (irMyocarditis). The pathogenesis of  irMyocarditis and its relationship to anti-tumor immunity remain poorly understood. We sought to define immune responses in heart, tumor, and blood","Not Applicable","Cardiovascular Diseases","Case-Control","Not Provided","RNA-Seq","5 phenotype datasets, 26 variables, 147 samples sequenced, 69 subjects, 147 samples","","NCI","GRU --- General Research Use","2024-06-03","2024-06-03","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs002732.v1.p1","NIH Division of Intramural Research Multiomic Monogenic Disease Study","This cross-sectional, observational study utilized high-dimensional approaches, including transcriptomic analysis, serum protein profiling, and peripheral blood frequency assessments, to compare 228 adult and pediatric patients diagnosed with 22 monogenic immune-mediated  conditions impacting various key immunological pathways, with 42 age- and sex-matched healthy controls. Participants were enrolled in clinical","Not Applicable","Immune System Diseases","Cross-Sectional","SomaScan, Affymetrix_expression_array","mRNA Expression (Array), Proteomics","7 phenotype datasets, 86 variables, 2 molecular datasets, 261 subjects, 625 samples","","NIAID","HMB --- Health/Medical/Biomedical, GRU --- General Research Use","2024-06-03","2024-06-03","Cryopyrin-Associated Periodic Syndromes; Familial Mediterranean Fever; Hereditary Autoinflammatory Diseases; Amyloid nephropathy with deafness and urticaria; CAPS2; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002206.v5.p1","Genomic Answers for Kids (GA4K)","Identification of complex genetic variants including defects in gene regulatory circuits and uncharacterized genes present challenges for rare disease diagnosis. In Genomic Answers for Kids program we apply the joint  interpretation of patient genome sequence with genomic endophenotypes to expand the clinically actionable genome among pediatric cases of suspected","Not Applicable","Genetic Diseases, Inborn","Prospective Longitudinal Cohort","Not Provided","Not Provided","5 phenotype datasets, 18 variables, 11422 subjects, 28498 samples","","NHGRI","DS-PEDD-IRB --- Disease-Specific (Pediatric Disease, IRB)","2024-06-03","2021-02-01","Chromosome Disorders; Family Health; Genetic Diseases, X-Linked; Genetic Diseases, Y-Linked; Anomaly of chromosome; Chromosomal Disorder",""
"phs003452.v1.p1","Phase 2 Study of Pembrolizumab in Combination with Gemcitabine and    Cisplatin as Neoadjuvant Therapy","The purpose of the clinical trial (NCT02690558) is to evaluate whether adding pembrolizumab (Keytruda) to the combination of gemcitabine and cisplatin will improve shrinkage of the tumor before having a  cystectomy, for people with muscle-invasive bladder cancer (MIBC). Patients from Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and","Not Applicable","Urinary Bladder Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 16 variables, 193 samples sequenced, 37 subjects, 193 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2024-05-30","2024-05-30","Bladder Cancer; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder; Cancer, Urinary Bladder","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002576.v1.p1","Longitudinal Immune Dynamics of Mild COVID-19 Define Signatures of    Recovery and Persistence","SARS-CoV-2 has infected over 160 million and caused more than 3 million deaths to date. Most individuals ( 80%) have mild symptoms and recover in the outpatient setting, but detailed  studies of immune responses have focused primarily on moderate to severe COVID-19. We deeply profiled the longitudinal immune response in individuals","Not Applicable","Immune System","Prospective Longitudinal Cohort","Not Provided","ATAC-seq, OTHER, RNA-Seq","4 phenotype datasets, 14 variables, 135 samples sequenced, 52 subjects, 203 samples","","NIAID","HMB --- Health/Medical/Biomedical","2024-05-30","2024-05-30","Not Provided",""
"phs001373.v3.p2","Brain Cell Type-Specific Enhancer-Promoter Connectivity Maps and Disease    Risk Association","These studies map the epigenetic landscape of microglia, neurons, astrocytes and oligodendrocytes. The initial study compared acutely isolated microglia to cultured microglia from the same donors, to identify changes that  occur when microglia are removed from the brain microenvironment. In collaboration with the Rady Children's Hospital, we obtained brain tissue","Not Applicable","Epilepsy","Case Set","Not Provided","ATAC-seq, ChIP-Seq, OTHER, RNA-Seq","4 phenotype datasets, 23 variables, 108 samples sequenced, 89 subjects, 108 samples","","NINDS","HMB --- Health/Medical/Biomedical","2024-05-28","2017-09-15","Hypoxia-Ischemia, Brain; Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour",""
"phs003538.v1.p1","Light at Night and Prostate Cancer in the Health Professionals Follow-Up    Study","The Health Professionals Follow-Up Study (HPFS) is a prospective cohort study of men designed to evaluate hypotheses about men's health related to diet and lifestyle to the incidence of serious  illnesses, such as cancer, heart disease, and other vascular diseases. It consisted of 51,529 U.S. male health professionals who were 40-75 years old","Not Applicable","Light Pollution","Prospective Longitudinal Cohort","Not Provided","Not Provided","3 phenotype datasets, 142 variables, 49148 subjects","","NCI","HMB --- Health/Medical/Biomedical","2024-05-20","2024-05-20","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs002317.v2.p1","Genetic Underpinnings of Ethnic Disparities in Bone Toxicities Between    Hispanic and Non-Hispanic Children Treated for Acute Lymphoblastic    Leukemia","Acute lymphoblastic leukemia (ALL) is the most common malignancy among children and young adolescents. More than 90% of children are cured with a combination of multiple chemotherapeutic drugs. Some may  suffer from debilitating toxicities due to the cytotoxic drugs, necessitating pharmacogenetic research to search for genetic markers predictive of","Not Applicable","Fractures, Bone","Clinical Trial","HumanOmniExpress-24","SNP Genotypes (Array)","5 phenotype datasets, 33 variables, 2 molecular datasets, 516 subjects, 516 samples","European (395), African (4), East Asian (3), African American (22), Hispanic1 (39), Hispanic2 (29), Other Asian or Pacific Islander (5), South Asian (9), Other (10)","NCI","GRU-PUB --- General Research Use (PUB), DS-LEUKLYM --- Disease-Specific (Leukemia and Lymphoblastic Lymphoma)","2024-05-20","2024-05-20","Osteonecrosis; Bone Fracture; Bone Fractures; Bone, Broken; Bones, Broken; Broken Bone",""
"phs001564.v4.p1","Structure and Diversity of Urinary Cell-Free DNA Informative of    Host-Pathogen Interactions in Human Urinary Tract Infection","The risk of acquiring urinary tract infection (UTI) is very high for patients who have received kidney transplants; nearly half will develop bacteriuria and an eighth viruria via BK polyomavirus  in the first three years following transplantation. Current methodology for diagnosing viral and bacterial infections, while well practiced, is often","Not Applicable","Bacteriuria","Methods","Not Provided","Bisulfite-Seq, WGS","4 phenotype datasets, 30 variables, 603 samples sequenced, 308 subjects, 603 samples","","NIAID","GRU-IRB-PUB-COL --- General Research Use (IRB, PUB, COL)","2024-05-20","2018-06-22","COVID-19; Chorioamnionitis; Inflammatory Bowel Disease; Peritonitis; Sepsis; Tuberculosis",""
"phs001052.v3.p1","Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children    and Adolescent Young Adults with Relapsed and Refractory Cancer: A    Report from the Center for Cancer Research","The Center for Cancer Research (CCR), of the intramural NCI undertook a multidimensional clinical genomics study of children and adolescent young adults with relapsed and refractory cancers who were enrolled  on other therapeutic trials to determine the feasibility of a genome guided precision therapy protocol in these patients. Note: NCIPM001blood - This","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, Targeted-Capture, WXS","4 phenotype datasets, 15 variables, 179 samples sequenced, 83 subjects, 180 samples","","NCI","GRU --- General Research Use","2024-05-17","2019-10-07","Carcinoma, Transitional Cell; Desmoplastic Small Round Cell Tumor; Neuroendocrine Tumors; Rhabdoid Tumor; Sarcoma; Sarcoma, Ewing","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003567.v1.p1","Association Between Telomere Length and Falciparum Malaria Endemicity in    Sub-Saharan Africans","The goal of this study was to identify the genetic and environmental drivers of telomere length variation in an ethnically diverse African cohort. It comprises 1,818 participants from Cameroon, Tanzania,  Ethiopia, and Botswana. For each participant, leukocyte telomere length was measured using the Southern blotting of the terminal restriction fragment","Not Applicable","Telomere","Cross-Sectional","HumanOmni5.4, H3Africa_Array","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 analyses, 1 molecular datasets, 1818 subjects, 1818 samples","","NIGMS","GRU-PUB-COL-NPU --- General Research Use (PUB, COL, NPU)","2024-05-16","2024-05-16","Not Provided",""
"phs003542.v1.p1","Heart Failure Network: Functional Impact of GLP-1 for Heart Failure    Treatment (HFN FIGHT-BioLINCC)","Objectives To test whether therapy with a GLP-1 agonist improves clinical stability following hospitalization for acute heart failure. Background Heart failure was the leading cause of hospitalization in the United  States with more than 4 million admissions per year from 2003&#x02013;2009. Abnormal cardiac metabolism contributes to the pathophysiology of","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 300 subjects, 300 samples","","NHLBI","GRU --- General Research Use","2024-05-16","2024-05-16","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003607.v1.p1","Type I Interferon Exacerbates Mycobacterium Tuberculosis Induced Human    Macrophage Death","In this study, we tested whether type I interferons (IFN-I), namely IFN-alpha and IFN-beta, may promote Mycobacterium tuberculosis (Mtb) pathogenesis by exacerbating cell death of human monocyte-derived macrophages (MDM) infected  with Mtb. We differentiated the MDM under two different published methods (see Document Method.pdf for Table 1 of Methods). To determine if MDM","Not Applicable","Mycobacterium tuberculosis","Collection","Not Provided","RNA-Seq","3 phenotype datasets, 10 variables, 2 documents, 28 samples sequenced, 3 subjects, 28 samples","","NIAID","HMB-IRB --- Health/Medical/Biomedical (IRB)","2024-05-15","2024-05-15","Not Provided",""
"phs003307.v1.p1","Global Endometrial DNA Methylation Analysis Reveals Insights into mQTL    Regulation and Associated Endometriosis Disease Risk and Endometrial    Function","Endometriosis is a common gynecological disorder affecting 11% of reproductive aged women and is a leading cause of pain and infertility. We investigated global DNA methylation (DNAm) profiles in endometrium  associated with endometriosis, menstruation, and genetic variation. Endometrial samples were collected from 984 patients with confirmed endometriosis","Not Applicable","Endometriosis","Case-Control","Axiom_PMRA","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 953 subjects, 953 samples","European (682), African (6), East Asian (52), African American (40), Hispanic1 (15), Hispanic2 (47), Other Asian or Pacific Islander (32), South Asian (47), Other (32)","NICHD","DS-EMS --- Disease-Specific (Endometriosis)","2024-05-15","2024-05-15","Not Provided",""
"phs003550.v1.p1","The Genetics of Food Cue Reactivity in Children","This study aimed to investigate genetic factors related to appetite, eating in the absence of hunger and brain reward response to food cues in a convenience sample of pre-adolescent children  taken through two studies (A and B). The study involved genome-wide genotyping using the Illumina Global Screening Array. The study found an obesity","Not Applicable","Pediatric Obesity","Clinical Trial","Global_Screening_Array-24","SNP Genotypes (Array)","5 phenotype datasets, 181 variables, 6 documents, 1 molecular datasets, 308 subjects, 315 samples","European (276), East Asian (1), African American (4), Hispanic1 (4), Hispanic2 (6), Other Asian or Pacific Islander (11), South Asian (4), Other (2)","NICHD","DS-OBS-IRB-PUB-COL-NPU --- Disease-Specific (Obesity, IRB, PUB, COL, NPU)","2024-05-14","2024-05-14","Child Obesity; Childhood Obesity; Childhood Onset Obesity; Childhood obesity BMI 95-100 percentile; Obesity in Childhood; Obesity, Child",""
"phs003501.v1.p1","Systems Analysis of Single-Cell Heterogeneity Underlying Glioma Drug    Resistance","This study characterizes the transcriptional regulatory mechanisms that drive responses of two patient-derived glioblastoma multiforme (GBM) stem-like cells (PD-GSCs) that have distinct phenotypes - one sensitive and another resistant to  the drug pitavastatin. This study investigates the differing mechanisms driving drug response in the two PD-GSCs at the single-cell level, and","Not Applicable","Glioma","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 22 variables, 29 samples sequenced, 2 subjects, 29 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2024-05-14","2024-05-14","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs002199.v1.p1","Changes in Oral and Gut Microbiota and Incidence and Severity of    Patient-Reported Symptoms in Pre- and Post-Kidney Transplant Patients","This novel prospective cohort explores the relationships between oral and fecal microbiome features (alpha and beta diversity, differential relative abundances of bacterial taxa, and functional genes) and the incidence and  severity of psychoneurological symptoms (e.g., pain, fatigue, depression, anxiety, and sleep disturbance) before and after patients receive a kidney","Not Applicable","Microbiota","Prospective Longitudinal Cohort","Not Provided","WGS","8 phenotype datasets, 297 variables, 7 documents, 204 samples sequenced, 35 subjects, 204 samples","","NINR","GRU --- General Research Use","2024-05-14","2024-05-14","Anxiety; Depression; Fatigue; Pain; Angst; Anxiety disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003586.v1.p1","Luminal Androgen Receptor-Enriched Triple Negative Breast Cancer","This is a study to determine the efficacy of androgen receptor (AR) inhibitors in LAR (luminal androgen receptor)-enriched triple-negative breast cancer (TNBC) in the neoadjuvant setting. Twenty-four patients were treated  with neoadjuvant AR inhibitor enzalutamide and paclitaxel for 12 weeks. Whole exome sequencing and RNA-sequencing was performed prior to treatment.","Not Applicable","Breast Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 15 variables, 4 samples sequenced, 2 subjects, 4 samples","","NCI","GRU --- General Research Use","2024-05-13","2024-05-13","Triple Negative Breast Neoplasms; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors",""
"phs003564.v1.p1","Nasal MicroRNA during Bronchiolitis and Age 6y Asthma: MARC-35 Cohort","We analyzed data from the 35th Multicenter Airway Research Collaboration (MARC-35) study to examine the relationship between nasal airway microRNAs (miRNAs) and the risk of developing childhood asthma. MARC-35 is  a multicenter prospective cohort study which enrolled infants (age 1 year) hospitalized for bronchiolitis from 17 sites across 14 US states during","Not Applicable","Asthma","Prospective Longitudinal Cohort","Not Provided","miRNA-Seq","4 phenotype datasets, 15 variables, 575 samples sequenced, 575 subjects, 575 samples","","NIAID","DS-ASTHMA-RD --- Disease-Specific (Asthma, RD)","2024-05-13","2024-05-13","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs003570.v1.p1","Detecting and Subtyping Lung Cancer Through Analysis of Circulating Tumor    DNA","Small cell lung cancer (SCLC) is among the most aggressive tumors with poor clinical outcomes. Tumors are rarely resected, which is a major barrier to molecular profiling of tumor tissue;  therefore, non-invasive approaches using circulating tumor DNA (ctDNA) from liquid biopsies are needed to help advance research and clinical care for","Not Applicable","Lung Neoplasms","Case-Control","Not Provided","Targeted-Capture, WGS","4 phenotype datasets, 15 variables, 348 samples sequenced, 143 subjects, 348 samples","","NCI","GRU --- General Research Use","2024-05-10","2024-05-10","Carcinoma, Neuroendocrine; Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002288.v1.p1","Analysis of Epigenomes and Genome Topology in Colorectal Cancer","When diagnosing cancer, pathologists use nuclear morphology as a hallmark of tumor cells, but the topological changes linked to alterations in the shape of the nucleus were poorly understood. To  uncover the molecular changes that occur in the 3D structure of cancer genomes, we integrated topological maps for colon tumors and normal colon","Not Applicable","Computational Biology","Case Set","Not Provided","Bisulfite-Seq, ChIP-Seq, Hi-C, OTHER, RNA-Seq, WGS","5 phenotype datasets, 21 variables, 99 samples sequenced, 28 subjects, 99 samples","","NCI","DS-GRR-MDS --- Disease-Specific (Gastroenterology related research, MDS)","2024-05-10","2024-05-10","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs003178.v1.p1","Combined PDCD1, BRAF and MAP2K7 Inhibition in BRAFV600E Colorectal    Cancer: A Phase 2 Trial","In this study, we evaluated the clinical efficacy of combined PDCD1, BRAF, and MAP2K7 inhibition in metastatic BRAFV600E Colorectal Cancer (CRC) patients (NCT03668431). We performed bulk whole exome sequencing (WXS)  and bulk RNA sequencing (RNA-Seq) in 35 pre-treatment tumor biopsies and matching germline for tumor mutational burden (TMB), BM1/BM2 transcriptional","Not Applicable","Colorectal Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 28 variables, 159 samples sequenced, 34 subjects, 159 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2024-05-09","2024-05-09","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs003589.v1.p1","Heart Failure Network - Renal Optimization Strategies Evaluation in Acute    Heart Failure and Reliable Evaluation of Dyspnea (HFN ROSE-BioLINCC)","Objectives To test the two independent hypotheses that when compared to placebo, addition of: (1) low dose dopamine; or (2) low dose nesiritide to diuretic therapy will enhance decongestion and  preserve renal function in patients with acute heart failure and renal dysfunction. Background A primary treatment goal in acute heart failure is to","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 360 subjects, 360 samples","","NHLBI","GRU --- General Research Use","2024-05-07","2024-05-07","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003551.v1.p1","Action to Control Cardiovascular Risk in Diabetes (ACCORD-BioLINCC)","Related Studies Whole genome and whole exome data is available on a subset of participants with phs001411. ECG signal data is available with phs003562. Objectives The purpose of this study  was to determine if intensive glycemic control, multiple lipid management and intensive blood pressure control could prevent major cardiovascular","Not Applicable","Diabetes Mellitus","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 10251 subjects, 10251 samples","","NHLBI","GRU --- General Research Use","2024-05-07","2024-05-07","Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Hypertension; Atherogeneses; Atherogenesis",""
"phs003511.v1.p1","Direct Transposition of Native DNA for Sensitive Multimodal    Single-Molecule Sequencing","STUDY GOALS: This study focuses on elucidating the epigenetic modulators of prostate cancer progression and metastasis at high resolution. This is achieved by applying a novel, high-sensitivity single molecule sequencing  assay that measures chromatin state on single DNA molecules (SMRT-Tag) to matched primary and metastatic tumor samples from the same patient. Samples","Not Applicable","Prostatic Neoplasms","Methods","Not Provided","OTHER","4 phenotype datasets, 23 variables, 15 samples sequenced, 1 subjects, 15 samples","","NHGRI","GRU --- General Research Use","2024-05-07","2024-05-07","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003604.v1.p1","HiDEF-seq Single-Molecule Sequencing of Single-Strand Mismatches and    Damage","Our study sought to resolve, with single-molecule resolution, the mismatches and damage events that precede DNA mutations. Using a novel single-molecule, long-read sequencing method (HiDEF-seq) we detected base substitutions when  present in either one or both DNA strands. We compared the fidelity for dsDNA mutations to that of the same samples profiled by NanoSeq duplex","Not Applicable","Neoplastic Syndromes, Hereditary","Case Set","Not Provided","WGS","3 phenotype datasets, 11 variables, 80 samples sequenced, 54 subjects, 80 samples","","NICHD","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-HCR_CA-IRB-NPU --- Disease-Specific (Hereditary colorectal cancer, IRB, NPU)","2024-05-06","2024-05-06","Cancer Syndrome, Hereditary; Cancer Syndromes, Hereditary; Familial Neoplastic Syndrome; Familial Tumor Syndrome; Germline Neoplastic Syndrome; Hereditary Cancer Syndrome",""
"phs000933.v4.p1","Genomic Profiling of Melanoma","This study reports on genomic profiling [whole-exome sequencing (WXS), bulk RNA sequencing (RNA-seq), and/or single-cell RNA sequencing (scRNA-seq)] of patient-derived melanoma samples and matched normal samples. The goal is to  elucidate the genetic and cellular basis of sun-exposed and sun-shielded melanomas and to relate these findings to survival and regional metastasis.","Not Applicable","Melanoma","Case Set","other","RNA-Seq, SNV (.MAF), SNV Aggregate (.MAF), WXS","4 phenotype datasets, 14 variables, 3 molecular datasets, 999 samples sequenced, 403 subjects, 999 samples","","NCI","DS-M-MDS-GSO --- Disease-Specific (Melanoma, MDS, GSO)","2024-05-06","2022-01-27","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs003557.v1.p1","Heart Failure Network Oral Iron Repletion Effects on Oxygen Uptake in    Heart Failure (HFN IRONOUT-BioLINCC)","Objectives To test the hypothesis that, compared to placebo, oral iron repletion in heart failure patients with iron deficiency improves exercise capacity after 16 weeks of therapy. Background Iron deficiency  affects approximately one half of patients with symptomatic heart failure. The presence of iron deficiency in patients with heart failure is","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 225 subjects, 225 samples","","NHLBI","GRU --- General Research Use","2024-05-03","2024-05-03","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac",""
"phs003005.v2.p1","Somatic Mutations in Single Human Neurons from Patients with Congenital    Neurodegenerative Diseases","It has been hypothesized that accumulating DNA lesions in neurons contribute to aging and neurodegeneration. Despite their pathophysiological importance, the DNA lesions have not been systematically examined with effective methods.  In this study, we developed a computational method for detecting genomic deletions in single-cell whole-genome sequencing (scWGS) data, and analyzed","Not Applicable","Ataxia Telangiectasia","Case-Control","Not Provided","RNA-Seq, WGA, WGS","4 phenotype datasets, 16 variables, 40 samples sequenced, 16 subjects, 40 samples","","NIA","DS-NEURO --- Disease-Specific (Neurological Diseases)","2024-05-02","2022-08-24","AT; AT, COMPLEMENTATION GROUP A; AT, COMPLEMENTATION GROUP C; AT, COMPLEMENTATION GROUP D; AT, COMPLEMENTATION GROUP E; AT1",""
"phs001657.v3.p1","Functional Genomic Landscape of Acute Myeloid Leukemia","The implementation of targeted therapies for acute myeloid leukemia has been challenged by complex mutational patterns within and across patients as well as a dearth of pharmacologic agents for most  mutational events. The initial findings from the Beat AML program were from a cohort of 672 tumor specimens collected from 562 patients. Additional","Not Applicable","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","3 phenotype datasets, 9 variables, 72 samples sequenced, 829 subjects, 2161 samples","","NCI","DS-LEU --- Disease-Specific (Leukemia)","2024-05-02","2019-08-26","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs002927.v1.p1","Blood Gene Signatures Associated with Stiffness After TKA","In this study, we used PAXgene Blood RNA tubes collected from patients undergoing total knee arthroplasty (TKA) for osteoarthritis. Samples were collected with IRB approval and patient consent. We identified  8 patients with knee stiffness after TKA (cases) and 10 patients without post-TKA stiffness (controls). We isolated RNA from cases and controls for","Not Applicable","Arthroplasty, Replacement, Knee","Case-Control","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 36 samples sequenced, 18 subjects, 36 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2024-04-30","2024-04-30","Not Provided",""
"phs001446.v3.p2","NHLBI TOPMed: Severe Asthma Research Program (SARP)","The overall goal of the Severe Asthma Research Program (SARP) is to identify and characterize subjects with severe asthma to understand pathophysiologic mechanisms in severe asthma. Subjects with mild and  moderate asthma were recruited for comparison but the program was enriched for subjects with severe asthma from multiple centers. Subjects were","Not Applicable","Asthma","Case Set","WGS_markerset_grc38, SV_STR_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 42 variables, 2 documents, 2 molecular datasets, 1890 samples sequenced, 1882 subjects, 1890 samples","European (1042), African (13), East Asian (19), African American (665), Hispanic1 (37), Hispanic2 (28), Other Asian or Pacific Islander (8), South Asian (19), Other (20)","NHLBI","GRU --- General Research Use, DS-AAI-PUB --- Disease-Specific (Asthma, Allergy and Inflammation, PUB)","2024-04-29","2024-04-29","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs003271.v1.p1","A Scalable, GMP-Compatible, Autologous Organotypic Cell Therapy for    Dystrophic Epidermolysis Bullosa","Gene editing in induced pluripotent stem (iPS) cells has been hailed for enabling new cell therapies for various monogenetic diseases including dystrophic epidermolysis bullosa (DEB). However, manufacturing, efficacy, and safety  roadblocks have limited the development of genetically corrected, autologous iPS cell-based therapies. Dystrophic Epidermolysis Bullosa Cell Therapy","Not Applicable","Induced Pluripotent Stem Cells","Case-Control","RNAseq_gene_transcripts, WGS_markerset_grc38","AMPLICON, OTHER, RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), WGS","4 phenotype datasets, 12 variables, 1 molecular datasets, 25 samples sequenced, 8 subjects, 25 samples","","NIAMS","GRU --- General Research Use","2024-04-26","2024-04-26","Epidermolysis Bullosa Dystrophica; Cockayne Touraine Disease; Cockayne Touraine Type Epidermolysis Bullosa; Cockayne Touraine epidermolysis bullosa; Cockayne-Touraine Type Epidermolysis Bullosa; EBDCT","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003351.v1.p1","Single Cell Analysis of Psoriasis Resolution following IL-23 Blockade","Full-thickness skin biopsies were obtained from five individuals with severe psoriasis who were receiving risankizumab treatment. Skin biopsies were taken from lesional and non-lesional sites at baseline, and from lesional  sites at day 3 and day 14 of therapy. All biopsies were taken from site-matched areas on the lower back/buttocks. Single-cell RNA sequencing was","Not Applicable","Psoriasis","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 20 samples sequenced, 5 subjects, 20 samples","","NIAMS","GRU --- General Research Use","2024-04-25","2024-04-25","Acropustulosis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis; Palmoplantar Pustulosis",""
"phs002431.v1.p1","Childhood Cancer Data Initiative (CCDI): Enhancement of Data Sharing in    Pediatric, Adolescent and Young Adult Cancers","NCI's Childhood Cancer Data Initiative (CCDI) is building a community centered around childhood cancer care and research data. Through enhanced data sharing, we can improve our understanding of cancer biology  to improve preventive measures, treatment, quality of life, and survivorship, as well as ensure that researchers learn from every child with cancer.","Not Applicable","Neoplasms","Clinical Genetic Testing","Not Provided","Not Provided","2 phenotype datasets, 7 variables, 611 subjects, 1448 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-04-23","2024-04-23","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002909.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R):    Subpopulations and Intermediate Outcome Measures in COPD Study    (SPIROMICS)","Cohort Description The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) is a multi-center, observational, longitudinal case-control study designed to guide future development of therapies for COPD. SPIROMICS has  recruited 2,983 COPD cases and controls, 40-80 years old with 20+ pack-years of smoking at 12 US sites in 2010&#x02013;2015. See dbGaP study","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 1579 subjects, 1579 samples","","NHLBI","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU), DS-COPD --- Disease-Specific (Chronic Obstructive Pulmonary Disease), DS-COPD-NPU --- Disease-Specific (Chronic Obstructive Pulmonary Disease, NPU), GRU-COL --- General Research Use (COL), GRU-COL-NPU --- General Research Use (COL, NPU), DS-COPD-COL --- Disease-Specific (Chronic Obstructive Pulmonary Disease, COL), DS-COPD-COL-NPU --- Disease-Specific (Chronic Obstructive Pulmonary Disease, COL, NPU)","2024-04-22","2024-04-22","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs003587.v1.p1","Laser Capture Microscopy (LCM)-RNAseq for Topological Mapping of Synovial    Pathology during Rheumatoid Arthritis","Synovial tissue from the hip or knee was collected from rheumatoid arthritis (RA) and osteoarthritis (OA) patients at the time of joint replacement surgery. Samples were analyzed using laser capture  microdissection (LCM) followed by RNA-seq to evaluate the transcriptome in distinct synovial compartments. Results indicated that synovial","Not Applicable","Arthritis, Rheumatoid","Case-Control","Not Provided","RNA-Seq","3 phenotype datasets, 12 variables, 41 samples sequenced, 13 subjects, 41 samples","","NIAMS","HMB-PUB --- Health/Medical/Biomedical (PUB)","2024-04-17","2024-04-17","",""
"phs002677.v1.p1","Childhood Cancer Data Initiative (CCDI): Integrating Longitudinal    Clinical, Sociodemographic and Genomic Data into the NCCR","The goal of this study is to contribute clinical and genomic data from a large institutional cohort of pediatric cancer patients who had tumor genomic profiling between 2013 and 2019  at Dana-Farber/Boston Children's Hospital Cancer and Blood Disorders Center. Clinical data include demographics, diagnosis (classified according to","Not Applicable","Pediatrics","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 835 subjects, 835 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-04-16","2024-04-16","Rare Diseases; Sarcoma, Ewing; Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm",""
"phs001472.v3.p2","NHLBI TOPMed: Evaluation of COPD Longitudinally to Identify Predictive    Surrogate Endpoints (ECLIPSE)","ECLIPSE was a longitudinal observational study of 2164 COPD subjects and a smaller number of smoking controls (337) and nonsmoking controls (245) followed regularly for three years, with three chest  CT scans (at baseline, one year, and three years) (Vestbo et al., 2008, PMID: 18216052). Subjects were enrolled at clinical centers in the US,","Not Applicable","Pulmonary Disease, Chronic Obstructive","Case-Control","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","3 phenotype datasets, 14 variables, 2 documents, 2 molecular datasets, 2355 samples sequenced, 2331 subjects, 2355 samples","European (2233), African (1), East Asian (3), African American (40), Hispanic1 (4), Hispanic2 (10), Other Asian or Pacific Islander (5), South Asian (2), Other (11)","NHLBI","DS-CS-MDS-RD --- Disease-Specific (COPD and Smoking, MDS, RD)","2024-04-16","2024-04-16","Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs003522.v1.p1","Epigenetic Damage in Women Living in LA Food-Desert Zip Codes","This study investigated the impact of insulin resistance on chromatin acetylation and inflammation. Blood samples were obtained from women consented to City of Hope Institutional Review Board (IRB)-approved COH Protocol#/Ref#:18306/158149.  Women provided demographic information and completed a survey assessing diet, housing and medical history. BMI was obtained from medical records.","Not Applicable","Insulin Resistance","Case Set","Not Provided","ChIP-Seq","4 phenotype datasets, 13 variables, 30 samples sequenced, 30 subjects, 30 samples","","NCI","GRU --- General Research Use","2024-04-15","2024-04-15","",""
"phs002503.v1.p1","GWA Study of Oral Cavity, Pharynx and Larynx Cancers in European, and    North and South American Populations - CIDR","There is striking geographical variation in head and neck cancer (HNC) incidence globally. Some of the highest incidence rates have been observed in Southern and Eastern Europe and South America.  The goal of this project is to assess susceptibility loci across and within ancestral backgrounds, using the All of Us array. Ten studies have come","Not Applicable","Head and Neck Neoplasms","Case-Control","Global_Diversity_Array, imputation_panel","SNP/CNV (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 35 variables, 2 molecular datasets, 10412 subjects, 10528 samples","","NIDCR","DS-CA --- Disease-Specific (Cancer), DS-HNC --- Disease-Specific (Head and Neck Cancer), HMB --- Health/Medical/Biomedical, HMB-IRB-NPU-GSO --- Health/Medical/Biomedical (IRB, NPU, GSO)","2024-04-15","2024-04-15","Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinoma, Squamous Cell; Carcinomas, Epidermoid; Carcinomas, Planocellular",""
"phs001703.v5.p1","Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression","While many genetic variants have been associated with risk for human diseases, how these variants affect gene expression in various cell types remains largely unknown. To address this gap, the  DICE [Database of Immune Cell Expression, Expression quantitative trait loci (eQTLs) and Epigenomics] project was established. Considering all human","Not Applicable","Gene Expression","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37, MEGA_Consortium_Array, ChIP_DNAseq_probe_set, RNAseq_gene_transcripts, ATAC_DNAseq_probe_set","ATAC-seq, SNP Genotypes (Array), ChIP-Seq, ChIP-seq Read Counts (NGS), SNP Genotypes (imputed), OTHER, RNA-Seq, Chromatin (NGS), RNA Seq (NGS), RNA Seq (NGS), scRNA_Seq (NGS)","4 phenotype datasets, 17 variables, 4 molecular datasets, 2000 samples sequenced, 100 subjects, 2091 samples","European (40), East Asian (18), African American (5), Hispanic1 (5), Hispanic2 (14), Other Asian or Pacific Islander (2), South Asian (4), Other (3)","NIAID","GRU --- General Research Use","2024-04-15","2022-02-25","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001963.v3.p1","DEMENTIA-SEQ: WGS in Lewy Body Dementia and Frontotemporal Dementia","Lewy body dementia, amyotrophic lateral sclerosis/frontotemporal dementia, and multiple system atrophy are age-related, neurodegenerative syndromes that are poorly understood. Delineating the genetic risk that is driving the pathophysiology of these  neurological diseases is fundamental for understanding disease mechanisms and for developing disease-modifying treatments. In version 1 of the","Not Applicable","Lewy Body Disease","Case-Control","WGS_markerset_grc38, MethylationEPIC, imputation_panel","Methylation (CpG), SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 20 variables, 1 documents, 3 molecular datasets, 7590 samples sequenced, 8040 subjects, 8040 samples","","NIA","GRU --- General Research Use","2024-04-12","2024-04-12","Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Multiple System Atrophy; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); ALS Compute (phs003184.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs003417.v2.p1","The Chromatin Landscape of Pathogenic Transcriptional Cell States in    Rheumatoid Arthritis","In this study, we characterized 24 rheumatoid arthritis (RA) synovial tissue chromatin classes (i.e., cell states defined by chromatin accessibility) across 5 cell types (T, B/plasma, myeloid, stromal, and endothelial).  We also investigated the transcription factors that may regulate these chromatin classes, their connections to transcriptional cell states in a","Not Applicable","Arthritis, Rheumatoid","Case Set","Not Provided","ATAC-seq, RNA-Seq","4 phenotype datasets, 19 variables, 31 samples sequenced, 35 subjects, 31 samples","","NHGRI","DS-ARTH --- Disease-Specific (Arthritis), HMB --- Health/Medical/Biomedical","2024-04-11","2024-02-23","Osteoarthritis; Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides; Degenerative Arthritis",""
"phs001587.v3.p1","Characterization of Prostate Cancer Organoids","Using models from the LuCaP series as well as those generated at the National Cancer Institute, we have established organoids for in vitro mechanistic testing, including drug screening and genetic  manipulation. The major findings from these continuing studies is the durability of organoids for maintaining complex subpopulation and intratumoral","Not Applicable","Prostatic Neoplasms","Case Set","HumanOmniExpress-24","ATAC-seq, SNP Genotypes (Array), ChIP-Seq, RNA-Seq, WGS, WXS","5 phenotype datasets, 17 variables, 1 molecular datasets, 153 samples sequenced, 34 subjects, 165 samples","","NCI","GRU --- General Research Use","2024-04-09","2018-06-25","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003102.v1.p1","Multivalent State Transitions Shape the Intratumoral Composition of Small    Cell Lung Carcinoma","Small cell lung carcinoma (SCLC) is an aggressive, tobacco-associated tumor characterized by rapid growth, early metastases, and initial response followed by almost invariable resistance to chemotherapy. Studies to date have  not resolved the extent that diverse transcriptional programs drive SCLC and contribute to its lethality. We combined patient-derived xenograft (PDX)","Not Applicable","Small Cell Lung Carcinoma","Xenograft","Not Provided","RNA-Seq","5 phenotype datasets, 20 variables, 70 samples sequenced, 64 subjects, 70 samples","","NCI","GRU-IRB --- General Research Use (IRB)","2024-04-03","2024-04-03","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL",""
"phs002175.v1.p1","The NCAA-DoD Concussion Assessment, Research, and Education (CARE)    Consortium","Study Description: Established in 2014, the U.S. Department of Defense (DoD) and the National Collegiate Athletic Association (NCAA) funded the Concussion Assessment, Research and Education (CARE) Consortium to inform science,  clinical care and public policy related to concussion and repetitive head impact exposure (HIE) in U.S. Military Service Academy (MSA) cadets and","Not Applicable","Brain Concussion","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","2 phenotype datasets, 5 variables, 5206 samples sequenced, 551 subjects, 5206 samples","","NINDS","GRU --- General Research Use","2024-04-02","2024-04-02","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001585.v4.p2","Identification of ALS Associated Genes Using Whole Genome Sequencing","The overall aim of this study is to discover of novel genetic elements associated with amyotrophic lateral sclerosis (ALS). Towards this goal, we have performed exome and whole genome sequencing  for over 2000 samples. This data will be process and harmonized to yield high quality variant calling. These variants will be combined with control","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","Not Provided","WGS, WXS","5 phenotype datasets, 23 variables, 637 samples sequenced, 2125 subjects, 2168 samples","","NINDS","GRU --- General Research Use","2024-04-02","2020-11-19","Lou Gehrig Disease; Motor Neuron Disease; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); ALS Compute (phs003184.v1.p1)"
"phs003574.v1.p1","Adult Eosinophilic Esophagitis Registry Atlas","Eosinophilic esophagitis (EoE) arises in the setting of type 2 cytokine-driven inflammation, is characterized by the infiltration of eosinophils in the esophageal mucosa, and is associated with dysphagia and fibrostenotic  complications. Disease development and progression involve complex interactions between epithelial cells, stromal cells and immune cells. Indeed,","Not Applicable","Eosinophilic Esophagitis","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 16 variables, 37 samples sequenced, 22 subjects, 37 samples","","NIDDK","DS-EE-MDS --- Disease-Specific (Eosinophilic Esophagitis, MDS)","2024-04-01","2024-04-01","Chronic Esophagitides, Eosinophilic; Chronic Esophagitis, Eosinophilic; EE; ESOPHAGITIS, EOSINOPHILIC; EoE; Eosinophilic Chronic Esophagitides",""
"phs003356.v1.p1","ChiLDReN/BA: Genetic Studies of Biliary Atresia in the Childhood Liver    Disease Research Network","Biliary atresia (BA) is a progressive necroinflammatory process initially involving the extra-hepatic biliary tree. Little is known about the factors that cause BA or the factors that influence disease progression.  A variety of genetic, autoimmune, and environmental influences have been hypothesized to be important. Most studies to date have focused on the","Not Applicable","Biliary Atresia","Cross-Sectional","WGS_markerset_grc38","OTHER, SNP/CNV Genotypes (NGS)","5 phenotype datasets, 27 variables, 1 molecular datasets, 182 samples sequenced, 182 subjects, 182 samples","","NIDDK","GRU --- General Research Use, DS-CHILDLIVD-IRB-NPU --- Disease-Specific (Children's Liver Disease, IRB, NPU), DS-CHILDCHOLLIVD-IRB-NPU --- Disease-Specific (Children's Cholestatic Liver Disease, IRB, NPU), HMB --- Health/Medical/Biomedical, DS-LIVD --- Disease-Specific (Liver Disease), DS-BA --- Disease-Specific (Biliary Atresia), DS-LIVD-PUB-NPU --- Disease-Specific (Liver Disease, PUB, NPU), DS-LIVD-GSO --- Disease-Specific (Liver Disease, GSO), DS-NEONATLIVD --- Disease-Specific (Neonatal Liver Disease)","2024-03-29","2024-03-29","Familial Extrahepatic Biliary Atresia",""
"phs001285.v2.p1","Response and Resistance to ER-Directed Therapy in Metastatic Breast    Cancer","Despite the reduction in cancer recurrence and mortality provided by hormonal therapy, estrogen receptor positive (ER+) metastatic breast cancer (MBC) remains the most common cause of breast cancer death, resulting  in more than 20,000 deaths in the U.S each year. Although several therapeutic options exist to target the estrogen receptor, resistance to these","Not Applicable","Breast Neoplasms","Case Set","other","RNA-Seq, SNV (.MAF), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 304 samples sequenced, 107 subjects, 304 samples","","NHGRI","DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS), HMB --- Health/Medical/Biomedical","2024-03-29","2023-01-26","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003532.v1.p1","Cellular Heterogeneity in Early Human Development at Stage CS16","In this study, we applied 10x Genomics Multiome assays for single-nucleus profiling of gene expression and chromatin accessibility simultaneously to a Carnegie stage 16 (37-42 days) specimen. These data can  be used to identify and characterize diverse human cell types and annotate them with respect to marker genes, expression, and regulatory modules.","Not Applicable","Human Development","Collection","Not Provided","ATAC-seq, ssRNA-seq","3 phenotype datasets, 8 variables, 10 samples sequenced, 1 subjects, 10 samples","","NICHD","HMB --- Health/Medical/Biomedical","2024-03-28","2024-03-28","Not Provided",""
"phs003531.v1.p1","A Prospective Study of Lifestyle, the Gut Microbiome, and Diverticulitis","By leveraging a large-scale collection of stool specimens (Micro-N) within the Nurses' Health Study II, we performed shotgun metagenomic sequencing and untargeted metabolomics profiling among 121 case women with a  diagnosis of diverticulitis requiring antibiotics or hospitalization, with each matched to a control woman without diverticulitis during the same","Not Applicable","Diverticulitis","Metagenomics","","Metabolomics, WGS","4 phenotype datasets, 20 variables, 1 molecular datasets, 241 samples sequenced, 241 subjects, 241 samples","","NIDDK","HMB --- Health/Medical/Biomedical","2024-03-26","2024-03-26","Diverticulitides; digestive tract diverticulum inflammation; inflammation of digestive tract diverticulum",""
"phs003561.v1.p1","Spatial Transcriptomics Reveals Discrete Tumor Microenvironments and    Autocrine Loops Within Ovarian Cancer Subclones","Ovarian masses from patients with high grade serous ovarian carcinoma undergoing debulking surgery were subjected to spatial transcriptomics profiling using the 10x Genomics Visium (fresh frozen) platform. Copy number inference  using inferCNV predicted the presence of subclones with mutually exclusive copy number alterations (CNAs) in 5 of the 8 patient samples studied. In","Not Applicable","Carcinoma, Ovarian Epithelial","Tumor vs. Matched-Normal","Not Provided","WGS","4 phenotype datasets, 16 variables, 12 samples sequenced, 2 subjects, 13 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2024-03-25","2024-03-25","Cancer, Epithelial Ovarian; Cancer, Ovarian Epithelial; Carcinoma of Ovary; Carcinoma of the Ovary; Carcinoma, Epithelial Ovarian; Epithelial Cancer, Ovarian","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs003535.v1.p1","Integrating Genomic and Transcriptomic Data to Identify Breast Cancer    Susceptibility Genes","Genetic factors play an important role in the etiology of both sporadic and familial breast cancer. Since 2007, common genetic variants in 200 loci have been identified in genome-wide association  studies (GWAS) in relation to breast cancer risk. However, it is often difficult to translate GWAS findings to disease prevention and treatment since","Not Applicable","Breast Neoplasms","Collection","custom_markerset","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 14 variables, 1 molecular datasets, 150 samples sequenced, 150 subjects, 150 samples","","NCI","DS-BRCA-PUB-NPU-MDS --- Disease-Specific (Breast Cancer, PUB, NPU, MDS)","2024-03-22","2024-03-22","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003156.v1.p1","Developing Biomarkers Incorporating High Throughput RNA, DNA, Small RNA    Sequencing and Protein Expression in Inflammatory Bowel Disease Using    Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples","This study included pediatric patients with suspected inflammatory bowel disease (IBD) who underwent endoscopy between 2008 and 2012. This included 101 colonic tissue samples and 100 ileal tissue samples. Biopsies  were obtained at the time of diagnosis, and patients were followed for a mean of 6 years to record clinical characteristics. These included baseline","Not Applicable","Crohn Disease","Case-Control","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","5 phenotype datasets, 23 variables, 1 molecular datasets, 201 samples sequenced, 119 subjects, 201 samples","","NIDDK","GRU --- General Research Use","2024-03-22","2024-03-22","CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's disease of colon; Crohn's disease of large bowel","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002171.v1.p1","Serrated Colorectal Cancer: An Emerging Disease Subtype","This dataset represents two combined study populations. Serrated Colorectal Cancer: An Emerging Disease Subtype (called the Advanced Colorectal Cancer of Serrated Subtype Study or ACCESS Study) was a grant awarded  to investigate a newly-recognized, biologically-distinct subtype of colorectal cancer (CRC) called &#x0201c;serrated CRC.&#x0201d; The objective of","Not Applicable","Colorectal Neoplasms","Case Set","imputation_panel, custom_PCR_marker_set","SNP Genotypes (imputed), Short Tandem Repeats (PCR)","7 phenotype datasets, 371 variables, 2 molecular datasets, 1364 subjects, 1466 samples","European (1126), African (1), East Asian (27), African American (17), Hispanic1 (5), Hispanic2 (36), Other Asian or Pacific Islander (24), South Asian (5), Other (3)","NCI","GRU --- General Research Use, DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS)","2024-03-22","2024-03-22","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs003099.v1.p1","Integration of Clinical and Molecular Biomarkers for Melanoma Survival    (Berwick)","The long-term goal of the InterMEL Program Project: Integration of Clinical and Molecular Biomarkers for Melanoma Survival is to identify molecular and clinical factors that predict survival of melanoma patients.  Our overarching hypothesis is that we can identify factors in the primary melanoma tumor that will lead to more aggressive disease. Melanoma patients","Not Applicable","Biomarkers, Tumor","Case-Control","MethylationEPIC, custom_probe_set","Methylation (CpG), miRNA Expression (Array), Targeted-Capture","4 phenotype datasets, 33 variables, 2 molecular datasets, 569 samples sequenced, 697 subjects, 697 samples","","NCI","GRU --- General Research Use","2024-03-21","2024-03-21","Not Provided",""
"phs003541.v1.p1","Identification of Novel Therapeutic Targets for Calcific Aortic Valve    Stenosis Using Integrative Genomics","In order to identify novel therapeutic targets for calcific aortic valve stenosis, we have generated a large transcriptomic dataset from RNA sequencing of human aortic valve tissues from 500 individuals  undergoing aortic valve replacement or heart transplant at the Institut universitaire de cardiologie et de pneumologie de Qu&#x000e9;bec &#x02013;","Not Applicable","Aortic Valve Disease","Case Set","Not Provided","ssRNA-seq","4 phenotype datasets, 11 variables, 500 samples sequenced, 500 subjects, 500 samples","","NHLBI","DS-CVD-IRB-COL-NPU --- Disease-Specific (Cardiovascular Disease, IRB, COL, NPU)","2024-03-18","2024-03-18","Aortic Valve Stenosis; AOVD; AOVD1; AVD - Aortic valve disease; Aortic Heart Disease; Aortic Heart Diseases",""
"phs000206.v6.p3","Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer    Cohort Consortium and Pancreatic Cancer Case-Control Consortium    (PanScan)","Within the framework of the NCI-sponsored Cohort Consortium, investigators from 12 prospective epidemiologic cohorts formed the Pancreatic Cancer Cohort Consortium in 2006. This study, also known as ""PanScan"", is funded  by the National Cancer Institute (NCI) and involves conducting a genome-wide association study (GWAS) of common genetic variants to identify markers","Not Applicable","Pancreatic Neoplasms","Case-Control","Human610-Quad, HumanHap550, HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 documents, 3 analyses, 2 molecular datasets, 9437 subjects, 9702 samples","European (8770), African (5), East Asian (320), African American (161), Hispanic1 (33), Hispanic2 (92), Other Asian or Pacific Islander (31), South Asian (14), Other (11)","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods, DS-PACA-GSO --- Disease-Specific (Pancreatic Cancer, GSO), DS-PACA-IRB-COL-GSO --- Disease-Specific (Pancreatic Cancer, IRB, COL, GSO), GRU --- General Research Use, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO)","2024-03-18","2015-09-25","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003442.v1.p1","Early Family Prevention of Adolescent Alcohol, Drug Use, and    Psychopathology","The Early Steps Multisite Study is comprised of researchers from the University of Virginia, the University of Pittsburgh, Arizona State University, and Oregon Research Institute. This longitudinal study has been  funded by the National Institute on Drug Abuse at the National Institutes of Health since 2002. The Early Steps Multisite Study conducted a","Not Applicable","Drug Misuse","Interventional","custom_markerset","SNP Genotypes (Array)","5 phenotype datasets, 267 variables, 1 molecular datasets, 515 subjects, 515 samples","European (238), African (1), African American (178), Hispanic1 (32), Hispanic2 (49), Other Asian or Pacific Islander (1), Other (16)","NIDA","HMB-IRB-GSO --- Health/Medical/Biomedical (IRB, GSO)","2024-03-15","2024-03-15","Not Provided",""
"phs003562.v1.p1","Action to Control Cardiovascular Risk in Diabetes (ACCORD - Imaging)","Available Data Action to Control Cardiovascular Risk in Diabetes (ACCORD-Imaging), provides access to ECG signals data from the ACCORD clinical trial. The clinical phenotyping and outcomes data from the trial  are associated with ACCORD-BioLINCC, phs003551. Objectives The purpose of this study was to determine if intensive glycemic control, multiple lipid","Not Applicable","Diabetes Mellitus","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 10251 subjects, 10251 samples","","NHLBI","GRU --- General Research Use","2024-03-14","2024-03-14","Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Hypertension; Atherogeneses; Atherogenesis",""
"phs002694.v4.p1","COVID-19 ACTIV-4 ACUTE: A Multicenter, Adaptive, Randomized Controlled    Platform Trial of the Safety and Efficacy of Antithrombotic Strategies    in Hospitalized Adults with COVID-19 (ACTIV4A)","This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of adverse outcomes in COVID-19 positive inpatients. Inclusion Criteria In order to  be eligible to participate in this study, an individual must meet all of the following criteria: &#x02265; 18 years of age Hospitalized for COVID-19","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 3425 subjects, 4072 samples","","NHLBI","GRU --- General Research Use","2024-03-14","2022-02-17","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001437.v2.p1","Pediatric Preclinical Testing Consortium (PPTC)","The Pediatric Preclinical Testing Consortium (PPTC) is addressing the unmet need of streamlining the development of new therapies for childhood cancers. The PPTC seeks to develop robust biomarkers of anticancer  drug activity, and the majority of these are predicted to be genetic mutations that can be detected in tumor DNA and/or RNA. In order to design the","Not Applicable","Leukemia, Lymphoid","Xenograft","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 33 variables, 300 samples sequenced, 267 subjects, 301 samples","","NCI","GRU --- General Research Use","2024-03-14","2019-09-25","Neoplasms, Germ Cell and Embryonal; Sarcoma, Ewing; ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003497.v1.p1","Combinatorial Indexed 10x Genomics Single-Cell ATAC-seq on Human Cerebral    Cortex","Single-cell chromatin accessibility profiling (scATAC) using droplet fluidics (10x Genomics) is inherently limited in throughput due to the number of available indexed droplets. This study leverages single-cell combinatorial indexing workflows  with modified adapter designs to enable indexed tagmentation and superloading of pre-indexed nuclei into the 10x Genomics scATAC workflow, enabling a","Not Applicable","Chromatin Assembly and Disassembly","Methods","Not Provided","ATAC-seq","3 phenotype datasets, 11 variables, 1 samples sequenced, 1 subjects, 1 samples","","NIMH","HMB --- Health/Medical/Biomedical","2024-03-13","2024-03-13","Not Provided",""
"phs002834.v1.p1","Clinical and Molecular Features of Acquired Resistance to Immunotherapy    in Non-Small Cell Lung Cancer","PD-(L)1 blockade has been shown to promote durable responses in non-small cell lung cancer (NSCLC) patients and has been rapidly incorporated into the treatment regimens for many with advanced disease.  Despite this, mechanisms of acquired resistance (AR) to PD-(L)1 have not been well understood. To address the clinical and molecular landscape of AR","Not Applicable","Immune Checkpoint Inhibitors","Case Set","Not Provided","WXS","5 phenotype datasets, 27 variables, 57 samples sequenced, 29 subjects, 57 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-03-13","2024-03-13","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell",""
"phs002185.v2.p1","Genome-Wide Association Study of Genetic Susceptibility for Graft-vs-Host    Disease Cohort 1","Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is the only curative therapy for many advanced hematologic malignancies. Allo-HSCT is associated with significant morbidities and mortality, mainly because of the graft-versus-host disease  (GVHD) caused by donor T cells recognizing antigens present in recipient tissues, and initiating an alloimmune response resulting in damage to many","Not Applicable","Graft vs Host Disease","Prospective Longitudinal Cohort","Global_Diversity_Array-8, imputation_panel","SNP/CNV (Array), SNP/CNV Genotypes (imputed)","5 phenotype datasets, 118 variables, 4 molecular datasets, 9352 subjects, 9518 samples","European (5030), African (15), East Asian (108), African American (207), Hispanic1 (70), Hispanic2 (313), Other Asian or Pacific Islander (37), South Asian (41), Other (45)","NCI","DS-HCTCT-GSO --- Disease-Specific (Hematopoietic Cell Transplantation and Cell Therapy, GSO)","2024-03-13","2024-03-13","Myelodysplastic-Myeloproliferative Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Disease, Graft-Versus-Host; Disease, Graft-vs-Host; Disease, Homologous Wasting; Disease, Runt",""
"phs003404.v1.p1","Genomic Analysis of Prostate Tumor Heterogeneity in Metastasis","To investigate the molecular changes, mutations, and signaling pathways that characterize the initial steps of prostate cancer metastasis to the lymph nodes, we analyzed 19 discrete lymph node (LN) metastases,  97 primary tumor foci, 39 benign lymph nodes, and 10 normal adjacent prostate tissue samples from 43 patients enrolled in a clinical trial","Not Applicable","Prostatic Neoplasms","Tumor vs. Matched-Normal","WES_markerset_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), SNV (.MAF), WXS","4 phenotype datasets, 30 variables, 1 molecular datasets, 302 samples sequenced, 43 subjects, 302 samples","","NCI","GRU --- General Research Use","2024-03-12","2024-03-12","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs003400.v1.p1","Dysregulation of Naive T Cell Quiescence during Aging","TEA-seq (novel trimodal single-cell analysis of mRNA transcripts, surface protein epitopes, and chromatin accessibility) was performed on CD3+ T cells isolated from peripheral blood of healthy pediatric (11&#x02013;13 yrs, n  8) and older adult (55&#x02013;65 yrs, n 8) female donors. Single-cell RNA sequencing (scRNA-seq) was additionally performed on peripheral blood","Not Applicable","Healthy Aging","Cross-Sectional","Not Provided","ATAC-seq, RNA-Seq, Targeted-Capture","5 phenotype datasets, 16 variables, 1 documents, 32 samples sequenced, 97 subjects, 128 samples","","NIA","GRU-IRB --- General Research Use (IRB), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-IR-IRB --- Disease-Specific (Immunological Research, IRB)","2024-03-12","2024-03-12","Aging; Aging, Biological; Biological Aging",""
"phs003489.v1.p1","FLG LoF Variants are Associated with Atopic Dermatitis in an Early-Life    Prospective Cohort","We performed targeted sequencing of the FLG gene in 438 children with physician-diagnosed Atopic Dermatitis (AD), identified Loss-of-Function (LoF) variants, and tested the association of having one or more of  these variants (binary composite) variants with AD-associated outcomes. We found that having a LoF variant was associated with moderate-severe AD","Not Applicable","Dermatitis, Atopic","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), Targeted-Capture","4 phenotype datasets, 27 variables, 1 molecular datasets, 438 samples sequenced, 438 subjects, 438 samples","","NIAID","GRU-NPU --- General Research Use (NPU)","2024-03-11","2024-03-11","AD - Atopic dermatitis; ATOD; Allergic eczema; Atopic Eczema; Atopic Neurodermatitis; Atopic dermatitis, chronic",""
"phs003566.v1.p1","Systolic Blood Pressure Intervention Trial (SPRINT-Imaging)","Available Data Systolic Blood Pressure Intervention Trial, SPRINT-Imaging, provides access to ECG signals data from the SPRINT clinical trial. The clinical phenotyping and outcomes data from the trial are associated  with SPRINT-BioLINCC, phs003483. Objective The Systolic Blood Pressure Trial (SPRINT) was conducted to test the hypothesis that treating systolic","Not Applicable","Hypertension","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 9361 subjects, 9361 samples","","NHLBI","GRU --- General Research Use","2024-03-08","2024-03-08","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; HBP - High blood pressure",""
"phs003515.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Impact of COVID-19 Testing and Mitigation on Equitable    Return-to-School in the Second Largest U.S. School District","This project will show how COVID-19 surveillance testing influences secondary infection and school attendance and how it influences disparities in these outcomes associated with student characteristics, including poverty, race and  ethnicity. The project will also study how surveillance testing influences disparities in parent perceptions of safety, decisions to return","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2024-03-08","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003514.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Enhancing SARS-CoV-2 Rapid Testing Acceptance in Latinx Communities","This project employs a data-informed approach for implementing preventive interventions designed to advance health equity and ameliorate health disparities among vulnerable populations. Building on the successful Phase I and II  projects, we will further tailor the Promotores de Salud COVID-19 evidence-based health promotion intervention to experimentally evaluate a brief","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2024-03-08","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003507.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Project IMPROVE: Implementing Community-Engaged Intervention Research    to Increase Rapid SARS-CoV-2 Self-Testing Among Diverse Underserved    and Vulnerable Asian Americans","Low-Income Asian Americans (AA) with limited English proficiency (LEP) represent a meaningful proportion of low-wage frontline workers in essential service industries. Many also live in multigenerational households with crowded conditions  and with their elderly relatives in ethnic neighborhoods, areas that have experienced high rates of COVID-19 infection. Unfortunately, AAs have","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2024-03-08","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003504.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    The Puerto Rico Community Action Research and Engagement (PR-CARE) to    Eliminate Disparities of COVID-19 Among Rural Underserved and    Vulnerable Populations","In Puerto Rico, the COVID-19 burden in the elderly population is significant as 23% of the confirmed COVID-19 cases and 75% of the deaths have been reported in this group  with a low testing rate (3.4 per 100,000) in those 65 years. The knowledge, beliefs, attitudes, and practices about the risk of infection from","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2024-03-08","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003484.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Increasing Representation of Black Communities in COVID-19 Home    Testing and Surveillance Data","Black communities in the U.S. have disproportionately experienced adverse outcomes attributable to the COVID-19 pandemic. While COVID-19 cases and deaths have declined in recent months, emergent variants continue to pose  threats to the health of Black communities and others. COVID-19 testing has recently shifted from primarily point-of-care testing to widespread use","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2024-03-08","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003368.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    SCALE UP Utah II: Community-Academic Partnership to Address COVID-19    Testing and Vaccination Among Utah Community Health Centers","SCALE-UP II is a state-wide, pragmatic study conducted among 11 Community Health Center (CHC) systems and 38 clinics across Utah. These CHCs serve low socioeconomic status, racially/ethnically diverse, and rural/frontier  populations. The long-term objective of SCALE-UP II is to increase the reach, uptake, and sustainability of COVID-19 testing among underserved","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2024-03-08","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003362.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Supported Employment to Create a Community Culture of Rapid Testing    Among People Who Inject Drugs: PeerConnect2Test","This Phase III project builds on the successes of our Phase I and Phase II projects but uses a novel approach to adapt to the changing pandemic context; facilitation of  rapid testing by people who inject drugs (PWID) via a supported employment program that trains PWID as peer health workers (PHW). PWID are vulnerable","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2024-03-08","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003517.v1.p1","A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor    Musculoskeletal Symptoms (AIMSS)","Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS) are common and frequently lead to Aromatase Inhibitor (AI) discontinuation. Single nucleotide polymorphisms (SNPs) in candidate genes have been associated with AIMSS and AI discontinuation.  E1Z11 is a prospective cohort study designed to validate associations between 10 SNPs and AI discontinuation due to AIMSS. We enrolled postmenopausal","Not Applicable","Musculoskeletal System","Prospective Longitudinal Cohort","custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 1 molecular datasets, 970 subjects, 970 samples","","NCI","GRU --- General Research Use","2024-03-07","2024-03-07","Not Provided",""
"phs002975.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Prevent    Pulmonary Fibrosis (PrePF)","Cohort Description Prevent Pulmonary Fibrosis (PrePF) has been investigating the clinical, physiologic and genetic phenotypes of interstitial lung disease (ILD) by focusing on families with two or more cases of  ILD and individuals with sporadic IPF. It has recruited over 1,200 families with two or more cases of pulmonary fibrosis. These families with","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 628 subjects, 628 samples","","NHLBI","DS-PMD-IRB --- Disease-Specific (Pulmonary Disease, IRB)","2024-03-07","2024-03-07","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002864.v2.p1","Genomic Analyses in Neoadjuvant Immunotherapy-Treated Head and Neck    Cancers","This is a phase 2 multicenter interventional trial involving the preoperative (neoadjuvant) administration of pembrolizumab, an anti-programmed cell death protein-1 (anti-PD-1) agent, to patients with pathologically confirmed, surgically resectable advanced  head and neck squamous cell carcinoma (HNSCC). Participating centers were Dana-Farber/Harvard Cancer Center, Alvin J. Siteman Cancer Center,","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Clinical Trial","Not Provided","RNA-Seq, Targeted-Capture, ssRNA-seq","4 phenotype datasets, 36 variables, 37 samples sequenced, 31 subjects, 37 samples","","NIDCR","HMB --- Health/Medical/Biomedical","2024-03-07","2023-08-04","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx",""
"phs003543.v1.p1","National Sleep Research Resource (NSRR): Hispanic Community Health    Study/Study of Latinos","The Hispanic Community Health Study / Study of Latinos (HCHS/SOL) is a multi-center epidemiologic study in Hispanic/Latino populations to determine the role of acculturation in the prevalence and development of  disease, and to identify risk factors playing a protective or harmful role in Hispanics/Latinos. The study is sponsored by the National Heart, Lung,","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 6 variables, 12121 subjects, 12121 samples","","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU), HMB --- Health/Medical/Biomedical","2024-03-06","2024-03-06","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse","Collection: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) (phs003650.v1.p1)"
"phs001667.v1.p1","Genomics of Kidney Transplantation","We have an established consortium consisting of 5 clinical centers which do a total of 800 kidney transplants/year. We have developed a quality-controlled multicenter database with high quality data, and  obtained DNA samples and clinical data on 962 recipients and 442 donors. Using our developed infrastructure, we propose to study whether genetic","Not Applicable","Kidney Transplantation","Prospective Longitudinal Cohort","Axiom_Transplant","SNP Genotypes (Array)","25 phenotype datasets, 265 variables, 1 molecular datasets, 1404 subjects, 1404 samples","European (1074), African (3), East Asian (25), African American (198), Hispanic1 (12), Hispanic2 (56), Other Asian or Pacific Islander (19), South Asian (9), Other (8)","NIAID","DS-KRD-IRB-PUB-COL-NPU-MDS --- Disease-Specific (Kidney and Related Disorders, IRB, PUB, COL, NPU, MDS)","2024-03-06","2024-03-06","Not Provided",""
"phs003546.v1.p1","Gene Expression and Biomarker Utility in Post-Mortem Samples","The FAA Functional Genomics Team examined the feasibility of analyzing gene expression profiles using post-mortem brain, lung, muscle, and blood samples collected from aviation accident fatalities, with the goal of  validating post-mortem extracted RNA for use in RNA sequencing. We compared the RNA sequencing results obtained from THC-positive and THC-negative","Not Applicable","RNA-Seq","Methods","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 10 variables, 1 molecular datasets, 201 samples sequenced, 57 subjects, 201 samples","","NHGRI","GRU-IRB --- General Research Use (IRB)","2024-03-05","2024-03-05","Not Provided",""
"phs003474.v1.p1","A Missense SNP in the Tumor Suppressor SETD2 Reduces H3K36me3 and Mitotic    Spindle Integrity in Drosophila","While examining DNA from renal cell carcinoma (RCC) patients we observed a single nucleotide polymorphism (SNP; rs58906143,chr3:47163422 C&#x02192;G (hg19); E902Q ) within SETD2 that was overrepresented in kidney cancer patients  compared to control patients. This original study utilized directed sequencing of 14 genes. In an expanded study using a Taqman assay to study the","Not Applicable","Kidney Neoplasms","Case-Control","custom_PCR_marker_set","SNP Genotypes (PCR), Targeted-Capture","4 phenotype datasets, 14 variables, 1 molecular datasets, 180 samples sequenced, 758 subjects, 758 samples","","NCI","GRU --- General Research Use","2024-03-05","2024-03-05","Kidney Tumor; Kidney cancer; Kidney neoplasm; Neoplasia of the kidneys; Neoplasm of Kidney; Neoplasm of the Kidney",""
"phs003453.v1.p1","Investigating Genetics in Suspected Congenital Syndromes","We employed forward and reverse genetics to identify individuals with heterozygous JAK1 variants associated with autoimmune and inflammatory diseases. We first recruited six unrelated probands and seven affected family members  presenting with a range of autoimmune and inflammatory conditions. Whole exome sequencing revealed 4 different variants spanning all domains of the","Not Applicable","Autoimmunity","Case Set","WES_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 19 variables, 1 molecular datasets, 43 subjects, 43 samples","","NIAID","GRU-NPU --- General Research Use (NPU)","2024-03-05","2024-03-05","Colitis; Autoimmune condition; Autoimmune disease; Autoimmune disorder; Autoimmunities",""
"phs002486.v2.p1","Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small    Cell Lung Cancer","We performed a trial of adoptive cell therapy using tumor infiltrating lymphocytes (TIL) in metastatic non-small cell lung cancer (NSCLC). We conducted a single-arm open- label phase 1 trial (NCT03215810)  of TIL administered with nivolumab in 20 patients with advanced NSCLC. Patients had tumor metastases resected for TIL, and the sequencing data from","Not Applicable","Carcinoma, Non-Small-Cell Lung","Clinical Trial","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 26 variables, 103 samples sequenced, 20 subjects, 103 samples","","NCI","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2024-03-01","2021-09-02","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs003410.v1.p1","A Human Lymphoma Organoid Model for Evaluating and Targeting the    Follicular Lymphoma Tumor Immune Microenvironment","Heterogeneity in the tumor microenvironment (TME) of follicular lymphoma (FL) can affect clinical outcomes. We developed a new organoid culture method for cultivating patient-derived lymphoma organoids (PDLOs), which include cells  from the native FL TME. We generated organoids from 12 FL patients at diagnosis, clinical progression, or relapse. These organoids were profiled with","Not Applicable","Lymphoma, Follicular","Case Set","custom_probe_set","RNA-Seq, RNA Seq (NGS), Targeted-Capture","4 phenotype datasets, 18 variables, 1 molecular datasets, 127 samples sequenced, 12 subjects, 127 samples","","NCI","DS-HLCA-IRB-PUB-COL --- Disease-Specific (Hodgkin Lymphoma, IRB, PUB, COL)","2024-02-29","2024-02-29","Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC; Follicle Center Lymphoma",""
"phs002445.v3.p1","Resistance to Latent Mycobacterium tuberculosis Infection in Uganda:    Immunologic Profiling","Despite significant exposure to Mycobacterium tuberculosis (Mtb), some humans remain uninfected, as defined by persistently negative immune sensitization tests (tuberculin skin test, TST; interferon gamma release assays, IGRA). To explore  mechanisms of natural resistance to Mtb infection, we profiled tissues from highly-exposed Mtb contacts from Uganda. The cohort from this submission","Not Applicable","Latent Tuberculosis","Case-Control","RNAseq_gene_transcripts, ATAC_DNAseq_probe_set","ATAC-seq, RNA-Seq, Chromatin (NGS), RNA Seq (NGS)","5 phenotype datasets, 29 variables, 3 molecular datasets, 418 samples sequenced, 153 subjects, 480 samples","","NIAID","GRU-COL --- General Research Use (COL)","2024-02-29","2024-02-29","Tuberculosis; Infection, Latent Tuberculosis; Infections, Latent Tuberculosis; LTBI; LTBI - Latent tuberculosis infection; Latent Tuberculoses",""
"phs002156.v1.p1","Molecular Characterization of Hemimegalencephaly","Somatic mutations, in which a fraction of the cells in the body have a deleterious mutation, are well recognized in cancer but only recently appreciated in neurological disease. Given a  somatic mutation in a population of progenitor cells, all daughter cells inherit the mutation and are able to express the resultant phenotype as a","Not Applicable","Hemimegalencephaly","Case Set","Not Provided","WXS","4 phenotype datasets, 15 variables, 52 samples sequenced, 52 subjects, 52 samples","","NINDS","GRU --- General Research Use","2024-02-28","2024-02-28","Hemimegalencephalies; Macrocephalies, Unilateral; Macrocephaly, Unilateral; Megalencephalies, Unilateral; Megalencephaly, Unilateral; Unilateral Macrocephalies","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003521.v1.p1","Cell Type-Specific and Disease-Associated eQTL in the Human Lung","This study was conducted to investigate the genetic control of gene expression in a cell-type and context-specific manner in the human lung. We performed single-cell RNA-sequencing (scRNA-seq) of lung tissue  from 66 Interstitial Lung Disease (ILD) cases and 48 unaffected donors. Employing a pseudo-bulk approach, we mapped expression quantitative trait","Not Applicable","Idiopathic Pulmonary Fibrosis","Case-Control","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 16 variables, 1 molecular datasets, 114 samples sequenced, 115 subjects, 114 samples","European (89), African American (12), Hispanic1 (1), Hispanic2 (9), South Asian (1), Other (1)","NHLBI","GRU --- General Research Use, HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2024-02-27","2024-02-27","Lung Diseases; Lung Diseases, Interstitial; Pulmonary Disease, Chronic Obstructive; Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003317.v1.p1","Integrative Age-Related Changes in Genome and Epigenome in Human Lung in    Relation to Smoking","The Integrative Age-Related Changes in Genome and Epigenome in Human Lung in Relation to Smoking study was designed to assess DNA methylation and gene expression profiles in cytologically normal bronchial  progenitor ""basal"" cells. The cells were collected from 54 consented bronchoscopy specimen donors at standard airway locations during clinically","Not Applicable","Lung Neoplasms","Case-Control","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 23 variables, 54 samples sequenced, 54 subjects, 54 samples","","NHLBI","HMB-IRB-PUB-NPU --- Health/Medical/Biomedical (IRB, PUB, NPU)","2024-02-27","2024-02-27","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs003495.v1.p1","Postmortem Analysis of the Caudate Nucleus in Schizophrenia","This postmortem study examines genomic signatures (gene, transcript, exon, and exon-exon junction) in the caudate nucleus of individuals with or without psychiatric illnesses. We characterized genetic and epigenetic changes across  the lifespan of 443 donor subjects, including 245 individuals without psychiatric illness, 154 individuals with schizophrenia, and 44 individuals","Not Applicable","Schizophrenia","Case-Control","custom_markerset","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 16 variables, 1 molecular datasets, 443 samples sequenced, 443 subjects, 443 samples","European (227), African (5), African American (202), Hispanic1 (2), Hispanic2 (3), Other Asian or Pacific Islander (1), South Asian (1), Other (2)","NIMH","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2024-02-23","2024-02-23","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder",""
"phs002960.v1.p1","Exploring the Microbiome-Gut-Brain Axis with Respect to    Psychoneurological Symptoms for Children with Solid Tumors","The human body hosts tens of trillions of microbes, a number 10 times greater than the number of human body cells. The collection of these human-associated microbes and their genomes  is called the &#x0201c;human microbiome&#x0201d;. More than 90% of these microbes live in the gastrointestinal (GI) tract, representing 500 species","Not Applicable","Neoplasms","Case-Control","human_microbiome","Human Metagenome (NGS)","4 phenotype datasets, 21 variables, 1 molecular datasets, 44 subjects, 57 samples","","NINR","GRU --- General Research Use","2024-02-23","2024-02-23","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002221.v1.p1","Genetic Modifiers of Syndromic Orofacial Clefts","Reduced penetrance and variable expressivity are common, but poorly understood, features of most monogenic diseases. Genetic modifiers are possible factors to contribute to this phenotypic variability and blur the traditional  distinction between monogenic and complex disease. This study focuses on the most common orofacial cleft syndrome (Van der Woude syndrome, VWS) and","Not Applicable","Not Provided","Family/Twin/Trios","Not Provided","WGS","5 phenotype datasets, 19 variables, 16 samples sequenced, 17 subjects, 16 samples","","NIDCR","DS-CFED --- Disease-Specific (Craniofacial and Eye Disorders)","2024-02-23","2024-02-23","Van der Woude syndrome; Van der Woude syndrome 2; Cleft Lip; Cleft Palate; CLEFT LIP AND/OR PALATE WITH MUCOUS CYSTS OF LOWER LIP; Cleft lip and-or palate with mucous cysts of lower lip",""
"phs003533.v1.p1","Heart Failure Network - Xanthine Oxidase Inhibition for Hyperuricemic    Heart Failure Patients (HFN EXACT-BioLINCC)","Objectives To determine the effect of allopurinol after 24 weeks on a composite clinical endpoint that classifies subject's clinical status (improved, worsened, unchanged) in patients with heart failure and high  uric acid levels. Background Morbidity and mortality rates for patients with heart failure are high, despite guideline-recommended therapy. Heart","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 253 subjects, 253 samples","","NHLBI","GRU --- General Research Use","2024-02-22","2024-02-22","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003512.v1.p1","Identification of Host Genetic Factors That Are Determinant for the    Development of Severe Forms of COVID-19","We conducted whole exome sequencing (WXS) on 21 cases of Multisystem Inflammatory Syndrome in Children (MIS-C) related to COVID-19 from Brazil. All patients who were hospitalized underwent serum (ELISA) and  molecular (RT-PCR) testing for SARS-CoV-2, and the main clinical symptoms associated with SARS-CoV-2 infection were collected. During","Not Applicable","COVID-19","Cross-Sectional","Not Provided","WXS","4 phenotype datasets, 13 variables, 88 samples sequenced, 21 subjects, 88 samples","","NHGRI","DS-MIS-NPU-GSO --- Disease-Specific (Multisystem Inflammatory Syndrome, NPU, GSO)","2024-02-22","2024-02-22","pediatric multisystem inflammatory disease, COVID-19 related; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus",""
"phs002047.v1.p1","Clinical and Genetic Analysis of Retinopathy of Prematurity (ROP)","Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide and is treated based on the presence of symptoms of ""plus disease"", a dilation and tortuosity of retinal  vessels. This project aims to identify the genetic and clinical underpinnings of the disease by comparing the germline variants of 1,400 premature","Not Applicable","Retinopathy of Prematurity","Case-Control","Not Provided","WXS","4 phenotype datasets, 13 variables, 100 samples sequenced, 100 subjects, 100 samples","","NEI","GRU --- General Research Use","2024-02-21","2024-02-21","Fibroplasia, Retrolental; Fibroplasias, Retrolental; Prematurity Retinopathies; Prematurity Retinopathy; RLF - Retrolental fibroplasia; ROP",""
"phs001684.v3.p1","Metatranscriptomic Sequencing of Pulmonary Fluid in Immunocompromised    Children","Despite improved diagnostics, pulmonary pathogens in immunocompromised children frequently evade detection, leading to significant mortality. In version 1 of this study, we performed RNA-based next generation sequencing (mNGS) on 41  lower respiratory samples collected from 34 children. We identified a rich cross-domain pulmonary microbiome containing bacteria, fungi, RNA viruses,","Not Applicable","Immunocompromised Host","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 376 samples sequenced, 320 subjects, 376 samples","","NICHD","HMB-IRB-COL-MDS --- Health/Medical/Biomedical (IRB, COL, MDS)","2024-02-21","2018-10-18","Respiratory Tract Infections; Host, Immunocompromised; Host, Immunosuppressed; Hosts, Immunocompromised; Hosts, Immunosuppressed; Immunocompromised Hosts",""
"phs003112.v1.p1","Transcriptomics of Liver and PBMCs in Alcohol-Associated Liver Disease","This study was designed to characterize the transcriptome of alcohol-associated hepatitis using RNA sequencing (RNA-seq) technology for both liver tissue biopsies and peripheral blood mononuclear cells (PBMCs) extracted from blood  samples, in order to identify expressed genes that are markers of the disease. To distinguish genes that differentiate alcohol-associated hepatitis","Not Applicable","Hepatitis, Alcoholic","Cross-Sectional","Not Provided","RNA-Seq","4 phenotype datasets, 12 variables, 566 samples sequenced, 185 subjects, 566 samples","","NIAAA","HMB-IRB-PUB-NPU --- Health/Medical/Biomedical (IRB, PUB, NPU)","2024-02-20","2024-02-20","Hepatitis C, Chronic; Liver Cirrhosis, Alcoholic; Non-alcoholic Fatty Liver Disease; Chronic Hepatitis C; Chronic type C viral hepatitis; AH - Alcoholic hepatitis",""
"phs001966.v1.p1","L1 Retrotransposon sequencing in Cocaine Use Disorder - Study 1","Cocaine Use Disorder (CUD) is a global public health problem, with no effective pharmacotherapies. While CUD is marked by high heritability, discovery of variants associated with risk for CUD has  proven difficult. We used Restriction Enzyme Based Enriched L1 sequencing (REBELseq) to amplify L1 retrotransposons in gDNA isolated from medial","Not Applicable","Cocaine-Related Disorders","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 14 variables, 49 samples sequenced, 51 subjects, 49 samples","","NIDA","GRU --- General Research Use","2024-02-20","2024-02-20","Cocaine Addiction; Abuse, Cocaine; Cocaine Abuse","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs001517.v4.p2","Genetics of Human Inherited Retinal Diseases (GHIRD)","The goal of this project is to identify novel mutations and genes involved in human retinal disorders, a stated priority of the National Eye Institute. To accomplish this, additional genes  whose mutations cause inherited retinal diseases (IRD) will be identified by combining targeted gene panel sequencing, whole exome sequencing, and","Not Applicable","Retinitis Pigmentosa","Case Set","target_markerset_grc37, WGS_markerset_grc37","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS)","4 phenotype datasets, 13 variables, 4 molecular datasets, 1067 subjects, 1067 samples","European (37), East Asian (1), African American (6), Hispanic1 (2), Hispanic2 (8), Other Asian or Pacific Islander (3), South Asian (3), Other (3)","NEI","DS-ED-NPU-GSO --- Disease-Specific (Eye Disease, NPU, GSO)","2024-02-20","2024-02-20","Cone-Rod Dystrophies; Macular Degenerations; CRD; Cone Rod Degenerations; Cone Rod Dystrophies; Cone Rod Dystrophy",""
"phs003509.v1.p1","Protracted Neuronal Recruitment in the Temporal Lobe of Young Children","This study describes a stream of migrating neurons directed to the human entorhinal cortex. This migration is among the most protracted in the developing human brain, with young neurons still  arriving at 2-3 years of age. We did not observe a similar migratory process in the early postnatal macaque brain, which suggests that this migration","Not Applicable","Entorhinal Cortex","Control Set","Not Provided","RNA-Seq","5 phenotype datasets, 18 variables, 12 samples sequenced, 10 subjects, 12 samples","","NINDS","HMB --- Health/Medical/Biomedical","2024-02-16","2024-02-16","Not Provided",""
"phs001886.v5.p1","Deciphering Maternal-Fetal Crosstalk in the Human Placenta During    Parturition Using Single-Cell RNA-Sequencing","Labor is a complex physiological process requiring a well-orchestrated dialogue between the mother and fetus. However, the cellular contributions and communications that facilitate maternal-fetal crosstalk in labor have not been  fully elucidated. In this latest version (#5), scRNA-seq was applied to decipher maternal-fetal signaling in the human placenta and chorioamniotic","Not Applicable","Delivery, Obstetric","Case-Control","WGS_markerset_grc37, target_markerset_grc37, imputation_panel","SNP Genotypes (imputed), OTHER, SNP/CNV Genotypes (NGS)","5 phenotype datasets, 26 variables, 3 molecular datasets, 76 samples sequenced, 159 subjects, 201 samples","","NICHD","GRU-NPU --- General Research Use (NPU)","2024-02-15","2024-02-15","Not Provided",""
"phs003298.v1.p1","Genetics and Functional Studies of Autosomal Recessive Neurological    Disorders","Neurological conditions account for over 6% of the global disease burden. There are more than 600 neurological disorders, and cognitive dysfunction, also referred to as intellectual disability (ID), occupies a  prominent position in this list. Cognitive dysfunction arises from the failure of neuronal cells to organize into a complex network and remodel this","Not Applicable","Intellectual Disability","Family/Twin/Trios","Not Provided","WXS","4 phenotype datasets, 24 variables, 69 samples sequenced, 95 subjects, 69 samples","","NINDS","DS-ID-PUB --- Disease-Specific (Intellectual Disability, PUB)","2024-02-13","2024-02-13","Idiocy; Mental retardation (profound); Profound intellectual development disorder; Profound mental retardation (I.Q. below 20); Profound mental retardation (Intelligence Quotient below 20)",""
"phs002094.v1.p1","Newborn Screening Translational Research Network (NBSTRN): Newborn    Sequencing in Genomic Medicine and Public Health (NSIGHT2)","Large-scale studies of whole genome sequencing (WGS) in neonates have largely been neglected. Thus, the clinical and social implications of this absence are largely unknown. The proposed study aims to  increase scientific knowledge for acutely ill neonates. This population may stand to benefit largely from WGS given the severity of illness. The","Not Applicable","Genetic Diseases, Inborn","Clinical Trial","Not Provided","WGS","4 phenotype datasets, 15 variables, 118 samples sequenced, 118 subjects, 118 samples","","NICHD","HMB-IRB-PUB --- Health/Medical/Biomedical (IRB, PUB)","2024-02-13","2024-02-13","Disease, Genetic; Disease, Hereditary; Diseases, Genetic; Diseases, Hereditary; Disorder, Genetic; Disorders, Genetic",""
"phs003486.v1.p1","Acquired Cross-Resistance in Small Cell Lung Cancer Patient-Derived    Xenografts","Here we present whole genome sequencing and RNA sequencing of patient-derived xenograft (PDX) models of small cell lung cancer (SCLC). These models were derived at a variety of clinical time  points from either biopsy/resection samples, malignant effusions, or circulating tumor cells (CTCs), and grown in the subcutaneous flank of NSG","Not Applicable","Small Cell Lung Carcinoma","Xenograft","WGS_markerset_grc38, RNAseq_probe_set_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), WGS, WXS","4 phenotype datasets, 20 variables, 1 molecular datasets, 133 samples sequenced, 42 subjects, 133 samples","","NCI","GRU --- General Research Use","2024-02-12","2024-02-12","DNA Damage; DNA Injuries; DNA Injury; DNA Lesion; DNA Lesions; Deoxyribonucleic acid damage","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003435.v1.p1","Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma","In this study, we show that the plasma representation of mutations exceeds the bulk tumor representation in most cases, making classic Hodgkin Lymphoma (cHL) particularly amenable to noninvasive profiling. Leveraging  single-cell transcriptional profiles of cHL tumors, we demonstrate hazard ratios (HRs) circulating tumor DNA (ctDNA) shedding to be shaped by","Not Applicable","Hodgkin Disease","Case-Control","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS), Targeted-Capture, WXS","4 phenotype datasets, 19 variables, 1 molecular datasets, 1195 samples sequenced, 445 subjects, 1281 samples","","NCI","DS-LYM-IRB-PUB-COL --- Disease-Specific (Lymphoma, IRB, PUB, COL)","2024-02-12","2024-02-12","CHL; Classic Hodgkin disease; Disease, Hodgkin; Disease, Hodgkin's; Disease, Hodgkins; Familial Hodgkin Disease",""
"phs000673.v5.p1","University of Michigan Clinical Sequencing Exploratory Research (CSER)","Overview. The personalization of therapy for cancer will require molecular characterization of unique and shared genetic aberrations. In particular, patients who have a sarcoma or other rare cancers and are  candidates for clinical trials could potentially benefit by identifying eligibility for ""targeted"" drugs based on the ""actionable"" genes in their","Not Applicable","Neoplasms","Case Set","Not Provided","RNA-Seq, Targeted-Capture, WXS","4 phenotype datasets, 21 variables, 4403 samples sequenced, 1427 subjects, 4403 samples","","NCI","GRU --- General Research Use","2024-02-12","2014-11-13","Sarcoma; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003510.v1.p1","Heart Failure Network - Effectiveness of Ultrafiltration in Treating    People with Acute Decompensated Heart Failure and Cardiorenal Syndrome    (HFN CARRESS - BioLINCC)","Objective The CARRESS trial examined the effectiveness of ultrafiltration compared with a strategy of diuretic-based stepped pharmacologic therapy on renal function and weight loss in patients with heart failure who  have worsening renal function and persistent congestion. Background Acute cardiorenal syndrome is defined as worsening renal function in patients","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 188 subjects, 188 samples","","NHLBI","GRU --- General Research Use","2024-02-08","2024-02-08","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003447.v1.p1","MAESTRO-Pool Enables Highly Parallel and Specific Mutation-Enrichment    Sequencing for Minimal Residual Disease Detection in Cohort Studies","MAESTRO-Pool builds upon the technology MAESTRO (Minor Allele Enriched Sequencing Through Recognition Oligonucleotides) by pooling tumor-specific MAESTRO probes from multiple patients and applying these to all samples from all patients.  In this study, MAESTRO-Pool was applied to a cohort of 9 melanoma patients where 98 plasma samples were screened for 22,333 mutations. Additionally,","Not Applicable","Melanoma","Methods","target_markerset_grc37","SNV Aggregate (.MAF), Targeted-Capture, WGS","3 phenotype datasets, 18 variables, 1 molecular datasets, 234 samples sequenced, 9 subjects, 234 samples","","NCI","DS-MSC-MDS --- Disease-Specific (Melanoma and Skin Cancer Research, MDS)","2024-02-08","2024-02-08","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs003524.v1.p1","Heart Failure Network: Diuretic Optimization Strategies Evaluation in    Acute Heart Failure (HFN DOSE-BioLINCC)","Objectives The DOSE study sought to evaluate the most effective dosing (high vs. low) and administration (continuous infusion vs. intermittent boluses) combination of the diuretic Furosemide in the treatment of  patients with acute decompensated heart failure. Background Acute decompensated heart failure is the most common cause of hospital admissions among","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 308 subjects, 308 samples","","NHLBI","GRU --- General Research Use","2024-02-07","2024-02-07","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs002819.v1.p1","Single-Nuclei Paired Multiomic Analysis of Young, Aged, and Parkinson's    Disease Human Midbrain Reveals Age-Associated Glial Changes and Their    Contribution to Parkinson's Disease","Age is the primary risk factor for Parkinson's disease (PD), but how aging to change the expression and regulatory landscape of the brain remains unclear. Here, we present a single-nuclei  multiomic study profiling shared gene expression and chromatin accessibility of young, aged and PD post-mortem midbrain samples. Combined multiomic","Not Applicable","Parkinson Disease","Collection","Not Provided","ATAC-seq, RNA-Seq","4 phenotype datasets, 14 variables, 34 samples sequenced, 34 subjects, 34 samples","","NINDS","HMB --- Health/Medical/Biomedical","2024-02-07","2024-02-07","Aging; Aging, Biological; Biological Aging; Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism",""
"phs003506.v1.p1","Heart Failure Network Aldosterone Targeted Neurohormonal Combined with    Natriuresis Therapy - (HFN ATHENA-BioLINCC)","Objective To assess whether high-dose spironolactone treatment for patients with acute heart failure lowers natriuretic peptide levels and improves outcomes better than usual care. Background Acute heart failure (AHF) accounts  for more than a million hospitalizations in the United States annually. The role of low-dose mineralocorticoid receptors antagonists (MRAs) therapy","Not Applicable","Heart Failure","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 360 subjects, 360 samples","","NHLBI","GRU --- General Research Use","2024-02-06","2024-02-06","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac","HeartShare - Extant Datasets - Harmonized Clinical Trials Collection (phs003989.v1.p1)"
"phs003483.v1.p1","Systolic Blood Pressure Intervention Trial (SPRINT-BioLINCC)","Available Data The available data include all elements of the previously released SPRINT Primary Outcome Paper (SPRINT-POP) data, the full SPRINT clinical data including the MRI and MIND data, and  select ancillary study data (Ambulatory Blood Pressure Monitoring, APOL1, Acute Kidney Injury, ASK, Heart, FAST, PWV, Renal Resistance, Biomarkers,","Not Applicable","Hypertension","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 9361 subjects, 9361 samples","","NHLBI","GRU --- General Research Use","2024-02-06","2024-02-06","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; HBP - High blood pressure",""
"phs002032.v2.p1","Genetic Neuroscience: How Human Genes and Alleles Shape Neuronal    Phenotypes","The goal of this collaborative, interdisciplinary project is to develop powerful, generalizable approaches for discovering how risk variants for psychiatric disorders shape neurobiological processes at multiple levels of analysis, and  to identify the processes whose dysregulation underlies disease. Induced pluripotent stem cells (iPSCs) were used towards the development of these","Not Applicable","Mental Disorders","Case-Control","Not Provided","Not Provided","Not Provided","","NIMH","GRU --- General Research Use, DS-SMA-MDS --- Disease-Specific (Spinal Muscular Atrophy, MDS), DS-MBND-MDS --- Disease-Specific (Mental, Behavioral and Neurodevelopmental Disorders, MDS)","2024-02-06","","Neurodegenerative Diseases; Amyotrophies, Spinal; Amyotrophy, Spinal; Atrophy, Spinal Muscular; Muscular Atrophy, Spinal; Progressive spinal muscular atrophy","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002937.v1.p1","Exploring the Genomic Dark Matter of Neurodevelopmental Disorders","Neurodevelopmental Disorders (NDDs) are a group of disorders that typically manifest early in development and may give rise to impaired cognition, communication, adaptive behavior, and psychomotor skills. This study aims  to take a more comprehensive view into the genomic landscape of structural variants implicated in NDDs with intellectual disability (ID). We have","Not Applicable","Neurodevelopmental Disorders","Family/Twin/Trios","SV_STR_grc38","CNV (NGS)","5 phenotype datasets, 18 variables, 1 molecular datasets, 52 subjects, 52 samples","","NINDS","HMB-NPU --- Health/Medical/Biomedical (NPU)","2024-02-02","2024-02-02","Idiocy; Mental retardation (profound); Profound intellectual development disorder; Profound mental retardation (I.Q. below 20); Profound mental retardation (Intelligence Quotient below 20); Child Mental Disorder",""
"phs002710.v1.p1","COVID-19 Outpatient Thrombosis Prevention Trial (ACTIV-4B)","An adaptive randomized double-blind placebo-controlled platform trial to compare the effectiveness of anticoagulation with antiplatelet agents and with placebo to prevent thrombotic events in patients diagnosed with COVID-19 who are  not admitted to hospital as COVID-19 related symptoms are currently stable. Inclusion criteria: Age between 40 and 80 years inclusive Documentation","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 657 subjects, 657 samples","","NHLBI","GRU --- General Research Use","2024-02-01","2024-02-01","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs003502.v1.p1","Single-Cell and Spatial Multi-Omics Highlight Effects of Anti-Integrin    Therapy Across Cellular Compartments in Ulcerative Colitis","This is a focused, nested case-control study within our larger cohort ""Immunoprofiling of the Blood and Intestine and Creation of a Gut Cell Atlas"". This sub-study is titled as ""Single-cell  and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis&#x0201d;. We examined the","Not Applicable","Colitis, Ulcerative","Case-Control","Not Provided","RNA-Seq","5 phenotype datasets, 26 variables, 15 samples sequenced, 15 subjects, 15 samples","","NIDDK","GRU --- General Research Use","2024-01-26","2024-01-26","Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - ulcerative colitis; ULCERATIVE COLITIS","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003496.v1.p1","Utility of Capillary Blood in Gene Expression Studies","The FAA Functional Genomics Team examined the feasibility of analyzing gene expression profiles using capillary blood collected by fingerstick, with the goal of developing practical fingerstick blood collections to expand  blood collection capabilities and allow large-scale or field-based collections. We compared the RNA sequencing results obtained from two different","Not Applicable","RNA-Seq","Methods","Not Provided","RNA-Seq","3 phenotype datasets, 14 variables, 160 samples sequenced, 40 subjects, 160 samples","","NHGRI","GRU-IRB --- General Research Use (IRB)","2024-01-26","2024-01-26","Not Provided",""
"phs003485.v1.p1","Germline Genome Sequencing from Patients with Early-Onset Merkel Cell    Carcinoma","Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer associated with advanced age. Approximately 5% of cases are early-onset MCC, occurring in individuals younger than 50 years. This study  used genome sequencing to identify germline risk factors among patients with early-onset MCC. The available data in the database of Genotypes and","Not Applicable","Carcinoma, Merkel Cell","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 14 variables, 1 molecular datasets, 37 samples sequenced, 37 subjects, 37 samples","","NIAMS","GRU --- General Research Use","2024-01-26","2024-01-26","Anaplastic carcinoma of the skin; Cancer, Merkel Cell; Cell Cancer, Merkel; Cutaneous APUDoma; MCC; Merkel Cell Cancer","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002697.v1.p1","A Multimodal Atlas of Human Brain Cell Types 2021 Data","Human neocortical neurons display diverse morphology, physiology and gene expression profiles. We use a method called Patch-seq, where these three data modalities are assayed simultaneously from the same neuron, to  understand how the genetic profile of human neocortical neuron types corresponds to their morphological and electrophysiological phenotypes. This","Not Applicable","Transcriptome","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 25 samples sequenced, 11 subjects, 25 samples","","NIMH","GRU --- General Research Use, DS-BHD --- Disease-Specific (Brain Health and Disease)","2024-01-26","2024-01-26","Not Provided",""
"phs001606.v3.p1","NHLBI TOPMed: Early-Onset Atrial Fibrillation in the Estonian Biobank","The Estonian Biobank is the population-based biobank of the Estonian Genome Centre of University of Tartu. The biobank is conducted according to the Estonian Gene Research Act and all participants  have signed broad informed consent. The cohort size is currently 51,535 people from 18 years of age and up. Principal Investigators: T&#x000f5;nu","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS)","4 phenotype datasets, 18 variables, 2 documents, 2 molecular datasets, 324 subjects, 324 samples","","NHLBI","GRU --- General Research Use","2024-01-26","2024-01-26","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs001451.v5.p1","A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma","Effective anti-tumor immunity in humans has been associated with presence of T cells targeting neoantigens that arise from non-silent tumor-specific mutations. Here we conducted whole-exome sequencing of tumor and normal  cells from individual patients to identify mutations. We assessed the expression of mutated alleles by RNA-sequencing of tumor. We demonstrated the","Not Applicable","Melanoma","Clinical Trial","Not Provided","OTHER, RNA-Seq, WGS, WXS","4 phenotype datasets, 15 variables, 132 samples sequenced, 12 subjects, 132 samples","","NCI","GRU --- General Research Use","2024-01-26","2018-02-28","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003399.v1.p1","Reference Standards for Mosaic Variant Detection","After conception, postzygotic mutations continuously occur throughout life in humans, causing somatic mosaicism in an individual. The variant type, time of origination, and locations of the mosaic mutations result in  unique mosaic patterns in a combinatorial manner and further affect phenotypes, including various noncancerous diseases. Several efforts have, thus,","Not Applicable","Cell Line","Methods","Not Provided","WXS","3 phenotype datasets, 9 variables, 1 samples sequenced, 1 subjects, 1 samples","","NHGRI","GRU-NPU --- General Research Use (NPU)","2024-01-25","2024-01-25","Not Provided",""
"phs003358.v1.p1","Patient Microbiome and Surgical Site Infection in Spine Surgery","Single center, prospective cohort study on the contribution of the preoperative patient microbiome and resistome to surgical site infection (SSI) and resistance to surgical antibiotic prophylaxis in spine surgery. The  samples in this entry comprise a subset of patients for whom paired preoperative microbiome samples and postoperative wound culture isolates were","Not Applicable","Surgical Wound Infection","Metagenomics","Not Provided","WGA","4 phenotype datasets, 22 variables, 76 samples sequenced, 14 subjects, 78 samples","","NIAMS","GRU --- General Research Use","2024-01-25","2024-01-25","Infected surgical wound; Infection, Postoperative Wound; Infection, Surgical Site; Infection, Surgical Wound; Infections, Postoperative Wound; Infections, Surgical Site",""
"phs003469.v1.p1","Genetic Markers of Lipids in Indians: A Validation Study of Most Relevant    Findings of Genome-Wide Association Studies","We aimed to validate the GWAS loci (identified in European populations) related to serum lipid levels (total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and very low-density  lipoprotein cholesterol (VLDL-C)) in the Indian population originally recruited to examine the 20-year trend of cardiometabolic risk factors in rural","Not Applicable","Dyslipidemias","Cross-Sectional","custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 26 variables, 1 analyses, 1 molecular datasets, 2117 subjects, 2117 samples","","NHLBI","GRU --- General Research Use","2024-01-24","2024-01-24","Dyslipidemia","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003283.v1.p1","eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD    Risk of Older Depressed Patients","Cardiovascular disease (CVD) is the #1 killer of American men and women, and its economic burden is substantial and on the rise. Adults with depression are at elevated risk of  CVD events and poor CVD prognosis. Unfortunately, past clinical trials of depression treatments have not observed the anticipated cardiovascular","Not Applicable","Depression","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 216 subjects, 216 samples","","NHLBI","GRU-NPU --- General Research Use (NPU)","2024-01-24","2024-01-24","Cardiovascular Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs002989.v1.p1","Genomic Analysis of Follicular Lymphoma","We included tumors from newly diagnosed or untreated follicular lymphoma in this study. Samples consented to the University of Iowa and Mayo Clinic Lymphoma Specialized Program of Research Excellence (SPORE)  were included for data sharing. RNA was extracted from 1) CD19 sorted B cells from tumor cell suspension frozen in dimethyl sulfoxide (DMSO; RNA","Not Applicable","Lymphoma, Follicular","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 18 variables, 430 samples sequenced, 117 subjects, 430 samples","","NCI","GRU --- General Research Use","2024-01-24","2024-01-24","Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC; Follicle Center Lymphoma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001998.v2.p1","Evolutionary Analysis of Chronic Lymphocytic Leukemia Cells During    Relapse After Allogeneic Hematopoietic Stem Cell Transplant","We investigated the molecular dynamics driving relapse of chronic lymphocytic leukemia (CLL) following allogeneic hematopoietic stem cell transplant (allo-HSCT) through an integrated analysis of whole exome, bulk transcriptome, bulk methylome  and single cell transcriptional data from paired leukemic samples representing 19 patients. We found that their clinical kinetics corresponded to","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case Set","Not Provided","Bisulfite-Seq, OTHER, RNA-Seq, WXS","3 phenotype datasets, 9 variables, 40 samples sequenced, 19 subjects, 40 samples","","NCI","GRU --- General Research Use, DS-HM-MDS --- Disease-Specific (Hematological Malignancies, MDS)","2024-01-24","2021-07-22","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003429.v1.p1","Whole-Exome Sequencing Study of Diabetic Nephropathy","To identify rare variants of diabetic kidney disease (DKD), we conducted a whole-exome sequencing (WES) study. This study employed an extreme case&#x02013;control design, which included a selection of the 593  most rapidly progressing DKD cases from the Chronic Renal Insufficiency Cohort (CRIC) Study (phs000524). In this two-stage WES study of DKD,","Not Applicable","Diabetic Nephropathies","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), CNV (NGS)","3 phenotype datasets, 11 variables, 1 documents, 3 analyses, 1 molecular datasets, 593 subjects, 593 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2024-01-23","2024-01-23","DKD; Diabetic Kidney Disease; Diabetic Kidney Diseases; Diabetic nephropathy; Diabetic renal disease; Kidney Disease, Diabetic",""
"phs003446.v1.p1","Profiling RNA Translation in Pediatric Medulloblastoma","This study provides RNA-sequencing and ribosome profiling data for patient-derived cell lines and patient tissue samples for children with medulloblastoma. Ribosome profiling is a variant protocol of RNA-sequencing that directly  sequences ribosome-bound RNA fragments only. Associated RNA-seq and Ribo-seq data obtained separately for some cancer cell lines can be found on the","Not Applicable","Medulloblastoma","Collection","Not Provided","OTHER, RNA-Seq","3 phenotype datasets, 10 variables, 57 samples sequenced, 21 subjects, 57 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-01-18","2024-01-18","Arachnoidal Cerebellar Sarcoma, Circumscribed; Circumscribed arachnoidal cerebellar sarcoma; Desmoplastic Medulloblastomas; Desmoplastic Nodular Medulloblastoma; Desmoplastic medulloblastoma; Medulloblastoma, Desmoplastic",""
"phs001820.v3.p1","The Institute for Genomic Medicine at Nationwide Children's Hospital    Pediatric Cancer and Blood Disorder Project","The aim of this study is to enable the unification of the clinical and research arms of comprehensive genomic profiling in the setting of cancer and hematologic disease. Increasingly, studies  of the genomic etiology of cancer and hematologic diseases are being utilized for patient management, including prognostication, informing diagnosis,","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38, WES_markerset_grc38, WGS_markerset_grc38, RNAseq_gene_transcripts","FL-cDNA, RNA-Seq, SNP Genotypes (NGS), RNA Seq (NGS), WGA, WGS, WXS","5 phenotype datasets, 27 variables, 2 molecular datasets, 1088 samples sequenced, 259 subjects, 1088 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2024-01-18","2022-08-15","Hematologic Diseases; Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour",""
"phs003269.v1.p1","GATA2 Deficiency and the MonoMAC Syndrome","The aim of this study was to identify the germline mutation(s) in an extended family with individuals having MonoMAC Syndrome/GATA2 deficiency but lacking a canonical GATA2 mutation. GATA2 deficiency patients  develop bone marrow failure, severe immunodeficiency and may progress to myeloid malignancies, including myelodysplastic syndrome (MDS), acute","Not Applicable","Bone Marrow Failure Disorders","Case Set","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGA","5 phenotype datasets, 21 variables, 1 molecular datasets, 6 samples sequenced, 6 subjects, 6 samples","","NCI","GRU --- General Research Use","2024-01-17","2024-01-17","Bone Marrow Transplantation; Congenital Bone Marrow Failure Syndromes; Bone Marrow Failure; Bone marrow hypoplasia; Failure, Bone Marrow; Hypoplastic bone marrow","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003188.v1.p1","Overcoming Clinical Resistance to EZH2 Inhibition Using Rational    Epigenetic Combination Therapy","Essential epigenetic dependencies have become evident in many cancers. Based on functional antagonism between BAF/SWI/SNF and PRC2 in SMARCB1-deficient sarcomas, we and colleagues recently completed the clinical trial of the  EZH2 inhibitor tazemetostat, leading to its FDA approval. However, the principles of tumor response to epigenetic therapy in general and tazemetostat","Not Applicable","Drug Resistance, Neoplasm","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","3 phenotype datasets, 12 variables, 17 samples sequenced, 11 subjects, 17 samples","","NCI","HMB --- Health/Medical/Biomedical","2024-01-17","2024-01-17","Not Provided",""
"phs003412.v1.p1","A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus    Nivolumab in Stage IV Squamous Cell Lung Cancer","Lung-MAP (S1400, NCT02785952) was a multicenter, open-label, phase III randomized clinical trial. The Lung-MAP-I substudy (S1400I) was conducted from December 2015 to April 2018, through the National Clinical Trials Network  and led by the SWOG Cancer Research Network. The trial compared nivolumab plus ipilimumab (nivo+ipi) with nivolumab monotherapy (nivo) in patients","Not Applicable","Carcinoma, Non-Small-Cell Lung","Interventional","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 160 subjects, 731 samples","","NCI","GRU --- General Research Use","2024-01-11","2024-01-11","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER",""
"phs001983.v1.p1","HTAN Pilot Project: Single-Cell Transcriptomics Toolbox for Fresh and    Frozen Human Tumors (Lung, Breast, Ovarian, Melanoma, Neuroblastoma,    Sarcoma, Glioblastoma, Glioma, and Leukemia)","Single cell transcriptomics is a powerful tool to map the complex tumor microenvironment, providing unprecedented resolution into cell types, cell states, cell interactions, and tumor heterogeneity. Depending on their tissue  site and whether processing begins from a fresh or frozen sample, different tumors require different optimizations in order to obtain high quality","Not Applicable","Carcinoma, Non-Small-Cell Lung","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 21 variables, 13 samples sequenced,  SRA, 23 subjects, 40 samples","","NCI","GRU --- General Research Use, DS-CA-MDS --- Disease-Specific (Cancer, MDS), HMB --- Health/Medical/Biomedical","2024-01-10","2024-01-10","Leukemia, Lymphoid; Sarcoma; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs003477.v1.p1","BPH Tissues for Cell Culture and Analysis - Spatial Transcriptomics    Identifies Candidate Stromal Drivers of Benign Prostatic Hyperplasia","The study goal was to apply spatial transcriptomics to identify candidate stromal drivers of benign prostatic hyperplasia (BPH). Laser microdissection (LCM) with RNA-seq of the stroma adjacent to hyperplastic and  budding BPH ducts identified secreted factors including IGF1 and CXCL13. Single&#x02010;cell RNA sequencing (scRNA&#x02010;seq) revealed their","Not Applicable","Prostatic Hyperplasia","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 16 variables, 14 samples sequenced, 6 subjects, 14 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2024-01-09","2024-01-09","BEP - Benign enlargement of prostate; BPH; BPH - benign prostatic hyperplasia; Benign Hyperplasia of Prostate; Benign Hyperplasia of the Prostate; Benign Prostate Hyperplasia",""
"phs002203.v2.p1","Longitudinal Study of Fluoride and Other Factors Related to Dental    Fluorosis, Dental Caries, and Bone Health","This project is a combination of the Iowa Fluoride Study and the Iowa Bone Development Study from 1992 - 2019. The Iowa Fluoride Study (IFS) began in 1992 with recruitment  of 1,882 mothers of newborns from eight Iowa hospital post-partum wards from March 1992 to February 1995. The focus of the IFS was to collect","Not Applicable","Fluorosis, Dental","Prospective Longitudinal Cohort","Not Provided","Not Provided","79 phenotype datasets, 3869 variables, 88 documents, 13334 images, 1584 subjects","","NIDCR","GRU --- General Research Use, DS-DOBC --- Disease-Specific (Dental/Oral and Bone Conditions)","2024-01-08","2024-01-08","Dental Caries; Malocclusion; Osteoporosis; Otitis Media; Caries; Caries, Dental",""
"phs002178.v1.p1","Genomic Characterization CS-MATCH-0007 Arm S2","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 252 variables, 3 subjects, 3 samples","","NCI","GRU-COL --- General Research Use (COL)","2024-01-08","2024-01-08","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002153.v1.p1","Genomic Characterization CS-MATCH-0007 Arm S1","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 277 variables, 41 subjects, 41 samples","","NCI","GRU-COL --- General Research Use (COL)","2024-01-08","2024-01-08","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002058.v1.p1","Genomic Characterization CS-MATCH-0007 Arm Z1I","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 413 variables, 26 subjects, 26 samples","","NCI","GRU-COL --- General Research Use (COL)","2024-01-08","2024-01-08","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002029.v1.p1","Genomic Characterization CS-MATCH-0007 Arm R","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 374 variables,  SRA, 28 subjects, 28 samples","","NCI","GRU-COL --- General Research Use (COL)","2024-01-08","2024-01-08","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs003416.v1.p1","Transcriptomic and Epigenetic Profiling of SCLC Patient Samples","Small cell lung cancer (SCLC) is an aggressive disease with poor outcomes and limited treatment options. Recent studies have identified transcriptionally defined subsets of SCLC that may allow for the  personalization of treatment. Here we use transcriptomic sequencing and methylation profiling (RRBS) of biopsy and cfDNA to develop a highly accurate","Not Applicable","Small Cell Lung Carcinoma","Case Set","Not Provided","Bisulfite-Seq, RNA-Seq","4 phenotype datasets, 13 variables, 344 samples sequenced, 181 subjects, 344 samples","","NCI","GRU --- General Research Use","2023-12-28","2023-12-28","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002430.v1.p1","Childhood Cancer Data Initiative (CCDI): Genomic Analysis in Pediatric    Malignancies","Pediatric solid tumors are highly heterogeneous, encompassing a large number of histotypes. The genomic landscape of these diseases is characterized by few single-nucleotide variants (SNVs) compared to adult cancers. In  contrast, many exhibit a high prevalence of structural or epigenetic changes that alter gene expression, underlining the need for comprehensive","Not Applicable","Pediatrics","Collection","Not Provided","Not Provided","2 phenotype datasets, 7 variables, 239 subjects, 500 samples","","NCI","GRU --- General Research Use","2023-12-27","2023-12-27","Rare Disease; Blastoma; CA; CA - Cancer; Cancer; MT",""
"phs003141.v1.p1","Integrative Somatic and Germline Computational Biology to Redefine    Clinical Actionability in Solid Tumors","Neuroendocrine tumors (NETs) are rare cancers that arise in the gastrointestinal tract and pancreas. The fundamental mechanisms driving gastroenteropancreatic NETs (GEP-NETs) growth remain incompletely elucidated; however, the heterogeneous clinical behavior  of GEP-NETs suggests that both cellular lineage dynamics and tumor microenvironment influence tumor pathophysiology. Here, we performed single-cell","Not Applicable","Gastro-enteropancreatic neuroendocrine tumor","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 8 samples sequenced, 8 subjects, 8 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-12-21","2023-12-21","Carcinoid Tumor; Intestinal Neoplasms; Neuroendocrine Tumors; Carcinoid; Carcinoid tumor (disease); Carcinoid tumors",""
"phs000810.v2.p2","Hispanic Community Health Study /Study of Latinos (HCHS/SOL)","The Hispanic Community Health Study / Study of Latinos (HCHS/SOL) is a multi-center epidemiologic study in Hispanic/Latino populations to determine the role of acculturation in the prevalence and development of  disease, and to identify risk factors playing a protective or harmful role in Hispanics/Latinos. The study is sponsored by the National Heart, Lung,","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Cardio-Metabo_Chip, HumanOmni2.5-8_plus, WGS_markerset_grc37, imputation_panel","Not Provided","3 phenotype datasets, 1571 variables, 243 samples sequenced, 12121 subjects, 36609 samples, 3 substudies","","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU), HMB --- Health/Medical/Biomedical","2023-12-21","2023-12-21","Asthma; Coronary Disease; Myocardial Infarction; Pulmonary Disease, Chronic Obstructive; Airway hyperreactivity; Asthma, Bronchial","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); Collection: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) (phs003650.v1.p1)"
"phs003457.v1.p2","National Sleep Research Resource (NSRR): Hispanic Community Health Study    / Study of Latinos","This dataset phs003457 contains the sleep-related data from the baseline HCHS/SOL exam and sleep data from the sleep sub-study, Sue&#x000f1;o. Individual level phenotype data and molecular data for all HCHS  SOL Cohort top-level study and sub-study are available by requesting Authorized Access to the NHLBI HCHS SOL Cohort phs000810 study. HCHS SOL NSRR:","Hispanic Community Health Study /Study of Latinos (HCHS/SOL) (phs000810.v2.p2)","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU), HMB --- Health/Medical/Biomedical","2023-12-21","2023-12-21","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs000880.v2.p2","Omics in Latinos (Ola) - Genetic Analysis of HCHS/SOL","This sub-study phs000880 HCHS SOL Hispanic Community Health Study contains genotype data and selected phenotype of subjects available from the phs000880. Summary level phenotypes for the NHLBI HCHS SOL Cohort  study participants can be viewed at the top-level study page phs000810 HCHS SOL Cohort. Individual level phenotype data and molecular data for all","Hispanic Community Health Study /Study of Latinos (HCHS/SOL) (phs000810.v2.p2)","Cardiovascular Diseases","Prospective Longitudinal Cohort","HumanOmni2.5-8_plus, imputation_panel","SNP Genotypes (Array), SNP/CNV Genotypes (imputed), SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","1 phenotype datasets, 5 variables, 34 analyses, 4 molecular datasets, 12010 subjects, 12970 samples","European (1284), African (2), East Asian (1), African American (1092), Hispanic1 (2776), Hispanic2 (6284), Other Asian or Pacific Islander (11), Other (987)","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU), HMB --- Health/Medical/Biomedical","2023-12-21","2023-12-21","Asthma; Coronary Disease; Myocardial Infarction; Pulmonary Disease, Chronic Obstructive; Airway hyperreactivity; Asthma, Bronchial",""
"phs000555.v2.p2","Population Architecture using Genomics and Epidemiology (PAGE): Causal    Variants Across the Life Course (CALiCo): Hispanic Community Health    Study / Study of Latinos (HCHS/SOL)","This sub-study phs000555 PAGE CALiCo SOL contains genotype data and selected phenotype of subjects available from the phs000555. Summary level phenotypes for the NHLBI HCHS SOL Cohort study participants can  be viewed at the top-level study page phs000810 HCHS SOL Cohort. Individual level phenotype data and molecular data for all HCHS SOL Cohort top-level","Hispanic Community Health Study /Study of Latinos (HCHS/SOL) (phs000810.v2.p2)","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","Cardio-Metabo_Chip, WGS_markerset_grc37","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WGS, SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WGS","1 phenotype datasets, 7 variables, 2 molecular datasets, 243 samples sequenced, 11043 subjects, 11518 samples","","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU), HMB --- Health/Medical/Biomedical","2023-12-21","2023-12-21","Asthma; Coronary Disease; Myocardial Infarction; Pulmonary Disease, Chronic Obstructive; Airway hyperreactivity; Asthma, Bronchial",""
"phs003017.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Multi-Ethnic    Study of Atherosclerosis (MESA)","Cohort Description The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (CVD) and the risk factors that predict progression to clinically overt CVD  or progression of the subclinical disease. MESA researchers study a diverse, population-based sample of 6,814 asymptomatic men and women aged 45-84.","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 3337 subjects, 3337 samples","","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-12-20","2023-12-20","Atherosclerosis; Cardiovascular Diseases; Atherogeneses; Atherogenesis; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection",""
"phs001519.v2.p1","A Phase I Study With a Personalized Neoantigen Cancer Vaccine in    Glioblastoma Multiforme","Neoantigens, which are derived from tumor-specific protein-coding gene mutations, are exempt from central tolerance, can generate robust immune responses and function as bona fide antigens that facilitate tumor rejection. A  strategy of using multi-epitope and personalized neoantigen vaccination has previously been tested in patients with high-risk melanoma. We","Not Applicable","Glioblastoma","Clinical Trial","Not Provided","OTHER, RNA-Seq, WXS","4 phenotype datasets, 14 variables, 33 samples sequenced, 11 subjects, 33 samples","","NCI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2023-12-20","2018-12-14","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs002164.v1.p1","Translating Gene-Calcium Interactions to Precision Medicine for    Colorectal Cancer","Identify functional and rare SNPs and their interactions with Ca intake levels in relation to risk of incident adenoma using whole-exome resequencing of 2468 colorectal adenoma cases and controls from  PLCO. We will genotype promising rare and functional SNPs associated with incident adenoma in 570 incident cancer cases, 1,710 healthy controls, 710","Not Applicable","Colorectal Adenoma","Case-Control","WES_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 16 variables, 1 molecular datasets, 2269 subjects, 2269 samples","","NCI","GRU --- General Research Use","2023-12-19","2023-12-19","Not Provided",""
"phs002031.v1.p1","Spatially Organized Cellular Communities Form the Developing Human Heart","The heart, which is the first organ to develop, is highly dependent on its form to function. However, how diverse cardiac cell types spatially coordinate to create complex morphological structures  critical for heart function remains to be elucidated. Here, we show that integration of single cell RNA-sequencing with high-resolution multiplexed","Not Applicable","Heart","Control Set","Not Provided","RNA-Seq","4 phenotype datasets, 11 variables, 40 samples sequenced, 8 subjects, 40 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2023-12-19","2023-12-19","Not Provided",""
"phs001752.v2.p1","Genomics and Methylation of Neuroendocrine Prostate Cancer from cfDNA    (Cornell/Trento 2019)","A subset of castration resistant prostate cancers develop small cell neuroendocrine prostate cancer (NEPC) as a mechanism of treatment resistance. Metastatic tissue biopsies to evaluate for NEPC transformation are invasive  and challenging to perform serially. We performed whole exome and whole genome bisulfite sequencing of plasma cfDNA and matched tumor biopsy samples","Not Applicable","Adenocarcinoma","Prospective Longitudinal Cohort","Not Provided","Bisulfite-Seq, WXS","3 phenotype datasets, 10 variables, 185 samples sequenced, 65 subjects, 185 samples","","NCI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-12-18","2020-02-21","Neuroendocrine Tumors; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma",""
"phs003475.v1.p1","PIEZO1 Loss of Function Compound Heterozygous Mutation in the Rare    Congenital Human Disorder Prune Belly Syndrome","Prune Belly Syndrome (PBS) is a rare congenital myopathy that is incompletely understood genetically. In this IRB approved study, one white Non-Hispanic 35 year-old male PBS proband was prospectively enrolled  and phenotyped. Blood lymphocyte DNA from the proband underwent paired-end Whole Exome Sequencing using the Illumina SureSelect kit and HiSeq2500","Not Applicable","Prune Belly Syndrome","Case Set","WES_markerset_grc38","SNP/CNV Genotypes (NGS), WXS","3 phenotype datasets, 10 variables, 1 molecular datasets, 1 samples sequenced, 1 subjects, 1 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2023-12-15","2023-12-15","ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM; Abdominal Muscle Deficiency Syndrome; Congenital Absence of the Abdominal Muscles; EAGLE-BARRETT SYNDROME; EGBRS; Eagle Barrett Syndrome",""
"phs003466.v1.p1","Breast Cancer in Blacks: Impact of Genomics, Healthcare Use and Lifestyle    on Outcomes (BRIGHT)","Young Black females bear a disproportionate burden of breast cancer (BC) mortality compared to White females and are underrepresented in clinical studies. It remains critical to understand factors that contribute  to the high mortality from BC among young Black females in order to improve outcomes. The higher BC mortality rate among young Black females with","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","Multi-Ethnic_Global","SNP Genotypes (Array), mRNA Expression (Array)","4 phenotype datasets, 20 variables, 1 molecular datasets, 378 subjects, 481 samples","","NCI","DS-BRCA-GSO --- Disease-Specific (Breast Cancer, GSO)","2023-12-15","2023-12-15","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003408.v1.p1","MILK-Omics: Systems Biology of Human Milk and Its Links to Maternal and    Infant Health","The primary objective of the project is to generate a systems-level view of human milk in the context of healthy mothers and their term infants. The study uses biospecimens and  clinical data from the Mothers and Infants LinKed for Healthy Growth Study (MILk Study), a prospective observational cohort of approximately 500","Not Applicable","Milk, Human","Prospective Longitudinal Cohort","WGS_markerset_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 12 variables, 1 documents, 1 molecular datasets, 346 samples sequenced, 346 subjects, 346 samples","European (226), African (2), East Asian (3), African American (4), Hispanic1 (5), Hispanic2 (7), Other Asian or Pacific Islander (2), Other (2)","NICHD","HMB-MDS --- Health/Medical/Biomedical (MDS)","2023-12-15","2023-12-15","Not Provided",""
"phs003376.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Empowering Schools as Community Assets to Mitigate the Adverse Impacts    of COVID-19","This community-based participatory study will implement and refine a SARS-CoV-2 testing program that will increase testing uptake, foster the return to face-to-face classroom instruction, promote school-based mitigation measures, and empower  student as changes agents. Goal and Specific Aims: Therefore, the primary goal of this study is to empower schools as community assets in the safe","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2023-12-15","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003375.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Collaborative Community Networks to Optimize Implementation of Low    Barrier COVID-19 Testing Efforts Among Diverse Latinx Populations in    Northern California","We will evaluate community-engaged approaches to improving access and uptake of COVID-19 testing among majority Latinx communities in Northern California, and to understanding local epidemiology and factors driving the stark  ethnic disparities observed in COVID-19 case rates. In Aim 1, we will evaluate implementation of a Latino Task Force (LTF) collaborative network","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2023-12-15","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003374.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Community Collaboration to Combat Coronavirus (C-FORWARD)","The novel Severe Acute Respiratory Syndrome (SARS) Coronavirus 2019 (SARS-CoV-2 or COVID-19) emerged as a new viral infection in December 2019. Now a global pandemic, COVID-19 has presently sickened more  than one million Americans in just three months with more than 50,000 deaths as of April 27, 2020. COVID-19 presents as a mild dry cough with or","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-12-15","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003373.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Rapid Optimization of COVID-19 Testing for People Affected by Dia","The Georgia Center for Diabetes Translation Research Center (P30DK111024) proposes to leverage its interdisciplinary expertise (clinicians, implementation and behavioral scientists, public health, technology, and diabetes experts) and collaborations (community, academic,  government, and health system partners) to rapidly scale a COVID-19 testing program for adults and children who are at high risk due to background","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2023-12-15","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003371.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    &#x000d3;RALE COVID-19! Vaccination: An Initiative to Increase COVID-19    Vaccination in Yolo, Madera, Fresno, Stanislaus Counties in California","Latinos have disproportionately suffered from COVID-19. In California, Latinos make up 39% of the population but 46% of deaths and more than half of all cases. Agricultural employees are essential  workers and the risk of SARS-CoV-2 transmission is high because social distancing and masking are difficult&#x02014;especially in very hot weather.","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2023-12-15","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003365.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Social, Behavioral, and Ethical Implications of COVID-19","The proposed research will examine ways of understanding and responding to sources of mistrust and misinformation about COVID-19. The research will also refine community-engaged research approaches to enhance the process  of building and sustaining trust with communities. A central theme of the proposed research will be to develop processes and resources to assure","Not Applicable","COVID-19","Case-Control","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2023-12-15","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003364.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Sin Duda: A Community-Driven Approach to Expand Reach, Access and    Uptake of COVID-19 Home-Based Tests for At-Risk Latinos","The COVID-19 pandemic disproportionately impacts Latinos in the US. COVID-19 testing remains critical for tracking and slowing the spread of the virus and preventing future outbreaks, particularly in communities disproportionately  affected by COVID-19 and where vaccination coverage is suboptimal. The goal of this project is to expand our RADx-UP Phase 1 COVID-19 testing project","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-12-15","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003359.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    WUSTL Supporting the Health and Well-being of Children with    Intellectual and Developmental Disability During COVID-19 Pandemic","Children with intellectual and developmental disabilities (IDD) are at major risk of irreversible harm from the Coronavirus Infectious Diseases 2019 (COVID-19) pandemic, particularly those from underserved populations. Not only are  they at dramatically higher risk of becoming infected with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and death from COVID-19, but","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2023-12-15","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003328.v1.p1","Genetic Causes of Congenital Anosmia","The Genetic Causes of Congenital Anosmia study was designed to provide a list of candidate genes that are potentially causal for isolated congenital anosmia (ICA), a rare inherited disorder where  individuals lack a sense of smell from birth in the absence of a known genetic syndrome (i.e. Kallman's syndrome). This study includes 193","Not Applicable","Congenital anosmia","Family/Twin/Trios","Not Provided","WXS","5 phenotype datasets, 29 variables, 194 samples sequenced, 194 subjects, 194 samples","","NIDCD","GRU-PUB --- General Research Use (PUB)","2023-12-13","2023-12-13","Anosmia; Olfaction Disorders; Absent smell; Anosmia (loss of sense of smell); Defective sense of smell; Loss of Smell",""
"phs003208.v1.p1","Transcriptomic Profiling of Bulk Tissue and Laser-Capture Microdissected    Neurons of Postmortem Human Brains in the Superior Temporal Gyrus","We performed RNA-Seq on bulk tissue and laser-capture microdissected (LCM) neurons from 59 postmortem human brains in the superior temporal gyrus (STG) to investigate Autism Spectrum Disorder (ASD)-associated transcriptomic changes.  We examined post-mortem brain tissue from 27 subjects with ASD and 32 neuro-typical controls. Raw RNA-Seq data in FASTQ format are provided.","Not Applicable","Autism Spectrum Disorder","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 22 variables, 88 samples sequenced, 59 subjects, 99 samples","","NIMH","GRU --- General Research Use","2023-12-13","2023-12-13","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs003473.v1.p1","Cellular and Molecular Investigations of Human Hearts","We aim to discover gene regulatory networks that govern heart morphogenesis in the early fetal heart. To this end, we have performed single-nucleus ATAC-seq on cells derived from 2 human  hearts at 15 weeks post conception to define the chromatin profiles and genomic regulatory networks for these in vivo specific cardiomyocyte lineages","Not Applicable","Heart","Control Set","Not Provided","ATAC-seq","4 phenotype datasets, 13 variables, 10 samples sequenced, 2 subjects, 10 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2023-12-12","2023-12-12","Not Provided",""
"phs003470.v1.p1","Unrelated Donor Reduced Intensity Bone Marrow Transplant for Children    with Severe Sickle Cell Disease (BMT CTN-0601-BioLINCC)","Objectives The primary objective is to determine event-free survival (EFS) at 1 year after unrelated donor (URD) hematopoietic stem cell transplantation (HCT) using bone marrow (BM) in patients with sickle  cell disease (SCD). Background Sickle cell disease (SCD), also known as sickle cell anemia, is an inherited blood disease that can cause organ","Not Applicable","Anemia, Hemolytic, Congenital","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 55 subjects, 55 samples","","NHLBI","GRU --- General Research Use","2023-12-11","2023-12-11","Anemia; Anemia, Hemolytic; Anemia, Sickle Cell; Hematologic Diseases; Hemoglobinopathies; Anaemia, Haemolytic",""
"phs002980.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Mediators of    Atherosclerosis in South Asians Living in America Study (MASALA)","Cohort Description The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study is a prospective cohort of South Asians that aims to identify risk factors for heart disease  in a large, growing Asian American subgroup. MASALA enrolled 906 South Asians in 2010-2013 and then added a new wave of 258 South Asian participants","Not Applicable","Asian","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 571 subjects, 571 samples","","NHLBI","HMB-IRB-COL --- Health/Medical/Biomedical (IRB, COL)","2023-12-07","2023-12-07","Arterial Occlusive Diseases; Atherosclerosis; COVID-19; Cardiovascular Diseases; Coronary Disease; Heart Diseases",""
"phs003448.v1.p1","Non-Coding Autoimmune Risk Variant Defines Role for ICOS in T Peripheral    Helper Cell Development","Our fine-mapping of 76 non-MHC loci associated with risk for rheumatoid arthritis (RA, 11,475 cases, 15,870 controls) has recently identified rs117701653, a non-coding single nucleotide polymorphism (SNP) in the CTLA4/CD28/ICOS  locus, as the variant most likely to modulate RA risk within this region, with the minor allele C showing disease protection compared to the major","Not Applicable","Arthritis, Rheumatoid","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 12 variables, 24 samples sequenced, 24 subjects, 24 samples","","NIAMS","DS-INIM --- Disease-Specific (Inflammatory, Immunological)","2023-12-05","2023-12-05","Autoimmune Diseases",""
"phs002458.v2.p1","Evolution of Chronic Lymphocytic Leukemia to Richter's Syndrome (RS)","Richter's syndrome arising from chronic lymphocytic leukemia is a striking example of an aggressive malignant histology that emerges from indolent cancer. To understand this process, we reconstructed phylogenies based on  whole exome sequencing of matched normal, CLL and RS samples. We computationally deconvoluted CLL and RS clones and identified drivers of","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case Set","Not Provided","RNA-Seq, WGS, WXS","4 phenotype datasets, 16 variables, 358 samples sequenced, 133 subjects, 384 samples","","NCI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical, DS-HM-MDS --- Disease-Specific (Hematological Malignancies, MDS)","2023-12-05","2021-11-23","Cell Transformation, Neoplastic; Cell Neoplastic Transformation; Cell Neoplastic Transformations; Cell Transformations, Neoplastic; Neoplastic Cell Transformations; Neoplastic Transformation, Cell","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003428.v1.p1","CALGB/SWOG 80405: Genome-Wide Association Study of Patients with Advanced    or Metastatic Colorectal Cancer Treated with First-Line Chemotherapy    Combined with Cetuximab and/or Bevacizumab","CALGB/SWOG 80405 (NCT00265850) was a randomized phase III study of bevacizumab, cetuximab, or the combination of these two monoclonal antibodies, in addition to systemic chemotherapy for patients with untreated metastatic  adenocarcinoma of the colon or rectum. We prospectively collected germline DNA and conducted genome-wide association studies using clinical outcomes","Not Applicable","Colorectal Neoplasms","Clinical Trial","WES_markerset_grc38","SNP Genotypes (NGS)","4 phenotype datasets, 66 variables, 1 molecular datasets, 1464 subjects, 1464 samples","European (1192), African (3), East Asian (25), African American (151), Hispanic1 (12), Hispanic2 (62), Other Asian or Pacific Islander (13), South Asian (4), Other (2)","NCI","DS-CA-COL --- Disease-Specific (Cancer, COL)","2023-12-04","2023-12-04","Adenocarcinoma; Neoplasm Metastasis; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant",""
"phs003381.v1.p1","Cryptic Splice Mutation in the Fumarate Hydratase Gene in Patients With    Clinical Manifestations of Hereditary Leiomyomatosis and Renal Cell    Cancer (HLRCC)","Four patients with hysterectomy were evaluated for biochemical and molecular evidence of autosomal dominant Fumarate Hydratase (FH) alterations causing Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC). HLRCC is an autosomal  dominant condition characterized by the development of cutaneous and uterine leiomyomas, and risk for development of an aggressive form of papillary","Not Applicable","Hereditary leiomyomatosis and renal cell cancer","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 17 variables, 1 molecular datasets, 4 samples sequenced, 4 subjects, 4 samples","","NCI","GRU --- General Research Use","2023-12-04","2023-12-04","Cutaneous leiomyomata with uterine leiomyomata; FH Deficiency; FH tumor predisposition syndrome; Familial leiomyomatosis; Familial leiomyomatosis and renal cell cancer; Familial leiomyomatosis cutis et uteri",""
"phs003255.v1.p1","Single Duplex DNA Sequencing with CODEC Detects Mutations with High    Sensitivity","Detecting mutations from single DNA molecules is crucial in many fields but challenging. Next generation sequencing (NGS) affords tremendous throughput but cannot directly sequence double-stranded DNA molecules (single duplexes) to  discern the true mutations on both strands. Here, we present Concatenating Original Duplex for Error Correction (CODEC) which confers single duplex","Not Applicable","Neoplasms","Collection","Not Provided","Targeted-Capture, WGS","4 phenotype datasets, 16 variables, 30 samples sequenced, 7 subjects, 30 samples","","NCI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical, HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-12-04","2023-12-04","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003187.v1.p1","LCLF1.0 Data","In this study, we investigated ad libitum food intake of 20 healthy adult volunteers who each completed a 4-week stay at the National Institutes of Health (NIH). During their stay,  they consumed a low-carbohydrate, high-fat (LCHF) diet and a low-fat, high-carbohydrate (LFHC) diet for 2 weeks each, in random order. We collected","Not Applicable","Diet","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 18 samples sequenced, 6 subjects, 18 samples","","NIDDK","GRU-PUB-COL --- General Research Use (PUB, COL)","2023-12-01","2023-12-01","Carbohydrate Metabolism; Lipid Metabolism; Metabolism, Carbohydrate; Metabolism, Carbohydrates/Storage/Polysaccharides",""
"phs003225.v1.p1","All of Us","The NIH's All of Us Research Program aims to develop one of the world's largest biomedical databases utilizing healthcare data from a diverse group of participants across the United States  for the goal of improving personalized healthcare strategies through research. This dataset includes electronic health record data, participant","Not Applicable","Population Characteristics","Case-Control","Not Provided","Not Provided","Not Provided","","OD","","2023-11-30","","Not Provided",""
"phs003436.v1.p1","KRT17High/CXCL8+ Tumor Cells Display Both Classical and Basal Features    and Regulate Myeloid Infiltration in the Pancreatic Cancer    Microenvironment","Recent studies have uncovered the co-existence of basal and classical subtypes within pancreatic ductal adenocarcinoma (PDAC). We sought to characterize these intermediary cells using single-cell RNA sequencing of PDAC. We  performed subtyping on 18 single-cell RNA sequencing human PDAC samples to identify multiple intermediary subtypes. We compared single-cell profiling","Not Applicable","Carcinoma, Pancreatic Ductal","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 16 variables, 6 samples sequenced, 6 subjects, 6 samples","","NCI","DS-PACA --- Disease-Specific (Pancreatic Cancer)","2023-11-30","2023-11-30","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas",""
"phs003415.v1.p1","Resistance Development in Basal Cell Nevus Syndrome through the Basal to    Squamous Transition","While basal cell carcinomas (BCCs) arise from ectopic hedgehog pathway activation and can be treated with pathway inhibitors, sporadic BCCs display high resistance rates, while tumors arising in Gorlin syndrome  patients with germline Patched (PTCH1) mutations are uniformly suppressed by inhibitor therapy. In rare cases, Gorlin syndrome patients on long-term","Not Applicable","Basal Cell Nevus Syndrome","Case Set","WES_markerset_grc36, custom_probe_set","OTHER, SNV Aggregate (.MAF), RNA Seq (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 9 samples sequenced, 1 subjects, 9 samples","","NIAMS","GRU --- General Research Use","2023-11-30","2023-11-30","BCNS; BCNS - Basal cell nevus syndrome; BCNS1; Basal cell carcinoma syndrome; Fifth Phacomatoses; Fifth Phacomatosis",""
"phs001272.v2.p1","Broad Institute Center for Mendelian Genomics","The Centers for Mendelian Genomics project uses next-generation sequencing and computational approaches to discover the genes and variants that underlie Mendelian conditions. By discovering genes that cause Mendelian conditions, we  will expand our understanding of their biology to facilitate diagnosis and new treatments. Prioritization Criteria: 1. Likely Mendelian cause: The","Not Applicable","Genetic Diseases, Inborn","Family/Twin/Trios","WES_markerset_grc37","RNA-Seq, SNP/CNV Genotypes (NGS), WGS, WXS","5 phenotype datasets, 18 variables, 1 molecular datasets, 1037 samples sequenced, 1031 subjects, 1037 samples","","NHGRI","GRU --- General Research Use, DS-KRD-RD --- Disease-Specific (Kidney and Related Disorders, RD), HMB-MDS --- Health/Medical/Biomedical (MDS), DS-NIC-EMP-LENF --- Disease-Specific (No Insurance companies, employers, or the police until required by court order or by law), DS-BFD-MDS --- Disease-Specific (Bone Failure Disorders, MDS), DS-NEUROLOGY-MDS --- Disease-Specific (Neurology, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), GRU-IRB --- General Research Use (IRB)","2023-11-29","2018-11-20","Bardet-Biedl Syndrome; Blepharoptosis; Chorea; Ciliopathies; Coffin-Siris syndrome; Congenital Abnormalities",""
"phs002033.v3.p1","A Chromatin Accessibility Atlas of the Developing Human Telencephalon","Gene expression differs between cell types and regions within complex tissues such as the developing brain. To discover regulatory elements underlying this specificity, we generated genome-wide maps of chromatin accessibility  in nine anatomically-defined regions of the developing human telencephalon. Additionally, we defined the histone modification landscape of the","Not Applicable","Chromatin Assembly and Disassembly","Prospective Longitudinal Cohort","Not Provided","ATAC-seq, ChIP-Seq, OTHER","4 phenotype datasets, 12 variables, 56 samples sequenced, 15 subjects, 56 samples","","NINDS","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-11-24","2020-07-06","Not Provided",""
"phs001933.v2.p1","NHLBI TOPMed - NHGRI CCDG: UCSF Atrial Fibrillation Study","The University of California San Francisco (UCSF) Cardiovascular Research Institute (CVRI) Resource in Arteriosclerosis and Metabolic Disease is an ongoing multi-ethnic study of adults &#x02265; 18 years of age which  was started in 1989 and now includes 28,000 participants recruited from the UCSF medical system. Within the Resource lies data and biospecimens from","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 21 variables, 2 documents, 2 molecular datasets, 1 samples sequenced, 113 subjects, 113 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2023-11-22","2023-11-22","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs001543.v3.p1","NHLBI TOPMed - NHGRI CCDG: AF Biobank LMU in the context of the MED    Biobank LMU","The Atrial Fibrillation Biobank Ludwig Maximilian University (AFLMU) Study contributes to the spectrum of disease by adding carefully characterized patients with atrial fibrillation. Atrial fibrillation, one of the most common  human arrhythmias confers major morbidity, mortality and health care cost, and has been demonstrated to be caused and influenced by genetic and","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 18 variables, 2 documents, 2 molecular datasets, 2 samples sequenced, 350 subjects, 350 samples","","NHLBI","HMB-IRB-PUB-COL-NPU-MDS --- Health/Medical/Biomedical (IRB, PUB, COL, NPU, MDS)","2023-11-22","2023-11-22","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs001189.v5.p1","NHLBI TOPMed: Cleveland Clinic Atrial Fibrillation (CCAF) Study","The Cleveland Clinic Atrial Fibrillation Study consists of clinical and genetic data of patients with atrial fibrillation and control cohorts from the Cleveland Clinic CV/Arrhythmia Biobank, including the Cleveland Clinic  Lone Atrial Fibrillation GeneBank. The Cleveland Clinic Lone AF GeneBank Study has enrolled patients with lone AF, defined as AF in the absence of","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","5 phenotype datasets, 37 variables, 2 documents, 2 molecular datasets, 364 samples sequenced, 363 subjects, 364 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2023-11-22","2023-11-22","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs003418.v1.p1","Altered Interactions between Circulating and Tissue-Resident CD8 T Cells    with the Colonic Mucosa Define Checkpoint Inhibitor Colitis","Therapeutic immune checkpoint blockade has revolutionized oncology, but treatments are limited by immune-related adverse events, including checkpoint inhibitor colitis (irColitis). To define molecular drivers of irColitis, we profiled 300,000 cells  from the colonic mucosa and blood of 29 patients and controls. Patients with irColitis showed expanded mucosal Tregs (regulatory T cells), CD8","Not Applicable","Colitis","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 171 samples sequenced, 33 subjects, 171 samples","","NCI","GRU --- General Research Use","2023-11-21","2023-11-21","","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002810.v1.p1","Genetic Analysis of Latin American Cervical Cancer","HPV16 is the most oncogenic type of human papillomaviruses (HPV). Integration of HPV into the human genome is an important mechanism of carcinogenesis but is absent in at least 30%  of HPV16+ tumors. We applied long-read whole-genome sequencing (WGS) to cervical cancer cell lines and tumors to characterize HPV16 carcinogenesis in","Not Applicable","Uterine Cervical Neoplasms","Case Set","Not Provided","WGS","4 phenotype datasets, 19 variables, 58 samples sequenced, 58 subjects, 58 samples","","NCI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-11-21","2023-11-21","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms",""
"phs001423.v4.p2","Tourette International Collaborative Genetics (TIC Genetics) Study -    NJCTS and NIMH","The Tourette International Collaborative Genetics (TIC Genetics) Study is an international collaboration of scientists and clinicians specialized in Tourette Disorder (TD) from more than 20 sites across the United States,  Europe, and South Korea. The study was established to further our understanding of the genetic architecture of tic disorders by developing a large","Not Applicable","Tourette Syndrome","Family/Twin/Trios","HumanOmniExpressExome-8","SNP Genotypes (Array), WXS","6 phenotype datasets, 104 variables, 3 documents, 1 molecular datasets, 1285 samples sequenced, 1615 subjects, 1706 samples","","NIMH","DS-TS-IRB-PUB-GSO-RD --- Disease-Specific (Tourette Syndrome, IRB, PUB, GSO, RD)","2023-11-21","2018-12-28","Attention Deficit-Hyperactivity Disorder; Chronic Motor or Vocal Tic Disorder; Obsessive-Compulsive Disorder; Tourette Disorder; ADD; ADDH",""
"phs003077.v1.p1","Retinoblastoma Aqueous Humor Liquid Biopsy Repository","This study involves the use of the aqueous humor (AH, the clear fluid in the front of the eye) as an organ specific liquid biopsy for retinoblastoma. This relatively new  liquid biopsy platform was started at CHLA/USC and was developed to overcome the lack of tumor tissue -- due to contraindication to biopsy -- for","Not Applicable","Retinoblastoma","Collection","Not Provided","WGS","4 phenotype datasets, 24 variables, 263 samples sequenced, 81 subjects, 264 samples","","NCI","DS-RET-DIS-IRB-PUB-COL-NPU --- Disease-Specific (Retinal Diseases, IRB, PUB, COL, NPU)","2023-11-20","2023-11-20","Retinal Neoplasms; Cancer of the Retina; Cancer, Retinal; Cancers, Retinal; Malignant Neoplasm of Retina; Malignant Neoplasm of the Retina",""
"phs002815.v2.p1","Center for Craniofacial and Dental Genetics (CCDG): Genetics of Orofacial    Clefts, Sub-types, and Subclinical Phenotypes - CIDR","The purpose of this project is to identify the genetic factors contributing to nonsyndromic orofacial clefts (OFCs), common subtypes, and related subclinical phenotypes. The most common subtypes of OFCs are  cleft lip alone (CL), cleft lip with cleft palate (CLP), and cleft palate alone (CP). CL and CLP can be unilateral (left or right) or bilateral.","Not Applicable","Mouth Abnormalities","Family/Twin/Trios","Global_Diversity_Array-8, imputation_panel","SNP/CNV (Array), SNP/CNV Genotypes (imputed)","5 phenotype datasets, 47 variables, 2 molecular datasets, 4114 subjects, 4203 samples","European (203), African (1000), East Asian (464), African American (62), Hispanic1 (191), Hispanic2 (247), Other Asian or Pacific Islander (1725), South Asian (25), Other (197)","NIDCR","DS-OBDR-RD --- Disease-Specific (Orofacial birth defects and related phenotypes, RD), GRU --- General Research Use, DS-CFR-IRB-COL --- Disease-Specific (Craniofacial Research, IRB, COL), HMB-MDS --- Health/Medical/Biomedical (MDS), HMB --- Health/Medical/Biomedical, DS-OBDR-MDS-RD --- Disease-Specific (Orofacial birth defects and related phenotypes, MDS, RD)","2023-11-20","2022-09-22","Cleft Lip; Cleft Palate; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003221.v1.p1","Sudden Death in the Young Case Registry","Knowledge gaps persist about the incidence of and risk factors for sudden death in the young (SDY). The SDY Case Registry is a collaborative effort between the National Institutes of  Health, the Centers for Disease Control and Prevention, and the Michigan Public Health Institute. Its goals are to: (1) describe the incidence of SDY","Not Applicable","Death, Sudden","Case Set","Not Provided","WGA, WGS","3 phenotype datasets, 8 variables, 269 samples sequenced, 294 subjects, 294 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2023-11-17","2023-11-17","CAV3-Related Sudden Infant Death Syndrome; Cot Death; Cot Deaths; Crib Death; Death, Cot; Death, Crib",""
"phs003093.v1.p1","The Genomic Landscape of Interval Colorectal Cancers","Interval colorectal cancers (CRC), cancers diagnosed after a screening/surveillance exam in which no cancer is detected, and before the date of the next recommended exam, reflect an unprecedented challenge in  CRC detection and prevention. To better understand this poorly characterized CRC variant, we examined the clinical and mutational characteristics of","Not Applicable","Colorectal Neoplasms","Tumor vs. Matched-Normal","Not Provided","WXS","4 phenotype datasets, 14 variables, 323 samples sequenced, 168 subjects, 323 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-11-17","2023-11-17","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs003217.v1.p1","Molecular Determinants of Esophageal Cancer in Tanzania","We describe the genomic profiles of 61 esophageal squamous cell carcinoma (ESCC) cases from Tanzania and compare them to profiles from an existing cohort of ESCC cases from Malawi. We  also provide a comparison to ESCC tumors in The Cancer Genome Atlas Program (TCGA). Despite a high burden of ESCC in Eastern Africa, investigations","Not Applicable","Esophageal Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 14 variables, 178 samples sequenced, 61 subjects, 178 samples","","NCI","DS-E-C-NPU --- Disease-Specific (Esophageal Cancer, NPU)","2023-11-16","2023-11-16","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophageal neoplasm; Esophageal tumour; Esophagus Neoplasm",""
"phs002041.v2.p1","WGSPD Project 1: Whole Genome Sequencing for Schizophrenia and Bipolar    Disorder","The Center for Genomic Psychiatry at the University of Southern California (USC) and an extensive network of academic medical centers have created the Genomic Psychiatry Cohort (GPC). The GPC consists  of a large clinical cohort of patients with schizophrenia, bipolar disorder, and healthy controls. The pilot phase of whole genome sequencing of the","Not Applicable","Schizophrenia","Case-Control","Not Provided","Not Provided","Not Provided","","NIMH","DS-MLHLTH-MDS --- Disease-Specific (Mental Health, MDS), DS-SZRD-MDS --- Disease-Specific (Schizophrenia and related disorders, MDS), GRU --- General Research Use, DS-MBND-MDS --- Disease-Specific (Mental, Behavioral, and Neurodevelopmental Disorders, MDS), DS-SZ-MDS --- Disease-Specific (Schizophrenia, MDS), HMB-MDS --- Health/Medical/Biomedical (MDS)","2023-11-16","","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003390.v1.p1","Adipose Tissue Omics In Obesity","This project used a multi-omics approach to study the adipose tissue transcriptome in humans with and without obesity. Our human cohort included males and females between the ages of 18-80  who underwent elective abdominal surgery at the University of Michigan and the Ann Arbor Veterans Affairs Healthcare System.Patients with advanced","Not Applicable","Adipose Tissue","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 33 samples sequenced, 10 subjects, 33 samples","","NIDDK","GRU --- General Research Use","2023-11-15","2023-11-15","Not Provided",""
"phs002926.v1.p1","Infant Immune Responses to Early Life Vaccinations","Infants are vulnerable to life-threatening infections due to an immature immune system. For this reason, vaccinations are provided early in life to increase protection against infectious agents. However, there is  a limited understanding on how routine vaccinations alter the different immune cell populations in infants. Here, we profiled peripheral blood","Not Applicable","Immunity","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 18 samples sequenced, 6 subjects, 18 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2023-11-14","2023-11-14","Not Provided",""
"phs001631.v1.p1","Genetics of Mood Disorders: Aging and Emotion Regulation Brain Circuitry    in Bipolar","This single-site study is designed to investigate age-related changes in structure and function of a ventral prefrontal cortex (VPFC) neural system, that subserves emotion processing and regulation, during mid to  later adulthood in individuals with bipolar disorder (BD), compared to healthy controls (HC). It is a 5-year study of age-related changes in mood,","Not Applicable","Bipolar Disorder","Case-Control","PsychArray-24","SNP Genotypes (Array)","5 phenotype datasets, 20 variables, 1 molecular datasets, 80 subjects, 78 samples","European (45), African (2), African American (16), Hispanic1 (1), Hispanic2 (2)","NIMH","GRU --- General Research Use","2023-11-14","2023-11-14","Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders; Bipolar Mood Disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs003422.v1.p1","Hereditary Gastric Cancer Syndromes: An Integrated Genomic and    Clinicopathologic Study of the Predisposition to Gastric Cancer","Gastric cancers are cancers of the stomach. Hereditary cancers are passed from parent to child. Researchers want to gather data about hereditary gastric cancers. Bulk RNA sequencing (RNA-seq) of signet  ring cells (SRCs) and adjacent non-SRC epithelium (NEP) was performed on laser-capture microdissected (LCM) regions of interest found in","Not Applicable","Stomach Neoplasms","Tumor vs. Matched-Normal","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 19 variables, 1 molecular datasets, 42 samples sequenced, 20 subjects, 42 samples","","NCI","GRU --- General Research Use","2023-11-13","2023-11-13","Ca lesser curvature - stomach; Cancer of Stomach; Cancer of the Stomach; Cancer, Gastric; Cancer, Stomach; Cancers, Gastric","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003361.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    COVID-19 Testing and Prevention in Correctional Settings","This study will work with diverse correctional facilities across MN, RI, WA, and FL to characterize the incidence of COVID-19 disease progression and related outcomes. The goal is to identify  barriers and facilitators to develop strategies to improve testing in these under-served populations by: Increasing the reach, access, uptake, and","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2023-11-13","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003310.v1.p1","Type I Interferon and Cycling Lymphocytes in Macrophage Activation    Syndrome","We performed immune profiling of peripheral blood mononuclear cells from patients with Still's disease and macrophage activation syndrome (MAS) using bulk RNA sequencing and single-cell RNA sequencing. Three groups were  included in the study: healthy controls, patients with Still's disease without macrophage activation syndrome, and patients with Still's disease and","Not Applicable","Macrophage Activation Syndrome","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 46 samples sequenced, 48 subjects, 46 samples","","NIAID","HMB --- Health/Medical/Biomedical","2023-11-13","2023-11-13","Arthritis, Juvenile; Arthritis, Juvenile Systemic; Juvenile Onset Still Disease; Juvenile Onset Stills Disease; Juvenile Systemic Arthritis; Juvenile onset Still's disease",""
"phs001282.v4.p1","Pathogenesis and Immunity in Endemic Burkitt Lymphoma","This genomic landscape of Burkitt lymphoma represents a multimodal sequencing of tumors and control tissues and individuals to better understand the etiology, and molecular pathogenesis of Burkitt lymphoma including the  roles of the associated Plasmodium falciparum malaria and EBV infections. Comprehensive sequencing set includes genomic, transcriptomic, and","Not Applicable","Burkitt Lymphoma","Case Set","Not Provided","RNA-Seq, miRNA-Seq, ssRNA-seq","4 phenotype datasets, 25 variables, 44 samples sequenced, 44 subjects, 44 samples","","NCI","DS-BL-PUB-NPU --- Disease-Specific (Burkitt Lymphoma, PUB, NPU)","2023-11-13","2017-02-13","Lymphoma, Non-Hodgkin; BL; BL - Burkitt's lymphoma; Burkitt Tumor; Burkitt lymphoma/leukemia; Burkitt's Lymphoma",""
"phs003427.v1.p1","Single-Cell Profiling of Premature Neonate Airways Reveals a Continuum of    Myeloid Differentiation","We set out to develop a reference single-cell transcriptomic profile of airway aspirate samples from extremely premature neonates (collected within an hour of birth). In this study, we profiled samples  from 10 subjects. We identified cells in the airways of premature neonates representing a continuum of myeloid differentiation, including fetal","Not Applicable","Infant, Extremely Premature","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 11 variables, 10 samples sequenced, 10 subjects, 10 samples","","NIGMS","GRU --- General Research Use","2023-11-09","2023-11-09","Infant, Very Low Birth Weight; Very Low Birth Weight","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001229.v2.p1","Sequencing Lymphoma","This repository contains sequencing data to describe the genomic profiles of several B-cell lymphomas including follicular lymphoma and Hodgkin lymphoma. We have used several different high throughput sequencing technologies to  interrogate genomic DNA and RNA from tumor cells obtained from lymph node biopsies and normal cells obtained from skin biopsies and peripheral blood","Not Applicable","Lymphoma, Follicular","Tumor vs. Matched-Normal","Not Provided","OTHER, RNA-Seq, WXS","12 phenotype datasets, 87 variables, 335 samples sequenced, 108 subjects, 335 samples","","NHGRI","DS-LYM --- Disease-Specific (Lymphoma)","2023-11-08","2023-11-08","Hodgkin Disease; CHL; Classic Hodgkin disease; Disease, Hodgkin; Disease, Hodgkin's; Disease, Hodgkins",""
"phs003403.v1.p1","Circulating RNAs in Acute Heart Failure (CRUCIAL)","The purpose of this American Heart Association-funded and NIH-funded study is to examine circulating RNAs in the acute congestive heart failure (CHF) setting, and how they change with decongestive therapy,  and their function in vitro and in vivo. The investigators are testing the hypothesis that ex-RNA levels change significantly during decongestion","Not Applicable","Heart Failure","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 92 samples sequenced, 41 subjects, 92 samples","","NHLBI","DS-HF-IRB --- Disease-Specific (Heart Failure, IRB)","2023-11-06","2023-11-06","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac",""
"phs003214.v1.p1","NPC Genome Project","Niemann-Pick disease, type C1 (NPC1) is neurodegenerative disorder due to pathological variants of NPC1. NPC1 is predominately a pediatric/adolescent disorder, although adult onset cases have been described. The NPC1 protein  functions to move unesterified cholesterol from the endolysosomal lumen to make it bioavailable for cellular function. Impaired NPC1 function results","Not Applicable","Niemann-Pick Diseases","Case Set","Not Provided","WGS","5 phenotype datasets, 21 variables, 120 samples sequenced, 120 subjects, 120 samples","","NICHD","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-11-06","2023-11-06","ASM Deficient Niemann Pick Disease; ASM-Deficient Niemann-Pick Disease; Acid Sphingomyelinase Deficiency; Acid Sphingomyelinase Deficient Niemann Pick Disease; Acid Sphingomyelinase-Deficient Niemann-Pick Disease; Deficiency, Acid Sphingomyelinase",""
"phs002910.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Genetic    Epidemiology of COPD Study (COPDGene)","Cohort Description The Genetic Epidemiology of COPD (COPDGene) study is a non-interventional, multicenter, longitudinal, case-control study at 21 US sites of smokers with a &#x02265;10 pack-year history of smoking, with  and without COPD, and healthy never smokers. The initial goal was to characterize disease-related phenotypes and explore associations with","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 4191 subjects, 4191 samples","","NHLBI","HMB --- Health/Medical/Biomedical, DS-CS --- Disease-Specific (COPD and Smoking)","2023-11-06","2023-11-06","COPD; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD","NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs003143.v1.p1","My Pediatric and Adult Rare Tumor (MyPART) Natural History Study of Rare    Solid Tumors","The goal of this study is to comprehensively and longitudinally evaluate the natural history of patients with rare solid tumors or tumor predisposition syndromes, estimating and defining their clinical spectrum  (e.g. disease course and survival). Clinical data, patient reported outcomes (PROs), and biospecimen associated data are collected. Clinical data","Not Applicable","Rare Diseases","Prospective Longitudinal Cohort","WES_markerset_grc38","SNP/CNV Genotypes (NGS)","18 phenotype datasets, 744 variables, 10 documents, 1 molecular datasets, 497 subjects, 192 samples","","NCI","GRU --- General Research Use","2023-11-03","2023-11-03","Carcinoma, Neuroendocrine; Chordoma; ACC; Adenoid Cystic Carcinoma; Adrenal Cortex Adenocarcinoma; Adrenal Cortex Cancer","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003028.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Northern    Manhattan Study (NOMAS)","Cohort Description The Northern Manhattan Study (NOMAS) is a study of the population of Washington Heights in Northern Manhattan. The ongoing study, which began in 1990, has enrolled over 4,400  people, some of whom have suffered a stroke or related neurological syndromes. As the cohort aged, the specific aims grew to include not only","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 995 subjects, 995 samples","","NHLBI","GRU --- General Research Use","2023-11-03","2023-11-03","Cognitive Decline; Dementia; Mild Cognitive Impairment; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002919.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): REasons for    Geographic and Racial Differences in Stroke (REGARDS)","Cohort Description The REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort is one of the nation's largest, most comprehensive population-based cohorts, and it uses innovative home- and telephone-based  data collection. REGARDS centrally recruited and initially examined 30,239 Black and White men and women aged &#x02265;45 years in 2003-7 to","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 8707 subjects, 8707 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-11-03","2023-11-03","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002913.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Severe    Asthma Research Program (SARP)","Cohort Description The Severe Asthma Research Program (SARP) has been investigating the clinical, physiologic and molecular phenotypes of asthma since 2000. It is currently following 400 deeply phenotyped asthma patients.  Data Being Submitted Wave 1 questionnaire data includes 397 variables for up to 375 SARP participants in C4R. Wave 2 questionnaire data includes 448","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 479 subjects, 479 samples","","NHLBI","GRU-PUB-NPU --- General Research Use (PUB, NPU), GRU-PUB --- General Research Use (PUB), DS-AAI-PUB-NPU --- Disease-Specific (Asthma, Allergy and Inflammation, PUB, NPU), DS-AAI-PUB --- Disease-Specific (Asthma, Allergy and Inflammation, PUB)","2023-11-03","2023-11-03","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002911.v1.p1","Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Framingham    Heart Study (FHS)","Cohort Description In 1948, the researchers recruited 5,209 men and women between the ages of 30 and 62 from the town of Framingham, Massachusetts, and began the first round of  extensive physical examinations and lifestyle interviews that they would later analyze for common patterns related to CVD development. Since 1948,","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 7270 subjects, 7270 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2023-11-03","2023-11-03","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002997.v1.p1","Genetic Analysis of Syndromic Orofacial Clefting","The goal of this study is to identify previously unknown genetic causes of human syndromic cleft lip/palate by using genome sequencing. Many previous studies have shown that isolated cleft lip  and/or palate are not often likely to be monogenic or Mendelian diseases. We hope that by focusing on syndromic presentations, we will find novel","Not Applicable","Cleft Palate","Family/Twin/Trios","Not Provided","WGS, WXS","5 phenotype datasets, 19 variables, 93 samples sequenced, 95 subjects, 93 samples","","NIDCR","HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-11-02","2023-11-02","Cleft Lip; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip",""
"phs002623.v1.p1","Whole Genome Sequencing of Bilateral Cleft Lip and Palate Families from    Africa: CIDR","The focus of this study is to identify and test both common and rare genetic variants that elevate risk for CL/P, and to identify genetic variants associated with specific orofacial  cleft (OFC) phenotypes in the population that has accumulated the greatest genetic variation in the human race. We hypothesize that bilateral","Not Applicable","Cleft Lip","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 25 variables, 1 molecular datasets, 804 samples sequenced, 804 subjects, 804 samples","","NIDCR","GRU --- General Research Use","2023-11-02","2023-11-02","Cleft Palate; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002193.v2.p1","The Gut Microbiome in Parkinson's Disease","The uploaded data come from a nested case-control study, with participants with Premotor Parkinson Disease (PPS) as cases. In addition to the PPS cases, the study has three control groups:  1) constipation only controls, defined as those who only reported constipation, but not probable REM sleep behavior disorder (pRBD) or hyposmia; 2)","Not Applicable","Gastrointestinal Microbiome","Case-Control","Not Provided","WGS","4 phenotype datasets, 17 variables, 652 samples sequenced, 420 subjects, 652 samples","","NINDS","HMB --- Health/Medical/Biomedical","2023-11-02","2022-07-25","Not Provided",""
"phs001547.v3.p1","NHLBI TOPMed - NHGRI CCDG: The GENetics in Atrial Fibrillation (GENAF)    Study","The Genetics in AF (GENAF) study enrolled individuals with early-onset lone AF before age 50 in Norway between 2009 and 2016. Early-onset was defined as diagnosis of AF before age  50. Lone AF was defined as AF in the absence of clinical or echocardiographic findings of cardiovascular disease, hypertension, metabolic or","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS)","4 phenotype datasets, 18 variables, 2 documents, 2 molecular datasets, 90 subjects, 90 samples","","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-11-02","2023-11-02","Atrial Flutter; A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations",""
"phs003064.v1.p1","Phenotypic Signatures of Circulating Neoantigen-Reactive CD8+ T Cells in    Patients with Metastatic Cancers","Following enrichment of neoantigen-reactive T cells using pHLA tetramers or cell-surface markers, we performed single-cell sequencing (RNA-seq and TCR-seq) of circulating CD8+ T cells from metastatic cancer patient samples (Melanoma,  Colorectal, and Breast cancer). In samples from previously studied patients, we identified cells bearing neoantigen-reactive T cell receptors and","Not Applicable","Breast Neoplasms","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 29 samples sequenced, 9 subjects, 29 samples","","NCI","GRU --- General Research Use","2023-11-01","2023-11-01","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003327.v1.p1","Experimental and Clinical Studies of Presbycusis","This study aimed to investigate genes and variants associated with adult-onset progressive hearing loss, a common and complex disease with a strong genetic component. Participants enrolled in an ongoing longitudinal  study of age-related hearing loss at the Medical University of South Carolina (MUSC), dating from 1987. Pure tone thresholds at 0.25, 0.5, 1.0, 2.0,","Not Applicable","Presbycusis","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 12 variables, 531 samples sequenced, 531 subjects, 531 samples","","NIDCD","DS-HL-D-NPU --- Disease-Specific (Hearing Loss or Deafness, NPU)","2023-10-31","2023-10-31","Aging; Aging, Biological; Biological Aging; Deafness Neurosensory; Deafness, Neurosensory; Deafness, Sensoryneural",""
"phs002361.v2.p1","Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines","Pneumococcal Vaccine Study: This is a study designed to develop a detailed transcriptional and cellular profile of the immune response to pneumococcal vaccination with conjugated and non-conjugated polysaccharide vaccines in  the senescent immune system of older adults. In this study, 39 healthy adults ages 60 and older that have never received pneumococcal vaccination,","Not Applicable","Vaccines","Prospective Longitudinal Cohort","RNAseq_gene_transcripts","ATAC-seq, RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 24 variables, 1 molecular datasets, 141 samples sequenced, 32 subjects, 141 samples","","NIA","GRU --- General Research Use","2023-10-31","2023-10-31","Not Provided","Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs002120.v1.p1","Center for Sub-Cellular Genomics","A cell is a highly complex system with distributed molecular physiologies in structured sub-cellular compartments whose interplay with the nuclear genome determine the functional characteristics of the cell. A classic  example of distributed genomic processes is found in neurons. Learning and memory require modulation of individual synapses through RNA localization,","Not Applicable","Genomics","Methods","Not Provided","OTHER","4 phenotype datasets, 28 variables, 19 samples sequenced, 2 subjects, 19 samples","","NHGRI","GRU-NPU --- General Research Use (NPU)","2023-10-31","2023-10-31","Not Provided",""
"phs002701.v1.p1","The Role of ZEB2 during Human Neural Crest Cell Formation","This study examined the role of ZEB2 during human neural crest cell formation. Human neural crest cells were differentiated from WiCell H1 human embryonic stem cells (WA01). Genome-wide transcriptional analysis  (RNA-seq) was performed at day-3 and day-5 of human neural crest cell formation following siRNA knockdown of ZEB2 and using an N-terminal ZEB2 mutant","Not Applicable","Neural Crest","Control Set","Not Provided","ATAC-seq, RNA-Seq","3 phenotype datasets, 12 variables, 32 samples sequenced, 1 subjects, 32 samples","","NIDCR","HMB --- Health/Medical/Biomedical","2023-10-26","2023-10-26","Mowat-Wilson syndrome; HIRSCHSPRUNG DISEASE-MENTAL RETARDATION SYNDROME; Hirschsprung disease intellectual disability syndrome; Hirschsprung disease mental retardation syndrome; Hirschsprung disease-intellectual disability syndrome; MICROCEPHALY, MENTAL RETARDATION, AND DISTINCT FACIAL FEATURES, WITH OR WITHOUT HIRSCHSPRUNG DISEASE",""
"phs000945.v1.p1","Genomic Characterization of African-American Prostate Cancer","African-American men have the highest incidence and mortality rate from prostate cancer. This study represents a whole exome sequencing study of prostate cancer samples from African-American men. We performed exome  sequencing and analysis of prostate tumors and matched normal tissues to identify somatic mutations and insertion/deletions across this cohort. All","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 18 variables, 190 samples sequenced,  SRA, 102 subjects, 190 samples","","NHGRI","GRU --- General Research Use","2023-10-26","2023-10-26","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs003402.v1.p1","Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing    Chemoradiation Therapy for Bladder Cancer","Bladder preservation with trimodality therapy (TMT), consisting of transurethral tumor resection followed by chemoradiation, is an alternative to radical cystectomy for muscle-invasive bladder cancer (MIBC), but molecular determinants of response  are poorly understood. Patients with cT2-T4aN0M0 MIBC treated with definitive-intent chemoradiation as part of TMT were retrospectively identified","Not Applicable","Urinary Bladder Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 19 variables, 76 samples sequenced, 76 subjects, 76 samples","","NCI","DS-BLADDERCA --- Disease-Specific (Bladder Cancer)","2023-10-24","2023-10-24","Urinary Bladder Neoplasm; Bladder Cancer; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder",""
"phs003249.v1.p1","Deterministic Evolution and Stringent Selection During Pre-Neoplasia","The earliest events during human tumor initiation are poorly characterized but may hold clues as to how to detect and prevent malignancy. Here we model this occult process by engineering  TP53 deficiency in primary human gastric organoids and performing experimental evolution in multiple clonally derived cultures over two years,","Not Applicable","Stomach Neoplasms","Prospective Longitudinal Cohort","WGS_markerset_grc38","AMPLICON, RNA-Seq, CNV Genotypes, WGS","3 phenotype datasets, 11 variables, 1 molecular datasets, 193 samples sequenced, 3 subjects, 193 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-10-24","2023-10-24","Ca lesser curvature - stomach; Cancer of Stomach; Cancer of the Stomach; Cancer, Gastric; Cancer, Stomach; Cancers, Gastric",""
"phs002641.v1.p1","Precision Medicine for Dilated Cardiomyopathy in European and African    Ancestry","The DCM Precision Medicine Study is a multi-site consortium-based cross-sectional study of families with an embedded open-label randomized controlled trial. The aims of the study are to test the hypothesis  that dilated cardiomyopathy (DCM) has a substantial genetic basis and to evaluate the effectiveness of a family communication intervention in","Not Applicable","Cardiomyopathy, Dilated","Clinical Trial","target_markerset_grc37, WES_markerset_grc37","SNP Genotypes (Array), SNP Genotypes (NGS), WXS","5 phenotype datasets, 21 variables, 1 molecular datasets, 1343 samples sequenced, 1343 subjects, 1343 samples","European (656), African (23), African American (536), Hispanic1 (22), Hispanic2 (84), Other Asian or Pacific Islander (5), Other (9)","NHLBI","DS-DC --- Disease-Specific (Dilated Cardiomyopathy)","2023-10-23","2023-10-23","CARDIOMYOPATHY, FAMILIAL IDIOPATHIC; Cardiomyopathies, Familial Idiopathic; Cardiomyopathies, Idiopathic Dilated; Cardiomyopathy, Dilated, Autosomal Recessive; Cardiomyopathy, Idiopathic Dilated; Dilated Cardiomyopathies, Idiopathic",""
"phs003349.v1.p1","Single-Cell Transcriptomics of Adult Recurrent Respiratory Papillomatosis","These single-cell sequencing data were generated from diseased respiratory tract papilloma tissue caused by chronic infection with HPV 6 or 11. Patients from which this tissue was derived participated in  a phase I clinical trial using a novel therapeutic vaccine, but these samples were acquired before this experimental treatment. The aim of performing","Not Applicable","Recurrent respiratory papillomatosis","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 13 samples sequenced, 13 subjects, 13 samples","","NIDCD","DS-RVI-PUB --- Disease-Specific (Respiratory Viral Infections, PUB)","2023-10-20","2023-10-20","AORRP (type); JORRP (type); Juvenile laryngeal papilloma; Juvenile-onset recurrent respiratory papillomatosis; Laryngeal papilloma, recurrent; RRP",""
"phs003240.v1.p1","Binding of Epstein Barr Virus EBNA2 Unifies Multiple Sclerosis Genetic    Mechanisms","This study is focused on multiple sclerosis (MS). MS is likely caused by a combination of genetic and environmental factors; however, the mechanisms contributing to these factors remain poorly understood.  Epstein-Barr virus (EBV) in particular is a well-established environmental risk factor for MS. We have created a computational algorithm that","Not Applicable","Multiple Sclerosis","Case-Control","Not Provided","WGS","4 phenotype datasets, 15 variables, 10 samples sequenced, 10 subjects, 10 samples","","NINDS","HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-10-20","2023-10-20","Autoimmune Diseases; Epstein-Barr Virus Infections; EBV Infections; EBV infection; Epstein Barr Virus Infection; Epstein Barr Virus Infections",""
"phs001727.v3.p1","NHLBI TOPMed: Pathways to Immunologically Mediated Asthma (PIMA)","Study designed to further our understanding of the pathogenesis of asthma exacerbations in children. Children enrolled in the study (n 217) were all asthmatic and primarily Hispanic white. The children  were followed for 18 months until they experienced an asthma exacerbation or completed the follow-up without an exacerbation. The time to the first","Not Applicable","Asthma","Prospective Longitudinal Cohort","WGS_markerset_grc38, SV_STR_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 24 variables, 2 documents, 2 molecular datasets, 62 samples sequenced, 73 subjects, 73 samples","","NHLBI","DS-ASTHMA-IRB-COL --- Disease-Specific (Asthma, IRB, COL)","2023-10-20","2023-10-20","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs003389.v1.p1","Genomic Studies in Charcot-Marie-Tooth Disease","The various forms of Charcot-Marie-Tooth disease (CMT) comprise a genetically heterogeneous set of peripheral neuropathies. Currently, 90 different CMT genes have been identified; yet, for the axonal CMT2 subtype these  genes explain only 30-40% of the genetic effect. In particular, the application of exome sequencing has led to an unprecedented pace in identifying","Not Applicable","Inherited Peripheral Neuropathy","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","3 phenotype datasets, 8 variables, 1 molecular datasets, 205 subjects, 205 samples","","NINDS","DS-PN --- Disease-Specific (Peripheral Neuropathies)","2023-10-19","2023-10-19","",""
"phs003326.v1.p1","Microvascular Permeability, Inflammation, and Lesion Physiology in    Endometriosis: A Microphysiological Systems Approach","The goal of the study is to identify novel molecular pathways involved in the etiology of endometriosis and to develop in vitro model systems to enable the study of the  mechanisms regulating reproductive function. Using a physiomimetic modeling approach, primary tissue samples of the human endometrium derived from","Not Applicable","Endometriosis","Case-Control","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 13 variables, 1 molecular datasets, 74 samples sequenced, 6 subjects, 74 samples","","NIBIB","DS-RD-IRB --- Disease-Specific (Reproductive Disorders, IRB)","2023-10-19","2023-10-19","Not Provided",""
"phs003166.v1.p1","Enhancing Open Data Sharing for Functional Genomics Experiments: Measures    to Quantify Genomic Information Leakage and File Formats for Privacy    Preservation","This study was designed to develop methods that address the privacy risk associated with genetic variants obtained from genomic sequencing experiments. The preponderance of readily available genetic sequencing experiments has  enabled the generation of datasets whose target purposes range from the genotyping of individuals for medical and forensic analyses, to the","Not Applicable","Genetic Privacy","Methods","WGS_markerset_grc37","SNP Genotypes (NGS), WGS","3 phenotype datasets, 11 variables, 1 documents, 1 molecular datasets, 3 samples sequenced, 3 subjects, 3 samples","","NHGRI","GRU --- General Research Use","2023-10-19","2023-10-19","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002814.v1.p1","Esophageal Squamous Cell Carcinoma Precursor Study","Esophageal cancer is the sixth most common cause of cancer death in the world. High-risk areas occur across central Asia and from eastern to southern Africa, and in these populations,  nearly all of the cases are esophageal squamous cell carcinoma (ESCC). ESCC has a dismal prognosis, largely because symptoms usually appear late in","Not Applicable","Esophageal Squamous Cell Carcinoma","Case Set","Not Provided","WGS","4 phenotype datasets, 17 variables, 66 samples sequenced, 33 subjects, 66 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-10-19","2023-10-19","ESCC; Esophageal Epidermoid Carcinoma; Esophageal SCC; Esophageal Squamous Cell Carcinoma, NOS; Esophageal Squamous Cell Carcinoma, Not Otherwise Specified; Esophagus SCC",""
"phs001080.v2.p1","Genome Studies in Hereditary Spastic Paraplegia","Next-generation sequencing technology is opening up new opportunities to rethink the way we identify disease causing genetic variation. An early application, whole exome sequencing, has now been established by a  small number of research labs, including ours. Exome sequencing allows obtaining a near complete set of protein coding genomic variation in single","Not Applicable","Spastic Paraplegia, Hereditary","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 16 variables, 1 molecular datasets, 103 samples sequenced, 112 subjects, 112 samples","","NINDS","GRU --- General Research Use","2023-10-19","2023-10-19","FSP; Familial spastic paraparesis; Familial spastic paraplegia; Familial spastic paraplegia syndrome; French settlement disease; HSP","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003392.v1.p1","Epigenetic Changes in Immune Response and Oncogenesis Related Genes    Caused by Heavy Metal Long-Term Exposure","Our study investigated methylation changes in CpG islands located in immune response and oncogenesis related genes in humans induced by long-term environmental heavy metal exposure. We assessed the methylation levels  of 654 CpG sites located on NFKB1, CDKN2A, ESR1, APOA5 and IGF2/H19 genes by targeted bisulfite sequencing (target enrichment by 48.48 Access Array","Not Applicable","Environmental Exposure","Case-Control","Not Provided","Bisulfite-Seq","4 phenotype datasets, 17 variables, 80 samples sequenced, 80 subjects, 80 samples","","NHGRI","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2023-10-18","2023-10-18","DNA Methylation",""
"phs003016.v1.p1","Coagulation and Fibrinolysis in a Pediatric Insulin Titration Trial","Summary of the Design and Aims: The Coagulation and Fibrinolysis in a Pediatric Insulin Titration Trial (CAF-PINT) is an ancillary study to the HALF PINT (NCT01565941) randomized, controlled trial that  was originally designed to study changes in inflammatory and thrombosis pathways in the setting of an interventional trial. The parent HALF PINT","Not Applicable","Intensive Care Units, Pediatric","Clinical Trial","RNAseq_probe_set_grc38","RNA Seq (NGS)","4 phenotype datasets, 47 variables, 1 molecular datasets, 303 subjects, 737 samples","","NHLBI","DS-HL-NPU --- Disease-Specific (Heart or Lung Diseases, NPU)","2023-10-18","2023-10-18","Not Provided",""
"phs003342.v1.p1","Meta-Analysis of Genome-Wide Association Studies of Bladder Cancer Risk","This meta-analysis consists of genome-wide genotype for 13,447 cases and 342,580 controls of European ancestry to identify novel susceptibility loci for bladder cancer. Cases were defined as histologically confirmed primary  carcinoma of the urinary bladder of all stages, including carcinoma in situ (International Classification of Diseases for Oncology, C670-C679, 188).","Not Applicable","Urinary Bladder Neoplasms","Case-Control","Not Provided","Not Provided","1 analyses","","NCI","DS-BLADDERCA --- Disease-Specific (Bladder Cancer)","2023-10-16","2023-10-16","Bladder Cancer; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder; Cancer, Urinary Bladder",""
"phs003190.v1.p1","Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer    Heterogeneity and is Associated with Worse Outcomes","Small-cell lung cancer (SCLC) is a very aggressive neuroendocrine lung cancer often associated with oncogenic MYC amplifications, which are known to drive SCLC heterogeneity marked by neuroendocrine (NE) and non-neuroendocrine  (non-NE) cell states. The genetic mechanisms of MYC amplification and phenotypic plasticity between cell states is not known. Using data from","Not Applicable","Small Cell Lung Carcinoma","Cross-Sectional","WGS_markerset_grc38","OTHER, RNA-Seq, SRA Metadata, WGS","4 phenotype datasets, 15 variables, 1 molecular datasets, 17 samples sequenced, 5 subjects, 23 samples","","NCI","GRU --- General Research Use","2023-10-16","2023-10-16","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002140.v1.p1","Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H.    Weiss","The Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss, which constitute the Epidemiology of the Weiss Cohort Projects, consist of a series of inter-connected projects, building upon  a set of cohort projects of various groups, mainly drug users from medication-assisted treatment programs, that Dr. Stanley H. Weiss first developed","Not Applicable","Substance-Related Disorders","Case Set","HumanOmniExpress-24","SNP Genotypes (Array)","5 phenotype datasets, 38 variables, 1 molecular datasets, 8898 subjects, 8898 samples","European (2954), African (125), East Asian (9), African American (3396), Hispanic1 (612), Hispanic2 (1684), Other Asian or Pacific Islander (18), South Asian (1), Other (99)","NIDA","HMB-IRB-PUB-NPU --- Health/Medical/Biomedical (IRB, PUB, NPU)","2023-10-16","2023-10-16","Alcoholism; Cocaine-Related Disorders; Marijuana Use; Opioid-Related Disorders; Tobacco Use Disorder; ALCOHOL DEPENDENCE, PROTECTION AGAINST",""
"phs003231.v1.p1","ApoA-1 and Atherosclerosis in Psoriasis","Apolipoprotein A-1 is a protein localized to high-density lipoprotein that functions to remove cholesterol from tissues for transport back to the liver. Psoriasis is a systemic inflammatory disease associated with  poor high-density lipoprotein function and accelerated non-calcified burden by coronary computed tomographic angiography. In this study, 310","Not Applicable","Atherosclerosis","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 310 subjects, 310 samples","","NHLBI","GRU --- General Research Use","2023-10-13","2023-10-13","Psoriasis; Atherogeneses; Atherogenesis; Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001968.v1.p1","L1 Retrotransposon Sequencing in Schizophrenia - Study 1","Schizophrenia (SZ) is a devastating psychiatric disorder with substantial global clinical and economic implications. While SZ is marked by high heritability, discovery of common variants associated with even moderate risk  for SZ has proven difficult. We used Restriction Enzyme Based Enriched L1 sequencing (REBELseq) to amplify L1 retrotransposons in gDNA isolated from","Not Applicable","Schizophrenia","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 14 variables, 126 samples sequenced, 126 subjects, 126 samples","","NIMH","GRU --- General Research Use","2023-10-10","2023-10-10","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001368.v4.p2","NHLBI TOPMed: Trans-Omics for Precision Medicine (TOPMed) Whole Genome    Sequencing Project: Cardiovascular Health Study","Participants from the Cardiovascular Health Study (CHS), a large population-based longitudinal cohort study (phs000287), have been included in the TOPMed project. Whole genome sequencing will be performed to contribute to  multiple analyses, including cardiovascular disease risk factors, subclinical disease measures, the occurrence of myocardial infarction (MI) and","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38, SV_STR_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","3 phenotype datasets, 17 variables, 2 documents, 2 molecular datasets, 4852 samples sequenced, 4877 subjects, 4852 samples","European (2801), African (41), African American (655), Hispanic1 (24), Hispanic2 (16), Other (5)","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), DS-CVD-NPU-MDS --- Disease-Specific (Cardiovascular Disease, NPU, MDS)","2023-10-06","2023-10-06","Brain Ischemia; Intracranial Hemorrhage; Myocardial Infarction; Pulmonary Embolism; Brain Ischemias; Encephalopathy, Ischemic","NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs003122.v1.p1","Human Blastocyst 10X Single Cell RNA Sequencing","Recent advances in human blastoids have opened new avenues for modeling early human development and implantation. One limitation of our first protocol for human blastoid generation was relatively low efficiency.  We now report an optimized protocol for the efficient generation of large quantities of high-fidelity human blastoids from naive pluripotent stem","Not Applicable","Blastocyst","Metagenomics","Not Provided","OTHER","4 phenotype datasets, 20 variables, 7 samples sequenced, 58 subjects, 7 samples","","NICHD","GRU --- General Research Use","2023-10-05","2023-10-05","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001729.v3.p1","NHLBI TOPMed: Characterizing the Response to a Leukotriene Receptor    Antagonist and an Inhaled Corticosteroid (CLIC)","Within-subject clinical responses to either inhaled corticosteroids or Montelukast were compared in 126 children with mild to moderate asthma. The children had mild to moderate asthma. Children 6 to 17  years of age with mild-to-moderate asthma were enrolled. They had asthma symptoms or rescue bronchodilator use on average of 3 or more days per week","Not Applicable","Asthma","Prospective Longitudinal Cohort","WGS_markerset_grc38, SV_STR_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 24 variables, 2 documents, 2 molecular datasets, 14 samples sequenced, 19 subjects, 19 samples","","NHLBI","DS-ASTHMA-IRB-COL --- Disease-Specific (Asthma, IRB, COL)","2023-10-05","2023-10-05","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs001644.v3.p2","NHLBI TOPMed - NHGRI CCDG: The BioMe Biobank at Mount Sinai","The IPM BioMe Biobank, founded in September 2007, is an ongoing, broadly-consented electronic health record (EHR)-linked clinical care biobank that enrolls participants non-selectively from the Mount Sinai Medical Center patient  population. BioMe currently comprises 42,000 participants from diverse ancestries, characterized by a broad spectrum of longitudinal biomedical","Not Applicable","Coronary Artery Disease","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 32 variables, 2 documents, 2 molecular datasets, 10178 samples sequenced, 12050 subjects, 12024 samples","European (3301), African (307), East Asian (159), African American (4056), Hispanic1 (2573), Hispanic2 (696), Other Asian or Pacific Islander (78), South Asian (356), Other (492)","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-10-05","2023-10-05","Atrial Fibrillation; Pulmonary Disease, Chronic Obstructive; A-fib; AF; AF - Atrial fibrillation; AFib",""
"phs003398.v1.p1","Non-Coding Mutations Cause Enhancer Targeting Resulting in Protein    Synthesis Dysregulation During B-Cell Lymphoma Progression","In this study, we performed whole-genome sequencing of longitudinal tumor pairs, representing transformation of follicular lymphoma (FL) to high grade B-cell lymphoma with MYC and BCL2 rearrangements (known as ""double  hit lymphoma"" or DHL), a very aggressive class of non-Hodgkin B cell lymphoma (B-NHL). We identified coding and noncoding genomic alterations","Not Applicable","Lymphoma, Non-Hodgkin","Tumor vs. Matched-Normal","Not Provided","WGS","4 phenotype datasets, 16 variables, 9 samples sequenced, 5 subjects, 9 samples","","NIAID","GRU-NPU --- General Research Use (NPU)","2023-10-04","2023-10-04","Lymphoma, Follicular; Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC",""
"phs003213.v1.p1","Melbourne Collaborative Cohort Study DNA Methylation Studies","This dataset contains raw Illumina 450K blood DNA methylation data from a subset of participants in the Melbourne Cohort Study (MCCS), a prospective study of 41,513 healthy adult volunteers (24,469  women) aged between 27 and 76 years when recruited between 1990 and 1994. Nested case-control studies: DNA methylation data were generated as part of","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","HumanMethylation450","SNP/CNV (Array)","4 phenotype datasets, 22 variables, 1 molecular datasets, 5951 subjects, 7898 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-10-04","2023-10-04","DNA Methylation; Life Style; Life Styles; Lifestyle; Blastoma; CA",""
"phs002863.v1.p1","Genome-Wide Association Study of Heparin-Induced Thrombocytopenia","Heparin-induced thrombocytopenia (HIT) is an unpredictable, potentially catastrophic adverse effect resulting from an immune response to platelet factor 4 (PF4)/heparin complexes. We performed a genome-wide association study (GWAS) with positive  functional assay as the outcome. Genetic associations were investigated in a cohort of functional assay-confirmed HIT cases, antibody-positive","Not Applicable","Thrombocytopenia","Case-Control","HumanOmniExpressExome-8","SNP Genotypes (Array)","4 phenotype datasets, 22 variables, 1 molecular datasets, 5212 subjects, 5212 samples","","NHLBI","DS-HIT-PUB --- Disease-Specific (Heparin-induced Thrombocytopenia, PUB)","2023-10-04","2023-10-04","Low platelet count; Thrombopenia; Thrombopenias; platelet count decreased; thrombocytopenic disorder",""
"phs002714.v2.p1","The National Myelodysplastic Syndromes (MDS) Study","Myelodysplastic syndromes (MDS) are the most common cause of adult bone marrow failure in the US and occur predominantly in people over the age of 60. Much of the morbidity  and mortality for MDS is due to complications from low blood counts (e.g., infections and bleeding). MDS is caused by acquired DNA mutations that","Not Applicable","Myelodysplastic Syndromes","Clinical Trial","Not Provided","Targeted-Capture","4 phenotype datasets, 13 variables, 1349 samples sequenced, 1354 subjects, 1354 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2023-10-04","2022-01-21","Hematopoetic Myelodysplasia; Hematopoetic Myelodysplasias; Myelodysplasia, Hematopoetic; Myelodysplasias, Hematopoetic",""
"phs002303.v2.p1","PEDS-PLAN - Pediatric Precision Laboratory Advanced Neuroblastoma Therapy","A multi-center clinical trial for newly diagnosed high-risk neuroblastoma patients. Molecular tumor boards selected one of six targeted agents based on tumor-normal whole exome sequencing and tumor RNA sequencing data.  Related Clinical Trails: NCT02559778 Principal Investigator: Giselle Saulnier Sholler, MD, MSc, Pediatric Oncology, Levine Children's Hospital,","Not Applicable","Neuroblastoma","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 14 variables, 147 samples sequenced, 45 subjects, 147 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-10-04","2022-05-18","Not Provided","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001728.v3.p1","NHLBI TOPMed: Best ADd-on Therapy Giving Effective Response (BADGER)","BADGER is a 56-week randomized, double-blind, three-treatment, three-period cross-over trial that will evaluate the differential improvement in control that is achieved following three separate treatment interventions in children whose asthma  is not acceptably controlled on a low dose of ICS (per NAEPP guidelines). All participants will enter an 8-week run-in period during which time they","Not Applicable","Asthma","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 24 variables, 2 documents, 2 molecular datasets, 37 samples sequenced, 50 subjects, 50 samples","","NHLBI","DS-ASTHMA-IRB-COL --- Disease-Specific (Asthma, IRB, COL)","2023-10-04","2023-10-04","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs003338.v1.p1","BarcUVa-Seq (Biology of Colorectal Cancer Risk Enhancers)","This study was designed to generate a cohort of normal colon mucosal biopsies from the ""average risk"" population. Its primary aims included the development of an RNA-seq dataset of normal  colon mucosal biopsies across three colon regions (ascending, transverse and descending). Further, we aimed to provide plausible prioritization to","Not Applicable","Colonic Neoplasms","Collection","imputation_panel","SNP/CNV Genotypes (imputed), RNA-Seq","4 phenotype datasets, 20 variables, 1 molecular datasets, 463 samples sequenced, 463 subjects, 463 samples","","NCI","DS-GID-IRB --- Disease-Specific (Gastrointestinal Diseases, IRB)","2023-10-03","2023-10-03","COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic; Cancers, Colon",""
"phs003288.v1.p1","Multi-Ethnic Study of Atherosclerosis (BioLINCC)","The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (disease detected non-invasively before it has produced clinical signs and symptoms) and the risk  factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease. MESA researchers study a","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 6814 subjects, 6814 samples","","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-09-29","2023-09-29","Atherosclerosis; Atherogeneses; Atherogenesis; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs003350.v1.p1","Diabetes Multi-Omic Investigation of Drug Response (DIAMOND)","The Diabetes Multi-omic Investigation of Drug Response (DIAMOND) cohort is a population-based cohort of individuals with type-2 diabetes (T2D) who receive their care through a large health system serving southeast  Michigan and metropolitan Detroit. The cohort represents the diversity of the population from which it was created. Because of their health plan","Not Applicable","Diabetes Mellitus, Type 2","Case Set","Axiom_PMRA","SNP/CNV (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 1902 subjects, 1902 samples","","NIDDK","DS-DRD-IRB --- Disease-Specific (diabetes-related disorders, IRB)","2023-09-28","2023-09-28","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs003343.v1.p1","Targeted Linked-Read DNA-seq Analysis of Castration-Resistant Prostate    Cancers","Androgen receptor (AR) inhibition is standard of care for advanced prostate cancer (PC). However, its efficacy is limited by progression to castration-resistant PC (CRPC), usually due to AR re-activation via  mechanisms that include AR amplification and structural rearrangement. These two classes of AR alterations often co-occur in CRPC tumors, but it is","Not Applicable","Prostatic Neoplasms","Case Set","Not Provided","OTHER","3 phenotype datasets, 13 variables, 35 samples sequenced, 35 subjects, 35 samples","","NCI","DS-PC --- Disease-Specific (Prostate Cancer)","2023-09-27","2023-09-27","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs003223.v1.p1","DIGEST: Dietary Influences on Glucuronidation, a Cross-Sectional Study of    Diet and Metabolism","Plasma samples derived from a study population of control participants (DIGEST: Dietary Influences on Glucuronidation, a Cross-Sectional Study of Diet and Metabolism) were used to profile miRNA circulating in plasma.  RNA was isolated from plasma samples using the Qiagen miRNeasy kit. Libraries were prepared using Illumina TruSeq Small RNA Library Prep Kit.","Not Applicable","Healthy Volunteers","Control Set","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 130 samples sequenced, 100 subjects, 130 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-09-27","2023-09-27","Not Provided",""
"phs002627.v1.p1","Kids First: The Genomic Basis of Structural Birth Defects Associated with    Chromosome 18 Copy Number Changes","Chromosome abnormalities are a common cause of structural birth defects. Both childhood cancers and structural birth defects are critical and costly conditions associated with substantial morbidity and mortality. Elucidating the  underlying genetic etiology of these diseases has the potential to profoundly improve preventative measures, diagnostics, and therapeutic","Not Applicable","Trisomy 18 Syndrome","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 149 subjects, 149 samples","","NICHD","GRU --- General Research Use","2023-09-27","2023-09-27","Complete Trisomy 18 Syndrome; EDWARDS SYNDROME",""
"phs003315.v1.p1","A Microwell Platform for High-Throughput Longitudinal Phenotyping and    Selective Retrieval of Organoids","In traditional bulk culture, organoids tend to overlap, hindering the analysis of individual organoid characteristics in a high-throughput manner. Additionally, variations in the local spatial properties of the bulk matrix  make it challenging to distinguish whether phenotypic differences between organoids stem from inherent cellular disparities or disparities in the","Not Applicable","Organoids","Case-Control","WES_markerset_grc38","ATAC-seq, RNA-Seq, CNV Segments (NGS), SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 12 variables, 1 molecular datasets, 45 samples sequenced, 1 subjects, 45 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-09-26","2023-09-26","Ca lesser curvature - stomach; Cancer of Stomach; Cancer of the Stomach; Cancer, Gastric; Cancer, Stomach; Cancers, Gastric",""
"phs002116.v3.p2","Unraveling the Genetic Architecture of Diabetic Retinopathy in South    India","This study aims to understand the genetic architecture of diabetic retinopathy in the South Indian population by examining participants with South Indian ancestry and type 2 diabetes (T2D) from two  sources: the Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS) and prospective recruitment at Sankara","Not Applicable","Diabetic Retinopathy","Cross-Sectional","WGS_markerset_grc38, MEGA_Consortium_Array","SNP/CNV (Array), SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 40 variables, 2 molecular datasets, 24 samples sequenced, 2393 subjects, 2417 samples","","NEI","DS-DRC-IRB --- Disease-Specific (Diabetes and Related Complications, IRB)","2023-09-26","2023-08-24","",""
"phs002097.v1.p1","Refractory Cancer (RC) Program","The Refractory Cancer (RC) Program will investigate the underlying genomic hallmarks involved in the observed inferior response to treatment of certain tumor types. Comprehensive genomic characterization will be performed utilizing  the NCI CCG Genome Characterization Pipeline. Subsequent genomic data will be hosted at the NCI Genomic Data Commons (GDC)","Not Applicable","Neoplasms","Case Set","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 278 subjects, 278 samples, 3 substudies","","NCI","GRU --- General Research Use","2023-09-26","2023-09-26","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002851.v1.p1","Refractory Cancer (RC) Burkitt's Lymphoma (BL)","The Refractory Cancer (RC) Burkitt's Lymphoma (BL) study will investigate the underlying genomic hallmarks involved in the observed inferior response to treatment of certain Burkitt Lymphoma patients. The study will  utilize a network of sites in the US to obtain the samples and clinical data. Comprehensive genomic characterization will be performed utilizing the","Refractory Cancer (RC) Program (phs002097.v1.p1)","Burkitt Lymphoma","Case Set","Not Provided","Not Provided","20 samples","","NCI","GRU --- General Research Use","2023-09-26","2023-09-26","BL; BL - Burkitt's lymphoma; Burkitt Tumor; Burkitt lymphoma/leukemia; Burkitt's Lymphoma; Burkitt's Tumor",""
"phs002247.v1.p1","Refractory Cancer - Peripheral T-Cell Lymphoma (RC-PTCL)","The Peripheral T-Cell Lymphoma (PTCL) study will investigate the underlying genomic hallmarks involved in the observed inferior response to treatment of certain PTCL patients. The study will utilize a network  of sites in the US and Asia to accrue up to 500 cases per tumor type. Comprehensive genomic characterization will be performed utilizing the NCI CCG","Refractory Cancer (RC) Program (phs002097.v1.p1)","Lymphoma, T-Cell, Peripheral","Case Set","Not Provided","Not Provided","168 samples","","NCI","GRU --- General Research Use","2023-09-26","2023-09-26","",""
"phs002098.v1.p1","Refractory Cancers (RC) HOPE-CARE","For the HOPE-CARE project, NCI will utilize whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing to try to identify recurrent genetic alterations (mutations, deletions, amplifications, rearrangements)  and/or gene expression signatures that would be important to the hypothesis(es) submitted by the investigators. The samples will be processed and","Refractory Cancer (RC) Program (phs002097.v1.p1)","Glioma","Case Set","Not Provided","Not Provided","90 samples","","NCI","GRU --- General Research Use","2023-09-26","2023-09-26","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia",""
"phs002181.v1.p1","Genomic Characterization CS-MATCH-0007 Arm I","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 439 variables, 60 subjects, 60 samples","","NCI","GRU-COL --- General Research Use (COL)","2023-09-25","2023-09-25","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002179.v1.p1","Genomic Characterization CS-MATCH-0007 Arm U","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 296 variables, 23 subjects, 23 samples","","NCI","GRU-COL --- General Research Use (COL)","2023-09-25","2023-09-25","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001973.v1.p1","Genomic Characterization CS-MATCH-0007 Arm Z1A","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 465 variables,  SRA, 45 subjects, 45 samples","","NCI","GRU-COL --- General Research Use (COL)","2023-09-25","2023-09-25","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001948.v1.p1","Genomic Characterization CS-MATCH-0007 Arm W","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 368 variables,  SRA, 45 subjects, 45 samples","","NCI","GRU-COL --- General Research Use (COL)","2023-09-25","2023-09-25","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001888.v1.p1","Genomic Characterization CS-MATCH-0007 Arm H","The CS-MATCH-0007 protocol is a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA sequencing using  pre-and post-treatment tumor biopsy specimens from all patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131). The goal of","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 379 variables,  SRA, 21 subjects, 21 samples","","NCI","GRU-COL --- General Research Use (COL)","2023-09-25","2023-09-25","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma; Melanoma, Malignant",""
"phs002372.v1.p1","Novel Approach to High-Throughput Identification and Characterization of    Neoantigens","This study focuses on the development of novel approach for the screening, identification and characterization of neoantigen-specific T-cell receptors (TCRs). The developed method consists of collecting targeted RNA-Seq from a  T-cell specific gene panel via 3' end Illumina sequencing combined to Oxford Nanopore based full-length TCR sequencing post T-cell activation. The","Not Applicable","Receptors, Antigen, T-Cell, alpha-beta","Methods","Not Provided","AMPLICON","4 phenotype datasets, 13 variables, 3 samples sequenced, 3 subjects, 4 samples","","NCI","GRU --- General Research Use","2023-09-21","2023-09-21","Not Provided",""
"phs003330.v1.p1","Uveal Melanoma Immunogenomics Predict Immunotherapy Resistance and    Susceptibility","Immunotherapy using immune checkpoint inhibition (ICI) has shown success in treating metastatic cutaneous melanoma but has limited efficacy against metastatic uveal melanoma (UM), a rare variant arising from the immune  privileged eye. To better understand this immune resistance, we performed comprehensive immunogenomic profiling of 100 human UM metastases using","Not Applicable","Uveal Melanoma","Collection","Not Provided","RNA-Seq","3 phenotype datasets, 12 variables, 100 samples sequenced, 84 subjects, 100 samples","","NCI","GRU --- General Research Use","2023-09-20","2023-09-20","Not Provided",""
"phs003194.v1.p1","Maternal and Developmental Risks from Environmental and Social Stressors    (MADRES) Center for Environmental Health Disparities","MADRES is a prospective pregnancy cohort based in urban Los Angeles, recruiting predominantly low income Hispanic mothers-to-be as part of a children's health study, funded by Environmental Influences on Child  Health Outcomes (ECHO). Participants were measured for a number of chemical exposures and biomarkers. Two epigenetic markers will be available","Not Applicable","Epigenomics","Cross-Sectional","MethylationEPIC, miRNA_ probe_set","Methylation (CpG), miRNA (NGS)","5 phenotype datasets, 36 variables, 2 molecular datasets, 588 subjects, 968 samples","","NIEHS","HMB --- Health/Medical/Biomedical","2023-09-20","2023-09-20","DNA Methylation; Gestation; Pregnancy, function",""
"phs000218.v26.p8","National Cancer Institute (NCI) TARGET: Therapeutically Applicable    Research to Generate Effective Treatments","The Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative seeks to accelerate research in novel marker and drug development, along with understanding the molecular basis of pediatric malignancy, through  identification of genomic changes associated with the following childhood cancers: Acute Lymphoblastic Leukemia (ALL) - A fast-growing type of blood","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 7 variables, 11287 samples sequenced, 6363 subjects, 13179 samples, 9 substudies","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2023-09-20","2012-04-10","Acute Lymphoblastic Leukemia; Clear Cell Sarcomas; Rhabdoid Tumor; ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia",""
"phs000471.v23.p8","TARGET: Kidney, Wilms Tumor (WT)","There are 130 fully characterized patient cases with high risk Wilms tumor (all tumor/normal pairs; 8 with additional samples for analysis 3 with tumor adjacent normal, 5 with relapse sample)  that will make up the TARGET WT dataset. Each case will have gene expression, tumor and paired normal copy number analyses, methylation and whole","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v26.p8)","Wilms Tumor","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, Targeted-Capture, WGS, WXS, miRNA-Seq","2 phenotype datasets, 8 variables, 987 samples sequenced, 653 subjects, 1018 samples","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2023-09-20","2012-04-10","Embryonal adenosarcoma; Embryonal nephroma; Kidney Nephroblastoma; NEPHROBLASTOMA; Nephroblastoma (Wilms tumor); Nephroblastomas",""
"phs000470.v23.p8","TARGET: Kidney, Rhabdoid Tumor (RT)","To further explore some more aggressive subtypes in pediatric cancer already under study in OCG, CGCI is partnering with TARGET initiative to support extensive sequencing analysis of three hard to  treat childhood cancers: refractory to treatment cases of acute myeloid leukemia and two rare kidney tumors; clear cell sarcoma of the kidney and","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v26.p8)","Rhabdoid Tumor","Tumor vs. Matched-Normal","Not Provided","Bisulfite-Seq, ChIP-Seq, RNA-Seq, WGS, miRNA-Seq","2 phenotype datasets, 8 variables, 234 samples sequenced, 70 subjects, 236 samples","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2023-09-20","2012-04-10","",""
"phs000469.v23.p8","TARGET: Cancer Model Systems (MDLS): Cell Lines and Xenografts (including    PPTP)","As part of the TARGET initiative, some disease projects characterized tumor cell lines or xenografts, with or without matched normal comparators, as well as some normal non-involved tissues. MDLS includes  acute leukemia cell lines and xenografts with matched primary and/or relapsed tumor information, neuroblastoma cell line and xenografts with matched","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v26.p8)","Xenograft Model Antitumor Assays","Tumor vs. Matched-Normal","Not Provided","Bisulfite-Seq, ChIP-Seq, RNA-Seq, Targeted-Capture, WGS, WXS, miRNA-Seq","2 phenotype datasets, 8 variables, 180 samples sequenced, 132 subjects, 183 samples","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2023-09-20","2012-04-10","Not Provided",""
"phs000468.v23.p8","TARGET: Osteosarcoma (OS)","There are 93 fully characterized patient cases that make up the TARGET OS dataset, each with gene expression, tumor and paired normal copy number analyses, methylation, miRNA profiles, along with  comprehensive next-generation sequencing to include mRNA-seq and exome sequencing (whole genome sequencing where available). There are additional","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v26.p8)","Osteosarcoma","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS, WXS","2 phenotype datasets, 8 variables, 624 samples sequenced, 310 subjects, 744 samples","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2023-09-20","2012-04-10","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteoblastic osteosarcoma; Osteoblastic sarcoma; Osteochondrosarcoma",""
"phs000467.v23.p8","TARGET: Neuroblastoma (NBL)","There are 214 fully characterized patient cases with neuroblastoma (all tumor/normal pairs, 10 with relapse sample as well) that will make up the TARGET NBL dataset, along with some cell  lines and xenografts. The dataset includes 24 4S cases as well. Each fully characterized case has gene expression, tumor and paired normal copy","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v26.p8)","Neuroblastoma","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, Targeted-Capture, WGS, WXS, miRNA-Seq","2 phenotype datasets, 29 variables, 1852 samples sequenced, 1204 subjects, 1977 samples","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2023-09-20","2012-04-10","Not Provided",""
"phs000466.v23.p8","TARGET: Kidney, Clear Cell Sarcoma of the Kidney (CCSK)","To further explore some more aggressive subtypes in pediatric cancer already under study in OCG, CGCI is partnering with TARGET initiative to support extensive sequencing analysis of three hard to  treat childhood cancers: refractory to treatment cases of acute myeloid leukemia and two rare kidney tumors; clear cell sarcoma of the kidney (CCSK)","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v26.p8)","Sarcoma, Clear Cell","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS","2 phenotype datasets, 8 variables, 39 samples sequenced, 14 subjects, 45 samples","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2023-09-20","2012-04-10","Clear Cell Sarcomas; Clear Cell Sarcoma; Clear Cell Sarcoma of Soft Parts; Clear Cell Sarcoma of Tendons and Aponeuroses; Malignant Melanoma of Soft Parts; Malignant melanoma of soft tissue",""
"phs000465.v23.p8","TARGET: Acute Myeloid Leukemia (AML)","There are 200+ fully characterized patient cases with AML (all tumor/normal pairs, 100 with relapse sample as well) that make up the TARGET AML dataset, each with gene expression, tumor  and paired normal copy number analyses, methylation and comprehensive next-generation sequencing to include whole genome sequencing, mRNA-seq and","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v26.p8)","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, Targeted-Capture, WGS, WXS, miRNA-Seq","2 phenotype datasets, 8 variables, 4014 samples sequenced, 2505 subjects, 5460 samples","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2023-09-20","2012-04-10","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs000464.v23.p8","TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2","There are 175 fully characterized patient cases with relapsed precursor B-cell ALL (all tumor/normal pairs, 85 with relapse sample as well) that will make up Phase II of the TARGET  ALL dataset, each with gene expression, tumor and paired normal copy number analyses, and comprehensive next-generation sequencing to include whole","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v26.p8)","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS, WXS, miRNA-Seq","2 phenotype datasets, 24 variables, 3309 samples sequenced, 1199 subjects, 3461 samples","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2023-09-20","2012-04-10","Acute Lymphoblastic Leukemia; ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic",""
"phs000463.v23.p8","TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1","There are 189 fully characterized patient cases that make up the pilot phase (Phase I) of the TARGET ALL dataset, each with gene expression, tumor and paired normal copy number  analyses, and at least one type of sequencing (Sanger and/or next-generation) data available. There are 230 cases with partial molecular","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v26.p8)","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS","2 phenotype datasets, 8 variables, 48 samples sequenced, 289 subjects, 65 samples","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2023-09-20","2012-04-10","Acute Lymphoblastic Leukemia; ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic",""
"phs003233.v1.p1","Single Cell Genotypic and Phenotypic Analysis of Measurable Residual    Disease in Acute Myeloid Leukemia","Acute myeloid leukemia (AML) is a group of blood cancers with high mortality. Even though complete remission is often achieved, majority of the AML patients still relapse. Measurable residual disease  (MRD), defined as the population of cancer cells which persists following chemotherapy, is responsible for AML relapse. Understanding the biology","Not Applicable","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","Not Provided","AMPLICON","4 phenotype datasets, 15 variables, 25 samples sequenced, 91 subjects, 25 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-09-19","2023-09-19","Neoplasm, Residual; AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult",""
"phs003318.v1.p1","Single-Cell Multi-Omic Analysis of the Vestibular Schwannoma Ecosystem    Uncovers a Nerve Injury-Like State","Vestibular schwannomas are benign tumors that can lead to significant morbidity, including hearing loss, facial nerve paralysis and obstructive hydrocephalus. The genomic landscape of vestibular schwannomas is relatively bland and  the molecular pathophysiology of vestibular schwannomas is poorly understood. Therefore, we performed single cell RNA sequencing on 15 sporadic","Not Applicable","Neuroma, Acoustic","Case Set","WES_markerset_grc38","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 1 molecular datasets, 24 samples sequenced, 12 subjects, 24 samples","","NCI","GRU --- General Research Use","2023-09-15","2023-09-15","Schwannoma, Vestibular; AN - Acoustic neuroma; Acoustic Neurilemmoma; Acoustic Neurilemmomas; Acoustic Neurilemoma; Acoustic Neurilemomas",""
"phs003155.v1.p1","TCGA WGS Variants Across 18 Cancer Types","Even though whole genome sequence (WGS) data has been generated and published in many studies, much of this information is not yet processed for use in down-stream analysis. This study's  aim is to provide 1342 WGS normal-tumor paired single nucleotide variations (SNP) over 18 different cancer types provided by The Cancer Genome Atlas","Not Applicable","Polymorphism, Genetic","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 1342 subjects, 2684 samples","","NCI","GRU --- General Research Use","2023-09-15","2023-09-15","Not Provided",""
"phs003151.v1.p1","Genetics of Glucose Regulation in Gestation and Growth (Gen3G) Cohort -    Placenta Transcriptomics RNA Sequencing","The overarching goals of Genetics of Glucose regulation in Gestation and Growth (Gen3G) are to increase our understanding of biological, environmental, and genetic determinants of glucose regulation during pregnancy and  their impact on fetal/child development. Gen3G is a prospective cohort study: we initially recruited 1,024 pregnant women between 2010-2013 at Blood","Not Applicable","growth & development","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, miRNA-Seq","11 phenotype datasets, 155 variables, 941 samples sequenced, 2222 subjects, 1353 samples","","NICHD","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-09-14","2023-09-14","Diabetes, Gestational; growth and development; Diabetes Mellitus, Gestational; Diabetes in Pregnancy; Diabetes mellitus arising in pregnancy; Diabetes, Pregnancy Induced",""
"phs003303.v1.p1","Molecular and Clinical Analyses of PHF6 Mutant Myeloid Neoplasia Provide    Clues as to Their Pathogenesis and Therapeutic Targeting","PHF6 mutations (PHF6MT) are identified in various myeloid neoplasms (MN). However, little is known about the precise function and consequences of PHF6 in MN. Our comprehensive genomic analyses yielded three  main findings. Firstly, we revealed a different pattern of genes correlating with PHF6MT in male and female cases. When analyzing male and female","Not Applicable","Leukemia, Myeloid","Collection","Not Provided","Targeted-Capture","4 phenotype datasets, 17 variables, 254 samples sequenced, 254 subjects, 254 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2023-09-13","2023-09-13","Chronic Monocytic Leukemias; Leukemia, Chronic Monocytic; Leukemia, Monocytic, Chronic; Leukemias, Chronic Monocytic; Monocytic Leukemia, Chronic; Monocytic Leukemias, Chronic",""
"phs003321.v1.p1","DNA Methylation Studies in CREW Cohorts (URECA and COAST)","Children's Respiratory Environment Workgroup (CREW) is an NIH-funded project consisting of 12 individual U.S. cohorts and three scientific centers working together to identify phenotypes and causes of childhood asthma. CREW  includes data from a large number of children and their families, with broad diversity in terms of ethnicity, family characteristics, neighborhoods","Not Applicable","Asthma","Case-Control","Not Provided","Bisulfite-Seq","4 phenotype datasets, 18 variables, 39 samples sequenced, 39 subjects, 39 samples","","NIAID","DS-AID-IRB-NPU --- Disease-Specific (Allergy and Immunologic Disease, IRB, NPU), DS-AID-MDS --- Disease-Specific (Allergy and Immunologic Disease, MDS), DS-AID --- Disease-Specific (Allergy and Immunologic Disease)","2023-09-12","2023-09-12","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs003370.v1.p1","Genetic Predictors of Ibrutinib-Related Cardiovascular Side Effects in    Patients with Chronic Lymphocytic Leukemia","The goal of this study was to identify genetic polymorphisms associated with ibrutinib-related cardiovascular side effects (CVSEs). This is an observational non-interventional pharmacogenomic study of 50 patients with newly diagnosed  or relapsed refractory chronic lymphocytic leukemia (NDCLL or RRCLL) receiving ibrutinib 420 mg for at least six months. The ibrutinib-related CVSEs","Not Applicable","Drug-Related Side Effects and Adverse Reactions","Case-Control","target_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 16 variables, 1 analyses, 1 molecular datasets, 50 subjects, 50 samples","","NHGRI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-09-08","2023-09-08","ADR; ADR - Adverse drug reaction; Adverse Drug Event; Adverse Drug Events; Adverse Drug Experience; Adverse Drug Reaction",""
"phs002513.v1.p1","Study of Environment, Lifestyle and Fibroids SNP Data","Uterine fibroids are hormonally-dependent benign tumors of the uterine muscle that develop in premenopausal women. Currently, the primary symptoms (pain and bleeding) are treated, but when those treatments fail, major  procedures to remove or shrink the fibroids are frequently the only options for women. Fibroids are the leading indication for hysterectomy in the","Not Applicable","Leiomyoma","Prospective Longitudinal Cohort","Global_Diversity_Array-8, imputation_panel","SNP/CNV (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 14 variables, 2 molecular datasets, 1656 subjects, 1701 samples","","NIEHS","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS)","2023-09-08","2023-09-08","Benign Smooth Muscle Neoplasm; Benign Smooth Muscle Tumor; Fibroid; Fibroid Tumors; Fibroleiomyoma; Fibromyoma",""
"phs003306.v1.p1","Characterization of Macrophage-Tropic HIV Infection of Central Nervous    System Cells and the Influence of Inflammation","In this study, we utilize macrophage-tropic and T cell-tropic HIV-1 Env proteins to establish accurate infection profiles for multiple CNS cells under basal and interferon alpha (IFN-&#x003b1;) or lipopolysaccharide (LPS)-induced  inflammatory states. We found that macrophage-tropic viruses confer entry advantages in primary myeloid cells, including monocyte-derived","Not Applicable","Macrophages","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 11 variables, 105 samples sequenced, 1 subjects, 105 samples","","NIDA","HMB --- Health/Medical/Biomedical","2023-09-07","2023-09-07","Not Provided",""
"phs003096.v1.p1","African Demographic History Study Based on WGS Data","These data were used as part of a study to characterize genomic diversity in Africa, population substructure, and evolutionary history. All individuals age 18 or older were eligible to participate.  Principle Investigator: Sarah Tishkoff, University of Pennsylvania, Philadelphia, Pennsylvania, USA Co-Investigators: Shaohua Fan, Fudan University,","Not Applicable","Genetic Variation","Collection","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","3 phenotype datasets, 11 variables, 1 molecular datasets, 180 subjects, 180 samples","","NIGMS","GRU-IRB-PUB-COL-NPU --- General Research Use (IRB, PUB, COL, NPU)","2023-09-07","2023-09-07","Not Provided",""
"phs003234.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    COVID-19 Testing and Vaccination Social Network Diffusion for Diverse    Criminal Legal Involved Communities","This RADx-UP Phase II proposal, ""Social network diffusion of COVID-19 prevention for diverse Criminal Legal Involved Communities"", will implement a situation appropriate COVID-19 testing and vaccination social network diffusion intervention  - C3 - building upon RADx-UP Phase I lessons and successful social network prevention interventions developed previously by the research team. C3","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2023-09-06","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003000.v1.p1","ALLELE Consortium Glioblastoma Project","Glioblastoma patient samples were sequenced for this project. The purposes of this project are: (1) to establish an umbrella protocol as a mechanism for identifying patients (in the USA and  international sites) who agree to the collection, storage, and broad usage of their specimens and ongoing collection, and review of their medical","Not Applicable","Glioblastoma","Case-Control","Not Provided","WXS","4 phenotype datasets, 15 variables, 220 samples sequenced, 110 subjects, 220 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-09-06","2023-09-06","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs001707.v3.p1","University of Pennsylvania CAR T Cell Responding and Non-responding    Patients","The adoptive transfer of autologous T cells genetically modified to express a CD19-specific, 4-1BB/CD3zeta-signaling chimeric antigen receptor (CAR; CTL019) has shown remarkable activity in patients with B acute lymphoblastic leukemia.  Similar therapy can induce long-term remissions for relapsed/refractory chronic lymphocytic leukemia (CLL) patients, but in only a small subset of","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Prospective Longitudinal Cohort","Not Provided","AMPLICON, RNA-Seq","4 phenotype datasets, 13 variables, 109 samples sequenced, 37 subjects, 109 samples","","NCI","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2023-09-06","2023-09-06","Sarcoma; B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade",""
"phs003287.v1.p1","FinaleMe: Predicting DNA Methylation by the Fragmentation Patterns of    Plasma Cell-Free DNA","Analysis of DNA methylation in cell-free DNA (cfDNA) reveals clinically relevant biomarkers but requires specialized protocols and sufficient input material that limits its applicability. Millions of cfDNA samples have been  profiled by genomic sequencing. To maximize the gene regulation information from existing datasets, we developed FinaleMe, a non-homogeneous Hidden","Not Applicable","Cell-Free Nucleic Acids","Methods","Not Provided","Bisulfite-Seq, WGS","4 phenotype datasets, 14 variables, 160 samples sequenced, 42 subjects, 160 samples","","NHGRI","GRU --- General Research Use","2023-09-05","2023-09-05","DNA Fragmentation; DNA Methylation; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002615.v1.p1","Somatic Mutations in Epilepsy: Whole Genome Sequence Analysis of Single    Neurons","Low-coverage whole-genome sequencing was performed on single-cells from resected brain tissues obtained from an individual with hemimegalencephaly (HMG) along with a somatic copy number variant (sCNV) of chromosome 1q in  order to characterize the sCNV at the single cell level. Single neuronal nuclei and non-neuronal nuclei were isolated by fluorescence-activated cell","Not Applicable","Hemimegalencephaly","Case Set","Not Provided","WGS","4 phenotype datasets, 17 variables, 80 samples sequenced, 1 subjects, 80 samples","","NINDS","DS-HME-RD --- Disease-Specific (hemimegalencephaly, RD)","2023-09-05","2023-09-05","Polymicrogyria; Hemimegalencephalies; Macrocephalies, Unilateral; Macrocephaly, Unilateral; Megalencephalies, Unilateral; Megalencephaly, Unilateral",""
"phs002225.v3.p1","HTAN MCL Pre-Cancer Atlas Pilot Project - Targeted Sequencing Development    Study","The HTAN-MCL Pre-Cancer Atlas Pilot Project (PCAPP) is the result of a collaboration between the seven members of the MCL consortium. Across four organ types, PCAPP's goal is to collect  and profile pre-malignant lesions for gene expression, DNA mutations, single-cell gene expression and immune-environment. Most PML are small in size","Not Applicable","Carcinoma, Intraductal, Noninfiltrating","Case Set","Not Provided","RNA-Seq, WXS","6 phenotype datasets, 29 variables, 430 samples sequenced, 63 subjects, 430 samples","","NCI","GRU --- General Research Use","2023-09-01","2023-09-01","Breast Ductal Carcinoma In Situ, NOS; Carcinoma, Intraductal; Carcinoma, Noninfiltrating Intraductal; Carcinomas, Intraductal; Carcinomas, Noninfiltrating Intraductal; DCIS","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002439.v1.p1","Development and Validation of Organoids from Fibrolamellar Carcinoma    Human Cells","Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare liver tumor affecting adolescents and young adults with no history of primary liver disease or cirrhosis. We collected fibrolamellar tumor tissue and the  adjacent non-tumor liver from patients at the time of surgery. We only used tumor tissue that was validated as fibrolamellar by the presence of the","Not Applicable","Fibrolamellar hepatocellular carcinoma","Tumor vs. Matched-Normal","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 25 samples sequenced, 5 subjects, 25 samples","","NCI","DS-HCC-IRB-COL --- Disease-Specific (Hepatocellular Carcinoma, IRB, COL)","2023-08-31","2023-08-31","Hepatocellular carcinoma (fibrolamellar variant); FHCC; FL-HCC; FLC; Fibrolamellar Carcinoma of Liver Cells; Fibrolamellar Carcinoma of the Liver Cells",""
"phs003313.v1.p1","RNA-Seq from PMM2-CDG Patients and Healthy Controls","Besides the predominant neurological involvement of PMM2-CDG patients, around 20% of patient mortality has been linked to severe infections. However, the immunological dysfunction in PMM2-CDG is not well understood. In  this study, we aimed to address this gap and study the molecular mechanisms affected behind immunological issues in PMM2-CDG. Primary skin","Not Applicable","Congenital Disorders of Glycosylation","Case-Control","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 20 variables, 1 molecular datasets, 11 samples sequenced, 6 subjects, 11 samples","","NIGMS","GRU-IRB-PUB-NPU --- General Research Use (IRB, PUB, NPU)","2023-08-28","2023-08-28","Inflammation; Pmm2-CDG; CDG; CDG - Carbohydrate-deficient glycoprotein syndrome; Carbohydrate Deficient Glycoprotein Syndrome; Carbohydrate deficiency glycoprotein syndrome",""
"phs001544.v3.p1","NHLBI TOPMed - NHGRI CCDG: Malmo Preventive Project (MPP)","The Malm&#x000f6; Preventive Project (MPP) was a community-based disease prevention program including 33,346 inhabitants from the city of Malm&#x000f6; in Southern Sweden. Complete birth cohorts between 1921-1949 were invited, and  the participation rate was 71%. Participants underwent screening between 1974 to 1992 for cardiovascular risk factors, alcohol abuse, and breast","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 18 variables, 2 documents, 2 molecular datasets, 2 samples sequenced, 121 subjects, 121 samples","","NHLBI","HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS)","2023-08-28","2023-08-28","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs003261.v1.p1","Studies in the Pathogenesis of Systemic Capillary Leak Syndrome (SCLS,    Clarkson Disease)","Systemic capillary leak syndrome (Clarkson disease) is an ultra-rare disease of unknown etiology. Patients experienced transient and recurrent episodes of hypotensive shock and massive peripheral edema due to plasma extravasation,  often precipitated by minor viral infections. Disease onset occurs most frequently in middle age, and there is no family history. More than 90% of","Not Applicable","Capillary Leak Syndrome","Case-Control","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 20 variables, 1 molecular datasets, 70 samples sequenced, 70 subjects, 70 samples","European (57), East Asian (1), African American (2), Hispanic1 (1), Hispanic2 (6), Other Asian or Pacific Islander (1), South Asian (1), Other (1)","NIAID","GRU --- General Research Use","2023-08-24","2023-08-24","Capillary leak syndrome with monoclonal gammopathy; AVLS; Acute Vascular Leak Syndrome; CLS; Capillary Leak Syndromes; Capillary hyperpermeability syndrome","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003250.v1.p1","Therapeutic Genetics and Disease Modeling in LAMA2-CMD","Merosin-deficient congenital muscular dystrophy (MDC1A) is an autosomal recessive disorder caused by mutations in the LAMA2 gene, resulting in a defective form of the extracellular matrix protein laminin-&#x003b1;2 (LAMA2). Individuals  diagnosed with MDC1A exhibit progressive muscle wasting and declining neuromuscular functions. No treatments for this disorder are currently","Not Applicable","Muscular dystrophy congenital, merosin negative","Interventional","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 7 samples sequenced, 5 subjects, 7 samples","","NIAMS","GRU --- General Research Use","2023-08-24","2023-08-24","CMD1A; CMD1A - congenital muscular dystrophy type 1A; Congenital merosin-deficient muscular dystrophy 1A; Congenital muscular dystrophy due to laminin alpha2 deficiency; Congenital muscular dystrophy type 1A; LAMA2 congenital muscular dystrophy","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003185.v1.p1","Molecular Subtyping Reveals Immune Alterations Associated with    Progression of Bronchial Premalignant Lesions","Exposure to cigarette smoke creates a field of injury throughout the entire respiratory tract inducing genomic alterations that lead to an ""at-risk"" airway where lung cancers develop. Lung squamous cell  carcinoma (SCC) arises in the epithelial layer of the bronchial airways and is often preceded by the development of premalignant lesions (PMLs).","Not Applicable","Lung Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 448 samples sequenced, 50 subjects, 448 samples","","NCI","GRU --- General Research Use","2023-08-23","2023-08-23","Bronchial Neoplasms; Bronchopulmonary Dysplasia; Disease Progression; Bronchial Neoplasm; Bronchial tumor; Neoplasm, Bronchial",""
"phs001598.v3.p1","NHLBI TOPMed - NHGRI CCDG: The Johns Hopkins University School of    Medicine Atrial Fibrillation Genetics Study","Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is the primary cause of many hospital admissions, and is associated with significant secondary morbidity by increasing the risk of stroke,  heart failure, and all-cause mortality. The incidence of AF is on the rise, and it is projected that by the year 2050 more than 10 million patients","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38, SV_STR_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 18 variables, 2 documents, 2 molecular datasets, 2 samples sequenced, 290 subjects, 290 samples","","NHLBI","HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS)","2023-08-23","2023-08-23","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs003346.v1.p1","Method to Assess Lung Water Accumulation During Exercise","The goal of this non-significant risk medical device study is to test the initial technical feasibility of a 0.55T MRI in healthy volunteers by technical optimization of scanner protocols, and  to test accuracy of standard MR measurements in adult patients with known stable disease. Exercise-induced lung water is a key feature in heart","Not Applicable","Extravascular Lung Water","Methods","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 19 subjects, 19 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2023-08-22","2023-08-22","Heart Failure; Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart",""
"phs002220.v1.p1","Discovering the Genetic Basis of Cleft Palate: CIDR","Cleft palate (CP) is a common craniofacial structural birth defect caused by the incomplete closure of the palate (the structure separating the oral and nasal cavities), resulting in feeding, speech,  and hearing problems. CP accounts for 33% of all orofacial clefts (OFCs) or approximately 1 in 1500 babies born worldwide. Although CP is commonly","Not Applicable","Cleft Palate","Family/Twin/Trios","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 51 variables, 1 molecular datasets, 1642 samples sequenced, 1693 subjects, 1642 samples","","NIDCR","HMB --- Health/Medical/Biomedical, HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), GRU --- General Research Use, DS-OC-PUB --- Disease-Specific (Oral Clefts, PUB), DS-OBDR-MDS --- Disease-Specific (Orofacial birth defects and related phenotypes, MDS), DS-CFR-IRB-COL --- Disease-Specific (Craniofacial Research, IRB, COL), HMB-MDS --- Health/Medical/Biomedical (MDS), DS-CFED --- Disease-Specific (Craniofacial and Eye Disorders)","2023-08-22","2023-08-22","",""
"phs001624.v3.p2","NHLBI TOPMed - NHGRI CCDG: The Vanderbilt University BioVU Atrial    Fibrillation Genetics Study","Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. At least 2.7  million Americans are living with AFib. Individuals with early onset atrial fibrillation (AF) are included in this study of cases from the BioVU","Not Applicable","Atrial Fibrillation","Case-Control","WGS_markerset_grc38, SV_STR_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 26 variables, 2 documents, 2 molecular datasets, 2117 samples sequenced, 2666 subjects, 2739 samples","European (1136), African (32), African American (1472), Hispanic1 (10), Hispanic2 (2), Other Asian or Pacific Islander (1), Other (3)","NHLBI","HMB-GSO --- Health/Medical/Biomedical (GSO)","2023-08-22","2023-08-22","Arrhythmias, Cardiac; Heart Diseases; Abnormal heart rate; Arrhythmia; Arrhythmia, Cardiac; Arrhythmias","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs002613.v1.p1","Characterizing Disease-Causing Variants Using Personal Genomes with Large    Recurrent Deletions","Individuals with recurrent genomic deletions are known to present variable clinical phenotypes, despite the apparent identical range of the genomic segments being affected in their genomes. We propose to study  the phenotypic variability and the molecular polymorphism in individuals with the recurrent 17q12 deletions or the recurrent 1q21.1 deletions, with","Not Applicable","Renal cysts and diabetes syndrome [Supplementary Concept]","Mendelian","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 21 variables, 1 molecular datasets, 6 samples sequenced, 6 subjects, 6 samples","","NHGRI","GRU --- General Research Use","2023-08-18","2023-08-18","Not Provided",""
"phs003260.v1.p1","Single Nucleus Transcriptomes from the Ventral Midbrain of Opioid    Overdose Cases and Controls","We generated ventral midbrain single nuclei RNA-seq libraries for 95 brain donors, including 45 subjects with documented histories of opioid abuse and overdose, and 50 demographically-matched, opioid-free control subjects, collected  from two geographically distinct regions within the U.S. (greater Detroit area, Michigan and Miami, Florida). Each sample included both substantia","Not Applicable","Opioid-Related Disorders","Case-Control","custom_markerset","SNP Genotypes (imputed), OTHER","5 phenotype datasets, 18 variables, 1 molecular datasets, 16 samples sequenced, 67 subjects, 67 samples","European (32), African American (12), Hispanic1 (3), Hispanic2 (3), Other (1)","NIDA","HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-08-17","2023-08-17","Addiction, Opiate; Dependence, Opiate; Opiate Addiction; Opiate Dependence; Opioid Related Disorders; Opioid-Related Disorder",""
"phs003053.v1.p1","Resilience and Susceptibility Patterns in the Viral Immune Response Using    RNA-Seq (ReSP VIRUS Study)","This is a cross sectional study to investigate the relationship between nasal mucosa gene expression and clinical outcomes in infants with critical Respiratory Syncytial Virus (RSV) infection. We collected nasal  mucosa samples from infants admitted to the pediatric intensive care unit with polymerase chain reaction confirmed RSV bronchiolitis. Samples were","Not Applicable","RSV","Cross-Sectional","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","5 phenotype datasets, 25 variables, 1 molecular datasets, 33 samples sequenced, 33 subjects, 33 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-08-17","2023-08-17","Pneumonia; Viral Infections; Inflammation, Lung; Inflammation, Pulmonary; Inflammations, Lung; Inflammations, Pulmonary",""
"phs002826.v1.p1","Analysis of Papilloma Infiltrating T cells from an Exceptional Responder    to Immunotherapy","This data corresponds to single cell RNA-seq data of TIL from a young woman with recurrent respiratory papillomatosis who was treated with PD-L1 blockade and experienced durable disease control over  a 4+ year period. A HPV6 E2-specific, HLA-B 55 restricted TCR was identified and shown to be present in both the immediate post treatment and 4 year","Not Applicable","Recurrent respiratory papillomatosis","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 16 variables, 2 samples sequenced, 1 subjects, 2 samples","","NIDCD","DS-RVI-PUB --- Disease-Specific (Respiratory Viral Infections, PUB)","2023-08-17","2023-08-17","AORRP (type); JORRP (type); Juvenile laryngeal papilloma; Juvenile-onset recurrent respiratory papillomatosis; Laryngeal papilloma, recurrent; RRP",""
"phs002189.v1.p1","Merkel Cell Carcinoma Tissue and Data Repository","Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer with increasing incidence in the United States. In this study we performed the first whole genome sequencing of three  Merkel cell carcinomas with their matched normal tissues for somatic variant calling. From these data we describe the likely mechanism of Merkel cell","Not Applicable","Carcinoma, Merkel Cell","Tumor vs. Matched-Normal","WGS_markerset_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 10 variables, 1 molecular datasets, 12 samples sequenced, 6 subjects, 12 samples","","NCI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-08-17","2023-08-17","Anaplastic carcinoma of the skin; Cancer, Merkel Cell; Cell Cancer, Merkel; Cutaneous APUDoma; MCC; Merkel Cell Cancer",""
"phs003319.v1.p1","Interruption of BTK Inhibitor Improves Response to SARS-CoV-2 Booster    Vaccination in Patients with Chronic Lymphocytic Leukemia","This study investigates the effect of booster SARS-CoV-2 vaccination and Bruton tyrosine kinase inhibitor (BTKi) interruption on antibody response to vaccination. Patients with chronic lymphocytic leukemia (CLL) are immunocompromised, at  increased risk of infection, and have historically poor response to immunization. BTKi therapy is a standard treatment for CLL in frontline and","Not Applicable","Immunogenicity, Vaccine","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 35 variables, 81 subjects","","NHLBI","GRU --- General Research Use","2023-08-16","2023-08-16","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003297.v1.p1","Population Genetic Testing and SERPINA1 Sequencing Identifies    Unidentified Alpha-1 Antitrypsin Deficiency Alleles and    Gene-Environment Interaction with Hepatitis C Infection","Design and aims: Data were available through an institutional effort to combine de-identified electronic health records (EHR) data with genomic information from a DNA biobank. The design of this work  was a retrospective cohort study in which we investigated the rates of liver transplantation and hepatitis C infection as it relates to genotype risk","Not Applicable","alpha 1-Antitrypsin Deficiency","Case-Control","Multi-Ethnic_Global","SNV (.MAF)","4 phenotype datasets, 18 variables, 1 molecular datasets, 72027 subjects, 72027 samples","","NHGRI","GRU --- General Research Use","2023-08-16","2023-08-16","","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002978.v1.p1","AC-ICAM: An Atlas and Compass of Immune-CAncer-Microbiome Interactions in    Colon Cancer","Fresh frozen tumor samples and matched normal colon specimens from chemotherapy na&#x000ef;ve, consecutive patients with a histological diagnosis of colon adenocarcinoma at Leiden University Medical Center (LUMC) were subjected to  multi-omics profiling at Sidra Integrated Genomics Services, part of Sidra Medicine, Doha, Qatar. This resulted in a high-quality dataset of samples","Not Applicable","Colonic Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WXS","5 phenotype datasets, 56 variables, 1258 samples sequenced, 348 subjects, 1258 samples","","NCI","DS-CA-PUB-MDS --- Disease-Specific (Cancer, PUB, MDS)","2023-08-16","2023-08-16","COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic; Cancers, Colon",""
"phs002005.v1.p1","MP2PRT: Comprehensive Genomic Profiling to Identify Alterations    Associated with Relapse for NCI Standard Risk (SR) B-Lineage ALL and    NCI High Risk (HR) B-Lineage ALL with Favorable Genetic Features","The Molecular Profiling to Predict Response to Treatment (MP2PRT) program is part of the NCI's Cancer Moonshot Initiative. The aim of this program is the retrospective characterization and analysis of  biospecimens collected from completed NCI-sponsored trials of the National Clinical Trials Network and the NCI Community Oncology Research Program.","Not Applicable","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Case-Control","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1510 subjects, 1510 samples","","NCI","GRU --- General Research Use","2023-08-16","2023-08-16","Acute Lymphoblastic Leukemia; ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic",""
"phs003229.v1.p1","Analysis of Donor Pancreata Defines the Transcriptomic Signature and    Microenvironment of Early Neoplastic Pancreatic Lesions","The adult healthy human pancreas has been poorly studied given lack of indication to obtain tissue from the pancreas in the absence of disease and rapid postmortem degradation. We obtained  pancreata from brain dead donors thus avoiding any warm ischemia time. We found that neoplastic lesions occur frequently in healthy organs, in donors","Not Applicable","Pancreas","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 13 samples sequenced, 7 subjects, 13 samples","","NCI","GRU --- General Research Use","2023-08-15","2023-08-15","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic",""
"phs002139.v1.p1","Environmental Arsenic and Diabetes Mellitus (Chihuahua Cohort)","The Chihuahua Cohort was established as part of a larger NIEHS-funded project that used laboratory models (tissue culture and mice) and human subjects to examine the association between exposure to  arsenic and diabetes, including identification of mechanisms underlying this association. All procedures involving human subjects were approved by","Not Applicable","Diabetes","Cross-Sectional","Not Provided","Not Provided","2 phenotype datasets, 59 variables, 1166 subjects","","NIEHS","GRU --- General Research Use","2023-08-15","2023-08-15","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002979.v2.p1","Evaluation of Nuclear DNA from Rootless Hairs for Forensic Purposes","The study aims to overcome current limitations in the recovery of DNA from small, difficult forensic samples. Particularly, our goal is to produce a robust laboratory protocol and the accompanying  software to accelerate adoption, as well as to evaluate the reliability and robustness of both the laboratory and computational aspects of generating","Not Applicable","Forensic Medicine","Methods","Multi-Ethnic_Global, Global_Screening_Array-24","SNP Genotypes (Array), WGS","3 phenotype datasets, 9 variables, 2 molecular datasets, 170 samples sequenced, 55 subjects, 179 samples","European (27), African (1), East Asian (2), African American (1), Hispanic2 (4), Other Asian or Pacific Islander (3), South Asian (3), Other (3)","NHGRI","GRU-PUB --- General Research Use (PUB)","2023-08-10","2023-08-10","Not Provided",""
"phs002973.v1.p1","Genomic Translation for ALS Care (GTAC) - WGS","To look for genetic correlates of disease progression, the GTAC study recruited patients with motor neuron disease from 13 academic medical center clinics and followed them longitudinally for up to  5 years. Participants were regularly assessed for changes in respiratory function, the ALS Functional Rating Scale, and the ALS Cognitive Behavioral","Not Applicable","Amyotrophic Lateral Sclerosis","Prospective Longitudinal Cohort","Not Provided","Not Provided","4 phenotype datasets, 15 variables, 1304 subjects, 1304 samples","","NINDS","HMB --- Health/Medical/Biomedical","2023-08-10","2023-08-10","Motor Neuron Disease; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease","ALS Compute (phs003184.v1.p1)"
"phs003054.v1.p1","Extracellular RNA Profiling of Serum, Plasma, and Urine of Healthy    Subjects","This study was conducted to generate a reference dataset of extracellular RNA (exRNA) from standard human biofluids. Small RNA-seq data was obtained from plasma, serum, and urine of healthy subjects.  Inclusion Criteria: Healthy volunteer subjects Principal Investigator: Jennifer C. Jones, MD, PhD, National Institutes of Health, Bethesda, MD, USA","Not Applicable","Healthy Volunteers","Control Set","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 53 samples sequenced, 53 subjects, 53 samples","","NCI","GRU-IRB-PUB-COL --- General Research Use (IRB, PUB, COL)","2023-08-09","2023-08-09","Not Provided",""
"phs003312.v1.p1","PD-1 Instructs a Tumor Suppressive Metabolic Program to Restrain AP-1    Activity in T Cell Lymphoma","T cell non-Hodgkin lymphomas (T-NHLs) represent a heterogeneous group of aggressive cancers of mature CD4+ T cells, for which therapeutic options are limited. Recent work uncovered that the PDCD1 encoded  immune checkpoint receptor PD-1 is a key tumor suppressor in T cells. PD-1 is recurrently inactivated in T-NHL and the highest frequencies of PDCD1","Not Applicable","Lymphoma, T-Cell, Cutaneous","Case Set","Not Provided","ATAC-seq, RNA-Seq, WGS","4 phenotype datasets, 17 variables, 18 samples sequenced, 11 subjects, 18 samples","","NIAID","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-08-08","2023-08-08","Lymphoma, T-Cell; Granulomatous Slack Skin; Slack Skin, Granulomatous",""
"phs003308.v1.p1","Whole Exome Sequencing Analysis of Carfilzomib-Related Cardiotoxicity in    Multiple Myeloma Patients","This study investigated the contribution of germline genetic variants in protein-coding genes in carfilzomib-related cardiovascular adverse events among patients with multiple myeloma using whole-exome sequencing (WES) analysis. We analyzed 247  patients with multiple myeloma who had been treated with carfilzomib at the Moffitt Cancer Center. We identified a missense mutation in the","Not Applicable","Multiple Myeloma","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 247 samples sequenced, 247 subjects, 247 samples","","NHLBI","GRU --- General Research Use","2023-08-08","2023-08-08","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003169.v1.p1","Extracellular microRNA Biomarkers for Diagnostic and Prognostic    Assessment of Preeclampsia at Triage","This study is comprised of samples from 123 donors (71 cases and 52 controls) undergoing evaluation for preeclampsia. All samples were collected between 20 and 40 weeks of gestation. Small  RNA sequencing was done on serum RNA obtained from donors. We were able to identify 3 bivariate extracellular miRNA biomarkers that can enable early","Not Applicable","Pre-Eclampsia","Case-Control","Not Provided","miRNA-Seq","4 phenotype datasets, 17 variables, 123 samples sequenced, 123 subjects, 123 samples","","NHLBI","GRU --- General Research Use","2023-08-08","2023-08-08","Preeclampsia; EPH - Edema, proteinuria and hypertension of pregnancy; EPH Complex; EPH Gestosis; EPH Toxemia; EPH Toxemias","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003170.v1.p1","Genome-Wide Analysis of Aberrant Position and Sequence of Plasma DNA    Fragment Ends in Patients With Cancer","This study investigated fragmentation characteristics in plasma cell-free DNA and evaluated the relevance of such analysis for cancer diagnostics. Specifically, we performed whole genome sequencing (WGS) of healthy individuals and  cancer patients, and evaluated genome-wide coverage and sequences surrounding fragment ends. This was a retrospective study of archived plasma","Not Applicable","Liquid Biopsy","Methods","Not Provided","WGS","4 phenotype datasets, 21 variables, 548 samples sequenced, 213 subjects, 548 samples","","NCI","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2023-08-03","2023-08-03","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs003152.v1.p1","CPTAC: Proteogenomic Studies of Ovarian Tumor Responses to Agents    Targeting the DNA Damage Response","There is a critical unmet need for predictors of chemo-refractory High-grade serous ovarian cancer (HGSOC). Despite over 3 decades of research on platinum responses in cancer, no predictive biomarker has  been translated into clinical use. Predictors of refractory disease could spare these patients the unnecessary toxicity of a platinum-based regimen","Not Applicable","Carcinoma, Ovarian Epithelial","Case Set","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 22 variables, 156 samples sequenced, 148 subjects, 156 samples","","NCI","GRU --- General Research Use","2023-08-03","2023-08-03","Cancer, Epithelial Ovarian; Cancer, Ovarian Epithelial; Carcinoma of Ovary; Carcinoma of the Ovary; Carcinoma, Epithelial Ovarian; Epithelial Cancer, Ovarian","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002579.v1.p1","Immune Response to Life-Threatening Respiratory Infections in Children    and Young Adults","This is a cross sectional study describing age-related differences in the nasal mucosal immune response to SARS-CoV-2. We collected nasal mucosal samples from six groups: healthy children, children infected with  SARS-CoV-2, children infected with respiratory syncytial virus, children infected with influenza virus, healthy adults, and adults infected with","Not Applicable","SARS-CoV-2","Cross-Sectional","RNAseq_probe_set_grc37","RNA-Seq, RNA Seq (NGS)","6 phenotype datasets, 32 variables, 1 molecular datasets, 105 samples sequenced, 105 subjects, 105 samples","","NHLBI","HMB-IRB-COL --- Health/Medical/Biomedical (IRB, COL)","2023-08-03","2023-08-03","Pneumonia; Virus Diseases; Inflammation, Lung; Inflammation, Pulmonary; Inflammations, Lung; Inflammations, Pulmonary",""
"phs001024.v6.p1","NHLBI TOPMed: Partners HealthCare Biobank","The Atrial Fibrillation Genetics Consortium (AFGen) was organized to identify common and rare genetic variation associated with atrial fibrillation risk. In the current study, we have performed whole genome sequencing  in cases with early-onset atrial fibrillation. Samples in this study were enrolled as a part of the Partners HealthCare Biobank. Cases with","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38, SV_STR_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 32 variables, 2 documents, 2 molecular datasets, 128 samples sequenced, 128 subjects, 128 samples","European (121), African (1), East Asian (1), African American (3), Hispanic1 (1), Other (1)","NHLBI","HMB --- Health/Medical/Biomedical","2023-08-03","2023-08-03","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs003322.v1.p1","Integrated Analysis of Multimodal Single-Cell Datasets for SARS-CoV-2    Vaccination","The study aimed to explore immune responses during a time course of BNT162b2 mRNA vaccination. To better characterize these responses, we utilize a suite of multi-modal single-cell sequencing technologies to  identify and characterize antigen-specific CD8+ T cells. We leverage an integrative analysis strategy to characterize five molecular modalities in","Not Applicable","Single-Cell Analysis","Collection","Not Provided","OTHER","4 phenotype datasets, 15 variables, 68 samples sequenced, 16 subjects, 68 samples","","NHGRI","HMB --- Health/Medical/Biomedical","2023-08-02","2023-08-02","Not Provided",""
"phs001119.v1.p1","Subpopulations and Intermediate Outcome Measures in COPD Study    (SPIROMICS)","Subpopulations and Intermediate Outcome Measures in COPD Study Description Subpopulations and intermediate outcome measures in COPD study (SPIROMICS) supports the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and  clinical data from subjects with COPD for the purpose of identifying subpopulations and intermediate outcome measures. It is funded by the National","Not Applicable","Pulmonary Disease, Chronic Obstructive","Prospective Longitudinal Cohort","HumanOmniExpressExome-8","Not Provided","3 phenotype datasets, 269 variables, 4 documents, 2973 subjects, 2611 samples, 1 substudies","","NHLBI","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU), DS-COPD --- Disease-Specific (Chronic Obstructive Pulmonary Disease), DS-COPD-NPU --- Disease-Specific (Chronic Obstructive Pulmonary Disease, NPU), GRU-COL --- General Research Use (COL), GRU-COL-NPU --- General Research Use (COL, NPU), DS-COPD-COL --- Disease-Specific (Chronic Obstructive Pulmonary Disease, COL), DS-COPD-COL-NPU --- Disease-Specific (Chronic Obstructive Pulmonary Disease, COL, NPU)","2023-07-31","2023-07-31","Bronchitis, Chronic; Pulmonary Emphysema; Chronic Bronchitis; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002399.v1.p1","SPIROMICS Genetic and Genomics","Subpopulations and intermediate outcome measures in COPD study (SPIROMICS) supports the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and clinical data from subjects with COPD for the purpose  of identifying subpopulations and intermediate outcome measures. It is funded by the National Heart, Lung, and Blood Institute and is coordinated by","Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) (phs001119.v1.p1)","Pulmonary Disease, Chronic Obstructive","Prospective Longitudinal Cohort","HumanOmniExpressExome-8","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 2611 subjects, 2611 samples","European (1965), African (12), East Asian (16), African American (490), Hispanic1 (49), Hispanic2 (40), Other Asian or Pacific Islander (11), South Asian (3), Other (25)","NHLBI","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU), DS-COPD --- Disease-Specific (Chronic Obstructive Pulmonary Disease), DS-COPD-NPU --- Disease-Specific (Chronic Obstructive Pulmonary Disease, NPU), GRU-COL --- General Research Use (COL), GRU-COL-NPU --- General Research Use (COL, NPU), DS-COPD-COL --- Disease-Specific (Chronic Obstructive Pulmonary Disease, COL), DS-COPD-COL-NPU --- Disease-Specific (Chronic Obstructive Pulmonary Disease, COL, NPU)","2023-07-31","2023-07-31","Bronchitis, Chronic; Pulmonary Emphysema; Chronic Bronchitis; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD",""
"phs003300.v1.p1","Small RNA Contents of Extracellular Vesicles from Patients with Cognitive    Decline","In this proposal, we examined samples from living neurologically normal individuals (n 72), cognitively normal Parkinson's disease (PD; n 21), PD with mild cognitive impairment (PD-MCI; n 18), PD with  dementia (PDD; n 23), and dementia with Lewy-bodies (DLB; n 18), Alzheimer&#x02019;s disease (AD; n 33) and mild cognitive impairment (MCI, n 38).","Not Applicable","Neurodegenerative Diseases","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 20 variables, 407 samples sequenced, 223 subjects, 407 samples","","NHLBI","GRU --- General Research Use","2023-07-26","2023-07-26","Cognitive Dysfunction; Lewy Body Disease; AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003268.v1.p1","Maintenance of Brain Tumor Profile on Organotypic Brain Slice Culture    (OBSC)","We used uncultured tumor resection tissue from an NF2 mutation-driven grade II meningioma (MG-II) to investigate whether tumors engrafted onto organotypic brain slice cultures (OBSCs) maintained the genetic profile of  the parent tumor. We prepared three groups of samples for whole exome sequencing (WES) from the same pool of dissociated MG-II tissue. Group HT is","Not Applicable","Neurofibromatosis 2","Case Set","custom_markerset","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 12 variables, 1 molecular datasets, 10 samples sequenced, 1 subjects, 10 samples","","NCATS","HMB --- Health/Medical/Biomedical","2023-07-26","2023-07-26","Meningioma; Diffuse meningiomatosis; Meningioma, Multiple; Meningiomas, Multiple; Meningiomatoses; Meningiomatosis",""
"phs002151.v1.p1","Genomic Characterization CS-MATCH-0007 Arm N","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 327 variables, 21 subjects, 21 samples","","NCI","GRU-COL --- General Research Use (COL)","2023-07-25","2023-07-25","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002028.v1.p1","Genomic Characterization CS-MATCH-0007 Arm B","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 362 variables, 33 subjects, 33 samples","","NCI","GRU-COL --- General Research Use (COL)","2023-07-25","2023-07-25","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs003074.v1.p1","A National Translational Science Network of Precision-Based Immunotherapy    for Primary Liver Cancer (PLC)","The primary objective of the NCI-CLARITY study is to establish a biospecimen repository for genomic, genetic and epigenetic analysis to study the biology of primary liver cancer (PLC) development and  progression. Secondary objectives include predicting overall and progression-free survival following immunotherapy. In the retrospective phase,","Not Applicable","Liver Neoplasms","Collection","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 15 variables, 482 samples sequenced, 93 subjects, 482 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-07-21","2023-07-21","Carcinoma, Hepatocellular; Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells",""
"phs002820.v1.p1","Cancer Risk Estimates Related to Susceptibility Genes (CARRIERS)","The CARRIERS study utilized custom amplicon-based variant screening of known cancer predisposition genes in germline DNA from breast cancer cases and age matched unaffected controls taken from predominantly cohort-based breast  cancer case-control studies to establish the risks of breast cancer associated with pathogenic variants in these genes. Inclusion Cases - affected","Not Applicable","Genetic Predisposition to Disease","Case-Control","target_markerset_grc37","AMPLICON, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 75490 samples sequenced, 75492 subjects, 75490 samples","","NCI","HMB-COL-NPU-GSO --- Health/Medical/Biomedical (COL, NPU, GSO), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA --- Disease-Specific (Cancer), HMB-PUB --- Health/Medical/Biomedical (PUB), GRU --- General Research Use, DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB --- Health/Medical/Biomedical, DS-CA-IRB-MDS --- Disease-Specific (Cancer, IRB, MDS), DS-BROC --- Disease-Specific (Breast and Ovarian cancer), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), GRU-NPU --- General Research Use (NPU)","2023-07-20","2023-07-20","Genetic Predispositions; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs003316.v1.p1","A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab and Intralesional    Oncolytic Virotherapy for HER2-Negative Breast Cancer","This study was a single arm phase 1 trial that assessed the regimen safety and feasibility as well as tumor response in patients with localized HER2-negative breast cancer treated with  talimogene laherparepvec (T-VEC) in combination with nivolumab and ipilimumab. The primary objective was to evaluate the safety and adverse event","Not Applicable","Breast Neoplasms","Clinical Trial","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 18 variables, 27 samples sequenced, 6 subjects, 27 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2023-07-18","2023-07-18","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003290.v1.p1","Cell-Free, Methylated DNA in Blood Samples Reveals Tissue-Specific,    Cellular Damage from Radiation Treatment","Radiation therapy is an effective cancer treatment, although damage to surrounding healthy tissues can also occur. Cell-type specific DNA methylation patterns can be used to decode the cellular origins of  cell-free DNA fragments, allowing for minimally-invasive monitoring of tissue damage. To evaluate whether changes in cell-free DNA methylation can","Not Applicable","DNA Methylation","Prospective Longitudinal Cohort","Not Provided","Bisulfite-Seq","4 phenotype datasets, 15 variables, 59 samples sequenced, 29 subjects, 59 samples","","NCI","GRU-IRB-COL --- General Research Use (IRB, COL)","2023-07-18","2023-07-18","",""
"phs002249.v2.p1","HuBMAP: KULMAP - Human Kidney, Urinary Tract, and Lung Mapping Center","The major goal of the Human Kidney, Urinary Tract, and Lung Mapping Center (KULMAP) is to generate multi-omic and spatially resolved molecular anatomical maps of the human bladder, ureter and  kidneys (BUKMAP) and the lung airways and parenchyma (LAPMAP) at a single cell resolution. This entails sequencing of the transcriptomes and","Not Applicable","Kidney","Case Set","Not Provided","ATAC-seq, RNA-Seq","3 phenotype datasets, 9 variables, 448 samples sequenced, 38 subjects, 448 samples","","NHGRI","GRU --- General Research Use","2023-07-18","2022-06-07","Not Provided",""
"phs002272.v1.p1","HuBMAP: Single-Cell Data from Human Tissues","The small bowel and colon are organs critical for maintaining homeostasis of the human body by mediating nutritional absorption upon the ingestion of food. Though both organs are extensive in  length, there are known differences in function and cellular heterogeneity within different portions of each. Also, a cross section anywhere in the","Not Applicable","Intestines","Collection","Not Provided","ATAC-seq, RNA-Seq, WGS","3 phenotype datasets, 9 variables, 187 samples sequenced, 11 subjects, 187 samples","","NHGRI","GRU --- General Research Use","2023-07-17","2023-07-17","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003320.v1.p1","RNA Sequencing of ECOG-E1308","This study reports the RNA sequencing of HPV positive oropharyngeal squamous cell carcinoma samples from patients with HPV-associated stage III or stage IV cancer of the oropharynx that was surgically  resectible. These patients participated in the ECOG-E1308 trial, a phase II trial that studied paclitaxel, cisplatin, and cetuximab followed by","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Case Set","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 71 samples sequenced, 71 subjects, 71 samples","","NCI","GRU --- General Research Use","2023-07-13","2023-07-13","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003147.v1.p1","A Phase II Neoadjuvant Study of Palbociclib in Combination with Letrozole    and Trastuzumab as Neoadjuvant Treatment of Stage II-III ER+ HER2+    Breast Cancer (PALTAN)","Women with early stage ER+/HER2+ breast cancer (BC) are less likely to achieve pathological complete response (pCR) after chemotherapy with standard of care dual HER2 blockade than patients with ER-/HER2+  BC. Additionally, the toxicity burden of standard systemic therapy is high. Thus, this single arm phase 2 clinical trial investigated a novel","Not Applicable","Breast Neoplasms","Clinical Trial","Not Provided","RNA-Seq, WXS","3 phenotype datasets, 14 variables, 55 samples sequenced, 17 subjects, 55 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2023-07-13","2023-07-13","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003136.v1.p1","African American Adolescent Idiopathic Scoliosis Whole Genome and Whole    Exome Study","Adolescent idiopathic scoliosis (AIS) is the most common pediatric spinal deformity. The causes of scoliosis are only now being discovered yet are important for predicting outcome and need for surgery.  Prior studies have investigated the causes of scoliosis, including common and rare variant risk factors, but have mostly used populations consisting","Not Applicable","Scoliosis","Case Set","Not Provided","WGS, WXS","4 phenotype datasets, 13 variables, 522 samples sequenced, 522 subjects, 522 samples","","NIAMS","GRU-IRB --- General Research Use (IRB), DS-IMD-IRB --- Disease-Specific (Inherited Musculoskeletal Disorders, IRB), DS-SCO-IRB --- Disease-Specific (Scoliosis, IRB)","2023-07-13","2023-07-13","Cobb angle greater than ten degrees; Scolioses; Scoliosis,",""
"phs002515.v1.p1","Mutational Landscape of MCPyV-Positive and MCPyV-Negative Merkel Cell    Carcinomas","Merkel cell carcinoma (MCC) is an aggressive neuroendocrine carcinoma of the skin most commonly found on the sun-exposed skin of older Caucasian adults. Roughly one-third of patients with MCCs die  of the disease; therefore, MCC is the most lethal skin cancer on a case-by-case basis. 49 cases were studied, and putative cancer driver gene","Not Applicable","Carcinoma, Merkel Cell","Case Set","Not Provided","WXS","4 phenotype datasets, 16 variables, 98 samples sequenced, 49 subjects, 98 samples","","NCI","GRU --- General Research Use","2023-07-13","2023-07-13","Anaplastic carcinoma of the skin; Cancer, Merkel Cell; Cell Cancer, Merkel; Cutaneous APUDoma; MCC; Merkel Cell Cancer","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003305.v1.p1","Whole Genome Sequencing for Metastatic Mutational Burden in Extraskeletal    Myxoid Chondrosarcoma","Extraskeletal myxoid chondrosarcoma (EMC) is an ultra-rare cancer. Though it has a favorable prognosis and an indolent course, it has high rates of local recurrence and metastasis to the lungs.  EMC is most often characterized by a translocation involving the NR4A3 gene most often fusing with EWSR1, leading to constitutive expression of","Not Applicable","Sarcoma","Case Set","Not Provided","WGS","3 phenotype datasets, 12 variables, 4 samples sequenced, 1 subjects, 4 samples","","NCI","GRU --- General Research Use","2023-07-12","2023-07-12","Chondrosarcoma; Neoplasms, Connective and Soft Tissue; Sarcoma, Spindle Cell; Sarcomas, Spindle Cell; Spindle Cell Sarcomas; spindle cell sarcoma",""
"phs003227.v1.p1","Hi-C Profiling of Solid Tumor Samples","Structural variants, such as translocations, inversions, duplications, and deletions, have long been recognized as mutations that can contribute to the initiation and progression of cancer. This can occur through a  variety of mechanisms, including changes in gene dosage and the generation of fusion genes. In recent years, it is becoming increasingly clear that","Not Applicable","Neoplasms","Case Set","target_markerset_grc38","Hi-C, Chromatin (NGS)","3 phenotype datasets, 10 variables, 1 molecular datasets, 10 samples sequenced, 10 subjects, 10 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2023-07-12","2023-07-12","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001941.v3.p1","NIDCD Otitis Media Genetic Susceptibility and Middle Ear Microbial Shifts","The study funded by R01 DC015004 aims to: (1) Identify rare OM susceptibility variants within families and in probands; and (2) Identify differences in the middle ear microbiome due to  OM susceptibility variants. This study will also elucidate mechanisms responsible for the formation and growth of cholesteatoma, and bony erosion and","Not Applicable","Otitis Media","Family/Twin/Trios","WES_markerset_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 43 samples sequenced, 37 subjects, 43 samples","","NIDCD","DS-OM-IRB-PUB-COL-NPU-MDS-GSO --- Disease-Specific (Otitis Media, IRB, PUB, COL, NPU, MDS, GSO)","2023-07-12","2023-07-12","Inflammation, Middle Ear; Middle Ear Inflammation; Middle ear infection; OM - Otitis media; inflammation of middle ear; medial otitis",""
"phs001413.v1.p1","Large Scale Genotyping of Psychiatric Disorders","Psychiatric disorders cause enormous human suffering and cost to society. The goal of this project is to elucidate the genetics of psychiatric disorders through a large consortium effort and genome-wide  genotyping. The Psychiatric Genomics Consortium (PGC) (https://www.med.unc.edu/pgc) is an international consortium to pursue genome-wide analyses of","Not Applicable","Schizophrenia","Case-Control","HumanExome-12","SNP Genotypes (Array)","5 phenotype datasets, 27 variables, 1 molecular datasets, 36626 subjects, 34943 samples","European (20290), African (19), East Asian (5208), African American (223), Hispanic1 (111), Hispanic2 (203), Other Asian or Pacific Islander (267), South Asian (1197), Other (1167)","NIMH","GRU --- General Research Use, DS-BPD-NPU-MDS --- Disease-Specific (Bipolar Disorder, NPU, MDS), MH-AO --- Mental Heath and Cognition in Adults over 18 years of age, HMB-NPU --- Health/Medical/Biomedical (NPU), DS-OCD-OPC-NPU-MDS --- Disease-Specific (Obsessive Compulsive Disorder and other psychiatric conditions, NPU, MDS), GRU-NPU --- General Research Use (NPU), DS-MHDR-NPU --- Disease-Specific (Mental Health Disorders Research, NPU), DS-SZRD-NPU --- Disease-Specific (Schizophrenia and related disorders, NPU), DS-SZRD-MDS-RD --- Disease-Specific (Schizophrenia and related disorders, MDS, RD), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-NDR-MDS --- Disease-Specific (Neurological Disorders Research, MDS), DS-MHDR-MDS --- Disease-Specific (Mental Health Disorders Research, MDS), HMB-MDS --- Health/Medical/Biomedical (MDS), DS-ADHD-MDS --- Disease-Specific (Attention deficit hyperactive disorder, MDS), DS-ADHD-RC-MDS-RD --- Disease-Specific (ADHD and Related Conditions, MDS, RD), DS-MHOCD-MDS-RD --- Disease-Specific (Mental Health - Disorders Related to OCD Only, MDS, RD)","2023-07-12","2023-07-12","Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Obsessive-Compulsive Disorder; ADD; ADDH; ADHD","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: Psychiatric Genomics Consortium (PGC) dbGaP Datasets (phs001254.v1.p1)"
"phs003272.v1.p1","Supraphysiologic MDM2 Expression Impacts P53-Independent Chromatin    Networks and Therapeutic Responses in Sarcoma","We collected multiple liposarcoma samples from different patients, including different subtypes (DD, WD) and normal adipose tissue as control. This study provides the biggest liposarcoma cohort to date, and examined  the molecular regulatory circuits associated with MDM2 overexpression. To this end, we obtained not only RNA-seq data, but also ChIP-seq from Jun,","Not Applicable","Liposarcoma","Collection","Not Provided","ChIP-Seq, Hi-C, RNA-Seq","3 phenotype datasets, 10 variables, 39 samples sequenced, 26 subjects, 40 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2023-07-11","2023-07-11","DDLPS; DDLS; Dedifferentiated Liposarcomas; Liposarcoma, Dedifferentiated; dedifferentiated liposarcoma",""
"phs002877.v1.p1","Mapping the Evolution of T Cell States During Response and Resistance to    Adoptive Cellular Therapy","We investigated single T cell transcriptional states that define donor lymphocyte infusion (DLI) response and resistance from cryopreserved bone marrow mononuclear cells from 15 patients with relapsed chronic myeloid leukemia  (CML) after allogeneic hematopoietic stem cell transplant. By integrating bulk ATAC-seq data from sorted T cell populations from these bone marrow","Not Applicable","Leukemia, Myelogenous, Chronic, BCR-ABL Positive","Case-Control","Not Provided","OTHER","4 phenotype datasets, 15 variables, 100 samples sequenced, 17 subjects, 106 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-07-11","2023-07-11","BCR-ABL Positive chronic myelogenous leukaemia; BCR-ABL Positive chronic myelogenous leukemia; CGL - Chronic granulocytic leukemia; CML; CML - Chronic myeloid leukemia; CML - chronic myelogenous leukaemia",""
"phs000235.v21.p6","National Cancer Institute Cancer Genome Characterization Initiative    (CGCI)","The Office of Cancer Genomics at the National Cancer Institute sponsored a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing technologies  in cancer. The CGCI program included comprehensive characterization of the genetic aberrations found in different pediatric and/or adult tumors. CGCI","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 257 samples sequenced, 762 subjects, 884 samples, 6 substudies","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, GRU-IRB --- General Research Use (IRB)","2023-07-11","2013-06-20","Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Lung Tumor; Lung cancer","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000532.v18.p6","National Cancer Institute (NCI) Cancer Genome Characterization Initiative    (CGCI): Non-Hodgkin Lymphoma","The Office of Cancer Genomics (OCG) at the National Cancer Institute sponsored a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing  technologies in cancer. The CGCI program included comprehensive characterization of the genetic aberrations found in different pediatric and/or adult","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v21.p6)","Lymphoma, Non-Hodgkin","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS, WXS","2 phenotype datasets, 33 variables, 207 samples sequenced, 118 subjects, 207 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, GRU-IRB --- General Research Use (IRB)","2023-07-11","2013-06-20","Lymphoma, Follicular; Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC",""
"phs000531.v18.p6","National Cancer Institute (NCI) Cancer Genome Characterization Initiative    (CGCI): Medulloblastoma","The Office of Cancer Genomics (OCG) at the National Cancer Institute sponsored a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing  technologies in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different pediatric and/or adult","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v21.p6)","Medulloblastoma","Tumor vs. Matched-Normal","Not Provided","Not Provided","Not Provided","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, GRU-IRB --- General Research Use (IRB)","2023-07-11","2013-06-20","Arachnoidal Cerebellar Sarcoma, Circumscribed; Circumscribed arachnoidal cerebellar sarcoma; Desmoplastic Medulloblastomas; Desmoplastic Nodular Medulloblastoma; Desmoplastic medulloblastoma; Medulloblastoma, Desmoplastic",""
"phs000530.v18.p6","National Cancer Institute (NCI) Cancer Genome Characterization Initiative    (CGCI): HIV+ Tumor Molecular Characterization Project - Lung Cancer    (HTMCP - LC)","The Office of Cancer Genomics at the National Cancer Institute sponsored a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing technologies  in cancer. The CGCI program included comprehensive characterization of the genetic aberrations found in different pediatric and/or adult tumors. All","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v21.p6)","Lymphoma, AIDS-Related","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS, miRNA-Seq","2 phenotype datasets, 8 variables, 39 samples sequenced, 39 subjects, 65 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, GRU-IRB --- General Research Use (IRB)","2023-07-11","2013-06-20","Lung Neoplasms; Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung",""
"phs000529.v18.p6","National Cancer Institute (NCI) Cancer Genome Characterization Initiative    (CGCI): HIV+ Tumor Molecular Characterization Project - Diffuse Large    B-Cell Lymphoma (HTMCP - DLBCL)","The Office of Cancer Genomics at the National Cancer Institute sponsored a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing technologies  in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different pediatric and/or adult tumors. All","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v21.p6)","Lymphoma, AIDS-Related","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS, miRNA-Seq","2 phenotype datasets, 8 variables, 11 samples sequenced, 70 subjects, 77 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, GRU-IRB --- General Research Use (IRB)","2023-07-11","2013-06-20","Lymphoma, Non-Hodgkin; AIDS Associated Lymphoma; AIDS Lymphoma; AIDS Related Lymphoma; AIDS-Associated Lymphoma; AIDS-Associated Lymphomas",""
"phs000528.v18.p6","National Cancer Institute (NCI) Cancer Genome Characterization Initiative    (CGCI): HIV+ Tumor Molecular Characterization Project - Cervical    Cancer (HTMCP - CC)","The Office of Cancer Genomics at the National Cancer Institute sponsored a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing technologies  in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different pediatric and/or adult tumors. All","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v21.p6)","Lymphoma, AIDS-Related","Tumor vs. Matched-Normal","Not Provided","Not Provided","212 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, GRU-IRB --- General Research Use (IRB)","2023-07-11","2013-06-20","AIDS Associated Lymphoma; AIDS Lymphoma; AIDS Related Lymphoma; AIDS-Associated Lymphoma; AIDS-Associated Lymphomas; AIDS-Related Lymphoma",""
"phs000527.v18.p6","National Cancer Institute (NCI) Cancer Genome Characterization Initiative    (CGCI): Burkitt Lymphoma Genome Sequencing Project (BLGSP)","The Office of Cancer Genomics at the National Cancer Institute sponsored a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing technologies  in cancer. The CGCI program included comprehensive characterization of the genetic aberrations found in different pediatric and/or adult tumors. All","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v21.p6)","Lymphoma, Non-Hodgkin","Tumor vs. Matched-Normal","Not Provided","Not Provided","323 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, GRU-IRB --- General Research Use (IRB)","2023-07-11","2013-06-20","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum Cell Sarcomas; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma",""
"phs002330.v2.p1","Kids First and INCLUDE: Down Syndrome, Heart Defects, and Acute    Lymphoblastic Leukemia","This project is a collaboration with the trans-NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project, which seeks to improve health and quality-of-life for individuals  with Down syndrome, and NHLBI's TransOmics for Precision Medicine (TOPMed) program, which seeks to apply omics technologies to improve scientific","Not Applicable","Down Syndrome","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 2489 subjects, 3122 samples","","NICHD","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU)","2023-07-10","2021-09-24","Precursor Cell Lymphoblastic Leukemia-Lymphoma; 47,XX,+21; 47,XY,+21; DS; Down syndrome chromosome region; Down syndrome critical region",""
"phs001040.v6.p1","NHLBI TOPMed: Novel Risk Factors for the Development of Atrial    Fibrillation in Women","The Women's Genome Health Study (WGHS) is a prospective cohort comprised of over 25,000 initially healthy female health professionals enrolled in the Women's Health Study, which began in 1992-1994. All  participants in WGHS provided baseline blood samples and extensive survey data. Women who reported atrial fibrillation during the course of the study","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","4 phenotype datasets, 61 variables, 2 documents, 2 molecular datasets, 117 samples sequenced, 118 subjects, 117 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2023-07-06","2023-07-06","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs002856.v1.p1","Genomic Studies of Bipolar Disorder in a Large Cohort from The    Netherlands","The transcriptomes of whole blood samples of a large cohort of individuals from the Netherlands were assayed using RNA-seq. These whole blood samples included patients diagnosed with schizophrenia or bipolar  disorder, family members of patients, and healthy controls. Within the whole blood dataset, about 600 of the samples were sequenced to an average of","Not Applicable","Sequence Analysis, RNA","Methods","custom_markerset, RNAseq_probe_set_grc38","SNP Genotypes (Array), RNA Seq (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 2278 subjects, 2412 samples","European (2495), African (2), East Asian (11), African American (6), Hispanic1 (16), Hispanic2 (13), Other Asian or Pacific Islander (8), South Asian (6), Other (32)","NIMH","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2023-07-05","2023-07-05","Bipolar and Related Disorders",""
"phs000946.v6.p2","NHLBI TOPMed: Boston Early-Onset COPD Study","Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States and the only leading cause of death that is steadily increasing in frequency. This  project collected a set of extended pedigrees ascertained through subjects with severe, early-onset COPD. This study has enrolled subjects with","Not Applicable","Pulmonary Disease, Chronic Obstructive","Family/Twin/Trios","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), CNV (NGS), WGS","3 phenotype datasets, 14 variables, 2 documents, 2 molecular datasets, 74 samples sequenced, 74 subjects, 74 samples","","NHLBI","DS-CS-RD --- Disease-Specific (COPD and Smoking, RD)","2023-07-03","2023-07-03","Chronic Obstructive Pulmonary Disease; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs003277.v1.p1","Cellular Indexing of Transcriptomes and Epitopes Sequencing (CITE-Seq)    Analysis to Investigate the Impact of Granulocyte-Colony Stimulating    Factor on CRISPR/Cas9 Gene Edited Human Hematopoietic Stem Cell    Function","Our research using in-vivo preclinical xenograft mouse models demonstrated that G-CSF impedes engraftment of CRISPR-Cas9 gene edited human hematopoietic stem cells (HSCs). In this CITE-seq study, we sought to investigate  the mechanisms by which G-CSF negatively impacts long-term repopulating functions of CRISPR-Cas9 gene edited human HSCs. Accordingly, human CD34+","Not Applicable","Hematopoietic Stem Cells","Xenograft","Not Provided","Not Provided","4 phenotype datasets, 15 variables, 1 subjects, 6 samples","","NHLBI","GRU --- General Research Use","2023-06-29","2023-06-29","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003270.v1.p1","Studies in the Natural History and Pathogenesis of Childhood-Onset and    Adult-Onset Idiopathic Inflammatory Myopathies","The present study compares transcript and protein regulation in peripheral blood of adult and juvenile dermatomyositis (DM) patients vs. healthy control subjects to identify novel pathways in active patients under  treatment. Whole blood data is submitted representing transcript and protein expression, including 14 adult DM and 11 juvenile DM (JDM) patients, and","Not Applicable","Dermatomyositis","Cross-Sectional","Affymetrix_expression_array, proteome","Proteomics, RNA Seq (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 51 subjects, 98 samples","","NIEHS","HMB --- Health/Medical/Biomedical","2023-06-29","2023-06-29","Adult dermatomyositis; Amyopathic dermatomyositis; DM; DM - Dermatomyositis; Dermatopolymyositis; Polymyositis Dermatomyositis",""
"phs003192.v1.p1","ARST17B2-Q Germline and Somatic Genetic Landscape of Pediatric    Rhabdomyosarcoma","Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. While these malignancies display aberrant myogenic differentiation, relatively little is known about genetic susceptibility to RMS, or how genetic  variants influence subsequent somatic events and may be used in risk stratification strategies. A small percentage of cases are associated with","Not Applicable","Rhabdomyosarcoma","Case Set","HumanOmniExpress-24","SNP Genotypes (Array)","4 phenotype datasets, 27 variables, 1 molecular datasets, 920 subjects, 920 samples","European (551), African (5), East Asian (14), African American (117), Hispanic1 (35), Hispanic2 (134), Other Asian or Pacific Islander (22), South Asian (14), Other (28)","NCI","GRU --- General Research Use","2023-06-29","2023-06-29","Not Provided",""
"phs003243.v1.p1","Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment    of a Repository for Related Biologic Studies (10C0086)","This study (10-C-0086) collected and analyzed tumor and circulating tumor omics of pediatric and young adult patients with relapsed rhabdomyosarcoma who were co-enrolled in and receiving treatment on the interventional  study 17-C-0049. We sought to describe the summary genomic findings of tumors, and report on the detection of circulating tumor DNA (ctDNA) in serial","Not Applicable","Rhabdomyosarcoma","Collection","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 17 variables, 66 samples sequenced, 12 subjects, 66 samples","","NCI","GRU --- General Research Use","2023-06-27","2023-06-27","Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; ARMS; Alveolar Rhabdomyosarcomas; Alveolar rhabdomyosarcoma (disease); Monomorphous Round Cell Rhabdomyosarcoma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003150.v1.p1","International Cancer Proteogenomics Consortium (ICPC): Proteogenomics of    East-Asian Breast Cancer","The incidence of invasive breast cancer is rapidly increasing in East Asia, enriching in younger patients and luminal disease. We presented a deep proteogenomic landscape of a prospectively enrolled early-stage  cohort in Taiwan to uncover the etiology, age-related subtype and oncogenic vulnerabilities underlying the heterogeneous disease. Multilayer","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","WES_markerset_grc37","RNA-Seq, SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 24 variables, 1 molecular datasets, 690 samples sequenced, 138 subjects, 690 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2023-06-26","2023-06-26","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003138.v1.p1","3/7 Psychiatric Genomics Consortium: Finding Actionable Variation","The goal of this study was to generate new therapeutic hypotheses by targeted sequencing of 161 genes most likely to harbor schizophrenia (SCZ) causal variants in multi-ancestry schizophrenia case-control cohorts.  The gene panel was intended to contain putative SCZ risk genes, from within which, the majority of new discoveries from additional WES/WGS would","Not Applicable","Schizophrenia","Case-Control","target_markerset_grc37","SNP Genotypes (NGS), Targeted-Capture","3 phenotype datasets, 15 variables, 1 analyses, 1 molecular datasets, 8543 samples sequenced, 8543 subjects, 8543 samples","","NIMH","HMB --- Health/Medical/Biomedical, DS-MLHLTH --- Disease-Specific (Mental Health)","2023-06-26","2023-06-26","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder",""
"phs003065.v1.p1","Uncovering RNA Signatures of C9orf72-Linked ALS and Related Disorders","Substantial clinical and pathological variability has been reported in patients carrying an expanded repeat in C9orf72, who are generally diagnosed with amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD). Emerging  evidence suggests that C9orf72 expression, RNA foci, and dipeptide-repeat proteins contribute to C9orf72-related diseases; however, the majority of","Not Applicable","C9orf72 Protein","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 193 samples sequenced, 193 subjects, 193 samples","","NINDS","GRU --- General Research Use","2023-06-22","2023-06-22","Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002260.v2.p1","Characterization of Immune Evasion in Merkel Cell Carcinoma","Merkel cell carcinoma (MCC) is a rare, neuroendocrine skin carcinoma that is caused by the Merkel cell polyomavirus (MCPyV) in 80% of cases and by ultraviolet (UV) damage in 20%  of cases. MCC should theoretically elicit a strong cytotoxic T cell response due to the high neoantigen and viral antigen burden in MCPyV- and MCPyV+","Not Applicable","Carcinoma, Merkel Cell","Collection","Not Provided","ATAC-seq, Bisulfite-Seq, RNA-Seq, WGS, WXS","4 phenotype datasets, 16 variables, 132 samples sequenced, 49 subjects, 132 samples","","NCI","DS-MCC-IRB-MDS --- Disease-Specific (Merkel cell carcinoma, IRB, MDS)","2023-06-22","2022-06-28","Anaplastic carcinoma of the skin; Cancer, Merkel Cell; Cell Cancer, Merkel; Cutaneous APUDoma; MCC; Merkel Cell Cancer",""
"phs003024.v1.p1","Gene Expression Analysis in Clonal Evolution of Fanconi Anemia","We examined hematopoietic progenitor cells derived from iPSCs from patients with Fanconi anemia, including bone marrow failure cells (FANCA-/- HPCs), 'healthy', complemented cells (FANCA-/- cells with a wild-type FANCA cDNA),  MDS-like cells (FANCA-/- HPCs with introduced mutations in RUNX1 and other MDS-associated genes), and Fanconi AML-like cells ('FAL'; MDS-like cells","Not Applicable","Fanconi Anemia","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 9 variables, 12 samples sequenced, 2 subjects, 12 samples","","NIDDK","HMB --- Health/Medical/Biomedical","2023-06-21","2023-06-21","Anemia, Fanconi; Anemia, Fanconi's; Anemias, Fanconi; FA; Fanconi Anemias; Fanconi Hypoplastic Anemia",""
"phs002461.v2.p1","Single-Cell Analysis of Human Adipogenesis","The data in this study consists of RNA sequencing reads and read counts from single-cell and single-nuclei RNA sequencing experiments performed on two cell lines to investigate the transcriptional landscape  of human adipogenesis in both the brown and white adipose tissue lineage. The two cell lines are human preadipocytes collected and isolated from a","Not Applicable","Adipogenesis","Collection","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 19 variables, 3 documents, 2 molecular datasets, 12 samples sequenced, 1 subjects, 12 samples","","NIGMS","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2023-06-15","2023-06-15","",""
"phs000989.v6.p1","Cellular Diversity of the Developing Human Cerebral Cortex","We sought to characterize cellular heterogeneity in the human cerebral cortex at a molecular level during cortical neurogenesis. We captured single cells and generated sequencing libraries using the C1TM Single-Cell  Auto Prep System (Fluidigm), the SMARTer Ultra Low RNA Kit (Clontech), and the Nextera XT DNA Sample Preparation Kit (Illumina). We performed","Not Applicable","Neural Stem Cells","Prospective Longitudinal Cohort","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 13 variables, 7829 samples sequenced, 102 subjects, 7829 samples","","NIMH","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-06-15","2016-01-12","Not Provided",""
"phs002637.v1.p1","CIDR: The Role of Rare Coding Variation in Prostate Cancer in Men of    African Ancestry - RESPOND Project 2","In RESPOND Project 2, we seek to identify rare genetic factors that are associated with prostate cancer (PCa) risk and aggressiveness in men of African ancestry (AA). We will conduct  exome sequencing of 15,000 prostate cancer cases and 5,000 controls from the RESPOND cohort and the African Ancestry Prostate Cancer Consortium","Not Applicable","Prostatic Neoplasms","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 45 variables, 1 documents, 1 molecular datasets, 12155 samples sequenced, 12049 subjects, 12171 samples","","NCI","GRU --- General Research Use, DS-PC-PUB-MDS --- Disease-Specific (Prostate Cancer, PUB, MDS), DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS), DS-CHDSAD-MDS --- Disease-Specific (Cancer, Heart Disease, Stroke, Alzheimer Disease, and Diabetes, MDS), DS-PC --- Disease-Specific (Prostate Cancer), HMB --- Health/Medical/Biomedical, DS-CA-IRB --- Disease-Specific (Cancer, IRB), DS-UC-MDS --- Disease-Specific (Urinary Conditions, MDS), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2023-06-14","2023-06-14","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs002102.v1.p1","Bone Microarchitecture","Osteoporosis affects more than 28 million people in the United States and the lifetime risk for osteoporosis-related morbidity is higher than a woman's combined risk for breast cancer, endometrial cancer  and ovarian cancer. Health care expenditures for osteoporotic patients in this country are currently nearly 13 billion dollars per annum and are","Not Applicable","Bone Density","Cross-Sectional","imputation_panel","SNP Genotypes (imputed)","4 phenotype datasets, 34 variables, 1 molecular datasets, 3355 subjects, 3355 samples","","NIAMS","HMB --- Health/Medical/Biomedical, DS-OSP-IRB-COL-GSO-RD --- Disease-Specific (Osteoporosis, IRB, COL, GSO, RD)","2023-06-14","2023-06-14","Osteoporosis; Age Related Osteoporosis; Age-Related Bone Loss; Age-Related Bone Losses; Age-Related Osteoporoses; Age-Related Osteoporosis",""
"phs003299.v1.p1","The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors    of Mitochondrial Metabolism","The Metabolism, Infection and Immunity (MINI) Study is a longitudinal natural history study at the National Institutes of Health (NIH) that aims to define the relationship between infection, immunity and  clinical decline in individuals with mitochondrial disease (MtD). This study was approved by the NIH Institutional Review Board (IRB). Study","Not Applicable","Mitochondrial Diseases","Case-Control","Not Provided","Not Provided","Not Provided","","NHGRI","","2023-06-12","","Inborn Errors of Metabolism; Depletion of mitochondrial deoxyribonucleic acid; Mitochondrial DNA Depletion Syndromes; Mitochondrial DNA depletions; mitochondrial DNA depletion; mtDNA depletion syndrome",""
"phs000431.v3.p1","GWAS for IgA Nephropathy","IgA nephropathy (IgAN) is a common form of immune-mediated glomerulonephritis characterized by glomerular deposition of IgA-containing immune complexes and manifesting with hematuria, proteinuria, and often kidney failure. This dataset is  from a genome-wide association study (GWAS) designed to identify novel genetic risk loci for IgAN. In this dataset, seven cohorts were genotyped by","Not Applicable","Glomerulonephritis, IGA","Case-Control","Human610-Quad, HumanOmni1-Quad, MEGA_Consortium_Array, ImmunoArray","SNP Genotypes (Array)","6 phenotype datasets, 20 variables, 3 molecular datasets, 11135 subjects, 11135 samples","European (1580), East Asian (3515), Hispanic1 (22), Hispanic2 (79), Other Asian or Pacific Islander (59), South Asian (64), Other (195)","NIDDK","GRU-IRB --- General Research Use (IRB)","2023-06-12","2023-06-12","BERGER DISEASE; Berger's Disease; Berger's IgA or IgG nephropathy; Bergers Disease; Glomerulonephritides, IGA; IGA Nephropathy",""
"phs003175.v1.p1","Long-term Impact and Intervention with Micronutrients in Brazil, Parque    Universit&#x000e1;rio, Community-Based Study","The Parque Universit&#x000e1;rio Zinc-Vitamin A cohort was a prospective, double-blind, randomized placebo-controlled trial with 324 children enrolled between 2000 and 2004 and randomized into 8 treatment arms: Placebo, Vitamin A,  Glutamine, Vitamin A + Glutamine, Zinc + Glutamine, Zinc, Vitamin A + Zinc, Vitamin A + Zinc + Glutamine. The Parque Universit&#x000e1;rio","Not Applicable","Child Development","Clinical Trial","Axiom_GW_LAT","SNP Genotypes (Array)","5 phenotype datasets, 23 variables, 1 molecular datasets, 210 subjects, 210 samples","","NIAID","DS-MAL-GD-GID-NPU --- Disease-Specific (Malnutrition, Human Growth and Development, and/or GI Diseases, NPU)","2023-06-09","2023-06-09","Gastrointestinal Diseases; Malnutrition; Digestive Disease; Digestive System Disease; Disease, Gastrointestinal; Diseases, Gastrointestinal",""
"phs003174.v1.p1","Intervention with Micronutrients and Long-Term Impact in Brazil-RECODISA","Intervention with Micronutrients and Long-Term Impact in Brazil, a partnership between the Federal University of Cear&#x000e1;, Brazil and the University of Virginia, USA, enrolled infants in the age group of  2-36 months to investigate trends in gastrointestinal infections and their effects on growth and development and to identify genetic factors","Not Applicable","Child Development","Case-Control","Axiom_GW_LAT","SNP Genotypes (Array)","5 phenotype datasets, 24 variables, 1 molecular datasets, 664 subjects, 664 samples","European (5), African American (24), Hispanic1 (468), Hispanic2 (5), Other (162)","NIAID","DS-MAL-GD-GID-NPU --- Disease-Specific (Malnutrition, Human Growth and Development, and/or GI Diseases, NPU)","2023-06-09","2023-06-09","Gastrointestinal Diseases; Malnutrition; Digestive Disease; Digestive System Disease; Disease, Gastrointestinal; Diseases, Gastrointestinal",""
"phs003173.v1.p1","Malnutrition and Enteric Disease Network (Mal-ED) Case-Control Study in    Brazil","The Malnutrition and Enteric Disease Network (Mal-ED) Case-Control Study enrolled children in the age range 6-24 months between 2010 and 2014 in Fortaleza, Cear&#x000e1;, Brazil. The aim of the study  was to understand the etiology and pathogenesis of malnutrition. Children were prospectively enrolled cases defined as weight for age Z Score (WAZ)","Not Applicable","Child Development","Case-Control","Axiom_GW_LAT","SNP Genotypes (Array)","4 phenotype datasets, 36 variables, 1 molecular datasets, 336 subjects, 336 samples","","NIAID","DS-MAL-GD-GID-NPU --- Disease-Specific (Malnutrition, Human Growth and Development, and/or GI Diseases, NPU)","2023-06-09","2023-06-09","Gastrointestinal Diseases; Malnutrition; Digestive Disease; Digestive System Disease; Disease, Gastrointestinal; Diseases, Gastrointestinal",""
"phs003172.v1.p1","Malnutrition and Enteric Disease Network (Mal-ED) Birth Cohort in Brazil","The Malnutrition and Enteric Disease Network (Mal-ED) Birth Cohort in Brazil enrolled 242 children between 2010 and 2014; an additional 101 infants recruited under the ICIDR (International Center for Infectious  Disease Research) program and evaluated by the same procedures as Mal-ED were included in the cohort. The aim of the study was to evaluate the role","Not Applicable","Child Development","Prospective Longitudinal Cohort","Axiom_GW_LAT","SNP Genotypes (Array)","4 phenotype datasets, 43 variables, 1 molecular datasets, 279 subjects, 279 samples","","NIAID","DS-MAL-GD-GID-NPU --- Disease-Specific (Malnutrition, Human Growth and Development, and/or GI Diseases, NPU)","2023-06-09","2023-06-09","Gastrointestinal Diseases; Malnutrition; Digestive Disease; Digestive System Disease; Disease, Gastrointestinal; Diseases, Gastrointestinal",""
"phs002934.v1.p1","Molecular Biomarkers of Obesity and Metformin Response in Endometrial    Cancer: Analysis of GOG-0286B","The primary endpoint for the phase 2 study was progression free survival (PFS), and the primary endpoint for the phase 3 study was overall survival (OS). Data from phase 2  were included in the phase 3 analysis. Tissue was collected from patients with endometrial cancer who participated in the study (NCT02065687). The","Not Applicable","Endometrial Neoplasms","Case Set","Not Provided","RNA-Seq, Targeted-Capture","4 phenotype datasets, 11 variables, 738 samples sequenced, 375 subjects, 738 samples","","NCI","DS-ECA --- Disease-Specific (Endometrial Cancer)","2023-06-07","2023-06-07","Endometrial Tumor; Endometrial neoplasm; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium",""
"phs003245.v1.p1","Phenotyping and Therapeutic Approaches for Patients with    Sellar/Suprasellar Disorders","The goal of the study is to phenotype and genotype patients with rare hypothalamic and pituitary disorders and identify biomarkers of disease diagnosis, presentation, and progression. We are investigating genetic  mechanisms of pituitary tumorigenesis as well as genomic/transcriptomic markers of disease presentation and severity. Patients with suspected or","Not Applicable","Pituitary Gland","Case Set","Not Provided","WXS","5 phenotype datasets, 21 variables, 3 samples sequenced, 4 subjects, 3 samples","","NICHD","GRU --- General Research Use","2023-06-05","2023-06-05","ACTH-Secreting Pituitary Adenoma; Growth Hormone-Secreting Pituitary Adenoma; Pituitary Neoplasms; ACTH Producing Pituitary Adenoma; ACTH Producing Pituitary Gland Adenoma; ACTH Secreting Adenoma of Pituitary","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003168.v1.p1","Phenotypic and Genotypic Study of Keratoconus","Keratoconus, a disease in which the cornea is abnormally steep and thin, affects approximately 1 in 2000 individuals and usually begins in the second decade of life. Keratoconus is a  progressive disorder that results in loss of vision that cannot be alleviated by contact lenses or glasses alone and is a leading indication for","Not Applicable","Keratoconus","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 30 variables, 1 molecular datasets, 140 samples sequenced, 140 subjects, 140 samples","","NEI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2023-06-01","2023-06-01","Degeneration, Pellucid Marginal; Marginal Degeneration, Pellucid; Pellucid Marginal Corneal Degeneration; Pellucid Marginal Degeneration; Pellucid Marginal Degenerations",""
"phs003186.v1.p1","Tamoxifen Response at Single Cell Resolution in Estrogen Receptor    Positive Primary Human Breast Tumors","Primary breast tissue, normal and cancerous, was collected immediately after resection. The tissue was dissociated and treated with 10uM tamoxifen or control media for 12 hours in suspension. Single cell  libraries were then created using a 10x Genomics gel bead droplet-based kit and sequenced via Illumina sequencing platforms. Differences in cell","Not Applicable","Breast Neoplasms","Case Set","target_markerset_grc38","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 26 samples sequenced, 13 subjects, 26 samples","","NCI","DS-BRCA --- Disease-Specific (Breast Cancer)","2023-05-30","2023-05-30","Breast Carcinoma In Situ; Carcinoma, Ductal, Breast; LCIS - lobular carcinoma in situ; LCIS, Lobular Carcinoma In Situ; Lobular Carcinoma In Situ; Lobular carcinoma, noninfiltrating",""
"phs003256.v1.p1","Therapy-Induced APOBEC3A Drives Evolution of Resistance to Targeted    Therapies in Non-Small Cell Lung Cancer","The purpose of this study was to identify mechanisms of resistance and associated mutational signatures in non-small cell lung cancers (NSCLCs) treated with targeted therapies. Whole genome sequencing (WGS) and  whole exome sequencing (WES) were performed on tumor tissue or cell lines derived from oncogene-driven NSCLCs before and after treatments with","Not Applicable","Carcinoma, Non-Small-Cell Lung","Tumor vs. Matched-Normal","custom_markerset","SNP Genotypes (NGS), WGS, WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 94 samples sequenced, 24 subjects, 98 samples","","NCI","GRU --- General Research Use","2023-05-25","2023-05-25","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER",""
"phs003198.v1.p1","Genomic Analyses of Germline and Somatic Variation in High-Grade Serous    Ovarian Cancer","The goal of this study was to identify and characterize germline and somatic genetic variation in women with high grade serous ovarian cancers treated at a single cancer center and  their associations with relapse-free and overall survival. We conducted paired tumor/normal targeted next-generation sequencing of 577 genes in","Not Applicable","Carcinoma, Ovarian Epithelial","Tumor vs. Matched-Normal","OncoScan_CNV_plus","CNV Genotypes, Targeted-Capture","4 phenotype datasets, 27 variables, 1 molecular datasets, 185 samples sequenced, 71 subjects, 185 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2023-05-22","2023-05-22","Cancer, Epithelial Ovarian; Cancer, Ovarian Epithelial; Carcinoma of Ovary; Carcinoma of the Ovary; Carcinoma, Epithelial Ovarian; Epithelial Cancer, Ovarian",""
"phs003279.v1.p1","MAITS in HCC","Hepatocellular Carcinoma (HCC) is a leading cause of cancer-related death and can be considered a prototype of inflammation-derived cancer arising from chronic liver injury. The cell composition of the HCC  tumor immune microenvironment (TiME) has a major impact on cancer biology as the TiME can have divergent capacities on tumor initiation, progress,","Not Applicable","Hepatocellular carcinoma; Mucosal-Associated Invariant T Cells;    tumor-associated macrophages; single-cell sequencing","Tumor vs. Matched-Normal","RNAseq_probe_set_grc38","RNA Seq (NGS)","3 phenotype datasets, 10 variables, 1 molecular datasets, 8 subjects, 36 samples","","NCI","GRU --- General Research Use","2023-05-18","2023-05-18","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003278.v1.p1","Sex Chromosome Aneuploidy Effects on Human Gene Expression","Sex chromosome aneuploidy (SCA) syndromes are defined by the presence of a sex chromosome complement other than the typical XX for females and XY for males. SCAs are collectively common  and increase risks for diverse immune, metabolic, and neuropsychiatric illnesses. Understanding genome-wide transcriptomic changes in SCAs is","Not Applicable","Sex Chromosome Aberrations","Case-Control","Not Provided","RNA-Seq","3 phenotype datasets, 13 variables, 197 samples sequenced, 197 subjects, 197 samples","","NIMH","HMB-IRB-PUB-COL --- Health/Medical/Biomedical (IRB, PUB, COL)","2023-05-18","2023-05-18","Aneuploidy; Alteration of chromosome number; Aneuploid; Aneuploidies; Aneuploids; chromosome number anomaly",""
"phs000331.v2.p1","A Genome-Wide Association Study in Patients Experiencing Drug-Induced    Long-QT Syndrome and/or Torsades de Pointes; A Collaboration Between    the NIH Pharmacogenomics Research Network and the RIKEN Yokohama    Institute Center for Genomic Medicine","The goal of this study was to identify genetic risk factors for drug-induced prolongation of the QT interval (diLQT) and the ventricular arrhythmia torsades de pointes (TdP). We conducted a  genome-wide association study (GWAS) focusing on subjects with a history of long QT and/or TdP after taking medication. Controls for this study were","Not Applicable","Long QT Syndrome","Case-Control","Human610-Quad","SNP Genotypes (Array)","3 phenotype datasets, 12 variables, 1 molecular datasets, 831 subjects, 831 samples","European (687), East Asian (14), African American (102), Hispanic1 (5), Hispanic2 (4), Other Asian or Pacific Islander (2), South Asian (6), Other (3)","NHLBI","HMB-GSO --- Health/Medical/Biomedical (GSO)","2023-05-18","2013-03-30","Torsades de Pointes; Electrocardiogram QT Prolonged; Increased QT interval; Long Q-T syndrome; Long QT syndrome; Prolong QT interval","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs003257.v1.p1","Investigating the Role of Neddylation in the Repair of Topoisomerase    I-Mediated DNA Damage in Colorectal Cancer","Colorectal cancer is one of the most lethal cancers worldwide. First-line chemotherapy for metastatic CRC (mCRC) entails a combination of irinotecan with 5-fluorouracil and leucovorin (FOLFIRI). Irinotecan is a prodrug  that is converted within the cell to its active metabolite SN38, a potent TOP1 inhibitor. TOP1 relieves DNA torsional strain arising from DNA","Not Applicable","Colorectal Neoplasms","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 3 samples sequenced, 3 subjects, 3 samples","","NCI","GRU --- General Research Use","2023-05-16","2023-05-16","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003158.v1.p1","S&#x000e9;zary Syndrome Originates from Heavily Mutated Hematopoietic Progenitors","The pathogenesis of cutaneous T cell lymphoma (CTCL) remains unclear. To study the malignant transformation of CTCL, we collected matched hematopoietic stem cell (HSC) extracts from bone marrow, CD4+CD26- malignant  T cells, CD4+CD26+ normal T cells, and CD34+ HSCs from apheresis performed on 4 patients. To establish the baseline for calling true mutations","Not Applicable","Sezary Syndrome","Tumor vs. Matched-Normal","Not Provided","WXS","4 phenotype datasets, 20 variables, 23 samples sequenced, 4 subjects, 23 samples","","NCI","GRU --- General Research Use","2023-05-16","2023-05-16","Lymphoma, T-Cell, Cutaneous; Granulomatous Slack Skin; Slack Skin, Granulomatous; CTCL / Sezary syndrome; Erythroderma, Sezary; Lymphoma, Sezary's","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001491.v3.p1","Genetics of Disorders Affecting Tooth Structure, Number, Morphology and    Eruption","The long-term objective of this research project is to discover the complete spectrum of genes that contribute to the etiologies of genetic disorders of dentition. Inherited tooth defects can be  isolated (the only symptom) or syndromic (having additional symptoms), and can be caused by mutations in many different genes. Clinically, it can be","Not Applicable","Amelogenesis Imperfecta","Case-Control","Not Provided","WGS, WXS","5 phenotype datasets, 20 variables, 392 samples sequenced, 392 subjects, 392 samples","","NIDCR","NTUH-HMB-IRB-PUB-COL-NPU-MDS-GSO --- NTUH Taiwan Health/Medical/Biomedical (IRB, PUB, COL, NPU, MDS, GSO), TURKEY-HMB-IRB-PUB-COL-NPU-MDS-GSO --- Turkey Health/Medical/Biomedical (IRB, PUB, COL, NPU, MDS, GSO), HMB --- Health/Medical/Biomedical","2023-05-16","2020-10-13","Dentin dysplasia, type 1; Dentinogenesis Imperfecta; Failure of Tooth Eruption, Primary; Tooth Abnormalities; Tooth, Supernumerary; AI",""
"phs001849.v1.p1","RNA sequencing, ATACseq, and TCR-seq of Tfh cells and CXCR5- CD4+ T cells    in HIV infected lymph nodes","The high dimensional analyses of CD4+ T cells in human lymph nodes are case-based analyses of the TCR repertoire, transcriptome, and epigenetic signatures of various CD4+ T cells in human  lymph nodes. The study aims to determine clonal overlap between phenotypically distinct CD4+ T cells and the similarities between these populations","Not Applicable","HIV","Prospective Longitudinal Cohort","Not Provided","ATAC-seq, OTHER, RNA-Seq","4 phenotype datasets, 19 variables, 15 samples sequenced, 15 subjects, 15 samples","","NIAID","DS-HIV-IRB --- Disease-Specific (Human Immunodeficiency Virus, IRB)","2023-05-15","2023-05-15","Not Provided",""
"phs003216.v1.p1","Whole Genome Sequencing Analysis in a Family of Discordant Twins With    Non-Syndromic Microtia and Hemifacial Microsomia: Identification of    Novel Candidate Genes and Variants","This research is a non-NIH effort to discover the pathogenesis of non-syndromic microtia and to detect potential candidate genes. Microtia (OMIM 600674, 612290, 251800) is a spectrum of congenital anomalies  and facial abnormalities, 90% of the cases followed by hearing loss. Two types of the disease are described in terms of connection to the affected","Not Applicable","Genetic Markers","Family/Twin/Trios","WGS_markerset_grc38","SNP Genotypes (NGS), WGS","5 phenotype datasets, 23 variables, 1 molecular datasets, 4 samples sequenced, 4 subjects, 4 samples","","NICHD","DS-MT-IRB --- Disease-Specific (Microtia, IRB)","2023-05-12","2023-05-12","Congenital Microtia; Bilateral microtia; Hypoplasia of the external ear; Hypoplastic ears; Hypoplastic pinna; Hypoplastic pinnae",""
"phs003072.v1.p1","RNA-Seq of Whole Blood from Patients with Intracranial Aneurysms","Rupture of intracranial aneurysms (IAs) causes intracranial hemorrhaging that leads to high rates of neurological deficits and death. Although rupture rates are low, clinicians must decide whether to treat or  monitor these potentially dangerous lesions. In the current clinical practice, the most common metric to measure risk of rupture is aneurysm size.","Not Applicable","Intracranial Aneurysm","Cross-Sectional","Not Provided","RNA-Seq","4 phenotype datasets, 20 variables, 43 samples sequenced, 43 subjects, 43 samples","","NINDS","GRU --- General Research Use","2023-05-12","2023-05-12","Subarachnoid Hemorrhage; Aneurysm, Middle Cerebral Artery; Middle Cerebral Artery Aneurysm; Hemorrhage, Subarachnoid; Hemorrhages, Subarachnoid; SAH (Subarachnoid Hemorrhage)","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000492.v4.p3","Genetics of Human Developmental Brain Disorders","Developmental brain malformations are at the core of significant neurological diseases affecting many families in the United States and around the world. It is known that epilepsy, specific learning deficits  and intellectual disability, cerebral palsy, and abnormalities of brain volume can be attributed in many cases to pathological malformations of the","Not Applicable","Microcephaly","Cross-Sectional","WES_markerset_grc37, HumanOmni2.5-8, Affymetrix_WG_Array, WGS_markerset_grc37, Human660W-Quad, HumanHap550","SNP Genotypes (Array), RNA-Seq, SNP/CNV Genotypes (NGS), Targeted-Capture, WXS","6 phenotype datasets, 20 variables, 3 molecular datasets, 399 samples sequenced, 275 subjects, 475 samples","","NHGRI","DS-EAC-PUB-GSO --- Disease-Specific (Epilepsy and Cognition, PUB, GSO), DS-MMS-PUB-GSO --- Disease-Specific (Microcephaly-Micromelia Syndrome, PUB, GSO), DS-PM-PUB-GSO --- Disease-Specific (Polymicrogyria, PUB, GSO), GRU-PUB --- General Research Use (PUB), GRU-IRB-NPU --- General Research Use (IRB, NPU), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), HMB --- Health/Medical/Biomedical, DS-NDR --- Disease-Specific (Neurological Disorders Research)","2023-05-12","2020-07-14","Abnormalities, Congenital, Nervous System; Agenesis of Corpus Callosum; Cerebellar Ataxia; Cobblestone Lissencephaly; Dysmorphism multiple structural anomalies; Epilepsy, Temporal Lobe",""
"phs002845.v1.p1","Expression of Activation Induced Cytidine Deaminase and Risk of    Transformation in Follicular Lymphoma","It is currently unclear how to identify follicular lymphoma (FL) patients with low disease burden but high risk for early progression. Building on a prior study demonstrating early transformation in  FLs with high variant allele frequency (VAF) BCL2 mutations at activation-induced cytidine deaminase (AICDA) sites, we examined 11 AICDA mutational","Not Applicable","Lymphoma, Follicular","Case Set","Not Provided","AMPLICON","4 phenotype datasets, 27 variables, 199 samples sequenced, 199 subjects, 199 samples","","NCI","GRU --- General Research Use","2023-05-11","2023-05-11","Cell Transformation, Neoplastic; Risk Factors; Cell Neoplastic Transformation; Cell Neoplastic Transformations; Cell Transformations, Neoplastic; Neoplastic Cell Transformations","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002950.v1.p1","Methylation Profiles of Cell-Free DNA Using Nanopore Sequencing","Epigenetic characterization of cell-free DNA (cfDNA) is an emerging approach for detecting and characterizing diseases such as cancer. We developed a strategy using nanopore-based single-molecule sequencing to measure cfDNA methylomes.  This approach generated up to hundreds of millions of reads for a single cfDNA sample from cancer patients, an order of magnitude improvement over","Not Applicable","Neoplasms","Methods","Not Provided","WGS","4 phenotype datasets, 11 variables, 65 samples sequenced, 27 subjects, 65 samples","","NCI","GRU --- General Research Use","2023-05-10","2023-05-10","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002935.v1.p1","Transcriptomic Profiling of Oropharyngeal Squamous Cell Carcinoma","The study is a retrospective transcriptomic profiling of oropharyngeal squamous cell carcinoma. The pathologic database was queried for squamous cell carcinoma tumors originating from the anatomic oropharynx (tonsil or tongue  base) with available samples from surgical archives. This retrospective RNA sequencing cohort included cases dating prior to the routine","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Case Set","RNAseq_probe_set_grc37","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 133 samples sequenced, 133 subjects, 133 samples","","NCI","GRU --- General Research Use","2023-05-10","2023-05-10","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003145.v1.p1","Tissue Sampling and Biorepository to improve Cancer Cell Therapy","This study focuses on the elucidation of determinants of response and resistance to anti-CD19 CAR T-cells in large B-cell lymphoma. Plasma samples were collected prior to treatment and serially post  CAR T-cell infusion. Pre-treatment and relapse tumor samples were also obtained as available. Germ-line DNA isolated from Peripheral Blood","Not Applicable","Lymphoma, Non-Hodgkin","Case Set","RNAseq_gene_transcripts","RNA Seq (NGS), Targeted-Capture","4 phenotype datasets, 22 variables, 1 molecular datasets, 694 samples sequenced, 139 subjects, 795 samples","","NCI","DS-LYD-IRB-PUB-COL --- Disease-Specific (Lymphatic Disease, IRB, PUB, COL)","2023-05-09","2023-05-09","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum Cell Sarcomas; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma",""
"phs003207.v1.p1","Single Cell Colony Whole Genome Sequencing Data From Individuals With    Telomere Syndromes","This is an observational study which examined the phylogenetic evolution of somatic clonal mutations in POT1 mutation carriers. Two individuals with telomere syndromes who carry a heterozygous germline POT1 p.R273Q  variant and one related control who did not carry this variant were studied. Single cell hematopoietic colonies were derived from peripheral blood","Not Applicable","Clonal Hematopoiesis","Cross-Sectional","Not Provided","WGS","5 phenotype datasets, 20 variables, 152 samples sequenced, 3 subjects, 152 samples","","NCI","HMB-IRB-PUB-NPU --- Health/Medical/Biomedical (IRB, PUB, NPU)","2023-05-08","2023-05-08","ARCH; ARCH Age related Clonal Hematopoiesis; ARCH Age-related Clonal Hematopoiesis; Age related Clonal Hematopoiesis; Age-related Clonal Hematopoiesis; Clonal Hematopoiesis, Age-related",""
"phs003179.v1.p1","Rheumatoid Arthritis Finger Stick RNA Sequence Data","This is a longitudinal study of 355 blood samples collected weekly from 5 patients with Rheumatoid Arthritis with varying disease activity over the course of one to five years. Blood  samples were self collected from finger sticks and mailed from home. RNA was extracted, purified and sequenced. Inclusion Criteria - 2010","Not Applicable","Arthritis, Rheumatoid","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 355 samples sequenced, 5 subjects, 355 samples","","NIAMS","GRU --- General Research Use","2023-05-05","2023-05-05","","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001642.v2.p1","Center for Common Disease Genomics [CCDG] - Autoimmune: Inflammatory    Bowel Disease (IBD) Exomes and Genomes","The National Human Genome Research Institute (NHGRI) has funded a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing to multiple common disease phenotypes. Called  the Centers for Common Disease Genomics (CCDG), this initiative will explore a range of diseases with the ultimate goal of: undertaking variant","Not Applicable","Inflammatory Bowel Diseases","Case-Control","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical, DS-IBD --- Disease-Specific (Inflammatory Bowel Disease), DS-GID --- Disease-Specific (Gastrointestinal Diseases), HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), DS-IBD-MDS --- Disease-Specific (Inflammatory Bowel Disease, MDS), HMB-MDS --- Health/Medical/Biomedical (MDS), DS-DSDI-MDS --- Disease-Specific (Digestive System Diseases, MDS), DS-GR-IRB-MDS --- Disease-Specific (Gastroenterology, IRB, MDS)","2023-05-05","","",""
"phs003212.v1.p1","A Pilot Trial of Complement Inhibition Using Eculizumab to Overcome    Platelet Transfusion Refractoriness in HLA Allo-Immunized Patients","Platelet transfusion can be a life-saving procedure in preventing or treating serious bleeding in patients who have low and/or dysfunctional platelets. Heavily transfused patients frequently develop human leukocyte antigen (HLA)  allo-immunization resulting in platelet transfusion refractoriness and a high risk for life-threatening thrombocytopenia. Data suggest complement","Not Applicable","Thrombocytopenia","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 10 subjects, 10 samples","","NHLBI","GRU --- General Research Use","2023-05-04","2023-05-04","Low platelet count; Thrombopenia; Thrombopenias; platelet count decreased; thrombocytopenic disorder",""
"phs002595.v1.p1","Kids First: Genomics of Orofacial Clefts in the Philippines","Orofacial clefts (OFCs) are the most common craniofacial structural birth defect in humans caused by incomplete formation of the upper lip and/or the palate. Over 4,000 children in the Philippines  are born with an OFC every year, and the Filipino OFC birth prevalence rate of 1 in 500 live births is one of the highest in the world. Genome-wide","Not Applicable","Cleft Lip","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1114 subjects, 1114 samples","","NICHD","HMB --- Health/Medical/Biomedical","2023-05-04","2023-05-04","Cleft Palate; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip",""
"phs002594.v1.p1","Kids First: Genetic Basis of Fetal Alcohol Spectrum Disorders","Fetal Alcohol Spectrum Disorder (FASD) is estimated to occur in at least 1-5% of all children in the USA and is a major public health issue. However, in addition to  alcohol, other susceptibility factors, such as maternal or fetal genetic variation, must play a role as not all children prenatally exposed to","Not Applicable","Fetal Alcohol Spectrum Disorders","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 65 subjects, 65 samples","","NICHD","GRU --- General Research Use","2023-05-04","2023-05-04","FAE (Fetal Alcohol Effects); FAEs (Fetal Alcohol Effects); Growth Retardation, Facial Abnormalities, and Central Nervous System Dysfunction",""
"phs002861.v1.p1","Genomic Data Archive From the Network for Pancreatic Organ Donors With    Diabetes","The Network for Pancreatic Organ Donors with Diabetes (nPOD) is the largest biorepository of human pancreata from organ donors with type 1 diabetes (T1D), maturity-onset diabetes of the young (MODY),  cystic fibrosis-related diabetes (CFRD), type 2 diabetes (T2D), gestational diabetes, and islet autoantibody positive (AAb+)/pre-T1D. The mission of","Not Applicable","Diabetes Mellitus, Type 1","Collection","WES_markerset_grc37, ImmunoArray","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 21 variables, 2 molecular datasets, 207 samples sequenced, 412 subjects, 412 samples","European (239), African (1), East Asian (2), African American (60), Hispanic1 (16), Hispanic2 (46), Other Asian or Pacific Islander (3), Other (5)","NIDDK","GRU --- General Research Use","2023-05-03","2023-05-03","Diabetes Mellitus, Congenital Autoimmune; Diabetes Mellitus, Permanent Neonatal; Diabetes, Gestational; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002476.v3.p1","Immune Profiling in Patients with High-Risk Smoldering Myeloma","Single-cell RNA-sequencing identifies immune biomarkers of response to immunotherapy in patients with high-risk Smoldering Multiple Myeloma (SMM). We conducted a Phase II trial of the immunotherapeutic anti-SLAMF7 antibody, Elotuzumab, in  combination with Lenalidomide and Dexamethasone (E-PRISM study), to determine the utility and safety of early immunotherapy in patients with","Not Applicable","Smoldering Multiple Myeloma","Clinical Trial","target_markerset_grc38, RNAseq_probe_set_grc38","OTHER, RNA-Seq, Custom targeted DNA/RNA sequencing, RNA Seq (NGS)","4 phenotype datasets, 22 variables, 2 molecular datasets, 240 samples sequenced, 55 subjects, 240 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-05-03","2023-02-13","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease",""
"phs002207.v2.p1","Genomic and Transcriptomic Profiling of Patients with Malignant Pleural    and Peritoneal Mesothelioma: The NCI Cohort","Malignant mesothelioma is an aggressive cancer with limited treatment options and poor prognosis. Better understanding of mesothelioma genomics and transcriptomics could advance novel therapies. We performed whole-exome sequencing (WXS) of  germline and tumors of 122 patients, and RNA-sequencing (RNA-Seq) of tumor samples of 100 patients with pleural, peritoneal, and tunica-vaginalis","Not Applicable","Mesothelioma","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 24 variables, 347 samples sequenced, 122 subjects, 347 samples","","NCI","GRU --- General Research Use","2023-05-03","2023-01-06","",""
"phs003218.v1.p1","Whole Exome Sequencing and RNA-Seq to Characterize the Somatic Breast    Cancer Landscape Among Latinas in California","Somatic mutational profiles are increasingly being used to guide treatment. However, there is a dearth of data from non-European populations. To address this gap, we conducted paired tumor/normal whole exome  paired-end sequencing and tumor RNA-Seq on 146 breast tumors from 140 Hispanic/Latina (H/L) women with breast cancer. We characterized somatic","Not Applicable","Hispanic or Latino","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 23 variables, 286 samples sequenced, 140 subjects, 286 samples","","NIMHD","DS-BRCABD-IRB-PUB-NPU-GSO --- Disease-Specific (Breast cancer and/or breast density, IRB, PUB, NPU, GSO)","2023-05-01","2023-05-01","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003209.v1.p1","Structurally Complex Osteosarcoma Genomes Exhibit Limited Heterogeneity    within Individual Tumors and across Evolutionary Time","A key characteristic of osteosarcoma is extensive and complex genomic rearrangements. However, published models explaining how these genomic rearrangements occur disagree about if these rearrangements occur early in tumor progression  and then are stable afterwards, or if there is ongoing genomic instability. Previous studies have employed bulk sequencing technologies to","Not Applicable","Osteosarcoma","Xenograft","target_markerset_grc38, WGS_markerset_grc38","OTHER, SNP/CNV Genotypes (NGS), SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 12 variables, 1 molecular datasets, 19 samples sequenced, 8 subjects, 19 samples","","NCI","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2023-04-28","2023-04-28","Chromosomal Instability; Sarcoma; Chromosomal Instabilities; Chromosome Instabilities; Chromosome Instability; Instabilities, Chromosomal",""
"phs003063.v1.p1","COVID-19: Post-Hospital Thromboprophylaxis A Multicenter, Adaptive,    Prospective, Randomized Trial Evaluating the Efficacy and Safety of    Antithrombotic Strategies in Patients with COVID-19 Following Hospital    Discharge (ACTIV-4C)","This study is an adaptive, prospective, randomized trial designed to compare the effectiveness and safety of antithrombotic therapy with no antithrombotic therapy after hospitalization for 48 hours or longer for  COVID-19. For Stage 1 of this study, participants will be randomized to either prophylactic anticoagulation or no anticoagulant therapy for 30 days,","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1217 subjects, 1294 samples","","NHLBI","GRU --- General Research Use","2023-04-28","2023-04-28","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002610.v2.p1","Maintenance of Genome Sequence Integrity in Long- and Short-lived Rodent    Species","In this study, we compared somatic mutation frequencies and spectra of bleomycin-treated and control fibroblasts of 5 species, i.e., mouse, guinea pig, blind mole-rat, naked mole-rat and humans, by using  single-cell whole-genome sequencing. Sequencing data of the human cells are deposited here in the dbGaP. Sequencing data of the rodent cells are in","Not Applicable","Longevity","Control Set","Not Provided","WGA, WGS","3 phenotype datasets, 8 variables, 39 samples sequenced, 3 subjects, 39 samples","","NIA","GRU --- General Research Use","2023-04-28","2021-11-16","Aging; Aging, Biological; Biological Aging","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs003224.v1.p1","NIA CARD Coriell Cell Lines","Here we report and share Oxford Nanopore Technologies (ONT) data from three widely used lymphobastoid cell lines (LCLs) (HG002, HG02723 and HG00733) obtained from Coriell (https://www.coriell.org/). This data was generated  during optimizing the ONT sequencing protocol for the long-read sequencing efforts of the NIH Intramural Center for Alzheimer's and Related Dementias","Not Applicable","Cell Line","Control Set","Not Provided","Not Provided","Not Provided","","NIA","","2023-04-27","","Not Provided",""
"phs003182.v1.p1","Reference Profiles of ExRNAs in Normal Human Pregnancy","In this study, we did a comprehensive exRNA profiling of plasma and serum specimens from healthy pregnant women, sampled at different gestational time points, and including subjects with diverse geographical  and ethnic backgrounds. This study also contains samples from male and female healthy donors to provide a baseline. The aim of this study is to","Not Applicable","Pregnant People","Prospective Longitudinal Cohort","Not Provided","miRNA-Seq","4 phenotype datasets, 26 variables, 1020 samples sequenced, 110 subjects, 1020 samples","","NHLBI","GRU --- General Research Use","2023-04-26","2023-04-26","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003046.v1.p1","Epigenetic Biomarkers of Aging","The aim of the study was to discover new epigenetic biomarkers of aging. We used a genome-wide screen for genetic loci showing consistent changes of DNA methylation with progressive aging.  Blood DNA samples from 19 apparently healthy individuals aged 22-80 years obtained from the NINDS repositories were analyzed for DNA methylation","Not Applicable","DNA Methylation","Control Set","Not Provided","Bisulfite-Seq","3 phenotype datasets, 11 variables, 19 samples sequenced, 19 subjects, 19 samples","","NINDS","HMB --- Health/Medical/Biomedical","2023-04-26","2023-04-26","",""
"phs003246.v1.p1","Multimodal Immune Profiling to Determine Mechanisms of COVID-19 Clinical    Trajectory in Uganda","We conducted a prospective cohort study of adults (RESERVE-U-C19) admitted to Entebbe Regional Referral Hospital (ERRH), a national COVID-19 referral center, across three viral variant-driven phases of the pandemic in  Uganda. In this cohort, which reflects the entire spectrum of SARS-CoV-2 infection, we integrated clinical data with serum proteomics (N 306) and","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 12 variables, 100 samples sequenced, 100 subjects, 100 samples","","NIAID","GRU-IRB-COL --- General Research Use (IRB, COL)","2023-04-25","2023-04-25","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002983.v1.p1","INCLUDE: Genetic Underpinnings of the Multifactorial Phenotype of Trisomy    21 Patients Unveiled by Multi-Omics Approaches","The INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project is an NIH-wide collaboration that seeks to improve health and quality-of-life for people with Down syndrome.  The INCLUDE Project Data Coordinating Center and partners created the INCLUDE Data Hub, a centralized data resource that allows access to large-scale","Not Applicable","Down Syndrome","Case Set","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 1152 subjects, 1519 samples","","NICHD","GRU --- General Research Use","2023-04-25","2023-04-25","47,XX,+21; 47,XY,+21; DS; Down syndrome chromosome region; Down syndrome critical region; Down syndrome, Isolated cases",""
"phs002982.v1.p1","INCLUDE: The Epidemiology of Transient Leukemia in Newborns with Down    Syndrome","The INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project is an NIH-wide collaboration that seeks to improve health and quality-of-life for people with Down syndrome.  The INCLUDE Project Data Coordinating Center and partners created the INCLUDE Data Hub, a centralized data resource that allows access to large-scale","Not Applicable","Down Syndrome","Case Set","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 436 subjects, 436 samples","","NICHD","GRU --- General Research Use","2023-04-25","2023-04-25","47,XX,+21; 47,XY,+21; DS; Down syndrome chromosome region; Down syndrome critical region; Down syndrome, Isolated cases",""
"phs003228.v1.p1","Genomics of Blastic Plasmacytoid Dendritic Cell Neoplasm","The goal of this study was to understand the genetic evolution and tumor phylogeny of blastic plasmacytoid dendritic cell neoplasm (BPDCN). BPDCN can present in patients with skin tumors of  leukemia cells and no bone marrow or blood involvement, or alternatively, with both skin tumors and blood/bone marrow leukemia cells at the time of","Not Applicable","High-Throughput Nucleotide Sequencing","Tumor vs. Matched-Normal","Not Provided","WGS, WXS","3 phenotype datasets, 13 variables, 25 samples sequenced, 6 subjects, 25 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-04-24","2023-04-24","Not Provided",""
"phs003200.v1.p1","High-Throughput RNA Isoform Sequencing using Programmable cDNA    Concatenation","MAS-ISO-seq is a novel technique for programmably concatenating cDNAs into single molecules for optimal long-read sequencing. In practice, this boosts throughput 15 fold to nearly 40 million cDNA reads per  run on the PacBio Sequel IIe sequencer. We have validated this method via application to synthetic RNA isoforms and single-cell sequencing of","Not Applicable","Melanoma","Methods","Not Provided","Not Provided","Not Provided","","NHGRI","DS-MSC-MDS --- Disease-Specific (Melanoma and Skin Cancer Research, MDS)","2023-04-24","","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs001967.v1.p1","Molecular Biomarkers in Glioma (Mechanisms and Therapeutic Implications    of Hypermutation in Gliomas)","This study seeks to genomically and mechanistically examine the basis for resistance of glioblastoma to chemotherapy, radiation therapy, and targeted therapy including immunotherapies. The study design addresses two Aims. In  Aim 1, we will test the hypothesis that treatment with radiation and temozolomide or other therapies leads to consistent genetic changes in human","Not Applicable","Glioma","Case Set","Not Provided","Targeted-Capture, WGS, WXS","4 phenotype datasets, 18 variables, 90 samples sequenced,  SRA, 3 subjects, 90 samples","","NCI","GRU-IRB --- General Research Use (IRB)","2023-04-21","2023-04-21","Diffuse Intrinsic Pontine Glioma; ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytoma (excluding glioblastoma)",""
"phs003242.v1.p1","TREM2+ Cells in Human Basal Cell Carcinomas","To explore the tumor immune microenvironment heterogeneity in sporadic human basal cell carcinoma tumors, we profiled two individual patient tumors by scRNA-Seq. We identified a population of TREM2+ macrophages, which  have been implicated in promoting an immunosuppressive tumor microenvironment. We identify that TREM2+ can promote tumor epithelial proliferation in","Not Applicable","Tumor-Associated Macrophages","Case Set","RNAseq_gene_transcripts","OTHER, RNA Seq (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 2 samples sequenced, 2 subjects, 2 samples","","NIAMS","GRU --- General Research Use","2023-04-20","2023-04-20","BCC - Basal cell carcinoma of skin; Basal Cell Cancer; Basal Cell Carcinoma; Basal Cell Carcinoma of Skin; Basal Cell Carcinoma of the Skin; Basal Cell Epithelioma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002929.v1.p1","The Genetic Basis of Progression in Multiple Sclerosis","This study examined the genetic determinants of multiple sclerosis (MS) severity in an international cohort of people with MS assembled by the International Multiple Sclerosis Genetics Consortium (IMSGC) and the  MultipleMS Consortium. A total of 12,584 people with MS of European ancestry were included in the main genome-wide association study (GWAS).","Not Applicable","Multiple Sclerosis","Case Set","Global_Screening_Array-24","SNP Genotypes (Array)","4 phenotype datasets, 27 variables, 1 molecular datasets, 4623 subjects, 4623 samples","","NINDS","GRU --- General Research Use, DS-MS --- Disease-Specific (Multiple Sclerosis), DS-MS-COL --- Disease-Specific (Multiple Sclerosis, COL), HMB --- Health/Medical/Biomedical","2023-04-19","2023-04-19","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple",""
"phs001322.v3.p1","NINDS Inherited Forms of Motor Neuron Disease Study","Sequencing data from primary fibroblasts were obtained from individuals with a family history of an inherited form of motor neuron disease (juvenile amyotrophic lateral sclerosis- ALS4). Inclusion criteria: Members of  a family with a history of inherited motor neuron disease. Related Genes: SETX Principal Investigator: Kenneth Fischbeck, MD, National Institutes of","Not Applicable","Amyotrophic Lateral Sclerosis 4, Juvenile","Mendelian","Not Provided","Bisulfite-Seq, ChIP-Seq, OTHER, RNA-Seq","4 phenotype datasets, 20 variables, 37 samples sequenced, 13 subjects, 37 samples","","NINDS","GRU --- General Research Use","2023-04-17","2018-02-02","ALS 4; ALS4; ALS4 - amyotrophic lateral sclerosis type 4; Distal hereditary motor neuropathy with upper motor neuron signs; NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES; SETX amyotrophic lateral sclerosis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003070.v1.p1","Single Cell RNA-Sequencing in Adenoid Cystic Carcinoma","This study of salivary adenoid cystic carcinoma aimed to profile individual malignant and stromal cells in treatment-naive head and neck adenoid cystic carcinoma, with or without metastatic cervical lymph nodes.  Clinical and pathologic information was collected on all patients, in addition to a fresh biopsy sample from the primary tumor and/or metastatic","Not Applicable","Carcinoma, Adenoid Cystic","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 25 variables, 10 samples sequenced, 7 subjects, 10 samples","","NCI","DS-ACC-IRB-MDS --- Disease-Specific (Adenoid Cystic Carcinoma, IRB, MDS)","2023-04-14","2023-04-14","Adenocarcinoma, cylindroid; Adenocystic Carcinoma; Adenocystic Carcinomas; Adenoid Cystic Carcinomas; Carcinoma, Adenocystic; Carcinomas, Adenocystic",""
"phs003140.v1.p1","Genetic Epidemiology of Ovarian Cancer Histotypes","Epithelial ovarian cancer is a highly fatal malignancy with known genetic etiology; however, it is estimated that a substantial portion of narrow sense heritability remains to be discovered. The goal  of this research was to use genetic information from distantly related ovarian cancer cases to identify regions of the genome that may harbor rare","Not Applicable","Ovarian Neoplasms","Case Set","Global_Screening_Array-24","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 15 subjects, 15 samples","","NCI","DS-CA-GSO --- Disease-Specific (Cancer, GSO)","2023-04-13","2023-04-13","Carcinoma, Ovarian Epithelial; Cancer, Epithelial Ovarian; Cancer, Ovarian Epithelial; Carcinoma of Ovary; Carcinoma of the Ovary; Carcinoma, Epithelial Ovarian","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002767.v1.p1","Epidemiologic Architecture for Genes Linked to Environment (EAGLE)    MetaboChip Study","The Epidemiologic Architecture for Genes Linked to Environment (EAGLE) study is a study site of the larger Population Architecture using Genomics and Epidemiology (PAGE) I study.&#x000a0; EAGLE accessed two data  resources during the course of study: the National Health and Nutrition Examination Surveys (NHANES) and BioVU, the Vanderbilt University Medical","Not Applicable","Lipids","Collection","Cardio-Metabo_Chip","SNP Genotypes (Array)","4 phenotype datasets, 30 variables, 1 molecular datasets, 13881 subjects, 13881 samples","","NHGRI","GRU --- General Research Use","2023-04-13","2023-04-13","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003201.v1.p1","E5103 Correlative Studies","ECOG-ACRIN E5103 (E5103) was a phase III adjuvant breast cancer trial that randomized 4994 patients with node-positive or high-risk node-negative breast cancer to intravenous doxorubicin and cyclophosphamide every 2 or  3 weeks (at the discretion of treating physician), for four cycles of adriamycin and cyclophosphamide (AC) followed by 12 weeks of weekly paclitaxel","Not Applicable","Breast Neoplasms","Case-Control","HumanOmniExpress-12, HumanOmni1-Quad","SNP Genotypes (Array), WXS","4 phenotype datasets, 13 variables, 1 molecular datasets, 672 samples sequenced, 3215 subjects, 3215 samples","European (2546), African (10), East Asian (56), African American (354), Hispanic1 (51), Hispanic2 (127), Other Asian or Pacific Islander (33), South Asian (18), Other (20)","NCI","GRU-COL --- General Research Use (COL)","2023-04-12","2023-04-12","Peripheral Neuropathy; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors",""
"phs002592.v1.p1","Kids First: Genomic Etiologies of CHARGE Syndrome, Related Conditions and    Structural Anomalies","Developmental disorders with structural birth defects account for the majority of morbidity and mortality in children's hospitals, and the genetic bases of many clinical phenotypes remain unknown. Genetic testing for  individuals with structural malformations has uncovered the basis of many such birth defects; however, many more cases remain unsolved, posing","Not Applicable","CHARGE Syndrome","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 547 subjects, 547 samples","","NICHD","GRU --- General Research Use","2023-04-12","2023-04-12","Choanal Atresia; Coloboma; Developmental Disabilities; CHARGE; CHARGE (coloboma, heart anomaly, choanal atresia, retardation, genital and ear anomalies) syndrome; CHARGE ASSOCIATION--COLOBOMA, HEART ANOMALY, CHOANAL ATRESIA, RETARDATION, GENITAL AND EAR ANOMALIES",""
"phs001560.v1.p1","Novel Genetic Factors for Subclinical Carotid Atherosclerosis","The overall goal for this study was to determine the genetic factors associated with extreme phenotypes of subclinical atherosclerosis (protective and deleterious). Study participants were selected from the Northern Manhattan  Study (NOMAS), a population based cohort study investigating stroke and stroke risk factors in Northern Manhattan. Cases and controls were","Not Applicable","Atherosclerosis","Case-Control","","SNP Genotypes (Array)","4 phenotype datasets, 34 variables, 1 molecular datasets, 904 subjects, 904 samples","","NINDS","DS-CVD --- Disease-Specific (Cardiovascular Disease)","2023-04-11","2023-04-11","Plaque, Atherosclerotic; Atherogeneses; Atherogenesis; Atheromas; Atheromatous Plaque; Atheromatous Plaques",""
"phs002589.v1.p1","Kids First: Congenital Heart Defects and Laterality Birth Defects","Laterality defects occur in approximately 1:10,000 newborns and are associated with a range of structural birth defects and abnormalities of organ positioning. Gut malrotation, biliary atresia, asplenia or polysplenia, complex  cardiovascular malformations, and midline defects such as neural tube defects, vertebral anomalies and rib fusions are found in various combinations","Not Applicable","Heterotaxy Syndrome","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 6 variables, 754 subjects, 754 samples","","NICHD","GRU --- General Research Use","2023-04-10","2023-04-10","VACTERL association; Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Abnormally shaped heart",""
"phs003199.v1.p1","RNA-Seq Data From Early Stage Triple Negative Breast Cancer Tumors    Treated With TVEC and Chemotherapy (MCC18621)","This study is a phase 1/phase 2 trial testing the combination of talimogene laherparepvec (TVEC) and neoadjuvant chemotherapy for the treatment of stage II-III triple negative breast cancer. The trial  demonstrated that the addition of TVEC to neoadjuvant chemotherapy was feasible, and resulted in a pathological complete response (pCR) rate of","Not Applicable","Triple Negative Breast Neoplasms","Interventional","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 75 samples sequenced, 45 subjects, 75 samples","","NCI","GRU --- General Research Use","2023-04-07","2023-04-07","ER-Negative PR-Negative HER2-Negative Breast Cancer; Breast Cancer, Triple-Negative; Breast Cancers, Triple-Negative; Breast Neoplasm, Triple-Negative; Breast Neoplasms, Triple-Negative; ER Negative PR Negative HER2 Negative Breast Cancer",""
"phs003025.v1.p1","Genetic Analysis of Substance Use Disorder Using the Indiana Biobank Data","The goal of this study is to identify genes related to substance use disorders. The study participants were selected from the Indiana Biobank. The Indiana Biobank provides centralized processing and  storage of specimens that are linked to participants' electronic medical information. Cases were defined as having any type of substance use","Not Applicable","Substance-Related Disorders","Case-Control","Global_Diversity_Array-8","SNP Genotypes (Array)","5 phenotype datasets, 19 variables, 1 molecular datasets, 3124 subjects, 3124 samples","European (2530), African (8), East Asian (11), African American (467), Hispanic1 (28), Hispanic2 (40), Other Asian or Pacific Islander (20), South Asian (6), Other (14)","NIDA","GRU-IRB --- General Research Use (IRB)","2023-04-07","2023-04-07","Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced",""
"phs003197.v1.p1","Genetic Study of Vascular Anomalies","Vascular anomalies are malformations or tumors of the vasculature that can result in significant morbidity and mortality. Vascular anomalies are caused by germline or post-zygotic pathogenic variants in genes that  regulate cell growth and vascular development. Complex or extensive vascular anomalies are often intractable despite interventions such as","Not Applicable","Vascular Diseases","Case Set","Not Provided","WXS","4 phenotype datasets, 12 variables, 154 samples sequenced, 154 subjects, 154 samples","","NICHD","GRU --- General Research Use","2023-04-05","2023-04-05","Vascular Disease; Angiopathy; Disease, Vascular; Diseases, Vascular; Disorder of blood vessel; disease of vasculature","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003139.v1.p1","Genetic Progression of Head and Neck Squamous Cell Carcinoma","These data are tumor/normal-matched exome sequencing results on 45 participants (median age of 58.6 years) treated for squamous cell carcinoma of the oropharynx at Mass Eye and Ear (MEE; Boston,  MA, USA). Some tumors had two portions sequenced separately. All research complied with all relevant ethical regulations. Human subject research on","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Tumor vs. Matched-Normal","target_markerset_grc37","SNV (.MAF), WXS","4 phenotype datasets, 28 variables, 1 molecular datasets, 129 samples sequenced, 45 subjects, 129 samples","","NIDCR","DS-HNSC-IRB-MDS --- Disease-Specific (Head and neck squamous cell carcinoma, IRB, MDS)","2023-04-05","2023-04-05","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx",""
"phs002808.v1.p1","Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be Heart    Health Study (nuMoM2b Heart Health Study)","Participants from study sites that recruited during the original study funded by NICHD of pregnant people, called nuMoM2b, participated in this study. The nuMoM2b-HHS1 was a prospective observational follow-up study  of the nuMoM2b cohort consisting of interval contacts via phone or web every 6 months to about a year, and an in-person visit 2 to 7 years after the","Not Applicable","Hypertension","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 8872 subjects, 8872 samples","European (5623), African (31), East Asian (205), African American (1454), Hispanic1 (448), Hispanic2 (694), Other Asian or Pacific Islander (146), South Asian (106), Other (158)","NHLBI","GRU-IRB --- General Research Use (IRB)","2023-03-31","2023-03-31","Diabetes, Gestational; Eclampsia; Hyperlipidemia; Hypertension, Pregnancy-Induced; Infant, Small for Gestational Age; Myocardial Infarction",""
"phs002228.v2.p1","Innate Immune Anti-Viral Deaminase Deregulation Fuels Pre-Leukemia Stem    Cell Evolution","This study evaluates the effect of Rebecsinib treatment on gene expression, isoform splicing, and ADAR1 mediated RNA editing in cells from an in vivo humanized mouse model which have been  engrafted with human secondary AML cells. For analysis of cells from Rebesinib-treated animals, CD34+ cells were obtained from bone marrow and","Not Applicable","Leukemia, Myeloid, Acute","Case-Control","RNAseq_gene_transcripts","RNA-Seq, MAF (NGS)","4 phenotype datasets, 30 variables, 1 molecular datasets, 129 samples sequenced, 70 subjects, 129 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2023-03-31","2021-04-26","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs003153.v1.p1","Neoantigen-Targeted CD8+ T-Cell Responses 1 With PD-1 Blockade Therapy","Background: The primary target of T-cell responses induced against cancer cells are peptides derived from non-synonymous mutations presented by HLA (neoantigens). However, the large diversity of HLA alleles and restricted  availability of clinical samples have limited the study of the specificity and the evolution over time of the neoantigen-specific T cell responses","Not Applicable","Melanoma","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 18 variables, 33 samples sequenced, 11 subjects, 33 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2023-03-30","2023-03-30","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs002659.v1.p1","Genomics from LCCC1525: A Priming Dose of Cyclophosphamide Prior to    Pembrolizumab to Treat mTNBC","This phase II, single-arm, multicenter study will evaluate pembrolizumab therapy, 200 mg IV, given every 3 weeks (Q3W), following a single priming dose of cyclophosphamide, 300 mg/m2 IV, in patients  with advanced triple-negative breast cancer (TNBC) who have received at least one prior line of therapy. Data uploaded consists of FASTQ sequencing","Not Applicable","Triple Negative Breast Neoplasms","Interventional","RNAseq_probe_set_grc38","AMPLICON, RNA-Seq, RNA Seq (NGS), WXS","4 phenotype datasets, 13 variables, 1 molecular datasets, 279 samples sequenced, 33 subjects, 279 samples","","NCI","DS-BRCA-IRB --- Disease-Specific (Breast Cancer, IRB)","2023-03-30","2023-03-30","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003183.v1.p1","The Ultrasound Study of Tamoxifen","The Ultrasound Study of Tamoxifen is a 12-month longitudinal study to describe volumetric breast density change over time among women with and without tamoxifen exposure. Women were enrolled at the  Karmanos Cancer Institute and Henry Ford Health Systems in Detroit, Michigan between 2011-2014. Enrollment included women prescribed tamoxifen for","Not Applicable","Tamoxifen","Prospective Longitudinal Cohort","target_markerset_grc38","AMPLICON, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 60 samples sequenced, 60 subjects, 60 samples","","NCI","DS-BRCA --- Disease-Specific (Breast Cancer)","2023-03-29","2023-03-29","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002762.v1.p1","Functional Multiomics of Cellular Therapy and Immune Checkpoint Blockade    Therapy for Solid Tumors","Tumor samples were collected from a patient with synovial sarcoma, which acquired resistance to ACT targeting NY-ESO-1. Biopsies (n 3; primary, metastasis, and recurrence) were subjected to bulk tumor DNA  and RNA sequencing, as well as high-dimensional spatial profiling of RNA and protein targets. Bulk tumor whole exome and RNA sequencing corresponding","Not Applicable","Adoptive Transfer","Tumor vs. Matched-Normal","WES_markerset_grc38, RNAseq_probe_set_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), WXS","4 phenotype datasets, 17 variables, 2 molecular datasets, 7 samples sequenced, 1 subjects, 7 samples","","NCI","DS-SARC-PUB --- Disease-Specific (Sarcoma, PUB)","2023-03-29","2023-03-29","Synovial Sarcoma; Malignant synovioma; Sarcoma, Synovial; Sarcomas, Synovial; Synovial Sarcomas; Synovialosarcoma",""
"phs001410.v2.p2","Kids First: Pediatric Research Project on Adolescent Idiopathic Scoliosis","Both childhood cancers and structural birth defects are critical and costly conditions associated with substantial morbidity and mortality. Elucidating the underlying genetic etiology of these diseases has the potential to  profoundly improve preventative measures, diagnostics, and therapeutic interventions. For the current study, families with inherited adolescent","Not Applicable","Scoliosis","Prospective Longitudinal Cohort","Not Provided","Not Provided","5 phenotype datasets, 21 variables, 598 subjects, 598 samples","","NCI","HMB --- Health/Medical/Biomedical, DS-MUS-SKEL-IRB --- Disease-Specific (Musculoskeletal Diseases, IRB)","2023-03-29","2018-10-12","Cobb angle greater than ten degrees; Scolioses; Scoliosis,","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002357.v1.p1","Lineage Plasticity and Immune Cell Heterogeneity Are Coordinately    Dysregulated Through Changes in FOXA1 Expression in Bladder Cancers    with Squamous Differentiation","We performed whole exome sequencing (WES) of paired, macrodissected regions of urothelial carcinoma (UC), not otherwise specified (NOS-UC) and squamous differentiation (SqD) from 21 bladder tumors in which distinct and  separable NOS-UC and SqD regions were present (total 42 exomes, in addition to matched normal exomes). Mean tumor mutational burden (TMB) was higher","Not Applicable","Carcinoma, Transitional Cell","Tumor vs. Matched-Normal","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS), WXS","4 phenotype datasets, 19 variables, 1 molecular datasets, 36 samples sequenced, 13 subjects, 36 samples","","NCI","DS-BLADDERCA-PUB-MDS --- Disease-Specific (Bladder Cancer, PUB, MDS)","2023-03-28","2023-03-28","",""
"phs001909.v1.p1","The Vaginal Microbiome in Reproductive Age Women","The focus of this cross-sectional study was to characterize the vaginal microbiota of asymptomatic, sexually-active, and reproductive-age women representing four self-reported ethnic groups (White, Black, Asian, and Hispanic). Each woman  self-collected two mid-vaginal swabs. The first swab was used to prepare a vaginal smear for Nugent gram stain analysis. The second swab was used for","Not Applicable","Microbiota","Cross-Sectional","Not Provided","AMPLICON","4 phenotype datasets, 46 variables, 360 samples sequenced,  SRA, 395 subjects, 395 samples","","NIAID","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2023-03-24","2023-03-24","Vaginosis, Bacterial; BV; BV - Bacterial vaginosis; Bacterial Vaginitides; Bacterial Vaginitis; Bacterial Vaginoses",""
"phs002705.v1.p1","Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages    of CLL that can be Reversed by Ibrutinib","We applied single cell RNA sequencing to broadly characterize circulating immune cells co-existing with leukemic cells during natural chronic lymphocytic leukemia (CLL) progression. We used peripheral blood mononuclear cells from  patients diagnosed from monoclonal B-lymphocytosis (MBL) and CLL at different time-points, and age-matched healthy donors (HDs). We analyzed the","Not Applicable","Lymphocytosis","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 30 samples sequenced, 16 subjects, 30 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-03-23","2023-03-23","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs003149.v1.p1","Bladder Cancer Organoids as a Functional System to Model Different    Disease Stages and Therapy Response","The study 'Bladder Cancer Organoids as a Functional System to Model Different Disease Stages and Therapy Response' reports the genomic characterization at the single allele level upon Whole Exome Sequencing  of Bladder Cancer (BLCa) Patient Tumor (PT) samples obtained from 18 patients and corresponding Patient Derived Organoids (PDOs), implementing the","Not Applicable","Urinary Bladder Neoplasms","Collection","Not Provided","WXS","4 phenotype datasets, 27 variables, 61 samples sequenced, 18 subjects, 61 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-03-22","2023-03-22","Bladder Cancer; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder; Cancer, Urinary Bladder",""
"phs003148.v1.p1","NCT03343197: Clinical Biomarker Data","Patients with IDH1-mutated low-grade glioma were treated with AG-120 (ivosidenib), AG-881 (vorasidenib), or Placebo for 28 days before surgical resection. A portion of the surgical sample was submitted for exome  capture-based transcriptome sequencing (Personalis ACE Whole Transcriptome). Following surgery, subjects had the option to continue (or initiate)","Not Applicable","Glioma","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 41 samples sequenced, 41 subjects, 41 samples","","NCI","DS-GL --- Disease-Specific (Glioma)","2023-03-22","2023-03-22","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia",""
"phs002324.v3.p1","CSER: Genomic Sequencing to Aid Diagnosis in Pediatric and Prenatal    Practice: Examining Clinical Utility, Ethical Implications, Payer    Coverage, and Data Integration in a Diverse Population","Congenital abnormalities and developmental disorders affect 3-5% of live born infants and children. Despite advances in both pre- and post-natal treatment, the utility of genetic testing in diagnosing the etiology  underlying such conditions in order to guide management has been frustratingly limited. Traditional genetic testing with specific gene tests, or even","Not Applicable","Genetic Diseases, Inborn","Clinical Genetic Testing","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use","2023-03-22","","Abnormalities, Multiple; Brain Diseases; Cerebral Palsy; Congenital Abnormalities; Metabolic Diseases; Neurodegenerative Diseases",""
"phs003191.v1.p1","RNA Splicing Dysregulation in the Pathogenesis of Chronic Lymphocytic    Leukemia","RNA splicing dysregulation is a hallmark of cancers, promoting the onset and progression of disease. In chronic lymphocytic leukemia (CLL), spliceosome mutations leading to aberrant splicing occurs in approximately 20%  of patients. However, the underlying mechanism for splicing defects in spliceosome unmutated CLL cases remains elusive. To discover","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case-Control","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 23 variables, 56 samples sequenced, 48 subjects, 56 samples","","NCI","DS-CLL-PUB-NPU --- Disease-Specific (Chronic Lymphocytic Leukemia, PUB, NPU)","2023-03-21","2023-03-21","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs003001.v1.p1","Assessment of RNA-Seq Sample Preparation Methodology","The goal of this study was two-fold, to determine if common purification techniques have any effect on downstream differential expression analysis and to evaluate combinations of alignment and differential expression  software for reliability. To this end, blood was collected from three individuals and pooled during and after extraction. After pooling and mixing","Not Applicable","Biomarkers","Methods","Not Provided","RNA-Seq","3 phenotype datasets, 15 variables, 48 samples sequenced, 24 subjects, 48 samples","","NHGRI","GRU --- General Research Use","2023-03-21","2023-03-21","Not Provided",""
"phs002435.v1.p1","Development and Validation of Patient-Derived Xenografts from    Fibrolamellar Carcinoma Human Tissue","We developed and validated Patient-Derived Xenografts (PDX) of Fibrolamellar Carcinoma human tissue from surgical resections. Human tissues from primary liver tumor, recurrent liver, and liver metastases were implanted into NOD-SCID-Gamma  (NSG) mice (Jackson laboratories) and monitored for tumor growth. Some of the original tissues were frozen for further analysis including RNA","Not Applicable","Carcinoma, Hepatocellular","Xenograft","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 19 samples sequenced, 5 subjects, 19 samples","","NCI","DS-HCC-IRB-COL --- Disease-Specific (Hepatocellular Carcinoma, IRB, COL)","2023-03-17","2023-03-17","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells",""
"phs003165.v1.p1","Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic    Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer    Brain Metastases","This study is a phase I trial combining ado-trastuzumab emtansine (T-DM1) with Temozolomide (TMZ) for the prevention of additional brain metastases after previous occurrence and local treatment in HER2+ breast  cancer patients. Twelve patients were enrolled in this study. Data includes whole exome sequencing (WES) from patients' cerebrospinal fluid (CSF) and","Not Applicable","Breast Neoplasms","Case Set","target_markerset_grc38","SNP Genotypes (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 69 samples sequenced, 12 subjects, 69 samples","","NCI","GRU --- General Research Use","2023-03-16","2023-03-16","Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003106.v1.p1","Genetic Effects on miRNA Expression During Mid-Gestation Neocortical    Development","In this study we aimed to find common genetic variants that influence miRNA expression during mid-gestation neocortical development. Small RNA-sequencing from 212 fetal cortical tissue samples between 14 and 21  weeks gestation were used to profile miRNA expression. Combined with donor genotypes, we were able to find miRNA-eQTLs during neocortical","Not Applicable","MicroRNAs","Collection","HumanOmni2.5","SNP Genotypes (Array), miRNA-Seq","4 phenotype datasets, 29 variables, 1 molecular datasets, 212 samples sequenced, 212 subjects, 424 samples","European (24), East Asian (7), African American (60), Hispanic1 (1), Hispanic2 (90), Other Asian or Pacific Islander (9), Other (21)","NIMH","GRU --- General Research Use","2023-03-16","2023-03-16","Educational Status; Hypovolemia; Academic achievement; Achievement, Educational; Attainment, Educational; Education","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs003105.v1.p1","Genetic and Phenotypic Analysis of Multiple Sclerosis in Hispanics","We sought to identify MS susceptibility variants specific to the Major Histocompatibility Complex and to assess the effect of ancestral risk modification within 2652 Latinx and Hispanic individuals, as well  as 2435 Black and African American individuals ascertained in collaboration with the Alliance for Research in Hispanic MS (ARHMS). All DNA samples","Not Applicable","Multiple Sclerosis","Case-Control","imputation_panel","SNP/CNV Genotypes (imputed)","4 phenotype datasets, 12 variables, 1 molecular datasets, 4765 subjects, 4765 samples","","NINDS","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-MS-IRB-MDS --- Disease-Specific (Multiple Sclerosis, IRB, MDS)","2023-03-15","2023-03-15","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple",""
"phs003101.v1.p1","A Model of Human Asthma Exacerbation Identifies Mechanisms That Drive    Allergic Asthma","In this study, we will enroll allergic adults to undergo bronchoscopic segmental allergen challenge, in order to identify differences in the airway immune response to allergen in those with asthma  compared to those without asthma. After a discussion about the study and potential risks, subjects giving written informed consent will undergo two","Not Applicable","Asthma","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 20 variables, 24 samples sequenced, 9 subjects, 24 samples","","NHLBI","GRU-COL --- General Research Use (COL)","2023-03-15","2023-03-15","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs002347.v1.p1","PDAC Prognosis Biomarkers in Genomic and Transcriptomic Molecular Data","Our study was designed to identify biomarkers related to the prognosis of Pancreatic Ductal AdenoCarcinoma (PDAC) patients using genomic variants and gene expression in coding regions of the human genome  (exome). PDAC is the 7th cause of cancer deaths and is among types of cancer having the poorest prognosis. To improve treatment outcomes of PDAC,","Not Applicable","Carcinoma, Pancreatic Ductal","Tumor vs. Matched-Normal","WES_markerset_grc38","RNA-Seq, SNP Genotypes (NGS), SNV Aggregate (.MAF), WXS","4 phenotype datasets, 24 variables, 1 molecular datasets, 450 samples sequenced, 150 subjects, 450 samples","","NCI","GRU --- General Research Use","2023-03-15","2023-03-15","Adenocarcinoma; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002337.v2.p1","CSER: Incorporating Genomics into the Clinical Care of Diverse NYC    Children (NYCKidSeq)","The NYCKidSeq program will significantly advance the implementation of genomic medicine, particularly for children, young adults and their families in Harlem and the Bronx. The study will assess the clinical  utility of genomic medicine in three broad areas of pediatric disorders, while engaging a range of providers and community advisors to overcome the","Not Applicable","Abnormalities, Multiple","Clinical Trial","Not Provided","Not Provided","Not Provided","","NHGRI","HMB --- Health/Medical/Biomedical, GRU --- General Research Use","2023-03-15","","Arrhythmias, Cardiac; Disability, Developmental; Diseases, Immunological; Disorders, Neurological; Heart Diseases; CONGENITAL ANOMALIES",""
"phs000966.v3.p2","National Institute of Neurological Disorders and Stroke (NINDS), Family    Study of Essential Tremor (FASET), Identification of Susceptibility    Genes for Essential Tremor","The Familial Study of Essential Tremor (FASET) was designed to identify susceptibility genes for Essential Tremor. ET is among the most common neurological diseases with a prevalence (age 40 years)  estimated to be 4.0% and prevalence in advanced age ( 90 years) exceeding 20%. ET, often referred to as ""familial tremor"", is generally regarded as a","Not Applicable","Essential Tremor","Family/Twin/Trios","HumanOmniExpress-12, WGS_markerset_grc37","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), Targeted-Capture, WGS","7 phenotype datasets, 339 variables, 7 documents, 2 molecular datasets, 539 samples sequenced, 1013 subjects, 674 samples","European (404), Hispanic1 (10), Hispanic2 (4), Other Asian or Pacific Islander (2), Other (14)","NINDS","DS-ETND-IRB-PUB-NPU-MDS-GSO-RD --- Disease-Specific (Essential Tremor and Neurodegenerative Diseases, IRB, PUB, NPU, MDS, GSO, RD)","2023-03-15","2021-09-02","Hereditary Essential Tremor; Tremor, Familial; Benign Essential Tremor; Benign Essential Tremors; Essential Tremor, Benign; Essential Tremors",""
"phs002849.v1.p1","A Sequential Window of Opportunity Trial of Anti-PD-L1/TGF-&#x003b2; trap (M7824)    Alone and in Combination with TriAd Vaccine and N-803 for Resectable    Head and Neck Squamous Cell Carcinoma not Associated with Human    Papillomavirus Infection","This submission includes the whole exome and bulk RNA sequencing associated with the correlative study of clinical specimens from a prospective clinical study of neoadjuvant bintrafusp alfa in patients with  newly diagnosed, surgically resectable oral cavity or laryngeal squamous cell carcinoma.&#x000a0; Eligible patients had newly diagnosed, surgically","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Clinical Trial","Not Provided","OTHER, RNA-Seq, WXS","4 phenotype datasets, 17 variables, 42 samples sequenced, 14 subjects, 42 samples","","NIDCD","DS-HNSC-PUB --- Disease-Specific (Head and neck squamous cell carcinoma, PUB)","2023-03-14","2023-03-14","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx",""
"phs003103.v1.p1","Single Cell Analysis of Sporadic Human Basal Cell Carcinomas","To explore tumor heterogeneity in sporadic human basal cell carcinoma tumors, we profiled three individual patient tumors by scRNA-Seq and scATAC-Seq. Basal cell carcinomas (BCCs) are driven by hedgehog signaling  with GLI1 representing the key downstream transcription factor that drives tumor growth. GLI1 as such is a readout of active hedgehog signaling. We","Not Applicable","Carcinoma, Basal Cell","Case Set","ATAC_DNAseq_probe_set","OTHER, RNA Seq (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 6 samples sequenced, 3 subjects, 6 samples","","NCI","GRU --- General Research Use","2023-03-09","2023-03-09","Basal Cell Nevus Syndrome; BCNS; BCNS - Basal cell nevus syndrome; BCNS1; Basal cell carcinoma syndrome; Fifth Phacomatoses",""
"phs002123.v2.p1","Drop-BS: High-Throughput Single-Cell Bisulfite Sequencing on a    Microfluidic Droplet Platform","We present a high-throughput droplet-based bisulfite sequencing library preparation platform. Our protocol allows the production of a BS library of 2,000-10,000 single cells within 2 days. In addition to validation  using mixed cell lines, we also used the technology to profile various cell types in mouse and human brain samples. Principal Investigator: Chang Lu,","Not Applicable","DNA Methylation","Methods","Not Provided","Bisulfite-Seq","5 phenotype datasets, 16 variables, 2 samples sequenced, 2 subjects, 2 samples","","NHGRI","GRU --- General Research Use","2023-03-09","2022-07-20","",""
"phs003203.v1.p1","A Comprehensive Platform for Analyzing Longitudinal Multi-Omics Data","PALMO (Platform for Analyzing Longitudinal Multi-omics data) is a platform for analyzing longitudinal data from bulk as well as single cell. It allows to identify inter-, intra-donor variations in genes  over longitudinal time points. The analysis can be done on bulk expression dataset without known cell type information or single cell with cell type","Not Applicable","methods","Methods","Not Provided","ATAC-seq, OTHER, RNA-Seq","4 phenotype datasets, 13 variables, 20 samples sequenced, 7 subjects, 46 samples","","NIAID","HMB --- Health/Medical/Biomedical","2023-03-08","2023-03-08","Not Provided",""
"phs003196.v1.p1","Detection and Targeting of Splicing Deregulation in Pediatric Acute    Myeloid Leukemia Stem Cells","This study evaluates the gene expression and splicing changes between pediatric patients with and without Acute Myeloid Leukemia (AML) and pediatric and adult patients with AML. We obtained bone marrow  or peripheral blood from patients and isolated CD34+ stem and/or progenitor cells from pediatric patients with AML (10) or without AML (6) and adult","Not Applicable","Leukemia, Myeloid, Acute","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 36 samples sequenced, 21 subjects, 36 samples","","NIDDK","GRU --- General Research Use","2023-03-08","2023-03-08","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003195.v1.p1","NSD2 E1099K Drives Relapse in Pediatric Acute Lymphoblastic Leukemia by    Disrupting 3D Chromatin Organization","NSD2 p.E1099K (EK) is a mutation shown to be enriched in patients that relapse with pediatric Acute Lymphoblastic Leukemia (ALL). This work aims to uncover 3D chromatin architecture-related mechanisms responsible  for drug resistance or therapy failure in these patients. We investigated this by performing Hi-C, ATAC-Seq, and RNA-Seq on three B-ALL cell lines","Not Applicable","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Clinical Trial","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 6 samples sequenced, 6 subjects, 6 samples","","NCI","GRU --- General Research Use","2023-03-08","2023-03-08","ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic; Leukemia, Lymphoblastic, Acute, L1",""
"phs002703.v1.p1","SEARCH for Diabetes in Youth Study - Genetic Risk Score","Genetic risk scores (GRS) quantify polygenic disease risk into a single measure and can aid in disease classification. GRS studies have focused primarily on adult populations of recent European ancestry.  We aimed to assess the utility of GRS in classification of diabetes type among racially/ethnically diverse youth in the United States. We used data","Not Applicable","Genetic Predisposition to Disease","Prospective Longitudinal Cohort","MEGA_Consortium_Array, Affymetrix_500K, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 57 variables, 4 molecular datasets, 2260 subjects, 2260 samples","European (70), African (2), East Asian (5), African American (126), Hispanic1 (3), Hispanic2 (65), Other Asian or Pacific Islander (2), Other (2)","NIDDK","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS)","2023-03-08","2023-03-08","Risk Factors; Genetic Predisposition; Genetic Predispositions; Genetic Susceptibilities; Genetic Susceptibility; Inherited Predisposition",""
"phs001896.v1.p1","Etiologic Studies of Macular Degeneration","This is a genotyping study of selected participants in an ongoing study of macular degeneration and related ocular disorders. DNA samples were obtained from 1985 (study initiation) to 2018. Phenotypes  were determined using the validated Clinical Age-Related Maculopathy Grading System (Ophthalmol 2006, PMID 16458093). Inclusion: Case subjects with","Not Applicable","Macular Degeneration","Cross-Sectional","Global_Screening_Array-24, imputation_panel","SNP/CNV (Array), SNP Genotypes (imputed)","5 phenotype datasets, 25 variables, 2 molecular datasets,  SRA, 1038 subjects, 1085 samples","","NEI","DS-AMD-NPU --- Disease-Specific (Age-Related Macular Degeneration, NPU), GRU-NPU --- General Research Use (NPU)","2023-03-08","2023-03-08","Geographic Atrophy; Wet Macular Degeneration; Atrophies, Geographic; Atrophy, Geographic; Degeneration, Dry Macular; Degenerations, Dry Macular",""
"phs002188.v2.p1","Single Cell Genomic Analysis of Lymphoma","Our study aimed to define the extent of heterogeneity between anatomically separated tumor manifestations in follicular lymphoma at single-cell resolution. We subjected single-cell suspensions derived from nodal, synchronously-acquired fine needle  aspirations from two distinct tumor sites to high-throughput microfluidics-based single-cell RNA sequencing. By comparing the relative composition of","Not Applicable","Lymphoma","Case Set","Not Provided","OTHER","4 phenotype datasets, 14 variables, 22 samples sequenced, 10 subjects, 22 samples","","NCI","GRU --- General Research Use","2023-03-03","2021-03-26","Follicular Lymphoma; Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002862.v1.p1","Improved T Cell Immunity Following Neoadjuvant Chemotherapy in Ovarian    Cancer","This study characterized the evolution of the peripheral immune cell function and composition across the course of standard of care platinum and taxane chemotherapy in ovarian cancer using bulk and  single cell transcriptomic approaches. Serial blood samples were collected from ten patients with advanced high-grade serous ovarian cancer treated","Not Applicable","Carcinoma, Ovarian Epithelial","Prospective Longitudinal Cohort","Not Provided","OTHER","4 phenotype datasets, 13 variables, 10 samples sequenced, 10 subjects, 10 samples","","NCI","GRU --- General Research Use","2023-03-02","2023-03-02","Cancer, Epithelial Ovarian; Cancer, Ovarian Epithelial; Carcinoma of Ovary; Carcinoma of the Ovary; Carcinoma, Epithelial Ovarian; Epithelial Cancer, Ovarian",""
"phs001460.v2.p1","Genomic-Enabled Medicine for Recurrent Glioblastoma","In this prospective study, we performed genome-wide tumor/normal exome sequencing and tumor RNA-sequencing for recurrent glioblastoma patients. A subset of patients had both enhancing tumor and non-enhancing tissue sequenced to  investigate spatial heterogeneity of this disease. Together, this information builds our understanding of the genomic underpinnings of glioblastoma,","Not Applicable","Glioblastoma","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 15 variables, 102 samples sequenced,  SRA, 16 subjects, 102 samples","","NHGRI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2023-03-02","2019-12-10","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs003010.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular: TexGen","Cardiovascular disease (CVD), especially coronary heart disease, heart failure and cerebrovascular disease remain the leading causes of death in men and women across all race groups in the United States.  Substantial evidence exists for genetic factors underlying CVD risk, and their discovery offers an opportunity to enhance understanding of disease","Not Applicable","Cardiovascular Diseases","Case Set","Not Provided","Not Provided","4 phenotype datasets, 14 variables, 6146 subjects, 6146 samples","","NHGRI","DS-CVD-IRB --- Disease-Specific (Cardiovascular Disease, IRB)","2023-03-01","2023-03-01","Heart Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs002939.v1.p1","NCI-Maryland Prostate Cancer Case-Control Study","The study seeks to examine the genetic and ancestral basis of prostate cancer-associated inflammation using a genome-wide association approach. The study population are the participants of the NCI Maryland Prostate  Cancer Case-Control study. This study recruited both African American and European American men, and investigated the causes for the excessive burden","Not Applicable","Prostatic Neoplasms","Case-Control","HumanOmni5Exome-4","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 molecular datasets, 1450 subjects, 1450 samples","European (753), African (16), African American (668), Hispanic1 (8), Hispanic2 (1), Other Asian or Pacific Islander (2), Other (2)","NCI","HMB-IRB-PUB-NPU-MDS --- Health/Medical/Biomedical (IRB, PUB, NPU, MDS)","2023-03-01","2023-03-01","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs003111.v1.p1","Childhood Cancer Data Initiative (CCDI): Clonal Evolution During    Metastatic Spread in High-Risk Neuroblastoma","The goal of this study is to deliver a detailed characterization of the patterns of disease dissemination at diagnosis, during progression and in response to therapy in high-risk neuroblastoma. Longitudinal  and spatially distinct tumors were collected from patients. Clinical data includes diagnosis and treatment information. Biospecimen data includes","Not Applicable","Rare Diseases","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS","2 phenotype datasets, 7 variables, 195 samples sequenced, 129 subjects, 487 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-02-28","2023-02-28","Rare Disease; Blastoma; CA; CA - Cancer; Cancer; MT",""
"phs003177.v1.p1","Comparison Between qPCR and RNA-Seq Reveals Challenges of Quantifying HLA    Expression","Human leukocyte antigen (HLA) class I and HLA class II loci are essential elements of innate and acquired immunity. Their exceptional influence on disease outcome is well documented by GWAS  and candidate gene studies. The impact of HLA allelic variation on human disease through allele-specific presentation of antigenic peptides to T","Not Applicable","HLA Antigens","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 12 variables, 125 samples sequenced, 96 subjects, 125 samples","","NCI","GRU --- General Research Use","2023-02-24","2023-02-24","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003110.v1.p1","Clonally Selected Lines after CRISPR/Cas Editing are not Isogenic","The CRISPR-Cas9 system has enabled researchers to precisely modify/edit the sequence of a genome. A typical editing experiment consists of two steps: (i) editing cultured cells and (ii) selection of  clones, which are presumed to be isogenic, with and without the intended edit. The application of the CRISPR-Cas9 system may result in off-target","Not Applicable","ATAD3A protein, human","Case Set","Not Provided","WGS","3 phenotype datasets, 12 variables, 4 samples sequenced, 1 subjects, 4 samples","","NICHD","DS-GIDIS --- Disease-Specific (Genetic and Inherited Disorders)","2023-02-24","2023-02-24","Not Provided",""
"phs003060.v1.p1","Whole Exome Sequencing of Calcitonin Producing Pancreatic Neuroendocrine    Neoplasms (CT-pNENs) Indicates a Unique Molecular Signature","Calcitonin-producing pancreatic neuroendocrine neoplasms (CT-pNENs), which can mimic clinical and laboratory features of medullary thyroid carcinoma, are an extremely rare clinical entity with approximately 60 cases reported worldwide. The molecular  profile of CT-pNENs is not yet known. Whole-exome sequencing (WES) was performed on tumor and corresponding serum samples of five patients with","Not Applicable","Insulinoma","Tumor vs. Matched-Normal","Not Provided","WGS","3 phenotype datasets, 15 variables, 10 samples sequenced, 5 subjects, 10 samples","","NCI","GRU --- General Research Use","2023-02-24","2023-02-24","Adenoma, beta Cell; Adenoma, beta-Cell; Adenomas, beta-Cell; Insulinomas; Insuloma; Insulomas",""
"phs001528.v2.p1","Gene Expression of Small Cell Carcinoma of the Ovary-Hypercalcemic Type    (SCCOHT)","Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) is a rare and aggressive form of ovarian cancer afflicting young women at a median age of 24 years. SCCOHTs are characterized  by loss of protein expression of SWI/SNF chromatin remodeling ATPases SMARCA4 and SMARCA2 through mutation and epigenetic silencing, respectively.","Not Applicable","Ovarian Neoplasms","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 23 variables, 9 samples sequenced, 9 subjects, 9 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-02-24","2018-02-22","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001273.v4.p2","Oncoarray Consortium - Lung Cancer Studies","The study was conducted under the auspices of the Transdisciplinary Research In Cancer of the Lung (TRICL) Research Team, which is a part of the Genetic Associations and MEchanisms in  ONcology (GAME-ON) consortium, and associated with the International Lung Cancer Consortium (ILCCO). Ethics: All participants provided written","Not Applicable","Lung Neoplasms","Case-Control","OncoArray, imputation_panel","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 20 variables, 1 documents, 6 analyses, 3 molecular datasets, 38721 subjects, 39518 samples","European (32953), African (12), East Asian (3553), African American (960), Hispanic1 (245), Hispanic2 (381), Other Asian or Pacific Islander (430), South Asian (22), Other (165)","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB --- Health/Medical/Biomedical, DS-CA --- Disease-Specific (Cancer), DS-CA-GSO --- Disease-Specific (Cancer, GSO), DS-CA-COL-NPU-MDS --- Disease-Specific (Cancer, COL, NPU, MDS), HMB-MDS-GSO --- Health/Medical/Biomedical (MDS, GSO), CHRONIC --- Chronic Diseases (including Cancer), Methods, EPIMEDCA --- Epidemiological and Medical Research on Cancer, Methods, DS-CALD-PUB-NPU --- Disease-Specific (Cancer or Lung Diseases, PUB, NPU), GRU --- General Research Use, LDS --- Lung Disease and Smoking, GRU-COL --- General Research Use (COL), DS-CA-MDS --- Disease-Specific (Cancer, MDS), LCEDOE --- Lung Cancer, Environmental, Diet, Occupational Exposures, HMB-PUB --- Health/Medical/Biomedical (PUB), DS-CA-PUB-NPU --- Disease-Specific (Cancer, PUB, NPU)","2023-02-24","2023-02-24","Adenocarcinoma; Neoplasms, Squamous Cell; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002921.v2.p1","Whole Genome Sequencing in the Inner City Asthma Consortium (ICAC)    Cohorts","We performed whole-genome sequencing on individuals from the Asthma Phenotypes in the Inner City (APIC) and Urban Environment and Childhood Asthma (URECA) study cohorts, which consist of children with asthma  who live in low-income neighborhoods across 10 U.S. cities. APIC was a one-year, prospective, observational study of children ages 6-17 with asthma.","Not Applicable","Asthma","Prospective Longitudinal Cohort","WGS_markerset_grc38","CNV Genotypes, WGS","4 phenotype datasets, 34 variables, 2 analyses, 1 molecular datasets, 1035 samples sequenced, 1035 subjects, 1035 samples","European (16), African (8), East Asian (1), African American (806), Hispanic1 (78), Hispanic2 (99), Other Asian or Pacific Islander (2), Other (25)","NIAID","DS-AST-ALL-IRB-NPU-MDS-GSO --- Disease-Specific (Asthma and Allergies, IRB, NPU, MDS, GSO)","2023-02-23","2022-11-18","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs001442.v4.p3","The Environmental Determinants of Diabetes in the Young Study (TEDDY)","Study Overview The Environmental Determinants of Diabetes in the Young (TEDDY) Study is a longitudinal study that investigates genetic and genetic-environmental interactions, including gestational events, childhood infections, dietary exposures, and  other environmental factors after birth, in relation to the development of islet autoimmunity and type 1 diabetes (T1D). A consortium of six clinical","Not Applicable","Diabetes Mellitus, Type 1","Prospective Longitudinal Cohort","HumanHT-12, ImmunoArray, WGS_markerset_grc37, RNAseq_gene_transcripts, HumanCoreExome-24, custom_array","AMPLICON, SNP Genotypes (Array), mRNA Expression (Array), OTHER, RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), WGS","9 phenotype datasets, 41 variables, 1 documents, 5 molecular datasets, 27173 samples sequenced, 25623 subjects, 66813 samples","","NIDDK","DS-T1DR-IRB-RD --- Disease-Specific (Type 1 diabetes, its complications and other autoimmune diseases, IRB, RD)","2023-02-22","2023-02-22","DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes Mellitus, Sudden Onset",""
"phs003090.v1.p1","Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model","Progress in the early detection and treatment of cancer requires accurate model systems to further evaluate new, promising discoveries. Small animal and, in particular, mouse model systems are attractive to  researchers for numerous reasons, including their ease of use and well-described platforms. The ability to grow human tumors in immune-deficient mice","Not Applicable","Melanoma","Xenograft","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 40 samples sequenced, 4 subjects, 40 samples","","NCI","GRU --- General Research Use","2023-02-14","2023-02-14","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs003094.v1.p1","Urothelial Cancer - Genomic Analysis to Improve Patient Outcomes and    Research (UC-GENOME): a Bladder Cancer Advocacy Network (BCAN)-Led    Collaborative Research Pilot Study - for Samples Collected at Johns    Hopkins","UC-GENOME is a real-world cohort of patients with metastatic urothelial carcinoma (UC). The study consisted of two co-equal aims: 1) to provide targeted DNA sequencing for clinical decision making at  no cost to patients; and 2) to create a resource for collaborative translational science including a clinically annotated biobank. The submitted data","Not Applicable","Urinary Bladder Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, Targeted-Capture","4 phenotype datasets, 13 variables, 14 samples sequenced, 8 subjects, 14 samples","","NCI","DS-TCC-IRB-NPU --- Disease-Specific (transitional cell carcinoma, IRB, NPU)","2023-02-09","2023-02-09","Bladder Cancer; Cancer of Urinary Tract; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder",""
"phs003059.v1.p1","Metastatic Colorectal Adenocarcinoma Tumor Purity Assessment from Whole    Exome Sequencing Data","As molecular medicine wields greater and greater influence on cancer patient care, including therapeutic selection, it becomes increasingly important to understand the power and deficiencies of computational tools used in  decision making processes. Here we use a set of unselected metastatic colorectal tumor samples in a head-to-head comparison between the calculation","Not Applicable","Colorectal Neoplasms","Case Set","Not Provided","WXS","3 phenotype datasets, 11 variables, 30 samples sequenced, 18 subjects, 30 samples","","NCI","GRU --- General Research Use","2023-02-08","2023-02-08","Neoplasm Metastases; CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002719.v1.p1","Reasons for Geographic and Racial Differences in Stroke Cardiorenal GWAS","REGARDS is a national, population-based, longitudinal study of incident stroke and associated risk factors including over 30,000 Black and White adults aged 45 years or older from all 48 contiguous  U.S. states and the District of Columbia. The study was designed to investigate reasons underlying the higher rate of stroke mortality among Black","Not Applicable","Stroke","Prospective Longitudinal Cohort","MEGA_Consortium_Array","SNP Genotypes (Array)","9 phenotype datasets, 112 variables, 1 molecular datasets, 10551 subjects, 10551 samples","European (1737), African (411), African American (8248), Hispanic1 (131), Hispanic2 (2), Other Asian or Pacific Islander (1), South Asian (1), Other (20)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2023-02-08","2023-02-08","Kidney Diseases; Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents; CEREBROVASCULAR ACCIDENT",""
"phs001904.v1.p1","Genomic Characterization CS-MATCH-0007 Arm Y","The CS-MATCH-0007 protocol is a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA sequencing using  pre-and post-treatment tumor biopsy specimens from all patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131). The goal of","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 380 variables,  SRA, 31 subjects, 31 samples","","NCI","GRU-COL --- General Research Use (COL)","2023-02-07","2023-02-07","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs003154.v1.p1","An Advanced Molecular Medicine Case Report of a Rare Human Tumor Using    Genomics, Pathomics, and Radiomics","The associated data of this study is derived from a single female patient with pulmonary sclerosing pneumocytoma (PSP). The aim of this study is to provide the most comprehensive, multi-modality  sequencing study of a single case of PSP to-date. To this end, the following sequencing experiments were performed: i) RNA-Seq of the primary tumor","Not Applicable","Pulmonary Sclerosing Hemangioma","Case-Control","Not Provided","RNA-Seq, Targeted-Capture, WGS","3 phenotype datasets, 15 variables, 16 samples sequenced, 1 subjects, 16 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2023-02-06","2023-02-06","Hemangioma, Sclerosing, Pulmonary; Lung Sclerosing Angioma; Lung Sclerosing Hemangioma; Lung Sclerosing Hemangiomas; Pneumocytoma; Pulmonary Sclerosing Hemangiomas",""
"phs003146.v1.p1","Predicting the Prevalence of Complex Genetic Diseases from Individual    Genotype Profiles Using Capsule Networks","Diseases with a complex genetic architecture, such as amyotrophic lateral sclerosis (ALS) as a most prominent example, are hard to disentangle. ""Human mind-friendly"" methods, such as linear approaches used in  genome wide association studies (GWAS), remain blind to many genetic variants that matter. On the other hand, methods that are sufficiently","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","MEGA_Consortium_Array","SNP Genotypes (Array)","3 phenotype datasets, 10 variables, 1 molecular datasets, 10405 subjects, 10405 samples","","NINDS","GRU-PUB-COL-NPU --- General Research Use (PUB, COL, NPU)","2023-02-06","2023-02-06","ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease; Disease, Lou-Gehrigs",""
"phs003042.v1.p1","Novel Strategies to Eliminate Resistance to B-cell Receptor Inhibitor    Therapy in Lymphoid Malignancies","Ibrutinib and acalabrutinib are BTK inhibitors (BTKi) used as frontline therapies for chronic lymphocytic leukemia (CLL). Clonal evolution during ibrutinib treatment has previously been studied, but limited study of clonal  evolution in patients receiving acalabrutinib has been done. Our group analyzed 216 blood samples from 38 CLL patients at multiple time points during","Not Applicable","Clonal Evolution","Case Set","Not Provided","WXS","4 phenotype datasets, 25 variables, 216 samples sequenced, 38 subjects, 216 samples","","NCI","GRU --- General Research Use","2023-02-06","2023-02-06","Evolution, Clonal; B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002822.v1.p1","SU2C-MARK Lung Cancer Consortium - Checkpoint Blockade Response Project","Immune checkpoint inhibitors have become a critical part of the armamentarium against advanced Non-Small Cell Lung Cancer (NSCLC). While early studies have identified Tumor Mutation Burden (TMB) and PD-L1 staining  as important biomarkers of response, they remain imperfect predictors. Here we describe a multi-institutional effort as part of the SU2C-MARK Lung","Not Applicable","Carcinoma, Non-Small-Cell Lung","Collection","WES_markerset_grc38","MAF (NGS), Targeted-Capture","4 phenotype datasets, 46 variables, 1 molecular datasets, 463 samples sequenced, 230 subjects, 463 samples","","NCI","DS-CATHLU-MDS --- Disease-Specific (Cancer -Thoracic and Lung, MDS), HMB-MDS --- Health/Medical/Biomedical (MDS), GRU --- General Research Use","2023-02-02","2023-02-02","Adenocarcinoma; Large Cell Carcinoma; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant",""
"phs001679.v1.p1","TRanscriptomic ANalySis of left ventriCulaR gene Expression (TRANSCRibE)","Myocardial ischemia occurs when there is a mismatch between coronary oxygen delivery and metabolic requirements of the myocardium, which may be clinically manifested during angina, coronary angioplasty or cardiopulmonary bypass  (CPB). Myocardial ischemia may lead to a spectrum of myocardial stunning, hibernating myocardium, and ultimately cell death if the ischemic insult is","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","imputation_panel","SNP/CNV Genotypes (imputed), RNA-Seq","4 phenotype datasets, 19 variables, 1 molecular datasets, 236 samples sequenced,  SRA, 119 subjects, 355 samples","","NHLBI","GRU --- General Research Use, DS-CI --- Disease-Specific (cardiac inflammation)","2023-02-02","2023-02-02","Myocardial Ischemia; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000721.v1.p1","Undiagnosed Diseases Program (UDP)","The NIH Undiagnosed Diseases Program collects phenotypic and genomic data from patients with medical conditions that have eluded diagnosis in order to provide explanations and to advance medical and scientific  understanding. Principal Investigator: William A. Gahl, National Institutes of Health, National Human Genome Research Institute, Bethesda, MD, USA","Not Applicable","Rare Diseases","Family/Twin/Trios","WES_markerset_grc37, HumanOmniExpress-12","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 25 variables, 1 documents, 1 molecular datasets, 1007 samples sequenced,  SRA, 1007 subjects, 1896 samples","","NHGRI","GRU --- General Research Use","2023-02-02","2023-02-02","Disease, Rare; Rare Disease",""
"phs003086.v1.p1","Single Cell Transcriptomic Data from CD4+ T Cells from Children with    MIS-C","Multisystem inflammatory syndrome in children (MIS-C) is a severe complication of SARS-CoV-2 infections in the pediatric population characterized by fever, multi-organ involvement and systemic inflammation. Single-cell RNA sequencing was used  to evaluate the transcriptomic signature of CD4+ T cells obtained from the peripheral blood of patients with MIS-C before (n 3) and after (n 5)","Not Applicable","pediatric multisystem inflammatory disease, COVID-19 related","Case-Control","Not Provided","RNA-Seq","3 phenotype datasets, 15 variables, 2 samples sequenced, 14 subjects, 14 samples","","NIAMS","DS-AIID --- Disease-Specific (Autoimmune/Inflammatory/Immune Disease)","2023-02-01","2023-02-01","MIS-C multisystem inflammatory syndrome in children; multisystem inflammatory syndrome in children; pediatric inflammatory multisystem syndrome",""
"phs002706.v1.p1","Transformation of Dysplasia in Barrett's Esophagus","Complex chromosomal alterations are a hallmark of advanced cancers but rarely seen in normal tissue. The progression of precancerous lesions to malignancy is often accompanied by increasing complexity of chromosomal  alterations that can drive their transformation through focal oncogenic amplifications. However, the etiology and evolution dynamics of these","Not Applicable","Barrett Esophagus","Case Set","Not Provided","WGS","4 phenotype datasets, 15 variables, 92 samples sequenced, 16 subjects, 92 samples","","NIDDK","HMB-MDS --- Health/Medical/Biomedical (MDS)","2023-02-01","2023-02-01","Adenocarcinoma Of Esophagus; Adenocarcinoma of the Esophagus; Esophageal adenocarcinoma; Esophagus Adenocarcinoma; adenocarcinoma - esophagus; adenocarcinoma - oesophagus",""
"phs003100.v1.p1","Whole-Genome Sequencing Analysis of Extrachromosomal DNA with Amplicon    Architect","The study is related to our manuscript entitled ""Single-cell genetic heterogeneity linked to immune infiltration in glioblastoma"". Using multiplexed FISH analysis of 3-4 tumor cores from 17 glioblastoma formalin-fixed paraffin-embedded  (FFPE) tumors, we identified two classes of tumors based on single cell co-occurrence of EGFR and CDK4 amplification. Tumors with a low odds ratio","Not Applicable","Glioblastoma","Case Set","Not Provided","WGS","4 phenotype datasets, 27 variables, 6 samples sequenced, 6 subjects, 6 samples","","NCI","GRU --- General Research Use","2023-01-31","2023-01-31","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs003085.v1.p1","RNA-Sequencing of B-Lymphoblastic Leukemia with Glucocorticoids and PI3K    Delta Inhibition","Mononuclear cells were isolated from bone marrow or peripheral blood of 7 pediatric subjects with B-lymphoblastic leukemia at the time of diagnosis. To determine the effect of PI3K delta inhibition  on glucocorticoid-induced gene regulation, B-lymphoblastic leukemia cells were treated with glucocorticoids +/- the PI3K delta inhibitor, idelalisib,","Not Applicable","Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","Case Set","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 65 samples sequenced, 7 subjects, 65 samples","","NCI","GRU --- General Research Use","2023-01-31","2023-01-31","Leukemia, Pre B Cell; Leukemia, Pre-B-Cell; Leukemias, Pre-B-Cell; Pre B ALL; Pre B Cell Leukemia; Pre B-ALL",""
"phs003159.v1.p1","Targeted Long-Read Sequencing of the Ewing Sarcoma 6p25.1 Susceptibility    Locus","Ewing Sarcoma (EwS) is rare but the second most common cancer in children, adolescents and young adults. Recent studies suggest germline variation in or around GGAA microsatellites may interact with  fusion oncoprotein binding causing changes in binding affinity and potentially impacting enhancer activity on nearby target genes. This study aims to","Not Applicable","Sarcoma, Ewing","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 13 variables, 462 samples sequenced, 231 subjects, 462 samples","","NCI","DS-ES --- Disease-Specific (Ewing's Sarcoma)","2023-01-27","2023-01-27","ES; Ewing Sarcoma; Ewing Tumor; Ewing tumour; Ewing's Sarcoma; Ewing's Tumor",""
"phs001978.v1.p1","IGNITE: Implementing GeNomics In practice: Genomic Medicine    Implementation - The Personalized Medicine Program","IGNITE is an NIH-funded network dedicated to supporting the implementation of genomics in healthcare. IGNITE was created to enhance the use of genomic medicine by supporting the development of methods  for incorporating genomic information into clinical care and exploration of the methods for effective implementation, diffusion and sustainability in","Not Applicable","Chronic Pain","Clinical Trial","SNP-PCR","SNP Genotypes (PCR)","4 phenotype datasets, 18 variables, 1 molecular datasets, 2950 subjects, 2950 samples","","NHGRI","GRU-IRB --- General Research Use (IRB)","2023-01-26","2023-01-26","Gastroesophageal Reflux; Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic; Widespread Chronic Pain",""
"phs002143.v1.p1","Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods    for exRNA Isolation","We tested the efficiency and reproducibility of 10 RNA isolation methods on 5 different biofluids. Pooled human plasma and serum, bile and urine were used along with cell culture supernatants  from human embryonic stem cells (hESC), primary neonatal rat ventricular myocytes (NRVM) and human cholangiocarcinoma cells (KMBC). 4 RNA isolation","Not Applicable","Gender Identity","Methods","Not Provided","miRNA-Seq","4 phenotype datasets, 21 variables, 264 samples sequenced, 24 subjects, 264 samples","","NHLBI","GRU --- General Research Use","2023-01-25","2023-01-25","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs003048.v1.p1","Juvenile Sjogren's Syndrome (JSS) Transcriptome Study","Sj&#x000f6;gren's disease (SjD) is a systemic autoimmune disorder with major clinical manifestations of dryness in the eyes and mouth, fatigue, and joint pain. Our interdisciplinary experts in SjD at the  University of Florida newly discovered and established a cohort of SjD in children. Many of these patients with childhood SjD (cSjD) demonstrated a","Not Applicable","Sjogren's Syndrome","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 16 variables, 10 samples sequenced, 20 subjects, 50 samples","","NIAMS","DS-JSS --- Disease-Specific (Juvenile Sjogren's syndrome and related diseases)","2023-01-23","2023-01-23","Parotitis, Juvenile Recurrent",""
"phs002093.v1.p1","NSIGHT BabySeq Project","The Genomic Sequencing for Childhood Risk and Newborn Illness (BabySeq Project) is a research study exploring the use of genomic sequencing in newborns. The National Institutes of Health is funding  this study. Investigators enrolled 240 healthy infants and their parents from the Brigham and Women's Hospital (BWH) Well Newborn Nursery and 240","Not Applicable","Infant, Newborn","Clinical Trial","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 159 samples sequenced, 159 subjects, 159 samples","","NICHD","HMB --- Health/Medical/Biomedical","2023-01-20","2023-01-20","Not Provided",""
"phs003003.v1.p1","Gene Expression between PMD and Control LCLs at Baseline, E2, and E2    Withdrawal","In this study, lymphoblastoid cell lines (LCLs) derived from women with past perimenopausal depression (PMD) (n 8) and asymptomatic controls (n 9) were compared via poly(A)-selected transcriptome sequencing (RNA-seq). LCLs  were cultured in three experimental conditions: at vehicle baseline (ovarian steroid-free), during estradiol (E2) treatment, and following","Not Applicable","Perimenopause","Case-Control","RNAseq_gene_transcripts","RNA Seq (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 17 subjects, 51 samples","","NIMH","GRU --- General Research Use","2023-01-19","2023-01-19","Depression","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs002746.v1.p1","Resistance to Latent Mycobacterium tuberculosis Infection in South    Africa: Immunologic Profiling","Despite significant exposure to Mycobacterium tuberculosis (Mtb), some humans remain uninfected, as defined by persistently negative immune sensitization tests (tuberculin skin test, TST; interferon gamma release assays, IGRA). To explore  mechanisms of natural resistance to Mtb infection, we profiled tissues from highly-exposed Mtb contacts from South Africa. The cohort in this","Not Applicable","Disease Resistance","Case-Control","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 26 variables, 1 molecular datasets, 158 samples sequenced, 58 subjects, 158 samples","","NIAID","DS-TB-IRB-COL --- Disease-Specific (Tuberculosis, IRB, COL)","2023-01-19","2023-01-19","Latent Tuberculosis; Infection, Latent Tuberculosis; Infections, Latent Tuberculosis; LTBI; LTBI - Latent tuberculosis infection; Latent Tuberculoses",""
"phs000820.v2.p1","The Cleveland Clinic Foundation's (CCF) Lone Atrial Fibrillation (AFIB)    GWAS Study","Blood samples were taken from patients who have lone atrial fibrillation. DNA samples were processed with Illumina Hap550 and Hap 610 chips. Patients who came to Cleveland Clinic for cardiac  treatment were voluntarily enrolled in a lone Atrial Fibrillation (AF) bio-repository, including those with AF without significant Structural Heart","Not Applicable","Atrial Fibrillation","Case Set","HumanHap550, Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 543 subjects, 543 samples","European (529), East Asian (2), African American (7), Hispanic1 (1), Hispanic2 (4)","NHLBI","GRU-IRB --- General Research Use (IRB)","2023-01-19","2015-11-17","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs003097.v1.p1","Multi-Modal Single-Cell and Whole-Genome Sequencing of Small, Frozen    Clinical Specimens","Clinical application of single-cell sequencing technologies has been hampered by their need for quick processing of relatively large, fresh specimens. Here, we benchmarked the performance of a new technique for  single-cell sequencing from snap-frozen clinical samples, vs. sequencing from fresh samples, on 5 samples from cutaneous melanoma brain metastasis, 6","Not Applicable","Neoplasm Metastasis","Collection","Not Provided","OTHER, WGS, WXS","4 phenotype datasets, 18 variables, 94 samples sequenced, 41 subjects, 94 samples","","NCI","GRU --- General Research Use","2023-01-18","2023-01-18","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell",""
"phs003075.v1.p1","Longitudinal Studies of Patients with Familial Platelet Disorder with    Associated Myeloid Malignancy (FPDMM)","FPDMM (OMIM #601399) is a rare autosomal dominant disease characterized by defective megakaryocytic development, thrombocytopenia, platelet functional defects, and a life-long risk of developing hematological malignancies. FPDMM is caused by  germline mutations in the RUNX1 gene, which encodes a master regulator of hematopoiesis. The overall lifetime risk of hematological malignancies in","Not Applicable","Platelet Disorder, Familial, with Associated Myeloid Malignancy","Case Set","HumanOmniExpress-12","SNP Genotypes (Array), RNA-Seq, WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 171 samples sequenced, 77 subjects, 229 samples","","NHGRI","GRU --- General Research Use","2023-01-18","2023-01-18","FPD/AML; FPD/AML syndrome; FPDAML; FPDMM; FPS/AML syndrome; Familial Platelet Disorder with Associated Myeloid Malignancy","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003066.v1.p1","Urothelial Cancer - Genomic Analysis to Improve Patient Outcomes and    Research (UC-GENOME): A Bladder Cancer Advocacy Network (BCAN)-Led    Collaborative Research Pilot Study","UC-GENOME is a real-world cohort of patients with metastatic urothelial carcinoma (UC). The study consisted of two co-equal aims: 1) to provide targeted DNA sequencing for clinical decision making at  no cost to patients; and 2) to create a resource for collaborative translational science including a clinically annotated biobank. The submitted data","Not Applicable","Urinary Bladder Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, Targeted-Capture","4 phenotype datasets, 13 variables, 353 samples sequenced, 194 subjects, 353 samples","","NCI","DS-UC --- Disease-Specific (Urinary Conditions)","2023-01-12","2023-01-12","Bladder Cancer; Cancer of the Urinary Tract; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder",""
"phs003115.v1.p1","Genetics of Male Infertility Initiative (GEMINI)","The Genetics of Male Infertility Initiative (GEMINI) project is a multi-center study designed to discover and characterize genetic variants conferring risk for male infertility. Patients enrolled in GEMINI have been  clinically diagnosed with male infertility. Patients are recruited from multiple medical centers and are primarily of European ancestry. DNA from","Not Applicable","Infertility, Male","Case Set","WES_markerset_grc38","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 molecular datasets, 107 subjects, 107 samples","","NICHD","DS-FI --- Disease-Specific (Fertility and infertility)","2023-01-10","2023-01-10","Decreased fertility in males; Decreased male fertility; Male Sub-Fertility; Male Subfertility; Sub Fertility, Male; Sub-Fertility, Male",""
"phs002378.v1.p1","CSER: Evaluating Utility and Improving Implementation of Genomic    Sequencing for Pediatric Cancer Patients in the Diverse Population and    Healthcare Settings of Texas: The KidsCanSeq Study","Through this Clinical Sequencing Evidence-Generating Research (CSER) with Enhanced Diversity project we are completing a clinical study (The Texas KidsCanSeq Study) comparing the results of targeted cancer panel sequencing versus  genome-scale testing in pediatric cancer patients across diverse clinical settings. We will compare the targeted pediatric cancer panel to germline","Not Applicable","Neoplasms","Case Set","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use","2023-01-10","","Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002111.v1.p1","CSER: Exome Sequencing in Diverse Populations in Colorado and    Oregon/CHARM Cancer Health Assessments Reaching Many","The CHARM (Cancer Health Assessment Reaching Many) study, part of the Clinical Sequencing Evidence-Generating Research (CS.ER2) effort, aimed to assess the utility of clinical exome sequencing and how it affects  care in diverse populations. The study population included adults at risk for hereditary cancer syndromes. The primary objective was the","Not Applicable","Neoplastic Syndromes, Hereditary","Clinical Trial","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use","2023-01-10","","Cancer Syndrome, Hereditary; Cancer Syndromes, Hereditary; Familial Neoplastic Syndrome; Familial Tumor Syndrome; Germline Neoplastic Syndrome; Hereditary Cancer Syndrome",""
"phs002110.v1.p1","CSER: North Carolina Clinical Genomic Evaluation by Next-Gen Exome    Sequencing 2","The North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing, 2 (NCGENES 2) study is part of a larger consortium project investigating the clinical utility, or net benefit of an  intervention on patient and family well-being as well as diagnostic efficacy, management planning, and medical outcomes. A clinical trial will be","Not Applicable","Genetic Diseases, Inborn","Clinical Trial","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use","2023-01-10","","Central Nervous System Diseases; Child Development Disorders, Pervasive; Chromosome Aberrations; Chromosome Disorders; Congenital Abnormalities; Craniofacial Abnormalities",""
"phs001926.v1.p1","Genomic Characterization CS-MATCH-0007 Arm Q","The CS-MATCH-0007 protocol is part of a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA  sequencing using pre-and post-treatment tumor biopsy specimens from patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131).","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 312 variables,  SRA, 35 subjects, 35 samples","","NCI","GRU-COL --- General Research Use (COL)","2023-01-10","2023-01-10","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002535.v1.p1","Rapid Acceleration of Diagnostics - Digital Health Technologies    (RADx-DHT): Personalized Analytics and Wearable Biosensor Platform for    Early Detection of Covid-19 Decompensation (DECODE)","The goal of this project is to develop an artificial intelligence-based data analytics and cloud computing platform, paired with U.S. Food and Drug Administration (FDA)-cleared wearable devices, to create a  personalized baseline index that could indicate a change in health status for patients who have tested COVID-19 positive. The project involves the","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2023-01-09","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Digital Health Technologies'    (RADx-DHT) Collection of General Research Use Datasets (phs003666.v1.p1)"
"phs002622.v1.p1","Aurora US Metastatic Breast Cancer Retrospective Project","The AURORA US Metastatic Breast Cancer project is funded by the Breast Cancer Research Foundation (BCRF) Evelyn H. Lauder Founder's Fund for Metastatic Breast Cancer Research. This multi-center effort conducted  within the Translational Breast Cancer Research Consortium (TBCRC) and cancer researchers to better understand the metastatic process through the","Not Applicable","Breast Neoplasms","Case Set","MethylationEPIC","Methylation (CpG), RNA-Seq, WGS, WXS","5 phenotype datasets, 17 variables, 1 molecular datasets, 325 samples sequenced, 55 subjects, 477 samples","","NCI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical, DS-BRCA --- Disease-Specific (Breast Cancer)","2023-01-06","2023-01-06","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003084.v1.p1","Genome Sequencing of Circulating Tumor Cells for Minimally Invasive    Molecular Characterization of Multiple Myeloma Pathology","&#x0200b;&#x0200b;Multiple Myeloma (MM) develops from well-defined precursor stages known as Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering MM (SMM); however, invasive bone marrow (BM) biopsy limits screening and monitoring  strategies for patients. In this study, we enumerated circulating tumor cells (CTCs) from patients with precursor and overt diseases, and developed a","Not Applicable","Multiple Myeloma","Tumor vs. Matched-Normal","Not Provided","WGS","4 phenotype datasets, 15 variables, 135 samples sequenced, 51 subjects, 135 samples","","NCI","HMB --- Health/Medical/Biomedical","2023-01-05","2023-01-05","Monoclonal Gammopathy of Undetermined Significance; Smoldering Multiple Myeloma; Asymptomatic monoclonal gammopathy; Benign Monoclonal Gammapathies; Benign Monoclonal Gammapathy; Benign Monoclonal Gammopathies",""
"phs003302.v1.p1","Epigenetic Landscape of Human Parathyroids","The goal of this study is to produce a comprehensive map of the chromatin landscape of human parathyroids. Data from 20 subjects with parathyroid adenoma causing primary hyperparathyroidism were used.  For the sequencing platform, Illumina HiSeq 2000 with V3 high-output kits were used. For the data processing pipeline, reads were aligned to hg19","Not Applicable","Epigenomics","Collection","WGS_markerset_grc37","ATAC-seq, ChIP-Seq, DNase-Hypersensitivity, RNA-Seq, Chromatin (NGS)","3 phenotype datasets, 9 variables, 1 molecular datasets, 18 samples sequenced, 20 subjects, 20 samples","","NIDDK","HMB --- Health/Medical/Biomedical","2023-01-04","2023-01-04","Not Provided",""
"phs003117.v1.p1","Multiregional Single-Cell Transcriptomic Analysis of Liver Cancer","In this study, we performed single-cell transcriptomic profiling of human liver tissues collected from hepatocellular carcinoma and intrahepatic cholangiocarcinoma patients. A total of seven primary liver cancer patients enrolled in  this study. Samples were collected from multiple regions, including tumor core, tumor border and adjacent non-tumor tissue. The 10x Genomics platform","Not Applicable","Carcinoma, Hepatocellular","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 34 samples sequenced, 7 subjects, 34 samples","","NCI","GRU-COL --- General Research Use (COL), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-LCCLD-IRB-NPU --- Disease-Specific (Liver Cancer and Chronic Liver Disease, IRB, NPU)","2023-01-04","2023-01-04","Liver Neoplasms; Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells",""
"phs000343.v4.p1","The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention    Stroke Prevention (VISP) Trial","The VISP trial (PI Jim Toole, M.D., Wake Forest University School of Medicine) was a multi-center, double-blind, randomized, controlled clinical trial that enrolled patients aged 35 or older with homocysteine  (Hcy) levels above the 25th percentile at screening and a non-disabling cerebral infarction (NDCI) within 120 days of randomization (Toole, 2002,","Not Applicable","Stroke","Case-Control","HumanOmni1-Quad, imputation_panel, HumanMethylation450","Methylation (CpG), SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","43 phenotype datasets, 2862 variables, 50 documents, 3 molecular datasets, 2164 subjects, 2536 samples","European (1720), African (16), East Asian (18), African American (246), Hispanic1 (12), Hispanic2 (54), Other Asian or Pacific Islander (7), South Asian (16), Other (11)","NHGRI","DS-SR --- Disease-Specific (Stroke Research)","2022-12-27","2022-12-27","Coronary Heart Disease; Myocardial Infarction; CHD - Coronary heart disease; Coronary Disease; Coronary Diseases; Coronary Heart Diseases",""
"phs002698.v1.p1","Identification of Structural Variants Relevant to Autism by Pacific    Biosciences HiFi Whole-Genome Sequencing","The purpose of this research study was to perform long-read whole-genome sequencing on a family with autism. This family had no known genetic cause based on clinical array and whole-exome  sequencing analysis. Utilizing PacBio HiFi long-read whole-genome sequencing, we identified a relevant missense variant in the KCNC2 gene. This","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 21 variables, 1 molecular datasets, 5 samples sequenced, 5 subjects, 5 samples","","NIMH","GRU-IRB --- General Research Use (IRB)","2022-12-23","2022-12-23","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs000898.v2.p1","Megabase-scale Haplotyped Genomic Analysis of Normal and Cancer Genomes","We experimentally determined Mb-scale haplotypes from germline and cancer genome sequencing. Using a microfluidic process that partitions long DNA fragments into hundreds of thousands of barcoded reactions, we determined haplotype  blocks from matched colorectal cancer samples in the delineation of haplotypes of allelic imbalances and other genomic instability events. Principal","Not Applicable","Colorectal Neoplasms","Case Set","Not Provided","WGS","4 phenotype datasets, 16 variables, 2 samples sequenced,  SRA, 1 subjects, 2 samples","","NHGRI","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2022-12-23","2016-07-28","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs000563.v2.p1","The Genomics of Pilocytic Astrocytoma Formation in Neurofibromatosis Type    1","Neurofibromatosis type 1 (NF1) inherited cancer predisposition syndrome is one of the most common autosomal dominant tumor predisposition syndromes in which affected individuals develop brain tumors. These low-grade glial neoplasms  (pilocytic astrocytomas) typically arise in children younger than 7 years of age and are hypothesized to result from a combination of germline and","Not Applicable","Astrocytoma","Case Set","custom_markerset","Methylation (CpG), WGS","4 phenotype datasets, 14 variables, 1 molecular datasets, 6 samples sequenced, 4 subjects, 10 samples","","NCI","DS-BST-GSO --- Disease-Specific (Brain and Spinal Tumors, GSO)","2022-12-23","2013-07-01","Neurofibromatosis Type 1; Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Glioma",""
"phs000253.v1.p1","Human Liver Cohort (HLC)","The Human Liver Cohort (HLC) study aimed to characterize the genetic architecture of gene expression in human liver using genotyping, gene expression profiling, and enzyme activity measurements of Cytochrom P450.  The HLC was assembled from a total of 780 liver samples screened. DNA samples were genotyped on the Affymetrix 500K SNP and Illumina 650Y SNP","Not Applicable","Liver","Cross-Sectional","Not Provided","Not Provided","4 phenotype datasets, 14 variables, 1 documents, 228 subjects, 228 samples","","NHLBI","GRU --- General Research Use","2022-12-23","2022-12-23","Not Provided","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002691.v1.p1","The MD Anderson Colorectal Cancer Case Control Study","Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US. Driven by common disease common variants hypothesis, genome-wide association studies only identified a number of common  susceptibility loci that explained a small portion of CRC heritability. We conducted a case-control study using whole exome sequencing to identify","Not Applicable","Colorectal Neoplasms","Case-Control","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 27 variables, 1 analyses, 1 molecular datasets, 5384 samples sequenced, 5384 subjects, 5384 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2022-12-22","2022-12-22","Family Medical History; CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine",""
"phs002866.v1.p1","Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma","In this study, we evaluated circulating tumor DNA (ctDNA) as a biomarker in the serum of 124 patients with newly diagnosed intermediate risk rhabdomyosarcoma (IR RMS) from the&#x000a0;Children's Oncology Group&#x000a0;(COG)  biorepository. In addition to pre-treatment serum, we also analyzed matched tumor tissue and germline in a subset of patients. We profiled samples","Not Applicable","Rhabdomyosarcoma","Case Set","Not Provided","Targeted-Capture, WGS","4 phenotype datasets, 13 variables, 295 samples sequenced, 124 subjects, 295 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-12-21","2022-12-21","Not Provided",""
"phs002432.v1.p1","Wistar PDX Development and Trial Center","Overall the outcomes of patients with metastatic melanoma have improved dramatically over the last decade due to an improved understanding of the molecular drivers of this disease. In particular, multiple  targeted therapy regimens have been approved for patients with a BRAFV600E/K mutation, which are present in 50% of cutaneous melanomas. These","Not Applicable","Melanoma","Case Set","Not Provided","Not Provided","4 phenotype datasets, 21 variables, 46 subjects, 185 samples","","NCI","GRU-COL --- General Research Use (COL)","2022-12-21","2022-12-21","Skin Neoplasms; Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant",""
"phs003080.v1.p1","Cell and Circuit-Specific Exploration of HIV Neurogenomics in Context of    Opiate and Cocaine Misuse","Utilizing frozen postmortem brain tissue from the Manhattan HIV Brain Bank, we performed cell-type-specific, genome-wide sequencing of three different types: 1) single-nucleus RNA-sequencing (snRNA-seq), 2) in situ Hi-C, and 3)  HIV integration site sequencing (IS-seq). We assayed tissue from three different donor types: 1) HIV-uninfected control (HIV-), HIV-infected (HIV+),","Not Applicable","HIV","Case-Control","Not Provided","AMPLICON, Hi-C, RNA-Seq","4 phenotype datasets, 28 variables, 75 samples sequenced, 50 subjects, 75 samples","","NIDA","HMB-IRB --- Health/Medical/Biomedical (IRB)","2022-12-20","2022-12-20","Not Provided",""
"phs002793.v2.p1","Study of Lyme Immunology and Clinical Events (SLICE)","The overall objective of this study is to measure risk factors, symptom patterns and severity, longitudinal course, and associated biomarkers in patients who develop symptoms of post treatment Lyme disease  (PTLD) in cohort studies.&#x000a0;&#x000a0; Principal Investigator: John Aucott, MD, Lyme Disease Research Center, Division of Rheumatology,","Not Applicable","PTLDS Transcriptome","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38","Not Provided","2 phenotype datasets, 6 variables, 428 samples sequenced, 321 subjects, 428 samples, 2 substudies","","NIAID","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2022-12-20","2022-12-20","Not Provided",""
"phs002795.v1.p1","Biomarker Set Identification for Post-Treatment Lyme Disease - Johns    Hopkins Lyme Disease Research Center and Mount Sinai Center for    Bioinformatics Collaboration","We investigated differences in differential gene expression in healthy controls, participants with acute Lyme disease (LD) followed over the course of their treatment, and participants with post-treatment Lyme disease (PTLD),  and identified a biomarker set that can distinguish healthy patients from those with acute LD or PTLD. Samples from 152 patients with PTLD were drawn","Study of Lyme Immunology and Clinical Events (SLICE) (phs002793.v2.p1)","Lyme Disease","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","1 phenotype datasets, 3 variables, 356 samples sequenced, 269 subjects, 356 samples","","NIAID","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2022-12-20","2022-12-20","B. burgdorferi Infection; B. burgdorferi Infections; Bannwarth syndrome; Bannworth's syndrome; Borrelia; Borrelia burgdorferi Infection",""
"phs002794.v2.p1","Immunobiology and Natural History of Human Infection with Agent of Lyme    Disease, Borrelia burgdorferi","The overall objective of this study is to measure risk factors, symptom patterns and severity, longitudinal course, and associated biomarkers in patients who develop symptoms of post-treatment Lyme disease (PTLD)  in a prospective cohort study. Phenotype data will be provided in the publication's supplemental materials. This dataset was used to develop a Lyme","Study of Lyme Immunology and Clinical Events (SLICE) (phs002793.v2.p1)","PTLDS Transcriptome","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS), RNA-Seq, RNA Seq (NGS)","1 phenotype datasets, 3 variables, 1 molecular datasets, 72 samples sequenced, 70 subjects, 72 samples","","NIAID","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2022-12-20","2022-12-20","Not Provided",""
"phs002232.v1.p1","TOPDECC-Trans-omics for Precision Dentistry and Early Childhood Caries:    Genome-Wide Genotyping (CIDR) and Microbiome in the ZOE 2.0 Study","The ZOE 2.0 study is a cross-sectional genetic epidemiologic investigation of early childhood oral health, conducted in a state-wide, community-based, multi-ethnic sample of 3-5-year-old preschool-age children in North Carolina, United  States. Between 2016-2019, 8,059 children were enrolled and 6,404 of them underwent comprehensive oral-clinical examinations that provided usable","Not Applicable","Dental Caries","Cross-Sectional","Global_Diversity_Array-8, imputation_panel","SNP/CNV (Array), SNP/CNV Genotypes (imputed), RNA-Seq, WGS","5 phenotype datasets, 73 variables, 2 molecular datasets, 597 samples sequenced, 6161 subjects, 6868 samples","European (1080), African (56), East Asian (10), African American (3322), Hispanic1 (382), Hispanic2 (1030), Other Asian or Pacific Islander (24), South Asian (4), Other (236)","NIDCR","HMB-MDS --- Health/Medical/Biomedical (MDS)","2022-12-19","2022-12-19","Caries; Caries, Dental; Cariosity of teeth; Carious Lesion; Carious Lesions; Cavities, Dental",""
"phs002802.v1.p1","Phase IB/II Study of Bazedoxifene in Combination with Palbociclib in    Patients with Endocrine Resistant Hormone Receptor-Positive Breast    Cancer","In this phase Ib/II clinical trial, the investigators evaluated the efficacy and safety of the combination of palbociclib with bazedoxifene in patients with a metastatic endocrine-resistant hormone receptor-positive, HER2-negative breast  cancer. Furthermore, whole exome sequencing of cell-free tumor DNA was done on serial samples from these patients, revealing potential molecular","Not Applicable","Breast Neoplasms","Clinical Trial","Not Provided","WGS, WXS","4 phenotype datasets, 18 variables, 98 samples sequenced, 32 subjects, 98 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-12-15","2022-12-15","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002479.v1.p1","HCI-PDX Trial Center for Breast Cancer Therapy","The HCI-PDX Trial Center for Breast Cancer Therapy study is a collection of patient-tumor samples that are serially established as patient-derived tumor xenografts (human tumor in mouse) and matching organoids.  For this study, we describe valuable methods and resources to generate organoids and use them as cost-effective models for precision drug screens.","Not Applicable","Breast Neoplasms","Xenograft","RNAseq_probe_set_grc38, WES_markerset_grc38, Affymetrix_WG_Array, HumanOmni2.5-8","CNV Genotypes, RNA-Seq, SNV (.MAF), RNA Seq (NGS), WXS","4 phenotype datasets, 35 variables, 1 molecular datasets, 152 samples sequenced, 37 subjects, 227 samples","","NCI","GRU --- General Research Use","2022-12-15","2022-12-15","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs003108.v1.p1","Role of Genetic Factors in the Pathogenesis of Lung Disease","Three individuals with lymphangioleiomyomatosis (LAM) underwent evaluation for Tuberous Sclerosis Complex (TSC)-associated mucocutaneous and internal findings. Next-generation sequencing (NGS) of cutaneous findings was used to confirm clinical suspicion for mosaic  TSC in individuals with LAM. Mosaic mutations in TSC2 were found in these three individuals. Subjects had a diagnosis of LAM and a few other features","Not Applicable","Lymphangioleiomyomatosis","Case Set","Not Provided","Targeted-Capture","3 phenotype datasets, 10 variables, 5 samples sequenced, 3 subjects, 5 samples","","NHLBI","DS-TSC-RD --- Disease-Specific (Tuberous Sclerosis Complex, RD)","2022-12-12","2022-12-12","LAM; LYMPHANGIOMYOMATOSIS; Lymphangioleiomyomatoses; Lymphangioleiomyomatosis, somatic; Lymphangiomyomatoses; TSC1-Related Lymphangioleiomyomatosis",""
"phs002518.v1.p1","Childhood Cancer Data Initiative (CCDI): OncoKids - NGS Panel for    Pediatric Malignancies","This study aimed to systematically collect clinical, registry and genomic data on pediatric cancer patients, and to contribute to the CCDI Pediatric Data Ecosystem. Clinical, treatment and outcome data on  1,039 pediatric cancer patients whose molecular profile was characterized on OncoKids gene panel at Children's Hospital Los Angeles was abstracted","Not Applicable","Neoplasms","Clinical Genetic Testing","Not Provided","AMPLICON","2 phenotype datasets, 5 variables, 2246 samples sequenced, 1039 subjects, 2246 samples","","NCI","GRU --- General Research Use","2022-12-07","2022-12-07","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs000560.v2.p1","Ecological Stressors, PTSD, and Drug Use in Detroit: The Detroit    Neighborhood Health Study (DNHS)","The Detroit Neighborhood Health Study (DNHS) is a prospective, representative longitudinal cohort study of predominantly African American adults living in Detroit, Michigan. The overall goal of the DNHS is to  identify how genetic variation, lifetime experience of stressful and traumatic events, and features of the neighborhood environment predict","Not Applicable","Stress Disorders, Post-Traumatic","Prospective Longitudinal Cohort","HumanOmniExpress-12, MethylationEPIC","Methylation (CpG), SNP Genotypes (Array)","6 phenotype datasets, 274 variables, 2 molecular datasets, 856 subjects, 963 samples","European (70), African (9), African American (415), Hispanic1 (3), Hispanic2 (6), Other Asian or Pacific Islander (1), South Asian (1), Other (2)","NIDA","GRU --- General Research Use","2022-12-07","2022-12-07","Combat Neurosis; Neuroses, Post Traumatic; Neuroses, Post-Traumatic; Neuroses, Posttraumatic; PTSD; PTSD - post-traumatic stress disorder","Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs002991.v1.p1","Improving Transcriptome Fidelity Following Synovial Tissue Disaggregation","Synovial tissue was collected at the time of arthroplasty from rheumatoid and osteoarthritis arthroplasty. Tissues were left intact or disaggregated with different methods to evaluate the effect on the transcriptome.  Inclusion Criteria: Rheumatoid arthritis or osteoarthritis Arthroplasty of knee or hip Exclusion Criteria: Other joint surgery within 6 months of","Not Applicable","Arthritis, Rheumatoid","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 51 samples sequenced, 11 subjects, 51 samples","","NIAMS","GRU --- General Research Use","2022-12-06","2022-12-06","Osteoarthritis; Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides; Degenerative Arthritis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002095.v1.p1","NSIGHT North Carolina Newborn Exome Sequencing for Universal Screening    (NC NEXUS)","Since newborn screening (NBS) began in the 1960s, technological advances have resulted in its use in an increasing number of disorders. Recent developments in whole-genome sequencing and its simpler corollary,  whole-exome sequencing (WES), now afford the opportunity to comprehensively define the variation within an individual's genome in a rapid and","Not Applicable","Metabolism, Inborn Errors","Clinical Trial","WES_markerset_grc38","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 13 variables, 1 molecular datasets, 83 samples sequenced, 83 subjects, 83 samples","","NICHD","HMB-IRB --- Health/Medical/Biomedical (IRB)","2022-12-06","2022-12-06","Hearing Loss; Disease, Genetic; Disease, Hereditary; Diseases, Genetic; Diseases, Hereditary; Disorder, Genetic",""
"phs003083.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal    Strategy to Protect a High Risk Population","We plan to offer SARS-CoV-2 screening tests at selected dialysis facilities in order to reduce transmission and detect early cases to prevent serious illness among patients receiving dialysis. Patients receiving  dialysis have an 8-fold higher risk of hospitalization and a 15-fold higher risk of death from COVID-19 compared to the general population. Patients","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003082.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Localized Mobile Health Approach to Boosting COVID-19 Testing and    Vaccine Literacy, Access, and Uptake Among Women with Criminal Legal    System Involvement","People with criminal legal system involvement (CLSI) have experienced five times as many COVID-19 infections and have three times the risk of death compared to general population in the U.S.  Heavily impacted by COVID-19 and squarely within NIH health disparities populations, people with CLSI are often poor and disproportionately from","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003081.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    COMMIT","In the United States underserved and socially vulnerable populations have endured higher rates and disparities of COVID-19 infection, morbidity, and mortality. This disproportionate burden has shone the light on the  root causes of COVID-19 disparities, such as longstanding systemic racial bias in health care delivery, discrimination, and poor social determinants","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003057.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Evidence-based Interventions - Individual, Community, and Structural    Factors That Predict Lower Rates of Covid-19 Screening Testing in    Underserved and Vulnerable Populations","The purpose of this proposal is to identify individual, community (population) and structural factors associated with lower rates of Covid-19 testing in Northern New England (NNE), with a focus on  underserved and vulnerable populations. Our study includes several COVID-19 medically and/or socially vulnerable populations: communities with high","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003056.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Social, Ethical, and Behavioral Factors in the Return to School Among    Underserved Communities in Maryland","The goal is of this study is to use surveys to characterize social, ethical, and behavioral factors associated with parents of K-8 students, their willingness to return their children to  in-person school (or to remain in school), and their support for and compliance with COVID-19 infection control and prevention strategies in eight","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU-NPU --- General Research Use (NPU)","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003051.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Using the Multiphase Optimization Strategy (MOST) to Optimize an    Intervention to Increase COVID-19 Testing for Black and    Latino/Hispanic Frontline Essential Workers","Among those at highest risk for exposure to COVID-19 is the large population of frontline essential workers (FEW) in lower status occupations (e.g., retail, in-home health care), among whom Black  and Latino/Hispanic (BLH) persons are over-represented. For those not vaccinated for COVID, regular COVID-19 screening testing is recommended even","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003050.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Improving Testing for COVID-19 in Skilled Nursing Facilities: IMPACT","Purpose: To assess beliefs, attitudes and intentions of skilled nursing facility staff, residents and family members concerning COVID-19 testing and vaccination, via survey and using mixed methods. Design and Methods:  E-surveys were developed and distributed to measure attitudes about SARS-CoV-2 testing and vaccine uptake among skilled nursing facility (SNF)","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003049.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Identifying COVID-19 Vaccine Deserts Using Machine Learning and    Geospatial Analyses to Target Community-Engaged Testing for Vulnerable    Rural Populations to Prevent Localized Outbreaks","As of June 30, 2021, 23% of West Virginia's (WV) 55 counties were ranked within the top 20% of counties most vulnerable to Covid-19 in the United States. Central to  the state's extreme vulnerability is higher prevalence of medical comorbidities, lower access to care among rural populations, and decreased vaccine","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003037.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Maximizing Child Health and Learning Potential: Promoting A School    Culture of Safety in the Era of COVID-19: Feasibility of Strategic    COVID-19 Testing Protocols in At-Risk Urban Schools","We will explore the feasibility of strategic COVID-19 testing protocols in at-risk urban school settings with the goal of increasing a sense of safety for parents and staff, and elucidating  information that could assist the district in adopting a testing protocol, which would increase the time students and staff physically spend in","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003033.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Social and Behavioral Implications for COVID-19 Testing in Delaware's    Underserved Communities","The focus of this project is to triangulate data from semi-structured surveys, serological testing, and census tract-linked public health and economic data to better understand social and behavioral factors related  to COVID-19 testing and vaccine uptake in minority communities, and to develop communication strategies to increase acceptance of testing and","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003032.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    RADx-UP Supplement-Vaccine Hesitancy and Uptake","The Georgia Center for Diabetes Translation Research Center (P30DK111024) proposes to collaborate with our RADx-UP Diabetes rural community partner and utilize locally developed and tested Georgia CEAL (1OT2HL156812-01/16-312-0217571-66105L) COVID-19 communication  materials to enhance COVID-19 testing in addition to vaccine confidence and uptake in underserved populations most severely affected by COVID-19","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003031.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Safer at School Early Alert Project HUB","Schools serve important community roles beyond academic education. In historically marginalized communities they are trusted providers for a range of support services for families in need. The tradeoff between these  crucial benefits of in-person learning against the risk of SARS-CoV-2 transmission in school settings has been hotly debated throughout much of 2020","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003030.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    REACH-OUT: Research, Engagement and Action on COVID-19 Health Outcomes    via Testing","As the coronavirus disease 2019 (COVID-19) pandemic evolves, equitable access to SARS-CoV testing and contact tracing will be critical to ongoing pandemic surveillance. Even as COVID-19 infection rates, hospitalizations, and  deaths are declining overall, testing will be necessary to identify people who may benefit from COVID-19 therapies, to encourage isolation and","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003029.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Southeast Asians in the US: Health Equity and Research to Understand    COVID-19 Stories (SEA US, HEAR US)","Unlike other ethnic minority groups, data on the impacts of COVID-19 on Southeast Asian Americans (SEAAs) are limited and oftentimes aggregated with other Asian American groups, thus limiting targeted assistance  efforts. Without adequate data to inform best practices around testing and vaccination, many SEAAs become invisible Americans who have difficulties","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003021.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Community Organizations for Natives: COVID-19 Epidemiology, Research,    Testing, and Services (CONCERTS)","As the COVID-19 pandemic spreads to every corner of the US, the plight of urban American Indian/Alaska Native (AI/AN) people is often overlooked or ignored. SARS-CoV-2 and the disease it  causes, COVID-19, disproportionately affect AI/ANs, who are at highest risk of any US racial or ethnic group for developing severe disease and dying","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002964.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Longitudinal at    Home Smell Testing to Detect Infection by SARS-CoV-2","Self-report of sudden loss of smell or taste substantially increases the odds of being diagnosed with SARS-CoV-2. However, self-report of smell function is an unreliable predictor of smell loss. We  created a self-administered easy to use ""at home"" 5-minute objective smell test to uncover alterations in smell function unbeknownst to many","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002948.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Motivational Enhancement to Augment Contingency Management for    SARS-CoV-2 Testing and Vaccination Utilization Among Syringe Exchange    Clients","People who inject drugs (PWIDs) are highly vulnerable to contracting SARS-CoV-2 and to the effects of the disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19). PWIDs experience underlying medical conditions  and unstable housing that put them at increased risk for COVID-19 morbidity and mortality. PWIDs also experience barriers such as a history of","Not Applicable","COVID-19","Case-Control","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002947.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Supporting the Health and Well-Being of Children with Intellectual and    Developmental Disability During the COVID-19 Pandemic","Not only are children with intellectual and developmental disabilities (IDD) at dramatically higher risk of becoming infected with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and death from COVID-19, they are  highly vulnerable to the negative impact of school closure. School districts provide critical services beyond education, including nutritional,","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002946.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Identifying and Addressing Critical Social, Ethical, and Behavioral    Factors Associated with COVID-19 Testing and Vaccination Among Spanish    Speakers","Latinx communities are disproportionately affected by the COVID-19 pandemic, with Spanish-speaking Latinx communities carrying even heavier burdens of infection, hospitalization, and mortality. Major barriers to COVID-19 testing and vaccination exist,  and a profound need remains to understand and address the social, ethical, and behavioral implications (SEBI) of COVID-19 testing and vaccination","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002945.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): A Data Science    Approach to Identify and Manage Multisystem Inflammatory Syndrome in    Children (MIS-C) Associated with SARS-CoV-2 Infection and Kawasaki    Disease in Pediatric Patients","The primary objective of this study was to design and validate a predictive decision support system for the identification, treatment, and management of SARS-CoV-2 associated with multisystem inflammatory syndrome in  children (MIS-C). To develop this system, we adapted and retrained machine learning algorithms, which we previously trained in patients with Kawasaki","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use, GRU-IRB --- General Research Use (IRB)","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002924.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Broad-Spectrum    Detection of VOC and Non-VOC Biomarkers from Patient Exhalant Using a    Biomimetic Multiplexed eNose Biosensor for COVID 19 Diagnosis","This project will develop biomimetic olfaction-based and gustation-based sensors for detecting volatile organic compound (VOC) biomarkers against SARS-CoV-2. We employ a computational design to deduce sets of odorant binding peptide  (OBP) sequences that will selectively bind to exhaled VOCs associated with SARS-CoV-2 from libraries of olfactory proteins. Chimeric peptides","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002920.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): A    Community Health Worker Intervention to Identify and Decrease Barriers    to Pre-Procedural COVID-19 Testing Among Los Angeles County Department    of Health Safety-Net Patients","African American and Latinx communities nationally and in California not only bear a disproportionate burden of COVID-19 positive cases and deaths but are also not taking part in COVID-19 testing  for a wide range of understudied reasons. This can have profound implications in safety net health care settings that care for our most vulnerable","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002917.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Reducing Ethical and Social Prejudicial Effects of COVID-19 Testing in    Underserved Populations (RESPECT-UP)","The community-engaged project, Reducing Ethical and Social Prejudicial Effects of COVID-19 Testing in Underserved Populations (RESPECT-UP), aims to understand the social, ethical, and behavioral factors surrounding COVID-19 testing in vulnerable  urban and rural African American Communities in Alabama (top 20% of the Social Vulnerability Index - SVI), and develop, in the form of RESPECT-UP","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002906.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): A    Nurse-Community Health Worker-Family Partnership Model: Addressing    Uptake of COVID-19 Testing and Control Measures","New York City (NYC) is a global epicenter of the SARS-CoV2/COVID-19 pandemic, with 222,000 cases and more than 25,000 deaths. Neighborhood-level disparities in cases and deaths in NYC can be  explained by socioeconomic and racial/ethnic characteristics, where Latinx and Black New Yorkers and those living in high poverty neighborhoods are","Not Applicable","COVID-19","Case-Control","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002905.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Safety, Testing/Transmission, and Outcomes in Pregnancies with    COVID-19 (STOP COVID-19)","Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk of preterm birth, cesarean section, and maternal intensive care. The objectives of this study  are to: (a) evaluate the full impact of SARS-CoV-2 in pregnancy to inform testing strategies, (b) examine the factors that impede testing during","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002904.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    ReSET: Restarting Safe Education and Testing for Children with Medical    Complexity","Our objective is to increase safe return to school for CMC (children with medical complexity) and school personnel through 3 complementary approaches. Aim 1 proposes to determine the feasibility of  in-home and school-based testing strategies for CMC, as well as to gain understanding of parent perceptions about in-person school attendance.","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002878.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Communities Fighting COVID!: Returning Our Kids Back to School Safely","Data for this study come from the Communities Fighting COVID!: Returning Our Kids Back to School Safely study, which is part of the National Institutes of Health RADx-UP Initiative, was  supported by the National Institute of Child Health and Human Development of the National Institutes of Health under Award Number 1OT2HD108112-01","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002875.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Assessing Vaccine Hesitancy and a Pharmacist Led Intervention Model to    Increase COVID-19 Vaccine Uptake Among African Americans","The investigators at Xavier University of Louisiana are utilizing a multicenter approach including a clinic, health care institution, and community survey-based research project to assess the beliefs and behaviors regarding  willingness to be vaccinated with a prospective COVID-19 vaccine among African Americans in the southeastern Louisiana region. The COVID-19 pandemic","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002874.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    COVID-19: Implementing Community-Based Approaches to Increase    SARS-CoV-2 Testing Among an Underserved and Vulnerable Hispanic    Population","Hispanics living in the United States have been negatively affected by the COVID-19 pandemic in a disproportionate manner, including significantly higher infection and hospitalization rates compared with non-Hispanic whites. The  El Paso, TX metropolitan area has a substantial Hispanic population that has been profoundly affected by the current SARS-CoV-2 pandemic, especially","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002873.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    The Cherokee Nation Community-Driven Program for Testing and Contact    Tracing (Cherokee PROTECT)","The Cherokee Nation Community-Driven Program for Testing and Contact Tracing (Cherokee PROTECT) unites tribal, academic, and community partners under the leadership of the Cherokee Nation (CN) to solve a dire  need for COVID-19 testing, contact tracing, and culturally informed education in underserved and vulnerable rural populations. Since the beginning of","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002872.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Implementation Science Center in Cancer Control Equity: A Competitive    Revision to Accelerate COVID Testing in Vulnerable Communities -    Project 08","This competitive revision submitted to the RADx-UP Initiative (NOT-20-121) aims to extend the infrastructure of our P50 Implementation Science Center for Cancer Control Equity (ISCCCE) to accelerate COVID testing in  9 hotspot communities in Massachusetts. ISCCCE is a strong partnership with the Massachusetts League of Community Health Centers, in which we","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002871.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): A    Dynamic COVID-19 Community-Engaged Testing Strategy in Alabama (COVID    COMET AL)","This study seeks to understand the factors associated with COVID-19 morbidity and mortality disparities and to lay the foundation to reduce disparities for those underserved and vulnerable populations that are  disproportionately affected by, have the highest infection rates of, and/or are most at risk for adverse outcomes from the COVID-19 pandemic. This","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002870.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    SARS-CoV-2 Screening and Diagnostic Testing for Return to K-12 Schools","By leveraging the infrastructure and community partnerships formed through the ABC Science Collaborative, this project will assess the effectiveness of rapid surveillance testing in reducing within-school transmission and restoring trust  among Black and Latino families to return to in-person school, as well as assess the uptake of school-based testing and time to safe school return","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002869.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    COVID-19 Testing in Underserved and Vulnerable Populations Receiving    Care in San Diego Community Health","Pronounced inequities and disparities in coronavirus disease COVID-19 morbidity and mortality have been reported, largely due to comorbid conditions and social determinants of health. Approximately 95% of COVID-19 related deaths  occur among individuals with underlying medical conditions. Of all racial/ethnic groups, Hispanic/Latino communities in San Diego County have","Not Applicable","COVID-19","Clinical Trial","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002868.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Obesity Health Disparities Research Center (OHDRC) COVID-19 Testing    Model Among Vulnerable Populations From Community Engagement to    Follow-Up","The overall goal of the Obesity Health Disparities Research Center (OHDRC) COVID-19 Testing Model of Vulnerable Populations: From Community Engagement to Follow-Up is to implement a three-component mobile community-based testing  model and evaluate its impact for improved reach, access, acceptance, uptake, and appropriate follow-up to COVID-19 testing. The proposed model,","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002825.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    SCALE UP COUNTS: A Health Information Technology Approach to    Increasing COVID-19 Testing in Elementary and Middle Schools and    Serving Disadvantaged Communities","Racial/ethnic minority and low socioeconomic status (SES) populations suffer profound health inequities across a wide variety of conditions as well as a disproportionate burden of the negative health consequences of  the COVID-19 pandemic. Latinos make up 14% of the Utah population vs. 21% of Utah's COVID-19 cases (50% higher) and the case rate is over 3-fold","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002821.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Harm Reduction Coalition San Diego - OnPoint","The project aims to increase access and uptake of COVID019 testing and vaccination among people who inject drugs (PWID), a population highly vulnerable to COVID-19. The proposed RADx-UP project, LinkUP,  will be nested within the San Diego component of our parent grant, La Frontera, which was funded by National Institute on Drug Abuse (NIDA) in April,","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002807.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Monitoring COVID-19 and Building Capacity with Northern Plains Tribes    and the Future of Pandemics","Monitoring COVID-19 and Building Capacity with Northern Plains Tribes and the Future of Pandemics will upgrade and sustain local capacity at the Native BioData Consortium (NBDC), an Indigenous-led research group,  with Lab Protocols to improve COVID-19 testing outcomes for Tribal populations by creating an improved diagnostics laboratory/local data resource","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002800.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Testing for COVID-19 in High Risk Children with Intellectual and    Developmental Disabilities (COV-IDD)","1. Virological Testing: We will establish a nasal-swab FDA-approved testing regimen to monitor and identify disease outbreaks in a specialized school setting serving 450 children with moderate-to-severe intellectual and developmental  disabilities (IDD) and the 500 staff supporting them, a setting at ultra-high risk for COVID-19 disease transmission. We will rapidly identify","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002799.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Leveraging Social Networks to Increase COVID-19 Testing Uptake: A    Comparison of Credible Messenger and Chain Referral Recruitment    Approaches","Until the advent of treatment or a vaccine, our ability to contain COVID-19 must rely on widespread identification of (asymptomatic) positive cases, their subsequent quarantine, and contact tracing of those  potentially exposed. Therefore, testing efforts must be targeted to those highly vulnerable yet unserved populations, including individuals who use","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002791.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Organizations to Reduce, Advance, and Lead for Equity (ORALE) Against    COVID-19","The COVID-19 pandemic has disproportionately affected the already underserved Latinx communities. The overall goal of the proposed testing research project is to decrease disparities in the morbidity and mortality patterns  for COVID-19 through engaged partnerships with several communities in central California that are both historically underserved and vulnerable to","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002786.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Lupus Education Alliance Program (LEAP)","People living with an autoimmune disease, including those with systemic lupus erythematosus (SLE), have been especially impacted by the COVID-19 pandemic. The purpose of this research project is to identify  barriers and facilitators to COVID-19 testing and vaccination among people living with SLE using both qualitative and quantitative methods. We will","Not Applicable","COVID-19","Case-Control","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002782.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): NIEHS    Diagnostic-Prognostic RNAseq","Infectious disease outbreaks like Coronavirus Disease 2019 (COVID-19) can overwhelm healthcare systems when screening tools are scarce or lacking. In the face of an ongoing COVID-19 pandemic and with single-plex  qPCR fluorometry inadequate for high throughput clinical diagnostics, the demand for testing exceeds the capacity, leading to limited availability,","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002781.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Discovery and    Clinical Validation of Host Biomarkers of Disease Severity and    Multi-system Inflammatory Syndrome in Children (MIS-C) and COVID-19","SARS-CoV-2 infection exhibits a wide range of clinical outcomes in both children and adults, from asymptomatic and mild disease to severe viral pneumonia, ARDS, acute kidney injury, thrombotic disorders, and  serious cardiac, cerebrovascular, and vascular complications. It is now known that severe infection can occur in both young children and young adults","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002778.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Microfluidic    Isolation and Characterization of SARS-CoV-2 and Virus Related    Exosomes","Robust, efficient, and reliable testing for SARS-CoV-2 is extraordinarily challenging due to our lack of ultra-sensitive assays and constantly evolving knowledge of the virus. Standard PCR based assays still result  in very high false negative rates in the earliest days of infection. Microfluidic processing of clinical samples is low cost and shows great promise","Not Applicable","COVID-19","Case-Control","Not Provided","Not Provided","Not Provided","","OD","HMB --- Health/Medical/Biomedical","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002777.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Social, Ethical, and Behavioral Implications Research on COVID-19:    Testing and Vaccine Uptake Among Rural Latino Migrants in Southwest    Florida","Latinos in Florida account for over 30% of all COVID-19 cases and hospitalizations. Most Latinos live in rural areas, work as migrant farmworkers, and have higher rates of underlying medical  conditions and limited access to health care. They live in circumstances that interfere with implementation of community mitigation measures, all","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002776.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Getting Asian Americans INFORMED To Facilitate COVID-19 Testing and    Vaccination","Getting Asian Americans informed to facilitate COVID-19 testing and vaccinations is a timely project to identify and address sociocultural, ethical and behavioral barriers, and to enable Asian Americans to make  well-informed decisions about getting tested for COVID-19. Asian Americans have been among the highest COVID-19 mortality rates when measured in case","Not Applicable","COVID-19","Case-Control","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002775.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Developing a Realtime Monitoring System and Program to Improve    COVID-19 Testing for Latinx Populations","Nationally, Latinx individuals have four times the rate of SARS-CoV-2 diagnoses, compared to Non-Hispanic Whites. Furthermore, Latinx populations may face barriers in accessing SARS-CoV-2 tests, receiving test results, interpreting test  results, and getting appropriate follow-up care. Improved understanding of the sources of health equity differences for Latinx populations can be","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002763.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Investigating the Effectiveness of COVID-19 Testing Choices, Community    Engagement, and Culturally-Embedded mHealth Literacy Delivery in a    Medically-Underserved, Community-Based Sample","This project will employ sentinel and community-based epidemiological surveillance and participatory research methods to evaluate whether a person-centered, rapid COVID-19 testing intervention (at-home swab and send, or on-site point of  care testing), coupled with a novel mobile health (mHealth) COVID-19 Literacy and Outreach Suite of apps and videos, and will serve to increase the","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002761.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Addressing COVID-19 Testing Disparities in Vulnerable Populations    Using a Community JITAI (Just in Time Adaptive Intervention)    Approach-A UTHealth CTSA Program","The novel coronavirus that causes COVID-19 has negatively impacted global health status and economies worldwide. In the USA, vulnerable populations experience significant disparities in terms of both infection and mortality  rates, especially in the State of Texas, where Hispanic, African American, and other groups have experienced substantial disparities in both","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002760.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    COVID Self-Testing Through Rapid Network Distribution (C-STRAND)","COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic and has exacerbated existing health inequities among vulnerable populations. Despite higher rates  of COVID-19 in Black and Latinx individuals compared to White individuals, rates of testing in predominately non-White, low-income communities are","Not Applicable","COVID-19","Clinical Trial","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002759.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Assessing Testing Strategies for Safe Return to K-12 Schools in an    Underserved Population","Children with intellectual and developmental disabilities (IDD) are at major risk of irreversible harm from the Coronavirus Infectious Diseases 2019 (COVID-19) pandemic, particularly those from underserved populations. Not only are  they at dramatically higher risk of becoming infected with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and death from COVID-19, but","Not Applicable","COVID-19","Case-Control","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002747.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): COVID-19    Detection through Scent Analysis with a Compact Gas Chromatography    Device","Recent studies, including ours, have suggested that a person's breath may used to diagnose COVID-19 infection and even to monitor its progress. In contrast to immunological and genetic based methods  that use sample media like blood, nasopharyngeal swabs, and saliva, breath analysis is non-invasive, simple, safe, and inexpensive; it allows a","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002745.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Epidemiologic Intelligence Network (EpI-Net) to Promote COVID-19    Testing and Prevention Practices Among Socially Vulnerable Communities    in Puerto Rico","In Puerto Rico (PR), the first COVID-19 case was confirmed early March 2020. To date cases have exponentially increased partly due to the lifting of locked-down restriction by the PR  government, limited COVID-19 testing, and contact tracing. Puerto Ricans living on the island are particularly vulnerable to the current overlapping","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002744.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Rolosense: An    Innovative Platform for Automatic Mobile Phone Readout of Active    SARS-CoV-2","The ultimate goal of this proposal is to develop a novel platform technology for automatic surveillance and tracing of airborne SARS-CoV-2 virus particles in real time. The centerpiece of this  proposal is the ""Rolosense"" technology, which leverages a DNA micromotor as the virus sensing and transduction material (VSTM) that can be detected","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002743.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Addressing Low-Income Housing Resident Mistrust in COVID-19 Guidance","The purpose of this project is to study how perceived legitimacy of important institutions and mistrust in sources of COVID-19 information affect compliance with public health guidance designed to mitigate  the impact of COVID-19, including maintaining physical distancing, mask wearing, testing, and vaccination. Creating capacity to interact with study","Not Applicable","COVID-19","Control Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002742.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Puipuia le Ola: Increasing Reach and Uptake of COVID-19 Testing Among    Pacific Islanders in Hawaii and Guam","Non-Native Hawaiian Pacific Islanders (PI), defined as indigenous people having origins in Guam, the Commonwealth of the Northern Mariana Islands, American Samoa, Federated States of Micronesia, Republic of the Marshall  Islands and Republic of Palau, have among the highest COVID-19-associated morbidity and mortality rates in the U.S. PI also suffer from medical","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002741.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Community-Engaged Research to Improve the COVID-19 Testing Cascade    Among Underserved Populations in the US Caribbean Territories","SARS-CoV-2, the virus that causes COVID-19, has ravaged underserved and vulnerable populations in the U.S., including in the U.S. territories of Puerto Rico (PR) and the U.S. Virgin Islands (USVI).  Pre-pandemic data from our Eastern Caribbean Health Outcomes Research Network (ECHORN) Cohort Study (ECS) (NIH/NIMHD U24MD006938; Pl: Nunez-Smith)","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002740.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Support for Safe Return to In-Person School: COVID-19 Testing,    Learning, and Consultation","The School TLC Study will develop and implement COVID-19 testing approaches in highly disadvantaged public school settings that address barriers to testing and returning to in-person school among vulnerable populations.  The study includes a COVID-19 test preference study and formative needs assessment to inform ongoing testing approaches and services to support","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002729.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Improved    Scalability, Sensitivity, and Interpretability of Pathogen Detection,    Including SARS-CoV-2, in Wastewater using High-Throughput, Highly    Multiplexed Digital Array PCR Technology","Presently, the application of molecular technologies, such as, RT-qPCR and digital PCR (dPCR) to quantify SARS-CoV-2 and related targets in wastewater is cumbersome, time consuming, and costly. While progress has  been made in the development of methods and in the interpretation of data, much remains to be improved for the technology to be used as a public","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002720.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Exploring Barriers and Facilitators to Women Who Use Drugs (WWUD)    Awareness, Acceptance and Uptake of COVID-19 Testing (The CARE Study)","In the U.S., women who use illicit drugs (WWUD) have disproportionately high rates of infectious (e.g., HIV, HCV), chronic, and pulmonary diseases that elevate their risk for COVID-19. Their health  and disease profile is driven by enduring social conditions (e.g., scarcity of income, food insecurity, access to health services, housing,","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002713.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Using Health Communication to Increase COVID-19 Testing and    Vaccination in Underserved Populations","Many low-income Americans, racial and ethnic minorities, and other marginalized groups live in information-poor environments, disproportionately exposed to misinformation about COVID-19, and distrusting medical, government, and scientific institutions and leaders.  These and other social, cultural, and behavioral factors pose significant obstacles to public health efforts to increase population testing and","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002709.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Multiparametric    Integrated Molecular Detection of SARS-CoV-2 from Biofluids by    Adapting Single Extracellular Vesicle Characterization Technologies","COVID-19, a global pandemic due to its rapid progression, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are different assays for COVID-19, including nucleic acid, serological,  antigen, and ancillary tests used in hospitals. In this study we will develop a biochip assay that can simultaneously detect SARS-CoV-2 protein and","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002708.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Community-Driven Optimization of COVID-19 Testing to Reach and Engage    Underserved Areas for Testing Equity (CO-CREATE)","UC San Diego's Superfund Research Center (SRC), supported by the NIEHS Superfund Research Program since 2000, is engaged in research and Public Health initiatives that examine the cumulative impacts of  poor nutrition and other health disparities on the etiology of a variety of diseases. The ethnically diverse low-income communities in San Diego we","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002707.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Understanding Factors Influencing COVID-19 Testing and Vaccination in    Immigrant Low-Income and Homeless Populations and Testing Targeted    Interventions","Working with our community partners, we will create and evaluate the impact of a public health intervention in the area of Cumberland County, Maine to provide outreach, testing, and vaccination  education to a large community of immigrants from sub-Saharan Africa, the Middle East, and Central America, higher-risk, low-income people accessing","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002704.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Use of Behavioral Economics in Repeat SARS-CoV-2 Antibody Testing in    Disadvantaged Communities","The rapid spread of the SARS-CoV-2 virus has greatly impacted underserved populations. This project aims to understand social and behavioral determinants of COVID-19 testing, and variations within sub-groups of this  population. In partnership with the largest federally-qualified health center in the United States, we will collect survey data and conduct a","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002702.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): A Scalable    Aptamer-Based Electrochemical Biosensor for Rapid Detection of    SARS-CoV-2 from Saliva","This study is designed to develop an aptamer-based electrochemical detection platform with SARS-CoV-2 as the model system to demonstrate its performance. As this study is a technology development, the data  generated do not involve anything related to human samples or human subjects. The project's goals will be relayed as a data summary in the form of a","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002700.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Nanobody-based    Electrochemical Biosensor for Real-Time Detection of Aerosolized    SARS-CoV2","Coronavirus 2019 (COVID-19) has afflicted 6.2 million Americans and killed 190,000 as of early September 2020 (WHO website); a roughly 3% mortality. Between a shortage in testing and unidentified asymptomatic  individuals, the actual number of those infected could be 6 to 24-fold higher than that reported. SARS-CoV-2 (CoV-2), the virus underlying the","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002699.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): SCENTinel: A    Rapid Smell Test for COVID-19 Surveillance","Smell loss is a predominant symptom of COVID-19, and initial evidence based on self-reports suggests that chemosensory loss is a sensitive predictor of COVID-19 in the general population, more so  than fever. However, given the natural lack of awareness of chemosensory changes, self-reports underestimate the true prevalence of smell loss in","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002689.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): A Rapid Saliva    Antigen Test for SARs-CoV-2 Detection","The pandemic caused by COVID-19 has been associated with a very high disease burden as well as high global financial costs. With this pandemic came massive shut downs of both  private and public businesses including schools, retail stores, and restaurants. In order to be able to safely open these places of business and have","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002685.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): DNA Star    SAS-CoV-2 Rapid Test","Automated, rapid diagnostics with little sample collection and preparation are needed to identify and trace affected persons in times when hyper-infectious pathogens cause pandemics. Frequent, low cost and highly scalable  testing is the only way to gain visibility on the magnitude of the pandemic and ultimately control the spread of the disease. We propose the","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002679.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Wastewater    Detection of COVID-19","When faced with a pandemic such as SARS-Coronavirus-2 (SAR-CoV-2), the virus responsible for COVID-19, timely risk assessment and action are required to prevent public health impacts to entire communities. Because  infected individuals may not have access to testing or may be asymptomatic, a proactive approach to detect the virus and to develop public health","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002662.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Developing Novel Strategies to Increase COVID-19 Testing Among    Underserved and Vulnerable Populations in West Virginia through    Community and State Partnerships","West Virginia (WV) is rated by Becker's Hospital Review as the state with the sixth most vulnerable population to the novel coronavirus (SARS CoV-2) while a second group at Wallethub,  using three key domains (medical, housing, financial), rates WV as the most vulnerable state to SARS CoV-2 impact. Central to the state's extreme","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002661.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Back to ECE Safely with SAGE: Reducing COVID-19 Transmission in    Hispanic and Low-Income Preschoolers","The overarching goal of this study is to determine the acceptability, feasibility, efficacy, and scalability of back-to-early childhood education (ECE) testing in young children (3-5 years). We will also determine  whether outdoor garden-based education can help close the education gap experienced by children who have been out of school during the pandemic. The","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002660.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Juntos (Together): A Community-Led Approach to Enhance COVID-19    Testing Among Vulnerable Latinos","Latinos are among the most heavily impacted communities by the COVID-19 pandemic in the U.S., with rates more than 3 times higher than among non-Hispanic whites. To address this disparity,  this team of investigators and community partners has established a multi-pronged approach that leverages the skill set of trusted","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002658.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    LITE CONNECT: Addressing Testing Gaps and Epidemiologic Disparities of    COVID-19 Among Transgender People in the United States","Transgender (TG) people are an NIH-designated health disparities population with high morbidity and mortality across multiple health conditions, including HIV infection, mental health, and substance use. These conditions are a  product of, and exacerbated by, historical and ongoing discrimination and inequities in access to healthcare. In early 2020, Severe Acute Respiratory","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002657.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Early Detection,    Containment, and Management of COVID-19 in Dialysis Facilities Using    Multi-Modal Data Sources","With older age and multiple comorbidities, dialysis patients are at high risk for serious complications, even death, from COVID-19. There is a large disproportionate representation of minorities, especially Blacks and  Hispanics. Over 85% of hemodialysis patients travel three times a week to dialysis facilities to receive life-sustaining treatments and cannot","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002651.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Community-Engaged Research on COVID-19 Testing Among Underserved    and/or Vulnerable Populations","The SARS-CoV-2 virus, responsible for the COVID-19 pandemic, has caused disastrous and unprecedented public health and economic consequences in the U.S., seriously affecting Americans' physical and mental health. Death rates  attributable to COVID-19 among minority populations are several-fold higher than among predominantly White counties. South Florida, and specifically","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002650.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Building Resiliency and Vital Equity (BRAVE)","This project will collaboratively partner with American Indian populations to establish COVID-19 services and resources for American Indian communities. The Building Resilience and Vital Equity (BRAVE) project seeks to partner  with American Indian tribal communities in North Carolina to establish COVID-19 services and resources for American Indian communities. The goal of","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002649.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Communities Fighting COVID-19","Given observed disparities in COVID-19 morbidity, hospitalization, and mortality across race, ethnicity, and socioeconomic status, there is a great need to increase testing access and uptake with rapid return of  test results. We propose a community health worker (CHW)-led approach to facilitate COVID-19 testing for underserved populations, with a focus on","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002648.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Keeping Rural Minority 'Essential' Workplaces Open Safely During the    COVID-19 Pandemic: The Role of Frequent Point-of-Care Molecular    Workplace Surveillance for Miners (The Miners' Pandemic Project)","There are limited studies on the spread of SARS-CoV-2 infection in rural essential workers. This gap in knowledge must be addressed to develop and implement novel pandemic strategies to keep  rural essential workplaces open, such as coal mines. The long-term goal of the study is to mitigate the spread of the pandemic in miners, a","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002647.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Supporting COVID-19 Prevention and Testing for Marginalized and    Minoritized Youth and Young Adults","This project will use a geographically diverse quantitative survey to assess patterns and disparities in COVID-19 testing and preventive behaviors longitudinally across 6 months, as well as survey the impact  of multilevel factors, including stigma and policy. Informed by the results of this survey, and guided by the Information, Motivation, and Behavioral","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002645.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Alive Church Network: Increasing COVID-19 Testing in Chicago's African    American Testing Deserts","The epidemic of novel coronavirus disease 2019 (COVID-19) has caused an unprecedented public health crisis in the United States. African Americans (AA) have been disproportionately impacted, as systemic inequities have  contributed to increased exposure and vulnerability to COVID-19. Evidence suggests that AAs are delaying testing and care for COVID-19, which","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002644.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Randomized COVID-19 Testing in Vulnerable Communities and Risk Tool    Creation (FightCOVIDMKE)","Fight COVID MKE will use randomized COVID antibody testing in Milwaukee County, Wisconsin to measure the population proportion infected and how this proportion varies over time and with patient demographic  and health characteristics. Through partnerships with 20 primary care health centers and with local churches and community agencies to conduct","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002643.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    COVID-19 Large Network Center","Ohio includes a very diverse population, with many minority, underserved, and vulnerable communities (MUVP). The need to increase testing in Ohio's MUVP is great - testing rates are only at  2.0 per 1000, with positivity rates indicating active community spread. With rapidly rising infection rates, ways to curb infection and","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002642.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): A    Confectionary-Based Screening Tool for Assessing Chemosensory Loss in    COVID-19 Patients","The goals of this Emergency Competitive Revision are to develop (Aim 1) and deploy (Aim 2) a novel, objective, psychophysical smell and taste screening test to detect the onset of  COVID-19 in at-risk populations. Complementary to the temperature screening procedures currently in use, this tool is predicted to promote early","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002634.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    COVID-19 Treatment Cascade Optimization Study","This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable  population. This study uses an integrated research collaborative framework that facilitates dialogue among researchers, community members, and","Not Applicable","COVID-19","Clinical Trial","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002633.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Transforming Community Engagement to Increase SARS-CoV-2 Testing in    Underserved Populations in Baton Rouge (TEST UP-BR)","In the US, COVID-19 has unveiled a disproportionate health burden in low income and underserved segments of society. In Louisiana, some of the greatest health and economic consequences are evident  in Black communities. There is an urgent need to establish effective testing strategies in these communities as the Fall/Winter virus surges unfold.","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002631.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Rapid Olfactory    Tools for Telemedicine-Friendly COVID-19 Screening and Survey","The COVID-19 pandemic is the most devastating infectious disease outbreak in a century, particularly in underserved and minoritized communities. In 2020 alone, it costed a million lives. It continues to  wreak economic havoc worldwide. Therefore, it is critical to develop new tools that can mitigate the spread of SARS-CoV-2, the virus that causes","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002619.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Improving the Response of Local Urban and Rural Communities to    Disparities in Covid-19 Testing","Local health departments are employing widely varying approaches to address the dramatic health inequities associated with the COVID-19 pandemic. Learning collaboratives have been effective in other settings for bringing entities  together to support joint problem solving and reduce variance in approach. These collaboratives build upon shared experiences to help their members","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002618.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Rapid Acceleration of Acceptable COVID Testing and Care Options for    NYC Public Housing Residents (RADx NYCHA)","The Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative supports supplements to individual NIH awards to increase COVID-19 testing among underserved populations. Leveraging the infrastructure of a current project  in NYC (National Cancer Institute, R01CA220591, ""Evaluation of Smoke-Free Housing Policy Impacts on Tobacco Smoke Exposure"") and a longstanding set","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002616.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Bridging the Evidence-to-Practice Gap: Evaluating Practice    Facilitation as a Strategy to Accelerate Translation of a    Systems-Level Adherence Intervention into Safety Net Practices/Project    Evidence","The COVID-19 pandemic is a major public health crisis, revealing deep and persistent racial/ethnic disparities in health. In New York City (NYC), one of the most affected cities in the  U.S., Black and Latinx communities suffered the highest rates of hospitalizations and mortality from COVID-19. Age-adjusted death rates for Blacks","Not Applicable","COVID-19","Cross-Sectional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002609.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Identifying    Biomarker Signatures of Prognostic Value for Multisystem Inflammatory    Syndrome in Children (MIS-C)","The purpose of this study is to develop a tool that can diagnose multisystem inflammatory syndrome in children (MIS-C.) Some children and young adults who have had Covid-19 develop this  rare disease about a month after they recover. It can be serious as it causes inflammation in various organs, including heart, lungs, kidneys, brain,","Not Applicable","COVID-19","Case-Control","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002608.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Increasing Representation of Black Communities in SARS-CoV-2    Serosurveys by Understanding Barriers and Motivations for    Participation (Represent ATL)","Racial minorities have disproportionate risk for SARS-CoV-2 diagnoses and adverse outcomes including death. Burden of disease in Black populations is likely underestimated due to sub-optimal access to, and usage of,  SARS-CoV-2 testing. Serosurveys, which use probability-based methods to select persons for SARS-CoV-2 testing and an accompanying survey, have","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002604.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Tracking the    COVID-19 Epidemic in Sewage (TRACES)","Wastewater based testing (WBT) holds great promise for cost-effective population surveillance and transmission tracking of SARS-CoV-2, but optimal sampling modalities and protocols are unknown. Taking advantage of a diverse inner  city urban campus encompassing undergraduate, postgraduate dorms, research buildings and medical facilities, this project includes optimization of","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002603.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Diagnosis of    MIS-C in Febrile Children","The recent emergence of SARS-CoV2 and resultant pandemic of COVID-19 disease has overwhelmed global health systems and led to over 200,000 American deaths to date. While initial reports suggested that  SARS-CoV-2 infection in children was generally being, a novel post-inflammatory syndrome known as multi system inflammatory syndrome in children","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002602.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Virus Counter:    Rapid and Sensitive Diagnostics Based on Digital Detection of    Individual Pathogens","To help diversify the approaches that can be used to sensitively detect SARS-CoV-2 and improve response resilience, we will pivot an established virus detection system that has already shown the  ability to detect viruses such as Ebola and Marburg viruses, and develop a focused assay for SARS-CoV-2. In parallel, we will prototype rapidly","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002601.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Community Network-Driven COVID-19 Testing of Vulnerable Populations in    the Central US (C3)","Community network-driven COVID-19 testing of vulnerable populations in the Central US (C3) will implement and evaluate a COVID-19 testing approach that combines an evidence-based Social Network Testing Strategy (SNS) with  community developed COVID-19 public health messages (SNS+). C3 will engage two disenfranchised populations across rural and urban sites in states","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002600.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Portable GC    Detector for COVID Diagnostics","The data herein combines GC-MS and GC-DMS analysis of exhaled breath vapor compounds. The intent of this study is to develop a portable GC-DMS system to diagnose SARS-CoV-2 infections from  a breath sample. The data was collected from hundreds of subjects in an IRB-sanctioned study. Breath vapor samples were collected from COVID-19(+)","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002588.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Effective,    Reagent-Free Detection of the Odor Signature of COVID-19 Infection    Using a Nano-Enabled Sensor Array","COVID-19 presents a public health emergency. There is a critical need for rapid, not reagent intensive, non-invasive testing technologies. This program will lead to the production of a prototype system  to diagnose COVID-19 infection using the body odor signature of the disease. Our goal is to maximize societal impact by creating a validated","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002585.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): AICORE-kids","This work is directed at characterizing pediatric COVID-19 and stratifying incoming patients by projected (future) disease severity. Such stratification has several implications: immediately improving treatment planning, and as disease mechanistic  pathways are uncovered, directing treatment. Predicting future severity will inform the risks of outpatient treatment - to the patients themselves,","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002584.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Scaling Up SARS-COV-2 Testing to Serve Latinx Communities","The global SARS-CoV-2 pandemic that causes the severe respiratory illness COVID-19 is the worst health crisis the United States has faced in a century. Although this highly contagious virus has  infected millions of Americans already, the disease burdens are disproportionately born by historically underserved populations such as Latinx","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002583.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): A Rapid    Breathalyzer Diagnostics Platform for COVID-19","We propose to develop a novel testing platform that detects SARS-CoV-2 virions in a patient's breath. When a person exhales into the COVID breathalyzer, droplets and other emitted particles are  captured by a liquid impactor inside the collection unit. Subsequently, the captured particles are deposited onto a microfluidic chip that contains","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002582.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Understanding the COVID-19, Racism, and Violence Syndemic and its    Effects on COVID-19 Testing Disparities","Black communities in the US are experiencing three converging public health crises: COVID-19, systemic racism, and community and police violence. Black Americans are significantly less likely to receive a needed  COVID-19 test and have higher rates of COVID-19 infection and death than white Americans. Additionally, Black communities have experienced a surge in","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002581.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Adapting Community-Based Task-Shifting for the COVID-19 Response Among    Underserved Populations in Piedmont, North Carolina (ACT UP)","In North Carolina and nationally, Black and Hispanic/Latinx communities have been disproportionately affected by COVID-19 due to multi-level risk factors and barriers to testing, prevention, and care, but have not  benefited from a clinical and public health response commensurate with the magnitude of the problem. To address this, we propose to adapt a proven","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002578.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx - UP):    COVID-19 Testing and Linkage to Care with African American Church and    Health Agency Partners","This 2-arm clustered, randomized community trial will test a multi-level, COVID-19 testing and linkage to care (eg, health insurance, medical appointments, community resources, contact tracing) intervention against a non-tailored, attention-control  condition on uptake of COVID-19 testing with adult African American church-affiliated members at 6 months. Contact tracing approval (beliefs and","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002575.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    SCALE UP Utah: A Community-Academic Partnership to Address COVID-19    Among Utah Community Health Centers","Racial/ethnic minority, low socioeconomic status (SES), and rural populations suffer profound health inequities across a wide variety of diseases and conditions, as well as a disproportionate burden of the negative  health consequences of the COVID-19 pandemic. Latinos make up 14% of the Utah population vs. 40% of Utah's COVID-19 cases, and the case rate is over","Not Applicable","COVID-19","Interventional","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002573.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Detection and    Automatic Privacy-Protected Contact Tracing System Designed for    COVID-19","The goal of the project is to develop a pipeline for automatic detection and tracing of active SARS-CoV-2 infection in a cost-effective, highly accurate, real-time, portable, and super-encrypted manner. Our  integrated approach first captures viral particles from patient samples to activate fluorescence reporters, followed by signal detection using a","Not Applicable","COVID-19","Case-Control","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002572.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): A SARS-CoV-2    Breathalyzer for Direct Virus Detection","A substantial and growing body of evidence has demonstrated that COVID-19 is transmitted by human-emitted airborne particles; therefore, it is critical to rapidly screen individuals to determine whether they are  at risk of transmitting the disease to others before they enter large venues (e.g., airports, schools), and smaller ones where extended exposure or","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002570.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): A Multimodal    Platform for Oral Screening of COVID-19","This project will develop a multiplexed sensor platform based on nanomaterials capable of rapid simultaneous detection of multiple components of viral particles in a field-applicable electrochemical device. The device has  synthetic biosensors that, in a multimodal, rapid, accurate, inexpensive, field-deployable test, will detect multiple SARS-CoV-2 biomarkers. Note for","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002569.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): COVID-19 Network    of Networks Expanding Clinical and Translational Approaches to Predict    Severe Illness in Children (CONNECT to Predict SIck Children)","This study's objective is to understand which children are at the highest risk for experiencing severe consequences from SARS-CoV-2 infection. The study will use clinical, epidemiologic, and sociodemographic data, alongside  specific biomarkers, and create machine-learning models designed to predict severe consequences. In order to accomplish this, we will establish a","Not Applicable","COVID-19","Case-Control","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002568.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Reaching Communities through the Design of Information Visualizations    (ReDIVis) Toolbox for Return of COVID-19 Results (RCR)","The overall goal of Reaching Communities through the Design of Information Visualizations (ReDIVis) Toolbox for Return of COVID-19 Results (RCR) is to decrease health disparities related to COVID-19 by enabling  widespread use of culturally congruent and health literate infographics to return the results of SARS-CoV-2 diagnostic and antibody testing in a","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002567.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): NJ    HEROES TOO: New Jersey Healthcare Essential Worker Outreach and    Education Study Testing Overlooked Occupations","The COVID-19 pandemic disproportionately impacts members of under-represented minority (URM) communities. Unfortunately, URM and other vulnerable communities remain profoundly under-tested. As such, new approaches are needed to disseminate and accomplish  testing that could be generalized across the US. New Jersey can serve as a unique, virtual testing laboratory, ranking 11th in the US in population,","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002565.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad):    Touchscreen-Compatible, Real-Time Electrochemical Sensing of    SARS-CoV-2","We are developing an electrochemical assay for detecting SARS-CoV-2. We will be generating data that includes a signal for a given virus or spike (S) protein concentration, as well as  binding constants for molecular recognition agents. Note for data in RADx: Instructions for requesting individual-level data are available on RADx","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002563.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): A Handheld    Microchip for GC Analysis of Breath to Screen for COVID-19","The COVID-19 pandemic has caused unprecedented societal suffering and economic disruption. Although current COVID-19 diagnostic testing technologies are critical for curbing the spread of the virus and preventing future outbreaks,  they are not practical for field use. Current diagnostic tests are cumbersome to perform because they use aqueous solutions, require multiple steps,","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002561.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): A Rapid,    Sensitive, Point-of-Care, Antigen-Based Diagnostics for SARS-CoV-2","A rapid, sensitive, low-cost diagnostic device for early detection of novel Coronavirus Disease (COVID-19) could significantly change the paradigm in real-time and efficient management of patients and available healthcare resources,  specifically during this time of increased demand for hospital services. The quantitative real-time polymerase chain reaction (qPCR) represents the","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002553.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Characterization    of Multisystem Inflammatory Syndrome in Children and its Relationship    to Kawasaki Disease","As the COVID-19 pandemic evolved in early 2020, case reports appeared describing children with unusual febrile illnesses with elevated inflammatory markers and multi-system involvement that is now termed Multisystem Inflammatory  Syndrome in Children (MIS-C). The illness occurs weeks following exposure to SARS-CoV-2 and these children have a wide spectrum of disease severity,","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002551.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Marshallese:    Alternate Surveillance for COVID-19 in a Unique Population","Marshallese Pacific Islanders bear a disproportionate burden of COVID-19 infection, hospitalization, and death, with rates 4 to 25 times higher than those of other US racial and ethnic groups in  the Continental US. For example, in Northwest Arkansas Marshallese people represent less than 3% of the total population, but they account for 1 out","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002550.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Direct    Bioelectronic Detection of SARS-CoV-2 From Saliva Using Singlemolecule    Field-effect Transistor Array","Nucleic acid test-standard for diagnostics testing for COVID-19, usually performed in specialized laboratories. Most are based on reverse-transcription quantitative polymerase chain reaction (qRT-PCR). The time required for specimen transport and  processing results in a turnaround time that is typically several days. The few rapid ( 1hour) point-of-care (POC) tests are more expensive, still","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002549.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Severity    Predictors Using Immunology and Transcriptomics in Saliva Using Multi    Neural Network Intelligence in SARS-CoV2 Infection in Children (SPITS    MISC)","Children have been disproportionately less impacted by the Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SAR-CoV-2) compared to adults. However, severe illnesses including Multisystem  Inflammatory Syndrome (MIS-C) and respiratory failure have occurred in a small proportion of children with SARS-CoV-2 infection. Nearly 80% of","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002546.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Development of an    Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable    Areas","The devastation caused by emerging pathogens with fast transmission capacity, such as SARS-CoV-2, has demonstrated the importance of preparedness for future viral outbreaks; this includes the ability for fast deployment  of in-situ testing tools and epidemiological surveillance with high temporal and spatial resolution; particularly in places that are most vulnerable","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002544.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): AFS/SERS    Saliva-Based SARS-CoV-2 Earliest Infection and Antibodies Detection","This U18 application is responsive to the NIH's RADx-rad Emergency Response to the COVID-pandemic for new or non-traditional technologies developed to single extracellular vesicle, exosome and extracellular RNA (exRNA) isolation  and analysis and reposition them for detection of SARS-CoV-2. The applicant's group is a grantee in the NIH Common Fund ""Extraceullar RNA","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002543.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Minimal    False-Alarm Touch-Based Detection of SARS-CoV-2 Virus Particles Using    Poly-Aptamers","Reliable real-time detection of SARS-CoV-2 virus represents a considerable challenge, with available tools requiring extensive sample preparation and/or expensive lab-based equipment to obtain accurate results. The objective in this proposal  is to build a touch-screen sensor array to directly capture, detect, and identify model SARS-CoV-2 virus particles with minimal false alarms. This","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002542.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Wastewater    Assessment for Coronavirus in Kentucky: Implementing Enhanced    Surveillance Technology","Developing next generation technology to simplify wastewater RNA extraction and quantification will make wastewater surveillance feasible and scalable in facilities and rural communities. Wastewater testing for SARS-CoV-2 in rural communities  using field-friendly technology will provide important information to local authorities and citizens about the spread and trend of SARS-CoV-2","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002527.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Bioinformatics    Framework for Wastewater-based Surveillance of Infectious Diseases","COVID-19 is expected to become one of the largest mass casualty events in the history of the United States (U.S.). Assessment of the true burden of disease in the population  is needed for the prevention and mitigation of this and future viral disease outbreaks. Currently, testing of new cases (via swabs / saliva) and","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002526.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Community Driven Approach to Mitigate COVID-19 Disparities in Hawaii's    Vulnerable Populations","The long-term goal of this proposal is to eliminate COVID-19 deiparities among Hawaii's racial/ethnically diverse yet vulnerable populations including Native Hawaiian and other Pacific Islanders (NHPI) living in rural and  underserved communities by integrating innovative SARS-CoV-2 testing capacity with novel community-specific messaging and education. Compounded by","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002525.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): SF-RAD:    Development and Proof-of-Concept Implementation of the South Florida    Miami RADx-rad SARS-CoV-2 Wastewater-Based Surveillance Infrastructure","The University of Miami (UM), with three primary campuses in Miami, Florida, is geographically spread within one of the worst current COVID-19 hotbeds. UM has deployed an elaborate human surveillance  testing, tracking and tracing (3T) system to monitor the student body, faculty, and staff. This 3T system includes a major hospital that is part of","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002524.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Validation of    Smart Masks for Surveillance of COVID-19","Vulnerable populations do not just need testing - they need surveillance. The ideal surveillance tool would operate in the background with minimal involvement of the population to be tested; it  would be simple, affordable, reliable, and accurate. Unfortunately, no such assay yet exists. Here, we propose a ""smart mask"" that changes colors","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002523.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Multi-Modal    Wireless COVID Monitoring and Infection Alerts for Concentrated    Populations","We plan to extend and improve our COH/PHD system in using wearables for the early detection of COVID-19 infection. With the over 5,000 patients who have been recruited in our  original Phase 1 IRB-approved study, we will further optimize our algorithms, especially on its application in individuals with diverse ethnic","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Radical (RADx-rad) Collection of    General Research Use Datasets (phs003834.v1.p1)"
"phs002522.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): MOF-SCENT:    Metal-Organic Frameworks for Screening COVID-19 by Electronic-Nose    Technology to Improve Selectivity and Time Response","This proposal describes the design, fabrication, and proof-of-concept testing of a novel MOF-SCENT system (Metal-Organic Frameworks for Screening COVID-19 by Electronic-Nose Technology) that features the following advantages: (1) Highly selective  and sensitive detection of a variety of VOCs; (2) fast response and recovery time; (3) portable, low-cost, robust, easy-to-use, and deployable in any","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002521.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Creating a Sustainable Infrastructure for SARS-CoV-2 Testing at    Syringe Exchange Programs","This study leverages a current partnership with HIV Alliance - an Oregon-based nonprofit dedicated to supporting individuals living with HIV/AIDS and preventing new HIV infections - to embed a COVID-19  testing program with a brief motivational enhancement intervention in their Syringe Services Programs (SSPs). SSPs offer a natural venue for testing","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002520.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Community Based COVID-19 Testing Evaluation","We have used a community-based participatory research approach guided by the Social Ecological Model to target testing strategies that will have the greatest impact for the Latinx and Marshallese communities  in Northwest Arkansas. Our specific aims are: Aim 1: leverage and fully engage our long-standing community-based partnerships to increase COVID-19","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-12-02","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs002242.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular:    SWISS-AF/SWISS-AF-PVI/BEAT-AF","This study is a part of NHGRI's Centers for Common Disease Genomics (CCDG), which is a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing  to multiple common disease phenotypes. Current estimates anticipate that the CCDG program will sequence approximately 140K whole genomes and 225K","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","NHGRI","DS-DCCA-NPU-MDS --- Disease-Specific (Diabetes mellitus, Circulatory, and/or Cardiovascular Systems Disease. Research excludes children younger than 18 years old., NPU, MDS)","2022-12-01","","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs000483.v1.p1","Massachusetts General Hospital/Eisai NIMH AD Genetics Initiative Study","This study cohort was collected as part of the National Institute of Mental Health (NIMH) Alzheimer's disease Genetics Initiative Study. Recruitment of families, predominantly sibling, for the cohort was focused  on local memory disorder clinics, nursing homes, and the surrounding community. Clinical evaluation was performed at the University of Alabama at","Not Applicable","Alzheimer Disease","Family/Twin/Trios","Affymetrix_500K","SNP Genotypes (Array)","5 phenotype datasets, 25 variables, 1 molecular datasets, 1504 subjects, 1504 samples","","NIMH","ADRD --- Alzheimer's disorder and related disorders","2022-11-30","2022-11-30","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases",""
"phs003027.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Test US Bank Study","This biorepository is being established to obtain, store, and share body fluid samples for SARS-CoV-2 research. Samples will be obtained at the study sites. The overall study duration will be  open ended to allow ongoing enrollment and indefinite storage of samples. There is no limit to the number of volunteers who can consent to","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-22","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Tech Program (RADx-Tech) Collection    of General Research Use Datasets (phs003831.v1.p1)"
"phs003026.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): COVID-19 Test At    Home Efficacy Sub-Study","The FDA has published a safety communication regarding At-Home COVID-19 Antigen Tests (https://www.fda.gov/medical-devices/safety-communications/home-covid-19-antigen-tests-take-steps-reduce-your-risk-false-negative-fda-safety-communication). In support of this notice, a preprint, Performance of Screening for SARS-CoV-2 using Rapid Antigen Tests to  Detect Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infection: findings from the Test Us at Home prospective cohort study | medRxiv","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-22","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Tech Program (RADx-Tech) Collection    of General Research Use Datasets (phs003831.v1.p1)"
"phs002739.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): COVID-19 Test At    Home Feasibility Sub-Study","The purpose of this feasibility study is to gather knowledge that will inform a future larger study using at-home SARS-CoV-2 testing and digital tools. This study will: 1) Test the  feasibility of daily home SARS-CoV-2 testing using the the Quidel QuickVue device; 2) Test whether a smartphone app (CareEvolution MyDataHelps)","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-22","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Tech Program (RADx-Tech) Collection    of General Research Use Datasets (phs003831.v1.p1)"
"phs002738.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Ultra-Sensitive    Immunoassay Test for Quantitation of SARS-CoV-2 Antigen","The 5534 study prospective clinical study seeks to examine the performance of the 5534 device, for the detection of SARS-CoV-2 nucleocapsid protein antigen compared to the Roche 6800 Cobas PCR  for SARS-CoV-2 assay. The goal of the 5534 study is for EUA approval that the device to use among symptomatic persons by trained healthcare personnel","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-22","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Tech Program (RADx-Tech) Collection    of General Research Use Datasets (phs003831.v1.p1)"
"phs002737.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Accurate, Sensitive    and Affordable POC and At Home Testing Device","The purpose of this study is to test the performance of the Saliva Test device in detecting SARS CoV-2 in symptomatic people for Emergency Use Authorization (EUA) as a point-of-care  (POC) test. The 2322 Saliva Test is a rapid real-time RT-PCR test intended for the qualitative detection of RNA from the SARS-CoV-2 virus in saliva","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-22","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Tech Program (RADx-Tech) Collection    of General Research Use Datasets (phs003831.v1.p1)"
"phs002442.v1.p1","Host Response to Respiratory Infections","In this study, we describe a strategy to identify undiagnosed respiratory viral infections through screening nasopharyngeal (NP) swabs for the chemokine CXCL10, which is highly induced in the nasopharynx as  part of the host antiviral response. Using this strategy, we conducted two screens: first, we screened NP swabs collected at Yale New Haven Hospital","Not Applicable","Respiratory Tract Infections","Collection","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 23 samples sequenced, 23 subjects, 23 samples","","NIAID","HMB-IRB --- Health/Medical/Biomedical (IRB)","2022-11-22","2022-11-22","Common Cold; Infection, Respiratory System; Infection, Respiratory Tract; Infections, Respiratory; Infections, Respiratory Tract; RTI - Respiratory tract infection",""
"phs002974.v1.p1","NTM and Healthy Donor Immunology and Genomics","Nontuberculous mycobacterial (NTM) infections are an increasing problem with limited diagnostics and treatments. To better understand NTM pathogenesis, we evaluated responses to Mycobacterium avium complex (MAC) in asymptomatic individuals with  a previous history of MAC lung disease (MACDZ). Peripheral blood monocytes from 17 MACDZ and 17 healthy controls were infected with M. avium for 6","Not Applicable","Mycobacterium Infections, Nontuberculous","Case-Control","Not Provided","Not Provided","Not Provided","","NIAID","","2022-11-21","","Atypical Mycobacterium Infection; Atypical Mycobacterium Infections; Atypical mycobacterial disease; Infection due to non-TB (tuberculous) mycobacteria; Infections, Atypical Mycobacterium; Mycobacterium Infection, Atypical",""
"phs003128.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Mobile Health-Targeted SARS-CoV-2 Testing and Community Interventions    to Maximize Migrant Children's School Attendance During the COVID-19    Pandemic","Prospective, mixed-methods cohort study of children who are eligible, enrolled, or who previously participated in the Nebraska Migrant Education Program (MEP) and their families who consent to enroll in an  mHealth-targeted, in-home SARS-CoV-2 testing and community aid program. Participant caregivers will perform household-level SARS-CoV-2 infection risk","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-21","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003127.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    ReOpening Schools Safely and Educating Youth (ROSSEY)","While public health measures with school closure helped mitigate the spread of COVID-19, Latino children from rural agricultural communities are experiencing learning gaps due to disproportionate access to resources. Analyzing  data collected from SARS-CoV-2 test results of students returning to in-person learning in the Yakima School District, combined with risk","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-21","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003126.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Conducting Correctional COVID Research and Implementing Novel,    Ethically Sound, Sustainable Surveillance Systems (CRAINES)","Throughout the COVID19 pandemic in the U.S., persons in jails have borne a share of disease 3-fold or greater than that seen in the general population. While many cases have  been imported from surrounding communities, crowding in these congregate settings has led to rapid in-house transmission, especially since testing in","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-21","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003125.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    Engaging Church Health Ministries to Decrease SARS-CoV-2 Vaccine    Hesitancy in Underserved Populations in Baton Rouge","In the US, COVID-19 unveiled a disproportionate health burden in low income and underserved segments of society. In Louisiana, some of the greatest health and economic consequences are evident in  our Black communities. Furthermore, despite the widespread availability of SARS-CoV-2 vaccines, approximately 30% of the US population reports that","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-21","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003124.v1.p1","Rapid Acceleration of Diagnostics - Radical (RADx-rad): Exosome-Based    Non-Traditional Technologies Towards Multi-Parametric and Integrated    Approaches for SARS-CoV-2","The urgent need to curb the spread of SARS-CoV-2 demands availability of diagnostics that are more rapid, accurate, sensitive and affordable than qPCR and antibody tests. Current qPCR tests are  specific and sensitive, but lengthy turnaround times limit interventions against disease spread. Antibody testing is faster, but","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","HMB --- Health/Medical/Biomedical","2022-11-21","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs003123.v1.p1","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP):    C2SPARC: Implementing Mobile, POC COVID-19 Testing in Partnership with    a Community-Based Organization to Reach Women Who Use Drugs","Through our RADx-UP Phase I ""CARE"" study, we are examining correlates of point-of-care COVID-19 testing (POCT) uptake at baseline and reuptake at a 3-month follow-up visit among WWUD (N 250)  in Baltimore, MD. In this Phase II, ""C2SPARC"" study, we will examine POCT uptake in both research and service delivery contexts. Specifically, we","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-21","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP)    Collection of General Research Use Datasets (phs003832.v1.p1)"
"phs003079.v1.p1","Spatiotemporal Evolution of the ccRCC Microenvironment Links    Intra-Tumoral Heterogeneity to Immune Escape CINOMA","We utilize temporal multi-regional multi-omics profiling to uncover the mechanisms of immune escape in clear cell renal cell carcinoma (ccRCC) in 29 patients including 17 patients from a neoadjuvant nivolumab  clinical trial. We observe that tumors can be broadly categorized into intra-tumoral heterogeneity (ITH) high and low, which correlates across","Not Applicable","Carcinoma, Renal Cell","Clinical Trial","Not Provided","AMPLICON, RNA-Seq, WXS","4 phenotype datasets, 28 variables, 449 samples sequenced, 29 subjects, 449 samples","","NCI","GRU --- General Research Use","2022-11-21","2022-11-21","ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal Cell",""
"phs002736.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Rapid Manufacturing    Scale-up for Compact Point-of-Care EUA SARS-CoV-2 RT-PCR Test","This prospective clinical study seeks to examine the performance of the device, a sample-to-answer nucleic acid PCR amplification platform solution for the point-of-care (POC) detection of SARS-CoV-2, compared to the  Roche 6800 Cobas PCR for SARS-CoV-2 assay. Secondary outcomes include usability and interpretability of results among POC device operators. The goal","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-21","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Tech Program (RADx-Tech) Collection    of General Research Use Datasets (phs003831.v1.p1)"
"phs002682.v1.p1","Rapid Acceleration of Diagnostics - TECH (RADx-TECH): 2183 SARS-CoV-2    Rapid Antigen Test","There are two device studies under the 2183 banner. The 2183b study uses an enhanced visual display compared to the original study (2183a), so it has been renamed. These prospective  clinical studies seek to examine the performance of the 2183 device (a and b), a lateral flow immunoassay for the point-of-care (POC) detection of","Not Applicable","COVID-19","Methods","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-21","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Tech Program (RADx-Tech) Collection    of General Research Use Datasets (phs003831.v1.p1)"
"phs002236.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular: Genetic and    Phenotypic Determinants of Blood Pressure and Other Cardiovascular    Risk Factors","This study is a part of NHGRI's Center for Common Disease Genomics, which is a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing to  multiple common disease phenotypes. Current estimates anticipate that the CCDG program will sequence approximately 140K whole genomes and 225K whole","Not Applicable","Atrial Fibrillation","Case-Control","Not Provided","Not Provided","Not Provided","","NHGRI","DS-DCCA-NPU-MDS --- Disease-Specific (Diabetes mellitus, Circulatory, and/or Cardiovascular Systems Disease. Research excludes children younger than 18 years old., NPU, MDS)","2022-11-21","","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs002009.v1.p1","Genomic Landscape of Pediatric Germ Cell Tumors","Germ cell tumors (GCTs) are cancers of the testis, ovary and extragonadal sites that occur in infants, children, adolescents, and adults. Post-pubertal (type II) malignant GCTs may present as a  seminoma, non-seminoma or with mixed histologies. In contrast, pre-pubertal (type I) GCTs are limited to (benign) teratomas and (malignant) yolk sac","Not Applicable","Neoplasms, Germ Cell and Embryonal","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 32 samples sequenced, 32 subjects, 32 samples","","NCI","DS-PEDCR --- Disease-Specific (Pediatric Cancer Research)","2022-11-21","2022-11-21","Seminoma; Germ Cell and Embryonal Neoplasms; Germ Cell and Embryonic Neoplasms; Neoplasms, Germ Cell and Embryonic",""
"phs002468.v1.p1","Type 1 Diabetes Genetics Consortium (T1DGC): Multi-Ethnic ImmunoChip    Study","Type 1 diabetes (T1D) is characterized by an autoimmune attack that destroys the insulin-producing pancreatic beta cells and is driven by diverse genetic and environmental factors. Between 8-100 chromosome regions  are known to contain variants that alter T1D risk, substantially fewer than many other common diseases. Less is known about the contribution of T1D","Not Applicable","Diabetes Mellitus, Type 1","Case-Control","Not Provided","Not Provided","1 analyses","","NIDDK","DS-T1DCR-IRB --- Disease-Specific (Type 1 Diabetes, Complications, and Related Traits, IRB)","2022-11-17","2022-11-17","DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes Mellitus, Sudden Onset",""
"phs003035.v1.p1","Genomic Analysis of Nucleic Acid Sequences from Pancreatic Cancer","Our study aims to perform multi-omics analysis of pancreatic ductal adenocarcinoma. We performed dual single-cell RNA sequencing and whole genome sequencing on fresh tumor specimens and dual bulk RNA-sequencing and  16S amplicon sequencing on frozen tumor specimens to identify human and non-human nucleic acid sequences. Additionally, we identified microbial","Not Applicable","Carcinoma, Pancreatic Ductal","Case Set","Not Provided","AMPLICON, RNA-Seq, WGS","4 phenotype datasets, 16 variables, 36 samples sequenced, 12 subjects, 36 samples","","NCI","GRU --- General Research Use","2022-11-16","2022-11-16","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas",""
"phs003068.v1.p1","Nanobody-Tethered Transposition Allows for Multifactorial Chromatin    Profiling at Single-Cell Resolution","Chromatin states are functionally defined by a complex combination of histone modifications, transcription factor binding, DNA accessibility, and other factors. However, most current single-cell-resolution methods are unable to measure more  than one aspect of chromatin state in a single experiment, limiting our ability to accurately measure chromatin states. Here we introduce","Not Applicable","Immune System","Methods","custom_markerset","OTHER, Chromatin (NGS)","3 phenotype datasets, 8 variables, 1 molecular datasets, 1 samples sequenced, 1 subjects, 1 samples","","NHGRI","GRU-NPU --- General Research Use (NPU)","2022-11-15","2022-11-15","Not Provided",""
"phs003095.v1.p1","Transcriptomic Analysis of HIV-Infected Cells","Defining the attributes of rare CD4 T cells that harbor latent HIV under therapy with anti-retroviral agents has been challenging due to difficulties in identifying and isolating these cells. These  cells represent an important barrier to cure, and characterizing them would aid the design and development of novel HIV cure strategies. In this","Not Applicable","HIV","Cross-Sectional","Not Provided","RNA-Seq","4 phenotype datasets, 21 variables, 148 samples sequenced, 11 subjects, 148 samples","","NIAID","DS-HIV-IRB-NPU --- Disease-Specific (Human Immunodeficiency Virus, IRB, NPU)","2022-11-14","2022-11-14","Not Provided",""
"phs002996.v1.p1","Biological Determinants of Peritoneal Dialysis Outcomes","Peritoneal Dialysis (PD) is a technique for treating kidney failure where fluid is instilled into the body's peritoneal cavity. Fluid and solutes travel across the peritoneum, and this is critical  to successful PD. Studies have shown that certain demographic and clinical variables explain a small part of the variability in baseline peritoneal","Not Applicable","Peritoneal Dialysis","Cross-Sectional","imputation_panel","SNP Genotypes (imputed)","4 phenotype datasets, 29 variables, 1 molecular datasets, 827 subjects, 827 samples","European (426), African (5), East Asian (56), African American (134), Hispanic1 (8), Hispanic2 (107), Other Asian or Pacific Islander (49), South Asian (27), Other (15)","NIDDK","GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2022-11-14","2022-11-14","Not Provided",""
"phs002840.v1.p1","The Transcriptomic Landscape of Oncogenic PI3K Reveals Key Functions in    Splicing and Gene Expression Regulation","This study includes RNA-seq of paired tumor biopsies from PIK3CA-mutated breast cancer patients that underwent treatment with PI3K&#x003b1; inhibitors. Patients with known PIK3CA mutations were enrolled in an open-label, phase  I dose-escalation study of oral daily GDC-0077 alone (Arm A), in combination with endocrine therapy with or without palbociclib (Arm C: GDC-0077 +","Not Applicable","Breast Neoplasms","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 36 samples sequenced, 18 subjects, 36 samples","","NCI","DS-BRCA --- Disease-Specific (Breast Cancer)","2022-11-14","2022-11-14","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002652.v1.p1","Identification of Somatic Changes in Tumors from Fanconi Anemia Patients","This study focused on the identification of genomic signatures present in tumors from Fanconi anemia patients. Fanconi anemia is a rare hereditary disease caused by defects in DNA interstrand crosslink  repair. The primary patient phenotypes are bone marrow failure and cancer predisposition. We concentrated on squamous cell carcinomas and used whole","Not Applicable","Fanconi Anemia","Tumor vs. Matched-Normal","MethylationEPIC","Methylation (CpG), OTHER, RNA-Seq, Synthetic-Long-Read, WGS, WXS","6 phenotype datasets, 56 variables, 1 molecular datasets, 1 images, 131 samples sequenced, 46 subjects, 137 samples","","NCI","GRU --- General Research Use","2022-11-14","2022-11-14","DNA Damage; Genomic Instability; DNA Injuries; DNA Injury; DNA Lesion; DNA Lesions","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000981.v1.p1","Effect of LGG Probiotic as Immune Adjuvant","Double blind Randomized Controlled trial to evaluate the safety of Lactobacillus rhamnosus GG ATCC 53103 (LGG) vs placebo in elderly receiving Trivalent Inactivated Influenza Vaccine (TIV) (study 1) or Double  blind Randomized Controlled trial to evaluate the safety of Lactobacillus rhamnosus GG ATCC 53103 (LGG) vs. placebo in elderly subjects receiving","Not Applicable","Healthy Volunteers","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","6 phenotype datasets, 33 variables, 2 documents, 255 samples sequenced,  SRA, 57 subjects, 255 samples","","NCCIH","GRU --- General Research Use","2022-11-07","2022-11-07","Not Provided",""
"phs002718.v1.p1","Genetics of Prostate Cancer in Africa","African Americans (AA) suffer from the highest rates of Prostate Cancer (CaP) in the world, but while men of African descent around the world suffer disproportionately from CaP compared to  men of other races or ethnicities, our understanding of the reasons for these disparities remains incomplete. To date, few exposure, lifestyle, or","Not Applicable","Prostatic Neoplasms","Case-Control","MADCaP_Array, imputation_panel","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 17 variables, 1 documents, 2 molecular datasets, 4728 subjects, 4728 samples","","NCI","GRU --- General Research Use, DS-CA-IRB --- Disease-Specific (Cancer, IRB), DS-PC --- Disease-Specific (Prostate Cancer)","2022-11-04","2022-11-04","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs003043.v1.p1","A Pilot Study to Evaluate Tissue- and Plasma-based DNA Driver Mutations    in a Cohort of Patients with Pancreatic Intraductal Papillary Mucinous    Neoplasms","This is a retrospective study aimed at evaluating concordance between intraductal papillary mucinous neoplasm (IPMN) tissue and patient-matched plasma circulating tumor DNA (ctDNA) using a targeted sequencing approach. Archival solid  tissue genomic DNA was available for 46 patient FFPE blocks patient-matched plasma ctDNA was available from 15 of those patients. All tissues were","Not Applicable","Pancreatic Intraductal Neoplasms","Tumor vs. Matched-Normal","Not Provided","Targeted-Capture","4 phenotype datasets, 14 variables, 61 samples sequenced, 46 subjects, 61 samples","","NCI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2022-11-03","2022-11-03","Cyst, Pancreatic; Intraductal Neoplasm, Pancreatic; Cyst of Pancreas; Cyst of the Pancreas; Cysts, Pancreatic; Multiple pancreatic cysts",""
"phs002106.v1.p1","Epigenetic Mechanisms of Inflammation and Fatigue in Head and Neck Cancer","This was a longitudinal observational study to examine the association between fatigue and DNA methylation as well as gene expression among patients with head and neck cancer. Demographic and clinical  variables were collected before chemoradiotherapy and/or at follow-up visits as appropriate. Fatigue was assessed and biosamples (for DNA methylation","Not Applicable","Fatigue","Prospective Longitudinal Cohort","Clariom_S_Assay, MethylationEPIC","Methylation (CpG), mRNA Expression (Array)","4 phenotype datasets, 35 variables, 1 documents, 1 molecular datasets, 60 subjects, 216 samples","","NINR","GRU-NPU --- General Research Use (NPU)","2022-11-03","2022-11-03","",""
"phs001971.v1.p1","Kidney Two-Hit Mapping","Germ-line genetic variants identified thus far generally account for only part of the genetic risk predicted for most cancers. A component of the remaining risk may be explained by functionally  consequent genetic variants that are individually very rare (or private to that individual's family). While their identification may be highly","Not Applicable","Kidney Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 13 variables, 108 samples sequenced, 57 subjects, 108 samples","","NCI","DS-KD --- Disease-Specific (Kidney Disease)","2022-11-03","2022-11-03","Kidney Tumor; Kidney cancer; Kidney neoplasm; Neoplasia of the kidneys; Neoplasm of Kidney; Neoplasm of the Kidney",""
"phs003020.v1.p1","Molecular Analysis of Short- Versus Long-Term Survivors of High-Grade    Serous Ovarian Carcinoma","The underlying determinants for long-term survival (LTS, &#x02265;10 years) versus short-term survival (STS, 3 years) of patients diagnosed with high-grade serous ovarian carcinoma (HGSC) are largely unknown. The present study  sought to identify molecular predictors of LTS for women with HGSC. A cohort of 24 frozen HGSC samples (12 LTS and 12 STS) were collected and","Not Applicable","Survival Analysis","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 15 variables, 69 samples sequenced, 24 subjects, 69 samples","","NCI","HMB-IRB-PUB-COL --- Health/Medical/Biomedical (IRB, PUB, COL)","2022-11-02","2022-11-02","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian",""
"phs002628.v1.p1","Rapid Acceleration of Diagnostics - Digital Health Technologies    (RADx-DHT): NIH Digital Health Solutions for COVID-19: Clear2Go - A    Digital Identity Wallet for Health Status","Clear2Go is a solution/app that provides digital, non-refutable cryptographic proof of testing or vaccination that can be used to evaluate risk of allowing individuals to return to normal work, travel,  and public life activities. It is a mobile service that maps a person's vetted identity and biometrics to the phone and then cryptographically binds","Not Applicable","COVID-19","Clinical Trial","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-01","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Digital Health Technologies'    (RADx-DHT) Collection of General Research Use Datasets (phs003666.v1.p1)"
"phs002540.v1.p1","Rapid Acceleration of Diagnostics - Digital Health Technologies    (RADx-DHT): NIH Digital Health Solutions for COVID-19: SAFER-COVID -    Integration of Testing and Digital Health","SAFER-COVID provides a set of self-management tools to consumers to track symptoms, test results, vaccine record, and environmental factors, such as exposure to others. Consumers may choose to integrate data  from wearables and electronic health records (EHR) for self management. These data are used to enable multiple use cases such as return-to-work,","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-01","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Digital Health Technologies'    (RADx-DHT) Collection of General Research Use Datasets (phs003666.v1.p1)"
"phs002539.v1.p1","Rapid Acceleration of Diagnostics - Digital Health Technologies    (RADx-DHT): Large Scale Flu Surveillance Study (LSFS)","The purpose of this study was to better understand behavioral and physiological functioning in relation to recent self-reported influenza and influenza-like-illness (ILI), including coronavirus disease (COVID-19). Over 65,000 Achievement members  responded to a weekly one-click survey asking if they had experienced ILI within the previous 7-day period. If they responded no, they were given the","Not Applicable","COVID-19","Collection","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-01","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Digital Health Technologies'    (RADx-DHT) Collection of General Research Use Datasets (phs003666.v1.p1)"
"phs002538.v1.p1","Rapid Acceleration of Diagnostics - Digital Health Technologies    (RADx-DHT): ILI Labels and Longitudinal Novel Engagement with Symptom    Surveillance (ILLNESS) Study","This study is a prospective observational study, approximately seven months in duration. Participants were asked to complete a weekly survey online asking about their ILI (influenza-like illness) experience over the  past seven days. The primary objective of this study was to collect a population-wide, longitudinal dataset of ILI events (with onset and recovery","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-01","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Digital Health Technologies'    (RADx-DHT) Collection of General Research Use Datasets (phs003666.v1.p1)"
"phs002537.v1.p1","Rapid Acceleration of Diagnostics - Digital Health Technologies    (RADx-DHT): COVID-19 Experience Study (C19EX) Survey","This was conducted virtually through the Achievement studies platform during the current COVID-19 pandemic. Participants were asked to complete a survey every day to capture information about whether they had  experienced symptoms corresponding to respiratory, ILI, and COVID-19 infections within the previous 24 hour period, their experiences with the","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-01","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Digital Health Technologies'    (RADx-DHT) Collection of General Research Use Datasets (phs003666.v1.p1)"
"phs002534.v1.p1","Rapid Acceleration of Diagnostics - Digital Health Technologies    (RADx-DHT): NIH Digital Health Solutions for COVID-19: Team SAE","The goal of this project is to develop a smartphone-based platform to monitor and support individuals with COVID-19 symptoms (who may need testing) and those who have already tested positive.  The app will integrate a Bluetooth-enabled thermometer and pulse oximeter into an approach uniquely designed for low-resource settings and","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-01","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Digital Health Technologies'    (RADx-DHT) Collection of General Research Use Datasets (phs003666.v1.p1)"
"phs002533.v1.p1","Rapid Acceleration of Diagnostics - Digital Health Technologies    (RADx-DHT): Digital Health Solutions for COVID-19: COVID Community    Action and Research Engagement (COVID-CARE)","Vibrent Health will expand the Vibrent Digital Health Solutions Platform (DHSP) implementation to additional populations among diverse user groups for additional validation of the technology's performance, usability, and reliability in  refinement of analytics generating predictive algorithms for infection and that support individual, organizational, community and societal-level","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-01","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Digital Health Technologies'    (RADx-DHT) Collection of General Research Use Datasets (phs003666.v1.p1)"
"phs002519.v1.p1","Rapid Acceleration of Diagnostics - Digital Health Technologies    (RADx-DHT): Covidseeker and COVID-19 Citizen Science: Leveraging    Citizen Science and Real-Time Geospatial Temporal Mobile Data for    Digital Contact Tracing and SARS-CoV-2 Hotspotting","The Covidseeker and COVID-19 Citizen Science Study integrates a retrospectively-determined geolocation digital program into an established digital infrastructure housed within the NIH-funded Eureka platform to enroll SARS-CoV-2 positive and negative  individuals. The solution also leverages the ongoing COVID-19 Citizen Science Study cohort both in-person and remotely to test and implement existing","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-11-01","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Digital Health Technologies'    (RADx-DHT) Collection of General Research Use Datasets (phs003666.v1.p1)"
"phs002881.v1.p1","The Pathogenesis and Genetics of Disseminated Coccidioidomycosis","Whole exome sequencing on patients 2 years of age with confirmed disseminated coccidioidomycosis, not undergoing active immunosuppressive therapy, negative HIV status.&#x000a0; Inclusion criteria: To be eligible for this study, potential  participants must meet the following criteria: Age greater than or equal to 2 years old. Enrollment of pediatric patients who are acutely ill or","Not Applicable","Coccidioidomycosis","Case Set","WES_markerset_grc38","SNP/CNV Genotypes (NGS), WXS","3 phenotype datasets, 12 variables, 1 molecular datasets, 67 samples sequenced, 67 subjects, 67 samples","","NIAID","GRU --- General Research Use","2022-10-31","2022-10-31","Valley Fever; California disease; Coccidioides Infection; Coccidioides Infections; Coccidioides immitis caused disease or disorder; Coccidioides immitis disease or disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs003019.v1.p1","Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the    Oral PARP Inhibitor Olaparib in Patients with Recurrent Triple    Negative Breast Cancer or High Grade Serous Ovarian Cancer","We analyzed massive parallel sequence data from patients with breast and ovarian cancer and identified single base substitution mutational signature 3 (Sig3) - extracted using SigMA - as a biomarker  of homologous recombination deficiency (HRD) and predictive for response to PARP inhibitors. Participants were patients enrolled in clinical trials","Not Applicable","Neoplasms by Site","Clinical Trial","Not Provided","WXS","4 phenotype datasets, 24 variables, 38 samples sequenced, 37 subjects, 38 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-10-27","2022-10-27","Neoplasm Site; Neoplasm Sites; Neoplasms by Sites; Site, Neoplasm; Sites, Neoplasm",""
"phs003071.v1.p1","POISED (Peanut Oral Immunotherapy: Safety, Efficacy, and Discovery)","Phase 2 POISED (Peanut Oral Immunotherapy: Safety, Efficacy, Discovery) Study In this randomized, double-blind, placebo-controlled (DBPC) clinical trial, blinded placebo group received oat flour, whereas in active participants, dosage was  built-up for over 52 weeks and subsequently maintained on 4000 mg peanut protein, daily for next 52 weeks. 80 (98.77%) per-protocol active","Not Applicable","Peanut Hypersensitivity","Clinical Trial","WGS_markerset_grc38","SNP Genotypes (NGS)","4 phenotype datasets, 19 variables, 1 molecular datasets, 118 subjects, 118 samples","","NIAID","GRU --- General Research Use","2022-10-24","2022-10-24","Food Hypersensitivity; Allergies, Food; Allergy, Food; Food Hypersensitivities; Food allergies; Food allergy","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002162.v2.p1","Kids First: Genetics of Kidney and Urinary Tract Malformations","Congenital defects of the kidney and urinary tract are a common cause of kidney failure in children and adults and elucidation of the genetics of these disorders will provide new  opportunities for diagnosis, risk stratification and prevention of complications. Around 550 trios were selected for whole genome sequencing as part","Not Applicable","Renal Adysplasia","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1667 subjects, 1673 samples","","NCI","GRU --- General Research Use","2022-10-21","2020-11-25","Hydronephrosis; Vesicoureteral Reflux; Hydronephroses; HEREDITARY RENAL APLASIA; HRA; RENAL AGENESIS","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs003036.v1.p1","Single Cell Genome Variation Induced by Mutational Processes in Cancer -    HGSOC Trios Study","Mutational signatures derived from whole genome sequencing have potential prognostic significance. Identification of high grade serous ovarian cancer patients with deficiency in homologous recombination repair pathways could identify a subset  of patients that would benefit from homologous recombination deficiency-specific treatments independent of identification of a pathological BRCA1/2","Not Applicable","Ovarian Neoplasms","Tumor vs. Matched-Normal","Not Provided","WGS","3 phenotype datasets, 10 variables, 26 samples sequenced, 8 subjects, 26 samples","","NCI","GRU --- General Research Use","2022-10-19","2022-10-19","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian",""
"phs003022.v1.p1","Circulating Tumor DNA Sequencing Provides Comprehensive Mutation    Profiling for Pediatric Central Nervous System Tumors","Tumor molecular profiling is increasingly important for the diagnosis and clinical management of childhood brain tumors, including diffuse midline glioma (DMG). We established a targeted deep sequencing approach using the  TruSight Oncology 500 ctDNA exome panel to detect tumor genomic mutations and copy number variations in circulating tumor DNA from children diagnosed","Not Applicable","Brain Neoplasms","Collection","Not Provided","Targeted-Capture, WXS","4 phenotype datasets, 11 variables, 29 samples sequenced, 10 subjects, 29 samples","","NCI","GRU-IRB --- General Research Use (IRB)","2022-10-19","2022-10-19","Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain; Neoplasm of the Brain",""
"phs002321.v1.p1","Characterizing Advanced Breast Cancer Heterogeneity and Treatment    Resistance through Serial Biopsies and Comprehensive Analytics","This dataset accompanies the manuscript ""Characterizing Advanced Breast Cancer Heterogeneity and Treatment Resistance Through Serial Biopsies and Comprehensive Analytics"". In this study we discuss the clinical implications and consequences of  molecular heterogeneity in a metastatic breast cancer patient identified through serial biopsies, multi-omic analysis, and longitudinal patient","Not Applicable","Breast Neoplasms","Case Set","RNAseq_probe_set_grc38, Reverse-Phase_Protein_Array","Proteomics, RNA-Seq, RNA Seq (NGS)","5 phenotype datasets, 36 variables, 1 molecular datasets, 1 samples sequenced, 1 subjects, 2 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-10-19","2022-10-19","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002510.v1.p1","Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral    Infection","We analyzed hepatitis C virus (HCV)-specific T cells and non-specific memory T cell populations from 6 patients with chronic HCV infection receiving 12 weeks of direct-acting antiviral (DAA) therapy with  aritaprevir/ritonavir/ombitasvir + dasabuvir + ribavirin. All patients were treated successfully. Peripheral blood mononuclear cells were obtained","Not Applicable","T-Lymphocytes","Interventional","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 128 samples sequenced, 20 subjects, 128 samples","","NIAID","HMB --- Health/Medical/Biomedical","2022-10-18","2022-10-18","Not Provided",""
"phs001239.v1.p1","Integrative Analysis of Lung Adenocarcinoma in EAGLE (Phase 2)","We performed whole genome sequencing and whole exome sequencing of 31 lung adenocarcinoma (LUAD) samples from the Environment And Genetics in Lung cancer Etiology (EAGLE) study. Lung adenocarcinoma cases only  Note for data in GDC: Molecular profiling data from CDDP EAGLE-1 study can be found at The NCI's Genomic Data Commons (GDC)","Not Applicable","Adenocarcinoma of Lung","Case Set","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 50 subjects, 150 samples","","NCI","DS-LDS-MDS --- Disease-Specific (Lung disease or smoking, MDS)","2022-10-18","2022-10-18","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs002423.v1.p1","Study of Controlled Human Malaria Infections to Evaluate Protection After    Intravenous or Intramuscular Administration of PfSPZ Vaccine in    Malaria-Naive Adults","The study was performed to evaluate whole-blood transcriptomic profiles via RNA-seq before, during, and after immunization with the PfSPZ Vaccine in malaria-na&#x000ef;ve, health adults enrolled in VRC 314 (NCT02015091). VRC  314 was designed as an open-label evaluation of the safety, tolerability, immunogenicity, and protective efficacy of the PfSPZ Vaccine. This study","Not Applicable","Plasmodium falciparum","Clinical Trial","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 49 samples sequenced, 49 subjects, 49 samples","","NIAID","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2022-10-17","2022-10-17","Malaria; Parasitic Diseases; Protozoan Infections; Fever, Marsh; Fever, Remittent; Infection, Plasmodium",""
"phs002422.v1.p1","Experimental PfSPZ Vaccine in Adults Without Malaria","The study was performed to evaluate whole-blood transcriptomic profiles via RNA-seq before, during, and after immunization with the PfSPZ Vaccine in malaria-na&#x000ef;ve, healthy adults enrolled in VRC 312 (NCT01441167). VRC  312 was the second study of the PfSPZ Vaccine and the first study to evaluate intravenous (IV) administration of this vaccine. The study was an","Not Applicable","Plasmodium falciparum","Clinical Trial","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 25 samples sequenced, 25 subjects, 25 samples","","NIAID","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2022-10-17","2022-10-17","Malaria; Parasitic Diseases; Protozoan Infections; Fever, Marsh; Fever, Remittent; Infection, Plasmodium",""
"phs001859.v1.p1","Genomic Characterization CS-MATCH-0007 Arm Z1D","The CS-MATCH-0007 protocol is a collaboration between the Center for Cancer Genomics (CCG) and the Division of Cancer Treatment and Diagnosis (DCTD) to perform whole-exome sequencing and RNA sequencing using  pre-and posttreatment tumor biopsy specimens from all patients enrolled on a treatment arm of the NCI-MATCH Clinical Trial (EAY131). The goal of this","Not Applicable","Neoplasms","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 387 variables,  SRA, 36 subjects, 36 samples","","NCI","GRU-COL --- General Research Use (COL)","2022-10-17","2022-10-17","Turcot syndrome; Blastoma; CA; CA - Cancer; Cancer; MT",""
"phs003062.v1.p1","De Novo Characterization of Cell-Free DNA Fragmentation Hotspots in    Plasma Whole-Genome Sequencing","The raw sequencing data deposited here are low-coverage ( 1X) whole-genome sequencing (WGS) of plasma cell-free DNA (cfDNA). The purpose is to validate the performance of early-stage cancer diagnosis in  the Zhou et al. 2020 BioRxiv paper, mainly for two types of cancer: early-stage liver cancer and breast cancer. The cases and controls are matched","Not Applicable","Carcinoma, Hepatocellular","Case-Control","Not Provided","WGS","4 phenotype datasets, 19 variables, 66 samples sequenced, 66 subjects, 66 samples","","NHGRI","GRU --- General Research Use","2022-10-13","2022-10-13","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002516.v1.p1","Rapid Acceleration of Diagnostics - Digital Health Technologies    (RADx-DHT): NIH Digital Health Solutions for COVID-19: IBM Covid19    Contact Tracing and Data Exchange Tools","The goal of this project is to develop both contact tracing and secure data exchange tools. The contact tracing solution securely combines data from a variety of sources (including manual  self-report data and mobile device surveys) to enable tracing of contacts with individuals that have tested positive for COVID-19 or have been","Not Applicable","COVID-19","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","OD","GRU --- General Research Use","2022-10-13","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","Rapid Acceleration of Diagnostics - Digital Health Technologies'    (RADx-DHT) Collection of General Research Use Datasets (phs003666.v1.p1)"
"phs002070.v1.p1","Genomic Landscape of High-Grade Neuroendocrine Neoplasms","This project is a multi-omics study of high grade (grade 3) neuroendocrine neoplasms across diverse organs. Genomic analysis using low-pass whole genome sequencing for copy number analysis, whole exome sequencing  and whole transcriptomic sequencing using RNAseq were performed. As high grade neuroendocrine neoplasms are highly lethal with a median survival of","Not Applicable","Carcinoma, Neuroendocrine","Prospective Longitudinal Cohort","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 69 samples sequenced, 36 subjects, 69 samples","","NCI","GRU --- General Research Use","2022-10-13","2022-10-13","Neuroendocrine Tumors",""
"phs000853.v2.p2","Normative Aging Study (NAS)","The Normative Aging Study (NAS) is a longitudinal study established by the United States Department of Veterans Affairs in 1963. Participants were male residents and free of chronic disease at  the time of recruitment. Participants were invited to undergo an in-person examination every 3-5 years. Participants provided information on medical","Not Applicable","mortality","Prospective Longitudinal Cohort","MethylationEPIC","Methylation (CpG)","3 phenotype datasets, 12 variables, 1 molecular datasets, 777 subjects, 1488 samples","","NIEHS","GRU --- General Research Use","2022-10-12","2022-10-12","DNA Methylation","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002859.v1.p1","RB1 Loss Triggers Dependence on ESRRG in Retinoblastoma","Retinoblastoma (Rb) is a deadly childhood eye cancer that is classically initiated by inactivation of the RB1 tumor suppressor. Clinical management continues to rely on nonspecific chemotherapeutic agents that are  associated with treatment resistance and toxicity. Here, we analyzed whole exomes from primary Rb tumors to identify novel Rb dependencies. Several","Not Applicable","Retinoblastoma","Tumor vs. Matched-Normal","Not Provided","WXS","5 phenotype datasets, 24 variables, 51 samples sequenced, 31 subjects, 51 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2022-10-11","2022-10-11","Cancer, Retinoblastoma Eye; Cancers, Retinoblastoma Eye; Eye Cancer, Retinoblastoma; Eye Cancers, Retinoblastoma; RB; RB - retinoblastoma",""
"phs003006.v1.p1","Transcriptional and Epigenetic Profiles of Male Breast Cancer at    Single-Cell Resolution Nominate Salient Cancer Specific Enhancers","We performed matched single-cell RNA sequencing (scRNA-seq) and single-cell chromatin accessibility sequencing (scATAC-seq) for two fresh human tumors collected from male breast cancer patients. The integration of these datasets revealed  the intratumoral heterogeneity in both transcription and chromatin accessibility for each male breast cancer patient and allowed for comparisons to","Not Applicable","Carcinoma, Ductal, Breast","Case Set","ATAC_DNAseq_probe_set","ATAC-seq, RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 19 variables, 1 molecular datasets, 4 samples sequenced, 2 subjects, 4 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-10-07","2022-10-07","BREAST CANCER, INVASIVE DUCTAL; Carcinoma, Infiltrating Duct; Carcinoma, Invasive Ductal, Breast; Carcinomas, Infiltrating Duct; Infiltrating Ductal Adenocarcinoma; Infiltrating Ductal Breast Carcinoma",""
"phs002571.v1.p1","Exome Sequencing for Head and Neck Cancer Susceptibility","This study seeks to find low frequency or rare genetic variants in genes carried by subjects from families with unexplained familial risk of head and neck cancer. Whole exome sequencing  was used to identify genetic variation in head and neck cancer cases. Cases consisted of patients that were (1) diagnosed with a primary oral cavity,","Not Applicable","Head and Neck Neoplasms","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 27 samples sequenced, 5 subjects, 32 samples","","NIDCR","DS-CA --- Disease-Specific (Cancer)","2022-10-07","2022-10-07","Head Neoplasm; Head Neoplasms; Neoplasm, Head; Neoplasms, Head",""
"phs002607.v1.p1","Modeling Malignant Progression in Glioma","Gliomas are the most common primary brain tumor in humans. Low-grade gliomas (WHO grade II) invariably progress to high-grade gliomas (WHO grade III or IV). Although malignant progression may take  many years, the survival rate after transformation to a high-grade glioma is poor, often only 12-15 months. In this data set, we have identified","Not Applicable","Glioma","Case Set","Not Provided","Not Provided","Not Provided","","NINDS","","2022-10-06","","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytoma (excluding glioblastoma); Astrocytomas",""
"phs002928.v1.p1","Adoptive Cell Therapy of Autologous T cell Receptor-Engineered T Cells    Targeting the p53 Neoantigens in Human Solid Tumors","Adoptive T cell therapy (ACT) using T cell receptor (TCR)-engineered T cells can mediate regression of advanced human cancers. How TCR-transduced T cells change post-ACT in vivo is currently not  well understood. We screened 78 patients for TP53 mutations by whole exome sequencing and whole transcriptome sequencing. Of the 78 patient samples,","Not Applicable","Immunotherapy, Adoptive","Clinical Trial","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 15 variables, 194 samples sequenced, 23 subjects, 194 samples","","NCI","GRU --- General Research Use","2022-10-06","2022-10-06","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002016.v1.p1","MicroRNA Biomarkers for Prediction of Preeclampsia","Maternal serum was collected between 17-28 weeks gestation. Samples were obtained from the high-risk Placental Study at the University of California, San Diego (n 48) and from the average-risk Proteomic  Assessment of Preterm Risk (PAPR) Study at Sera Prognostics (n 164). RNA was extracted from 500 microliter of maternal serum using the miRNeasy Micro","Not Applicable","Pre-Eclampsia","Case-Control","Not Provided","miRNA-Seq","4 phenotype datasets, 25 variables, 212 samples sequenced, 212 subjects, 212 samples","","NHLBI","GRU --- General Research Use","2022-10-06","2022-10-06","EPH - Edema, proteinuria and hypertension of pregnancy; EPH Complex; EPH Gestosis; EPH Toxemia; EPH Toxemias; Edema Proteinuria Hypertension Gestosis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002994.v1.p1","BRCA Mutation Status Shapes the Microenvironment of Pancreatic    Adenocarcinoma","This study was established in order to address how the stromal landscape is influenced by BRCA-mutated and BRCA Wild-type (WT) pancreatic ductal adenocarcinoma (PDAC). A primary cohort of 12 PDAC  patients (7 BRCA-WT and 5 germline BRCA-mut) was analyzed by laser-capture microdissection, RNA-sequencing and multiplexed immunofluorescence. Only","Not Applicable","Genes, BRCA2","Collection","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 12 samples sequenced, 12 subjects, 12 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-10-05","2022-10-05","Carcinoma, Pancreatic Ductal; Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas",""
"phs002811.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular: The Genetics    of Atrial Fibrillation","This study is a part of NHGRI's Center for Common Disease Genomics, which is a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing to  multiple common disease phenotypes. Current estimates anticipate that the CCDG program will sequence approximately 140K whole genomes and 225K whole","Not Applicable","Cardiovascular Diseases","Case Set","Not Provided","Not Provided","Not Provided","","NHGRI","DS-CCSD-MDS --- Disease-Specific (Circulatory and Cardiovascular System Diseases, MDS)","2022-10-05","","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs001280.v1.p1","Exome Sequencing of Chordoma Cases","Chordoma is a rare tumor that is believed to develop from notochord remnants. We previously identified germline duplication of the TBXT gene as a major susceptibility mechanism in several chordoma  families. Currently, we are using whole exome sequencing to identify additional susceptibility genes in chordoma families without TBXT duplication as","Not Applicable","Chordoma","Case Set","","AMPLICON, RNA Seq (NGS), WXS","4 phenotype datasets, 13 variables, 1 molecular datasets, 232 samples sequenced, 132 subjects, 374 samples","","NCI","DS-CHR-MDS --- Disease-Specific (Chordoma, MDS)","2022-10-05","2022-10-05","",""
"phs002688.v1.p1","CIDR Estrogen Receptor Negative Breast Cancer in African American Women:    DNA Methylation, Reproductive Events, and Mammary Epithelial Cell    Populations","We conducted methylation profiling of breast tumor DNA from Formalin-Fixed Paraffin-Embedded (FFPE) samples for 1,550 cases from a cohort of Black women from the Black Women's Health Study (BWHS), the  Women's Circle of Health Study (WCHS), and from the Pathways Study using the Illumina MethylationEPIC array. We will examine differentially","Not Applicable","Breast Neoplasms","Case Set","MethylationEPIC","Methylation (CpG)","4 phenotype datasets, 22 variables, 1 molecular datasets, 1550 subjects, 1550 samples","","NCI","HMB-IRB-PUB-NPU-GSO --- Health/Medical/Biomedical (IRB, PUB, NPU, GSO), HMB-COL-NPU-GSO --- Health/Medical/Biomedical (COL, NPU, GSO), HMB-IRB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (IRB, PUB, NPU, MDS, GSO)","2022-10-04","2022-10-04","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001485.v3.p1","Somatic Mutations and Cell Lineage in the Human Brain","Genetic mutations causing human disease are conventionally thought to be inherited from one's parents and present in all somatic (body) cells. Increasingly however, somatic mutations are implicated in neurological diseases.  Somatic mutations that arise during the cell divisions of prenatal brain development are inherited in clonal fashion and can cause neurodevelopmental","Not Applicable","Cockayne Syndrome","Case-Control","Not Provided","ATAC-seq, RNA-Seq, WGA, WGS","4 phenotype datasets, 21 variables, 266 samples sequenced, 30 subjects, 266 samples","","NINDS","DS-NEURO-PUB-GSO --- Disease-Specific (Neurological Diseases, PUB, GSO)","2022-10-04","2018-02-02","Xeroderma Pigmentosum; Cockayne's syndrome; Dwarfism-Retinal Atrophy-Deafness Syndrome; Neill-Dingwall syndrome; Progeria Like Syndrome; Progeria-Like Syndrome",""
"phs003011.v1.p1","APOLLO1: Proteogenomic Analysis of Lung Adenocarcinoma","APOLLO is a proteogenomic study seeking to describe the major genome, transcriptome, proteome and phosphoproteome alterations, subtypes, and molecular predictors of patient outcomes. This study includes 87 lung adenocarcinomas and  matched normal tissues from the Lung Cancer Biospecimen Resource Network (https://lungbio.sites.virginia.edu/). Tumor tissues were profiled by whole","Not Applicable","Adenocarcinoma of Lung","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 5 variables, 87 subjects, 261 samples","","NCI","GRU --- General Research Use","2022-10-03","2022-10-03","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs002809.v1.p1","Genome-Wide Pleiotropy Scan Across Multiple Cancers","A whole-exome sequencing (WES) study was conducted in 3,233 cases diagnosed with multiple primary cancers and 3,229 matched cancer-free controls (90% non-Hispanic white, 3% African-American, 3% East Asian, and 4%  Latino) selected from individuals in the Kaiser Permanente Research Bank (KPRB) who were members of the Kaiser Permanente Northern California (KPNC)","Not Applicable","Neoplasms, Multiple Primary","Case-Control","WES_markerset_grc38","SNP Genotypes (NGS), WXS","4 phenotype datasets, 32 variables, 1 molecular datasets, 5432 samples sequenced, 5432 subjects, 5432 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2022-10-03","2022-10-03","Multiple Primary Neoplasm; Multiple Primary Neoplasms; Multiple Primary Neoplasms, Synchronous; Neoplasm, Multiple Primary; Neoplasm, Synchronous; Neoplasms, Synchronous",""
"phs001772.v3.p2","A Genomic Approach to Improved Diagnosis and Treatment of Neuroendocrine    Tumors","These are RNA-Seq samples from patients undergoing surgery for small bowel and pancreatic neuroendocrine tumors. Normal tissue, primary tumors, lymph nodes, and liver metastases were collected at surgery and stored  in RNAlater until RNA extraction was carried out for RNA-Seq. Patients having surgery for small bowel and pancreatic neuroendocrine tumors.","Not Applicable","Intestinal Neoplasms","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 24 variables, 210 samples sequenced, 62 subjects, 210 samples","","NCI","HMB-PUB-COL --- Health/Medical/Biomedical (PUB, COL)","2022-10-03","2020-06-19","Neoplasm Metastasis; Intestinal Tumor; Intestinal Tumors; Intestines Neoplasm; Intestines Neoplasms; Neoplasm of Intestines",""
"phs003038.v1.p1","Exploiting New Patterns of Genome Damage in Triple Negative Breast Cancer","Genomic instability, a feature of triple negative breast cancers (TNBC), represents an opportunity for discovery of biologic and clinically relevant subgroups of patients. Owing to TP53 mutation in the majority  of cases, DNA repair deficiency through loss of BRCA1 and BRCA2, and by expression features patterning a basal cell of origin, TNBC represents a","Not Applicable","Triple Negative Breast Neoplasms","Tumor vs. Matched-Normal","other","SNV (.MAF)","3 phenotype datasets, 9 variables, 1 molecular datasets, 16 subjects, 32 samples","","NCI","GRU --- General Research Use","2022-09-30","2022-09-30","Breast Cancer, Triple-Negative; Breast Cancers, Triple-Negative; Breast Neoplasm, Triple-Negative; Breast Neoplasms, Triple-Negative; ER Negative PR Negative HER2 Negative Breast Cancer; ER Negative PR Negative HER2 Negative Breast Neoplasms",""
"phs001550.v3.p1","The Genetic and Transcriptomic Evolution of Melanoma","The overarching goal of the study was to better understand the evolution of melanoma. To do this, we collected archival tissue of melanomas adjacent to their intact, remnant precursor lesions.  We also collected archival tissue of primary melanomas and their matching metastases. From the formalin-fixed paraffin-embedded (FFPE) blocks, we","Not Applicable","Melanoma","Tumor vs. Matched-Normal","Not Provided","Hi-C, RNA-Seq, Targeted-Capture, WXS, miRNA-Seq","4 phenotype datasets, 19 variables, 361 samples sequenced, 85 subjects, 361 samples","","NCI","DS-M-NPU --- Disease-Specific (Melanoma, NPU)","2022-09-30","2018-03-19","Clonal Evolution; Nevus; Evolution, Clonal; Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma",""
"phs002998.v1.p1","Immune Profiles Study","This study assesses glioma patient blood methylation longitudinally beginning pre-surgery through other clinically important timepoints. Progression and survival are studied in relation to methylation derived immunologic profiles and other characteristics.  For this study, patients scheduled for surgery at University of California San Francisco (UCSF) for a possible newly diagnosed glioma (grades 2-4) or","Not Applicable","Glioma","Case Set","MethylationEPIC","Methylation (CpG)","4 phenotype datasets, 14 variables, 1 molecular datasets, 135 subjects, 135 samples","","NCI","GRU --- General Research Use","2022-09-29","2022-09-29","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002959.v1.p1","Joslin Study on the Genetics of Type 2 Diabetes","Between 1993 and 2003, families were recruited in the Joslin Study on the Genetics of Type 2 Diabetes for the presence of an autosomal dominant mode of inheritance of diabetes.  Recruiting and screening of families occurred through probands who were receiving medical care at the Joslin Clinic (Boston, MA). Screening of","Not Applicable","Diabetes Mellitus","Family/Twin/Trios","HumanExome-12, WGS_markerset_grc37","SNP Genotypes (Array), SNP/CNV Genotypes (NGS)","4 phenotype datasets, 22 variables, 1 molecular datasets, 14 subjects, 14 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2022-09-29","2022-09-29","Diabetic Nephropathies; Hypoadiponectinemia; DKD; Diabetic Kidney Disease; Diabetic Kidney Diseases; Diabetic nephropathy",""
"phs002977.v1.p1","Functional Analysis of Genetic Variants in African Americans with Breast    Cancer","The goal of this study is to identify and characterize novel genetic variants associated with a predisposition to breast cancer (BCa) in African Americans (AAs) using a family case-family control  study design. Variants of unknown clinical significance (VUS) were characterized using bioinformatics tools. Future studies will further characterize","Not Applicable","Breast Neoplasms","Family/Twin/Trios","Not Provided","WXS","4 phenotype datasets, 19 variables, 88 samples sequenced, 88 subjects, 88 samples","","NCI","DS-BRCA --- Disease-Specific (Breast Cancer)","2022-09-28","2022-09-28","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002692.v1.p1","Pulmonary Fibrosis and Telomerase Dysfunction","This study was used to perform an exome-limited analysis of whole genome sequencing data of patients with idiopathic pulmonary fibrosis (IPF) or familial pulmonary fibrosis. Case cohorts were derived from  local centers at University of Southwestern or Columbia University, and subjects were from the IPFnet cohort of clinical trial. Rare damaging","Not Applicable","Idiopathic Pulmonary Fibrosis","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 393 subjects, 393 samples","","NHLBI","HMB-IRB-PUB-MDS --- Health/Medical/Biomedical (IRB, PUB, MDS)","2022-09-28","2022-09-28","Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary; FIBROCYSTIC PULMONARY DYSPLASIA; FIBROSING ALVEOLITIS, CRYPTOGENIC; Fibrocystic Pulmonary Dysplasias",""
"phs001810.v2.p2","Gene-Environment Interactions in COCCaINE Use Disorder: Collaborative    Case-Control Initiative in Cocaine Addiction","Drug addiction is a phenotype that has high heritability estimates. In recent years, association studies of candidate genes and some genome-wide association studies (GWAS) have identified a large number of  SNPs associated with substance use, abuse or dependence, particularly in phenotypes related to alcohol and nicotine use. Regarding snorted or smoked","Not Applicable","Cocaine","Prospective Longitudinal Cohort","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 46 variables, 1 molecular datasets, 1874 subjects, 1874 samples","European (636), East Asian (1), African American (203), Hispanic1 (368), Hispanic2 (266), Other (400)","NIDA","GRU --- General Research Use","2022-09-27","2022-09-27","Psychological Trauma; Trauma, Psychological","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001379.v1.p1","A Joint Linkage/Association Strategy to Interrogate AMD Genetic    Susceptibility","The cohort consists of a collection of large multigenerational families where minimally 4 members have advanced age related macular degeneration (AMD). Retinal photographs were used to determine AMD phenotype and  genomic DNA extracted from whole blood was used for sequencing. Gender, age at phenotyping, smoking status, self-declared race and ethnicity, and","Not Applicable","Macular Degeneration","Family/Twin/Trios","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 30 variables, 1 molecular datasets,  SRA, 95 subjects, 99 samples","","NEI","DS-AMD --- Disease-Specific (Age-Related Macular Degeneration)","2022-09-27","2022-09-27","Choroidal Neovascularization; Geographic Atrophy; Choroid Neovascularization; Choroid Neovascularizations; Choroidal Neovascularizations; Choroidal neovascular membrane",""
"phs003023.v1.p1","Whole-Genome Sequencing Reveals Complex Genomic Features Underlying    Anti-CD19 CAR T-Cell Treatment Failure in Lymphoma","We performed Whole-Genome Sequencing (WGS) on 100 tumor and matched germline samples from 49 CD19-directed chimeric antigen receptor (CAR-19)-treated diffuse large B cell lymphoma (DLBCL) patients. We found that the  presence of complex structural variants, APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide) mutational signatures, and genomic","Not Applicable","Lymphoma","Tumor vs. Matched-Normal","Not Provided","WGS","4 phenotype datasets, 20 variables, 100 samples sequenced, 49 subjects, 100 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2022-09-22","2022-09-22","Cancer of lymphatic system; Germinoblastic Sarcoma; Germinoblastic Sarcomas; Germinoblastoma; Germinoblastomas; Lymphoma (Hodgkin and Non-Hodgkin)",""
"phs002986.v1.p1","A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant    Therapy in Patients with Locally Advanced Squamous Cell Cancer of the    Head and Neck","This genomic study was an analysis of DNA samples from subjects enrolled in a randomized, interventional, parallel assignment trial of everolimus versus placebo in advanced Head and Neck Cancer. Next  Generation Sequencing was performed on samples obtained from primary tumors before treatment. The purpose was to evaluate potential associations","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 12 variables, 42 samples sequenced, 42 subjects, 42 samples","","NCI","GRU --- General Research Use","2022-09-21","2022-09-21","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002253.v1.p1","CCG Multicentric Italian Lung Detection (MILD)","For the CCG-MILD project, NCI will utilize whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing to try to identify recurrent genetic alterations (mutations, deletions, amplifications, rearrangements)  and/or gene expression signatures that would be important to the hypothesis(es) submitted by the investigators. The samples will be processed and","Not Applicable","Lung Neoplasms","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 160 subjects, 160 samples","","NCI","GRU --- General Research Use","2022-09-21","2022-09-21","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs001554.v2.p1","Detection of Colorectal Cancer Susceptibility Loci Using Genome-Wide    Sequencing","The Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) is a collaborative effort comprised of a coordinating center and scientific researchers from well-characterized cohort and case-control studies. This international consortium  aims to accelerate the discovery of common and rare genetic risk variants for colorectal cancer by conducting large-scale meta-analyses of existing","Not Applicable","Colorectal Neoplasms","Case-Control","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 22 variables, 1 molecular datasets, 2892 samples sequenced, 2892 subjects, 2892 samples","","NCI","GRU --- General Research Use, HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), CADM --- Cancer in all age groups, other diseases in adults only, and methods","2022-09-19","2018-08-06","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001141.v2.p1","PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE) of    Castration Resistant Prostate Cancer (CRPC) Patients Treated with    Abiraterone Acetate","The Prostate Cancer Medically Optimized Genome-Enhanced Therapy (PROMOTE) study uses genetic clues in castration-resistant prostate cancer that may identify an individualized treatment approach for men with the disease. Understanding the  molecular biology behind castration-resistant prostate cancer has led to more treatment options, but there are still no definite conclusions about","Not Applicable","Prostatic Neoplasms, Castration-Resistant","Case Set","WES_markerset_grc37","RNA-Seq, SNP Genotypes (NGS), WXS","4 phenotype datasets, 25 variables, 1 molecular datasets, 398 samples sequenced, 88 subjects, 398 samples","","NCI","GRU --- General Research Use","2022-09-16","2017-02-21","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002990.v1.p1","Investigation of the Causal Etiology in a Patient with T-B+NK+    Immunodeficiency","We describe a male proband with normal B lymphocyte and natural killer (NK) cell numbers, but who had T lymphopenia beginning at 1 week of age. His peripheral blood contained  very few T cell receptor excision circles (TREC), suggesting impaired thymic T cell development. He received an allogeneic hematopoietic stem cell","Not Applicable","Immunologic Deficiency Syndromes","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 18 variables, 1 molecular datasets, 4 subjects, 4 samples","","NHLBI","GRU --- General Research Use","2022-09-13","2022-09-13","causality; causes; etiology; Antibody Deficiency Syndrome; Antibody Deficiency Syndromes; Deficiency Syndrome, Antibody","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002968.v1.p1","Inherited T Cell Defects: Diagnosis, Mechanisms and Treatments","Infants with abnormal newborn screen results for severe combined immunodeficiency (SCID) and their parents were enrolled in UCSF IRB approved protocols with informed consent to have molecular and immunologic investigation  to determine the cause of the infant's low T lymphocytes. Studies included exome sequencing of DNA from the infant and both parents. Candidate","Not Applicable","Lymphopenia","Family/Twin/Trios","Not Provided","WXS","5 phenotype datasets, 15 variables, 3 samples sequenced, 3 subjects, 3 samples","","NIAID","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2022-09-07","2022-09-07","Absolute lymphocyte count decrease; Decreased blood lymphocyte number; Low lymphocyte number; Lymphocytopenia; Lymphocytopenias; Lymphopenias",""
"phs002010.v1.p1","The Research Institute at Nationwide Children's Hospital Genetics of    Congenital Heart Disease (CHD)","Congenital heart disease (CHD) is the most common type of birth defect, but the cause for the majority of cardiac birth defects remains unknown. Numerous epidemiologic studies have demonstrated evidence  that genetic factors likely play a contributory, if not causative, role in CHD. A few genes have been identified by us and other investigators using","Not Applicable","Ventricular Outflow Obstruction, Left","Case Set","WES_markerset_grc38","CNV Genotypes, WXS","5 phenotype datasets, 29 variables, 1 molecular datasets, 597 samples sequenced,  SRA, 597 subjects, 597 samples","","NHLBI","GRU-NPU --- General Research Use (NPU)","2022-09-07","2022-09-07","Aortic Aneurysms; Aortic Stenosis; Aortic Valve, Bicuspid; Atrial Fibrillations; Coarctation of the Aorta; Congenital complete heart block",""
"phs002940.v1.p1","PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study","The PRE-DETERMINE Study is a prospective, multi-center study of 5,764 patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild  to moderate left ventricular dysfunction (LVD) with left ventricular ejection fraction (LVEF) 35-50%. Patients were enrolled at 136 sites where","Not Applicable","Coronary Artery Disease","Prospective Longitudinal Cohort","Global_Screening_Array-24","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 4335 subjects, 4335 samples","","NHLBI","DS-CAD --- Disease-Specific (Coronary Artery Disease)","2022-09-02","2022-09-02","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery",""
"phs002429.v1.p1","UNC Tumor Donation Program Set 2021","The goal of this study is to study gene expression patterns in primary, metastatic tumors, and normal tissues. The samples were obtained through the UNC tumor donation program. Inclusion criteria  were UNC patients with metastatic breast cancer with and without treatment options.&#x000a0; Principal Investigator: Charles M. Perou, PhD,","Not Applicable","Breast Neoplasms","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 22 variables, 125 samples sequenced, 30 subjects, 125 samples","","NCI","HMB --- Health/Medical/Biomedical, DS-CA --- Disease-Specific (Cancer)","2022-09-02","2022-09-02","Metastasis; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002635.v1.p1","Myelofibrosis Etiology and Transplant Outcomes","The Myelofibrosis Etiology and Transplant Outcomes study is a collaboration between the National Cancer Institute and the Center for International Blood and Marrow Transplant Research (CIBMTR). The study aims to  identify genomic factors affecting myelofibrosis pathogenesis and prognosis. Principal Investigator: Shahinaz Gadalla, PhD, MD, National Institutes","Not Applicable","Primary Myelofibrosis","Case Set","Global_Screening_Array-24","AMPLICON, SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 14 variables, 1 molecular datasets, 548 samples sequenced, 548 subjects, 1096 samples","European (473), East Asian (9), African American (29), Hispanic1 (6), Hispanic2 (20), Other Asian or Pacific Islander (6), South Asian (2), Other (3)","NCI","DS-HCTCT-IRB --- Disease-Specific (Hematopoietic Cell Transplantation and Cell Therapy, IRB)","2022-08-30","2022-08-30","AMM; Agnogenic Myeloid Metaplasia; Agnogenic Myeloid Metaplasias; Bone Marrow Fibroses; Bone Marrow Fibrosis; CIMF",""
"phs002447.v1.p1","Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)","The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has sponsored a consortium of investigators to conduct a clinical treatment trial,  Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY). The primary objective of the TODAY trial is to compare the efficacy of three","Not Applicable","Diabetes Mellitus, Type 2","Clinical Trial","target_markerset_grc37","SNP Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 503 subjects, 503 samples","","NIDDK","DS-DIAB-NPU --- Disease-Specific (Diabetes, NPU)","2022-08-30","2022-08-30","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000845.v1.p1","Genomic Factors Involved in Chromosome Rearrangements","Approximately 15-20% of children referred for chromosomal microarray analysis (CMA) testing have a clinically relevant CNV that in many cases explains their phenotype. The goal of this study is to  discover the genomic factors that mediate chromosome rearrangements and the phenotypic effects of chromosome rearrangements. We hypothesize that","Not Applicable","Chromosome Breakage","Prospective Longitudinal Cohort","Not Provided","WGS","4 phenotype datasets, 18 variables, 7 samples sequenced,  SRA, 11 subjects, 11 samples","","NIMH","GRU --- General Research Use","2022-08-29","2022-08-29","Break, Chromosomal; Break, Chromosome; Breaks, Chromosomal; Breaks, Chromosome; Chromosomal Break; Chromosomal Breaks","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs002865.v1.p1","Accurate Genome-Wide Germline DNA Profiling from Decade-Old Archival    Tissue Specimens","We evaluate the validity of repurposing archival tissue specimens for germline genetic studies. We performed lc-WGS and imputed genotypes on 10 pairs of matching blood and tumor tissue and benchmarked  the accuracy of genome-wide genotypes, HLA haplotypes, and several polygenic risk scores (PRSs). The reported results indicate the high accuracy of","Not Applicable","Neoplasms","Case Set","Not Provided","WGS","4 phenotype datasets, 13 variables, 50 samples sequenced, 50 subjects, 50 samples","","NCI","GRU --- General Research Use","2022-08-25","2022-08-25","Breast Carcinoma In Situ; Carcinoma, Ductal, Breast; Multifactorial Inheritance; LCIS - lobular carcinoma in situ; LCIS, Lobular Carcinoma In Situ; Lobular Carcinoma In Situ",""
"phs001539.v4.p1","Myocardial Applied Genomics Network (MAGNet) Study","The MAGNet repository includes non-failing samples from organ donors with no history of heart failure and failing samples from explanted hearts of donors receiving a heart transplant. The study protocol  was approved by the Institutional Review Board at the University of Pennsylvania, and all patients provided written informed consent to participate.","Not Applicable","Health","Case-Control","Not Provided","ATAC-seq, ChIP-Seq, RNA-Seq, WGS","4 phenotype datasets, 14 variables, 324 samples sequenced, 151 subjects, 324 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2022-08-22","2018-09-04","CARDIOMYOPATHY, FAMILIAL IDIOPATHIC; Cardiomyopathies, Familial Idiopathic; Cardiomyopathies, Idiopathic Dilated; Cardiomyopathy, Dilated, Autosomal Recessive; Cardiomyopathy, Idiopathic Dilated; Dilated Cardiomyopathies, Idiopathic","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs001202.v2.p1","OncoArray: Oral and Pharynx Cancer","Genetic factors play an important role in susceptibility to head and neck cancer and could also explain differences in response to treatment and outcome. The goal of this project is  to investigate genetic variation involved in oral and oropharyngeal cancer susceptibility by performing the largest GWAS on these diseases, using a","Not Applicable","Head and Neck Neoplasms","Case-Control","OncoArray","SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets, 10096 subjects, 10219 samples","European (8148), African (21), African American (661), Hispanic1 (895), Hispanic2 (141), Other Asian or Pacific Islander (5), South Asian (4), Other (221)","NIDCR","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS), DS-CA-PUB-MDS --- Disease-Specific (Cancer, PUB, MDS)","2022-08-22","2017-08-23","Hypopharyngeal Neoplasms; Mouth Neoplasms; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Head Neoplasm; Head Neoplasms",""
"phs002985.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular:    Pharmacokinetic Polymorphisms in Japanese General Population","This study is a part of NHGRI's Center for Common Disease Genomics, which is a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing to  multiple common disease phenotypes. Current estimates anticipate that the CCDG program will sequence approximately 140K whole genomes and 225K whole","Not Applicable","Cardiovascular Diseases","Control Set","Not Provided","Not Provided","Not Provided","","NHGRI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2022-08-19","","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs001417.v2.p1","Scalable Whole-Exome Sequencing of Cell-Free DNA Reveals High Concordance    with Metastatic Tumors","We performed whole genome sequencing and whole-exome sequencing of cell-free DNA (cfDNA) and whole-exome sequencing of matched tumor biopsies and germline DNA from patients with metastatic cancer. Using ichorCNA, a  software tool that quantifies tumor content in ultra-low pass whole genome sequencing ( 0.1x) of cfDNA without prior genomic characterization of the","Not Applicable","Neoplasms","Case Set","Not Provided","WGS, WXS","4 phenotype datasets, 12 variables, 1722 samples sequenced, 545 subjects, 1722 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS), DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS)","2022-08-18","2018-03-27","Neoplasm Metastasis; Metastase; Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000744.v5.p2","Yale Center for Mendelian Genomics (YCMG)","From 2012-2021, Yale University was home to one of four national centers created by the National Institutes of Health (NIH) to study the genetics of rare inherited diseases. Researchers at  Yale University, University of Washington, the Broad Institute and a center operated jointly by Baylor University and Johns Hopkins University","Not Applicable","Idiopathic Pulmonary Fibrosis","Mendelian","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use, DS-THAL-IRB --- Disease-Specific (Thalassemia, IRB), DS-BPEAKD --- Disease-Specific (Abnormal Blood Pressure, Electrolyte Abnormalities, or Kidney Disease), DS-RD --- Disease-Specific (Reproductive Disorders), HMB --- Health/Medical/Biomedical, DS-RARED --- Disease-Specific (Rare Disease), DS-GSD-GSO --- Disease-Specific (Genetic Skin Disease, GSO), DS-MC --- Disease-Specific (Mendelian Conditions), HMB-GSO --- Health/Medical/Biomedical (GSO), DS-MCDMS --- Disease-Specific (Moyamoya, Chiari Disease, Mesial Sclerosis), DS-GD --- Disease-Specific (Gaucher Disease), HMB-IRB --- Health/Medical/Biomedical (IRB)","2022-08-12","","Aortic Coarctation; Aortic Stenosis, Supravalvular; Aortic Valve, Bicuspid; Blepharophimosis; Bronchiectasis; Ciliary Motility Disorders","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002597.v2.p1","DNA Replication Timing Alterations in Genetic Diseases","This study contains a collection of lymphoblastoid cell line (LCL) and induced pluripotent stem cell (iPSC) whole genome sequencing from individuals with an without a diagnosed genetic disease. Several types  of genetic diseases are included such as translocations, repeat expansions, and heritable or spontaneous mutations of genes. We used the whole genome","Not Applicable","DNA Replication Timing","Collection","Not Provided","WGS","5 phenotype datasets, 23 variables, 200 samples sequenced, 184 subjects, 200 samples","","NIGMS","GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2022-08-11","2022-05-12","Not Provided",""
"phs002424.v1.p1","Epigenetic Moderators of Naltrexone Efficacy for Alcohol Use Disorder","This study was a 16-week randomized controlled trial of oral naltrexone (50 mg daily) vs. placebo among adults with Alcohol Use Disorder. DNA was extracted from peripheral mononuclear cells isolated  from a blood sample collected at baseline, prior to study medication ingestion. The Illumina MethylationEPIC BeadChip was subsequently used to","Not Applicable","Alcoholism","Clinical Trial","MethylationEPIC","Methylation (CpG)","4 phenotype datasets, 43 variables, 1 molecular datasets, 145 subjects, 145 samples","","NIAAA","GRU-IRB --- General Research Use (IRB)","2022-08-11","2022-08-11","ALCOHOL DEPENDENCE, PROTECTION AGAINST; Addiction, Alcohol; Addictive alcohol use; Alcohol Addiction; Alcohol Dependence; Alcohol dependence syndrome",""
"phs000722.v3.p2","Whole Exome Sequencing of Colorectal Cancer Patients from the Nurses'    Health Study (NHS) and Health Professionals Follow-up Study (HPFS)","Colorectal cancer is a molecularly heterogeneous disease. Whole Exome Sequencing from patients diagnosed with colorectal cancer in the NHS and HPFS cohorts will extend our understanding of the genetic changes  occurring in specific clinical contexts in the disease. This effort has the potential to discover novel recurrently mutated genes and pathways in","Not Applicable","Colorectal Neoplasms","Tumor vs. Matched-Normal","other","SNV Aggregate (.MAF), WXS","3 phenotype datasets, 8 variables, 2 molecular datasets, 1957 samples sequenced, 954 subjects, 1957 samples","","NHGRI","GRU --- General Research Use, DS-MH --- Disease-Specific (Men's Health)","2022-08-08","2017-05-04","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000261.v2.p1","The Microbial Ecology of Bacterial Vaginosis","Archived self-collected vaginal swabs were utilized from a pilot study of vaginal douching cessation (NIH/NIAID R03-AI061131). Thirty-nine non-pregnant, reproductive-age women who reported the use of vaginal douche products in the  two months prior to screening were enrolled. Thirty-three of these successfully completed the 16-week longitudinal study. Participants self-collected","Not Applicable","Vaginosis, Bacterial","Metagenomics","Not Provided","AMPLICON","5 phenotype datasets, 30 variables, 6 documents, 1038 samples sequenced, 34 subjects, 1038 samples","","NIAID","HMP --- Human Microbiome Research","2022-08-08","2022-08-08","BV; BV - Bacterial vaginosis; Bacterial Vaginitides; Bacterial Vaginitis; Bacterial Vaginoses; Nonspecific Vaginitis",""
"phs002323.v2.p1","Defining and Overcoming Intrinsic T Cell Dysfunction to Enable Pediatric    Immunotherapy","T-cells from 71 children and young adults with B-cell malignancies on trial to receive anti-CD19 CAR T-cell therapy were analyzed. These T-cells represent the pre-manufacture T-cells that were subsequently used  for CAR T manufacture. Bulk RNA-Seq was performed on sorted T-cell subsets for all patients, in addition to CITE-Seq and single-cell ATAC-Seq on a","Not Applicable","Immunotherapy","Case Set","RNAseq_probe_set_grc38, custom_probe_set, WES_markerset_grc38","ATAC-seq, RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), RNA Seq (NGS), scRNA_Seq (NGS), WXS","7 phenotype datasets, 36 variables, 2 molecular datasets, 393 samples sequenced, 84 subjects, 393 samples","","NCI","DS-CTOGVHD-IRB-NPU --- Disease-Specific (cancer, cell processing, transplantation outcomes and graft versus host disease, IRB, NPU)","2022-08-03","2022-08-03","Not Provided",""
"phs002496.v1.p1","Germline Whole-Exome Sequencing of Lung Cancer in EAGLE","EAGLE is a large population-based case-control study designed and conducted to investigate the genetic and environmental determinants of lung cancer and smoking persistence using an integrative approach that allows combined  analysis of genetic, environmental, clinical, and behavioral data. Here, we applied whole exome sequencing (WES) to EAGLE study, in a group of 2,777","Not Applicable","Lung Neoplasms","Case-Control","Not Provided","WXS","4 phenotype datasets, 18 variables, 4036 samples sequenced, 4036 subjects, 4036 samples","","NCI","DS-LDS-MDS --- Disease-Specific (Lung disease or smoking, MDS)","2022-08-02","2022-08-02","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs001736.v2.p1","NCI Expanded Genome-Wide Association Study of Renal Cell Carcinoma","The National Cancer Institute (NCI) expanded genome-wide association study (GWAS) of renal cell carcinoma (RCC) was a 2nd GWAS of this cancer performed by NCI to further investigate common genetic  variants associated with RCC risk. The GWAS includes 2,781 cases and 2,940 controls of European background from 13 studies conducted in the US and","Not Applicable","Carcinoma, Renal Cell","Case Set","HumanOmniExpress-12, HumanOmni2.5-4","SNP/CNV Genotypes (imputed), SNP/CNV Genotypes (NGS)","4 phenotype datasets, 19 variables, 3 analyses, 2 molecular datasets, 2385 subjects, 2385 samples","","NCI","GRU --- General Research Use, GRU-IRB-NPU --- General Research Use (IRB, NPU), DS-RCC --- Disease-Specific (Kidney Cancer), CADM --- Cancer in all age groups, other diseases in adults, and methods","2022-08-02","2019-09-27","ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal Cell","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002505.v1.p1","CPTAC: Molecular Dissection of Chemotherapy Response in Triple Negative    Breast Cancer","Sporadic Triple Negative Breast Cancer (TNBC) represents 10-15% of breast cancers (BC) worldwide. Non-specific chemotherapy remains the standard of care as there are no targeted agents. In 50% of cases,  pathological complete response (pCR) is not achieved, and these individuals experience poor survival. Predictive markers for chemotherapy have proved","Not Applicable","Triple Negative Breast Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 12 variables, 135 samples sequenced, 48 subjects, 135 samples","","NCI","HMB --- Health/Medical/Biomedical, GRU --- General Research Use","2022-08-01","2022-08-01","Breast Cancer, Triple-Negative; Breast Cancers, Triple-Negative; Breast Neoplasm, Triple-Negative; Breast Neoplasms, Triple-Negative; ER Negative PR Negative HER2 Negative Breast Cancer; ER Negative PR Negative HER2 Negative Breast Neoplasms","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002941.v1.p1","CALGB/SWOG 80405 ct DNA Biomarker Evaluation","To investigate treatment-specific mutations that underlie resistance to treatment with chemotherapy +/- bevacizumab or cetuximab in first line metastatic Colorectal Cancer (mCRC) patients, we performed targeted sequencing of circulating free  DNA (cfDNA) from longitudinal plasma samples. These samples were collected at baseline (PRE, n 354), during treatment (OTH, n 259), and/or at","Not Applicable","Colorectal Neoplasms","Clinical Genetic Testing","Not Provided","WXS","3 phenotype datasets, 10 variables, 968 samples sequenced, 367 subjects, 968 samples","","NCI","GRU-COL --- General Research Use (COL), DS-CA-COL --- Disease-Specific (Cancer, COL)","2022-07-29","2022-07-29","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs002835.v1.p1","Breast Cancer Family Registry","The Breast Cancer Family Registry (BCFR) is a multi-center prospective cohort, comprised of over 30,000 women and men from nearly 12,000 families from the United States, Canada, and Australia. Our  BCFR resource has been used, and continues to be used, by breast cancer researchers around the world in order to find new ways to prevent, diagnose,","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Provided","10 phenotype datasets, 996 variables, 2 documents, 32726 subjects","","NCI","DS-CA --- Disease-Specific (Cancer), DS-BOCC-IRB --- Disease-Specific (Breast, Ovary, and/or Colon Cancer, IRB), DS-CA-IRB --- Disease-Specific (Cancer, IRB), DS-CA-PUB-NPU-MDS --- Disease-Specific (Cancer, PUB, NPU, MDS), DS-CA-IRB-MDS --- Disease-Specific (Cancer, IRB, MDS)","2022-07-29","2022-07-29","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002933.v1.p1","Single-Cell RNA-Sequencing Analysis of Responses to Pembrolizumab in    Sezary Syndrome","This phase 2 single arm clinical trial assessed the efficacy of pembrolizumab in patients with previously treated mycosis fungoides or Sezary syndrome. Pembrolizumab was found to have a 38% overall  response rate, and a 27% overall response rate in subjects with Sezary syndrome. We performed single-cell RNA-sequencing on samples collected before","Not Applicable","Sezary Syndrome","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 15 samples sequenced, 6 subjects, 15 samples","","NCI","GRU-COL --- General Research Use (COL)","2022-07-28","2022-07-28","Cutaneous T Cell Lymphoma; CTCL / Sezary syndrome; Erythroderma, Sezary; Lymphoma, Sezary's; SC)zary syndrome; SEZARY SYNDROME, SOMATIC",""
"phs002879.v1.p1","Vulnerabilities of Midbrain Dopaminergic Neurons to Parkinson's Disease    Revealed by Single-Cell Genomics","We developed a novel protocol for the enrichment of midbrain DA neurons from frozen tissue. We subsequently performed single-nuclei RNA-sequencing on enriched samples from postmortem midbrain tissue from human, macaque,  tree shrew, rat, and mouse. We identified vulnerable and resistant populations from these data and associated genetic enrichments and differential","Not Applicable","Parkinson Disease","Cross-Sectional","Not Provided","RNA-Seq","5 phenotype datasets, 18 variables, 97 samples sequenced, 21 subjects, 97 samples","","NIA","HMB-MDS --- Health/Medical/Biomedical (MDS)","2022-07-28","2022-07-28","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs002478.v1.p1","iRHOM2 Deficiency Causes Environmentally Directed Immunodysregulatory    Disease","We have conducted a study of two kindreds each with a unique mutation in the gene RHBDF2 that encodes the protein iRHOM2. Whole exome (kindred 1) and whole genome sequencing  (kindred 2) have uncovered the first human loss-of-function mutations of RHBDF2 in 4 individuals. The affected patients are all children, 8 years old","Not Applicable","Immunologic Deficiency Syndromes","Case Set","WES_markerset_grc37, WGS_markerset_grc37","CNV Genotypes","5 phenotype datasets, 19 variables, 2 molecular datasets, 8 subjects, 8 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2022-07-28","2022-07-28","Respiratory Tract Infections; Antibody Deficiency Syndrome; Antibody Deficiency Syndromes; Deficiency Syndrome, Antibody; Deficiency Syndromes, Antibody; Syndrome, Antibody Deficiency",""
"phs002284.v1.p1","Single Cell, Whole Genome Analysis of the Aging Human Cardiomyocytes","In this study we have sequenced single cardiomyocytes from 12 individuals (ages from 0.4 to 82 yrs.). We have identified and characterized the somatic single-nucleotide variants (sSNVs). Our study indicates  that cardiomyocyte sSNVs increased with age with distinctive mutational signatures. Inclusion Criteria: accident and natural death Exclusion","Not Applicable","Myocytes, Cardiac","Control Set","Not Provided","WGS","4 phenotype datasets, 14 variables, 68 samples sequenced, 12 subjects, 68 samples","","NHLBI","HMB-PUB-GSO --- Health/Medical/Biomedical (PUB, GSO)","2022-07-28","2022-07-28","Not Provided",""
"phs002769.v1.p1","Multi-Omic Investigation of Beckwith-Wiedemann Syndrome Wilms Tumor","Wilms' Tumor (WT), also known as nephroblastoma, is one of the most common malignant kidney tumors diagnosed in children. One of the most common WT predisposition syndromes is Beckwith-Wiedemann Syndrome  (BWS, OMIM: 130650), which affects approximately 1/10,000 live births. In this study, we perform Whole Exome Sequencing (WES), DNA methylation array,","Not Applicable","Wilms Tumor","Tumor vs. Matched-Normal","MethylationEPIC, RNAseq_probe_set_grc37","Methylation (CpG), RNA Seq (NGS), WXS","4 phenotype datasets, 11 variables, 2 molecular datasets, 18 samples sequenced, 14 subjects, 27 samples","","NCI","GRU-PUB-COL-NPU --- General Research Use (PUB, COL, NPU)","2022-07-27","2022-07-27","Beckwith-Wiedemann Syndrome; BWS; Beckwith Wiedemann Syndrome; Beckwith's syndrome; Beckwith-Wiedemann syndrome chromosome region; EMG SYNDROME",""
"phs002903.v1.p1","The Role of CDX2 in Controlling ABCB1 Expression and Chemosensitivity in    Human Colon Cancer","This study reports the results of RNA sequencing (RNA-seq) experiments performed on two human colon cancer cell lines (HT-29, DLD-1) that were genetically engineered to achieve either the constitutive expression  (in HT-29 cells) or the selective inactivation (in DLD-1 cells) of the transcription factor CDX2, a master regulator of embryonic gut development and","Not Applicable","Colonic Neoplasms","Interventional","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 12 samples sequenced, 2 subjects, 12 samples","","NCI","GRU --- General Research Use","2022-07-26","2022-07-26","COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic; Cancers, Colon","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002966.v1.p1","Single-Cell Analysis of CD19-Specific CAR T Cell Treatment of    Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia","By leveraging single-cell transcriptome and T cell receptor (TCR) sequencing, we aimed to track the transcriptional signatures of chimeric antigen receptor (CAR) T cell clonotypes throughout the course of treatment  and furthermore identify molecular patterns leading to potent CAR T cell cytotoxicity. The data presented in this study encompass blood and bone","Not Applicable","Allergy and Immunology","Clinical Trial","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 15 variables, 200 samples sequenced, 16 subjects, 200 samples","","NCI","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2022-07-25","2022-07-25","Leukemia, B-Cell; B Cell Leukemia; B Lymphocytic Leukemia; B-Cell Leukemia; B-Cell Leukemias; B-Cell Lymphocytic Leukemia",""
"phs002817.v1.p1","Mutations in GNAI2 Cause Developmental Abnormalities and Immune    Dysregulation","To define a genetic syndrome of dysmorphism, brain malformations, skeletal defects, endocrine and immune dysfunction, 11 patients from 11 unrelated families who had similar features were studied. Whole exome sequencing  was performed to identify disease-causing mutations. A disease segregated with de-novo or autosomal dominant mutations in a single gene, GNAI2,","Not Applicable","Congenital Abnormalities","Family/Twin/Trios","WES_markerset_grc38","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 23 variables, 1 molecular datasets, 23 subjects, 23 samples","","NIAID","GRU --- General Research Use","2022-07-25","2022-07-25","Autoimmunity; Autoimmune condition; Autoimmune disease; Autoimmune disorder; Autoimmunities; Abnormalities, Congenital","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002931.v1.p1","Decade-Long Leukemia Remissions with Persistence of CD4+ CAR T-Cells","Two patients with chronic lymphocytic leukemia (CLL) were treated with CD19 targeted CAR T therapy and followed over several years. Peripheral blood from both patients at multiple time points was  collected, and 5' CITE-Seq with TCR profiling was performed on sorted CD3+CAR+ T cells at multiple time points. Here, we deposit the raw sequencing","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 6 samples sequenced, 2 subjects, 6 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-07-22","2022-07-22","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002250.v1.p1","CIDR: Discovery, Biology, and Risk of Inherited Variants in Glioma","This is a gliogene brain tumor family study. This study includes glioma cases with a family history of glioma in a first, second, or third degree relative.&#x000a0; Inclusion criteria: Glioma  cases with a reported family history of glioma Note for data in CDS: The raw sequencing files for this study are available via the NCI Cancer Data","Not Applicable","Glioma","Family/Twin/Trios","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 21 variables, 1 molecular datasets, 146 samples sequenced, 151 subjects, 146 samples","European (139), East Asian (2), African American (1), Hispanic1 (1), Hispanic2 (1), South Asian (1), Other (1)","NCI","GRU --- General Research Use","2022-07-22","2022-07-22","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002902.v1.p1","Ribosomal Depleted Total RNA-Seq of PBMCs and Skin from Controls and    Systemic Sclerosis Patients","This study involved prospective collection of skin biopsies and peripheral blood mononuclear cell (PBMC) samples from controls with no self-reported history of autoimmune or inflammatory disease and cases with Rheumatologist-confirmed  systemic sclerosis: limited cutaneous systemic sclerosis (lcSSc), diffuse cutaneous systemic sclerosis (dcSSc), very early diagnosis of systemic","Not Applicable","Scleroderma, Systemic","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 31 variables, 2 documents, 90 samples sequenced, 35 subjects, 90 samples","","NCATS","GRU --- General Research Use","2022-07-21","2022-07-21","Fibrosis; Scleroderma, Diffuse; Scleroderma, Limited; Diffuse Cutaneous Systemic Sclerosis; Diffuse Systemic Scleroses; Diffuse Systemic Sclerosis",""
"phs002336.v1.p1","NIDDK International IBD Genetics Consortium Repository Global Screening    Array","The purpose of this GWAS meta-analysis is to assess IBD risk alleles using data collected by members of the International IBD Genetics Consortium and their collaborators around the world. Data  from over 30 cohorts have been identified and are being combined for analysis. Genotyping has been conducted using a variety of chips with most","Not Applicable","Inflammatory Bowel Diseases","Case-Control","Global_Screening_Array-24","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 1 molecular datasets, 10503 subjects, 10503 samples","European (9216), African (21), East Asian (118), African American (344), Hispanic1 (134), Hispanic2 (376), Other Asian or Pacific Islander (86), South Asian (77), Other (131)","NIDDK","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS), DS-IBD-IRB-NPU --- Disease-Specific (Inflammatory Bowel Disease, IRB, NPU)","2022-07-18","2022-07-18","Ulcerative Colitis; CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's disease of colon",""
"phs002858.v1.p1","The Mood and Methylation Study (MMS)","The Mood Methylation Study (MMS) is an observational study designed to understand epigenetic mechanisms underlying major depression symptoms (MDD) using a co-twin control design. Twins enrolled in the MMS were  monozygotic (MZ) twin pairs discordant on lifetime history of MDD. All twins were members of the Washington State Twin Registry (WSTR), a","Not Applicable","Depression","Family/Twin/Trios","MethylationEPIC","Methylation (MREs), RNA-Seq","5 phenotype datasets, 19 variables, 1 molecular datasets, 136 samples sequenced, 138 subjects, 138 samples","","NIMH","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2022-07-15","2022-07-15","",""
"phs002944.v1.p1","Melanoma Brain Metastasis Single-Cell RNA Sequencing Atlas","Melanoma brain metastasis (MBM) frequently occurs in patients with advanced melanoma, yet our understanding of the underlying salient biology is rudimentary. Here, we performed single-cell/nucleus RNA-seq in 22 treatment-naive MBM  (scRNA-seq n 5; snRNA-seq n 17) and 10 extracranial melanoma metastases (ECM; all snRNA-seq), and matched spatial single-cell transcriptomics (n 16)","Not Applicable","Melanoma","Collection","Not Provided","ATAC-seq, OTHER, RNA-Seq","3 phenotype datasets, 13 variables, 105 samples sequenced, 35 subjects, 105 samples","","NCI","DS-M --- Disease-Specific (Melanoma)","2022-07-13","2022-07-13","Neoplasm Metastasis; Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant",""
"phs002401.v1.p1","High Glucose Macrophage Exosomes Enhance Atherosclerosis by Driving    Cellular Proliferation and Hematopoiesis","In this study, we aimed to explore whether hyperglycemia alters inflammatory properties and microRNA levels in immune cells as well as their extracellular vesicles (EVs) as a mode of intercellular  communication in cardiovascular disease. To this end, we isolated EVs from the plasma of diabetic mice as well as from human subjects that included 7","Not Applicable","Extracellular Vesicles","Case-Control","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 15 variables, 1 molecular datasets, 26 samples sequenced, 26 subjects, 26 samples","","NHLBI","GRU --- General Research Use","2022-07-13","2022-07-13","Diabetes Mellitus; Peripheral Arterial Disease; Arterial Disease, Peripheral; Arterial Diseases, Peripheral; Artery Disease, Peripheral; Artery Diseases, Peripheral","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000185.v8.p1","Genetic Studies in the Hutterites","We conducted genetic studies of disease-associated quantitative phenotypes, including microbiome and gene expression studies, and common diseases, such as asthma and Alzheimer's disease, by genotyping and/or sequencing in the Hutterites,  a founder population of European descent. The Hutterites who have participated in our studies live on communal farms in South Dakota and are related","Not Applicable","Prospective Studies","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37, WGS_markerset_grc37","AMPLICON, RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), WGS, WXS","14 phenotype datasets, 77 variables, 337 analyses, 4 molecular datasets, 1357 samples sequenced, 399 subjects, 1632 samples","","NHLBI","GRU-NPU --- General Research Use (NPU)","2022-07-08","2022-07-08","Asthma; Bronchial Hyperreactivity; Cardiovascular Diseases; Carotid Artery Diseases; AD; AD - Alzheimer's disease",""
"phs001392.v2.p1","Natural History Study of SCID Disorders","Individuals with a recent or new diagnosis of severe combined immune deficiency (including infants who were identified by newborn screening) may be eligible to be enrolled on the PIDTC research  study 6901. Speak to your doctor to determine if you or your child may be eligible. Protocol 6901 follows patients with SCID prospectively, meaning","Not Applicable","Severe Combined Immunodeficiency","Prospective Longitudinal Cohort","Not Provided","Not Provided","45 phenotype datasets, 3252 variables, 27 documents, 105 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2022-07-07","2022-07-07","Reticular dysgenesis; Combined Immunodeficiencies, Severe; Combined Immunodeficiency, Severe; Combined T-cell and B-cell immunodeficiency; Immunodeficiencies, Severe Combined; Immunodeficiency Syndrome, Severe Combined",""
"phs002842.v1.p1","Gene Expression in an African American Schizophrenia Dataset","Schizophrenia is a common and severe psychotic disorder. While some common SNPs and rare copy number variants have been identified as being significantly associated with disease risk, the biological mechanisms  remain largely undefined. To identify gene expression abnormalities in schizophrenia, we generated whole-genome gene expression profiles using RNAseq","Not Applicable","Schizophrenia","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 25 variables, 756 samples sequenced, 756 subjects, 756 samples","","NIMH","GRU --- General Research Use, DS-SZRD --- Disease-Specific (Schizophrenia and related disorders)","2022-07-06","2022-07-06","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder",""
"phs001326.v2.p1","A Retrospective and Cross-Sectional Analysis of Patients Treated for SCID    Since January 1, 1968","Individuals with a past diagnosis of severe combined immune deficiency (including many cases of ""leaky SCID"", Omenn syndrome, and reticular dysgenesis) who have undergone blood and marrow transplant, gene therapy,  or enzyme replacement in the past may be eligible for 6902. The purpose of 6902 is very similar to 6901, except 6902 is looking backwards at what has","Not Applicable","Severe Combined Immunodeficiency","Cross-Sectional","Not Provided","Not Provided","65 phenotype datasets, 4045 variables, 35 documents, 811 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2022-07-06","2022-07-06","Reticular dysgenesis; Combined Immunodeficiencies, Severe; Combined Immunodeficiency, Severe; Combined T-cell and B-cell immunodeficiency; Immunodeficiencies, Severe Combined; Immunodeficiency Syndrome, Severe Combined",""
"phs001310.v2.p1","PCD Longitudinal Prior to 10","Primary Ciliary Dyskinesia (PCD) is a genetic defect in airway host-defense, and typically results in chronic infection of the airways. Patients with PCD have chronic lung, sinus and ear infections.  This longitudinal study is designed to define the rate of progression of PCD lung function in participants prior to 10 years of age using special","Not Applicable","Kartagener Syndrome","Prospective Longitudinal Cohort","Not Provided","Not Provided","12 phenotype datasets, 1202 variables, 13 documents, 56 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2022-07-06","2017-10-23","Primary Ciliary Dyskinesia; Bronchiectasis, chronic sinusitis AND dextrocardia syndrome; DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS; Kartagener Triad; Kartagener's Syndrome; Kartagener's Triad",""
"phs001279.v2.p1","Cross-Sectional Characterization of Idiopathic Bronchiectasis","This GDMCC protocol will study adult patients with non-CF, idiopathic bronchiectasis, whose genetic etiologies are not known. Idiopathic bronchiectasis is reportedly more common in females with certain tall, thin body  types and associated with environmental organisms, such as nontuberculous mycobacterium (NTM). The other susceptibility factors predisposing to","Not Applicable","Bronchiectasis","Cross-Sectional","Not Provided","Not Provided","17 phenotype datasets, 2285 variables, 14 documents, 217 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2022-07-06","2018-02-09","Bronchiectases; Permanent enlargement of the airways of the lungs; Polynesian bronchiectasis",""
"phs000596.v2.p1","Longitudinal Study of PCD: 5-18 Years of Age","The purpose of this longitudinal study protocol is to define age-related prevalence of phenotypic characteristics and the progression of key features of lung disease in participants with one of these  disorders, Primary Ciliary Dyskinesia (PCD). In PCD, the abnormal structure and function of cilia results in impaired clearance of secretions and","Not Applicable","Ciliary Motility Disorders","Clinical Genetic Testing","Not Provided","Not Provided","17 phenotype datasets, 1529 variables, 16 documents, 124 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2022-07-06","2022-07-06","Ciliary Dyskinesia; Ciliary Dyskinesias; Ciliary Motility Disorder; Dextrocardia bronchiectasis and sinusitis; Dextrocardia-bronchiectasis-sinusitis syndrome; Disorder, Ciliary Motility",""
"phs000576.v2.p1","Angelman Syndrome Natural History Protocol","This study is a longitudinal multidisciplinary investigation on the natural history, morbidity and mortality of Angelman Syndrome (AS). We will collect detailed longitudinal data on a cohort of AS individuals  to gain a better understanding of the disease progression, and to follow the natural history of the clinical features of this cohort including","Not Applicable","Angelman Syndrome","Clinical Trial","Not Provided","Not Provided","21 phenotype datasets, 3361 variables, 23 documents, 300 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2022-07-06","2022-07-06","AS; Angelmans syndrome; Angelman syndrome chromosome region; Angelman's syndrome; Children, Puppet; HAPPY PUPPET SYNDROME",""
"phs002756.v1.p1","Characterizing the Role of the Immune Microenvironment in Multiple    Myeloma Progression at a Single Cell Level","The plasma cell disease multiple myeloma (MM) is highly dependent on its bone marrow microenvironment (BMME). Early alterations within the bone marrow microenvironment that contribute to the progression of multiple  myeloma (MM) from its precursor stages could hold the key to identifying novel therapeutic approaches, yet the intrinsic variability in cellular","Not Applicable","Multiple Myeloma","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 16 variables, 20 samples sequenced, 20 subjects, 20 samples","","NIGMS","GRU --- General Research Use","2022-07-01","2022-07-01","Monoclonal Gammopathy of Undetermined Significance; Smoldering Multiple Myeloma; Asymptomatic monoclonal gammopathy; Benign Monoclonal Gammapathies; Benign Monoclonal Gammapathy; Benign Monoclonal Gammopathies","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001874.v1.p1","Noncoding, Regulatory Mutations in Neurodevelopmental Disorders","This dbGaP study contains variant call files generated from whole-genome sequencing data of families with autism. The variant callers include FreeBayes, GATK, Platypus, and Strelka2. A family-level VCF file, from  each caller, is provided for each family in the study. The families included in this study are from the Simons Simplex Collection (SSC), the Study of","Not Applicable","Autistic Disorder","Case-Control","WGS_markerset_grc38","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 molecular datasets, 9945 subjects, 9945 samples","European (7431), African (34), East Asian (112), African American (400), Hispanic1 (281), Hispanic2 (554), Other Asian or Pacific Islander (231), South Asian (142), Other (262)","NIMH","DS-AUT --- Disease-Specific (Autism)","2022-07-01","2022-07-01","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile","dbGaP Collection: NIH Autism -omics Studies (phs000764.v1.p1)"
"phs002914.v1.p1","Ultrasensitive Profiling of UV Mutations in Facial Tumors in TSC","In this study we searched for mutations in the TSC2 and TP53 genes in sample sets from individuals with Tuberous Sclerosis Complex (TSC) and from subjects without TSC. The study  was focused on the analysis of TSC facial angiofibroma. All subjects provided informed consent for the analysis of their skin and other tissue","Not Applicable","Tuberous Sclerosis","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 15 variables, 106 samples sequenced, 36 subjects, 106 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2022-06-30","2022-06-30","Angiofibroma; Adenoma sebaceum syndrome; Bourneville Disease; Bourneville Phacomatosis; Bourneville Phakomatosis; Bourneville Pringle Disease",""
"phs002925.v1.p1","Genomic Analysis of Extra-Nodal Natural Killer/T-Cell Lymphoma (ENKTCL)","In this study, we performed extensive genetic profiling on 209 extra-nodal natural killer/T-cell lymphoma (ENKTCL) nasal-type cases, including 174 Chinese from four hospitals in China, and 31 Hispanic and 4  Caucasian patients from City of Hope and Eberhard Karls University of T&#x000fc;bingen. All of the cases were reviewed by experienced","Not Applicable","Lymphoma, Extranodal NK-T-Cell","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 27 variables, 209 samples sequenced, 209 subjects, 209 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2022-06-29","2022-06-29","Angiocentric T-Cell Lymphoma; Extranodal NK T Cell Lymphoma, Nasal; Extranodal NK T Cell Lymphoma, Nasal Type; Extranodal NK T Cell Lymphoma, Nasal and Nasal Type; Extranodal NK-T-Cell Lymphoma, Nasal; Extranodal NK-T-Cell Lymphoma, Nasal Type",""
"phs002548.v1.p1","Transcriptome of Chronic Pain and Disease","The Functional Genomics Section (FGS) is a part of the National Institute of Dental and Craniofacial Research (NIDCR) within the National Institutes of Health (NIH). Research at the FGS focuses  on understanding the mechanics involved in nociception through both clinical samples from patients with chronic pain and mouse models of pain. Pain","Not Applicable","Diabetic Neuropathies","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 12 samples sequenced, 12 subjects, 12 samples","","NIDCR","GRU --- General Research Use","2022-06-29","2022-06-29","Pain; Symmetric Diabetic Proximal Motor Neuropathy; Symmetric proximal motor neuropathy with diabetes mellitus; Pain, Splitting; Pains, Splitting; Splitting Pains",""
"phs002015.v2.p1","National Eye Institute (NEI) Age-Related Eye Disease Study 2 (AREDS2)","The Age-Related Eye Disease Study 2 (AREDS2) was a multi-center, randomized Phase III clinical trial designed to assess the effects of oral supplementation of high doses of lutein, zeaxanthin, and  omega-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EPA]) in reducing the risk of progression to late age-related macular","Not Applicable","Macular Degeneration","Case Set","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","41 phenotype datasets, 1844 variables, 15 documents, 1 molecular datasets, 97 images, 1363 samples sequenced, 4203 subjects, 1363 samples","","NEI","GRU-IRB-PUB --- General Research Use (IRB, PUB), DS-ED-IRB-PUB --- Disease-Specific (Eye Disease, IRB, PUB)","2022-06-27","2022-06-27","CRYGS cataract (disease); CTRCT20; Cataract, Membranous; Cataracts, Membranous; Membranous Cataract; Membranous Cataracts",""
"phs002654.v1.p1","Genetic Study of Northern Kenya Pastoral Populations","Human populations in Africa are the most genetically diverse in the world, having a rich history, and yet are severely understudied. The purpose of this study is to understand the  population history of four ethnolinguistic groups in northern Kenya - the Turkana, Samburu, Rendille, and Borana. This study aims to measure the","Not Applicable","Population Groups","Control Set","Multi-Ethnic_Global","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 376 subjects, 378 samples","","NIGMS","GRU-COL-NPU --- General Research Use (COL, NPU)","2022-06-24","2022-06-24","Not Provided",""
"phs002128.v1.p1","Identification and Molecular Characterization of Somatic Mutations in    Malformations of Cortical Development","Genetic mutations causing disease may be inherited, newly acquired in parental gametes and present in the zygote or acquired as somatic events at some point in development after fertilization. The  burden and localization of an acquired mutation depend on when the mutation arises. As is the case for inherited genetic variation, there is","Not Applicable","Malformations of Cortical Development","Case Set","Not Provided","WXS","4 phenotype datasets, 12 variables, 188 samples sequenced, 114 subjects, 188 samples","","NINDS","GRU --- General Research Use, DS-EP --- Disease-Specific (Epilepsy)","2022-06-17","2022-06-17","Cortical Dysplasia-Focal Epilepsy Syndrome; Hemimegalencephaly; CDFE SYNDROME; CDFES; CNTNAP2-related DEE; PTHSL1","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002678.v1.p1","Microbiome-Host Interactions in Oral Squamous Cell Carcinoma: a    Metatranscriptomic Exploratory Study","Oral cancer (predominantly squamous cell carcinoma; OSCC) is the 14th most prevalent malignancy worldwide, accounting for more than 300,000 new cases and 145,000 deaths annually. Despite advances in cancer treatment  modalities, OSCC continues to have poor prognosis with 5-year survival rates less than 50%. Although use of tobacco and alcohol consumption","Not Applicable","Head and Neck Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq","4 phenotype datasets, 22 variables, 60 samples sequenced, 40 subjects, 60 samples","","NIDCR","HMB --- Health/Medical/Biomedical, MIC-HMB --- Use of the data is limited to microbial sequences for health/medical/biomedical purposes","2022-06-10","2022-06-10","Mouth Neoplasms; Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinoma, Squamous Cell; Carcinomas, Epidermoid",""
"phs002456.v1.p1","Integrated Genomic Analyses of Cutaneous T Cell Lymphomas Reveal the    Molecular Bases for Disease Heterogeneity","Cutaneous T cell lymphomas (CTCLs) are a clinically diverse collection of lymphomas of the skin-homing T cell. In the present study, we performed DNA and RNA sequencing on a cohort  of CTCLs with representative samples from varying disease subtypes and stages. We characterized the landscape of putative driver genes, identified","Not Applicable","Lymphoma, T-Cell, Cutaneous","Case Set","Not Provided","RNA-Seq, WGS, WXS","4 phenotype datasets, 17 variables, 255 samples sequenced, 103 subjects, 255 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2022-06-10","2022-06-10","Cutaneous T Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Granulomatous Slack Skin; Slack Skin, Granulomatous; CTCL / Sezary syndrome",""
"phs002766.v1.p1","Generation of a Cellular Atlas of Human Adipose Tissue","White adipose tissue (WAT), once regarded as morphologically and functionally bland, is now recognized to be dynamic, plastic, heterogenous, and involved in a wide array of biological processes including energy  homeostasis, glucose and lipid handling, blood pressure control, and host defense.&#x000a0; High fat feeding and other metabolic stressors cause","Not Applicable","Adipose Tissue, White","Collection","HumanOmniExpress-12","SNP Genotypes (Array), RNA-Seq","5 phenotype datasets, 19 variables, 1 molecular datasets, 133 samples sequenced, 65 subjects, 176 samples","European (28), East Asian (2), African American (5), Hispanic1 (3), Hispanic2 (1), Other (4)","NIDDK","GRU --- General Research Use","2022-06-09","2022-06-09","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002716.v1.p1","Genetics of Hypertension Associated Treatment (GenHAT) Study, Genomic    Background of Blood Pressure Response to Treatment in African    Americans","The GenHAT study is an ancillary pharmacogenomics study to the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT was a randomized, double-blind, multi-center trial that enrolled  42,418 participants &#x02265;55 years of age with hypertension and at least one additional risk factor for cardiovascular disease (CVD). Participants","Not Applicable","Blood Pressure","Clinical Trial","MEGA_Consortium_Array","SNP Genotypes (Array)","14 phenotype datasets, 149 variables, 1 molecular datasets, 6908 subjects, 11187 samples","European (23), African (427), African American (6013), Hispanic1 (345), Hispanic2 (22), South Asian (1), Other (77)","NHLBI","GRU-IRB --- General Research Use (IRB)","2022-06-09","2022-06-09","Cardiovascular Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs002599.v1.p1","NCI CCSG CCDI Supplement Additional Genomic Submission","The implementation of targeted therapies for acute myeloid leukaemia (AML) has been challenging because of the complex mutational patterns within and across patients as well as a dearth of pharmacologic  agents for most mutational events. This supplement data from the Beat AML program provides Adolescent and Young Adult (AYA) and pediatric tumor","Not Applicable","Leukemia, Myeloid, Acute","Case Set","Not Provided","RNA-Seq, Targeted-Capture, WXS","3 phenotype datasets, 7 variables, 152 samples sequenced, 104 subjects, 203 samples","","NCI","GRU --- General Research Use","2022-06-09","2022-06-09","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002598.v1.p1","Inherited Defect in ST6GalNAc1 Reveals Roles of Sialylation in Intestinal    Homeostasis","We have conducted a study of patients with unique mutations in the gene ST6GALNAC1 that encodes the protein ST6GALNAC1 (ST6). Exome sequencing was used to screen worldwide inflammatory bowel disease  cohorts, which identified human loss of function mutations of ST6 in individual patients. The affected patients had very early onset ( 6 years old)","Not Applicable","Inflammatory Bowel Diseases","Family/Twin/Trios","WES_markerset_grc37","CNV Genotypes","5 phenotype datasets, 22 variables, 1 molecular datasets, 3 subjects, 3 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2022-06-09","2022-06-09","",""
"phs002297.v2.p1","The Immune Microenvironment Shapes Transcriptional and Genetic    Heterogeneity in Chronic Lymphocytic Leukemia","Tumor microenvironment (TME) and somatic mutations drive progression of chronic lymphocytic leukemia (CLL). Integrated bulk and single-cell RNA sequencing (RNA-seq) of paired peripheral blood (PB) and lymph node (LN) samples  from patients with treatment-na&#x000ef;ve CLL showed upregulation of oncogenic processes in LN attributable to a minor population of activated tumor","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Tumor vs. Matched-Normal","Not Provided","WXS","4 phenotype datasets, 15 variables, 57 samples sequenced, 21 subjects, 57 samples","","NHLBI","GRU --- General Research Use","2022-06-09","2022-04-01","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002753.v1.p1","Ameloblastoma Cell Line Resource","Ameloblastoma (AB) is an odontogenic tumor that is locally destructive to the jaw bone. Treatment entails surgical resection, but AB often recurs locally. Recent driver mutations have been identified in  the MAPK and Hedgehog pathways. However, translation to molecularly-targeted therapies has been hampered by the lack of AB cell line models. The goal","Not Applicable","Ameloblastoma","Case Set","Not Provided","RNA-Seq, Targeted-Capture","4 phenotype datasets, 16 variables, 1 documents, 8 samples sequenced, 6 subjects, 8 samples","","NIDCR","DS-ODON --- Disease-Specific (Odontogenic Tumors)","2022-06-08","2022-06-08","Odontogenic Tumors; Dental Tissue Neoplasm; Dental Tissue Neoplasms; Neoplasm, Dental Tissue; Neoplasms, Dental Tissue; Tissue Neoplasm, Dental",""
"phs000454.v2.p2","Genome-Wide Association Study of HIV-1 Host Genetics Among Injection Drug    Users","The overarching goal of this project is to identify and characterize genetic determinants of HIV 1 susceptibility and resistance in samples of African American (AA) and European American (EA) injection  drug users (IDUs) by conducting (1) a case/control genome-wide association (GWA) study of HIV 1 infection (positive/negative); (2) a case-only GWA","Not Applicable","HIV","Case-Control","HumanOmni1-Quad, HumanOmni2.5-8","SNP/CNV (Array)","4 phenotype datasets, 70 variables, 1 molecular datasets, 6207 subjects, 6207 samples","European (2619), African (79), African American (3304), Hispanic1 (59), Hispanic2 (90), Other Asian or Pacific Islander (4), South Asian (1), Other (51)","NIDA","HMB-NPU --- Health/Medical/Biomedical (NPU)","2022-06-08","2022-06-08","Substance Abuse, Intravenous; Viral Load; Intravenous Substance Abuse; Burden, Viral; Load, Viral; Quantity concentration of viral nucleic acid in specimen",""
"phs002833.v1.p1","A Phase 2 Study of Lamivudine in Patients with p53 Mutant Metastatic    Colorectal Cancer","This was an open-label, single-arm Phase II study of lamivudine in patients who had progressed on systemic therapy for advanced colorectal cancer with TP53 mutations. The phase II study had  a two-stage design, with a target accrual of 20 evaluable patients for the first stage and a total of 32 patients for the whole study. The first 9","Not Applicable","Colorectal Neoplasms","Clinical Trial","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 17 variables, 67 samples sequenced, 31 subjects, 67 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-06-07","2022-06-07","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001813.v3.p1","Integrative Tissue Analysis of Men with Prostate Cancer","Prostate cancer is readily curable if detected early. The goal of this research is to assess the molecular alterations that contribute to prostate cancer development, and how the interaction of  tumor-cell autonomous alterations and immune cell proportions contribute to the predictability of recurrence. Inclusion: Men diagnosed with localized","Not Applicable","Prostatic Neoplasms","Case Set","Not Provided","AMPLICON, RNA-Seq, WGS, WXS","5 phenotype datasets, 20 variables, 1366 samples sequenced, 255 subjects, 1624 samples","","NCI","GRU --- General Research Use","2022-06-07","2019-09-09","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002818.v1.p1","Intercepting Progression from Pre-Invasive to Invasive Lung    Adenocarcinoma","An improved understanding of the biology of lung cancer is needed to intercept the disease at an early point in its progression. In this project we have used multidimensional methods  to profile the tumor microenvironment (TME) and to determine the crosstalk between cancer cells and the TME in pre-invasive to invasive human lung","Not Applicable","Lung Neoplasms","Tumor vs. Matched-Normal","Not Provided","WXS","4 phenotype datasets, 18 variables, 84 samples sequenced, 42 subjects, 84 samples","","NCI","GRU --- General Research Use","2022-06-06","2022-06-06","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001977.v1.p1","Large Cancer Fingerprint Screening for Detection of Minimal Residual    Disease.","We describe an approach for large cancer fingerprint screening and its application to cell-free DNA from patients with cancer. Our approach involves tracking somatic mutations identified from patients' tumor biopsies,  in the cell-free DNA from a blood draw. All patients provided written informed consent to allow the collection of blood and/or tumor tissue and","Not Applicable","Neoplasms","Case-Control","Not Provided","Targeted-Capture, WGS, WXS","4 phenotype datasets, 11 variables, 788 samples sequenced, 158 subjects, 788 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB --- Health/Medical/Biomedical","2022-06-06","2022-06-06","Neoplasm Metastasis; Metastase; Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002380.v1.p1","Characterizing TP53 and PPM1D Mutations as Resistance Drivers to    Radiation Therapy in Diffuse Intrinsic Pontine Gliomas","Pediatric high-grade gliomas (pHGGs), encompassing diffuse midline gliomas (DMGs) and hemispheric tumors, represent the most common cause of cancer-related deaths in children age 0-14 years. Over the last decade, several  landmark papers have revealed recurrent single nucleotide variants (SNVs) in the core histones H3.3 and H3.1, co-occurring with alterations in the","Not Applicable","Brain Neoplasms","Case Set","WGS_markerset_grc37","RNA-Seq, SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 17 variables, 1 molecular datasets, 115 samples sequenced, 61 subjects, 122 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-05-26","2022-05-26","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Glioma; Neoplasm of Neuroglia","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002305.v1.p1","Washington University PDX Development and Trial Center","This data set is a collection of patient specimens from common and rare cancers that have been developed into patient-derived xenograft (PDX) models at the Washington University PDX Development and  Trial Center (WU-PDTC). The goal of the PDTC is to develop and characterize PDX models, gaining insight into tumor biology, and validating biomarkers","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Provided","4 phenotype datasets, 27 variables, 127 subjects, 495 samples","","NCI","GRU --- General Research Use, DS-SARC --- Disease-Specific (Sarcoma)","2022-05-26","2022-05-26","Bone Neoplasms; Gastrointestinal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Rectal Neoplasms; Soft Tissue Neoplasms","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002876.v1.p1","CTN - 0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid    Treatment (X:BOT)","The overarching goal of CTN-0051 is to foster adoption of new relapse-prevention pharmacotherapies in community-based treatment programs (CTPs) where these could have a substantial public health impact. To this end  CTN-0051 will assess the comparative effectiveness of extended-release injectable naltrexone (XR-NTX, Vivitrol&#x000ae;), an opioid antagonist","Not Applicable","Opioid-Related Disorders","Clinical Trial","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 65 variables, 3 documents, 1 molecular datasets, 638 subjects, 615 samples","European (429), African (1), East Asian (3), African American (61), Hispanic1 (41), Hispanic2 (46), Other Asian or Pacific Islander (5), South Asian (3), Other (26)","NIDA","GRU --- General Research Use","2022-05-25","2022-05-25","Addiction, Opiate; Dependence, Opiate; Opiate Addiction; Opiate Dependence; Opioid Related Disorders; Opioid-Related Disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs002780.v1.p1","IFN-&#x003b3; and TNF-&#x003b1; drive a CXCL10+ CCL2+ Macrophage Phenotype Expanded in    Severe COVID-19 Lungs and Inflammatory Diseases with Tissue    Inflammation","We explored how the human macrophages response to different inflammatory factors, focusing particularly on the effects of antiviral interferons (IFN-&#x003b2; and IFN-&#x003b3;), pro-inflammatory cytokines such as TNF-&#x003b1;, and other mediators  like IL-4. Co-cultured fibroblasts were a component in some conditions to generate factors produced by resident stroma. We used a single-cell","Not Applicable","Inflammation","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 10 variables, 4 samples sequenced, 4 subjects, 4 samples","","NIAMS","GRU --- General Research Use","2022-05-25","2022-05-25","Arthritis, Rheumatoid; COVID-19; Colitis, Ulcerative; Lupus Erythematosus, Systemic; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection",""
"phs001473.v2.p2","Clonal Evolution and Transcriptomic Analysis of Chronic Lymphocytic    Leukemia Treated with Ibrutinib","Disease progression has been increasingly appreciated with the use of ibrutinib to treat chronic lymphocytic leukemia (CLL). Understanding the pattern of clonal evolution and transcriptomic changes during the early treatment  period with ibrutinib may provide insight into the mechanisms of resistance. We performed whole exome sequencing on sequential samples with matched","Not Applicable","Leukemia, Lymphoid","Prospective Longitudinal Cohort","Not Provided","Bisulfite-Seq, RNA-Seq, WXS","4 phenotype datasets, 14 variables, 312 samples sequenced, 77 subjects, 317 samples","","NCI","GRU --- General Research Use","2022-05-25","2021-02-02","Leukemia, Lymphocytic; Leukemias, Lymphocytic; Leukemias, Lymphoid; Lymphatic leukemia; Lymphocytic Leukemia; Lymphocytic Leukemias","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002816.v1.p1","Genetic Diseases of Immune Homeostasis and Autoimmunity Caused by GIMAP    Deficiency","We investigated 17 affected individuals in 9 kindreds with lymphopenia, splenomegaly, liver disease, thrombocytopenia, lymphadenopathy, severe recurrent lung infections, skin diseases, and lymphoma. Whole-exome sequencing of the cohort revealed mutations  in GIMAP5. We also found another patient from one kindred with a unique mutation in the gene GIMAP6, discovered by whole-exome sequencing. A","Not Applicable","Immune System Diseases","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 molecular datasets, 23 subjects, 23 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2022-05-24","2022-05-24","Hypertension, Pulmonary; Respiratory Tract Infections; Disease, Immune; Disease, Immune System; Disease, Immunologic; Disease, Immunological",""
"phs002472.v1.p1","Airway Epithelial Cell Culture RNA Expression","This study seeks to characterize airway epithelial mRNA and miRNA expression under a variety of experimental conditions. Samples are available from primary human cell cultures as well as cell lines  grown under a variety of experimental conditions as documented in the phenotype and conditions associated with each individual sample. For some","Not Applicable","Head and Neck Neoplasms","Collection","Not Provided","RNA-Seq, WXS, miRNA-Seq","5 phenotype datasets, 15 variables, 159 samples sequenced, 39 subjects, 159 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2022-05-24","2022-05-24","Lung Neoplasms; Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung",""
"phs001751.v1.p1","Rare Disease Susceptibility Variants in Children with Crohn's Disease.","We performed targeted, massively-parallel sequencing of 101 genes in 205 children with Crohn's disease, including 179 parent-child trios and 200 controls, both of European ancestry. We identified three genes with  nominally significant p-values: NOD2, RTKN2, and MGAT3. Only NOD2 was significant after correcting for multiple comparisons. We identified eight","Not Applicable","Crohn Disease","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), Targeted-Capture","5 phenotype datasets, 22 variables, 1 molecular datasets, 763 samples sequenced, 763 subjects, 763 samples","","NIDDK","DS-CROHN-IRB-PUB-NPU --- Disease-Specific (Crohn's Disease, IRB, PUB, NPU)","2022-05-20","2022-05-20","CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's disease of colon; Crohn's disease of large bowel",""
"phs002804.v1.p1","DNA Double Strand Breaks in KMT2A-Rearranged AML patients","DNA breakage at specific rearrangement-participating genes, which are more sensitive to a range of environmental and chemotherapeutic agents than other regions of the human genome, contributes to the generation of  leukemia-causing rearrangements, and can be used as a predictor of susceptibility to cancer caused by gene rearrangements. As a direct","Not Applicable","DNA Breaks, Double-Stranded","Case-Control","Not Provided","OTHER","4 phenotype datasets, 10 variables, 6 samples sequenced, 6 subjects, 6 samples","","NCI","GRU --- General Research Use","2022-05-19","2022-05-19","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001431.v2.p1","Whole Exome and Whole Genome Profiling as well Genome-Wide Methylation    Profiling from Early to Advanced Chronic Lymphocytic leukemia (CLL),    Genome-Wide Methylation Profiling in Monoclonal B Cell Lymphocytosis    (MBL)","Serial whole exome sequencing of samples collected from 21 patients at multiple time points during progression from early to late chronic lymphocytic leukemia (CLL) and one matching non-tumor tissue sample  from each patient. Additional whole genome sequencing of samples from 3 selected patients. Genome-wide B cell methylation compared between 5 healthy","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case Set","Not Provided","Bisulfite-Seq, RNA-Seq, WGS, WXS","4 phenotype datasets, 14 variables, 227 samples sequenced, 35 subjects, 227 samples","","NCI","GRU --- General Research Use","2022-05-19","2021-12-06","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002852.v1.p1","A Pilot Study of NKTR-214 and Nivolumab in Selected Patients with Locally    Advanced/Metastatic Sarcoma","Study cohort comprises samples derived from patients that received treatment on an open-label, non-randomized, non-comparative pilot study of bempegaldesleukin, a CD122-preferential interleukin-2 pathway agonist, with nivolumab in refractory sarcoma at  Memorial Sloan Kettering/MD Anderson Cancer Centers (NCT03282344). Patient tumors include a variety of sarcoma subtypes. Samples include whole exome","Not Applicable","Sarcoma","Clinical Trial","Not Provided","AMPLICON, RNA-Seq, WXS","4 phenotype datasets, 15 variables, 195 samples sequenced, 54 subjects, 195 samples","","NCI","DS-SARC-PUB --- Disease-Specific (Sarcoma, PUB)","2022-05-18","2022-05-18","Sarcoma, Spindle Cell; Sarcomas, Spindle Cell; Spindle Cell Sarcomas; spindle cell sarcoma",""
"phs002734.v1.p1","Rapid Idiosyncratic Mechanisms of Clinical Resistance to KRAS G12C    Inhibition","Using deep RNA and whole exome sequencing of pre- and post-treatment autopsy samples, we reveal diverse clonal populations that occurred through altered cell intrinsic, tumor microenvironment and immunologic remodeling mechanisms  of resistance. Deceased lung cancer patient treated at UNC hospitals Related Genes: KRAS, MAPK1, YAP1 Principal Investigator: Chad Pecot, MD,","Not Applicable","Adenocarcinoma of Lung","Case Set","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets, 42 samples sequenced, 1 subjects, 42 samples","","NCI","GRU --- General Research Use","2022-05-18","2022-05-18","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002528.v1.p1","Neuropsychiatric Genetics of African Populations - Psychosis    (NeuroGAP-Psychosis)","The NeuroGAP-Psychosis study was conducted in South Africa, Kenya, Uganda and Ethiopia as a response to the lack of genetic diversity in large genomic studies of psychiatric disorders. The study  aims to expand knowledge of the genetic and environmental risk factors for neuropsychiatric disorders in Africa through large-scale sample collection","Not Applicable","Psychotic Disorders","Case-Control","Global_Screening_Array-24","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 1 molecular datasets, 900 subjects, 900 samples","European (4), African (186), African American (664), Hispanic1 (12), Other (34)","NIMH","GRU --- General Research Use, HMB-MDS --- Health/Medical/Biomedical (MDS), DS-MLHLTH-MDS --- Disease-Specific (Mental Health, MDS)","2022-05-18","2022-05-18","Bipolar and Related Disorders; Schizophrenia Spectrum and Other Psychotic Disorders; Illness, Mental; Mental Disorder; Mental Disorders; Mental Dysfunction",""
"phs002219.v1.p1","Genetic Study of Present-Day Populations of Northern Kenya","Human populations in Africa are the most genetically diverse in the world, having a rich history, and yet are severely understudied. The purpose of this study is to understand the  population history of the Turkana. This study aims to measure the extent of genetic variation using whole genome and whole exome sequencing in this","Not Applicable","Population Groups","Control Set","Not Provided","WGS, WXS","4 phenotype datasets, 16 variables, 290 samples sequenced, 82 subjects, 290 samples","","NIGMS","GRU-COL-NPU --- General Research Use (COL, NPU)","2022-05-18","2022-05-18","Not Provided",""
"phs002846.v1.p1","Pharmacogenomics of Mercaptopurine Intolerance in Children with Acute    Lymphoblastic Leukemia (AALL03N1)","Mercaptopurine (MP) is the mainstay of curative therapy for acute lymphoblastic leukemia (ALL). We performed a genome-wide association study (GWAS) to comprehensively identify the genetic basis of MP intolerance in  children with ALL in AALL03N1. MP dose intensity was defined as prescribed dose divided by the planned protocol dose during maintenance","Not Applicable","Mercaptopurine","Clinical Trial","HumanExome-12, Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 11 variables, 2 molecular datasets, 657 subjects, 650 samples","European (216), African (5), East Asian (44), African American (108), Hispanic1 (11), Hispanic2 (201), Other Asian or Pacific Islander (19), South Asian (34), Other (13)","NIGMS","HMB --- Health/Medical/Biomedical","2022-05-17","2022-05-17","Drug Tolerance; Precursor Cell Lymphoblastic Leukemia-Lymphoma; ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia",""
"phs002754.v1.p1","PROGRESS/ELEMENT DNA Methylation Study","An extension to the Early Life Exposures in Mexico to Environmental Toxicants (ELEMENT) birth cohort of Mexico City, the Programming Research in Obesity, GRowth, Environment and Social Stress (PROGRESS) Cohort  is an ongoing longitudinal pre-birth cohort, established in 2006 in Mexico City, partnering Icahn School of Medicine at Mount Sinai with Harvard","Not Applicable","Obesity","Prospective Longitudinal Cohort","MethylationEPIC","Methylation (CpG)","4 phenotype datasets, 20 variables, 1 molecular datasets, 1001 subjects, 1184 samples","","NIEHS","HMB --- Health/Medical/Biomedical","2022-05-17","2022-05-17","Asthma; Cardiovascular Diseases; Diabetes Mellitus; Metabolic Syndrome; Airway hyperreactivity; Asthma, Bronchial",""
"phs002783.v1.p1","Pan Cancer Investigation of Human Leukocyte Antigen Loss of    Heterozygosity","Cancer cells can escape immune recognition through human leukocyte antigen (HLA) loss of heterozygosity (LOH) which results in deletion of HLA alleles, causing a reduction in presentation of tumor neoantigens.  Despite its influence on immunotherapy response, few methods exist to detect HLA LOH, and accuracy of the approaches is poorly defined. Here, we","Not Applicable","HLA Antigens","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 1118 samples sequenced, 559 subjects, 1118 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2022-05-13","2022-05-13","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs002717.v1.p1","Study of Cutaneous Biology of Cutaneous T Cell Lymphoma","This study is designed to help us understand the biological factors that contribute to the development of Cutaneous T Cell Lymphoma (CTCL) through the use of single-cell -omics technologies. The  data that will be available include single-cell RNAseq and paired single-cell TCRseq data from the primary lesions of CTCL patients. The number of","Not Applicable","Lymphoma, T-Cell, Cutaneous","Case Set","RNAseq_probe_set_grc38","OTHER, RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 17 variables, 1 molecular datasets, 3 samples sequenced, 3 subjects, 9 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2022-05-13","2022-05-13","Granulomatous Slack Skin; Slack Skin, Granulomatous",""
"phs001073.v3.p1","Epigenetic Analysis of Malnutrition","The PROVIDE study (Dhaka, Bangladesh) is a randomized clinical trial platform which evaluated the efficacy of delayed-dose oral rotavirus vaccine as well as the benefit of an injectable polio vaccine  replacing one dose of oral polio vaccine. This rigorous infrastructure supported the additional examination of hypotheses of vaccine","Not Applicable","Growth Disorders","Clinical Trial","Not Provided","ChIP-Seq, WCS","5 phenotype datasets, 41 variables, 14 documents, 156 samples sequenced, 66 subjects, 156 samples","","NICHD","HMB-IRB --- Health/Medical/Biomedical (IRB)","2022-05-13","2018-11-13","Digestive System Diseases; Disorders of Environmental Origin; Immune System Diseases; Malnutrition; Nervous System Diseases; Nutritional and Metabolic Diseases",""
"phs000879.v2.p1","DFCI Brown Lab CLL Sequencing Study","Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by accumulation of CD5+CD19+ B cells in peripheral lymphoid organs, bone marrow and blood. In this study we analyze matched whole  genome sequencing and RNA-seq data from CLL patients to characterize the mutational processes operative throughout tumor evolution. Source of tumor","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WGS, WXS","4 phenotype datasets, 11 variables, 156 samples sequenced,  SRA, 58 subjects, 156 samples","","NHGRI","GRU --- General Research Use","2022-05-13","2015-11-04","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs002803.v1.p1","A Phase II Clinical Trial of the PARP Inhibitor Talazoparib in BRCA1 and    BRCA2 Wild-Type Patients","The Talazoparib Beyond BRCA (TBB), a phase II proof-of-concept clinical trial, was designed to test the efficacy of talazoparib, a potent, orally bioavailable PARP inhibitor, with an established Phase II  recommended dose, in the treatment of advanced BRCA wildtype (WT), HER2-negative breast cancer and other solid tumors with homologous recombination","Not Applicable","Breast Neoplasms","Clinical Trial","Not Provided","OTHER, WXS","4 phenotype datasets, 43 variables, 89 samples sequenced, 20 subjects, 89 samples","","NCI","GRU --- General Research Use","2022-05-12","2022-05-12","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001897.v2.p1","Regulatory and Effector T cells in Oral Immunotherapy for Food Allergy","This study consisted of a clinical trial for peanut oral immunotherapy (OIT) and a follow-up project (see below). Patients were included from 2013-2015, and samples from the last timepoints were  collected in 2017. The study focused on peanut-specific CD4+ T cell responses before, during, and after OIT with peanut protein. We analyzed T cell","Not Applicable","Peanut Hypersensitivity","Clinical Trial","target_markerset_grc37","AMPLICON, RNA-Seq, Custom targeted DNA/RNA sequencing","4 phenotype datasets, 20 variables, 2 molecular datasets, 273 samples sequenced, 75 subjects, 529 samples","","NIAID","DS-PH --- Disease-Specific (Peanut Hypersensitivity)","2022-05-12","2022-05-12","Food Hypersensitivity; Allergies, Food; Allergy, Food; Food Hypersensitivities; Food allergies; Food allergy",""
"phs002847.v1.p1","Circulating Tumor DNA as a Biomarker in Patients with Stage III and IV    Wilms Tumor: Analysis from a Children's Oncology Group Trial, AREN0533","We evaluated the utility of circulating tumor DNA (ctDNA) as a biomarker in the serum and urine of 50 patients with Stage III or Stage IV Wilms tumor (WT) that  were enrolled on Children's Oncology Group&#x000a0;(COG) trial AREN0533. 49 out of 50 patients had matched tumor samples available for comparison. We","Not Applicable","Wilms Tumor","Case Set","Not Provided","Targeted-Capture, WGS","4 phenotype datasets, 12 variables, 149 samples sequenced, 50 subjects, 149 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-05-11","2022-05-11","Embryonal adenosarcoma; Embryonal nephroma; Kidney Nephroblastoma; NEPHROBLASTOMA; Nephroblastoma (Wilms tumor); Nephroblastomas","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002764.v1.p1","Dissecting Cell Composition and Drug Sensitivity in Human Adenoid Cystic    Carcinomas (ACCs)","The study reports the results of single-cell RNA sequencing (scRNA-seq), RNA sequencing (RNA-seq), and whole-exome sequencing (WES) experiments performed on malignant cells isolated by flow cytometry from seven patient-derived xenograft  (PDX) lines established from human Adenoid Cystic Carcinomas (ACCs). Of these seven lines, five are characterized by well differentiated histology","Not Applicable","Carcinoma, Adenoid Cystic","Xenograft","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 18 variables, 25 samples sequenced, 7 subjects, 25 samples","","NIDCR","GRU --- General Research Use","2022-05-11","2022-05-11","Salivary Gland Neoplasms; Adenocarcinoma, cylindroid; Adenocystic Carcinoma; Adenocystic Carcinomas; Adenoid Cystic Carcinomas; Carcinoma, Adenocystic","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002725.v1.p1","Novel Gene-Environment Regulatory Circuit in Chamber-Specific Growth of    Perinatal Heart","We report a case of hypertrophic cardiomyopathy and lactic acidosis in a 3-year-old female. Cardiac and skeletal muscle biopsies exhibited mitochondrial hyperplasia with decreased complex VI activity. Whole exome sequencing  identified compound heterozygous variants, p.Arg333Trp and p.Val119Leu, in TSFM, a nuclear gene that encodes a mitochondrial translation elongation","Not Applicable","Cardiomyopathy, Hypertrophic","Mendelian","Not Provided","WXS","5 phenotype datasets, 23 variables, 2 samples sequenced, 2 subjects, 2 samples","","NHLBI","HMB-IRB-MDS-GSO --- Health/Medical/Biomedical (IRB, MDS, GSO)","2022-05-11","2022-05-11","Not Provided",""
"phs002771.v1.p1","SLAMF7 Regulates Synovial Macrophages in Rheumatoid Arthritis","The purpose of this study was to characterize the role of SLAMF7 on human macrophages. RNA-sequencing was performed on myeloid populations from blood of healthy controls or rheumatoid arthritis patients,  or synovial fluid of rheumatoid arthritis patients, based on high or low expression of SLAMF7. Then, monocyte-derived macrophages from healthy","Not Applicable","Arthritis","Case-Control","Not Provided","RNA-Seq","6 phenotype datasets, 25 variables, 99 samples sequenced, 17 subjects, 99 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2022-05-09","2022-05-09","Osteoarthritis; Rheumatoid Arthritis; Oligoarthritides; Oligoarthritis; Pauciarthritis; Arthritides, Degenerative",""
"phs002416.v2.p1","Characterization of CNS Metastases","Metastatic disease to the central nervous system (CNS) is devastating, with a poor prognosis. There are limited treatment options for patients with CNS metastases, and in particular with leptomeningeal carcinomatosis  (LMD). In this study, we evaluated the molecular and cellular features of parenchymal brain metastases and LMD. We used single-cell RNA and cell-free","Not Applicable","Meningeal Carcinomatosis","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 71 samples sequenced, 46 subjects, 71 samples","","NCI","GRU --- General Research Use","2022-05-06","2021-08-23","Leptomeningeal Carcinomatosis; Carcinomatoses, Leptomeningeal; Carcinomatoses, Meningeal; Carcinomatosis of the Meninges; Carcinomatosis, Leptomeningeal; Carcinomatosis, Meningeal","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002867.v1.p1","Blood Somatic Mutations in TCGA Donors Suffering from Solid Tumors","Blood somatic mutations identified across 8,530 solid tumor patients in TCGA cohort. We reasoned that low-coverage whole-genome sequencing of blood samples routinely carried out in cancer genomics projects may be  repurposed to detect clonal hematopoiesis (CH). Thus, inspired by a previous approach to identify early mutations in the development of the","Not Applicable","Clonal Hematopoiesis","Case Set","Somatic_Variant","SNV (.MAF)","3 phenotype datasets, 8 variables, 1 molecular datasets, 8315 subjects, 8315 samples","","NCI","GRU --- General Research Use","2022-05-04","2022-05-04","ARCH; ARCH Age related Clonal Hematopoiesis; ARCH Age-related Clonal Hematopoiesis; Age related Clonal Hematopoiesis; Age-related Clonal Hematopoiesis; Clonal Hematopoiesis, Age-related","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002443.v1.p1","Molecular Signatures of DCIS to Invasive Progression for Basal-Like    Breast Cancers: An Integrated Mouse Model and Human Tumor Study","We studied the genomic signatures of progression in breast ductal carcinoma in situ (DCIS) as it progresses towards triple negative invasive breast cancer (TNBC). Single cell RNA sequencing (scRNAseq) was  performed on the C3Tag genetically engineered mouse model that forms human breast-like DCIS and TNBC. Bulk RNA sequencing was performed on RNA","Not Applicable","Carcinoma, Intraductal, Noninfiltrating","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 16 variables, 18 samples sequenced, 11 subjects, 18 samples","","NCI","GRU --- General Research Use","2022-05-04","2022-05-04","Triple Negative Breast Neoplasms; Breast Ductal Carcinoma In Situ, NOS; Carcinoma, Intraductal; Carcinoma, Noninfiltrating Intraductal; Carcinomas, Intraductal; Carcinomas, Noninfiltrating Intraductal","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002758.v1.p1","Single-Cell Analysis of Somatic Mutations in Human Bronchial Epithelial    Cells in Relation to Aging and Smoking","While lung cancer risk among smokers is dependent on smoking dose, it remains unknown if this increased risk reflects an increased rate of somatic mutation accumulation in normal lung cells.  Here we applied single-cell whole genome sequencing of proximal bronchial basal cells from 33 subjects, aged between 11 and 86 years, with smoking","Not Applicable","Lung","Cross-Sectional","Not Provided","WGA","4 phenotype datasets, 16 variables, 167 samples sequenced, 33 subjects, 167 samples","","NIA","DS-LC-IRB-PUB-NPU --- Disease-Specific (Lung Cancer, IRB, PUB, NPU)","2022-05-03","2022-05-03","Not Provided",""
"phs002723.v1.p1","Discovery and Characterization of Genetic Risk Loci in Sjogren's Syndrome","The Sj&#x000f6;gren's Genetics Network (SGENE) is an international collaboration focused on identifying and understanding the genetic variations that influence Sj&#x000f6;gren's pathology. Collectively, SGENE collaborators from 26 different sites (5 in  the United States; 21 in foreign countries) have recruited a large cohort of geographically diverse participants of European ancestry. Recruitment,","Not Applicable","Sjogren's Syndrome","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 12 variables, 2 documents, 1 analyses, 1 molecular datasets, 43 samples sequenced, 1199 subjects, 1199 samples","European (41), African American (1), Hispanic1 (1), Hispanic2 (1), South Asian (1)","NIAMS","DS-SJO-IRB --- Disease-Specific (Sjogren's Syndrome, IRB), DS-SJO-SLE-RA-RD-IRB --- Disease-Specific (Sjogren's, LUPUS, RA AND RELATED DISEASES, IRB), DS-SJO-PUB-GSO --- Disease-Specific (Sjogren's Syndrome, PUB, GSO)","2022-05-03","2022-05-03","Keratoconjunctivitis Sicca; Xerostomia; Absent salivary secretion; Aptyalia; Aptyalism; Asialia",""
"phs002620.v1.p1","Feasibility and Clinical Utility of Whole Genome Profiling in Pediatric    and Young Adult Cancers","Comprehensive Whole Genome Sequencing and Whole Transcriptome (RNASeq) analyses from 114 pediatric patients at Memorial Sloan Kettering. This dataset was used as a prospective clinical utility and feasibility study. By  using our Isabl infrastructure for precision medicine, we developed a 2-week end-to-end pipeline to analyze cfDNA, WGS and WTS, which we refer to as","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WGS","3 phenotype datasets, 14 variables, 326 samples sequenced, 114 subjects, 326 samples","","NCI","GRU --- General Research Use","2022-05-02","2022-05-02","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000328.v3.p1","Genome-Wide Analysis of Diffuse Large B-Cell Lymphoma (De Novo and    Derived from the High Grade Transformation of Follicular Lymphoma)","Version 1. Diffuse Large B-cell Lymphoma (DLBCL) represents the most common form of B-cell non-Hodgkin Lymphoma (B-NHL), accounting for 30% of the de novo diagnoses and also arising as a  frequent clinical evolution of Follicular Lymphoma (FL). The molecular pathogenesis of DLBCL is associated with multiple genetic lesions that in part","Not Applicable","Lymphoma, Large B-Cell, Diffuse","Tumor vs. Matched-Normal","Affymetrix_WG_Array","SNP Genotypes (Array), Targeted-Capture, WGS, WXS","3 phenotype datasets, 12 variables, 2 molecular datasets, 258 samples sequenced, 194 subjects, 333 samples","","NCI","DS-CA-PUB-MDS --- Disease-Specific (Cancer, PUB, MDS)","2022-04-29","2022-04-29","Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers",""
"phs002765.v1.p1","Transcriptomic Profiles of Neoantigen-Reactive T Cells in Human    Gastrointestinal Cancers","This study explores the transcriptomic profiles of neoantigen-reactive tumor-infiltrating lymphocytes (TILs) from human bile duct and pancreatic cancer. The submitted data are bulk tumor RNA-Seq, tumor and germline whole-exome sequencing  from 10 patients, and single cell RNA-Seq data from TIL of 5 of these patients. Inclusion: patients with gastrointestinal cancer Related Genes: GZMA,","Not Applicable","Gastrointestinal Neoplasms","Case Set","RNAseq_gene_transcripts","AMPLICON, RNA-Seq, RNA Seq (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets, 3134 samples sequenced, 10 subjects, 3134 samples","","NCI","GRU --- General Research Use","2022-04-28","2022-04-28","Carcinoma, Pancreatic Ductal; Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002724.v1.p1","(Epi)genetic Risk Architectures of Opioid-Dependent Brain","With nearly 20,000 overdose deaths in 2014 alone, opioid addiction (OA) has emerged as one of the most pressing public health crises in recent US history. One-fifth of individuals who  try heroin develop an addiction to opioids. Genetics is a major contributor to OA with an estimated 60% heritability, only somewhat less than","Not Applicable","Opioid-Related Disorders","Case-Control","Not Provided","ChIP-Seq, RNA-Seq","4 phenotype datasets, 21 variables, 153 samples sequenced, 121 subjects, 153 samples","","NIDA","GRU-IRB --- General Research Use (IRB)","2022-04-27","2022-04-27","Opioid Use Disorders; Addiction, Opiate; Dependence, Opiate; Opiate Addiction; Opiate Dependence; Opioid Related Disorders",""
"phs002300.v1.p1","Successful Clinical Response in Pneumonia Therapy (SCRIPT)","The goal of this study is to iteratively identify, validate and refine biomarkers to predict clinical failure, and identify novel targets for therapy, beyond traditional antibiotics, for patients with severe  pneumonia requiring intubation, including severe community-acquired pneumonia (CAP), hospital-acquired pneumonia, and ventilator-associated pneumonia","Not Applicable","Pneumonia","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","5 phenotype datasets, 19 variables, 246 samples sequenced, 181 subjects, 246 samples","","NIAID","HMB-IRB --- Health/Medical/Biomedical (IRB)","2022-04-27","2022-04-27","COVID-19; Pneumonia, Bacterial; Pneumonia, Viral; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease",""
"phs002752.v1.p1","Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)","The Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) is a multicenter, randomized, single blind, two-arm, placebo controlled Phase III trial with blinded outcome assessments to establish the safety  and efficacy of single dose of convalescent plasma for preventing the progression from mild to severe COVID-19 illness. Note for data in BioData","Not Applicable","COVID-19","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 511 subjects, 511 samples","","NHLBI","GRU --- General Research Use","2022-04-26","2022-04-26","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001548.v2.p1","TCR Repertoire Sequencing to Evaluate the Diversity of Follicular Helper    T Cells in HIV Infected Lymph Nodes","The TCR repertoire of CD4+ T cells in human lymph nodes is a case-based analysis of the TCR repertoire of CD4+ T cells in human lymph nodes. The study aims  to determine how HIV infection alters the repertoire complexity of follicular helper T cells (TFH) in relationship to other T cell subsets in the","Not Applicable","HIV","Prospective Longitudinal Cohort","Not Provided","AMPLICON, RNA-Seq","4 phenotype datasets, 21 variables, 80 samples sequenced, 8 subjects, 80 samples","","NIAID","DS-HIV-PUB-NPU --- Disease-Specific (Human Immunodeficiency Virus, PUB, NPU)","2022-04-26","2018-03-14","Not Provided",""
"phs001965.v1.p1","MP2PRT: Identification of Genetic Changes Associated with Relapse and/or    Adaptive Resistance in Patients Registered as Favorable Histology    Wilms Tumor on AREN03B2","The Molecular Profiling to Predict Response to Treatment (MP2PRT) program is part of the NCI's Cancer Moonshot Initiative. The aim of this program is the retrospective characterization and analysis of  biospecimens collected from completed NCI-sponsored trials of the National Clinical Trials Network and the NCI Community Oncology Research Program.","Not Applicable","Wilms Tumor","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables,  SRA, 84 subjects, 84 samples","","NCI","GRU --- General Research Use","2022-04-22","2022-04-22","Embryonal adenosarcoma; Embryonal nephroma; Kidney Nephroblastoma; NEPHROBLASTOMA; Nephroblastoma (Wilms tumor); Nephroblastomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002482.v1.p1","Combined Targeting of CDK4/6 and HER2 Signaling in Orthotopic    Patient-Derived Xenografts of HER2-Positive Breast Cancer Brain    Metastases","Patients with metastatic HER2-positive (HER2+) breast cancer will frequently develop brain metastases (BCBMs). Here, we report that p16INK4A, a tumor suppressor, is deficient in the majority of HER2+ BCBMs. Furthermore,  p16INK4A deficiency, as measured by protein immunohistochemistry, can be a predictive marker associated with response to combined treatment with","Not Applicable","Breast Neoplasms","Collection","Not Provided","RNA-Seq, WXS","3 phenotype datasets, 13 variables, 96 samples sequenced, 39 subjects, 96 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-04-15","2022-04-15","Neoplasm Metastasis; Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002564.v1.p1","Transcriptional Profiling of Macrophages In Situ in Metastatic Melanoma    Reveals Localization-Dependent Phenotypes and Function","Therapeutic interventions modulating immune function at the tumor site could improve outcomes in cancer. Here we analyzed metastatic melanoma, a tumor type highly responsive to T-cell based therapies, and found  that the tumor-infiltrating T cells are localized closely to CD14+ monocytes/macrophages rather than to melanoma cells. Using novel","Not Applicable","Melanoma","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 21 variables, 64 samples sequenced, 8 subjects, 64 samples","","NCI","GRU --- General Research Use","2022-04-11","2022-04-11","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002389.v2.p1","MicroRNAs, Hypertension and End Organ Damage in Humans","Study 1) Profiling of microRNAs in plasma of patients with hypertension complicated or not by metabolic syndrome or chronic kidney disease Hypertension (HTN) or high blood pressure is associated with  subclinical target organ damage such as cardiac, vascular and kidney injury, which may lead to complications and death. In this study, we","Not Applicable","Hypertension","Case-Control","target_markerset_grc37","RNA-Seq, RNA Seq (NGS), miRNA (NGS), miRNA-Seq","4 phenotype datasets, 50 variables, 2 molecular datasets, 151 samples sequenced, 62 subjects, 151 samples","","NHLBI","GRU-PUB --- General Research Use (PUB)","2022-04-08","2022-04-08","Metabolic Syndrome; Renal Insufficiency, Chronic; Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High",""
"phs001939.v3.p1","Count Me In (CMI): The Metastatic Prostate Cancer (MPC) Project    (CMI-MPCproject)","Count Me In - The Metastatic Prostate Cancer Project: A Patient-Driven Research Initiative to Accelerate Metastatic Prostate Cancer Research The Metastatic Prostate Cancer Project (MPCproject; http://mpcproject.org/) is a research study  that empowers men with metastatic and advanced prostate cancer to partner directly with researchers by sharing their samples and clinical","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Provided","4 phenotype datasets, 11 variables, 63 subjects, 126 samples","","NCI","GRU --- General Research Use","2022-04-07","2020-02-12","Neoplasm Metastasis; Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001369.v1.p1","Germline hypomorphic CARD11 mutations in severe atopic disease","We described five patients from four unrelated families who had severe atopic dermatitis and susceptibility to mild skin viral infections. Some patients also exhibited other allergic symptoms such as asthma  and food allergy. We performed targeted sequencing for affected patients A-I of family A and B-I of family B, whole exome sequencing for D-I, D-II.1","Not Applicable","Allergy and Immunology","Case-Control","WES_markerset_grc38, WGS_markerset_grc38, target_markerset_grc37, target_markerset_grc38","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 7 subjects, 7 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2022-04-07","2022-04-07","Asthma; Dermatitis, Atopic; Food Hypersensitivity; Skin Diseases, Infectious; Airway hyperreactivity; Asthma, Bronchial",""
"phs002683.v1.p1","Combined Tumor and Immune Signals From Genomes or Transcriptomes Predict    Outcomes of Checkpoint Inhibition in Melanoma","Cancer immunotherapy with checkpoint blockade (CPB) leads to improved outcomes in melanoma and other tumor types, but a majority of patients do not respond. High tumor mutation burden (TMB) and  high levels of tumor-infiltrating T cells have been associated with response to immunotherapy, and integrative models using DNA and RNA have improved","Not Applicable","Melanoma","Collection","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 20 variables, 169 samples sequenced, 61 subjects, 169 samples","","NCI","DS-MSC-MDS --- Disease-Specific (Melanoma and Skin Cancer Research, MDS)","2022-04-06","2022-04-06","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs001267.v1.p1","CIDR/NICHD Genetic Basis of Recessive Pediatric Brain Diseases - Group 2","The purpose of this study is to identify new genetic causes of recessive forms of pediatric neurodevelopmental disorders (NDDs) including Cerebellar hypoplasia (CBH), Lissencephaly (LIS), Microcephaly (MIC), Corpus callosum hypoplasia  (CCH), Pontocerebellar hypoplasia (PCH), Pontine tegemental cap dysplasia (PTCD), and Aicardi syndrome among many others. Using whole exome","Not Applicable","Cerebellar Hypoplasia","Prospective Longitudinal Cohort","HumanCoreExome-24","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 782 subjects, 818 samples","","NICHD","GRU --- General Research Use","2022-04-05","2022-04-05","Agenesis of Corpus Callosum; Microcephaly; ACC; ACC - Agenesis of corpus callosum; Absence of Corpus Callosum; Absence of the corpus callosum",""
"phs002715.v1.p1","National Sleep Research Resource (NSRR): Cleveland Family Study (CFS)","The Cleveland Family Study (CFS) is a family-based study of sleep apnea, consisting of 2,284 individuals (46% African American) from 361 families studied on up to 4 occasions over a  period of 16 years. The study began in 1990 with the initial aims of quantifying the familial aggregation of sleep apnea. National Institutes of","Not Applicable","Sleep Apnea Syndromes","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 9 variables, 710 subjects, 710 samples","","NHLBI","DS-HLBS-IRB-NPU --- Disease-Specific (Heart, Lung, Blood, and Sleep Disorders, IRB, NPU)","2022-04-01","2022-04-01","Diabetes Mellitus; Hypertension; Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High",""
"phs001980.v2.p1","University of Texas PDX Development and Trial Center Grant","The goal for the University Texas PDX Development and Trial Center (UTPDTC) is to optimize personalized biomarker-based cancer therapy and identify effective targeted drugs based on the molecular characteristics of  each tumor. Our short-term goals are to establish a biobank of clinically, and molecularly-annotated Patient-Derived Xenografts (PDXs) and to use","Not Applicable","Lung Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 28 variables, 77 samples sequenced, 36 subjects, 77 samples","","NCI","DS-LC-COL --- Disease-Specific (Lung Cancer, COL)","2022-04-01","2021-02-11","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell",""
"phs001951.v2.p1","Relapsed Acute Lymphoblastic Leukemia (ALL): Mutational Landscape","Multi-agent combination chemotherapy can be curative in acute lymphoblastic leukemia (ALL). Still, patients with primary refractory disease or those with relapsed leukemia have a very poor prognosis. Here we report  the mutational landscape of matched diagnostic and relapsed pediatric and adult ALL samples. Our data provides comprehensive annotation of genetic","Not Applicable","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Prospective Longitudinal Cohort","Not Provided","WGS, WXS","4 phenotype datasets, 17 variables, 159 samples sequenced, 56 subjects, 159 samples","","NCI","GRU --- General Research Use","2022-04-01","2022-04-01","ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic; Leukemia, Lymphoblastic, Acute, L1","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000985.v2.p1","Functional Significance of Prostate Cancer Risk-SNPs","Prostate Cancer (PrCa), the most frequently diagnosed solid tumor in men in the U.S., results in 192,000 new cases and 27,000 deaths per year. Although the variation of PrCa incidence  is likely to be the result of several factors, there is a large body of literature that strongly implicates a genetic etiology. Genome-wide","Not Applicable","Prostatic Neoplasms","Control Set","RNAseq_probe_set_grc37, HumanOmni2.5-8, RNAseq_gene_transcripts","SNP Genotypes (Array), RNA Seq (NGS), miRNA (NGS)","4 phenotype datasets, 29 variables, 8 documents, 3 molecular datasets, 471 subjects, 1383 samples","","NCI","DS-PC-PUB-MDS --- Disease-Specific (Prostate Cancer, PUB, MDS)","2022-03-30","2022-03-30","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs002492.v1.p1","Study of Leukemia Stem Cells in B-ALL","This study focused on the biologic properties of human B acute lymphoblastic leukemia (ALL) stem cells. We used human leukemia cell lines, primary patient specimens, and patient derived xenografts in  experiments using ChIP-seq, bulk RNA sequencing, single cell RNA sequencing, and CITE-seq. Diagnosis of high-risk B acute lymphoblastic leukemia.","Not Applicable","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Case Set","Not Provided","ChIP-Seq, RNA-Seq","4 phenotype datasets, 15 variables, 20 samples sequenced, 4 subjects, 20 samples","","NIDDK","HMB --- Health/Medical/Biomedical","2022-03-29","2022-03-29","ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic; Leukemia, Lymphoblastic, Acute, L1",""
"phs001004.v1.p1","Genetic Analysis of Parkinson's Disease","A portion of the sample includes multiplex PD families recruited as part of a previously funded study (R01NS037167; PI: Tatiana Foroud). Families were ascertained initially through a living affected sibling  pair. Subsequently, ascertainment was loosened to include PD probands having a positive family history of PD in a first degree relative, who was not","Not Applicable","Parkinson Disease","Family/Twin/Trios","target_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 53 variables, 1 molecular datasets, 1529 samples sequenced,  SRA, 1529 subjects, 1529 samples","","NINDS","GRU --- General Research Use","2022-03-28","2022-03-28","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs002792.v1.p1","Characterization of Neoantigen-reactive T cells by Single-Cell Analysis","Through CITE-seq and TCR-seq analysis of non-small cell lung cancer (NSCLC) tumor-infiltrating lymphocytes (TIL), we developed a neoantigen-reactive T-cell signature based on clonotype frequency and CD39 protein and CXCL13 mRNA  expression. There are four datasets from four NSCLC cases. Each dataset includes (1) Transcriptome of tumor infiltrating lymphocytes (TIL), (2) Cell","Not Applicable","Lymphocytes, Tumor-Infiltrating","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 48 samples sequenced, 4 subjects, 48 samples","","NCI","GRU --- General Research Use","2022-03-25","2022-03-25","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001920.v1.p1","Genomic Characterization of Brain Metastases from Lung Cancer","Metastatic disease to the brain is associated with a poor prognosis. Our understanding of the genetic drivers of metastasis remain limited. Whole-exome sequencing was performed from brain metastases from lung  adenocarcinoma to identify putative drivers of metastatic progression. We identified patients with brain metastases from lung adenocarcinoma from our","Not Applicable","Neoplasm Metastasis","Prospective Longitudinal Cohort","Not Provided","WXS","3 phenotype datasets, 10 variables, 120 samples sequenced,  SRA, 40 subjects, 120 samples","","NCI","GRU --- General Research Use, DS-BT --- Disease-Specific (Brain Tumors), DS-LCTC-MDS --- Disease-Specific (Lung Cancer and Thoracic Malignancies, MDS)","2022-03-25","2022-03-25","Metastase; Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize; Neoplasm Metastases","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001593.v1.p1","Genome Sequencing of Familial Cholangiocarcinoma","In this study, sequencing data (WES, WGS, linked-read WGS) was used to identify candidate causal germline variants in a family with inherited cholangiocarcinoma. Candidate causal SNVs and indels were identified  from the germline WES data of eight siblings (four affected, four unaffected), then somatic second hits were identified from matched tumor/normal","Not Applicable","Cholangiocarcinoma","Family/Twin/Trios","Not Provided","WGS, WXS","5 phenotype datasets, 20 variables, 11 samples sequenced, 8 subjects, 11 samples","","NHGRI","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2022-03-25","2022-03-25","Bile duct cancer; CC; CCA; Carcinoma, Cholangiocellular; Carcinomas, Cholangiocellular; Cholangiocar.- intra/extrahepatic",""
"phs002196.v1.p1","Systems Analysis of the PfSPZ Vaccine in Kenyan Infants","The PfSPZ vaccine is a candidate vaccine targeting the Plasmodium falciparum parasite, which is the cause of the most lethal type of human malaria. This study used de-identified blood samples  collected from 316 infants aged 5 to 12 months (inclusive) enrolled in a Phase 2, randomized, placebo-controlled trial (NCT02687373) of the PfSPZ","Not Applicable","Parasitic Diseases","Clinical Trial","RNAseq_probe_set_grc38","RNA Seq (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 263 subjects, 515 samples","","NIAID","HMB-NPU --- Health/Medical/Biomedical (NPU)","2022-03-23","2022-03-23","Malaria; Protozoan Infections; Fever, Marsh; Fever, Remittent; Infection, Plasmodium; Infections, Plasmodium",""
"phs002728.v1.p1","RNA-Seq of PBMC's from rUTI Patients and Healthy Controls","Recurrent urinary tract infections (rUTIs) are a major health burden worldwide, with history of infection being a significant risk factor. While the gut is a known reservoir for uropathogenic bacteria,  the role of the microbiota in rUTI remains unclear. We conducted a year-long study of women with and without history of rUTIs, from whom we collected","Not Applicable","Urinary Tract Infections","Collection","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 17 variables, 1 molecular datasets, 48 samples sequenced, 30 subjects, 48 samples","","NIAID","GRU --- General Research Use","2022-03-22","2022-03-22","","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001350.v1.p1","Pancreatitis after Treatment for Acute Lymphoblastic Leukemia (SJIRB    XPD04-123 and XPD05-078)","A complication of acute lymphoblastic leukemia (ALL) treatment is acute pancreatitis, which is one of the common causes of asparaginase intolerance. To determine clinical and genetic risk factors for pancreatitis,  we studied a cohort of children and young adults with ALL enrolled on COG trials (9904/9905/9906, AALL0232) and on St. Jude trial Total XV. We","Not Applicable","Leukemia, Lymphoid","Case-Control","Affymetrix_WG_Array, HumanExome-12","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 5040 subjects, 7732 samples","European (3056), African (11), East Asian (81), African American (365), Hispanic1 (136), Hispanic2 (1019), Other Asian or Pacific Islander (84), South Asian (78), Other (127)","NIGMS","HMB --- Health/Medical/Biomedical","2022-03-22","2022-03-22","Pancreatitis; Leukemia, Lymphocytic; Leukemias, Lymphocytic; Leukemias, Lymphoid; Lymphatic leukemia; Lymphocytic Leukemia",""
"phs002395.v1.p1","Mitochondrial Abnormalities in Schizophrenia and Bipolar Disorder","Mitochondrial DNA structural variation is one proposed indicator of mitochondrial dysfunction. The large common deletion of mitochondrial DNA (mtDNA) increases with aging across multiple brain regions. We found other large  deletions of mtDNA in brain at levels comparable to the common deletion (PMID: 30869147). Since mtDNA molecules replicate independently of nuclear","Not Applicable","Mitochondria","Case-Control","Not Provided","AMPLICON, WXS","6 phenotype datasets, 534 variables, 428 samples sequenced, 100 subjects, 428 samples","","NIMH","GRU --- General Research Use","2022-03-18","2022-03-18","Bipolar Disorder; Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders","Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs000931.v1.p1","DMET Genes, Nicotine Metabolism and Prospective Abstinence","This study (DA033813; PI: Andrew W Bergen; PMID:26132489) includes samples from two laboratory studies of nicotine metabolism. The Pharmacokinetics of Nicotine Metabolism in Twins study (PKTWIN; PI: Gary E Swan;  PMID: 15527659) was based on recruitment from a twin registry (PMID: 23084148). The Integrated Research Project on Tobacco Use and Dependence (IRP;","Not Applicable","Nicotine","Family/Twin/Trios","Affymetrix_expression_array","SNP Genotypes (Array)","6 phenotype datasets, 46 variables, 1 molecular datasets, 548 subjects, 548 samples","","NIDA","NMSB --- Nicotine metabolism and smoking behaviors","2022-03-16","2022-03-16","Lung Neoplasms; Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung",""
"phs002283.v2.p1","Selenium Chemoprevention: Benefits and Harms","Selenium is a trace element that may have anti-carcinogenetic effect, but heterogenous treatment effects have been observed. This genome-wide association study investigates if genetic variation modifies the effect of selenium  chemoprevention in the Selenium and Celecoxib Trial, a randomized, double-blind, placebo-controlled trial conducted at the University of Arizona","Not Applicable","Neoplasms, Second Primary","Clinical Trial","Not Provided","SNP Genotypes (Array)","4 phenotype datasets, 27 variables, 1323 subjects, 1323 samples","European (1222), East Asian (9), African American (29), Hispanic1 (5), Hispanic2 (51), Other Asian or Pacific Islander (3), South Asian (4)","NCI","GRU-IRB-COL-NPU --- General Research Use (IRB, COL, NPU)","2022-03-14","2021-01-13","Malignancies, Second; Malignancy, Second; Metachronous Neoplasm; Metachronous Neoplasms; Metachronous Second Primary Neoplasms; Neoplasm, Metachronous",""
"phs001145.v1.p1","Exceptional Responders Initiative","The Exceptional Responders Initiative is a pilot study to investigate the underlying molecular factors driving exceptional treatment responses of cancer patients to drug therapies. Study researchers will examine molecular profiles  of tumors from patients either enrolled in a clinical trial for an investigational drug(s) and who achieved an exceptional response relative to other","Not Applicable","Neoplasms","Case-Control","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 170 subjects, 170 samples","","NCI","GRU --- General Research Use","2022-03-11","2022-03-11","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002731.v1.p1","Multi-Omic Analysis of Von Willebrand Factor Regulation in Endothelial    Colony Forming Cells","This study evaluated the multi-omic analysis of endothelial cells with a focus on von Willebrand factor regulation, and investigated aspects of endothelial regulation in the context of blood disorders. The  data available at dbGaP consist of multi-omic analyses of these cells.&#x000a0; Inclusion Criteria 1. Patients age of 1 with a specific blood","Not Applicable","Hematologic Diseases","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 8 samples sequenced, 36 subjects, 8 samples","","NHLBI","DS-BD-NPU --- Disease-Specific (Blood Disorders, NPU)","2022-03-10","2022-03-10","Blood Disease; Blood Diseases; Blood Disorder; Blood dyscrasia; Disease of blood AND/OR blood forming organ; Disease, Blood",""
"phs002653.v1.p1","Tumor Mutation Burden, Expressed Neoantigen and Immune Microenvironment    in Diffuse Gliomas","A consistent correlation between tumor mutation burden (TMB) and tumor immune microenvironment has not been observed in gliomas as in other cancers. Driver germline and somatic mutations, TMB, neoantigen, and  immune cell signatures were analyzed using whole exome sequencing (WES) and transcriptome sequencing of tumor and WES of matched germline DNA in a","Not Applicable","Glioma","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 18 variables, 66 samples sequenced, 48 subjects, 66 samples","","NCI","GRU --- General Research Use","2022-03-09","2022-03-09","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002566.v1.p1","Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric    Cancer Risk","The study is composed of two sub-studies. The first study, conducted by NYU Grossman School of Medicine, is a case-control study of 89 cases with gastric intestinal metaplasia (IM) and  89 matched controls who underwent upper gastrointestinal endoscopy at three sites affiliated with NYU Langone Health. Shotgun metagenomic sequencing","Not Applicable","Metaplasia","Case-Control","Not Provided","WGS","7 phenotype datasets, 59 variables, 776 samples sequenced, 679 subjects, 776 samples","","NCI","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), DS-GICA --- Disease-Specific (Gastric Cancer), DS-GICA-NPU --- Disease-Specific (Gastric Cancer, NPU)","2022-03-09","2022-03-09","Ca lesser curvature - stomach; Cancer of Stomach; Cancer of the Stomach; Cancer, Gastric; Cancer, Stomach; Cancers, Gastric",""
"phs001525.v2.p1","Assembling the Genetic Architecture of X-Linked Dystonia-Parkinsonism","X-linked Dystonia-Parkinsonism (XDP, DYT3) is a long-standing quandary in human disease genetics. XDP is predominantly observed on Panay island in the Philippines. This study is one of the first of  its kind to interrogate an unsolved Mendelian disorder by integrating genome and transcriptome assembly methods using Illumina, 10X Genomics, Pacific","Not Applicable","X-Linked Dystonia Parkinsonism","Mendelian","target_markerset_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), Targeted-Capture, WGS","6 phenotype datasets, 39 variables, 1 molecular datasets, 359 samples sequenced, 62 subjects, 359 samples","","NINDS","HMB --- Health/Medical/Biomedical","2022-03-09","2022-03-09","Dystonia 3, Torsion, X-Linked; Lubag Syndrome; Torsion Dystonia-Parkinsonism, Filipino Type; DYSTONIA-PARKINSONISM, X-LINKED; DYT-TAF1; DYT3",""
"phs002562.v1.p1","Utlizing the RA signature to predict response to TNFi","This study involves bulk RNA-seq analyses of blood cells from patients with rheumatoid arthritis who have had an inadequate response to methotrexate, collected before and 12 weeks after effective treatment  with either etanercept or adalimumab. Peripheral blood mononuclear cells were stimulated with anti-CD3 for 24 hours and sorted into CD4+, CD19+, and","Not Applicable","Arthritis, Rheumatoid","Interventional","Not Provided","RNA-Seq","3 phenotype datasets, 10 variables, 42 samples sequenced, 7 subjects, 42 samples","","NIAMS","HMB-IRB-PUB --- Health/Medical/Biomedical (IRB, PUB)","2022-03-08","2022-03-08","",""
"phs002556.v1.p1","Genomic Features of Lung Adenocarcinoma from Individuals with    10    Pack-Year Smoking History","Actionable oncogenic alterations are identified in a subset of lung adenocarcinomas. Many of these driver alterations are enriched in lung adenocarcinomas from individuals with minimal smoking history and are generally  mutually exclusive of one another. We generated whole-exome and RNA-seq data from lung adenocarcinomas obtained from individuals with &#x02264;10","Not Applicable","Adenocarcinoma of Lung","Case Set","RNAseq_probe_set_grc37","RNA-Seq, SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets, 75 samples sequenced, 25 subjects, 75 samples","","NCI","DS-LC --- Disease-Specific (Lung Cancer)","2022-03-08","2022-03-08","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs002498.v1.p1","Integrative Genomic and Transcriptomic Analyses of Refractory Multiple    Myeloma","This study reports results from integrative sequencing analyses that combine capture transcriptome sequencing with a comparative analysis of exome capture between the malignant plasma cells and normal cells of patients  with relapsed and refractory multiple myeloma (RRMM). This approach has enabled the detection of point mutations, insertions/deletions, gene fusions","Not Applicable","Neoplasms","Case Set","Not Provided","RNA-Seq, Targeted-Capture","4 phenotype datasets, 15 variables, 1530 samples sequenced, 511 subjects, 1530 samples","","NCI","DS-MM --- Disease-Specific (Multiple Myeloma)","2022-03-07","2022-03-07","Immunoglobulin Light-chain Amyloidosis; Monoclonal Gammopathy of Undetermined Significance; Plasmacytoma; Smoldering Multiple Myeloma; AL; AL AMYLOIDOSIS",""
"phs002449.v1.p1","Tissue and Fluid Analysis in Ocular Inflammatory Disease","Granulomas are found in multiple infectious and non-infectious human diseases, yet the pathogenic drivers of granulomatous disease are still poorly understood. To enrich for pathologic inflammatory cells, we leveraged the  intrinsic immunologic isolation of the eye by examining granulomatous uveitis, a form of ocular inflammation. We performed single-cell RNA-sequencing","Not Applicable","Uveitis","Cross-Sectional","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 8 samples sequenced, 4 subjects, 8 samples","","NEI","GRU --- General Research Use","2022-03-07","2022-03-07","","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002231.v1.p1","Germ Cell and Associated Heme Malignancies Evolve from a Common Shared    Precursor","Germ cell tumors (GCTs) are the most common cancer in men between the ages of 15-40. While most patients are cured, those with disease arising in the mediastinum have distinctly  poor outcomes. One in every 17 patients with primary mediastinal non-seminomatous GCTs develop an incurable hematologic malignancy and prior data","Not Applicable","Neoplasms, Germ Cell and Embryonal","Tumor vs. Matched-Normal","Not Provided","WXS","4 phenotype datasets, 27 variables, 19 samples sequenced,  SRA, 5 subjects, 19 samples","","NCI","HMB --- Health/Medical/Biomedical","2022-03-07","2022-03-07","Mediastinal Neoplasms; HEMOLYMPHORETICULAR tumor, malignant; Hematopoietic Malignancies; Hematopoietic Malignancy; Hematopoietic Neoplasm; Hematopoietic Neoplasms Including Lymphomas","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001323.v3.p1","Multiple Myeloma Genomic Study (MMGS)","Multiple Myeloma (MM) is a plasma cell dyscrasia characterized by bone marrow (BM) infiltration and lytic bone lesions. Recent studies of massive parallel sequencing of tumor cells obtained from the  BM of patients with MM have demonstrated significant clonal heterogeneity in MM. Despite this remarkable clonal heterogeneity, it could be envisioned","Not Applicable","Multiple Myeloma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, Targeted-Capture, WXS","4 phenotype datasets, 15 variables, 1078 samples sequenced, 883 subjects, 1078 samples","","NCI","DS-PCD --- Disease-Specific (plasma cell dyscrasias)","2022-03-07","2020-04-20","Monoclonal Gammopathy of Undetermined Significance; Asymptomatic monoclonal gammopathy; Benign Monoclonal Gammapathies; Benign Monoclonal Gammapathy; Benign Monoclonal Gammopathies; MGUS",""
"phs002748.v1.p1","Transcriptome and TCR Sequencing of T Cells from Metastectomies","T cells were sorted from metastatic tumors (colon, rectal, breast, anal, melanoma primary histologies) following tumor dissociation and single-cell sequencing was performed (RNAseq and TCRseq). For samples from tumors that  had been previously studied, cells were analyzed comparing known neoantigen-reactive TCR-expressing cells to other T cells. For samples without","Not Applicable","Colonic Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 15 variables, 123 samples sequenced, 15 subjects, 123 samples","","NCI","GRU --- General Research Use","2022-03-02","2022-03-02","Anus Neoplasms; Rectal Neoplasms; Anal Neoplasms; Anal Neoplasms, Benign and Malignant; Anal Tumor; Anal Tumors","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002393.v2.p1","Precision Medicine for ABCA4 Disease: Modifier Alleles","Genetic variation affecting the structure and function of the ABCA4 protein gives rise to a broad collection of genetically and clinically heterogeneous diseases, collectively known as ABCA4 disease, which are  characterized by both phenotypic overlap and variable penetrance and expressivity. These include autosomal recessive Stargardt disease, cone-rod","Not Applicable","Retina","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 15 variables, 2 molecular datasets, 350 subjects, 350 samples","","NEI","DS-RET-DIS-NPU --- Disease-Specific (Retinal Diseases, NPU), DS-RET-DIS-NPU-GSO --- Disease-Specific (Retinal Diseases, NPU, GSO)","2022-03-01","2022-03-01","Cone-Rod Dystrophies; CRD; Cone Rod Degenerations; Cone Rod Dystrophies; Cone Rod Dystrophy; Cone Rod Retinal Dystrophy",""
"phs002455.v1.p1","Dissecting Autoimmune Cellular and Molecular Networks in Vitiligo","This study consists of suction blister biopsies of primary human skin samples, collected from healthy patients, or patients with vitiligo. Healthy patients had healthy skin sampled. Vitiligo patients had both  unaffected (non-lesional) and affected (lesional) skin sampled. The generated data consists of scRNA-seq samples generated following the inDrops","Not Applicable","Vitiligo","Case-Control","RNAseq_probe_set_grc37","RNA-Seq, RNA Seq (NGS)","5 phenotype datasets, 22 variables, 1 molecular datasets, 40 samples sequenced, 17 subjects, 40 samples","","NIAMS","GRU-PUB --- General Research Use (PUB)","2022-02-18","2022-02-18","",""
"phs001957.v2.p1","Investigation of Human DNA Replication Timing Variation by Whole Genome    Sequencing","To study inter-individual variation in human DNA replication timing, we performed whole-genome sequencing of human pluripotent stem cell lines. This data was used to infer replication timing and link them  to genetic polymorphisms. Principal Investigator: Amnon Koren, PhD, Cornell University, Ithaca, NY, USA Co-Principal Investigator: Dieter Egli, PhD,","Not Applicable","DNA Replication Timing","Prospective Longitudinal Cohort","Not Provided","WGS","3 phenotype datasets, 7 variables, 90 samples sequenced, 54 subjects, 90 samples","","NIGMS","GRU --- General Research Use","2022-02-18","2020-06-18","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001347.v3.p2","Prematurity, Respiratory Outcomes, Immune System, and Microbiome Study    (PRISM)","Public health importance: Babies born preterm, approximately 1 out of every 9 live births in the United States, have significant respiratory morbidity over the first two years of life, exacerbated  by respiratory viral infections. Many ( 50%) return to pediatricians, emergency rooms and pulmonologists with symptoms of respiratory dysfunction","Not Applicable","Infant, Premature","Prospective Longitudinal Cohort","human_microbiome","AMPLICON, Human Metagenome (NGS)","4 phenotype datasets, 135 variables, 1 molecular datasets, 6256 samples sequenced,  SRA, 267 subjects, 9858 samples","","NIAID","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2022-02-17","2022-02-17","Bronchopulmonary Dysplasia; Premature Birth; Respiratory Tract Diseases; Neonatal Prematurity; Prematurity, Neonatal; Birth, Premature",""
"phs002470.v1.p1","A Polygenic Score for Acute Vaso-Occlusive Pain in Pediatric Sickle Cell    Disease","Recurrent acute pain, or vaso-occlusive pain crisis (VOP), is the most common complication of sickle cell disease and correlates strongly with increased hospital visits and early mortality (PMID: 1710777). While  the genetics of VOP in sickle cell patients has been studied (PMID: 29205277, 27883292, 25102390, 30079801, 22925497, 29531649, 29620434, 19468207,","Not Applicable","Anemia, Sickle Cell","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 16 variables, 1 analyses, 1 molecular datasets, 327 subjects, 327 samples","","NHLBI","DS-SCD --- Disease-Specific (Sickle Cell Disease)","2022-02-14","2022-02-14","Pain; Polygenic Trait; Sickle Cell Anemias; Thalassemia; Pain, Splitting; Pains, Splitting",""
"phs002684.v1.p1","Single Suture Craniosynostosis: Gene and Pathway Discovery","Craniosynostosis is the premature fusion of one or more of the calvarial sutures. In this work, we used genomics and network modeling to reveal genetic and developmental pathways which, when  disrupted, result in premature calvarial fusion. Calvarial bone explants were obtained from children undergoing surgery for single suture","Not Applicable","Craniosynostoses","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 13 variables, 386 samples sequenced, 386 subjects, 386 samples","","NIDCR","DS-CSA --- Disease-Specific (Craniosynostosis, all)","2022-02-11","2022-02-11","CRANIOSTENOSIS; CRS; CSO; CSO - Craniosynostosis; Congenital ossification of cranial sutures; Congenital ossification of sutures of skull",""
"phs002774.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular: ENGAGE Atrial    Fibrillation-TIMI 48","This study is a part of NHGRI's Center for Common Disease Genomics, which is a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing to  multiple common disease phenotypes. Current estimates anticipate that the CCDG program will sequence approximately 140K whole genomes and 225K whole","Not Applicable","Cardiovascular Diseases","Case Set","Not Provided","Not Provided","Not Provided","","NHGRI","DS-CCSD-MDS --- Disease-Specific (Circulatory and Cardiovascular System Diseases, MDS), DS-BBFOD-MDS --- Disease-Specific (Blood and blood-forming organ disorders, MDS)","2022-02-10","","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs002414.v1.p1","Human Companion Data for 'A Transcriptomic Atlas of Mouse Cerebellar    Cortex Reveals Novel Cell Types'","In this study, we used single-nucleus RNA-seq to comprehensively define the cell specialization of the mouse cerebellar cortex and vermis. We focused in particular on two interneuron populations&#x02014;the unipolar brush  cells (UBCs) and the molecular layer interneurons (MLIs), identifying continuous variation within the former population, and a new discrete axis of","Not Applicable","Cerebellar Cortex","Control Set","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 2 samples sequenced, 2 subjects, 2 samples","","NIA","HMB-MDS --- Health/Medical/Biomedical (MDS)","2022-02-10","2022-02-10","Not Provided",""
"phs002507.v1.p1","Developmental Maturation of Hematopoietic Stem and Progenitor Cells    Mediated by Lin28b/Let-7/Cbx2","This study encompasses two human cell lines used to profile polycomb repressive complex markers during hematopoietic maturation. &#x000a0;This study includes epigenomic mark sequencing data obtained via the CUT&RUN protocol. This  study included human hematopoietic stem and progenitor cell model cell lines. Principal Investigator: Robert Grant Rowe, Boston Children's Hospital,","Not Applicable","Hematopoiesis","Methods","Not Provided","OTHER","4 phenotype datasets, 14 variables, 5 samples sequenced, 2 subjects, 5 samples","","NIDDK","HMB --- Health/Medical/Biomedical","2022-02-07","2022-02-07","Not Provided",""
"phs002400.v1.p1","The Role of Myeloid Cells in Parkinson's Disease","The Myeloid cells in Neurodegenerative Diseases (MyND) initiative is a collaborative effort with the goal of creating a multi-omic atlas of myeloid cells from the periphery and from autopsied brains  of subjects with Parkinson's disease (PD), Alzheimer's disease (AD), and age-matched controls. We have generated large-scale transcriptomic profiles","Not Applicable","Parkinson Disease","Case-Control","Global_Screening_Array-24","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 15 variables, 4 analyses, 1 molecular datasets, 358 samples sequenced, 285 subjects, 358 samples","","NINDS","GRU --- General Research Use","2022-02-04","2022-02-04","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002735.v1.p1","Tumor Infiltrating Lymphocytes (TIL) Recognize Unique Somatic Mutations    and Mediate Objective Clinical Responses in Metastatic Breast Cancer","The purpose of this study is to investigate the immunogenicity of tumor mutations in patients with metastatic cancer. Harvest and analysis of progressing metastatic lesions are used for generation of  tumor infiltrating lymphocyte (TIL) cultures and the detections of somatic mutations. In vitro T cell activation assays are used to examine the","Not Applicable","Breast Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 15 variables, 358 samples sequenced, 42 subjects, 358 samples","","NCI","GRU --- General Research Use","2022-02-02","2022-02-02","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001863.v1.p1","Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin    +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by    Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast    Cancer","This randomized phase II trial studies how well paclitaxel with or without carboplatin and/or bevacizumab followed by doxorubicin and cyclophosphamide works in treating patients with breast cancer that can be  removed by surgery. Drugs used in chemotherapy, such as paclitaxel, carboplatin, doxorubicin, and cyclophosphamide, work in different ways to stop","Not Applicable","Breast Neoplasms","Interventional","Not Provided","RNA-Seq","4 phenotype datasets, 53 variables, 2 documents, 389 samples sequenced,  SRA, 389 subjects, 389 samples","","NCI","DS-CA-COL --- Disease-Specific (Cancer, COL)","2022-02-01","2022-02-01","Breast Diseases; Neoplasms by Site; Skin Diseases; Triple Negative Breast Neoplasms; Breast Disease, Endocrine; Breast Diseases, Endocrine",""
"phs002495.v1.p1","Clinical and Genetic Analysis of Costa Rican Patients with Parkinson's    Disease","This study is a pilot study designed to describe the clinical and genetic landscape of Parkinson's disease in Costa Rica. While most genetic studies have been conducted on Europeans, few  have examined Parkinson's disease in Costa Ricans. 118 patients and 97 controls were recruited at the Movement Disorders Unit of the Department of","Not Applicable","Parkinson Disease","Case-Control","target_markerset_grc37","CNV Genotypes","4 phenotype datasets, 12 variables, 1 molecular datasets, 176 subjects, 176 samples","","NINDS","GRU-COL --- General Research Use (COL)","2022-01-26","2022-01-26","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs002388.v1.p1","Genomic and Transcriptomic Markers Associated with Response to Immune    Checkpoint Blockade","The neoantigen presentation score (NEOPS) study was designed to better understand molecular determinants of response to immunotherapies, including pembrolizumab and nivolumab in stage III or IV melanoma patients. From this  work, we developed a composite approach to predicting neoantigens (NEOPS), which takes into account additional escape mechanisms, including HLA LOH","Not Applicable","Melanoma","Case Set","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS), WXS","4 phenotype datasets, 22 variables, 1 molecular datasets, 151 samples sequenced, 52 subjects, 199 samples","","NCI","GRU --- General Research Use","2022-01-25","2022-01-25","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001802.v2.p1","Genetics of Lymphatic Anomalies from CAG","Lymphatic anomaly, a rare and devastating disease spectrum of mostly unknown etiologies, is characterized by diffuse or multicentric proliferation of dilated lymphatic vessels, and includes a variety of diagnoses: lymphangiectasia,  central conducting lymphatic anomaly, generalized lymphatic anomaly, kaposiform lymphangiomatosis, and Gorham Stout disease. Currently, most","Not Applicable","Lymphatic Diseases","Case Set","Not Provided","WXS","4 phenotype datasets, 17 variables, 6 samples sequenced,  SRA, 6 subjects, 6 samples","","NHGRI","GRU --- General Research Use","2022-01-25","2019-05-23","Lymphatism","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002726.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular: Cardiology    Biobanking for Biomarker Discovery","This study is a part of NHGRI's Center for Common Disease Genomics, which is a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing to  multiple common disease phenotypes. Current estimates anticipate that the CCDG program will sequence approximately 140K whole genomes and 225K whole","Not Applicable","Cardiovascular Diseases","Case Set","Not Provided","Not Provided","Not Provided","","NHGRI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2022-01-24","","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs002625.v1.p1","The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to    Relapse-Refractory States","In multiple myeloma, the spatio-temporal evolution patterns of cancer cells in the bone marrow remain largely unknown. Here, we applied spatial-longitudinal sequencing, including a total of 179 samples collected from  25 patients during a follow-up of up to 14 years. Our study highlights focal bone lesions (FL) as hotspots of tumor evolution and provides possible","Not Applicable","Multiple Myeloma","Collection","Not Provided","WXS","4 phenotype datasets, 16 variables, 179 samples sequenced, 25 subjects, 179 samples","","NIGMS","GRU --- General Research Use","2022-01-21","2022-01-21","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002460.v1.p1","Health Professionals Follow-Up Study","Health Professionals Follow-up Study (HPFS) is a prospective cohort study of men designed to evaluate hypotheses about men's health related to diet and lifestyle to the incidence of serious illnesses,  such as cancer, heart disease, and other vascular diseases. It consisted of 51,529 U.S. male health professionals who were 40-75 years old at","Not Applicable","Diet","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 398 variables, 1 documents, 20064 subjects","","NCI","HMB --- Health/Medical/Biomedical","2022-01-20","2022-01-20","Not Provided","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002695.v1.p1","Development of Computational Approaches for Cell Hashing in scRNA-Seq","As a test of cell overloading after cell hashing, a sample of peripheral blood mononuclear cells (PBMC) from a single subject was separated into naive T cells, memory T cells,  and non-T cell PBMC populations using fluorescence activated cell sorting (FACS). Each population was separated into two technical replicates, then","Not Applicable","Cells","Methods","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 13 variables, 8 samples sequenced, 1 subjects, 8 samples","","NIAID","HMB --- Health/Medical/Biomedical","2022-01-13","2022-01-13","Not Provided",""
"phs002396.v1.p1","Integrated Metabolic Profiling and Gene Expression Analysis Reveals    Therapeutic Modalities in Breast Cancer","In this study, we performed metabolite profiling and RNA-sequencing on human breast cancer tumors and normal breast tissue samples, including triple negative breast cancer (TNBC), estrogen receptor positive breast cancer  (ER+) and paired normal samples, and patient-derived xenografts (PDX) samples. Here, we report two distinctive groups defined by metabolites; a","Not Applicable","Triple Negative Breast Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq","5 phenotype datasets, 17 variables, 40 samples sequenced, 26 subjects, 40 samples","","NCI","GRU --- General Research Use","2022-01-13","2022-01-13","Breast Cancer, Triple-Negative; Breast Cancers, Triple-Negative; Breast Neoplasm, Triple-Negative; Breast Neoplasms, Triple-Negative; ER Negative PR Negative HER2 Negative Breast Cancer; ER Negative PR Negative HER2 Negative Breast Neoplasms","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002170.v1.p1","Genome-Wide Association Study of Patients with Coccidioidomycosis","Background Valley Fever is typically an infection of the lungs caused by the fungi Coccidioides immitis and Coccidioides posadasii. The incidence of Coccidioidomycosis (CM), or infection with Coccidioides, has dramatically  increased over the last 20 years. This is particularly true in the Southwest of the United States, where people often breathe fungal spores that","Not Applicable","Coccidioidomycosis","Metagenomics","Not Provided","Not Provided","1 analyses","","NIAID","GRU --- General Research Use","2022-01-12","2022-01-12","California disease; Coccidioides Infection; Coccidioides Infections; Coccidioides immitis caused disease or disorder; Coccidioides immitis disease or disorder; Coccidioides immitis infection","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002050.v2.p1","OICR: Molecular Pathological Epidemiology of Colorectal Cancer","Colorectal cancer, the second most commonly diagnosed cancer, is a biologically heterogeneous disease. To characterize the molecular attributes of colorectal tumors, we conducted targeted sequencing at the Ontario Cancer Research  Institution (OICR) of tumor and matched normal DNA samples from 2,542 colorectal cancer cases in the Genetics and Epidemiology of Colorectal Cancer","Not Applicable","Colorectal Neoplasms","Case Set","target_markerset_grc38","SNP Genotypes (NGS), WXS","4 phenotype datasets, 29 variables, 1 molecular datasets, 5056 samples sequenced, 2528 subjects, 5056 samples","","NCI","HMB-IRB-COL --- Health/Medical/Biomedical (IRB, COL), GRU --- General Research Use, HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS)","2022-01-12","2021-01-15","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002222.v2.p1","Transcriptomic and Clonal Characterization of T Cells in the Human    Central Nervous System","The cerebrospinal fluid (CSF) is thought to be a main route for immune surveillance in the central nervous system (CNS). Understanding the composition and state of CSF in healthy individuals  may provide insight into perturbations present during neuroinflammation. Here, we have used single-cell RNA and TCR sequencing to profile CSF and","Not Applicable","Multiple Sclerosis","Case-Control","target_markerset_grc38, RNAseq_probe_set_grc38","OTHER, RNA-Seq, Custom targeted DNA/RNA sequencing, RNA Seq (NGS)","4 phenotype datasets, 21 variables, 2 molecular datasets, 46 samples sequenced, 12 subjects, 46 samples","","NIAID","GRU --- General Research Use","2022-01-11","2022-01-11","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001746.v2.p1","A Genomic Atlas of Systemic Interindividual Epigenetic Variation in    Humans (GTEx)","Methylation of cytosines in CpG dinucleotides is an epigenetic mechanism with essential roles in mammalian development. To explore its functions in cellular differentiation, unbiased analysis of CpG methylation by whole  genome bisulfite sequencing (WGBS) has been used to characterize epigenetic differences among different human tissues and cell types. Meanwhile,","Not Applicable","Reference Values","Control Set","Not Provided","Bisulfite-Seq","4 phenotype datasets, 16 variables, 30 samples sequenced, 194 subjects, 830 samples","","NHGRI","GRU --- General Research Use","2022-01-10","2022-01-10","Not Provided",""
"phs002687.v1.p1","RNA-Seq of Whole Blood from Pediatric Sickle Cell Anemia (SCA) Patients","The aim of this study is to define the immune cell transcriptome by next generation RNA sequencing in blood from individuals with SCA, in comparison to healthy African American controls.  This study has a cross-sectional case-control design. We will compare the transcriptome profiles of blood mononuclear cells from healthy age-matched","Not Applicable","Anemia, Sickle Cell","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 28 variables, 48 samples sequenced, 48 subjects, 48 samples","","NHLBI","HMB-IRB-PUB --- Health/Medical/Biomedical (IRB, PUB)","2021-12-29","2021-12-29","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S",""
"phs002309.v2.p1","Identification and Characterization of Skin-Resident Memory T cells in    Patients with Melanoma-Associated Vitiligo","Metastatic melanoma patients who develop melanoma-associated vitiligo, an autoimmune cutaneous side effect after receiving immunotherapy, have better overall survival than those who do not develop vitiligo. The objective of this  study is to determine the tumor-specific memory T cell responses in the skin, tumor and blood of melanoma patients with vitiligo. Matched melanoma","Not Applicable","Melanoma","Case Set","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS), Targeted-Capture","4 phenotype datasets, 19 variables, 2 molecular datasets, 32 samples sequenced, 5 subjects, 32 samples","","NCI","GRU --- General Research Use","2021-12-27","2021-12-27","Vitiligo; Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002027.v2.p1","Induction of HIV-1 Env-Specific Peripheral Blood Plasmablasts and Clonal    Persistence as Bone Marrow Plasma Cells Following Vaccination in    Humans","Induction of persistent HIV-1 Envelope (Env) specific antibody (Ab) is a primary goal of HIV vaccine strategies, however, it is unclear if HIV Env immunization in humans induces bone marrow  plasma cells, the presumed source of long-lived systemic Ab. To define the features of Env-specific plasma cells after vaccination, samples were","Not Applicable","HIV","Prospective Longitudinal Cohort","Not Provided","AMPLICON","3 phenotype datasets, 8 variables, 175 samples sequenced, 30 subjects, 175 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2021-12-23","2020-09-22","Not Provided",""
"phs001999.v1.p1","Advanced Genetic and Molecular Analysis of Solid Tumors","This study is designed to understand the role of immunosuppressive regulatory B cells (Breg) in pancreatic cancer. Breg and conventional B cells (Bcon) from patients are compared by RNA sequencing  analysis. Bregs and Bcon were isolated from freshly isolated PBMCs in peripheral blood. These data represent the examination of differentially","Not Applicable","Carcinoma, Pancreatic Ductal","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 2 samples sequenced, 1 subjects, 2 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2021-12-23","2021-12-23","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002406.v1.p1","The Northern Manhattan Family Study - a Sub-Study of the Epidemiologic    Study of Stroke Outcome in 3 Ethnic Groups: The Northern Manhattan    Study","The Northern Manhattan Family Study is a sub-study of the Northern Manhattan Study (NOMAS), a population-based cohort study investigating stroke and stroke risk factors among individuals from three ethnic groups  residing in northern Manhattan. The overall goal for the Northern Manhattan Family Study was to determine the genetic factors associated with stroke","Not Applicable","Atherosclerosis","Family/Twin/Trios","target_markerset_grc38, Illumina_Exome_Array, custom_markerset","SNP Genotypes (Array), SNP Genotypes (NGS)","6 phenotype datasets, 53 variables, 1 molecular datasets, 1686 subjects, 2564 samples","European (11), African (2), African American (681), Hispanic1 (932), Hispanic2 (2), Other (22)","NINDS","GRU-PUB --- General Research Use (PUB)","2021-12-16","2021-12-16","Plaque, Atherosclerotic; Atherogeneses; Atherogenesis; Atheromas; Atheromatous Plaque; Atheromatous Plaques",""
"phs001647.v2.p1","Varieties of Impulsivity in Opiate and Stimulant Users","The study was conducted in Bulgaria as a collaboration between Virginia Commonwealth University (Richmond, VA, USA), the Bulgarian Addictions Institute (Sofia, Bulgaria), the Molecular Medicine Center/Medical University (Sofia, Bulgaria), and  Indiana University (Bloomington, IN, USA). The overall aim of this study is to investigate the role of impulsivity as an endophenotype for drug","Not Applicable","Impulsive Behavior","Case-Control","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 82 variables, 2 molecular datasets, 597 subjects, 597 samples","European (576), Hispanic1 (3), Other Asian or Pacific Islander (1), South Asian (3), Other (14)","NIDA","DS-SUD-IRB-NPU-MDS-GSO --- Disease-Specific (Substance Use Disorders, IRB, NPU, MDS, GSO)","2021-12-16","2021-12-16","Amphetamine-Related Disorders; Heroin Dependence; Amphetamine Related Disorders; Amphetamine induced mental disorder; Amphetamine-related disorder; Disorder, Amphetamine-Related",""
"phs002467.v1.p1","Multimodal Profiling of 500,000 Memory T Cells from a Tuberculosis Cohort    Identifies Cell State Associations with Demographics, Environment, and    Disease","We conducted CITE-seq to measure whole transcriptome gene expression and surface expression of 31 proteins. We assayed 500K memory T cells from 259 donors from a tuberculosis progression cohort (128  cases: former progressors and 131 controls: non-progresssors/latent infection) 4 years post-infection after returning to immune steady state. We","Not Applicable","Tuberculosis","Case-Control","Not Provided","RNA-Seq","5 phenotype datasets, 21 variables, 265 samples sequenced, 259 subjects, 271 samples","","NIAID","GRU --- General Research Use","2021-12-10","2021-12-10","Latent Tuberculosis; Tuberculosis, Pulmonary; Infection, Latent Tuberculosis; Infections, Latent Tuberculosis; LTBI; LTBI - Latent tuberculosis infection",""
"phs002541.v1.p1","Integrated Genomic and Transcriptomic Analysis of Small Cell Lung Cancer    Reveals Inter- and Intratumoral Heterogeneity and a Novel    Chemotherapy-Refractory Subtype","We integrated histology, transcriptome, exome, and treatment outcomes of small cell neuroendocrine cancer (SCNC) from a range of metastatic sites, revealing complex intra- and intertumoral heterogeneity of neuroendocrine (NE) differentiation  and transcriptomic subtypes (ASCL1, NEUROD1, POU2F3, YAP1 and ATOH1). High NE SCNCs were more likely to benefit from replication stress-targeted","Not Applicable","Small Cell Lung Carcinoma","Cross-Sectional","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 12 variables, 168 samples sequenced, 72 subjects, 168 samples","","NCI","GRU --- General Research Use","2021-12-08","2021-12-08","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002463.v1.p1","Natural Genetic Variation in the Human Genome","In this study, we used existing whole genome sequencing data from the TOPMed Amish and Jackson Heart Study, as well as the GTEx study, to identify mobile element insertions in  the genomes of these individuals.&#x000a0; A total of 1112 TOPMed Amish, 3331 TOPMed Jackson Heart Study, and 698 GTEx individuals were","Not Applicable","Interspersed Repetitive Sequences","Collection","WGS_markerset_grc37","CNV (NGS)","3 phenotype datasets, 11 variables, 1 molecular datasets, 5068 subjects, 5068 samples","","NHGRI","GRU --- General Research Use, HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU)","2021-12-08","2021-12-08","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002612.v1.p1","Immunogenomics of Malignant Brain Tumors","We performed systematic and comprehensive multi-sector immunogenomic analyses on 93 samples from a cohort of 30 patients with primary or recurrent gliomas or metastatic brain tumors, representing the largest cohort  of these brain cancers studied spatially to date. For each patient, we characterized multiple spatially distinct regions using whole-exome (WES),","Not Applicable","Genetic Heterogeneity","Tumor vs. Matched-Normal","WES_markerset_grc38, RNAseq_probe_set_grc38","RNA-Seq, CNV Genotypes, RNA Seq (NGS), WXS","4 phenotype datasets, 22 variables, 2 documents, 1 molecular datasets, 203 samples sequenced, 30 subjects, 203 samples","","NCI","GRU --- General Research Use","2021-12-07","2021-12-07","Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002363.v1.p1","PETAL Repository of Electronic Data COVID-19 Observational Study (RED    CORAL)","To describe characteristics, treatment, and outcomes among patients hospitalized with COVID-19 early in the pandemic, 1480 consecutive adult inpatients with laboratory-confirmed, symptomatic SARS-CoV-2 infection admitted to 57 US hospitals from  March 1 to April 1, 2020 were studied. It was found that in a geographically diverse early-pandemic COVID-19 cohort with complete hospital","Not Applicable","COVID-19","Control Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1480 subjects, 1480 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2021-12-03","2021-12-03","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002639.v1.p1","Genomic Analysis of Metastatic Brain Cancer","This study contains targeted exome and transcriptome sequencing of metastatic brain tumors from 68 patients. Sequencing data includes i) targeted Tempus xT exome sequencing from matched tumor/normal from 68 patients,  and ii) whole-transcriptome RNA sequencing from a subset of 65 patients. Related Genes: BRAF, CDKN2A, KRAS, SMAD4, MCL1, NFE2L2, NRAS, PIK3CA, PTEN,","Not Applicable","Neoplasm Metastasis","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, Targeted-Capture","4 phenotype datasets, 11 variables, 201 samples sequenced, 68 subjects, 201 samples","","NCI","GRU --- General Research Use","2021-12-02","2021-12-02","Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002373.v1.p1","Avelumab or M7824 for People with Recurrent Respiratory Papillomatosis","This submission includes genomic data derived from the study of clinical samples from two different phase II trials. These trials evaluated the clinical efficacy and safety of avelumab or M7824  in the treatment of adults with recurrent respiratory papillomatosis (RRP). Subjects with aggressive RRP were treated with three to six doses of","Not Applicable","Recurrent respiratory papillomatosis","Clinical Trial","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 50 samples sequenced, 20 subjects, 50 samples","","NIDCD","DS-RVI-PUB --- Disease-Specific (Respiratory Viral Infections, PUB)","2021-12-02","2021-12-02","AORRP (type); JORRP (type); Juvenile laryngeal papilloma; Juvenile-onset recurrent respiratory papillomatosis; Laryngeal papilloma, recurrent; RRP",""
"phs002307.v1.p1","CSER: South-Seq: DNA Sequencing for Newborn Nurseries in the South","SouthSeq, part of the Clinical Sequencing Evidence-Generating Research (CSER2) effort, aims to perform genome sequencing for infants in nurseries at hospitals in Alabama, Mississippi, Louisiana, and Kentucky. SouthSeq aims to  sequence 600 newborn babies presenting with congenital anomalies, or other signs of a rare genetic disorder. The primary goals of SouthSeq are to","Not Applicable","Abnormalities, Multiple","Case Set","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use","2021-11-22","","Autoimmune Diseases; Eye Abnormalities; Gastrointestinal Diseases; Growth Disorders; Nervous System Diseases; Rare Diseases",""
"phs002066.v2.p1","Mechanisms of Extreme Genomic Instability at Large Transcribed Genes","Inhibiting DNA replication leads to copy number variant (CNV) formation throughout the genome, especially at chromosome fragile sites (CFSs). We previously showed that these hotspots for genome instability reside in  late-replicating domains associated with large transcribed genes. In this study, we compared aphidicolin (APH)-induced CNV and CFS frequency between","Not Applicable","Chromosome Fragile Sites","Case-Control","Multi-Ethnic_Global, target_markerset_grc38","CNV Genotypes, OTHER, RNA-Seq, RNA Seq (NGS), WGS","3 phenotype datasets, 18 variables, 1 documents, 1 molecular datasets, 22 samples sequenced, 2 subjects, 182 samples","","NCI","GRU --- General Research Use","2021-11-22","2020-08-19","Genomic Instability; Genome Instabilities; Genome Instability; Genomic Instabilities; Instabilities, Genome; Instabilities, Genomic","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001689.v1.p1","Multiethnic Cohort Adiposity Phenotype Study (MEC-APS)","A total of 1,861 healthy men and postmenopausal women aged 60-77 years with body mass indexes (BMIs) of 17.1-46.2 kg/m2 were enrolled into the study. Stratified sampling was conducted based  on sex, race/ethnicity, and six BMI categories (18.5-21.9, 22-24.9, 25-26.9, 27-29.9, 30-34.9, and 35-40 kg/m2) to balance the sample size across the","Not Applicable","Intra-Abdominal Fat","Cross-Sectional","MEGA_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 27 variables, 1 molecular datasets, 1849 subjects, 1849 samples","European (412), African (14), East Asian (438), African American (293), Hispanic1 (12), Hispanic2 (370), Other Asian or Pacific Islander (241), Other (69)","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2021-11-22","2021-11-22","Not Provided",""
"phs002587.v1.p1","Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to    Transcriptional CDK Inhibitors through Antagonism of E2F-Driven    Oncogenic Gene Expression","Leiomyosarcoma (LMS) is a smooth muscle-derived mesenchymal cancer commonly found to have recurrent loss of tumor suppressor genes and a poorly defined oncogenic program. Empiric cytotoxic chemotherapy is the standard  systemic treatment for LMS, and while more targeted and effective therapies are urgently needed, insights into therapeutic vulnerabilities in LMS","Not Applicable","Leiomyosarcoma","Case Set","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 13 variables, 67 samples sequenced, 11 subjects, 67 samples","","NCI","HMB --- Health/Medical/Biomedical","2021-11-18","2021-11-18","Epithelioid Leiomyosarcomas; Leiomyosarcoma, Epithelioid; Leiomyosarcomas, Epithelioid; epithelioid leiomyosarcoma","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002441.v1.p1","High-Throughput and High-Dimensional Single Cell Analysis of    Antigen-Specific CD8+ T Cells","We developed a high-dimensional, tetramer associated T cell receptor sequencing (TetTCR-SeqHD) method to simultaneously profile cognate antigen specificities, TCR sequences, targeted gene-expression, and surface protein expression. Cultured antigen-specific CD8+ T  cell clones were studied as a proof-of-concept experiment. In addition, both the antigen specific CD8+ T cells from healthy subjects and Type I","Not Applicable","Diabetes Mellitus, Type 1","Methods","Not Provided","AMPLICON","4 phenotype datasets, 15 variables, 16 samples sequenced, 22 subjects, 16 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2021-11-18","2021-11-18","DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes Mellitus, Sudden Onset",""
"phs002064.v1.p1","Metagenomic Analysis to Identify Novel Infectious Agents in Systemic    Anaplastic Large Cell Lymphoma","Anaplastic large cell lymphoma (ALCL) is a rare T-cell non-Hodgkin lymphoma (NHL). Risk of systemic ALCL is markedly increased among immunosuppressed people, such as those with human immunodeficiency virus (HIV)  infection or solid organ transplant recipients. This increased risk in immunosuppressed populations suggests a viral etiology, given similar","Not Applicable","Lymphoma, Large-Cell, Anaplastic","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 26 samples sequenced,  SRA, 26 subjects, 26 samples","","NCI","GRU --- General Research Use","2021-11-17","2021-11-17","ALCL; Anaplastic Large-Cell Lymphoma; Anaplastic Large-Cell Lymphomas; Anaplastic large cell lymphoma (ALCL) CD30+; Anaplastic large cell lymphoma CD30 positive; Anaplastic large cell lymphoma, CD30+","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002489.v1.p1","Developmental Dynamics of Translation in the Human Brain","We performed ribosome profiling and RNA sequencing from a total of 43 adult brain and 30 prenatal brain samples. The age of adult brain donors ranged from 18 to 82  years (average 39.5 years), with an average post-mortem interval of 9.9 hours. The gestational age of prenatal cortex samples ranged from 12 to 23","Not Applicable","Brain","Collection","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 13 variables, 73 samples sequenced, 73 subjects, 73 samples","","NINDS","GRU --- General Research Use","2021-11-15","2021-11-15","Not Provided",""
"phs001938.v3.p1","Genomic and Genetic Characterization of Prostate Tumors Treated with    Neoadjuvant Intense Androgen Deprivation Therapy","The purpose of this study was to develop better ways of detecting prostate cancer before and after pre-operative treatment, and to test the feasibility of multi parametric magnetic resonance imaging  (mpMRI) for the localization and detection of focal prostate cancer both before and after pre-operative treatment with ADT and enzalutamide. In this","Not Applicable","Prostatic Neoplasms","Case Set","Affymetrix_WG_Array","AMPLICON, SNP Genotypes (Array), RNA-Seq, WGS, WXS","5 phenotype datasets, 40 variables, 1 molecular datasets, 450 samples sequenced, 39 subjects, 487 samples","","NCI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2021-11-15","2021-11-15","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs002457.v1.p1","Comprehensive Analysis of the Immunogenomics of Triple Negative Breast    Cancer Brain Metastases from LCCC1419","Triple negative breast cancer (TNBC) is an aggressive subset of breast cancer that lacks expression of the estrogen and progesterone receptors (ER and PR) and HER2. Nearly 50% of patients  with advanced TNBC will develop brain metastases (BrM), commonly with progressive extracranial disease. Immunotherapy has shown promise in the","Not Applicable","Triple Negative Breast Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 95 samples sequenced, 25 subjects, 95 samples","","NCI","HMB --- Health/Medical/Biomedical","2021-11-10","2021-11-10","Neoplasm Metastasis; Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002238.v1.p1","Genomic Profiling of Relapsed and Refractory Childhood Cancers","Through clinical trials focused on molecularly guided therapy in pediatric cancers (NCT01355679, NCT01802567, NCT02162732), the Beat Childhood Cancer Consortium performed paired tumor/normal whole exome sequencing and/or tumor mRNA sequencing for  202 pediatric or adolescent young adult patients with rare, relapsed and refractory cancers (including neuroblastoma, Ewing sarcoma, osteosarcoma,","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 14 variables, 683 samples sequenced, 202 subjects, 683 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2021-11-09","2021-11-09","Desmoplastic Small Round Cell Tumor; Hepatoblastoma; Sarcoma; Sarcoma, Ewing; Brain Neoplasms; Brain Tumor","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000095.v4.p2","Dental Caries: Whole Genome Association and Gene x Environment Studies","Dental caries (also known as tooth decay) remains the most common chronic disease of childhood, five times more common than asthma and seven times more common than environmental allergies, with  more than 40% of children exhibiting caries when they enter kindergarten. In 2005, it was estimated that dental health care costs were approximately","Not Applicable","Dental Caries","Family/Twin/Trios","Human610-Quad, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","6 phenotype datasets, 195 variables, 76 documents, 3 molecular datasets, 4657 subjects, 4412 samples","European (3609), African (1), East Asian (9), African American (342), Hispanic1 (62), Hispanic2 (41), Other Asian or Pacific Islander (12), South Asian (21), Other (19)","NIDCR","DS-OH-GSO --- Disease-Specific (Oral Health, GSO)","2021-11-08","2015-12-18","Caries; Caries, Dental; Cariosity of teeth; Carious Lesion; Carious Lesions; Cavities, Dental",""
"phs002340.v1.p1","A Multi-Omic Single-Cell Atlas of Human Gynecological Malignancies","Matched single-cell transcriptomic sequencing (scRNA-seq) and single-cell chromatin accessibility sequencing (scATAC-seq) were performed for 11 fresh human tumors collected from the endometrium or ovary. More detailed information for each patient  tumor will be provided in selected phenotype/attributes data. Both scRNA-seq and scATAC-seq assays revealed the underlying cellular heterogeneity in","Not Applicable","Carcinoma, Ovarian Epithelial","Case Set","Not Provided","ATAC-seq, RNA-Seq","5 phenotype datasets, 18 variables, 22 samples sequenced, 11 subjects, 22 samples","","NCI","GRU --- General Research Use","2021-11-04","2021-11-04","Cancer, Epithelial Ovarian; Cancer, Ovarian Epithelial; Carcinoma of Ovary; Carcinoma of the Ovary; Carcinoma, Epithelial Ovarian; Epithelial Cancer, Ovarian","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002346.v1.p1","Characterization of Immune-Related Gene Expression in Lung Cancer","We performed a comprehensive analysis of inter- and intratumor heterogeneity of immune gene expression in 160 lung cancer patients from the Environment And Genetics in Lung cancer Etiology (EAGLE) study.  The transcriptome was profiled with RNA sequencing in 269 tumor samples and 110 normal tissue samples from 160 subjects. Lung cancer cases only","Not Applicable","Lung Neoplasms","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 16 variables, 378 samples sequenced, 160 subjects, 378 samples","","NCI","DS-LDS-MDS --- Disease-Specific (Lung disease or smoking, MDS)","2021-11-03","2021-11-03","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs002224.v1.p1","Sputum RNA-Seq from Asthmatic Patients for Microbes and Genes","RNA-seq files and other data associated with an investigation of the relationship between microbes, genes and immune cells present in the sputum of humans with asthma. Two groups of subjects  will be recruited for participation into the study 1) normal subjects without lung disease (including family members); 2) subjects with lung","Not Applicable","Asthma","Cross-Sectional","Not Provided","RNA-Seq","4 phenotype datasets, 35 variables, 8 documents, 116 samples sequenced, 116 subjects, 116 samples","","NHLBI","GRU --- General Research Use","2021-11-02","2021-11-02","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001945.v1.p1","National Institutes of Health H3Africa African Collaborative Center for    Microbiome and Genomics Research (ACCME)","The African Collaborative Center for Microbiome and Genomics Research is a multi-institutional collaborative research project. The objectives of the project are to collaborate and implement high impact integrative epidemiology and  genomics research into discovery of biomarkers associated with cervical carcinogenesis. Specifically ACCME links and leverages existing funded","Not Applicable","Uterine Cervical Neoplasms","Prospective Longitudinal Cohort","H3Africa_Array, imputation_panel","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 25 variables, 2 molecular datasets, 11215 subjects, 11688 samples","African (10755), East Asian (1), African American (457), Hispanic1 (1), Other (1)","NHGRI","GRU --- General Research Use","2021-11-01","2021-11-01","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001138.v4.p2","National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet    Program: The Gabriella Miller Kids First Pediatric Research Program of    the Pediatric Cardiac Genetics Consortium (PCGC)","Multi-center, prospective observational cohort study of individuals with congenital heart defects (CHD). Phenotypic data and source DNA derived from 300 probands and their parents, and family of interest collected to  investigate relationships between genetic factors and phenotypic and clinical outcomes in patients with CHD. This Kids First project represents a","Not Applicable","Heart Defects, Congenital","Family/Twin/Trios","Not Provided","WGS","3 phenotype datasets, 10 variables, 890 samples sequenced, 2966 subjects, 2987 samples","","NICHD","HMB --- Health/Medical/Biomedical, DS-CHD --- Disease-Specific (Congenital Heart Disease)","2021-10-29","2018-09-14","Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Abnormally shaped heart; Cardiac abnormalities",""
"phs000922.v2.p1","Genetic Aberrations and Subclonal Structure Impact Chronic Lymphocytic    Leukemia","Large-scale whole-exome sequencing (WES) of primary tumor samples enables the unbiased discovery of recurrent putative driver events and patterns of clonal evolution. We report the identification of 44 recurrently mutated  genes and 11 recurrent CNVs through the WES of 538 chronic lymphocytic leukemia (CLL) and matched germline DNAs. These include previously","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case Set","other","Bisulfite-Seq, RNA-Seq, SNV (.MAF), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets, 688 samples sequenced, 337 subjects, 688 samples","","NHGRI","DS-CRM-MDS --- Disease-Specific (Cancer Research and Methods, MDS)","2021-10-29","2016-10-20","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs002632.v1.p1","Whole Exome Sequencing in Alopecia Areata Identifies Rare Mutations in    KRT82","Alopecia areata (AA) is an autoimmune disorder, in which the body's own immune cells attack hair follicels resulting in hair loss. It is a complex genetic disease with 14 associated  loci previously identified in our genome-wide association study (GWAS). In the study, we performed the whole-exome sequencing (WES) on 849 AA","Not Applicable","Alopecia Areata","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 849 samples sequenced, 849 subjects, 849 samples","","NIAMS","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2021-10-28","2021-10-28","Autoimmunity; AA - Alopecia areata; Alopecia Circumscripta; Circumscribed alopecia; Patchy loss of hair; Autoimmune condition",""
"phs002407.v1.p1","A Single Cell Atlas of MMRd and MMRp Colorectal Cancer","Immune responses to cancer vary across cancer types and patients. Colorectal cancer tumors with mismatch repair-deficiency (MMRd) show an elevated immune cell activity as compared to mismatch repair proficient (MMRp)  tumors. To understand the immune response patterns in these two types of colorectal cancer, we transcriptionally profiled 371,223 tumor and adjacent","Not Applicable","Colorectal Neoplasms","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 40 variables, 181 samples sequenced, 62 subjects, 181 samples","","NCI","GRU --- General Research Use","2021-10-27","2021-10-27","Microsatellite Instability; CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002508.v1.p1","Human Vaccines Project: scRNAseq Characterization of HepB Vaccine    Response","In adult systems vaccinology studies, baseline immune status (i.e. pre-vaccine) of vaccine recipients was highly predictive of vaccine immunogenicity. The aim of this study is to characterize pre-vaccine immune signatures  that predict immunogenicity of HBV in humans using single cell transcriptomics. To investigate the pre-vaccine status of these patients, we","Not Applicable","Vaccines","Prospective Longitudinal Cohort","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 10 variables, 1 molecular datasets, 2856 samples sequenced, 6 subjects, 2856 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2021-10-22","2021-10-22","Not Provided",""
"phs002121.v1.p1","Integrated Clinical and Transcriptomic Profiling to Characterize Disease    Phenotype","Personalized medicine requires that we first address the challenge of genetic heterogeneity, prominent in rare cancers to common disease. While current clinical DNA sequence data successfully identify novel genetic variants,  the genomic data alone are insufficient biomarkers of clinical phenotype. There is an unmet need for systematic integration of specific functional","Not Applicable","Myeloproliferative Disorders","Cross-Sectional","Not Provided","RNA-Seq","4 phenotype datasets, 16 variables, 120 samples sequenced, 120 subjects, 120 samples","","NHGRI","DS-HEM --- Disease-Specific (Hematologic Disease)","2021-10-19","2021-10-19","Disorder, Myeloproliferative; Disorders, Myeloproliferative; Myeloproliferative Disorder; Myeloproliferative disease; Myeloproliferative neoplasms; Proliferation of myeloid cells",""
"phs002434.v1.p1","Mentored Patient Oriented Research in Lymphoma","Significant racial differences have been observed in the incidence and clinical outcomes of diffuse large B-cell lymphoma (DLBCL) in the United States, but to the authors' knowledge it remains unclear  whether genomic differences contribute to these disparities. To understand the influences of genetic ancestry on tumor genomic alterations, the","Not Applicable","Lymphoma, Large B-Cell, Diffuse","Case Set","Not Provided","Not Provided","Not Provided","","NCI","","2021-10-18","","Centroblastic diffuse large B-cell malignant lymphoma; Centroblastic diffuse malignant lymphoma; Centroblastic malignant lymphoma; DLBCL; DLBCL - diffuse large B cell lymphoma; Diffuse Histiocytic Lymphoma",""
"phs001918.v2.p1","STAMPEED: Whole Genome Association Analysis of Hematopoietic Cell    Transplant (HCT) Outcomes","This retrospective cohort study was designed to identify single nucleotide polymorphisms (SNPs) that are associated with complications after allogeneic hematopoietic cell transplantation (HCT). Validated discoveries provide information to improve risk  assessment, counseling and treatment planning and to direct future mechanistic studies of the genes and pathways that influence outcomes, thereby","Not Applicable","Graft vs Host Disease","Cross-Sectional","","SNP Genotypes (Array)","4 phenotype datasets, 76 variables, 1 molecular datasets, 9088 subjects, 9099 samples","European (8117), African (6), East Asian (203), African American (124), Hispanic1 (86), Hispanic2 (348), Other Asian or Pacific Islander (100), South Asian (45), Other (59)","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2021-10-18","2020-06-24","Aspergillosis; Cytomegalovirus Infection; Gram-Negative Bacterial Infections; Recurrence; Renal Insufficiency; Aspergilloses",""
"phs002557.v1.p1","Homozygous Duplication Identified by Whole Genome Sequencing Causes LRBA    Deficiency","In more than one third of primary immunodeficiency (PID) patients, extensive genetic analysis including whole exome sequencing (WES) fails to identify the genetic defect. Whole genome sequencing (WGS) is able  to detect variants missed by other genomics platforms, enabling the molecular diagnosis of otherwise unresolved cases. Here, we report two siblings,","Not Applicable","LRBA protein, human","Case Set","Not Provided","WGS","5 phenotype datasets, 26 variables, 2 samples sequenced, 2 subjects, 2 samples","","NIAID","HMB-IRB-COL --- Health/Medical/Biomedical (IRB, COL)","2021-10-15","2021-10-15","Not Provided",""
"phs001542.v2.p1","NHLBI TOPMed: Genetics of Asthma in Latino Americans (GALA)","This is a case pharmacogenetic study of bronchodilator drug response (Albuterol) among racially admixed Latino children with asthma between the ages of 8-40. Lung function testing was performed using the  KoKo PFT system and each participant was administered albuterol dependent on age. Participants under 16 years of age, were administered 2 puffs of","Not Applicable","Asthma","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 26 variables, 2 documents, 2 molecular datasets, 964 samples sequenced, 1024 subjects, 1011 samples","European (11), African American (35), Hispanic1 (417), Hispanic2 (442), Other Asian or Pacific Islander (1), Other (56)","NHLBI","DS-LD-IRB-COL --- Disease-Specific (Lung Diseases, IRB, COL)","2021-10-15","2021-10-15","Allergies; Allergic disorders; Allergy; Hypersensitive; Hypersensitivities; Sensitivity",""
"phs002344.v1.p1","Study of Tumor Recurrence Related to the Expression of the PAX3-FOXO1    Oncogenic Transcription Factor in Fusion-Positive Rhabdomyosarcoma","Alveolar rhabdomyosarcoma (ARMS) is a highly aggressive pediatric soft tissue cancer characterized by a recurrent 2;13 chromosome translocation. This translocation generates a PAX3-FOXO1 (P3F) fusion gene, which encodes a chimeric  transcription factor with oncogenic activity. Using a human myoblast system that models targeted therapy directed against P3F, we demonstrated that","Not Applicable","Rhabdomyosarcoma","Case Set","custom_markerset","SNP/CNV (Array)","3 phenotype datasets, 14 variables, 1 molecular datasets, 17 subjects, 17 samples","","NCI","GRU --- General Research Use","2021-10-14","2021-10-14","Not Provided","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001608.v2.p1","NHLBI TOPMed: Outcome Modifying Genes in Sickle Cell Disease (OMG)","Sickle cell disease (SCD) is caused by homozygosity for a single mutation of the beta hemoglobin gene. Despite the constancy of this genetic abnormality, the clinical course of patients with  SCD is remarkably variable. SCD can affect the function and cause the failure of multiple organ systems through the pathophysiologic processes of","Not Applicable","Anemia, Sickle Cell","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 65 variables, 2 documents, 2 molecular datasets, 640 samples sequenced, 642 subjects, 640 samples","","NHLBI","DS-SCD-IRB-PUB-COL-MDS-RD --- Disease-Specific (Sickle Cell Disease, IRB, PUB, COL, MDS, RD)","2021-10-13","2021-10-13","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S",""
"phs002506.v1.p1","Genome-Wide Approach to Measure Variant-Based Heritability of Drug    Outcome Phenotypes","Current pharmacogenetic approaches often use a few large-effect alleles to predict drug outcomes. However, many drug outcome phenotypes are determined by complex pathways that may be influenced by common single-nucleotide  variants (SNVs) across the genome. We ascertained how much variation in drug response is explained by common SNVs for pharmacokinetic (drug levels)","Not Applicable","Pharmacology","Case Set","HumanOmniExpress-12","SNP/CNV (Array)","4 phenotype datasets, 32 variables, 1 molecular datasets, 7093 subjects, 7093 samples","","NIGMS","HMB --- Health/Medical/Biomedical","2021-10-06","2021-10-06","Not Provided",""
"phs001782.v2.p1","Effect of the Placental Transcriptome on Stunting in a Longitudinal    African Cohort","Mammals with placentas and flowering plants evolved genomic imprinting in nutritive tissues, the placenta and endosperm, respectively. In these tissues, the genomes inherited from the mother and father are in  conflict over resource allocation to offspring. In imprinted genes, transcription is repressed on the paternal or the maternal allele, resulting in","Not Applicable","growth & development","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38, target_markerset_grc38","Allele-Specific Expression, RNA-Seq, SNP/CNV Genotypes (NGS), Targeted-Capture","5 phenotype datasets, 21 variables, 4 molecular datasets, 1217 samples sequenced, 802 subjects, 1217 samples","","NICHD","GRU-IRB-PUB-COL --- General Research Use (IRB, PUB, COL)","2021-10-04","2021-10-04","growth",""
"phs001468.v3.p1","NHLBI TOPMed: Recipient Epidemiology and Donor Evaluation Study-III    Brazil Sickle Cell Disease Cohort (REDS-BSCDC)","Establishing a Brazilian Sickle Cell Disease Cohort and Identifying Molecular Determinants of Response to Transfusions, Genetic Determinants of Alloimmunization, and Risk Factors Associated with HIV Infection. The REDS-III Brazil SCD  Cohort study focused on transfusion practices and predictors of health outcomes in patients with Sickle Cell Disease (SCD) and began in the Fall of","Not Applicable","Anemia, Sickle Cell","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 25 variables, 2 documents, 2 molecular datasets, 2621 samples sequenced, 2795 subjects, 2748 samples","European (10), African (11), African American (1511), Hispanic1 (1000), Other (89)","NHLBI","GRU-IRB-PUB-COL-NPU --- General Research Use (IRB, PUB, COL, NPU)","2021-10-04","2021-10-04","Sickle Cell Anemia; Disease, Hemoglobin SC; Disease, SC; Diseases, Hemoglobin SC; Diseases, SC; Double heterozygous for Hb S and Hb D",""
"phs000663.v3.p3","Drug-Induced Liver Injury Network (DILIN)","The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has established the Drug-Induced Liver Injury Network (DILIN) to collect and analyze cases of severe liver injury caused by  prescription drugs, over-the-counter drugs, and alternative medicines, such as herbal products and supplements. Inclusion Criteria: Age 2 years at","Not Applicable","Chemical and Drug Induced Liver Injury","Case Set","Human1M-Duo, Illumina_Exome_Array, MEGA_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 36 variables, 3 molecular datasets, 1573 subjects, 1579 samples","European (592), African (2), East Asian (17), African American (63), Hispanic1 (12), Hispanic2 (38), Other Asian or Pacific Islander (8), South Asian (6), Other (5)","NIDDK","DS-DILI-IRB --- Disease-Specific (Drug-Induced Liver Injury, IRB)","2021-10-04","2021-10-04","Drug-Induced Liver Injury; Hepatitides, Toxic; Hepatitis, Toxic; Toxic Hepatitides; Toxic Hepatitis; Toxin-associated hepatitis",""
"phs002415.v1.p1","Hydroxyurea to Prevent Organ Damage in Children with Sickle Cell Anemia    (BABY HUG) Phase III Clinical Trial and Follow-Up Observational    Studies I and II","Sickle cell anemia is associated with substantial morbidity from acute complications and organ dysfunction beginning in the first year of life. In 1995, the Multicenter Study of Hydroxyurea (MSH) (dbGaP  phs002348) demonstrated that, in adults, hydroxyurea is effective in decreasing the frequency of painful crises, hospitalizations for crises, acute","Not Applicable","Anemia, Sickle Cell","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 219 subjects, 219 samples","","NHLBI","DS-SCD-IRB-RD --- Disease-Specific (Sickle Cell Disease, IRB, RD)","2021-10-01","2021-10-01","Anemia; Hematologic Diseases; Hemoglobinopathies; Hemolytic Anemia; Molecular Mechanisms of Pharmacological Action; Sickle Cell Anemia",""
"phs002001.v1.p1","Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance    Mechanisms in EGFR Mutant Lung Cancer","Current understanding of acquired resistance to osimertinib in EGFR-mutant lung cancer is largely based on the use of targeted sequencing platforms and cell-free DNA. In this study we examined the  clonal evolution and heterogeneity of acquired resistance mechanisms to osimertinib through whole exome and RNA-sequencing of prospectively collected","Not Applicable","Lung Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, Targeted-Capture, WXS","4 phenotype datasets, 19 variables, 133 samples sequenced, 15 subjects, 133 samples","","NCI","GRU --- General Research Use","2021-09-30","2021-09-30","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001515.v2.p2","NHLBI TOPMed: My Life Our Future (MLOF) Research Repository of Patients    with Hemophilia A (Factor VIII Deficiency) or Hemophilia B (Factor IX    Deficiency)","Hemophilia A and B are X-linked bleeding disorders resulting from a deficiency in coagulation factor VIII (FVIII) or factor IX (FIX), respectively. Hemophilia affects approximately 1/5000 male births worldwide, and  results in premature death and disability due to bleeding if coagulation factor replacement therapy is not used effectively. Hemophilia is clinically","Not Applicable","Hemophilia A","Cross-Sectional","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 21 variables, 2 documents, 2 molecular datasets, 5137 samples sequenced, 9104 subjects, 9170 samples","European (3422), African (14), East Asian (102), African American (460), Hispanic1 (164), Hispanic2 (712), Other Asian or Pacific Islander (65), South Asian (89), Other (100)","NHLBI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2021-09-30","2021-09-30","Hemophilia; Hemophilia A, Congenital; AHG deficiency disease; AUTOSOMAL HEMOPHILIA A; Classic Hemophilia; Classic Hemophilias","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs002487.v1.p1","Epigenomes and Transcriptomes of Brain Samples of Schizophrenics and    Controls","We examined the effects of antipsychotic medications on the cell-specific epigenomics and transcriptomics in the frontal cortex of schizophrenic subjects. We performed ChIP-seq (H3K4me3 and H3K27ac) and RNA-seq on neuronal  and non-neuronal nuclei of postmortem frontal cortex samples from two cohorts of schizophrenics, either previously treated or not with antipsychotic","Not Applicable","Schizophrenia","Case-Control","Not Provided","ChIP-Seq, RNA-Seq","5 phenotype datasets, 22 variables, 700 samples sequenced, 58 subjects, 700 samples","","NIMH","GRU --- General Research Use","2021-09-29","2021-09-29","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001619.v3.p1","Genetic analysis of patients with Inherited Retinal Dystrophies (IRDs)    using next generation sequencing to identify the causative variants","Genetic analysis of patients with Inherited Retinal Dystrophies (IRDs) was carried out by performing Whole Genome Sequencing (WGS). The main purpose of this study is to identify simple and complex  mutations responsible for IRD in patients. WGS was performed on selected affected and unaffected individuals using the Illumina HiSeqX10. The reads","Not Applicable","Retinal Degeneration","Case-Control","WGS_markerset_grc37, WES_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 30 variables, 3 molecular datasets, 426 samples sequenced,  SRA, 425 subjects, 426 samples","European (196), East Asian (1), African American (4), Hispanic1 (2), Hispanic2 (130), Other Asian or Pacific Islander (2), South Asian (78), Other (1)","NEI","DS-HED-NPU-GSO --- Disease-Specific (Hereditary Eye Diseases, NPU, GSO)","2021-09-29","2021-09-29","Degeneration, Retinal; Degenerations, Retinal; Retina degeneration; Retinal Degenerations; degeneration of retina; retina, Degeneration Of",""
"phs001089.v4.p1","HudsonAlpha Institute for Biotechnology Clinical Sequencing Exploratory    Research (CSER): Genomic Diagnosis in Children with Developmental    Delay","The overarching goal of this project is to explore the ability for whole exome and genome sequencing technologies to identify the genetic causes of unexplained developmental delay, intellectual disability (DD/ID),  and related congenital anomalies in children. Such information may be useful as an endpoint to the otherwise fruitless ""diagnostic odyssey"" that many","Not Applicable","Intellectual Disability","Family/Twin/Trios","Not Provided","WGS, WXS","5 phenotype datasets, 44 variables, 1413 samples sequenced, 1403 subjects, 1413 samples","","NHGRI","GRU --- General Research Use","2021-09-27","2017-06-15","Ataxia; Autoimmune Diseases; Congenital Abnormalities; Craniofacial Abnormalities; Eye Abnormalities; Gastrointestinal Diseases",""
"phs001929.v1.p1","Neurogenetic Investigations of Obsessive-Compulsive Disorder","Obsessive-compulsive disorder (OCD) is a disabling early-onset neuropsychiatric disorder with a clear genetic contribution to risk but unclear underlying pathophysiology, which has hindered the development of new treatments and interventions.  This study uses high-throughput sequencing approaches to identify OCD risk genes, detect gene expression differences in OCD, and determine epigenetic","Not Applicable","Obsessive-Compulsive Disorder","Family/Twin/Trios","Not Provided","WXS","5 phenotype datasets, 20 variables, 600 samples sequenced, 600 subjects, 600 samples","","NIMH","DS-OCD --- Disease-Specific (Obsessive Compulsive Disorder)","2021-09-24","2021-09-24","Anancastic neurosis; Anankastic Personalities; Anankastic Personality; Disorder, Obsessive-Compulsive; Disorders, Obsessive-Compulsive; Neuroses, Obsessive-Compulsive",""
"phs002493.v1.p1","Genetic Effects on Gene Expression and Splicing during Human Neurogenesis","Interpretation of the function of non-coding risk loci for neuropsychiatric disorders and brain-relevant traits via gene expression and alternative splicing quantitative trait locus (e/sQTL) analyses is generally performed in bulk  post-mortem adult tissue. However, genetic risk loci are enriched in regulatory elements active during neocortical differentiation, and regulatory","Not Applicable","RNA-Seq","Collection","HumanOmni2.5","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 37 variables, 1 molecular datasets, 159 samples sequenced, 89 subjects, 248 samples","European (6), East Asian (3), African American (22), Hispanic2 (49), Other Asian or Pacific Islander (4), Other (5)","NIMH","GRU --- General Research Use","2021-09-23","2021-09-23","Not Provided","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs002484.v1.p1","Bulk RNA Sequencing of 86 Human Donor Lungs","The goal of this study was to characterize the effect of age on gene expression in normal human lung. We collected distal lung samples from 86 human donors distributed in  age between 16 and 76 years and extracted RNA for Illumina-based sequencing.","Not Applicable","Lung","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 86 samples sequenced, 86 subjects, 86 samples","","NHLBI","GRU-IRB-PUB-COL --- General Research Use (IRB, PUB, COL)","2021-09-23","2021-09-23","Aging; Aging, Biological; Biological Aging",""
"phs001027.v4.p1","Epigenomics Studies in Acute Myeloid Leukemia (AML)","Acute Myeloid Leukemia (AML) remains a clinical challenge since most patients diagnosed with AML will die from the disease. Some patients harbor treatment-refractory disease and many others relapse with disease  that in many cases is resistant to treatments. Our study was designed to understand the molecular basis of disease progression in AML through","Not Applicable","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","target_markerset_grc37, WES_markerset_grc37","Bisulfite-Seq, RNA-Seq, SNP/CNV Genotypes (NGS), Targeted-Capture, WGS, WXS","5 phenotype datasets, 29 variables, 1 molecular datasets, 910 samples sequenced, 155 subjects, 961 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2021-09-23","2021-05-18","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs001497.v2.p1","UCSF Adult Glioma Study","The UCSF Adult Glioma Study is a case-control study conducted at the University of California, San Francisco. The goals of the study were to discover inherited (genetic), developmental, immunologic and  other risk factors for glioma and to determine molecular level tumor markers that would be helpful in classifying glioma into more homogeneous","Not Applicable","Glioma","Case-Control","OncoArray, HumanCNV370-Duo, HumanMethylation450","Methylation (CpG), SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 2 molecular datasets, 3173 subjects, 3173 samples","European (1842), African (1), East Asian (60), African American (69), Hispanic1 (20), Hispanic2 (93), Other Asian or Pacific Islander (41), South Asian (17), Other (32)","NCI","GRU --- General Research Use, DS-BT-CA-MDS --- Disease-Specific (Brain tumors and all cancer, MDS)","2021-09-22","2021-09-22","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia",""
"phs002421.v1.p1","Transcriptomic Profiling of Patient Derived Alternative Lengthening of    Telomeres (ALT) and Non-MYCN-Amplified Neuroblastoma Cell Lines","Patient derived neuroblastoma cell lines are excellent tools to study biology of the disease. While many previous studies sequenced neuroblastoma cell lines, there are very few ALT and non-MYCN-amplified neuroblastoma  cell lines that were sequenced previously. Here, we present raw RNA sequencing data for 3 ALT (CHLA-90, SK-N-FI, COG-N-515) and 8 non-MYCN-amplified","Not Applicable","Neuroblastoma","Collection","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 14 variables, 1 molecular datasets, 11 samples sequenced, 11 subjects, 11 samples","","NCI","GRU --- General Research Use","2021-09-20","2021-09-20","Not Provided","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002545.v1.p1","Nivolumab and Ipilimumab and Radiation Therapy in Microsatellite Stable    (MSS) and Microsatellite Instable (MSI) High Colorectal and Pancreatic    Cancer","This is a single-arm, non-randomized, phase 2 trial (NCT03104439) combining radiation, ipilimumab and nivolumab in patients with metastatic MSS Colorectal Cancer (CRC; n 40) and Pancreatic Ductal Adenocarcinoma Cancer (PDAC;  n 25). Patients were previously treated population, and the primary endpoint was disease control rate. Pre- and post-treatment samples were subjected","Not Applicable","Immunotherapy","Case Set","Not Provided","WXS","5 phenotype datasets, 19 variables, 58 samples sequenced, 26 subjects, 72 samples","","NCI","HMB --- Health/Medical/Biomedical","2021-09-17","2021-09-17","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001735.v2.p1","NHLBI TOPMed: Pediatric Cardiac Genomics Consortium (PCGC)'s Congenital    Heart Disease Biobank","The Pediatric Cardiovascular Genetics Consortium (PCGC) proposes to define genetic causes for congenital heart defects (CHD) as part of the TOPMed Program are the most common form of heart disease  in childhood and are also the most prevalent form of birth defects, occurring in 2-3% of live births. The PCGC has recruited and clinically","Not Applicable","Heart Defects, Congenital","Prospective Longitudinal Cohort","WGS_markerset_grc38","RNA-Seq, SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 17 variables, 2 documents, 2 molecular datasets, 3226 samples sequenced, 4550 subjects, 4589 samples","European (2168), African (25), East Asian (81), African American (201), Hispanic1 (194), Hispanic2 (331), Other Asian or Pacific Islander (61), South Asian (99), Other (66)","NHLBI","HMB --- Health/Medical/Biomedical, DS-CHD --- Disease-Specific (Congenital Heart Disease)","2021-09-17","2021-09-17","Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Abnormally shaped heart; Cardiac abnormalities","NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs000971.v3.p1","The ClinSeq Project: Piloting Large-Scale Genome Sequencing for Research    in Genomic Medicine","ClinSeq is a pilot project to investigate the use of whole-genome sequencing as a tool for clinical research. By piloting the acquisition of large amounts of DNA sequence data from  individual human subjects, we are fostering the development of hypothesis-generating approaches for performing research in genomic medicine,","Not Applicable","Atherosclerosis","Case Set","WES_markerset_grc37","OTHER, RNA-Seq, SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 187 variables, 2 molecular datasets, 1634 samples sequenced, 1477 subjects, 1634 samples","European (747), African (27), East Asian (4), African American (467), Hispanic1 (150), Hispanic2 (9), Other Asian or Pacific Islander (37), South Asian (18), Other (23)","NHGRI","GRU --- General Research Use","2021-09-17","2020-02-13","Atherogeneses; Atherogenesis",""
"phs002410.v1.p1","FHIR Test Study BETA","FHIR Test Study BETA. This study was created with 3 consent groups to simulate an actual study for FHIR API testing project. The data herein is simulated and are intended  for development of FHIR representation of dbGaP phenotype data. Simulated data","Not Applicable","Heart Failure","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 58 variables, 813 subjects","","NLM","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU), HMB --- Health/Medical/Biomedical","2021-09-14","2021-09-14","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac",""
"phs002471.v1.p1","Base Editing Reduces Misfolded Protein Accumulation and Toxicity in    Alpha-1 Antitrypsin Deficient Patient iPSC-Hepatocytes","This study evaluates the efficiency and biological consequences of base editing of the single base &#x0201c;Z&#x0201d; mutation in the SERIPNA1 gene responsible for causing misfolding of the alpha-1 antitrypsin protein  that leads to the clinical disease &#x0201c;alpha-1 antitrypsin deficiency"". Samples on which the editing is performed are patient-derived iPSCs from","Not Applicable","alpha 1-Antitrypsin Deficiency","Collection","Not Provided","WGS","4 phenotype datasets, 15 variables, 5 samples sequenced, 1 subjects, 5 samples","","NCATS","GRU --- General Research Use","2021-09-13","2021-09-13","",""
"phs001882.v1.p1","OncoArray: Follow-up of Ovarian Cancer Genetic Association and    Interaction Studies (FOCI)","The Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI) was one of five projects funded in 2010 as part of the NCI's Genetic Associations and Mechanisms in Oncology  (GAME-ON) initiative (http://epi.grants.cancer.gov/gameon/). FOCI represents a collective effort that builds upon the strengths and history of","Not Applicable","Carcinoma, Ovarian Epithelial","Case-Control","OncoArray-500K","SNP Genotypes (Array)","4 phenotype datasets, 49 variables, 1 molecular datasets, 50315 subjects, 50671 samples","European (38518), African (79), East Asian (6355), African American (1730), Hispanic1 (191), Hispanic2 (808), Other Asian or Pacific Islander (881), South Asian (244), Other (267)","NCI","GRU --- General Research Use, DS-BCEMOPCA-NPU-MDS --- Disease-Specific (Breast, Colorectal, Endometrial, Melanoma, Ovarian, and/or Prostate Cancer, NPU, MDS), DS-BOED-MDS --- Disease-Specific (Breast, Ovarian, or Endometrial Disease, MDS), DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS), HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), GRU-NPU --- General Research Use (NPU), GRU-PUB-NPU --- General Research Use (PUB, NPU), HMB --- Health/Medical/Biomedical, HMB-PUB --- Health/Medical/Biomedical (PUB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS), GRU-COL --- General Research Use (COL), CADM --- Cancer in all age groups, other diseases in adults only, and methods, DS-BROC --- Disease-Specific (Breast and Ovarian cancer), DS-CA-NPU-GSO --- Disease-Specific (Cancer, NPU, GSO), DS-CA-MDS --- Disease-Specific (Cancer, MDS), OVCA --- Ovarian Cancer Only, DS-CA --- Disease-Specific (Cancer), DS-OVCA --- Disease-Specific (Ovarian Cancer), DS-OVCA-MDS --- Disease-Specific (Ovarian Cancer, MDS), DS-OVCA-MDS-GSO --- Disease-Specific (Ovarian Cancer, MDS, GSO), DS-OVCA-NPU --- Disease-Specific (Ovarian Cancer, NPU), DS-OVCA-NPU-MDS --- Disease-Specific (Ovarian Cancer, NPU, MDS), DS-OVTU --- Disease-Specific (Ovarian Tumors)","2021-09-13","2021-09-13","Genital Neoplasms, Female; Cancer, Epithelial Ovarian; Cancer, Ovarian Epithelial; Carcinoma of Ovary; Carcinoma of the Ovary; Carcinoma, Epithelial Ovarian","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002499.v1.p1","Primary Cytotoxic T Cell Lymphomas Harbor Recurrent Targetable    Alterations in the JAK-STAT Pathway","Cytotoxic cutaneous T cell lymphomas (CTCLs) are uncommon but highly aggressive cancers of skin-homing cytotoxic T cells. These include the established World Health Organization (WHO) entity primary cutaneous gamma delta  T cell lymphomas (PCGDTLs), the provisional WHO entity primary cutaneous CD8+ aggressive epidermotropic T cell lymphoma (PCAETCL), and samples that","Not Applicable","Lymphoma, T-Cell, Cutaneous","Case Set","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 18 variables, 19 samples sequenced, 9 subjects, 19 samples","","NIAMS","GRU --- General Research Use","2021-09-10","2021-09-10","Granulomatous Slack Skin; Slack Skin, Granulomatous",""
"phs001730.v2.p1","NHLBI TOPMed: Pediatric Asthma Controller Trial (PACT)","After a 2-4 week assessment/characterization run-in period, 6-14 year-old children who met NAEPP criteria for mild-moderate persistent asthma specifically based on symptom criteria and methacholine PC20 &#x02264; 12.5 mg/ml and  FEV1 &#x02265; 80% were randomized to one of the three active treatment arms for 12 months. Randomization was stratified according to clinical","Not Applicable","Asthma","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 24 variables, 2 documents, 2 molecular datasets, 27 samples sequenced, 41 subjects, 41 samples","","NHLBI","DS-ASTHMA-IRB-COL --- Disease-Specific (Asthma, IRB, COL)","2021-09-10","2021-09-10","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs002462.v1.p1","Circulating Tumor Cell Heterogeneity in Neuroendocrine Prostate Cancer by    Single Cell Copy Number Analysis","Neuroendocrine prostate cancer (NEPC) is an aggressive variant of prostate cancer that may arise de novo or develop from pre-existing prostate adenocarcinoma as a mechanism of treatment resistance. Combined loss  of tumor suppressors RB1, TP53, PTEN are frequent in NEPC but also present in a subset of prostate adenocarcinomas. Most clinical and preclinical","Not Applicable","Prostatic Neoplasms","Case Set","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 13 variables, 1 molecular datasets, 215 samples sequenced, 12 subjects, 215 samples","","NCI","DS-PC-IRB --- Disease-Specific (Prostate Cancer, IRB)","2021-09-09","2021-09-09","Carcinoma, Neuroendocrine; NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic",""
"phs002409.v1.p1","FHIR Test Study's ALPHA","FHIR Test Study ALPHA. This study was created to simulate an actual study for FHIR API testing project. The data herein is simulated and are intended for development of FHIR  representation of dbGaP phenotype data. Simulated data to be used for FHIR testing","Not Applicable","Asthma","Case-Control","Not Provided","Not Provided","2 phenotype datasets, 58 variables, 813 subjects","","NLM","GRU --- General Research Use","2021-09-09","2021-09-09","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs002377.v1.p1","A Phase I/IB Study of Ipilimumab or Nivolumab in Patients With Relapsed    Hematologic Malignancies After Allogeneic Hematopoietic Cell    Transplantation","Relapse after allogeneic hematopoietic stem cell transplantation (HSCT) is characterized by poor outcomes and novel therapeutic options are urgently needed. Immune checkpoint blockade using CTLA-4 and PD-1 blocking antibodies are  a potential concept for reinstating a dormant graft-versus-leukemia (GvL) effect.This study investigated transcriptomic changes in biopsies obtained","Not Applicable","Hematologic Neoplasms","Clinical Trial","Not Provided","RNA-Seq","3 phenotype datasets, 13 variables, 78 samples sequenced, 36 subjects, 78 samples","","NCI","HMB-COL --- Health/Medical/Biomedical (COL)","2021-09-03","2021-09-03","Relapse; HEMOLYMPHORETICULAR tumor, malignant; Hematopoietic Malignancies; Hematopoietic Malignancy; Hematopoietic Neoplasm; Hematopoietic Neoplasms Including Lymphomas",""
"phs002392.v1.p1","Transcriptome of 2-Hydroxypropyl-Beta-Cyclodextrin Treatment in    Niemann-Pick Disease Type C1","Niemann-Pick type C (NPC) disease is a rare and fatal lysosomal storage disorder. Classically, children with NPC demonstrate neurological dysfunction with cerebellar ataxia, dysarthria, seizures, vertical gaze palsy, motor impairment,  dysphagia, psychotic episodes, and progressive dementia. In general, adolescent and adult onset forms have a more insidious onset and slower","Not Applicable","Niemann-Pick Disease, Type C","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 82 samples sequenced, 41 subjects, 82 samples","","NICHD","DS-NPC1-IRB --- Disease-Specific (Niemann-Pick disease type C1, IRB)","2021-09-01","2021-09-01","Lysosomal Storage Diseases; Niemann-Pick Diseases; Disease, Lysosomal Storage; Diseases, Lysosomal Storage; Disorder, Lysosomal Enzyme; Disorders, Lysosomal Enzyme",""
"phs001467.v2.p2","NHLBI TOPMed: Study of Asthma Phenotypes and Pharmacogenomic Interactions    by Race-Ethnicity (SAPPHIRE)","Started in 2007, the Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-ethnicity (SAPPHIRE) is one of the largest asthma cohort studies in the United States. Its overarching goal is  to elucidate the genetic underpinnings of asthma and asthma medication treatment response. The cohort was recruited from a large health care system","Not Applicable","Asthma","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 32 variables, 2 documents, 2 molecular datasets, 4816 samples sequenced,  SRA, 4857 subjects, 4859 samples","European (195), African (35), East Asian (22), African American (4245), Hispanic1 (89), Hispanic2 (120), Other Asian or Pacific Islander (19), South Asian (14), Other (39)","NHLBI","HMB-COL --- Health/Medical/Biomedical (COL)","2021-08-31","2021-08-31","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs002229.v1.p1","Germ Cell Tumor Molecular Heterogeneity Revealed through Analysis of    Primary and Metastasis Pairs","Purpose: While primary germ cell tumors (GCTs) have been extensively characterized, molecular analysis of metastatic sites has been limited. We performed whole-exome sequencing and targeted next-generation sequencing on paired primary  and metastatic GCT samples in a patient cohort enriched for cisplatin-resistant disease. Experimental Design: Tissue sequencing was performed on 100","Not Applicable","Neoplasms, Germ Cell and Embryonal","Case Set","Not Provided","WXS","4 phenotype datasets, 48 variables, 30 samples sequenced,  SRA, 10 subjects, 30 samples","","NCI","GRU --- General Research Use","2021-08-30","2021-08-30","Testicular Neoplasms; Germ Cell and Embryonal Neoplasms; Germ Cell and Embryonic Neoplasms; Neoplasms, Germ Cell and Embryonic; Neoplasm of Testis; Neoplasm of the Testis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002512.v1.p1","Center for Common Disease Genomics [CCDG] - Neuropsychiatric: Simons    Searchlight","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","Not Provided","Not Provided","Not Provided","","NHGRI","DS-AUT-IRB-RD --- Disease-Specific (Autism, IRB, RD)","2021-08-25","","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs002511.v1.p1","Center for Common Disease Genomics [CCDG] - Neuropsychiatric: SPARK    Simons Foundation Powering Autism Research for Knowledge","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","Not Provided","Not Provided","Not Provided","","NHGRI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2021-08-25","","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs002509.v1.p1","Center for Common Disease Genomics [CCDG] - Neuropsychiatric: Genomics of    Autism Spectrum Disorder (GASD)","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","Not Provided","Not Provided","Not Provided","","NHGRI","GRU-NPU --- General Research Use (NPU)","2021-08-25","","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs002056.v1.p1","Genetic Factors associated with Conversion from Active Surveillance to    Treatment for Prostate Cancer","This is a genome-wide association study (GWAS) of conversion from active surveillance (AS) for prostate cancer (PC) to treatment. AS is the monitoring with screening tests and/or biopsies over time  of men usually with low-risk, early-stage PC to avoid harmful side effects of PC treatment. ""Conversion"" refers to patients who withdraw from AS","Not Applicable","Prostatic Neoplasms","Case Set","Multi-Ethnic_Global, imputation_panel","SNP/CNV (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 57 variables, 2 molecular datasets, 6323 subjects, 6577 samples","European (5370), African (40), East Asian (134), African American (407), Hispanic1 (63), Hispanic2 (127), Other Asian or Pacific Islander (35), South Asian (91), Other (56)","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS), DS-PC --- Disease-Specific (Prostate Cancer), DS-PC-IRB-MDS --- Disease-Specific (Prostate Cancer, IRB, MDS), DS-PC-IRB-PUB-MDS --- Disease-Specific (Prostate Cancer, IRB, PUB, MDS), DS-PC-IRB-NPU-MDS --- Disease-Specific (Prostate Cancer, IRB, NPU, MDS), DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS), DS-PC-PUB-MDS --- Disease-Specific (Prostate Cancer, PUB, MDS), DS-PC-PUB-NPU-MDS --- Disease-Specific (Prostate Cancer, PUB, NPU, MDS), GRU --- General Research Use","2021-08-25","2021-08-25","Death; Neoplasm Metastasis; Neoplasm Recurrence, Local; Deceased; End Of Life; End-Of-Life","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002437.v1.p1","Metformin for Oral Cancer Prevention","The M4OC-PREVENT clinical trial addressed whether metformin has utility in the prevention of oral cancer. It is a phase IIa clinical trial of metformin ER 2,000 mg per day given  for 12-14 weeks to individuals with oral premalignant lesions, either oral leukoplakia or erythroplakia (which are precursors to oral cancer). The","Not Applicable","Leukoplakia, Oral","Case Set","Not Provided","WXS","4 phenotype datasets, 22 variables, 34 samples sequenced, 17 subjects, 34 samples","","NCI","GRU --- General Research Use","2021-08-24","2021-08-24","Erythroplasia; Leukoplakia; Erythroplasias; erythroplakia; Keratotic Plaque; Lesion, Leukoplakic","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002315.v1.p1","Integrated Analysis of Multimodal Single-Cell Data","The simultaneous measurement of multiple modalities, known as multimodal analysis, represents an exciting frontier for single cell genomics and necessitates new computational methods that can define cellular states based on  multiple data types. Here, we introduce 'weighted nearest neighbor' analysis, an unsupervised framework to learn the relative utility of each data","Not Applicable","Single-Cell Analysis","Case Set","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 12 variables, 1 samples sequenced, 9 subjects, 1 samples","","NHGRI","GRU --- General Research Use","2021-08-20","2021-08-20","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001466.v2.p1","NHLBI TOPMed: Pharmacogenomics of Hydroxyurea in Sickle Cell Disease    (PharmHU)","Sickle cell disease (SCD) is characterized by the presence of sickle hemoglobin (HbS) within circulating erythrocytes resulting in hemolytic anemia, vascular occlusion, and end organ damage due to alterations in  the shape and deformability of the cell membrane. The disease is inherited in an autosomal recessive pattern, and is most commonly caused by a single","Not Applicable","Anemia, Sickle Cell","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 22 variables, 2 documents, 2 molecular datasets, 839 samples sequenced, 900 subjects, 900 samples","European (1), African (95), African American (687), Hispanic1 (9), Hispanic2 (18), South Asian (1), Other (17)","NHLBI","HMB --- Health/Medical/Biomedical, DS-SCD-RD --- Disease-Specific (Sickle Cell Disease, RD), DS-SCD --- Disease-Specific (Sickle Cell Disease)","2021-08-20","2021-08-20","Sickle Cell Anemia; Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle","NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs002446.v1.p1","Single Cell Omics Resolves Transcriptional Alterations in Sjogren's    Syndrome","Single cell omics resolves transcriptional alterations in Sjogren's Syndrome. This data compares the single cell transcriptional profiles of the minor salivary glands between Sjogren's Syndrome patients and non-Sjogren's Syndrome subjects.  Portions of this data were reported in two separate publications: Huang & Perez, et al., 2021 Nature Medicine and Yin, et al., 2021, Frontiers in","Not Applicable","Sjogren's Syndrome","Cross-Sectional","Not Provided","RNA-Seq","4 phenotype datasets, 21 variables, 12 samples sequenced, 12 subjects, 12 samples","","NIDCR","HMB --- Health/Medical/Biomedical","2021-08-19","2021-08-19","Autoimmune Diseases; Hereditary Autoinflammatory Diseases; Autoinflammation Disease, Hereditary; Autoinflammation Diseases, Hereditary; Autoinflammatory Disease, Hereditary; Autoinflammatory Diseases, Hereditary",""
"phs002046.v1.p1","Grady Trauma Project (GTP)","Not everyone exposed to traumatic experience develops Posttraumatic Stress Disorder (PTSD). Genetic background is one of the predisposing risk factors causing differential outcomes of trauma exposure. A primary goal of  the Grady Trauma Project (GTP) is to pinpoint and understand genetic polymorphisms that contribute to development of PTSD. Both PTSD diagnosis binary","Not Applicable","Stress Disorders, Post-Traumatic","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","7 phenotype datasets, 25 variables, 2 analyses, 1 molecular datasets, 5585 subjects, 5585 samples","","NIMH","GRU --- General Research Use","2021-08-19","2021-08-19","Combat Neurosis; Neuroses, Post Traumatic; Neuroses, Post-Traumatic; Neuroses, Posttraumatic; PTSD; PTSD - post-traumatic stress disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001806.v1.p1","Kids First: Whole Genome Sequencing of Nonsyndromic Craniosynostosis","Nonsyndromic craniosynostosis (NCS) is a common, major structural birth defect - due to the premature fusion of one or more cranial sutures - that requires extensive surgical correction and is  associated with considerable ongoing medical problems and health care costs. Because little is known about the causes of NCS, whole genome sequencing","Not Applicable","Craniosynostoses","Cross-Sectional","Not Provided","Not Provided","2 phenotype datasets, 4 variables,  SRA, 974 subjects, 1036 samples","","NCI","GRU --- General Research Use, HMB-GSO --- Health/Medical/Biomedical (GSO)","2021-08-19","2021-08-19","Craniofacial Abnormalities; Abnormalities, Craniofacial; Abnormality, Craniofacial; Craniofacial Abnormality; CRANIOSTENOSIS; CRS","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001785.v1.p1","Gabriella Miller Kids First Pediatric Research Program for Infantile    Hemangiomas Associated with Multi-Organ Structural Birth Defects","Infantile hemangiomas are the most common benign vascular tumor in infants, affecting 4-5% of children. Thirty percent of segmental infantile hemangiomas on the face and scalp are associated with birth  defects of multiple organs. This condition is known as PHACE, an acronym for posterior fossa brain malformations, segmental facial hemangiomas,","Not Applicable","Hemangioma","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables,  SRA, 274 subjects, 274 samples","","NCI","HMB --- Health/Medical/Biomedical, DS-PHACE --- Disease-Specific (PHACE Syndrome)","2021-08-17","2021-08-17","Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Abnormally shaped heart; Cardiac abnormalities","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001604.v2.p1","NHLBI TOPMed: Children's Health Study (CHS) Effects of Air Pollution on    the Development of Obesity in Children (Meta-AIR)","The Effects of Air Pollution on the Development of Obesity in Children (Meta-AIR) study was proposed to study a subset of the Children's Health Study (CHS) participants representing the extremes  of long-term traffic-related air pollution exposure occurring in Southern California CHS communities. The primary aim of the Meta-AIR study was to","Not Applicable","Asthma","Case-Control","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 25 variables, 2 documents, 2 molecular datasets, 52 samples sequenced, 56 subjects, 56 samples","","NHLBI","GRU --- General Research Use","2021-08-17","2021-08-17","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002325.v1.p1","Center for Common Disease Genomics (CCDG) - Cardiovascular: BioImage    Cohort","The genetic basis of cardiovascular disease in individuals of non-European ancestry remains largely unknown. Availability of ethnically diverse study populations is essential to fully investigate the underlying causes of disease.  The BioImage Study enrolled adults aged 55-80 in a prospective observational study. Subjects had no prior history of cardiovascular disease, but were","Not Applicable","Cardiovascular Diseases","Case-Control","Not Provided","Not Provided","Not Provided","","NHGRI","DS-HBVD --- Disease-Specific (Heart and Blood Vessel Disease)","2021-08-12","","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs002282.v1.p1","Center for Common Disease Genomics (CCDG) - Cardiovascular: Harvard    Gene-Diet Interaction in a Costa Rican Cohort","The National Human Genome Research Institute (NHGRI) has funded the Centers for Common Disease Genomics (CCDG), a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants  contributing to multiple common disease phenotypes and to better understand the general principles of genomic architecture underlying common, complex","Not Applicable","Cardiovascular Diseases","Case Set","Not Provided","Not Provided","Not Provided","","NHGRI","DS-CVDRF --- Disease-Specific (Cardiovascular Disease and Risk Factors)","2021-08-12","","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs002444.v1.p1","Germline Genetic Variants in Cancer-Susceptibility Genes in Patients with    Osteosarcoma","We conducted whole-exome sequencing of germline DNA from patients with osteosarcoma to estimate the frequency of pathogenic/likely pathogenic germline genetic variants in known cancer-susceptibility genes in a large population of  osteosarcoma patients unselected for family history. Osteosarcoma cases of all ages unselected for family history from 10 international centers or","Not Applicable","Osteosarcoma","Case Set","Not Provided","WXS","4 phenotype datasets, 13 variables, 720 samples sequenced, 720 subjects, 720 samples","","NCI","HMB --- Health/Medical/Biomedical","2021-08-11","2021-08-11","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteoblastic osteosarcoma; Osteoblastic sarcoma; Osteochondrosarcoma","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001603.v2.p1","NHLBI TOPMed: Children's Health Study (CHS) Integrative Genomics and    Environmental Research of Asthma (IGERA)","The Integrative Genomics and Environmental Research of Asthma (IGERA) Study was proposed to collect immortalized cell lines, RNA, cDNA and DNA from 400 well-characterized subjects who participated in the southern  California Children's Health Study (CHS) and to develop an accompanying database for these samples consisting of extensive phenotype, exposure,","Not Applicable","Asthma","Case-Control","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 25 variables, 2 documents, 2 molecular datasets, 154 samples sequenced, 160 subjects, 156 samples","European (24), African American (1), Hispanic1 (3), Hispanic2 (117), Other Asian or Pacific Islander (3), Other (6)","NHLBI","GRU --- General Research Use","2021-08-11","2021-08-11","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001602.v2.p1","NHLBI TOPMed: Children's Health Study (CHS) Integrative Genetic    Approaches to Gene-Air Pollution Interactions in Asthma (GAP)","The Integrative Genetic Approaches to Gene-Air Pollution Interactions in Asthma (GAP) study was proposed to use an innovative genetics approach in mice and humans to identify novel variants that interact  with traffic-related pollutant exposures to affect lung function phenotypes and the risk of childhood asthma. The study participants were enrolled","Not Applicable","Asthma","Case-Control","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 25 variables, 2 documents, 2 molecular datasets, 7 samples sequenced, 7 subjects, 7 samples","","NHLBI","GRU --- General Research Use","2021-08-11","2021-08-11","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001599.v1.p1","NHLBI TOPMed: Boston-Brazil Sickle Cell Disease (SCD) Cohort","This study involves sequencing of patients with a diagnosis of sickle cell disease from Brazil. No exclusionary criteria were employed and any eligible patients that consented to this study were  recruited. All included patients had a diagnosis of sickle cell disease, including genotypes hemoglobin SS, SC, and S-beta thalassemia. Principal","Not Applicable","Anemia, Sickle Cell","Prospective Longitudinal Cohort","Not Provided","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 32 variables, 1 documents, 1 molecular datasets, 387 samples sequenced,  SRA, 943 subjects, 943 samples","","NHLBI","HMB-IRB-COL --- Health/Medical/Biomedical (IRB, COL)","2021-08-11","2021-08-11","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S",""
"phs002464.v1.p1","Leveraging Extended Families for Cardiovascular Disease Genomic Discovery","This study characterizes a large early onset atrial fibrillation family and identifies a rare causative mutation (R231H) in the KCNQ1 gene. The age of this mutation is 5000 years, as  estimated using IBD-coalescent methods. The geographic distribution and demographic history of the mutation is described. Induced pluripotent stem","Not Applicable","Atrial Fibrillation","Family/Twin/Trios","WGS_markerset_grc37, RNAseq_gene_transcripts","RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq (NGS), WGS, WXS","5 phenotype datasets, 22 variables, 1 molecular datasets, 23 samples sequenced, 10 subjects, 23 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2021-08-02","2021-08-02","Atrial fibrillation, familial 1; A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations",""
"phs001546.v2.p1","NHLBI TOPMed: Determining the Association of Chromosomal Variants with    Non-PV Triggers and Ablation-Outcome in AF (DECAF)","The DECAF trial was conducted at the Texas Cardiac Arrhythmia Institute (TCAI) in 2013 in collaboration with the University of Texas at Austin. Four hundred consecutive AF patients undergoing catheter  ablation were enrolled. All participants provided voluntary informed consents. Blood samples were collected before the ablation procedure and labeled","Not Applicable","Atrial Fibrillation","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 19 variables, 2 documents, 2 molecular datasets, 6 subjects, 6 samples","","NHLBI","GRU --- General Research Use","2021-07-23","2021-07-23","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001881.v1.p1","A Large Data Resource of Genomic Copy Number Variation across    Neurodevelopmental Disorders","This study presents the first genome-wide copy number variation (CNV) analysis across autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), schizophrenia (SCZ), and obsessive-compulsive disorder (OCD). A total of  2,691 subjects diagnosed with a neurodevelopmental disorder (NDD), and a total of 1,769 unaffected family members from Ontario, Canada were assayed","Not Applicable","Autism Spectrum Disorder","Case-Control","Cytogenetic_Arrays","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 4384 subjects, 4384 samples","","NIMH","DS-AUT-IRB --- Disease-Specific (Autism, IRB)","2021-07-22","2021-07-22","Attention Deficit Hyperactivity Disorder; Obsessive Compulsive Disorder; ADD; ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity",""
"phs002436.v1.p1","Transcriptome and Epigenome of TIL Infusion for Cancer Immunotherapy","Adoptive T cell therapy (ACT) using ex vivo&#x02013;expanded autologous tumor-infiltrating lymphocytes (TILs) can mediate complete regression of certain human cancers. The impact of TIL phenotypes on clinical success of TIL-ACT  is currently unclear. Samples were analyzed from TIL infusion products from metastatic melanoma human patients who responded to TIL-ACT (responders)","Not Applicable","Melanoma","Case Set","Not Provided","ATAC-seq, RNA-Seq","4 phenotype datasets, 15 variables, 36 samples sequenced, 13 subjects, 36 samples","","NCI","GRU --- General Research Use","2021-07-21","2021-07-21","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001017.v1.p1","Breast Cancer Susceptibility","Genetic factors account for a large fraction of breast cancer risk and it is estimated that up to 30% of breast cancers have a heritable component. Inherited cancer susceptibility is  associated with early-onset of malignancies in general. Although 20% of young women with breast cancer have germline mutations in the best understood","Not Applicable","Breast Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 1759 samples sequenced, 1759 subjects, 1759 samples","","NHGRI","DS-CA --- Disease-Specific (Cancer), DS-BRCA --- Disease-Specific (Breast Cancer)","2021-07-19","2021-07-19","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002490.v1.p1","Studies of Diabetes Mellitus and its Complications in American Indians","Genomic data have been generated for several studies conducted by the intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIH protocol numbers: OH76-DK-0256, 01-DK-N117,  OH82-DK-0186, 13-DK-N151, 08-DK-N109). To protect the privacy of the individual participants and the involved tribes, these studies have been granted","Not Applicable","Diabetes Mellitus","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","NIDDK","","2021-07-15","","Diabetes Mellitus Complications; Diabetes Complications; Diabetes Mellitus Complication; Diabetes Related Complications; Diabetes-Related Complication; Diabetes-Related Complications",""
"phs002073.v1.p1","Effect of Breast Feeding on Immunologic Priming in Young Infants","The mechanisms generating immunoglobulin heavy chain (IgH) biodiversity result in over potentially unique immunoglobulin sequences within an individual. However, over the course of B cell development, B cell receptor (BCR)  selection constrains the repertoire significantly. In newborn infants compared to adults, developmental regulation of terminal deoxynucleotidyl","Not Applicable","Breast Feeding","Prospective Longitudinal Cohort","Not Provided","Not Provided","3 phenotype datasets, 13 variables, 45 samples sequenced, 40 subjects, 240 samples, 1 substudies","","NIAID","GRU-IRB-PUB-COL-NPU --- General Research Use (IRB, PUB, COL, NPU)","2021-07-15","2021-07-15","BF - Breastfed; BF - Breastfeeding; Breast Fed; Breast Feedings; Breastfed; Breastfeeding",""
"phs002074.v1.p1","Gene Therapy Normalizes the IgH Repertoire in ADA Deficiency","Adenosine deaminase (ADA) deficiency causes severe combined immunodeficiency (SCID) through an accumulation of toxic metabolites within lymphocytes. Recently, ADA deficiency has been successfully treated using lentiviral-transduced autologous CD34+ cells carrying  the ADA gene. T and B cell function appears to be fully restored but in many patients' B cell numbers remain low and assessments of the","Effect of Breast Feeding on Immunologic Priming in Young Infants (phs002073.v1.p1)","Severe combined immunodeficiency due to adenosine deaminase deficiency","Case-Control","Not Provided","RNA-Seq, RNA-Seq","1 phenotype datasets, 7 variables, 45 samples sequenced, 40 subjects, 240 samples","","NIAID","GRU-IRB-PUB-COL-NPU --- General Research Use (IRB, PUB, COL, NPU)","2021-07-15","2021-07-15","ADA Deficiency; ADA-SCID; SCID Due to ADA Deficiency; ADA; Adenosine Deaminase Deficiency; Adenosine Deaminase Deficient Severe Combined Immunodeficiency",""
"phs002316.v1.p1","Simultaneous Trimodal Single Cell Measurement of Transcripts, Epitopes,    and Chromatin Accessibility Using TEA-Seq","Single-cell measurements of cellular characteristics have been instrumental in understanding the heterogeneous pathways that drive differentiation, cellular responses to signals, and human disease. Recent advances have allowed paired capture of  protein abundance and transcriptomic state, but a lack of epigenetic information in these assays has left a missing link to gene regulation. Using","Not Applicable","Single-Cell Analysis","Methods","Not Provided","ATAC-seq, OTHER","4 phenotype datasets, 13 variables, 34 samples sequenced, 6 subjects, 34 samples","","NIAID","GRU --- General Research Use","2021-07-09","2021-07-09","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002311.v1.p1","GATA2 Deficiency","The aim of this study is to identify somatic mutations that contribute to the progression of GATA2 Deficiency patients from bone marrow failure to myelodysplastic syndrome (MDS) to acute myeloid  leukemia (AML) or chronic myelomonocytic leukemia (CMML). We investigated somatic mutations in 100 patients by whole exome and myeloid malignancy","Not Applicable","Neoplasms","Case Set","other","SNV (.MAF), Targeted-Capture, WXS","5 phenotype datasets, 21 variables, 1 molecular datasets, 294 samples sequenced, 106 subjects, 294 samples","","NCI","GRU --- General Research Use","2021-07-09","2021-07-09","Immune System Diseases; Disease, Immune; Disease, Immune System; Disease, Immunologic; Disease, Immunological; Diseases of Immune System","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001922.v1.p1","Chromosome Errors in Human Eggs and Natural Fertility","The overall aim of this project is to investigate chromosome errors in human oocytes as a function of age. We aimed to identify molecular mechanisms underpinning these errors and how  they may shape the curve of natural fertility in humans. Recruitment and informed consent procedures followed national standards, including the","Not Applicable","Aneuploidy","Case Set","HumanKaryomap-12","SNP Genotypes (Array), WGS","4 phenotype datasets, 26 variables, 1 molecular datasets, 181 samples sequenced, 35 subjects, 339 samples","European (17), East Asian (1), Hispanic1 (8), Hispanic2 (1), Other Asian or Pacific Islander (1), Other (1)","NICHD","OTHER-IRB-PUB-COL-NPU-MDS --- Other","2021-07-09","2021-07-09","Alteration of chromosome number; Aneuploid; Aneuploidies; Aneuploids; chromosome number anomaly",""
"phs002394.v1.p1","Chromatin Accessibility Landscape of Human Pancreatic Ductal    Adenocarcinoma (PDAC)","Therapeutic options in pancreatic ductal adenocarcinoma (PDAC) are largely limited to cytotoxic chemotherapy without the benefit of molecular markers predicting response. By ATAC-seq analyses of EpCAM+ PDAC malignant epithelial cells  sorted from 54 freshly resected human tumors, we discovered a signature of 1092 chromatin loci displaying differential accessibility between patients","Not Applicable","Pancreatic Neoplasms","Case Set","Not Provided","ATAC-seq, OTHER","5 phenotype datasets, 28 variables, 174 samples sequenced, 53 subjects, 174 samples","","NCI","DS-PACA-PUB --- Disease-Specific (Pancreatic Cancer, PUB)","2021-07-08","2021-07-08","Recurrence; Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas",""
"phs002230.v1.p1","The UCSD / O'Connor ""TSP"" (Twin/Sibling/Pedigree) Resource in    Hypertension","Study Design: The UCSD / O'Connor ""TSP"" (Twin/Sibling/Pedigree) Resource in Hypertension contains N 797 participants. At the time of recruitment individuals ranged from 15-84 years of age and had varying  ethnic backgrounds (Whites, African-Americans and Hispanics). The cohort was developed to study the genetic basis of autonomic dysfunction in human","Not Applicable","Hypertension","Family/Twin/Trios","Not Provided","WGS","5 phenotype datasets, 145 variables, 4 documents, 708 samples sequenced, 780 subjects, 797 samples","","NHLBI","GRU-NPU --- General Research Use (NPU)","2021-07-08","2021-07-08","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; HBP - High blood pressure",""
"phs002448.v1.p1","Inhibition of CDK4/6 Promotes CD8 T Cell Memory","Inhibitors of Cyclin-Dependent Kinase 4 and 6 (CDK4/6) have been recently deployed for the treatment of advanced breast cancer. Despite their success, the mechanism of action of these drugs is  unclear. In mice, treatment with a CDK4/6 inhibitor improve T cell memory responses and protect mice against tumor rechallenge. We aimed to identify","Not Applicable","Immunologic Memory","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 14 samples sequenced, 7 subjects, 14 samples","","NIAID","HMB --- Health/Medical/Biomedical","2021-07-07","2021-07-07","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002417.v1.p1","Low Density Genotyping from the Fragile Families and Child Wellbeing    Study","The Fragile Families and Child Wellbeing Study (FFCWS) is based on a stratified, multistage sample of 4898 children born in large U.S. cities (population over 200,000) between 1998 and 2000,  where births to unmarried mothers were oversampled by a ratio of 3 to 1. This sampling strategy resulted in the inclusion of a large number of Black,","Not Applicable","Population Groups","Prospective Longitudinal Cohort","PsychArray-24","SNP Genotypes (Array)","4 phenotype datasets, 23 variables, 1 molecular datasets, 3085 subjects, 3093 samples","European (536), African (14), East Asian (19), African American (1610), Hispanic1 (150), Hispanic2 (612), Other Asian or Pacific Islander (29), South Asian (12), Other (103)","NICHD","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2021-07-07","2021-07-07","Not Provided",""
"phs002002.v1.p1","Landscape of Intratumoral NK Cell and ILC in Head and Neck Squamous Cell    Carcinoma","In this study, total innate lymphoid cells (ILCs), including natural killer (NK) cells, were FACS-sorted from eight dissociated primary head and neck squamous cell carcinoma (HNSCC) tumors. In addition, ILCs  and NK cells were sorted from peripheral blood of tumor patients. The ILCs and NK cells were analyzed by single-cell RNA sequencing (scRNA-seq) using","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 2747 samples sequenced, 8 subjects, 2747 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2021-07-07","2021-07-07","Pharyngeal Neoplasms; Tongue Neoplasms; Neoplasia of the pharynx; Neoplasm of Pharynx; Neoplasm of the Pharynx; Neoplasm, Pharyngeal",""
"phs001514.v2.p1","NHLBI TOPMed: Walk-PHaSST Sickle Cell Disease (SCD)","Walk-PHaSST study is a multi-center clinical trial to evaluate the effects of sildenafil on Sickle Cell Disease (SCD) population with low exercise capacity associated with an increased Doppler-estimated pulmonary artery  systolic pressure (as assessed by the tricuspid regurgitant velocity (TRV)). It is a double-blind, placebo-controlled trial to assess the safety,","Not Applicable","Anemia, Sickle Cell","Cross-Sectional","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 92 variables, 2 documents, 2 molecular datasets, 429 samples sequenced, 445 subjects, 448 samples","European (1), African (78), African American (328), Hispanic1 (10), Hispanic2 (1), Other (8)","NHLBI","HMB-IRB-PUB-COL-NPU-MDS-GSO --- Health/Medical/Biomedical (IRB, PUB, COL, NPU, MDS, GSO), DS-SCD-IRB-PUB-COL-NPU-MDS-RD --- Disease-Specific (Sickle Cell Disease, IRB, PUB, COL, NPU, MDS, RD)","2021-07-07","2021-07-07","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S",""
"phs001412.v3.p1","NHLBI TOPMed: Diabetes Heart Study (DHS) African American Coronary Artery    Calcification (AA CAC)","The Diabetes Heart Study (DHS) is a family-based study enriched for type 2 diabetes (T2D). The cohort included 1443 European American and African American participants from 564 families with multiple  cases of type 2 diabetes (Bowden et al., 2010. Review of Diabetic Studies 7:188-201. PMID: 21409311). The cohort was recruited between 1998 and 2006.","Not Applicable","Cardiovascular Diseases","Cross-Sectional","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 54 variables, 2 documents, 2 molecular datasets, 392 samples sequenced, 405 subjects, 403 samples","","NHLBI","HMB-IRB-COL-NPU --- Health/Medical/Biomedical (IRB, COL, NPU), DS-DHD-IRB-COL-NPU --- Disease-Specific (Diabetes and Heart Disease, IRB, COL, NPU)","2021-07-06","2021-07-06","Cardiovascular Disease; Diabetes Mellitus; Vascular Calcification; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs001834.v1.p1","Genetics of Fuchs Corneal Dystrophy","This grant proposal continues to expand our understanding of the clinical presentation of Fuchs corneal dystrophy, and its underlying genetic basis, which will lead to the development of better therapeutic  models and treatment for a common corneal dystrophy that affects 4% of the US population over age 40. The proposed investigation is a family-based","Not Applicable","Fuchs' Endothelial Dystrophy","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 13 variables, 1 molecular datasets, 30 samples sequenced, 30 subjects, 30 samples","","NEI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2021-07-02","2021-07-02","Dystrophy, Fuch's Endothelial; Dystrophy, Fuchs' Endothelial; Endoepithelial corneal dystrophy; Endothelial Dystrophy, Fuch's; Endothelial Dystrophy, Fuchs'; FCED",""
"phs000720.v4.p1","Genomic Sequencing of Pediatric Rhabdomyosarcoma","Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood accounting for approximately 350 newly diagnosed cases yearly in the United States. With the development of multimodal chemotherapy regimens,  relapse-free survival rates have improved to 70-80% in patients with localized disease albeit with significant toxicity. Unfortunately, despite","Not Applicable","Rhabdomyosarcoma","Case Set","HumanOmni2.5-4, HumanOmni2.5-8, HumanOmni5-4","SNP Genotypes (Array), RNA-Seq, Targeted-Capture, WGS, WXS","4 phenotype datasets, 18 variables, 1 molecular datasets, 953 samples sequenced,  SRA, 807 subjects, 953 samples","","NCI","GRU-PUB-MDS --- General Research Use (PUB, MDS), DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2021-07-02","2019-10-07","Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; ARMS; Alveolar Rhabdomyosarcomas; Alveolar rhabdomyosarcoma (disease); Monomorphous Round Cell Rhabdomyosarcoma","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002240.v1.p1","Characterization of Sex Differences in Human Placentas","Whole exome and whole transcriptome sequencing data from human (Homo sapiens) placenta and maternal decidua tissues. This study characterizes sex differences in gene expression in the placenta. Differences in gene  expression in maternal decidua from pregnancy with a male or female placenta. Patterns of X chromosome inactivation in the placenta. Genome-wide","Not Applicable","Birth Weight","Control Set","Not Provided","RNA-Seq, WXS","5 phenotype datasets, 28 variables, 249 samples sequenced, 96 subjects, 252 samples","","NIGMS","GRU --- General Research Use","2021-07-01","2021-07-01","Gravidity; Parity; Multigravidities; Multigravidity; Parity Progression Ratio; Parity Progression Ratios",""
"phs002034.v1.p1","Genomic Evolution of Low- and High-Grade Glioma","Malignant transformation (MT) of IDH-mutant low-grade glioma (LGG) to aggressive high-grade tumors is an event of major clinical significance, eventually leading to death in the majority of LGG patients. While  patients with primary glioblastoma (GBM) have benefited from increased overall survival due to treatment with the alkylating chemotherapy","Not Applicable","Glioma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 157 samples sequenced,  SRA, 42 subjects, 157 samples","","NCI","HMB-MDS-GSO --- Health/Medical/Biomedical (MDS, GSO)","2021-07-01","2021-07-01","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs001865.v1.p1","Emory University African American Microbiome in Pregnancy Cohort Study","The Emory University African American Microbiome in Pregnancy Cohort Study prospectively enrolls African American women between 18-40 years of age without chronic medical conditions into a longitudinal follow-up study that  involves completing microbiome sampling and data collection at two time points in pregnancy (8-14 weeks gestation and 24-30 weeks gestation). The","Not Applicable","Microbiota","Prospective Longitudinal Cohort","Not Provided","OTHER","4 phenotype datasets, 19 variables, 552 samples sequenced,  SRA, 122 subjects, 552 samples","","NINR","GRU --- General Research Use","2021-07-01","2021-07-01","Not Provided",""
"phs001387.v3.p1","NHLBI TOPMed: Rare Variants for Hypertension in Taiwan Chinese (THRV)","The THRV-TOPMed study consists of three cohorts: The SAPPHIRe Family cohort (N 1,271), TSGH (Tri-Service General Hospital, a hospital-based cohort, N 160), and TCVGH (Taichung Veterans General Hospital, another hospital-based  cohort, N 922), all based in Taiwan. 1,271 subjects were previously recruited as part of the NHLBI-sponsored SAPPHIRe Network (which is part of the","Not Applicable","Blood Pressure","Prospective Longitudinal Cohort","WGS_markerset_grc38","CNV Genotypes, SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 90 variables, 4 documents, 2 molecular datasets, 2160 samples sequenced, 2353 subjects, 2343 samples","","NHLBI","DS-CVD-IRB-COL-NPU-RD --- Disease-Specific (Cardiovascular Disease, IRB, COL, NPU, RD)","2021-07-01","2021-07-01","Not Provided",""
"phs002088.v2.p1","Drug Signatures for Prediction and Mitigation of Toxicity","The overall goal of the drug signatures for prediction and mitigation of toxicity study is to use genomic and proteomic high-throughput measurements as the basis for computational analysis that integrates  network analyses with structural constraints and dynamical models in multiple cell types to identify signatures that predict toxicity induced by 55","Not Applicable","Drug-Related Side Effects and Adverse Reactions","Control Set","WGS_markerset_grc37, custom_markerset","Short Tandem Repeats (PCR), CNV Genotypes, WGS","7 phenotype datasets, 69 variables, 2 molecular datasets, 40 images, 40 samples sequenced, 40 subjects, 40 samples","","NINDS","GRU-IRB-PUB-NPU --- General Research Use (IRB, PUB, NPU)","2021-06-30","2021-06-30","ADR; ADR - Adverse drug reaction; Adverse Drug Event; Adverse Drug Events; Adverse Drug Experience; Adverse Drug Reaction",""
"phs001617.v1.p1","Genetic Causes of Growth Disorders","Description of the disorder: A very common disorder presenting to pediatricians/pediatric endocrinologists is childhood growth failure. Sometimes the cause is evident, for example, growth hormone deficiency. In other children, the  etiology remains unknown despite extensive evaluation, resulting in the unhelpful diagnosis of severe idiopathic short stature (SISS). These","Not Applicable","Growth Disorders","Family/Twin/Trios","custom_markerset","SNP Genotypes (NGS), WXS","5 phenotype datasets, 41 variables, 1 molecular datasets, 122 samples sequenced,  SRA, 194 subjects, 122 samples","","NICHD","GRU-IRB --- General Research Use (IRB)","2021-06-30","2021-06-30","Brachydactyly; Dwarfism; Hypertelorism; Scoliosis; Brachydactylia; Brachydactylias",""
"phs001435.v2.p1","NHLBI TOPMed: Australian Familial Atrial Fibrillation Study","In the Australian Familial AF Study, a cohort of probands with familial AF was recruited for genetics studies at the Victor Chang Cardiac Research Institute. Familial AF cases were identified  from in-patient and out-patient populations at St. Vincent's Hospital and by referral from collaborating physicians throughout Australia. Study","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 31 variables, 2 documents, 2 molecular datasets, 120 subjects, 120 samples","","NHLBI","HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS)","2021-06-30","2021-06-30","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs001402.v3.p1","NHLBI TOPMed: Whole Genome Sequencing of Venous Thromboembolism (WGS of    VTE)","This study consists of 338 VTE cases from an inception cohort of Olmsted County, MN residents (OC) with a first lifetime objectively-diagnosed idiopathic VTE during the 40-year study period, 1966-2005.  All living study subjects were invited to provide a whole blood sample at the Mayo Clinical Research Unit for leukocyte genomic DNA and plasma","Not Applicable","Venous Thromboembolism","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 58 variables, 2 documents, 2 molecular datasets, 1354 samples sequenced, 1535 subjects, 1534 samples","European (1324), African American (3), Hispanic1 (5), Hispanic2 (14), Other Asian or Pacific Islander (2), South Asian (1), Other (2)","NHLBI","GRU --- General Research Use","2021-06-28","2021-06-28","Pulmonary Embolism; Blood clot in vein; Phlebothromboses; Phlebothrombosis; Thromboses, Venous; Thrombosis, Venous","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001359.v3.p1","NHLBI TOPMed: GOLDN Epigenetic Determinants of Lipid Response to Dietary    Fat and Fenofibrate","The GOLDN study was initiated to assess how genetic factors interact with environmental (diet and drug) interventions to influence blood levels of triglycerides and other atherogenic lipid species and inflammation  markers (registered at clinicaltrials.gov, number NCT00083369). The study recruited Caucasian participants primarily from three-generational","Not Applicable","Lipids","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 17 variables, 2 documents, 2 molecular datasets, 960 samples sequenced, 1069 subjects, 1064 samples","European (950), Hispanic1 (3), Hispanic2 (2), Other Asian or Pacific Islander (2), Other (2)","NHLBI","DS-CVD-IRB --- Disease-Specific (Cardiovascular Disease, IRB)","2021-06-24","2021-06-24","Cardiovascular Diseases; Glucose Metabolism Disorders; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs001345.v3.p1","NHLBI TOPMed: Genetic Epidemiology Network of Arteriopathy (GENOA)","The Genetic Epidemiology Network of Arteriopathy (GENOA) is one of four networks in the NHLBI Family-Blood Pressure Program (FBPP). GENOA's long-term objective is to elucidate the genetics of target organ  complications of hypertension, including both atherosclerotic and arteriolosclerotic complications involving the heart, brain, kidneys, and","Not Applicable","Hypertension","Family/Twin/Trios","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 16 variables, 2 documents, 2 molecular datasets, 1253 samples sequenced, 1854 subjects, 1266 samples","","NHLBI","DS-ASC-RF-NPU --- Disease-Specific (Arteriosclerosis and its Risk Factors, NPU)","2021-06-24","2021-06-24","Aging; Arterial Pressure; Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Hyperglycemia",""
"phs001293.v3.p1","NHLBI TOPMed: HyperGEN - Genetics of Left Ventricular (LV) Hypertrophy","The Hypertension Genetic Epidemiology Network Study (HyperGEN) - Genetics of Left Ventricular (LV) Hypertrophy is a familial study aimed to understand genetic risk factors for LV hypertrophy by conducting genetic  studies of continuous traits from echocardiography exams. The originating HyperGEN study aimed to understand genetic risk factors for hypertension.","Not Applicable","Hypertrophy, Left Ventricular","Family/Twin/Trios","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 164 variables, 2 documents, 2 molecular datasets, 1896 samples sequenced, 2104 subjects, 2104 samples","European (1), African (74), East Asian (1), African American (1813), Hispanic1 (3)","NHLBI","GRU-IRB --- General Research Use (IRB), DS-CVD-IRB-RD --- Disease-Specific (Cardiovascular Disease, IRB, RD)","2021-06-24","2021-06-24","Hypertension; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Ejection Fraction; Arterial hypertension; BP - High blood pressure",""
"phs001845.v1.p1","Transcriptomic Analysis of Human Hematopoietic Progenitors from Healthy    Donors and Bone Marrow Failure Patients","The purpose of this study was to define transcriptional changes that occur in the rare and heterogeneous bone marrow progenitors that are affected in Shwachman-Diamond Syndrome. Data are reported for  four genetically confirmed SDS patients ranging from 11-26 years old, 3 male and 1 female, and four healthy donors ranging from 25-29 years old, 2","Not Applicable","Shwachman-Diamond Syndrome","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 21 variables, 579 samples sequenced, 8 subjects, 579 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2021-06-18","2021-06-18","Shwachman Syndrome; Congenital Lipomatosis of Pancreas; LIPOMATOSIS OF PANCREAS, CONGENITAL; Metaphyseal Chondrodysplasia, Shwachman Type; Metaphyseal chondrodysplasia with pancreatic insufficiency AND neutropenia; Metaphyseal dysplasia with malabsorption and neutropenia",""
"phs001218.v3.p1","NHLBI TOPMed: Genetic Study of Atherosclerosis Risk (GeneSTAR)","GeneSTAR began in 1982 as the Johns Hopkins Sibling and Family Heart Study, a prospective longitudinal family-based study conducted originally in healthy adult siblings of people with documented early onset  coronary disease under 60 years of age. Commencing in 2003, the siblings, their offspring, and the coparent of the offspring participated in a 2 week","Not Applicable","Platelet Aggregation","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 157 variables, 17 documents, 2 molecular datasets, 1778 samples sequenced, 1787 subjects, 1785 samples","European (976), African (9), African American (768), Hispanic1 (12), Other Asian or Pacific Islander (5), Other (7)","NHLBI","DS-CVD-IRB-NPU-MDS --- Disease-Specific (Cardiovascular Disease, IRB, NPU, MDS)","2021-06-17","2021-06-17","Not Provided",""
"phs001163.v1.p1","CRU-Ukrainian National Research Center for Radiation Medicine Trio Study","Data on transgenerational effects following nuclear accidents are important for understanding fully the consequences of parental exposure to ionizing radiation. Few studies to date have had adequate statistical power to  detect effects of the magnitude expected based on animal data, and most have not been of low-dose, protracted exposures associated with nuclear","Not Applicable","Germ-Line Mutation","Family/Twin/Trios","Not Provided","Not Provided","5 phenotype datasets, 27 variables,  SRA, 340 subjects, 340 samples","","NCI","GRU --- General Research Use","2021-06-17","2021-06-17","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001914.v1.p1","Improved Detection and Identification of Microsatellite Instability    Features in Colorectal Cancer","In this study, we analyzed a series of colorectal cancers using a new sequencing technology that sequences more than 200 microsatellite regions in parallel. With this technology, we evaluated mono-,  di- , tri- and tetranucleotide repeats to provide a broad spectrum of microsatellite instability (MSI) events. This deep sequencing technology","Not Applicable","Colorectal Neoplasms","Case-Control","Not Provided","Targeted-Capture, WGS","4 phenotype datasets, 17 variables, 112 samples sequenced,  SRA, 48 subjects, 112 samples","","NHGRI","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2021-06-16","2021-06-16","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs002433.v1.p1","Nasopharyngeal RNASeq Comparing SARS-CoV-2+ Patients and SARS-CoV-2    Negative Control Subjects","The goal of this analysis was to compare RNAs enriched in the upper respiratory tract of SARS-CoV-2 patients and SARS-CoV-2 negative controls. RNA-sequencing of RNA isolated from the viral transport  medium associated with nasopharyngeal swab samples from SARS-CoV-2+ patients and SARS-COV-2 negative controls. Nasopharyngeal (NP) swab samples were","Not Applicable","COVID-19","Collection","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 38 samples sequenced, 38 subjects, 38 samples","","NIAID","HMB-IRB --- Health/Medical/Biomedical (IRB)","2021-06-15","2021-06-15","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002208.v1.p1","Metatranscriptomic Sequencing of Pre-Transplant Bronchoalveolar Lavage in    Pediatric Stem Cell Transplant Patients","Children with malignancies, immunodeficiencies, and other life-threatening diseases sometimes receive allogeneic hematopoietic cell transplantation (HCT) as a treatment for their disease. The HCT process can be complicated by the development  of lung disease from infection, alloreactivity, or other causes. To identify patients at-risk for post-HCT lung disease, this study uses","Not Applicable","Hematopoietic Stem Cell Transplantation","Prospective Longitudinal Cohort","RNAseq_gene_transcripts","RNA Seq (NGS)","4 phenotype datasets, 29 variables, 1 molecular datasets, 181 subjects, 181 samples","","NHLBI","GRU-IRB-COL --- General Research Use (IRB, COL)","2021-06-15","2021-06-15","Not Provided",""
"phs001217.v3.p1","NHLBI TOPMed: Genetic Epidemiology Network of Salt Sensitivity (GenSalt)","The GenSalt study aims to identify genes which interact with dietary sodium and potassium intake to influence blood pressure in Han Chinese participants from rural north China. Whole genome sequencing  will be conducted among 1,860 participants of the Genetic Epidemiology Network of Salt Sensitivity (GenSalt) Study. We will work in collaboration","Not Applicable","Arterial Pressure","Family/Twin/Trios","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 28 variables, 2 documents, 2 molecular datasets, 1850 samples sequenced, 3142 subjects, 1908 samples","","NHLBI","DS-HCR-IRB --- Disease-Specific (High blood pressure and related cardiovascular-renal disease, IRB)","2021-06-15","2021-06-15","Arterial Pressure, Mean; Aortic Blood Pressure; Aortic Blood Pressures; Aortic Pressure; Aortic Pressures; Aortic Tension",""
"phs002398.v1.p1","Genomics of Prostate Cancer","This dataset includes genomic data from patients with prostate cancer. Specimens include archival active surveillance biopsies, radical prostatectomy specimens selected based on evidence of PD-L1 expression and/or T lymphocyte infiltrates,  and rapid autopsy material from patients deceased of prostate cancer. These data include low pass whole genome sequencing and targeted sequencing","Not Applicable","Prostatic Neoplasms","Cross-Sectional","Not Provided","OTHER, WGS","4 phenotype datasets, 21 variables, 129 samples sequenced, 43 subjects, 129 samples","","NCI","GRU --- General Research Use","2021-06-11","2021-06-11","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002259.v1.p1","Human CD4 Memory T Cell Activation Time Course","We performed a high-resolution time course RNA-seq experiment on CD4+ memory T cells during activation with anti-CD3/CD28 beads. We performed this in 24 adult individuals of European ancestry with no  autoimmune diseases. We used 1 million cells as starting material, per time point (up to 8 time points per individual from 0 to 72 hours). We","Not Applicable","RNA-Seq","Control Set","RNAseq_probe_set_grc38","ATAC-seq, RNA-Seq, SNP Genotypes (NGS)","4 phenotype datasets, 15 variables, 1 molecular datasets, 202 samples sequenced, 25 subjects, 226 samples","","NIGMS","DS-IR --- Disease-Specific (Immunological Research)","2021-06-10","2021-06-10","Not Provided",""
"phs001358.v1.p1","RareBliss: Rare Bipolar Loci Identification Through Sequencing Study","Bipolar disorder is a complex psychiatric disease for which few causative genes have been discovered. Targeted sequencing of bipolar cases and unaffected controls was performed to elucidate the contribution of  rare variants to bipolar disorder. This study included the standard exome targets as well as genes involved in synaptic function and genes previously","Not Applicable","Bipolar Disorder","Case-Control","target_markerset_grc37","SNP Genotypes (NGS), Targeted-Capture","5 phenotype datasets, 19 variables, 1 molecular datasets, 2322 samples sequenced,  SRA, 2322 subjects, 2322 samples","","NIMH","DS-BPD-IRB-NPU --- Disease-Specific (Bipolar Disorder, IRB, NPU)","2021-06-10","2021-06-10","Schizoaffective Disorder; Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders",""
"phs002428.v1.p1","Tandem DNA Repeats Activate hTERT Gene Transcription","Multiple independent sequence variants of the hTERT locus have been associated with telomere length and cancer risks in genome-wide association studies. Here, we identified an intronic variable number tandem repeat,  VNTR2-1, as an enhancer-like element, which activated hTERT transcription in a cell and chromatin-dependent manner. VNTR2-1, consisting of 42-bp","Not Applicable","Centenarians","Case-Control","target_markerset_grc38","ChIP_Seq (NGS)","4 phenotype datasets, 12 variables, 1 molecular datasets, 209 subjects, 418 samples","","NIGMS","GRU --- General Research Use","2021-06-09","2021-06-09","Aging; Aging, Biological; Biological Aging",""
"phs002048.v2.p1","Mapping Systemic Lupus Erythematosus Heterogeneity at the Single Cell    Level","Patients with Systemic Lupus Erythematosus (SLE) display a complex blood transcriptome whose cellular origin is poorly resolved. Using single-cell RNA-seq, we profiled 276,000 PBMCs from 33 children with SLE (cSLE)  with different degrees of disease activity (DA) and 11 matched controls. Increased expression of Interferon-stimulated genes (ISGs) distinguished","Not Applicable","Lupus Erythematosus, Systemic","Case-Control","RNAseq_probe_set_grc37","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 67 variables, 1 molecular datasets, 57 samples sequenced, 58 subjects, 58 samples","","NIAMS","HMB --- Health/Medical/Biomedical, DS-ADO --- Disease-Specific (Autoimmune Diseases), HMB-MDS --- Health/Medical/Biomedical (MDS)","2021-06-08","2021-06-08","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus",""
"phs001143.v4.p1","NHLBI TOPMed: The Genetics and Epidemiology of Asthma in Barbados","Asthma is a complex disease where the interplay between genetic factors and environmental exposures influences susceptibility and disease prognosis. Asthmatics of African descent tend to have more severe asthma and  more severe clinical symptoms than individuals of European ancestry. The baseline prevalence of asthma in Barbados is high ( 20%), and from admixture","Not Applicable","Asthma","Family/Twin/Trios","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), De-novo Mutations (NGS), WGS","5 phenotype datasets, 54 variables, 3 documents, 2 molecular datasets, 1022 samples sequenced, 1527 subjects, 1022 samples","European (3), African (90), African American (900), Hispanic1 (5), Other (5)","NHLBI","GRU-IRB --- General Research Use (IRB)","2021-06-08","2021-06-08","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs001327.v2.p1","Childhood Cancer Survivor Study (CCSS)","Background and Rationale for the Childhood Cancer Survivor Study (CCSS) Over the last several decades, advances in treatments for childhood and adolescent cancer have substantially improved survival following diagnosis. These  improvements gave rise to the responsibility for investigating long-term treatment-associated morbidity and mortality. Early efforts to describe late","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","imputation_panel","SNP/CNV Genotypes (imputed), WXS","21 phenotype datasets, 1158 variables, 6 documents, 1 molecular datasets, 5451 samples sequenced, 30716 subjects, 11363 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2021-06-04","2021-06-04","Bone Diseases; Cardiovascular Diseases; Cognitive Dysfunction; Dwarfism, Pituitary; Heart Failure; Infertility","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002331.v1.p1","Prevention of Viral Hepatitis and HIV in Drug Users - A Hepatitis B Model    for HIV and an HB Vaccine Model for HIV Vaccine Trials in Drug Users    (DASH)","The goal of the proposed study is to use the Hepatitis B virus (HBV) vaccine as a model for a future Human Immunodeficiency Virus (HIV) vaccine trial, examining the efficacy  of community-based outreach intervention as well as an accelerated vaccine schedule as a method for increasing acceptance/adherence with HBV","Not Applicable","Drug Users","Interventional","HumanOmniExpress-24","SNP Genotypes (Array)","5 phenotype datasets, 86 variables, 1 molecular datasets, 2439 subjects, 2225 samples","European (246), African (45), East Asian (1), African American (1803), Hispanic1 (9), Hispanic2 (107), Other Asian or Pacific Islander (2), Other (12)","NIDA","GRU-NPU --- General Research Use (NPU)","2021-06-03","2021-06-03","Communicable Diseases; Digestive System Diseases; Hepatitis; Hepatitis A; Hepatitis B; Hepatitis C",""
"phs001032.v6.p2","NHLBI TOPMed: The Vanderbilt Atrial Fibrillation Registry (VU_AF)","The Vanderbilt Atrial Fibrillation (AF) Registry was founded in 2001. Patients with AF and family members are prospectively enrolled. At enrollment a detailed past medical history is obtained along with  an AF symptom severity assessment. Blood samples are obtained for DNA extraction. Patients are followed longitudinally along with serial collection","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 38 variables, 2 documents, 2 molecular datasets, 1134 samples sequenced, 1134 subjects, 1134 samples","European (1060), African (3), East Asian (1), African American (45), Hispanic1 (2), Hispanic2 (6), Other Asian or Pacific Islander (3), South Asian (2)","NHLBI","GRU-IRB --- General Research Use (IRB)","2021-06-03","2021-06-03","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs000993.v5.p2","NHLBI TOPMed: Heart and Vascular Health Study (HVH)","Objectives The Heart and Vascular Health Study (HVH) is a case-control study of risk factors for the development of myocardial infarction (MI), stroke, venous thrombosis (VT), and atrial fibrillation (AF).  The study setting is Group Health, an integrated health care delivery system in Washington State. Only VT cases and early-onset AF cases are included","Not Applicable","Cardiovascular Diseases","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 14 variables, 2 documents, 2 molecular datasets, 699 samples sequenced, 709 subjects, 711 samples","European (649), East Asian (5), African American (26), Hispanic1 (3), Hispanic2 (6), Other Asian or Pacific Islander (2), South Asian (1), Other (5)","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), DS-CVD-IRB-MDS --- Disease-Specific (Cardiovascular Disease, IRB, MDS)","2021-06-02","2021-06-02","Atrial Fibrillation; Cardiovascular Disease; A-fib; AF; AF - Atrial fibrillation; AFib",""
"phs000972.v5.p1","NHLBI TOPMed: Genome-Wide Association Study of Adiposity in Samoans","The individuals sequenced here represent a small subset of the parent study (described below) and were carefully selected for the purpose of creating a Samoan-specific reference panel for imputation back  into the parent study. The INFOSTIP algorithm of Gusev et. al. (2012) (PMID: 22135348) was used to optimally choose the individuals for sequencing.","Not Applicable","Obesity","Cross-Sectional","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 13 variables, 2 documents, 2 molecular datasets, 1295 samples sequenced, 1332 subjects, 1342 samples","","NHLBI","GRU-IRB-PUB-COL-NPU-GSO --- General Research Use (IRB, PUB, COL, NPU, GSO)","2021-06-02","2021-06-02","Not Provided",""
"phs002176.v2.p1","Notch Signaling and Efficacy PD-1/PD-L1 Blockade in Relapsed Small Cell    Lung Cancer","Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine (NE) cancer that accounts for approximately 15% of all lung cancer, with an annual incidence of more than 34,000 in  the United States alone. SCLC is characterized by loss of function of p53 and RB and high tumor mutational burden, which suggests that these tumors","Not Applicable","Small Cell Lung Carcinoma","Clinical Trial","Not Provided","OTHER, RNA-Seq, WXS","4 phenotype datasets, 20 variables, 101 samples sequenced, 38 subjects, 101 samples","","NCI","GRU --- General Research Use","2021-06-01","2021-03-09","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001062.v5.p2","NHLBI TOPMed - NHGRI CCDG: Massachusetts General Hospital (MGH) Atrial    Fibrillation Study","The Massachusetts General Hospital (MGH) Atrial Fibrillation Study was initiated in 2001. The study has enrolled serial probands, unaffected and affected family members with atrial fibrillation. At enrollment participants undergo  a structured interview to systematically capture their past medical history, AF treatments, and family history. An electrocardiogram is performed;","Not Applicable","Atrial Fibrillation","Case Set","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 16 variables, 2 documents, 2 molecular datasets, 1104 samples sequenced, 1163 subjects, 1163 samples","European (1090), East Asian (2), African American (3), Hispanic1 (2), Hispanic2 (4), South Asian (1), Other (1)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), DS-AF-IRB-RD --- Disease-Specific (Atrial Fibrillation, IRB, RD)","2021-05-28","2021-05-28","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs002411.v1.p1","Genome Instability in Mammary Cells of Pathogenic BRCA1/2 Mutation    Carriers","It remains unknown if inherited germline mutations in the BRCA1 or BRCA2 gene increase the risk of breast and ovarian cancer by elevating mutation rate in mammary cells. Here we  show, using a single-cell whole genome sequencing approach, that mammary luminal epithelial cells isolated from tissues obtained from preventive","Not Applicable","Breast","Cross-Sectional","Not Provided","WGA, WGS","4 phenotype datasets, 20 variables, 88 samples sequenced, 16 subjects, 88 samples","","NIA","DS-BRCA-PUB-NPU --- Disease-Specific (Breast Cancer, PUB, NPU)","2021-05-27","2021-05-27","Not Provided",""
"phs002408.v1.p1","The Role of CTCF in the Organization of the Centromeric 11p15 Imprinted    Domain Interactome","Beckwith-Wiedemann Syndrome (BWS) is the most common human imprinting disorder and comprises a spectrum of overgrowth phenotypes. While approximately 35% of BWS cases are caused by isolated loss of methylation  (LOM) at the human imprinting center 2 (IC2) on chromosome 11p15, only around 5% of patients develop BWS due to structural alterations to the IC2","Not Applicable","Beckwith-Wiedemann Syndrome","Case-Control","target_markerset_grc38","ChIP_Seq (NGS), WGS","4 phenotype datasets, 11 variables, 1 molecular datasets, 2 samples sequenced, 7 subjects, 9 samples","","NCI","GRU-PUB-COL-NPU --- General Research Use (PUB, COL, NPU)","2021-05-27","2021-05-27","BWS; Beckwith Wiedemann Syndrome; Beckwith's syndrome; Beckwith-Wiedemann syndrome chromosome region; EMG SYNDROME; EMG Syndromes",""
"phs001500.v2.p1","National Cancer Institute (NCI) Primary Human Melanocyte QTL Study","In order to create a melanocyte-specific QTL resource, we obtained primary human melanocyte cultures isolated from foreskin of 106 healthy newborn males predominantly of European descent. Melanocytes were cultured in  lot-matched culture medium in randomized batches to minimize variability that could be introduced by culturing conditions. RNA sequencing and direct","Not Applicable","Melanocytes","Methods","RNAseq_probe_set_grc37, HumanOmniExpress-24, HumanMethylation450","Methylation (CpG), SNP Genotypes (Array), RNA-Seq, RNA Seq (NGS)","5 phenotype datasets, 26 variables, 3 molecular datasets, 106 samples sequenced,  SRA, 106 subjects, 106 samples","","NCI","GRU --- General Research Use","2021-05-27","2021-05-27","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002292.v1.p1","Functional Enhancer Elements Drive Subclass-Selective Expression From    Mouse to Human Neocortex","A complete epigenomic map of human brain cell types will be necessary to fully understand their genetic regulation, and to create the next generation of non-species-restricted genetic tools for their  functional characterization. Here we performed both bulk and single-nucleus ATAC-seq studies of fresh human neocortical samples excised during","Not Applicable","Neocortex","Collection","Not Provided","ATAC-seq, RNA-Seq","4 phenotype datasets, 20 variables, 4155 samples sequenced, 23 subjects, 4155 samples","","NIMH","GRU --- General Research Use, BHD --- Brain health and disease","2021-05-26","2021-05-26","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002280.v1.p1","Multimodal Analysis for Human Ex Vivo Studies Shows Extensive Molecular    Changes from Delays in Blood Processing","Multi-omic profiling of human peripheral blood is increasingly utilized to identify biomarkers and pathophysiologic mechanisms of disease. The importance of these platforms in clinical and translational studies led us to  investigate the impact of delayed blood processing on the numbers and state of peripheral blood mononuclear cells (PBMC) and on the plasma proteome.","Not Applicable","Leukocytes, Mononuclear","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 12 variables, 55 samples sequenced, 11 subjects, 55 samples","","NIAID","GRU --- General Research Use","2021-05-25","2021-05-25","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001749.v2.p1","Genetics of Congenital Anomalies of the Kidney and Urinary Tract","The Genetics of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) contributes data from unrelated individuals who were recruited at the Columbia University Medical Center (New York, USA), the  Polish Registry of Congenital Malformations (Poland), the Universities of Parma, Bari, and Brescia, and the Gaslini Institute (Italy), the University","Not Applicable","Cakut","Prospective Longitudinal Cohort","MEGA_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 2 molecular datasets, 2115 subjects, 2115 samples","","NIDDK","GRU --- General Research Use","2021-05-24","2021-05-24","CAKUT; Congenital Anomalies Of Kidney And Urinary Tract; Congenital anomalies of the kidney and the urinary tract (CAKUT); Congenital anomalies of the kidney and urinary tract; Congenital anomalies of the kidney and urinary tract (CAKUT); congenital anomaly of kidney and urinary tract",""
"phs002385.v1.p1","Hematopoietic Cell Transplant for Sickle Cell Disease (HCT for SCD)","The Center for International Blood and Marrow Transplant Research (CIBMTR) is a hematopoietic cell transplant registry that was established in 1972 at the Medical College of Wisconsin. The overarching goal  of the registry is to study trends in transplantations and to advance the understanding and application of allogeneic hematopoietic cell","Not Applicable","Anemia, Sickle Cell","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 1518 subjects, 1518 samples","","NHLBI","GRU --- General Research Use","2021-05-20","2021-05-20","Hematologic Diseases; Neoplasms by Site; Sickle Cell Disease; Thalassemia; Blood Disease; Blood Diseases","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002383.v1.p1","Treatment of Pulmonary Hypertension and Sickle Cell Disease with    Sildenafil Therapy (Walk-PHaSST)","Pulmonary arterial hypertension (PAH) is a progressive condition characterized by narrowing or stiffening pulmonary arterioles resulting in increased pulmonary blood pressure and reduced delivery of oxygenated blood to the body.  It is a common complication of sickle cell disease and initially presents with the symptom of shortness of breath (dyspnea) on exertion. As the","Not Applicable","Anemia, Sickle Cell","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 720 subjects, 720 samples","","NHLBI","DS-SCD-IRB-PUB-COL-NPU-MDS-RD --- Disease-Specific (Sickle Cell Disease, IRB, PUB, COL, NPU, MDS, RD)","2021-05-20","2021-05-20","Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Cardiovascular Disease; Hematologic Diseases; Hemoglobinopathies",""
"phs001800.v2.p1","Genomics of Pediatric Renal Medullary Carcinomas","Version 1 We derived faithful cancer cell lines from patients with a diagnosis of renal medullary carcinomas (RMC). These models have been sequenced with whole genome, exome and transcriptome technologies  along with the patient's primary germline and tumor samples. We took these faithful models and performed loss-of-function genetic perturbation","Not Applicable","SMARCB1 Protein","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WGS, WXS","4 phenotype datasets, 14 variables, 30 samples sequenced, 15 subjects, 30 samples","","NCI","HMB --- Health/Medical/Biomedical, DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use","2021-05-20","2019-06-14","Kidney Neoplasms; Kidney Tumor; Kidney cancer; Kidney neoplasm; Neoplasia of the kidneys; Neoplasm of Kidney","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002341.v1.p1","RNA Expression in Diverse Donor Derived Dermal Fibroblasts Correlates    with Reprogramming to Pluripotency","The cohort used in this study includes 36 African American (17 female, 19 male) and 36 White American (19 female, 17 male) individuals. The total cohort has a median age  of 32 years, with a range of 20-64 years. The African American cohort has a median age of 34, with a range of 21-52 years. The White American cohort","Not Applicable","Induced Pluripotent Stem Cells","Collection","RNAseq_probe_set_grc37","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 144 samples sequenced, 72 subjects, 144 samples","","NIEHS","HMB --- Health/Medical/Biomedical","2021-05-19","2021-05-19","Not Provided",""
"phs001825.v1.p1","Study of 5'UTR Mutations in Prostate Cancer","The 5' untranslated region (5' UTR) of mRNA controls the translation of specific transcripts through encoded cis-regulatory elements. Yet exceedingly little is known about the prevalence and function of 5'  UTR mutations in cancer. We have uncovered many 5' UTR mutations in our analysis of localized and castration resistant prostate cancer patients, and","Not Applicable","Prostatic Neoplasms","Xenograft","Not Provided","WXS","4 phenotype datasets, 25 variables, 164 samples sequenced,  SRA, 82 subjects, 164 samples","","NCI","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2021-05-19","2021-05-19","Prostatic Neoplasms, Castration-Resistant; NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic",""
"phs002310.v1.p1","International Collaboration of Incident HIV and HCV in Injecting Cohorts    (InC3)","This study represents a merged international multi-cohort project of pooled biological and behavioral data from ten prospective cohorts of injection drug users (Grebely J, Morris MD, Rice TM, Bruneau J,  Cox AL, Kim AY, et al., 2012, PMID: 23203695). Of the 10 cohorts, six provided data and samples for the genome wide association study (GWAS) entitled","Not Applicable","Hepatitis C","Prospective Longitudinal Cohort","HumanOmniExpress-24, Axiom_Smokesc","SNP/CNV (Array)","6 phenotype datasets, 36 variables, 1 molecular datasets, 1887 subjects, 1887 samples","European (1531), East Asian (58), African American (30), Hispanic1 (23), Hispanic2 (51), Other Asian or Pacific Islander (60), South Asian (7), Other (127)","NIDA","GRU-IRB --- General Research Use (IRB)","2021-05-18","2021-05-18","Substance-Related Disorders; HCV Infection; Hepatitis C Virus Infection; Hepatitis C virus caused hepatitis; Hepatitis C virus hepatitis; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted",""
"phs000956.v5.p1","NHLBI TOPMed: Genetics of Cardiometabolic Health in the Amish","The Amish Complex Disease Research Program includes a set of large community-based studies focused largely on cardiometabolic health carried out in the Old Order Amish (OOA) community of Lancaster, Pennsylvania  (http://medschool.umaryland.edu/endocrinology/amish/research-program.asp). The OOA population of Lancaster County, PA immigrated to the Colonies from","Not Applicable","Cardiovascular Diseases","Family/Twin/Trios","WGS_markerset_grc38","SNP/CNV Genotypes (NGS), De-novo Mutations (NGS), WGS","5 phenotype datasets, 74 variables, 3 documents, 3 molecular datasets, 1111 samples sequenced, 1123 subjects, 1111 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS)","2021-05-18","2021-05-18","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs002304.v1.p1","Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma","Dynamic approaches that integrate population-based research and molecular biology are needed to explain the mechanisms underlying pediatric rhabdomyosarcoma (RMS) and to determine novel prevention strategies. RMS, the most common soft-tissue  sarcoma in children and adolescents, has one of the poorest 5-year survival rates among all pediatric cancers (less than 65%). One of the strongest","Not Applicable","Rhabdomyosarcoma","Case Set","Not Provided","WXS","4 phenotype datasets, 15 variables, 621 samples sequenced, 621 subjects, 621 samples","","NCI","GRU --- General Research Use","2021-05-12","2021-05-12","Sarcoma; Blastoma; CA; CA - Cancer; Cancer; MT","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001711.v1.p1","Single-Cell Genome Sequencing of Gastrointestinal Carcinomas","We experimentally derived copy number profiles and transcriptome profiles of gastrointestinal cancers using single cell sequencing. Using a microfluidic droplet partitioning system, we isolated individual cells of a suspension from  a primary solid tumor into droplets. These droplets tag the resultant genomic or transcriptomic material with an identifying barcode that enables","Not Applicable","Gastrointestinal Neoplasms","Case Set","Not Provided","OTHER","4 phenotype datasets, 16 variables, 32 samples sequenced,  SRA, 8 subjects, 32 samples","","NHGRI","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2021-05-12","2021-05-12","Cancer of Gastrointestinal Tract; Cancer of the Gastrointestinal Tract; Cancer, Gastrointestinal; Cancers, Gastrointestinal; Gastrointestinal Cancer; Gastrointestinal Cancers",""
"phs001404.v1.p1","Molecular Profiling of Gallbladder Cancer (MPOG)","The purpose of this study is to investigate the underlying genetic factors involved in gallbladder cancer. All cases from the Shanghai Biliary Cancer Study and the Chile Gallbladder Cancer Pilot  Study with fresh frozen tissue that were included in the molecular profiling analysis. Principal Investigator: Jill Koshiol, PhD, National Institutes","Not Applicable","Gallbladder Neoplasms","Case Set","MethylationEPIC","CNV Genotypes, Methylation (CpG), RNA-Seq, Targeted-Capture, WXS","4 phenotype datasets, 157 variables, 2 molecular datasets, 274 samples sequenced,  SRA, 158 subjects, 433 samples","","NCI","GRU --- General Research Use","2021-05-10","2021-05-10","Gallbladder Cancer; Bladder Cancer, Gall; Bladder Cancers, Gall; Cancer of Gallbladder; Cancer of the Gallbladder; Cancer, Gall Bladder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000649.v2.p2","Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR and    PEAR-2))","The primary aim of the Pharmacogenomic Evaluation of Antihypertensive Responses grant (funded by NIH Pharmacogenomic Research Network grant U01 GM074492) was to identify genetic determinants of blood pressure response and  adverse events after antihypertensive treatments. Two different clinical trials with genomic information available were included: PEAR-1 and PEAR-2","Not Applicable","Hypertension","Prospective Longitudinal Cohort","other","SNP Genotypes (Array)","5 phenotype datasets, 140 variables, 11 analyses, 1 molecular datasets, 1040 subjects, 1040 samples","European (570), African (25), East Asian (4), African American (415), Hispanic1 (4), Hispanic2 (10), Other Asian or Pacific Islander (6), South Asian (4), Other (2)","NIGMS","PEAR --- All PEAR patients","2021-05-10","2021-05-10","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; HBP - High blood pressure",""
"phs002146.v1.p1","Evolution of Chromatin Architecture and Transcriptional Regulation in    Mammals","Changes in gene expression are a critical force driving the evolution of form and function. As a result, the mechanisms by which gene expression evolves have become a subject of  intense interest. A number of investigators have measured evolutionary changes in gene expression at the chromatin, mRNA, and protein levels, leading","Not Applicable","Transcription, Genetic","Collection","RNAseq_gene_transcripts","Hi-C, OTHER, RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 11 variables, 1 molecular datasets, 22 samples sequenced, 3 subjects, 22 samples","","NHGRI","GRU --- General Research Use","2021-05-06","2021-05-06","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002059.v1.p1","Genes for Non-Syndromic Congenital Heart Disease","Congenital heart defects (CHDs) are the most common serious birth defect and a leading cause of infant mortality. Affected individuals who survive infancy require substantial medical care and experience lifelong  morbidity and early mortality. Despite their prevalence and impact upon public health, the etiology of CHDs is poorly understood. Our long-term goal","Not Applicable","Heart Defects, Congenital","Family/Twin/Trios","HumanOmni2.5Exome-8, imputation_panel","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","7 phenotype datasets, 32 variables, 2 molecular datasets, 1812 subjects, 1908 samples","European (1262), African (7), East Asian (24), African American (242), Hispanic1 (100), Hispanic2 (62), Other Asian or Pacific Islander (21), South Asian (61), Other (33)","NICHD","HMB --- Health/Medical/Biomedical","2021-05-05","2021-05-05","Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Abnormally shaped heart; Cardiac abnormalities",""
"phs001942.v1.p1","Molecular Genetics of Secondary Histiocytic/Dendritic Sarcoma","This is a comprehensive genomic analysis of a rare set of secondary histiocytic/dendritic sarcomas from the consult service of the Hematopathology section of the Laboratory of Pathology, NCI, NIH. All  archived consult cases with a confirmed pathologic diagnosis of secondary histiocytic/dendritic sarcoma were eligible for this study. Principal","Not Applicable","Histiocytic Sarcoma","Case Set","WGS_markerset_grc38","SNV (.MAF), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets, 19 samples sequenced, 16 subjects, 19 samples","","NCI","GRU --- General Research Use","2021-05-05","2021-05-05","Histiocytic Lymphoma, True; Histiocytic Lymphomas, True; Histiocytic Sarcomas; Histiocytoses, True Malignant; Histiocytosis, True Malignant; Lymphoma, True Histiocytic","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001590.v2.p1","National Epidemiologic Survey on Alcohol and Related Conditions-III    (NESARC-III)","The National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) is a nationally representative cross-sectional survey of the U.S. general population, which was sponsored by the National Institute on Alcohol  Abuse and Alcoholism (NIAAA) and conducted in 2012-2013. The NESARC-III's target population was the U.S. noninstitutionalized civilian population, 18","Not Applicable","Alcoholism","Cross-Sectional","Axiom_PMRA","SNP Genotypes (Array)","4 phenotype datasets, 4329 variables, 12 documents, 1 molecular datasets, 22848 subjects, 22848 samples","European (12870), African (183), East Asian (438), African American (4316), Hispanic1 (510), Hispanic2 (3065), Other Asian or Pacific Islander (439), South Asian (193), Other (569)","NIAAA","HMB-PUB-NPU-MDS --- Health/Medical/Biomedical (PUB, NPU, MDS)","2021-05-05","2021-05-05","Anxiety Disorders; Drug Use Disorders; Eating Disorders; Major Depressive Disorder; Marijuana Abuse; Mood Disorders",""
"phs001908.v2.p1","Spatiotemporal Analysis of the Human Cerebellum","We sought to characterize neural progenitors within spatially demarcated regions of the human cerebellum at a molecular level during neurogenesis. We used laser-capture microdissection to enrich for cells within the  ventricular zone and subventricular zone regions of the rhombic lip, external granule cell layer and Purkinje cell layer, then performed","Not Applicable","Neural Stem Cells","Control Set","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 50 samples sequenced, 12 subjects, 50 samples","","NINDS","HMB --- Health/Medical/Biomedical","2021-04-28","2020-10-06","Not Provided",""
"phs001982.v1.p1","Rb and p53-Deficient Pleomorphic Myofibroblastic Sarcomas Require Skp2","Myxofibrosarcoma (MFS) and undifferentiated pleomorphic sarcoma (UPS) are highly genetically complex soft tissue sarcomas. Up to 50% of patients develop distant metastases, but current systemic therapies have limited efficacy. MFS  and UPS have recently been shown to commonly harbor copy number alterations or mutations in the tumor suppressor genes RB1 and TP53. As these","Not Applicable","Sarcoma","Case Set","Not Provided","WXS","5 phenotype datasets, 16 variables, 62 samples sequenced,  SRA, 62 subjects, 62 samples","","NCI","GRU --- General Research Use","2021-04-23","2021-04-23","Histiocytoma, Malignant Fibrous; Sarcoma, Soft Tissue; Fibrohistiocytic Tumor, Malignant; Fibrohistiocytic Tumors, Malignant; Fibrous Histiocytoma, Malignant; Fibrous Histiocytomas, Malignant","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002061.v1.p1","Genomic Damage in HIV-Uninfected Children with In Utero Zidovudine    Exposure","Zidovudine (ZDV) is a nucleoside reverse transcriptase inhibitor (NRTI) which competitively inhibits HIV reverse transcriptase and is incorporated into the viral DNA, resulting in DNA chain termination. It was the  first approved antiretroviral medication used for preventing HIV transmission from mother to child. However, in vitro and animal studies have","Not Applicable","HIV","Prospective Longitudinal Cohort","WES_markerset_grc38","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets, 185 samples sequenced,  SRA, 186 subjects, 364 samples","European (14), African (7), African American (68), Hispanic1 (42), Hispanic2 (24), Other Asian or Pacific Islander (3), Other (21)","NCI","DS-HIV-COL --- Disease-Specific (Human Immunodeficiency Virus, COL)","2021-04-22","2021-04-22","Not Provided",""
"phs002364.v1.p1","Oral Mucosa Transcriptomic Data from Three HIV+cART Patients","Systemic inflammation and mortality in people living with HIV (PLWH) are associated with mucosal immune dysfunction and persistent viral reservoirs in the mucosa and lymphoid tissues. This study determined the  underlying mechanism of immunological dysfunction in the mouth and will reveal new directions to address oral disease and systemic inflammation n","Not Applicable","HIV","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 3 samples sequenced, 3 subjects, 3 samples","","NIDCR","GRU --- General Research Use","2021-04-21","2021-04-21","Inflammation; Mouth Diseases; Inflammatory Response, Innate; Innate Inflammatory Response; Innate Inflammatory Responses; Disease, Mouth",""
"phs001675.v1.p1","CCDG: Exomes of Orofacial Clefts","Orofacial Clefts (OFCs) are genetically complex structural birth defects caused by genetic factors, environmental exposures, and their interactions. OFCs are the most common craniofacial anomalies in humans. Affect about 1  in 800 newborns, OFCs are also one of the most common structural birth defects worldwide. OFCs can impose a substantial personal cost resulting from","Not Applicable","Cleft Lip","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 30 variables, 1 molecular datasets, 319 samples sequenced,  SRA, 385 subjects, 319 samples","","NIDCR","DS-OBDR-MDS-RD --- Disease-Specific (Orofacial birth defects and related phenotypes, MDS, RD), DS-OBDR-RD --- Disease-Specific (Orofacial birth defects and related phenotypes, RD), HMB-MDS --- Health/Medical/Biomedical (MDS), DS-CFR --- Disease-Specific (Craniofacial Research)","2021-04-19","2021-04-19","Cleft Palate; Velopharyngeal Insufficiency; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips",""
"phs002301.v1.p1","Whole Genome Sequencing of Skull-Based Chordoma","Chordoma is a rare bone tumor, which is believed to originate from notochordal remnants. Based on the United States Surveillance Epidemiology and End Results (SEER) data, the incidence of chordoma  varies by gender and race; however, little is known about the etiologic factors that predispose to it. Genomic profiling studies of chordoma are","Not Applicable","Chordoma","Case Set","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 14 variables, 198 samples sequenced, 80 subjects, 198 samples","","NCI","DS-CHR --- Disease-Specific (Chordoma)","2021-04-14","2021-04-14","",""
"phs001349.v2.p1","Identification of 22 Novel Loci Associated with Susceptibility to    Testicular Germ Cell Tumors","Testicular germ cell tumors (TGCT) are the most common cancers in young men of European ancestry aged 20 to 39 years. The Testicular Cancer Consortium (TECAC) has brought together the  largest genome-wise association study (GWAS) study of TGCT to date. We conducted a GWAS of 5,602 cases and 5,006 controls aggregated from 12","Not Applicable","Testicular Germ Cell Tumor","Case-Control","HumanCore-24_plus","SNP Genotypes (Array)","4 phenotype datasets, 27 variables, 1 documents, 2 analyses, 1 molecular datasets, 10608 subjects, 10608 samples","European (10576), Hispanic1 (11), Hispanic2 (4), South Asian (1), Other (16)","NCI","DS-TGCT-PUB-MDS --- Disease-Specific (Testicular Cancer, PUB, MDS), DS-CA-MDS --- Disease-Specific (Cancer, MDS), HMB --- Health/Medical/Biomedical, DS-TGCT-MDS --- Disease-Specific (Testicular Cancer, MDS)","2021-04-14","2022-10-03","Cryptorchidism; Nonseminomatous germ cell tumor; Cryptorchidism (unilateral or bilateral); Cryptorchidism, Unilateral Or Bilateral; Cryptorchism; IDT - Imperfectly descended testis","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001120.v2.p2","ELLIPSE Prostate Cancer Meta-Analysis and Genotyping","The ELLIPSE Consortium is an international effort to discover risk loci for prostate cancer. It includes the meta-analysis of existing GWAS data as well as novel GWAS, exome, and iCOGS  genotyping. The GWAS meta-analysis includes the following cases and controls from studies of European ancestry: UK GWAS stage 1 (Illumina Infinium","Not Applicable","Prostatic Neoplasms","Case-Control","OncoArray, HumanExome-12, HumanOmni2.5-8","Not Provided","2 phenotype datasets, 10 variables, 5 analyses, 12947 subjects, 12947 samples, 2 substudies","","NCI","DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB), DS-PC --- Disease-Specific (Prostate Cancer)","2021-04-14","2017-03-31","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs000711.v7.p2","Baylor Hopkins Center for Mendelian Genomics (BH CMG)","The Centers for Mendelian Genomics project uses next-generation sequencing and computational approaches to discover the genes and variants that underlie Mendelian conditions. By discovering genes that cause Mendelian conditions, we  will expand our understanding of their biology to facilitate diagnosis and new treatments. Sequencing Centers: Baylor Hopkins Center for Mendelian","Not Applicable","Mendelian Randomization Analysis","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 19 variables, 5 molecular datasets, 2451 samples sequenced, 2445 subjects, 2451 samples","","NHGRI","HMB-NPU --- Health/Medical/Biomedical (NPU), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2021-04-14","2021-04-14","Achondroplasia; Acne Inversa; Alstrom Syndrome; Aortic Aneurysm, Thoracic; Arthrogryposis, Renal Dysfunction, And Cholestasis; BO Syndrome 3",""
"phs001125.v2.p2","ELLIPSE Prostate Cancer Genotyping","The Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium is an international effort to discover risk loci for prostate cancer. The following de novo genotyping was performed. The OMNI  2.5M genotyping was conducted for 977 prostate cancer cases from UKGPCS. The Exome SNP array genotyping was conducted for 4741 subjects from UKGPCS.","ELLIPSE Prostate Cancer Meta-Analysis and Genotyping (phs001120.v2.p2)","Prostatic Neoplasms","Case-Control","OncoArray, HumanExome-12, HumanOmni2.5-8","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 3 molecular datasets, 12947 subjects, 12947 samples","European (11012), African (4), East Asian (1), African American (12), Hispanic1 (13), Hispanic2 (2), South Asian (12), Other (16)","NCI","DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB), DS-PC --- Disease-Specific (Prostate Cancer)","2021-04-14","2017-03-31","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs001081.v2.p2","ELLIPSE Prostate Cancer Meta-Analysis","The Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium is an international effort to discover risk loci for prostate cancer. It includes the meta-analysis of existing GWAS data. The  GWAS meta-analysis includes the following cases and controls from studies of European ancestry: UK GWAS stage 1 (Illumina Infinium HumanHap 550","ELLIPSE Prostate Cancer Meta-Analysis and Genotyping (phs001120.v2.p2)","Prostatic Neoplasms","Case-Control","Not Provided","Not Provided","2 analyses","","NCI","DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB), DS-PC --- Disease-Specific (Prostate Cancer)","2021-04-14","2017-03-31","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs001561.v1.p1","NIAID Clinical Center Genomics Opportunity (CCGO) Study","Background: - There are many types of immune disorders. These range from rare immune deficiencies to allergies to autoimmune disease like rheumatoid arthritis. Genes are the instructions our body uses  to work and develop. A new technology called whole exome sequencing may help find the cause of these disorders. Whole exome sequencing is a way to","Not Applicable","Immunologic Deficiency Syndromes","Prospective Longitudinal Cohort","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 22 variables, 1 molecular datasets, 135 subjects, 135 samples","European (101), African American (10), Hispanic1 (13), Hispanic2 (4), Other (7)","NIAID","GRU --- General Research Use","2021-04-13","2021-04-13","Mastocytosis; Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections; Antibody Deficiency Syndrome; Antibody Deficiency Syndromes; Deficiency Syndrome, Antibody; Deficiency Syndromes, Antibody","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001307.v1.p1","Inherited Genetic Variation and Predisposition to Testicular Germ Cell    Tumor: UPenn Local TGCT Study","Testicular germ cell tumors (TGCT) are the most common cancer in men ages 20-40. The incidence of TGCT has more than doubled over the past forty years, without clear etiology.  Both genetic effects and environmental exposures, specifically during the pre-natal period, are likely to play an important role in determining TGCT","Not Applicable","Testicular Germ Cell Tumor","Case-Control","","SNP Genotypes (Array)","4 phenotype datasets, 40 variables, 1 molecular datasets, 1397 subjects, 1400 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2021-04-13","2021-04-13","Seminoma","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001388.v2.p1","Slim Initiative in Genomic Medicine for the Americas (SIGMA): Diabetes in    Mexico Study (DMS)","The 52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2  diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","Illumina_Exome_Array, HumanOmni2.5-4, WES_markerset_grc37","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 45 variables, 2 molecular datasets, 3041 samples sequenced, 3296 subjects, 3296 samples","","NIDDK","GRU --- General Research Use","2021-04-12","2019-01-31","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002226.v1.p1","Multicenter AIDS Cohort Study (MACS)","The Multicenter AIDS Cohort Study (MACS) - now part of the MACS-WIHS Combined Cohort Study (MWCCS) investigates the epidemiology of human immunodeficiency virus (HIV) infection among men who have sex  with men. Over 7,000 participants volunteered for semiannual interview, physical examination, and laboratory testing across the 325 years of the","Not Applicable","HIV","Prospective Longitudinal Cohort","Multi-Ethnic_Global","SNP Genotypes (Array)","4 phenotype datasets, 24 variables, 1 molecular datasets, 3747 subjects, 3747 samples","European (2756), African (11), East Asian (12), African American (677), Hispanic1 (38), Hispanic2 (224), Other Asian or Pacific Islander (10), South Asian (1), Other (18)","NIDA","HMB-IRB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (IRB, PUB, NPU, MDS, GSO)","2021-04-09","2021-04-09","Not Provided",""
"phs001504.v2.p1","Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in    Multi-Ethnic Samples (T2D-GENES) Follow-Up Study: Research Studies in    Hong Kong","The 52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2  diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","WGS_markerset_grc37, custom_markerset","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 45 variables, 1 molecular datasets, 976 samples sequenced, 976 subjects, 976 samples","","NIDDK","DS-ENDO-IRB-NPU-MDS --- Disease-Specific (Endocrine Diseases, IRB, NPU, MDS)","2021-04-09","2018-05-29","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001028.v1.p1","Complete Genomics Deep Whole-Genome Sequencing of Circulating Tumor Cells","Circulating tumor cells (CTCs) are considered to be informative non-invasive biopsy for the early detection, diagnosis or therapy guidance of cancer. CTCs also contain most of the heterogeneity found across  multiple metastatic sites. In this study, we combine recently improved CTC isolation methods, resulting in almost pure CTCs, with advanced whole","Not Applicable","Breast Neoplasms","Case Set","WGS_markerset_grc37","SNP Genotypes (NGS)","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 1 subjects, 10 samples","","NHGRI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2021-04-09","2021-04-09","Carcinoma, Lobular; Neoplasm Metastasis; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor",""
"phs002235.v1.p1","Global Microbiome Conservancy Sequence Data","The human body is a complex ecosystem, hosting tens of billions of bacteria, primarily in the gut. This community, known as the 'gut microbiome', is vital to human health, affecting  functions ranging from metabolism, immunity, and development, to behavior. Conversely, reduced microbiome diversity and other imbalances of the gut","Not Applicable","Gastrointestinal Microbiome","Cross-Sectional","human_microbiome","Human Metagenome (NGS), WGS","4 phenotype datasets, 24 variables, 1 molecular datasets, 4186 samples sequenced, 37 subjects, 8335 samples","","NHGRI","GRU-NPU --- General Research Use (NPU)","2021-04-08","2021-04-08","Not Provided",""
"phs002365.v1.p1","Derivation and Investigation of The First Human Cell-Based Model of    Beckwith-Wiedemann Syndrome","Beckwith-Wiedemann Syndrome (BWS) is the most common human imprinting disorder, and phenotypes include hepatomegaly and hepatoblastoma development. In approximately 20% of patients, this syndrome is caused by uniparental isodisomy of  the paternal allele across chromosome 11p15 (pUPD11). From fibroblasts cultured from 2 BWS patients with pUPD11, we derived induced pluripotent stem","Not Applicable","Beckwith-Wiedemann Syndrome","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 10 variables, 18 samples sequenced, 4 subjects, 18 samples","","NCI","GRU --- General Research Use","2021-04-07","2021-04-07","BWS; Beckwith Wiedemann Syndrome; Beckwith's syndrome; Beckwith-Wiedemann syndrome chromosome region; EMG SYNDROME; EMG Syndromes","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001375.v2.p1","Slim Initiative in Genomic Medicine for the Americas (SIGMA): Mexico City    Diabetes Study (MCDS)","The 52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2  diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","HumanOmni2.5-4, HumanCoreExome-24, custom_array","SNP Genotypes (Array), SNP/CNV (Array), WXS","4 phenotype datasets, 45 variables, 1 molecular datasets, 829 samples sequenced, 1036 subjects, 1036 samples","","NIDDK","GRU --- General Research Use","2021-04-02","2020-07-21","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001383.v1.p1","Birth Defects: Moebius Syndrome and Related Congenital Facial Weakness    Disorders","It is estimated that about 1 in every 33 infants in the United States is born with a birth defect. Among these, the subset of birth defect syndromes associated with  facial weakness and lack of facial expression can have profound implications for social interactions and psychosocial development. Moebius syndrome","Not Applicable","Mobius Syndrome","Family/Twin/Trios","HumanOmni2.5","SNP Genotypes (Array), WGS, WXS","5 phenotype datasets, 17 variables, 1 molecular datasets, 165 samples sequenced, 485 subjects, 267 samples","","NHGRI","HMB-IRB --- Health/Medical/Biomedical (IRB), DS-MOEBIUS-RD --- Disease-Specific (Moebius Syndrome, RD), DS-SCCD --- Disease-Specific (Strabismus, Congenital Cranial Dysinnervation Disorders, and related anomalies)","2021-04-01","2021-04-01","Abducens Palsy; Cleft Palate; Congenital facial diplegia; Cranial Nerve Diseases; Craniofacial Abnormalities; Facial Paralysis",""
"phs001819.v2.p1","Whole Genome Sequencing to Discover Familial Myeloma Risk Genes","We identified germline KDM1A truncating mutations in patients with multiple myeloma (MM), and loss of heterozygosity (LOH) in tumors. KDM1A mutation burden is higher in sporadic MM patients than in  controls, and mRNA levels are lower in MM compared with normal plasma cells. KDM1A pharmacological inhibition in vitro promotes myeloma cell","Not Applicable","Multiple Myeloma","Case Set","WES_markerset_grc37","SNP Genotypes (NGS)","4 phenotype datasets, 15 variables, 1 molecular datasets, 39 subjects, 39 samples","","NCI","GRU --- General Research Use, DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2021-03-31","2019-12-13","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000959.v1.p1","Genomics of Schizophrenia in the South African Xhosa","The goal of this international collaborative project is to identify genes responsible for Schizophrenia in the Xhosa population of South Africa. The vast majority of the genetic basis for Schizophrenia  has yet to be explained. We hypothesize that genes and pathways important to Schizophrenia will harbor different, severe disease-causing mutations in","Not Applicable","Schizophrenia","Case-Control","Not Provided","WXS","4 phenotype datasets, 13 variables, 1537 samples sequenced,  SRA, 1537 subjects, 1537 samples","","NIMH","DS-SZRD-IRB-GSO --- Disease-Specific (Schizophrenia and related disorders, IRB, GSO), HMB-IRB-GSO --- Health/Medical/Biomedical (IRB, GSO)","2021-03-30","2021-03-30","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder",""
"phs002204.v1.p1","A Single Cell Atlas of Gene Regulatory Elements in the Human Heart","Background: Cis-regulatory elements such as enhancers and promoters are crucial for directing gene expression in the human heart. Dysregulation of these elements can result in many cardiovascular diseases that are  major leading causes of morbidity and mortality worldwide. In addition, genetic variants associated with cardiovascular disease risk are enriched","Not Applicable","Heart","Control Set","Not Provided","ATAC-seq, RNA-Seq","4 phenotype datasets, 19 variables, 21 samples sequenced, 4 subjects, 21 samples","","NHLBI","DS-HTD-IRB --- Disease-Specific (Heart Disease, IRB)","2021-03-29","2021-03-29","Not Provided",""
"phs002386.v1.p1","Optimizing Primary Stroke Prevention in Children with Sickle Cell Anemia    (STOP II)","The STOP II trial evaluated whether prophylactic transfusion in patients with sickle cell disease and high risk of stroke can be safely halted after 30 months of treatment during which  patients became low risk for stroke. Stroke causes substantial morbidity in children with sickle cell disease. To prevent first strokes, the Stroke","Not Applicable","Anemia, Sickle Cell","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 79 subjects, 79 samples","","NHLBI","GRU --- General Research Use","2021-03-26","2021-03-26","Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Brain Diseases; Cardiovascular Diseases; Central Nervous System Diseases","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001122.v1.p1","Genome-wide Identification of Variants Affecting Early Human Brain    Development","This is a genome-wide association study (GWAS) of global brain tissue volumes in human infants. The published study for this project includes 561 infants, and 239 parents gave consent for  data sharing through dbGaP. An intronic single-nucleotide polymorphism (SNP) in IGFBP7 (rs114518130; GeneID: 3490) met genome-wide significance for","Not Applicable","Brain","Prospective Longitudinal Cohort","Axiom_GW_LAT, Axiom_Exome","SNP Genotypes (Array), WXS","5 phenotype datasets, 40 variables, 1 molecular datasets, 18 samples sequenced,  SRA, 239 subjects, 436 samples","European (142), African American (58), Hispanic1 (10), Hispanic2 (14), Other Asian or Pacific Islander (3), South Asian (1), Other (11)","NIMH","GRU --- General Research Use","2021-03-25","2021-03-25","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs002212.v1.p1","ZRSR2 Mutant Myelodysplastic Syndromes","Mutations in splicing factor genes are common in myelodysplastic syndromes but the reason for selection of these mutations remains incompletely understood. This study aimed to identify the effect of minor  intron retention due to ZRSR2 mutations in myelodysplastic syndromes. Nine samples from patients with myelodysplastic syndromes bearing ZRSR2","Not Applicable","Myelodysplastic Syndromes","Case Set","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 18 samples sequenced, 18 subjects, 18 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2021-03-24","2021-03-24","Hematopoetic Myelodysplasia; Hematopoetic Myelodysplasias; Myelodysplasia, Hematopoetic; Myelodysplasias, Hematopoetic","NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs002063.v1.p1","Innate and Adaptive Immunity in Parkinson Disease-P20","Increasing evidence supports the role of brain and systemic inflammation in the etiology of Parkinson disease (PD). We used gene expression profiling (RNA-seq) to examine the activation state of peripheral  blood monocytes in 18 patients with early, untreated PD and 16 healthy control (HC) subjects. Monocytes were isolated by negative selection, and gene","Not Applicable","Parkinson Disease","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 23 variables, 34 samples sequenced,  SRA, 34 subjects, 34 samples","","NINDS","DS-PDBD --- Disease-Specific (Parkinson's Disease and other Brain Disorders)","2021-03-24","2021-03-24","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs002368.v1.p1","CaBagE: a Cas9-Based Background Elimination Strategy for Targeted,    Long-Read DNA Sequencing","While repeat-expansion polymorphisms are known to underlie several developmental and neurological disorders, technological limitations have inhibited the ability to resolve accurate genotypes for these variants. A pertinent example is the  (CCCCGG)n repeat expansion in C9orf72 that segregates with up to 40% of familial amyotrophic lateral sclerosis (ALS) cases. There is a clear","Not Applicable","Amyotrophic Lateral Sclerosis","Case Set","Not Provided","OTHER","3 phenotype datasets, 9 variables, 4 samples sequenced, 2 subjects, 4 samples","","NHGRI","GRU --- General Research Use","2021-03-23","2021-03-23","ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease; Disease, Lou-Gehrigs","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002313.v1.p1","Copy-Number Analysis of Understudied Black Women Ovarian Cancers","Two general types of genetic alterations drive cancer progression: mutations and copy number alterations (CNAs). With the exception of p53, single nucleotide variant mutations (here, simply ""mutations"") are not drivers  of 80% of tumors within the most frequent and deadly histotype of ovarian cancer: serous ovarian cancer (SOC). Rather, CNAs are more prevalent in SOC","Not Applicable","Neoplasms","Case Set","WGS_markerset_grc37","CNV Genotypes, WXS","4 phenotype datasets, 18 variables, 1 molecular datasets, 21 samples sequenced, 20 subjects, 21 samples","","NCI","GRU --- General Research Use","2021-03-23","2021-03-23","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002089.v1.p1","Dynamics of Genomic and Immune Responses During Primary Immunotherapy    Resistance in Mismatch Repair Deficient Tumors","We study a patient with dMMR lung cancer refractory to immunotherapy. Post-treatment tumor demonstrated compound heterozygous frameshift deletions located upstream of the kinase domain in the gene encoding JAK1 protein,  downregulation of JAK1 and mediators of its signal transduction, and total loss of JAK1 phosphorylation. Importantly, one of the JAK1 mutations,","Not Applicable","Small Cell Lung Carcinoma","Case Set","Not Provided","RNA-Seq, WGS, WXS","4 phenotype datasets, 16 variables, 6 samples sequenced, 1 subjects, 6 samples","","NCI","GRU --- General Research Use","2021-03-23","2021-03-23","Turcot syndrome; Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001623.v2.p1","Genomic Analysis of Head and Neck Cancers","These aggregate studies focus on specimens from head and neck squamous cell carcinoma (HNSCC) patients who were treated with standard of care or window of opportunity clinical trial approaches. Specimens  were interrogated with exome and RNA-Seq analysis. Patient derived xenografts (PDXs) represent a robust platform for performing co-clinical trial","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Case Set","Not Provided","OTHER, RNA-Seq, WGS, WXS","4 phenotype datasets, 20 variables, 473 samples sequenced,  SRA, 52 subjects, 473 samples","","NIDCR","GRU --- General Research Use, DS-CA --- Disease-Specific (Cancer)","2021-03-23","2018-10-23","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx",""
"phs001018.v1.p1","Molecular Characterization of Clinical Renal Tumors","We performed comprehensive molecular profiling of renal tumors, including whole exome sequencing and transcriptome sequencing, derived from patient samples. This project additionally explores mechanisms of response and resistance to existing  and emerging therapies in this disease, as well as mechanisms of tumor evolution in the context of treatment. Inclusion: Renal cancer Availability of","Not Applicable","Kidney Neoplasms","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 10 variables, 22 samples sequenced, 11 subjects, 22 samples","","NHGRI","DS-RCCA-MDS-RD --- Disease-Specific (Renal Cell Carcinoma, MDS, RD)","2021-03-23","2021-03-23","Kidney Tumor; Kidney cancer; Kidney neoplasm; Neoplasia of the kidneys; Neoplasm of Kidney; Neoplasm of the Kidney",""
"phs002273.v1.p1","Analysis of Recurrently Protected Genomic Regions in Urine Cell-Free DNA","This study investigated fragmentation patterns in urine and plasma cell-free DNA and evaluated the relevance of such analysis for cancer diagnostics using urine samples. Specifically, we performed whole-genome sequencing at  variable depths and evaluated genome-wide coverage in urine and plasma samples, relative to known genome annotation features. Tumor/germline exome","Not Applicable","Cell-Free Nucleic Acids","Methods","Not Provided","WGS, WXS","3 phenotype datasets, 13 variables, 89 samples sequenced, 60 subjects, 89 samples","","NCI","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2021-03-22","2021-03-22","Not Provided",""
"phs001916.v2.p1","Pilot Sequencing Study of Peripheral Blood Mononuclear Cells in Human    Aging","This study was a pilot analysis of samples of human peripheral blood mononuclear cell (PBMCs) from 10 young (23-30 years) and 10 older (68-76 years) healthy Caucasian female volunteers. Whole  genome sequencing was performed to assess multiple epigenetic mechanisms and gene expression, including 5hmC-capture sequencing and RNA-sequencing,","Not Applicable","Healthy Aging","Case-Control","Not Provided","ATAC-seq, ChIP-Seq, OTHER, RNA-Seq","4 phenotype datasets, 13 variables, 100 samples sequenced,  SRA, 20 subjects, 100 samples","","NIA","GRU-IRB --- General Research Use (IRB)","2021-03-22","2020-01-20","Not Provided",""
"phs002348.v1.p1","Multicenter Study of Hydroxyurea (MSH)","This study aimed to determine whether or not treatment with hydroxyurea titrated to maximum tolerated doses would reduce the frequency of vaso-occlusive (painful) crises by at least 50% in 299  men and women between 18 and 50 years old with a diagnosis of sickle cell anemia by gel electrophoresis conducted by a Core Laboratory. A secondary","Not Applicable","Anemia, Sickle Cell","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 299 subjects, 1059 samples","","NHLBI","GRU --- General Research Use","2021-03-19","2021-03-19","Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Hematologic Diseases; Hemoglobinopathies; Molecular Mechanisms of Pharmacological Action","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002328.v1.p1","International Genetics of Parkinson Disease Progression (IGPP)    Consortium: EPIPARK and HBS2 Cohorts","EPIPARK and HBS2 cohorts were analyzed as part of the International Genetics of Parkinson Disease Progression (IGPP) Consortium. EPIPARK is a population-based cohort to study non-motor symptoms in parkinsonism in  the city of L&#x000fc;beck, Germany led by Drs. Meike Kasten and Christine Klein. HBS2 is a recently enrolled subset of participants in the Harvard","Not Applicable","Parkinson Disease","Prospective Longitudinal Cohort","MEGA_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 268 subjects, 268 samples","","NINDS","DS-NDRD --- Disease-Specific (Neurological and Related Disorders)","2021-03-19","2021-03-19","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs002237.v1.p1","Investigation of MMBIR DNA Repair in Normal and Cancer Human Cells","Microhomology-mediated break-induced replication (MMBIR) is a DNA repair pathway in which template switching at microhomology was proposed to promote complex genomic rearrangements (CGRs) that contribute to cancer. Yet, the extent  of MMBIR activity in genomes is poorly understood due to difficulty in directly identifying MMBIR events by whole genome sequencing (WGS). This study","Not Applicable","Adenocarcinoma of Lung","Case-Control","Not Provided","WGS","4 phenotype datasets, 18 variables, 5 samples sequenced, 2 subjects, 5 samples","","NIGMS","GRU-NPU --- General Research Use (NPU)","2021-03-17","2021-03-17","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs002068.v1.p1","Sporadic ALS Australia Systems Genomics Consortium (SALSA-SGC)","In 2016 we established the Sporadic ALS Australia Systems Genomics Consortium (SALSA-SGC) funded by the Ice Bucket Challenge Grant administered by the Motor Neurone Disease Research Institute of Australia. The  goals of the SALSA-SGC are to collect biological samples from clinics across Australia with matched in depth clinical and self-report phenotypes and","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","custom_markerset, HumanMethylation450","Methylation (CpG), SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 molecular datasets, 1444 subjects, 2757 samples","European (1406), East Asian (8), African American (1), Hispanic1 (6), Hispanic2 (3), Other Asian or Pacific Islander (3), South Asian (8), Other (9)","NINDS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2021-03-17","2021-03-17","ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease; Disease, Lou-Gehrigs",""
"phs001771.v1.p1","Genomic Diagnosis and Individualized Therapy of Monogenic Diabetes","The most common and well-known causes of diabetes are type 1 and type 2 diabetes; however, there are many other etiologies of diabetes. At least 1-2% of diabetes cases result  from high penetrance single gene defects, most commonly in a gene encoding either a transcription factor involved in beta cell development and","Not Applicable","Diabetes Mellitus","Prospective Longitudinal Cohort","target_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 140 variables, 11 documents, 1 molecular datasets,  SRA, 443 subjects, 443 samples","","NHGRI","GRU --- General Research Use","2021-03-17","2021-03-17","Diabetes Mellitus, Lipoatrophic; Diabetes Mellitus, Type 1; Diabetes, Gestational; Wolfram Syndrome; Diabete, Lipoatrophic; Diabetes, Lipoatrophic",""
"phs001264.v1.p1","A Super-Enhancer Associated with CD47 in Breast Cancer","CD47 is a cell surface molecule that inhibits phagocytosis of cells that express it by binding to its receptor, SIRP&#x003b1;, on macrophages and other immune cells. CD47 is expressed at  different levels in normal cells, however, in cancer cells, CD47 transcript and protein expression is aberrantly increased. Here we sought to uncover","Not Applicable","Breast Neoplasms","Xenograft","Not Provided","ChIP-Seq","4 phenotype datasets, 24 variables, 4 samples sequenced,  SRA, 4 subjects, 4 samples","","NCI","GRU --- General Research Use, DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS)","2021-03-17","2021-03-17","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001374.v2.p1","VA APOLLO Project - Research for Precision Oncology (RePOP)","The Research for Precision Oncology Program (RePOP) is a research activity that establishes a cohort of Veterans diagnosed with cancer and who have had genomic analyses performed on their tumor  tissue as part of standard of care. All data relevant to a patient's cancer and cancer care will be collected under RePOP, including patient","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 4 variables,  SRA, 170 subjects, 170 samples","","NCI","GRU --- General Research Use","2021-03-15","2018-08-22","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002362.v1.p1","Cooperative Study of Sickle Cell Disease (CSSCD)","The Cooperative Study of Sickle Cell Disease was initiated in 1977 to determine the natural history of sickle cell disease (SCD) from birth to death in order to identify those  factors contributing to the morbidity and mortality of the disease. Specific objectives included: 1) to study the effect of sickle cell disease on","Not Applicable","Anemia, Sickle Cell","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 4085 subjects, 5946 samples","","NHLBI","GRU --- General Research Use","2021-03-12","2021-03-12","Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Hematologic Diseases; Hemoglobinopathies; Sickle Cell Anemia","NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002295.v1.p1","Cross-site Concordance Evaluation of Tumor DNA and RNA Sequencing    Platforms of CIMAC-CIDC Network","The Cancer Immune Monitoring and Analysis Centers (CIMACs) and the Cancer Immunologic Data Commons (CIDC)&#x000a0; has engaged in efforts to harmonize Whole-exome (WES) and RNA-sequencing (RNA-seq) data from three different  experimental platforms (MD Anderson, NCI MoCha lab, and Broad Institute) and are using a series of developed pipelines to process the early trial","Not Applicable","Carcinoma, Non-Small-Cell Lung","Case Set","WES_markerset_grc38, RNAseq_probe_set_grc38","SNV (.MAF), RNA Seq (NGS)","3 phenotype datasets, 12 variables, 2 molecular datasets, 8 subjects, 234 samples","","NCI","GRU --- General Research Use","2021-03-11","2021-03-11","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002252.v1.p1","Cellular and Molecular Characterization of Renal Cell Carcinoma","We are performing a comprehensive cellular and molecular characterization of renal cell carcinoma. This work includes an initial cohort of patients whose tumors (and adjacent normal tissue) underwent single cell  analysis. Single-cell RNA sequencing (scRNA-seq) and TCR sequencing (scTCR-seq) analysis of untreated clear cell renal cell carcinoma tumor and","Not Applicable","Carcinoma, Renal Cell","Tumor vs. Matched-Normal","Not Provided","OTHER, WXS","4 phenotype datasets, 21 variables, 52 samples sequenced, 13 subjects, 53 samples","","NCI","DS-RCCA-MDS --- Disease-Specific (Renal Cell Carcinoma, MDS)","2021-03-11","2021-03-11","Kidney Neoplasms; ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell",""
"phs001754.v4.p2","Spit for Science","Spit for Science&#x02122; is a university-wide research opportunity with the scientific goal of understanding how genetic and environmental factors come together to influence substance use and emotional health across the  college years and beyond. To address this goal, we have comprehensively and longitudinally studied eligible incoming freshmen (18 years or older)","Not Applicable","Mental Health","Prospective Longitudinal Cohort","Axiom_Smokesc, Axiom_Biobank_plus, Axiom_PMRA","SNP Genotypes (Array)","4 phenotype datasets, 32 variables, 3 molecular datasets, 9917 subjects, 9917 samples","European (4807), African (149), East Asian (591), African American (1936), Hispanic1 (339), Hispanic2 (486), Other Asian or Pacific Islander (575), South Asian (647), Other (387)","NIDA","DS-ADX-PUB-NPU-MDS --- Disease-Specific (Addictive Disorders, PUB, NPU, MDS)","2021-03-10","2021-02-11","Not Provided",""
"phs002342.v1.p1","Optimized Polyepitope Neoantigen DNA Vaccines Elicit Neoantigen-Specific    Immune Responses in Preclinical Models and in Clinical Translation","A patient with Lynch syndrome and a neuroendocrine tumor sequenced with exome, whole genome, and bulk RNAseq. Sequence data was used to create a personalized cancer vaccine. Principal Investigator: William  Gillanders, MD, Washington University School of Medicine, St Louis, MO, USA","Not Applicable","Carcinoma, Neuroendocrine","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS, WXS","4 phenotype datasets, 16 variables, 5 samples sequenced, 1 subjects, 5 samples","","NCI","GRU --- General Research Use","2021-03-09","2021-03-09","","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002335.v1.p1","Dana-Farber Cancer Institute (DFCI) Wu Lab/Avicenne CLL RNA-Seq Study","Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by accumulation of CD5+ B cells in peripheral lymphoid organs, bone marrow and blood. Recently, the advent of large-scale whole-exome sequencing  of hundreds of CLL samples has led to gain a comprehensive understanding of the mutational landscape of this clonal B cell malignancy, but the","Not Applicable","Leukemia","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 14 samples sequenced, 12 subjects, 14 samples","","NCI","HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS)","2021-03-09","2021-03-09","Blood (Leukemia); Blood cancer; Leucocythaemia; Leucocythaemias; Leucocythemia; Leucocythemias",""
"phs002334.v1.p1","Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic    Response In Vivo","Oncogenic alterations in EGFR frequently co-occur with additional genetic alterations in EGFR-driven lung adenocarcinoma (LUAD), but how specific combinations of mutations affect tumor phenotypes and responses to targeted therapy is  yet unknown. We leveraged a genetically engineered mouse model of EGFR mutant/Trp53-deficient LUAD to study the consequences of inactivating 10","Not Applicable","Adenocarcinoma of Lung","Collection","Not Provided","WXS","4 phenotype datasets, 20 variables, 78 samples sequenced, 29 subjects, 78 samples","","NCI","DS-LCTC-MDS --- Disease-Specific (Lung Cancer and Thoracic Malignancies, MDS)","2021-03-09","2021-03-09","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs001816.v1.p1","CRISPR-Mediated ASD Gene Knockout Reduces Neuronal Activity","Autism Spectrum Disorder is phenotypically and genetically heterogeneous. We present a CRISPR gene editing strategy to insert a protein tag and premature termination sites creating an induced pluripotent stem cell  (iPSC) knockout resource for functional studies of 10 ASD-relevant genes (AFF2/FMR2, ANOS1, ASTN2, ATRX, CACNA1C, CHD8, DLGAP2, KCNQ2, SCN2A, TENM1).","Not Applicable","Autism Spectrum Disorder","Case-Control","Not Provided","WGS","3 phenotype datasets, 11 variables, 11 samples sequenced,  SRA, 11 subjects, 11 samples","","NIMH","DS-AUT-IRB --- Disease-Specific (Autism, IRB)","2021-03-09","2021-03-09","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs002210.v1.p1","Comprehensive Analysis of Structural Variants in Breast Cancer Genomes    Using Single Molecule Sequencing","This study used the SKBR3 breast cell line and tumor/normal organoids derived from breast tissue to explore the utility of long read sequencing for detecting structural variants in complex samples.  Three technologies were used to characterize the samples: Illumina/10X, Pacific Biosciences, and Oxford Nanopore. Methylation results were derived","Not Applicable","Breast Neoplasms","Case Set","target_markerset_grc38","CNV (NGS), WGS","4 phenotype datasets, 15 variables, 1 molecular datasets, 7 samples sequenced, 2 subjects, 7 samples","","NCI","GRU-IRB --- General Research Use (IRB)","2021-03-05","2021-03-05","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs002065.v1.p1","Integrative Somatic and Germline Molecular Characterization of    Genitourinary Cancers","We have performed integrative bulk (whole exome sequencing of tumor and normal paired and whole transcriptome sequencing) and single cell analysis of primary and metastatic non-prostate genitourinary cancer specimens, such  as renal and bladder tumors. Principal Investigator: Eliezer M. Van Allen, MD, Dana-Farber Cancer Institute, Boston, MA, USA Funding Sources: R37","Not Applicable","Urinary Bladder Neoplasms","Case-Control","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 18 samples sequenced, 8 subjects, 18 samples","","NCI","HMB --- Health/Medical/Biomedical","2021-03-05","2021-03-05","Bladder Neoplasms; Kidney Neoplasms; Bladder Cancer; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002294.v1.p1","Evolution of Core Archetypal Phenotypes in High-Grade Serous Ovarian    Cancer (HGSOC)","The evolution of resistance in high-grade serous ovarian cancer (HGSOC) cells in response to chemotherapy is only partially understood. To uncover phenotypic changes associated with chemotherapy resistance, we performed single-cell  RNA-sequencing (scRNA-seq) or whole-genome sequencing of 23 total patients, with longitudinal samples collected from 9, treatment-na&#x000ef;ve","Not Applicable","Ovarian Neoplasms","Tumor vs. Matched-Normal","Not Provided","OTHER, WGS","3 phenotype datasets, 11 variables, 72 samples sequenced, 23 subjects, 72 samples","","NCI","GRU --- General Research Use","2021-03-04","2021-03-04","Carcinoma, Ovarian Epithelial; Cancer, Epithelial Ovarian; Cancer, Ovarian Epithelial; Carcinoma of Ovary; Carcinoma of the Ovary; Carcinoma, Epithelial Ovarian","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002291.v1.p1","Whole Transcriptome Sequencing of Human Tumor Cells and Hematopoietic    Stem and Progenitor Cells During Aging and Bone Marrow Disorders","Whole transcriptome sequencing analyses were performed on human hematopoietic stem and progenitor cells during aging and bone marrow disorders. For this purpose, normal and diseased bone marrow or peripheral blood-derived  mononuclear cells were FACS-purified into hematopoietic stem (CD34+CD38-Lin-) or hematopoietic progenitor (CD34+CD38+Lin-) populations. Primary human","Not Applicable","Multiple Myeloma","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 10 samples sequenced, 5 subjects, 10 samples","","NIDDK","GRU --- General Research Use","2021-03-04","2021-03-04","Neoplasms, Plasma Cell; Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002308.v1.p1","Characterizing Individual Cells Obtained from Bone Marrow Biopsies of MPN    Patients","We profiled the transcriptomes of individual cells obtained from bone marrow aspirates of 7 treatment-na&#x000ef;ve newly diagnosed JAK2-mutant myeloproliferative neoplasm (MPN) patients (3 polycythemia vera and 4 essential thrombocythemia patients),  and 2 healthy controls. The submitted data corresponds to sequencing reads mapped to the human reference genome GhRC38 build using CellRanger for a","Not Applicable","Myeloproliferative Disorders","Case-Control","Not Provided","RNA-Seq, WGS","3 phenotype datasets, 11 variables, 88 samples sequenced, 9 subjects, 88 samples","","NIGMS","HMB --- Health/Medical/Biomedical","2021-03-03","2021-03-03","ET; Essential Thrombocytemia; Essential Thrombocythemias; Essential Thrombocytosis; Essential hemorrhagic thrombocythemia; Essential thrombocythemia (clinical disorder)",""
"phs001935.v1.p1","National Cancer Institute Clinical and Laboratory Analysis of Familial    Cancer","The purpose of this study is to continue the analysis begun on 09C0079 which was focused on identification of the genetic mutation associated with a new gastric polyposis syndrome, Gastric  Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS). GAPPS, first described in 2012, is an autosomal dominant gastric polyposis syndrome","Not Applicable","Stomach Neoplasms","Case Set","Not Provided","WXS","5 phenotype datasets, 24 variables, 6 samples sequenced,  SRA, 6 subjects, 12 samples","","NCI","GRU --- General Research Use","2021-03-03","2021-03-03","Adenocarcinoma; Polyposis, Gastric; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant",""
"phs001812.v1.p1","Genetic and Epigenetic Determinants of Pediatric Obesity-Associated    Asthma","Fifty-nine obese and sixty-one normal-weight asthmatic children of African American or Hispanic background, age 7-11 years, with well controlled asthma, were recruited from clinics affiliated with Children's Hospital at Montefiore,  Bronx, New York, USA. We isolated CD4+ T cells (Th cells) from a fasting sample of peripheral blood and conducted genome-wide assays of gene","Not Applicable","Asthma","Case-Control","RNAseq_probe_set_grc38, Multi-Ethnic_Global, WGS_markerset_grc38","SNP Genotypes (Array), OTHER, RNA-Seq, Methylome sequencing, RNA Seq (NGS)","5 phenotype datasets, 28 variables, 2 molecular datasets, 215 samples sequenced,  SRA, 115 subjects, 326 samples","African (3), African American (51), Hispanic1 (28), Hispanic2 (13), Other (16)","NHLBI","GRU-IRB-COL --- General Research Use (IRB, COL)","2021-03-03","2021-03-03","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs001427.v2.p1","Resistance to Checkpoint Blockade Therapy Through Inactivation of Antigen    Presentation","Although immune checkpoint blockade (CPB) leads to prolonged responses in 15-40% of patients with metastatic melanoma, treatment refractory disease and progression after initial response remain major causes of mortality. While  predictors of response have been reported, the common mechanisms of both primary and acquired resistance are poorly understood. To identify","Not Applicable","Immunotherapy","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 21 variables, 123 samples sequenced, 17 subjects, 123 samples","","NHGRI","DS-MSC --- Disease-Specific (Melanoma and Skin Cancer Research)","2021-03-03","2018-02-21","Not Provided",""
"phs002333.v1.p1","Massively Parallel Single-Cell RNA-Sequencing of Chronic Rhinosinusitis    Nasal and Sinus Tissue","Single-cell RNA sequencing (scRNA-seq) using the SeqWell V1 platform on sinus mast cells flow cytometrically sorted from the nasal polyps of patients with chronic rhinosinsusitis (CRS) with nasal polyps (CRSwNP)  and aspirin-exacerbated respiratory disease (AERD). Eligibility criteria for subjects with AERD: 1. History of AERD, defined as meeting the","Not Applicable","Paranasal Sinus Diseases","Collection","RNAseq_probe_set_grc37","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 12 samples sequenced, 8 subjects, 12 samples","","NIAID","GRU --- General Research Use","2021-02-26","2021-02-26","Disease of accessory sinus; Disease, Paranasal Sinus; Diseases, Paranasal Sinus; Disorder of paranasal sinuses; Paranasal Sinus Disease; Paranasal sinus disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002270.v1.p1","Very Low Tumor Mutation Burden Identifies Inflamed Recurrent    Glioblastomas Responsive to Cancer Immunotherapy","A subset of available tumors (with matched blood) from patients enrolled in a phase I clinical trial testing a recombinant poliovirus, published by Desjardins et al. NEJM 2018 (PMID:29943666), were  analyzed by whole exome sequencing and RNA-seq. It was discovered that low tumor mutation burden correlated with survival outcome, and also","Not Applicable","Glioblastoma","Clinical Trial","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 82 samples sequenced, 34 subjects, 82 samples","","NINDS","GRU --- General Research Use","2021-02-25","2021-02-25","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002205.v1.p1","Center for Common Disease Genomics [CCDG] - Inflammatory Bowel Disease    (IBD) - Global Microbiome Conservancy Host Exomes","The human body is a complex ecosystem, hosting tens of billions of bacteria, primarily in the gut. This community, known as the 'gut microbiome', is vital to human health, affecting  functions ranging from metabolism, immunity, and development, to behavior. Conversely, reduced microbiome diversity and other imbalances of the gut","Not Applicable","Microbiota","Cross-Sectional","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU)","2021-02-24","","Not Provided",""
"phs001790.v2.p1","NIMH Human Middle Temporal Gyrus (MTG) Cell Types","Elucidating the cellular architecture of the human neocortex is central to understanding our cognitive abilities and susceptibility to disease. In this study, we applied single nucleus RNA sequencing to perform  a comprehensive analysis of cell types in the middle temporal gyrus of human cerebral cortex. We identify a highly diverse set of excitatory and","Not Applicable","Cerebral Cortex","Cross-Sectional","Not Provided","Not Provided","Not Provided","","NIMH","","2021-02-23","","Not Provided",""
"phs002057.v1.p1","Systems genetics in human endothelial cells identifies non-coding    variants modifying enhancers, expression, and complex disease traits","Identification of causal variants and mechanisms underlying complex disease traits in humans requires strategies to locate and fine-map functional regulatory variants in disease-relevant cell types. To discover functional regulatory variants  in primary aortic endothelial cells (ECs) from humans, we collected genetic, transcriptomic, and four epigenomic phenotypes in a population of 153","Not Applicable","Endothelial Cells","Control Set","WES_markerset_grc37","SNP Genotypes (Array)","5 phenotype datasets, 16 variables, 1 molecular datasets, 153 subjects, 167 samples","European (69), East Asian (3), African American (14), Hispanic1 (1), Hispanic2 (62), Other Asian or Pacific Islander (2), South Asian (1), Other (1)","NHLBI","GRU-PUB --- General Research Use (PUB)","2021-02-23","2021-02-23","Not Provided",""
"phs001860.v1.p1","Genetics and Pathophysiology of Autoinflammatory Disorders","In this study, patients with suspected disorders of inflammation and innate immune system dysregulation will undergo whole exome sequencing. This will involve both family studies (often trios or multiplex families  including affected and unaffected individuals) and sporadic cases. The overall objective is to discover rare/novel high-penetrance mutations in genes","Not Applicable","Hereditary Autoinflammatory Diseases","Prospective Longitudinal Cohort","Not Provided","WXS","5 phenotype datasets, 20 variables, 206 samples sequenced,  SRA, 206 subjects, 206 samples","","NHGRI","GRU --- General Research Use","2021-02-23","2021-02-23","Cryopyrin-Associated Periodic Syndromes; Familial Mediterranean Fever; Periodic fever, familial, autosomal dominant; Stomatitis, Aphthous; Amyloid nephropathy with deafness and urticaria; CAPS2",""
"phs002327.v1.p1","Therapeutic Targeting of ATR Yields Durable Regressions in High    Replication Stress Tumors","Patients with relapsed or recurrent small cell lung cancer or extra-pulmonary small cell cancers were enrolled on an investigator-initiated, single-arm, phase 2 trial (NCT02487095) combining an ATR inhibitor M6620 (VX-970,  berzosertib) administered at 210 mg/m2 intravenously over 60 minutes on day 2 and day 5, and topotecan 1.25 mg/m2 intravenously over 30 minutes every","Not Applicable","Small Cell Lung Carcinoma","Clinical Trial","RNAseq_gene_transcripts, other","RNA-Seq, SNV (.MAF), RNA Seq (NGS), MAF (NGS), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets, 24 samples sequenced, 24 subjects, 24 samples","","NCI","GRU --- General Research Use","2021-02-22","2021-02-22","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002319.v1.p1","International Verapamil SR/Trandolapril [INVEST] Genes Study","INternational VErapamil SR-Trandolapril STudy (INVEST) was a prospective, multicenter, randomized, open-label, parallel-clinical trial that evaluated blood pressure response and adverse outcomes in patients randomized to either an atenolol-based or a  verapamil SR-based hypertension treatment strategy in 22,576 patients with documented coronary artery disease and hypertension (PMID:","Not Applicable","Heart Diseases","Clinical Trial","HumanOmniExpressExome-8","SNP Genotypes (Array)","4 phenotype datasets, 26 variables, 1 molecular datasets, 1529 subjects, 1529 samples","European (770), African (11), East Asian (1), African American (217), Hispanic1 (386), Hispanic2 (69), South Asian (1), Other (74)","NIGMS","GRU --- General Research Use","2021-02-19","2021-02-19","Heart Disease; Hypertension; Cardiac Disease; Cardiac Diseases; Cardiac Disorder; Cardiac Disorders","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001140.v1.p1","ALCHEMIST Study","The ALCHEMIST study will accrue patients that are potentially eligible for the Intergroup adjuvant studies and perform central EGFR and ALK genotyping using a central reference laboratory certified by the  Clinical Laboratory Improvement Amendments of 1988 (CLIA). Patients may either present prior to surgery with resectable NSCLC, may present following","Not Applicable","Carcinoma, Non-Small-Cell Lung","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables,  SRA, 5731 subjects, 5731 samples","","NCI","GRU --- General Research Use","2021-02-17","2021-02-17","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001422.v2.p1","GEnomics and Transcriptomics of Human INsulinoma (GETHIN)","The Genomics and Transcriptomics of Human Insulinoma (GETHIN) The common forms of diabetes - Types 1 and 2 - ultimately result from a deficiency of insulin-producing pancreatic beta cells. The  Genomics and Transcriptomics of Human Insulinoma (GETHIN) study was performed in order to identify novel approaches to inducing human pancreatic beta","Not Applicable","Insulinoma","Case-Control","WES_markerset_grc37, target_markerset_grc37, WES_markerset_grc38","RNA-Seq, Methylome sequencing, SNP Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 2 molecular datasets, 26 samples sequenced,  SRA, 36 subjects, 46 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2021-02-16","2021-02-16","Adenoma, beta Cell; Adenoma, beta-Cell; Adenomas, beta-Cell; Insulinomas; Insuloma; Insulomas",""
"phs001984.v1.p1","GWAS for Membranous Nephropathy","Primary membranous nephropathy (MN) is a rare autoimmune cause of kidney failure. This dataset is from a genome-wide association study (GWAS) designed to identify novel genetic risk loci for MN.  The provided cohort (named as European-1 Cohort) is composed of 611 cases of primary MN and 1,246 healthy controls of European ancestry. This cohort","Not Applicable","Glomerulonephritis, Membranous","Case-Control","MEGA_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 1857 subjects, 1857 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2021-02-11","2021-02-11","Chronic nephritic syndrome, diffuse membranous glomerulonephritis; Extramembranous Glomerulopathy; Extramembranous glomerulonephritis; Glomerulonephritides, Membranous; Glomerulonephropathy, Membranous; Glomerulopathy, Extramembranous",""
"phs002040.v1.p1","Homozygous IL37 Mutation Leads to Infantile Inflammatory Bowel Disease","Whole-exome sequencing of a trio (parents and offspring) reveals IL37 mutation leads to infantile IBD. Inclusion criteria: Patients known to have or suspected of having an inherited disease of the  immune system are be eligible for enrollment. Because of the intensive time and labor required for research laboratory testing, patients are enrolled","Not Applicable","Inflammatory Bowel Diseases","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 18 variables, 1 molecular datasets, 3 subjects, 3 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2021-02-10","2021-02-10","",""
"phs002039.v1.p1","scRNA-Seq Analysis of Influenza Infected Upper Airway Patient Samples","This observational study was designed to determine the cellular tropism of Influenza A and B Viruses (IAV, IBV) from samples taken from the upper respiratory tract collected during routine nasal  washes during the 2017-2018 season. Using single-cell RNA sequencing (scRNA-seq) we sought to determine which cell types could be infected, what the","Not Applicable","Influenza, Human","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","5 phenotype datasets, 32 variables, 1 molecular datasets, 175 samples sequenced,  SRA, 18 subjects, 35655 samples","","NIAID","DS-RVI --- Disease-Specific (Respiratory Viral Infections)","2021-02-10","2021-02-10","Flu; Flu, Human; Grippe; Human Flu; Human Influenza; Human Influenzas",""
"phs002037.v1.p1","Methylation Biomarker Study of Magnesium Deficiency and Colorectal Cancer","Five US studies using the Mg tolerance test, the ""gold standard"" test of Mg status, indicated that 50% participants had Mg deficiency. In our ongoing US trial, we have found  a similar result. In growing recognition of the importance of Mg in human health, very recently, Mg was selected by the US Federal Dietary Reference","Not Applicable","Magnesium Deficiency","Clinical Trial","MethylationEPIC","Methylation (CpG)","4 phenotype datasets, 16 variables, 1 molecular datasets, 238 subjects, 476 samples","","NCI","GRU --- General Research Use","2021-02-10","2021-02-10","DNA Methylation; Deficiencies, Magnesium; Deficiency, Magnesium; Magnesium Deficiencies","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002075.v1.p1","Fetal Chorioamniotic Membranes Show Molecular Changes in Placenta Previa    and Placenta Accreta Spectrum","Placenta previa and the placenta accreta spectrum (PAS) are understudied pregnancy disorders with serious consequences for both mother and infant. To better understand the molecular and cellular etiologies of these  diseases, we performed 3SEQ of formalin-fixed paraffin-embedded (FFPE) fetal chorioamniotic membrane samples from PAS, previa, and gestationally","Not Applicable","Placenta Previa","Clinical Genetic Testing","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 13 samples sequenced,  SRA, 12 subjects, 13 samples","","NICHD","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2021-02-09","2021-02-09","Fetal Membranes, Premature Rupture; Placenta Accreta; Premature Birth; Membrane Premature Rupture (Pregnancy); Membrane Premature Ruptures (Pregnancy); PROM (Pregnancy)",""
"phs002290.v1.p1","Tumor Fraction Guided Cell-Free DNA Profiling in Metastatic Cancer    Patients","Cell-free DNA (cfDNA) profiling is increasingly used to guide cancer care, yet mutations are not always identified. The ability to detect somatic mutations in plasma depends on both assay sensitivity  and the fraction of circulating DNA in plasma that is tumor-derived (i.e cfDNA tumor fraction). We hypothesized that cfDNA tumor fraction could","Not Applicable","Cell-Free Nucleic Acids","Tumor vs. Matched-Normal","Not Provided","WGS, WXS","4 phenotype datasets, 13 variables, 131 samples sequenced, 118 subjects, 131 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2021-02-05","2021-02-05","Not Provided","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002083.v1.p1","Role of Tobacco Smoke in Clear Cell Renal Cell Carcinoma","Background. Clear cell renal cell carcinoma (ccRCC) is the most common histologically defined renal cancer. However, it is not a uniform disease and includes several genetic subtypes with different prognoses.  ccRCC is also characterized by distinguished metabolic reprogramming. Tobacco smoking (TS) is an established risk factor for ccRCC with unknown","Not Applicable","Carcinoma, Renal Cell","Collection","Not Provided","RNA-Seq","4 phenotype datasets, 22 variables, 50 samples sequenced, 32 subjects, 50 samples","","NCI","GRU --- General Research Use","2021-02-05","2021-02-05","ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal Cell","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001748.v1.p1","Molecular Genetics of Histiocytic Sarcoma","This is a comprehensive genomic analysis of a rare set of histiocytic sarcomas from the consult service of the Hematopathology section of the Laboratory of Pathology, NCI, NIH. The study  identifies two distinct groupings of these tumors based on the site of disease, their mutational spectrum, and proliferation signature. All archived","Not Applicable","Histiocytic Sarcoma","Case Set","RNAseq_probe_set_grc37, WES_markerset_grc37","RNA-Seq, SNV (.MAF), RNA Seq (NGS), WXS","4 phenotype datasets, 15 variables, 2 molecular datasets, 44 samples sequenced, 25 subjects, 54 samples","","NCI","GRU --- General Research Use","2021-02-05","2021-02-05","Histiocytic Lymphoma, True; Histiocytic Lymphomas, True; Histiocytic Sarcomas; Histiocytoses, True Malignant; Histiocytosis, True Malignant; Lymphoma, True Histiocytic","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001857.v1.p1","Genetics of Mammographic Density in Ashkenazi Jews","Mammographic density (MD) is a strong risk factor for breast cancer and is also a highly heritable trait with 60-70% of the variance due to genetic factors, based on twin  studies. MD is also higher in families with a strong history of breast cancer. Genome-wide association studies (GWAS), which focus on common genetic","Not Applicable","Breast Density","Cross-Sectional","Multi-Ethnic_Global","SNP Genotypes (Array)","5 phenotype datasets, 46 variables, 1 molecular datasets, 677 subjects, 677 samples","European (667), African American (1), Hispanic2 (3), Other Asian or Pacific Islander (1), Other (5)","NCI","DS-MDBRCA-MDS --- Disease-Specific (Mammographic Density and Breast Cancer Risk, MDS)","2021-02-03","2021-02-03","Mammographic Breast Density; Breast Densities, Mammographic; Breast Density, Mammographic; Density, Mammographic; Mammographic Breast Densities; Mammographic Densities",""
"phs001981.v1.p1","NIAAA Postmortem Prefrontal Cortex eQTL and mQTL Study","Mapping expression and methylation quantitative trait loci (eQTLs and mQTLs) using genome-wide genotype, transcriptome, and DNA methylome data can provide an unbiased approach to identify novel functional variants. One critical  issue of the eQTL/mQTL analysis is that the role of genetic variants in regulating gene expression (or DNA methylation) can be tissue- or","Not Applicable","Alcoholism","Case-Control","custom_markerset","SNP Genotypes (NGS)","5 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 48 subjects, 48 samples","","NIAAA","DS-ALC-IRB-NPU --- Disease-Specific (Alcoholism, IRB, NPU)","2021-02-01","2021-02-01","ALCOHOL DEPENDENCE, PROTECTION AGAINST; Addiction, Alcohol; Addictive alcohol use; Alcohol Addiction; Alcohol Dependence; Alcohol dependence syndrome",""
"phs001501.v1.p1","Impact of Race and Genetic Factors on Beta Blocker Effectiveness in HF","Heart Failure (HF) continues to be an enormous public health problem, despite the many advances in its pharmacotherapy over the past 25 years. The availability of multiple therapeutic options for  HF requires individualization of therapy. However, there are currently insufficient tools to guide the optimal selection of therapy. The expansion of","Not Applicable","Heart Failure","Prospective Longitudinal Cohort","Axiom_Biobank_plus","SNP Genotypes (Array)","4 phenotype datasets, 23 variables, 1 molecular datasets, 1117 subjects, 1076 samples","European (519), African (7), East Asian (3), African American (511), Hispanic1 (14), Hispanic2 (11), Other Asian or Pacific Islander (2), South Asian (6), Other (3)","NHLBI","DS-HF-IRB --- Disease-Specific (Heart Failure, IRB)","2021-02-01","2021-02-01","Cardiac Failure; Cardiac insufficiency; HF - Heart failure; Weak heart; failure, heart; insufficiency, Cardiac",""
"phs001976.v2.p1","Natural History, Pathogenesis and Outcome of Melorheostosis","Melorheostosis is a rare osteosclerotic disease resulting in exuberant excessive bone growth with a characteristic radiographic appearance often described as ""dripping candle wax"". As a result of these bony formations,  patients report mild to moderate pain that interferes with their routine activities. It is usually diagnosed on radiographs but bone biopsy may be","Not Applicable","Melorheostosis","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 60 samples sequenced,  SRA, 12 subjects, 60 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2021-01-29","2020-03-18","Candle wax disease; Flowing hyperostosis; Leri's disease; Melorheostosis of Leri; Osteopathia hyperostotica congenita; Rheostosis",""
"phs002062.v1.p1","Polygenic Risk Score for the Prediction of Breast Cancer Is Related to    Lesser Terminal Duct Lobular Unit Involution of the Breast","The Susan G. Komen Tissue Bank (KTB) at the Indiana University Simon Cancer Center is an annotated biobank, which has recruited healthy women who provided demographic, lifestyle, and cancer-related information  via self-administered questionnaire, blood samples and normal breast tissues. H&E slides of the normal breast tissues were scanned for image analysis","Not Applicable","Breast Neoplasms","Cross-Sectional","Not Provided","Not Provided","4 phenotype datasets, 25 variables, 1089 subjects, 1089 samples","","NCI","DS-BRCA --- Disease-Specific (Breast Cancer)","2021-01-28","2021-01-28","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001962.v1.p1","Genomic Profiling of Peripheral T-cell Lymphoma","Peripheral T-cell lymphomas (PTCLs) are malignant and highly aggressive hematologic tumors arising from mature post-thymic T cells. The diagnosis of PTCL includes diverse lymphoma subgroups, altogether accounting for about 15%  of all non-Hodgkin lymphomas. Despite recent advances in uncovering the mutational landscape of PTCLs, the prognoses of most PTCLs remain poor. To","Not Applicable","Lymphoma, T-Cell, Peripheral","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 12 variables, 20 samples sequenced,  SRA, 20 subjects, 20 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2021-01-28","2021-01-28","Lymphoma, Non-Hodgkin; Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum Cell Sarcomas; Reticulum cell sarcoma morphology",""
"phs000584.v1.p1","The Longevity Genes Project","Aging is a complex, universal condition leading to the functional decline of all cells and organisms, and to major national and global public health problems. Although aging is the major  risk factor for developing most adult-onset diseases, systematic investigations into the fundamental physiology, biology and genetics of aging are","Not Applicable","Longevity","Case-Control","HumanOmniExpress-12, imputation_panel","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","5 phenotype datasets, 31 variables, 2 molecular datasets, 2140 subjects, 2235 samples","","NIA","GRU --- General Research Use","2021-01-28","2021-01-28","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs002298.v1.p1","Genome-wide association study of skin pigmentation in African Americans","Genome-wide association study of skin pigmentation in African Americans Major genes linked to pigmentation traits, such as skin color, eye color, tanning, and hair color, have been identified, but unidentified  population-specific variants affecting skin pigmentation variation in African Americans and other African descent populations may exist. The goal of","Not Applicable","Skin Pigmentation","Cross-Sectional","custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 395 subjects, 395 samples","African (38), African American (349), Hispanic1 (3), Hispanic2 (1), Other (4)","NHGRI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2021-01-27","2021-01-27","Not Provided",""
"phs001744.v1.p1","Genome-Wide Association Study of HCC in Non-Asian USA Population","This GWAS of HCC relied on existing biological and data resources from 7 USA sites and one Canadian site which allows for the integration of genetic and environmental data. Total  of 2199 case patients and 1103 non cancer controls were genotyped. Case patients are defined as patients with pathological or radiological diagnosis","Not Applicable","Liver Neoplasms","Case-Control","HumanOmniExpressExome-8, imputation_panel","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 19 variables, 2 molecular datasets, 3225 subjects, 3352 samples","European (2849), African (1), East Asian (3), African American (147), Hispanic1 (39), Hispanic2 (172), Other Asian or Pacific Islander (3), South Asian (1), Other (10)","NCI","DS-LCCLD-MDS --- Disease-Specific (Liver Cancer and Chronic Liver Disease, MDS), DS-HCC-IRB --- Disease-Specific (Hepatocellular Carcinoma, IRB)","2021-01-27","2021-01-27","Carcinoma, Hepatocellular; Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells",""
"phs001480.v1.p1","Genetics of Chemotherapy Induced Peripheral Neuropathy in N08C1 and N08CB","Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially dose-limiting toxicity of chemotherapy treatment. CIPN severity varies widely between cancer patients, and previous studies had found evidence of genes and  single nucleotide variants (SNV) being associated with CIPN. The goal of this study was to further identify genetic markers and pathways associated","Not Applicable","Peripheral Nervous System Diseases","Case-Control","WGS_markerset_grc37, WES_markerset_grc37","SNP Genotypes (NGS)","4 phenotype datasets, 16 variables, 1 molecular datasets, 274 subjects, 274 samples","","NINR","DS-CA-NPU --- Disease-Specific (Cancer, NPU), DS-PAP-NPU --- Disease-Specific (Paclitaxel-associated pain, NPU)","2021-01-21","2021-01-21","Drug-Related Side Effects and Adverse Reactions; Genetic Association Studies; ADR; ADR - Adverse drug reaction; Adverse Drug Event; Adverse Drug Events",""
"phs002287.v1.p1","Evolution of Resistance in ER+ Breast Cancer","While the combination of endocrine therapy and CDK4/CDK6 inhibitors has been shown to be effective in the metastatic ER+ breast cancer setting, to test whether it is effective in an  earlier stage neoadjuvant setting, the FELINE trial (NCT02712723) was established to test the efficacy of letrozole and ribociclib in a ER-positive,","Not Applicable","Breast Neoplasms","Tumor vs. Matched-Normal","Not Provided","WXS","5 phenotype datasets, 18 variables, 72 samples sequenced, 24 subjects, 72 samples","","NCI","GRU --- General Research Use","2021-01-15","2021-01-15","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002243.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular: PEGASUS-TIMI    54","This study is a part of NHGRI's Center for Common Disease Genomics, which is a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing to  multiple common disease phenotypes. Current estimates anticipate that the CCDG program will sequence approximately 140K whole genomes and 225K whole","Not Applicable","Cardiovascular Diseases","Case-Control","Not Provided","Not Provided","Not Provided","","NHGRI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2021-01-13","","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs001960.v1.p1","Epigenome Wide DNA Methylation Study for Osteoporosis Risk","Osteoporosis is characterized by low bone mineral density (BMD). The advancement of high-throughput technologies and integrative approaches provided an opportunity for deciphering the mechanisms underlying osteoporosis. In this study, we  generated genomic (from whole blood DNA), transcriptomic and methylomic (from peripheral blood monocytes, PBMs), and serum metabolomic datasets from","Not Applicable","Osteoporosis","Case-Control","target_markerset_grc37, WGS_markerset_grc37, RNAseq_probe_set_grc37, custom_probe_set","Legacy Genotypes, Methylome sequencing, SNP Genotypes (NGS), WGS","4 phenotype datasets, 20 variables, 1 molecular datasets, 143 samples sequenced,  SRA, 143 subjects, 143 samples","","NIAMS","HMB-MDS --- Health/Medical/Biomedical (MDS)","2021-01-08","2021-01-08","Age Related Osteoporosis; Age-Related Bone Loss; Age-Related Bone Losses; Age-Related Osteoporoses; Age-Related Osteoporosis; Bone Loss, Age Related",""
"phs002255.v1.p1","Understanding the Biology of Language Impairment through Whole Genome    Sequencing","This study involves the whole genome sequencing of a cohort of 390 individuals assessed for language ability, IQ, and behavior as schoolchildren. The primary goal of the study is to  identify genes, regulatory elements, and pathways which may underlie variation in language ability within an average population.&#x000a0; This study","Not Applicable","Language Development","Collection","custom_markerset","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 39 variables, 1 molecular datasets, 389 subjects, 389 samples","European (365), African American (10), Hispanic1 (1), Hispanic2 (9), Other Asian or Pacific Islander (1), Other (3)","NIDCD","HMB-COL-MDS --- Health/Medical/Biomedical (COL, MDS)","2020-12-23","2020-12-23","Specific Language Disorder; Disorder, Specific Language; Disorders, Specific Language; Impairment, Specific Language; Impairments, Specific Language; Language Disorder, Specific",""
"phs002060.v1.p1","Pharmacogenomic Analysis of Microtubule Targeting Agent Response and    Toxicity","Microtubule targeting agents are commonly prescribed for early and metastatic breast cancer and other solid tumors. However, interindividual variability in microtubule targeting drug response and toxicity can cause limited therapeutic  benefit and impact quality of life. In the present study, genome-wide analyses were performed to investigate how genetic factors can be used to","Not Applicable","Peripheral Nervous System Diseases","Prospective Longitudinal Cohort","WES_markerset_grc38, HumanOmniExpress-12","SNP Genotypes (Array), SNP/CNV Genotypes (NGS)","4 phenotype datasets, 34 variables, 1 molecular datasets, 624 subjects, 624 samples","European (483), African (6), East Asian (8), African American (77), Hispanic1 (13), Hispanic2 (22), Other Asian or Pacific Islander (12), South Asian (1), Other (2)","NCI","HMB --- Health/Medical/Biomedical","2020-12-22","2020-12-22","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001787.v1.p1","Discovery of Colorectal Cancer Susceptibility Genes in High-Risk Families","Colorectal cancer remains one of the most common cancers in the US with 146,970 new diagnoses and 49,920 deaths estimated for 2009. Colon cancer is also one of the most  familial of cancers. Individuals with a first-degree relative with colon cancer have a 2- to 3-fold increased risk, and those with more than one","Not Applicable","Colorectal Neoplasms, Hereditary Nonpolyposis","Case Set","HumanOmniExpressExome-8","SNP Genotypes (Array), WXS","4 phenotype datasets, 17 variables, 1 molecular datasets, 159 samples sequenced,  SRA, 51 subjects, 206 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2020-12-22","2020-12-22","Familial Nonpolyposis Colon Cancer","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001846.v1.p1","Kids First: The Intersection of Childhood Cancer and Birth Defects","Birth defects and childhood cancer share biological pathways that are important for cell growth and division. We propose that sequencing pediatric patients suffering both conditions will allow us to discover  the underlying genes and in turn advance our understanding of the causes of these devastating diseases. 1806 samples were selected for whole genome","Not Applicable","Neoplasms","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables,  SRA, 1805 subjects, 1805 samples","","NCI","GRU --- General Research Use","2020-12-21","2020-12-21","Congenital Abnormalities; Abnormalities, Congenital; Abnormality, Congenital; Birth Defect; Birth Defects; CM - Congenital malformation","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002299.v1.p1","PETAL Network: Outcomes Related to COVID-19 Treated With    Hydroxychloroquine Among Inpatients With Symptomatic Disease (ORCHID)    Trial","ORCHID was a multicenter, blinded, placebo-controlled randomized trial conducted at 34 hospitals in the US between April 2 and June 19, 2020. Adults hospitalized with respiratory symptoms from severe acute  respiratory syndrome coronavirus 2 infection were enrolled, with the last outcome assessment on July 17, 2020. The planned sample size was 510","Not Applicable","COVID-19","Clinical Trial","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 479 subjects, 479 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2020-12-18","2020-12-18","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV","NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs001899.v2.p1","NIAID Centralized Sequencing Program","Investigators at the National Institute of Allergy and Infectious Diseases (NIAID) use next-generation sequencing technologies to help determine genetic contributions to immune diseases. These efforts have increased rates of molecular  diagnosis for a subset of NIAID participants as well as uncovered fundamental insights into the cellular and signaling pathways in host defense and","Not Applicable","Immunologic Deficiency Syndromes","Prospective Longitudinal Cohort","WES_markerset_grc37, WES_markerset_grc38","Custom targeted DNA sequencing, SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 21 variables, 2 molecular datasets, 1880 samples sequenced,  SRA, 1940 subjects, 1880 samples","","NIAID","GRU --- General Research Use","2020-12-18","2020-12-18","Autoimmune Diseases; Bronchiectasis; Mastocytosis; Bronchiectases; Permanent enlargement of the airways of the lungs; Polynesian bronchiectasis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002279.v1.p1","DNA and RNA Sequencing of Single Human Haploid Germ Cells","Our goal was to look at allele-specific gene expression in single spermatids from two human donors. We first genotyped and phased each donor using a combination of linked-read sequencing (one  sample per donor, 10X Chromium), and single haploid whole genome sequencing (53 spermatids for the first donor, and 19 for the second). We then","Not Applicable","Germ Cells","Case Set","Not Provided","RNA-Seq, WGA, WGS","4 phenotype datasets, 13 variables, 540 samples sequenced, 2 subjects, 540 samples","","NICHD","GRU --- General Research Use","2020-12-17","2020-12-17","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002105.v1.p1","Genomics of Opioid Pharmacogenomics and Acute/Chronic Postsurgical Pain    after Major Surgery in Children","Pain management after surgery is not optimal, partly due to great interindividual variability in pain perception and coping. This can lead to persistent pain beyond the healing period and disability.  Up to two-thirds of the inter-individual variability results from genetic variations in pain perception as well as response to the pain medicine. The","Not Applicable","Opioid-Related Disorders","Prospective Longitudinal Cohort","HumanOmni5Exome-4","SNP Genotypes (Array)","4 phenotype datasets, 24 variables, 1 molecular datasets, 219 subjects, 219 samples","European (182), African (4), East Asian (1), African American (19), Hispanic1 (5), Hispanic2 (2), Other Asian or Pacific Islander (3), South Asian (2), Other (1)","NICHD","HMB-IRB --- Health/Medical/Biomedical (IRB)","2020-12-17","2020-12-17","Pain, Postoperative; Addiction, Opiate; Dependence, Opiate; Opiate Addiction; Opiate Dependence; Opioid Related Disorders",""
"phs002286.v1.p1","A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7    for HPV-Associated Cancers","This is a phase I clinical trial testing the safety and efficacy of gene-engineered T cells expressing a T-cell receptor targeting an HLA-A 02:01-restricted epitope of HPV-16 E7 (E7 TCR  T cells) in patients with metastatic HPV-16+ epithelial cancers. A total of 12 patients were treated. The maximum tested dose was tolerated. Side","Not Applicable","Neoplasms","Clinical Trial","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 21 variables, 17 samples sequenced, 6 subjects, 17 samples","","NCI","GRU --- General Research Use","2020-12-16","2020-12-16","Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Otorhinolaryngologic Diseases; Virus Diseases; Genitourinary Disease, Male; Genitourinary Diseases, Male","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002161.v1.p1","Kids First: Genomic Analysis of Esophageal Atresia and Tracheoesophageal    Fistulas and Associated Congenital Anomalies","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by the  NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella Miller","Not Applicable","Tracheoesophageal Fistula","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 410 subjects, 410 samples","","NCI","GRU --- General Research Use","2020-12-16","2020-12-16","Abnormal connection between trachea and esophagus; Abnormal connection between trachea and oesophagus; Esophageal Atresia and/or Tracheoesophageal Fistula; Esophagotracheal Fistula; Esophagotracheal Fistulas; Fistula, Esophagotracheal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002071.v1.p1","Multimodal Mapping of the Immune Landscape in Human Pancreatic Cancer","Pancreatic ductal adenocarcinoma (PDA) is characterized by an immune-suppressive tumor microenvironment that has rendered it largely refractory to immunotherapy. We used single-cell RNA sequencing on patient tumors and matched blood,  and we uncovered a previously unappreciated, complex environment of immune-suppressive cellular interactions. These experiments reveal immune","Not Applicable","Carcinoma, Pancreatic Ductal","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","3 phenotype datasets, 18 variables, 41 samples sequenced,  SRA, 25 subjects, 41 samples","","NCI","HMB --- Health/Medical/Biomedical","2020-12-14","2020-12-14","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001758.v1.p1","Identification of Rare Germline Variants in Familial Patients with    Non-medullary Thyroid Cancer","As the most common malignancy of the endocrine system, thyroid cancer is classified into two major categories, non-medullary thyroid cancer (NMTC) and medullary thyroid cancer (MTC) according to the origins  and clinical features. NMTC includes papillary thyroid cancer (PTC), follicular thyroid cancer (FTC), and anaplastic thyroid cancer (ATC). Sporadic","Not Applicable","Thyroid Cancer, Papillary","Case Set","Not Provided","WGS","5 phenotype datasets, 18 variables, 10 samples sequenced, 10 subjects, 10 samples","","NCI","GRU --- General Research Use","2020-12-14","2020-12-14","Cancer, Papillary Thyroid; Cancers, Papillary Thyroid; Carcinoma, Papillary Thyroid; Carcinomas, Papillary Thyroid; Familial Papillary Thyroid Carcinoma; NONMEDULLARY THYROID CARCINOMA, PAPILLARY","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002008.v1.p1","The Epigenomic Atlas of Early Human Craniofacial Development","Parallel profiling of six distinct histone modifications via ChIP-Seq in craniofacial tissue samples from individual human embryos was performed. Epigenomic marks imputed with ChromImpute and a 25-state chromatin state model  of uniformly processed epigenomic data was produced through ChromHMM. Samples were obtained from the MRC-Wellcome Trust Human Developmental Biology","Not Applicable","Embryonic and Fetal Development","Control Set","Not Provided","ChIP-Seq, RNA-Seq","5 phenotype datasets, 16 variables, 118 samples sequenced,  SRA, 22 subjects, 118 samples","","NIDCR","HMB --- Health/Medical/Biomedical","2020-12-10","2020-12-10","Congenital Abnormalities; Abnormalities, Congenital; Abnormality, Congenital; Birth Defect; Birth Defects; CM - Congenital malformation",""
"phs001518.v1.p1","Translational Research Investigating Underlying disparities in acute    Myocardial infarction Patients' Health status (TRIUMPH)","The Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health status (TRIUMPH) cohort is a cohort of 4340 patients prospectively enrolled after hospitalization for acute myocardial infarction (AMI)  between June 1, 2005, and December 31, 2008 from 24 U.S. hospitals. Consenting patients had detailed chart abstractions of their medical history and","Not Applicable","Myocardial Infarction","Prospective Longitudinal Cohort","MEGA_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 1 molecular datasets, 2579 subjects, 2579 samples","European (1684), African (28), East Asian (9), African American (622), Hispanic1 (79), Hispanic2 (110), Other Asian or Pacific Islander (5), South Asian (20), Other (22)","NINR","DS-MI --- Disease-Specific (Myocardial Infarction)","2020-12-10","2020-12-10","Age at Onset; Age-at-Onset; Onset Age; Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes",""
"phs001831.v1.p1","Elucidating Transcription Regulation by Epigenetics in Neuroblastoma","PURPOSE Whole-genome profiles of the epigenetic modification 5-hydroxymethylcytosine (5-hmC) are robust diagnostic biomarkers in adult patients with cancer. We investigated if 5-hmC profiles would serve as novel prognostic markers in  neuroblastoma, a clinically heterogeneous pediatric cancer. Because this DNA modification facilitates active gene expression, we hypothesized that","Not Applicable","Neuroblastoma","Prospective Longitudinal Cohort","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 32 variables, 287 samples sequenced,  SRA, 189 subjects, 287 samples","","NCI","GRU --- General Research Use","2020-12-09","2020-12-09","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000510.v1.p1","Study of Osteoporotic Fractures (SOF)","The Study of Osteoporotic Fractures (SOF) is a prospective multicenter study of risk factors for vertebral and non vertebral fractures. The cohort is comprised of 9704 community-dwelling women 65 years  old or older recruited from populations-based listings in four U.S. areas: Baltimore, Maryland; Minneapolis, Minnesota; Portland, Oregon; and the","Not Applicable","Osteoporosis","Prospective Longitudinal Cohort","HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 120 variables, 1 molecular datasets, 3625 subjects, 3778 samples","European (3614), East Asian (4), Hispanic1 (3), Hispanic2 (2), Other Asian or Pacific Islander (1), Other (1)","NIAMS","DS-AGR1-RD --- Disease-Specific (Aging Related 1, RD)","2020-12-08","2020-12-08","Osteoarthritis; Sleep; Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides",""
"phs002172.v1.p1","Gabriella Miller Kids First Pediatric Research Project in Microtia in    Hispanic Populations","Microtia is a rare congenital deformity of the external ear, the pinna. The severity of microtia is variable and ranges from subtle deformities in the pinna to absence of the  external ear. Microtia is often associated with closure of the external auditory ear canal causing significant hearing loss. Microtia can be an","Not Applicable","Congenital Microtia","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 403 subjects, 403 samples","","NICHD","GRU --- General Research Use","2020-12-04","2020-12-04","Microtia-Anotia; Bilateral microtia; Hypoplasia of the external ear; Hypoplastic ears; Hypoplastic pinna; Hypoplastic pinnae",""
"phs002019.v1.p1","WES and RNA-Seq Analysis in Paired Sun-Exposed Epidermis and SCCIS    Samples","Squamous cell carcinoma in situ (SCCIS) is a prevalent precancerous lesion that can progress to cutaneous squamous cell carcinoma (cSCC). Although SCCIS is common, its pathogenesis remains poorly understood. To  better understand SCCIS development, we performed laser-captured microdissection of human SCCIS and adjacent epidermis to isolate genomic DNA and RNA","Not Applicable","Carcinoma in Situ","Case-Control","WES_markerset_grc38","RNA-Seq, SNP Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 22 samples sequenced,  SRA, 11 subjects, 22 samples","","NCI","HMB --- Health/Medical/Biomedical","2020-12-04","2020-12-04","Cancer in situ; Carcinoma, Intraepithelial; Carcinoma, Preinvasive; Intraepithelial Carcinoma; Non-invasive Carcinoma; Preinvasive Carcinoma","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001584.v2.p2","eMERGE Network Phase III: HRC Imputed Array Data","The Electronic Medical Records and Genomics (eMERGE) Network is a National Institutes of Health (NIH)-organized and funded consortium of U.S. medical research institutions. The primary goal of the eMERGE Network  is to develop, disseminate, and apply approaches to research that combine biorepositories with electronic medical record (EMR) systems for genomic","Not Applicable","Electronic Health Records","Case-Control","imputation_panel","SNP Genotypes (imputed)","8 phenotype datasets, 77 variables, 39 documents, 1 molecular datasets, 104874 subjects, 104703 samples","European (62164), African (222), East Asian (478), African American (15386), Hispanic1 (2218), Hispanic2 (1886), Other Asian or Pacific Islander (295), South Asian (327), Other (616)","NHGRI","GRU --- General Research Use, HMB-GSO --- Health/Medical/Biomedical (GSO), GRU-IRB-PUB-GSO --- General Research Use (IRB, PUB, GSO), GRU-IRB-NPU --- General Research Use (IRB, NPU), HMB --- Health/Medical/Biomedical, HMB-MDS --- Health/Medical/Biomedical (MDS), DS-CHILDD --- Disease-Specific (Childhood Diseases), DS-DEM --- Disease-Specific (Dementia), HMB-PUB-GSO --- Health/Medical/Biomedical (PUB, GSO), GRU-IRB-PUB --- General Research Use (IRB, PUB)","2020-12-03","2020-12-03","Aortic Aneurysm, Abdominal; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Carotid Artery Diseases; Colonic Polyps",""
"phs001700.v1.p1","Exome Sequencing of Large Multiethnic Population of Moyamoya Patients","We report a significant advance in Moyamoya disease (MMD) research through our unique access to a large MMD patient population combined with high depth exome sequencing and bioinformatics. We confirm  a reported RNF213 founder mutation (FM), provide evidence for its ethnic specificity and identify novel variants in other genes that associate with","Not Applicable","Moyamoya Disease","Case-Control","Not Provided","WXS","4 phenotype datasets, 16 variables, 124 samples sequenced,  SRA, 124 subjects, 124 samples","","NINDS","GRU --- General Research Use","2020-12-01","2020-12-01","Cerebrovascular Moyamoya Disease; Disease, Moya-Moya; Idiopathic Moyamoya disease; MYMY; Moya Moya Disease; Moya-Moya Disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001182.v2.p1","National Institute of Environmental Health (NIEHS) Sciences Study of    Somatic Mutation Load in Clones of Single Human Cells","Accumulation of genetic changes with time and proliferation of cells is inevitable. We report here the genome-wide magnitude and spectra of mutations accrued in skin fibroblasts over the lifetime of  healthy humans. We found that every cell contains at least one somatic chromosomal rearrangement and 600 - 13,000 base substitutions, similar to the","Not Applicable","Clonal Evolution","Control Set","Somatic_Variant","SNV (.MAF), WGS, WXS","4 phenotype datasets, 19 variables, 1 documents, 1 molecular datasets, 92 samples sequenced,  SRA, 21 subjects, 92 samples","","NIEHS","GRU --- General Research Use","2020-11-25","2016-10-27","Evolution, Clonal","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002006.v2.p1","Segmental Overgrowth/Vascular Anomalies/Dermatologic Disorders","This study was designed to determine the molecular etiology of disorders characterized by segmental overgrowth, vascular anomalies, or dermatologic conditions that are part of the diagnostic criteria for Proteus syndrome  or PIK3CA-related overgrowth spectrum (PROS). Somatic variants in AKT1 or PIK3CA have been identified as causative for Proteus syndrome and PROS","Not Applicable","Proteus Syndrome","Case Set","target_markerset_grc37","SNP Genotypes (NGS), Targeted-Capture","4 phenotype datasets, 13 variables, 1 molecular datasets, 29 samples sequenced,  SRA, 27 subjects, 29 samples","","NHGRI","HMB --- Health/Medical/Biomedical","2020-11-24","2020-07-06","ELATTOPROTEUS SYNDROME; Elephant Man Disease; GIGANTISM, PARTIAL, OF HANDS AND FEET, NEVI, HEMIHYPERTROPHY, AND MACROCEPHALY; Hemihypertrophy and macrocephaly; Macrocephaly mesodermal hamartoma spectrum; PROTEUS SYNDROME, SOMATIC",""
"phs002067.v1.p1","Temporal Lobe Epilepsy and Retrotransposons","Idiopathic (cryptogenic) epilepsy is a common, chronic group of brain disorders, affecting 1-2% of the US population, creating a significant public health problem because of the associated morbidity and mortality.  One subtype of this complex group of brain disorders, temporal lobe epilepsy (TLE), is particularly burdensome, because a substantial fraction of","Not Applicable","Epilepsy, Temporal Lobe","Case-Control","target_markerset_grc38","CNV (NGS), Tn-Seq","4 phenotype datasets, 17 variables, 1 molecular datasets, 66 samples sequenced,  SRA, 66 subjects, 66 samples","","NINDS","GRU-PUB-NPU --- General Research Use (PUB, NPU), DS-EP-PUB-NPU-GSO --- Disease-Specific (Epilepsy, PUB, NPU, GSO)","2020-11-23","2020-11-23","Benign Psychomotor Epilepsy, Childhood; Childhood Benign Psychomotor Epilepsy; Epilepsy, Benign Psychomotor, Childhood",""
"phs002202.v1.p1","A New High-Throughput Sequencing-Based Technology to Study    Heterochromatin Structure","In this study we report epigenomic and transcriptomics datasets for normal control fibroblasts. The following cell lines were obtained from the NIGMS Human Genetic Cell Repository at the Coriell Institute  for Medical Research: AG08498, AG07095, originally collected as part of the NIA Aging Cell Repository study. We applied a high-throughput","Not Applicable","Healthy Volunteers","Control Set","Not Provided","ChIP-Seq, RNA-Seq, WGS","3 phenotype datasets, 11 variables, 10 samples sequenced,  SRA, 2 subjects, 10 samples","","NIA","GRU --- General Research Use","2020-11-20","2020-11-20","Not Provided","Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs002244.v1.p1","A Model for Predicting Response to PD-1 Inhibitors in NSCLC","Whole exome sequencing was used to examine the impact of human leukocyte antigen B44 in a non-small cell lung cancer cohort treated with single agent pembrolizumab with over five years  of follow-up. Study participants were treated on clinical trials with single-agent pembrolizumab at the University of California, Los Angeles who","Not Applicable","Carcinoma, Non-Small-Cell Lung","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 26 variables, 66 samples sequenced, 33 subjects, 66 samples","","NCI","DS-CA-IRB-PUB-NPU --- Disease-Specific (Cancer, IRB, PUB, NPU)","2020-11-19","2020-11-19","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER",""
"phs002197.v1.p1","Single Cell and Tissue Level Functional Genomics Analysis of    Astrocyte-Related Mechanisms in Taupathy","This data is the first part of a larger single cell and tissue level functional genomics analysis of dementias with tau pathology. &#x000a0;Cellular resolution will clarify the role of glial  genes and pathways in neurodegenerative disease. This includes understanding the role of microglia and astrocytes in neurodegenerative disorders","Not Applicable","Pick Disease of the Brain","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 22 variables, 16 samples sequenced, 16 subjects, 16 samples","","NINDS","GRU --- General Research Use","2020-11-18","2020-11-18","Frontotemporal Dementia; Complex, Disinhibition-Dementia-Parkinsonism-Amyotrophy; Complex, Disinhibition-Dementia-Parkinsonism-Amytrophy; Complices, Disinhibition-Dementia-Parkinsonism-Amyotrophy; Complices, Disinhibition-Dementia-Parkinsonism-Amytrophy; DDPAC","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001616.v2.p2","eMERGE Network Phase III Clinical Sequencing: eMERGEseq Panel","The Electronic Medical Records and Genomics (eMERGE) Network is a National Institutes of Health (NIH)-organized and funded consortium of U.S. medical research institutions. The primary goal of the eMERGE Network  is to develop, disseminate, and apply approaches to research that combine biorepositories with electronic medical record (EMR) systems for genomic","Not Applicable","Precision Medicine","Prospective Longitudinal Cohort","target_markerset_grc37","SNP/CNV Genotypes (NGS), Targeted-Capture","9 phenotype datasets, 70 variables, 1 documents, 1 molecular datasets, 24839 samples sequenced,  SRA, 24944 subjects, 49844 samples","","NHGRI","GRU --- General Research Use, HMB-IRB-PUB --- Health/Medical/Biomedical (IRB, PUB), GRU-IRB --- General Research Use (IRB), GRU-IRB-NPU --- General Research Use (IRB, NPU), GRU-IRB-PUB-NPU --- General Research Use (IRB, PUB, NPU), HMB --- Health/Medical/Biomedical, HMB-GSO --- Health/Medical/Biomedical (GSO), HMB-NPU --- Health/Medical/Biomedical (NPU), GRU-NPU --- General Research Use (NPU)","2020-11-16","2020-11-16","Colonic Polyps; Hyperlipidemias; Lung Neoplasms; Rare Diseases; Breast Cancer; Breast Malignant Neoplasm",""
"phs002130.v1.p1","Gabriella Miller Kids First Pediatric Research Program in Craniofacial    Microsomia","Craniofacial microsomia (CFM), also termed hemifacial microsomia or oculo-auricular-vertebral spectrum, is the third most common congenital craniofacial condition. CFM comprises a variable phenotype and the most common features include malformations  of the ear (i.e. microtia) and lower jaw (i.e. mandibular hypoplasia) on one or both sides. Microtia in the absence of other anomalies is believed to","Not Applicable","Goldenhar Syndrome","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 4 variables, 278 subjects, 278 samples","","NCI","DS-CFD --- Disease-Specific (Craniofacial Disorders)","2020-11-13","2020-11-13","Congenital Microtia; Hemifacial Microsomia; Microtia-Anotia; Bilateral microtia; Hypoplasia of the external ear; Hypoplastic ears",""
"phs000397.v3.p3","NIA Long Life Family Study (LLFS)","The Long Life Family Study (LLFS) is an international collaborative study of the genetics and familial components of exceptional survival, longevity, and healthy aging. Families were recruited through elderly probands  (generally in their 90s) who self-reported on the survival history of their parents and siblings, and on the basis of this information, families","Not Applicable","Longevity","Family/Twin/Trios","HumanOmni2.5-8","SNP Genotypes (Array)","5 phenotype datasets, 123 variables, 11 documents, 1 molecular datasets, 4997 subjects, 5154 samples","European (4673), East Asian (4), African American (16), Hispanic1 (7), Hispanic2 (2), Other Asian or Pacific Islander (1), South Asian (1), Other (3)","NIA","GRU-IRB --- General Research Use (IRB), GRU-IRB-NPU --- General Research Use (IRB, NPU), DS-LARHC-IRB-NPU --- Disease-Specific (Longevity, age-related health conditions, IRB, NPU)","2020-11-10","2014-12-12","Aging; Cardiovascular Diseases; Depression; Diabetes Mellitus; Dyslipidemias; Hypertension",""
"phs002003.v1.p1","University of Washington Developmental Single Cell Atlas","We set out to generate a human cell atlas of both gene expression and chromatin accessibility using tissues obtained during development. In this study, we applied an assay for single  cell profiling of gene expression based on three-level combinatorial indexing (sci-RNA-seq3) to 121 fetal tissue samples representing 15 organs,","Not Applicable","Human Development","Control Set","RNAseq_gene_transcripts","ATAC-seq, RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 10 variables, 1 molecular datasets, 161 samples sequenced, 38 subjects, 221 samples","European (17), African American (7), Hispanic1 (2), Hispanic2 (1), Other Asian or Pacific Islander (3), Other (6)","NICHD","HMB --- Health/Medical/Biomedical","2020-11-05","2020-11-05","Not Provided",""
"phs001761.v1.p1","Genomic Characteristics of MPNs in IR-Exposed Patients","The study ""Genomic Characteristics of Myeloproliferative Neoplasms in Patients Exposed to Ionizing Radiation following the Chernobyl Nuclear Accident"" was designed as case-control study. We studied genomic characteristics of chronic Philadelphia  chromosome-negative myeloproliferative neoplasm (MPNs) in Ukrainian patients who were previously exposed to Ionizing Radiation (IR) due to Chernobyl","Not Applicable","Primary Myelofibrosis","Case-Control","target_markerset_grc38, WES_markerset_grc37","SNV (.MAF), Targeted-Capture, WXS","4 phenotype datasets, 22 variables, 1 molecular datasets, 155 samples sequenced,  SRA, 155 subjects, 155 samples","","NCI","GRU --- General Research Use","2020-11-05","2020-11-05","Acquired primary erythrocytosis; Disease, Osler-Vaquez; Erythremia; Erythremias; Osler Vaquez Disease; Osler-Vaquez Disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002269.v1.p1","A New Pipeline to Predict and Confirm Tumor Neoantigens Predicts Better    Response to Checkpoint Blockade","Mutations that drive oncogenesis in cancer can generate neoantigens that may be recognized by the immune system. Identification of these neoantigens remains challenging due to the complexity of the major  histocompatibility complex (MHC) antigen and T-cell receptor interaction. Here we describe the development of a systematic approach to efficiently","Not Applicable","Antigens, Neoplasm","Case Set","Not Provided","WXS","3 phenotype datasets, 9 variables, 37 samples sequenced, 37 subjects, 37 samples","","NCI","GRU --- General Research Use","2020-11-04","2020-11-04","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001925.v1.p1","Characterization of Clonal Evolution in Microsatellite Unstable    Metastatic Cancers through Multi-Regional Tumor Sequencing","Whole exome sequencing was performed on blood and multiple tumor samples from six patients with known microsatellite unstable tumors. Subclones within each tumor site were identified and within each subclone,  differing microsatellite instability was characterized. Inclusion Criteria: 1) A histologically or cytologically confirmed diagnosis of cancer 2)","Not Applicable","Microsatellite Instability","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 38 samples sequenced, 6 subjects, 38 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2020-11-04","2020-11-04","Clonal Evolution; Evolution, Clonal; Error Phenotype, Replication; Error Phenotypes, Replication; Phenotype, Replication Error; Phenotypes, Replication Error","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002254.v1.p1","Cystic Fibrosis Nasal Epithelium Gene Expression by RNAseq","Cystic fibrosis (CF) is a monogenic disorder leading to multi-organ system dysfunction, with the primary cause of morbidity and mortality being lung disease. Mutations in CFTR result in defective ion  channel transport leading to hyperviscous mucus, airway infection, inflammation and lung function decline. While the Phe508del mutation is the most","Not Applicable","Cystic Fibrosis","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 30 variables, 134 samples sequenced,  SRA, 134 subjects, 134 samples","","NHLBI","DS-CF --- Disease-Specific (Cystic Fibrosis)","2020-11-03","2020-11-03","CF; CF - Cystic fibrosis; Fibrocystic disease; Fibrosis, Cystic; MUCOVISCIDOSIS; cystic fibrosis lung disease, modifier of",""
"phs001892.v1.p1","miRNA Profiling of Maternal and Non-Maternal Healthy Adult Blood Plasma    Using Small RNA-Sequencing","We compared several performance characteristics of four miRNA profiling methods: small RNA-sequencing, HTG EdgeSeq, Abcam FirePlex, and NanoString nCounter. We used pools of synthetic miRNAs and extracellular RNA from healthy  individuals to assess these characteristics. Principal Investigator: Louise Laurent, University of California, San Diego, CA, USA Funding Sources:","Not Applicable","MicroRNAs","Case-Control","Not Provided","miRNA-Seq","4 phenotype datasets, 18 variables, 3 samples sequenced, 13 subjects, 3 samples","","NHLBI","GRU --- General Research Use","2020-11-03","2020-11-03","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001786.v1.p1","SU2C GEMM Trial","The goal of the GEMM Trial is to ascertain if comprehensive and systematic interrogation of a patient's tumor molecular profile improves outcomes compared to the current practice of physician's choice  for metastatic melanoma patients who have progressed following first line therapy. The data shared here includes tumor/normal exome and tumor RNAseq","Not Applicable","Melanoma","Case Set","WES_markerset_grc37, RNAseq_probe_set_grc37","CNV (NGS)","4 phenotype datasets, 17 variables, 2 molecular datasets,  SRA, 36 subjects, 137 samples","","NCI","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2020-11-03","2020-11-03","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs002069.v1.p1","Predictors of Spontaneous Cerebral AVM Hemorrhage","The Predictors of Spontaneous Cerebral AVM Hemorrhage study was designed to identify genetic markers that predict adverse outcomes in brain arteriovenous malformation (BAVM) patients, examine race-ethnicity influences on BAVM hemorrhage  risk, and use genome-wide association analysis to identify novel genetic predictors of AVM and hemorrhage using the Affymetrix GeneChip. We performed","Not Applicable","Intracranial Arteriovenous Malformations","Case Set","","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 338 subjects, 338 samples","European (308), East Asian (1), African American (3), Hispanic1 (5), Hispanic2 (13), Other Asian or Pacific Islander (3), Other (5)","NINDS","DS-AVM-STK-VD --- Disease-Specific (Arteriovenous Malformation, Stroke and related Vascular Diseases)","2020-10-30","2020-10-30","Cerebrovascular Disorders; Intracranial Hemorrhage; Vascular Diseases; Brain Capillary Telangiectasia; Brain Capillary Telangiectasias; Capillary Telangiectasia, Brain",""
"phs002245.v1.p1","Genetic Determinants of Susceptibility to Severe COVID-19 Infection","The goal of the project is to identify genetic susceptibility variants associated with acute COVID-19 infection susceptibility and severity using whole genome sequencing. The target of the project will include  WGS data from whole blood samples of up to approximately 2000 COVID-19 patients (including critical/severe patient subgroup, asymptomatic/mild","Not Applicable","COVID-19","Interventional","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 585 subjects, 594 samples","European (554), African (1), East Asian (3), African American (2), Hispanic1 (7), Hispanic2 (10), Other Asian or Pacific Islander (1), South Asian (3), Other (4)","NIAID","GRU --- General Research Use","2020-10-28","2020-10-28","pediatric multisystem inflammatory disease, COVID-19 related; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus",""
"phs001459.v1.p1","Accelerating Medicines Partnership-Systemic Lupus Erythematosus (AMP-SLE)","This project is analyzing tissue and blood samples from people with rheumatoid arthritis (RA) and lupus to pinpoint genes, proteins, chemical pathways, and networks involved at a single cell level.  This type of modular, molecular analysis will allow comparisons across the diseases and will provide insights into key aspects of the disease","Not Applicable","Lupus Erythematosus, Systemic","Case-Control","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 22 variables, 1 molecular datasets, 26042 samples sequenced,  SRA, 60 subjects, 26073 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2020-10-22","2020-10-22","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus",""
"phs000960.v2.p1","Genome-Wide Association Study of Biliary Atresia","Biliary atresia causes jaundice and liver failure in newborn children. In this study, single nucleotide polymorphisms were characterized in children with biliary atresia and identified ARF6 as a susceptibility gene  for this disease. Knockdown of this gene in zebrafish embryos impaired formation of bile ducts and excretion of bile from the zebrafish liver.","Not Applicable","Biliary Atresia","Case Set","HumanHap550","SNP Genotypes (Array)","3 phenotype datasets, 13 variables, 2 molecular datasets, 63 subjects, 63 samples","","NIDDK","DS-BA-IRB-NPU-GSO --- Disease-Specific (Biliary Atresia, IRB, NPU, GSO)","2020-10-22","2020-10-22","Familial Extrahepatic Biliary Atresia",""
"phs001912.v1.p1","Somatic Genome Dynamics of Barrett's Esophagus Patients with Non-Cancer    and Cancer Outcomes","A case-control study was designed with 80 participants diagnosed with Barrett's Esophagus (BE) selected from a larger case-cohort study (Li et al., 2014, PMID: 24253313) within the Seattle Barrett's Esophagus  Program (SBEP) at the Fred Hutchinson Cancer Research Center. The study included 40 cases with BE with non-cancer outcomes, ""NCO"", who did not","Not Applicable","Barrett Esophagus","Case-Control","HumanOmni2.5-8","SNP Genotypes (Array), WGS","4 phenotype datasets, 56 variables, 1 molecular datasets, 427 samples sequenced,  SRA, 80 subjects, 427 samples","","NCI","DS-BE-EA --- Disease-Specific (Barrett's Esophagus or EA)","2020-10-19","2020-10-19","BARRETT METAPLASIA; BE; Barret syndrome; Barrett Metaplasias; Barrett Syndrome; Barrett esophagus/esophageal adenocarcinoma",""
"phs001889.v1.p1","Transposable Elements in FTLD-TDP and ALS-TDP","Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease involving the rapid and progressive loss of motor neurons. While a number of inherited mutations have been identified as causing ALS,  the vast majority of cases are sporadic with no family history of disease. This has led to the model that ALS may be a complex syndrome with an","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","target_markerset_grc38","RNA Seq (NGS)","5 phenotype datasets, 15 variables, 1 molecular datasets, 19 subjects, 38 samples","","NINDS","GRU --- General Research Use","2020-10-19","2020-10-19","ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease; Disease, Lou-Gehrigs","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001866.v1.p1","RNA Sequence-Based Analysis Used to Compare Breast Primary and Metastatic    Tumor Pairs","The goal of this study is to capture the transcriptome landscape of luminal and basal-like metastatic breast tumors. We will aim to show the importance of using the most up-to-date  cancer biopsy for detecting cancer drivers that were often not present in the primary tumor. RNA-Seq data are available through dbGaP's Authorized","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 26 variables, 166 samples sequenced, 166 subjects, 166 samples","","NCI","GRU --- General Research Use","2020-10-19","2020-10-19","Metastases; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001775.v1.p1","Alcohol Dependence: Sequencing from Multiplex Families","Two multiplex for alcohol dependence family studies were initiated based on the gender of a pair of probands. Ascertainment of a pair of AD probands was used to increase the  density of alcohol dependence within the family. Identification of male (Cognitive and Personality Factors in Relatives of Alcoholics Family Study)","Not Applicable","Alcoholism","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 40 samples sequenced,  SRA, 40 subjects, 40 samples","","NIAAA","DS-ALC-IRB-PUB-NPU-MDS-RD --- Disease-Specific (Alcoholism, IRB, PUB, NPU, MDS, RD)","2020-10-19","2020-10-19","ALCOHOL DEPENDENCE, PROTECTION AGAINST; Addiction, Alcohol; Addictive alcohol use; Alcohol Addiction; Alcohol Dependence; Alcohol dependence syndrome",""
"phs001340.v1.p1","Identification and Targeting of Inflammatory Macrophage-Fibroblast    Crosstalk in Rheumatoid Arthritis","Heavily inflamed synovial tissue from patients diagnosed with rheumatoid arthritis (RA) were disaggregated and cultured for 24h with medications used in the clinic to treat RA. Total cell RNA sequencing  was performed on samples treated with or without the medications. Data on 2 patients is provided here. In addition, primary fibroblasts from 2","Not Applicable","Arthritis, Rheumatoid","Case Set","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 12 variables, 1 molecular datasets, 24 samples sequenced,  SRA, 4 subjects, 24 samples","","NIAMS","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2020-10-19","2020-10-19","Arthritis; Oligoarthritides; Oligoarthritis; Pauciarthritis",""
"phs001011.v2.p1","CCHMC-eMERGE-Phase IIIA","This submission includes genotyping or sequencing data from separate cohorts, each is described in separate paragraphs below. Extreme early onset obesity Obesity is a serious epidemic condition and on the  rise in the United States. Today, nearly one out of three children is overweight or obese in this country. According to the Center for Disease","Not Applicable","Electronic Health Records","Case-Control","Cytogenetic_Arrays, Human1M-Duo, WES_markerset_grc37","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 2 molecular datasets, 206 samples sequenced,  SRA, 1568 subjects, 1571 samples","European (790), African (3), East Asian (12), African American (126), Hispanic1 (42), Hispanic2 (27), Other Asian or Pacific Islander (2), South Asian (4), Other (11)","NHGRI","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2020-10-19","2016-09-27","Arthritis, Juvenile; Child Development Disorders, Pervasive; Cholangitis, Sclerosing; Developmental Disabilities; Eosinophilic Esophagitis; Infection",""
"phs002053.v1.p1","Neoadjuvant Pazopanib in Renal Cell Carcinoma","This study examined the tissue of patients who received oral pazopanib prior to nephrectomy. Patients were consented and underwent a pre-treatment biopsy. Pretreatment samples for analysis were preserved as available.  Subjects underwent a proscribed course of treatment with pazopanib. At the completion of treatment, subjects underwent a planned nephrectomy, and","Not Applicable","Carcinoma, Renal Cell","Prospective Longitudinal Cohort","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 10 variables, 36 samples sequenced,  SRA, 22 subjects, 36 samples","","NCI","DS-KD-IRB --- Disease-Specific (Kidney Disease, IRB)","2020-10-13","2020-10-13","ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal Cell",""
"phs001958.v1.p1","Cell-Type Specific Effects of Genetic Variation on Chromatin    Accessibility During Human Neuronal Differentiation","Common genetic risk for neuropsychiatric disorders is enriched in regulatory elements active during cortical neurogenesis. However, the mechanisms mediating the effects of genetic variants on gene regulation are poorly understood.  To determine the functional impact of common genetic variation on the non-coding genome longitudinally during human cortical development, we","Not Applicable","Mental Disorders","Prospective Longitudinal Cohort","HumanOmni2.5-8","ATAC-seq, CNV Genotypes","4 phenotype datasets, 31 variables, 1 molecular datasets, 137 samples sequenced,  SRA, 85 subjects, 222 samples","European (6), East Asian (3), African American (22), Hispanic2 (49), Other Asian or Pacific Islander (2), Other (3)","NIMH","GRU --- General Research Use","2020-10-13","2020-10-13","Illness, Mental; Mental Disorder; Mental Dysfunction; Mental Illness; Mental Illnesses; Mental disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs002217.v1.p1","Single Cell ATAC-Seq of MELAS","This dataset includes combined single Assay for Transposase-Accessible Chromatin, using sequencing (ATAC-seq), and mitochondrial DNA sequencing of peripheral blood mononuclear cells from three individuals with m.3243A G associated MELAS (Mitochondrial  Encephalopathy, Lactic Acidosis, and Stroke-like episodes). Patients with genetically confirmed mitochondrial disease were included. Individuals with","Not Applicable","MELAS Syndrome","Case Set","target_markerset_grc38","ATAC-seq, Chromatin (NGS)","4 phenotype datasets, 12 variables, 1 molecular datasets, 3 samples sequenced,  SRA, 3 subjects, 3 samples","","NIGMS","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS)","2020-10-08","2020-10-08","Juvenile myopathy, encephalopathy, lactic acidosis, stroke; MELAS; MELAS - mitochondrial encephalopathy, lactic acidosis and stroke-like episodes; Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes; Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes; Mitochondrial Myopathy, Lactic Acidosis, Stroke-Like Episode",""
"phs002227.v1.p1","NeuroCHARGE Consortium GWAS of White Matter Hyperintensities on MRI","Meta-analysis results of white matter hyperintensities (WMH) volume genome wide association study (GWAS) in older population-based studies from the CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) consortium  and the UK biobank. Individuals with a history of stroke (or MRI-defined brain infarcts involving the cortical grey matter), or other pathologies","Not Applicable","Leukoencephalopathies","Prospective Longitudinal Cohort","Not Provided","Not Provided","1 analyses","","NINDS","","2020-10-07","","Cerebral Microangiopathies; Cerebral Microangiopathy; Cerebral Small Vessel Disease; Cerebral Small Vessel Diseases; Microangiopathies, Cerebral; Microangiopathy, Cerebral",""
"phs001809.v1.p1","GSCAN GWAS Meta-analysis of Tobacco and Alcohol use (GSCAN-GWAS)","This study was a meta-analysis of genome-wide association study (GWAS) of substance use across 1.2 million total participants with European ancestry (some phenotypes are based on fewer participants). The phenotypes  were chosen to represent different stages and kinds of substance use from initiation (age of smoking initiation) to regular use (cigarettes per day","Not Applicable","Smoking","Prospective Longitudinal Cohort","Not Provided","Not Provided","5 analyses","","NIDA","","2020-10-07","","Not Provided",""
"phs001290.v1.p1","CIDR: NCI Genome Wide Predictors of Survival in Colorectal Cancer","CIDR/Molecular Correlates: This study genotyped archived blood samples from colorectal cancer cases participating in clinical trials. The goals of this project were to identify genetic variants associated with survival outcomes  treatment and treatment-related severe adverse events among patients with colorectal cancer. Another goal was to examine the impact of adding","Not Applicable","Colorectal Neoplasms","Clinical Trial","HumanOmniExpressExome-8, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 37 variables, 2 molecular datasets, 6077 subjects, 6371 samples","European (5107), African (20), East Asian (172), African American (397), Hispanic1 (65), Hispanic2 (205), Other Asian or Pacific Islander (53), South Asian (18), Other (40)","NCI","GRU-PUB --- General Research Use (PUB), GRU-COL-NPU --- General Research Use (COL, NPU), GRU-COL --- General Research Use (COL)","2020-10-07","2020-10-07","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs002234.v1.p1","Effect of Xq28 Deletion on Hypergonadotropic Hypogonadism","Hypergonadotropic hypogonadism (HH) is characterized by low sex steroid levels and secondarily elevated gonadotropin levels with either congenital or acquired etiology. Genetic factors leading to HH have yet to be  fully elucidated. We submit genome and transcriptome data analyses from a male patient with HH and history of growth delay who has an inherited","Not Applicable","Hypogonadism","Case-Control","Not Provided","RNA-Seq","5 phenotype datasets, 18 variables, 4 samples sequenced,  SRA, 4 subjects, 4 samples","","NIGMS","GRU-IRB --- General Research Use (IRB)","2020-09-25","2020-09-25","CRYGS cataract (disease); CTRCT20; Cataract, Membranous; Cataracts, Membranous; Membranous Cataract; Membranous Cataracts",""
"phs001133.v1.p1","Follow-up of Ovarian Cancer Genetic Association and Interaction Studies    (FOCI)","(Excerpted/paraphrased from original grant application): FOCI seeks to expand our understanding of epithelial ovarian cancer through a coordinated and comprehensive approach. Project 1 will focus on discovery, expansion, and replication.  By pooling GWAS, we expect to identify new associations and achieve independent replication, explore whether there are risk variants specific for","Not Applicable","Ovarian Neoplasms","Case-Control","Axiom_Biobank_plus, imputation_panel, HumanOmni2.5-8, meta_analysis_markerset","Not Provided","2 phenotype datasets, 7 variables, 14796 subjects, 16783 samples, 4 substudies","","NCI","GRU --- General Research Use, DS-BOED-MDS --- Disease-Specific (Breast, Ovarian, or Endometrial Disease, MDS), DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS), HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), OVCARES --- Ovarian Cancer Only, GRU-COL --- General Research Use (COL), DS-CA --- Disease-Specific (Cancer), DS-OVCA --- Disease-Specific (Ovarian Cancer), DS-OVCA-MDS --- Disease-Specific (Ovarian Cancer, MDS), DS-OVCA-MDS-GSO --- Disease-Specific (Ovarian Cancer, MDS, GSO), DS-OVCA-NPU --- Disease-Specific (Ovarian Cancer, NPU), DS-OVCA-NPU-MDS --- Disease-Specific (Ovarian Cancer, NPU, MDS), DS-OVTU --- Disease-Specific (Ovarian Tumors)","2020-09-24","2020-09-24","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001150.v1.p1","FOCI Mayo 2.5M","This sub-study phs001150 Mayo 2 5M contains genotype data generated using 2.5M genotyping array and selected phenotype of subjects available from the phs001150 study. Summary level phenotypes for the NCI  FOCI Cohort study participants can be viewed at the top-level study page phs001133 FOCI Cohort. Individual level phenotype data and molecular data","Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI) (phs001133.v1.p1)","Ovarian Neoplasms","Case-Control","HumanOmni2.5-8","SNP/CNV (Array), SNP/CNV (Array)","2 phenotype datasets, 15 variables, 1 molecular datasets, 1000 subjects, 1021 samples","European (971), East Asian (4), African American (7), Hispanic1 (1), Hispanic2 (9), Other Asian or Pacific Islander (4), Other (2)","NCI","GRU --- General Research Use, DS-BOED-MDS --- Disease-Specific (Breast, Ovarian, or Endometrial Disease, MDS), DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS), HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), OVCARES --- Ovarian Cancer Only, GRU-COL --- General Research Use (COL), DS-CA --- Disease-Specific (Cancer), DS-OVCA --- Disease-Specific (Ovarian Cancer), DS-OVCA-MDS --- Disease-Specific (Ovarian Cancer, MDS), DS-OVCA-MDS-GSO --- Disease-Specific (Ovarian Cancer, MDS, GSO), DS-OVCA-NPU --- Disease-Specific (Ovarian Cancer, NPU), DS-OVCA-NPU-MDS --- Disease-Specific (Ovarian Cancer, NPU, MDS), DS-OVTU --- Disease-Specific (Ovarian Tumors)","2020-09-24","2020-09-24","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian",""
"phs001142.v1.p1","FOCI Mayo OmniExpress","This sub-study phs001142 Mayo Omni Express contains genotype data and selected phenotype of subjects available from the phs001142 study. Summary level phenotypes for the NCI FOCI Cohort study participants can  be viewed at the top-level study page phs001133 FOCI Cohort. Individual level phenotype data and molecular data for all FOCI Cohort top-level study","Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI) (phs001133.v1.p1)","Ovarian Neoplasms","Case Set","imputation_panel","SNP Genotypes (imputed), SNP Genotypes (imputed)","2 phenotype datasets, 10 variables, 1 molecular datasets, 171 subjects, 171 samples","","NCI","GRU --- General Research Use, DS-BOED-MDS --- Disease-Specific (Breast, Ovarian, or Endometrial Disease, MDS), DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS), HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), OVCARES --- Ovarian Cancer Only, GRU-COL --- General Research Use (COL), DS-CA --- Disease-Specific (Cancer), DS-OVCA --- Disease-Specific (Ovarian Cancer), DS-OVCA-MDS --- Disease-Specific (Ovarian Cancer, MDS), DS-OVCA-MDS-GSO --- Disease-Specific (Ovarian Cancer, MDS, GSO), DS-OVCA-NPU --- Disease-Specific (Ovarian Cancer, NPU), DS-OVCA-NPU-MDS --- Disease-Specific (Ovarian Cancer, NPU, MDS), DS-OVTU --- Disease-Specific (Ovarian Tumors)","2020-09-24","2020-09-24","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian",""
"phs001132.v1.p1","FOCI GWAS Meta-Analysis","This sub-study phs001132 GWAS Meta Analysis contains genotype data pulled from several GWAS studies and selected phenotype of subjects available from the phs001132 study. Summary level phenotypes for the NCI  FOCI Cohort study participants can be viewed at the top-level study page phs001133 FOCI Cohort. Individual level phenotype data and molecular data","Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI) (phs001133.v1.p1)","Ovarian Neoplasms","Case-Control","meta_analysis_markerset","CNV Genotypes, CNV Genotypes","2 phenotype datasets, 10 variables, 6 analyses, 1 molecular datasets, 2818 subjects, 2818 samples","","NCI","GRU --- General Research Use, DS-BOED-MDS --- Disease-Specific (Breast, Ovarian, or Endometrial Disease, MDS), DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS), HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), OVCARES --- Ovarian Cancer Only, GRU-COL --- General Research Use (COL), DS-CA --- Disease-Specific (Cancer), DS-OVCA --- Disease-Specific (Ovarian Cancer), DS-OVCA-MDS --- Disease-Specific (Ovarian Cancer, MDS), DS-OVCA-MDS-GSO --- Disease-Specific (Ovarian Cancer, MDS, GSO), DS-OVCA-NPU --- Disease-Specific (Ovarian Cancer, NPU), DS-OVCA-NPU-MDS --- Disease-Specific (Ovarian Cancer, NPU, MDS), DS-OVTU --- Disease-Specific (Ovarian Tumors)","2020-09-24","2020-09-24","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian",""
"phs001131.v1.p1","FOCI Affymetrix Exome Chip","This sub-study phs001131&#x000a0;Affymetrix Exome Chip contains genotype data generated using exome genotyping array and selected phenotype of subjects available from the phs001131 study. Summary level phenotypes for the NCI FOCI  Cohort study participants can be viewed at the top-level study page phs001133 FOCI Cohort. Individual level phenotype data and molecular data for all","Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI) (phs001133.v1.p1)","Ovarian Neoplasms","Case-Control","Axiom_Biobank_plus","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 13 variables, 1 molecular datasets, 12773 subjects, 12773 samples","","NCI","GRU --- General Research Use, DS-BOED-MDS --- Disease-Specific (Breast, Ovarian, or Endometrial Disease, MDS), DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS), HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), OVCARES --- Ovarian Cancer Only, GRU-COL --- General Research Use (COL), DS-CA --- Disease-Specific (Cancer), DS-OVCA --- Disease-Specific (Ovarian Cancer), DS-OVCA-MDS --- Disease-Specific (Ovarian Cancer, MDS), DS-OVCA-MDS-GSO --- Disease-Specific (Ovarian Cancer, MDS, GSO), DS-OVCA-NPU --- Disease-Specific (Ovarian Cancer, NPU), DS-OVCA-NPU-MDS --- Disease-Specific (Ovarian Cancer, NPU, MDS), DS-OVTU --- Disease-Specific (Ovarian Tumors)","2020-09-24","2020-09-24","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian",""
"phs002049.v1.p1","Memorial Sloan Kettering (MSKCC) Single Cell Mutational Profiling in    Myeloid Malignancies","Myeloid malignancies have previously been characterized by large scale bulk molecular profiling studies on patient samples. These studies, while clinically informative, are unable to delineate mutation order as well as  clonal architecture and complexity. To investigate the clonal framework of myeloid malignancies, the Single Cell Mutational Profiling in Myeloid","Not Applicable","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","target_markerset_grc38","AMPLICON, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 148 samples sequenced,  SRA, 117 subjects, 148 samples","","NCI","HMB --- Health/Medical/Biomedical","2020-09-23","2020-09-23","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001913.v1.p1","CCDG - Cardiovascular: eMERGE - Northwestern Cohort","The National Human Genome Research Institute (NHGRI) has funded the Centers for Common Disease Genomics (CCDG), a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants  contributing to common disease phenotypes and to better understand the general principles of genomic architecture underlying common, complex","Not Applicable","Cardiovascular Diseases","Case-Control","Not Provided","Not Provided","4 phenotype datasets, 14 variables, 277 subjects, 277 samples","","NHGRI","GRU-IRB --- General Research Use (IRB)","2020-09-22","2020-09-22","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs001993.v1.p1","WES, RNASeq and CNV Analysis of NF1-Associated Atypical Neurofibromas","Neurofibromatosis type 1 (NF1) is a tumor-predisposition disorder caused by germline mutations in NF1. NF1 patients have an 8-16% lifetime risk of developing a malignant peripheral nerve sheath tumor (MPNST),  a highly aggressive soft-tissue sarcoma, often arising from pre-existing benign plexiform neurofibromas (PN) and atypical neurofibromas (ANF). ANF","Not Applicable","Neurofibromatosis 1","Prospective Longitudinal Cohort","WES_markerset_grc38","RNA-Seq, CNV Genotypes, WXS","5 phenotype datasets, 29 variables, 1 molecular datasets, 69 samples sequenced,  SRA, 69 subjects, 74 samples","","NCI","GRU --- General Research Use","2020-09-15","2020-09-15","Molluscum Fibrosum; Multiple non-ossifying fibromatosis; NEUROFIBROMATOSIS TYPE 1; NEUROFIBROMATOSIS, PERIPHERAL TYPE; NEUROFIBROMATOSIS, TYPE I; NEUROFIBROMATOSIS, TYPE I, SOMATIC","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001903.v1.p1","dbGaP submission of CORECT OncoArray GWAS data","This analysis represents the genome-wide association study results of several international case-control studies of colorectal cancer. Inclusion Criteria In general, for cases: (1) age 18 years (some studies capped age  at 69, and others did not), (2) newly-diagnosed CC (stages I-III), (3) English or German or Spanish speaking dependent on study locale, and (4)","Not Applicable","Colorectal Neoplasms","Case-Control","OncoArray-500K","SNP Genotypes (Array)","4 phenotype datasets, 37 variables, 1 analyses, 1 molecular datasets, 37437 subjects, 37437 samples","European (31101), African (24), East Asian (3646), African American (591), Hispanic1 (1142), Hispanic2 (350), Other Asian or Pacific Islander (292), South Asian (54), Other (237)","NCI","EPIMEDCA-MDS --- Epidemiological and Medical Research on Cancer and Methods, DS-CA-NPU-GSO --- Disease-Specific (Cancer, NPU, GSO), GRU-PUB --- General Research Use (PUB), DS-COC-MDS --- Disease-Specific (Colon Cancer, MDS), HMB --- Health/Medical/Biomedical, DS-CC --- Disease-Specific (Colorectal Cancer), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), DS-COC-PUB-NPU --- Disease-Specific (Colon Cancer, PUB, NPU), DS-CC-PUB --- Disease-Specific (Colorectal Cancer, PUB), CHRONIC-MDS --- Chronic Diseases (including Cancer) and Methods, GRU --- General Research Use, CADM --- Cancer in all age groups, other diseases in adults only, and methods, CRCSTATS --- Colorectal Cancer and Statistical Methods, DS-CA-GSO --- Disease-Specific (Cancer, GSO), DS-CC-COL-NPU --- Disease-Specific (Colorectal Cancer, COL, NPU), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB-COL --- Health/Medical/Biomedical (IRB, COL), DS-COC-IRB-COL --- Disease-Specific (Colon Cancer, IRB, COL), DS-CA-IRB-PUB-NPU-MDS --- Disease-Specific (Cancer, IRB, PUB, NPU, MDS), DS-BCEMOPCA-NPU-MDS --- Disease-Specific (Breast, Colorectal, Endometrial, Melanoma, Ovarian, and/or Prostate Cancer, NPU, MDS), DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2020-09-15","2020-09-15","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001299.v2.p1","Nicotine Addiction Genetics and Correlates","Ascertainment: Families were ascertained through panels of adult Australian twins, and a sample of spouses of Australian twins. Families with at least one offspring who was identified as a current  or former smoker in an earlier survey. Screening telephone interviews were conducted with index cases to provide confirmation of a history of heavy","Not Applicable","Behavior, Addictive","Family/Twin/Trios","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 41 variables, 3 documents, 1 molecular datasets, 3508 subjects, 2452 samples","","NIDA","GRU --- General Research Use","2020-09-14","2018-04-26","Substance-Related Disorders; Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001266.v2.p1","Genome-Wide Analysis for Addiction Susceptibility Genes","Genome wide analysis for addiction susceptibility genes is an affected sibling pair linkage study using subjects who were patients in methadone replacement treatment programs (MMTP). Such patients are highly addicted  to opioids and usually to other addicting substances as well. For entry into the programs, patients had to be at least 18 years of age and had to","Not Applicable","Opioid-Related Disorders","Family/Twin/Trios","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 40 variables, 3 documents, 1 molecular datasets, 1331 subjects, 645 samples","European (64), African (4), African American (176), Hispanic1 (274), Hispanic2 (24), Other (103)","NIDA","GRU --- General Research Use","2020-09-14","2018-03-15","Substance-Related Disorders; Addiction, Opiate; Dependence, Opiate; Opiate Addiction; Opiate Dependence; Opioid Related Disorders","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001135.v2.p1","Starting Treatment with Agonist Replacement Therapies (START)","The Starting Treatment with Agonist Replacement Therapy (START) study was a 24-week, open-label, randomized trial of methadone versus Suboxone (buprenorphine/naloxone) for the treatment of opioid dependence. Patients were over the  age of 18 and met DSM-IV qualifications for opioid dependence. The primary goal of the study was to determine if either medicine was associated with","Not Applicable","Opioid-Related Disorders","Prospective Longitudinal Cohort","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 40 variables, 3 documents, 1 molecular datasets, 979 subjects, 978 samples","European (692), East Asian (2), African American (128), Hispanic1 (41), Hispanic2 (75), Other Asian or Pacific Islander (11), Other (29)","NIDA","GRU --- General Research Use","2020-09-14","2017-02-02","Substance-Related Disorders; Addiction, Opiate; Dependence, Opiate; Opiate Addiction; Opiate Dependence; Opioid Related Disorders","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001258.v2.p1","Total exRNA Profiles from Plasma, Saliva, and Urine of Healthy Subjects","We sequenced small RNAs from 183 plasma samples, 204 urine samples and 46 saliva samples from 55 college athletes ages 18-25 years. Many of the participants provided more than one  sample, weeks or months apart, allowing us to assess variability in an individual's exRNA expression levels over time. Several individuals provided","Not Applicable","MicroRNAs","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, miRNA-Seq","4 phenotype datasets, 18 variables, 676 samples sequenced,  SRA, 57 subjects, 676 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2020-09-11","2017-07-25","Not Provided","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs000968.v2.p1","The Cardiopulmonary Effects of Particulate Exposure","The study was initially designed as a longitudinal cohort study of cardiovascular effects of particulate exposure. Participants were boilermaker construction workers who were exposed to particulate matter (PM) component (e.g.  a focus on metal constituents) while performing welding, grinding or cutting work in the welding plants. Participants were followed up approximately","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","HumanMethylation450","Methylation (CpG)","4 phenotype datasets, 21 variables, 1 molecular datasets, 75 subjects, 208 samples","","NIEHS","HMB-IRB --- Health/Medical/Biomedical (IRB)","2020-09-11","2016-05-19","Cardiovascular Disease; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs001875.v1.p1","Determinants of Venetoclax Resistance","The study aimed to identify genetic determinants of resistance to Venetoclax, a recently approved BCL-2 inhibitor for patients with chronic lymphocytic leukemia (CLL). Whole exome sequencing of tumor samples from  6 CLL patients relapsing on Venetoclax revealed clonal evolution when comparing pre- and post-Venetoclax samples. Genetic screens for genes involved","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 23 variables, 19 samples sequenced,  SRA, 6 subjects, 19 samples","","NCI","GRU --- General Research Use","2020-09-10","2020-09-10","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001955.v1.p1","NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)-III - Red    Blood Cell Omics (RBC-Omics) Study","The Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) is an initiative launched by the National Heart, Lung, and Blood Institute (NHLBI) with the goal to improve transfusion medicine practice, ensure  safety and reduce risks. Extensive variation exists in donor iron metabolism, hemoglobin production, and hemolysis. Despite this variation, current","Not Applicable","Transfusion Medicine","Prospective Longitudinal Cohort","Affymetrix_Custom_Array","SNP/CNV (Array)","4 phenotype datasets, 54 variables, 1 molecular datasets,  SRA, 13403 subjects, 12688 samples","European (8176), African (35), East Asian (851), African American (1544), Hispanic1 (438), Hispanic2 (578), Other Asian or Pacific Islander (480), South Asian (348), Other (238)","NHLBI","GRU-IRB-PUB-NPU --- General Research Use (IRB, PUB, NPU)","2020-09-04","2020-09-04","Not Provided",""
"phs001972.v1.p1","NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)-III - Brazil    Sickle Cell Disease Cohort (REDS-BSCDC)","The Recipient Epidemiology and Donor Evaluation Study (REDS)-III program established a Brazilian Sickle Cell Disease (SCD) Cohort to identify molecular determinants of response to transfusions, alloimmunization and risk factors associated  with HIV infection. The Brazil population presents a complex admixture of African, European, Asian and Indigenous heritage and will provide insights","Not Applicable","Anemia, Sickle Cell","Prospective Longitudinal Cohort","Affymetrix_Custom_Array","SNP/CNV (Array)","4 phenotype datasets, 57 variables, 1 molecular datasets,  SRA, 2793 subjects, 2684 samples","European (14), African (8), African American (1562), Hispanic1 (940), Hispanic2 (1), Other (159)","NHLBI","GRU-IRB-PUB-COL-NPU --- General Research Use (IRB, PUB, COL, NPU)","2020-09-03","2020-09-03","Acute Chest Syndrome; Bacteremia; Hemorrhagic Stroke; Hypertension, Pulmonary; Kidney Failure, Chronic; Leg Ulcer",""
"phs000998.v2.p1","Transcriptome Profile of Endothelial Cells in PAH Patients vs Controls","The transcriptome of pulmonary arterial endothelial cells from healthy lungs and from lungs of patients with idiopathic pulmonary arterial hypertension have been analyzed and specific differences in disease-relevant pathways were  identified. The genes identified as altered in these patients have direct effects on pulmonary arterial endothelial cell function. This finding may","Not Applicable","Pulmonary Arterial Hypertension","Case-Control","Not Provided","RNA-Seq","5 phenotype datasets, 24 variables, 48 samples sequenced,  SRA, 34 subjects, 48 samples","","NHLBI","GRU --- General Research Use","2020-09-03","2020-09-03","Not Provided","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001532.v2.p1","Nicotine Dependence GWAS Meta-Analysis","Cigarette smoking is the leading cause of preventable morbidity and mortality. Knowledge is evolving on genetics underlying initiation, regular smoking, nicotine dependence (ND), and cessation. We performed a genome-wide association  study using the Fagerstr&#x000f6;m Test for ND (FTND) in 58,000 smokers of European or African ancestry. Five genome-wide significant loci, including","Not Applicable","Tobacco Use Disorder","Cross-Sectional","Not Provided","Not Provided","6 analyses","","NIDA","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2020-09-01","2020-09-01","Compulsive tobacco user syndrome; Dependence, Tobacco; Tobacco Dependence",""
"phs002055.v1.p1","Peripheral Blood Transcriptome Analysis of ALS Patients","Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative disorders which overlap in their clinical presentation, pathology, and genetic origin. An over-representation of autoimmune disorders exists in both ALS  and FTD, but this remains an unexplained epidemiologic observation. Expansions of a hexanucleotide repeat (GGGGCC) in the C9orf72 gene","Not Applicable","Amyotrophic Lateral Sclerosis","Case Set","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 30 variables, 1 molecular datasets, 279 samples sequenced,  SRA, 279 subjects, 279 samples","","NINDS","HMB --- Health/Medical/Biomedical","2020-08-27","2020-08-27","ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease; Disease, Lou-Gehrigs",""
"phs002020.v1.p1","Imaging and Informatics in Retinopathy of Prematurity (i-ROP)","This project aims to identify genetic variants that contribute to the development of retinopathy of prematurity (ROP). ROP is a leading cause of childhood blindness worldwide. We have performed a  genome wide association study (GWAS) using Illumina Global Screening Array (GSA) BeadChip. For this GWAS design we assembled the largest group of ROP","Not Applicable","Retinopathy of Prematurity","Prospective Longitudinal Cohort","Global_Screening_Array-24","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 1064 subjects, 1064 samples","European (349), African (6), East Asian (10), African American (154), Hispanic1 (74), Hispanic2 (371), Other Asian or Pacific Islander (29), South Asian (11), Other (60)","NEI","GRU --- General Research Use","2020-08-26","2020-08-26","Fibroplasia, Retrolental; Fibroplasias, Retrolental; Prematurity Retinopathies; Prematurity Retinopathy; RLF - Retrolental fibroplasia; ROP",""
"phs001493.v2.p1","Whole Exome Predictors Immune Checkpoint Therapy Response in Renal Cell    Carcinoma","Immune checkpoint therapies, including monoclonal antibodies to programmed cell death-1 (PD-1) and cytotoxic % lymphocyte associated protein-4 (CTLA-4), yield durable clinical responses across many tumor types, including metastatic melanoma, non-small  cell lung cancer (NSCLC), and renal cell carcinoma (RCC). However, predictors of response to these therapies in RCC are still unknown. Genomic","Not Applicable","Carcinoma, Renal Cell","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 143 samples sequenced,  SRA, 71 subjects, 143 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use","2020-08-26","2018-02-02","ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal Cell","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001949.v1.p1","Phenome-wide scanning identifies multiple diseases and disease severity    phenotypes associated with HLA variants","We discover numerous associations between human leukocyte antigen (HLA) variation and a comprehensive set of phenotypes derived from electronic health records. Related Genes: HLA-A, HLA-B, HLA-C, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQB1,  HLA-DRB1 Principal Investigator: Joshua C. Denny, MD, MS, Vanderbilt University Medical Center, Nashville, TN, USA Co-Investigator: Jason H. Karnes,","Not Applicable","Diabetes Mellitus, Type 1","Case-Control","custom_markerset","HLA_Imputed","4 phenotype datasets, 266 variables, 1 molecular datasets, 28820 subjects, 28820 samples","","NIGMS","GRU-NPU --- General Research Use (NPU)","2020-08-25","2020-08-25","Arthritis, Juvenile; Arthritis, Rheumatoid; Celiac Disease; Dermatomyositis; Hypothyroidism; Liver Cirrhosis, Biliary",""
"phs001169.v2.p1","Integrative Analysis of Lung Adenocarcinoma (Version 2)","We performed a comprehensive analysis of intratumor heterogeneity of somatic mutations in cancer driver genes, copy number aberrations and DNA methylation in 292 tumor samples from 84 lung adenocarcinoma (LUAD)  patients from the Environment And Genetics in Lung cancer Etiology (EAGLE) study. SNVs of 37 established lung cancer driver genes were profiled by","Not Applicable","Adenocarcinoma of Lung","Case Set","HumanOmniExpress-12, HumanMethylation450","SNP Genotypes (Array), RNA-Seq, Methylome sequencing, Targeted-Capture, WXS","4 phenotype datasets, 14 variables, 2 molecular datasets, 512 samples sequenced,  SRA, 132 subjects, 1114 samples","","NCI","DS-LDS-MDS --- Disease-Specific (Lung disease or smoking, MDS)","2020-08-24","2020-08-24","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs002054.v1.p1","Genomic Characterization of 9p- Syndrome","We characterized the precise genomic breakpoints of the complex structural variant associated with 9p- syndrome in one individual. To be included in the study, the case had to have 9p-  syndrome. Principal Investigator: F. Sessions Cole, MD, Washington University School of Medicine, St. Louis, MO, USA","Not Applicable","Chromosome 9p Deletion Syndrome","Case Set","Not Provided","WGS","4 phenotype datasets, 11 variables, 1 samples sequenced, 1 subjects, 1 samples","","NHGRI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2020-08-19","2020-08-19","9p deletion; 9p deletion syndrome; 9p monosomy; 9p syndrome; 9p- syndrome; Alfi syndrome",""
"phs002000.v1.p1","The Genomic Landscape of Mongolian Hepatocellular Carcinoma","Background and Hypotheses: Mongolia has the highest reported incidence of - and mortality from - hepatocellular carcinoma (HCC) in the world, which is between three and seven times higher than  that observed in other high-incidence populations, such as South Korea, Thailand, and China. Although its causative factors and underlying tumor","Not Applicable","Carcinoma, Hepatocellular","Case Set","Not Provided","Targeted-Capture","5 phenotype datasets, 34 variables, 142 samples sequenced, 76 subjects, 142 samples","","NCI","GRU --- General Research Use","2020-08-19","2020-08-19","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells",""
"phs001815.v1.p1","Minority Health GRID - Consortium","The Minority Health Genomics and Translational Research Bio-repository Database (MHGRID) Network infrastructure facilitated the collection of biospecimens and related multidimensional data elements within a consortium of minority-serving clinics. This initiative  expands the diversity of ancestral groups in national genomic medicine datasets and promises to accelerate the translation of personalized medicine","Not Applicable","Hypertension","Case-Control","WES_markerset_grc38","SNP Genotypes (NGS)","4 phenotype datasets, 12 variables, 1 molecular datasets,  SRA, 1637 subjects, 1637 samples","","NHGRI","GRU-IRB --- General Research Use (IRB)","2020-08-19","2020-08-19","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; HBP - High blood pressure",""
"phs001571.v1.p1","Genetics of Crohn's Disease in African Americans","Association studies have previously identified 200 genome-wide significant (GWS) IBD susceptibility loci in European ancestry populations. At least thirty-five loci have been identified in Asians and a handful appear Asian  specific. AAs have a higher risk for developing disease complications in IBD and worse disease outcome, suggesting that significant differences in","Not Applicable","Crohn Disease","Case-Control","Axiom_GW_AFR, HumanOmni2.5-8, HumanOmni2.5Exome-8","SNP Genotypes (Array)","5 phenotype datasets, 20 variables, 1 documents, 3 molecular datasets, 2234 subjects, 2234 samples","European (10), African (37), African American (2096), Hispanic1 (63), South Asian (1), Other (27)","NIDDK","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2020-08-19","2020-08-19","Colitis, Ulcerative; Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - ulcerative colitis",""
"phs002022.v1.p1","Genomic Analysis of Primary Plasma Cell Leukemia","Primary plasma cell leukemia (pPCL) is a rare and aggressive form of multiple myeloma (MM) that is characterized by poor overall survival despite advances in anti-MM therapy. The disease biology  as well as molecular mechanisms that distinguish pPCL from non-pPCL MM remain poorly understood. In an attempt to identify key biological mechanisms","Not Applicable","Leukemia, Plasma Cell","Prospective Longitudinal Cohort","Not Provided","WXS","5 phenotype datasets, 16 variables, 46 samples sequenced,  SRA, 23 subjects, 46 samples","","NCI","GRU --- General Research Use","2020-08-18","2020-08-18","Leukemia Plasmacytic; Leukemia, Plasmacytic; Leukemias, Plasma Cell; Leukemias, Plasmacytic; PCL; Plasma Cell Leukemia","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002051.v1.p1","DNA Methylation in Rhabdomyosarcoma PDX and PDX-Derived Primary Cells","Conditions to maintain primary tumor cells in culture are largely unknown for most tumor entities including rhabdomyosarcoma. In this collaborative study with Dr. Beat Sch&#x000e4;fer's laboratory, we performed DNA methylation  profiles of rhabdomyosarcoma patient-derived xenograft (PDX) and their matching PDX-derived primary cells (PPC), where the PPCs were developed and","Not Applicable","Rhabdomyosarcoma","Case Set","Cytogenetic_Arrays, MethylationEPIC","CNV Genotypes, Methylation (CpG), WXS","3 phenotype datasets, 12 variables, 1 molecular datasets, 31 samples sequenced,  SRA, 39 subjects, 99 samples","","NCI","GRU --- General Research Use","2020-08-17","2020-08-17","Not Provided","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002021.v1.p1","Chemotherapy and Unrelated Donor SCT for Blood and Immune System Cancers","Background: Major problems with stem cell transplantation (SCT) for cancer treatment are a lack of suitable donors for patients without an HLA tissue-matched sibling and graft-versus-host disease (GVHD), a serious  side effects of immune-suppressing chemotherapy that is given to bring the cancer under control before SCT. In GVHD, the patient's immune system","Not Applicable","Graft vs Host Disease","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 27 variables, 2 samples sequenced,  SRA, 2 subjects, 2 samples","","NCI","GRU --- General Research Use","2020-08-14","2020-08-14","Blood Protein Disorders; Bone Marrow Diseases; Cardiovascular Diseases; Hematologic Diseases; Hemorrhagic Disorders; Hemostatic Disorders","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001714.v1.p1","Gabriella Miller Kids First Pediatric Research Program: An Integrated    Clinical and Genomic Analysis of Treatment Failure in Pediatric    Osteosarcoma","Although the survival of children with relapsed osteosarcoma is very poor, little is known about the etiology of treatment failure in this disease. The purpose of this project is to  perform whole genome sequencing on serial samples from patients with osteosarcoma obtained before treatment, after treatment, and at","Not Applicable","Osteosarcoma","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 4 variables,  SRA, 84 subjects, 311 samples","","NCI","GRU --- General Research Use","2020-08-14","2020-08-14","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteoblastic osteosarcoma; Osteoblastic sarcoma; Osteochondrosarcoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002052.v1.p1","Mitochondrial DNA Deletion Detection from Human Tissues","Accumulation of deletions in the mitochondrial genome is a pathological hallmark of both aging and a broad range of neurometabolic disorders. Prior mtDNA deletion studies have been limited by reliance  upon either long range PCR or NGS strategies that target specific regions of the mitochondrial genome. We developed an ultrasensitive high throughput","Not Applicable","Mitochondrial Diseases","Case-Control","Not Provided","WGS","4 phenotype datasets, 21 variables, 41 samples sequenced,  SRA, 40 subjects, 41 samples","","NIEHS","DS-MD --- Disease-Specific (Mitochondrial Disease)","2020-08-11","2020-08-11","Depletion of mitochondrial deoxyribonucleic acid; Mitochondrial DNA Depletion Syndromes; Mitochondrial DNA depletions; mitochondrial DNA depletion; mtDNA depletion syndrome; CPEO",""
"phs001992.v1.p1","Reference Haplotypes for Complement Component 4 (C4) Gene Variation","Neuropsychiatric and autoimmune disorders have substantial epidemiological correlations (Benros et al., JAMA Psychiatry 2013, PMID: 23760347) and broad, genome-wide patterns of shared genetic risk (Pouget et al., Hum Mol Genet,  PMID: 31211845; Tylee et al., Am J Med Genet B Neuropsychiatr Genet 2018, PMID: 30325587). Some cases of psychosis involve autoantibodies against the","Not Applicable","Neuropsychiatry","Prospective Longitudinal Cohort","target_markerset_grc37","SNP/CNV Genotypes (NGS)","2 phenotype datasets, 6 variables, 1 molecular datasets,  SRA, 1234 subjects, 1265 samples","","NIMH","GRU --- General Research Use, DS-MLHLTH-MDS --- Disease-Specific (Mental Health, MDS)","2020-08-11","2020-08-11","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs002045.v1.p1","Intraductal Transplantation Models of PDAC Reveal Progression of Subtypes","Pancreatic ductal adenocarcinoma (PDAC) is the most lethal common malignancy, with little improvement in patient outcomes over the past few decades. Recently, subtypes of pancreatic cancer with different prognoses have  been elaborated. However, the inability to model these subtypes has precluded mechanistic investigation of their origins. Here, we present an","Not Applicable","Carcinoma, Pancreatic Ductal","Case Set","custom_markerset","RNA-Seq, CNV Genotypes, RNA Seq (NGS), WGS","4 phenotype datasets, 26 variables, 1 molecular datasets, 70 samples sequenced,  SRA, 15 subjects, 70 samples","","NCI","GRU --- General Research Use","2020-08-10","2020-08-10","Pancreatic Intraductal Neoplasms; Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001856.v1.p1","CORECT: Affymetrix Axiom GWAS Data","This study is part 1 of 2 for Schumacher et al, Nat Commun. 2015 Jul 7;6:7138. Part 1 is the original GWAS data for 9,259 participants on the Affymetrix Axiom  platform of the studies listed below in the Inclusion Criteria. Inclusion Criteria The CORECT consortium coordinated the analysis of six","Not Applicable","Colorectal Neoplasms","Case-Control","Axiom_Array","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 1 analyses, 1 molecular datasets, 9924 subjects, 9924 samples","","NCI","GRU --- General Research Use, DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), DS-CC --- Disease-Specific (Colorectal Cancer), DS-COC-IRB-COL --- Disease-Specific (Colon Cancer, IRB, COL), HMB --- Health/Medical/Biomedical, HMB-IRB-COL --- Health/Medical/Biomedical (IRB, COL), DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-CA-IRB-PUB-NPU-MDS --- Disease-Specific (Cancer, IRB, PUB, NPU, MDS)","2020-08-10","2020-08-10","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001841.v1.p1","Antisocial Drug Dependence","CADD (Center for Antisocial Drug Dependence): Funded through NIDA 011015 to study genetic influences on, and treatment of, antisocial drug dependence, studying both clinical probands and their families, and community  samples of matched controls, twins, and participants in an ongoing longitudinal adoption study. A collaboration between three organizations at two","Not Applicable","Opioid-Related Disorders","Prospective Longitudinal Cohort","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 61 variables, 1 molecular datasets, 573 subjects, 552 samples","European (380), East Asian (3), African American (18), Hispanic1 (3), Hispanic2 (136), Other Asian or Pacific Islander (4), Other (8)","NIDA","DS-SUD-IRB-NPU --- Disease-Specific (Substance Use Disorders, IRB, NPU)","2020-08-10","2020-08-10","Cocaine-Related Disorders; Abuse, Cocaine; Cocaine Abuse; Addiction, Opiate; Dependence, Opiate; Opiate Addiction",""
"phs001793.v1.p1","Pharmacogenomic Interactions in Glioblastoma Cell Line Models","Glioblastoma (GBM) is a lethal disease without effective treatments. To advance toward effective therapeutic approaches that are biomarker-driven, there is a need for new targeted agents and to develop accurate  preclinical models that encompass its cellular and molecular diversity. Historical cell line models poorly represent molecular diversity of GBMs, so","Not Applicable","Glioma","Case Set","Not Provided","WXS","4 phenotype datasets, 21 variables, 34 samples sequenced,  SRA, 33 subjects, 34 samples","","NCI","HMB --- Health/Medical/Biomedical","2020-08-06","2020-08-06","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs002007.v1.p1","Transcriptomic Characterization of Human Innate T Cells","We performed low input RNA-seq and single-cell RNA-seq on 7 lymphocyte populations with the objective of finding the common transcriptional programs shared among innate T cells. In brief, we drew  blood from healthy donors and isolated CD4+ T cells, CD8+ T cells, Natural Killer cells, invariant natural killer T (iNKT) cells, mucosal-associated","Not Applicable","Lymphocyte Subsets","Control Set","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 11 variables, 84 samples sequenced,  SRA, 8 subjects, 84 samples","","NIGMS","DS-IR --- Disease-Specific (Immunological Research)","2020-08-03","2020-08-03","Not Provided",""
"phs001471.v1.p1","Heart Healthy Lenoir (HHL) Genomics Study","The HHL genomics study uses a systems approach to develop models integrating clinical and genomic data. Previously we developed and tested an approach known as the SAMARA (Supporting A Multidisciplinary  Approach to Research in Atherosclerosis) project that applied recent advances in biomedical and computational sciences at The University of North","Not Applicable","Cardiovascular Diseases","Interventional","HumanOmniExpressExome-8","SNP Genotypes (Array)","8 phenotype datasets, 1500 variables, 1 documents, 1 molecular datasets, 664 subjects, 511 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2020-08-03","2020-08-03","Hypertension; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs000481.v3.p2","Cholesterol and Pharmacogenetics (CAP) Study","The Cholesterol and Pharmacogenetics Study was a 6-week open label, non-randomized study of 40mg/day simvastatin treatment in 335 black and 609 white (944 total) men and women. Plasma lipids and  lipoproteins were measured on two occasions prior to treatment and at 4 and 6 weeks of treatment. The study was designed to test for genetic","Not Applicable","Hypercholesterolemia","Clinical Trial","HumanHap300, Human610-Quad, HumanOmni2.5Exome-8","SNP Genotypes (Array), RNA-Seq","5 phenotype datasets, 30 variables, 3 molecular datasets, 866 samples sequenced,  SRA, 762 subjects, 1615 samples","European (545), African (1), African American (150), Hispanic1 (11), Hispanic2 (17), Other Asian or Pacific Islander (3), South Asian (1), Other (10)","NHLBI","GRU --- General Research Use","2020-07-31","2020-07-31","Cardiovascular Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs002035.v1.p1","National Heart, Lung and Blood Institute: Regulation of Motile Cilia    Assembly in Lung Disease","This study of 59 primary ciliary dyskinesia (PCD) patients utilized whole-exome capture sequencing to help identify variants that may be causative for PCD. Our goal was to provide insights into  disease pathophysiology in samples, most of which had no obvious phenotype from transmission electron microscopy. This class of patients has been","Not Applicable","Ciliary Motility Disorders","Case Set","Not Provided","WXS","4 phenotype datasets, 15 variables, 59 samples sequenced, 59 subjects, 59 samples","","NHLBI","GRU-IRB --- General Research Use (IRB), DS-LD-IRB --- Disease-Specific (Lung Diseases, IRB)","2020-07-29","2020-07-29","Ciliary Dyskinesia; Ciliary Dyskinesias; Ciliary Motility Disorder; Dextrocardia bronchiectasis and sinusitis; Dextrocardia-bronchiectasis-sinusitis syndrome; Disorder, Ciliary Motility",""
"phs001648.v2.p1","Genomic Characterization of Metastatic Castration Resistant Prostate    Cancer","Biopsies of castration resistant prostate cancer metastases were subjected to whole genome sequencing (WGS), along with RNA-sequencing (RNA-Seq). The overarching goal of the study is to illuminate molecular mechanisms of  acquired resistance to therapeutic agents, and particularly androgen signaling inhibitors, in the treatment of metastatic castration resistant","Not Applicable","Prostatic Neoplasms, Castration-Resistant","Prospective Longitudinal Cohort","Not Provided","Bisulfite-Seq","4 phenotype datasets, 13 variables, 100 samples sequenced,  SRA, 101 subjects, 311 samples","","NCI","GRU --- General Research Use","2020-07-28","2019-05-02","Neoplasm Metastasis; Metastase; Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002025.v1.p1","Early Progression to Active Tuberculosis is a Highly Heritable Trait    Driven by 3q23 in Peruvians","In a genome-wide genetic study of early progression to active tuberculosis (TB), we genotyped 4,002 active TB cases and their household contacts in Lima, Peru. We first established TB progression  has a strong genetic basis, and is comparable to traits with well-established genetic bases (h2g 0.212). We identified a novel association between","Not Applicable","Tuberculosis, Pulmonary","Case-Control","target_markerset_grc38","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 3999 subjects, 4002 samples","European (5), African American (5), Hispanic1 (1), Hispanic2 (3761), Other Asian or Pacific Islander (1), Other (226)","NIAID","GRU --- General Research Use","2020-07-23","2020-07-23","Latent Tuberculosis; Infection, Latent Tuberculosis; Infections, Latent Tuberculosis; LTBI; LTBI - Latent tuberculosis infection; Latent Tuberculoses",""
"phs000725.v2.p1","Rare Cancer Tumors Project","A large proportion of common cancers affecting patients around the world have been selected for comprehensive cancer genome studies. Further efforts will be needed to tackle the remaining tumor types,  including the rare forms of cancers. Although rare, these cancers tend to be more aggressive and fast growing with an early recurrence following","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","WES_markerset_grc37, custom_markerset","Not Provided","2 phenotype datasets, 11 variables, 248 samples sequenced,  SRA, 99 subjects, 248 samples, 3 substudies","","NHGRI","GRU --- General Research Use","2020-07-23","2020-07-23","Carcinoma, Embryonal; Choriocarcinoma; Endodermal Sinus Tumor; Germinoma; Neoplasms, Germ Cell and Embryonal; Teratoma",""
"phs000861.v2.p1","Whole Exome Sequencing of Craniopharyngioma Tumors","This sub-study phs000861 Craniopharyngioma Tumors molecular and phenotype data of subjects available from the phs000861 study. Summary level phenotypes for the NHGRI Rare Cancer Tumors study participants can be viewed  at the top-level study page phs000725 Rare Cancer Tumors Cohort. Individual level phenotype data and molecular data for all Rare Cancer Tumors Cohort","Rare Cancer Tumors Project (phs000725.v2.p1)","Craniopharyngioma","Prospective Longitudinal Cohort","Not Provided","WXS, WXS","2 phenotype datasets, 10 variables, 58 samples sequenced,  SRA, 29 subjects, 58 samples","","NHGRI","GRU --- General Research Use","2020-07-23","2020-07-23","Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain",""
"phs000859.v2.p1","Integrated Genomic Analysis of Sezary Syndrome","This sub-study phs000859 Sezary Syndrome Genomic Analysis molecular and phenotype data of subjects available from the phs000859 study. Summary level phenotypes for the NHGRI Rare Cancer Tumors study participants can  be viewed at the top-level study page phs000725 Rare Cancer Tumors Cohort. Individual level phenotype data and molecular data for all Rare Cancer","Rare Cancer Tumors Project (phs000725.v2.p1)","Sezary Syndrome","Prospective Longitudinal Cohort","custom_markerset","SNP Genotypes (Array), RNA-Seq, WXS, SNP Genotypes (Array), RNA-Seq, WXS","2 phenotype datasets, 10 variables, 1 molecular datasets, 134 samples sequenced,  SRA, 42 subjects, 134 samples","European (24), African American (6), Hispanic1 (1), Hispanic2 (4), Other Asian or Pacific Islander (1)","NHGRI","GRU --- General Research Use","2020-07-23","2020-07-23","Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum Cell Sarcomas",""
"phs000754.v2.p1","HGSC-BCM Whole-exome Sequencing of Intracranial Germ Cell Tumors (IGCTs)","This sub-study phs000754 Intracranial Germ Cell Tumors molecular and phenotype data of subjects available from the phs000754 study. Summary level phenotypes for the NHGRI Rare Cancer Tumors study participants can  be viewed at the top-level study page phs000725 Rare Cancer Tumors Cohort. Individual level phenotype data and molecular data for all Rare Cancer","Rare Cancer Tumors Project (phs000725.v2.p1)","Neoplasms","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 8 variables, 1 molecular datasets, 56 samples sequenced,  SRA, 28 subjects, 56 samples","","NHGRI","GRU --- General Research Use","2020-07-23","2020-07-23","Carcinoma, Embryonal; Choriocarcinoma; Endodermal Sinus Tumor; Germinoma; Neoplasms, Germ Cell and Embryonal; Teratoma",""
"phs001835.v1.p1","Whole-Exome Sequencing and Targeted DNA Sequencing of Matched Ocular    Melanocytosis and Uveal Melanoma","Ocular melanocytosis is the most important predisposing condition for the eye cancer uveal melanoma (UM). Here we used whole-exome and deep targeted sequencing to identify for the first time a  clonal Gq pathway mutation in ocular melanocytosis, which gave rise to UM. Additionally, we elucidated the order in which canonical genetic","Not Applicable","Uveal Melanoma","Case Set","Not Provided","WXS","3 phenotype datasets, 17 variables, 3 samples sequenced, 1 subjects, 3 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2020-07-21","2020-07-21","Not Provided",""
"phs001778.v1.p1","Myelodysplastic Syndrome (MDS) in Humanized Mice","This study was to develop a faithful pre-clinical MDS patient-derived xenotransplantation model in cytokine-humanized immunodeficient ""MISTRG"" mice. We performed targeted genome sequencing on bone marrow from patients with MDS or  AML and from bone marrow of mice engrafted with the respective patient bone marrow. Cytokine-humanized immunodeficient mice faithfully replicate","Not Applicable","Myelodysplastic Syndromes","Case Set","target_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 11 subjects, 11 samples","","NIDDK","DS-MDS --- Disease-Specific (Myelodysplasia)","2020-07-21","2020-07-21","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs000480.v1.p1","Familial Breast Cancer Study (FBCS)","Breast cancer has a significant genetic component. The strongest epidemiologic risk factor is family history of the disease. Familial studies have identified a number of genes contributing to increased risk.  Of these, the highly penetrant BRCA1 and BRCA2 genes account for the majority of families in whom disease-causal mutations have been identified.","Not Applicable","Breast Neoplasms","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 1 documents, 1 molecular datasets, 126 samples sequenced,  SRA, 136 subjects, 129 samples","","NCI","DS-BRCA --- Disease-Specific (Breast Cancer)","2020-07-21","2020-07-21","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001990.v1.p1","Epigenomics of Patient Outcomes after SAH","This project was focused on understanding the pathophysiology following aneurysmal subarachnoid hemorrhage (aSAH). DNA methylation is a key mechanism for regulation of gene expression and function in the adult brain  and appears to play an important role in neuroprotection during ischemic events in the brain. Delayed cerebral ischemia (DCI), occurring during the","Not Applicable","Subarachnoid Hemorrhage","Prospective Longitudinal Cohort","HumanMethylation450","Methylation (CpG)","4 phenotype datasets, 40 variables, 1 molecular datasets, 283 subjects, 1152 samples","","NINR","DS-CASH-IRB-PUB-MDS-GSO --- Disease-Specific (cerebral aneurysm or subarachnoid hemorrhage, IRB, PUB, MDS, GSO)","2020-07-17","2020-07-17","Aneurysmal Subarachnoid Hemorrhage; Hemorrhage, Subarachnoid; Hemorrhages, Subarachnoid; SAH (Subarachnoid Hemorrhage); SAH - Subarachnoid hemorrhage; SAHs (Subarachnoid Hemorrhage)",""
"phs001683.v2.p1","CSER: Incorporation of Genomic Sequencing into Pediatric Cancer Care","This project includes data derived from subjects enrolled in the BASIC3 (Baylor College of Medicine Advancing Sequencing in Childhood Cancer Care) study. BASIC3 is a National Genome Human Research Institute  (NHGRI) and National Cancer Institute-funded Clinical Sequencing Exploratory Research (CSER) consortium project that focused on prospective","Not Applicable","Genes, Neoplasm","Prospective Longitudinal Cohort","Not Provided","Not Provided","3 phenotype datasets, 17 variables, 482 samples sequenced,  SRA, 631 subjects, 773 samples, 2 substudies","","NHGRI","GRU-PUB --- General Research Use (PUB)","2020-07-17","2019-08-20","Bone Neoplasms; Soft Tissue Neoplasms; Bone Cancer; CA - bone cancer; Cancer of Bone; Cancer of the Bone",""
"phs001620.v1.p1","GUARDD Study","People of African ancestry (Blacks) have increased risk of kidney failure due to numerous socioeconomic, environmental, and clinical factors. Two variants in the APOL1 gene (GeneID: 8542) are now thought  to account for much of the racial disparity associated with hypertensive kidney failure in Blacks. One in 7 AAs carry this risk allele, but it is","Not Applicable","Apolipoprotein L1","Clinical Genetic Testing","target_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 33 variables, 1 molecular datasets,  SRA, 2052 subjects, 2011 samples","","NHGRI","HMB-GSO --- Health/Medical/Biomedical (GSO)","2020-07-17","2020-07-17","End-Stage Kidney Disease; Hypertension; Kidney Failure, Chronic; CRF - Chronic Renal Failure; Chronic Kidney Failure; Chronic Renal Disease",""
"phs001878.v2.p1","Gabriella Miller Kids First Pediatric Research Program in Novel Cancer    Susceptibility in Families (from BASIC3)","This sub-study phs001878 GMKF BASIC3 contains sequence data, and selected phenotype of subjects available from the phs001878 study. Summary level phenotypes for the NCI Clinical Sequencing Exploratory Research Consortium Cohort  study participants can be viewed at the top-level study page phs001683 Clinical Sequencing Exploratory Research Consortium Cohort. Individual level","Clinical Sequencing Exploratory Research Consortium: Incorporation of Genomic Sequencing into Pediatric Cancer Care (phs001683.v2.p1)","Genes, Neoplasm","Prospective Longitudinal Cohort","Not Provided","Not Provided","291 samples","","NHGRI","GRU-PUB --- General Research Use (PUB)","2020-07-17","2019-08-20","Bone Neoplasms; Soft Tissue Neoplasms; Bone Cancer; CA - bone cancer; Cancer of Bone; Cancer of the Bone",""
"phs001026.v3.p1","BCM Advancing Sequencing in Childhood Cancer Care Study (BASIC3)","This sub-study phs001026 BASIC3 contains sequence data, and selected phenotype of subjects available from the phs001026 study. Summary level phenotypes for the NCI Clinical Sequencing Exploratory Research Consortium Cohort study  participants can be viewed at the top-level study page phs001683 Clinical Sequencing Exploratory Research Consortium Cohort. Individual level","Clinical Sequencing Exploratory Research Consortium: Incorporation of Genomic Sequencing into Pediatric Cancer Care (phs001683.v2.p1)","Genes, Neoplasm","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","2 phenotype datasets, 13 variables, 482 samples sequenced,  SRA, 252 subjects, 482 samples","","NHGRI","GRU-PUB --- General Research Use (PUB)","2020-07-17","2019-08-20","Bone Neoplasms; Soft Tissue Neoplasms; Bone Cancer; CA - bone cancer; Cancer of Bone; Cancer of the Bone",""
"phs001573.v1.p1","Intra-Tumor Heterogeneity and Clonal Evolution of Papillary Renal Cell    Carcinoma","Limited knowledge of intratumor heterogeneity (ITH), and clonal evolution of papillary renal cell carcinoma (pRCC) and rare kidney tumor subtypes hinders understanding of tumorigenesis and therapeutic efficacy. We conducted an  integrative genomic and epigenomic ITH analysis and studied clonal evolutionary history of pRCC and rare kidney tumor subtypes. We dissected multiple","Not Applicable","Carcinoma, Renal Cell","Case Set","HumanMethylation450, HumanOmniExpress-24","Methylation (CpG), SNP Genotypes (Array), Targeted-Capture, WGS","4 phenotype datasets, 13 variables, 1 molecular datasets, 263 samples sequenced,  SRA, 39 subjects, 502 samples","","NCI","GRU --- General Research Use","2020-07-14","2020-07-14","Sarcoma; ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell",""
"phs000723.v1.p1","Sequencing of Cervical Cancer","Precision mapping of genetic alterations in cancer can enable better selection of therapies and improved outcomes when combined with new sequencing diagnostics. We describe whole-exome sequences from cervical adenocarcinomas and  paired normal samples in Hong Kong Chinese women. These data uncover a heterogeneous genomic landscape but identify commonly aberrant loci including","Not Applicable","Uterine Cervical Neoplasms","Case-Control","Not Provided","Targeted-Capture","4 phenotype datasets, 29 variables, 29 samples sequenced,  SRA, 15 subjects, 29 samples","","NCI","GRU-NPU-MDS --- General Research Use (NPU, MDS)","2020-07-14","2020-07-14","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms",""
"phs001779.v1.p1","CIDR-NIA Whole Exome Analysis of Ehlers-Danlos Syndrome","The Ehlers-Danlos syndromes (EDS) are a family of hereditary disorders of connective tissue characterized by joint hypermobility and skin involvement with soft, translucent, stretchy skin, and atrophic scarring. To date,  over 12 different types of EDS are known, and the genes causing almost all of them have been found. However, the gene(s) underlying the most common","Not Applicable","Ehlers-Danlos syndrome type 3","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 90 variables, 1 molecular datasets, 160 samples sequenced,  SRA, 153 subjects, 160 samples","","NIA","DS-HCT-IRB-COL-GSO-RD --- Disease-Specific (Hereditary connective tissue disorders, IRB, COL, GSO, RD)","2020-07-13","2020-07-13","Ehlers-Danlos Syndrome; Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified; Cutis Elastica; Cutis hyperelastica; Cutis hyperelastica dermatorrhexis; Danlos Disease, Ehlers",""
"phs002030.v1.p1","Impact of Mobile Element Insertions on Human Transcriptome Variation","Mobile DNA elements are ubiquitous in nearly all species and mobile element insertions can affect nearby gene expression through many mechanisms, from disrupting coding regions to initiating DNA methylation to  altering RNA splicing patterns. Thousands of mobile element insertions are still polymorphic in human populations, and these polymorphic mobile","Not Applicable","Reference Values","Cross-Sectional","WGS_markerset_grc38","CNV Genotypes","3 phenotype datasets, 10 variables, 1 molecular datasets, 638 subjects, 638 samples","","NHGRI","GRU --- General Research Use","2020-07-10","2020-07-10","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001994.v1.p1","Smoking and Tumor Immune Microenvironment in HNSCC","This study was designed to measure immune cell differences between HNSCC patients according to smoking history. We measured CD3, CD8, FoxP3, PD-1 and PD-L1 for immune markers and Pancytokeratin to  distinguish between tumor and surrounding tissue. We observed that current smokers have significantly lower numbers of immune cells surrounding the","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 26 variables, 120 samples sequenced,  SRA, 61 subjects, 120 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2020-07-09","2020-07-09","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx",""
"phs000277.v2.p1","International Consortium on the Genetics of Heroin Dependence","This collaboration of Australian and American investigators aims to identify genes associated with liability for heroin dependence. The project uses a case-control design in which cases met lifetime DSM-IV criteria  for heroin dependence. Controls included assessed individuals who did not meet DSM-IV heroin dependence criteria and unassessed general population","Not Applicable","Heroin Dependence","Case-Control","Human660W-Quad, HumanCNV370-Duo, Human610-Quad","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 108 variables, 1 molecular datasets, 22 samples sequenced, 6488 subjects, 6754 samples","European (6069), East Asian (69), African American (6), Hispanic1 (47), Hispanic2 (33), Other Asian or Pacific Islander (68), South Asian (21), Other (172)","NIDA","SUD --- Substance Use Dependence Only, RATRP --- Research on Alcohol and Tobacco Related Phenotypes, SUDCT --- Substance Dependence, Childhood Trauma and Related Disorders, ARC --- Alcohol Related Conditions","2020-07-09","2014-08-14","Addiction, Heroin; Dependence on diamorphine; Dependence, Heroin; Heroin Addiction",""
"phs002023.v1.p1","Drug Screening of Patient-Derived Organoids from Colorectal Peritoneal    Metastases","Colorectal cancer (CRC) patients with peritoneal metastases (CRPM) have limited treatment options and the lowest CRC survival rates. We trialed the possibility of organoid directed precision treatment for CRPM patients.  CRPM organoids (peritonoids) isolated from patients underwent next-generation sequencing and medium-throughput drug panel testing ex vivo to identify","Not Applicable","Peritoneal Neoplasms","Prospective Longitudinal Cohort","Not Provided","WXS","5 phenotype datasets, 16 variables, 30 samples sequenced,  SRA, 14 subjects, 30 samples","","NCI","GRU --- General Research Use","2020-07-08","2020-07-08","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001883.v1.p1","Whole Exome Sequencing of DNA in Breast Cancers Enrolled in the S0800    Trial","Purpose: The purpose of this study was to assess the somatic mutation landscape of breast tumors before and after neoadjuvant chemotherapy. The data includes whole exome sequencing of pre- and  post- tissues that were collected in the context of an already published clinical trial SWOG S0800 (ZA Nahleh et al. Breast Cancer Research and","Not Applicable","Breast Neoplasms","Clinical Trial","Not Provided","WXS","5 phenotype datasets, 20 variables, 45 samples sequenced, 29 subjects, 45 samples","","NCI","GRU-COL --- General Research Use (COL)","2020-07-08","2020-07-08","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001630.v1.p1","The Immunogenetics of Measles Immunity (NIAID/NIH)","To examine the role of gene polymorphisms (including functional studies of SNPs) on variations in vaccine-induced immune responses, in approximately 3,000 healthy school-age children, adolescents and young adults/adults, who were  vaccinated with measles-containing vaccine (MMR). To achieve greatest power to detect SNPs associated with measles-specific immune response","Not Applicable","Measles Vaccine","Prospective Longitudinal Cohort","HumanHap550, HumanHap650Y, HumanOmni1-Quad, HumanOmni1S-8","SNP Genotypes (Array)","5 phenotype datasets, 82 variables, 3 documents, 1 molecular datasets, 2676 subjects, 2676 samples","European (1932), African (13), African American (308), Hispanic1 (79), Hispanic2 (288), Other Asian or Pacific Islander (14), South Asian (8), Other (34)","NIAID","GRU-IRB --- General Research Use (IRB)","2020-07-08","2020-07-08","Not Provided",""
"phs001829.v1.p1","Molecular Characterization of Response to Rectal Chemoradiation","Pre-operative chemoradiation (CRT) followed by resection is the standard of care option for patients with locally advanced rectal adenocarcinoma. Pathologic downstaging after CRT is associated with improved outcomes, but molecular  predictors of response are poorly understood. We performed whole exome sequencing, gene expression profiling, and immune infiltrate analysis on","Not Applicable","Rectal Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 19 variables, 48 samples sequenced,  SRA, 17 subjects, 48 samples","","NCI","DS-GID-MDS --- Disease-Specific (Gastrointestinal Diseases, MDS)","2020-07-06","2020-07-06","Cancer of Rectum; Cancer of the Rectum; Cancer, Rectal; Cancer, Rectum; Carcinoma of Rectum; Carcinoma of the Rectum",""
"phs002036.v1.p1","Chromoanasynthesis as a Cause of Jacobsen Syndrome","Jacobsen syndrome (OMIM #147791) is a rare multisystem genomic disorder involving craniofacial abnormalities, intellectual disability, other neurodevelopmental defects and terminal truncation of chromosome 11q, typically deleting 170 to 340 genes.  We describe the first case of Jacobsen syndrome caused by congenital chromoanasynthesis, an extreme form of complex chromosomal rearrangement. Six","Not Applicable","Jacobsen Distal 11q Deletion Syndrome","Case Set","Not Provided","WGS","4 phenotype datasets, 17 variables, 1 samples sequenced,  SRA, 1 subjects, 1 samples","","NIAID","HMB-IRB --- Health/Medical/Biomedical (IRB)","2020-07-02","2020-07-02","Chromothripsis; Chromosome Shattering; Chromosome Shatterings; Chromothripses; Shattering, Chromosome; 11q Deletion Disorder",""
"phs002017.v1.p1","Circulating RNA Profiles of Healthy and Preeclamptic Pregnancies","This prospective study investigated whether circulating RNA (C-RNA; cell free RNA present in the bloodstream) measurements could non-invasively monitor pregnancy status, with emphasis on detecting molecular markers associated with preterm  preeclampsia. Whole blood samples were collected from pregnant women at the time of diagnosis with early-onset preeclampsia with severe features.","Not Applicable","Pre-Eclampsia","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 21 variables, 289 samples sequenced,  SRA, 178 subjects, 289 samples","","NICHD","HMB --- Health/Medical/Biomedical, HMB-IRB --- Health/Medical/Biomedical (IRB)","2020-07-01","2020-07-01","Pregnancy Complications; EPH - Edema, proteinuria and hypertension of pregnancy; EPH Complex; EPH Gestosis; EPH Toxemia; EPH Toxemias",""
"phs001979.v1.p1","Genomic Landscape of Human Skin at a Single-Cell Resolution","Every cell in the human body has a unique set of somatic mutations, yet it remains difficult to comprehensively genotype an individual cell. Here, we developed solutions to overcome this  obstacle in the context of normal human skin, thus offering the first glimpse into the genomic landscapes of melanocytes at single-cell resolution.","Not Applicable","Melanoma","Cross-Sectional","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS), Targeted-Capture, WXS","4 phenotype datasets, 21 variables, 1 molecular datasets, 355 samples sequenced,  SRA, 7 subjects, 355 samples","","NCI","GRU --- General Research Use","2020-07-01","2020-07-01","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001180.v2.p1","Genes-Environments and Admixture in Latino Asthmatics (GALA II) Study","A case-control pharmacogenetic study of bronchodilator drug response among racially admixed Latino children with asthma. Each participant had two spirometry measurements using the KoKo PFT System. With the first spirometry  test, participant was administered with 4 puffs of HFA Albuterol. The second albuterol measurement was based on age, for participants under 16 years","Not Applicable","Lung Diseases","Case-Control","Axiom_GW_LAT","Not Provided","4 phenotype datasets, 26 variables, 4458 subjects, 4427 samples, 1 substudies","","NHLBI","DS-LD-IRB-COL --- Disease-Specific (Lung Diseases, IRB, COL)","2020-07-01","2017-12-20","Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders; Lung disorder",""
"phs001274.v2.p1","Genes-environments and Admixture in Latino Asthmatics (GALA II) GWAS    Study","This study contains Genome Wide Association sequence data and phenotype variables. A case-control pharmacogenetic study of bronchodilator drug response among racially admixed Latino children with asthma. The overall goal is  to identify genetic factors which are predictive of drug response in children with asthma. The principal tools include a questionnaire and biological","Genes-Environments and Admixture in Latino Asthmatics (GALA II) Study (phs001180.v2.p1)","Asthma","Case-Control","Axiom_GW_LAT","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 4427 subjects, 4427 samples","European (27), African American (210), Hispanic1 (1735), Hispanic2 (1978), Other (477)","NHLBI","DS-LD-IRB-COL --- Disease-Specific (Lung Diseases, IRB, COL)","2020-07-01","2017-12-20","Lung Diseases; Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma",""
"phs001085.v1.p1","Genetic History of Melanesian Individuals","This study describes high-coverage whole-genome sequencing of 35 individuals sampled from the Bismarck Archipelago of Northern Island Melanesia, Papua New Guinea as described in PMID: 26989198 Principal Investigator: Joshua M  Akey, PhD, Department of Genome Sciences, University of Washington, WA, USA Co-Investigator: Svante P&#x000e4;&#x000e4;bo, Department of Evolutionary","Not Applicable","Neanderthals","Collection","WGS_markerset_grc37","SNP Genotypes (NGS), WGS","3 phenotype datasets, 14 variables, 1 molecular datasets, 35 samples sequenced,  SRA, 35 subjects, 35 samples","","NIGMS","GRU-NPU --- General Research Use (NPU)","2020-06-29","2020-06-29","Not Provided",""
"phs001222.v1.p1","CCDG - Whole Genome Sequencing in Type 1 Diabetes (T1DGC)","The Type 1 Diabetes Genetics Consortium (T1DGC) was established to collect resources (biological samples and data) and conduct research to better understand the genetic basis of type 1 diabetes (T1D).  Collection was initiated by ascertaining affected sib-pair families (both parents, two affected siblings and, when available, an unaffected sibling),","Not Applicable","Diabetes Mellitus, Type 1","Case-Control","WGS_markerset_grc38","SNP Genotypes (NGS), CNV (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets,  SRA, 1414 subjects, 1414 samples","European (17), African (46), African American (1200), Hispanic1 (47), Hispanic2 (95), Other (9)","NHGRI","DS-DRC-IRB-NPU --- Disease-Specific (Diabetes and Related Complications, IRB, NPU)","2020-06-25","2020-06-25","DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes Mellitus, Sudden Onset",""
"phs001969.v1.p1","Cellular Origins and Genetic Landscape of Cutaneous GD T Cell Lymphoma","Cutaneous gamma-delta T cell lymphomas are a rare and aggressive subtype of cutaneous lymphoma. In the present study, we analyzed these cancers by DNA and RNA sequencing in order to  illuminate the genetic landscape for this rare disease. We obtained tumor samples from multiple institutions, including Northwestern University","Not Applicable","Lymphoma, T-Cell, Cutaneous","Case Set","Not Provided","OTHER, RNA-Seq, Targeted-Capture, WGS, WXS","4 phenotype datasets, 18 variables, 37 samples sequenced,  SRA, 20 subjects, 37 samples","","NCI","GRU --- General Research Use","2020-06-24","2020-06-24","Granulomatous Slack Skin; Slack Skin, Granulomatous","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001738.v1.p1","Kids First Pediatric Research Study in Familial Predisposition to    Hematopoietic Malignancies (SJFAMILY-HM)","Acute lymphoblastic leukemia (ALL) is the commonest childhood tumor and a leading cause of cancer death in children, adolescents and young adults. Hodgkin and non-Hodgkin lymphoma are also important hematologic  malignancies (HM) that occur in children. Each are genetic diseases with growing evidence for a germline predisposition of both familial and sporadic","Not Applicable","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 5 variables,  SRA, 366 subjects, 373 samples","","NCI","GRU --- General Research Use","2020-06-18","2020-06-18","Hodgkin Disease; Lymphoma, Non-Hodgkin; CHL; Classic Hodgkin disease; Disease, Hodgkin; Disease, Hodgkin's","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000999.v3.p1","CSER: Clinical Sequencing in Cancer: Clinical, Ethical, and Technological    Studies","The Clinical Sequencing Exploratory Research (CSER) program supports multi-disciplinary projects that bring together clinicians, bioinformaticians, and ethicists to research the challenges of utilizing genomic sequence data in the clinic in  the routine practice of medicine. The challenges are many and not disease-specific. Important aims of the research include: development of technical","Not Applicable","Colorectal Neoplasms","Prospective Longitudinal Cohort","HumanOmniExpressExome-8, WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 19 variables, 2 molecular datasets, 158 samples sequenced,  SRA, 242 subjects, 242 samples","","NHGRI","GRU --- General Research Use","2020-06-18","2020-06-18","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001794.v1.p1","Beckwith-Wiedemann Syndrome (BWS) Study","miRNA data from Beckwith-Wiedemann syndrome patients was compared with samples from large overgrowth syndrome animals (GSE117015). Tongue samples from patients with Beckwith-Wiedemann Syndrome were included. Principal Investigator: Jennifer Kalish, MD,  PhD, Children's Hospital of Philadelphia, Philadelphia, PA, USA Funding Sources: K08 CA193915, National Institutes of Health, Bethesda, MD, USA","Not Applicable","Beckwith-Wiedemann Syndrome","Prospective Longitudinal Cohort","Not Provided","miRNA-Seq","4 phenotype datasets, 14 variables, 12 samples sequenced,  SRA, 12 subjects, 12 samples","","NCI","GRU --- General Research Use","2020-06-16","2020-06-16","Macroglossia; BWS; Beckwith Wiedemann Syndrome; Beckwith's syndrome; Beckwith-Wiedemann syndrome chromosome region; EMG SYNDROME","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002044.v1.p1","CCDG-Neuropsychiatric: Victorian Collaborative AuTism Study (CATS)","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","Not Provided","Not Provided","Not Provided","","NHGRI","DS-ASD-IRB --- Disease-Specific (Autism Spectrum Disorder, IRB)","2020-06-12","","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs001970.v1.p1","DNA Methylation in Rhabdomyosarcoma","Rhabdomyosacoma (RMS) is a common pediatric soft tissue tumor that is associated with the skeletal muscle lineage. RMS comprises two major subtypes: fusion-positive (FP, most commonly PAX3- FOXO1 or PAX7-FOXO1)  and fusion-negative (FN, frequently associated with mutations in RAS pathway). Our previous study demonstrated that FP and FN tumors exhibit distinct","Not Applicable","Rhabdomyosarcoma","Case Set","HumanMethylation450","Methylation (CpG)","3 phenotype datasets, 12 variables, 1 molecular datasets, 134 subjects, 134 samples","","NCI","GRU --- General Research Use","2020-06-12","2020-06-12","Not Provided","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs002043.v1.p1","CCDG Neuropsychiatric: Multimodal Developmental Neurogenetics of Females","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use, DS-AASD --- Disease-Specific (Autism or Autism Spectrum Disorder)","2020-06-11","","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs002042.v1.p1","CCDG Neuropsychiatric: Autism Center of Excellence (ACE II)","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","Not Provided","Not Provided","Not Provided","","NHGRI","GRU --- General Research Use, DS-ASD --- Disease-Specific (Autism Spectrum Disorder)","2020-06-11","","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs002024.v1.p1","DCCT/EDIC Epigenetics (DNA Methylation) Study","Metabolic memory (persistent benefits of early glycemic control on preventing/delaying diabetic complications development) was observed in the Diabetes Control and Complications Trial (DCCT) and follow-up Epidemiology of Diabetes Interventions and  Complications (EDIC) study, dbGaP phs000086.v3.p1, but mechanisms are unclear. We investigated the involvement of epigenetic DNA methylation (DNAme)","Not Applicable","Diabetes Mellitus, Type 1","Prospective Longitudinal Cohort","MethylationEPIC","Methylation (CpG)","4 phenotype datasets, 23 variables, 1 molecular datasets, 499 subjects, 499 samples","","NIDDK","GRU-IRB-PUB-NPU --- General Research Use (IRB, PUB, NPU)","2020-06-05","2020-06-05","Diabetic Nephropathies; Diabetic Retinopathy; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset",""
"phs001766.v1.p1","CCDG-Neuropsychiatric: Autism- Autism Genetic Resource Exchange (AGRE)","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","NHGRI","DS-ASD-IRB --- Disease-Specific (Autism Spectrum Disorder, IRB)","2020-06-05","","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs001339.v1.p1","Developmental Mechanisms of Human Congenital Heart Disease","The study is designed to identify genetic modifiers of cardiovascular defects in subjects with 22q11.2 deletion syndrome (22q11.2DS), also known as DiGeorge syndrome or velo-cardio-facial syndrome. Affymetrix 6.0 arrays were  processed on 1,480 subjects with known cardiovascular anomalies or with normal structures, all with 22q11.2DS. One sample is a duplicate so it was","Not Applicable","DiGeorge Syndrome","Case Set","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 22 variables, 1 molecular datasets, 1460 subjects, 1460 samples","","NICHD","GRU-IRB --- General Research Use (IRB)","2020-06-04","2020-06-04","22q11 Deletion Syndrome; Tetralogy of Fallot; 22q11 Deletion Syndromes; Deletion Syndrome, 22q11; Deletion Syndromes, 22q11; Syndrome, 22q11 Deletion",""
"phs001164.v1.p1","The Role of Germline Mutation and Parental Age in Autism Spectrum    Disorders","We will apply whole genome sequencing of trio families to determine how patterns of germline mutation throughout the genome determine risk for Autism Spectrum Disorder (ASD). We will investigate the  nature intrinsic hypermutability and the extrinsic forces, such as paternal age, that influence rates of germline mutation. We will accomplish these","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","WGS_markerset_grc36","SNP Genotypes (NGS)","5 phenotype datasets, 25 variables, 1 molecular datasets,  SRA, 41 subjects, 41 samples","","NIMH","GRU --- General Research Use","2020-06-04","2020-06-04","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NIH Autism -omics Studies (phs000764.v1.p1); Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs001959.v1.p1","Nanopore Sequencing of Chronic Lymphocytic Leukemia","While splicing changes caused by somatic mutations in SF3B1 are known, identifying full-length isoform changes may better elucidate the functional consequences of these mutations. We have performed nanopore sequencing of  full-length cDNA from CLL samples with and without SF3B1 mutation, as well as normal B cell samples. With long reads, we analyzed alternative","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case-Control","RNA_Nanopore_targeted","RNA-Seq, SRA Metadata","4 phenotype datasets, 16 variables, 1 molecular datasets, 12 samples sequenced,  SRA, 9 subjects, 12 samples","","NHGRI","GRU --- General Research Use","2020-06-02","2020-06-02","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs001997.v1.p1","Kids First: Genomics of African and Asian Orofacial Clefts Triads","The focus of this study is to identify novel risk variants for OFC in Africa and Asian OFC case-parent triads through analysis of Whole Genome Sequencing data. About 300 Case-parent  trio samples were selected for this whole genome sequencing as part of the Gabriella Miller Kids First Orofacial Clefts Projects. Samples of","Not Applicable","Cleft Lip","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 6 variables,  SRA, 791 subjects, 791 samples","","NCI","DS-OC-PUB-MDS --- Disease-Specific (Oral Clefts, PUB, MDS), GRU --- General Research Use","2020-05-22","2020-05-22","Cleft Palate; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001828.v1.p1","Genetic Studies of Chronic Kidney Disease (CKD)","The Genetic Studies of Chronic Kidney Disease (CKD) is an ongoing genetic research and biobanking protocol which aims to elucidate the genetic basis CKD. The study recruits patients seen at  the Columbia University Medical Center (CUMC) Nephrology Division for the evaluation and care of CKD. All patients clinically diagnosed with CKD are","Not Applicable","Renal Insufficiency, Chronic","Case Set","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets,  SRA, 1392 subjects, 1392 samples","","NIDDK","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2020-05-19","2020-05-19","Chronic Kidney Insufficiencies; Chronic Renal Insufficiencies; Chronic Renal Insufficiency; Chronic renal impairment; Kidney Insufficiencies, Chronic; Kidney Insufficiency, Chronic",""
"phs001360.v1.p1","Genome-Wide Association Study in African-Americans with RA","The Consortium for the Longitudinal Evaluation of African-Americans with Early Rheumatoid Arthritis (CLEAR) Registry and Repository, supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), was  established in 2000 to provide a resource for the scientific community to explore genetic and non-genetic factors affecting rheumatoid arthritis (RA)","Not Applicable","Arthritis, Rheumatoid","Case-Control","ImmunoArray, HumanOmni1S-8","SNP Genotypes (Array)","4 phenotype datasets, 26 variables, 8 documents, 2 molecular datasets, 1504 subjects, 2297 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2020-05-18","2020-05-18","",""
"phs001890.v1.p1","Single Molecule Molecular Inversion Probe Capture Developed Using CIViC","This study evaluated the use of the Clinical Interpretations of Variants in Cancer database (CIViC) to develop an Open-sourced CIViC Annotation Pipeline (OpenCAP). OpenCAP is a resource that allows users  to develop a clinical capture panel that can be linked back to clinical summaries within the CIViC database. This method for capture panel","Not Applicable","Database Management Systems","Tumor vs. Matched-Normal","Not Provided","AMPLICON","4 phenotype datasets, 14 variables, 31 samples sequenced,  SRA, 17 subjects, 31 samples","","NCI","GRU --- General Research Use, GRU-IRB --- General Research Use (IRB), DS-CA --- Disease-Specific (Cancer), DS-LC-IRB --- Disease-Specific (Lung Cancer, IRB)","2020-05-07","2020-05-07","Not Provided","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs002012.v1.p1","SEER Remote Access Pilot Test Data (2018)","This is a limited use Surveillance, Epidemiology, and End Results (SEER) file for use in a pilot test of remote data access. The SEER Program of the National Cancer Institute  (NCI) is an authoritative source of information on cancer incidence and survival in the United States. SEER currently collects and publishes cancer","Not Applicable","SEER Program","Methods","Not Provided","Not Provided","Not Provided","","NCI","GRU --- General Research Use","2020-05-05","","Not Provided","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001943.v1.p1","Hereditary Cancer Predisposition Syndromes and Uveal Melanoma","Uveal melanoma (UM) is a subtype of melanoma characterized by the strong contribution of genetic rather than environmental factors in the pathogenesis of the disease, making it an ideal model  disease to study the genetic basis of cancer. The long-term goal of our laboratory is to determine the genes and mechanisms responsible for","Not Applicable","Uveal Melanoma","Prospective Longitudinal Cohort","Not Provided","WXS","5 phenotype datasets, 19 variables, 34 samples sequenced,  SRA, 34 subjects, 34 samples","","NCI","DS-CA-PUB-NPU-MDS-GSO --- Disease-Specific (Cancer, PUB, NPU, MDS, GSO)","2020-05-01","2020-05-01","Cancer Syndrome, Hereditary; Cancer Syndromes, Hereditary; Familial Neoplastic Syndrome; Familial Tumor Syndrome; Germline Neoplastic Syndrome; Hereditary Cancer Syndrome",""
"phs000521.v2.p1","Episodic Ataxia Syndrome: Longitudinal Study","Individuals with episodic ataxia experience recurrent attacks of dizziness and incoordination; between attacks patients are typically normal. The majority of cases are likely caused by an inherited genetic mutation. However,  in some patients we are unable to identify the mutation. So far, 2 genes have been identified which cause different types of episodic ataxia.","Not Applicable","Ataxia","Prospective Longitudinal Cohort","Not Provided","Not Provided","15 phenotype datasets, 1885 variables, 10 documents, 131 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2020-05-01","2017-10-26","Ataxia (loss of muscle coordination); Ataxia,; Ataxias; Ataxy; Cerebellar ataxia; Coordination Impairment",""
"phs001676.v1.p1","CCDG- Neuropsychiatric: Autism - Simons Simplex Collection (SSC)","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Prospective Longitudinal Cohort","Not Provided","Not Provided","5 phenotype datasets, 19 variables,  SRA, 9201 subjects, 9201 samples","","NHGRI","DS-AONDD-IRB --- Disease-Specific (Autism or other Neurodevelopmental Disease, IRB)","2020-04-29","2020-04-29","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs001650.v1.p1","Genetic and Genomic Stability Across Lymphoblastoid Cell Line Expansions","This study was focused on exploring genetic and genomic stability across cell line expansions. We used DNA and cell lines sampled from six apparently healthy research participants. We assayed genome-wide  genetic variants and inferred structural variants for DNA extracted from blood, from transformed cell cultures, and from three generations of","Not Applicable","Control Groups","Control Set","","SNP Genotypes (Array)","3 phenotype datasets, 11 variables, 1 molecular datasets, 6 subjects, 129 samples","","NIGMS","GRU --- General Research Use","2020-04-29","2020-04-29","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000287.v7.p1","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational    study of risk factors for cardiovascular disease in adults 65 years or    older","The Cardiovascular Health Study (CHS) is a prospective study of risk factors for development and progression of CHD and stroke in people aged 65 years and older. The 5,888 study  participants were recruited from four U.S. communities and have undergone extensive clinic examinations for evaluation of markers of subclinical","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","CVDSNP55, HumanCNV370-Duo, WES_markerset_grc37, custom_PCR_marker_set, HumanOmni1-Quad, WES_markerset_grc36, target_markerset_grc37, WGS_markerset_grc37, Cardio-Metabo_Chip, HumanExome-12","Not Provided","56 phenotype datasets, 14717 variables, 22 documents, 3922 samples sequenced, 5609 subjects, 17192 samples, 5 substudies","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), DS-CVD-NPU-MDS --- Disease-Specific (Cardiovascular Disease, NPU, MDS)","2020-04-29","2018-01-13","Aging; Angina Pectoris; Atherosclerosis; Cerebrovascular Disorders; Diabetes Mellitus; Heart Failure","NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs000667.v4.p1","Building on GWAS for NHLBI-Diseases: The U.S. CHARGE Consortium -    Sequencing (CHARGE-S): CHS","Note: This substudy phs000667 CHARGE-S Cardiovascular Health Study contains harmonized phenotype data, whole genome, exome, targeted sequencing and exome chip data of a subset of the CHS cohort selected for  NHLBI's CHARGE-S CONSORTIUM Project. Summary level phenotypes of the Cardiovascular Health Cohort study participants may be viewed at the top-level","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v7.p1)","Cardiovascular Diseases","Prospective Longitudinal Cohort","target_markerset_grc37, WGS_markerset_grc37, WES_markerset_grc37, HumanExome-12","SNP Genotypes (Array), SNP Genotypes (NGS), WGS, WXS","4 phenotype datasets, 37 variables, 3 molecular datasets, 3715 samples sequenced,  SRA, 5188 subjects, 8743 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), DS-CVD-NPU-MDS --- Disease-Specific (Cardiovascular Disease, NPU, MDS)","2020-04-29","2018-01-13","Atherosclerosis; Atrial Fibrillation; Heart Failure, Congestive; Hypertension; Osteoporosis; Pulmonary Disease, Chronic Obstructive",""
"phs000400.v6.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)","Note: This substudy phs000400 GO-ESP Cardiovascular Health Study contains harmonized phenotype data, whole exome sequencing and .vcf data of the subset of the CHS cohort selected for NHLBI's GO-ESP Exome  Sequencing Project. Summary level phenotypes of the Cardiovascular Health Cohort study participants may be viewed at the top-level study page,","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v7.p1)","Cardiovascular Diseases","Prospective Longitudinal Cohort","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (NGS), WXS","2 phenotype datasets, 118 variables, 3 molecular datasets, 211 samples sequenced,  SRA, 210 subjects, 211 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), DS-CVD-NPU-MDS --- Disease-Specific (Cardiovascular Disease, NPU, MDS)","2020-04-29","2018-01-13","Brain Ischemia; Myocardial Infarction; Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies",""
"phs000377.v6.p1","NHLBI Cardiovascular Health Study (CHS) Candidate Gene Association    Resource (CARe)","Note: This substudy phs000377 CARe Cardiovascular Health Study contains 50K genotypes from 2,100 candidate genes produced as part of NHLBI's Candidate-Gene Association Resource (CARe) project. Summary level phenotypes for the  Cardiovascular Health Study Cohort study participants can be viewed at the top-level study page phs000287 Cardiovascular Health Study (CHS) Cohort.","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v7.p1)","Cardiovascular Diseases","Prospective Longitudinal Cohort","CVDSNP55","SNP Genotypes (Array)","1 phenotype datasets, 2 variables, 1 molecular datasets, 5279 subjects, 5282 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), DS-CVD-NPU-MDS --- Disease-Specific (Cardiovascular Disease, NPU, MDS)","2020-04-29","2018-01-13","Angina Pectoris; Atherosclerosis; Diabetes Mellitus; Heart Failure; Intermittent Claudication; Ischemic Attack, Transient",""
"phs000301.v6.p1","PAGE: CALiCo: Cardiovascular Health Study (CHS)","Note: This substudy phs000301 PAGE Cardiovascular Health Study contains genotypes on selected SNP loci of the subset of the CHS cohort selected for the NHGRI's Population Architecture using Genomics and  Epidemiology (PAGE) project. Summary level phenotypes for the Cardiovascular Health Study Cohort study participants can be viewed at the top-level","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v7.p1)","Cardiovascular Diseases","Prospective Longitudinal Cohort","custom_PCR_marker_set, Cardio-Metabo_Chip","SNP Genotypes (Array), SNP Genotypes (PCR)","1 phenotype datasets, 5 variables, 4 analyses, 2 molecular datasets, 5346 subjects, 5346 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), DS-CVD-NPU-MDS --- Disease-Specific (Cardiovascular Disease, NPU, MDS)","2020-04-29","2018-01-13","Angina Pectoris; Atherosclerosis; Diabetes Mellitus; Heart Failure; Intermittent Claudication; Ischemic Attack, Transient",""
"phs000226.v7.p1","STAMPEED: Cardiovascular Health Study (CHS)","Note: This substudy phs000226 STAMPEED Cardiovascular Health Study contains GWAS data of the subset of the CHS cohort selected for the NHLBI's SNP Typing for Association with Multiple Phenotypes from  Existing Epidemiologic Data (STAMPEED) project. Summary level phenotypes for the Cardiovascular Health Study Cohort study participants can be viewed","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v7.p1)","Cardiovascular Diseases","Prospective Longitudinal Cohort","HumanCNV370-Duo, HumanOmni1-Quad","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 2 variables, 2 documents, 6 analyses, 2 molecular datasets, 4211 subjects, 4792 samples","European (3345), African (48), East Asian (2), African American (763), Hispanic1 (26), Hispanic2 (19), Other (7)","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS), HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS), DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS), DS-CVD-NPU-MDS --- Disease-Specific (Cardiovascular Disease, NPU, MDS)","2020-04-29","2018-01-13","Aging; Cerebrovascular Disorders; Aging, Biological; Biological Aging; Adverse Cardiac Event; Adverse Cardiac Events",""
"phs002018.v1.p1","Center Common Disease Genomics [CCDG] - Cardiovascular: Partners Biobank","This study is a part of NHGRI's Center for Common Disease Genomics, a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing to multiple common  disease phenotypes. Current estimates anticipate that the CCDG program will perform whole genome sequencing of 140K individuals and whole exome","Not Applicable","Myocardial Infarction","Case-Control","Not Provided","Not Provided","Not Provided","","NHGRI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2020-04-27","","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery",""
"phs001868.v1.p1","Genetic Architecture of Susceptibility to Melanoma","Most genetic susceptibility to cutaneous melanoma (CM) remains to be discovered. Meta-analysis genome-wide association study (GWAS) of 36,760 melanoma cases (67% newly-genotyped) and 375,188 controls identified 54 significant loci with  68 independent SNPs. Analysis of risk estimates across geographical regions and host factors suggests the acral melanoma subtype is uniquely","Not Applicable","Melanoma","Case-Control","HumanOmniExpress-24","SNP Genotypes (Array)","4 phenotype datasets, 24 variables, 1 analyses, 1 molecular datasets, 11234 subjects, 11234 samples","","NCI","GRU --- General Research Use","2020-04-24","2020-04-24","Nevus; Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001743.v1.p1","Contribution of Systemic and Somatic Factors to Clinical Response and    Resistance in Urothelial Cancer","Patients with metastatic urothelial cancer (n 29) were treated with atezolizumab (anti-PD-L1). All 29 patients had T-cell receptor sequencing (TCR-seq) of the pre-treatment blood; 24 also had TCR-seq on at  least one post-treatment blood sample. 24 patients had TCR-seq of their pre-treatment tumors. TCR-seq data can be found at","Not Applicable","Urologic Neoplasms","Prospective Longitudinal Cohort","WES_markerset_grc37","RNA-Seq, SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 37 variables, 1 molecular datasets, 78 samples sequenced,  SRA, 29 subjects, 78 samples","","NCI","DS-BLADDERCA-GSO --- Disease-Specific (Bladder Cancer, GSO)","2020-04-24","2020-04-24","Neoplasm of Urinary System; Neoplasm of the Urinary System; Neoplasm, Urinary Tract; Neoplasm, Urologic; Neoplasm, Urological; Neoplasms, Urinary Tract",""
"phs002011.v1.p1","PLCO - Limited Use Pilot Test Data","This is a sample of Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial data for limited use in a pilot test for remote data access. The PLCO is a  randomized, controlled trial of screening tests for prostate, lung, colorectal and ovarian cancers. Approximately 155,000 participants were enrolled","Not Applicable","Early Detection of Cancer","Clinical Trial","Not Provided","Not Provided","Not Provided","","NCI","CADM --- Research relating to adults diseases and methods","2020-04-21","","Not Provided",""
"phs001947.v1.p1","Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma    Evaluated After Starting Hu14.18-IL2 Predicts Outcome","Background: We analyzed whole transcriptome sequencing in tumors from 23 patients with stage III or IV melanoma from a pilot trial of the anti-GD2 immunocytokine, hu14.18-IL2, to identify predictive immune  and/or tumor biomarkers in melanoma patients at high risk for recurrence. Methods: Patients were randomized to receive the first of 3 monthly-courses","Not Applicable","Melanoma","Prospective Longitudinal Cohort","Not Provided","Not Provided","5 phenotype datasets, 31 variables,  SRA, 23 subjects, 23 samples","","NCI","GRU --- General Research Use","2020-04-21","2020-04-21","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001626.v1.p1","Longitudinal Multi'omics of the Human Microbiome in IBD (IBDMDB)","Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), affect millions of individuals worldwide. The Integrative Human Microbiome Project (HMP2) characterized a total of 132 CD, UC  and non-IBD patients across a year to generate longitudinal molecular profiles of host and microbial activity during this time frame. A total of","Not Applicable","Inflammatory Bowel Diseases","Case-Control","Not Provided","Bisulfite-Seq, RNA-Seq, WXS","4 phenotype datasets, 27 variables, 793 samples sequenced, 132 subjects, 793 samples","","NIDDK","GRU-IRB --- General Research Use (IRB), DS-IBD-IRB-MDS-RD --- Disease-Specific (Inflammatory Bowel Disease, IRB, MDS, RD), HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS)","2020-04-21","2020-04-21","Colitis, Ulcerative; Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - ulcerative colitis",""
"phs001940.v2.p1","Genomic Determinants of Response to Immunotherapy","This study evaluates integrated genomic models of response to immune checkpoint blockade for lung cancer patients. A computationally adjusted tumor mutation burden was combined with HLA class I genetic variation,  mutational smoking signature and activating mutations in receptor tyrosine kinase genes to generate a prognostic classifier that outperforms tumor","Not Applicable","Carcinoma, Non-Small-Cell Lung","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 18 variables, 72 samples sequenced,  SRA, 36 subjects, 72 samples","","NCI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2020-04-17","2020-01-13","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER",""
"phs001894.v1.p1","CCDG-Neuropsychiatric: Autism- Genetics of Human Developmental Brain    Disorders","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Family/Twin/Trios","Not Provided","Not Provided","5 phenotype datasets, 26 variables, 724 subjects, 724 samples","","NHGRI","DS-EAC-PUB-GSO --- Disease-Specific (Epilepsy and Cognition, PUB, GSO)","2020-04-17","2020-04-17","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs002004.v1.p1","CCDG-Neuropsychiatric: A Study of the Genetic Causes of Complex Pediatric    Disorders","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","NHGRI","DS-AUT --- Disease-Specific (Autism)","2020-04-16","","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs001213.v2.p1","Molecular Genetics of Heroin Dependence in China","Our principal goal was to determine the chromosomal locations of genetic variations associated with increased vulnerability to heroin dependence. This goal was attained by identifying specific DNA markers that are  genetically linked to heroin dependence. We collected blood and diagnostic information (using a structured diagnostic interview) from 1230 people","Not Applicable","Substance-Related Disorders","Family/Twin/Trios","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 45 variables, 3 documents, 1 molecular datasets, 1711 subjects, 1043 samples","European (1), East Asian (636), African American (1), Hispanic1 (1), Other Asian or Pacific Islander (404)","NIDA","GRU --- General Research Use","2020-04-16","2017-02-02","Drug Dependence; Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001975.v1.p1","SNP Array Analysis of Gene Edited SDV Patient iPSCs","This study, ""SNP Array Analysis of Gene Edited SDV Patient iPSCs"" is part of a larger study where we applied our recently established experimental in vitro model system of the  human segmentation clock, for the analysis of human segmentation defects of the vertebrae (SDV) including spondylocostal dysostosis (SCD). To this","Not Applicable","Gene Editing","Case-Control","HumanOmniExpress-24","SNP Genotypes (Array)","3 phenotype datasets, 11 variables, 1 molecular datasets, 1 subjects, 5 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2020-04-10","2020-04-10","Not Provided",""
"phs000876.v2.p1","Transdisciplinary Research Into Cancer of the Lung (TRICL)","The study was conducted under the auspices of the Transdisciplinary Research In Cancer of the Lung (TRICL) Research Team, which is a part of the Genetic Associations and MEchanisms in  ONcology (GAME-ON) consortium, and associated with the International Lung Cancer Consortium (ILCCO). Ethics All participants provided written","Not Applicable","Lung Neoplasms","Case-Control","WES_markerset_grc37, Axiom_GW_Human_Origins","Not Provided","2 phenotype datasets, 11 variables, 2030 samples sequenced, 12178 subjects, 12225 samples, 3 substudies","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, DS-CA --- Disease-Specific (Cancer), HMB-MDS --- Health/Medical/Biomedical (MDS), LCRF --- Lung Cancer Risk Factors, DS-LCS-RD --- Disease-Specific (Lung Cancer or Smoking, RD), GRU-COL --- General Research Use (COL), DS-CA-PUB --- Disease-Specific (Cancer, PUB), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB --- Health/Medical/Biomedical (PUB)","2020-04-10","2020-04-10","Adenocarcinoma; Neoplasms, Squamous Cell; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001681.v1.p1","Transdisciplinary Research Into Cancer of the Lung (TRICL) - Affymetrix","This sub-study phs001681 Affy Axiom Array contains genotype, sequence data, and selected phenotype of subjects available from the phs001681 study. Summary level phenotypes for the NCI Lung Cancer Transdisciplinary Research  Cohort study participants can be viewed at the top-level study page phs000876 Lung Cancer Transdisciplinary Research Cohort. Individual level","Transdisciplinary Research Into Cancer of the Lung (TRICL) (phs000876.v2.p1)","Lung Neoplasms","Case-Control","Axiom_GW_Human_Origins","SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 10195 subjects, 10195 samples","European (8923), East Asian (385), African American (10), Hispanic1 (67), Hispanic2 (268), Other Asian or Pacific Islander (317), South Asian (15), Other (193)","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, DS-CA --- Disease-Specific (Cancer), HMB-MDS --- Health/Medical/Biomedical (MDS), LCRF --- Lung Cancer Risk Factors, DS-LCS-RD --- Disease-Specific (Lung Cancer or Smoking, RD), GRU-COL --- General Research Use (COL), DS-CA-PUB --- Disease-Specific (Cancer, PUB), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB --- Health/Medical/Biomedical (PUB)","2020-04-10","2020-04-10","Adenocarcinoma; Neoplasms, Squamous Cell; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant",""
"phs000878.v2.p1","Transdisciplinary Research Into Cancer of the Lung (TRICL) - Exome Plus    Targeted Sequencing","This sub-study phs000878 CIDR Lung Cancer contains genotype, sequence data, and selected phenotype of subjects available from the phs000878 study. Summary level phenotypes for the NCI Lung Cancer Transdisciplinary Research  Cohort study participants can be viewed at the top-level study page phs000876 Lung Cancer Transdisciplinary Research Cohort. Individual level","Transdisciplinary Research Into Cancer of the Lung (TRICL) (phs000876.v2.p1)","Lung Neoplasms","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 14 variables, 1 molecular datasets, 2030 samples sequenced,  SRA, 1942 subjects, 2030 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, DS-CA --- Disease-Specific (Cancer), HMB-MDS --- Health/Medical/Biomedical (MDS), LCRF --- Lung Cancer Risk Factors, DS-LCS-RD --- Disease-Specific (Lung Cancer or Smoking, RD), GRU-COL --- General Research Use (COL), DS-CA-PUB --- Disease-Specific (Cancer, PUB), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB --- Health/Medical/Biomedical (PUB)","2020-04-10","2020-04-10","Adenocarcinoma; Neoplasms, Squamous Cell; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant",""
"phs000877.v2.p1","Transdisciplinary Research Into Cancer of the Lung (TRICL) - Meta    Analysis","This sub-study phs000877 Meta Analysis contains genotype, sequence data, and selected phenotype of subjects available from the phs000877 study. Summary level phenotypes for the NCI Lung Cancer Transdisciplinary Research Cohort  study participants can be viewed at the top-level study page phs000876 Lung Cancer Transdisciplinary Research Cohort. Individual level phenotype data","Transdisciplinary Research Into Cancer of the Lung (TRICL) (phs000876.v2.p1)","Lung Neoplasms","Case-Control","Not Provided","Not Provided","3 analyses","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, DS-CA --- Disease-Specific (Cancer), HMB-MDS --- Health/Medical/Biomedical (MDS), LCRF --- Lung Cancer Risk Factors, DS-LCS-RD --- Disease-Specific (Lung Cancer or Smoking, RD), GRU-COL --- General Research Use (COL), DS-CA-PUB --- Disease-Specific (Cancer, PUB), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB --- Health/Medical/Biomedical (PUB)","2020-04-10","2020-04-10","Adenocarcinoma; Neoplasms, Squamous Cell; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant",""
"phs001932.v1.p1","RNAseq Transcriptomic Analyses of European Ancestry Samples in MGS    Dataset","Schizophrenia is a common and severe psychotic disorder. While some common SNPs and rare copy number variants have been identified as being significantly associated with disease risk, the biological mechanisms  remain undefined. To identify gene expression abnormalities in schizophrenia, we generated whole-genome gene expression profiles using RNAseq on","Not Applicable","Schizophrenia","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 35 variables, 2605 samples sequenced, 1400 subjects, 2605 samples","","NIMH","GRU --- General Research Use, DS-SZRD --- Disease-Specific (Schizophrenia and related disorders)","2020-04-09","2020-04-09","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001109.v3.p2","Addictions: Genotypes and Genetic Correlates","Drug addiction continues to be a major medical and social problem. It is estimated that one million or more persons in the United States are currently addicted to heroin or  prescription opioids, with millions more worldwide. Cocaine addiction and alcohol dependence are frequent comorbid conditions in persons with","Not Applicable","Substance-Related Disorders","Case-Control","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 41 variables, 4 documents, 2 molecular datasets, 1795 subjects, 1794 samples","European (697), African (32), East Asian (11), African American (693), Hispanic1 (187), Hispanic2 (76), Other Asian or Pacific Islander (11), South Asian (12), Other (75)","NIDA","DS-ADX-IRB-NPU --- Disease-Specific (Addictive Disorders, IRB, NPU)","2020-04-09","2019-12-30","Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced",""
"phs001862.v1.p1","Michigan Polybrominated Biphenyl (PBB) Exposure Registry","Humans are exposed to chemicals such as brominated flame retardants (BFRs) at unprecedented levels, and a wide variety of health effects are attributed to such exposures. However, the biological mechanisms  that link exposures to its consequences remain unknown. An industrial accident in the 1970's exposed over 4000 individuals in rural Michigan to","Not Applicable","Endocrine Disruptors","Prospective Longitudinal Cohort","MEGA_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 658 subjects, 658 samples","","NIEHS","HMB-COL --- Health/Medical/Biomedical (COL)","2020-04-08","2020-04-08","Not Provided",""
"phs001123.v2.p1","Consortium on Asthma among African-ancestry Populations in the Americas","Asthma is a complex disease where the interplay between genetic factors and environmental exposures influences susceptibility and disease prognosis. Asthmatics of African descent tend to have more severe asthma and  more severe clinical symptoms than individuals of European ancestry. Advances in genetic and genomic technologies have revolutionized gene discovery","Not Applicable","Asthma","Case-Control","WGS_markerset_grc37","SNP Genotypes (NGS), WGS","5 phenotype datasets, 22 variables, 2 molecular datasets, 908 samples sequenced, 14548 subjects, 14692 samples","European (14), African (233), African American (6039), Hispanic1 (537), Hispanic2 (60), South Asian (1), Other (1236)","NHLBI","GRU-IRB --- General Research Use (IRB), HMB --- Health/Medical/Biomedical, DS-LD --- Disease-Specific (Lung Disease), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-FDO-IRB-NPU --- Disease-Specific (Focused Disease Only, IRB, NPU), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-FDO-IRB --- Disease-Specific (Focused Disease Only, IRB)","2020-04-07","2020-04-07","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs001641.v1.p1","Implementation, Adoption, and Utility of Family History in Diverse Care    Settings","The purpose of this study is to address the key question of whether and how family health history (FHH) is adopted as a tool to more efficiently manage patients at  risk for breast, colon, ovarian, and hereditary cancer syndromes as well as thrombophilia and coronary heart disease (CHD) and to provide evidence","Not Applicable","Progressive Patient Care","Clinical Trial","Not Provided","Not Provided","17 phenotype datasets, 576 variables, 6 documents, 2385 subjects","","NHGRI","GRU --- General Research Use","2020-04-06","2020-04-06","Not Provided",""
"phs001541.v1.p1","Anorexia Nervosa Genetics Initiative (ANGI)","The Anorexia Nervosa Genetics Initiative (ANGI) is an international collaboration that recruited individuals with a lifetime history of anorexia nervosa from the United States (US), Australia/New Zealand (ANZ), Sweden (SE),  and Denmark (DK). Matched controls, with no history of eating disorders, were also recruited from the US, SE, and DK. Recruitment avenues included","Not Applicable","Anorexia Nervosa","Case-Control","Multi-Ethnic_Global","SNP Genotypes (Array)","4 phenotype datasets, 133 variables, 1 analyses, 1 molecular datasets, 13406 subjects, 12918 samples","","NIMH","HMB-IRB-PUB-MDS --- Health/Medical/Biomedical (IRB, PUB, MDS)","2020-03-27","2020-03-27","Feeding and Eating Disorders; AN - Anorexia nervosa; Anorexia Nervosas; Nervosa, Anorexia; Nervosas, Anorexia; Appetite Disorder",""
"phs001911.v1.p1","Identifying Novel DNA Damage Response Genes in Radiosensitive Individuals","Ionizing radiation is an effective therapeutic agent for cancer treatment as well as a potent carcinogen. Sensitivity to the cell-killing effects of radiation can vary across human population with a  subset of individuals displaying extreme hypersensitivity. It is usually attributable to inherited defects in DNA damage response pathways. The","Not Applicable","Ataxia Telangiectasia","Case Set","Not Provided","WXS","5 phenotype datasets, 18 variables, 53 samples sequenced,  SRA, 53 subjects, 53 samples","","NIEHS","HMB-NPU --- Health/Medical/Biomedical (NPU)","2020-03-23","2020-03-23","Nijmegen Breakage Syndrome; AT; AT, COMPLEMENTATION GROUP A; AT, COMPLEMENTATION GROUP C; AT, COMPLEMENTATION GROUP D; AT, COMPLEMENTATION GROUP E",""
"phs001964.v1.p1","Women's Health Study Accelerometry Dataset","Background The Women's Health Study (WHS) was a randomized trial testing low-dose aspirin and vitamin E for preventing cancer and CVD among 39,876 women aged &#x02265;45 years throughout the US  from 1992-2004. When the trial ended as planned, women who were willing to participate continued in an observational follow-up study. Participants in","Not Applicable","Exercise","Prospective Longitudinal Cohort","Not Provided","Not Provided","5 phenotype datasets, 90 variables, 9 documents, 17062 subjects","","NCI","GRU --- General Research Use","2020-03-19","2020-03-19","Sedentary Behavior; Behavior, Sedentary; Lifestyle, Sedentary; Reclining Position; Sedentariness; Sedentary Behaviors","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001722.v1.p1","Understanding the Progression of Metastatic Colorectal Cancer","This study is to understand (1) the clonal evolution of metastatic colorectal cancer using DNA sequencing and (2) long non-coding RNAs associated with metastatic colon cancer using RNA sequencing. Our  goal is to better understand the progression of aggressive colorectal cancer. All metastatic colon cancer patients coming in for surgery were","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, Targeted-Capture, WGS, WXS","3 phenotype datasets, 22 variables, 219 samples sequenced, 20 subjects, 219 samples","","NCI","GRU --- General Research Use","2020-03-17","2020-03-17","Neoplasm Metastasis; CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001919.v1.p1","PAK4 Inhibition Improves PD-1 Blockade Immunotherapy","Introduction with rationale and aims for study Immune checkpoint blockade therapies have significantly altered the current landscape of cancer treatment. However, this immunotherapy still fails more often than it succeeds.  There are now evidences that the lack of tumour infiltration by immune cells is the main mechanism of primary resistance to PD&#x02010;1 blockade","Not Applicable","Melanoma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","5 phenotype datasets, 27 variables, 60 samples sequenced,  SRA, 39 subjects, 60 samples","","NCI","HMB-PUB-NPU-MDS --- Health/Medical/Biomedical (PUB, NPU, MDS)","2020-03-13","2020-03-13","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs001741.v1.p1","CCDG- Neuropsychiatric: Autism- The Autism Simplex Collection (TASC)","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 21 variables, 1 molecular datasets, 905 subjects, 905 samples","European (772), African (3), East Asian (15), African American (30), Hispanic1 (25), Hispanic2 (15), Other Asian or Pacific Islander (10), South Asian (15), Other (20)","NHGRI","DS-ASD-IRB --- Disease-Specific (Autism Spectrum Disorder, IRB)","2020-03-12","2020-03-12","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs001221.v1.p1","ProHealth: Kaiser Permanente Genome-wide Association Study of Prostate    Cancer","A genome-wide association study (GWAS) of prostate cancer (PCa) was conducted in Kaiser Permanente (KP) Northern California health plan members (7,783 cases, 38,595 controls; 80.3% non-Hispanic white, 4.9% African-American, 7.0%  East Asian, and 7.8% Latino) [PMID: 26034056]. The data for these members were drawn from three KP cohort studies: Research Program in Genes,","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","Axiom_GW_EUR, Axiom_GW_EAS, Axiom_Exome_plus, Axiom_GW_AFR, Axiom_GW_LAT, imputation_panel","SNP/CNV (Array), SNP/CNV Genotypes (imputed)","6 phenotype datasets, 72 variables, 2 molecular datasets, 34736 subjects, 34736 samples","","NCI","DS-PC-IRB-NPU-MDS --- Disease-Specific (Prostate Cancer, IRB, NPU, MDS)","2020-03-12","2020-03-12","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs001861.v1.p1","Single Cell Analysis Reveals New Evolutionary Complexity in Uveal    Melanoma","Uveal melanoma (UM) is a rare eye cancer that is highly aggressive and leads to metastatic death in up to half of patients. Here, we conduct droplet-based single-cell RNA sequencing  of 59,915 neoplastic and non-neoplastic cells from 8 primary and 3 metastatic UMs. Single-cell VDJ sequencing of RNA is conducted to determine","Not Applicable","Uveal Melanoma","Case Set","Not Provided","RNA-Seq, WGA","3 phenotype datasets, 15 variables, 24 samples sequenced,  SRA, 11 subjects, 24 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2020-03-11","2020-03-11","Not Provided",""
"phs001900.v1.p1","Genetic Control of Expression and Splicing in Developing Human Brain","Most genetic risk for human diseases lies within non-coding regions of the genome that are predicted to regulate gene expression in a tissue- and stage-specific manner. Given the importance of  regulatory pathways during brain development, we characterized the genetic control of the transcriptome in 201 mid-gestational human brains,","Not Applicable","Autism Spectrum Disorder","Prospective Longitudinal Cohort","HumanOmni2.5-8","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 16 variables, 1 molecular datasets, 971 samples sequenced,  SRA, 219 subjects, 1190 samples","European (23), East Asian (8), African American (61), Hispanic1 (1), Hispanic2 (95), Other Asian or Pacific Islander (10), Other (21)","NIMH","GRU --- General Research Use","2020-03-09","2020-03-09","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001774.v1.p1","UW-CMG: Atrioventricular Septal Defects (AVSD) Study","The Centers for Mendelian Genomics project uses next-generation sequencing and computational approaches to discover the genes and variants that underlie Mendelian conditions. By discovering genes that cause Mendelian conditions, we  will expand our understanding of their biology to facilitate diagnosis and new treatments. Sequencing Center: UW Center for Mendelian Genomics,","Not Applicable","Complete atrioventricular septal defect","Mendelian","Not Provided","Not Provided","5 phenotype datasets, 21 variables,  SRA, 50 subjects, 50 samples","","NHLBI","DS-CHD-IRB --- Disease-Specific (Congenital Heart Disease, IRB)","2020-03-09","2020-03-09","Atrioventricular canal type ventricular septal defect; CAVC; Common atrioventricular canal; Common atrioventricular valve; Complete AVSD; Complete atrioventricular canal",""
"phs001177.v2.p1","Rare Germline Variations in Familial Melanoma","Although a number of high-risk melanoma genes have been identified, they account for melanoma risk in less than 40% of melanoma-prone families. The major goals of our research are to  identify novel high-penetrance genes for familial melanoma in melanoma-prone families without known mutations and to identify modifier factors,","Not Applicable","Melanoma, Cutaneous Malignant","Family/Twin/Trios","HumanOmniExpress-12","SNP Genotypes (Array), RNA-Seq, Targeted-Capture, WXS","5 phenotype datasets, 21 variables, 1 molecular datasets, 3381 samples sequenced,  SRA, 3357 subjects, 3495 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2020-03-09","2017-03-30","CMM; Cutaneous Malignant Melanoma; Cutaneous melanoma; MELANOMA, MALIGNANT; MM (malignant melanoma) of skin; Malignant Cutaneous Melanoma","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001901.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular: Genetics of    Coronary Heart Disease - Characterizaton of Coronary Prone Pedigrees","The primary cohort includes samples from 499 men and 154 women who survived a myocardial infarction, percutaneous transluminal angioplasty, or coronary artery bypass grafting (CABG) by age 55 years for  men or age 65 years for women. Patients were seen at least six months after their acute event. Samples from another 488 men and 541 women that showed","Not Applicable","Myocardial Infarction","Case-Control","Not Provided","Not Provided","4 phenotype datasets, 9 variables,  SRA, 1475 subjects, 1475 samples","","NHGRI","DS-CVD-MDS --- Disease-Specific (Cardiovascular Disease, MDS)","2020-03-06","2020-03-06","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart",""
"phs001803.v1.p1","Identification of Genomic Markers of Cervical Dystonia and Subtypes","As the third most common movement disorder, dystonias collectively affect more than 2 million people worldwide. Despite their high prevalence, their biological roots are largely unknown. Genetic influences are suggested  in familial studies, however, no specific genetic variants are responsible for a significant proportion of identified cases. Previous genome-wide","Not Applicable","Torticollis","Prospective Longitudinal Cohort","Multi-Ethnic_Global","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 919 subjects, 919 samples","","NINDS","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2020-03-06","2020-03-06","Cervical Dystonia; Contracture of neck; Inherited torticollis; Loxia; Neck contractures; Spasmodic torticollis",""
"phs001723.v1.p1","NIDDK IBD Genetics Consortium Repository Exome Chip","The Illumina Infinium HumanExome+ BeadChip contains putative functional exonic variants selected from individual exome and whole-genome sequences from diverse populations. It includes nonsynonymous variants, splice variants and stop-altering variants. It  also includes tags for previous GWAS-identified loci, ancestry informative markers, markers designed for identity by descent analyses, synonymous","Not Applicable","Inflammatory Bowel Diseases","Case-Control","HumanExome-12_plus","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 molecular datasets, 4793 subjects, 4793 samples","","NIDDK","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2020-03-06","2020-03-06","Inflammatory Bowel Disease; Ulcerative Colitis; CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis",""
"phs001721.v1.p1","NIDDK IBD Genetics Consortium Repository Immunochip","The Immunochip is a custom Illumina Infinium chip comprising 196,524 SNPs and small indels selected primarily based on GWAS analysis of 12 autoimmune and inflammatory diseases. The chip has two  purposes: fine mapping of 289 established associations corresponding to 187 distinct loci, and deep replication of suggestive, but not yet proven,","Not Applicable","Inflammatory Bowel Diseases","Case-Control","ImmunoArray","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 molecular datasets, 4808 subjects, 4808 samples","","NIDDK","HMB-IRB-NPU-MDS --- Health/Medical/Biomedical (IRB, NPU, MDS)","2020-03-06","2020-03-06","Inflammatory Bowel Disease; Ulcerative Colitis; CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis",""
"phs001895.v2.p1","Genome Sequencing of Lung Cancer in European Americans and African    Americans","The goal of this study is to compare the somatic mutation landscape between European Americans and African Americans. It includes various histological forms of lung cancer. In LUAD, we find  increased prevalence of PTPRT and JAK2 mutations among African Americans. These proteins function in the same pathway and as such, this may be a new","Not Applicable","Lung Neoplasms","Case-Control","OncoScan_CNV_plus","CNV Genotypes, Targeted-Capture","4 phenotype datasets, 17 variables, 1 molecular datasets, 356 samples sequenced,  SRA, 286 subjects, 578 samples","","NCI","GRU --- General Research Use","2020-03-05","2020-03-05","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001663.v1.p1","Genomic Analysis of CNS Cancer","Whole genome and exome-based DNA sequencing of germline and tumor specimens from serial samples of patients with glioblastoma. The data set includes several metastases and recurrences from a patient with  germline POLE-deficiency. The data reveal extensive tumor heterogeneity, clonal evolution, and genomic responses to immunotherapy. Sequencing to date","Not Applicable","Glioblastoma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 7 samples sequenced, 1 subjects, 7 samples","","NINDS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2020-03-02","2020-03-02","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs001152.v1.p1","Somatic Mutational Analysis by Exome Sequencing Endometrial    Carcinosarcomas","The purpose of this study was to identify somatic (tumor-specific) mutations in endometrial carcinosarcoma tumor exomes. The dataset was generated at the NIH Intramural Sequencing Center (NISC) and NHGRI by  next generation sequencing the exomes of 14 de-identified primary tumor DNAs and matched non-tumor DNAs. Inclusion criteria: 1. Endometrial","Not Applicable","Endometrial Neoplasms","Case Set","WES_markerset_grc37","SNV (.MAF), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 28 samples sequenced,  SRA, 14 subjects, 28 samples","","NHGRI","DS-UEC-COL --- Disease-Specific (Uterine Endometrial Carcinosarcoma, COL)","2020-03-02","2020-03-02","Carcinosarcoma; Endometrial Tumor; Endometrial neoplasm; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium",""
"phs000575.v2.p1","PWS Natural History Protocol","Overview: An 8 year multicenter longitudinal observational natural history study of individuals with Prader-Willi syndrome (PWS) and others with non-PWS Early-onset Morbid Obesity (EMO) was conducted at 4 different sites  by investigators who were leading experts in the study of PWS. The first subject was enrolled on September 7, 2006. The study ended on July 31, 2014.","Not Applicable","Prader-Willi Syndrome","Case Set","Not Provided","Not Provided","20 phenotype datasets, 3106 variables, 15 documents, 390 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2020-03-02","2020-03-02","Obesity, Morbid; Morbid Obesities; Morbid Obesity; OBESITY, SEVERE; Obesities, Morbid; Obesities, Severe",""
"phs001380.v1.p1","Genomic Studies of Gilles de la Tourette Syndrome","This study consists of three components. The first component includes genome-wide association study (GWAS) data on 695 TS cases and 198 ancestry matched controls from the first TS GWAS of  1285 TS cases and 4964 ancestry matched controls. The second component includes genome-wide association study (GWAS) data on 2106 TS cases from the","Not Applicable","Tourette Syndrome","Family/Twin/Trios","Human610-Quad, HumanOmniExpressExome-8","SNP Genotypes (Array), WXS","9 phenotype datasets, 45 variables, 1 molecular datasets, 438 samples sequenced,  SRA, 3296 subjects, 3437 samples","","NINDS","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU), DS-TSRD --- Disease-Specific (Tourette Syndrome and Related Disorders), DS-TSRD-NPU --- Disease-Specific (Tourette Syndrome and Related Disorders, NPU), DS-TS-NPU --- Disease-Specific (Tourette Syndrome, NPU)","2020-02-27","2020-02-27","Tics; Child Mental Disorder; Child Mental Disorders; Disorder, Child Mental; Disorder, Neurodevelopmental; Mental Disorder, Child",""
"phs000681.v2.p1","Diabetes Prevention Program Genetics (DPPG)","The Diabetes Prevention Program (DPP) was a multicenter controlled clinical trial examining the efficacy of an intensive lifestyle intervention or metformin to prevent or delay the development of diabetes in  a population selected to be at high risk due to the presence of impaired glucose tolerance (IGT) and obesity. Development of diabetes, defined by","Not Applicable","Diabetes Mellitus, Type 2","Clinical Trial","iPLEX_gold, custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 2 molecular datasets, 2535 subjects, 2535 samples","European (1312), African (16), East Asian (43), African American (438), Hispanic1 (40), Hispanic2 (296), Other Asian or Pacific Islander (32), South Asian (31), Other (36)","NIDDK","DS-DHD-IRB --- Disease-Specific (Diabetes and Heart Disease, IRB)","2020-02-27","2020-02-27","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000222.v6.p2","PREDICT-HD Huntington Disease Study","The purpose of this project is to make clinical measurements from the PREDICT-HD consortium available through the dbGaP mechanism. The phenotype data will first be converted into a community open  standard and subsequently exported to dbGaP for archival and open access distribution of the results of the studies. This will permit members of the","Not Applicable","Huntington Disease","Prospective Longitudinal Cohort","Not Provided","Not Provided","22 phenotype datasets, 1667 variables, 9 documents, 6784 images, 1485 subjects","","NINDS","GRU --- General Research Use","2020-02-27","2020-02-27","Chorea, Chronic Progressive Hereditary (Huntington); Chorea, Huntington; Chorea, Huntington's; Chronic Progressive Hereditary Chorea (Huntington); Chronic progressive chorea; Chronic progressive hereditary chorea","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001934.v1.p1","Sexual Dimorphism in Human Immune System Aging","We isolated peripheral blood mononuclear cells (PBMCs) from 172 community-dwelling healthy volunteers (91 women, 81 men) ages spanning adult lifespan: 54 young (ages 22-40: 23 men, 31 women), 59 middle-aged  (ages 41-64: 31 men, 28 women), and 59 older subjects (65+: 27 men, 32 women). PBMCs were profiled using ATAC-seq (54 men, 66 women), RNA-seq (41","Not Applicable","Immune System","Cross-Sectional","Not Provided","ATAC-seq, RNA-Seq","4 phenotype datasets, 30 variables, 371 samples sequenced,  SRA, 172 subjects, 371 samples","","NIGMS","GRU --- General Research Use","2020-02-25","2020-02-25","Not Provided",""
"phs001871.v1.p1","Center for Common Disease Genomics (CCDG)-Cardiovascular:Cleveland Clinic","The National Human Genome Research Institute (NHGRI) has funded the Centers for Common Disease Genomics (CCDG), a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants  contributing to common disease phenotypes and to better understand the general principles of genomic architecture underlying common, complex","Not Applicable","Cardiovascular Diseases","Case-Control","Not Provided","Not Provided","4 phenotype datasets, 14 variables, 348 subjects, 348 samples","","NHGRI","DS-CAD-IRB --- Disease-Specific (Coronary Artery Disease, IRB)","2020-02-25","2020-02-25","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs001858.v1.p1","Germline Variants of Clinical Cancer Specimens","These clinical specimens represent solid tumors and matched blood controls that were collected as part of patients' routine care at Memorial Sloan Kettering Cancer Center. They were sequenced on the  targeted platform MSK-IMPACT. Here, we performed germline variant calling on the normal blood specimens and assessed their zygosity in the","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","other","SNV (.MAF)","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 17152 subjects, 34304 samples","","NCI","DS-CA-PUB-MDS --- Disease-Specific (Cancer, PUB, MDS)","2020-02-25","2020-02-25","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001430.v2.p1","STAIR SLOS Longitudinal Study of Patients Receiving Cholesterol","Smith-Lemli-Opitz syndrome (SLOS) is a disorder of cholesterol production by the body. It is caused by changes in the DHCR7 gene, which is the blueprint for an enzyme called 7-dehydrocholesterol-  delta7-reductase. This enzyme is necessary for the production of cholesterol by all cells in the body. People with SLOS often have malformations of","Not Applicable","Smith-Lemli-Opitz Syndrome","Prospective Longitudinal Cohort","Not Provided","Not Provided","39 phenotype datasets, 2811 variables, 28 documents, 28 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2020-02-25","2020-02-25","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile",""
"phs001312.v1.p1","Primary Open-Angle African American Glaucoma Genetics (POAAGG) Study","The purpose of the POAAGG study is to investigate the genetic architecture of primary open-angle glaucoma (POAG) in African Americans. This population is up to eight times more likely to  develop glaucoma than non-Hispanic whites, yet no large-scale genetics studies have specifically addressed this ethnic group. The POAAGG study aims","Not Applicable","Glaucoma, Open-Angle","Case-Control","other","SNP Genotypes (Array)","4 phenotype datasets, 58 variables, 4 documents, 1 molecular datasets, 5188 subjects, 5218 samples","European (14), African (337), African American (4769), Hispanic1 (43), Hispanic2 (2), South Asian (1), Other (22)","NEI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2020-02-25","2020-02-25","Compensated Glaucoma; Compensative Glaucoma; Glaucoma Simplex; Glaucoma, Compensated; Glaucoma, Compensative; Glaucoma, Open Angle",""
"phs001227.v1.p1","Washington University Coronary Artery Disease Study","The genetic basis of coronary artery disease in individuals of non-European ancestry is largely unknown. The Washington University Coronary Artery Disease Study (WUCADS) recruited participants of non-European ancestry with and  without coronary artery disease to address this question. Whole genome sequencing in WUCADS was performed at the McDonnell Genome Institute at","Not Applicable","Coronary Artery Disease","Case-Control","Not Provided","Not Provided","4 phenotype datasets, 14 variables,  SRA, 165 subjects, 165 samples","","NHGRI","DS-ATHSCL-IRB-MDS --- Disease-Specific (Atherosclerosis, IRB, MDS), GRU-IRB --- General Research Use (IRB)","2020-02-25","2020-02-25","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery",""
"phs000815.v2.p1","Gene Expression and Regulatory Networks in Human Leukocytes","Profiling of gene expression with microarrays holds great potential for human health, for illuminating disease pathways or providing biomarkers to monitor disease or its resolution. Using high-throughput approaches for genotyping,  immunophenotyping and gene expression analysis, the project will examine the basis for the control of gene expression in human immune cells, and how","Not Applicable","Gene Expression Regulation","Control Set","HumanOmniExpressExome-8","SNP Genotypes (Array), OTHER, RNA-Seq","7 phenotype datasets, 33 variables, 1 molecular datasets, 705 samples sequenced, 690 subjects, 1395 samples","European (359), African (20), East Asian (139), African American (135), Hispanic1 (10), Hispanic2 (4), Other Asian or Pacific Islander (15), Other (5)","NIGMS","DS-IR --- Disease-Specific (Immunological Research)","2020-02-25","2020-02-25","Not Provided",""
"phs001880.v1.p1","Center for Common Disease Genomics (CCDG) - Cardiovascular: Emory Cohort","The National Human Genome Research Institute (NHGRI) has funded the Centers for Common Disease Genomics (CCDG), a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants  contributing to common disease phenotypes and to better understand the general principles of genomic architecture underlying common, complex","Not Applicable","Cardiovascular Diseases","Case-Control","Not Provided","Not Provided","4 phenotype datasets, 14 variables, 429 subjects, 429 samples","","NHGRI","GRU-NPU --- General Research Use (NPU)","2020-02-24","2020-02-24","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs001698.v1.p1","Genomic Analysis of Benign Prostatic Hyperplasia","Benign prostatic hyperplasia (BPH) entails growth in the central regions of the prostate gland and is common among older men. BPH obstructs urinary outflow, resulting in voiding symptoms for which  current treatments that target prostate physiology are only partially effective. A better understanding of BPH may suggest new treatment strategies","Not Applicable","Prostatic Hyperplasia","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 19 variables, 129 samples sequenced, 66 subjects, 129 samples","","NIDDK","DS-BPH-IRB --- Disease-Specific (Benign prostatic hyperplasia, IRB)","2020-02-24","2020-02-24","BEP - Benign enlargement of prostate; BPH; BPH - benign prostatic hyperplasia; Benign Hyperplasia of Prostate; Benign Hyperplasia of the Prostate; Benign Prostate Hyperplasia",""
"phs001461.v1.p1","Temporal and Clonal Progression in Pediatric Ependymoma","Whole genome and exome-based DNA sequencing of germline and tumor specimens from serial samples of a single patient's ependymoma. The findings reveal the extent to which treatment with radiation and  chemotherapies resulted in the diversification of the tumor subclonal architecture and shaped the neo-antigen landscape, and provide new insights","Not Applicable","Ependymoma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 16 variables, 11 samples sequenced, 1 subjects, 11 samples","","NCI","DS-BT-PUB-NPU-MDS --- Disease-Specific (Brain Tumors, PUB, NPU, MDS)","2020-02-24","2020-02-24","Supratentorial Neoplasms; Cellular Ependymoma; Clear Cell Ependymoma; Brain Neoplasms, Supratentorial; Neoplasm, Supratentorial; Neoplasms, Supratentorial",""
"phs001853.v1.p1","MGH Gastrointestinal Malignancies Resistance Initiative","Tumor heterogeneity can drive the evolution of multiple tumor subclones harboring unique molecular resistance alterations in different metastatic lesions in an individual patient, under the selective pressure of therapy1-3. Studies  have suggested that liquid biopsy may better capture the heterogeneity of acquired resistance, but systematic, direct comparisons of post-progression","Not Applicable","Colorectal Neoplasms","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 21 variables, 44 samples sequenced, 15 subjects, 44 samples","","NCI","DS-GICA-MDS --- Disease-Specific (Gastric Cancer, MDS)","2020-02-21","2020-02-21","Esophageal Neoplasms; Bile duct cancer; CC; CCA; Carcinoma, Cholangiocellular; Carcinomas, Cholangiocellular",""
"phs001508.v1.p1","Genetic Analysis of Metopic Nonsyndromic Craniosynostosis","Craniosynostosis (CS), the premature fusion of one or more cranial sutures, is a common defect occurring in 1 in 2,500 live births. About 85% of infants with CS present as  nonsyndromic (i.e., without unrelated, major birth defects or developmental delay). Nonsyndromic CS (NCS) is a heterogeneous condition with presumed","Not Applicable","Craniosynostoses","Case Set","Not Provided","Not Provided","2 documents, 1 analyses","","NIDCR","DS-CSM --- Disease-Specific (Craniosynostosis, metopic)","2020-02-19","2020-02-19","Craniofacial Abnormality; Abnormalities, Craniofacial; Abnormality, Craniofacial; Craniofacial Abnormalities; CRANIOSTENOSIS; CRS",""
"phs001575.v2.p1","Assessment of Neurological Deterioration in Subjects with LINCL","Late infantile ceroid lipofuscinosis (LINCL) is a rare, rapidly progressing lysosomal storage disease resulting from mutations in the CLN2 gene that lead to deficiency in the lysosomal protease tripeptidyl peptidase  I (TPP-I). The symptoms are largely neurological with onset at 2-4 years age with progression to death at age 8-12 yrs. The rareness of the disease","Not Applicable","Neuronal Ceroid-Lipofuscinoses","Prospective Longitudinal Cohort","Not Provided","Not Provided","7 phenotype datasets, 135 variables, 13 documents, 42 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2020-02-18","2020-02-18","Batten Disease; Late Infantile Neuronal Ceroid Lipofuscinosis; Amaurotic idiocy early juvenile type; Amaurotic idiocy late infantile type; Amaurotic idiocy, early juvenile type; Amaurotic idiocy, late infantile type",""
"phs001330.v2.p1","Characterizing Phenotype(s) in MPS III","Mucopolysaccharidosis III (MPSIII) syndrome is characterized by a severe cognitive decline ending in dementia and death. MPSIII is also associated with a range of abnormal and disruptive behaviors that can  include, but go well beyond, childhood noncompliance and oppositionality. The purpose of this study is to conduct a cross-sectional investigation to","Not Applicable","Mucopolysaccharidosis III","Prospective Longitudinal Cohort","Not Provided","Not Provided","14 phenotype datasets, 961 variables, 11 documents, 40 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2020-02-18","2018-05-18","MPS3; MPSIII; Mucopoly-saccharidosis type 3; Mucopolysaccharidosis 3; Mucopolysaccharidosis IIIs; Mucopolysaccharidosis Type III",""
"phs001953.v1.p1","Genomic Profiling of Metastatic Uveal Melanoma","Up to 50% of patients with uveal melanoma (UM) develop metastatic disease, for which there is no effective systemic treatment. This study aimed to evaluate the safety and efficacy of  the orally available protein kinase C inhibitor, AEB071, in patients with metastatic UM, and to perform genomic profiling of metastatic tumor","Not Applicable","Uveal Neoplasms","Clinical Trial","Not Provided","WXS","3 phenotype datasets, 11 variables, 89 samples sequenced,  SRA, 89 subjects, 89 samples","","NCI","DS-UM-GSO --- Disease-Specific (Uveal Melanoma, GSO)","2020-02-14","2020-02-14","Eye Neoplasms; Neoplasm Metastasis; Cancer of Eye; Cancer of the Eye; Cancer, Eye; Cancers, Eye",""
"phs001931.v1.p1","Count Me In: Angiosarcoma Project (CMI-ASCproject)","Count Me In - The Angiosarcoma Project: A Patient-Partnered Research Initiative to Accelerate Research in a Rare Sarcoma The Angiosarcoma Project (ASCproject) is a research study that directly engages angiosarcoma  patients online and empowers them to accelerate cancer research by sharing medical information and clinical samples. Angiosarcoma is an exceedingly","Not Applicable","Sarcoma","Prospective Longitudinal Cohort","Not Provided","Not Provided","4 phenotype datasets, 10 variables,  SRA, 36 subjects, 84 samples","","NCI","GRU --- General Research Use","2020-02-14","2020-02-14","Angiosarcoma; Angiosarcomas; Hemangioendothelial sarcoma; Hemangiosarcomas; Malignant hemangioendothelioma; angiosarcoma (disease)","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001386.v2.p1","Smoking and the Vaginal Microbiome","The focus of this study was to better understand the effects of cigarette smoking on the vaginal microbiome. There were two phases of the study, cross-sectional and longitudinal, conducted at  the Center for Health Behavior Research at the University of Maryland School of Public Health. In the cross-sectional phase, 20 smokers and 20","Not Applicable","Smoking","Case-Control","Not Provided","Not Provided","7 phenotype datasets, 1339 variables,  SRA, 47 subjects, 195 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2020-02-13","2017-12-06","Not Provided",""
"phs001230.v1.p1","Estonian Biobank | Estonian Genome Center, University of Tartu","The Estonian Biobank is the population-based biobank of the Estonian Genome Centre of University of Tartu. The biobank is conducted according to the Estonian Gene Research Act and all participants  have signed broad informed consent. The cohort size is currently 51,535 people from 18 years of age and up. Metabolite concentrations (over 110; NMR","Not Applicable","Population Groups","Prospective Longitudinal Cohort","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 8 variables, 1 molecular datasets, 2280 samples sequenced,  SRA, 2280 subjects, 2280 samples","","NHGRI","GRU --- General Research Use","2020-02-13","2020-02-13","Not Provided",""
"phs000224.v3.p2","VitGene Generalized Vitiligo Genetics Study-Phase 2","Generalized vitiligo is an autoimmune disease in which melanocyte loss results in patchy depigmentation of skin and hair. For this third GWAS of generalized vitiligo, SNPs were genotyped in 1,059  generalized vitiligo cases of European-derived white (EUR) ancestry using the Illumina Human OmniExpress BeadChip array. The data were combined with","Not Applicable","Vitiligo","Case-Control","Human610-Quad, Human660W-Quad","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 3 molecular datasets, 2857 subjects, 2938 samples","European (2825), African (1), East Asian (2), African American (3), Hispanic1 (5), Hispanic2 (8), Other Asian or Pacific Islander (1), South Asian (2), Other (10)","NIAMS","DS-VTO --- Disease-Specific (Vitiligo), DS-VAD --- Disease-Specific (Vitiligo or Autoimmune Disorders)","2020-02-13","2020-02-13","",""
"phs001811.v1.p1","Molecular Determinants of Tumor Behavior in Early Lung Adenocarcinoma","Lung adenocarcinoma is the leading cause of cancer death worldwide and a heterogeneous disease with poor survival in the advanced stage. Given that the frequency of early diagnosis is increasing,  the investigation of the molecular determinants of disease progression is paramount. Prediction of whether the tumor is indolent or aggressive has","Not Applicable","Adenocarcinoma of Lung","Prospective Longitudinal Cohort","Not Provided","Targeted-Capture","4 phenotype datasets, 24 variables, 102 samples sequenced,  SRA, 102 subjects, 102 samples","","NCI","DS-LC-NPU --- Disease-Specific (Lung Cancer, NPU)","2020-02-12","2020-02-12","Adenocarcinoma in Situ; AIS; AIS - Adenocarcinoma in situ; Adenocarcinoma in Situs; Adenocarcinoma, Intraepithelial; Adenocarcinoma, Preinvasive",""
"phs001020.v2.p1","Genomic Psychiatry Cohort (GPC) Whole Genome Sequencing and Genotyping    Study","The Center for Genomic Psychiatry at the University of Southern California (USC), SUNY Downstate and an extensive network of academic medical centers have created the Genomic Psychiatry Cohort (GPC). The  GPC consists of a large clinical cohort of patients with schizophrenia, bipolar disorder, and healthy controls. The data generation of genotyping and","Not Applicable","Schizophrenia","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 16 variables, 1 documents, 1 molecular datasets, 1251 samples sequenced,  SRA, 1251 subjects, 1251 samples","European (707), African American (9), Hispanic1 (5), Hispanic2 (23), Other Asian or Pacific Islander (2), Other (4)","NIMH","DS-SZRD --- Disease-Specific (Schizophrenia and related disorders), DS-BPD --- Disease-Specific (Bipolar Disorder), GRU --- General Research Use","2020-02-07","2016-12-14","Bipolar Disorder; Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001956.v1.p1","Genome Instability in Liver Stem and Mature Cells","Highly metabolic liver is exposed to many sources of spontaneous mutagenesis resulting in increased genome instability that, potentially, causes age-related functional liver failure. Here we comparatively characterize the somatic mutational  landscape in single human liver cells from individuals of various ages. Mutation frequency is very high in normal human hepatocytes, increasing","Not Applicable","Mutation","Cross-Sectional","Not Provided","WGA, WGS","4 phenotype datasets, 18 variables, 79 samples sequenced,  SRA, 15 subjects, 79 samples","","NIA","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2020-01-31","2020-01-31","Not Provided",""
"phs001937.v1.p1","DNA Methylomic Profiling of Preeclampsia Across Pregnancy","Preeclampsia (PE) is a hypertensive, multi-system disorder of pregnancy that significantly impacts maternal and infant morbidity/mortality across the globe, as it increases risk of cardiovascular disease and remains a leading  killer of women and babies. Despite PE's significant impact on morbidity/mortality, there are no clinically reliable biomarkers that predict PE. DNA","Not Applicable","Pre-Eclampsia","Prospective Longitudinal Cohort","MethylationEPIC","Methylation (CpG)","4 phenotype datasets, 36 variables, 1 molecular datasets, 56 subjects, 189 samples","","NICHD","HMB-PUB-NPU-MDS --- Health/Medical/Biomedical (PUB, NPU, MDS)","2020-01-30","2020-01-30","EPH - Edema, proteinuria and hypertension of pregnancy; EPH Complex; EPH Gestosis; EPH Toxemia; EPH Toxemias; Edema Proteinuria Hypertension Gestosis",""
"phs001936.v1.p1","Genome, Exome, and Transcriptome Sequencing of Gastric Cancer","The integration of exogenous DNA into the human genome can cause somatic mutations associated with oncogenesis. For example, the insertion of HPV DNA into human chromosomes is the single most  important event leading to tumorigenesis in cervical cancer. It is also now preventable with vaccines against HPV. In contrast to viral DNA","Not Applicable","Gastrointestinal Neoplasms","Case Set","Not Provided","RNA-Seq, WGS, WXS","4 phenotype datasets, 15 variables, 19 samples sequenced,  SRA, 9 subjects, 19 samples","","NCI","DS-GICA-PUB-NPU-MDS --- Disease-Specific (Gastric Cancer, PUB, NPU, MDS)","2020-01-30","2020-01-30","Cancer of Gastrointestinal Tract; Cancer of the Gastrointestinal Tract; Cancer, Gastrointestinal; Cancers, Gastrointestinal; Gastrointestinal Cancer; Gastrointestinal Cancers",""
"phs001898.v1.p1","Invariant Patterns of Clonal Succession Determine Specific Clinical    Features of Myelodysplastic Syndromes (MDS)","Myelodysplastic Syndromes (MDS) are heterogeneous myeloid neoplasms, characterized by stepwise acquisitions of multiple somatic mutations. Mutational configurations (e.g. bi-allelic) and specific distributions, timing of acquisitions corresponding to rank within the  clonal hierarchy, and combinatorial spectrum are not elucidated. Therefore, we conducted targeted deep sequencing in a panel of the 36 most","Not Applicable","Myelodysplastic Syndromes","Case Set","Not Provided","AMPLICON, Targeted-Capture","4 phenotype datasets, 10 variables, 552 samples sequenced,  SRA, 552 subjects, 552 samples","","NHLBI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2020-01-29","2020-01-29","Hematopoetic Myelodysplasia; Hematopoetic Myelodysplasias; Myelodysplasia, Hematopoetic; Myelodysplasias, Hematopoetic",""
"phs001930.v1.p1","Mechanism of Action of Vitamin E in NAFLD","We conducted a single-center prospective mechanistic randomized trial (clinicaltrials.gov NCT01792115). Adult patients with NAFLD were enrolled between May 2013 and November 2016. All patients underwent a 12 weeks run-in period  of lifestyle intervention. Following the run-in phase, patients underwent a baseline evaluation including blood tests, glucose tolerance testing,","Not Applicable","Non-alcoholic Fatty Liver Disease","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 114 samples sequenced,  SRA, 19 subjects, 114 samples","","NIDDK","DS-LIVD --- Disease-Specific (Liver Disease)","2020-01-28","2020-01-28","Fatty Liver, Nonalcoholic; Fatty Livers, Nonalcoholic; Liver, Nonalcoholic Fatty; Livers, Nonalcoholic Fatty; MASLD; MASLD - metabolic dysfunction-associated steatotic liver disease",""
"phs001885.v1.p1","Endometrial Cancer Association Consortium - OncoArray Genotypes","The data come from 9 studies participating in the Endometrial Cancer Association Consortium (ECAC). ECAC data included in this dbGaP submission include OncoArray data from 4486 endometrial cancer cases genotyped  at the Center for Inherited Disease Research (CIDR). Samples were genotyped using the Illumina OncoArray beadchip 500K SNP custom array. Details of","Not Applicable","Endometrial Neoplasms","Case Set","OncoArray-500K","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 1 molecular datasets, 4486 subjects, 4486 samples","European (4425), Hispanic1 (3), Hispanic2 (8), South Asian (22), Other (28)","NCI","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU), ENDTU-MDS --- Endometrial Tumors (MDS), DS-BCEMOPCA-NPU-MDS --- Disease-Specific (Breast, Colorectal, Endometrial, Melanoma, Ovarian, and/or Prostate Cancer, NPU, MDS)","2020-01-27","2020-01-27","Endometrial Tumor; Endometrial neoplasm; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001788.v1.p1","CFAR Network of Integrated Clinical Systems (CNICS)","Advances in antiretroviral therapies (ART) and patient management have improved survival of people living with HIV (PLWH). However, with exposure to ART and associated side effects and toxicities as well  as to the virus itself, PLWH are at an increased risk of several chronic diseases. The Centers for AIDS Research (CFAR) Network of Integrated","Not Applicable","HIV Infections","Case-Control","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 24 variables, 1 molecular datasets, 4761 subjects, 4761 samples","European (2179), African (39), East Asian (17), African American (1810), Hispanic1 (81), Hispanic2 (510), Other Asian or Pacific Islander (47), South Asian (5), Other (73)","NIDA","GRU-IRB --- General Research Use (IRB)","2020-01-21","2020-01-21","HIV - Human immunodeficiency virus infection; HIV infection; HIV infectious disease; HTLV III Infections; HTLV III LAV Infections; HTLV-III Infection",""
"phs000791.v2.p1","Integrated Epigenetic Maps of Human Embryonic, Extraembryonic and Adult    Cells","Working cooperatively with other Mapping Centers and the Data Coordination Center (EDACC) funded by this Roadmap mechanism we have comprehensively mapped the epigenomes of select human cells with significant relevance  to complex human disease. Our effort has been focused on cells relevant to human health and complex disease including cells from the blood, brain,","Not Applicable","Neoplasms","Control Set","Not Provided","Bisulfite-Seq, ChIP-Seq, MRE-Seq, MeDIP-Seq, RNA-Seq, WGS, miRNA-Seq","5 phenotype datasets, 31 variables, 259 samples sequenced,  SRA, 50 subjects, 259 samples","","NIDA","HMB --- Health/Medical/Biomedical","2020-01-21","2016-12-24","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001580.v1.p1","MGH/Broad Hurthle Cell Carcinoma Whole Exome Sequencing Study","In this study, we performed whole-exome sequencing of 41 patients with Hurthle cell carcinoma, a thyroid cancer variant with abundant mitochondria. We were able to identify recurrent somatic mutations in  both the nuclear and mitochondrial genomes of Hurthle cell carcinoma. Our study identifies mutations in DAXX (GeneID: 1616), TP53 ( GeneID:7157),","Not Applicable","Thyroid cancer, Hurthle cell","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 13 variables, 111 samples sequenced,  SRA, 41 subjects, 111 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2020-01-15","2020-01-15","Neoplasm Metastasis; Metastase; Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001005.v2.p1","Antigen Discovery in Melanoma","This study of three metastatic melanoma patients utilized exome sequencing and RNA sequencing to help identify putative neoantigen peptides that could be further validated by standard immunological assays before design  of a personalized vaccine. For each set of neoantigens identified and verified by standard assays, we designed GMP peptides that correspond to the","Not Applicable","Melanoma-Specific Antigens","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 13 variables, 31 samples sequenced,  SRA, 5 subjects, 31 samples","","NHGRI","DS-MSC --- Disease-Specific (Melanoma and Skin Cancer Research)","2020-01-13","2015-10-29","Not Provided",""
"phs001917.v1.p1","DNA Methylation Markers and Pancreatic Cancer Risk","Pancreatic cancer is the 4th leading cause of cancer deaths in the US. Due to the lack of early symptoms, pancreatic cancer is difficult to identify at early stages and  no screening is available for the general population. Identifying pancreatic cancer at earlier stages could significantly improve survival with","Not Applicable","Pancreatic Neoplasms","Case-Control","MethylationEPIC","Methylation (CpG)","4 phenotype datasets, 21 variables, 1 molecular datasets, 824 subjects, 824 samples","","NCI","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2020-01-08","2020-01-08","Carcinoma, Pancreatic Ductal; Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas",""
"phs001884.v1.p1","Cognitive Ability and Homozygosity Study","Recent studies of genetic foundations of cognitive ability rely on large samples (hundreds of thousands) of individuals from relatively outbred populations of mostly European ancestry. Hypothesizing that the genetic foundation  of cognitive ability depends on the broader population-specific genetic context, we performed a genome-wide association study and homozygosity","Not Applicable","Intelligence","Prospective Longitudinal Cohort","HumanCoreExome-12","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 4 analyses, 1 molecular datasets, 354 subjects, 354 samples","European (32), African (1), African American (8), Hispanic1 (298), Other Asian or Pacific Islander (3), South Asian (3), Other (9)","NICHD","GRU --- General Research Use","2020-01-07","2020-01-07","Consanguinity; Consanguinities","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001817.v1.p1","GeneScreen, a Population Based, Targeted Genomic Screening Study","The GeneScreen research study was based at the University of North Carolina (UNC) at Chapel Hill. It brought together researchers from different disciplines, including genetics, clinical medicine, bioethics, sociology, anthropology,  psychology, and public health, to study the best ways to offer targeted genetic screening to the general adult population. DNA samples were collected","Not Applicable","Genetics, Population","Cross-Sectional","target_markerset_grc38","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 11 variables, 1 molecular datasets,  SRA, 262 subjects, 262 samples","","NHGRI","GRU-IRB --- General Research Use (IRB)","2020-01-07","2020-01-07","Not Provided",""
"phs001921.v1.p1","DNA Methylation and Prostate Cancer","The study cohort includes 525 Caucasian and African American prostate cancer (PCa) patients who underwent radical prostatectomy (RP) as primary therapy for clinically localized adenocarcinoma of the prostate. These patients  were previously enrolled in one of two population-based studies: 1) men 40-64 years of age, diagnosed between January 1993 and December 1996; and, 2)","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","HumanMethylation450","Methylation (CpG)","4 phenotype datasets, 19 variables, 1 molecular datasets, 525 subjects, 525 samples","","NCI","DS-PRD-PUB-NPU-MDS --- Disease-Specific (Prostate Disease, PUB, NPU, MDS)","2019-12-27","2019-12-27","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs001907.v1.p1","CPTAC: Microscaled Proteogenomic Methods for Precision Oncology","Cancer proteogenomics combines genomics, transcriptomics and mass spectrometry-based proteomics to gain insights into cancer biology and treatment outcomes. To promote clinical investigation, we developed a ""microscaled"" proteogenomics approach for tumor-rich  frozen core needle biopsies. Tissue-sparing specimen processing (""Biopsy Trifecta EXTraction"", BioTExt) and microscaled proteomics (MiProt) generated","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","other","RNA-Seq, SNV (.MAF), WXS","3 phenotype datasets, 15 variables, 1 molecular datasets, 58 samples sequenced, 14 subjects, 58 samples","","NCI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2019-12-27","2019-12-27","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001805.v1.p1","Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer, including    KRAS and Her2","Neoantigen-specific T cell responses were characterized in 4 patients with non-small cell lung cancer. Candidate neoantigens were identified by sequencing tumor and normal DNA from each patient, and ranking single  nucleotide variants by expression. Multiple T cell responses were isolated, and in two patients with lung adenocarcinoma, CD4+ T cell responses to","Not Applicable","Adenocarcinoma of Lung","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 16 variables, 10 samples sequenced,  SRA, 4 subjects, 10 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2019-12-26","2019-12-26","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs001713.v1.p1","LCCC 1108 (UNCseqTM)","The primary objective of this specimen correlative study was two-fold: to provide a mechanism for the association of known molecular alterations with clinical outcomes, and to provide rapid genetic profiling  of alterations with known clinical utility using tumor and germline specimens to support treatment decisions. Inclusion Criteria: 1.Current or","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","Not Provided","Targeted-Capture","4 phenotype datasets, 14 variables, 3558 samples sequenced,  SRA, 2074 subjects, 3558 samples","","NCI","GRU --- General Research Use","2019-12-26","2019-12-26","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000785.v1.p1","Sequencing Analysis of Cutaneous Squamous Cell Carcinoma","The Exome Sequencing Analysis of Cutaneous Squamous Cell Carcinoma (SCC) study is a single-center cohort study. To identify recurrent genomic aberrations that might underlie the development of this malignancy, we  performed whole exome sequencing on a series of SCC-normal pairs to distill a list of 336 candidate genes that were subsequently re-sequenced in 100","Not Applicable","Carcinoma, Squamous Cell","Prospective Longitudinal Cohort","Not Provided","WXS","3 phenotype datasets, 11 variables, 198 samples sequenced,  SRA, 198 subjects, 198 samples","","NIAMS","DS-SKCA --- Disease-Specific (Skin Cancer)","2019-12-26","2019-12-26","Skin Cancer; Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinomas, Epidermoid; Carcinomas, Planocellular",""
"phs001902.v1.p1","Whole Exome Sequencing Study of TGF&#x003b2; Pathway Genes in HCV Liver Fibrosis","Despite the astonishing progress in treating chronic hepatitis C virus (HCV) infection with direct-acting antiviral agents, liver fibrosis remains a major health concern in HCV infected patients, in particular due  to the treatment cost and insufficient HCV screening in many countries. Only a fraction of patients with chronic HCV infection develop liver","Not Applicable","Hepatitis C, Chronic","Case-Control","Not Provided","Not Provided","1 analyses","","NIAID","DS-HCV-IRB-COL-NPU --- Disease-Specific (Hepatitis C, IRB, COL, NPU)","2019-12-18","2019-12-18","Chronic Hepatitis C; Chronic type C viral hepatitis",""
"phs000178.v11.p8","The Cancer Genome Atlas (TCGA)","The Cancer Genome Atlas (TCGA) is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale  genome sequencing. TCGA is a joint effort of the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), which are","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","WGS_markerset_grc37","Not Provided","3 phenotype datasets, 8 variables, 11429 subjects, 11467 samples, 1 substudies","","NCI","GRU --- General Research Use","2019-12-18","2018-08-17","Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Transitional Cell; Cystadenocarcinoma, Serous; Esophageal Neoplasms; Invasive Ductal Carcinoma, Breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000854.v3.p8","Genome-Wide Analysis of Noncoding Regulatory Mutations in Cancer","Large-scale sequencing of human tumor samples has transformed the identification of somatic genetic alterations that drive the cancer phenotype. However, most efforts have focused on the protein-coding exome, which comprises  less than 2% of the human genome. Here, we analyzed whole genome sequences from The Cancer Genome Atlas with a focus on recurrently mutated","National Institutes of Health The Cancer Genome Atlas (TCGA) (phs000178.v11.p8)","Neoplasms","Tumor vs. Matched-Normal","WGS_markerset_grc37","SNV Aggregate (.MAF)","2 phenotype datasets, 4 variables, 1 molecular datasets, 356 subjects, 356 samples","","NCI","GRU --- General Research Use","2019-12-18","2018-08-17","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001906.v1.p1","Altered topology drives oncogenic programs in SDH-deficient GIST","Metabolic lesions with pleiotropic effects on epigenetic regulation and other cellular processes are widely implicated in cancer, yet their oncogenic mechanisms remain poorly understood. Succinate dehydrogenase (SDH) deficiency causes a  subset of gastrointestinal stromal tumors (GISTs) with DNA hyper-methylation. Here we associate this hyper-methylation with changes in chromosome","Not Applicable","Gastrointestinal Stromal Tumors","Case Set","Not Provided","Bisulfite-Seq, ChIP-Seq, RNA-Seq","5 phenotype datasets, 18 variables, 84 samples sequenced,  SRA, 22 subjects, 84 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), HMB --- Health/Medical/Biomedical","2019-12-17","2019-12-17","GANT; GI stroma tumor; GI stroma tumour; GIST; GIST - Gastrointestinal stromal tumor; Gastrointestinal Stromal Neoplasm","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001877.v1.p1","Genetics of Cutaneous T-Cell Lymphoma","Mycosis fungoides (MF) is a common extranodal T-cell lymphoma primarily arising in the skin. In early disease stages, MF presents as skin patches and plaques that in some cases may  progress to tumor and disperse to lymph nodes and other internal organs. The 10-year overall survival is 50% in advanced stages. Early diagnosis is","Not Applicable","Mycosis Fungoides","Case-Control","Not Provided","WXS","4 phenotype datasets, 15 variables, 82 samples sequenced, 31 subjects, 82 samples","","NCI","GRU-IRB --- General Research Use (IRB)","2019-12-16","2019-12-16","Lymphoma, T-Cell, Cutaneous; Granulomatous Slack Skin; Slack Skin, Granulomatous",""
"phs001842.v1.p1","RNAseq of Sj&#x000f6;gren's Syndrome and Healthy Volunteers' Salivary Glands","Mechanistic genetic and inflammatory endpoints were studied to gain insight into the molecular mechanisms of Sj&#x000f6;gren's syndrome. Transcriptomic studies allowed the exploration of molecular alterations that might cause or influence  the studied salivary gland pathology and potentially elucidate druggable pathways for intervention. 1.1 Inclusion Criteria Persons older than 4 years","Not Applicable","Sjogren's Syndrome","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 21 variables, 44 samples sequenced,  SRA, 44 subjects, 44 samples","","NIDCR","HMB --- Health/Medical/Biomedical","2019-12-10","2019-12-10","Autoimmune Diseases",""
"phs001470.v1.p1","Study of Women's Health Across the Nation (SWAN) Repository","The Study of Womens Health Across the Nation (SWAN) is an active multi-site, multi-disciplinary, longitudinal study of women's health. Initially funded in 1994 by the National Institute on Aging (NIA),  the National Institute of Nursing Research (NINR), and the Office of Research on Women's Health (ORWH), the overall goal of SWAN is to describe the","Not Applicable","Menopause","Prospective Longitudinal Cohort","Multi-Ethnic_Global, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 47 variables, 2 molecular datasets, 1463 subjects, 1522 samples","European (755), African (7), East Asian (291), African American (377), Hispanic1 (9), Hispanic2 (2), Other Asian or Pacific Islander (18), Other (4)","NIA","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-12-10","2019-12-10","Cardiovascular Disease; Depression; Hot Flashes; Metabolic Diseases; Osteoporosis; Adverse Cardiac Event",""
"phs001455.v1.p1","Screening Cases of Isolated Dystonia for Variants in CIZ1","Recently, we have identified that variants in CIZ1 gene is associated with dystonia. To identify the prevalence of CIZ1 mutations in dystonia population, we use High resolution melting (HRM) to  examine all the coding sequence in 3976 subjects with primary dystonia as well as 1819 subjects of normal controls. Indels in Q rich region of exon 2","Not Applicable","Dystonia","Case Set","SNP-PCR","SNP Genotypes (PCR)","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 5795 subjects, 5795 samples","","NINDS","GRU --- General Research Use","2019-12-10","2019-12-10","Blepharospasm; Cervical Dystonia, Primary; Dystonic Disorders; DYT7; Dystonia 7; Dystonia 7, Torsion","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001337.v1.p1","AACR Project GENIE","AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) is an international pancancer registry of real-world data assembled through data sharing between 19 leading international cancer centers with the goal of  improving clinical decision-making. The registry leverages ongoing clinical sequencing efforts (CLIA/ISO-certified) at participating cancer centers","Not Applicable","Neoplasms","Case Set","Not Provided","Not Provided","2 phenotype datasets, 6 variables, 46510 subjects, 48447 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2019-12-09","2019-12-09","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001332.v2.p1","Spinocerebellar Ataxias Natural History","Spinocerebellar ataxias (SCA) are genetic neurological diseases that cause imbalance, poor coordination, and speech difficulties. There are different kinds of SCA and this study will focus on types 1, 2,  3, and 6 (SCA 1, SCA 2, SCA 3, also known as Machado-Joseph disease and SCA 6). The diseases are rare, slowly progressive, cause increasingly severe","Not Applicable","Spinocerebellar Ataxias","Prospective Longitudinal Cohort","Not Provided","Not Provided","20 phenotype datasets, 3288 variables, 18 documents, 354 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-12-06","2018-02-16","Machado-Joseph Disease; 3s, Spinocerebellar Ataxia; AZOREAN NEUROLOGIC DISEASE; Ataxia 3, Spinocerebellar; Ataxia 3s, Spinocerebellar; Atrophy III, Spinocerebellar",""
"phs000572.v8.p4","Alzheimer's Disease Sequencing Project (ADSP)","THE ALZHEIMER'S DISEASE SEQUENCING PROJECT (ADSP) DATA ARE HOSTED AT NIAGADS DSS: Please go to NIAGADS DSS to apply for build 38 ADSP genetic and phenotypic data. See Background below  for more details. For instructions on how to access the additional ADSP data that are shared through NIAGADS DSS, visit the Application Instructions","Not Applicable","Alzheimer Disease","Case-Control","WGS_markerset_grc37, WES_markerset_grc37","CNV Genotypes, SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WGS, WXS","8 phenotype datasets, 68 variables, 6 molecular datasets, 11525 samples sequenced,  SRA, 15630 subjects, 11529 samples","European (233), African American (78), Hispanic1 (256), Hispanic2 (7), Other (4)","NIA","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-ALZ-IRB --- Disease-Specific (Alzheimer Disease, IRB), DS-ALZ-IRB-NPU --- Disease-Specific (Alzheimer Disease, IRB, NPU), DS-ND-IRB --- Disease-Specific (Neurodegenerative Disease, IRB), DS-ND-IRB-NPU --- Disease-Specific (Neurodegenerative Disease, IRB, NPU)","2019-12-05","2017-05-15","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases",""
"phs001854.v1.p1","Human Pilocytic Astrocytoma Single Cell RNA Sequencing","Pilocytic astrocytoma (PA), the most common childhood brain tumor, is a low-grade glioma with a single driver BRAF rearrangement. Here, we perform scRNAseq in six PAs using methods that enabled  detection of the rearrangement. When compared to higher-grade gliomas, a strikingly higher proportion of the PA cancer cells exhibit a","Not Applicable","Astrocytoma","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 11 variables, 1234 samples sequenced,  SRA, 6 subjects, 1234 samples","","NCI","DS-NDR-MDS --- Disease-Specific (Neurological Disorders Research, MDS)","2019-12-03","2019-12-03","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytoma (excluding glioblastoma); Astrocytomas",""
"phs001814.v1.p1","Molecular Genetics of Heterotaxy and Related Congenital Heart Defects","Heterotaxy syndrome is a congenital anomaly syndrome accompanied by thoracic and abdominal situs abnormalities. The study cohort comprises of individuals with heterotaxy or related congenital heart disease (CHD) who have  undergone exome sequencing. The purpose of the study is to elucidate the molecular genetics of the disorder as well as contribute to knowledge about","Not Applicable","Heterotaxy Syndrome","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 55 variables, 1 molecular datasets, 279 samples sequenced,  SRA, 279 subjects, 279 samples","","NHLBI","GRU --- General Research Use","2019-11-29","2019-11-29","Ciliopathy; Ciliopathies; Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001433.v1.p1","Non-coding RNAs Activated in Hepatoblastoma","Hepatoblastoma (HB) is the most common pediatric liver tumor, affecting mostly children under 3 years of age. This rare tumor represents 1% of all pediatric cancers. Genetic studies have shown  that HB is characterized by high frequency mutations of the CTNNB1 gene encoding beta-catenin (around 75%) and relative genomic stability. Here we","Not Applicable","Hepatoblastoma","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 42 samples sequenced, 21 subjects, 42 samples","","NCI","HMB --- Health/Medical/Biomedical","2019-11-27","2019-11-27","","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000784.v3.p1","Genetic Epidemiology Network of Salt Sensitivity (GenSalt)","The GenSalt study is aimed at identifying novel genes which interact with the effect of dietary sodium and potassium intake or cold pressor on blood pressure. Inclusion criteria for proband  Men or women aged 18-60 years Systolic BP 130-160mm Hg and/or diastolic BP 85-100mm Hg Both parents (two-generation nuclear family) or at least one","Not Applicable","Arterial Pressure","Interventional","Affymetrix_WG_Array","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 1675 subjects, 1000 samples","","NHLBI","DS-HCR-IRB --- Disease-Specific (High blood pressure and related cardiovascular-renal disease, IRB)","2019-11-27","2014-11-05","Arterial Pressure, Mean; Aortic Blood Pressure; Aortic Blood Pressures; Aortic Pressure; Aortic Pressures; Aortic Tension",""
"phs000700.v2.p1","RoadmapEpigenomics_Broad","For the NIH Roadmap Epigenomics project, we applied ChlP-Seq, HTBS and WGBS pipelines to generate comprehensive high-resolution maps of chromatin state and DNA methylation for 100 diverse cell types. Cell  types were selected for their biological and medical importance, and for their potential to maximize the comprehensiveness of acquired epigenomic","Not Applicable","Nervous System Diseases","Methods","Not Provided","Not Provided","2 phenotype datasets, 10 variables, 20 samples sequenced,  SRA, 3 subjects, 22 samples, 1 substudies","","NIDA","AARC --- Alzheimer's and age related conditions","2019-11-27","2015-04-23","Disease, Nervous System; Diseases, Nervous System; Disorder, Nervous System; Disorder, Neurologic; Disorder, Neurological; Disorders, Nervous System",""
"phs000610.v2.p1","RM Epigenomics Program - Broad_Alz_and_Age-Related","This sub-study phs000610 RM_Epigenomics_Broad_Alz contains molecular data of subjects available from the phs000610 study. Summary level phenotypes for the NADI Roadmap Epigenomics Broad cohort study participants can be viewed at  the top-level study page phs000700 Roadmap Epigenomics Broad cohort. Individual level phenotype data and molecular data for all Roadmap Epigenomics","NIH Roadmap Epigenomics Program - Broad Institute (phs000700.v2.p1)","Nervous System Diseases","Methods","Not Provided","Bisulfite-Seq, ChIP-Seq, RNA-Seq, WGS, Bisulfite-Seq, ChIP-Seq, RNA-Seq, WGS","3 phenotype datasets, 12 variables, 20 samples sequenced,  SRA, 3 subjects, 22 samples","","NIDA","AARC --- Alzheimer's and age related conditions","2019-11-27","2015-04-23","Disease, Nervous System; Diseases, Nervous System; Disorder, Nervous System; Disorder, Neurologic; Disorder, Neurological; Disorders, Nervous System",""
"phs001910.v1.p1","Enhancer Signatures of Neuroendocrine Tumors","Most pancreatic neuroendocrine tumors (PNETs) do not produce symptoms of hormonal excess and are hence considered &#x0201c;non-functional&#x0201d;. Their clinical behaviors vary widely, emphasizing the need for a robust classification with  prognostic power. Using enhancer maps to infer regulatory programs, we find that the large majority of non-functional PNETs fall into two major","Not Applicable","Neuroendocrine Tumors","Case Set","Not Provided","ChIP-Seq, RNA-Seq","5 phenotype datasets, 16 variables, 62 samples sequenced, 46 subjects, 62 samples","","NCI","HMB --- Health/Medical/Biomedical, DS-PACA-MDS --- Disease-Specific (Pancreatic Cancer, MDS), DS-PACA-NPU-MDS --- Disease-Specific (Pancreatic Cancer, NPU, MDS)","2019-11-25","2019-11-25","","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001876.v1.p1","Rare CNVs in High-Risk Infant Siblings of Individuals With Autism","Identification of genetic biomarkers associated with autism spectrum disorders (ASDs) could improve recurrence prediction for families with a child with ASD. Here, we describe clinical microarray findings for 253 longitudinally  phenotyped ASD families from the Baby Siblings Research Consortium (BSRC), encompassing 288 infant siblings. By age 3, 103 siblings (35.8%) were","Not Applicable","Autism Spectrum Disorder","Case-Control","Cytogenetic_Arrays","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 1016 subjects, 1016 samples","","NIMH","DS-ASD-IRB-GSO --- Disease-Specific (Autism Spectrum Disorder, IRB, GSO)","2019-11-25","2019-11-25","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs001855.v1.p1","Effects of Exercise on Cardiovascular Health (STRRIDE)","The STRRIDE study is the combination of three interventional trials to evaluate dose and intensity of physical activity on cardiometabolic health. The three component studies are Peripheral Effects of Exercise  on Cardiovascular Health (STRRIDE I, ClinicalTrials.gov Identifier: NCT00200993), Effects of Resistence and Aerobic Exercise on Cardiovascular Health","Not Applicable","Exercise","Clinical Trial","HumanOmniExpressExome-8, target_markerset_grc37","SNP Genotypes (Array), SNP Genotypes (PCR)","4 phenotype datasets, 38 variables, 2 molecular datasets, 883 subjects, 600 samples","European (457), African (5), African American (119), Hispanic1 (6), Hispanic2 (6), Other Asian or Pacific Islander (3), South Asian (4)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2019-11-22","2019-11-22","Metabolic Syndrome; Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery",""
"phs001797.v1.p1","UW TAN Study of Metastatic Urothelial Carcinoma","Patients with metastatic urothelial carcinoma treated at our institution, who elected to undergo rapid autopsy at the time of death, are included in this study. These patients agreed to submit  their tissue (normal samples for germline analysis [kidney or liver] as well as primary and metastatic tumor sites [urothelial carcinoma]) and the","Not Applicable","Urogenital Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 30 variables, 46 samples sequenced, 7 subjects, 46 samples","","NCI","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2019-11-21","2019-11-21","Genito-urinary Neoplasm; Genito-urinary Neoplasms; Genitourinary Neoplasm; Genitourinary tract neoplasia; Genitourinary tract neoplasm; Genitourinary tract tumors",""
"phs001083.v1.p1","99 Cases of Small Cell Lung Cancer Study","Small cell lung cancer (SCLC) is an aggressive disease with poor survival. A few sequencing studies performed on limited number of samples have revealed potential disease-driving genes in SCLC, however,  much still remains unknown, particularly in the Asian patient population. Here we conducted whole exome sequencing (WES) and transcriptomic","Not Applicable","Small Cell Lung Carcinoma","Case Set","Not Provided","WXS","3 phenotype datasets, 16 variables, 99 samples sequenced,  SRA, 99 subjects, 99 samples","","NCI","GRU-PUB-MDS --- General Research Use (PUB, MDS)","2019-11-21","2019-11-21","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL",""
"phs001045.v1.p1","Molecular Epidemiology of Colorectal Cancer (MECC) Metastasis Study","This study compared Ashkenazi Jewish individuals with Stage IV metastatic colon cancer to those with non-metastatic Stage I or II colon cancers. A genome-wide association study, using a 2-stage design,  identified a significant association with rs60745952. Inclusion Criteria Cases Diagnosis with a primary colorectal cancer Stage IV, Stage I, Stage II","Not Applicable","Colorectal Neoplasms","Case Set","","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 323 subjects, 323 samples","","NCI","DS-CC --- Disease-Specific (Colorectal Cancer)","2019-11-21","2019-11-21","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs000808.v1.p1","PGRN/PAT: diLQTS Study","The goal of this study was to search for genetic variants that could be responsible for modifying the risk of drug-induced long QT syndrome (diLQTS). diLQTS is a relatively common  adverse drug event and has been a leading cause for drug relabeling and withdrawal from the market. Our hypothesis, that variants in genes which","Not Applicable","Long QT Syndrome","Case-Control","WES_markerset_grc37, target_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 250 subjects, 239 samples","","NHLBI","GRU --- General Research Use","2019-11-20","2019-11-20","Torsades de Pointes; Electrocardiogram QT Prolonged; Increased QT interval; Long Q-T syndrome; Long QT syndrome; Prolong QT interval","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs001924.v1.p1","Case Study of Acquired Resistance to FGFR Inhibition in    Cholangiocarcinoma","Targeted sequencing was performed on blood, tumor, and cell free DNA samples from an FGFR2-fusion positive cholangiocarcinoma patient before and after treatment with an FGFR targeted therapy. Inclusion Criteria: 1.  A histologically or cytologically confirmed diagnosis of cancer 2. Patients with any malignancy 3. Patients must have tumor suitable for research","Not Applicable","Cholangiocarcinoma","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 15 variables, 8 samples sequenced,  SRA, 1 subjects, 8 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2019-11-15","2019-11-15","Bile duct cancer; CC; CCA; Carcinoma, Cholangiocellular; Carcinomas, Cholangiocellular; Cholangiocar.- intra/extrahepatic","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001742.v2.p1","Clonal Mapping of Multi-Organ Metastasis and Chemoresistance in Triple    Negative Breast cancer","Clonal dynamics during metastasis were studied in two patient-derived xenograft (PDX) models established from treatment-naive primary breast tumors from TNBC patients diagnosed with concurrent metastatic disease. Genomic sequencing and barcode-mediated  clonal tracking revealed robust alterations in clonal architecture between primary tumors and metastases. Polyclonal seeding and maintenance of","Not Applicable","Triple Negative Breast Neoplasms","Case-Control","Not Provided","RNA-Seq, Targeted-Capture, WXS","4 phenotype datasets, 21 variables, 113 samples sequenced,  SRA, 4 subjects, 113 samples","","NCI","GRU --- General Research Use","2019-11-15","2019-11-15","Neoplasm Metastasis; Metastase; Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001196.v1.p1","Schizophrenia Trios from Taiwan","The substantial reproductive impact of schizophrenia, for which affected individuals have fewer than half as many offspring as unaffected individuals do, implies that mutations of largest effect will frequently be  de novo mutations. Ascertaining exome sequence variation in father-mother-offspring trios allows such mutations to be identified and distinguished","Not Applicable","Schizophrenia","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets, 5196 samples sequenced,  SRA, 5196 subjects, 5196 samples","","NIMH","DS-SZRD-GSO-RD --- Disease-Specific (Schizophrenia and related disorders, GSO, RD)","2019-11-15","2019-11-15","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder",""
"phs000624.v1.p1","The Lung Genomics Research Consortium (LGRC)","Chronic lung diseases represent a broad spectrum of chronic fibrosing/inflammatory lung conditions that are for the most part poorly responsive to treatment and often fatal. COPD/emphysema is the fourth leading  cause of death in the United States and the incidence and rate of death from pulmonary fibrosis is increasing each year. Although progress has been","Not Applicable","Pulmonary Disease, Chronic Obstructive","Prospective Longitudinal Cohort","target_markerset_grc37, HumanOmni2.5-8, HumanOmni1-Quad","SNP Genotypes (Array), SNP/CNV Genotypes (NGS)","4 phenotype datasets, 25 variables, 1 molecular datasets, 622 subjects, 766 samples","","NHLBI","DS-LD-IRB-PUB-MDS --- Disease-Specific (Lung Diseases, IRB, PUB, MDS)","2019-11-15","2019-11-15","Lung Diseases, Interstitial; Pulmonary Emphysema; Interstitial Pneumonias; Interstitial Pneumonitides; Interstitial Pneumonitis; Pneumonias, Interstitial",""
"phs001792.v1.p1","Intergenerational Blood Pressure Study (InterGEN Study)","This research study focuses on the genomic and psychological environmental effects on blood pressure among mothers and their children. The study includes 250 mothers who self-identify as AA/black, and 250  children between the ages of 3 and 5 years old at the time of enrollment. The study is longitudinal and data collection interviews are scheduled","Not Applicable","Hypertension","Prospective Longitudinal Cohort","Multi-Ethnic_Global","SNP Genotypes (Array)","5 phenotype datasets, 20 variables, 2 documents, 1 molecular datasets, 464 subjects, 464 samples","","NINR","DS-CVD-NPU-MDS-GSO-RD --- Disease-Specific (Cardiovascular Disease, NPU, MDS, GSO, RD)","2019-11-13","2019-11-13","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; HBP - High blood pressure",""
"phs001511.v1.p1","ProDIGY Exome Sequencing Study: SEARCH for Diabetes in Youth","The 52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2  diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","WES_markerset_grc37, custom_markerset","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 21 variables, 1 molecular datasets, 550 samples sequenced, 550 subjects, 550 samples","European (131), African (4), East Asian (8), African American (236), Hispanic1 (7), Hispanic2 (147), Other Asian or Pacific Islander (9), South Asian (1), Other (7)","NIDDK","HMB-NPU-MDS --- Health/Medical/Biomedical (NPU, MDS)","2019-11-13","2019-11-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000929.v1.p1","High-Risk Breast Cancer GWAS","The GWAS includes High Risk Women from the following epidemiological studies of breast cancer, comprising a total of 3,719 cases and 3,642 controls (cases/controls: MEC, 0/200; ABCFR, 326/418; FCCC, 56/3;  BCFR-UT, 66/32; CNIO-BC, 87/92; GESBC, 65/0; LIFE, 164/0; MARIE, 41/105; MAYO, 208/210; MNYR, 293/409; MSKCC, 310/0; NC-BCFR, 234/233; OFBCR,","Not Applicable","Breast Neoplasms","Case-Control","OncoArray, imputation_panel","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 25 variables, 2 molecular datasets, 7258 subjects, 7369 samples","European (6974), African (6), East Asian (28), African American (63), Hispanic1 (82), Hispanic2 (46), Other Asian or Pacific Islander (12), South Asian (20), Other (27)","NCI","GRU --- General Research Use, HMB-PUB --- Health/Medical/Biomedical (PUB), DS-CA-IRB-PUB-COL-NPU-MDS-GSO --- Disease-Specific (Cancer, IRB, PUB, COL, NPU, MDS, GSO), DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS), CABNHD-MDS --- Cancer, Benign Neoplasms, or Hematopoietic Diseases (MDS), DS-BROC-GSO --- Disease-Specific (Breast and Ovarian cancer, GSO), DS-CA-GSO --- Disease-Specific (Cancer, GSO), DS-BRCA-PUB-MDS --- Disease-Specific (Breast Cancer, PUB, MDS), DS-BRD --- Disease-Specific (Breast Diseases), DS-CA-PUB --- Disease-Specific (Cancer, PUB)","2019-11-13","2019-11-13","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000828.v1.p1","Genomic Analysis of Hepatocellular Carcinoma","Fibrolamellar hepatocellular carcinoma (FL-HCC) is a very rare and distinct subtype of hepatocellular carcinoma that occurs in the previously healthy livers of adolescents and young adults. The low incidence rate  has kept FL-HCC an understudied cancer, thus the list of FL-HCC markers is limited and the genetic alterations driving its growth have remained","Not Applicable","Fibrolamellar hepatocellular carcinoma","Case Set","WGS_markerset_grc37","RNA-Seq, SNP Genotypes (NGS), WGS, WXS","3 phenotype datasets, 14 variables, 1 molecular datasets, 5 samples sequenced,  SRA, 1 subjects, 5 samples","","NCI","DS-PLC-GSO --- Disease-Specific (Pediatric Liver Cancer, GSO)","2019-11-13","2019-11-13","Carcinoma, Hepatocellular; Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells",""
"phs001808.v1.p1","Landscape of Somatic Mutations in B Lymphocytes Across Human Lifespan","The accumulation of spontaneous mutations in somatic cells has been implicated as a cause of aging since 1950. Yet, attempts to establish a causal relationship between somatic mutations and aging  have been constrained by the lack of methods to directly identify mutational events in primary human tissues. Using a highly accurate single-cell","Not Applicable","Aging","Cross-Sectional","Not Provided","ATAC-seq, RNA-Seq, WGA, WGS","4 phenotype datasets, 10 variables, 76 samples sequenced,  SRA, 14 subjects, 76 samples","","NIA","DS-AGR1-NPU --- Disease-Specific (Aging Related 1, NPU)","2019-11-12","2019-11-12","Aging, Biological; Biological Aging",""
"phs000996.v2.p1","Gene-Environment Interaction Effects in Neurodevelopment","Cognitive development is known to be highly heritable, but various genome wide association studies (GWAS) have failed to find common single nucleotide polymorphisms (SNPs) which can explain a large proportion  of the variance in cognitive ability. We hypothesized that an interaction between genes and exposure to potentially toxic metals may account for some","Not Applicable","Environmental Medicine","Case Set","Human1M-Duo, Human660W-Quad","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 2 analyses, 2 molecular datasets, 1385 subjects, 1385 samples","","NIEHS","GRU --- General Research Use","2019-11-12","2017-02-15","Not Provided",""
"phs001444.v2.p1","Genomic Variation in Diffuse Large B Cell Lymphomas","Integrative analysis of genetic lesions in 574 diffuse large B cell lymphomas (DLBCL). The study investigates genomic structural variation, genetic alteration and its effect on the development and biology of  lymphomas by using high throughput sequencing, gene expression, and methylation status. Clinically diagnosed as DLBCL Note: Controlled datasets at","Not Applicable","Lymphoma, Large B-Cell, Diffuse","Case Set","Not Provided","Not Provided","2 phenotype datasets, 7 variables, 489 subjects, 1916 samples","","NCI","GRU --- General Research Use","2019-11-08","","Centroblastic diffuse large B-cell malignant lymphoma; Centroblastic diffuse malignant lymphoma; Centroblastic malignant lymphoma; DLBCL; DLBCL - diffuse large B cell lymphoma; Diffuse Histiocytic Lymphoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001691.v1.p1","Pittsburgh Heterotaxy Study","To understand the genetic etiology of heterotaxy, patients with heterotaxy were consented and recruited, with blood drawn for DNA extraction and exome sequencing. Using the exome sequencing dataset obtained, rare  coding sequence variants were identified. Inclusion criteria: Case: Heterotaxy. It is defined as an abnormal assembly of the thoracic and abdominal","Not Applicable","Heterotaxy Syndrome","Case Set","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 2 samples sequenced, 2 subjects, 2 samples","","NHLBI","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2019-11-07","2019-11-07","ASPLENIA WITH CARDIOVASCULAR ANOMALIES; Asplenia Syndromes; Bilateral right-sidedness sequence; IVEMARK SYNDROME; RAI - right sided atrial isomerism; RIGHT ISOMERISM",""
"phs001176.v3.p1","GxE and Complex Traits","Functional variants associated with complex traits tend to fall in non-coding regions and affect regulatory mechanisms that are not yet well characterized. Furthermore, it is generally difficult to determine in  which tissues and conditions they may have a functional impact. This is because the effect of a genetic variant on a molecular pathway, and","Not Applicable","Gene-Environment Interaction","Collection","WGS_markerset_grc37","ATAC-seq, OTHER, RNA-Seq, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 19 variables, 2 documents, 1 molecular datasets, 1532 samples sequenced,  SRA, 29 subjects, 1549 samples","","NIGMS","GRU --- General Research Use","2019-11-07","2019-11-07","Not Provided",""
"phs001465.v1.p1","Multiregion Sequencing of Localized Prostate Cancer","Ten patients with treatment-na&#x000ef;ve, locally advanced or localized prostate cancer underwent radical prostatectomy. Pathological stage ranged from T2aN0 to T3bN1, and Gleason scores from 3+4 to 4+5. Tumor foci were  mapped, and DNA was extracted from multiple (5-9) regions from a single, contiguous index focus. Whole exome sequencing was performed to identify","Not Applicable","Prostatic Neoplasms","Case Set","other","SNV (.MAF), WGS, WXS","4 phenotype datasets, 44 variables, 1 molecular datasets, 153 samples sequenced,  SRA, 10 subjects, 153 samples","","NCI","DS-CA-IRB-NPU --- Disease-Specific (Cancer, IRB, NPU)","2019-11-04","2019-11-04","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs001837.v1.p1","NAFLD Microbiome","Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in children in the United States. NAFLD is associated with obesity and metabolic syndrome; however, there  is limited understanding of the development and progression of NAFLD. There is evidence of abnormalities of bacterial colonization, and intestinal","Not Applicable","Non-alcoholic Fatty Liver Disease","Case-Control","Not Provided","AMPLICON, WGS","4 phenotype datasets, 35 variables, 248 samples sequenced, 124 subjects, 248 samples","","NIDDK","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-NAFLD-IRB-NPU --- Disease-Specific (Nonalcoholic Fatty Liver Disease, IRB, NPU)","2019-11-01","2019-11-01","Fatty Liver, Nonalcoholic; Fatty Livers, Nonalcoholic; Liver, Nonalcoholic Fatty; Livers, Nonalcoholic Fatty; MASLD; MASLD - metabolic dysfunction-associated steatotic liver disease",""
"phs000256.v4.p3","The Vaginal Microbiome: Disease, Genetics and the Environment","The vagina is an interactive interface with the environment, and as such is covered by a protective epithelial surface. This surface is colonized by a biofilm consisting of bacteria and  other microorganisms, which through a variety of mechanisms serve to protect the host from invasion by pathogens. Alterations in the normal vaginal","Not Applicable","Microbiota","Metagenomics","Not Provided","AMPLICON","4 phenotype datasets, 97 variables, 6476 samples sequenced,  SRA, 4800 subjects, 6476 samples","","NIAID","HMP --- Human Microbiome Research","2019-11-01","2012-07-08","Not Provided",""
"phs001887.v1.p1","Single-Sperm Genome Sequencing","This study performed single-cell DNA sequencing of sperm from 20 presumably fertile sperm donors from a sperm bank. In aggregate, these single-cell sequences yield the genomes of the sperm donors.  Original analyses consisted of inferring recombination and aneuploidy from the single-cell sequences. The raw data may be useful for re-processing,","Not Applicable","Spermatozoa","Prospective Longitudinal Cohort","Not Provided","WGS","3 phenotype datasets, 12 variables, 50 samples sequenced,  SRA, 20 subjects, 50 samples","","NHGRI","GRU --- General Research Use","2019-10-31","2019-10-31","Aneuploidy; Alteration of chromosome number; Aneuploid; Aneuploidies; Aneuploids; chromosome number anomaly","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001406.v1.p1","Duke Cognition Cohort","The overall goal is to identify genetic variants influencing normal variation between humans, with a focus on cognitive and neurosensory traits. Because of the focus of funding agencies on disease,  very few studies of the genetics of non-disease traits have been performed. The genetic variation underlying the vast majority of differences between","Not Applicable","Cognition","Control Set","Human1M-Duo, Illumina_Exome_Array, target_markerset_grc37, WES_markerset_grc37, WGS_markerset_grc37","SNP Genotypes (Array), SNP/CNV Genotypes (NGS)","14 phenotype datasets, 1479 variables, 2 molecular datasets,  SRA, 5199 subjects, 5199 samples","European (973), African (22), East Asian (221), African American (194), Hispanic1 (24), Hispanic2 (43), Other Asian or Pacific Islander (29), South Asian (102), Other (24)","NIMH","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-10-31","2019-10-31","Prosopagnosia; Sleep; Yawning; Agnosia for Face; Agnosia for Faces; Agnosia, Facial Recognition",""
"phs001872.v1.p1","Genome Sequencing of Large, Multigenerational CEPH/Utah Families","Blood-derived DNA samples were collected from 603 members of large, multigenerational families, collected as part of the Centre d'Etude du Polymorphisme Humain (CEPH) consortium. These DNA samples were sequenced (using  Illumina HiSeq technology) to a median genome-wide depth of 30X. Sequenced reads from each individual were aligned to the human reference genome","Not Applicable","Population Groups","Prospective Longitudinal Cohort","WGS_markerset_grc37","SNP Genotypes (Array), WGS","4 phenotype datasets, 17 variables, 1 molecular datasets, 599 samples sequenced,  SRA, 599 subjects, 599 samples","","NHGRI","GRU --- General Research Use","2019-10-25","2019-10-25","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001499.v1.p1","CORECT: Meta-analysis","This study is part 2 of 2 for Schumacher et al, Nat Communication. 2015 Jul 7;6:7138. Part 2 is the pooled meta-analysis of 29 different studies of 37,955 European (18,299  Cases/19,656 Controls) participants using eight different genotyping platforms/variations. Study Name Participants Platform CFR-1 2976 Illumina 1M,","Not Applicable","Colorectal Neoplasms","Case-Control","Not Provided","Not Provided","1 analyses","","NCI","DS-CC --- Disease-Specific (Colorectal Cancer)","2019-10-25","2019-10-25","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001534.v1.p1","Pathways Study","The Pathways Study (NCI R01 CA105274, PI: Kushi), is a prospective cohort study of a diverse population of recently diagnosed breast cancer survivors in KPNC. The aims are to examine  the effect on recurrence and survival of 1) lifestyle factors such as diet, physical activity, and use of complementary and alternative therapies and","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","MEGA_Consortium_Array_plus, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 34 variables, 2 molecular datasets, 4383 subjects, 4576 samples","European (2993), African (11), East Asian (334), African American (324), Hispanic1 (32), Hispanic2 (384), Other Asian or Pacific Islander (196), South Asian (49), Other (53)","NCI","DS-BRCA-IRB-PUB-NPU-MDS --- Disease-Specific (Breast Cancer, IRB, PUB, NPU, MDS)","2019-10-18","2019-10-18","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000897.v1.p1","Mayo Clinic and Illumina Collaborative Early Stage Ovarian Cancer (ESOC)    Study","Twenty five patients with early stage carcinoma (Stage I and II) of the ovary were consented for this study. As part of a collaborative agreement with Illumina Inc, Tumor-DNA and  patient matched normal DNA from blood underwent whole genome sequencing and microarray genotyping and RNA underwent RNASeq. Tissue also underwent IHC","Not Applicable","Cystadenocarcinoma, Serous","Case Set","HumanHap650Y","SNP Genotypes (Array), RNA-Seq, WGS","4 phenotype datasets, 63 variables, 1 molecular datasets, 32 samples sequenced,  SRA, 16 subjects, 142 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2019-10-18","2019-10-18","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001847.v1.p1","Understanding RNA Biology and Therapeutics in Hematopoiesis and Leukemia","Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults and is expected to increase in frequency as the population ages. Most subtypes of AML are  difficult to treat, in part due to a lack of understanding of possible molecular targets. Furthermore, the peak incidence of AML is in the sixth","Not Applicable","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","Not Provided","WGS","4 phenotype datasets, 15 variables, 4 samples sequenced, 2 subjects, 4 samples","","NCI","GRU --- General Research Use","2019-10-17","2019-10-17","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001799.v1.p1","Genomic landscape of Neutrophilic Leukemias of Ambiguous Diagnosis","Chronic neutrophilic leukemia (CNL), atypical chronic myeloid leukemia (aCML), and unclassified myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN-U) are a group of rare, heterogeneous myeloid disorders. There is strong morphologic resemblance amongst these  distinct diagnostic entities as well as lack of specific molecular markers and limited understanding of disease pathogenesis, which has made their","Not Applicable","Leukemia","Prospective Longitudinal Cohort","Not Provided","Not Provided","3 phenotype datasets, 9 variables, 176 subjects, 238 samples","","NCI","DS-LEU --- Disease-Specific (Leukemia)","2019-10-17","2019-10-17","Blood (Leukemia); Blood cancer; Leucocythaemia; Leucocythaemias; Leucocythemia; Leucocythemias",""
"phs001851.v1.p1","The MALT1 Locus and Peanut Avoidance in the Risk for Peanut Allergy","The LEAP study was a randomized controlled clinical trial in children at increased risk for peanut allergy, in which intervention using dietary introduction of peanut protein beginning in the first  4 to 11 months of life, continued until age 5 years, significantly decreased the frequency of peanut allergy later in childhood and modulated the","Not Applicable","Peanut Hypersensitivity","Prospective Longitudinal Cohort","WGS_markerset_grc37, HumanOmni2.5-8","SNP Genotypes (Array)","3 phenotype datasets, 8 variables, 1 molecular datasets,  SRA, 556 subjects, 556 samples","European (401), African (23), East Asian (8), African American (35), Hispanic1 (18), Hispanic2 (1), Other Asian or Pacific Islander (16), South Asian (21), Other (19)","NIAID","DS-ALERG-IRB-PUB-COL-NPU --- Disease-Specific (Allergy, IRB, PUB, COL, NPU)","2019-10-15","2019-10-15","Allergies, Peanut; Allergy, Peanut; Groundnut Hypersensitivity; Hypersensitivity, Groundnut; Hypersensitivity, Peanut; Peanut Allergies",""
"phs000200.v12.p3","Women's Health Initiative","The Women's Health Initiative (WHI) is a long-term national health study that has focused on strategies for preventing heart disease, breast and colorectal cancer, and osteoporotic fractures in postmenopausal women.  The original WHI study included 161,808 postmenopausal women enrolled between 1993 and 1998. The Fred Hutchinson Cancer Research Center in Seattle,","Not Applicable","Women's Health","Prospective Longitudinal Cohort","Affymetrix_WG_Array, HumanOmni1-Quad, WES_markerset_grc37, Cardio-Metabo_Chip, custom_PCR_marker_set, HumanOmniExpressExome-8, imputation_panel, WES_markerset_grc36, MEGA_Consortium_Array, target_markerset_grc37, HumanMethylation450","Not Provided","86 phenotype datasets, 6207 variables, 72 documents, 2234 samples sequenced, 143213 subjects, 105604 samples, 10 substudies","European (588), African (302), East Asian (2), African American (7967), Hispanic1 (526), Hispanic2 (2407), Other Asian or Pacific Islander (19), Other (196)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Adrenal Gland Neoplasms; Angina Pectoris; Anus Neoplasms; Appendiceal Neoplasms; Arthritis, Rheumatoid; Biliary Tract Neoplasms",""
"phs001614.v1.p3","WHI Long Life Study Phase III GWAS Data","Introduction/Intent 7,875 WHI Extension II Study participants participated in the WHI Long Life Study (LLS). The LLS consisted of a one-time in-person visit (conducted between March 2012 and May 2013)  with a blood draw, a brief clinical assessment, and an assessment of functional status. Primary aims of the blood collection: 1. Establish a","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v12.p3)","Women's Health","Prospective Longitudinal Cohort","HumanOmniExpressExome-8","SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 1446 subjects, 1446 samples","European (1129), African (9), African American (242), Hispanic1 (8), Hispanic2 (54), Other (4)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Adrenal Gland Neoplasms; Angina Pectoris; Anus Neoplasms; Appendiceal Neoplasms; Arthritis, Rheumatoid; Biliary Tract Neoplasms",""
"phs001335.v2.p3","NHLBI's BA23 in WHI","This substudy phs001335 Integrative genomics and risk of CHD and related phenotypes in WHI study was to analyze epigenetic markers in blood and to associate these markers with phenotypes related  to coronary heart disease. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page phs000200 WHI","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v12.p3)","Coronary Artery Disease","Case-Control","target_markerset_grc37, HumanMethylation450","Methylation (CpG), miRNA Expression (Array)","2 phenotype datasets, 23 variables, 2 documents, 1 molecular datasets, 2129 subjects, 4256 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Aging; Aging, Biological; Biological Aging; Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease",""
"phs001334.v2.p3","Metabolomics of Coronary Heart Disease (CHD) in the WHI","The primary goal of this substudy phs001334 Metabolomics of CHD in WHI study was to analyze the relationship between metabolite profiles and incident coronary heart disease (CHD) in women using  a nested case-control design. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page phs000200 WHI","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v12.p3)","Coronary Disease","Case-Control","Not Provided","Not Provided","3 phenotype datasets, 746 variables, 1 documents, 2151 subjects","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Coronary Heart Disease; CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart",""
"phs000746.v3.p3","WHI Harmonized and Imputed GWAS Data","This substudy phs000746 WHI Imputation is the effort of a joint imputation and harmonization effort for many of the Genome Wide Association Studies (GWAS) within the Women's Health Initiative (WHI)  Clinical Trials and Observational Studies. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v12.p3)","Women's Health","Prospective Longitudinal Cohort","imputation_panel","SNP Genotypes (imputed)","1 phenotype datasets, 19 variables, 2 documents, 1 molecular datasets, 29814 subjects, 31806 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Not Provided",""
"phs000675.v4.p3","WHIMS+ GWAS: GWAS on Selected WHI Hormone Trial European Americans","WHI WHIMS+ GWAS This substudy contains genotypes generated using Illumina Omni Express on additional WHI European American (EA) participants. When these participants are combined with the GARNET participants, they form  a population that is representative of the entire WHI EA HT population. Also, all Women's Health Initiative Memory Study (WHIMS) participants who","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v12.p3)","Memory","Prospective Longitudinal Cohort","HumanOmniExpressExome-8","SNP Genotypes (Array)","1 phenotype datasets, 6 variables, 1 molecular datasets, 5740 subjects, 5740 samples","European (5709), East Asian (1), African American (4), Hispanic1 (11), Hispanic2 (10), Other Asian or Pacific Islander (1), Other (4)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Adrenal Gland Neoplasms; Angina Pectoris; Anus Neoplasms; Appendiceal Neoplasms; Arthritis, Rheumatoid; Biliary Tract Neoplasms",""
"phs000503.v6.p3","Women's Health Initiative Sight Examination (WHISE)","This substudy phs000503 WHISE contains phenotypes only for the Sight Examination study. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page phs000200  WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and substudies are available by requesting Authorized","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v12.p3)","Macular Degeneration","Clinical Trial","Not Provided","Not Provided","1 phenotype datasets, 192 variables, 1 documents, 3031 subjects","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Geographic Atrophy; Wet Macular Degeneration; Atrophies, Geographic; Atrophy, Geographic; Degeneration, Dry Macular; Degenerations, Dry Macular",""
"phs000386.v8.p3","NHLBI WHI SHARe","This substudy phs000386 WHI SHARe contains genotypes generated using Affymetrix array, produced as part of NHLBI's SNP Health Association Resource (SHARe) project. Summary level phenotypes for the WHI Cohort study  participants can be viewed at the top-level study page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v12.p3)","Women's Health","Prospective Longitudinal Cohort","Affymetrix_WG_Array","SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 12007 subjects, 12262 samples","European (598), African (283), East Asian (1), African American (7983), Hispanic1 (541), Hispanic2 (2406), Other Asian or Pacific Islander (19), Other (176)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Not Provided",""
"phs000315.v8.p3","WHI GARNET","This substudy phs000315 WHI GARNET contains genotypes generated using Illumina array, produced as part of NHGRI's GARNET project. Summary level phenotypes for the WHI Cohort study participants can be viewed  at the top-level study page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and substudies are","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v12.p3)","Cardiovascular Diseases","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 4894 subjects, 4983 samples","European (4338), African (13), East Asian (64), African American (273), Hispanic1 (45), Hispanic2 (105), Other Asian or Pacific Islander (36), Other (20)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Myocardial Infarction; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs000281.v8.p3","NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) -    WHISP","This substudy phs000281 WHISP contains exome sequencing, produced as part of NHLBI's GO-ESP project. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study  page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and substudies are available by requesting","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v12.p3)","Women's Health","Prospective Longitudinal Cohort","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (NGS), WXS","2 phenotype datasets, 79 variables, 1 documents, 5 molecular datasets, 1969 samples sequenced,  SRA, 2150 subjects, 2206 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Cardiovascular Diseases; Myocardial Infarction; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs000227.v5.p3","PAGE: Women's Health Initiative (WHI)","This substudy phs000227 PAGE WHI contains genotypes generated using BeadXpress and Metabochip, produced as part of NHGRI's PAGE project. Summary level phenotypes for the WHI Cohort study participants can be  viewed at the top-level study page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v12.p3)","Women's Health","Prospective Longitudinal Cohort","Cardio-Metabo_Chip, custom_PCR_marker_set, MEGA_Consortium_Array","SNP Genotypes (Array), SNP Genotypes (PCR), WGS","1 phenotype datasets, 6 variables, 9 analyses, 4 molecular datasets, 265 samples sequenced, 45707 subjects, 56001 samples","European (1014), African (233), East Asian (366), African American (6584), Hispanic1 (625), Hispanic2 (3296), Other Asian or Pacific Islander (69), South Asian (5), Other (276)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-11","2019-10-11","Coronary Disease; Inflammation; Myocardial Infarction; CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease",""
"phs001351.v1.p1","Research Study into The Molecular Genetics of Hereditary Neuropathies","Identification of genes implicated in inherited neuropathy through collecting and sequencing multiple generation families with inherited neuropathy. Patients in this study have been evaluated for demyelinating peripheral neuropathy as determined  by decreased motor nerve conduction velocities in the sural nerve. Patients have also been screened for mutations in all genes implicated in","Not Applicable","Inherited Peripheral Neuropathy","Case Set","WES_markerset_grc37","SNP Genotypes (NGS)","3 phenotype datasets, 12 variables, 1 molecular datasets,  SRA, 2 subjects, 2 samples","","NINDS","DS-HN-IRB-GSO --- Disease-Specific (Hereditary Neuropathies, IRB, GSO)","2019-10-10","2019-10-10","",""
"phs001826.v1.p1","Intern Health Study (IHS)","The Intern Health Study is an NIH-funded longitudinal cohort study that assesses stress and mood in medical interns at institutions around the US, enrolling over 3000 new interns each year.  We are hopeful that data collected in this study will further understanding of the psychological, genetic, and program factors involved in the","Not Applicable","Depression","Prospective Longitudinal Cohort","HumanCoreExome-24","SNP Genotypes (Array)","4 phenotype datasets, 26 variables, 2 documents, 1 molecular datasets, 6136 subjects, 6136 samples","European (3932), African (81), East Asian (649), African American (204), Hispanic1 (126), Hispanic2 (181), Other Asian or Pacific Islander (164), South Asian (670), Other (129)","NIMH","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-10-09","2019-10-09","Anxiety; Angst; Anxiety disease; Anxiety reaction; Anxiety-related personality traits; Anxiousness",""
"phs001864.v1.p1","MAP Kinase-Mutant Hematologic Malignancies and Their Therapeutic    Resistance","The Mitogen-Activated Protein Kinase (MAPK) signaling pathway has been critically important in understanding pathology and developing targeted therapy for many cancers, but high frequency mutations in this pathway in hematopoietic  malignancies were unknown until a series of sequencing studies from our group and others revealed a high frequency of activating mutations in BRAF","Not Applicable","Histiocytosis","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 15 variables, 22 samples sequenced, 22 subjects, 22 samples","","NCI","DS-HIST-MDS --- Disease-Specific (Histiocytoses, MDS)","2019-10-08","2019-10-08","Dendritic Cell Sarcoma, Interdigitating; Erdheim-Chester Disease; Histiocytic Sarcoma; Histiocytosis, Langerhans-Cell; Histiocytosis, Non-Langerhans-Cell; Leukemia, Hairy Cell",""
"phs001753.v1.p1","Rapid Evolution of a Skin Lightening Allele in Southern African KhoeSan","The genetic architecture and polygenicity of skin pigmentation is explored in KhoeSan communities, including Nama individuals whose phenotype and genotype data are provided in this dataset. By pairing genotypes and  quantitative spectrophotometric skin pigmentation phenotypes, we show that skin pigmentation is highly heritable in KhoeSan, yet known pigmentation","Not Applicable","Skin Pigmentation","Prospective Longitudinal Cohort","HumanOmni2.5-8, HumanOmniExpress-12, Multi-Ethnic_Global, target_markerset_grc37","SNP Genotypes (Array), CNV Genotypes","4 phenotype datasets, 13 variables, 1 analyses, 1 molecular datasets, 225 subjects, 225 samples","","NIGMS","GRU-IRB-PUB-NPU --- General Research Use (IRB, PUB, NPU)","2019-10-08","2019-10-08","Not Provided",""
"phs001597.v1.p1","Genomic Analysis of Bevacizumab-induced Hypertension","Bevacizumab use in the treatment of cancer can lead to the development of hypertension in some patients, and high-grade toxicity can limit therapy or lead to cardiovascular complications. The factors  that contribute to interindividual variability in blood pressure rise during bevacizumab treatment are not well understood. In the present study,","Not Applicable","Hypertension","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS)","4 phenotype datasets, 22 variables, 2 analyses, 1 molecular datasets,  SRA, 62 subjects, 62 samples","","NCI","DS-CA-COL --- Disease-Specific (Cancer, COL)","2019-10-08","2019-10-08","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; HBP - High blood pressure",""
"phs000217.v3.p1","Genome-Wide Association Study of Leprosy and Dapsone Hypersensitivity    Syndrome (DHS)","Leprosy GWAS (1) Leprosy is a chronic infectious disease caused by Mycobacterium leprae (M. leprae). Due to M. leprae's narrow host range and an inability to be cultured in vitro,  the biological investigation of this disease has been difficult. Host genetic factors have been suggested to play an important role in disease","Not Applicable","Leprosy","Case-Control","Not Provided","Not Provided","5 analyses, 1220 subjects","","NIAID","LSO --- Leprosy Studies Only","2019-10-08","2019-10-08","Drug Hypersensitivity; Allergic drug reaction; Allergic reaction caused by drug; Allergic reaction to medication; Allergies, Drug; Allergy to drugs",""
"phs001869.v1.p1","ADHD Genomic Association Study","Studies at Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands, has recruited participants with ADHD and participants without ADHD, which included matched healthy controls and family members  of participants with ADHD. ADHD participants met DSM-IV-TR criteria for ADHD. DNAs of these participants, 1005 samples, were anonymously genotyped","Not Applicable","Attention Deficit Disorder with Hyperactivity","Case-Control","PsychArray-24","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 1 analyses, 1 molecular datasets, 1001 subjects, 1001 samples","European (985), African American (1), Hispanic1 (3), Hispanic2 (1), South Asian (1), Other (10)","NIMH","GRU --- General Research Use","2019-10-03","2019-10-03","ADD; ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorders with Hyperactivity; Attention Deficit Hyperactivity Disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001576.v2.p2","Longitudinal Study of Bone and Endocrine Disease","Mucopolysaccharidoses (MPS) I, II, and VI are a group of rare, lysosomal storage diseases in which certain enzymes are missing that are normally required for breaking down specific complex carbohydrates.  Deficiencies in these enzymes result in the build-up of toxic substances in various tissues and cause damage to the body's organs. In the past,","Not Applicable","Mucopolysaccharidoses","Prospective Longitudinal Cohort","Not Provided","Not Provided","12 phenotype datasets, 467 variables, 10 documents, 52 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-10-01","2018-08-14","Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis VI; Alpha-L-iduronidase deficiency; Hurler syndrome (subtype); Hurler-Scheie syndrome (subtype)",""
"phs001333.v2.p1","Natural History in Fabry Renal Disease","Fabry disease is a rare genetic disease with deficient activity of an enzyme, which leads to accumulation of inclusions in different organs including kidney, heart and vessels. The purpose of  the study is to conduct a cross-sectional investigation of the natural history of Fabry renal disease and measure renal function and renal structure","Not Applicable","Fabry Disease","Prospective Longitudinal Cohort","Not Provided","Not Provided","8 phenotype datasets, 561 variables, 8 documents, 21 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-10-01","2017-06-27","ALPHA-GALACTOSIDASE A DEFICIENCY; ANDERSON-FABRY DISEASE; Anderson Fabry Disease; Angiokeratoma Corporis Diffusum; Angiokeratoma Diffuse; Angiokeratoma corporis diffusum universale",""
"phs001839.v1.p1","Deep Sequencing of 3 Cancer Cell Lines on 2 Sequencing Platforms","To test the performance of a new sequencing platform, develop an updated somatic calling pipeline and establish a reference for future benchmarking experiments, we performed whole-genome sequencing of 3 common  cancer cell lines (COLO-829, HCC-1143 and HCC-1187) along with their matched normal cell lines to great sequencing depths (up to 278X coverage) on","Not Applicable","Neoplasms","Case Set","Not Provided","WGS","4 phenotype datasets, 19 variables, 12 samples sequenced, 3 subjects, 12 samples","","NCI","GRU --- General Research Use","2019-09-27","2019-09-27","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001737.v2.p1","Ectrodactyly Ectodermal Dysplasia Cleft Lip/Palate (EEC) Syndrome Study","Transcription factor p63 is a key regulator of epidermal keratinocyte proliferation and differentiation. Heterozygous mutations of TP63 encoding p63 cause a spectrum of developmental disorders. EEC syndrome is caused by  point mutations in the p63 DNA-binding domain, and manifests ectodermal dysplasia with defects in the epidermis and epidermal related appendages,","Not Applicable","Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3","Case-Control","RNAseq_probe_set_grc37, ChIP_DNAseq_probe_set","ChIP-Seq, ChIP-seq Read Counts (NGS), RNA-Seq, RNA Seq (NGS)","5 phenotype datasets, 22 variables, 2 documents, 1 molecular datasets, 82 samples sequenced,  SRA, 14 subjects, 86 samples","","NIAMS","GRU-IRB-PUB-NPU --- General Research Use (IRB, PUB, NPU)","2019-09-25","2019-09-25","EEC SYNDROME 3; EEC syndrome caused by mutation in TP63; EEC3; Ectrodactyly, Ectodermal Dysplasia, Cleft Lip/Palate Syndrome 3 (EEC3); Ectrodactyly, Ectodermal Dysplasia, Clefting Syndrome; Ectrodactyly, Ectodermal Dysplasia, Clefting Syndrome Type 3 (EEC3)",""
"phs001436.v1.p1","Discovering the Genetic Basis of Human Neuroblastoma: A Gabriella Miller    Kids First Pediatric Research Program (Kids First) Project","Children with disseminated neuroblastoma have a very high risk of treatment failure and death despite receiving intensified chemotherapy, radiation therapy and immunotherapy. The long-term goal of our research program is  to ultimately improve neuroblastoma cure rates by first comprehensively defining the genetic basis of the disease. The central hypothesis to be","Not Applicable","Neuroblastoma","Tumor vs. Matched-Normal","Not Provided","Not Provided","2 phenotype datasets, 6 variables,  SRA, 1694 subjects, 2281 samples","","NCI","GRU --- General Research Use","2019-09-25","2019-09-25","Not Provided","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001701.v1.p1","INGENIOUS","The INGenious trial planed to enroll a total of 6,000 patients, with 2,000 patients assigned to a pharmacogenetic testing arm and 4,000 to a control arm who will be followed,  but not tested. It is randomized between an intervention arm and one that receives no intervention in order that the genotyped group can be compared","Not Applicable","metabolism","Prospective Longitudinal Cohort","SNP-PCR","CNV Genotypes","4 phenotype datasets, 13 variables, 1 molecular datasets, 1309 subjects, 1309 samples","","NHGRI","HMB --- Health/Medical/Biomedical","2019-09-24","2019-09-24","Not Provided",""
"phs001718.v1.p1","C9ORF72 Hexanucleotide Repeat Sequence Genotyping Project","This study reports long-range and high-resolution repeat sizing of the C9orf72 repeat region for 2095 samples from the National Institute of Neurological Disorders and Stroke (NINDS) repository's ALS collection. Genomic  DNA samples were analyzed with a PCR assay (AmplideX&#x000ae; PCR/CE C9orf72 Kit) and resolved on capillary electrophoresis. Expanded samples were","Not Applicable","Amyotrophic Lateral Sclerosis","Prospective Longitudinal Cohort","target_markerset_grc37","CNV Genotypes","4 phenotype datasets, 15 variables, 1 molecular datasets, 2095 subjects, 2095 samples","","NINDS","GRU --- General Research Use","2019-09-19","2019-09-19","Frontotemporal Dementia; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001124.v1.p1","Mechanisms of Risk for Sulfonamide Hypersensitivity","Hypersensitivity (HS) reactions to sulfonamide antibiotics occur uncommonly, but with potentially severe clinical manifestations. A familial predisposition to sulfonamide HS is suspected, but robust predictive genetic risk factors have yet  to be identified. Strongly linked genetic polymorphisms have been used clinically as screening tests for other HS reactions prior to administration","Not Applicable","Drug Hypersensitivity Syndrome","Case-Control","Human660W-Quad, HumanCore-12","SNP Genotypes (Array)","4 phenotype datasets, 22 variables, 1 documents, 1 molecular datasets, 297 subjects, 333 samples","","NIGMS","GRU --- General Research Use","2019-09-17","2019-09-17","Anticonvulsant hypersensitivity syndrome; DHS; DRESS; DRESS Syndrome; DRESS Syndromes; Drug Hypersensitivity Syndromes",""
"phs001331.v2.p1","Immune Mediated Disorders after Allo-HCG","Allogeneic hematopoietic cell transplantation (HCT) is the only known curative option for many hematologic disorders. After transplantation, many patients develop immune mediated disorders that may be life-threatening. Post-HCT immune mediated  disorders are rare relative to other diseases but the prototype of graft versus host disease (GVHD) develops in 30-70% of patients. The morbidity and","Not Applicable","Graft vs Host Disease","Prospective Longitudinal Cohort","Not Provided","Not Provided","21 phenotype datasets, 1251 variables, 21 documents, 1023 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-09-16","2019-09-16","Bronchiolitis Obliterans; Sclerosis; Bronchiolitides, Exudative; Bronchiolitis, Exudative; Exudative Bronchiolitides; Exudative Bronchiolitis",""
"phs001502.v1.p1","CCDG-Cardiovascular: University of Pennsylvania Cohort","The National Human Genome Research Institute (NHGRI) has funded the Centers for Common Disease Genomics (CCDG), a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants  contributing to multiple common disease phenotypes and to better understand the general principles of genomic architecture underlying common, complex","Not Applicable","Cardiovascular Diseases","Case-Control","custom_markerset, WGS_markerset_grc37","SNP Genotypes (NGS), Legacy Genotypes","4 phenotype datasets, 13 variables, 1 molecular datasets, 1373 subjects, 95 samples","European (1), African (6), African American (82), Hispanic1 (2), Other (3)","NHLBI","HMB-IRB-PUB --- Health/Medical/Biomedical (IRB, PUB)","2019-09-12","2019-09-12","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs000233.v1.p1","Genome Wide Association Study of Asthma","This data forms part of an ongoing genome wide association study into the genetic variants that predispose to pediatric asthma at the Children's Hospital of Philadelphia (CHOP). All cases and  controls were recruited at CHOP and genotyped at the Center for Applied Genomics (CAG). The data set includes 793 cases and 1988 controls. The","Not Applicable","Asthma","Case-Control","Not Provided","Not Provided","1 analyses","","NHLBI","DS-AS-AT --- Disease-Specific (Asthma and atopy)","2019-09-12","2019-09-12","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs001201.v2.p1","ASsessing and Predicting Infant RSV Effects and Severity (AsPIRES) Study","A prospective multi-year clinical translational study including three cohorts of term infants experiencing their first Respiratory Syncytial Virus (RSV) season. All infants are less than or equal to nine months  of age at study entry. The three subject cohorts represent the full spectrum of RSV disease severity and include a birth cohort, a cohort of infants","Not Applicable","Respiratory Syncytial Virus Infections","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37","RNA-Seq, RNA Seq (NGS), AMPLICON","8 phenotype datasets, 133 variables, 1 molecular datasets, 974 samples sequenced,  SRA, 186 subjects, 1460 samples","","NIAID","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-09-11","2019-09-11","Human respiratory syncytial virus infection; Infection, RSV; Infections, Respiratory Syncytial Virus; RSV - Respiratory syncytial virus infection; RSV Infection; Respiratory Syncytial Virus Infection",""
"phs001632.v1.p1","African American Multiple Myeloma GWAS","The case set is from a case-control study designed to identify common genetic risk factors for multiple myeloma in African Americans, the population with the highest risk for this cancer.  We conducted two GWAS and combined each of these with convenience controls consisting of unaffected African American participants in cohorts with","Not Applicable","Multiple Myeloma","Case Set","HumanCoreExome-12, MEGA_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 1408 subjects, 1408 samples","European (2), African (43), African American (1348), Hispanic1 (8), Other (7)","NCI","GRU --- General Research Use, DS-CA --- Disease-Specific (Cancer), GRU-NPU --- General Research Use (NPU), GRU-PUB-NPU --- General Research Use (PUB, NPU), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), DS-MM-MDS --- Disease-Specific (Multiple Myeloma, MDS), DS-CA-IRB-GSO --- Disease-Specific (Cancer, IRB, GSO)","2019-09-06","2019-09-06","Smoldering Multiple Myeloma; Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001687.v1.p1","West Africa Breast Cancer Study (WABCS)","Differences in breast cancer incidence and mortality rates between North American Caucasian and African American women are well-described and transcend socioeconomic issues. Black women are diagnosed with breast cancer at  a younger median age; have more clinically aggressive disease and stage-for-stage; and have higher mortality rates than age-matched Caucasian women.","Not Applicable","Breast Neoplasms","Case-Control","Not Provided","Not Provided","4 phenotype datasets, 63 variables,  SRA, 294 subjects, 722 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2019-08-29","2019-08-29","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001852.v1.p1","Analysis of the Genetic Basis of Height in Large Jewish Nuclear Families","This is a family based study of the genetic basis of height, which focused on very large nuclear families (10 siblings or more, average of 12), all from a founder  (Jewish) population. All participants have completed their growth. This study design increases the frequency of some genetic variants that are rare","Not Applicable","Body Height","Family/Twin/Trios","Axiom_Array","SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 1 molecular datasets, 404 subjects, 399 samples","","NICHD","HMB-IRB --- Health/Medical/Biomedical (IRB), LHMB --- Limited Health/Medical/Biomedical","2019-08-28","2019-08-28","Crown-Rump Length; CRL - Crown rump length; Crown Rump Length; Crown-Rump Lengths; Length, Crown-Rump; Lengths, Crown-Rump",""
"phs001296.v2.p1","UCD Imaging Study","This is a case controlled, observational study. This project studies cognitive and motor dysfunction in adult and pediatric patients who are female carriers of ornithine transcarbamylase deficiency (OTCD) or are  males with late onset presentation (outside of the newborn period) of OTCD, utilizing state of the art MRI (magnetic resonance imaging), a","Not Applicable","Urea Cycle Disorders, Inborn","Case-Control","Not Provided","Not Provided","9 phenotype datasets, 421 variables, 8 documents, 41 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-08-19","2019-08-19","Disorder of urea cycle; Disorder, Urea Cycle; Disorders, Urea Cycle; Inborn Urea Cycle Disorder; UCD; Urea Cycle Disorder",""
"phs001705.v1.p1","NCI-Epidemiology of Burkitt Lymphoma in East African Children and Minors    (EMBLEM)","A genome-wide analysis of genetic structure, gene flow, and natural selection was conducted in populations in the endemic Burkitt lymphoma (eBL) belt in Ghana and Northern Uganda, both subject to  a high incidence of falciparum malaria and eBL. These populations have different ethnolinguistic ancestries and are located 2400 miles apart in","Not Applicable","Burkitt Lymphoma","Case-Control","HumanOmni5Exome-4","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 568 subjects, 568 samples","","NCI","GRU-IRB --- General Research Use (IRB)","2019-08-15","2019-08-15","Malaria; BL; BL - Burkitt's lymphoma; Burkitt Tumor; Burkitt lymphoma/leukemia; Burkitt's Lymphoma",""
"phs001281.v2.p1","Establish Reliability for qEEG, Transcranial Doppler and OCT in SWS","Sturge-Weber syndrome (SWS) is a rare, congenital syndrome with vascular malformations of the brain, skin and eye. The underlying cause of SWS is unknown and the extent of involvement varies  greatly from patient to patient. Those with brain involvement present with seizures, stroke-like episodes and neurologic deficits, usually in","Not Applicable","Sturge-Weber Syndrome","Cross-Sectional","Not Provided","Not Provided","14 phenotype datasets, 867 variables, 11 documents, 40 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-08-15","2017-02-27","Angiomatosis Oculoorbital-Thalamic Syndrome; Angiomatosis oculo-orbital-thalamo-encephalic syndrome; Angiomatosis, Meningo-Oculo-Facial; Encephalocutaneous angiomatosis; Encephalofacial Hemangiomatosis Syndrome; Encephalofacial angiomatosis",""
"phs001781.v1.p1","Proteogenomic Landscape of Squamous Cell Lung Cancer","To provide a detailed analysis on how genomic and transcriptomic alterations related to proteome level changes in squamous cell lung cancer (SCC), we performed an integrated analysis incorporating DNA copy  number, somatic mutations, expression RNA-sequencing, and expression proteomics in 108 SCC nested within clinical outcome, tumor pathology, and other","Not Applicable","Carcinoma, Non-Small-Cell Lung","Prospective Longitudinal Cohort","Not Provided","Targeted-Capture, RNA-Seq","4 phenotype datasets, 18 variables, 108 samples sequenced,  SRA, 108 subjects, 108 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2019-08-14","2019-08-14","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000588.v1.p1","VCRC5502: Longitudinal Protocol for Giant Cell Arteritis","The development and validation of accurate biological markers and predictors of disease activity and outcome for Giant Cell Arteritis, a form of idiopathic vasculitis, would have a major positive impact  on the clinical care of patients with this rare disease, be an important insight into the design of clinical trials and feasibility of new drug","Not Applicable","Giant Cell Arteritis","Prospective Longitudinal Cohort","Not Provided","Not Provided","32 phenotype datasets, 3390 variables, 30 documents, 194 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-08-14","2019-08-14","Arteritis; Arterial Inflammation; Arteritides; Inflammation of artery; Inflammation, Arterial; artery inflammation",""
"phs001428.v1.p1","GWAS for Breast Cancer Chemotherapy Toxicities in S0221","When undergoing treatment for breast cancer, many women experience severe side effects, some of which result in treatment-related death and some that can persist for years. Little is understood regarding  factors that may predict drug toxicities. Pharmacogenetics, the investigation of variants in candidate genes in drug metabolism pathways, has been","Not Applicable","Peripheral Nervous System Diseases","Clinical Trial","HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 24 variables, 1 molecular datasets, 1847 subjects, 1847 samples","European (1465), African (5), East Asian (46), African American (161), Hispanic1 (24), Hispanic2 (106), Other Asian or Pacific Islander (29), South Asian (6), Other (5)","NCI","DS-BRCATOX-COL-MDS-GSO --- Disease-Specific (Breast Cancer Treatment Toxicities, COL, MDS, GSO)","2019-08-13","2019-08-13","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001568.v1.p1","Genetic Epidemiology of CLL","Chronic lymphocytic leukemia (CLL) is a subtype of B-cell lymphoproliferative disorders (LPD), and is the most common form of adult leukemia in Caucasians in the United States. Small lymphocytic lymphoma  (SLL) is also a B-cell LPD and is typically considered to be the same disease as CLL, based on pathology. We consider CLL and SLL as the same disease","Not Applicable","Leukemia, Lymphoid","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","3 phenotype datasets, 12 variables, 1 molecular datasets, 715 subjects, 715 samples","European (701), East Asian (3), African American (2), Hispanic2 (8), Other Asian or Pacific Islander (1)","NCI","DS-HM-GSO --- Disease-Specific (Hematological Malignancies, GSO)","2019-08-12","2019-08-12","Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic; Leukemias, Lymphocytic; Leukemias, Lymphoid; Lymphatic leukemia; Lymphocytic Leukemia",""
"phs001823.v1.p1","Genome and Transcriptome Analysis of Lung Cancer Cell Lines","We have used a ""chemistry first"" approach to discover druggable acquired vulnerabilities that arised in the pathogenesis of non-small cell lung cancer (NSCLC). We screened chemical libraries ( 200,000 compounds)  for chemical toxins that killed subsets of NSCLC but not normal human lung epithelial cells (HBECs). We first screened a panel of 12 NSCLC lines that","Not Applicable","Carcinoma, Non-Small-Cell Lung","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38, WES_markerset_grc38","WXS, RNA-Seq, SNV (.MAF), RNA Seq (NGS)","4 phenotype datasets, 19 variables, 2 molecular datasets, 813 samples sequenced, 279 subjects, 813 samples","","NCI","DS-LC-IRB --- Disease-Specific (Lung Cancer, IRB)","2019-08-09","2019-08-09","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER",""
"phs001284.v1.p1","NCI Waldenstrom Macroglobulinemia Genome-Wide Association Study","A discovery GWAS is performed, consisting of genotyping 221 Waldenstrom macroglobulinemia (WM) cases on the Illumina Omni Express 12v1.1 platform and analyzing the genotypes together with those of 3798 previously  genotyped controls in a model taking into account gender, age, and principal components of ancestry (i.e., significant eigenvectors). Directly","Not Applicable","Waldenstrom Macroglobulinemia","Case-Control","HumanOmniExpress-12, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 17 variables, 2 molecular datasets, 217 subjects, 217 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use","2019-08-09","2019-08-09","Lymphoplasmacytoid Lymphoma; Lymphoma, Lymphocytic, Plasmacytoid; Lymphoma, Lymphoplasmacytoid; Lymphomas, Lymphoplasmacytoid; Lymphoplasmacytoid Lymphomas; Macroglobulinaemia, Waldenstrom's","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001867.v1.p1","Detection of Somatic Mutations In Vitro Aging Cells","Deep sequencing was performed to analyze the prevalence of somatic mutations during in vitro cell aging. Primary dermal fibroblasts from healthy subjects of young and advanced age, from Hutchinson-Gilford progeria  syndrome, and from Xeroderma Pigmentosum complementation group A (XPA) and C (XPC), were first restricted in number and then expanded in vitro. DNA","Not Applicable","Progeria","Cross-Sectional","HumanOmniExpress-12","SNP Genotypes (Array), Targeted-Capture","5 phenotype datasets, 26 variables, 1 molecular datasets, 24 samples sequenced, 13 subjects, 25 samples","","NHGRI","GRU --- General Research Use","2019-08-06","2019-08-06","Aging; Hutchinson-Gilford Progeria Syndrome; Xeroderma Pigmentosum, Complementation Group C; Aging, Biological; Biological Aging; HGPS","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001830.v1.p1","Tumor Heterogeneity and Drug Resistance in FGFR2-Fusion    Cholangiocarcinoma","Whole exome sequencing was performed on blood and tumor specimens (collected from biopsy or rapid research autopsy) from a patient with FGFR2 fusion positive cholangiocarcinoma. Inclusion Criteria: 1) A histologically  or cytologically confirmed diagnosis of cancer 2) Patients with any malignancy 3) Patients must have tumor suitable for research tumor biopsy (as","Not Applicable","Cholangiocarcinoma","Case Set","WES_markerset_grc37","CNV Genotypes, WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 12 samples sequenced,  SRA, 1 subjects, 12 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2019-08-06","2019-08-06","Clonal Evolution; Bile duct cancer; CC; CCA; Carcinoma, Cholangiocellular; Carcinomas, Cholangiocellular","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001740.v1.p1","CCDG- Neuropsychiatric: Autism- Study of Autism Genetics Exploration    (SAGE)","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed  for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the","Not Applicable","Autism Spectrum Disorder","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 26 variables, 1 molecular datasets,  SRA, 580 subjects, 580 samples","","NHGRI","DS-ASD-RD-IRB --- Disease-Specific (Autism Spectrum Disorder and Related Diseases, IRB)","2019-08-02","2019-08-02","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum",""
"phs001370.v1.p1","Whole Exome Sequencing of Uveal Melanoma","Uveal melanoma is a rare form of melanoma that occurs in the eye and has no effective treatment once metastatic. To further characterize the genomic events driving uveal melanoma, whole  exome sequencing was performed on 61 primary tumors derived from enucleations, 3 liver metasases, and paired normal DNA. Recurrent somatic genetic","Not Applicable","Uveal Melanoma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 14 variables, 144 samples sequenced,  SRA, 89 subjects, 144 samples","","NHGRI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-UM-NPU --- Disease-Specific (Uveal Melanoma, NPU)","2019-07-30","2019-07-30","Melanoma, Uveal; Choroidal melanoma; Intraocular Melanoma; Iris melanoma; Melanoma Of The Uvea; Melanoma of Uvea",""
"phs000589.v1.p1","VCRC5503: Longitudinal Protocol for Takayasu's Arteritis","The development and validation of accurate biological markers and predictors of disease activity and outcome for Takayasu's arteritis, a form of idiopathic vasculitis, would have a major positive impact on  the clinical care of patients with this rare disease, be an important advance in the design of clinical trials and feasibility of new drug","Not Applicable","Takayasu Arteritis","Prospective Longitudinal Cohort","Not Provided","Not Provided","33 phenotype datasets, 3409 variables, 30 documents, 138 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-07-30","2019-07-30","Arteritis; Arterial Inflammation; Arteritides; Inflammation of artery; Inflammation, Arterial; artery inflammation",""
"phs001848.v1.p1","Human PI3K&#x003b3; Deficiency with Immunodeficiency and Tissue Immunopathology","Whole exome sequencing of a trio (parents and offspring) reveals PIK3CG mutations that result in loss of protein in the child with immunodeficiency and immunopathology. Inclusion criteria: Patients known to  have or suspected of having an inherited disease of the immune system are eligible for enrollment. Because of the intensive time and labor required","Not Applicable","Immune System Diseases","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 3 subjects, 3 samples","","NIAID","HMB-IRB --- Health/Medical/Biomedical (IRB)","2019-07-26","2019-07-26","Immunologic Deficiency Syndromes; Disease, Immune; Disease, Immune System; Disease, Immunologic; Disease, Immunological; Diseases of Immune System",""
"phs001850.v1.p1","Systemic Lupus Erythematosus Subtypes in a Multi-Ethnic Cohort","Systemic lupus erythematosus (SLE) is a complex autoimmune disease that affects multiple organ systems and varies in severity across different populations. To examine the clinical heterogeneity of SLE, we sought  to identify different lupus subtypes within our multi-ethnic cohort using a clustering approach. Additionally, with genome-wide methylation and","Not Applicable","Lupus Erythematosus, Systemic","Prospective Longitudinal Cohort","MethylationEPIC, Axiom_Array","Methylation (CpG), SNP Genotypes (Array)","4 phenotype datasets, 22 variables, 1 molecular datasets, 333 subjects, 310 samples","European (89), African (1), East Asian (76), African American (32), Hispanic1 (2), Hispanic2 (46), Other Asian or Pacific Islander (23), South Asian (3), Other (10)","NIAMS","HMB --- Health/Medical/Biomedical","2019-07-24","2019-07-24","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus",""
"phs001833.v1.p1","Genetic Model of MS Severity","The goal of ""Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the CNS"" is to define the pathophysiological mechanisms underlying the development of disability in immune-mediated disorders of the central nervous  system (CNS) and to distinguish these from physiological (and often beneficial) responses of the human immune system to CNS injury. The long-term","Not Applicable","Multiple Sclerosis","Prospective Longitudinal Cohort","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 16 variables, 1 molecular datasets, 299 subjects, 299 samples","","NIAID","GRU-IRB-PUB-NPU --- General Research Use (IRB, PUB, NPU)","2019-07-23","2019-07-23","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple",""
"phs001680.v1.p1","T Cell States Associated with Response to Checkpoint Blockade in Melanoma","Checkpoint blockade therapy using antibodies targeting CTLA4, PD1 or PDL1 have changed the way cancer patients with advanced disease are being treated, as evident by their FDA approval in a  wide variety of malignancies, and their ability to induce high response rates when compared to conventional therapies (e.g. chemotherapy). However,","Not Applicable","Immunotherapy","Prospective Longitudinal Cohort","Not Provided","WXS, ATAC-seq, RNA-Seq","5 phenotype datasets, 19 variables, 92 samples sequenced, 32 subjects, 98 samples","","NCI","DS-MSC-MDS --- Disease-Specific (Melanoma and Skin Cancer Research, MDS), DS-CA-IRB-PUB --- Disease-Specific (Cancer, IRB, PUB)","2019-07-23","2019-07-23","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma; Melanoma, Malignant",""
"phs001586.v1.p1","Rhode Island Child Health Study (RICHS)","Mother and infant pairs were enrolled in the Rhode Island Child Health Study (RICHS) at the Woman and Infant's Hospital from 2009 through 2014. This population consists of singleton, term  infants (&#x02265;37 weeks gestation) born without serious pregnancy complications or congenital or chromosomal abnormalities. Given a priority","Not Applicable","Child Health","Prospective Longitudinal Cohort","MEGA_Consortium_Array","RNA-Seq, SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets, 199 samples sequenced,  SRA, 199 subjects, 348 samples","European (99), African (2), East Asian (2), African American (17), Hispanic1 (9), Hispanic2 (11), Other Asian or Pacific Islander (6), South Asian (1), Other (2)","NIEHS","GRU --- General Research Use","2019-07-23","2019-07-23","Not Provided",""
"phs001836.v1.p1","A Single Cell Transcriptomic Analysis of Human Neocortical Development","Defining the number, proportion, or lineage of distinct cell types in the developing human brain is an important goal of modern brain research. We produced single cell transcriptomic profiles for  40,000 cells at mid-gestation to define deep expression profiles corresponding to all known major cell types at this developmental period and compare","Not Applicable","Autism Spectrum Disorder","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 76 samples sequenced,  SRA, 4 subjects, 76 samples","","NIMH","GRU --- General Research Use","2019-07-18","2019-07-18","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001292.v2.p1","Sleep in Rare Disease","This research study will investigate sleep behavior in the rare neurological disorders Angelman Syndrome (AS), Rett Syndrome (RTT), Prader-Willi Syndrome (PWS) and Early-onset Morbid Obesity (EMO). Sleep is very important  to proper health and plays a critical role in learning, memory, brain development and brain function. Sleep disturbances can have negative effects on","Not Applicable","Angelman Syndrome","Case-Control","Not Provided","Not Provided","12 phenotype datasets, 278 variables, 6 documents, 808 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-07-18","2019-07-18","Prader-Willi Syndrome; Rett Syndrome; AS; Angelmans syndrome; Angelman syndrome chromosome region; Angelman's syndrome",""
"phs001840.v1.p1","Single-Cell Analysis of Human Pancreatic Ductal Adenocarcinoma","Cancer-associated fibroblasts (CAFs) are major players in the progression and drug resistance of pancreatic ductal adenocarcinoma (PDAC). CAFs constitute a diverse cell population consisting of several recently described subtypes, although  the extent of CAF heterogeneity has remained undefined. Here we employ single-cell RNA-sequencing to thoroughly characterize the neoplastic and tumor","Not Applicable","Carcinoma, Pancreatic Ductal","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37","RNA Seq (NGS), RNA-Seq","4 phenotype datasets, 15 variables, 1 molecular datasets, 9 samples sequenced, 6 subjects, 9 samples","","NCI","GRU --- General Research Use","2019-07-17","2019-07-17","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001784.v1.p1","Functional Genomics and Molecular Imaging of Liver Disease and Cancer","Molecular imaging with 18F-fluorocholine PET/CT reveals two distinct imaging phenotypes for hepatocellular carcinoma (HCC) as a potential source of non-invasive insight into its molecular heterogeneity. Using gene set enrichment analyses,  we found 18F-fluorocholine-avid tumors to be significantly enriched by genes comprising a subset of previously published HCC-related gene signatures.","Not Applicable","Carcinoma, Hepatocellular","Case Set","HumanHT-12","mRNA Expression (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets,  SRA, 41 subjects, 41 samples","","NCI","DS-LCCLD-COL --- Disease-Specific (Liver Cancer and Chronic Liver Disease, COL)","2019-07-15","2019-07-15","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells",""
"phs001776.v1.p1","NCI LTG Human Pancreas QTL Study","We created a human histologically normal pancreas eQTL resource using 91 fresh frozen tissue samples from patients diagnosed with pancreatic cancer (Mayo Clinic and Memorial Sloan Kettering Cancer Center) or  from organ donors without a history of pancreatic cancer (Penn State University) by RNA-Sequencing. Genome wide genotyping was done using blood","Not Applicable","Pancreas","Case-Control","HumanOmni1-Quad, HumanOmniExpress-12, HumanOmniExpress-24","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 16 variables, 1 molecular datasets, 91 samples sequenced,  SRA, 91 subjects, 182 samples","","NCI","DS-PACA-IRB-MDS --- Disease-Specific (Pancreatic Cancer, IRB, MDS), GRU-IRB-PUB-NPU --- General Research Use (IRB, PUB, NPU)","2019-07-12","2019-07-12","Not Provided",""
"phs000740.v1.p1","Whole Genome Sequencing of Waldenstrom's Macroglobulinemia","Whole genome sequencing was conducted on 10 tumor/germline paired samples along with 20 additional unpaired tumor samples from patients with Waldesntrom's macroglobulinemia. Tumor lymphoplasmacytic lymphoma cells were obtained from CD19+  selected bone marrow mononuclear cells. Germline tissue was obtained from CD19 depleted peripheral blood mononuclear cells. High molecular weight DNA","Not Applicable","Waldenstrom Macroglobulinemia","Case-Control","Not Provided","WGS","4 phenotype datasets, 19 variables, 35 samples sequenced,  SRA, 30 subjects, 40 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2019-07-11","2019-07-11","Lymphoma, Lymphocytic, Plasmacytoid; Lymphoma, Lymphoplasmacytoid; Lymphomas, Lymphoplasmacytoid; Lymphoplasmacytoid Lymphoma; Lymphoplasmacytoid Lymphomas; Macroglobulinaemia, Waldenstrom's","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000507.v2.p2","Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans","Benign ethnic neutropenia (BEN) is a clinical condition more commonly observed in African-Americans. It is characterized by a relative reduction in neutrophil count by about 1000 cells per microliter, leading  to a decrease in total leukocyte count by similar decrement. Previous reports of this condition showed that there was neither higher frequency nor","Not Applicable","Neutropenia","Case-Control","HumanOmniExpress-12, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 34 variables, 4 documents, 2 molecular datasets, 1200 subjects, 1273 samples","European (5), African (48), African American (1119), Hispanic1 (15), Other (1)","NHLBI","HMB --- Health/Medical/Biomedical","2019-07-10","2019-07-10","","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs001747.v1.p1","Caregiving as a Natural Stressor in Coronary Heart Disease (CAREGIVER)","The burden of caregiving for an ill relative has been shown to interact with existing comorbidities to increase risk of several health outcomes including metabolic syndrome and blood pressure reactivity.  The CAREGIVER study was developed to compare cardiometabolic risk factors in caregivers and controls. These risk factors include physiologic","Not Applicable","Coronary Disease","Case-Control","target_markerset_grc38, HumanMethylation450","SNP Genotypes (PCR), Methylation (CpG)","4 phenotype datasets, 40 variables, 1 molecular datasets, 342 subjects, 342 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2019-07-05","2019-07-05","Stress, Psychological; CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary",""
"phs001259.v1.p1","CCDG CVD: VIRGO - Variation in Recover-Role of Gender on Outcomes of    Young Acute Myocardial Infarction (AMI) Patients","The VIRGO study is a four year research project funded by the NHLBI to study young women and men with heart attacks. A total of 2,000 women who are 18  - 55 years of age and a smaller comparison group of 1,000 similarly aged men will be enrolled in this multi-site observational study from","Not Applicable","Myocardial Infarction","Prospective Longitudinal Cohort","WGS_markerset_grc38","SNP Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 2149 subjects, 2150 samples","European (1574), African (7), East Asian (20), African American (344), Hispanic1 (48), Hispanic2 (103), Other Asian or Pacific Islander (19), South Asian (19), Other (15)","NHGRI","DS-CARD-MDS-GSO --- Disease-Specific (Cardiology, MDS, GSO)","2019-07-03","2019-07-03","Anterior Wall Myocardial Infarction; Inferior Wall Myocardial Infarction; Anterolateral Myocardial Infarction; Anterolateral Myocardial Infarctions; Infarction, Anterolateral Myocardial; Infarctions, Anterolateral Myocardial",""
"phs001824.v1.p1","RNASeq of Plasmacytoid Dendritic Cells in Head and Neck Squamous Cell    Cancer","Plasmacytoid dendritic cells (pDC) are a subset of dendritic cells with unique immunophenotypic properties and functions. While their role in antiviral immunity through production of type I interferons is well-established,  their contributions to anti-tumor immunity are less clear. While some evidence demonstrates that pDC in the tumor microenvironment (TME) may drive","Not Applicable","Dendritic Cells","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 19 samples sequenced,  SRA, 7 subjects, 19 samples","","NCI","GRU --- General Research Use","2019-06-28","2019-06-28","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001804.v1.p1","Genetic Epidemiology of Opioid Dependence in Bulgaria (GEODB)","The study was conducted in Bulgaria as a collaboration between the Molecular Medicine Center (Medical University, Sofia), the Bulgarian Addictions Institute (Sofia), the Initiative for Health Foundation (Sofia) and Washington  University School of Medicine (Saint Louis, MO, USA). This is a case-population control study. Participants (N 2,499 interviews; N 1,995 with GWAS","Not Applicable","Opioid-Related Disorders","Case-Control","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 370 variables, 1 molecular datasets, 3001 subjects, 3001 samples","European (2593), Hispanic1 (26), Hispanic2 (1), Other Asian or Pacific Islander (1), South Asian (162), Other (218)","NIDA","DS-SUD --- Disease-Specific (Substance Use Disorders)","2019-06-28","2019-06-28","Addiction, Opiate; Dependence, Opiate; Opiate Addiction; Opiate Dependence; Opioid Related Disorders; Opioid-Related Disorder",""
"phs001795.v1.p1","Genetic Analysis of the Chiari I Malformation","This study used whole exome sequencing (WES) on families affected with Chiari I Malformation (CM1). Individuals were recruited from the Republic of Tartarstan in the Russian Federation, where CM1 has  a high prevalence (approximately 413 out of 100,000). At least one-third of these affected individuals have an affected relative. In collaboration","Not Applicable","Arnold-Chiari Malformation","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 analyses, 1 molecular datasets,  SRA, 62 subjects, 62 samples","European (10), Hispanic2 (4), Other Asian or Pacific Islander (1), South Asian (1), Other (46)","NINDS","GRU --- General Research Use","2019-06-28","2019-06-28","(Arnold) Chiari malformation; Arnola-Chiari malformation; Arnold Chiari Deformity; Arnold Chiari Syndrome; Arnold-Chiari Deformity; Arnold-Chiari Syndrome",""
"phs000416.v2.p1","Genetics of Cerebral Hemorrhage with Anticoagulation (GOCHA)","This is a prospective, longitudinal cohort study of spontaneous ICH. Subjects were recruited from among consecutive patients &#x02265; 55 years old who presented with primary hemorrhage to the Massachusetts General  Hospital or one of our off-site collaborators from 1999 to 2010. Potential subjects were identified by screening lists of all admissions to the","Not Applicable","Intracranial Hemorrhages","Case-Control","HumanHap550","Targeted-Capture, SNP Genotypes (Array)","4 phenotype datasets, 48 variables, 5 documents, 1 molecular datasets, 2132 samples sequenced,  SRA, 3569 subjects, 3590 samples","European (1667), African (7), East Asian (4), African American (27), Hispanic1 (13), Hispanic2 (7), Other Asian or Pacific Islander (1), South Asian (1), Other (14)","NINDS","DS-STK --- Disease-Specific (Stroke)","2019-06-27","2019-06-27","Amyloid Angiopathy, Cerebral; Angiopathy, Cerebral Amyloid; Hemorrhage, Hypertensive Intracranial; Hypertensive Intracranial Hemorrhages; Intracranial Hemorrhage; Sporadic Cerebral Amyloid Angiopathy",""
"phs001611.v1.p1","Pancreas Cancer Organoid Profiling","We generated a collection of patient-derived pancreatic normal and cancer organoids. We performed whole genome sequencing, targeted exome sequencing, and RNA sequencing on organoids as well as matched tumor and  normal tissue if available. This dataset is a valuable resource for pancreas cancer researchers, and those looking to compare primary tissue to","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Provided","4 phenotype datasets, 16 variables, 1 documents,  SRA, 71 subjects, 188 samples","","NCI","GRU --- General Research Use","2019-06-21","2019-06-21","Carcinoma, Pancreatic Ductal; Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001688.v1.p1","Microarray Gene Expression Data from Early Skin Biopsies of a Secukinumab    Clinical Trial in Psoriasis","The phase II clinical study CAIN457A2223 (NCT01537432) was designed to evaluate the proportion of patients achieving reversal of chronic plaque psoriasis at weeks 4 and 12 following multiple doses of  secukinumab, administered subcutaneously, compared to placebo. 36 patients were enrolled in this study, with 24 being randomly assigned to the","Not Applicable","Psoriasis","Clinical Trial","Affymetrix_expression_array","SNP Genotypes (Array)","4 phenotype datasets, 42 variables, 1 molecular datasets, 35 subjects, 183 samples","","NIAMS","DS-PSO-RD-NPU --- Disease-Specific (Psoriasis and related diseases, NPU)","2019-06-19","2019-06-19","Acropustulosis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis; Palmoplantar Pustulosis",""
"phs001420.v1.p1","Kids First: Genomics of Orofacial Cleft Birth Defects in Latin American    Families","The Kids First study of nonsyndromic orofacial cleft (OFC) birth defects in Latin American families is a whole genome sequencing study of 283 Latin-American parent-case trios drawn from ongoing collaborations  led by Dr. Mary L. Marazita of the University of Pittsburgh Center for Craniofacial and Dental Genetics, and including a collaboration with Dr. Lina","Not Applicable","Cleft Lip","Family/Twin/Trios","Not Provided","Not Provided","2 phenotype datasets, 7 variables,  SRA, 828 subjects, 828 samples","","NCI","DS-OBDR-RD --- Disease-Specific (Orofacial birth defects and related phenotypes, RD)","2019-06-14","2019-06-14","Cleft Palate; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip",""
"phs001807.v1.p1","InTEAM Consortium - Alcoholic Hepatitis","Alcoholic hepatitis (AH) is a life-threatening condition characterized by profound hepatocellular dysfunction for which targeted treatments are urgently needed. Identification of molecular drivers is hampered by the lack of suitable  animal models. By performing RNA sequencing in livers from patients with different phenotypes of alcohol-related liver disease (ALD), we describe the","Not Applicable","Hepatitis, Alcoholic","Case Set","MethylationEPIC","RNA-Seq, Methylation (CpG)","6 phenotype datasets, 50 variables, 1 molecular datasets, 79 samples sequenced,  SRA, 90 subjects, 90 samples","","NIAAA","DS-ALC-IRB-NPU-RD --- Disease-Specific (Alcoholism, IRB, NPU, RD)","2019-06-13","2019-06-13","Fatty Liver, Alcoholic; Liver Cirrhosis, Alcoholic; Liver Diseases, Alcoholic; Alcoholic Fatty Liver; Alcoholic fatty liver disease; alcoholic Steatohepatitis",""
"phs001432.v1.p1","Rapid Autopsy in Thoracic Malignancy Cancer Patients to Investigate Tumor    Heterogeneity","Integrated proteo-genomics studies to characterize tumor heterogeneity of metastatic lung adenocarcinoma and thymic carcinoma are lacking. We carried out whole exome sequencing, RNA sequencing, copy number estimation and mass spectrometry-based  proteomics of 40 tumors from five rapid/warm autopsy patients. We found highly variable mutational heterogeneity that was largely driven by","Not Applicable","Adenocarcinoma of Lung","Case Set","WES_markerset_grc37, RNAseq_probe_set_grc37","RNA-Seq, WXS, SNP/CNV Genotypes (NGS), RNA Seq (NGS)","4 phenotype datasets, 31 variables, 1 molecular datasets, 86 samples sequenced,  SRA, 6 subjects, 86 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2019-05-28","2019-05-28","Mesothelioma; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung",""
"phs001090.v1.p1","GWAS for Non-syndromic Clefts in the African Population: CIDR","The focus of this project is to identify genetic variants that are associated with orofacial clefts in African populations in sub-Saharan Africa. Most genetic studies of CLP (including the vast  majority of GWAS) have been conducted in populations of European origin with only a few focused on Asian or African populations. We choose to study","Not Applicable","Cleft Lip","Family/Twin/Trios","MEGA_Consortium_Array, imputation_panel","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","5 phenotype datasets, 27 variables, 2 molecular datasets, 3179 subjects, 3327 samples","","NIDCR","DS-CFR --- Disease-Specific (Craniofacial Research)","2019-05-28","2019-05-28","Cleft Palate; Mouth Abnormalities; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips",""
"phs001796.v1.p1","Molecular and Cellular Correlates of Nerve Repair in Humans","This is a longitudinal prospective cohort study in patients with carpal tunnel syndrome undergoing decompression surgery. Phenotypic data and skin biopsies were collected before and 6 months after surgery to  determine molecular and cellular correlates associated with neural regeneration and neuropathic pain. RNA sequencing was performed in the skin","Not Applicable","Carpal Tunnel Syndrome","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 46 variables, 92 samples sequenced, 78 subjects, 92 samples","","NINDS","GRU --- General Research Use","2019-05-24","2019-05-24","Nerve Compression Syndromes; Neuralgia; AMYOTROPHY, THENAR, OF CARPAL ORIGIN; CTS; CTS - Carpal tunnel syndrome; Carpal Tunnel Syndromes","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001596.v1.p1","Acral Melanoma Targeted Sequencing Study (UCSF)","Acral melanoma affects world populations irrespective of skin color. It has comparatively few single nucleotide mutations, but exhibits genomic instability characterized by structural rearrangements and amplifications. As acral melanoma harbors  BRAF (GeneID:673) mutations at low frequencies, we searched for alternative therapeutic targets. We performed targeted deep sequencing of","Not Applicable","Melanoma","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 14 variables, 37 samples sequenced,  SRA, 37 subjects, 37 samples","","NCI","DS-M-NPU --- Disease-Specific (Melanoma, NPU)","2019-05-22","2019-05-22","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs001329.v2.p1","The Natural History of Mucolipidosis Type IV","Mucolipidosis type IV (MLIV) is an autosomal recessive disorder typically characterized by severe psychomotor delay evident by the end of the first year of life and slowly progressive visual impairment  during the first decade as a result of a combination of corneal clouding and retinal degeneration. The purpose of this research study is to look at","Not Applicable","Mucolipidoses","Prospective Longitudinal Cohort","Not Provided","Not Provided","14 phenotype datasets, 2868 variables, 13 documents, 5 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-05-15","2019-05-15","Mucolipidosis IV; I Cell Disease; I-CELL DISEASE; I-Cell Diseases; I-cell - Inclusion cell disease; ICD",""
"phs001673.v1.p1","ADAGESIII: Contribution of Genotype to Glaucoma Phenotype in African    Americans","Glaucoma results in vision loss due to damage of the optic nerve that is irreversible if undetected or untreated. The most common form of glaucoma is primary open angle glaucoma  (POAG). While glaucoma affects all races, persons of African descent are disproportionately affected; studies show African-Americans (AAs) are about","Not Applicable","Glaucoma","Case-Control","MEGA_Consortium_Array","SNP Genotypes (Array)","5 phenotype datasets, 23 variables, 1 molecular datasets, 2058 subjects, 2058 samples","European (4), African (224), African American (1755), Hispanic1 (39), Hispanic2 (2), South Asian (2), Other (32)","NEI","DS-G-PUB-GSO --- Disease-Specific (Glaucoma, PUB, GSO)","2019-05-14","2019-05-14","",""
"phs001719.v1.p1","Longitudinal Multi-Omics Profiling of Prediabetes","Type 2 diabetes mellitus (T2D) is a significant health problem. Close to 20 million individuals in the United States have T2D, and 79 million aged 20 years or older are  clinically pre-diabetic, with a 5-year conversion rate of 10% to 23% from prediabetes to T2D. In a collaborative effort to systematically understand","Not Applicable","Prediabetic State","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 15 variables, 111 samples sequenced,  SRA, 111 subjects, 111 samples","","NIDDK","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-05-10","2019-05-10","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001768.v1.p1","Longitudinal Assessment of Methylmercury and Gut Microbes During    Pregnancy","Methylmercury is a potent neurotoxin, and the fetal period is the most vulnerable exposure period. There is significant variability in methylmercury metabolism, which has been attributed to differences in the  structure and function of the gut microbiome. Our main objective was to better understand the interplay between gut microorganisms and methylmercury","Not Applicable","Methylmercury Compounds","Prospective Longitudinal Cohort","Not Provided","OTHER","4 phenotype datasets, 38 variables, 53 samples sequenced,  SRA, 29 subjects, 53 samples","","NIEHS","DS-MERCURY --- Disease-Specific (Mercury and Other Environmental Exposures)","2019-05-09","2019-05-09","Not Provided",""
"phs001409.v1.p1","Genetic Risk Underlying Racial Disparities in Uterine Fibroids","Fibroids affect 77% of women by onset of menopause in the U.S. and account for $2.1 billion in healthcare costs each year. Fibroids negatively impact reproductive health causing heavy and  painful menses, pelvic pain and pressure, pregnancy complications, and interventions including myomectomy and hysterectomy. Until recently, tumor","Not Applicable","Leiomyoma","Case-Control","Axiom_Biobank_plus, Axiom_GW_AFR","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 4600 subjects, 4594 samples","European (3128), African (42), East Asian (1), African American (1326), Hispanic1 (46), Hispanic2 (13), Other Asian or Pacific Islander (7), South Asian (11), Other (20)","NICHD","DS-UF-PUB-COL --- Disease-Specific (Uterine Fibroids, PUB, COL)","2019-05-08","2019-05-08","Benign Smooth Muscle Neoplasm; Benign Smooth Muscle Tumor; Fibroid; Fibroid Tumors; Fibroleiomyoma; Fibromyoma",""
"phs001378.v1.p1","scRNA-Seq Reveals Lymphoma B Cell Diversity and T Cell Immune Checkpoint    Co-Expression","Follicular lymphoma (FL) is a generally incurable B-cell malignancy which has the potential to transform into highly aggressive lymphomas. Genomic studies indicate it is often a small subpopulation rather than  the dominant population in the FL that gives rise to the more aggressive subtype. To resolve the underlying transcriptional networks of follicular","Not Applicable","Lymphoma, Follicular","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 22 variables, 10 samples sequenced,  SRA, 10 subjects, 10 samples","","NHGRI","DS-FL-PUB-NPU --- Disease-Specific (Follicular Lymphoma, PUB, NPU)","2019-05-07","2019-05-07","Lymphoma, Non-Hodgkin; Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC",""
"phs001526.v1.p1","Next Generation Sequencing of Diffuse Intrinsic Pontine Glioma Samples","Diffuse intrinsic pontine glioma (DIPG) is an extremely rare ( 350 cases/year) and universally fatal childhood brain cancer. Standard clinical strategies such as chemotherapy and radiotherapy show only transient improvement  in patient condition and result in negligible change in survival, DIPG remains at below 1% survival after 5 years. Prioritization of panobinostat","Not Applicable","Glioma","Prospective Longitudinal Cohort","other","RNA Seq (NGS), RNA-Seq, WXS","4 phenotype datasets, 27 variables, 1 molecular datasets, 52 samples sequenced,  SRA, 14 subjects, 52 samples","","NCI","GRU --- General Research Use, GRU-COL --- General Research Use (COL), GRU-COL-NPU --- General Research Use (COL, NPU)","2019-05-06","2019-05-06","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia",""
"phs001295.v2.p1","Development and Validation of a Disability Severity Index for    Charcot-Marie-Tooth Disease","In Charcot-Marie-Tooth Disease (CMT) or inherited neuropathy research studies, it is the researcher who has selected what they believe to be important markers of impairment in function in patients. For  example, it has been inferred that the wearing of ankle-foot-orthosis (AFOs), the use of walking aids such as canes, or the use of wheelchairs, are","Not Applicable","Charcot-Marie-Tooth Disease","Cross-Sectional","Not Provided","Not Provided","3 phenotype datasets, 71 variables, 1 documents, 293 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-05-06","2017-07-06","Atrophies, Peroneal Muscular; Atrophy, Muscular, Peroneal; Atrophy, Peroneal Muscular; CMT; CMT - Charcot-Marie-Tooth disease; CMT/HMSN",""
"phs001717.v1.p1","Genetic Variants Influence on the Placenta Regulatory Landscape","This study of the regulatory landscape of the placenta relies on the identification of associations between genetic variant and gene expression changes (eQTLs); genetic variant and DNA methylation changes (mQTLs);  and, gene expression change and DNA methylation change (eQTMs). It involves the analysis of DNA sequence variation (n 303), DNA methylation (n 303)","Not Applicable","Control Groups","Control Set","","RNA Seq (NGS), Methylome sequencing, SNP Genotypes (Array)","4 phenotype datasets, 25 variables, 1 molecular datasets,  SRA, 302 subjects, 302 samples","European (72), African (7), East Asian (27), African American (82), Hispanic1 (30), Hispanic2 (46), Other Asian or Pacific Islander (14), South Asian (11), Other (13)","NICHD","HMB-IRB-PUB-COL-MDS --- Health/Medical/Biomedical (IRB, PUB, COL, MDS)","2019-05-01","2019-05-01","Not Provided",""
"phs001483.v1.p1","DRIVE Breast Cancer Whole Genome Sequencing","This study consists of whole genome sequencing (target: average 30x coverage) of 110 European-ancestry (EA), early-onset, family-history-positive breast cancer cases, 21 Asian cases, 25 African-American cases, and 24 controls from  six studies participating in the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) consortium, part of the NCI's Genetic","Not Applicable","Breast Neoplasms","Case Set","WGS_markerset_grc37","WGS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 79 samples sequenced,  SRA, 180 subjects, 180 samples","","NCI","DS-CA-PUB --- Disease-Specific (Cancer, PUB), GRU --- General Research Use, DS-BRD-MDS --- Disease-Specific (Breast Diseases, MDS), DS-BRD --- Disease-Specific (Breast Diseases), DS-COBC-NPU-MDS --- Disease-Specific (Colorectal, ovarian, and/or breast cancer, NPU, MDS), HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), HMB-PUB --- Health/Medical/Biomedical (PUB)","2019-05-01","2019-05-01","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000899.v1.p1","NIMH Amish Mennonite Bipolar Genetics Study (AmBiGen)","Bipolar affective disorder is a severe, heritable condition affecting about one percent of the population. The mode of inheritance is poorly understood and probably involves multiple loci of small to  moderate effect. In this project, we use genetic mapping and sequencing methods to identify genetic markers and variations that contribute to the","Not Applicable","Bipolar Disorder","Prospective Longitudinal Cohort","HumanOmniExpress-12, WES_markerset_grc37, WGS_markerset_grc37","SNP/CNV Genotypes (NGS), SNP Genotypes (Array)","5 phenotype datasets, 24 variables, 3 molecular datasets, 166 subjects, 166 samples","","NIMH","GRU --- General Research Use, DS-BPD --- Disease-Specific (Bipolar Disorder)","2019-05-01","2019-05-01","Depressive Disorder, Major; Psychotic Disorders; Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis",""
"phs001685.v1.p1","DNA Repair Profiling of HGSC Organoids","In this study, 34 ovarian tumor organoids generated from 23 patients underwent paired DNA damage repair defect functional analyses and whole exome sequencing analysis to compare genetic mutational status to  DNA repair functional capacity. 22 of the patients had high grade serous cancer and 1 of the patients had low grade serous cancer. A normal control,","Not Applicable","Ovarian Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 22 variables, 91 samples sequenced,  SRA, 23 subjects, 91 samples","","NHLBI","HMB --- Health/Medical/Biomedical, DS-GC --- Disease-Specific (Gynecological Cancer)","2019-04-30","2019-04-30","Fallopian Tube Neoplasms; Cancer of Fallopian Tube; Cancer of the Fallopian Tube; Cancer, Fallopian Tube; Cancers, Fallopian Tube; Carcinoma of Fallopian Tube","NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs001666.v1.p1","Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration    Resistant and Neuroendocrine Prostate Cancer","Neuroendocrine prostate cancer (NEPC) is an aggressive variant of prostate cancer that may develop de novo or as a mechanism of treatment resistance. N-myc is capable of driving NEPC progression.  Alisertib inhibits the interaction between N-myc and its stabilizing factor Aurora-A, inhibiting N-myc signaling, and suppressing tumor growth. In","Not Applicable","Adenocarcinoma","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 14 variables, 64 samples sequenced,  SRA, 49 subjects, 64 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2019-04-25","2019-04-25","Neuroendocrine Tumors; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma",""
"phs001757.v1.p1","Sequencing of the olfactory receptor subgenome","The goal of this study was to explore the relationship between genetic variation in the olfactory receptor family and odor perception. 332 subjects rated the intensity and pleasantness of 66  odors at 2 concentrations and 2 solvents. Detection thresholds of 3 odors were also measured. Targeted sequencing was performed on 413 olfactory","Not Applicable","Smell","Collection","Not Provided","Targeted-Capture","4 phenotype datasets, 15 variables, 345 samples sequenced,  SRA, 332 subjects, 345 samples","","NIDCD","HMB-NPU --- Health/Medical/Biomedical (NPU)","2019-04-15","2019-04-15","Not Provided",""
"phs001653.v1.p1","Coding and Non-coding Elements Implicated in Holoprosencephaly","We applied targeted capture to examine 153 genes representative of all the major vertebrate developmental pathways among 340 probands and 285 of their unaffected parents to rank their relative significance  as causes for holoprosencephaly (HPE). Samples were included for analysis if patient had a clinical diagnosis of holoprosencephaly. Parental samples","Not Applicable","Holoprosencephaly","Cross-Sectional","target_markerset_grc37","Targeted-Capture, SNP/CNV Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 molecular datasets, 625 samples sequenced,  SRA, 625 subjects, 625 samples","","NHGRI","DS-BDIS-IRB-PUB --- Disease-Specific (Brain Disorders, IRB, PUB)","2019-04-15","2019-04-15","Cingulosynapsis; Holoprosencephalies, Lobar; Holoprosencephaly, Lobar; Lobar Holoprosencephalies; Lobar Holoprosencephaly; Olfactory aplasia",""
"phs000645.v5.p1","Location and Function of Cytosine-5 Methylation in RNA","Mutations in the cytosine-5 RNA methyltransferase NSun2 can cause neurodevelopmental disorders and symptoms commonly found in patients with Dubowitz-like syndrome. Some tRNAs are known to be methylated NSun2, however the  occurrence of cytosine-5 methylation (m5C) in other RNA biotypes is still under debate. Location in RNA and function of m5C has not been studied yet.","Not Applicable","Dubowitz syndrome","Case-Control","Not Provided","RNA-Seq, Bisulfite-Seq, ncRNA-Seq, OTHER","4 phenotype datasets, 23 variables, 309 samples sequenced,  SRA, 4 subjects, 273 samples","","NICHD","GRU --- General Research Use","2019-04-11","2016-05-22","Dubowitz's syndrome; Dwarfism-eczema-peculiar facies syndrome; intrauterine growth retardation, short stature, microcephaly, mild intellectual disability with behavior problems, eczema, and unusual and distinctive faci; intrauterine growth retardation, short stature, microcephaly, mild intellectual disability with behaviour problems, eczema, and unusual and distinctive faci; intrauterine growth retardation, short stature, microcephaly, mild mental retardation with behavior problems, eczema, and unusual and distinctive faci; intrauterine growth retardation, short stature, microcephaly, mild mental retardation with behaviour problems, eczema, and unusual and distinctive faci",""
"phs001670.v1.p1","Genetic Variants Associated with Tacrolimus Metabolism in Kidney    Transplant Recipients","An extreme phenotype sampling (EPS) model with targeted next-generation sequencing (NGS) identified genetic variants associated with tacrolimus (Tac) metabolism in subjects from the Deterioration of Kidney Allograft Function (DeKAF) Genomics  cohort which included 1,442 European Americans (EA) and 345 African Americans (AA). This study included 48 subjects separated into 4 groups of 12 (AA","Not Applicable","Tacrolimus","Prospective Longitudinal Cohort","Not Provided","Not Provided","5 phenotype datasets, 61 variables,  SRA, 48 subjects, 48 samples","","NIAID","DS-KTO-IRB-PUB-COL-NPU-MDS --- Disease-Specific (Kidney Transplant Outcomes, IRB, PUB, COL, NPU, MDS)","2019-04-10","2019-04-10","Not Provided",""
"phs001592.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular ATVB:    Atherosclerosis Thrombosis and Vascular Biology","Italian Atherosclerosis Thrombosis and Vascular Biology study is a prospective, nationwide, case-control study involving 125 coronary care units in Italy. The cases were patients who were hospitalised for a first  MI before the age of 45 years and underwent coronary angiography. Acute MI was defined as resting chest pain lasting more than 30 minutes,","Not Applicable","Atherosclerosis","Case-Control","WGS_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 9 variables, 1 molecular datasets, 58 samples sequenced,  SRA, 58 subjects, 58 samples","","NHLBI","DS-CVD --- Disease-Specific (Cardiovascular Disease)","2019-04-08","2019-04-08","Atherogeneses; Atherogenesis; Blood Clot; Blood Clots; Thrombi","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs001168.v2.p2","Kids First: Genomic Studies of Orofacial Cleft Birth Defects","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by the  NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella Miller","Not Applicable","Cleft Lip","Family/Twin/Trios","Not Provided","WGS","5 phenotype datasets, 23 variables, 1117 samples sequenced,  SRA, 1378 subjects, 1311 samples","","NCI","DS-OBDR-MDS --- Disease-Specific (Orofacial birth defects and related phenotypes, MDS), DS-OBD-MDS --- Disease-Specific (Orofacial birth defects, MDS), DS-OC-PUB-MDS --- Disease-Specific (Oral Clefts, PUB, MDS), HMB-MDS --- Health/Medical/Biomedical (MDS), GRU --- General Research Use","2019-04-05","2018-03-20","Cleft Palate; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001777.v1.p1","Sertoli Cell-Only Syndrome Human Transcriptome Profiling Study","Sertoli cell-only syndrome is severe form of human male infertility in which most seminiferous tubules appear to lack all spermatogenic cells, including spermatogonial stem cells (SSCs). However, a few small  tubule segments of some patients have active spermatogenesis and, thus, functional stem cell niches and SSCs. Normally SSCs replicate, migrate and","Not Applicable","Sertoli Cell-Only Syndrome","Case-Control","Not Provided","RNA-Seq","3 phenotype datasets, 13 variables, 11 samples sequenced, 11 subjects, 11 samples","","NICHD","DS-MINF-IRB-PUB-COL --- Disease-Specific (Male Infertility, IRB, PUB, COL)","2019-04-04","2019-04-04","Arrest of spermatogenesis; AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS; AZOOSPERMIA WITH MATURATION ARREST; Aspermatogenesis; PREGNANCY LOSS 4; SPERMATOGENESIS ARREST",""
"phs001734.v1.p1","Youth Drug Abuse, ADHD and Related Disorders","There are two major aims with this study. 1. To describe the developmental trajectory of (a) a community-based sample of youth with a childhood diagnosis of ADHD that has been  prospectively followed from childhood into adulthood (approximately a 17-year span), and (b) a clinical sample of youth that received drug abuse","Not Applicable","Attention Deficit Disorder with Hyperactivity","Prospective Longitudinal Cohort","HumanOmni2.5-8","SNP Genotypes (Array)","4 phenotype datasets, 66 variables, 1 molecular datasets,  SRA, 607 subjects, 607 samples","European (516), African (2), East Asian (5), African American (47), Hispanic1 (9), Hispanic2 (22), Other Asian or Pacific Islander (3), South Asian (1), Other (2)","NIDA","HMB --- Health/Medical/Biomedical","2019-04-03","2019-04-03","Behavior, Addictive; ADD; ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorders with Hyperactivity",""
"phs001346.v1.p1","Human Gene Expression Patterns Associated with Experimental P. falciparum    Infection","Description: Experimental exposure to malaria parasites can lead to development of protective immunity, providing a foothold for the development of a malaria vaccine. The goal of this study is to  investigate immune transcriptional profiles associated with malaria protective immune responses induced by experimental Chemo-Prophylaxis and","Not Applicable","Malaria","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 21 variables, 219 samples sequenced, 15 subjects, 219 samples","","NIAID","DS-MALARIA-IRB --- Disease-Specific (Malaria, IRB)","2019-04-01","2019-04-01","Malaria, Falciparum; Fever, Marsh; Fever, Remittent; Infection, Plasmodium; Infections, Plasmodium; Marsh Fever",""
"phs001699.v1.p1","Germline DNA Methylation Associated with Breast Cancer Predisposition","Understanding and explaining hereditary predisposition to cancer has focused on the genetic etiology of the disease. However, mutations in known genes associated with breast cancer such as BRCA1 and BRCA2  account for less than 25% of familial cases of breast cancer. Heritable epigenetic modifications, in the form of hypermethylated MLH1 promoter","Not Applicable","DNA Methylation","Case-Control","Not Provided","Bisulfite-Seq","4 phenotype datasets, 18 variables, 155 samples sequenced, 155 subjects, 155 samples","","NHGRI","GRU --- General Research Use","2019-03-29","2019-03-29","",""
"phs001628.v1.p1","Clinical Crenolanib Resistance in AML","FLT3 mutations are commonly detected in Acute Myeloid Leukemia (AML) patients and are associated with poor prognosis. Crenolanib, a potent type I pan-FLT3 (GeneID:2322) inhibitor, is effective against both internal  tandem duplications (ITD) and resistance-conferring tyrosine kinase domain (TKD) mutations. While crenolanib monotherapy has demonstrated significant","Not Applicable","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 6 variables,  SRA, 56 subjects, 119 samples","","NCI","DS-LEU --- Disease-Specific (Leukemia)","2019-03-29","2019-03-29","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs000842.v2.p1","PediGFR","The Pediatric Investigation for Genetic Factors Associated with Renal Progression (PediGFR) (RO1-DK082394) is an international collaborative study among three large prospective cohort studies of children with chronic kidney disease. The  participating parent cohort studies are the Chronic Kidney Disease in Children (CKiD), the Effect of Strict Blood Pressure Control and ACE Inhibition","Not Applicable","Kidney Diseases","Prospective Longitudinal Cohort","HumanOmni2.5-8","Not Provided","2 phenotype datasets, 8 variables, 1828 subjects, 1580 samples, 3 substudies","","NIDDK","DS-CKD-COMP-IRB --- Disease-Specific (Chronic Kidney Disease and Related Complications, IRB)","2019-03-29","2019-03-29","Renal Insufficiency; Renal Insufficiency, Chronic; Failure, Kidney; Failure, Renal; Failures, Kidney; Failures, Renal",""
"phs000844.v2.p1","PediGFR - ESCAPE Trial Cohort","This sub-study phs000844 ESCAPE contains genotype and selected phenotype of subjects available from the phs000844 study. Summary level phenotypes for the NIDDK PediGFR_v2 Cohort study participants can be viewed at  the top-level study page phs000842 PediGFR_v2 Cohort. Individual level phenotype data and molecular data for all PediGFR_v2 Cohort top-level study","Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR) (phs000842.v2.p1)","Kidney Diseases","Prospective Longitudinal Cohort","HumanOmni2.5-8","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 21 variables, 1 molecular datasets, 309 subjects, 293 samples","European (247), African American (2), Hispanic1 (2), Other Asian or Pacific Islander (1), Other (41)","NIDDK","DS-CKD-COMP-IRB --- Disease-Specific (Chronic Kidney Disease and Related Complications, IRB)","2019-03-29","2019-03-29","Renal Insufficiency; Renal Insufficiency, Chronic; Failure, Kidney; Failure, Renal; Failures, Kidney; Failures, Renal",""
"phs000843.v2.p1","PediGFR - 4C Study Cohort","This sub-study phs000843 4C contains genotype and selected phenotype of subjects available from the phs000843 study. Summary level phenotypes for the NIDDK PediGFR_v2 Cohort study participants can be viewed at  the top-level study page phs000842 PediGFR_v2 Cohort. Individual level phenotype data and molecular data for all PediGFR_v2 Cohort top-level study","Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR) (phs000842.v2.p1)","Kidney Diseases","Prospective Longitudinal Cohort","HumanOmni2.5-8","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 23 variables, 1 molecular datasets, 677 subjects, 663 samples","European (423), African (5), African American (1), Hispanic1 (41), Hispanic2 (2), South Asian (13), Other (178)","NIDDK","DS-CKD-COMP-IRB --- Disease-Specific (Chronic Kidney Disease and Related Complications, IRB)","2019-03-29","2019-03-29","Renal Insufficiency; Renal Insufficiency, Chronic; Failure, Kidney; Failure, Renal; Failures, Kidney; Failures, Renal",""
"phs000650.v3.p1","PediGFR-CKiD","This sub-study phs000650 CKiD contains genotype and selected phenotype of subjects available from the phs000650 study. Summary level phenotypes for the NIDDK PediGFR_v2 Cohort study participants can be viewed at  the top-level study page phs000842 PediGFR_v2 Cohort. Individual level phenotype data and molecular data for all PediGFR_v2 Cohort top-level study","Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR) (phs000842.v2.p1)","Kidney Diseases","Prospective Longitudinal Cohort","HumanOmni2.5-8","SNP Genotypes (Array)","2 phenotype datasets, 28 variables, 2 molecular datasets, 842 subjects, 624 samples","European (430), East Asian (5), African American (42), Hispanic1 (5), Hispanic2 (42), Other Asian or Pacific Islander (4), Other (6)","NIDDK","DS-CKD-COMP-IRB --- Disease-Specific (Chronic Kidney Disease and Related Complications, IRB)","2019-03-29","2019-03-29","Renal Insufficiency; Renal Insufficiency, Chronic; Failure, Kidney; Failure, Renal; Failures, Kidney; Failures, Renal",""
"phs001625.v1.p1","Whole Genome Sequencing in Psychotic Major Depression","The goal of this case-control study, ""Whole Genome Sequencing in Psychotic Major Depression"", is to identify genes that contribute to the psychotic major depression phenotype. The samples herein were used  as controls and were obtained from the NIMH Repository Study #29, ""Molecular Genetics of Schizophrenia"". These samples originated from the NIMH","Not Applicable","Control Groups","Control Set","Not Provided","WGS","4 phenotype datasets, 19 variables, 252 samples sequenced,  SRA, 252 subjects, 252 samples","","NIMH","GRU-PUB --- General Research Use (PUB)","2019-03-27","2019-03-27","Not Provided",""
"phs001415.v1.p1","Uncovering the Genetic Architecture of Colorectal Cancer with Focus of    Rare and Less Frequent Variants","The Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) is a collaborative effort comprised of a coordinating center and scientific researchers from well-characterized cohort and case-control studies conducted in North  America and Europe. This international consortium aims to accelerate the discovery of common and rare genetic risk variants for colorectal cancer by","Not Applicable","Colorectal Neoplasms","Case-Control","OncoArray-500K_plus, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","4 phenotype datasets, 29 variables, 3 molecular datasets, 29540 subjects, 30487 samples","European (25853), African (85), East Asian (762), African American (1990), Hispanic1 (98), Hispanic2 (107), Other Asian or Pacific Islander (410), South Asian (55), Other (180)","NCI","GRU --- General Research Use, DS-CA-IRB --- Disease-Specific (Cancer, IRB), RCV-CRC-MDS --- Rare and common variants associated with colorectal cancer risk, and methods, CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-GSO --- Health/Medical/Biomedical (PUB, NPU, GSO), HMB-COL-GSO --- Health/Medical/Biomedical (COL, GSO), HMB --- Health/Medical/Biomedical, HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), HMB-PUB --- Health/Medical/Biomedical (PUB), DS-BOCA --- Disease-Specific (Bowel Cancer), GRU-GSO --- General Research Use (GSO), DS-CEC-IRB --- Disease-Specific (Colorectal and Endometrial Cancer, IRB)","2019-03-27","2019-03-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001739.v1.p1","Role of the Cervico-Vaginal Microbiome in Spontaneous Preterm Birth","Preterm birth is the leading cause of neonatal morbidity and mortality. A failure to predict and understand the causes of preterm birth have limited effective interventions and therapeutics. From a  cohort of 2,000 pregnant women, we performed a nested case control study on 107 well-phenotyped cases of spontaneous preterm birth (sPTB) and 432","Not Applicable","Premature Birth","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 25 variables, 1505 samples sequenced,  SRA, 539 subjects, 1505 samples","","NINR","GRU --- General Research Use","2019-03-26","2019-03-26","Nulliparity; Parity Progression Ratio; Parity Progression Ratios; Ratio, Parity Progression; Ratios, Parity Progression; Birth, Premature","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001715.v1.p1","Protocol for Imaging in Takayasu's Arteritis","Takayasu's arteritis is a rare disease that affects the blood vessels. Takayasu's arteritis can cause swelling of large and medium-sized blood vessels. The blood vessels that are commonly affected are  the branches of the aorta (the main blood vessel that leaves the heart). The purpose of this study is to help doctors learn more about this disease","Not Applicable","Vasculitis","Prospective Longitudinal Cohort","Not Provided","Not Provided","8 phenotype datasets, 146 variables, 9 documents, 19 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-03-26","2019-03-26","Aortic Arch Syndromes; Aortic Diseases; Cardiovascular Diseases; Skin Diseases; Skin Diseases, Vascular; Takayasu's Arteritis",""
"phs001706.v1.p1","Castleman Genome Project","Multicentric Castleman disease (MCD) is a rare lymphoproliferative disorder driven by excessive production of inflammatory cytokines. Patients can exhibit a wide range of clinical features from mild flu-like symptoms to  multiple organ failure and death. Human herpesvirus-8 (HHV-8) is a well-established cause of MCD in individuals who are immunosuppressed due to human","Not Applicable","Castleman Disease","Prospective Longitudinal Cohort","Not Provided","WGS","4 phenotype datasets, 16 variables, 32 samples sequenced,  SRA, 32 subjects, 32 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2019-03-26","2019-03-26","Multi-centric Castleman's Disease; AFLH; ALNH; Angiofollicular Lymph Hyperplasia; Angiofollicular Lymph Hyperplasias; Angiofollicular Lymph Node Hyperplasia",""
"phs001759.v1.p1","Profiles of exRNA in CSF and Plasma from Subarachnoid Hemorrhage Patients","Brain injury resulting from hemorrhagic stroke is clinically challenging to manage and results in high rates of morbidity and mortality. The pathophysiology of brain damage resulting from aneurysmal subarachnoid hemorrhage  (aSAH) is largely unknown, and methods to treat and monitor patients are variable with no meaningful correlations to patient outcome. Prediction of","Not Applicable","Circulating MicroRNA","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 23 variables, 126 samples sequenced,  SRA, 7 subjects, 126 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2019-03-25","2019-03-25","Subarachnoid Hemorrhage; Hemorrhage, Subarachnoid; Hemorrhages, Subarachnoid; SAH (Subarachnoid Hemorrhage); SAH - Subarachnoid hemorrhage; SAHs (Subarachnoid Hemorrhage)","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs001791.v1.p1","A Multimodal Atlas of Human Brain Cell Types","""A multimodal atlas of human brain cell types"" includes sample data targeting two cell types that show species differences between mouse and human. First, it includes a detailed transcriptomic, morphological,  and electrophysiological characterization of cell types in layer 1 of human middle temporal gyrus, focusing primarily on different inhibitory cell","Not Applicable","Cerebral Cortex","Cross-Sectional","Not Provided","Not Provided","4 phenotype datasets, 19 variables, 2 subjects, 2472 samples","","NIMH","NHD --- Neuroscience, health and disease","2019-03-21","2019-03-21","Not Provided",""
"phs001235.v1.p1","Rhinovirus Susceptibility in Human MDA5 Deficiency","We studied a child with life-threatening and recurrent respiratory tract infections, caused by multiple viruses including rhinovirus, influenza virus, and respiratory syncytial virus (RSV). We identified in her a homozygous  missense mutation in IFIH1 that encodes MDA5 by Whole Exome Sequencing. MDA5-deficiency is a novel inborn error of innate immunity that results in","Not Applicable","Immunologic Deficiency Syndromes","Case-Control","WGS_markerset_grc37","WXS, SNP Genotypes (NGS)","5 phenotype datasets, 23 variables, 1 molecular datasets, 2 samples sequenced,  SRA, 5 subjects, 5 samples","","NIAID","GRU --- General Research Use","2019-03-21","2019-03-21","RNA Virus Infections; Respiratory Tract Infections; Antibody Deficiency Syndrome; Antibody Deficiency Syndromes; Deficiency Syndrome, Antibody; Deficiency Syndromes, Antibody",""
"phs001767.v1.p1","Identifying Novel Small RNA Biomarkers for Patients with Gastric Cancer","The biomarker development study consisted of two parts: discovery and validation. The first part was the discovery and verification phase of biomarkers using two different platforms: transcriptomic and miRNA. The  salivary transcriptomes of 63 GC samples and 31 non-GC controls were profiled using Affymetrix HG U133+2.0 microarrays (Affymetrix, Santa Clara, CA).","Not Applicable","Circulating MicroRNA","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 22 variables, 198 samples sequenced,  SRA, 198 subjects, 198 samples","","NHLBI","HMB-IRB-PUB-NPU --- Health/Medical/Biomedical (IRB, PUB, NPU)","2019-03-20","2019-03-20","Ca lesser curvature - stomach; Cancer of Stomach; Cancer of the Stomach; Cancer, Gastric; Cancer, Stomach; Cancers, Gastric",""
"phs000748.v7.p4","Multiple Myeloma CoMMpass Study","The Multiple Myeloma Research Foundation (MMRF) CoMMpass (Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile) trial (NCT01454297) is a longitudinal observation study of 1000 newly diagnosed myeloma  patients receiving various standard approved treatments that aim at collecting tissue samples, genetic information, Quality of Life (QoL) and various","Not Applicable","Multiple Myeloma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS, WGS","4 phenotype datasets, 29 variables, 5118 samples sequenced,  SRA, 1014 subjects, 5118 samples","","NCI","GRU-MDS --- General Research Use (MDS), DS-MCRD-MDS --- Disease-Specific (Myeloma and other cancer-related disorders, MDS)","2019-03-20","2014-10-07","Neoplasms, Plasma Cell; Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001745.v1.p1","Human Lung Tissue eQTL Study","Genetic risks underlying respiratory diseases (e.g. COPD and asthma) are carefully studied by large genome-wide association studies (GWAS), where many loci were identified. In the post-GWAS era, the main challenge  is to find the causal genes and pathways in GWAS-nominated chromosomal regions and to characterize etiology mechanism. The Lung eQTL Consortium is an","Not Applicable","Smoking","Prospective Longitudinal Cohort","Human1M-Duo","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 1103 subjects, 1103 samples","European (1087), Hispanic1 (2), Hispanic2 (8), South Asian (2), Other (4)","NHLBI","DS-LD-IRB-COL-NPU-GSO --- Disease-Specific (Lung Disease, IRB, COL, NPU, GSO)","2019-03-19","2019-03-19","Not Provided",""
"phs001594.v1.p1","Mucosal Melanoma Targeted Sequencing Study (UCSF)","Mucosal melanoma is a deadly disease that carries the worst prognosis amongst subtypes of melanoma. Like all melanomas, mucosal melanomas are frequently driven by activating mutations in the MAPK and/or  PI3K pathways; however, unlike melanomas that arise on sun-exposed skin, mucosal melanomas harbor few point mutations. Instead, most somatic","Not Applicable","Melanoma","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 15 variables, 4 documents, 43 samples sequenced,  SRA, 38 subjects, 43 samples","","NCI","DS-M-NPU --- Disease-Specific (Melanoma, NPU)","2019-03-19","2019-03-19","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs001178.v1.p1","UCLA/Gabriella Miller Kids First Disorders of Sex Development Study","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by the  NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella Miller","Not Applicable","Disorders of Sex Development","Family/Twin/Trios","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 20 variables, 1 molecular datasets, 300 samples sequenced,  SRA, 300 subjects, 300 samples","","NCI","GRU --- General Research Use","2019-03-19","2019-03-19","46, XX Testicular Disorders of Sex Development; Hypospadias; Mullerian aplasia; Omphalocele Exstrophy Imperforate Anus; Ovotesticular Disorders of Sex Development; Sex Chromosome Disorders of Sex Development","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001780.v1.p1","African Demographic History Study Using Illumina 1M Array Data","These data were used as part of a study to characterize genomic diversity in Africa, population substructure, and evolutionary history. All individuals over age 18 were eligible to participate. Principal  Investigator: Sarah Tishkoff, PhD, University of Pennsylvania, Depts. of Biology and Genetics, Philadelphia, PA, USA Funding Sources:","Not Applicable","African People","Cross-Sectional","Human1M-Duo","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 697 subjects, 697 samples","","NIGMS","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2019-03-18","2019-03-18","Not Provided",""
"phs001724.v1.p1","Genomics and Modification of Pain","We have capitalized on inherited erythromelalgia (IEM) as a well-characterized genetic model of chronic pain, and studied IEM patients carrying Nav1.7 mutations which affect channel activation and often produce hyperexcitability  of DRG neurons. Whole exome sequencing was used to discover multiple gene variants that might contribute to neuronal excitability and that might","Not Applicable","Erythromelalgia","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets, 3 samples sequenced,  SRA, 3 subjects, 3 samples","","NINDS","DS-EM-COL --- Disease-Specific (Erythromelalgia, COL)","2019-03-15","2019-03-15","Erythermalgia; Erythermalgias; Erythralgia; Erythromelalgias; Weir Mitchell's disease",""
"phs001686.v1.p1","IL-17 Signaling in Midbrain Neurons in Parkinson's Disease","To determine IL-17-induced global transcriptome changes in midbrain neurons derived from induced pluripotent stem cells (iPSC) from three sporadic Parkinson's disease (PD) patients and three age- and sex-machted controls, deep  RNA sequencing (RNA-Seq) of IL-17-treated and untreated PD and control iPSC-dderived midbrain neurons was performed. Total RNA was isolated from","Not Applicable","Parkinson Disease","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 29 variables, 24 samples sequenced,  SRA, 6 subjects, 24 samples","","NINDS","HMB-COL-NPU --- Health/Medical/Biomedical (COL, NPU)","2019-03-14","2019-03-14","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs001440.v1.p1","AMP-AD/M&#x000b2;OVE-AD Genomic Data Umbrella - A Data Resource Hosted by the NIA    Supported AMP-AD Knowledge Portal for the Study of Alzheimer's Disease","The AMP-AD/M2OVE-AD Genomic Data Umbrella was created as part of the AMP-AD Knowledge Portal, funded by the National Institute on Aging (NIA). The overarching purpose of the Knowledge Portal is  to provide data, analysis results, analytical methodology and research tools to enable transparent and reproducible systems biology research on","Not Applicable","Alzheimer Disease","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","NIA","","2019-03-08","","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases",""
"phs000781.v1.p1","Children's Hospital of Philadelphia: GWAS of Left-Sided Cardiac Defects","This is a family-based genome-wide association study of congenital left-sided cardiac lesions (LSLs). Cases with LSLs and their parents were recruited from the Cardiac Center at The Children's Hospital of  Philadelphia between 1997 and 2010. The discovery dataset included 405 LSL case-parent triads. DNA was extracted from blood or saliva samples from","Not Applicable","Heart Defects, Congenital","Family/Twin/Trios","Not Provided","Not Provided","Not Provided","","NHLBI","","2019-03-08","","Hypoplastic Left Heart Syndrome; Abnormal heart morphology; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Abnormally shaped heart",""
"phs001589.v1.p1","Breast Cancer Family Registry Early-onset Breast Cancer GWAS","In order to enhance our understanding of the genetic etiology of breast cancer, this study analyzed 1,265,548 Hapmap3 single-nucleotide polymorphisms (SNP) among a discovery set of 3,523 EOBC incident cases  and 2,702 age-matched population control women, all of whom were age 50 or younger at enrollment. Subjects were recruited from the eight sites, some","Not Applicable","Breast Neoplasms","Case-Control","Not Provided","Not Provided","2 analyses","","NCI","GRU --- General Research Use","2019-03-07","2019-03-07","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001770.v1.p1","Assessment of Health-related Quality of Life in Rare Kidney Stones","The purpose of this study is to learn about Health-related Quality Of Life (HRQoL) in patients enrolled in the Rare Kidney Stone Consortium (RKSC) registries. Quality of life studies look  at different aspects of both physical and mental components of people's lives. HRQoL data for people affected by kidney stones are not currently","Not Applicable","Dent Disease","Prospective Longitudinal Cohort","Not Provided","Not Provided","5 phenotype datasets, 91 variables, 1 documents, 356 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-03-06","2019-03-06","Adenine phosphoribosyltransferase deficiency; Cystinuria; Hyperoxaluria, Primary; 2,8-dihydroxyadenine urolithiasis; 2,8-dihydroxyadeninuria disease; APRT DEFICIENCY",""
"phs001495.v2.p1","DAXX Suppression of ALT","Many tumors maintain chromosome ends through a telomerase-independent, homologous recombination based mechanism called alternative lengthening of telomeres (ALT). While ALT occurs in only a subset of tumors, it is strongly  associated with mutations in the genes encoding components of the histone H3.3 chaperone complex, ATRX and DAXX. To date the mechanistic role of ATRX","Not Applicable","Osteosarcoma","Case Set","Not Provided","OTHER, RNA-Seq","4 phenotype datasets, 20 variables, 14 samples sequenced,  SRA, 5 subjects, 14 samples","","NCI","GRU --- General Research Use","2019-03-06","2018-02-02","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteoblastic osteosarcoma; Osteoblastic sarcoma; Osteochondrosarcoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001769.v1.p1","Intravenous Norepinephrine for Orthostatic Hypotension","Patients with chronic autonomic failure (CAF) often have disabling orthostatic hypotension (OH). OH in CAF patients is often associated with supine hypertension (hypertension while lying down), which can be severe.  Drugs to treat OH worsen supine hypertension. Therefore, the combination of OH with supine hypertension poses a difficult therapeutic challenge. This","Not Applicable","Pure Autonomic Failure","Interventional","Not Provided","Not Provided","3 phenotype datasets, 164 variables, 6 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-03-05","2019-03-05","Hypotension, Orthostatic; Decrease in blood pressure upon standing up; Hypotension, Postural; Orthostatic Hypotension; Orthostatic hypotension (disease); Postural Hypotension",""
"phs001720.v1.p1","Kidney on a Chip","We generated primary cultures from mechanically isolated kidney glomeruli (filtration unit of the nephron) which are composed of podocytes and mesangial cells. In parallel, we generated primary kidney cortex tubule  cell cultures, which are composed primarily of proximal tubule cells. Early passage cultures of these two cell types were subjected to chromatin","Not Applicable","Podocytes","Collection","target_markerset_grc37, RNAseq_probe_set_grc37","RNA-Seq, RNA Seq (NGS), DNase-seq Footprints (NGS), DNase-Hypersensitivity","4 phenotype datasets, 17 variables, 1 molecular datasets, 10 samples sequenced,  SRA, 2 subjects, 10 samples","","NHGRI","KF --- Kidney Function","2019-03-04","2019-03-04","ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal Cell",""
"phs000756.v1.p1","Exome Sequence of Finnish Sub-Isolate Samples from the FINRISK Cohort","We propose to undertake, at the McDonnell Genome Institute of Washington University, a collaborative exome sequencing project of 10,000 samples from a large Finnish population cohort, FINRISK, a participating component  of the Sequencing Initiative Suomi (SISu) consortium. Together these sequenced samples will provide a unique resource for identification of","Not Applicable","Cohort Studies","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 27 variables, 9332 samples sequenced,  SRA, 9335 subjects, 9335 samples","","NHGRI","DS-CBCDAA --- Disease-Specific (Cardio-Brain-Cancer-Diabetes-Asthma-Allergy)","2019-03-04","2019-03-04","Not Provided",""
"phs000771.v2.p1","Bladder Cancer Clinical Cohorts","Cisplatin-based chemotherapy is the standard of care for patients with muscle invasive urothelial carcinoma. Pathologic downstaging to pT0/pTis after neoadjuvant cisplatin-based chemotherapy is associated with improved survival, and some patients  with metastatic disease achieve complete responses to these therapies. However, the molecular determinants of cisplatin response are incompletely","Not Applicable","Urinary Bladder Neoplasms","Case-Control","other","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 232 samples sequenced,  SRA, 101 subjects, 232 samples","","NHGRI","DS-BLADDERCA --- Disease-Specific (Bladder Cancer), DS-GEN-URI-CA --- Disease-Specific (Genitourinary Cancer), HMB-MDS --- Health/Medical/Biomedical (MDS)","2019-02-28","2014-09-25","Bladder Cancer; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder; Cancer, Urinary Bladder",""
"phs001765.v1.p1","Genomic Characterization of Parathyroid Cancer","Here we performed genomic characterization of twenty-nine sporadic parathyroid cancers using next generation whole exome sequencing. Thirty-three novel candidate driver genes for sporadic parathyroid cancer were proposed, in addition to  previously known driver genes CDC73 and MEN1. All patients undergoing surgical resection for sporadic parathyroid cancer at a tertiary cancer center","Not Applicable","Parathyroid Neoplasms","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 20 variables, 41 samples sequenced, 41 subjects, 41 samples","","NCI","GRU --- General Research Use","2019-02-27","2019-02-27","Neoplasm of Parathyroid; Neoplasm of Parathyroid Gland; Neoplasm of the Parathyroid; Neoplasm of the Parathyroid Gland; Neoplasm, Parathyroid; Neoplasms, Parathyroid","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001649.v1.p1","Center for Education and Drug Abuse Research (CEDAR)","Under its programmatic name, the Center for Education and Drug Abuse research (CEDAR), this Center of Excellence project was completed in 2015. The CEDAR sample consists of 775 nuclear families  comprising an adult male (proband), his spouse/mate, and their biological child who is 10-12 years of age at recruitment. This child is designated as","Not Applicable","Substance-Related Disorders","Prospective Longitudinal Cohort","Human660W-Quad","SNP Genotypes (Array)","4 phenotype datasets, 37 variables, 1 molecular datasets, 469 subjects, 469 samples","","NIDA","DS-ADX-IRB-GSO-RD --- Disease-Specific (Addictive Disorders, IRB, GSO, RD)","2019-02-27","2019-02-27","Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced",""
"phs001660.v1.p1","Lung Cancer Pharmacogenomics (LUPG)","Lung cancer is frequently treated with paclitaxel in combination with several other agents; however, paclitaxel treatment is often ineffective or limited by treatment-related toxicities. Heritable variants in genes associated with  absorption, distribution, metabolism, and elimination may predict paclitaxel clinical outcome and toxicity. We designed a prospective","Not Applicable","Paclitaxel","Case Set","Affymetrix_expression_array","SNP Genotypes (Array)","4 phenotype datasets, 274 variables, 1 molecular datasets, 103 subjects, 103 samples","","NCI","GRU-IRB --- General Research Use (IRB), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-IRB --- Disease-Specific (Cancer, IRB)","2019-02-22","2019-02-22","Lung Neoplasms; Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung",""
"phs001677.v1.p1","Adolescent Idiopathic Scoliosis (AIS) 1000 Exomes Study","Adolescent idiopathic scoliosis (AIS) is the most common pediatric spinal deformity. Although the Bracing in AIS Trial (BrAIST) recently demonstrated the effectiveness of bracing for preventing scoliosis progression in some  patients, more than 20,000 children undergo major spinal fusion surgery at an annual cost of $3 billion. Spinal fusion surgery is a major operation","Not Applicable","Scoliosis","Case Set","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 1093 samples sequenced, 1093 subjects, 1093 samples","","NIAMS","DS-IMD-IRB --- Disease-Specific (Inherited Musculoskeletal Disorders, IRB), DS-SCOID-IRB --- Disease-Specific (Scoliosis, idiopathic, IRB)","2019-02-21","2019-02-21","Cobb angle greater than ten degrees; Scolioses; Scoliosis,",""
"phs001645.v1.p1","Genomic Landscape of Cutaneous Diffuse Large B Cell Lymphoma","Cutaneous diffuse large B cell lymphomas (DLBCL) are aggressive lymphomas with a poor prognosis. To elucidate their genetic bases, we performed whole exome capture and massively parallel sequencing on 19  tumor samples of diffuse large B cell lymphoma, leg type (DLBCL-LT) and 6 samples of secondary cutaneous diffuse large B cell lymphoma, not otherwise","Not Applicable","Lymphoma, Large B-Cell, Diffuse","Case Set","Not Provided","WXS","4 phenotype datasets, 22 variables, 25 samples sequenced, 25 subjects, 25 samples","","NCI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2019-02-19","2019-02-19","Lymphoma, B-Cell; Centroblastic diffuse large B-cell malignant lymphoma; Centroblastic diffuse malignant lymphoma; Centroblastic malignant lymphoma; DLBCL; DLBCL - diffuse large B cell lymphoma",""
"phs001578.v1.p1","The Preterm Infant Microbiome: Biological, Behavioral and Health Outcomes    at 2 and 4 Years of Age","This project follows a cohort of 78 Very Low Birth Weight (VLBW) previously enrolled infants in a R21 grant plus additional 25 infants through their Neonatal Intensive Care Unit (NICU)  stay until they reach the age of 4 years. The data, gathered over 6 weeks of the NICU stay, includes multiple factors, such as prenatal and postnatal","Not Applicable","Microbiota","Prospective Longitudinal Cohort","Not Provided","AMPLICON","4 phenotype datasets, 219 variables, 368 samples sequenced,  SRA, 82 subjects, 368 samples","","NINR","HMB --- Health/Medical/Biomedical","2019-02-15","2019-02-15","growth",""
"phs001712.v1.p1","VCRC One-Time DNA Study","The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Better methods are  needed to recruit patients with these rare diseases into cohorts of adequate size for high-quality genetics studies, and the existing infrastructure","Not Applicable","Vasculitis","Case-Control","Not Provided","Not Provided","12 phenotype datasets, 2586 variables, 7 documents, 152 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2019-02-11","2019-02-11","Churg-Strauss Syndrome; Giant Cell Arteritis; Granulomatosis with Polyangiitis; Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu Arteritis",""
"phs000915.v2.p2","Integrative Clinical Sequencing Analysis of Metastatic Castration    Resistant Prostate Cancer Reveals a High Frequency of Clinical    Actionability","Most prostate cancer deaths are caused by metastatic, castration resistant disease (mCRPC). To develop a precision medicine framework for mCRPC, we established a multi-institutional, international clinical sequencing infrastructure to enroll  and carry out prospective whole exome and transcriptome sequencing of tumors from a cohort of mCRPC patients. We obtained high quality DNA and RNA","Not Applicable","Prostatic Neoplasms","Case Set","other","WXS, SNV (.MAF), RNA-Seq","4 phenotype datasets, 10 variables, 1 molecular datasets, 749 samples sequenced,  SRA, 274 subjects, 763 samples","","NCI","DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS), DS-CA-MDS --- Disease-Specific (Cancer, MDS), GRU --- General Research Use, HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2019-02-08","2016-01-15","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001361.v2.p1","Genetics of Age-Related Macular Degeneration in the Amish","Identifying genetic risk loci for Age-Related Macular Degeneration is important. Most of the loci identified to date have been found through the interrogation of common variants. This study initiates the  identification of rare variants in a founder population, the Amish, and will use genotyping of known risk loci and ultimately use the whole exome","Not Applicable","Macular Degeneration","Family/Twin/Trios","Not Provided","Not Provided","1 documents, 2 analyses","","NEI","GRU-IRB --- General Research Use (IRB)","2019-02-06","2019-02-06","Degeneration, Macular; Degenerative disorder of macula; Dystrophy, Macular; Macular Degenerations; Macular Dystrophies; Macular Dystrophy",""
"phs001733.v1.p1","Molecular Etiology of Early-Onset Dystonia","Primary torsin dystonias (PTD) are a group of movement disorders characterized by twisting muscle contractures, where dystonia is the only clinical sign (except for tremor) and there is no evidence  of neuronal degeneration or an acquired cause. Eleven genes have been mapped for primary dystonia including DYT1 (TOR1A), DYT2, DYT4 (TUBB4A), DYT6","Not Applicable","Dystonia","Prospective Longitudinal Cohort","Not Provided","WXS","5 phenotype datasets, 25 variables, 17 samples sequenced,  SRA, 17 subjects, 17 samples","","NINDS","DS-MDP --- Disease-Specific (Movement Disorders Phenotypes)","2019-02-05","2019-02-05","Dystonia musculorum deformans type 1; Dystonia, Muscle; Dystonic disease; Dystonic movements; Muscle Dystonia; dystonia disorder",""
"phs001655.v1.p1","Human Skin Metagenome Associated with Acne","Studies have emphasized the importance of disease-associated microorganisms in perturbed communities, however, the protective roles of commensals are largely under recognized and poorly understood. Using acne as a model disease,  we investigated the determinants of the overall virulence property of the skin microbiota when disease- and health-associated organisms coexist in","Not Applicable","Acne Vulgaris","Case-Control","Not Provided","WGS","4 phenotype datasets, 16 variables, 82 samples sequenced, 82 subjects, 82 samples","","NIAMS","DS-HMP --- Disease-Specific (Human Microbiome Research)","2019-01-31","2019-01-31","",""
"phs001175.v2.p2","CTSP: Clinical Trial Sequencing Project","For the Clinical Trials Sequencing Project (CTSP), National Cancer Institute (NCI) will utilize whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing to try to identify recurrent  genetic alterations (mutations, deletions, amplifications, rearrangements) and/or gene expression signatures that would be important to the","Not Applicable","Breast","Collection","Not Provided","Not Provided","2 phenotype datasets, 6 variables,  SRA, 366 subjects, 366 samples, 1 substudies","","NCI","GRU --- General Research Use","2019-01-29","2018-04-11","ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal Cell","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001184.v2.p2","CTSP Diffuse Large B-Cell Lymphoma (DLBCL) CALGB 50303","For the CTSP-DLBCL sub-project, National Cancer Institute (NCI) will utilize whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing to try to identify recurrent genetic alterations (mutations,  deletions, amplifications, rearrangements) and/or gene expression signatures that would be important to the hypothesis(es) submitted by the","CTSP: Clinical Trial Sequencing Project (phs001175.v2.p2)","Lymphoma, Large B-Cell, Diffuse","Case Set","Not Provided","Not Provided","366 samples","","NCI","GRU --- General Research Use","2019-01-29","2018-04-11","Centroblastic diffuse large B-cell malignant lymphoma; Centroblastic diffuse malignant lymphoma; Centroblastic malignant lymphoma; DLBCL; DLBCL - diffuse large B cell lymphoma; Diffuse Histiocytic Lymphoma",""
"phs001659.v1.p1","Bayesian-Based Noninvasive Prenatal Diagnosis of Single-Gene Disorders","In the last decade, non-invasive prenatal diagnosis (NIPD) has emerged as an effective procedure for early detection of inherited diseases during pregnancy. This technique is based on using cell-free DNA  (cfDNA) and fetal cfDNA (cffDNA) in maternal blood, and hence, has minimal risk for the mother and fetus compared with invasive techniques. NIPD is","Not Applicable","Noninvasive Prenatal Testing","Family/Twin/Trios","WGS_markerset_grc38","WXS, WGS, SNP/CNV Genotypes (NGS)","3 phenotype datasets, 10 variables, 1 molecular datasets, 12 samples sequenced,  SRA, 9 subjects, 12 samples","","NICHD","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2019-01-24","2019-01-24","Not Provided",""
"phs001439.v1.p1","University of Utah Pelvic Organ Prolapse Disorder Study","The overall purpose of this University of Utah Pelvic Organ Prolapse Disorder Study was to identify and localize predisposition genes contributing to pelvic organ prolapse (POP). POP cases recruited for  this study were identified by one of three methods: high-risk POP pedigree cases, POP sister pairs, and surgically-treated POP cases reporting a","Not Applicable","Pelvic Organ Prolapse","Case Set","HumanOmni2.5-8, HumanOmni1-Quad, HumanOmniExpress-24","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 334 subjects, 335 samples","","NICHD","DS-PFD-RD --- Disease-Specific (Pelvic Floor Disorders, RD)","2019-01-22","2019-01-22","Urinary Bladder, Overactive; Urinary Incontinence, Urge; Bulge of the vaginal vault; Prolapse, Vaginal Vault; Prolapses, Vaginal Vault; Vaginal Vault Prolapse",""
"phs001750.v1.p1","Single Cell Analysis of Pulmonary Fibrosis","Pulmonary fibrosis is a heterogenous syndrome in which fibrotic scar replaces normal lung tissue. We performed massively parallel single-cell RNA-Seq on lung tissue from eight lung transplant donors and eight  patients with pulmonary fibrosis. Combined with in situ RNA hybridization, with amplification, these data provide a molecular atlas of disease","Not Applicable","Pulmonary Fibrosis","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 18 variables, 1 molecular datasets, 83 samples sequenced,  SRA, 39 subjects, 83 samples","","NHLBI","GRU --- General Research Use","2019-01-14","2019-01-14","Alveolitides, Fibrosing; DIPF - Diffuse interstitial pulmonary fibrosis; Fibrosing Alveolitides; Fibrosing Alveolitis; Idiopathic Diffuse Interstitial Pulmonary Fibrosis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001609.v1.p1","Genetic Contributions of Lupus Nephritis in A Multi-Ethnic Cohort","Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) and it occurs at a much higher rate in patients that are not of European descent. The purpose  of this study is to identify genetic variants contributing to the risk of LN in a multi-ethnic cohort of SLE patients. We used a comprehensive","Not Applicable","Lupus Erythematosus, Systemic","Case-Control","Axiom_Array","SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets, 964 subjects, 964 samples","European (364), African (4), East Asian (165), African American (217), Hispanic1 (6), Hispanic2 (123), Other Asian or Pacific Islander (59), South Asian (14), Other (12)","NIAMS","DS-ADO --- Disease-Specific (Autoimmune Diseases), DS-SLE-IRB-PUB-NPU-MDS --- Disease-Specific (Systemic lupus erythematosus, IRB, PUB, NPU, MDS), DS-SLE-PUB --- Disease-Specific (Systemic lupus erythematosus, PUB), DS-SLE-GSO --- Disease-Specific (Systemic lupus erythematosus, GSO)","2019-01-10","2019-01-10","Lupus Nephritis; Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic",""
"phs000755.v2.p1","BrainSpan Atlas of the Human Brain","The NIH-funded BrainSpan (www.brainspan.org) and PsychENCODE (www.psychencode.org). Consortia sought to generate and analyze multi-dimensional genomics data from the developing and adult human brain in healthy and disease states. One of  the main goals has been to perform large-scale and integrated analysis of the genome, transcriptome, and epigenome of the human brain to broaden our","Not Applicable","Brain Diseases","Control Set","HumanOmni2.5-4, HumanMethylation450","Not Provided","3 phenotype datasets, 12 variables, 954 samples sequenced, 61 subjects, 1279 samples, 2 substudies","","NIMH","GRU --- General Research Use","2019-01-08","2018-05-23","Aging; growth and development; Aging, Biological; Biological Aging; Brain Disease; Brain Disorders","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000731.v2.p1","BrainSpan Atlas of the Developing and Adult Human Brain","The NIH-funded BrainSpan (www.brainspan.org) and PsychENCODE (www.psychencode.org). Consortia sought to generate and analyze multi-dimensional genomics data from the developing and adult human brain in healthy and disease states. One of  the main goals has been to perform large-scale and integrated analysis of the genome, transcriptome, and epigenome of the human brain to broaden our","BrainSpan Atlas of the Human Brain (phs000755.v2.p1)","Brain Diseases","Control Set","HumanMethylation450","WGS, miRNA-Seq, ChIP-Seq, miRNA-Seq, WGS, ChIP-Seq, Methylation (CpG), RNA-Seq, RNA-Seq, Methylation (CpG)","1 phenotype datasets, 3 variables, 1 molecular datasets, 954 samples sequenced,  SRA, 48 subjects, 1222 samples","","NIMH","GRU --- General Research Use","2019-01-08","2018-05-23","growth and development; Brain Disease; Brain Disorders; CNS Disorder, Intracranial; CNS Disorders, Intracranial; Central Nervous System Disorders, Intracranial",""
"phs000406.v3.p1","Spatiotemporal Transcriptome of the Human Brain","Comprehensive knowledge about the spatiotemporal dynamics of the brain transcriptome is essential for a better understanding of neurodevelopment, sexual dimorphism, and evolution, as well as our increased susceptibility to certain  brain disorders. We generated and analyzed genome-wide exon-level transcriptome data from 16 brain regions of 57 postmortem human brains, spanning","BrainSpan Atlas of the Human Brain (phs000755.v2.p1)","Aging","Control Set","HumanOmni2.5-4","SNP Genotypes (Array)","2 phenotype datasets, 8 variables, 1 molecular datasets, 57 subjects, 57 samples","European (30), African American (15), Hispanic1 (4), Hispanic2 (2), Other Asian or Pacific Islander (2), South Asian (1), Other (3)","NIMH","GRU --- General Research Use","2019-01-08","2018-05-23","Aging, Biological; Biological Aging",""
"phs001146.v1.p1","eQTL Mapping of Mid-Secretory Phase Endometrial Cells","We performed an unbiased genome-wide expression quantitative trait locus (eQTL) mapping study to identify common regulatory (expression) single nucleotide polymorphisms (eSNPs) in mid-secretory endometrium, corresponding to the luteal phase of  the ovarian cycle. Biopsies were collected from 58 women with two or more early pregnancy losses and 53 of these samples passed all quality control.","Not Applicable","Fertility","Collection","Axiom_GW_EUR","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 53 subjects, 53 samples","European (42), East Asian (2), African American (2), Hispanic1 (2), Hispanic2 (3), South Asian (2)","NICHD","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2019-01-07","2019-01-07","Infertility, Female; Postpartum Sterility; Sterility, Postpartum",""
"phs001298.v1.p1","Fine Mapping of Eight Psoriasis Susceptibility Loci","Psoriasis is a common immune-mediate disease identified through scaly patches of the skin. In this study we collected genotype information on 5,067 samples of European ancestry as a follow-up study  of our initial GWAS (Nair et al. 2009). We designed an Illumina iSelect custom genotyping array with 2,269 tagging SNPs in the eight known psoriasis","Not Applicable","Psoriasis","Case-Control","iSelect_BeadChip","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 4806 subjects, 4806 samples","","NIAMS","GRU-PUB --- General Research Use (PUB), DS-PSO-PSA-PUB --- Disease-Specific (Psoriasis and Psoriatic Arthritis, PUB)","2019-01-05","2019-01-05","Acropustulosis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis; Palmoplantar Pustulosis",""
"phs001193.v1.p1","Hispanic Colorectal Cancer Study","Genome-wide association studies (GWAS) of colorectal cancer (CRC) have been instrumental in identifying a number of common susceptibility loci in Non Hispanic (NH)-White populations, and a NCI priority is to  extend GWAS findings to other populations to address racial/ethnic disparities in cancer susceptibility. Currently, GWA studies of CRC in NH-Whites,","Not Applicable","Colorectal Neoplasms","Case-Control","HumanOmni2.5-8","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 7 documents, 1 molecular datasets, 1597 subjects, 1597 samples","European (81), African (1), African American (6), Hispanic1 (20), Hispanic2 (1438), Other Asian or Pacific Islander (10), Other (41)","NCI","GRU --- General Research Use, DS-CA --- Disease-Specific (Cancer), HMB-MDS --- Health/Medical/Biomedical (MDS)","2018-12-27","2018-12-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001621.v1.p1","The Platinum Study","The Platinum Study is an R01-funded, multicenter study of testicular cancer survivors that characterizes both long-term cisplatin-induced peripheral neuropathy (CisIPN) and cisplatin-associated ototoxicity, i.e., permanent, bilateral hearing loss. We collected  data abstracted from medical records (e.g., cumulative cisplatin dose), conducted audiometric examinations, and administered self-report","Not Applicable","Cisplatin","Cross-Sectional","imputation_panel, HumanOmniExpress-12","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 28 variables, 2 molecular datasets, 680 subjects, 680 samples","","NCI","GRU --- General Research Use","2018-12-21","2018-12-21","Not Provided","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001704.v1.p1","Enhancer Mapping in Chronic Lymphocytic Leukemia","In this study we profile the epigenomic enhancer landscapes of CLL B cells (CD19+/CD5+) harvested from peripheral blood of patients from our Center. Included are results of ChIPseq profiling using  chromatin immunoprecipitation of the enhancer histone mark H3K27ac (acetylated lysine 27 on histone H3), and open chromatin profiles using ATAC-seq","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case-Control","Not Provided","ATAC-seq, RNA-Seq, ChIP-Seq","4 phenotype datasets, 19 variables, 66 samples sequenced,  SRA, 28 subjects, 66 samples","","NCI","DS-CLL --- Disease-Specific (Chronic Lymphocytic Leukemia)","2018-12-18","2018-12-18","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs001049.v1.p1","Genomics of Relapsed Small Cell Lung Cancer Progression","Small cell lung cancer (SCLC) accounts for nearly 15% of all patients with lung cancer. Though the response to initial therapy is favorable in many patients, a majority of patients  go on to develop recurrent disease which is very difficult to treat. The response rates to chemotherapy are very low and most patients succumb to","Not Applicable","Small Cell Lung Carcinoma","Case Set","Not Provided","WXS, RNA-Seq","4 phenotype datasets, 18 variables, 105 samples sequenced,  SRA, 30 subjects, 105 samples","","NHGRI","DS-LC --- Disease-Specific (Lung Cancer)","2018-12-18","2018-12-18","Recurrence; Recrudescence; Recrudescences; Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma",""
"phs001521.v1.p1","Immunoprotective Mechanisms and Microbiota Interplay in Salmonella Typhi    Infection","Vaccine development against Salmonella enterica serovar Typhi (S. Typhi) requires a better understanding of interaction between human host and the resident microbial consortia in gastrointestinal tract. Healthy adult volunteers received  either Ty21a, M01ZH09 or placebo, and underwent challenges with wt S. Typhi. Stool samples were collected at the screening interview (Baseline 1),","Not Applicable","Microbiota","Prospective Longitudinal Cohort","Not Provided","Not Provided","5 phenotype datasets, 18 variables,  SRA, 99 subjects, 297 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2018-12-12","2018-12-12","Not Provided",""
"phs001418.v1.p1","Molecular Role of DNA Variants Associated with Crohn's Disease","Crohn's disease (CD), one of the two major inflammatory bowel diseases (IBD), results from an inappropriately directed inflammatory response to the enteric microbiota in a genetically susceptible host. Genome wide  association studies (GWAS) have linked 200 specific single nucleotide polymorphisms (SNPs) to CD disease pathogenesis. Within these regions, there","Not Applicable","Crohn Disease","Case-Control","imputation_panel, ImmunoArray","SNP Genotypes (imputed), FAIRE-seq, RNA-Seq, SNP Genotypes (Array)","4 phenotype datasets, 36 variables, 2 molecular datasets, 31 samples sequenced, 33 subjects, 33 samples","","NIEHS","GRU --- General Research Use","2018-12-12","2018-12-12","CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's disease of colon; Crohn's disease of large bowel",""
"phs001496.v1.p1","A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean    Hispanics","Warfarin is an oral anticoagulant and one of the most used drugs in the world accounting for up to 1.5% of prescriptions globally. Warfarin inhibits vitamin K epoxide reductase complex  1 (VKORC1), an enzyme responsible for the vitamin K recycling that is required for the activation of clotting factors. Warfarin is prescribed at an","Not Applicable","Warfarin Sensitivity","Case-Control","target_markerset_grc37, custom_markerset","SNP Genotypes (NGS), SNP Genotypes (Array)","4 phenotype datasets, 45 variables, 8 documents, 2 analyses, 1 molecular datasets,  SRA, 115 subjects, 212 samples","","NHLBI","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2018-12-07","2018-12-07","",""
"phs001658.v1.p1","Tumor Heterogeneity in Metastatic Adrenocortical Tumors","We have analyzed 33 human metastatic adrenocortical tumors from 14 patients with advanced metastases and performed whole exome sequencing to identify novel signatures in these tumors. We observed tumor heterogeneity  in these tumors coming from the same metastatic tissue site across different patients while the different metastatic tumor sites coming from the same","Not Applicable","Adrenocortical Carcinoma","Prospective Longitudinal Cohort","other","SNV (.MAF), WXS","3 phenotype datasets, 22 variables, 1 molecular datasets, 33 samples sequenced,  SRA, 14 subjects, 33 samples","","NCI","GRU --- General Research Use","2018-12-04","2018-12-04","ACC; Adenoid Cystic Carcinoma; Adrenal Cortex Adenocarcinoma; Adrenal Cortex Cancer; Adrenal Cortex Carcinoma; Adrenal Cortical Adenocarcinoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000284.v2.p1","NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource    (CARe)","The Cleveland Family Study is the largest family-based study of sleep apnea world-wide, consisting of 2284 individuals (46% African American) from 361 families studied on up to 4 occasions over  a period of 16 years. The study was begun in 1990 with the initial aims of quantifying the familial aggregation of sleep apnea. NIH renewals provided","Not Applicable","Sleep Apnea Syndromes","Prospective Longitudinal Cohort","Affymetrix_WG_Array, CVDSNP55","SNP Genotypes (Array)","5 phenotype datasets, 2339 variables, 9 documents, 2 molecular datasets, 1473 subjects, 1538 samples","","NHLBI","DS-HLBS-IRB-NPU --- Disease-Specific (Heart, Lung, Blood, and Sleep Disorders, IRB, NPU)","2018-12-03","2011-02-08","Diabetes Mellitus; Hypertension; Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High",""
"phs001654.v1.p1","NSAIDS and Somatic Mutations in Barrett's Esophagus","Background: Use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been shown to protect against tetraploidy, aneuploidy, and chromosomal alterations in the metaplastic condition Barrett's esophagus (BE) and to  lower the incidence and mortality of esophageal adenocarcinoma (EA). The esophagus is exposed to both intrinsic and extrinsic mutagens resulting from","Not Applicable","Barrett Esophagus","Case-Control","HumanOmniExpress-12","OTHER, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 164 samples sequenced,  SRA, 82 subjects, 164 samples","","NCI","DS-BE --- Disease-Specific (Barrett's Esophagus)","2018-11-28","2018-11-28","BARRETT METAPLASIA; BE; Barret syndrome; Barrett Metaplasias; Barrett Syndrome; Barrett esophagus/esophageal adenocarcinoma",""
"phs001696.v1.p1","Genomic Studies for Understanding Etiology of Esophageal Adenocarcinoma    (EsophagealAdenocarcinoma_Chinese)","While the incidence of esophageal adenocarcinoma (EAC) has risen drastically in Western countries over the last 40 years, a similar trend has not been observed for EAC in China. Here  we analyzed mutational spectrum, copy number alterations, and structural variants from whole-genome sequencing of ten Chinese EAC tumor samples and","Not Applicable","Esophageal Neoplasms","Case Set","WGS_markerset_grc37","WGS, SNP Genotypes (NGS)","4 phenotype datasets, 26 variables, 1 molecular datasets, 20 samples sequenced,  SRA, 10 subjects, 20 samples","","NCI","DS-E-C-NPU --- Disease-Specific (Esophageal Cancer, NPU)","2018-11-27","2018-11-27","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophageal neoplasm; Esophageal tumour; Esophagus Neoplasm",""
"phs001078.v1.p1","Common Variant GWAS, GECCO","Genetics & Epidemiology of Colorectal Cancer Consortium (GECCO) is a collaborative effort which aims to accelerate the discovery of colorectal cancer-related variants by discovering, replicating and fine-mapping Genome Wide Association  Study (GWAS) findings, conducting a meta-analysis of GWAS data, and investigating how genetic variants are modified by environmental risk factors.","Not Applicable","Colorectal Neoplasms","Case-Control","HumanCytoSNP-12, HumanOmniExpress-12","Not Provided","2 phenotype datasets, 9 variables, 17766 subjects, 18509 samples, 12 substudies","","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001171.v1.p1","Multiethnic Cohort Study (MEC)","This study phs001171 MEC Colorectal Cancer contains genotype and phenotype of subjects available from the phs001171 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed  at the top-level study page phs001078 GECCO Consortioum. Individual level phenotype data and molecular data for all GECCO Consortium top-level study","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Case-Control","HumanCytoSNP-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 722 subjects, 735 samples","European (674), African (1), East Asian (1), African American (2), Hispanic1 (7), Hispanic2 (15), Other Asian or Pacific Islander (13), Other (6)","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC --- Health/Medical/Biomedical (PUB), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001170.v1.p1","Hawai'i Colorectal Cancer Studies 2&3 (Colo2&3)","This study phs001170 Colo2and3 contains genotype and phenotype of subjects available from the phs001170 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at the  top-level study page phs001078 GECCO Consortioum. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Case-Control","HumanCytoSNP-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 225 subjects, 232 samples","European (214), East Asian (1), Hispanic1 (3), Hispanic2 (3), Other Asian or Pacific Islander (4)","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001129.v1.p1","Nurses' Health Study (NHS)","This study phs001129 NHS contains genotype and phenotype of subjects available from the phs001129 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at the  top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 2606 subjects, 2660 samples","","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001128.v1.p1","Physicians' Health Study (PHS)","This study phs001128 PHS contains genotype and phenotype of subjects available from the phs001128 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at the  top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Prospective Longitudinal Cohort","HumanOmniExpress-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 806 subjects, 817 samples","European (775), East Asian (12), African American (4), Hispanic1 (1), Hispanic2 (4), Other Asian or Pacific Islander (5), South Asian (3), Other (2)","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001114.v1.p1","Health Professionals Follow-up Study (HPFS)","This study phs001114 HPFS contains genotype and phenotype of subjects available from the phs001114 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at the  top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 1497 subjects, 1539 samples","","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001113.v1.p1","Darmkrebs: Chancen der Verhutung durch Screening (DACHS)","This study phs001113 DACHS contains genotype and phenotype of subjects available from the phs001113 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at the  top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Case-Control","HumanCytoSNP-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 4686 subjects, 5125 samples","European (3496), African (1), East Asian (3), African American (1), Hispanic1 (4), South Asian (2), Other (4)","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC --- Health/Medical/Biomedical (PUB), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001104.v1.p1","French Association STudy Evaluating RISK for Sporadic Colorectal Cancer    (ASTERISK)","This study phs001104 ASTERISK contains genotype and phenotype of subjects available from the phs001104 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at the  top-level study page phs001078 GECCO Consortioum. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Case-Control","HumanCytoSNP-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 1937 subjects, 2005 samples","","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001094.v1.p1","Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)","This study phs001094 PLCO contains genotype and phenotype of subjects available from the phs001094 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at the  top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Prospective Longitudinal Cohort","HumanCytoSNP-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 1123 subjects, 1189 samples","European (917), African (3), East Asian (58), African American (108), Hispanic1 (5), Hispanic2 (15), Other Asian or Pacific Islander (14), South Asian (1), Other (2)","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001092.v1.p1","Postmenopausal Hormones Supplementary Study to the Colon Cancer Family    Registry (PMH-CCFR)","This study phs001092 PMH CCFR contains genotype and phenotype of subjects available from the phs001092 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at  the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Case-Control","HumanCytoSNP-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 450 subjects, 463 samples","","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001077.v1.p1","Women's Health Initiative (WHI)","This study phs001077 WHI Colorectal Cancer contains genotype and phenotype of subjects available from the phs001077 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed  at the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Case-Control","HumanCytoSNP-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 2191 subjects, 2191 samples","","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001056.v1.p1","Diet, Activity, and Lifestyle Study (DALS)","This study phs001056 DALS contains genotype and phenotype of subjects available from the phs001056 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at the  top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Case-Control","HumanCytoSNP-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 880 subjects, 916 samples","","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs000965.v1.p1","VITamins And Lifestyle (VITAL)","This study phs000965 VITAL contains genotype and phenotype of subjects available from the phs000965 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at the  top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","Colorectal Neoplasms","Case-Control","HumanCytoSNP-12","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 607 subjects, 637 samples","","NCI","GRU --- General Research Use, HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU), CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO), DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-MDS --- Disease-Specific (Colorectal Cancer, MDS), HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001678.v1.p1","High-Throughput Determination of the Antigen Specificities of T cell    Receptors in Single Cells","High-throughput linking of T cell receptor (TCR) sequences to their binding antigens is vital for immune profiling, yet challenging. We present Tetramer associated TCR Sequencing (TetTCR-Seq) to address this challenge.  Binding is determined using a library of DNA-barcoded antigen tetramers that are rapidly and inexpensively generated using an in vitro","Not Applicable","Humans","Methods","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 88 samples sequenced,  SRA, 10 subjects, 144 samples","","NCI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2018-11-23","2018-11-23","Not Provided",""
"phs001629.v1.p1","Single Patient BRAF Mutant Brain Tumor, Pre- and Post-dabrafenib WES.","A single adolescent patient with a BRAF V600E mutated brain tumor was treated with dabrafenib and had a complete response, followed by progression. The pre-treatment and post-progression tumors were both  sequenced in order to identify potential drivers of resistance. The patient had both pre-treatment and post-progression specimens available for","Not Applicable","Ganglioglioma","Case Set","Somatic_Variant","WXS, SNV (.MAF)","4 phenotype datasets, 25 variables, 1 molecular datasets, 2 samples sequenced,  SRA, 1 subjects, 2 samples","","NCI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-11-08","2018-11-08","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytoma (excluding glioblastoma); Astrocytomas",""
"phs001690.v1.p1","Endometrial Carcinoma Somatic Copy Number Analysis Study","Endometrial cancer (EC) is the most commonly diagnosed gynecologic malignancy in the United States and is the sixth leading cause of cancer death amongst American women. The purpose of this  study was to identify somatic (tumor-specific) copy number alterations in 7 clear cell ECs, 31 serous ECs, 17 endometrioid ECs, and the clear cell","Not Applicable","Endometrial Neoplasms","Case Set","Human660W-Quad, HumanHap650Y","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 57 subjects, 114 samples","","NHGRI","DS-ECA-COL-NPU-GSO --- Disease-Specific (Endometrial Cancer, COL, NPU, GSO)","2018-11-06","2018-11-06","Endometrial Tumor; Endometrial neoplasm; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium",""
"phs001674.v1.p1","The Genomic Landscape of Endocrine Resistant Advanced Breast Cancers.","The genomic evolution of breast cancers exposed to systemic therapy and its effects on clinical outcome have not been broadly characterized. We integrated the genomic sequencing of 1918 breast cancers,  including 1501 hormone receptor-positive tumors, with detailed clinical information and treatment outcomes. Functional mutations in ERBB2 and","Not Applicable","Breast Neoplasms","Case Set","Not Provided","WXS","3 phenotype datasets, 17 variables, 95 samples sequenced,  SRA, 30 subjects, 95 samples","","NCI","HMB --- Health/Medical/Biomedical","2018-11-05","2018-11-05","Neoplasm Metastasis; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001581.v1.p1","Genomic Characterization of Head and Neck Cancer Cell Lines","Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cancer by incidence worldwide(1). Various chemical carcinogens (tobacco, alcohol and betel nut), human papillomavirus (HPV) infection, and genetic predisposition  contribute to the etiology of HNSCC, and to the complex genetic alterations in tumor subsets that differ in prognosis and response to therapies (2).","Not Applicable","Head and Neck Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 25 variables, 37 samples sequenced,  SRA, 25 subjects, 37 samples","","NIDCD","GRU-PUB-NPU --- General Research Use (PUB, NPU), DS-HNSC-PUB-NPU --- Disease-Specific (Head and neck squamous cell carcinoma, PUB, NPU)","2018-11-05","2018-11-05","Papillomavirus Infections; Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma",""
"phs001695.v1.p1","UCSF Center for Reproductive Health (CRH) Research Bank","The purpose of this study is to provide a reference profile of small extracellular RNAs in body fluids. These samples were originally obtained in a study that had a different  purpose. The purpose of the original study was to add excess biological materials during the course of IVF treatment to a tissue bank. These","Not Applicable","MicroRNAs","Prospective Longitudinal Cohort","Not Provided","miRNA-Seq","4 phenotype datasets, 20 variables, 10 samples sequenced,  SRA, 10 subjects, 10 samples","","NHLBI","DS-INF --- Disease-Specific (Infertility and Infertility Treatments)","2018-10-30","2018-10-30","Infertility; Abnormal fertility; Decreased fertility; Sub-Fertility",""
"phs001694.v1.p1","CSF Analysis in HIV-1 Infected Subjects: Response to Antiretroviral    Therapy","The purpose of this study is to provide a reference profile of small extracellular RNAs in body fluids. These samples were originally obtained in a study that had a different  purpose. The purpose of the original study was to collect information on the changes in cerebrospinal fluid (CSF) related to HIV infection, including","Not Applicable","MicroRNAs","Prospective Longitudinal Cohort","Not Provided","miRNA-Seq","4 phenotype datasets, 21 variables, 8 samples sequenced,  SRA, 8 subjects, 8 samples","","NHLBI","DS-MHIV --- Disease-Specific (Markers of HIV Infection)","2018-10-30","2018-10-30","Not Provided",""
"phs001693.v1.p1","Maternal-Fetal Immune Responses in Preterm Labor and Congenital Anomalies","The purpose of this study is to provide a reference profile of small extracellular RNAs in body fluids. These samples were originally obtained in a study that had a different  purpose. The purpose of the original study was to learn and understand more about the causes of preterm labor, how to prevent it, and how to treat","Not Applicable","MicroRNAs","Prospective Longitudinal Cohort","Not Provided","miRNA-Seq","4 phenotype datasets, 20 variables, 20 samples sequenced,  SRA, 20 subjects, 20 samples","","NHLBI","DS-PTL --- Disease-Specific (Pre-Term Labor)","2018-10-30","2018-10-30","Not Provided",""
"phs001692.v1.p1","Lifestyle, Infertility, Fertility, and Evaluation (LIFE) Study","The purpose of this study is to provide a reference profile of small extracellular RNAs in body fluids. These samples were originally obtained in a study that had a different  purpose. The purpose of the original study was to establish a data and biological specimen repository to advance future research into male","Not Applicable","MicroRNAs","Prospective Longitudinal Cohort","Not Provided","miRNA-Seq","4 phenotype datasets, 20 variables, 8 samples sequenced,  SRA, 8 subjects, 8 samples","","NHLBI","DS-MRUH --- Disease-Specific (Male Reproductive and Urologic Health)","2018-10-30","2018-10-30","Not Provided",""
"phs001646.v1.p1","Regulatory Changes in Glioblastoma Brain Tumors and Xenografts","Non-coding elements in our genomes that play critical roles in complex disease are frequently marked by highly unstable RNA species. Sequencing nascent RNAs attached to an actively transcribing RNA polymerase  complex can identify unstable RNAs, including those templated from gene-distal enhancers (eRNAs). However, nascent RNA sequencing techniques remain","Not Applicable","Glioblastoma","Case Set","custom_markerset","OTHER, Legacy Genotypes","3 phenotype datasets, 16 variables, 1 molecular datasets, 30 samples sequenced,  SRA, 23 subjects, 30 samples","","NHGRI","DS-BT-IRB --- Disease-Specific (Brain Tumors, IRB)","2018-10-26","2018-10-26","Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain",""
"phs001702.v1.p1","eQTL Interactions in Lupus Patients","The purpose of this study is to discover in vivo cytokine expression quantitative trait locus (eQTL) interactions from a cohort of patients with systemic lupus erythematosus. 157 lupus patients were  enrolled in a clinical trial to test the efficacy and safety of an anti-IL-6 monoclonal antibody. At three time points, we measured interferon (IFN)","Not Applicable","Lupus Erythematosus, Systemic","Prospective Longitudinal Cohort","HumanOmniExpressExome-8","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 160 subjects, 160 samples","European (89), African (1), African American (20), Hispanic1 (2), Hispanic2 (39), Other Asian or Pacific Islander (1), Other (8)","NIAMS","HMB --- Health/Medical/Biomedical","2018-10-25","2018-10-25","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus",""
"phs001563.v1.p1","Blood Handling and Leukocyte Isolation Methods Impact the Global    Transcriptome of Immune Cells","In order to characterize the effects of upstream sample handling on the transcriptome of isolated leukocyte populations, we simulated various sample handling methods on whole blood prior to leukocyte isolation  for low-input RNA-sequencing. Blood was collected from healthy donors and intracerebral hemorrhage patients. Principal Investigator: Lauren Sansing,","Not Applicable","Cerebral Hemorrhage","Control Set","Not Provided","RNA-Seq","3 phenotype datasets, 12 variables, 87 samples sequenced, 9 subjects, 87 samples","","NINDS","HMB --- Health/Medical/Biomedical","2018-10-22","2018-10-22","Bleeding in brain; Brain Hemorrhage, Cerebral; Brain Hemorrhages, Cerebral; Cerebral Brain Hemorrhage; Cerebral Brain Hemorrhages; Cerebral Hemorrhages",""
"phs001372.v1.p1","Integrated Single-Cell Analysis in Chronic Lymphocytic Leukemia","Intratumoral genetic heterogeneity has been characterized across cancers by genome sequencing of bulk tumors, including chronic lymphocytic leukemia (CLL). In order to more accurately identify subclones, define phylogenetic relationships, and  probe genotype-phenotype relationships, we developed methods for targeted mutation detection in DNA and RNA isolated from thousands of single cells","Not Applicable","Leukemia, Lymphoid","Case Set","target_markerset_grc37, RNAseq_probe_set_grc37","SNP Genotypes (NGS), RNA Seq (NGS)","4 phenotype datasets, 15 variables, 2 molecular datasets,  SRA, 5 subjects, 1567 samples","","NCI","GRU --- General Research Use","2018-10-18","2018-10-18","Leukemia, Lymphocytic; Leukemias, Lymphocytic; Leukemias, Lymphoid; Lymphatic leukemia; Lymphocytic Leukemia; Lymphocytic Leukemias","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001106.v1.p1","Genomics of Hepatocellular Carcinoma","Despite the growing incidence of hepatocellular carcinoma (HCC) due to increased hepatitis C virus infection and non-alcoholic steatohepatitis in Western populations, the genetic determinants of this cancer have yet to  be established. A minority (15-20%) of HCC occurs in livers without cirrhosis or other chronic disease. Because the liver is functionally preserved","Not Applicable","Carcinoma, Hepatocellular","Case Set","Not Provided","WGS, RNA-Seq, WXS","4 phenotype datasets, 31 variables, 380 samples sequenced,  SRA, 120 subjects, 380 samples","","NHGRI","DS-CA --- Disease-Specific (Cancer)","2018-10-17","2018-10-17","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells",""
"phs001234.v1.p1","Sequence of Primary ER+ Breast Tumors Treated with 5 Years of Tamoxifen","Targeted massively parallel sequencing analysis was conducted on DNA extracted from archived 22-28 year old, formalin-fixed primary breast tumors from 625 patents from British Columbia treated with five years of  adjuvant tamoxifen monotherapy and followed for over 10 years. Genes were selected for targeted sequencing by review of existing large-scale breast","Not Applicable","Breast Neoplasms","Case Set","Not Provided","WXS","3 phenotype datasets, 12 variables, 625 samples sequenced,  SRA, 625 subjects, 625 samples","","NCI","DS-CA-IRB --- Disease-Specific (Cancer, IRB)","2018-10-16","2018-10-16","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001304.v1.p1","NCI Biospecimen Pre-analytical Variables (BPV) Analysis","The Biospecimen Pre-analytical Variables (BPV) Program is a National Cancer Institute-sponsored study to systematically assess the effects of pre-analytical factors on the molecular profile of biospecimens. A robust biospecimen collection  infrastructure was established to prospectively collect biospecimens using rigorous standard operating procedures to control for most variables while","Not Applicable","Carcinoma, Renal Cell","Case Set","SNP-PCR, Cytogenetic_Arrays, custom_markerset","Not Provided","3 phenotype datasets, 466 variables, 341 samples sequenced,  SRA, 153 subjects, 1554 samples, 7 substudies","","NCI","GRU-PUB --- General Research Use (PUB)","2018-10-12","2018-10-12","Fallopian Tube Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung",""
"phs001640.v1.p1","TumorStorage","This study phs001640 Tumor Storage contains molecular data and phenotype of subjects available from the phs001640 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can be  viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV cohort","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Carcinoma, Renal Cell","Case Set","custom_markerset","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 156 variables, 1 molecular datasets,  SRA, 53 subjects, 340 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2018-10-12","2018-10-12","Fallopian Tube Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung",""
"phs001639.v1.p1","NGS","This study phs001639 NGS contains molecular data and phenotype of subjects available from the phs001639 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can be viewed  at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV cohort","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Carcinoma, Renal Cell","Case Set","Not Provided","miRNA-Seq, WXS, RNA-Seq, RNA-Seq, miRNA-Seq, WXS","1 phenotype datasets, 129 variables, 341 samples sequenced,  SRA, 35 subjects, 341 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2018-10-12","2018-10-12","Fallopian Tube Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung",""
"phs001638.v1.p1","mRNA_TaqMan","This study phs001638 mRNA TaqMan contains molecular data and phenotype of subjects available from the phs001638 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can be  viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV cohort","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Carcinoma, Renal Cell","Case Set","SNP-PCR","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 124 variables, 1 molecular datasets,  SRA, 20 subjects, 100 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2018-10-12","2018-10-12","Fallopian Tube Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung",""
"phs001637.v1.p1","GlobalMetaboliteProfiling","This study phs001637 Global Metabolite Profiling contains molecular data and phenotype of subjects available from the phs001637 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can  be viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Carcinoma, Renal Cell","Case Set","custom_markerset","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 49 variables, 1 molecular datasets,  SRA, 40 subjects, 240 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2018-10-12","2018-10-12","Fallopian Tube Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung",""
"phs001636.v1.p1","FixationDelay","This study phs001636 Fixation Delay contains molecular data and phenotype of subjects available from the phs001636 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can be  viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV cohort","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Carcinoma, Renal Cell","Case Set","custom_markerset","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 116 variables, 1 molecular datasets,  SRA, 20 subjects, 95 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2018-10-12","2018-10-12","Fallopian Tube Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung",""
"phs001635.v1.p1","CNV_aCGH","This study phs001635 CNV aCGH contains molecular data and phenotype of subjects available from the phs001635 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can be  viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV cohort","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Carcinoma, Renal Cell","Case Set","Cytogenetic_Arrays","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 168 variables, 1 molecular datasets,  SRA, 38 subjects, 229 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2018-10-12","2018-10-12","Fallopian Tube Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung",""
"phs001634.v1.p1","CIT_mRNA","This study phs001634 CIT mRNA contains molecular data and phenotype of subjects available from the phs001634 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can be  viewed at the top-level study page phs001304 Biospecimen PV study. Individual level phenotype data and molecular data for all Biospecimen PV cohort","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Carcinoma, Renal Cell","Case Set","SNP-PCR","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 131 variables, 1 molecular datasets,  SRA, 40 subjects, 209 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2018-10-12","2018-10-12","Fallopian Tube Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung",""
"phs001664.v1.p1","Parkinson's Disease Cognitive Genetics Consortium (PDCGC)","Cognitive impairment is a common and disabling problem in Parkinson's disease (PD). Identification of genetic variants that influence the presence or severity of cognitive deficits in PD might provide a  clearer understanding of the pathophysiology underlying this important nonmotor feature. We are presently undertaking a large-scale, two-stage study","Not Applicable","Parkinson Disease","Case Set","target_markerset_grc37","SNP Genotypes (NGS)","4 phenotype datasets, 32 variables, 1 molecular datasets, 1219 subjects, 1219 samples","","NINDS","DS-NDR-IRB-NPU --- Disease-Specific (Neurological Disorders Research, IRB, NPU), DS-PDND-PUB-MDS-GSO --- Disease-Specific (Parkinson's disease or other neurodegenerative disorders, PUB, MDS, GSO), DS-PDND-MDS --- Disease-Specific (Parkinson's disease or other neurodegenerative disorders, MDS), GRU --- General Research Use","2018-10-11","2018-10-11","Cognitive Dysfunction; Genetic Association Studies; Lewy Body Disease; Cognitive Decline; Cognitive Declines; Cognitive decline, progressive","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001572.v1.p1","Pan-Tumor Genomic Biomarkers for PD-1 Based Immunotherapy","Tumor mutation burden (TMB) and a T-cell-inflamed gene expression profile (GEP) independently predict clinical outcome in pembrolizumab-treated patients in 22 indications and stratify distinct targets of resistance biology. TMB was  evaluated by whole exome sequencing (WES) of germline and tumor DNA from formalin-fixed paraffin-embedded (FFPE) pre-treatment samples in multiple","Not Applicable","Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 15 variables, 624 samples sequenced,  SRA, 312 subjects, 624 samples","","NCI","DS-CA-IRB --- Disease-Specific (Cancer, IRB)","2018-10-11","2018-10-11","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001531.v1.p1","Genetic Variation Associated with Bicuspid Aortic Valve in Turner    Syndrome","Turner syndrome is a disorder affecting only girls and women, which is caused by a complete or partial loss of the second sex chromosome. Girls and women with Turner syndrome  have a variety of phenotypes. Of interest to this study is aortopathy, including bicuspid aortic valve (BAV) and thoracic aortic dilation (TAD) in","Not Applicable","Turner Syndrome","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 22 variables, 1 documents, 1 molecular datasets, 188 samples sequenced,  SRA, 188 subjects, 188 samples","","NHLBI","DS-TS-X-IRB-NPU-MDS --- Disease-Specific (Turner Syndrome, IRB, NPU, MDS)","2018-10-11","2018-10-11","Aortic Aneurysm; Bicuspid Aortic Valve; AORTIC VALVE, BICUSPID; Aortic valve has two leaflets rather than three; BAV; Bicommissural Aortic Valve",""
"phs001527.v1.p1","Oral Microbiome in Esophageal Adenocarcinoma","The purpose of our study was to assess the influence of oral microbiota on the development of esophageal cancer. Our preliminary case-control studies reported a global alteration of foregut microbiome  in esophageal adenocarcinoma with the strongest changes found in the oral microbiome. We hypothesise that commensal oral bacteria are capable of","Not Applicable","Esophageal Neoplasms","Case-Control","Not Provided","WGS","4 phenotype datasets, 18 variables, 219 samples sequenced,  SRA, 219 subjects, 219 samples","","NCI","HMB-IRB-PUB-COL --- Health/Medical/Biomedical (IRB, PUB, COL)","2018-09-28","2018-09-28","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophageal neoplasm; Esophageal tumour; Esophagus Neoplasm",""
"phs001130.v1.p1","NIDDM-Atherosclerosis Study (NIDDM-Athero)","The NIDDM-Atherosclerosis Study, funded by NHLBI, was designed as a family study to examine the genetic basis of subclinical atherosclerosis and diabetes in Hispanic families. Family members of probands with  T2D were recruited in the Los Angeles area. The baseline examination of the cohort included the euglycemic hyperinsulinemic clamp test from which the","Not Applicable","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","HumanOmniExpress-12_plus","SNP Genotypes (Array)","5 phenotype datasets, 24 variables, 1 molecular datasets, 247 subjects, 247 samples","","NHLBI","DS-DHD-IRB-NPU-MDS-RD --- Disease-Specific (Diabetes and Heart Disease, IRB, NPU, MDS, RD)","2018-09-28","2018-09-28","Diabetes Complications; Diabetes Mellitus Complication; Diabetes Mellitus Complications; Diabetes Related Complications; Diabetes-Related Complication; Diabetes-Related Complications",""
"phs000357.v2.p1","Genome-Wide Association Study in Systemic Sclerosis","The Scleroderma Family Registry and DNA Repository (Registry) was initially developed as a registry and bio-specimen repository of patients with systemic sclerosis (scleroderma), family members and unaffected healthy controls. A  case-control design was later adopted due to the lack of availability of many parents in this adult-onset disease, which precluded a linkage","Not Applicable","Scleroderma, Systemic","Case-Control","Human610-Quad, ImmunoArray","SNP Genotypes (Array)","7 phenotype datasets, 102 variables, 11 documents, 2 molecular datasets, 833 subjects, 833 samples","","NIAMS","DS-SSCAA --- Disease-Specific (Systemic Sclerosis (Scleroderma) and other autoimmune diseases)","2018-09-28","2018-09-28","Systemic Sclerosis; Diffuse Scleroderma; Diffuse Sclerosis; PSS (progressive systemic sclerosis); SS - Systemic sclerosis; SSc",""
"phs001615.v1.p1","Comprehensive Epigenetic Landscape of Rheumatoid Arthritis FLS","We characterized the epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes (FLS) compared with osteoarthritis FLS. Multiple technologies were used, including ChIP-seq to assay H3K27ac, H3K4me1, H3K4me3, H3K36me3, H3K27me3, and H3K9me3,  ATAC-seq for chromatin accessibility, the transcriptome by RNA-seq and whole genomic bisulfite sequencing for DNA methylation. Integrative analysis","Not Applicable","Arthritis, Rheumatoid","Case-Control","Not Provided","Bisulfite-Seq, RNA-Seq, ChIP-Seq, ATAC-seq","4 phenotype datasets, 14 variables, 213 samples sequenced,  SRA, 22 subjects, 213 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2018-09-27","2018-09-27","Osteoarthritis; Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides; Degenerative Arthritis",""
"phs001643.v1.p1","Chordoma Genomics","In this study, we performed paired tumor/normal whole exome and shallow long insert whole genome sequencing, as well as tumor RNAseq, from archival chordoma specimens collected from four patients at  the Barrow Neurological Institute in Phoenix, AZ. The purpose of this analysis was to identify potential therapeutic targets. In three patients, we","Not Applicable","Chordoma","Case Set","Not Provided","RNA-Seq, WXS, WGS","4 phenotype datasets, 15 variables, 8 samples sequenced,  SRA, 4 subjects, 8 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-09-25","2018-09-25","",""
"phs001154.v1.p1","Indexing Genes Impacted by Copy Number Variation in Developmental    Disorders","A challenge in clinical genomics is to predict whether copy number variation (CNV) affecting a gene or multiple genes will manifest as disease. Increasing recognition of gene dosage effects in  neurodevelopmental disorders prompted us to develop a computational approach based on critical-exon (highly expressed in brain, highly conserved)","Not Applicable","Developmental Disabilities","Case-Control","Cytogenetic_Arrays","CNV Genotypes","4 phenotype datasets, 12 variables, 1 molecular datasets, 10618 subjects, 10618 samples","","NICHD","HMB-IRB-PUB-NPU-GSO --- Health/Medical/Biomedical (IRB, PUB, NPU, GSO)","2018-09-25","2018-09-25","Child Development Disorder; Child Development Disorders; Development Disorder, Child; Development Disorders, Child; Developmental Disability; Disabilities, Developmental",""
"phs000257.v3.p1","Human Gut Microbiome in Crohn's Disease","Inflammatory bowel diseases (IBD), such as Crohn's disease, are chronic, immunologically mediated disorders that have severe medical consequences. The current hypothesis is that these diseases are due to an overly  aggressive immune response to a subset of commensal enteric bacteria. Studies to date on IBD have suggested that the disorder may be caused by a","Not Applicable","Crohn Disease","Family/Twin/Trios","Not Provided","WGS","5 phenotype datasets, 30 variables, 4 documents, 168 samples sequenced,  SRA, 69 subjects, 34 samples","","NIDDK","HMP --- Microbiome","2018-09-25","2018-09-25","Colitis; CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's disease of colon",""
"phs001552.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: PGR","The 52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2  diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","Illumina_Exome_Array, WES_markerset_grc37","SNP/CNV Genotypes (NGS), SNP Genotypes (Array), WXS","4 phenotype datasets, 20 variables, 2 molecular datasets, 1826 samples sequenced,  SRA, 1826 subjects, 1826 samples","African American (2), Hispanic1 (7), Other Asian or Pacific Islander (1), South Asian (1783), Other (33)","NIDDK","GRU-IRB --- General Research Use (IRB)","2018-09-24","2018-09-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001651.v1.p1","Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky","This is a pilot study of squamous cell lung cancer and matched normal tissue pairs collected (convenience sample) from patients from Central Appalachia, in Southeastern Kentucky. This study performed whole  exome sequencing on tumor and matched normal DNA samples from 51 lung squamous cell carcinoma (SQCC) subjects from Appalachian Kentucky (AppKY).","Not Applicable","Lung Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 24 variables, 102 samples sequenced,  SRA, 51 subjects, 102 samples","","NCATS","HMB-IRB --- Health/Medical/Biomedical (IRB)","2018-09-19","2018-09-19","Neoplasms, Squamous Cell; Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung",""
"phs001006.v1.p1","Intra-Lesion Heterogeneity and Clonality of Lobular Carcinomas In Situ","This study comprises prospectively accrued, microdissected fresh frozen samples of multifocal lobular carcinoma in situ (LCIS), ductal carcinoma in situ (DCIS), invasive lobular carcinoma and invasive ductal carcinoma from patients  undergoing prophylactic or therapeutic mastectomies after a diagnosis on LCIS diagnosed and managed at Memorial Sloan Kettering Cancer Center","Not Applicable","Carcinoma, Lobular","Collection","Not Provided","WXS","4 phenotype datasets, 26 variables, 94 samples sequenced,  SRA, 24 subjects, 94 samples","","NCI","GRU --- General Research Use","2018-09-13","2018-09-13","Carcinoma in Situ; Cancer in situ; Carcinoma, Intraepithelial; Carcinoma, Preinvasive; Intraepithelial Carcinoma; Non-invasive Carcinoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001577.v1.p1","Structural Alterations in Castration-Resistant Prostate Cancer","Adapted from manuscript in review: Nearly all prostate cancer deaths are from metastatic castration-resistant prostate cancer (mCRPC) but there have been few whole genome sequencing (WGS) studies of this disease  state. We performed linked-read WGS on 23 mCRPC biopsy specimens and analyzed cell-free DNA sequencing data from 86 patients with mCRPC. In addition","Not Applicable","Prostatic Neoplasms, Castration-Resistant","Prospective Longitudinal Cohort","Not Provided","WGS","4 phenotype datasets, 11 variables, 2 samples sequenced,  SRA, 20 subjects, 43 samples","","NCI","DS-MDS --- Disease-Specific (Cancer, MDS), DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS)","2018-09-12","2018-09-12","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs001505.v1.p1","Host Genetic Determinants of the Outcome of SAB by WES","In this case-control study, Complicated Staphylococcus aureus (case) is defined as bacteremia plus endocarditis or bone/joint infection, and Uncomplicated Staphylococcus aureus (control) has no such complications and was cured at  follow-up. We used whole exome sequencing to examine the cumulative effect of coding variants in each gene on risk of complicated SAB in a discovery","Not Applicable","Staphylococcus aureus","Case-Control","WES_markerset_grc37, target_markerset_grc37","SNP Genotypes (NGS), WXS, Targeted-Capture","4 phenotype datasets, 17 variables, 1 molecular datasets, 408 samples sequenced,  SRA, 408 subjects, 408 samples","","NIAID","DS-GNB-IRB --- Disease-Specific (Gram negative bacteremia, IRB)","2018-09-12","2018-09-12","Not Provided",""
"phs001551.v1.p1","Epilepsy Genetics Initiative","The Epilepsy Genetics Initiative (EGI) was created in 2014 with the goal of amassing a database of clinically-generated exome sequence data for patients with epilepsy who have had diagnostic whole  exome sequencing. Most of the subjects enrolled in the study did not receive a secure genetic diagnosis from their initial sequencing. Following","Not Applicable","Epilepsy","Family/Twin/Trios","Not Provided","WXS","5 phenotype datasets, 22 variables, 101 samples sequenced,  SRA, 101 subjects, 101 samples","","NINDS","GRU-PUB --- General Research Use (PUB)","2018-09-11","2018-09-11","Epilepsies; Seizure Disorder; Seizure Disorders; epilepsy",""
"phs000101.v5.p1","Genome-Wide Association Study of Amyotrophic Lateral Sclerosis","Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder clinically characterized by rapidly progressive paralysis and death due to respiratory failure, typically within two to three years of symptom onset. The  number of ALS cases across the globe will increase to nearly 400,000 in 2040, predominantly due to aging of the population. Unraveling the genetics","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","HumanHap550, HumanHap240S, Human660W-Quad, WES_markerset_grc37, HumanOmniExpress-24","WXS, SNP Genotypes (NGS), SNP Genotypes (Array)","10 phenotype datasets, 181 variables, 5 documents, 1 analyses, 5 molecular datasets, 202 samples sequenced, 15480 subjects, 15480 samples","European (11990), African (17), East Asian (28), African American (66), Hispanic1 (63), Hispanic2 (53), Other Asian or Pacific Islander (14), South Asian (62), Other (26)","NINDS","GRU --- General Research Use","2018-09-11","2018-09-11","ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease; Disease, Lou-Gehrigs","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001481.v1.p1","Inherited Bone Marrow Failure Syndromes Study","Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Mutations in IBMFS genes are relevant to  carcinogenesis in sporadic cancers. Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with","Not Applicable","Bone Marrow Failure Disorders","Prospective Longitudinal Cohort","Not Provided","WXS","5 phenotype datasets, 19 variables, 456 samples sequenced, 456 subjects, 456 samples","","NCI","GRU --- General Research Use","2018-09-06","2018-09-06","Bone Marrow Failure Syndromes; Dyskeratosis Congenita; Anemia, Fanconi; Anemia, Fanconi's; Anemias, Fanconi; FA","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001342.v1.p1","Genetic Susceptibility to Statin-Induced Myopathy","Severe myopathic events occur in 0.1-0.5% of patients taking statins. Although genetic association studies have identified some possibly associated gene loci, these have not been reproducible in additional studies with  independent patient cohorts. A more reasonable explanation for susceptibility to statin-induced myopathy is the presence of rare pathogenic variants","Not Applicable","Muscular Diseases","Case-Control","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","5 phenotype datasets, 26 variables, 1 molecular datasets, 46 samples sequenced,  SRA, 46 subjects, 46 samples","","NHLBI","DS-MP-IRB-NPU-GSO --- Disease-Specific (Myopathy, IRB, NPU, GSO)","2018-09-06","2018-09-06","Carnitine palmitoyl transferase 2 deficiency; Glycogen Storage Disease Type V; Malignant Hyperthermia; CPT II Deficiency; CPT-II; CPT2",""
"phs000590.v1.p1","VCRC5504: Longitudinal Protocol for Polyarteritis Nodosa","The development and validation of accurate biological markers and predictors of disease activity and outcome in Polyarteritis Nodosa (PAN), a form a idiopathic vasculitis, would have a major positive impact  on the clinical care of patients with this rare disease, be an important advance in the design of clinical trials and feasibility of new drug","Not Applicable","Polyarteritis Nodosa","Prospective Longitudinal Cohort","Not Provided","Not Provided","28 phenotype datasets, 3245 variables, 28 documents, 71 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-09-06","2018-09-06","Arteritis; Arterial Inflammation; Arteritides; Inflammation of artery; Inflammation, Arterial; artery inflammation",""
"phs001549.v1.p1","Genome-Wide Association Study and Meta-Analysis of Ewing Sarcoma","We combined a set of 122 French Ewing sarcoma (EWS) cases from the Institut Curie, 19 EWS cases from the National Cancer Institute (NCI) Center for Cancer Research (CCR), and  29 EWS cases from the NCI Bone Disease and Injury Study. All EWS cases were confirmed by medical record review and the presence of a specific","Not Applicable","Sarcoma, Ewing","Case-Control","imputation_panel, HumanOmniExpress-12","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 13 variables, 2 molecular datasets, 170 subjects, 170 samples","","NCI","DS-BONE --- Disease-Specific (Bone Cancers), DS-ES --- Disease-Specific (Ewing's Sarcoma), GRU --- General Research Use","2018-08-31","2018-08-31","ES; Ewing Sarcoma; Ewing Tumor; Ewing tumour; Ewing's Sarcoma; Ewing's Tumor",""
"phs001247.v1.p1","GMKF: Kids First Pediatric Research Program on Congenital Cranial    Dysinnervation Disorders and Related Birth Defects","Goals of this ongoing study are to identify novel ""congenital cranial dysinnervation disorder"" (CCDD) genes and define the role of the wildtype and mutant genes in normal and aberrant development.  The umbrella term (CCDD) refers to congenital birth defects with malformation of one or more cranial nerves, typically resulting in limitations of","Not Applicable","Cranial Nerve Diseases","Family/Twin/Trios","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","6 phenotype datasets, 41 variables, 1 molecular datasets, 899 samples sequenced,  SRA, 899 subjects, 899 samples","","NCI","DS-EMD --- Disease-Specific (Eye Movement Disorders), DS-ELMD --- Disease-Specific (Eye and Lid Movement Disorders), DS-CCDD-RD --- Disease-Specific (Congenital Cranial Dysinnervation Disorders, RD)","2018-08-24","2018-08-24","Abducens Nerve Diseases; Facial Nerve Diseases; Oculomotor Nerve Diseases; Trochlear Nerve Diseases; Abducens Nerve Disease; Abducens nerve weakness",""
"phs001559.v1.p1","Contribution of Genetic Polymorphisms to the Abuse Liability of Oxycodone","The proposed study examined the prevalence of various genetic polymorphisms thought to be involved in opioid abuse among current heroin users. In addition to providing blood samples for genetics analysis,  participants completed a number of questionnaires that allowed us to learn detailed information about their current and history of opioid drug use.","Not Applicable","Heroin Dependence","Case Set","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 37 variables, 2 documents, 1 molecular datasets, 190 subjects, 183 samples","European (44), African (2), African American (82), Hispanic1 (40), Hispanic2 (2), Other (13)","NIDA","GRU-IRB --- General Research Use (IRB)","2018-08-23","2018-08-23","Addiction, Heroin; Dependence on diamorphine; Dependence, Heroin; Heroin Addiction",""
"phs001535.v1.p1","Offspring Sex Affects Placental DNA Methylation and Gene Expression in    Diabetics","Exposure to diabetes in utero is known to increase the offspring's likelihood of developing metabolic disease in adulthood, but the mechanisms involved are unknown. It has been proposed that early  exposure to hyperglycemia and elevated insulin levels may lead to malprogramming of the fetus leading to the subsequent development of diabetes and","Not Applicable","Diabetes, Gestational","Case-Control","HumanMethylation450","Methylation (CpG)","4 phenotype datasets, 15 variables, 1 molecular datasets, 34 subjects, 34 samples","","NIDDK","DS-T2D_GDM-IRB-COL --- Disease-Specific (Type 2 Diabetes or Gestational Diabetes Mellitus, IRB, COL)","2018-08-22","2018-08-22","Diabetes Mellitus, Gestational; Diabetes in Pregnancy; Diabetes mellitus arising in pregnancy; Diabetes, Pregnancy Induced; Diabetes, Pregnancy-Induced; GDM",""
"phs001487.v1.p1","Center Common Disease Genomics [CCDG] - CVD - TAICHI","The TaiChi consortium consists of 6 studies that collaborated initially in a large scale metabochip study, and became an ongoing consortium for studies of cardiometabolic disease in the Chinese population  in Taiwan. The six studies included the following: 1) SAPPHIRe (Stanford-Asian Pacific Program in Hypertension and Insulin Resistance), a family","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc37","SNP Genotypes (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets,  SRA, 770 subjects, 770 samples","","NHGRI","DS-MULTIPLE_DISEASES-IRB-COL-NPU-RD --- Disease-Specific (Cardiovascular, metabolic disease and associated risk factors, IRB, COL, NPU, RD)","2018-08-15","2018-08-15","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs001398.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular: The    Bangladesh Risk of Acute Vascular Events (BRAVE) Study","The Bangladesh Risk of Acute Vascular Events (BRAVE) study is a hospital-based case-control study in Bangladesh which was established by the Cardiovascular Epidemiology Unit of Cambridge University in the UK  in partnership with the key local cardiology and research centres to examine environmental, genetic, lifestyle and biochemical determinants of","Not Applicable","Myocardial Infarction","Prospective Longitudinal Cohort","WGS_markerset_grc38, WES_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 12 variables, 2 molecular datasets, 1991 subjects, 1991 samples","","NHGRI","GRU --- General Research Use","2018-08-09","2018-08-09","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart",""
"phs001238.v2.p1","Genetic Epidemiology Network of Arteriopathy (GENOA)","The Genetic Epidemiology Network of Arteriopathy (GENOA) is one of four networks in the NHLBI Family-Blood Pressure Program (FBPP). GENOA's long-term objective is to elucidate the genetics of target organ  complications of hypertension, including both atherosclerotic and arteriolosclerotic complications involving the heart, brain, kidneys, and","Not Applicable","Hypertension","Prospective Longitudinal Cohort","Human1M-Duo, Human660W-Quad","Not Provided","39 phenotype datasets, 1118 variables, 1 documents, 3462 subjects, 3039 samples, 1 substudies","","NHLBI","DS-ASC-RF-NPU --- Disease-Specific (Arteriosclerosis and its Risk Factors, NPU)","2018-08-08","2017-09-08","Aging; Arterial Pressure; Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Hyperglycemia",""
"phs001401.v2.p1","Genetic Epidemiology Network of Arteriopathy (GENOA): GWAS Studies","This substudy phs001401 GENOA GWAS Studies, contains genome-wide genetic variants on a subset of participants in the GENOA Cohorts. A total of 1385 European American and 1263 African American participants  from GENOA were genotyped on the Affymetrix Genome-Wide Human SNP Array 6.0 array using the protocol outlined by Affymetrix (Affymetrix, 2007) at the","Genetic Epidemiology Network of Arteriopathy (GENOA) (phs001238.v2.p1)","Hypertension","Prospective Longitudinal Cohort","Human1M-Duo, Human660W-Quad","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 1 molecular datasets, 3039 subjects, 3039 samples","European (1507), African (48), African American (1478), Hispanic1 (4), Other (2)","NHLBI","DS-ASC-RF-NPU --- Disease-Specific (Arteriosclerosis and its Risk Factors, NPU)","2018-08-08","2017-09-08","Aging; Arterial Pressure; Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Hyperglycemia",""
"phs001618.v1.p1","Dormant TILs and Sensitivity to Immune Checkpoint Blockers in Lung Cancer","The biological determinants of sensitivity and resistance to immune checkpoint inhibitors are not completely understood. To elucidate the role of intratumoral T-cells and its association with the tumor genomic landscape,  we perform paired whole exome DNA sequencing and multiplexed quantitative immunofluorescence (QIF) in pre-treatment samples from non-small cell lung","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","WES_markerset_grc37","WXS, SNP Genotypes (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 84 samples sequenced,  SRA, 49 subjects, 84 samples","","NCI","GRU --- General Research Use, DS-LCTC-MDS --- Disease-Specific (Lung Cancer and Thoracic Malignancies, MDS)","2018-08-03","2018-08-03","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001513.v1.p1","Mechanisms of Chemotherapy Resistance in T-ALL","The goals of this study are to unravel the molecular mechanisms underlying leukemic transformation and chemotherapy resistance in T-cell acute lymphoblastic leukemia (T-ALL). Towards this end, a cohort of T-ALL  lymphoblast specimens was collected at the time of initial T-ALL diagnosis (prior to the start of therapy) from children enrolled on contemporary","Not Applicable","Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","Prospective Longitudinal Cohort","Not Provided","Targeted-Capture, RNA-Seq","4 phenotype datasets, 17 variables, 109 samples sequenced,  SRA, 109 subjects, 109 samples","","NCI","DS-LEU --- Disease-Specific (Leukemia)","2018-08-02","2018-08-02","Acute T Cell Leukemia; Acute T Cell Lymphoblastic Leukemia; Acute T-Cell Leukemia; Acute T-Cell Leukemias; Acute T-Cell Lymphoblastic Leukemia; Acute T-Lymphocytic Leukemia",""
"phs001457.v1.p1","Accelerating Medicines Partnership-Rheumatoid Arthritis (AMP-RA)","This project is analyzing tissue and blood samples from people with RA and lupus to pinpoint genes, proteins, chemical pathways, and networks involved at a single cell level. This type  of modular, molecular analysis will allow comparisons across the diseases and will provide insights into key aspects of the disease process. The","Not Applicable","Arthritis, Rheumatoid","Case-Control","RNAseq_probe_set_grc37","RNA-Seq, Legacy Genotypes","4 phenotype datasets, 21 variables, 1 molecular datasets, 10001 samples sequenced,  SRA, 55 subjects, 10193 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2018-07-30","2018-07-30","Osteoarthritis; Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides; Degenerative Arthritis",""
"phs001566.v1.p1","Mutations in Breast Cancer Patient with Neurofibromatosis","Targeted genetic sequencing was performed on a 41-year-old female with metaplastic breast cancer (MBC) and neurofibromatosis type I (NF1). A custom panel capturing 279 cancer related genes was used to  identify a germline pathogenic SNV in NF1, as well several other somatic alterations. Single case report Related Genes: NF1 Principal Investigator:","Not Applicable","Neurofibromatosis 1","Case Set","target_markerset_grc37","SNP Genotypes (NGS)","4 phenotype datasets, 24 variables, 1 molecular datasets, 1 subjects, 2 samples","","NCI","GRU --- General Research Use","2018-07-25","2018-07-25","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000742.v1.p1","The Epilepsy Phenome/Genome Project","The Epilepsy Phenome/Genome Project (EPGP) is a large-scale, international, multi-institutional, collaborative research project, sponsored by the National Institute of Neurological Disorders and Stroke, designed to understand the genes that cause  common and rare epilepsies. The overall goal of EPGP is to collect detailed, high quality phenotypic (i.e., characteristics of individuals, from the","Not Applicable","Epilepsy","Family/Twin/Trios","Not Provided","Not Provided","19 phenotype datasets, 1866 variables, 5538 subjects","","NINDS","DS-EP --- Disease-Specific (Epilepsy)","2018-07-25","2018-07-25","Cryptogenic West Syndrome; Epilepsy, Idiopathic Generalized; Epileptic Encephalopathy, Early Infantile, 1; Epileptic Encephalopathy, Early Infantile, 2; Infantile Spasm; Lennox-Gastaut Syndrome",""
"phs001627.v1.p1","Single-Cell DNA Sequencing of AML with Droplet Microfluidics","We developed a novel microfluidic platform to automatically barcode genomic DNA from individual cancer cells. Using this approach, we sequenced acute myeloid leukemia (AML) tumors targeting up to 62 loci  relevant for the disease from thousands of cells. We predict that our platform will enable analysis of heterogeneity in AML and improve","Not Applicable","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","Not Provided","AMPLICON","4 phenotype datasets, 14 variables, 3 samples sequenced,  SRA, 1 subjects, 3 samples","","NHGRI","GRU --- General Research Use","2018-07-24","2018-07-24","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs001588.v1.p1","Low LDL Cholesterol and Increased Risk of Type 2 Diabetes","Lipid lowering therapy using HMG-CoA reductase inhibitors (statins) is associated with an approximately 9-12% increase in the risk of new-onset type 2 diabetes (T2DM). The risk of diabetes could be  increased by statins directly; however, genetic approaches have also implicated low LDL cholesterol (LDL-C) concentrations as a risk factor for T2DM.","Not Applicable","Diabetes Mellitus, Type 2","Cross-Sectional","Not Provided","Not Provided","2 phenotype datasets, 19 variables, 80286 subjects","","NIGMS","HMB-IRB-PUB-COL-NPU --- Health/Medical/Biomedical (IRB, PUB, COL, NPU)","2018-07-24","2018-07-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001556.v1.p1","BRAINcode","BRAINCODE: How Does the Human Genome Function in Specific Brain Neurons? The human brain comprises about 86 billion neurons whose function is central to human biology. How does the human  genome program high performing neurons and neural networks in response to experience? What subprograms does the genome express in physiologically and","Not Applicable","Parkinson Disease","Control Set","HumanOmniExpressExome-8","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 20 variables, 1 molecular datasets, 115 samples sequenced,  SRA, 100 subjects, 211 samples","","NINDS","HMB-COL --- Health/Medical/Biomedical (COL)","2018-07-19","2018-07-19","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs001306.v1.p1","Large Scale Meta-analysis Characterizes Genetic Architecture for Common    Psoriasis-associated Variants","The genotypes obtained from the Affymetrix Biobank Plus array constituted one of eight Caucasian datasets used in a large genome-wide meta-analysis of the association of psoriasis cases versus unaffected controls.  With a combined effective sample size of 39,000 individuals, this study identified 16 new psoriasis loci achieving genome-wide significance,","Not Applicable","Psoriasis","Case-Control","Axiom_PMRA","SNP Genotypes (Array)","4 phenotype datasets, 23 variables, 1 analyses, 1 molecular datasets, 11675 subjects, 11675 samples","","NIAMS","GRU-PUB --- General Research Use (PUB), DS-PSO-PUB --- Disease-Specific (Psoriasis, PUB)","2018-07-13","2018-07-13","Acropustulosis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis; Palmoplantar Pustulosis",""
"phs001595.v1.p1","Norepinephrine Transporter Blockade in Neurogenic Orthostatic Hypotension","The clinical picture of autonomic failure is dominated by disabling orthostatic hypotension. Recent developments in the understanding of the underlying pathophysiology of the discrete clinical forms of autonomic failure have  revealed that participants with multiple system atrophy (MSA) are characterized by impairment of central autonomic pathways crucial for autonomic","Not Applicable","Hypotension, Orthostatic","Prospective Longitudinal Cohort","Not Provided","Not Provided","3 phenotype datasets, 878 variables, 22 documents, 50 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-07-12","2018-07-12","Multiple System Atrophy; Pure Autonomic Failure; Decrease in blood pressure upon standing up; Hypotension, Postural; Orthostatic Hypotension; Orthostatic hypotension (disease)",""
"phs000298.v4.p3","Autism Sequencing Consortium (ASC)","The ARRA Autism Sequencing Collaboration was created in 2010 bringing together expert large-scale sequencing center (at the Baylor College of Medicine, PI Richard Gibbs and the Board Institute of MIT  and Harvard, PI Mark J. Daly) and a collaborative network of research labs focused on the genetics of autism (brought together by the Autism Genome","Not Applicable","Autistic Disorder","Case-Control","WES_markerset_grc36, WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 29 variables, 2 molecular datasets, 12767 samples sequenced,  SRA, 12772 subjects, 12772 samples","","NIMH","DS-ASD --- Disease-Specific (Autism Spectrum Disorder), GRU --- General Research Use, DS-AOND-MDS --- Disease-Specific (Autism or Other Neurodevelopment Conditions, MDS), HMB-MDS --- Health/Medical/Biomedical (MDS)","2018-07-12","2018-07-12","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NIH Autism -omics Studies (phs000764.v1.p1)"
"phs001490.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: BioMe Biobank Program","The 52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2  diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","Illumina_Exome_Array, WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS), SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 2 molecular datasets, 2572 samples sequenced,  SRA, 2587 subjects, 2587 samples","European (9), African (245), African American (2297), Hispanic1 (18), Hispanic2 (1), South Asian (4), Other (18)","NIDDK","HMB-MDS --- Health/Medical/Biomedical (MDS)","2018-07-09","2018-07-09","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001565.v1.p1","Pre-treatment Molecular Characterizations of Tumors from Patients Who    Receive Immune Checkpoint Therapies","Immune checkpoint inhibitors yield clinical benefit in many cancer types, but molecular predictors of response have not yet been robustly characterized. In this study, we pursued whole exome sequencing (WES)  of pre-treatment tumors from patients treated with immune checkpoint therapies - including monoclonal antibodies targeting programmed cell death-1","Not Applicable","Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 142 samples sequenced, 71 subjects, 142 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-BLADDERCA-MDS --- Disease-Specific (Bladder Cancer, MDS), DS-CATHLU-MDS --- Disease-Specific (Cancer -Thoracic and Lung, MDS), GRU --- General Research Use","2018-07-03","2018-07-03","Carcinoma, Transitional Cell; Lung Neoplasms; Urinary Bladder Neoplasms; Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001314.v1.p1","OPG in CAH","21-hydroxylase deficiency (21-OHD) is an inherited disorder that results from a mutation on the CYP21A2 gene. It affects the adrenal glands and is the most common cause of congenital adrenal  hyperplasia (CAH). 21-OHD CAH causes the body to produce an insufficient amount of cortisol and an excess of androgen, the type of hormone that","Not Applicable","Steroid 21-Hydroxylase","Case-Control","Not Provided","Not Provided","5 phenotype datasets, 97 variables, 4 documents, 17 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-07-02","2018-07-02","Not Provided",""
"phs000220.v2.p2","PAGE: Multiethnic Cohort (MEC)","The Multiethnic Cohort (MEC) has established a large biorepository of blood and urine (N 67,000) and cryopreserved lymphocytes (N 15,000) linked to extensive, prospectively collected risk factors (e.g., diet, smoking,  physical activity), biomarkers and clinical data for five racial/ethnic groups. This cohort study of over 215,000 men and women in Hawaii and","Not Applicable","Neoplasms","Case-Control","Cardio-Metabo_Chip, MEGA_Consortium_Array","SNP Genotypes (Array), WGS","4 phenotype datasets, 68 variables, 1 analyses, 4 molecular datasets, 70 samples sequenced, 27995 subjects, 37714 samples","European (105), African (129), East Asian (3648), African American (4958), Hispanic1 (200), Hispanic2 (55), Other Asian or Pacific Islander (2973), South Asian (1), Other (709)","NHGRI","DS-CRM-PUB-MDS --- Disease-Specific (Cancer Research and Methods, PUB, MDS), GRU --- General Research Use","2018-06-27","2018-06-27","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001538.v1.p1","NAMDC Patient Registry and Biorepository","Mitochondrial diseases are caused by dysfunction of the mitochondria, which are specialized compartments that are present in every cell of the body except red blood cells. Mitochondria generate more than  90% of the energy that the body needs to sustain life and support growth. When they fail, less and less energy is generated within the cell. This","Not Applicable","Mitochondrial Diseases","Methods","Not Provided","Not Provided","12 phenotype datasets, 610 variables, 1 documents, 541 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-06-25","2018-06-25","Ataxia Neuropathy Spectrum; Barth Syndrome; Brain Diseases; Coenzyme Q10 Deficiency; Cytochrome-c Oxidase Deficiency; Deafness, Aminoglycoside-Induced",""
"phs001318.v1.p1","Phase I/II Study of Revlimid/Azacitidine","This single-arm study design has been selected to investigate the safety of combination therapy with Vidaza&#x000ae; (azacitidine) and Revlimid&#x000ae; (lenalidomide) in a population of 18 participants with advanced MDS for  the Phase I portion, and 18 participants for the Phase II portion. The multi-center nature of the study should enhance the general applicability of","Not Applicable","Myelodysplastic Syndromes","Case Set","Not Provided","Not Provided","24 phenotype datasets, 3105 variables, 17 documents, 50 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-06-22","2018-06-22","Hematopoetic Myelodysplasia; Hematopoetic Myelodysplasias; Myelodysplasia, Hematopoetic; Myelodysplasias, Hematopoetic",""
"phs001316.v1.p1","TAPP-ATS","Andersen-Tawil syndrome (ATS) is an ion channel disorder that causes episodes of muscle weakness and potentially life-threatening heart arrhythmias. The majority of ATS cases are caused by a mutation in  the KCNJ2 gene, which is linked to potassium channels in the heart, brain, and skeletal muscle; other cases are presumed to be caused by an","Not Applicable","Andersen Syndrome","Clinical Trial","Not Provided","Not Provided","15 phenotype datasets, 651 variables, 11 documents, 3 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-06-22","2018-06-22","ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS; ANDERSEN-TAWIL SYNDROME; ATS; Andersen Cardiodysrythmic Periodic Paralysis; Andersen Tawil Syndrome; LONG QT SYNDROME 7",""
"phs001381.v1.p1","Gut Microbiome and Types of Colorectal Polyps","Colorectal cancer is a heterogeneous disease arising from at least two precursors-the conventional adenoma and the serrated polyp. This dataset was used to test the relationship of the gut microbiota  to specific colorectal polyp types. We included samples from two independent study populations based at colonoscopy clinics: the Centers for Disease","Not Applicable","Colonic Polyps","Cross-Sectional","Not Provided","AMPLICON","4 phenotype datasets, 43 variables, 667 samples sequenced, 667 subjects, 667 samples","","NCI","GRU --- General Research Use","2018-06-15","2018-06-15","Adenomatous Polyps","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001479.v1.p1","Heterozygous Missense Mutation in the Coiled-Coil Domain of STAT5B","We describe one patient with a heterozygous missense mutation in the coiled-coil domain of STAT5B. This patient presented with leukocytosis, lymphadenopathy, splenomegaly, necrotizing granulomas, hyper-IgM and autoimmune thrombocytopenia. Mutant STAT5B  protein was shown to dominantly-interfere with IL2-induced transcriptional activity resulting in global downregulation of STAT5-regulated genes in","Not Applicable","Lymphadenopathy","Case-Control","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 27 variables, 1 molecular datasets, 2 subjects, 3 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2018-06-13","2018-06-13","Granuloma; Hyper-IgM Immunodeficiency Syndrome; Purpura, Thrombocytopenic, Idiopathic; Splenomegaly; Hyper IgM; Hyper IgM Immunodeficiency Syndrome",""
"phs001317.v1.p1","Long-Term Outcome in Offspring and Mothers of Dexamethasone-Treated    Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Owing    to 21-Hydroxylase Deficiency","Summary The purpose of this study is to perform the first long-term follow up study both of adolescents and young adults with a history of prenatal treatment with dexamethasone and  of their mothers and to test for adverse medical or behavioral side effects. The emphasis will be on the outcome of this prenatal treatment in those","Not Applicable","Adrenal Hyperplasia, Congenital","Clinical Trial","Not Provided","Not Provided","8 phenotype datasets, 458 variables, 8 documents, 166 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-06-13","2018-06-13","",""
"phs001046.v1.p1","Genomic Architecture of Progression and Treatment Response in AMD","Numerous studies have identified common and rare genetic variation associated with risk of advanced age-related macular degeneration (AMD). However, risk is just one facet of AMD disease architecture. Both disease  progression and response to treatment are two critical elements that may also be influenced by genetic variation. The primary aim of this study was","Not Applicable","Macular Degeneration","Case-Control","HumanCoreExome-12, HumanCoreExome-24, WES_markerset_grc37","WXS, SNP Genotypes (Array), SNP Genotypes (NGS)","6 phenotype datasets, 28 variables, 1 molecular datasets, 204 samples sequenced,  SRA, 897 subjects, 915 samples","European (677), East Asian (1), African American (22), Hispanic1 (2), Hispanic2 (6), Other Asian or Pacific Islander (1), Other (2)","NEI","GRU-IRB --- General Research Use (IRB), DS-AMD-IRB --- Disease-Specific (Age-Related Macular Degeneration, IRB)","2018-06-06","2018-06-06","Degeneration, Macular; Degenerative disorder of macula; Dystrophy, Macular; Macular Degenerations; Macular Dystrophies; Macular Dystrophy",""
"phs000382.v3.p1","CIDR Whole Exome Sequencing in Joubert Syndrome","The purpose of this study is to identify new genetic causes of neurodevelopmental diseases (NDDs) in the Joubert syndrome (JS) spectrum. Joubert syndrome is a recessive disease characterized by cerebellar  vermis hypoplasia. Our currently funded NINDS award entitled ""Molecular characterization of Joubert syndrome"" seeks to identify new genetic causes","Not Applicable","Agenesis of Cerebellar Vermis","Prospective Longitudinal Cohort","WES_markerset_grc36, WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 17 variables, 4 documents, 3 molecular datasets, 106 samples sequenced,  SRA, 106 subjects, 106 samples","","NINDS","ARU --- Academic Research Use","2018-06-06","2018-06-06","COACH syndrome; Cerebellar Ataxias; Developmental Delay Disorders; Joubert syndrome 1; Spastic Paraplegia, Hereditary; Walker-Warburg Syndrome",""
"phs001198.v1.p1","Early Methamphetamine Abstinence: fMRI and Brain Function","This study included two groups of subjects, methamphetamine-dependent and healthy control participants, with the purpose of characterizing brain structure and cognition during the first month of abstinence from methamphetamine. Participants  were able to participate in one or both phases of the study. Methamphetamine abusers were held as inpatients and abstained from methamphetamine use","Not Applicable","Substance-Related Disorders","Case-Control","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 38 variables, 1 molecular datasets, 107 subjects, 93 samples","European (45), East Asian (2), African American (10), Hispanic1 (3), Hispanic2 (22), Other Asian or Pacific Islander (3), South Asian (1), Other (7)","NIDA","GRU --- General Research Use","2018-06-01","2018-06-01","Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001399.v1.p1","Development of Precision Neoadjuvant-Adjuvant Therapies","In clinical trials assessing neoadjuvant androgen deprivation therapy plus next-generation androgen receptor axis inhibitors, a subset of patients fail to demonstrate a complete pathologic response following treatment and radical prostatectomy.  We performed exome and transcriptome analyses on laser capture microdissected foci of residual tumor from these patients. Patients with residual","Not Applicable","Prostatic Neoplasms","Case Set","Not Provided","WXS","5 phenotype datasets, 23 variables, 50 samples sequenced,  SRA, 19 subjects, 69 samples","","NCI","DS-CA-NPU --- Disease-Specific (Cancer, NPU)","2018-05-31","2018-05-31","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs000862.v1.p1","Immune Response to IT ERT in Mucopolysaccharidosis I Patient","In this study we characterized the immune response to intrathecal (IT) recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis I (MPS I) subjects with spinal cord compression who had been previously treated  with intravenous rhIDU. Concentrations of specific antibodies and cytokines were measured in serum and cerebrospinal fluid (CSF) collected before","Not Applicable","Mucopolysaccharidosis I","Clinical Trial","Not Provided","Not Provided","5 phenotype datasets, 40 variables, 8 documents, 5 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-05-31","2018-05-31","Lysosomal Storage Diseases; Disease, Lysosomal Storage; Diseases, Lysosomal Storage; Disorder, Lysosomal Enzyme; Disorders, Lysosomal Enzyme; Enzyme Disorder, Lysosomal",""
"phs000234.v2.p2","Group Health/UW Aging and Dementia eMERGE Study","The ""Development and Use of Network Infrastructure for High-Throughput GWA Studies"" project is collaboration between Group Health Cooperative (GH), the University of Washington (UW), and the Fred Hutchinson Cancer Research  Center (FHCRC). It is one of 5 sites participating in The Electronic Medical Records and Genomics (eMERGE) Network funded by the National Human","Not Applicable","Dementia","Case-Control","Human660W-Quad","SNP Genotypes (Array)","5 phenotype datasets, 43 variables, 12 documents, 1 molecular datasets, 3756 subjects, 3746 samples","European (3498), African (5), East Asian (68), African American (128), Hispanic1 (10), Hispanic2 (18), Other Asian or Pacific Islander (13), South Asian (2), Other (4)","NHGRI","HR_MC --- Health Research - Marshfield Clinic, HR_VU --- Health/Medical/Biomedical (PUB, GSO), HR_GHS --- Health/Medical/Biomedical (PUB, GSO), AGING_GHS --- Dementia or Aging - Group Health Seattle, HR_MYO --- Health/Medical/Biomedical (PUB, GSO)","2018-05-30","2018-05-30","Aging; Aging, Biological; Biological Aging; AD; AD - Alzheimer's disease; ALZHEIMER DISEASE",""
"phs001313.v1.p1","Examining Genetic Differences Among People With 21-Hydroxylase Deficiency","CAH is a genetic steroidogenesis disorder. The most common form, 21OHD, leads to cortisol deficiency and, in turn, an excess of androgen, a hormone that promotes the development and maintenance  of male sex characteristics. As a result of this androgen excess, prepubescent males and newborn, prepubescent, and grown females exhibit mature","Not Applicable","Adrenal Hyperplasia, Congenital","Clinical Trial","Not Provided","Not Provided","8 phenotype datasets, 584 variables, 9 documents, 17 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-05-25","2018-05-25","",""
"phs001165.v1.p1","eMERGE: Children's Hospital of Philadelphia - WGS","The Center for Applied Genomics (CAG) is a specialized Center of Emphasis at the Children's Hospital of Philadelphia (CHOP) with the primary goal of translating basic research findings to medical  innovations. The mission of CAG is to develop new and better ways to diagnose and treat children affected by rare and complex medical disorders. We","Not Applicable","Pediatrics","Prospective Longitudinal Cohort","Not Provided","WGS","4 phenotype datasets, 13 variables, 900 samples sequenced, 900 subjects, 900 samples","","NHGRI","GRU --- General Research Use","2018-05-25","2018-05-25","Not Provided",""
"phs001315.v1.p1","GECCO: Detecting Common and Rare Genetic Loci and GxE Interactions in    Colorectal Cancer","COLON, Colorectal Cancer: Longitudinal Observational study on Nutritional and lifestyle factors that influence colorectal tumor recurrence, survival and quality of life: The COLON study is a multi-center prospective cohort study  to assess the role of diet and other lifestyle factors in cancer recurrence and survival among incident colorectal cancer patients in the","Not Applicable","Colorectal Neoplasms","Case-Control","HumanOmniExpressExome-8, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 24 variables, 2 molecular datasets, 8725 subjects, 9101 samples","European (8607), African (1), East Asian (17), African American (23), Hispanic1 (11), Hispanic2 (6), Other Asian or Pacific Islander (18), Other (42)","NCI","GRU --- General Research Use, DS-CC-NPU-GSO --- Disease-Specific (Colorectal Cancer, NPU, GSO), DS-CC-PUB-NPU --- Disease-Specific (Colorectal Cancer, PUB, NPU), HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-05-23","2018-05-23","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001311.v1.p1","Mexiletine in Non-Dystrophic Myotonia","Non-dystrophic myotonias are a group of rare muscle disorders caused by abnormalities in different muscle cell membrane proteins. Patients experience delayed muscle relaxation that causes impaired physical activity, stiffness, and  pain. Mexiletine has been shown to be beneficial for symptoms of myotonia in case reports of patients with non-dystrophic myotonia, however, current","Not Applicable","Myotonia","Case Set","Not Provided","Not Provided","20 phenotype datasets, 647 variables, 15 documents, 62 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-05-22","2018-05-22","Delayed relaxation of muscle fibers after contraction; Delayed relaxation of muscle fibres after contraction; Myotonias; Myotonus; Tonic spasm of muscle",""
"phs001309.v1.p1","MICEPAP Trial","The purpose of this study is to (1) compare a technically improved assay with an existing assay used to measure serum anti-GM-CSF antibodies in stored serum samples previously obtained from  patients diagnosed with either primary, secondary, congenital or idiopathic pulmonary alveolar proteinosis (PAP), other chronic diseases or","Not Applicable","Pulmonary Alveolar Proteinosis","Clinical Trial","Not Provided","Not Provided","5 phenotype datasets, 384 variables, 13 documents, 159 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-05-22","2018-05-22","Not Provided",""
"phs001484.v1.p1","Pharmacogenomics of HIV Therapy - Atazanavir Bilirubin-related Side    Effects","This is an evaluation of genetic associations with atazanavir (ATV) discontinuation for bilirubin-related causes within 12 months of treatment. Patients were treated at an HIV primary care clinic in Nashville  TN from 1998 to 2012. A previously known SNP in UGT1A1 (rs887829) was used to define metabolizer genotypes (extensive, intermediate, slow","Not Applicable","Drug-Related Side Effects and Adverse Reactions","Case-Control","HumanCoreExome-12","SNP Genotypes (Array)","4 phenotype datasets, 54 variables, 1 molecular datasets, 321 subjects, 321 samples","","NIAID","DS-HIV-IRB --- Disease-Specific (Human Immunodeficiency Virus, IRB)","2018-05-18","2018-05-18","Jaundice; ADR; ADR - Adverse drug reaction; Adverse Drug Event; Adverse Drug Events; Adverse Drug Experience",""
"phs000607.v3.p2","Neurodevelopmental Genomics: Trajectories of Complex Phenotypes","This study is a collaboration between the Center for Applied Genomics (CAG) at Children's Hospital of Philadelphia (CHOP) and the Brain Behavior Laboratory at the University of Pennsylvania (Penn). The  cohort consists of youths aged 8-21 years who consulted the CHOP network and volunteered to participate in genomic studies of complex pediatric","Not Applicable","Mental Processes","Prospective Longitudinal Cohort","WES_markerset_grc37, Human610-Quad, Affymetrix_WG_Array, HumanHap550, Axiom_Array, HumanOmniExpress-12, Human1M-Duo, HumanOmniExpressExome-8","SNP Genotypes (Array)","7 phenotype datasets, 936 variables, 3 documents, 2 molecular datasets, 1598 images, 9496 subjects, 9267 samples","European (5285), African (55), East Asian (72), African American (3257), Hispanic1 (300), Hispanic2 (85), Other Asian or Pacific Islander (55), South Asian (44), Other (121)","NIMH","GRU-NPU --- General Research Use (NPU)","2018-05-17","2018-05-17","Not Provided",""
"phs001557.v1.p1","Mosaic Chromosomal Aneuploidy","Mosaic chromosomal aneuploidy occurs when only a subset of cells carries an abnormal number of chromosomes. Mosaic aneuploidy has been reported in multiple types of diseases. Here we have developed  a new sequencing-based approach to identify, characterize and quantify mosaic aneuploidy events in human tissue samples. This ongoing study has begun","Not Applicable","Hemihyperplasia, Isolated","Case-Control","target_markerset_grc37, WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS), Targeted-Capture","4 phenotype datasets, 19 variables, 1 molecular datasets, 3 samples sequenced, 2 subjects, 3 samples","","NICHD","GRU-PUB --- General Research Use (PUB)","2018-05-16","2018-05-16","Hemihyperplasia; ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders",""
"phs001396.v1.p1","Genetics of Pigmentation in Eastern and Southern African Populations    Study","The goal of this study was to identify genes and loci associated with pigmentation in African populations. It comprises 1,593 participants from Ethiopia, Tanzania, and Botswana. Sexes are evenly represented  (768 males and 825 females) and self reported ages ranged from 18 to 103. Mean age was used for individuals without ages. For each participant, a DSM","Not Applicable","Skin Pigmentation","Cross-Sectional","HumanOmni2.5-8, WGS_markerset_grc37","SNP Genotypes (NGS), SNP Genotypes (Array), WGS","4 phenotype datasets, 14 variables, 1 molecular datasets, 135 samples sequenced,  SRA, 1573 subjects, 1573 samples","","NCI","GRU-NPU --- General Research Use (NPU)","2018-05-15","2018-05-15","Not Provided",""
"phs001344.v1.p1","GnRH Agonist-Induced Ovarian Suppression and Ovarian Steroids in PMDD and    Controls","In this study, lymphoblastoid cell line cultures (LCLs) from women with premenstrual dysphoric disorder (PMDD) and asymptomatic controls were compared via whole-transcriptome sequencing (RNA-seq) during untreated (ovarian steroid-free) conditions and  after estradiol and progesterone treatment. In untreated LCLs, pathway analysis of the LCL transcriptome revealed, among others, over-expression of","Not Applicable","Premenstrual Dysphoric Disorder","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 52 samples sequenced,  SRA, 22 subjects, 52 samples","","NIMH","GRU --- General Research Use","2018-05-15","2018-05-15","Disorder, Premenstrual Dysphoric; Dysphoric Disorder, Premenstrual; Premenstrual Dysphoric Syndrome; Syndrome, Premenstrual Dysphoric","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000788.v2.p3","Research Program on Genes, Environment and Health (RPGEH)","The Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) is a resource developed to facilitate research on genetic and environmental factors on common diseases and healthy aging. The  RPGEH resource links biospecimens, health surveys, and comprehensive electronic medical records on broadly consented adult members of Kaiser","Not Applicable","Aging","Prospective Longitudinal Cohort","Axiom_GW_EUR, Axiom_GW_AFR, Axiom_GW_EAS, Axiom_GW_LAT, WGS_markerset_grc37","Not Provided","3 phenotype datasets, 12 variables, 78423 subjects, 78423 samples, 2 substudies","","NIA","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2018-05-15","2018-05-15","Anemia, Iron-Deficiency; Anxiety Disorders; Asthma; Bacterial Infections and Mycoses; Cardiovascular Diseases; Dermatomycoses",""
"phs000786.v2.p3","RPGEH WGS Pilot Study","The Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) is a resource developed to facilitate research on genetic and environmental factors on common diseases and healthy aging. The  RPGEH resource links biospecimens, health surveys, and comprehensive electronic medical records on broadly consented adult members of Kaiser","Research Program on Genes, Environment and Health (RPGEH) (phs000788.v2.p3)","Environment and Public Health","Prospective Longitudinal Cohort","WGS_markerset_grc37","SNP Genotypes (NGS), SNP Genotypes (NGS)","1 phenotype datasets, 3 variables, 1 molecular datasets,  SRA, 4 subjects, 4 samples","","NIA","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2018-05-15","2018-05-15","Not Provided",""
"phs000674.v3.p3","Resource for Genetic Epidemiology Research on Aging (GERA)","The Resource for Genetic Epidemiology Research on Aging (GERA) Cohort was created by a RC2 ""Grand Opportunity"" grant that was awarded to the Kaiser Permanente Research Program on Genes, Environment,  and Health (RPGEH) and the UCSF Institute of Human Genetics (AG036607; Schaefer/Risch, PIs). The RC2 project enabled a genome-wide SNP genotyping","Research Program on Genes, Environment and Health (RPGEH) (phs000788.v2.p3)","Aging","Prospective Longitudinal Cohort","Axiom_GW_EUR, Axiom_GW_AFR, Axiom_GW_EAS, Axiom_GW_LAT","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 79 variables, 6 documents, 2 molecular datasets, 78419 subjects, 78419 samples","European (66620), African (42), East Asian (3751), African American (1913), Hispanic1 (390), Hispanic2 (3462), Other Asian or Pacific Islander (1330), South Asian (365), Other (546)","NIA","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2018-05-15","2018-05-15","Anemia, Iron-Deficiency; Anxiety Disorders; Asthma; Bacterial Infections and Mycoses; Cardiovascular Diseases; Dermatomycoses",""
"phs001503.v1.p1","Women's Interagency HIV Study (WIHS)","The Women's Interagency HIV Study (WIHS), a multicenter, prospective study, was established in August 1993 to carry out comprehensive investigations of the impact of HIV infection and its clinical, laboratory,  and psychosocial effects in women. The purpose of this study is to collect and evaluate these data from HIV infected and at-risk women to better","Not Applicable","HIV","Prospective Longitudinal Cohort","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 26 variables, 3 documents, 1 molecular datasets, 864 subjects, 864 samples","European (95), African (26), African American (693), Hispanic1 (17), Hispanic2 (18), Other Asian or Pacific Islander (3), South Asian (1), Other (11)","NIDA","HMB-IRB --- Health/Medical/Biomedical (IRB)","2018-05-14","2018-05-14","Cardiovascular Diseases; Substance-Related Disorders; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs001231.v2.p1","NeuroLINCS","The NeuroLINCS Center is part of the NIH Common Fund's Library of Integrated Network-based Cellular Signatures (LINCS) program, which aims to characterize how a variety of human cells, tissues and  the entire organism respond to perturbations by drugs and other molecular factors. As Part of the LINCS program, the NeuroLINCS study concentrates on","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","WGS_markerset_grc37","SNP Genotypes (NGS), RNA-Seq, OTHER, WGS","4 phenotype datasets, 37 variables, 1 molecular datasets, 148 samples sequenced,  SRA, 20 subjects, 148 samples","","NINDS","GRU --- General Research Use, DS-NNMC --- Disease-Specific (neurologic and neuromuscular conditions)","2018-05-11","2017-04-24","Spinal Muscular Atrophies of Childhood; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000304.v3.p1","Genes and Blood Clotting Study (GABC)","Objectives: Use genome-wide approaches to identify genetic variants that influence common thrombosis and hemostasis factors, as well as selected common human traits. Design/Methods: The GABC study was a prospective sibling  cohort design. Siblings were recruited by targeted email to the undergraduate and graduate student email lists at the University of Michigan. Healthy","Not Applicable","von Willebrand Diseases","Family/Twin/Trios","HumanOmni1-Quad","SNP Genotypes (imputed), SNP Genotypes (Array)","5 phenotype datasets, 105 variables, 1 documents, 2 molecular datasets, 1179 subjects, 1218 samples","European (953), African (5), East Asian (78), African American (34), Hispanic1 (8), Hispanic2 (27), Other Asian or Pacific Islander (18), South Asian (35), Other (8)","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2018-05-11","2016-05-28","Acne Vulgaris; Dental Caries; Epistaxis; Eye Diseases; Flatfoot; Freckles",""
"phs001219.v1.p1","Detection of Genes Predisposing to Hematologic Malignancies","We have been conducting genetic studies on families at high risk of different hematologic malignancies, in order to define the related tumors in the families, define precursor and other related  conditions, and map and identify susceptibility genes. We have focused mainly on four types of lymphoid malignancies: chronic lymphocytic leukemia","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Family/Twin/Trios","Not Provided","WXS","5 phenotype datasets, 26 variables, 475 samples sequenced,  SRA, 475 subjects, 475 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2018-05-10","2018-05-10","Hodgkin Disease; Leukemia, Hairy Cell; Leukemia, Myelomonocytic, Juvenile; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia; CHL","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001555.v1.p1","CRIM Status and Follow-up of Individuals with Pompe Disease","Infantile-onset Pompe disease is an inherited disorder that is normally diagnosed within the first months of life. It is caused by lack of or defect in an enzyme (a special  protein that carries out normal chemical reactions within the body) called acid alpha-glucosidase (GAA). GAA normally breaks down glycogen (stored","Not Applicable","Glycogen Storage Disease Type II","Prospective Longitudinal Cohort","Not Provided","Not Provided","3 phenotype datasets, 91 variables, 3 documents, 144 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-05-08","2018-05-08","Acid Maltase Deficiency; Pompe Disease; ACID ALPHA-GLUCOSIDASE DEFICIENCY; ACID ALPHA-GLUCOSIDASE DEFICIENCY, INFANTILE-ONSET; ACID MALTASE DEFICIENCY, INFANTILE-ONSET; ALPHA-1,4-GLUCOSIDASE DEFICIENCY",""
"phs001156.v2.p1","The EVE Asthma Genetics Consortium: Building Upon GWAS","The EVE Asthma Genetics Consortium comprises U.S. investigators who have conducted genome-wide association studies (GWAS) of asthma; the main objective is to combine results of individual studies to increase the  overall power to identify loci for asthma and asthma-associated traits. The consortium includes investigators at 9 U.S. institutions with GWAS","Not Applicable","Asthma","Case-Control","Not Provided","WGS","4 phenotype datasets, 19 variables, 4 analyses, 1 samples sequenced, 296 subjects, 296 samples","","NHLBI","GRU-NPU --- General Research Use (NPU)","2018-05-08","2018-05-08","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs001341.v1.p1","NextGen Consortium: iPS Derived Hepatocytes Study (PhLiPS Study)","The goal of the PhLiPS study is to create a library of induced pluripotent stem cell (iPSC) lines and iPSC-derived hepatocytes of diverse genotypes for use in metabolic profiling and  interrogating lipid phenotypes. These cell lines were created as a part of the Next Generation Genetic Association Studies (Next Gen) Program, which","Not Applicable","Lipids","Prospective Longitudinal Cohort","HumanCoreExome-24","SNP Genotypes (Array), RNA-Seq","5 phenotype datasets, 28 variables, 1 molecular datasets, 172 samples sequenced, 90 subjects, 264 samples","European (46), African (4), African American (35), Hispanic2 (2), South Asian (2)","NHLBI","GRU --- General Research Use","2018-05-04","2018-05-04","Dyslipidemias; Dyslipidemia","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs001075.v1.p1","Sequencing to Guide Cancer Care (CanSeq)","The overall goal of the CanSeq U01 project is to study the impact of whole-exome sequencing (WES) on the clinical care of cancer patients and oncology provider practices. The aims  of Project 1 are to implement and establish the feasibility of germline and somatic WES in patients with advanced solid tumors (lung and colon); to","Not Applicable","Neoplasms","Case Set","other","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets, 332 samples sequenced,  SRA, 166 subjects, 332 samples","","NHGRI","GRU --- General Research Use","2018-05-04","2018-05-04","Lung Neoplasms; ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung",""
"phs001365.v1.p1","Neoadjuvant Chemotherapy +/- Bevacizumab Pharmacogenomics","Neoadjuvant chemotherapy (NAC) for breast cancer is widely employed. We performed genome-wide association studies (GWAS) to determine if germline genetic variability was associated with benefits, in terms of pathological complete  response (pCR), disease-free survival (DFS), and overall survival (OS), in patients entered on the NSABP B-40 NAC (National Surgical Adjuvant Breast","Not Applicable","Breast Neoplasms","Case-Control","HumanOmniExpressExome-8","SNP Genotypes (Array)","4 phenotype datasets, 31 variables, 1 molecular datasets, 920 subjects, 920 samples","European (676), African (7), East Asian (6), African American (111), Hispanic1 (33), Hispanic2 (64), Other Asian or Pacific Islander (10), South Asian (3), Other (10)","NIGMS","GRU --- General Research Use","2018-05-01","2018-05-01","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001289.v1.p1","Characteristics of Andersen-Tawil Syndrome","Andersen-Tawil Syndrome (ATS) is a rare, genetic disorder that causes episodes of muscle weakness, potentially life-threatening changes in heart rhythm, and developmental abnormalities. Disease symptoms can vary, the cause of  some ATS cases remains unknown, and no specific treatment has been identified. The purpose of this multi-site study is to better characterize ATS,","Not Applicable","Andersen Syndrome","Prospective Longitudinal Cohort","Not Provided","Not Provided","16 phenotype datasets, 1814 variables, 15 documents, 29 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-05-01","2018-05-01","ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS; ANDERSEN-TAWIL SYNDROME; ATS; Andersen Cardiodysrythmic Periodic Paralysis; Andersen Tawil Syndrome; LONG QT SYNDROME 7",""
"phs001197.v1.p1","Neural Systems, Inhibitory Control, and Methamphetamine Dependence","The Neural Systems, Inhibitory Control, and Methamphetamine Dependence study started in 2011 and is currently finishing data collection for its last participants. The study included methamphetamine abusing individuals and healthy  control participants aged 18-55 years. Participants who qualified over the telephone were scheduled to visit the London Laboratory at the UCLA Semel","Not Applicable","Substance-Related Disorders","Case-Control","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 37 variables, 1 molecular datasets, 193 subjects, 188 samples","European (63), African (2), East Asian (3), African American (30), Hispanic1 (3), Hispanic2 (69), Other Asian or Pacific Islander (8), South Asian (1), Other (9)","NIDA","GRU --- General Research Use","2018-05-01","2018-05-01","Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001291.v1.p1","Neoadjuvant Trastuzumab Response in Breast Cancer","HER2 (ERBB2) gene amplification and overexpression are present in 15-30% of invasive breast cancers. While HER2-targeted agents such as trastuzumab are effective treatments, therapeutic resistance remains a concern in HER2-positive  breast cancer with 40-50% of patients having residual disease after neoadjuvant treatment with chemotherapy and trastuzumab. To investigate features","Not Applicable","Breast Neoplasms","Case Set","Not Provided","WXS, RNA-Seq, WGS","4 phenotype datasets, 13 variables, 234 samples sequenced, 48 subjects, 234 samples","","NHGRI","DS-CA --- Disease-Specific (Cancer)","2018-04-24","2018-04-24","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001458.v1.p1","Deep Sequencing Studies for Cannabis and Stimulant Dependence","Cannabis and stimulants are among the most widely used illicit drug in the United States, and their use is associated with substantial physical and psychiatric sequelae. Twin studies have shown  a substantial genetic component to the etiology of cannabis and stimulant use disorders, but, genome-wide association studies using genotype data","Not Applicable","Marijuana Abuse","Family/Twin/Trios","Not Provided","WGS","5 phenotype datasets, 62 variables, 1887 samples sequenced, 2573 subjects, 1887 samples","","NIDA","DS-ADMH-IRB --- Disease-Specific (Addiction and Mental Health, IRB)","2018-04-20","2018-04-20","Substance-Related Disorders; Tobacco Use Disorder; Addictive cannabis use; Addictive marijuana use; Cannabis addiction; Dependence, Cannabis",""
"phs001522.v1.p1","Germline De Novo Mutations with Parent of Origin in WGS Trios","This study is part of the 'First 1,000 Days of Life and Beyond' study at the Inova Translational Medicine Institute. Whole-genome sequencing data from 1,291 parent-offspring trios was used to  study the properties of clustered de novo mutations. The maternal clusters were found to be enriched in regions with accelerated maternal mutation","Not Applicable","Parent-Child Relations","Family/Twin/Trios","WGS_markerset_grc37","SNP Genotypes (NGS)","5 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 3813 subjects, 1291 samples","","NICHD","GRU-IRB --- General Research Use (IRB)","2018-04-19","2018-04-19","Not Provided",""
"phs000783.v2.p1","Gene Mutation and Rescue in Human Congenital Diaphragmatic Hernia (CDH)","Congenital diaphragmatic hernia (CDH) is a common and severe birth defect characterized by structural defects of the diaphragm and by pulmonary hypoplasia. Congenital diaphragmatic hernia patient may present either as  an isolated phenotype or together with other congenital anomalies in a complex phenotype. Despite the clinical significance of CDH, the underlying","Not Applicable","Hernias, Diaphragmatic, Congenital","Prospective Longitudinal Cohort","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","5 phenotype datasets, 27 variables, 2 molecular datasets, 471 samples sequenced,  SRA, 469 subjects, 471 samples","","NICHD","DS-CDH-IRB-COL --- Disease-Specific (Congenital Diaphragmatic Hernia, IRB, COL)","2018-04-18","2018-04-18","Abnormalities, Multiple; Congenital Abnormalities; Hypertension, Pulmonary; Lung agenesis; CONGENITAL ANOMALIES; MCA",""
"phs000697.v1.p1","Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome","In people with MDS, the bone marrow stops making healthy blood cells and instead produces poorly functioning, malformed, and immature blood cells. This can lead to anemia resulting from too  few healthy red blood cells, infection resulting from too few healthy white blood cells, and bleeding resulting from too few healthy platelets. The","Not Applicable","Myelodysplastic Syndromes","Clinical Trial","Not Provided","Not Provided","16 phenotype datasets, 2379 variables, 9 documents, 39 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-04-18","2018-04-18","Hematopoetic Myelodysplasia; Hematopoetic Myelodysplasias; Myelodysplasia, Hematopoetic; Myelodysplasias, Hematopoetic",""
"phs001529.v1.p1","Single-Cell RNA-Seq of Rheumatoid Arthritis Synovial Tissue","Droplet-based single-cell RNA-seq has emerged as a powerful technique for massively parallel cellular profiling. While these approaches offer the exciting promise to deconvolute cellular heterogeneity in diseased tissues, the lack  of cost-effective, reliable, and user-friendly instrumentation has hindered widespread adoption of droplet microfluidic techniques. To address this,","Not Applicable","Arthritis, Rheumatoid","Methods","RNAseq_probe_set_grc37","RNA Seq (NGS), RNA-Seq","3 phenotype datasets, 13 variables, 1 molecular datasets, 17 samples sequenced, 6 subjects, 20287 samples","","NIAMS","HMB-MDS --- Health/Medical/Biomedical (MDS)","2018-04-16","2018-04-16","",""
"phs001108.v1.p1","Assessing Neural Mechanisms using MRI and Magnetic Resonance Spectroscopy","Urea cycle disorders represent a group of rare inborn errors of metabolism that lead to accumulation of ammonia, a toxic product of protein metabolism. Individuals with urea cycle disorders cannot  metabolize the ammonia that accumulates due to enzyme deficiency. The symptoms of these disorders may present at birth, childhood or adulthood","Not Applicable","Urea Cycle Disorders, Inborn","Case-Control","Not Provided","Not Provided","9 phenotype datasets, 633 variables, 6 documents, 46 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-04-16","2018-04-16","Disorder of urea cycle; Disorder, Urea Cycle; Disorders, Urea Cycle; Inborn Urea Cycle Disorder; UCD; Urea Cycle Disorder",""
"phs001411.v1.p1","Action to Control Cardiovascular Risk in Diabetes (ACCORD)","The Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial was a randomized, multicenter, double 2 x 2 factorial design study involving 10,251 middle-aged and older participants with type-2  diabetes who are at high risk for CVD events because of existing CVD or additional risk factors. The purpose of ACCORD was to determine if intensive","Not Applicable","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","Axiom_Biobank_plus, HumanOmniExpressExome-8","SNP Genotypes (Array)","3 phenotype datasets, 10 variables, 2 molecular datasets, 6385 subjects, 6385 samples","European (4418), African (48), East Asian (186), African American (853), Hispanic1 (207), Hispanic2 (160), Other Asian or Pacific Islander (39), South Asian (96), Other (52)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), DS-CDKD-IRB --- Disease-Specific (Cardiovascular Disease, Diabetes and Kidney Disease, IRB)","2018-04-12","2018-04-12","Cardiovascular Diseases; Diabetic Nephropathies; Diabetic Retinopathy; Dyslipidemias; Hypertension; Myocardial Infarction",""
"phs001553.v1.p1","Charcot-Marie-Tooth Disease Pediatric Scale","Information about how different forms of CMT affect children is not readily available because there are not good methods to measure impairment of children with CMT. The purpose of this  project is to develop and test such a method and to then test this scale to ensure that it is an effective measurement of impairment of CMT in","Not Applicable","Charcot-Marie-Tooth Disease","Prospective Longitudinal Cohort","Not Provided","Not Provided","3 phenotype datasets, 21 variables, 1 documents, 208 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-04-10","2018-04-10","Atrophies, Peroneal Muscular; Atrophy, Muscular, Peroneal; Atrophy, Peroneal Muscular; CMT; CMT - Charcot-Marie-Tooth disease; CMT/HMSN",""
"phs000695.v1.p1","A Phase I/II Trial of Sirolimus (Rapamune&#x000ae;) and Cyclosporine in Patients    with Refractory Aplastic Anemia","The most successful treatment for aplastic anemia is bone marrow transplantation. However, few patients are eligible for this procedure. For others, treatment usually consists of immunosuppressive agents, such as antithymocyte  globulin (ATG) and cyclosporine. Unfortunately, even with immunosuppressive therapy, relapse is common. New combinations of medications may offer","Not Applicable","Anemia, Aplastic","Clinical Trial","Not Provided","Not Provided","16 phenotype datasets, 707 variables, 9 documents, 17 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-04-06","2018-04-06","Aplastic Anemia",""
"phs001512.v1.p1","Platform for Assessing Immune Response Signatures in Healthy Human    Subjects","RNA sequencing (RNAseq) of peripheral blood lymphocytes was used to develop a means to assess immune function in a way that can be used in discovery science and applied to  patients individually in clinical settings. The premise is that profiles of RNA present in immune cells is reflective of the combined influence of","Not Applicable","Immune System Phenomena","Methods","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 67 samples sequenced,  SRA, 17 subjects, 68 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2018-04-05","2018-04-05","Not Provided",""
"phs001463.v1.p1","Differential Transcription Start Site Usage in Brain-Related Samples","RNA-Seq is an effective method to study the transcriptome, but specialized methods are required to identify 5' ends of transcripts. Several published strategies exist for this specific purpose, but their  relative merits have not been systematically analyzed. Here, we directly compare the performance of six such methods - testing five with cellular RNA","Not Applicable","Brain","Control Set","Not Provided","RNA-Seq","3 phenotype datasets, 12 variables, 8 samples sequenced,  SRA, 8 subjects, 8 samples","","NIMH","GRU --- General Research Use","2018-04-02","2018-04-02","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000698.v1.p1","The Use of High Resolution Chest Computed Tomography in Alpha-1    Antitrypsin Deficiency (QUANTUM-1)","AAT deficiency is a genetic disorder associated with emphysema. Spirometry, the lung function test that measures how well the lungs exhale air, is used to diagnose and track the progression  of emphysema. Some studies have suggested that forced expiratory volume in 1 second (FEV1) measurements, a type of spirometry test, may lack accuracy","Not Applicable","alpha 1-Antitrypsin Deficiency","Prospective Longitudinal Cohort","Not Provided","Not Provided","22 phenotype datasets, 1170 variables, 19 documents, 51 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-03-30","2018-03-30","",""
"phs000605.v1.p1","Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus    Trial (The MILES Trial)","Lymphangioleiomyomatosis (LAM) is an uncommon, progressive, cystic lung disease that predominantly affects young women. It is believed to be caused by defects within cellular pathways that regulate nutrient uptake, cell  size, cell migration, and cell proliferation. The disease is caused by mutations in tuberous sclerosis complex (TSC) genes. Individuals with","Not Applicable","Lymphangioleiomyomatosis","Clinical Trial","Not Provided","Not Provided","20 phenotype datasets, 3727 variables, 37 documents, 111 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-03-30","2018-03-30","LAM; LYMPHANGIOMYOMATOSIS; Lymphangioleiomyomatoses; Lymphangioleiomyomatosis, somatic; Lymphangiomyomatoses; TSC1-Related Lymphangioleiomyomatosis",""
"phs001195.v1.p1","A Study to Assess the Cardiovascular, Cognitive, and Subjective Effects    of Atomoxetine in Combination with Intravenous Methamphetamine","The Study to Assess the Cardiovascular, Cognitive, and Subjective Effects of Atomoxetine in Combination with Intravenous Methamphetamine started in 2007 and ended in 2011. It was a small pilot study  that included methamphetamine abusing individuals and healthy control participants aged 18-50 years. Participants who qualified over the telephone","Not Applicable","Substance Abuse, Intravenous","Case-Control","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 37 variables, 3 documents, 1 molecular datasets, 13 subjects, 13 samples","European (6), East Asian (1), African American (2), Hispanic1 (1), Hispanic2 (2), Other (1)","NIDA","GRU --- General Research Use","2018-03-29","2018-03-29","Drug Users; Drug User, IV; Drug User, Intravenous; Drug Users, IV; Drug Users, Intravenous; IDU - Intravenous drug user","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001488.v1.p1","Creatine in Huntington's Disease (HD) (CREST-E)","This is a multi-center, randomized, double-blind, placebo-controlled trial of creatine monohydrate involving 553 ambulatory subjects with HD who are not requiring skilled care or institutionalization. Eligible subjects were randomized to  receive up to 40 grams daily of creatine monohydrate or matching placebo. Randomization will be followed by a Titration Phase, a Maintenance Phase,","Not Applicable","Huntington Disease","Clinical Trial","Not Provided","Not Provided","61 phenotype datasets, 767 variables, 50 documents, 553 subjects","","NINDS","DS-NDR-COL --- Disease-Specific (Neurological Disorders Research, COL)","2018-03-26","2018-03-26","Chorea, Chronic Progressive Hereditary (Huntington); Chorea, Huntington; Chorea, Huntington's; Chronic Progressive Hereditary Chorea (Huntington); Chronic progressive chorea; Chronic progressive hereditary chorea",""
"phs001391.v1.p1","OncoArray: Prostate Cancer","Original description of the study: From ELLIPSE (linked to the PRACTICAL consortium), we contributed 78,000 SNPs to the OncoArray. A large fraction of the content was derived from the GWAS  meta-analyses in European ancestry populations (overall and aggressive disease; 27K SNPs). We also selected just over 10,000 SNPs from the","Not Applicable","Prostatic Neoplasms","Case-Control","OncoArray","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 99622 subjects, 99622 samples","European (87794), African (1216), East Asian (390), African American (6686), Hispanic1 (361), Hispanic2 (2309), Other Asian or Pacific Islander (212), South Asian (276), Other (378)","NCI","GRU --- General Research Use, CADM --- Cancer in all age groups, other diseases in adults only, and methods, CHRONIC --- Chronic Diseases (including Cancer), Methods, DS-BCEMOPCA-NPU-MDS --- Disease-Specific (Breast, Colorectal, Endometrial, Melanoma, Ovarian, and/or Prostate Cancer, NPU, MDS), DS-CA --- Disease-Specific (Cancer), DS-CA-MDS-GSO --- Disease-Specific (Cancer, MDS, GSO), DS-CA-NPU --- Disease-Specific (Cancer, NPU), DS-CA-NPU-GSO --- Disease-Specific (Cancer, NPU, GSO), DS-PC-MDS-GSO --- Disease-Specific (Prostate Cancer, MDS, GSO), DS-PCP --- Disease-Specific (Prostate Cancer Predisposition), GRU-IRB --- General Research Use (IRB), DS-PC-PUB-MDS --- Disease-Specific (Prostate Cancer, PUB, MDS), GRU-NPU --- General Research Use (NPU), MHNSI-MDS --- Men's Health and Nutrition in Serious Illnesses (MDS), PC-RITPC --- Prostate Cancer or Radiation-induced Toxicity in Prostate Cancer Patients, HMB-PUB --- Health/Medical/Biomedical (PUB), DS-CA-PUB --- Disease-Specific (Cancer, PUB), DS-CA-MDS --- Disease-Specific (Cancer, MDS), EPIMEDCA --- Epidemiological and Medical Research on Cancer, Methods, DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS), PC-MDS-NOCTRL --- Prostate Cancer, Methods, Non-control, HMB-NPU --- Health/Medical/Biomedical (NPU), DS-CHDSAD-MDS --- Disease-Specific (Cancer, Heart Disease, Stroke, Alzheimer Disease, and Diabetes, MDS), HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), DS-PC --- Disease-Specific (Prostate Cancer), HMB --- Health/Medical/Biomedical","2018-03-21","2018-03-21","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001516.v1.p1","Phenotype Risk Score Study of Rare Variants","This study was designed to assess the phenotypic effects of rare variants. Rare variants are difficult to study in a high-throughput manner because most cohorts are underpowered to detect associations.  In order to gain power to test rare variants, we use Phenotype Risk Scores (PheRS) based on features of Mendelian diseases. PheRS is calculated using","Not Applicable","Genetic Diseases, Inborn","Case-Control","HumanExome-12","SNP Genotypes (Array)","4 phenotype datasets, 1217 variables, 1 documents, 1 analyses, 1 molecular datasets,  SRA, 21701 subjects, 21701 samples","","OD","GRU-NPU --- General Research Use (NPU)","2018-03-16","2018-03-16","Disease, Genetic; Disease, Hereditary; Diseases, Genetic; Diseases, Hereditary; Disorder, Genetic; Disorders, Genetic",""
"phs000606.v1.p1","HIT after Cardiac Bypass","The purpose of this study is to determine how often heart surgery patients who receive heparin develop an immune response (heparin-induced thrombocytopenia) that leads to clots forming in different parts  of the body. These clots usually occur in the legs (deep venous thrombosis or DVT) or lungs (pulmonary embolism or PE) or cause heart attacks","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","11 phenotype datasets, 626 variables, 14 documents, 1051 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-03-16","2018-03-16","Myocardial Infarction; Pulmonary Embolism; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs001494.v1.p1","AIDS Linked to the Intravenous Experience (ALIVE) Cohort","The AIDS Linked to the Intravenous Experience (ALIVE) Study is a long-standing community based research effort that includes past and current injection drug users (IDUs). ALIVE has been ongoing since  1988 and is one of the longest-running community-based cohorts of IDUs in existence. The primary objectives when the study started were to","Not Applicable","Substance-Related Disorders","Prospective Longitudinal Cohort","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 35 variables, 1 molecular datasets, 1145 subjects, 1140 samples","European (163), African (18), African American (944), Hispanic1 (7), Hispanic2 (1), Other Asian or Pacific Islander (1), Other (6)","NIDA","GRU --- General Research Use","2018-03-14","2018-03-14","Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced","Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs000603.v1.p1","Rare Genetic Steroid Disease Consortium (GSD) Apparent Mineralocorticoid    Excess (AME) Syndrome Natural History Clinical Protocol","The objective of this project is to observe the natural history of apparent mineralocorticoid excess (AME). AME is a rare monogenic hypertensive disease first described by the Principal Investigator, Dr.  Maria I. New, in 1977 [1], for which the first mutation in the causative HSD11B2 gene was reported by her group in 1995. [2] Little is known about","Not Applicable","Mineralocorticoid Excess Syndrome, Apparent","Case Set","Not Provided","Not Provided","10 phenotype datasets, 506 variables, 9 documents, 17 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-03-14","2018-03-14","11 Beta-hydroxysteroid dehydrogenase type 2 deficiency; 11-beta-Ketoreductase Deficiency, Cortisol; 11-beta-hydroxysteroid dehydrogenase deficiency type 2; AME; AME - apparent mineralocorticoid excess; AME 1",""
"phs001492.v1.p1","GWAS on Calcific Aortic Valve Stenosis in Quebec (QUEBEC-CAVS)","Calcific aortic valve stenosis (CAVS) is a common and life-threatening heart disease with no drug that can stop or delay its progression. A genome-wide association study (GWAS) on 1,009 cases  and 1,017 ethnically-matched controls was performed to identify susceptibility genes for CAVS. Inclusion - Cases: Patients with severe tricuspid","Not Applicable","Aortic Valve Stenosis","Case-Control","Not Provided","Not Provided","1 analyses","","NHLBI","GRU --- General Research Use","2018-03-13","2018-03-13","AS; Aortic Stenosis; Aortic Valve Stenoses; Narrowing of aortic valve; Stenosed aortic valve; Stenoses, Aortic","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs001064.v1.p1","Whole Exome Sequencing of Signet Ring/Plasmacytoid Variant Bladder Cancer","In this study, six plasmacytoid bladder cancers were analyzed by whole exome sequencing. The results show loss of the CDH1 gene in every sample and correlate with E-cadherin loss of  expression by immunohistochemistry. A separate validation cohort of plasmacytoid samples showed loss of E-cadherin expression by CDH1 mutation or","Not Applicable","Carcinoma, Signet Ring Cell","Case Set","other","WXS, SNV Aggregate (.MAF)","4 phenotype datasets, 15 variables, 1 molecular datasets, 12 samples sequenced,  SRA, 6 subjects, 12 samples","","NCI","DS-BLADDERCA --- Disease-Specific (Bladder Cancer)","2018-03-12","2018-03-12","Urinary Bladder Neoplasms; Signet Ring Cell Carcinoma; Signet ring carcinoma; Signet ring cell adenocarcinoma; Signet-Ring Cell Carcinoma; signet ring carcinoma NOS (morphologic abnormality)",""
"phs001447.v1.p1","Metastatic Castrate-Resistant Prostate Cancer Study (MCRPCS)","We examined genetic resistance to second generation androgen targeting therapies (abiraterone acetate or enzalutamide) by analyzing whole exome sequencing of patient-matched pre-treatment and post-resistance tumors from a series of castrate-resistant  prostate cancer (CRPC) patients. Abiraterone resistant tumors harbored alterations in AR and MYC, whereas patients treated with enzalutamide had","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 12 variables, 21 samples sequenced, 7 subjects, 21 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS)","2018-03-07","2018-03-07","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001405.v1.p1","Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212","In this study the investigators looked at adaptive reprogramming impact on the kinome when a MEK inhibitor called GSK1120212 (trametinib) was administered in a ""window of opportunity"" trial. GSK1120212 is  not yet approved by the FDA for use in breast cancer patients. The investigators gave GSK1120212 for a short period of time (one week) to examine MEK","Not Applicable","Triple Negative Breast Neoplasms","Clinical Trial","Not Provided","RNA-Seq","5 phenotype datasets, 32 variables, 5 documents, 28 samples sequenced,  SRA, 12 subjects, 28 samples","","NCI","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2018-03-07","2018-03-07","Breast Diseases; Molecular Mechanisms of Pharmacological Action; Neoplasms by Site; Skin Diseases; Breast Disease, Endocrine; Breast Diseases, Endocrine",""
"phs001389.v1.p1","Gene Expression and Histone Modification Profiles in GBM Tumors","The primary goal of this study was to collect and analyze genomic data from primary glioblastoma multiforme tumors. Our collaborators at St David's Medical Center (SDMC) obtained informed consent from  patients undergoing surgery to remove a tumor in the brain. After consent was obtained, specimens were removed from the operating suite and flash","Not Applicable","Glioblastoma","Case Set","Not Provided","RNA-Seq, ChIP-Seq","4 phenotype datasets, 23 variables, 109 samples sequenced,  SRA, 13 subjects, 109 samples","","NCI","HMB --- Health/Medical/Biomedical","2018-03-06","2018-03-06","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytoma (excluding glioblastoma); Astrocytomas","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001001.v1.p1","MGH Atrial Fibrillation Study","The Massachusetts General Hospital (MGH) Atrial Fibrillation Study was initiated in 2001. The study has enrolled serial probands, unaffected and affected family members with atrial fibrillation. At enrollment participants undergo  a structured interview to systematically capture their past medical history, AF treatments, and family history. An electrocardiogram is performed;","Not Applicable","Atrial Fibrillation","Case Set","WES_markerset_grc37, target_markerset_grc37","Not Provided","4 phenotype datasets, 35 variables, 941 samples sequenced,  SRA, 1025 subjects, 949 samples, 3 substudies","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), DS-AF-IRB-RD --- Disease-Specific (Atrial Fibrillation, IRB, RD)","2018-03-06","2018-03-06","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs001118.v1.p1","MGH AF Study: Resequencing Five GWAS Loci for Atrial Fibrillation","This substudy phs001118 Massachusetts General Hospital (MGH) AF Study: Resequencing includes deep coverage targeted re-sequencing and variant identification for 5 GWAS loci in the MGH AF sample collection. Summary level  phenotypes for the Massachusetts General Hospital (MGH) Atrial Fibrillation (AF) Study participants can be viewed at the top-level study page","Massachusetts General Hospital (MGH) Atrial Fibrillation Study (phs001001.v1.p1)","Atrial Fibrillation","Case Set","target_markerset_grc37","Targeted-Capture, SNP/CNV Genotypes (NGS), Targeted-Capture, SNP/CNV Genotypes (NGS)","1 phenotype datasets, 4 variables, 1 molecular datasets, 462 samples sequenced, 462 subjects, 462 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), DS-AF-IRB-RD --- Disease-Specific (Atrial Fibrillation, IRB, RD)","2018-03-06","2018-03-06","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs001117.v1.p1","MGH AF Study: Exome Sequencing in Early-Onset Atrial Fibrillation","This substudy phs001117 Massachusetts General Hospital (MGH) AF Study: Exome Sequencing Study includes exome sequencing for subjects with early-onset atrial fibrillation. Summary level phenotypes for the Massachusetts General Hospital (MGH)  Atrial Fibrillation (AF) Study participants can be viewed at the top-level study page phs001001 MGH AF Study. Individual level phenotype data and","Massachusetts General Hospital (MGH) Atrial Fibrillation Study (phs001001.v1.p1)","Atrial Fibrillation","Case Set","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS)","1 phenotype datasets, 4 variables, 1 molecular datasets, 287 samples sequenced, 287 subjects, 287 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), DS-AF-IRB-RD --- Disease-Specific (Atrial Fibrillation, IRB, RD)","2018-03-06","2018-03-06","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs001116.v1.p1","CHARGE-S: MGH AF Study","This substudy phs001116 CHARGE-S: Massachusetts General Hospital (MGH) AF Study includes targeted capture sequencing produced as part of NHLBI's CHARGE-S project. Summary level phenotypes for the Massachusetts General Hospital (MGH)  Atrial Fibrillation (AF) Study participants can be viewed at the top-level study page phs001001 MGH AF Study. Individual level phenotype data and","Massachusetts General Hospital (MGH) Atrial Fibrillation Study (phs001001.v1.p1)","Atrial Fibrillation","Case Set","target_markerset_grc37","Targeted-Capture, Targeted-Capture, SNP/CNV Genotypes (NGS), SNP/CNV Genotypes (NGS)","1 phenotype datasets, 4 variables, 1 molecular datasets, 192 samples sequenced, 200 subjects, 200 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), DS-AF-IRB-RD --- Disease-Specific (Atrial Fibrillation, IRB, RD)","2018-03-06","2018-03-06","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation",""
"phs001469.v1.p1","High Response Rate to Anti PD-1 Therapy in Desmoplastic Melanoma","Desmoplastic melanoma (DM) is a rare subtype of melanoma characterized by dense fibrous stroma, resistance to chemotherapy and a lack of actionable driver mutations, but is highly associated with ultraviolet  light DNA damage. We analysed 60 patients with advanced DM treated with programmed cell death 1 (PD-1) or PD-1 ligand (PD-L1) blocking antibody","Not Applicable","Immunotherapy","Case-Control","WES_markerset_grc37","WXS, SNV (.MAF)","4 phenotype datasets, 24 variables, 1 molecular datasets, 34 samples sequenced,  SRA, 17 subjects, 34 samples","","NCI","HMB-PUB-NPU-MDS --- Health/Medical/Biomedical (PUB, NPU, MDS)","2018-03-01","2018-03-01","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma; Melanoma, Malignant",""
"phs001364.v1.p1","Mapping the Human Connectome: Structure, Function, and Heritability","The Human Connectome Project (HCP) has acquired vast amounts of data about the pattern of long-distance connections (wiring) in the brains of large numbers of healthy participants aged 22-35 using  cutting-edge MRI and MEG neuroimaging, and extensive behavioral testing. Types of MR data collected included diffusion MRI (dMRI), resting-state","Not Applicable","Connectome","Control Set","imputation_panel, MEGAEx_Immunov2_0_Psych, Neuro_Consortium_Array","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 22 variables, 4 molecular datasets, 1142 subjects, 1142 samples","European (781), African (3), East Asian (38), African American (183), Hispanic1 (12), Hispanic2 (72), Other Asian or Pacific Islander (23), South Asian (14), Other (15)","NIMH","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-03-01","2018-03-01","Not Provided",""
"phs001206.v1.p1","Blepharospasm in a Multiplex African-American Pedigree","Blepharospasm (BSP) is a late-onset focal dystonia characterized by involuntary contractions of the orbicularis oculi muscles. Genetics plays an important role on the pathogenesis of BSP, especially in hereditary BSP  families. In this project, a large African-American pedigree with BSP was phenotypically characterized and its relationship with known common","Not Applicable","Blepharospasm","Family/Twin/Trios","WES_markerset_grc37","SNP Genotypes (NGS), SNP Genotypes (PCR)","6 phenotype datasets, 31 variables, 1 molecular datasets,  SRA, 12 subjects, 12 samples","","NINDS","GRU --- General Research Use","2018-03-01","2018-03-01","Dystonia; Dystonia, Muscle; Dystonic disease; Dystonic movements; Muscle Dystonia; dystonia disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000676.v2.p2","Sequence-Based Analysis of Human Breast Tumors","The goal of this study is to study gene expression patterns in tumors, normal tissues, and cell lines. Principal Investigator: Charles Perou, PhD, Lineberger Comprehensive Cancer Center, University of North  Carolina at Chapel Hill,Chapel Hill, NC, USA Funding Source: P50-CA058223, P50-CA058223","Not Applicable","Breast Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WXS","5 phenotype datasets, 37 variables, 232 samples sequenced,  SRA, 28 subjects, 232 samples","","NCI","GRU-MDS --- General Research Use (MDS), DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2018-02-28","2014-10-29","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001426.v1.p1","Type 1 Diabetes Genetics Consortium (T1DGC): Case-only RNA-Seq Study","Peripheral blood mononuclear cells (PBMC) from 82 T1D cases from the T1DGC study were fractionated by positive selection on magnetic beads into CD4+ T cells, CD8+ T cells and CD19+  B cells. RNA purification, library preparation and sequencing to an average of 50 million reads per sample were performed by the HudsonAlpha Genome","Not Applicable","Diabetes Mellitus, Type 1","Case Set","Not Provided","RNA-Seq","5 phenotype datasets, 23 variables, 8 documents, 246 samples sequenced,  SRA, 82 subjects, 246 samples","","NIDDK","DS-T1DR-IRB-RD --- Disease-Specific (Type 1 diabetes, its complications and other autoimmune diseases, IRB, RD)","2018-02-27","2018-02-27","DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes Mellitus, Sudden Onset",""
"phs001084.v1.p1","Differential Mutations in Matched Primary and Metastatic Colorectal    Cancers","This study compares DNA mutations detected in matched primary and metastatic colorectal cancer samples from 18 individuals across 1,321 genes. We found many more mutations were shared between tumor pairs  (avg. 33.3 mutations/tumor) than were discordant (avg. 2.3 mutations / tumor). Nearly all tumors showed at least one discordance, and these were","Not Applicable","Colorectal Neoplasms","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 14 variables, 38 samples sequenced, 18 subjects, 38 samples","","NCI","GRU --- General Research Use","2018-02-20","2018-02-20","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001053.v1.p1","NEI Exfoliation Genotyping Study","The overall goal of our research is to elucidate the pathogenesis of exfoliation syndrome and the associated glaucoma, making it possible to implement effective screening and prevention strategies and to  develop novel therapies. Cases genotyped for this project are from the Nurses Health Study (NHS), the Health Professionals Follow-up Study (HPFS),","Not Applicable","Glaucoma","Case Set","HumanOmniExpressExome-8","SNP Genotypes (Array)","5 phenotype datasets, 25 variables, 1 documents, 1 molecular datasets, 1506 subjects, 1572 samples","European (1435), African (1), East Asian (3), African American (23), Hispanic1 (20), Hispanic2 (14), Other Asian or Pacific Islander (2), Other (8)","NEI","GRU --- General Research Use, DS-ED --- Disease-Specific (Eye Disease)","2018-02-20","2018-02-20","Exfoliation Syndrome; EXFOLIATION GLAUCOMA; Exfoliation Syndromes; Exfoliative Syndrome; Exfoliative Syndromes; Glaucoma Capsulare",""
"phs000774.v2.p1","CCDG: Genetics of Orofacial Clefts and Related Phenotypes","The purpose of this study is to investigate the genetics of orofacial clefts (OFCs) in a large study population, and importantly, to incorporate subclinical phenotypic features into these studies. Orofacial  clefts (OFCs) comprise a significant fraction of human birth defects (about 1/700 live births (Rahimov et al. 2012) and represent a major public","Not Applicable","Cleft Lip","Family/Twin/Trios","HumanCoreExome-24_plus","SNP Genotypes (imputed), SNP Genotypes (Array)","5 phenotype datasets, 76 variables, 9 documents, 2 molecular datasets, 11925 subjects, 12248 samples","European (3972), African (222), East Asian (1056), African American (302), Hispanic1 (444), Hispanic2 (3210), Other Asian or Pacific Islander (773), South Asian (346), Other (1402)","NIDCR","DS-CFR --- Disease-Specific (Craniofacial Research)","2018-02-16","2015-11-02","Cleft Palate; Genotype-Phenotype Associations; Velopharyngeal Insufficiency; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip",""
"phs000819.v1.p1","Normal Human Tissue Sequencing Project","The Normal Human Tissue Sequencing Project provides RNA expression and DNA methylation data from normal (non-diseased) human tissues. This data set from a variety of source tissue is a valuable  resource for human disease studies. All samples were isolated or procured from normal, healthy, non-diseased human subjects and were deemed","Not Applicable","Healthy Volunteers","Control Set","HumanMethylation450","Methylation (CpG), RNA-Seq","4 phenotype datasets, 17 variables, 1 molecular datasets, 36 samples sequenced, 27 subjects, 54 samples","","NHGRI","HMB --- Health/Medical/Biomedical, DS-HEM --- Disease-Specific (Hematologic Disease)","2018-02-09","2018-02-09","Not Provided",""
"phs000228.v4.p1","HMP Core Microbiome Sampling Protocol A (HMP-A)","This first clinical study of the Human Microbiome Project (HMP) addresses whether individuals share a core human microbiome. It involves broad determination of the microbiota found in five anatomical sites:  the oral cavity, skin, nasal cavity, gastrointestinal tract and vagina. This study will enroll approximately 300 healthy male and female adults,","Not Applicable","Metagenomics","Control Set","target_markerset_grc37","SNP Genotypes (NGS), WGS, AMPLICON, OTHER","7 phenotype datasets, 269 variables, 35 documents, 1 molecular datasets, 12047 samples sequenced,  SRA, 300 subjects, 55762 samples","European (214), East Asian (14), African American (20), Hispanic1 (5), Hispanic2 (26), Other Asian or Pacific Islander (5), South Asian (13), Other (1)","NHGRI","HMP --- Human microbiome research","2018-02-08","2018-02-08","Not Provided",""
"phs001091.v1.p1","Clonal Evolution in Patients with Chronic Lymphocytic Leukemia","We analyzed clonal evolution in serial samples from five CLL patients who became resistant to the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, using whole-exome and deep targeted sequencing. We observe  a BTK-C481S mutation in one of five patients, and multiple PLCG2 mutations in a second patient. The other patients had an expansion of clones","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Prospective Longitudinal Cohort","WES_markerset_grc37","WXS, RNA-Seq, SNV (.MAF)","4 phenotype datasets, 15 variables, 1 molecular datasets, 19 samples sequenced, 5 subjects, 19 samples","","NHGRI","GRU --- General Research Use","2018-02-07","2018-02-07","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs001245.v1.p1","Autosomal Recessive CD70 Deficiency","We describe four patients from two unrelated families of different ethnicities who had primary immunodeficiency predominantly manifesting as susceptibility to EBV-related diseases. We performed whole exome sequencing (P1 and P2  from family 1) or whole genome sequencing (P4 and both parents from family 2) in those two families and identified homozygous frameshift or in-frame","Not Applicable","Immunologic Deficiency Syndromes","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 24 variables, 1 molecular datasets, 5 subjects, 5 samples","","NIAID","GRU --- General Research Use","2018-02-02","2018-02-02","Epstein-Barr Virus Infections; EBV Infections; EBV infection; Epstein Barr Virus Infection; Epstein Barr Virus Infections; Epstein-Barr Virus Infection","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000904.v1.p1","APC Promoter Deletion in Classic Familial Adenomatous Polyposis","The 80% of individuals with classic familial adenomatous polyposis (FAP) have detectable mutations in the coding sequence of the adenomatous polyposis coli (APC) gene. To investigate the 20% of families  without detectable causative mutations, we used exome sequencing and second-generation sequencing of the APC locus including non-coding regions. We","Not Applicable","Adenomatous Polyposis Coli","Mendelian","Not Provided","WXS","5 phenotype datasets, 26 variables, 8 samples sequenced,  SRA, 8 subjects, 8 samples","","NIDDK","HMB-IRB --- Health/Medical/Biomedical (IRB)","2018-02-02","2018-02-02","Familial Adenomatous Polyposis; COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic",""
"phs000577.v1.p1","UCDC Longitudinal Study","Individuals with Urea Cycle Disorders (UCD) cannot remove ammonia, a waste product, from the blood. The purpose of this study is to conduct a longitudinal investigation of the natural history,  morbidity, and mortality in people with UCD. This study will look at how people with a UCD grow and develop over time and how often they get sick.","Not Applicable","Urea Cycle Disorders, Inborn","Prospective Longitudinal Cohort","Not Provided","Not Provided","30 phenotype datasets, 12964 variables, 41 documents, 542 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-01-31","2018-01-31","Disorder of urea cycle; Disorder, Urea Cycle; Disorders, Urea Cycle; Inborn Urea Cycle Disorder; UCD; Urea Cycle Disorder",""
"phs000728.v1.p1","Lung Cancer Susceptibility in Smokers","Over 85% of all patients diagnosed with lung cancer report a history of tobacco use, though only 10% of tobacco smokers eventually develop lung cancer. Epidemiologic studies have shown that  family members of patients with lung cancer have a higher risk of developing lung cancer than controls. In an effort to identify variants associated","Not Applicable","Lung Neoplasms","Family/Twin/Trios","Not Provided","WXS","3 phenotype datasets, 9 variables, 204 samples sequenced,  SRA, 204 subjects, 204 samples","","NHGRI","GRU --- General Research Use, DS-LC --- Disease-Specific (Lung Cancer)","2018-01-30","2018-01-30","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001421.v1.p1","Whole Exome Sequencing and Methylation Profiling of Uveal Melanoma","Uveal melanoma (UM) is the most common primary cancer of the eye and frequently leads to metastatic death. Metastatic risk can be stratified into low, intermediate and high based on  the presence of mutually exclusive mutations in EIF1AX, SF3B1 and BAP1, respectively. The purpose of this study was to comprehensively profile the","Not Applicable","Uveal Melanoma","Prospective Longitudinal Cohort","HumanMethylation450","WXS, Methylation (CpG)","4 phenotype datasets, 27 variables, 1 molecular datasets, 57 samples sequenced,  SRA, 37 subjects, 64 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2018-01-25","2018-01-25","Methylation",""
"phs001305.v1.p1","Buphenyl and Low-Dose Arginine Vs. High-Dose Arginine in Patients with    ASA","Individuals with Urea Cycle Disorders (UCD) cannot remove ammonia, a waste product, from the blood. At present there is little information on the use of sodium phenylbutyrate (Buphenyl&#x02122;) in children  with argininosuccinic aciduria (ASA). It is hoped that this drug may help lower ammonia and argininosuccinic acid levels in patients with ASA.","Not Applicable","Urea Cycle Disorders, Inborn","Interventional","Not Provided","Not Provided","12 phenotype datasets, 313 variables, 8 documents, 12 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2018-01-19","2018-01-19","Disorder of urea cycle; Disorder, Urea Cycle; Disorders, Urea Cycle; Inborn Urea Cycle Disorder; UCD; Urea Cycle Disorder",""
"phs001013.v3.p2","Heart and Vascular Health Study (HVH)","Objectives The Heart and Vascular Health Study (HVH) is a case-control study of risk factors for the development of myocardial infarction (MI), stroke, venous thrombosis (VT), and atrial fibrillation (AF).  The study setting is Group Health, an integrated health care delivery system in Washington State. Background The HVH originated in 1988 with the","Not Applicable","Cardiovascular Diseases","Case-Control","HumanOmniExpress-12, HumanOmniExpressExome-8","SNP Genotypes (Array)","4 phenotype datasets, 38 variables, 5 documents, 1 molecular datasets, 1204 subjects, 1014 samples","European (943), African (1), East Asian (13), African American (24), Hispanic1 (3), Hispanic2 (12), Other Asian or Pacific Islander (8), South Asian (4), Other (6)","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS), DS-CVD-IRB-MDS --- Disease-Specific (Cardiovascular Disease, IRB, MDS)","2018-01-16","2018-01-16","Atrial Fibrillation; Cardiovascular Disease; Myocardial Infarction; A-fib; AF; AF - Atrial fibrillation",""
"phs001366.v1.p1","Pilot Study of Exome and mRNA Profiling in Small Cell Lung Cancer    Patients","In this prospective study, custom genome-wide exome and whole transcriptome sequencing (NGS) was used to identify genomic events and associated expression changes in advanced Small Cell Lung Cancer (SCLC) and  attempt to prescribe systemic therapy based on the results. Tumor/normal pairs were sequenced from 12 patients with advanced SCLC for this study. To","Not Applicable","Small Cell Lung Carcinoma","Case Set","WES_markerset_grc37","CNV Genotypes, RNA-Seq, WXS, SNV (.MAF)","4 phenotype datasets, 18 variables, 1 molecular datasets, 35 samples sequenced,  SRA, 12 subjects, 35 samples","","NHGRI","DS-LC-PUB-MDS --- Disease-Specific (Lung Cancer, PUB, MDS)","2018-01-08","2018-01-08","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Lung oat cell carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL",""
"phs000950.v1.p1","NCI SEER Formalin Fixed Paraffin Embedded (FFPE) Tissue Feasibility Study","Next Generation Sequencing (NGS) technologies are being used for detection of somatic mutations in tumors and studies of germline variation. However, most NGS studies used DNA isolated either from whole  blood or fresh frozen tissue specimens. Meanwhile, the tissue specimens available from most National Cancer Institute (NCI) funded cohorts and the","Not Applicable","Neoplasms","Case Set","WES_markerset_grc37","RNA-Seq, SNP Genotypes (NGS), WXS","4 phenotype datasets, 21 variables, 1 molecular datasets, 127 samples sequenced,  SRA, 59 subjects, 129 samples","","NCI","GRU --- General Research Use, HMB-MDS --- Health/Medical/Biomedical (MDS)","2018-01-04","2018-01-04","Adenocarcinoma; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs001397.v1.p1","Mexican-American Coronary Artery Disease Study (MACAD)","The MACAD Study, funded by NHLBI, was designed to explore genetic contributions to coronary artery disease and glucose homeostasis traits among Hispanics using a family-based design. The baseline examination of  the cohort included the euglycemic hyperinsulinemic clamp test from which the two key phenotypes were obtained: insulin sensitivity (M) and metabolic","Not Applicable","Coronary Artery Disease","Family/Twin/Trios","HumanOmni1S-8","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 821 subjects, 821 samples","European (6), African American (2), Hispanic1 (2), Hispanic2 (780), Other (31)","NHLBI","DS-CMED-IRB-NPU-MDS-GSO --- Disease-Specific (Cardiovascular, Metabolic, and Endocrine Diseases, IRB, NPU, MDS, GSO)","2018-01-03","2018-01-03","Insulin Resistance; Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery",""
"phs001394.v1.p1","Hypertension-Insulin Resistance Family Study (HTN-IR)","The HTN-IR Study, funded by NHLBI, was designed to explore genetic contributions to hypertension and glucose homeostasis traits among Hispanics using a family-based design. The baseline examination of the cohort  included the euglycemic hyperinsulinemic clamp test from which the two key phenotypes were obtained: insulin sensitivity (M) and metabolic clearance","Not Applicable","Hypertension","Family/Twin/Trios","HumanOmni1S-8","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 765 subjects, 765 samples","","NHLBI","DS-CMED-IRB-NPU-MDS-GSO --- Disease-Specific (Cardiovascular, Metabolic, and Endocrine Diseases, IRB, NPU, MDS, GSO)","2018-01-03","2018-01-03","Insulin Resistance; Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High",""
"phs001385.v1.p1","Ancestry Admixture among Chileans","The purpose of this study is to investigate ancestry admixture among Chileans with and without gallbladder cancer. All cases from the Chile Gallbladder Cancer Pilot and Expansion studies with available  genotype data. Principal Investigator: Jill Koshiol, PhD, National Institutes of Health, Bethesda, MD, USA Funding Source: Z01 CP010218, National","Not Applicable","Gallbladder Neoplasms","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 189 subjects, 204 samples","","NCI","GRU --- General Research Use","2017-12-28","2017-12-28","Bladder Cancer, Gall; Bladder Cancers, Gall; Cancer of Gallbladder; Cancer of the Gallbladder; Cancer, Gall Bladder; Cancer, Gallbladder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000295.v2.p1","Next Generation Mendelian Genetics: Kabuki Syndrome","The ultimate purpose of this research is to identify genes causing hereditary disorders. We are scaling a new approach to identify the candidate genes and gene mutations that underlie rare  human Mendelian (a set of primary tenets relating to the transmission of hereditary characteristics from parent to child) diseases by using exome","Not Applicable","Kabuki syndrome","Mendelian","Not Provided","WGS","4 phenotype datasets, 28 variables, 10 samples sequenced,  SRA, 10 subjects, 10 samples","","NHGRI","GRU --- General Research Use","2017-12-22","2017-12-22","KABUK1; KABUKI MAKE-UP SYNDROME; KMS; Kabuki Makeup Syndrome; Kabuki make up syndrome; NIIKAWA-KUROKI SYNDROME",""
"phs001438.v1.p1","Chromatin Accessibility in Developing Human Brain","Non-coding regions comprise most of the human genome and harbor a significant fraction of risk alleles for neuropsychiatric diseases, yet their functions remain poorly defined. We created a high-resolution map  of non-coding elements involved in human cortical neurogenesis by contrasting chromatin accessibility and gene expression in the germinal zone and","Not Applicable","Chromatin","Collection","Not Provided","RNA-Seq, ATAC-seq","5 phenotype datasets, 28 variables, 37 samples sequenced,  SRA, 3 subjects, 37 samples","","NIMH","GRU --- General Research Use","2017-12-21","2017-12-21","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs001441.v1.p1","Admixture Mapping of Staphylococcus Aureus Bacteremia","In this study, we used admixture mapping to test the hypothesis that genomic variations with different frequencies in European and African ancestral genomes influence susceptibility to Staphylococcus aureus bacteremia (SAB)  in a sample of African Americans. A total of 565 adult African Americans were genotyped for admixture mapping. Cases were unique African American","Not Applicable","Staphylococcus aureus","Case-Control","MEGA_Consortium_Array","SNP Genotypes (NGS)","4 phenotype datasets, 15 variables, 1 analyses, 1 molecular datasets, 565 subjects, 565 samples","","NIAID","DS-GNB-IRB --- Disease-Specific (Gram negative bacteremia, IRB)","2017-12-15","2017-12-15","Not Provided",""
"phs001348.v2.p1","Biesecker Lab (NHGRI) Whole Genome Medical Sequencing for Gene Discovery","We aim to use whole-genome medical sequencing (WGMS) to discover causative molecular lesions for a set of rare, severe phenotypes hypothesized to be caused by either somatic mutations, germline de  nova heterozygous mutations, germline inherited recessive, or germline inherited dominant mutations in currently unknown or uncharacterized genes.","Not Applicable","Not Provided","Family/Twin/Trios","WGS_markerset_grc37","Targeted-Capture, SNP Genotypes (NGS), WXS","5 phenotype datasets, 22 variables, 2 molecular datasets, 45 samples sequenced,  SRA, 45 subjects, 45 samples","","NHGRI","HMB --- Health/Medical/Biomedical","2017-12-13","2017-12-13","",""
"phs001159.v1.p1","Genetic Analysis to Interrogate Tumor Heterogeneity in Lung    Adenocarcinoma","We employed next-generation sequencing to identify somatic alterations in multiple metastatic sites from an ""exceptional responder"" lung adenocarcinoma patient during his seven year course of ERBB2-directed therapies. The degree of  heterogeneity was unprecedented, with 1% similarity between somatic alterations of the lung and lymph nodes. One novel translocation, PLAG1-ACTA2,","Not Applicable","Adenocarcinoma of Lung","Case Set","WGS_markerset_grc37, Somatic_Variant","WGS, SNP/CNV Genotypes (NGS), WXS","3 phenotype datasets, 22 variables, 2 molecular datasets, 4 samples sequenced,  SRA, 1 subjects, 4 samples","","NCI","HMB-IRB-PUB --- Health/Medical/Biomedical (IRB, PUB)","2017-12-12","2017-12-12","ADENOCARCINOMA OF LUNG; Adenocarcinoma of lung, somatic; Adenocarcinoma of the Lung; Adenocarcinoma, Lung; Adenocarcinomas, Lung; Lung Adenocarcinoma",""
"phs001419.v1.p1","Natural History Study of Charcot-Marie-Tooth Disease","Charcot Marie Tooth disease (CMT) is an umbrella term that covers any inherited peripheral neuropathy. People with CMT have a problem with the nerves that go to the feet and  hands that cause muscle and sensation loss, as well as difficulty with balance. There are at least forty genes that, when mutated, cause CMT. The","Not Applicable","Charcot-Marie-Tooth Disease","Prospective Longitudinal Cohort","Not Provided","Not Provided","19 phenotype datasets, 2553 variables, 17 documents, 1002 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2017-12-11","2017-12-11","Atrophies, Peroneal Muscular; Atrophy, Muscular, Peroneal; Atrophy, Peroneal Muscular; CMT; CMT - Charcot-Marie-Tooth disease; CMT/HMSN",""
"phs001212.v1.p1","NextGen Consortium: Globin Gene Expression in Sickle Cell    Genotype-Specific iPS Cells","1. Implement an efficient, highly reproducible and 'scalable' system for the production of large numbers of sickle cell anemia-specific iPS cells (iPSC). 2. Derive and characterize a novel, in vitro  system for the production of an unlimited supply of erythroid lineage cells from the directed differentiation of 'clinical grade' transgene-free iPS","Not Applicable","Anemia, Sickle Cell","Case Set","target_markerset_grc37","SNV Aggregate (.MAF), SNP Genotypes (NGS)","4 phenotype datasets, 23 variables, 1 molecular datasets, 55 subjects, 91 samples","European (1), African (7), African American (28), Hispanic1 (17), Other (1)","NHLBI","GRU --- General Research Use","2017-12-11","2017-12-11","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000906.v1.p1","eMERGE Network PGx Cohort","eMERGE-PGx is a multi-site test of the concept that sequence information can be coupled to electronic medical records (EMRs) for use in healthcare. The promise of personalized medicine - health  care guided by each individual's biological characteristics - is being fostered by increasingly powerful and economical methods to acquire clinically","Not Applicable","Pharmacogenetics","Prospective Longitudinal Cohort","WGS_markerset_grc37","OTHER, SNP Genotypes (NGS)","7 phenotype datasets, 44 variables, 1 molecular datasets, 9473 samples sequenced,  SRA, 9010 subjects, 9473 samples","","NHGRI","HMB --- Health/Medical/Biomedical, DS-DEM --- Disease-Specific (Dementia), GRU --- General Research Use","2017-12-06","2017-12-06","Atrial Fibrillation; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Heart Failure; Hypertension; Malignant Hyperthermia",""
"phs000313.v4.p2","SardiNIA Medical Sequencing Discovery Project","The SardiNIA Medical Sequencing Discovery Project studies the genetics of blood lipid levels and personality in a Sardinian population cohort. The project has generated draft genome sequences for approximately 2,000  individuals using whole genome shotgun sequencing. The draft sequences will allow investigators to evaluate the contribution of common and rare","Not Applicable","Cardiovascular Diseases","Family/Twin/Trios","Not Provided","WGS","5 phenotype datasets, 24 variables, 2077 samples sequenced,  SRA, 2105 subjects, 2077 samples","","NIA","GRU-IRB --- General Research Use (IRB)","2017-12-05","2011-10-20","Lipid Metabolism; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs001482.v1.p1","Genetic Ancestry and Self-reported Ethnicity in Carrier Screening","Current professional society guidelines recommend genetic carrier screening be offered on the basis of ethnicity, or when using expanded carrier screening panels, they recommend to compute residual risk based on  ethnicity. We investigated the reliability of self-reported ethnicity in 9125 subjects referred to carrier screening. We identified several","Not Applicable","Infertility","Cross-Sectional","custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 9125 subjects, 9125 samples","","NICHD","GRU --- General Research Use","2017-12-01","2017-12-01","Abnormal fertility; Decreased fertility; Sub-Fertility",""
"phs000373.v1.p1","Osteoporotic Fractures in Men (MrOS)","The Osteoporotic Fractures in Men Study (MrOS) is a multi-center prospective, longitudinal, observational study of risk factors for vertebral and all non-vertebral fractures in older men, and of the sequelae  of fractures in men. The original specific aims of the study include: (1) to define the skeletal determinants of fracture risk in older men, (2) to","Not Applicable","Osteoporosis","Prospective Longitudinal Cohort","HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 134 variables, 4 documents, 1 molecular datasets, 5130 subjects, 5274 samples","European (4655), African (4), East Asian (143), African American (178), Hispanic1 (17), Hispanic2 (99), Other Asian or Pacific Islander (18), South Asian (10), Other (6)","NIAMS","DS-AGR1-RD --- Disease-Specific (Aging Related 1, RD), DS-AGR2-RD --- Disease-Specific (Aging Related 2, RD), DS-AGR3-RD --- Disease-Specific (Aging Related 3, RD)","2017-12-01","2017-12-01","Osteoarthritis; Sleep; Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides",""
"phs001403.v1.p1","WES and CNV analysis of NF1-Associated Plexiform Neurofibromas","Neurofibromatosis type 1 (NF1) is a common tumor-predisposition disorder due to germline mutations in the tumor suppressor gene NF1. A virtually pathognomonic finding of NF1 is the plexiform neurofibroma (PN),  a benign, likely congenital tumor that arises from biallelic inactivation of NF1. PN can undergo transformation to a malignant peripheral nerve","Not Applicable","Neurofibromatosis 1","Case-Control","HumanOmni2.5-8","WXS, SNP Genotypes (Array)","5 phenotype datasets, 26 variables, 1 molecular datasets, 44 samples sequenced, 21 subjects, 44 samples","","NCI","GRU --- General Research Use","2017-11-30","2017-11-30","Neurofibromatosis Type I; Molluscum Fibrosum; Multiple non-ossifying fibromatosis; NEUROFIBROMATOSIS TYPE 1; NEUROFIBROMATOSIS, PERIPHERAL TYPE; NEUROFIBROMATOSIS, TYPE I","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000747.v2.p1","Whole Exome and Transcriptome Sequencing in Sporadic ALS","Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal and devastating neurodegenerative disorder that causes the progressive death of upper and lower motor neurons. Although many  efforts have been done to elucidate molecular factors involved in the onset and progression of the disorder, the causes of ALS are yet unknown and","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS), RNA-Seq, miRNA-Seq, WXS","4 phenotype datasets, 19 variables, 1 molecular datasets, 40 samples sequenced,  SRA, 17 subjects, 40 samples","","NINDS","GRU --- General Research Use","2017-11-30","2015-08-20","Motor Neuron Disease; Neurodegenerative Diseases; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000833.v7.p1","Single Cell Analysis Program - Transcriptome (SCAP-T)","This initiative is part of the Single Cell Analysis Program (SCAP) and is funded through the NIH Common Fund (See http://nihroadmap.nih.gov/), which supports cross-cutting programs that are expected to have  exceptionally high impact. Common Fund initiatives address key roadblocks in biomedical research that impede basic scientific discovery and its","Not Applicable","Single-Cell Analysis","Case Set","RNAseq_probe_set_grc38","Not Provided","3 phenotype datasets, 22 variables, 1 documents, 9269 samples sequenced, 215 subjects, 9269 samples, 3 substudies","","NIMH","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU)","2017-11-27","2017-11-27","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000836.v7.p1","Single Cell Analysis Program - Transcriptome (SCAP-T) (USC)","This study aims to assess the technical and biological noise in measured RNA levels in single cells in a number of human tissue types, and to develop analytical tools to  address the complexity observed at the single-cell level. Understanding the sources and relative sizes of technical and biological noise has become","Single Cell Analysis Program - Transcriptome (SCAP-T) (phs000833.v7.p1)","Neurons","Case Set","RNAseq_probe_set_grc38","RNA Seq (NGS), RNA-Seq, RNA Seq (NGS), RNA-Seq","4 phenotype datasets, 137 variables, 1037 documents, 5 molecular datasets, 3039 samples sequenced,  SRA, 170 subjects, 3039 samples","","NIMH","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU)","2017-11-27","2017-11-27","Not Provided",""
"phs000835.v7.p1","Single Cell Analysis Program - Transcriptome (SCAP-T) (U. Penn)","The goal of this study is to characterize and understand the variability in the expressed transcriptome of human excitable cells. There are two predominant types of excitable cell in the  human body, neurons and muscle cells, including cardiac cells. Many human CNS diseases result from modulation of the electrical responsiveness of","Single Cell Analysis Program - Transcriptome (SCAP-T) (phs000833.v7.p1)","Brain","Case Set","RNAseq_probe_set_grc38","WGS, RNA-Seq, RNA Seq (NGS), WGS, RNA-Seq, RNA Seq (NGS)","3 phenotype datasets, 128 variables, 330 documents, 6 molecular datasets, 1069 samples sequenced,  SRA, 38 subjects, 1069 samples","","NIMH","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU)","2017-11-27","2017-11-27","Not Provided",""
"phs000834.v7.p1","Single Cell Analysis Program - Transcriptome (SCAP-T) (UCSD)","A comprehensive characterization of transcriptional diversity and heterogeneity of the human cortex is crucial to understand its functions in healthy and disease conditions. The diversity and cellular states of the  densely packed cellular network in the cortex can be accurately captured by the transcriptional activities of individual cells. An overarching goal","Single Cell Analysis Program - Transcriptome (SCAP-T) (phs000833.v7.p1)","Prefrontal Cortex","Case Set","RNAseq_probe_set_grc38","RNA-Seq, RNA Seq (NGS), RNA-Seq, RNA Seq (NGS)","2 phenotype datasets, 123 variables, 2 documents, 5 molecular datasets, 5161 samples sequenced,  SRA, 6 subjects, 5161 samples","","NIMH","GRU --- General Research Use, GRU-NPU --- General Research Use (NPU)","2017-11-27","2017-11-27","Not Provided",""
"phs001241.v1.p1","Clonal Architectures and Driver Mutations in Metastatic Melanomas","This study contains sequence data from 15 patients with stage IV melanoma, including the whole genome sequence of 15 metastatic tumors and corresponding normal blood samples from 13 cases, and  targeted capture sequence of four synchronous metastatic samples from two additional cases. These data provide a comprehensive survey of the clonal","Not Applicable","Melanoma","Case Set","Not Provided","WXS, WGS","4 phenotype datasets, 14 variables, 36 samples sequenced, 15 subjects, 36 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2017-11-20","2017-11-20","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000288.v2.p2","Ciliopathies Exome Sequencing Initiative","The study is aimed at identifying new genes involved in pediatric brain disorders from inbred families originating predominantly in the Middle East. Each patient analyzed to date has a specific  and highly unique neurodevelopmental disorder that is likely to be recessive in nature. Many patients have one of the diseases along the ""ciliopathy""","Not Applicable","Congenital Abnormalities","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 21 variables, 4 documents, 1 molecular datasets, 2568 samples sequenced,  SRA, 2569 subjects, 2569 samples","","NHGRI","GRU --- General Research Use","2017-11-15","2017-11-15","Bardet-Biedl Syndrome; Orofaciodigital Syndromes; BBS; Bardet Biedl Syndrome; Biedl-Bardet syndrome; LMBB - Laurence-Moon-Bardet-Biedl syndrome",""
"phs001088.v1.p1","Shanghai Breast Cancer Genetics Study (SBCGS)","The Shanghai Breast Cancer Genetics Study (SBCGS) includes data from four population-based studies conducted among Chinese women in urban Shanghai: the Shanghai Breast Cancer Study (SBCS), the Shanghai Breast Cancer  Survival Study (SBCSS), the Shanghai Women's Health Study (SWHS), and the Shanghai Endometrial Cancer Study (SECS, contributing controls only).","Not Applicable","Breast Neoplasms","Case-Control","HumanExome-12","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 2392 subjects, 2392 samples","","NCI","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2017-11-14","2017-11-14","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001400.v1.p1","Advanced Genomic Techniques in Sequencing of Colorectal Cancer","We developed a method that uses allelic imbalance information in combination with phased genomic sequencing to generate mega-haplotypes that can encompass entire chromosome arms. We applied this technique to characterize  aneuploidy and chromosomal alterations in colorectal cancers. Principal Investigator: Hanlee P. Ji, MD, Stanford University School of Medicine,","Not Applicable","Colorectal Neoplasms","Case-Control","Not Provided","WGS","4 phenotype datasets, 15 variables, 11 samples sequenced, 4 subjects, 11 samples","","NHGRI","HMB-PUB-NPU-MDS --- Health/Medical/Biomedical (PUB, NPU, MDS)","2017-11-13","2017-11-13","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001288.v1.p1","Evaluating the Genetic Causes and Progression of Cholestatic Liver    Diseases (LOGIC)","This longitudinal observational study will investigate the natural history and progression of four genetic causes of intrahepatic cholestasis of childhood, including alpha-1 antitrypsin deficiency (&#x003b1;1-AT), Alagille syndrome (AGS), progressive familial  intrahepatic cholestasis (PFIC), and bile acid synthesis defects (BAD). This study will be conducted as part of the Cholestatic Liver Disease","Not Applicable","alpha 1-Antitrypsin Deficiency","Prospective Longitudinal Cohort","Not Provided","Not Provided","24 phenotype datasets, 2842 variables, 55 documents, 264 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2017-11-13","2017-11-13","Cholestasis, Intrahepatic; Metabolic Diseases; Steroid Metabolism, Inborn Errors; AHD; ALAGILLE SYNDROME; ALAGILLE-WATSON SYNDROME",""
"phs001277.v1.p1","NHGRI Genome Integrity of iPSCs Study","The purpose of this study is to compare mutation load in induced pluripotent stem cells derived from skin fibroblasts. Related Genes: RUNX1 Principal Investigator: Paul Liu, MD, PhD, National Institutes  of Health, Bethesda, MD, USA Funding Source: Intramural Program, National Institutes of Health, Bethesda, MD, USA","Not Applicable","Platelet Disorder, Familial, with Associated Myeloid Malignancy","Case-Control","HumanOmniExpressExome-8","WXS, Targeted-Capture, SNP Genotypes (Array)","3 phenotype datasets, 12 variables, 1 molecular datasets, 50 samples sequenced, 2 subjects, 75 samples","","NHGRI","DS-PF-RD --- Disease-Specific (Platelet Function, RD)","2017-11-01","2017-11-01","FPD/AML; FPD/AML syndrome; FPDAML; FPDMM; FPS/AML syndrome; Familial Platelet Disorder with Associated Myeloid Malignancy",""
"phs001448.v1.p1","Sub-Saharan Sophageal Squamous Cell Carcinoma Molecular Analysis","Esophageal squamous cell carcinoma (ESCC) occurs as much as 20x more frequently in sub-Saharan Africa than Western countries. Through the UNC-Malawi project collaboration we obtained whole-exome matched tumor/normal and RNA  sequencing of 59 ESCC from Malawi between 2011-2012. DNA analysis revealed similar mutations as other cohorts, while RNA analysis revealed three","Not Applicable","Esophageal Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 35 variables, 177 samples sequenced,  SRA, 59 subjects, 177 samples","","NCI","DS-E-C --- Disease-Specific (Esophageal Cancer)","2017-10-27","2017-10-27","Esophageal Neoplasm; Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinoma, Squamous Cell; Carcinomas, Epidermoid",""
"phs001352.v1.p1","Metagenomics-Guided Pathogen Discovery in Travelers' Diarrhea","Traveler's diarrhea (TD) is caused by enterotoxigenic Escherichia coli (ETEC), other pathogenic gram-negative pathogens, norovirus and some parasites. Nevertheless, standard diagnostic methods fail to identify pathogens in more than 30%  of TD patients, so it is predicted that new pathogens or groups of pathogens may be causative agents of disease. A comprehensive metagenomic study of","Not Applicable","Diarrhea","Case-Control","Not Provided","WGS, AMPLICON","4 phenotype datasets, 17 variables, 30 samples sequenced, 30 subjects, 30 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2017-10-27","2017-10-27","Gastroenteritis",""
"phs001303.v1.p1","GWAS of Sporadic and Familial Testicular Germ Cell Tumors","Case-Control Study: Testicular germ cell cancer has been increasing among men during most of the 20th century. Despite this increase, the etiology of testicular cancer is poorly understood. To better  understand the molecular epidemiology of testicular cancer, the National Cancer Institute and the Department of Defense are conducting a case-control","Not Applicable","Germinoma","Case-Control","HumanHap550","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 1509 subjects, 1556 samples","European (1354), East Asian (10), African American (40), Hispanic1 (24), Hispanic2 (64), Other Asian or Pacific Islander (10), South Asian (1), Other (6)","NCI","GRU --- General Research Use, DS-TGCT-COL-MDS --- Disease-Specific (Testicular Cancer, COL, MDS)","2017-10-26","2017-10-26","","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000578.v1.p1","Nondystrophic Myotonias","NMD are rare ion channel disorders. The optimal management and treatment of these disorders are not known. This multi-center proposal will allow the prospective collection of standardized data from a  critical number of patients to help better define the clinical features of NDM. The data will also be used to establish clinically relevant endpoints","Not Applicable","Nondystrophic myotonia","Clinical Trial","Not Provided","Not Provided","23 phenotype datasets, 2896 variables, 18 documents, 95 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2017-10-24","2017-10-24","NDM",""
"phs000962.v1.p1","Exploring the Genetic Variants Associated with Brain Growth in Children","Understanding the genetic factors that control brain growth during childhood and adolescence is a priority for neuroscience. Its importance lies partly in the finding that disturbances in the course of  brain development characterizes many common childhood behavioral problems. Recent advances in neuroimaging such as the use of non-invasive magnetic","Not Applicable","Cerebral Cortex","Case Set","imputation_panel, HumanOmniExpressExome-8","SNP Genotypes (imputed), SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 2 molecular datasets, 377 subjects, 387 samples","European (330), African (2), East Asian (1), African American (21), Hispanic1 (6), Hispanic2 (1), Other Asian or Pacific Islander (7), South Asian (1), Other (8)","NHGRI","GRU-NPU --- General Research Use (NPU)","2017-10-23","2017-10-23","growth and development; growth",""
"phs001209.v1.p1","MIDCIRS Reveals Antibody Diversification in Young Children with Malaria","This study describes a novel Immune Repertoire Sequencing technique, termed Molecular Identifier Clustering-based Immune Repertoire Sequencing (MIDCIRS), to reduce sequencing error while maintaining extremely high coverage and applies this technique  to investigate the differential immune response to malaria between infants and toddlers. Despite a lower somatic hypermutation load, we found an","Not Applicable","Malaria","Prospective Longitudinal Cohort","Not Provided","AMPLICON","4 phenotype datasets, 16 variables, 80 samples sequenced,  SRA, 22 subjects, 80 samples","","NIA","GRU --- General Research Use","2017-10-20","2017-10-20","Malaria, Falciparum; Fever, Marsh; Fever, Remittent; Infection, Plasmodium; Infections, Plasmodium; Marsh Fever","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000554.v1.p1","Mutational Landscape of Lethal Castrate Resistant Prostate Cancer","Exome sequencing of matched pairs of tumor / normal genomic DNA was performed from high risk localized prostate cancer or lethal, metastatic, castrate resistant prostate cancer (CRPC). Exome libraries were  prepared using Illumina Paired_End Genome DNA Sample Prep Kit and captured using Agilent SureSelect Capture Library or Roche EZ Exome capture","Not Applicable","Prostatic Neoplasms","Tumor vs. Matched-Normal","Not Provided","WXS","5 phenotype datasets, 30 variables, 120 samples sequenced,  SRA, 59 subjects, 120 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2017-10-17","2017-10-17","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001424.v1.p1","Genomic Analysis of Pre-Treatment and Autopsy Glioblastoma Specimens","We performed whole exome sequencing data of pre-treatment glioblastoma specimens, matched to post-treatment recurrent intracranial autopsy samples and metastatic extracranial post-treatment autopsy samples. We identified early genetic events common to  the evolutionary ancestry of both pre-treatment glioblastoma and later recurrences. We demonstrated that there were no protein-coding mutations as","Not Applicable","Glioblastoma","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 12 variables, 36 samples sequenced,  SRA, 12 subjects, 36 samples","","NCI","DS-NDC-MDS --- Disease-Specific (Neurological Disorders and Cancer, MDS)","2017-10-13","2017-10-13","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs001357.v1.p1","The Genomic Landscape of Tuberous Sclerosis Complex (TSC)","In this study, we characterized the genomic landscape of tuberous sclerosis complex (TSC), a rare genetic disease causing multisystem growth of benign tumors and other hamartomatous lesions. We analyzed 127  human tissues, including 111 TSC-associated samples and 16 non-TSC negative controls, using multiple genomic platforms including whole exome","Not Applicable","Tuberous Sclerosis","Case-Control","HumanOmni2.5-8, HumanMethylation450","Targeted-Capture, Methylation (CpG), SNP Genotypes (Array), RNA-Seq, WXS","4 phenotype datasets, 22 variables, 1 documents, 1 molecular datasets, 223 samples sequenced,  SRA, 74 subjects, 424 samples","","NHGRI","GRU --- General Research Use","2017-10-13","2017-10-13","Adenoma sebaceum syndrome; Bourneville Disease; Bourneville Phacomatosis; Bourneville Phakomatosis; Bourneville Pringle Disease; Bourneville Pringle's Disease",""
"phs000260.v4.p2","Foregut Microbiome in Development of Esophageal Adenocarcinoma","The distal esophagus is an important anatomical area where gastric acid reflux can cause reflux esophagitis (RE), Barrett's esophagus (BE) (intestinal metaplasia), and esophageal adenocarcinoma (EA). The incidence of EA  has increased 6-fold in the U.S. since the 1970s, parallel to a significant increase in the prevalence of gastroesophageal reflux diseases (GERD).","Not Applicable","Adenocarcinoma Of Esphophagus","Case-Control","Not Provided","WGS, AMPLICON","4 phenotype datasets, 20 variables, 5 documents, 575 samples sequenced,  SRA, 110 subjects, 575 samples","","NCI","HMP --- Human Microbiome Research","2017-10-13","2011-07-01","Adenocarcinoma Of Esophagus; Barrett's Esophagus; GERD; Adenocarcinoma of the Esophagus; Esophageal adenocarcinoma; Esophagus Adenocarcinoma",""
"phs001382.v1.p1","Reproductive Health in Men and Women with Vasculitis","The purpose of this study is to learn about reproductive health, including fertility and pregnancies, in people with vasculitis. All patients enrolled in the Vasculitis Clinical Research Consortium's Contact Registry  will be invited via email to participate in this study. The Contact Registry includes people who self-identify as having one of 11 vasculities:","Not Applicable","Vasculitis","Clinical Trial","Not Provided","Not Provided","3 phenotype datasets, 2071 variables, 1 documents, 467 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2017-10-12","2017-10-12","Aortic Arch Syndromes; Arteritis; Behcet Syndrome; Blood Coagulation Disorders; Cardiovascular Diseases; Churg-Strauss Syndrome",""
"phs001454.v1.p1","Genomic Regions Associated with Susceptibility to Barrett's Esophagus and    Esophageal Adenocarcinoma in African Americans: The Cross BETRNet    Admixture Study","Differences in rates of diseases between different populations with similar environments are presumed to be secondary to variability in population frequencies of disease causing alleles. Recently admixed populations such as  African Americans (AAs) provide a natural opportunity to identify disease-causing variants by examining the ancestry of long chromosomal haplotypes.","Not Applicable","Adenocarcinoma Of Esophagus","Case Set","HumanOmni2.5-8","SNP Genotypes (Array)","3 phenotype datasets, 11 variables, 1 molecular datasets, 28 subjects, 28 samples","","NCI","GRU-IRB --- General Research Use (IRB)","2017-10-10","2017-10-10","Barrett Esophagus; Esophageal Neoplasms; Adenocarcinoma of the Esophagus; Esophageal adenocarcinoma; Esophagus Adenocarcinoma; adenocarcinoma - esophagus",""
"phs001464.v1.p1","Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer","Mechanisms of acquired resistance to immune checkpoint inhibitors (ICIs) are poorly understood. The purpose of this study was to investigate whether alterations in genes encoding components of the HLA Class  I antigen processing and presentation machinery or interferon signaling pathways play a role in acquired resistance to PD-1 or PD-L1 antagonistic","Not Applicable","Carcinoma, Non-Small-Cell Lung","Prospective Longitudinal Cohort","Not Provided","WXS, RNA-Seq","4 phenotype datasets, 24 variables, 63 samples sequenced, 14 subjects, 63 samples","","NCI","DS-LCTC-MDS --- Disease-Specific (Lung Cancer and Thoracic Malignancies, MDS)","2017-10-06","2017-10-06","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER",""
"phs001270.v1.p1","Sleep and Circadian Disorders Study (SACDS)","Sleep is essential for life. A good night's sleep is pleasurable and sleep deprivation is stressful. Prolonged sleep loss impairs temperature control, metabolism, immunity, and ultimately leads to death. Extensive  observational and epidemiological evidence indicates that optimal sleep duration of 8 hours is associated with the maintenance of good health. In our","Not Applicable","Sleep Wake Disorders","Prospective Longitudinal Cohort","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 1 documents, 1 molecular datasets, 10 samples sequenced, 10 subjects, 10 samples","","NINDS","DS-SLCD --- Disease-Specific (Sleep and Circadian Disorders)","2017-10-06","2017-10-06","Long Sleeper Syndrome; Short Sleeper Syndrome; Long Sleeper Syndromes; Sleeper Syndrome, Long; Sleeper Syndromes, Long; Syndrome, Long Sleeper",""
"phs000782.v1.p1","Post-Liver Transplant Recurrent Human Hepatocellular Carcinoma Study    (RHCCS)","The whole exome sequencing showed that HERC5 deletion and under-expression associates with shorter: time to tumor recurrence, progression-free, and overall survival in hepatocellular carcinoma (HCC) in two independent studies (p1  0.004, HR1 1.80; p2 0.018, HR2 3.31) totaling 286 HCC patients. Matched primary and recurrent tumors indicated a clonal selection advantage in","Not Applicable","Carcinoma, Hepatocellular","Prospective Longitudinal Cohort","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 26 variables, 1 molecular datasets, 20 samples sequenced,  SRA, 16 subjects, 46 samples","","NCI","GRU-PUB-MDS --- General Research Use (PUB, MDS)","2017-10-06","2017-10-06","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells",""
"phs001191.v1.p1","NUgene WGS","The NUgene Project is a biorepository with longitudinal medical information from participating patients at Northwestern Medicine affiliated hospitals and outpatient clinics. Participants' DNA samples are coupled with data from a  self-reported questionnaire (2 versions were used, 1 before and 1 after February 2006, both are included) and continuously updated data from our","Not Applicable","Healthy Volunteers","Prospective Longitudinal Cohort","Not Provided","WGS","4 phenotype datasets, 18 variables, 3 documents, 900 samples sequenced,  SRA, 900 subjects, 900 samples","","NHGRI","GRU --- General Research Use","2017-10-03","2017-10-03","Not Provided",""
"phs001377.v1.p1","Epigenetics of Cocaine and Nicotine Addiction","This project characterizes DNA methylation and gene expression changes that occur in the human brain, specifically in neurons from the rostral striatum. Major advances from NIDA funded initiatives for noninvasive  neuroimaging studies have made it possible to study neuroanatomical, neurochemical and functional changes in the human brain that contribute to the","Not Applicable","Cocaine-Related Disorders","Case Set","Axiom_Smokesc","SNP Genotypes (Array)","5 phenotype datasets, 53 variables, 1 molecular datasets, 380 subjects, 365 samples","European (147), African (5), East Asian (1), African American (152), Hispanic1 (26), Hispanic2 (22), Other Asian or Pacific Islander (2), South Asian (1), Other (9)","NIDA","GRU --- General Research Use","2017-10-02","2017-10-02","Abuse, Cocaine; Cocaine Abuse","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000978.v1.p1","WGS of a Malignant GCT with Metabolic Response to Pazopanib","We report one case study of a malignant granular cell tumor patient with metabolic response to pazopanib. In this study, we used whole-genome sequencing of the tumor with the matched  blood to characterize the somatic mutation profile in this tumor. This is the first reported whole-genome sequencing study of the rare malignant","Not Applicable","Granular Cell Tumor","Case-Control","Not Provided","WGS","3 phenotype datasets, 22 variables, 2 samples sequenced,  SRA, 1 subjects, 2 samples","","NCI","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2017-10-02","2017-10-02","Abrikosoff's granulous cell tumor; Abrikosoff's granulous cell tumour; Abrikosoff's tumor; Abrikosoff's tumour; Abrikosovs tumor; Abrikosovs tumour",""
"phs001071.v1.p1","NINDS Family-Based Whole-Genome Sequencing to Find HD Modifiers","The goal of our studies is to identify genetic modifiers of neurodegeneration in Huntington's disease (HD). HD is caused by expansion of CAG repeats in the huntingtin (Htt) gene, with  longer stretches often leading to more rapid disease onset and progression. Yet, for a given number of repeats, the age of symptom onset can be","Not Applicable","Huntington Disease","Family/Twin/Trios","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 23 variables, 1 molecular datasets, 38 samples sequenced,  SRA, 37 subjects, 39 samples","","NINDS","GRU --- General Research Use","2017-09-28","2017-09-28","Ataxia; Brain Diseases; Chorea; Cognition Disorders; Degenerative Hereditary Diseases, Nervous System; Dyskinesias",""
"phs001236.v1.p1","Genetic Analysis of Tuberous Sclerosis Complex (TSC) Hypomelanotic    Macules","In this study we searched for mutations in the TSC1 and TSC2 genes in cultured melanocytes from individuals with the genetic disease Tuberous Sclerosis Complex. Cases had to have a  definite diagnosis of Tuberous Sclerosis Complex, a typical hypomelanotic macule, and sign informed consent. Related Genes: TSC1, TSC2 Principal","Not Applicable","Tuberous Sclerosis","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 5 samples sequenced,  SRA, 5 subjects, 5 samples","","NHLBI","DS-TSC-IRB-NPU-MDS-GSO --- Disease-Specific (Tuberous Sclerosis Complex, IRB, NPU, MDS, GSO)","2017-09-27","2017-09-27","Macules hereditary congenital hypopigmented and hyperpigmented; Congenital hypomelanotic and hypermelanotic macules; Hereditary congenital hypopigmented and hyperpigmented macules; Hypo-and hypermelanotic cutaneous macules, retarded growth, intellectual disability syndrome; Macules, Hereditary Congenital Hypopigmented and Hyperpigmented; Westerhof Beemer Cormane syndrome",""
"phs001173.v1.p1","Head and Neck Cancer Genome-Wide Association Study","Head and neck cancers have well-documented associations with tobacco and alcohol exposure, but the disease develops in only a small fraction of users, which implies an important role for genetic  susceptibility. Therefore, head and neck cancers are an excellent model for studying genetic susceptibility to environmental carcinogens. The primary","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 molecular datasets, 3333 subjects, 3333 samples","European (3301), African American (1), Hispanic1 (3), Hispanic2 (22), Other Asian or Pacific Islander (3), Other (3)","NCI","GRU --- General Research Use","2017-09-27","2017-09-27","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001153.v1.p1","Somatic Mutational Analysis by Exome Sequencing Late-Stage Endometrioid    Endometrial Carcinoma","The purpose of this study was to identify somatic (tumor-specific) mutations in advanced stage endometrioid endometrial carcinoma tumor exomes. The dataset was generated at the NIH Intramural Sequencing Center (NISC)  and NHGRI by next generation sequencing the exomes of 19 de-identified primary tumor DNAs, from advanced stage tumors, and matched non-tumor DNAs.","Not Applicable","Endometrial Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 16 variables, 38 samples sequenced,  SRA, 19 subjects, 38 samples","","NHGRI","DS-ECA-COL --- Disease-Specific (Endometrial Cancer, COL)","2017-09-25","2017-09-25","Endometrial Tumor; Endometrial neoplasm; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium",""
"phs001384.v1.p1","Time Lapse to Cancer-Defining the Transition from Polyp to Cancer","In the US, CRC incidence has declined with uptake in colonoscopy for early detection and removal of polyps, the precursor lesion, can stop a cancer from developing but in spite  of this, CRC remains the second leading cause of cancer death in the United States. One third of people who undergo screening colonoscopy will have","Not Applicable","Colorectal Neoplasms","Case Set","WGS_markerset_grc37","Bisulfite-Seq, WGS, RNA-Seq, SNP Genotypes (NGS)","4 phenotype datasets, 19 variables, 1 molecular datasets, 268 samples sequenced,  SRA, 31 subjects, 268 samples","","NCI","HMB --- Health/Medical/Biomedical","2017-09-20","2017-09-20","Adenoma; Adenoma, Microcystic; Adenomas, Microcystic; Microcystic Adenomas; microcystic adenoma; microcystic adenoma (morphologic abnormality)","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000803.v2.p1","Gastorointestinal Cancer Clinical Cohorts","Comprehensive genomic profiling of colon adenocarcinomas has revealed multiple recurrent alterations that may inform new treatment strategies. Clinical trials of these agents are ongoing, although the mechanisms of response and  resistance to these agents are not well characterized. The goal of this study is to perform comprehensive profiling of pre-treatment and","Not Applicable","Colonic Neoplasms","Prospective Longitudinal Cohort","WES_markerset_grc37","WXS, SNV Aggregate (.MAF), RNA-Seq","4 phenotype datasets, 10 variables, 1 molecular datasets, 22 samples sequenced,  SRA, 6 subjects, 22 samples","","NHGRI","DS-MULT --- Disease-Specific (MULTIPLE), DS-CA --- Disease-Specific (Cancer)","2017-09-20","2015-05-13","Bile Duct Neoplasms; Bile Duct Cancer; Bile Duct Cancers; Cancer of Bile Duct; Cancer of the Bile Duct; Cancer, Bile Duct",""
"phs001407.v1.p1","HNPCC-Sys: Molecular Characterization of Lynch Syndromes","Lynch Syndrome (LS) tumors are characterized by constitutional mutations in DNA mismatch-repair genes. Colorectal cancers (CRCs) are the predominant tumor type in patients with LS. Here, we have used whole-genome  and transcriptome sequencing of LS- CRC to find similarities and differences of mutation and gene expression characteristics between LS-CRC and","Not Applicable","Colorectal Neoplasms, Hereditary Nonpolyposis","Tumor vs. Matched-Normal","Not Provided","WGS, RNA-Seq","4 phenotype datasets, 30 variables, 46 samples sequenced,  SRA, 11 subjects, 46 samples","","NCI","DS-LYN-PUB-NPU --- Disease-Specific (Lynch Syndrome, PUB, NPU)","2017-09-18","2017-09-18","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs001261.v1.p1","DNA Inverted Repeats as an At-risk Motif for Palindromic Gene    Amplification","DNA Inverted Repeats as an At-risk Motif for Palindromic Gene Amplification defines oncogene amplification that is configured as a series of inverted duplications (palindromic gene amplification). To study the impact  of palindromic gene amplification in cancer genomes, we developed an approach to enrich DNA palindromes from genomic DNA (Genome-wide Analysis of","Not Applicable","Neoplasms by Site","Case Set","Affymetrix_WG_Array","SNP Genotypes (Array), OTHER, WGS","4 phenotype datasets, 21 variables, 1 molecular datasets, 9 samples sequenced,  SRA, 8 subjects, 17 samples","","NCI","DS-BRCA-NPU-MDS --- Disease-Specific (Breast Cancer, NPU, MDS)","2017-09-13","2017-09-13","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000472.v2.p1","Estrogen Receptor Positive Breast Cancer: Aromatase Inhibitor Response    Study","Highly variable outcomes are observed in patients with estrogen receptor positive (ER+) breast cancer who undergo preoperative estrogen deprivation therapy with aromatase inhibitors (AI). In this study, 46 baseline tumor  and normal genomes and 31 baseline tumor/normal exomes of participants selected from two clinical trials of neoadjuvant AI therapy on ER+ breast","Not Applicable","Breast Neoplasms","Tumor vs. Matched-Normal","Not Provided","WXS, WGS, RNA-Seq","5 phenotype datasets, 73 variables, 473 samples sequenced,  SRA, 115 subjects, 473 samples","","NHGRI","DS-CA --- Disease-Specific (Cancer)","2017-09-13","2017-09-13","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001105.v1.p1","NHGRI-Mayo Clinic Whole Genome Sequencing of Aggressive Prostate Tumors","We collected DNA from fresh frozen prostate tumor samples and matched peripheral blood from 10 subjects with aggressive, Gleason score &#x02265;8 disease. Tumor and normal samples were sequenced on the  Illumina HiSeq 2000 to mean depths of 95.3X and 48.3X, respectively. Cases were selected on the basis of Gleason score and availability of fresh","Not Applicable","Prostatic Neoplasms","Case-Control","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 33 variables, 1 molecular datasets, 20 samples sequenced,  SRA, 10 subjects, 20 samples","","NHGRI","GRU-IRB-PUB-GSO --- General Research Use (IRB, PUB, GSO)","2017-09-12","2017-09-12","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs001321.v1.p1","Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) - OncoArray    Genotypes","The data come from 40 studies participating in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). CIMBA recruits individuals with pathogenic mutations in BRCA1 or BRCA2. The majority of  carriers were recruited through cancer genetics clinics offering genetic testing, and were enrolled into national or regional studies. The remainder","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","OncoArray","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 molecular datasets, 11841 subjects, 11841 samples","European (11666), East Asian (125), Hispanic1 (13), Hispanic2 (8), South Asian (1), Other (28)","NCI","GRU --- General Research Use, GRU-IRB --- General Research Use (IRB), GRU-NPU --- General Research Use (NPU), CABNHD-MDS --- Cancer, Benign Neoplasms, or Hematopoietic Diseases (MDS), DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS), DS-BROC-MDS-GSO --- Disease-Specific (Breast and Ovarian cancer, MDS, GSO), DS-BROC-NPU --- Disease-Specific (Breast and Ovarian cancer, NPU), DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-CA-MDS-GSO --- Disease-Specific (Cancer, MDS, GSO)","2017-09-11","2017-09-11","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000262.v3.p2","The Role of the Gut Microbiota in Ulcerative Colitis","The aims of the multi-center Ulcerative Colitis Human Microbiome Project (UCHMP) are to examine the role of the enteric microbiome in causing human ulcerative colitis, specifically the development of pouchitis.  Pouchitis is an inflammatory condition of the surgically-created ileoanal pouch that serves as a pseudo-rectum in patients with ulcerative colitis","Not Applicable","Pouchitis","Prospective Longitudinal Cohort","Not Provided","AMPLICON, WGS","4 phenotype datasets, 26 variables, 6 documents, 612 samples sequenced,  SRA, 50 subjects, 612 samples","","NIDDK","HMP --- Human Microbiome Research","2017-09-08","2017-09-08","Colitis, Ulcerative; Inflammatory Bowel Diseases; Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type",""
"phs000694.v3.p2","Clinical Cancer Sequencing","Translating whole exome sequencing (WES) for prospective clinical use may impact the care of cancer patients; however, multiple innovations are necessary for clinical implementation. These include: (1) rapid and robust  WES from formalin-fixed paraffin embedded (FFPE) tumor tissue, (2) analytical output similar to data from frozen samples, and (3) clinical","Not Applicable","Neoplasms","Case Set","Somatic_Variant","SNV (.MAF), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 39 samples sequenced,  SRA, 15 subjects, 39 samples","","NHGRI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2017-09-07","2014-05-16","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001079.v2.p1","PD-1+ and PD-1- CD4+ Teff and Treg cells in Glioblastoma and Health","PD-1 is an important immune checkpoint inhibitor that shows great promise in the clinic, particularly for melanoma and lung cancers. Since PD-1 is also expressed on infiltrating CD4+ Treg and  Teffector cells in glioblastoma, we sought to better understand the role of PD-1 on these infiltrating CD4+ Treg and Teffector cells. To this end, we","Not Applicable","Glioblastoma","Case-Control","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 66 samples sequenced,  SRA, 10 subjects, 66 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2017-09-01","2016-05-20","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs000939.v2.p1","Epigenetic and Genetic Profiling in Lymphoma","Lymphomas are a prevalent and heterogeneous family of cancers arising in cells of the immune system. Drivers of lymphomagenesis include genomic rearrangements that juxtapose active regulatory elements with specific oncogene  targets, as well as mutations affecting specific transcription factors and chromatin regulatory proteins. This study seeks to combine genome-wide","Not Applicable","Lymphoma, B-Cell","Case Set","Not Provided","ChIP-Seq","4 phenotype datasets, 20 variables, 20 samples sequenced,  SRA, 20 subjects, 20 samples","","NHGRI","GRU --- General Research Use","2017-09-01","2015-08-12","Lymphoma, Mantle-Cell; B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade",""
"phs001363.v1.p1","The Pioneer 100 Wellness Project (P100)","108 individuals (age 21-89+ years; 59% males, 41% females; 89% Caucasian; not recruited based on any specific phenotype) participated in an IRB-approved study from April 2014 to January 2015. Each  individual had the genome sequenced in full. Blood was collected in clinics every three months. Additionally, participants completed at-home","Not Applicable","Health","Prospective Longitudinal Cohort","WGS_markerset_grc37","RNA-Seq, SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 22 variables, 1 molecular datasets, 106 samples sequenced,  SRA, 108 subjects, 107 samples","European (92), East Asian (7), African American (2), Hispanic2 (1), Other Asian or Pacific Islander (2), South Asian (1), Other (2)","NIGMS","GRU-IRB-PUB-COL-NPU --- General Research Use (IRB, PUB, COL, NPU)","2017-08-30","2017-08-30","Genetic Predisposition to Disease; Genetic Predisposition; Genetic Predispositions; Genetic Susceptibilities; Genetic Susceptibility; Inherited Predisposition",""
"phs001055.v1.p1","Whole Genome Study for De Novo Mutation Rates","Germline mutations are the source of evolution and contribute substantially to many health-related processes. In this study, we use whole genome deep sequencing data from parents-offspring trios to examine the  de novo point mutations (DNMs) in the offspring. We studied correlation between parental ages with de novo mutation rates. This study is published in","Not Applicable","Premature Birth","Family/Twin/Trios","WGS_markerset_grc37","SNP Genotypes (NGS)","5 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 2397 subjects, 817 samples","","NHGRI","GRU --- General Research Use","2017-08-25","2017-08-25","Preterm Birth; Birth, Premature; Birth, Preterm; Births, Premature; Births, Preterm; Premature Births",""
"phs001425.v1.p1","Melanoma Sequential Immune Checkpoint Blockade Treatment Sequencing Study","Blockade of T cell coinhibitory molecules such as CTLA-4 and PD-1, can activate T cell antitumor response. Although these immune checkpoint blockades (CTLA-4 blockade and PD-1 blockade) have shown durable  response, response rate is modest. Therefore, there is a need to find stable biomarkers predictive of response to immune checkpoint blockades and to","Not Applicable","Melanoma","Case Set","Not Provided","WXS","4 phenotype datasets, 20 variables, 85 samples sequenced, 34 subjects, 85 samples","","NCI","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2017-08-24","2017-08-24","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs001022.v1.p1","PsychENCODE: Autism Transcriptional and Epigenetic Profiling","Our current understanding of autism spectrum disorders (ASD) delineates a highly heritable, yet etiologically heterogeneous disease. Forward genetic approaches to find disease associated mutations or common variation have been successful  and continue to offer considerable power. Yet, given the accumulating evidence for very significant heterogeneity and environmental influences,","Not Applicable","Autistic Disorder","Case-Control","Not Provided","Not Provided","3 phenotype datasets, 18 variables, 499 samples sequenced,  SRA, 123 subjects, 499 samples, 4 substudies","","NIMH","GRU --- General Research Use","2017-08-18","2017-08-18","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000595.v1.p1","PCD Cross-Sectional","We have established a consortium of 7 geographically-dispersed clinical research sites that are designed to study rare diseases of the airways, which involve defects in clearance of mucus secretions from  the airways (defective ""mucociliary clearance""). These sites will collaborate in diagnostic, genetic, and other studies in patients with impairments","Not Applicable","Ciliary Motility Disorders","Clinical Genetic Testing","Not Provided","Not Provided","16 phenotype datasets, 2059 variables, 14 documents, 617 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2017-08-18","2017-08-18","Primary Ciliary Dyskinesia; Ciliary Dyskinesia; Ciliary Dyskinesias; Ciliary Motility Disorder; Dextrocardia bronchiectasis and sinusitis; Dextrocardia-bronchiectasis-sinusitis syndrome",""
"phs001220.v1.p1","PsychENCODE Consortium: Epigenetic Dysregulation in Autism Spectrum    Disorder","Autism spectrum disorder (ASD) is a collection of neuro-developmental disorders characterized by deficits in social interaction and social communication, along with restricted and repetitive behaviour patterns. The etiology of ASD  is complex and multifactorial, including both genetic and environmental components. Large scale gene expression studies on ASD postmortem brain","PsychENCODE Consortium: Epigenetic and Transcriptional Dysregulation in Autism Spectrum (phs001022.v1.p1)","Autistic Disorder","Case-Control","Not Provided","ChIP-Seq, ChIP-Seq","2 phenotype datasets, 13 variables, 288 samples sequenced,  SRA, 117 subjects, 288 samples","","NIMH","GRU --- General Research Use","2017-08-18","2017-08-18","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile",""
"phs001190.v1.p1","PsychENCODE Consortium: Chromatin contact map in human brain development","Chromosome conformation capture experiments demonstrate that chromatin is organized into hierarchical structures, which include compartments, topological associating domains (TADs), and loops. These structures are thought to play a role in  gene regulation and biological function by defining functional genomic units and mediating the effects of cis-regulatory elements via both short- and","PsychENCODE Consortium: Epigenetic and Transcriptional Dysregulation in Autism Spectrum (phs001022.v1.p1)","Brain","Control Set","Not Provided","OTHER, OTHER","4 phenotype datasets, 15 variables, 6 samples sequenced,  SRA, 3 subjects, 6 samples","","NIMH","GRU --- General Research Use","2017-08-18","2017-08-18","Not Provided",""
"phs001061.v1.p1","PsychENCODE Consortium: Autism Post-Mortem Brain RNA-Sequencing - Global    Changes in Patterning, Splicing and lncRNAs","Autism spectrum disorder (ASD) is a neurodevelopmental syndrome characterized by deficits in social communication and mental flexibility. Genetic risk factors contribute substantially to ASD risk, and recent studies support the  potential contribution of more than a thousand genes to ASD risk. However, given the shared cognitive and behavioral features across the autism","PsychENCODE Consortium: Epigenetic and Transcriptional Dysregulation in Autism Spectrum (phs001022.v1.p1)","Autistic Disorder","Case-Control","Not Provided","RNA-Seq, RNA-Seq","2 phenotype datasets, 13 variables, 181 samples sequenced,  SRA, 78 subjects, 181 samples","","NIMH","GRU --- General Research Use","2017-08-18","2017-08-18","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile",""
"phs000872.v2.p1","PsychENCODE Consortium: Autism Post-Mortem Brain RNA-Sequencing - SRRM4    Splicing Study","Purpose: The goal of this study was to assess the status of splicing changes in microexons in the cortex of individuals with autism. Methods: We performed RiboZero Gold (rRNA depleted)  50bp PE RNA-seq in a larger set of case and control samples to define 12 autism and 12 control samples showing the greatest global differential gene","PsychENCODE Consortium: Epigenetic and Transcriptional Dysregulation in Autism Spectrum (phs001022.v1.p1)","Autistic Disorder","Case-Control","Not Provided","RNA-Seq","3 phenotype datasets, 17 variables, 24 samples sequenced,  SRA, 24 subjects, 24 samples","","NIMH","GRU --- General Research Use","2017-08-18","2017-08-18","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile",""
"phs000858.v1.p1","Whole Genome Sequencing and Haplotyping of Blastocyst Biopsies","Current methods available for pre-implantation genetic diagnosis (PGD) of in vitro fertilized (IVF) embryos do not detect de novo. Detection of these types of mutations requires whole genome sequencing (WGS).  In this study advanced massively parallel WGS was performed on three 5-10 cell biopsies from two blastocyst-stage embryos. Overall, greater than 95%","Not Applicable","Fertilization in Vitro","Family/Twin/Trios","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 17 variables, 1 molecular datasets, 6 subjects, 7 samples","","NHGRI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2017-08-07","2017-08-07","Not Provided",""
"phs000852.v1.p1","GEDI: A Developmental Model of Gene-Environment Interplay in SUDs","1. Great Smoky Mountains Study (GSMS; Costello et al. 1996, 1997) Three cohorts of boys and girls, aged 9, 11, and 13 years at intake in 1993, were selected from  a rural population of some 20,000 children using a household equal probability design. A two-phase procedure was used for White and African-American","Not Applicable","Substance-Related Disorders","Family/Twin/Trios","imputation_panel","SNP Genotypes (imputed)","4 phenotype datasets, 16 variables, 1 molecular datasets, 784 subjects, 784 samples","","NIDA","DS-ADMH-IRB-GSO-RD --- Disease-Specific (Addiction and Mental Health, IRB, GSO, RD)","2017-08-01","2017-08-01","Organic Mental Disorders, Substance Induced; Organic Mental Disorders, Substance-Induced",""
"phs000247.v5.p3","The Neonatal Microbiome and NEC","The Neonatal Microbiome and Necrotizing enterocolitis (NEC) study is a multi-centered case control study testing the hypothesis that NEC is a direct or indirect consequence of the enteric biomass, its  products, or both. Very low birth weight infants (VLBW; birth weight &#x02264; 1500 grams) admitted to the neonatal intensive care unit are","Not Applicable","Enterocolitis, Necrotizing","Case-Control","Not Provided","AMPLICON, WGS","7 phenotype datasets, 67 variables, 3 documents, 3882 samples sequenced,  SRA, 1962 subjects, 3882 samples","","NIAID","HMP --- Human Microbiome Research","2017-08-01","2015-04-25","Gastrointestinal Diseases; Infant, Very Low Birth Weight; Digestive Disease; Digestive System Disease; Disease, Gastrointestinal; Diseases, Gastrointestinal",""
"phs001179.v1.p1","Foundation Medicine Adult Cancer Clinical Dataset (FM-AD)","The Foundation Medicine adult cancer clinical dataset consists of 18,004 unique solid tumor samples that underwent genomic profiling on a single uniform platform as part of standard clinical care. The  dataset is derived from the FoundationOne&#x000ae; genomic profiling assay version 2 that interrogates exonic regions of 287 cancer-related genes and","Not Applicable","Neoplasms","Case Set","Not Provided","Not Provided","2 phenotype datasets, 4 variables,  SRA, 18004 subjects, 18004 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2017-07-31","2017-07-31","Abdominal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Nervous System Neoplasms; Skin Neoplasms; Thoracic Neoplasms",""
"phs000592.v1.p1","Screening Protocol and Longitudinal Study of Bone Marrow Failure    Syndromes and Cytopenias","The purpose of this study is to characterize patients with Bone Marrow Failure Syndromes (BMFS) and to track the clinical course of patients with these diseases over time. An exact  and comprehensive diagnosis at presentation is essential. Due to the sporadic nature of BMFS (aplastic anemia, myelodysplastic syndrome, paroxysmal","Not Applicable","Anemia, Aplastic","Clinical Trial","Not Provided","Not Provided","22 phenotype datasets, 2534 variables, 22 documents, 341 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2017-07-27","2017-07-27","Hemoglobinuria, Paroxysmal; Leukemia, Large Granular Lymphocytic; Red-Cell Aplasia, Pure; Acquired paroxysmal nocturnal hemoglobinuria; Hemoglobinuria, Nocturnal Paroxysmal; Hemoglobinuria, Paroxysmal Nocturnal",""
"phs001252.v1.p1","Evaluation of COPD Longitudinally to Identify Predictive Surrogate    Endpoints (ECLIPSE)","ECLIPSE was a longitudinal observational study of 2164 COPD subjects and a smaller number of smoking controls (337) and nonsmoking controls (245) followed regularly for three years, with three chest  CT scans (at baseline, one year, and three years) (Vestbo, European Respiratory Journal 2008; 31: 869). Inclusion criteria included age 40-75, at","Not Applicable","Pulmonary Disease, Chronic Obstructive","Case-Control","HumanHap550","SNP Genotypes (Array)","41 phenotype datasets, 1182 variables, 1 molecular datasets, 2746 subjects, 2159 samples","European (2123), African American (5), Hispanic1 (5), Hispanic2 (14), Other Asian or Pacific Islander (1), Other (11)","NHLBI","DS-COPD-RD --- Disease-Specific (Chronic Obstructive Pulmonary Disease, RD)","2017-07-25","2017-07-25","Pulmonary Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs001338.v1.p1","Tibetan Population History and High Altitude Adaptation Study","Due to a unique adaptation to high altitude, the Tibetan Plateau population has been the subject of much research interest. In this study, we conducted whole genome sequencing of 27  Tibetan individuals. Through our analysis, we inferred a detailed history of demography and revealed the natural selection of Tibetan population. We","Not Applicable","Tibetan people","Control Set","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 12 variables, 1 documents, 1 molecular datasets, 27 subjects, 27 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2017-07-03","2017-07-03","Not Provided",""
"phs001376.v1.p1","Autosomal Recessive CD55 Deficiency","We describe 11 patients from 8 families with homozygous LOF mutations in the complement regulatory protein CD55. Loss of CD55 is associated with increased complement activation, severe protein losing enteropathy  accompanying a primary intestinal lymphangiectasia, and deep vein thrombotic events. We have named this disease CHAPLE after the principle components","Not Applicable","Protein-Losing Enteropathies","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 25 variables, 1 molecular datasets, 9 subjects, 9 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2017-06-30","2017-06-30","Lymphangiectasis, Intestinal; Intestinal Lymphangiectases; Intestinal Lymphangiectasis; Intestinal lymphangiectasia; Lymphangiectases, Intestinal; Lymphangiectasia, Intestinal",""
"phs000768.v2.p1","Genomic Sequencing of Ewing's Sarcoma","The Ewing sarcoma family of tumors (EFT) is a group of malignant small round blue cell tumors that arise in bone or soft tissue. Ewing sarcoma (ES) is the second  most common type of primary bone tumor to affect children and adolescents and accounts for 2.9% of all childhood cancers. This data set reports","Not Applicable","Sarcoma, Ewing","Case Set","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 21 variables, 99 samples sequenced,  SRA, 93 subjects, 99 samples","","NCI","GRU --- General Research Use","2017-06-29","2016-07-28","Neuroectodermal Tumors, Primitive, Peripheral; (pPNET) Peripheral Primitive Neuroectodermal Tumors; Ewing sarcoma / PNET; Extracranial Primitive Neuroectodermal Tumor; Neuroectodermal Neoplasm, Peripheral Primitive; Neuroectodermal Tumor, Peripheral","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001371.v1.p1","Inflammation-Induced Stabilization of mRNA in Rheumatoid Arthritis","During rheumatoid arthritis (RA), TNF activates fibroblast-like synoviocytes (FLS) inducing in a temporal order a constellation of genes, which perpetuate synovial inflammation. Although the molecular mechanisms regulating TNF-induced transcription are  well characterized, little is known about the impact of mRNA stability on gene expression and the impact of TNF on decay rates of mRNA transcripts in","Not Applicable","Arthritis, Rheumatoid","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 11 variables, 20 samples sequenced,  SRA, 2 subjects, 20 samples","","NIAMS","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2017-06-27","2017-06-27","Arthritis; Oligoarthritides; Oligoarthritis; Pauciarthritis",""
"phs001250.v1.p1","Sequencing of Coding and Non-coding Regions in Primary Breast Cancers and    Patient-matched Controls","Genomic analysis of tumor samples has led to the identification of hundreds of cancer genes based on the presence of mutations in protein-coding regions. By contrast, much less is known  about cancer-causing mutations in non-coding regions. Here, we performed deep sequencing in 360 primary breast cancers and developed computational","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","other","WXS, SNV Aggregate (.MAF)","4 phenotype datasets, 17 variables, 1 molecular datasets, 720 samples sequenced,  SRA, 360 subjects, 720 samples","","NHGRI","GRU --- General Research Use, DS-CA-MDS --- Disease-Specific (Cancer, MDS), HMB-MDS --- Health/Medical/Biomedical (MDS)","2017-06-27","2017-06-27","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001278.v1.p1","Longitudinal Study of the Porphyrias","This is an observational, longitudinal study of approximately 800 individuals with various types of porphyria. Those participants will be evaluated annually for 5 years, or longer if they agree. Participation  in this project will include: Participating in annual visits or contacts. Providing samples, including blood, buccal cells (cells from inside of the","Not Applicable","Porphyrias","Prospective Longitudinal Cohort","Not Provided","Not Provided","21 phenotype datasets, 5272 variables, 30 documents, 198 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2017-06-26","2017-06-26","Disorder, Porphyrin; Disorders, Porphyrin; Porphyria; Porphyrin Disorder; Porphyrin Disorders",""
"phs000594.v1.p1","A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia","LGL leukemia can be divided into three subsets including the following: &#x003b1;&#x003b2; or &#x003b3;&#x003b4;T-LGL and NK-LGL leukemia. All three subtypes will be enrolled using a two-stage design. The primary endpoint  of the study is assessment of overall clinical response. Correlative laboratory studies will be performed aimed at determining the mechanism of","Not Applicable","Leukemia, Large Granular Lymphocytic","Clinical Trial","Not Provided","Not Provided","21 phenotype datasets, 2605 variables, 16 documents, 9 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2017-06-21","2017-06-21","Aggressive NK Cell Leukemia; Aggressive Natural Killer Cell Leukemia; LGL Leukemia; LGL Leukemias; LGLL - Large granular lymphocytic leukemia; Large Granular Lymphocyte Leukemia",""
"phs001275.v1.p1","Differential Gene Expression in Cryptorchid Testes","Differential Gene Expression in Cryptorchid Testes Study uses whole-genome RNA profiling of testicular biopsies to determine a potential causative role of isolated congenital cryptorchidism in azoospermia and/or infertility in the  context of our previously published GeneChip data. Cryptorchid patients, aged 7 months to 5 years and otherwise healthy, were enrolled in this","Not Applicable","Cryptorchidism","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 24 variables, 70 samples sequenced, 70 subjects, 70 samples","","NICHD","DS-CRYPT-IRB-PUB-NPU-GSO --- Disease-Specific (Cryptorchidism, IRB, PUB, NPU, GSO)","2017-06-20","2017-06-20","Idiopathic Hypogonadotropic Hypogonadism; Cryptorchidism (unilateral or bilateral); Cryptorchidism, Unilateral Or Bilateral; Cryptorchism; IDT - Imperfectly descended testis; Imperfectly descended testis",""
"phs001297.v1.p1","PROP Functional and Lymphocytic Markers of Respiratory Morbidity in    Hyperoxic Preemies","Approximately 550,000 babies born prematurely each year in the United States suffer from birth at a time in development when the respiratory tract and immune system would normally be protected  and maintained in a na&#x000ef;ve state. This project is a component of the NIH Prematurity and Respiratory Outcomes Program (PROP) whose goals are","Not Applicable","Infant, Premature","Prospective Longitudinal Cohort","Not Provided","AMPLICON","4 phenotype datasets, 46 variables, 721 samples sequenced,  SRA, 277 subjects, 721 samples","","NHLBI","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2017-06-16","2017-06-16","Bronchopulmonary Dysplasia; Premature Infant; Preterm Birth; Neonatal Prematurity; Prematurity, Neonatal; Birth, Premature",""
"phs001157.v1.p1","Wisconsin Longitudinal Study on Aging","NOTE: It is easiest to apply for these data directly with the Wisconsin Longitudinal Study via the link below. The Wisconsin Longitudinal Study (WLS) is a long-term study of a  random sample of men and women, who graduated from Wisconsin high schools in 1957, and their siblings. The WLS panel started out with a panel of","Not Applicable","Aging","Prospective Longitudinal Cohort","HumanOmniExpress-24, imputation_panel","SNP/CNV Genotypes (imputed), SNP Genotypes (Array)","4 phenotype datasets, 23 variables, 2 molecular datasets, 9027 subjects, 9429 samples","European (8971), East Asian (3), African American (14), Hispanic1 (6), Hispanic2 (31), Other (2)","NIA","GRU --- General Research Use","2017-06-14","2017-06-14","Aging, Biological; Biological Aging","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001265.v1.p1","DRIVE Breast Cancer OncoArray Genotypes","Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) was one of five projects funded in 2010 as part of the NCI's Genetic Associations and Mechanisms in Oncology  (GAME-ON) initiative (http://epi.grants.cancer.gov/gameon/). GAME-ON's overall goal was to foster an intra-disciplinary and collaborative approach to","Not Applicable","Breast Neoplasms","Case-Control","OncoArray","SNP Genotypes (Array)","4 phenotype datasets, 27 variables, 1 molecular datasets, 60015 subjects, 60015 samples","European (58491), African (541), African American (812), Hispanic1 (54), Hispanic2 (53), South Asian (3), Other (61)","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods, HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU), DS-BROC --- Disease-Specific (Breast and Ovarian cancer), DS-BRCA-PUB --- Disease-Specific (Breast Cancer, PUB), DS-BCEMOPCA-NPU-MDS --- Disease-Specific (Breast, Colorectal, Endometrial, Melanoma, Ovarian, and/or Prostate Cancer, NPU, MDS), DS-BOED-MDS --- Disease-Specific (Breast, Ovarian, or Endometrial Disease, MDS), DS-CA --- Disease-Specific (Cancer), DS-CA-NPU-GSO --- Disease-Specific (Cancer, NPU, GSO), GRU --- General Research Use, HMB-PUB --- Health/Medical/Biomedical (PUB)","2017-06-12","2017-06-12","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000927.v1.p1","CSER: Clinical Implementation of Carrier Testing Using NGS (NextGen)","We will investigate the clinical implementation of genome sequencing (GS) for carrier screening to aid reproductive decision-making in adults. The study is organized into three inter-related Projects. The study population  will include women and their partners who receive pre-conception testing. In Project 1, we will conduct a Randomized Clinical Trial to test clinical","Not Applicable","High-Throughput Nucleotide Sequencing","Clinical Genetic Testing","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets, 202 samples sequenced,  SRA, 202 subjects, 202 samples","European (162), East Asian (7), African American (3), Hispanic1 (3), Hispanic2 (11), Other Asian or Pacific Islander (8), South Asian (4), Other (4)","NHGRI","GRU --- General Research Use","2017-06-12","2017-06-12","Not Provided",""
"phs000773.v1.p1","CTLA4:CD28 in Sezary Syndrome","We sequenced two tumor and one normal whole genome libraries for a Sezary syndrome patient and also sequenced RNA libraries for each tumor. We identified a novel, highly expressed CTLA4:CD28  gene fusion that is predicted to results in a leading to stimulatory T-cell signaling in the presence of an inhibitory signal. Principal","Not Applicable","Sezary Syndrome","Prospective Longitudinal Cohort","WGS_markerset_grc37","WGS, RNA-Seq, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 15 variables, 1 molecular datasets, 7 samples sequenced, 3 subjects, 7 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2017-06-12","2017-06-12","CTCL / Sezary syndrome; Erythroderma, Sezary; Lymphoma, Sezary's; SC)zary syndrome; SEZARY SYNDROME, SOMATIC; SS","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001362.v1.p1","Linked Read Sequencing of Gastric Cancer Metastases","In this study, linked read sequencing was performed on two ovarian metastases and matched normal tissue, from a patient with primary diffuse gastric cancer. Linked read sequencing is a DNA  preparation technology whereby high molecular weight molecules of DNA are uniquely barcoded prior to fragmentation and sequencing, thus retaining","Not Applicable","Stomach Neoplasms","Case-Control","Not Provided","WGS","4 phenotype datasets, 16 variables, 3 samples sequenced,  SRA, 1 subjects, 3 samples","","NHGRI","HMB-PUB-NPU-MDS --- Health/Medical/Biomedical (PUB, NPU, MDS)","2017-06-09","2017-06-09","Krukenberg Tumor; Carcinoma, Krukenberg; Krukenbergs tumor; Krukenbergs tumour; Krukenberg Carcinoma; Krukenberg Neoplasm",""
"phs001255.v1.p1","Molecular Evolution of Cancer","Recently developed methods that utilize partitioning of long genomic DNA fragments, and barcoding of shorter fragments derived from them, have succeeded in retaining long-range information in short sequencing reads. These  so-called read cloud approaches represent a powerful, accurate, and cost-effective alternative to single-molecule long-read sequencing. We developed","Not Applicable","Liposarcoma","Tumor vs. Matched-Normal","Not Provided","WGS","3 phenotype datasets, 11 variables, 8 samples sequenced, 1 subjects, 8 samples","","NCI","DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS)","2017-06-09","2017-06-09","DDLPS; DDLS; Dedifferentiated Liposarcomas; Liposarcoma, Dedifferentiated; dedifferentiated liposarcoma",""
"phs001328.v1.p1","Longitudinal Studies of Brain Structure and Function in MPS Disorders","Mucopolysaccharidosis (MPS) types I, II, IV, VI and VII, are inherited diseases that result from the bodies inability to break down large sugar molecules that are by-products of metabolism. MPS  affects most organs of the body and causes abnormalities in the liver, spleen, bones, and brain. We are studying the central nervous system","Not Applicable","Mucopolysaccharidoses","Prospective Longitudinal Cohort","Not Provided","Not Provided","17 phenotype datasets, 2444 variables, 24 documents, 93 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2017-06-02","2017-06-02","Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis IV; Mucopolysaccharidosis VI; Mucopolysaccharidosis VII; Alpha-L-iduronidase deficiency",""
"phs001030.v1.p1","Viral Respiratory Pathogens Genetics","The overall purpose of this study is to investigate the host genetic factors in response to influenza virus infection, with the focus on influenza vaccination in the first substudy ""Adult  Influenza Vaccine Genetics"" and with the focus on influenza natural infection and other acute respiratory infections (ARIs) in the second substudy","Not Applicable","Influenza, Human","Prospective Longitudinal Cohort","HumanOmniExpress-12","Not Provided","2 phenotype datasets, 9 variables, 388 subjects, 518 samples, 2 substudies","","NIAID","GRU-IRB --- General Research Use (IRB)","2017-06-02","2024-07-17","Flu; Flu, Human; Grippe; Human Flu; Human Influenza; Human Influenzas",""
"phs001031.v1.p1","Acute Viral Respiratory Infection Genetics","This study was conducted at Texas A&M University, College Station. Healthy adults at the college and in the community were invited to enroll to be followed for acute respiratory illness  (ARI) through two consecutive influenza seasons 2009-2010 and 2010-2011. After subjects provided consent, a medical history was taken to ensure good","Viral Respiratory Pathogens Genetics (phs001030.v1.p1)","Influenza, Human","Prospective Longitudinal Cohort","HumanOmniExpress-12","SNP Genotypes (Array), SNP Genotypes (Array)","3 phenotype datasets, 25 variables, 1 molecular datasets, 142 subjects, 272 samples","European (98), African (1), East Asian (3), African American (3), Hispanic1 (1), Hispanic2 (13), Other Asian or Pacific Islander (3), South Asian (18), Other (2)","NIAID","GRU-IRB --- General Research Use (IRB)","2017-06-02","2024-07-17","Influenza; Flu; Flu, Human; Grippe; Human Flu; Human Influenza",""
"phs000635.v1.p1","Adult Influenza Vaccine Genetics","This study includes two cohorts composed of healthy adults immunized with seasonal influenza vaccine. The first cohort was composed exclusively of males and second of females. Enrollment was restricted to  individuals of European heritage to simplify the genetic analysis. Serum samples were collected prior to immunization and at 14 days and 28 days post","Viral Respiratory Pathogens Genetics (phs001030.v1.p1)","Influenza, Human","Prospective Longitudinal Cohort","HumanOmniExpress-12","SNP Genotypes (Array), SNP Genotypes (Array)","3 phenotype datasets, 30 variables, 1 molecular datasets, 246 subjects, 246 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2017-06-02","2024-07-17","Flu; Flu, Human; Grippe; Human Flu; Human Influenza; Human Influenzas",""
"phs000356.v2.p1","Population Architecture using Genomics and Epidemiology (PAGE)","PAGE II (2013-2019) seeks to expand understanding gained during PAGE I and similar studies of how ancestry-specific differences in allele frequencies and LD may explain differences in risks of common  traits and conditions. Recent studies have identified rare genetic variants that are likely to contribute to common diseases and traits and observed","Not Applicable","Genetics, Population","Cross-Sectional","Not Provided","Not Provided","20 analyses","","NHGRI","GRU --- General Research Use","2017-05-31","2017-05-31","Asthma; Coronary Disease; Gout; Hypertension; Macular Degeneration; Myocardial Infarction",""
"phs001320.v1.p1","Investigating Human Placentation and Pregnancy Using First Trimester    Chorionic Villi","Chorionic villus sampling (CVS) is routinely used for prenatal diagnosis of cytogenetic disorders, but also possesses great potential for studying placentation. To better understand villi biology, human placentation, and how  these relate to pregnancy outcomes, we examined the morphology and transcriptomes of villi obtained via CVS from 10-14 weeks of pregnancy and","Not Applicable","Pre-Eclampsia","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37","RNA Seq (NGS), RNA-Seq","4 phenotype datasets, 18 variables, 1 documents, 1 molecular datasets, 59 samples sequenced,  SRA, 59 subjects, 59 samples","","NICHD","GRU-IRB-PUB-COL --- General Research Use (IRB, PUB, COL)","2017-05-24","2017-05-24","abnormalities; Anemia; Diabetes, Gestational; Hypertension, Pregnancy-Induced; Premature Birth; Trisomy",""
"phs001336.v1.p1","ECLS Survival in Pediatric HCT Recipient with Presumed Cardiac GVHD","We report the case of a 15-year-old female with hypodiploid pre-B acute lymphoblastic leukemia status post allogeneic hematopoietic stem cell transplantation (HCT) from a matched unrelated male donor who presented  on transplant day +75 with cardiac arrest due to ventricular fibrillation associated with fulminant myocarditis. Using conventional diagnostics, an","Not Applicable","Bone Marrow Transplantation","Case Set","Not Provided","WGS","4 phenotype datasets, 19 variables, 1 documents, 1 samples sequenced,  SRA, 1 subjects, 1 samples","","NICHD","HMB-IRB-PUB-COL-MDS-GSO --- Health/Medical/Biomedical (IRB, PUB, COL, MDS, GSO)","2017-05-23","2017-05-23","Graft vs Host Disease; Myocarditis; BMT - Bone marrow transplant; Bone Marrow Grafting; Bone Marrow Transplant; Bone marrow graft",""
"phs001256.v2.p1","Hypoplastic Left Heart Syndrome Study","To understand the genetic etiology of hypoplastic left heart syndrome (HLHS), patients with HLHS were consented and recruited, with blood drawn for DNA extraction and exome sequencing. Using the exome  sequencing dataset obtained, rare coding sequence variants were recovered and enrichment analysis was carried out to identify genes and pathways that","Not Applicable","Hypoplastic Left Heart Syndrome","Case-Control","Not Provided","WXS","4 phenotype datasets, 18 variables, 68 samples sequenced,  SRA, 68 subjects, 163 samples","","NHLBI","GRU-IRB-NPU --- General Research Use (IRB, NPU)","2017-05-16","2017-04-26","HLH - Hypoplastic left heart syndrome; HLHS; HLHS - Hypoplastic left heart syndrome; Heart left ventricle hypoplasia; Hypoplastic left heart; Left Heart Hypoplasia Syndrome",""
"phs001343.v1.p1","Biological Insights from the genome Sequences of Human Embryonic Stem    Cell Lines","Human embryonic stem cells (hESCs) are a powerful tool for the study of human development and can form the basis of cellular disease models or therapies. However, the genetic make-up  and stability of hESCs has not been systematically studied at a genome-wide level with single nucleotide resolution. We therefore sequenced the whole","Not Applicable","Human Embryonic Stem Cells","Control Set","Not Provided","WXS","3 phenotype datasets, 13 variables, 125 samples sequenced,  SRA, 125 subjects, 125 samples","","NIGMS","GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2017-05-11","2017-05-11","Not Provided",""
"phs000871.v1.p1","Whole Exome Sequencing of Pancreatic Neuroendocrine Tumors","Pancreatic neuroendocrine tumors (PNETs), often referred to as ""islet cell tumors"", are neuroendocrine neoplasms that arise from cells of the endocrine and nervous system within the pancreas. These rare tumors  which originate from the pancreatic islet are divided into many categories and are often classified by the hormone most strongly secreted. With the","Not Applicable","Carcinoma, Neuroendocrine","Prospective Longitudinal Cohort","other","WXS, SNV Aggregate (.MAF)","4 phenotype datasets, 35 variables, 1 molecular datasets, 66 samples sequenced, 33 subjects, 66 samples","","NHGRI","GRU --- General Research Use","2017-05-09","2017-05-09","Neuroendocrine Tumors; Pancreatic Islet Cell Tumors; Island Cell Tumor; Island Cell Tumors; Islet Cell Tumors; Islet cell tumor",""
"phs001076.v1.p1","Inflammatory Bowel Disease Exome Sequencing Study","The Broad Institute and Massachusetts General Hospital (MGH) are launching a new initiative to perform large-scale exome sequencing in inflammatory bowel disease (Crohn's disease and ulcerative colitis). Given the considerable  unmet therapeutic need in inflammatory bowel disease (IBD), the recent emergence of rapid and efficient genome sequencing technologies and the","Not Applicable","Inflammatory Bowel Diseases","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 17 variables, 1 molecular datasets, 4626 samples sequenced,  SRA, 4626 subjects, 4629 samples","","NHGRI","DS-IBD --- Disease-Specific (Inflammatory Bowel Disease), GRU --- General Research Use","2017-05-04","2017-05-04","Colitis, Ulcerative; Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - ulcerative colitis",""
"phs001216.v1.p1","A Genome-Wide Association Study for Post-bronchodilator Lung Function in    Children with Asthma","In this study, we conducted a genome-wide association study (GWAS) of post-bronchodilator (BD) FEV1 (forced expiratory volume in 1 second) and FEV1/FVC (forced vital capacity) in Puerto Rican children with  asthma. From September 2003 to June 2010, we recruited 618 Puerto Rican children with asthma, which was defined as physician diagnosed asthma and at","Not Applicable","Asthma","Prospective Longitudinal Cohort","HumanOmni2.5-8","SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets, 447 subjects, 447 samples","European (2), African American (38), Hispanic1 (362), Hispanic2 (8), Other (37)","NHLBI","DS-ASTHMA-IRB-PUB-NPU-MDS-GSO-RD --- Disease-Specific (Asthma, IRB, PUB, NPU, MDS, GSO, RD)","2017-04-21","2017-04-21","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs001174.v1.p1","Female Infertility: Primary ovarian insufficiency","Premature ovarian failure, or primary ovarian insufficiency (POI) is a phenotype of diminished or absent ovarian function occurring in 1-2% of reproductive aged women. Most cases occur spontaneously. Evaluation of  the gametes in women with POI is difficult and invasive. Practitioners must often rely on indirect biomarkers of ovarian function and oocyte health,","Not Applicable","Infertility, Female","Case Set","Not Provided","WXS","4 phenotype datasets, 13 variables, 98 samples sequenced,  SRA, 98 subjects, 98 samples","","NHGRI","HMB --- Health/Medical/Biomedical","2017-04-20","2017-04-20","Postpartum Sterility; Sterility, Postpartum",""
"phs000816.v2.p1","Characterization of X Chromosome Inactivation by high-throughput    sequencing","This study of DNA and RNA sequencing of 5 parent-offspring trios is a single center study. The goal of this study is to characterize X chromosome inactivation (XCI) ratio in  females using phased genomic variations obtained through whole genome or exome sequencing in trios, followed by allele-specific expression analysis","Not Applicable","X Chromosome Inactivation","Family/Twin/Trios","WES_markerset_grc37, WGS_markerset_grc37","WGA, RNA-Seq, WXS, SNP Genotypes (NGS)","5 phenotype datasets, 63 variables, 1 molecular datasets, 510 samples sequenced,  SRA, 424 subjects, 511 samples","","NHGRI","GRU --- General Research Use","2017-04-20","2015-06-18","Aicardi Syndrome; Chromosome Deletion; Genes, X-Linked; Neurobehavioral Manifestations; AIC; AIC - Aicardi syndrome","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000707.v2.p1","Next Generation Mendelian Genetics: Hereditary Neurological Disorders","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. This dataset was obtained from exome analyses of people with hereditary neurologic disorders  of unknown cause. Individuals with inherited neurologic disorders of unknown etiology were included in the studies. In most cases there is a","Not Applicable","Nervous System Diseases","Case Set","WES_markerset_grc37","WXS, SNP Genotypes (NGS)","4 phenotype datasets, 17 variables, 2 molecular datasets, 18 samples sequenced,  SRA, 18 subjects, 18 samples","","NHGRI","DS-HND-NPU --- Disease-Specific (Hereditary Neurological Disorders, NPU)","2017-04-20","2017-04-20","Ataxia; Charcot-Marie-Tooth Disease; Dyskinesia, Familial, with Facial Myokymia; Dystonia; Hereditary Sensory and Motor Neuropathy; Parkinsonian Disorders",""
"phs000516.v2.p1","Genome Sequencing of Pancreatic Ductal Adenocarcinoma","Pancreatic ductal adenocarcinomas (PDAC) is the 11th most common cancer in the USA but the 4th in fatalities. The onset and progression of cancer is driven by extensive rearrangement and  mutation of the genome. We combined our capability to capture and enrich exome DNA with the next generation sequencing capacity to allow us to detect","Not Applicable","Carcinoma, Pancreatic Ductal","Case Set","WES_markerset_grc36","SNP Genotypes (NGS), WXS","4 phenotype datasets, 37 variables, 1 molecular datasets, 118 samples sequenced,  SRA, 59 subjects, 118 samples","","NHGRI","GRU --- General Research Use","2017-04-13","2014-03-20","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001257.v2.p1","Genetic Analysis of Tumor Samples","Antibody blockade of the inhibitory CTLA-4 pathway has led to clinical benefit in a subset of patients with metastatic melanoma. Anti-CTLA-4 enhances T cell responses, including production of IFN-&#x003b3;, which  is a critical cytokine for host immune responses. However, the role of IFN-&#x003b3; signaling in tumor cells in the setting of anti-CTLA-4 therapy","Not Applicable","Melanoma","Case Set","Not Provided","WXS","4 phenotype datasets, 21 variables, 44 samples sequenced,  SRA, 22 subjects, 44 samples","","NCI","DS-M-PUB-NPU --- Disease-Specific (Melanoma, PUB, NPU)","2017-04-12","2017-01-18","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs001192.v1.p1","Thoracic Patient-Derived Xenografts","Targeted capture sequencing of 341 cancer associated genes in thoracic patient-derived xenografts. Principal Investigator: John Thomas Poirier, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA Funding Source: P01  CA129243-09, National Institutes of Health, Bethesda, MD, USA","Not Applicable","Lung Neoplasms","Case Set","Not Provided","Targeted-Capture","3 phenotype datasets, 19 variables, 4 samples sequenced,  SRA, 1 subjects, 4 samples","","NCI","DS-LC-PUB-NPU --- Disease-Specific (Lung Cancer, PUB, NPU)","2017-04-11","2017-04-11","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs000795.v1.p1","Gastric Cancer Genetic Analysis of Metastasis","To identify candidate drivers involved in oncogenesis and tumor evolution, we conducted an extensive genome sequencing analysis of metastatic progression in diffuse gastric cancer. This involved a comparison between a  primary tumor from a Hereditary Diffuse Gastric Cancer Syndrome proband and its subsequent recurrence as an ovarian metastasis. Principal","Not Applicable","Stomach Neoplasms","Case-Control","Not Provided","WXS, WGS","5 phenotype datasets, 23 variables, 6 samples sequenced, 17 subjects, 6 samples","","NCI","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2017-04-11","2017-04-11","Krukenberg Tumor; Carcinoma, Krukenberg; Krukenbergs tumor; Krukenbergs tumour; Krukenberg Carcinoma; Krukenberg Neoplasm",""
"phs000586.v1.p1","Genome Wide Association Studies in Alopecia Areata","1054 unrelated alopecia areata patients were genotyped with the Illumina HumanHap550v3.0 genotyping chip. Allele frequencies were compared to publically available data from three population cohorts of controls. All cases were  ascertained through the National Alopecia Areata Registry and self-reported European ancestry. Only unrelated cases were included in the study.","Not Applicable","Alopecia Areata","Case Set","HumanHap550","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 1054 subjects, 1054 samples","European (1039), African American (1), Hispanic1 (3), Hispanic2 (4), South Asian (2), Other (5)","NIAMS","DS-AA-MDS-RD --- Disease-Specific (Alopecia areata, MDS, RD)","2017-04-10","2017-04-10","AA - Alopecia areata; Alopecia Circumscripta; Circumscribed alopecia; Patchy loss of hair",""
"phs001210.v1.p1","NCI Lung Cancer and Smoking Phenotypes in African-American Subjects","This is a two-stage case-control study designed to evaluate the association between common genetic variants and the risk of lung cancer. The stage 1 studies included 1737 cases and 3602  controls from the following studies: MD Anderson Lung Cancer Epidemiology Study, The Multiethnic Cohort Study (MEC), NCI-MD Lung Cancer-Case Control","Not Applicable","Lung Neoplasms","Case-Control","Human1M-Duo","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 molecular datasets, 5339 subjects, 5644 samples","European (1), African (133), African American (5102), Hispanic1 (86), Other (17)","NCI","DS-CA --- Disease-Specific (Cancer), GRU --- General Research Use, GRU-IRB --- General Research Use (IRB), DS-CA-PUB-NPU-RD --- Disease-Specific (Cancer, PUB, NPU, RD), DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2017-04-07","2017-04-07","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000987.v1.p1","Whole Exome Sequence of 184 Individuals with 22q11.2 Deletion Syndrome","Our goal is to find genetic modifiers of major phenotypes in patients with 22q11.2 deletion syndrome, also known as DiGeorge syndrome or velo-cardio-facial syndrome. Whole exome sequencing was performed as  part of a contract to the NHLBI, Resequencing and Genotyping Service. We have obtained cardiac phenotype information from the de-identified subjects","Not Applicable","DiGeorge Syndrome","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 28 variables, 1 molecular datasets, 183 samples sequenced,  SRA, 184 subjects, 184 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2017-04-07","2017-10-07","CATCH 22; CATCH22; CHROMOSOME 22q11.2 DELETION SYNDROME; DGS; DGS1; Di-George syndrome",""
"phs000558.v1.p1","Glaucoma Exome Sequencing","This is a study of primary open angle glaucoma (POAG) conducted through exome sequencing of cases and comparison of variant frequencies with general population frequencies available in dbGAP and controlled  for sequencing platform artifact to minimize false positives. POAG is an intraocular pressure (IOP) related progressive optic neuropathy that","Not Applicable","Glaucoma","Case Set","Not Provided","WXS","4 phenotype datasets, 21 variables, 175 samples sequenced,  SRA, 175 subjects, 175 samples","","NEI","GRU-IRB --- General Research Use (IRB)","2017-04-07","2017-10-07","",""
"phs000435.v3.p1","Whole Exome Sequencing of Chronic Lymphocytic Leukemia","The somatic genetic basis of chronic lymphocytic leukemia (CLL), a common and clinically heterogenous adult leukemia, remains poorly understood. Massively parallel sequencing technology now provides a method for systematic discovery  of genetic alterations that underlie disease, and for uncovering new therapeutic targets and biomarkers. In study version 2 we presented a dataset","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case Set","other, Affymetrix_WG_Array, WES_markerset_grc36","WGS, SNV (.MAF), SNV Aggregate (.MAF), WXS, SNP Genotypes (Array), RNA-Seq, Bisulfite-Seq","4 phenotype datasets, 24 variables, 2 molecular datasets, 959 samples sequenced,  SRA, 186 subjects, 959 samples","","NHGRI","GRU --- General Research Use","2017-04-05","2013-06-03","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001249.v1.p1","Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived    Xenografts","Genetic and epigenetic analysis of patient-derived xenograft models of acquired chemoresistance in small cell lung cancer. Principal Investigator: John Thomas Poirier, PhD, Memorial Sloan Kettering Cancer Center, New York, NY,  USA Funding Source: R01 CA197936, National Institutes of Health, Bethesda, MD, USA","Not Applicable","Lung Neoplasms","Case Set","Not Provided","RNA-Seq, WXS, WGS, ChIP-Seq","3 phenotype datasets, 21 variables, 110 samples sequenced, 10 subjects, 110 samples","","NCI","HMB-PUB --- Health/Medical/Biomedical (PUB)","2017-04-03","2017-04-03","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs001319.v1.p1","Glioma International Case Control Study (GICC)","The main goals of the GICC Study were: 1) to identify novel genetic risk variants for glioma, as well as validate variants implicated by previous genome-wide association studies of glioma;  and 2) to explore biologically relevant gene-gene and gene-environment interactions in glioma susceptibility. The GICC Study includes participants","Not Applicable","Glioma","Case-Control","OncoArray","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 7566 subjects, 7566 samples","European (7500), Hispanic1 (18), Hispanic2 (26), South Asian (1), Other (21)","NCI","GRU --- General Research Use, DS-BT --- Disease-Specific (Brain Tumors), DS-GL-PUB --- Disease-Specific (Glioma, PUB), DS-GL --- Disease-Specific (Glioma), GRU-COL --- General Research Use (COL), DS-CA --- Disease-Specific (Cancer), DS-GLRC --- Disease-Specific (Glioma and Related Conditions)","2017-03-31","2017-03-31","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000925.v1.p1","PAGE: IPM BioMe Biobank","The Institute for Personalized Medicine (IPM) BioMe Biobank is a consented, EMR-linked medical care setting biorepository of the Mount Sinai Medical Center (MSMC) drawing from a population of over 70,000  inpatients and 800,000 outpatient visits annually. MSMC serves diverse local communities of upper Manhattan, including Central Harlem (86% African","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","MEGA_Consortium_Array","SNP Genotypes (Array), WGS","4 phenotype datasets, 21 variables, 1 molecular datasets, 313 samples sequenced, 13067 subjects, 13883 samples","European (308), African (509), East Asian (615), African American (5928), Hispanic1 (2720), Hispanic2 (1044), Other Asian or Pacific Islander (245), South Asian (695), Other (690)","NHGRI","GRU --- General Research Use","2017-03-29","2017-03-29","Coronary Disease; Inflammation; Kidney Failure, Chronic; Myocardial Infarction; Adverse Cardiac Event; Adverse Cardiac Events",""
"phs001226.v1.p1","Regulatory Genomics of Human Embryonic Development","We used epigenetic profiling to map active enhancers in the developing human limb and cortex as described in two published studies: Cotney J, Leng J, Yin J, Reilly SK et  al. The evolution of lineage-specific regulatory activities in the human embryonic limb. Cell 2013;154(1):185-96. Reilly SK, Yin J, Ayoub AE, Emera D","Not Applicable","embryology","Control Set","Not Provided","RNA-Seq, ChIP-Seq","3 phenotype datasets, 10 variables, 64 samples sequenced, 19 subjects, 64 samples","","NIGMS","HMB-NPU --- Health/Medical/Biomedical (NPU)","2017-03-28","2017-03-28","Not Provided",""
"phs001181.v1.p1","Single-Cell DNA and RNA Sequencing over A 29-Year Period of A CLL Patient","Chronic lymphocytic leukemia (CLL) is a frequent B-cell malignancy characterized by recurrent somatic chromosome alterations and a low level of point mutations. Here we present single nucleotide polymorphism (SNP) microarray  analyses of a single CLL patient over 29-years of observation and treatment, and transcriptome and whole genome sequencing at selected timepoints. We","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Case Set","HumanOmniExpress-12","WGS, SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 15 variables, 1 molecular datasets, 8 samples sequenced,  SRA, 1 subjects, 16 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2017-03-24","2017-03-24","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001121.v1.p1","Integrated Genetic and Pharmacologic Interrogation of Rare Cancers","Due to the paucity of patient derived models in rare cancers, identification of therapeutic targets remains challenging. We developed a patient derived model, CLF-PED-015-T, from a patient with an undifferentiated  sarcoma. From this model, we performed pooled RNAi and CRISPR-Cas9 negative selection screens and integrated that with a small molecule screen.","Not Applicable","Sarcoma","Prospective Longitudinal Cohort","other","SNV Aggregate (.MAF), WXS, RNA-Seq","4 phenotype datasets, 14 variables, 1 molecular datasets, 3 samples sequenced, 1 subjects, 3 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2017-03-21","2017-03-21","Sarcoma, Spindle Cell; Sarcomas, Spindle Cell; Spindle Cell Sarcomas; spindle cell sarcoma","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001260.v1.p1","Metagenomic Epidemiology of Antibiotic Resistance in Infectious Diarrhea","The study of antimicrobial resistance (AMR) in infectious diarrhea has generally been limited to cultivation, antimicrobial susceptibility testing and targeted PCR assays. When individual strains of significance are identified, whole  genome shotgun (WGS) sequencing of important clones and clades is performed. Genes that encode resistance to antibiotics have been detected in","Not Applicable","Diarrhea","Prospective Longitudinal Cohort","Not Provided","WGS, AMPLICON","4 phenotype datasets, 41 variables, 43 samples sequenced,  SRA, 43 subjects, 43 samples","","NIAID","HMB-IRB --- Health/Medical/Biomedical (IRB)","2017-03-13","2017-03-13","Gastroenteritis",""
"phs000574.v1.p1","Rett Syndrome Natural History Protocol","This observational study will involve the comprehensive assessment of the clinical features of Rett syndrome with this Rare Diseases Clinical Research Network. A clinical database of 1350 individuals with Rett  syndrome including MECP2 mutation status for the purpose of elaborating phenotype-genotype correlations will be established. Eligible participants","Not Applicable","Rett Syndrome","Case Set","Not Provided","Not Provided","21 phenotype datasets, 2728 variables, 13 documents, 1020 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2017-03-13","2017-03-13","AUTISM, DEMENTIA, ATAXIA, AND LOSS OF PURPOSEFUL HAND USE; Autism Dementia Ataxia Loss of Purposeful Hand Use Syndrome; Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome; Cerebroatrophic Hyperammonemia; Cerebroatrophic Hyperammonemias; Classic Rett Syndrome",""
"phs001276.v1.p1","Single-Cell Profiling of hESC-Derived Interneuron Development","GABAergic interneurons are essential for neural circuit function and their loss or dysfunction is implicated in human neuropsychiatric disease. In vitro methods for interneuron generation hold promise for studying human  cellular and functional properties and ultimately therapeutic cell replacement. We used a protocol for generating cortical interneurons from hESCs","Not Applicable","growth & development","Control Set","RNAseq_gene_transcripts","RNA Seq (NGS), RNA-Seq","4 phenotype datasets, 17 variables, 1 molecular datasets, 104 samples sequenced,  SRA, 4 subjects, 104 samples","","NINDS","GRU-NPU --- General Research Use (NPU)","2017-03-10","2017-03-10","growth and development; growth",""
"phs001248.v1.p1","Gene Array to Predict Bacterial Infection with in Respiratory Illness","Accurate tests for microbiologic diagnosis of lower respiratory tract infections (LRTI) are needed. Gene expression profiling of whole blood represents a powerful new approach for analysis of the host response  during respiratory infection that can be used to supplement pathogen detection testing. Using qPCR, we prospectively validated the differential","Not Applicable","Respiratory Tract Infections","Case Set","RNAseq_gene_transcripts","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 37 variables, 1 molecular datasets, 94 samples sequenced,  SRA, 94 subjects, 94 samples","","NIAID","HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2017-03-10","2017-09-10","Infection, Respiratory System; Infection, Respiratory Tract; Infections, Respiratory; Infections, Respiratory Tract; RTI - Respiratory tract infection; Respiratory Infections",""
"phs001263.v1.p1","DRIVE Breast Cancer GWAS Meta-Analysis","Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) was one of five projects funded in 2010 as part of the NCI's Genetic Associations and Mechanisms in Oncology  (GAME-ON) initiative (http://epi.grants.cancer.gov/gameon/). GAME-ON's overall goal was to foster an intra-disciplinary and collaborative approach to","Not Applicable","Breast Neoplasms","Case-Control","Not Provided","Not Provided","1 documents, 2 analyses","","NCI","DS-BRCA-MDS --- Disease-Specific (Breast Cancer, MDS)","2017-03-09","2017-03-09","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs001253.v1.p1","Pharmacogenetics of Efavirenz Discontinuation for Reported CNS Symptoms","This is an evaluation of genetic associations with efavirenz (EFV) discontinuation for central nervous system (CNS) symptoms within 12 months of treatment. Patients were treated at an HIV primary care  clinic in Nashville TN from 1998 to 2012. Previously known SNPs in CYP2B6 and CYP2A6 were used to define metabolizer genotypes (extensive,","Not Applicable","Enfermedades del Sistema Nervioso Central","Case-Control","HumanCore-12","SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 1 molecular datasets, 563 subjects, 563 samples","European (334), African (8), East Asian (2), African American (188), Hispanic1 (2), Hispanic2 (21), Other Asian or Pacific Islander (4), Other (4)","NIAID","DS-HIV-IRB --- Disease-Specific (Human Immunodeficiency Virus, IRB)","2017-03-01","2017-03-01","Central Nervous System Diseases; Dizziness; Hallucinations; Headache; Insomnia; CNS Disease",""
"phs001043.v1.p1","GWAS of Breast Events with Adjuvant Aromatase Inhibitors","Source of patients:The source of the patients for this genome-wide case-control study was MA.27, which was conducted as a multi-cooperative group effort under the auspices of the NCI Breast Cancer  Intergroup of North America. The NCIC Clinical Trials Group (CTG) serves as the coordinating group, with participation by the NCI-sponsored North","Not Applicable","Neoplasms","Case-Control","Human610-Quad, HumanOmniExpress-12, HumanOmniExpressExome-8","SNP Genotypes (Array)","4 phenotype datasets, 39 variables, 1 molecular datasets, 4658 subjects, 4658 samples","European (4316), African (4), East Asian (41), African American (138), Hispanic1 (47), Hispanic2 (67), Other Asian or Pacific Islander (12), South Asian (20), Other (13)","NIGMS","DS-CA --- Disease-Specific (Cancer)","2017-03-01","2017-09-01","Neoplasm Metastasis; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors",""
"phs001036.v1.p1","Genomic Characterization of Acral Melanoma","In this study, we performed paired tumor/normal long insert whole genome and exome sequencing and tumor RNA sequencing on primary or metastatic acral melanoma tumors collected from 34 patients. Patients  were enrolled from either Vanderbilt University or the Memorial Sloan-Kettering Cancer Center. We report an integrated analysis of DNA and RNA","Not Applicable","Melanoma","Tumor vs. Matched-Normal","other","WXS, RNA-Seq, SNV Aggregate (.MAF), WGS","4 phenotype datasets, 16 variables, 1 molecular datasets, 109 samples sequenced,  SRA, 34 subjects, 109 samples","","NCI","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2017-03-01","2017-03-01","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs001271.v1.p1","Pooled Genome-Wide Analysis of Kidney Cancer Risk (KIDRISK)","Incidence rates of renal cell carcinoma (RCC) are rising and the latest estimates show that it accounts for over 300,000 cases and 120,000 deaths worldwide each year. Mechanisms underlying RCC  occurrence are not fully understood and a large part of the disease heritability remains unexplained. The study aimed at augmenting the size of","Not Applicable","Carcinoma, Renal Cell","Case-Control","HumanOmni5-4","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 5307 subjects, 5307 samples","European (5208), Hispanic1 (6), Hispanic2 (1), South Asian (3), Other (89)","NCI","HMB-PUB-NPU-MDS --- Health/Medical/Biomedical (PUB, NPU, MDS), DS-CA-NPU-GSO --- Disease-Specific (Cancer, NPU, GSO), DS-RCC-MDS --- Disease-Specific (Kidney Cancer, MDS)","2017-02-28","2017-02-28","Kidney Neoplasms; ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell",""
"phs001139.v1.p1","NextGen/GENESiPS","Variability in induced pluripotent stem cell (iPSC) lines remains a roadblock for disease modeling and regenerative medicine. Through linear mixed models we have described different sources of gene expression variability  from RNA sequencing data in 317 human iPSC lines from 101 individuals. We found that 50% of genome-wide expression variability is explained by","Not Applicable","Insulin Resistance","Case-Control","imputation_panel","SNP Genotypes (imputed)","4 phenotype datasets, 11 variables, 1 molecular datasets,  SRA, 94 subjects, 94 samples","European (66), African (1), East Asian (8), African American (6), Hispanic2 (6), Other Asian or Pacific Islander (2), South Asian (4), Other (1)","NHLBI","GRU-IRB --- General Research Use (IRB)","2017-02-27","2018-02-27","",""
"phs001200.v1.p1","Neutralizing Antibodies against West Nile Virus from Human B Cells","West Nile virus (WNV) infection is a mosquito-borne disease that can cause severe neurological illness. We analyzed the humoral response to WNV of subjects infected with WNV at different stages  of the infection and at different levels of detail, from single cells to the repertoire level. We integrated single-cell analysis by microengraving","Not Applicable","West Nile Fever","Case Set","Not Provided","AMPLICON","4 phenotype datasets, 18 variables, 26 samples sequenced,  SRA, 7 subjects, 26 samples","","NIAID","DS-IR-IRB --- Disease-Specific (Immunological Research, IRB)","2017-02-23","2017-02-23","Infection, WNV; WNV Infection; WNV Infections; West Nile Virus Infection; West Nile virus caused disease or disorder; West Nile virus disease or disorder",""
"phs001244.v1.p1","Nasopharynx Cancer Whole Exome Sequencing","Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer characterized by Epstein-Barr virus (EBV) infection and dense lymphocyte infiltration. The scarcity of NPC genomic data hinders the understanding of  NPC biology, disease progression, and rational therapy design. Here, we performed whole-exome sequencing (WES) on 111 micro-dissected EBV-positive","Not Applicable","Nasopharyngeal Neoplasms","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 22 variables, 211 samples sequenced, 108 subjects, 211 samples","","NHGRI","DS-CA-NPU-MDS --- Disease-Specific (Cancer, NPU, MDS)","2017-02-21","2017-02-21","Nasopharyngeal Tumor; Nasopharyngeal neoplasm; Nasopharynx Neoplasm; Nasopharynx Neoplasms; Neoplasia of the nasopharynx; Neoplasm of Nasopharynx",""
"phs001187.v1.p1","Epigenomics of Human CD8 T cell Differentiation and Aging","The efficacy of the adaptive immune response declines dramatically with age, but the cell-intrinsic mechanisms driving the changes characteristic of immune aging in humans remain poorly understood. One hallmark of  immune aging is the loss of self-renewing naive cells and the accumulation of differentiated but dysfunctional cells within the CD8 T cell","Not Applicable","Aging","Case-Control","Not Provided","ChIP-Seq, Tn-Seq, RNA-Seq","3 phenotype datasets, 16 variables, 75 samples sequenced,  SRA, 23 subjects, 75 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2017-02-16","2017-10-16","Aging, Biological; Biological Aging",""
"phs001082.v1.p1","T Cell Responses to Varicella Zoster Virus","Diversity and size of the antigen-specific T cell receptor (TCR) repertoire are two critical determinants for successful control of chronic infection. Varicella zoster virus (VZV) that establishes latency during childhood  is able to escape control mechanisms, in particular with increasing age. We examined the TCR diversity of VZV-specific CD4 T cells in individuals","Not Applicable","Herpes Zoster","Prospective Longitudinal Cohort","Not Provided","OTHER","5 phenotype datasets, 23 variables, 197 samples sequenced,  SRA, 9 subjects, 197 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2017-02-14","2017-08-14","Herpes zoster infection; Shingles; Zona; Zoster; herpes zona; postherpetic neuralgia",""
"phs001251.v1.p1","Family-Based Study on Ulcerative Colitis with Whole Exome Sequencing","Genetic risk factors for ulcerative colitis are not well understood. We performed a family-based whole exome sequencing analysis to identify potential causal mutations. In the proband, we found a heterozygous  de novo mutation in the gene HSPA1L. Our results indicate that the de novo mutation in HSPA1L is associated with ulcerative colitis. Related Genes:","Not Applicable","Colitis, Ulcerative","Family/Twin/Trios","Not Provided","WGS, WXS","5 phenotype datasets, 18 variables, 4 samples sequenced,  SRA, 4 subjects, 4 samples","","NHGRI","GRU --- General Research Use","2017-02-02","2017-02-02","Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - ulcerative colitis; ULCERATIVE COLITIS",""
"phs000428.v2.p2","Health and Retirement Study (HRS)","Introduction to V2: This data release comprises data from the V1 release combined with approximately 3,000 additional samples, collected during the HRS 2010 field period. The 2010 data include samples  from a random half of the new cohort enrolled in 2010 along with a significant expansion of the minority sample. Description: The University of","Not Applicable","Aging","Prospective Longitudinal Cohort","HumanOmni2.5-4, imputation_panel, HumanOmni2.5-8","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","5 phenotype datasets, 25 variables, 4 molecular datasets, 15620 subjects, 16508 samples","European (11124), African (145), East Asian (94), African American (2425), Hispanic1 (216), Hispanic2 (1394), Other Asian or Pacific Islander (58), South Asian (58), Other (106)","NIA","NPR --- Non-profit research use only","2017-02-02","2017-02-02","Arthritis; Dementia; Depression; Diabetes Mellitus; Educational Status; Employment",""
"phs001262.v1.p1","PROSET-HD (Profiling of Cell Subsets in Human Disease)","PROSET-HD aims to identify and study immune cell populations altered in patients with autoimmune and inflammatory diseases. We have identified a population of PD-1hi CXCR5- 'peripheral helper' T (Tph) cells  that are expanded in the joints and circulation of patients with seropositive rheumatoid arthritis. This T cell population uniquely combines potent B","Not Applicable","Arthritis, Rheumatoid","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 32 samples sequenced,  SRA, 4 subjects, 32 samples","","NIAMS","HMB --- Health/Medical/Biomedical","2017-02-01","2017-02-01","",""
"phs001246.v1.p1","Genetics of Arhinia","The goal of this project is to determine the genetic etiology of congenital arhinia and Bosma arhinia microphthalmia syndrome through a combination of whole-exome, whole-genome, and targeted sequencing followed by  in silico, in vitro, and in vivo functional modeling. Inclusion: Whole exome sequencing: Patients with arhinia and available family members Whole","Not Applicable","Arhinia, choanal atresia, and microphthalmia","Case-Control","Not Provided","WXS, RNA-Seq","5 phenotype datasets, 20 variables, 26 samples sequenced,  SRA, 28 subjects, 26 samples","","NICHD","GRU --- General Research Use","2017-01-27","2017-01-27","Kallmann Syndrome; ARHINIA, CHOANAL ATRESIA, MICROPHTHALMIA, AND HYPOGONADOTROPIC HYPOGONADISM; Arrhinia-choanal atresia-microphthalmia syndrome; BAMS; Bosma Arhinia Microphthalmia Syndrome; Bosma Henkin Christiansen syndrome",""
"phs000882.v1.p1","Prostate Cancer Genome-Wide Association Study for Uncommon Susceptibility    Loci (PEGASUS)","This genome-wide association study was funded by the National Cancer Institute (NCI) to identify uncommon susceptibility loci for prostate cancer. A total of 4,600 prostate cancer cases and 2,840 controls  of European ancestry from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial were genotyped using the Illumina HumanOmni2.5","Not Applicable","Prostatic Neoplasms","Case-Control","HumanOmni2.5-4","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 7440 subjects, 7639 samples","","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods","2017-01-24","2017-01-24","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs001242.v1.p1","Small Genomic Insertions form Enhancers that Misregulate Oncogenes","ChIP-Seq data from 102 cell lines were processed to identify insertions relative to the human reference genome. To confirm the ability of a computational pipeline to identify insertions that are  actually present in these genomes, we PCR-amplified and deeply sequenced regions where insertions were predicted to exist in MOLT4 T-cell acute","Not Applicable","Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","Case Set","Not Provided","AMPLICON","3 phenotype datasets, 13 variables, 1 samples sequenced,  SRA, 1 subjects, 1 samples","","NHGRI","GRU --- General Research Use","2017-01-19","2017-01-19","Acute T Cell Leukemia; Acute T Cell Lymphoblastic Leukemia; Acute T-Cell Leukemia; Acute T-Cell Leukemias; Acute T-Cell Lymphoblastic Leukemia; Acute T-Lymphocytic Leukemia",""
"phs000655.v3.p1","Genetics of Inherited Muscle Disease","The samples are drawn from a collection of patients with a heterogeneous set of neuromuscular disorders, including congenital muscular dystrophy, congenital myopathy, limb-girdle muscular dystrophy, Emery-Dreifuss muscular dystrophy, and arthrogryposis,  along with unaffected parents and siblings in some cases. The samples were collected by the following clinicians affiliated with the associated","Not Applicable","Muscular Dystrophies","Collection","WES_markerset_grc36, WES_markerset_grc37, WGS_markerset_grc37","RNA-Seq, WXS, WGS, SNP Genotypes (NGS)","4 phenotype datasets, 11 variables, 3 molecular datasets, 744 samples sequenced,  SRA, 708 subjects, 744 samples","European (94), African American (2), Hispanic1 (3), Hispanic2 (3), Other Asian or Pacific Islander (1), South Asian (2), Other (1)","NHGRI","GRU --- General Research Use, DS-NMD --- Disease-Specific (Neuromuscular Disease), HMB --- Health/Medical/Biomedical","2017-01-19","2017-01-19","AMC; AMC - arthrogryposis multiplex congenita; Amyoplasia Congenita; Arthrogryposes; Arthrogryposes, Congenital Multiple; Arthrogryposis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000198.v1.p1","Sporadic Amyotrophic Lateral Sclerosis Study","Genomewide association study of risk for sporadic amyotrophic lateral sclerosis (ALS) and ALS patient phenotype. Genotypes were analyzed for 288,357 markers in 1,821 sporadic ALS patients and 2,258 controls. DNA  from study participants were obtained from one of three centres in the US (Boston, Atlanta, National Institute of Neurological Disorders and Stroke)","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","Not Provided","Not Provided","Not Provided","","NINDS","","2017-01-12","","Lou Gehrig Disease; Motor Neuron Disease, Amyotrophic Lateral Sclerosis; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease",""
"phs001025.v1.p1","Hispanic Lupus GWAS_HISPSLEI Study","The study comprises SLE patients recruited from specialist rheumatology clinics from the United States, Mexico, Argentina, Chile and Peru. Two strategies were used to enrich samples for Native American ancestry:  a. previously genotyped Hispanic and Latin American and US Native American individuals were selected according to their ancestry based on 253","Not Applicable","Lupus Erythematosus, Systemic","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 analyses, 1 molecular datasets, 2279 subjects, 2279 samples","","NIAMS","DS-SLE-NPU-MDS-RD --- Disease-Specific (Systemic lupus erythematosus, NPU, MDS, RD)","2017-01-11","2017-01-11","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus",""
"phs000896.v1.p1","Functional Dynamics of the Elderly Gut Microbiome During Probiotic    Consumption","A mechanistic understanding of the health benefits conferred by consumption of probiotic bacteria has been limited by our knowledge of the resident gut microbiota and its interaction with the host.  We used fecal samples from a study of twelve healthy individuals aged 65-80 to characterize the structure and functional dynamics of the gut","Not Applicable","Microbiota","Prospective Longitudinal Cohort","Not Provided","AMPLICON, RNA-Seq","5 phenotype datasets, 22 variables, 72 samples sequenced,  SRA, 12 subjects, 72 samples","","NCCIH","GRU --- General Research Use","2017-01-11","2017-01-11","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000267.v5.p2","Autism Genome Project (AGP) Consortium - GWAS - Stage I and II","Autism spectrum disorders (ASDs) are highly heritable ( 90%), yet the underlying genetic determinants are largely unknown. To understand the genetic and phenotypic heterogeneity in ASDs, we analyzed 2,611 strictly  defined ASD families with over 1,000,000 single nucleotide polymorphisms (SNPs), and applied multiple analytical strategies to examine these families","Not Applicable","Autistic Disorder","Family/Twin/Trios","Human1M-Duo","CNV Genotypes, SNP Genotypes (Array)","5 phenotype datasets, 25 variables, 1 documents, 126 analyses, 4 molecular datasets, 7880 subjects, 7880 samples","European (6911), African (38), East Asian (77), African American (115), Hispanic1 (109), Hispanic2 (390), Other Asian or Pacific Islander (53), South Asian (74), Other (80)","NIMH","DS-ASD --- Disease-Specific (Autism Spectrum Disorder)","2017-01-09","2014-04-24","ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders; Disorder, Autistic Spectrum","dbGaP Collection: NIH Autism -omics Studies (phs000764.v1.p1)"
"phs001033.v1.p1","PAGE: Global Reference Panel","Stanford contributed samples to the PAGE study that can act as a population reference dataset across the globe. Therefore this dataset includes reference individuals, without phenotypes, chosen to help infer  ancestry that will help us understand the diverse samples available in PAGE. The complete dataset comprises individuals of European, African, Asian,","Not Applicable","Population","Control Set","MEGA_Consortium_Array","SNP Genotypes (Array), WGS","3 phenotype datasets, 15 variables, 1 molecular datasets, 78 samples sequenced,  SRA, 1517 subjects, 2065 samples","European (195), African (99), East Asian (141), African American (56), Hispanic1 (115), Hispanic2 (514), Other Asian or Pacific Islander (120), South Asian (138), Other (61)","NHGRI","GRU --- General Research Use","2016-12-27","2016-12-27","Not Provided",""
"phs001172.v1.p2","NINDS Parkinson's Disease","This study utilized the well characterized collection of North American Caucasians with Parkinson's disease, and neurologically normal controls from the sample population which are banked in the National Institute of  Neurological Disorders and Stroke (NINDS Repository) collection. Two sub-studies are included, in sub-study ""NINDS-Genome-Wide Genotyping in","Not Applicable","Parkinson Disease","Case-Control","WES_markerset_grc37","Not Provided","2 phenotype datasets, 9 variables, 1223 samples sequenced,  SRA, 2116 subjects, 3582 samples, 2 substudies","","NINDS","GRU --- General Research Use","2016-12-22","2016-12-22","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000907.v1.p1","Brain Metastases in Squamous Cell Lung Cancers","Putative oncogenic pathways in squamous cell lung cancer have been recently characterized, although their biologic repercussions in patients is largely unknown. This study sought to discover potential clinical manifestations of  major pathways in squamous cell lung cancer, particularly the PI3K pathway. Two key findings emerged: patients with stage IV squamous cell lung","Not Applicable","Carcinoma, Squamous Cell","Case Set","other","WXS, SNV Aggregate (.MAF)","4 phenotype datasets, 28 variables, 1 molecular datasets, 13 samples sequenced,  SRA, 5 subjects, 13 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2016-12-22","2016-12-22","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001103.v1.p2","NINDS-Exome Sequencing in Parkinson's Disease","This sub-study phs001103 PD Exome contains whole exome sequence data and selected phenotype of subjects available from the phs001103 study. Summary level phenotypes for the NINDS Parkinson's Disease Cohort participants  can be viewed at the top-level study page phs001172 NINDS Parkinson's Disease Cohort. Individual level phenotype data and molecular data for all","National Institute of Neurological Disorders and Stroke (NINDS) Parkinson&#39;s Disease (phs001172.v1.p2)","Parkinson Disease","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS, WXS, SNP/CNV Genotypes (NGS)","2 phenotype datasets, 11 variables, 1 molecular datasets, 1223 samples sequenced,  SRA, 618 subjects, 1841 samples","","NINDS","GRU --- General Research Use","2016-12-22","2016-12-22","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs000089.v4.p2","NINDS- Genome-Wide Genotyping in Parkinson's Disease","This sub-study phs000089 PD GWAS contains genotype and selected phenotype of subjects available from the phs001172 study. Summary level phenotypes for the NINDS Parkinson's Disease Cohort study participants can be  viewed at the top-level study page phs001172 NINDS Parkinson's Disease Cohor. Individual level phenotype data and molecular data for all NINDS","National Institute of Neurological Disorders and Stroke (NINDS) Parkinson&#39;s Disease (phs001172.v1.p2)","Parkinson Disease","Prospective Longitudinal Cohort","Not Provided","Not Provided","3 phenotype datasets, 113 variables, 3 documents, 3 analyses, 1 molecular datasets, 1741 subjects, 1741 samples","European (1697), Hispanic1 (9), Hispanic2 (13), Other Asian or Pacific Islander (1), Other (21)","NINDS","GRU --- General Research Use","2016-12-22","2016-12-22","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs000973.v1.p1","The Genomic Landscape of Juvenile Myelomonocytic Leukemia","This study analyzed samples from 29 patients with juvenile myelomonocytic leukemia (JMML) using whole exome sequencing. Each patient had a paired germline tissue along with a diagnostic leukemia sample. Germline  tissue types included buccal mucosa, cordblood, Epstein-Barr virus immortalized cell lines and fibroblasts from either skin or bone marrow. Leukemia","Not Applicable","Leukemia, Myelomonocytic, Juvenile","Collection","WES_markerset_grc37","SNV (.MAF), WXS","4 phenotype datasets, 24 variables, 1 molecular datasets, 65 samples sequenced,  SRA, 29 subjects, 65 samples","","NCI","DS-CA-NPU-MDS --- Disease-Specific (Cancer, NPU, MDS)","2016-12-21","2016-12-21","JCML; JCML - Juvenile chronic myeloid leukemia; JMML; Juvenile Chronic Myelogenous Leukemia; Juvenile Myelomonocytic Leukemias; Juvenile chronic myelomonocytic leukemia",""
"phs001243.v1.p1","Genetic Basis of Breast Cancer Resistance in BRCA1 Mutation Carrier","Our study addressed a specific question in NCI RFA-CA-12-022: ""What underlying causal events - e.g., genetic, epigenetic, biologic, behavioral, or environmental - allow certain individuals to survive beyond the expected  limits of otherwise highly lethal cancers?"". A germline mutation in BRCA1 (BRCA1+) is the most penetrant genetic predisposition for breast cancer.","Not Applicable","Breast Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 14 variables, 54 samples sequenced, 54 subjects, 54 samples","","NCI","GRU-PUB --- General Research Use (PUB)","2016-12-15","2017-06-15","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000847.v2.p1","T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)","The Type 2 Diabetes (T2D) Genetic Exploration by Next-generation sequencing in Ethnic Samples (T2D-GENES) Consortium is a collaborative international effort to identify genes influencing susceptibility to type 2 diabetes in  multiple ethnic groups using next generation sequencing. To fulfill this objective, T2D-GENES Consortium undertook two large sequencing studies,","Not Applicable","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","Human-6_Expression_Array, WGS_markerset_grc37, WES_markerset_grc37","Not Provided","3 phenotype datasets, 14 variables, 1098 samples sequenced, 1539 subjects, 2142 samples, 2 substudies","","NIDDK","DS-DIAB-IRB-RD --- Disease-Specific (Diabetes, IRB, RD)","2016-12-13","2016-12-13","Heart Diseases; Kidney Diseases; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II",""
"phs000849.v2.p1","T2D-GENES Project 1: San Antonio Mexican American Family Studies    (SAMAFS), Substudy 1: Whole Exome Sequencing","The Type 2 Diabetes (T2D) Genetic Exploration by Next-generation sequencing in Ethnic Samples (T2D-GENES) Consortium is a collaborative international effort to identify genes influencing susceptibility to type 2 diabetes in  multiple ethnic groups using next generation sequencing. T2D-GENES Project 1 uses whole exome sequencing to identify low frequency or rare variants","T2D-GENES Consortium: San Antonio Mexican American Family Studies (SAMAFS) (phs000847.v2.p1)","Diabetes Mellitus, Type 2","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS), SNP Genotypes (NGS), WXS, WXS","3 phenotype datasets, 40 variables, 1 molecular datasets, 491 samples sequenced,  SRA, 491 subjects, 491 samples","","NIDDK","DS-DIAB-IRB-RD --- Disease-Specific (Diabetes, IRB, RD)","2016-12-13","2016-12-13","Heart Diseases; Kidney Diseases; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II",""
"phs000462.v2.p1","T2D-GENES Project 2: San Antonio Mexican American Family Studies    (SAMAFS), Substudy 2: Whole Genome Sequencing in Pedigrees","The Type 2 Diabetes (T2D) Genetic Exploration by Next-generation sequencing in Ethnic Samples (T2D-GENES) Consortium is a collaborative international effort to identify genes influencing susceptibility to type 2 diabetes in  multiple ethnic groups using next generation sequencing. T2D-GENES Project 2 (San Antonio Mexican American Family Studies [SAMAFS], Substudy 2) is a","T2D-GENES Consortium: San Antonio Mexican American Family Studies (SAMAFS) (phs000847.v2.p1)","Diabetes Mellitus, Type 2","Family/Twin/Trios","Human-6_Expression_Array, WGS_markerset_grc37","SNP Genotypes (NGS), WGS, mRNA Expression (Array), mRNA Expression (Array), WGS, SNP Genotypes (Array), SNP Genotypes (NGS), SNP Genotypes (Array)","3 phenotype datasets, 272 variables, 2 molecular datasets, 607 samples sequenced, 1048 subjects, 1651 samples","European (6), East Asian (1), Hispanic1 (2), Hispanic2 (1016), Other Asian or Pacific Islander (4), Other (6)","NIDDK","DS-DIAB-IRB-RD --- Disease-Specific (Diabetes, IRB, RD)","2016-12-13","2016-12-13","Heart Diseases; Kidney Diseases; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II",""
"phs000488.v2.p1","Genomic Sequencing of Lung Adenocarcinoma","Lung carcinoma is the leading cause of cancer death in the United States and world-wide; lung adenocarcinoma is the most common cause of lung cancer. Pilot studies of lung adenocarcinoma  with hybrid-capture based whole exome sequencing will enable us to identify new targets for therapy and improve diagnosis. We will analyze a blend of","Not Applicable","Carcinoma, Non-Small-Cell Lung","Case Set","Affymetrix_WG_Array","WXS, SNP Genotypes (Array), WGS","4 phenotype datasets, 20 variables, 1 molecular datasets, 430 samples sequenced,  SRA, 208 subjects, 430 samples","","NHGRI","GRU --- General Research Use, DS-CA --- Disease-Specific (Cancer), DS-LC --- Disease-Specific (Lung Cancer), DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2016-12-08","2012-10-18","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001233.v1.p1","Disease Severity in Familial Dysautonomia","Familial Dysautonomia (FD) is a developmental and degenerative genetic disease that manifests in the neural crest cells and peripheral nervous system (PNS). Despite all FD patients having the same mutation  in IKBKAP, patients present with varying disease severity, ranging from mild to severe. We used the human pluripotent stem cell technology to","Not Applicable","Dysautonomia, Familial","Case Set","Not Provided","WXS","4 phenotype datasets, 16 variables, 6 samples sequenced,  SRA, 6 subjects, 6 samples","","NINDS","DS-FDY-COL --- Disease-Specific (Familial Dysautonomia, COL)","2016-11-30","2016-11-30","DYS; Dominant Hereditary Sensory Neuropathy, Type III; FD; Familial Dysautonomia; HSAN (Hereditary Sensory and Autonomic Neuropathy) Type III; HSAN 3",""
"phs000741.v2.p1","Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Lipidomics    Study","The GOLDN study was initiated to assess how genetic factors interact with environmental (diet and drug) interventions to influence blood levels of triglycerides and other atherogenic lipid species and inflammation  markers (registered at clinicaltrails.gov, number NCT00083369). The study recruited Caucasian participants primarily from three-generational","Not Applicable","Metabolomics","Prospective Longitudinal Cohort","Affymetrix_WG_Array, HumanMethylation450","SNP Genotypes (Array), Methylation (CpG)","5 phenotype datasets, 123 variables, 3 molecular datasets, 968 subjects, 968 samples","European (689), Hispanic1 (3), Hispanic2 (2), Other Asian or Pacific Islander (1), Other (1)","NHLBI","DS-CVD-IRB --- Disease-Specific (Cardiovascular Disease, IRB)","2016-11-29","2016-11-29","Cardiovascular Diseases; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs001224.v1.p1","Platinum Genomes","Improvement of variant calling in next-generation sequence data requires a comprehensive, genome-wide catalogue of high-confidence variants called in a set of genomes for use as a benchmark. We generated deep,  whole-genome sequence data of seventeen individuals in a three-generation pedigree and called variants in each genome using a range of currently","Not Applicable","Computational Biology","Control Set","WGS_markerset_grc37, WGS_markerset_grc38","WGS, SNP/CNV Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 molecular datasets, 17 samples sequenced,  SRA, 17 subjects, 17 samples","","NHGRI","GRU --- General Research Use","2016-11-23","2016-11-23","Not Provided",""
"phs000935.v1.p1","Applying Genomic Sequencing in Pediatrics (PediSeq)","The purpose of this research study is to learn more about newer types of genetic testing called whole exome sequencing and whole genome sequencing. Current genetic testing usually examines one  gene or a few genes at a time. Exome and genome sequencing allow us to test most of a person's genes at one time with a single test. This testing","Not Applicable","Genetic Testing","Cross-Sectional","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 22 variables, 1 molecular datasets, 159 samples sequenced,  SRA, 159 subjects, 159 samples","","NHGRI","GRU --- General Research Use","2016-11-23","2016-11-23","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile",""
"phs000827.v3.p1","N.C. Clinical Genomic Evaluation by NextGen Exome Sequencing (NCGENES)","North Carolina Clinical Genomic Evaluation by Next-generation Exome Sequencing This study is part of a larger consortium project investigating the validity and best use of next-generation sequencing (in particular, whole  exome sequencing, or WES) in clinical care. Participants are patients who were either seen in the UNC Cancer and Adult Genetics Clinic or referred to","Not Applicable","Genetic Diseases, Inborn","Case Set","WES_markerset_grc37","SNP Genotypes (NGS)","4 phenotype datasets, 24 variables, 3 molecular datasets, 592 subjects, 592 samples","","NHGRI","GRU --- General Research Use","2016-11-22","2016-11-22","Adenomatous Polyposis Coli; Anemia; Aortic Aneurysm, Thoracic; Arrhythmias, Cardiac; Autoimmune Diseases; Central Nervous System Diseases","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000371.v2.p1","Genetic Modifiers of Huntington's Disease","Huntington's disease (HD) is a neurodegenerative disorder typically diagnosed in mid-life that is caused by expansion of an otherwise polymorphic CAG trinucleotide repeat. The mutation causes a gain-of-function of the  huntingtin protein to trigger a pathogenic process that produces detectable phenotypic differences many years before the traditional diagnosis, which","Not Applicable","Huntington Disease","Prospective Longitudinal Cohort","HumanOmni2.5-8","SNP Genotypes (Array), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets, 221 samples sequenced, 2802 subjects, 3211 samples","European (2679), African (3), East Asian (2), African American (48), Hispanic1 (4), Hispanic2 (43), Other Asian or Pacific Islander (6), South Asian (6), Other (11)","NINDS","GRU --- General Research Use, HDR --- Huntington's Disease Research","2016-11-21","2014-06-12","Chorea, Chronic Progressive Hereditary (Huntington); Chorea, Huntington; Chorea, Huntington's; Chronic Progressive Hereditary Chorea (Huntington); Chronic progressive chorea; Chronic progressive hereditary chorea","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001012.v1.p1","The Diabetes Heart Study (DHS)","The Diabetes Heart Study is a family based study enriched for type 2 diabetes (T2D). The cohort included 1220 self-reported European Americans from 475 families (Bowden et al 2010 Review  of Diabetic Studies 7:188-201: PMID: 21409311; Bowden et al 2008 Annals of Human Genetics 72:598-601 PMID: 18460048) and included siblings concordant","Not Applicable","Cardiovascular Diseases","Cross-Sectional","Affymetrix_WG_Array","SNP Genotypes (Array)","5 phenotype datasets, 29 variables, 1 analyses, 1 molecular datasets, 1177 subjects, 1177 samples","","NHLBI","DS-DRC-IRB --- Disease-Specific (Diabetes and Related Complications, IRB)","2016-11-15","2017-11-15","Diabetes Mellitus; Vascular Calcification; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse",""
"phs001185.v1.p1","Genome-Wide Scan of Early-onset Prostate Cancer","This is a genome-wide association scan of 931 early-onset prostate cancer cases of European ancestry. The samples were selected from prostate cancer studies at the University of Michigan. Controls were  previously genotyped individuals selected from the Cancer Genetics Markers of Susceptibility (CGEMS) and Illumina's iControlDB database. All subjects","Not Applicable","Prostatic Neoplasms","Case-Control","Human660W-Quad","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 931 subjects, 931 samples","","NCI","DS-CA --- Disease-Specific (Cancer)","2016-11-03","2016-11-03","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001223.v1.p1","Analysis of AR Gene Rearrangements in Prostate Cancer","Molecularly-targeted therapies for advanced prostate cancer include castration modalities that suppress ligand-dependent transcriptional activity of the androgen receptor (AR). However, persistent AR signaling undermines therapeutic efficacy and promotes progression to  lethal castration-resistant prostate cancer (CRPC), even when patients are treated with potent second-generation AR-targeted therapies abiraterone","Not Applicable","Prostatic Neoplasms","Case Set","Not Provided","RNA-Seq, OTHER","4 phenotype datasets, 17 variables, 57 samples sequenced, 42 subjects, 57 samples","","NCI","DS-CA-PUB-MDS --- Disease-Specific (Cancer, PUB, MDS)","2016-10-31","2016-10-31","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs001214.v1.p1","DNA and RNA Profiling Using Simultaneous Sequencing (Simul-seq)","Paired DNA and RNA profiling is increasingly employed in genomics research to uncover molecular mechanisms of disease and to explore personal genotype and phenotype correlations. We developed a novel simultaneous  DNA and RNA sequencing approach (Simul-seq) that enables comprehensive genomic and transcriptomic profiles from small quantities of cells or tissues.","Not Applicable","Esophageal Neoplasms","Case Set","Not Provided","WGS, WGA, RNA-Seq","4 phenotype datasets, 22 variables, 13 samples sequenced,  SRA, 2 subjects, 13 samples","","NHGRI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2016-10-31","2016-10-31","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophageal neoplasm; Esophageal tumour; Esophagus Neoplasm",""
"phs001205.v1.p1","Cell Types and Lineages of hESC-Derived Brain Cells","During development of the human brain, multiple cell types with diverse regional identities are generated. Here we report a system to generate early human brain forebrain and mid/hindbrain cell types  from human embryonic stem cells (hESCs), and infer and experimentally confirm a lineage tree for the generation of these types based on single-cell","Not Applicable","Neural Stem Cells","Control Set","RNAseq_probe_set_grc37","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 19 variables, 1 molecular datasets, 472 samples sequenced,  SRA, 2 subjects, 472 samples","","NINDS","GRU-NPU --- General Research Use (NPU)","2016-10-27","2016-10-27","Not Provided",""
"phs000893.v1.p1","Genome-Wide Association Study of Endometrial Cancer in E2C2","Endometrial cancer, the most common gynecological malignancy in the United States, has both an environmental and genetic component. To this end, we conducted a genome-wide association study to identify genes  involved in endometrial cancer using studies from the NCI-supported Epidemiology of Endometrial Cancer Consortium (E2C2). For the discovery stage we","Not Applicable","Carcinoma, Endometrioid","Case-Control","HumanExome-12, Human660W-Quad, HumanOmniExpress-12","SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 1 molecular datasets, 8622 subjects, 8622 samples","","NCI","GRU-MDS --- General Research Use (MDS), GRU-COL-MDS --- General Research Use (COL, MDS), DS-CA --- Disease-Specific (Cancer), DS-EC-MDS --- Disease-Specific (Endometrial Carcinoma, MDS), DS-ENDOMETRIAL-MDS --- Disease-Specific (Endometrial Diseases, MDS), DS-BOED-MDS --- Disease-Specific (Breast, Ovarian, or Endometrial Disease, MDS), DS-CHRONIC --- Disease-Specific (Chronic Diseases), CADM --- Cancer in all age groups, other disease in adults only and methods, HMB-PUB-NPU-MDS-GSO --- Health/Medical/Biomedical (PUB, NPU, MDS, GSO)","2016-10-27","2016-10-27","Uterine Neoplasms; Endometrial Neoplasms; Endometrial Tumor; Endometrial neoplasm; Endometrium Neoplasm; Endometrium Tumor","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs001039.v1.p1","International AMD Genomics Consortium - Exome Chip Experiment","Advanced age-related macular degeneration (AMD) is the leading cause of blindness in the elderly, with limited therapeutic options. To further our understanding of AMD genetics, we examined the contribution of  common and rare genetic variation in the International AMD Genomics Consortium that included 50,000 samples of 26 AMD case - control cohorts that","Not Applicable","Macular Degeneration","Case-Control","HumanCoreExome-24, imputation_panel","SNP/CNV Genotypes (imputed), SNP/CNV Genotypes (NGS)","4 phenotype datasets, 14 variables, 2 molecular datasets, 35358 subjects, 35358 samples","European (32554), African (26), East Asian (1289), African American (398), Hispanic1 (144), Hispanic2 (158), Other Asian or Pacific Islander (492), South Asian (101), Other (196)","NEI","GRU --- General Research Use, DS-AMD --- Disease-Specific (Age-Related Macular Degeneration)","2016-10-26","2017-04-26","Geographic Atrophy; Wet Macular Degeneration; Atrophies, Geographic; Atrophy, Geographic; Degeneration, Dry Macular; Degenerations, Dry Macular","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000991.v1.p1","VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment","The Vanderbilt Electronic Systems for Pharmacogenomic Assessment (VESPA) Project is a large electronic medical record (EMR)- and biobank-based initiative for translational pharmacogenomics discoveries. Key research resources utilized in this effort  include the BioVU DNA databank and associated Synthetic Derivative database of clinical information, and software tools developed to identify drugs","Not Applicable","Dose-Response Relationship, Drug","Cross-Sectional","HumanOmni1-Quad, HumanOmni5-4","Not Provided","2 phenotype datasets, 7 variables, 2252 subjects, 2252 samples, 2 substudies","","NIGMS","HMB --- Health/Medical/Biomedical","2016-10-26","2017-10-26","Not Provided",""
"phs000585.v2.p1","International Consortium for Blood Pressure (ICBP)","The ICBP consortium is an international effort to investigate blood-pressure genetics. The consortium was formed by two parent consortia, the CHARGE-BP consortium (Cohorts for Heart and Aging Research in Genomic  Epidemiology - blood pressure) and the GBPGEN consortium (Global Blood Pressure Genetics Consortium). In 2011 we performed genome-wide association","Not Applicable","Hypertension","Metagenomics","Not Provided","Not Provided","6 analyses","","NHLBI","GRU-IRB --- General Research Use (IRB)","2016-10-26","2016-10-26","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; HBP - High blood pressure",""
"phs000473.v2.p2","Sweden-Schizophrenia Population-Based Case-Control Exome Sequencing","Current findings of the genetic risk of schizophrenia and bipolar disorder emerging from genome wide association studies (GWAS) support a highly polygenic model displaying the full spectrum of causal alleles  that includes the extremes of rare, penetrant alleles as well as common alleles of small effect. Lower frequency polymorphism, rare variants and","Not Applicable","Schizophrenia","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 19 variables, 2 molecular datasets, 12380 samples sequenced,  SRA, 12380 subjects, 12380 samples","","NIMH","GRU --- General Research Use","2016-10-26","2016-10-26","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder","dbGaP Collection: Open Translational Science in Schizophrenia (OPTICS) (phs000887.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000992.v1.p1","VESPA: Genome Wide Study of Ace Inhibitor Cough","The goal of this study was to identify single nucleotide polymorphisms (SNPs) associated with the adverse reaction of cough due to an ace inhibitor. Subjects were identified through the Electronic  Medical Records and Genomics (eMERGE) network, a consortium of medical centers that utilize electronic medical records (EMR) as a tool for genomic","VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment (phs000991.v1.p1)","Cough","Case-Control","HumanOmni1-Quad, HumanOmni5-4","SNP Genotypes (Array), SNP Genotypes (Array)","3 phenotype datasets, 20 variables, 1 molecular datasets, 1697 subjects, 1697 samples","European (1447), African (5), East Asian (10), African American (189), Hispanic1 (11), Hispanic2 (19), Other Asian or Pacific Islander (4), South Asian (8), Other (4)","NIGMS","HMB --- Health/Medical/Biomedical","2016-10-26","2017-10-26","",""
"phs000894.v2.p1","VESPA: Genome Wide Study of Vancomycin","The goal of this study was to identify genetic variants associated with risk for acute kidney injury (AKI) in patients being treated with vancomycin and genetic variants associated with variability  in vancomycin pharmacokinetics. AKI is a common adverse drug event and known complication of vancomycin therapy. Known risk factors fail to","VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment (phs000991.v1.p1)","Acute Kidney Injury","Prospective Longitudinal Cohort","HumanOmni1-Quad","SNP Genotypes (Array)","3 phenotype datasets, 12 variables, 1 molecular datasets, 555 subjects, 555 samples","","NIGMS","HMB --- Health/Medical/Biomedical","2016-10-26","2017-10-26","AKI - acute kidney injury; ARF - Acute renal failure; Acute Kidney Failure; Acute Kidney Failures; Acute Renal Failure; Acute Renal Failures",""
"phs000669.v1.p1","AMBER Consortium","The AMBER Consortium Study was formed to pool interview data, questionnaire data, and biological samples from epidemiological studies of breast cancer in African-American women to discover the potential causes of  early-onset and aggressive breast cancer in African-American women. AMBER is funded through a Program Project grant from the National Cancer","Not Applicable","Breast Neoplasms","Case-Control","imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","4 phenotype datasets, 23 variables, 2 molecular datasets, 6830 subjects, 7127 samples","European (5), African (151), African American (3782), Hispanic1 (42), Other (19)","NCI","DS-BRCA-COL-MDS-GSO --- Disease-Specific (Breast Cancer, COL, MDS, GSO)","2016-10-21","2016-10-21","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000866.v1.p1","Family Genomics of Bipolar Disorder","This study examined the segregation of variants with phenotype in pedigrees harboring bipolar disorder. We chose a subset of individuals within each pedigree so as to maximize power under the  most likely inheritance mode, as follows: (i) We sequenced a single affected individual and a single unaffected individual from pedigrees with a","Not Applicable","Bipolar Disorder","Case-Control","WGS_markerset_grc37","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 87 subjects, 87 samples","","NIMH","DS-PD-RSC-RD --- Disease-Specific (Psychiatric Disorders and Related Somatic Conditions, RD)","2016-10-20","2016-10-20","Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders; Bipolar Mood Disorder",""
"phs000497.v3.p2","Genetic Analysis of Hirschsprung Disease","Hirschsprung disease (HSCR) is a birth defect resulting from the absence of nerve (ganglion) cells in the gastrointestinal tract. Hirschsprung disease has a population incidence of 1/5,000 live births and  most often occurs as an isolated condition. However, approximately 30% of HSCR cases are associated with other birth defects such as Down syndrome,","Not Applicable","Hirschsprung Disease","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 2 molecular datasets, 421 samples sequenced,  SRA, 416 subjects, 421 samples","","NHGRI","DS-HD --- Disease-Specific (Hirschsprung Disease)","2016-10-13","2013-12-03","Aganglionic Megacolon; Aganglionosis; Colonic aganglionosis; Congenital Megacolon; Congenital intestinal aganglionosis; Disease, Hirschsprung",""
"phs001072.v1.p1","Genomic Analysis of Relapsed Pediatric Acute Lymphoblastic Leukemia","Although multi-agent combination chemotherapy is curative in a significant fraction of childhood acute lymphoblastic leukemia (ALL) patients, 20% of cases relapse and most die due to chemo-refractory disease. Here we  used whole-exome and whole-genome sequencing to analyze the mutational landscape and pattern of clonal evolution at relapse in pediatric ALL cases.","Not Applicable","Leukemia, Lymphoid","Tumor vs. Matched-Normal","Not Provided","WXS, WGS","4 phenotype datasets, 21 variables, 179 samples sequenced,  SRA, 57 subjects, 179 samples","","NCI","DS-CA-PUB-MDS-GSO --- Disease-Specific (Cancer, PUB, MDS, GSO)","2016-10-11","2016-10-11","Lymphoblastic Leukemia, Acute, T-Cell; Precursor B-Cell Lymphoblastic Leukemia; Leukemia, Lymphocytic; Leukemias, Lymphocytic; Leukemias, Lymphoid; Lymphatic leukemia",""
"phs001015.v1.p1","Deciphering the Pathophysiology of Chronic Fatigue Syndrome","Myalgic encephalomyelitis, also known as chronic fatigue syndrome or ME/CFS, is a complex and heterogeneous disease that severely impacts the health and quality of life of those afflicted. Several lines  of evidence support the possibility that ME/CFS development may involve a heritable component. In this pilot study, 42 cases that meet the diagnostic","Not Applicable","Fatigue Syndrome, Chronic","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 80 subjects, 80 samples","","NIAID","DS-ME-CFS-IRB --- Disease-Specific (Myalgic Encephalopathy - Chronic Fatigue Syndrome, IRB)","2016-10-04","2016-10-04","Benign myalgic encephalomyelitis; CFS; CFS - Chronic fatigue syndrome; Chronic Fatigue Disorder; Chronic Fatigue Disorders; Chronic Fatigue Fibromyalgia Syndrome",""
"phs001095.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: Ashkenazi","T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) is a NIDDK-funded international research consortium which seeks to identify genetic variants for type 2 diabetes (T2D) through  multiethnic sequencing studies. T2D-GENES Project 1 is a multi-ethnic sequencing study designed to assess whether less common variants play a role in","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 39 variables, 1 molecular datasets, 858 samples sequenced,  SRA, 858 subjects, 867 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-Specific (Type 2 Diabetes, IRB, RD)","2016-09-30","2016-09-30","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000126.v2.p1","CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)","This proposal brings together the two largest NIH funded genetic studies focused on the identification of novel genes that influence the risk of PD. These two studies, PROGENI (PI: Tatiana  Foroud; R01NS037167) and GenePD (PI: Richard Myers; R01NS036711) have been evaluating and recruiting families with two or more PD affected members","Not Applicable","Parkinson Disease","Case-Control","HumanCNV370-Duo","SNP Genotypes (Array)","6 phenotype datasets, 165 variables, 11 documents, 1 analyses, 1 molecular datasets, 1991 subjects, 2082 samples","","NINDS","GRU --- General Research Use, DS-PDRD-NPU --- Disease-Specific (Parkinson's Disease and Related Disorders, NPU)","2016-09-29","2017-09-29","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000923.v1.p1","Molecular Characterization of Germ Cell Tumors","We performed comprehensive molecular profiling of germ cell tumors, including whole exome sequencing and transcriptome sequencing, derived from patient samples. This project additionally explores mechanisms of chemosensivity in these patients,  as well as mechanisms of tumor evolution in the context of treatment. Inclusion: Germ cell tumor Availability of tumor and germline samples Principal","Not Applicable","Male Germ Cell Tumor","Prospective Longitudinal Cohort","other","SNV Aggregate (.MAF), RNA-Seq, WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 142 samples sequenced,  SRA, 55 subjects, 141 samples","","NHGRI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-GCT-MDS --- Disease-Specific (Germ Cell Tumors, MDS)","2016-09-28","2016-09-28","",""
"phs000984.v1.p1","Pharmacogenomics of Metformin Dose Response in T2DM Patients","Type 2 Diabetes Mellitus (T2DM) is a chronic and sometimes debilitating disease that affects millions of adults in the USA. Metformin is commonly prescribed for T2DM; yet some T2DM patients  do not tolerate it or respond well. This pharmacogenomics study will examine response, as both change in T2DM patients' weight and hemoglobin A1c","Not Applicable","Diabetes Mellitus, Type 2","Case Set","HumanOmniExpressExome-8","SNP Genotypes (Array)","7 phenotype datasets, 38 variables, 1 molecular datasets, 202 subjects, 208 samples","European (66), African (5), African American (123), Hispanic1 (3), Hispanic2 (3), Other Asian or Pacific Islander (1), Other (1)","NIGMS","GRU --- General Research Use","2016-09-23","2017-03-23","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000801.v2.p1","NCI Non-Hodgkin Lymphoma GWAS","Within the framework of the International Lymphoma Epidemiology Consortium (InterLymph) Consortium and NCI-sponsored Cohort Consortium, investigators from 22 studies came together to conduct a genome-wide association study (GWAS) of non-Hodgkin  lymphoma (NHL). The goal of the study was to identify common genetic variants associated with the risk of NHL. As described previously (Berndt SI et","Not Applicable","Lymphoma, Non-Hodgkin","Prospective Longitudinal Cohort","HumanOmniExpressExome-8, HumanOmniExpress-12","Not Provided","2 phenotype datasets, 7 variables, 10491 subjects, 10791 samples, 5 substudies","","NCI","DS-CA-IRB-NPU-GSO --- Disease-Specific (Cancer, IRB, NPU, GSO), DS-NHL-NPU-GSO --- Disease-Specific (non-Hodgkin Lymphoma, NPU, GSO), GRU-NPU-MDS --- General Research Use (NPU, MDS)","2016-09-22","2016-09-22","Lymphoma, Follicular; B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade",""
"phs000891.v1.p1","NCI Non-Hodgkin Lymphoma GWAS: MZL","This sub-study phs000891 NCI Non-Hodgkin Lymphoma GWAS: MZL contains genotype and subject and sample phenotype of subjects available from the phs000891 study. Summary level phenotypes for the NCI Non-Hodgkin Lymphoma  GWAS study participants can be viewed at the top-level study page phs000801 NCI Non-Hodgkin Lymphoma GWAS. Marginal zone lymphoma (MZL) encompasses a","National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS) (phs000801.v2.p1)","Lymphoma, Non-Hodgkin","Case Set","HumanOmniExpress-12","SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 825 subjects, 839 samples","","NCI","DS-CA-IRB-NPU-GSO --- Disease-Specific (Cancer, IRB, NPU, GSO), DS-NHL-NPU-GSO --- Disease-Specific (non-Hodgkin Lymphoma, NPU, GSO), GRU-NPU-MDS --- General Research Use (NPU, MDS)","2016-09-22","2016-09-22","Lymphoma, B-Cell, Marginal Zone; Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue; Extranodal marginal zone B-cell lymphoma; Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT-lymphoma); Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue; Immunocytoma",""
"phs000890.v1.p1","NCI Non-Hodgkin Lymphoma GWAS: FL","This sub-study phs000890 NCI Non-Hodgkin Lymphoma GWAS: FL contains genotype and subject and sample phenotype of subjects available from the phs000890 study. Summary level phenotypes for the NCI Non-Hodgkin Lymphoma  GWAS study participants can be viewed at the top-level study page phs000801 NCI Non-Hodgkin Lymphoma GWAS. Genome-wide association studies (GWAS) of","National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS) (phs000801.v2.p1)","Lymphoma, Non-Hodgkin","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 2142 subjects, 2186 samples","","NCI","DS-CA-IRB-NPU-GSO --- Disease-Specific (Cancer, IRB, NPU, GSO), DS-NHL-NPU-GSO --- Disease-Specific (non-Hodgkin Lymphoma, NPU, GSO), GRU-NPU-MDS --- General Research Use (NPU, MDS)","2016-09-22","2016-09-22","Lymphoma, Follicular; Non-Hodgkin Lymphoma; Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers",""
"phs000889.v1.p1","NCI Non-Hodgkin Lymphoma GWAS: DLBCL","This sub-study phs000889 NCI Non-Hodgkin Lymphoma GWAS: DLBCL contain genotype and subject and sample phenotype of subjects available from the phs000889 study. Summary level phenotypes for the NCI Non-Hodgkin Lymphoma  GWAS study participants can be viewed at the top-level study page phs000801 NCI Non-Hodgkin Lymphoma GWAS. Diffuse large B-cell lymphoma (DLBCL) is a","National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS) (phs000801.v2.p1)","Lymphoma, Non-Hodgkin","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 2661 subjects, 2706 samples","","NCI","DS-CA-IRB-NPU-GSO --- Disease-Specific (Cancer, IRB, NPU, GSO), DS-NHL-NPU-GSO --- Disease-Specific (non-Hodgkin Lymphoma, NPU, GSO), GRU-NPU-MDS --- General Research Use (NPU, MDS)","2016-09-22","2016-09-22","Centroblastic diffuse large B-cell malignant lymphoma; Centroblastic diffuse malignant lymphoma; Centroblastic malignant lymphoma; DLBCL; DLBCL - diffuse large B cell lymphoma; Diffuse Histiocytic Lymphoma",""
"phs000818.v2.p1","NCI Non-Hodgkin Lymphoma GWAS: Controls","This sub-study phs000818 NCI Non-Hodgkin Lymphoma GWAS: Controls contains genotype and subject and sample phenotype of subjects available from the phs000818 study. Summary level phenotypes for the NCI Non-Hodgkin Lymphoma  GWAS study participants can be viewed at the top-level study page phs000801 NCI Non-Hodgkin Lymphoma GWAS. Within the framework of the International","National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS) (phs000801.v2.p1)","Lymphoma, Non-Hodgkin","Prospective Longitudinal Cohort","HumanOmniExpressExome-8","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 2685 subjects, 2835 samples","","NCI","DS-CA-IRB-NPU-GSO --- Disease-Specific (Cancer, IRB, NPU, GSO), DS-NHL-NPU-GSO --- Disease-Specific (non-Hodgkin Lymphoma, NPU, GSO), GRU-NPU-MDS --- General Research Use (NPU, MDS)","2016-09-22","2016-09-22","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum Cell Sarcomas; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma",""
"phs000802.v2.p1","NCI Non-Hodgkin Lymphoma GWAS: CLL","This sub-study phs000802 NCI Non-Hodgkin Lymphoma GWAS: CLL contains genotype and subject and sample phenotype data from subjects available from the phs000802 study. Summary level phenotypes for the NCI Non-Hodgkin  Lymphoma GWAS study participants can be viewed at the top-level study page phs000801 NCI Non-Hodgkin Lymphoma GWAS. Individual level phenotype data","National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS) (phs000801.v2.p1)","Lymphoma, Non-Hodgkin","Prospective Longitudinal Cohort","HumanOmniExpressExome-8","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 2178 subjects, 2225 samples","","NCI","DS-CA-IRB-NPU-GSO --- Disease-Specific (Cancer, IRB, NPU, GSO), DS-NHL-NPU-GSO --- Disease-Specific (non-Hodgkin Lymphoma, NPU, GSO), GRU-NPU-MDS --- General Research Use (NPU, MDS)","2016-09-22","2016-09-22","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs001111.v1.p1","A Prognostic Role of APC in Colorectal Cancers","Colorectal cancer (CRC) is a highly heterogeneous disease, for which prognosis has been relegated to clinic-pathologic staging for decades. There is a need to molecularly stratify subpopulations of CRC to  better predict outcome and assign therapies. Here we report targeted exome sequencing of 1,321 cancer-related genes on 468 tumor specimens, which","Not Applicable","Colorectal Neoplasms","Case Set","Not Provided","Targeted-Capture","4 phenotype datasets, 29 variables, 468 samples sequenced,  SRA, 468 subjects, 468 samples","","NCI","GRU --- General Research Use","2016-09-21","2016-09-21","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001044.v1.p1","Breast Cancer Risk Pathways","We sought to identify genomic variants that differed between individuals who developed familial breast cancer and individuals who had a family history of breast cancer but who had not developed  breast cancer. We aggregated these data at the pathway level to identify pathways that play a role in familial breast cancer development. We profiled","Not Applicable","Breast Neoplasms","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 35 samples sequenced,  SRA, 35 subjects, 35 samples","","NCI","GRU --- General Research Use","2016-09-19","2016-09-19","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001127.v1.p1","Genomic Analysis of Paired Endometrial Cancer Primaries and Metastases","Formation of metastases is the major cause of cancer related deaths. Recent studies have sequenced primary endometrial carcinomas yielding data for a single entity in the progression from the birth  of a progenitor tumor cell to metastatic disease. However, the progression of these tumors to metastases has not been characterized. We performed","Not Applicable","Endometrial Neoplasms","Case Set","Affymetrix_WG_Array","SNP Genotypes (Array), WXS","4 phenotype datasets, 17 variables, 1 molecular datasets, 126 samples sequenced, 52 subjects, 143 samples","","NHGRI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2016-09-15","2016-09-15","Neoplasm Metastasis; Endometrial Tumor; Endometrial neoplasm; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium",""
"phs000770.v1.p1","Somatic Mutation Profile by Next Generation Sequencing in HER2+ Breast    Cancer","The HER pathway is the driving force behind 30% of human breast cancers. It is important to understand how targeted therapies block different cellular pathways, and mechanisms of escape from  this blockage. Therapies directed at HER2 establish a successful treatment paradigm, but de novo and acquired resistance exist. The HER signaling","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 13 variables, 29 samples sequenced, 14 subjects, 29 samples","","NHGRI","GRU --- General Research Use","2016-09-02","2016-09-02","Neoplasm, Residual; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors",""
"phs000937.v1.p1","The Landscape of Antisense Gene Expression in Human Cancers","High throughput RNA Sequencing has revealed that the human genome is widely transcribed. However, the extent of natural antisense transcription, the molecular mechanisms by which natural antisense transcripts (NATs) might  affect their cognate sense genes, and the role of NATs in cancer are less well understood. Here, we use strand-specific paired-end RNA sequencing","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 376 samples sequenced, 376 subjects, 376 samples","","NCI","DS-CA-NPU-MDS --- Disease-Specific (Cancer, NPU, MDS), DS-LC-MDS --- Disease-Specific (Lung Cancer, MDS)","2016-08-24","2016-08-24","Carcinoma, Merkel Cell; Hodgkin Disease; Lung Neoplasms; Meningioma; Sarcoma; ADENOCARCINOMA OF LUNG",""
"phs001074.v1.p1","GeneSTAR NextGen Functional Genomics of Platelet Aggregation","The causal mechanisms of common diseases and their therapies have been only marginally illuminated by genetic variants identified in genome wide association studies (GWAS) utilizing single nucleotide polymorphism (SNPs). Platelet  activation pathways reflecting hemostasis and thrombosis are the underlying substrate for many cardiovascular diseases and related acute events. To","Not Applicable","Platelet Aggregation","Prospective Longitudinal Cohort","MEGA_Consortium_Array, HumanExome-12","SNP Genotypes (Array)","5 phenotype datasets, 125 variables, 10 documents, 1 molecular datasets, 250 subjects, 440 samples","European (136), African (2), African American (108), Hispanic1 (3), Other (1)","NHLBI","DS-CVD-IRB-NPU-RD --- Disease-Specific (Cardiovascular Disease, IRB, NPU, RD)","2016-08-23","2016-08-23","Not Provided",""
"phs001151.v1.p1","Region-Specific Transcriptome Analysis of the Human Retina and    RPE/Choroid","Proper spatial differentiation of retinal cell types is necessary for normal human vision. Many retinal diseases, such as Best disease and male germ cell associated kinase (MAK)-associated retinitis pigmentosa, preferentially  affect distinct topographic regions of the retina. While much is known about the distribution of cell types in the retina, the distribution of","Not Applicable","Retina","Control Set","Not Provided","RNA-Seq","4 phenotype datasets, 24 variables, 29 samples sequenced,  SRA, 5 subjects, 29 samples","","NEI","GRU-NPU --- General Research Use (NPU)","2016-08-15","2016-08-15","Not Provided",""
"phs000888.v1.p1","eMERGE Network Imputed GWAS for 41 Phenotypes","The electronic Medical Records and Genomics (eMERGE) Network is a consortium of ten participating sites (Cincinnati Children's Hospital Medical Center/Boston Children's Hospital, Children's Hospital of Philadelphia, Essentia Institute of Rural  Health, Marshfield Clinic Research Foundation and Pennsylvania State University, Geisinger Clinic, Group Health Cooperative/University of Washington,","Not Applicable","Genome-Wide Association Study","Case-Control","imputation_panel","SNP Genotypes (imputed)","46 phenotype datasets, 394 variables, 39 documents, 2 molecular datasets, 55029 subjects, 55029 samples","European (40624), African (532), East Asian (267), African American (11129), Hispanic1 (1229), Hispanic2 (518), Other Asian or Pacific Islander (190), South Asian (136), Other (404)","NHGRI","HMB --- Health/Medical/Biomedical, DS-DEM --- Disease-Specific (Dementia), HM-B-GSO-NIC --- Health/Medical/Biomedical - Genetic Studies Only-No Insurance Companies, HMB-GSO --- Health/Medical/Biomedical (GSO), GRU --- General Research Use, DS-CHILDD --- Disease-Specific (Childhood Diseases)","2016-08-11","2017-05-10","Aortic Aneurysm, Abdominal; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Carotid Artery Diseases; Colonic Polyps",""
"phs000360.v3.p1","eMERGE Network Combined Dataset","The electronic Medical Records and Genomics (eMERGE) Network is a consortium of five participating sites (Group Health Seattle, Marshfield Clinic, Mayo Clinic, Northwestern University, and Vanderbilt University) funded by the  NHGRI to investigate the use of electronic medical record systems for genomic research. The goal of eMERGE is to conduct genome-wide association","Not Applicable","Electronic Health Records","Case-Control","Human660W-Quad","SNP Genotypes (Array)","6 phenotype datasets, 94 variables, 9 documents, 4 analyses, 1 molecular datasets, 18663 subjects, 18663 samples","European (15595), African (65), East Asian (86), African American (2702), Hispanic1 (60), Hispanic2 (79), Other Asian or Pacific Islander (35), South Asian (14), Other (27)","NHGRI","HMB --- Health/Medical/Biomedical, DS-DEM --- Disease-Specific (Dementia), HM-B-GSO-NIC --- Health/Medical/Biomedical - Genetic Studies Only-No Insurance Companies, HMB-GSO --- Health/Medical/Biomedical (GSO)","2016-08-11","2017-08-11","Chronic Disease; Diabetic Retinopathy; Hematologic Diseases; Hypothyroidism; Chronic Diseases; Chronic Illness",""
"phs001101.v1.p1","MIGen_ExS: MDC","The Malmo Diet and Cancer Study (MDCS) is a community-based prospective epidemiologic cohort of 28,449 subjects who were recruited for baseline examination between 1991 and 1996. From this cohort, 6103  subjects were randomly selected to participate in a cardiovascular cohort (MDCSCC), which seeks to investigate risk factors for cardiovascular","Not Applicable","Myocardial Infarction","Case-Control","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 10 variables, 1 molecular datasets, 1081 samples sequenced, 1081 subjects, 1081 samples","","NHLBI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2016-08-10","2016-08-10","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs000840.v1.p1","GoT2D","The Genetics of Type 2 Diabetes Consortium (GoT2D) is a collaboration between the University of Michigan, the Broad Institute and the Wellcome Trust Centre for Human Genetics. The overall aim  is to extend upon recent efforts, such as genome-wide association studies (GWAS) and large scale meta-analyses. While they have proved successful at","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","WGS_markerset_grc37","WGS, SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 33 variables, 1 molecular datasets, 4617 samples sequenced,  SRA, 2348 subjects, 6965 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-Specific (Type 2 Diabetes, IRB, RD)","2016-08-10","2016-08-10","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000337.v1.p1","Genetic Basis of Developmental Disabilities","Developmental disabilities are birth defects that cause lifelong problems with how a body part or system works. Developmental disabilities include nervous system insults affecting how the brain, spinal cord and  nervous system function; they cause intellectual disability, including Down syndrome and fragile X syndrome; and they also cause learning and","Not Applicable","Intellectual Disability","Family/Twin/Trios","HumanExome-12, HumanOmni1-Quad, Affymetrix_WG_Array","WXS, WGS, SNP Genotypes (Array)","5 phenotype datasets, 37 variables, 1 molecular datasets, 90 samples sequenced,  SRA, 94 subjects, 184 samples","","NICHD","GRU-GSO --- General Research Use (GSO), DS-DD-GSO-RD --- Disease-Specific (Developmental Disabilities, GSO, RD)","2016-07-29","2017-07-29","Self-Injurious Behavior; ASD; AUTISM SPECTRUM DISORDER; Autism spectrum disorders; Autistic Spectrum Disorder; Autistic Spectrum Disorders",""
"phs000916.v1.p1","MIGen_ExS: Munich-MI","The Munich-MI study is a case-control cohort study recruited at the German Heart Center in Munich, Germany. It is focused on understanding the genetic contributors to early myocardial-infarction (MI) in  the German population. All exome sequencing was performed at the Broad Institute of Harvard and MIT; samples sequence capture was performed using","Not Applicable","Coronary Artery Disease","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 799 samples sequenced, 799 subjects, 799 samples","","NHLBI","DS-CVD-NPU --- Disease-Specific (Cardiovascular Disease, NPU)","2016-07-28","2016-07-28","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery",""
"phs000701.v1.p1","Efficacy of a Therapeutic Treatment Trial in Angelman Syndrome","This study has been designed to evaluate the possible therapeutic benefits of L-5-methyltetrahydrofolate (Metafolin), vitamin B12, creatine and betaine in children with Angelman Syndrome (AS). This study is based on  the hypotheses 1) that dietary manipulation may increase global DNA methylation; 2) that increased methylation of the paternal chromosome in AS","Not Applicable","Angelman Syndrome","Interventional","Not Provided","Not Provided","20 phenotype datasets, 2419 variables, 16 documents, 91 subjects","","NCATS","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2016-07-28","2016-07-28","AS; Angelmans syndrome; Angelman syndrome chromosome region; Angelman's syndrome; Children, Puppet; HAPPY PUPPET SYNDROME",""
"phs001023.v1.p1","Male Infertility: Genetics of Spermatogenic Failure","Spermatogenesis is a complex biological process that requires the coordination of thousands of genes. Perhaps because of the large number of genes involved, spermatogenic failure occurs frequently and affects approximately  1% of men. While environmental and genetic factors likely contribute to this disorder, it is thought that the majority of cases have an underlying","Not Applicable","Azoospermia","Case-Control","Not Provided","WXS","4 phenotype datasets, 13 variables, 601 samples sequenced,  SRA, 601 subjects, 601 samples","","NHGRI","DS-RD --- Disease-Specific (Reproductive Disorders)","2016-07-18","2016-07-18","Not Provided",""
"phs000839.v1.p1","Bitter Blockers (BB)","The goal of this project is to determine variation in human bitter perception and the effectiveness of bitter blockers in individuals of different genotypes. The project is based on the  parent project titled ""Efficacy of bitter taste blockers on flavor acceptance in pediatric population"", which addresses how bitter taste perception","Not Applicable","Taste Perception","Control Set","HumanOmni2.5-8, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","4 phenotype datasets, 114 variables, 1 analyses, 2 molecular datasets, 139 subjects, 145 samples","European (28), African (1), African American (97), Hispanic1 (5), Hispanic2 (3), Other Asian or Pacific Islander (3), South Asian (1), Other (1)","NIDCD","GRU-PUB --- General Research Use (PUB)","2016-07-18","2017-05-18","Not Provided",""
"phs001167.v1.p1","Type 2 Diabetes in African Americans, GWAS and Exome Sequencing","The T2D Seq GWAS AA Cohort is utilized in the following dbGaP sub-studies. To view genotypes, other molecular data, and derived variables collected in these sub-studies, please click on the  following sub-studies below or in the ""Sub-studies"" section of this top-level study page phs001167 T2D Seq GWAS AA Cohort. phs000140 CIDR T2D Bowdens","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","Affymetrix_WG_Array, WES_markerset_grc37","Not Provided","2 phenotype datasets, 13 variables, 1050 samples sequenced,  SRA, 3054 subjects, 3192 samples, 2 substudies","","NIDDK","DS-T2D-IRB-RD --- Disease-Specific (Type 2 Diabetes, IRB, RD)","2016-07-13","2016-07-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001166.v1.p1","Type 2 Diabetes Starr County GWAS and Exome Sequencing","The T2D Seq GWAS Starr County Cohort is utilized in the following dbGaP sub-studies. To view genotypes, other molecular data, and derived variables collected in these sub-studies, please click on  the following sub-studies below or in the ""Sub-studies"" section of this top-level study page phs001166 T2D Seq GWAS Starr County Cohort. phs000143","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","Affymetrix_WG_Array, WES_markerset_grc37","Not Provided","2 phenotype datasets, 11 variables, 1457 samples sequenced,  SRA, 1997 subjects, 2121 samples, 2 substudies","","NIDDK","GRU-IRB --- General Research Use (IRB)","2016-07-13","2016-07-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001102.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: Wake Forest African    American","This sub-study phs001102 T2D GENES AA contains genotype data and selected phenotype of subjects available from the phs001102 study. Summary level phenotypes for the NIDDK T2D Seq GWAS AA Cohort  study participants can be viewed at the top-level study page phs001167 T2D Seq GWAS AA Cohort. Individual level phenotype data and molecular data for","Type 2 Diabetes in African Americans, GWAS and Exome Sequencing (phs001167.v1.p1)","Bacterial Infections and Mycoses","Case-Control","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 16 variables, 1 molecular datasets, 1050 samples sequenced,  SRA, 1050 subjects, 1050 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-Specific (Type 2 Diabetes, IRB, RD)","2016-07-13","2016-07-13","",""
"phs001099.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: Starr County","This sub-study phs001099 T2D GENES Starr County contains genotype data and selected phenotype of subjects available from the phs001099 study. Summary level phenotypes for the NIDDK T2D Seq GWAS Starr  County Cohort study participants can be viewed at the top-level study page phs001166 T2D Seq GWAS Starr County Cohort. Individual level phenotype","Type 2 Diabetes Starr County GWAS and Exome Sequencing (phs001166.v1.p1)","Diabetes Mellitus, Type 2","Case-Control","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS)","2 phenotype datasets, 29 variables, 1 molecular datasets, 1457 samples sequenced,  SRA, 1474 subjects, 1457 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2016-07-13","2016-07-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000143.v2.p1","Starr County Health Studies' Genetics of Diabetes Study","This sub-study phs000143 CIDR T2D Hanis contains genotype data and selected phenotype of subjects available from the phs000143 study. Summary level phenotypes for the NIDDK T2D Seq GWAS Starr County  Cohort study participants can be viewed at the top-level study page phs001166 T2D Seq GWAS Starr County Cohort. Individual level phenotype data and","Type 2 Diabetes Starr County GWAS and Exome Sequencing (phs001166.v1.p1)","Diabetes Mellitus, Type 2","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","2 phenotype datasets, 28 variables, 1 molecular datasets, 1980 subjects, 2121 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2016-07-13","2016-07-13","Diabetic Retinopathy; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset",""
"phs000140.v2.p1","A Whole Genome Association Search for Type 2 Diabetes Genes in African    Americans","This sub-study phs000140 CIDR T2D Bowden contains genotype data and selected phenotype of subjects available from the phs000140 study. Summary level phenotypes for the NIDDK T2D Seq GWAS AA Cohort  study participants can be viewed at the top-level study page phs001167 T2D Seq GWAS AA Cohort. Individual level phenotype data and molecular data for","Type 2 Diabetes in African Americans, GWAS and Exome Sequencing (phs001167.v1.p1)","Diabetes Mellitus, Type 2","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 52 variables, 2 documents, 1 molecular datasets, 2004 subjects, 2142 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-Specific (Type 2 Diabetes, IRB, RD)","2016-07-13","2016-07-13","Diabetic Nephropathies; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset",""
"phs001097.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: Singapore","T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) is a NIDDK-funded international research consortium which seeks to identify genetic variants for type 2 diabetes (T2D) through  multiethnic sequencing studies. T2D-GENES Project 1 is a multi-ethnic sequencing study designed to assess whether less common variants play a role in","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 39 variables, 1 molecular datasets, 2226 samples sequenced,  SRA, 2226 subjects, 2226 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-Specific (Type 2 Diabetes, IRB, RD)","2016-07-08","2016-08-10","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001093.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: UK South Asian","T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) is a NIDDK-funded international research consortium which seeks to identify genetic variants for type 2 diabetes (T2D) through  multiethnic sequencing studies. T2D-GENES Project 1 is a multi-ethnic sequencing study designed to assess whether less common variants play a role in","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 36 variables, 1 molecular datasets, 1068 samples sequenced,  SRA, 1068 subjects, 1068 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-Specific (Type 2 Diabetes, IRB, RD)","2016-07-08","2016-07-08","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs001096.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: KARE","T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) is a NIDDK-funded international research consortium which seeks to identify genetic variants for type 2 diabetes (T2D) through  multiethnic sequencing studies. T2D-GENES Project 1 is a multi-ethnic sequencing study designed to assess whether less common variants play a role in","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 38 variables, 1 molecular datasets, 1087 samples sequenced,  SRA, 1087 subjects, 1087 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-Specific (Type 2 Diabetes, IRB, RD)","2016-07-07","2016-07-07","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000986.v1.p1","Genetic Basis of Cryptorchidism","Non-syndromic cryptorchidism is a common malformation, but the genetic loci that increase susceptibility to cryptorchidism remain unknown. A genome-wide association study (GWAS) was completed to determine whether common allelic variants  are associated with susceptibility to cryptorchidism. Two sets of discovery groups were genotyped. Group 1 (559 cases and 1772 controls) was","Not Applicable","Cryptorchidism","Case-Control","Not Provided","Not Provided","2 analyses","","NICHD","DS-CRYPT-PUB-COL-NPU-GSO --- Disease-Specific (Cryptorchidism, PUB, COL, NPU, GSO)","2016-07-05","2017-07-05","Cryptorchidism (unilateral or bilateral); Cryptorchidism, Unilateral Or Bilateral; Cryptorchism; IDT - Imperfectly descended testis; Imperfectly descended testis; Maldescent of testis",""
"phs001112.v1.p1","Chromosome X Mosaicism Methylation Study","This study investigates methylation patterns in promoter regions on the X chromosomes of females with X chromosome mosaicism in an effort to phase mosaic events to either the active or  inactive X chromosome. Females with genotyping array detected X mosaic events greater than 2 Mb in size and with available DNA Principal","Not Applicable","Neoplasms","Case Set","HumanMethylation450","Methylation (CpG)","4 phenotype datasets, 14 variables, 1 molecular datasets, 33 subjects, 33 samples","","NCI","O-MDS_ONLY --- Methods Only","2016-07-01","2016-07-01","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs000955.v1.p1","Genetic Components of Knee Osteoarthritis (GeCKO) Study: OAI","The Osteoarthritis Initiative (OAI) is a publicly and privately funded prospective longitudinal cohort with a primary objective of identifying risk factors for incidence and progression of tibiofemoral knee OA. The  OAI utilized a focused population-based recruitment to enroll 4,674 men and women between the ages of 45-79 years who either had radiographic","Not Applicable","Osteoarthritis","Prospective Longitudinal Cohort","HumanOmni2.5-4","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 documents, 1 molecular datasets, 4129 subjects, 4129 samples","European (3341), African (15), African American (738), Hispanic1 (22), Hispanic2 (7), Other Asian or Pacific Islander (1), Other (5)","NIAMS","DS-OA-RD --- Disease-Specific (Osteoarthritis, RD)","2016-06-29","2016-06-29","Arthritides, Degenerative; Arthritis, Degenerative; Arthrosis; Degenerative Arthritides; Degenerative Arthritis; Degenerative arthropathy",""
"phs001115.v1.p1","Tissue Specimens from Patients with Melanoma for Genetic Analysis","The purpose of this study was to obtain tissue specimens derived from patients with melanoma to generate research tools to advance our understanding of the genetics, pathogenesis, and therapeutics of  melanoma. Briefly, tissue was obtained from metastatic lesions and used to generate clonal primary cell lines from melanoma cells and fibroblasts","Not Applicable","Melanoma, Cutaneous Malignant","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 20 variables, 1 documents, 6 samples sequenced,  SRA, 3 subjects, 6 samples","","NCI","GRU --- General Research Use","2016-06-27","2016-06-27","CMM; Cutaneous Malignant Melanoma; Cutaneous melanoma; MELANOMA, MALIGNANT; MM (malignant melanoma) of skin; Malignant Cutaneous Melanoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000823.v1.p1","Discovery of Novel Melanoma Predisposing Mutations by Exome Sequencing","Melanoma risk shows clear heritability, but the inherited genetic factors remain largely unknown. Rare high risk mutations in CDKN2A, CDK4, BAP1 and TERT have been described but these variants, in  aggregate, account for less than 50% of the kindreds reporting a family history of melanoma. This project will seek to identify new genes which may","Not Applicable","Melanoma","Case Set","WES_markerset_grc37","WXS, SNP Genotypes (NGS)","4 phenotype datasets, 12 variables, 1 molecular datasets, 387 samples sequenced, 387 subjects, 387 samples","","NHGRI","DS-CA --- Disease-Specific (Cancer), GRU --- General Research Use, DS-UM-NPU --- Disease-Specific (Uveal Melanoma, NPU)","2016-06-21","2017-06-21","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs000205.v6.p2","International Standards for Cytogenomic Arrays","The International Standards for Cytogenomic Arrays (ISCA) Consortium is a rapidly growing group of clinical cytogenetics and molecular genetics laboratories committed to improving quality of patient care related to clinical  genetic testing using new molecular cytogenetic technologies including array comparative genomic hybridization (aCGH) and quantitative SNP analysis","Not Applicable","Developmental Disabilities","Case Set","Cytogenetic_Arrays","CNV Genotypes","4 phenotype datasets, 18 variables, 4 molecular datasets, 53936 subjects, 49013 samples","","NICHD","GRU --- General Research Use","2016-06-20","2017-06-20","Congenital Abnormalities; AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000617.v1.p1","KCNE1Polymorphism as Possible Modulator of Drug-Induced TdP","The goal of this study was to search for genetic variants that could be responsible for modifying the risk of drug-induced long QT syndrome (diLQTS). diLQTS is a relatively common  adverse drug event and has been a leading cause for drug relabeling and withdrawal from the market. Our hypothesis, that variants in genes which","Not Applicable","Long QT Syndrome","Case-Control","GoldenGate_Array","SNP Genotypes (Array)","4 phenotype datasets, 23 variables, 1 molecular datasets, 290 subjects, 290 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2016-06-16","2017-06-16","Torsades de Pointes; Electrocardiogram QT Prolonged; Increased QT interval; Long Q-T syndrome; Long QT syndrome; Prolong QT interval","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000932.v1.p1","Somatic Reference Standard for Cancer Sequencing","In this study, we separately performed PCR-free whole genome sequencing on the paired tumor/normal melanoma COLO-829 and lymphoblastoid COLO-829BL cell lines across three separate institutions (TGen, Illumina, Genome Sciences Centre  at the British Columbia Cancer Agency). We performed a meta-analysis of all data, in combination with the originally reported analysis of these cell","Not Applicable","Melanoma","Tumor vs. Matched-Normal","WGS_markerset_grc37","WGA, SNP Genotypes (NGS)","4 phenotype datasets, 17 variables, 1 molecular datasets, 8 samples sequenced,  SRA, 1 subjects, 8 samples","","NCI","GRU --- General Research Use","2016-06-15","2016-06-15","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs001041.v1.p1","Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma","Immune checkpoint inhibitors are effective cancer treatments, but molecular determinants of clinical benefit are unknown. Ipilimumab and tremelimumab are antibodies against cytotoxic T-lymphocyte antigen 4 (CTLA-4). Anti-CTLA-4 treatment prolongs overall  survival in patients with melanoma. CTLA-4 blockade activates T cells and enables them to destroy tumor cells. We obtained tumor tissue from patients","Not Applicable","Melanoma","Prospective Longitudinal Cohort","other","WXS, SNP Genotypes (NGS)","4 phenotype datasets, 41 variables, 1 molecular datasets, 128 samples sequenced,  SRA, 64 subjects, 128 samples","","NCI","HMB-PUB-NPU-MDS --- Health/Medical/Biomedical (PUB, NPU, MDS)","2016-06-10","2016-06-10","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs000895.v1.p1","Integrated Genomic Analysis of Periampullary Tumors","Adenocarcinomas arising in the complex environment of the ampulla of Vater constitute a histopathological heterogenous group, presumably originating from the different epithelial cellular constituents present at the site: pancreas, bile  duct, and intestinal duodenum. These tumors have been described in many different ways: intra-ampullary, periampullary, intra-ampullary","Not Applicable","Gastrointestinal Neoplasms","Prospective Longitudinal Cohort","Not Provided","WXS, OTHER","4 phenotype datasets, 19 variables, 320 samples sequenced,  SRA, 160 subjects, 320 samples","","NHGRI","GRU --- General Research Use","2016-06-10","2016-06-10","Cancer of Gastrointestinal Tract; Cancer of the Gastrointestinal Tract; Cancer, Gastrointestinal; Cancers, Gastrointestinal; Gastrointestinal Cancer; Gastrointestinal Cancers",""
"phs000911.v1.p1","Type 1 Diabetes Genetics Consortium (T1DGC): ImmunoChip Study","The Type 1 Diabetes Genetics Consortium (T1DGC) was formed to address issues of limited sample size and consistency of phenotyping that had limited genetic investigations on risk of type 1  diabetes (T1D). The T1DGC first collected affected sib pair (ASP) families from four geographic networks (Asia-Pacific, Europe, North America, United","Not Applicable","Diabetes Mellitus, Type 1","Case-Control","custom_markerset","SNP Genotypes (Array)","6 phenotype datasets, 31 variables, 1 molecular datasets, 17460 subjects, 17460 samples","","NIDDK","DS-T1DR-IRB-RD --- Disease-Specific (Type 1 diabetes, its complications and other autoimmune diseases, IRB, RD)","2016-06-09","2016-06-09","Autoimmune Diseases; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset",""
"phs001107.v1.p1","Patient-Specific Factors Influence Somatic Variations in VHL Tumors","Patients affected with von Hippel-Lindau disease are at risk of developing multiple independent clear cell renal carcinomas. This study performed whole genome sequencing on 40 tumors from 6 VHL patients  to compare somatic variation patterns within and between patients. Although tumors from the same patient showed many differences, within-patient","Not Applicable","von Hippel-Lindau Disease","Tumor vs. Matched-Normal","WES_markerset_grc37","SNP Genotypes (NGS), WGS","4 phenotype datasets, 33 variables, 1 molecular datasets, 51 samples sequenced,  SRA, 6 subjects, 51 samples","","NCI","DS-RCC-IRB --- Disease-Specific (Kidney Cancer, IRB)","2016-06-08","2016-06-08","Angiomatoses, Familial Cerebello-Retinal; Angiomatoses, Familial Cerebelloretinal; Angiomatosis Retinae; Angiomatosis, Familial Cerebello-Retinal; Angiomatosis, Familial Cerebelloretinal; Cerebello-Retinal Angiomatoses, Familial",""
"phs000886.v1.p1","An Omics View of Asthma through Monozygotic Twins","The etiology of asthma involves both genetic and non-genetic factors. We performed whole transcriptome sequencing on monozygotic twins discordant or concordant for asthma (with concordant healthy twins as controls), and  identified multiple potential transcriptomic profiles associated with the asthma phenotype. We included only monozygotic twins in our study, who were","Not Applicable","Asthma","Case-Control","Not Provided","RNA-Seq","5 phenotype datasets, 27 variables, 1 documents, 74 samples sequenced,  SRA, 74 subjects, 74 samples","","NHLBI","GRU --- General Research Use","2016-06-08","2016-06-08","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000961.v1.p1","eMERGE III: Columbia GENIE (Genomic Integration with EHR)","The Columbia GENIE study contributes and shares phenotype and genotype data for individuals who were treated with our healthcare facilities and consented to share their data with dbGaP for scientific  discovery. Some of these individuals have kidney or neurological problems and some are healthy volunteers from the Washington Height patient","Not Applicable","Genomic Medicine","Case-Control","Affymetrix_WG_Array, MEGA_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 33 variables, 1 molecular datasets, 3065 subjects, 2317 samples","European (895), African (30), East Asian (67), African American (570), Hispanic1 (457), Hispanic2 (140), Other Asian or Pacific Islander (25), South Asian (68), Other (65)","NHGRI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2016-06-07","2016-06-07","Aortic Aneurysm, Abdominal; Asthma; Attention Deficit Disorder with Hyperactivity; Dermatitis, Atopic; Heart Diseases; Herpes Zoster",""
"phs001065.v1.p1","Coenzyme Q10 (CoQ) in Huntington's Disease (HD) (2CARE)","This is a multi-center, randomized, double-blind, placebo-controlled trial of CoQ involving 609 ambulatory subjects with HD who are not requiring skilled care or institutionalization. Eligible subjects were randomized to receive  either CoQ 2400 mg/day or matching placebo. Subjects were followed prospectively and systematically for 60 months of double-blind observation. The","Not Applicable","Huntington Disease","Clinical Trial","Not Provided","Not Provided","46 phenotype datasets, 735 variables, 609 subjects","","NINDS","GRU --- General Research Use","2016-06-06","2016-06-06","Chorea, Chronic Progressive Hereditary (Huntington); Chorea, Huntington; Chorea, Huntington's; Chronic Progressive Hereditary Chorea (Huntington); Chronic progressive chorea; Chronic progressive hereditary chorea",""
"phs000914.v1.p1","Genome-Wide Association Study of Adiposity in Samoans","The research goal of this study is to identify genetic variation that increases susceptibility to obesity and cardiometabolic phenotypes among adult Samoans using genome-wide association (GWAS) methods. DNA from peripheral  blood and phenotypic information were collected from 3,119 adult Samoans, 23 to 70 years of age. The participants reside throughout the independent","Not Applicable","Obesity","Cross-Sectional","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 182 variables, 8 documents, 1 molecular datasets, 3501 subjects, 3293 samples","","NHLBI","GRU-IRB-PUB-COL-NPU-GSO --- General Research Use (IRB, PUB, COL, NPU, GSO)","2016-06-06","2017-06-06","Not Provided",""
"phs001066.v1.p1","DNA and RNA Sequence of an Acute Lymphoblastic Leukemia","We used massively parallel sequencing technology to profile the genomic DNA and RNA of tumor cells (leukemic bone marrow) and normal cells (skin biopsy) obtained from a single patient with  Acute Lymphoblastic Leukemia (ALL), referred to throughout this study as 'ALL1'. Included in this study are samples obtained from a primary tumor,","Not Applicable","Neoplasms","Case Set","Not Provided","WGS, RNA-Seq, WXS","4 phenotype datasets, 13 variables, 23 samples sequenced,  SRA, 1 subjects, 23 samples","","NCI","HMB --- Health/Medical/Biomedical","2016-05-19","2016-05-19","Blood (Leukemia); Blood cancer; Leucocythaemia; Leucocythaemias; Leucocythemia; Leucocythemias","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000796.v1.p1","Genome Wide Association Study of Chronic TMD: Discovery Phase","The OPPERA project is investigating effects of genetic, physiological, psychological and clinical factors on the risk of developing painful temporomandibular disorder (TMD). This case-control study is a discovery-phase genome wide  association study that aims to identify commonly-occurring genetic variants associated with chronic TMD. It represents the first step in a series of","Not Applicable","Temporomandibular Joint Disorders","Case-Control","imputation_panel, HumanOmni2.5-8","SNP Genotypes (imputed), SNP Genotypes (Array)","5 phenotype datasets, 1184 variables, 21 documents, 2 molecular datasets, 3104 subjects, 3239 samples","European (1935), African (25), East Asian (84), African American (725), Hispanic1 (63), Hispanic2 (72), Other Asian or Pacific Islander (41), South Asian (117), Other (42)","NIDCR","DS-TMJD-RD --- Disease-Specific (Temporomandibular Joint Disorder, RD)","2016-05-19","2016-05-19","Chronic Pain; Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic; Widespread Chronic Pain",""
"phs000963.v1.p1","PGRN-RIKEN:Genetic Determinants of Cardiovascular Events while on Statins","Coronary heart disease (CHD) is an important public health problem in developed countries. Statins are effective in the prevention and treatment of CHD; nevertheless, many patients receiving statins still suffer  cardiovascular events (CV) such as heart attack. Identifying genetic variants responsible for differential clinical responses to statins will not","Not Applicable","Myocardial Revascularization","Case-Control","HumanOmniExpressExome-8","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 documents, 1 molecular datasets, 5890 subjects, 5890 samples","European (5816), African American (20), Hispanic1 (13), Hispanic2 (26), Other Asian or Pacific Islander (2), South Asian (1), Other (12)","NHLBI","HMB --- Health/Medical/Biomedical","2016-05-16","2017-05-16","Myocardial Infarction; Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Not Allowed) (phs003133.v1.p1)"
"phs001063.v1.p1","Genomic Characterization of PDX Models for Breast Cancer Brain Metastases","We have developed orthotopic patient-derived xenograft models of HER2 positive breast cancer metastasized into the brain of patients to test novel therapeutic strategies. In this study, we identified a novel  combinatorial therapeutic strategy that has resulted in a durable remission and markedly increased overall survival in majority of patient-derived","Not Applicable","Breast Neoplasms","Case Set","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets, 12 samples sequenced,  SRA, 12 subjects, 12 samples","","NCI","GRU-IRB-PUB --- General Research Use (IRB, PUB)","2016-05-12","2016-05-12","Neoplasm Metastasis; Brain Neoplasms; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour",""
"phs000990.v1.p1","MIGen_ExS: University of Lubeck","MI cases were recruited from the German MI Family Study and the Angio-Lub study. Controls were recruited from the German MI Family Study and the Angio-Lub study. All exome sequencing  was performed at the Broad Institute of Harvard and MIT; samples sequence capture was performed using Illumina's ICE Capture reagent and sequencing","Not Applicable","Myocardial Infarction","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 1773 samples sequenced, 1766 subjects, 1766 samples","","NHLBI","DS-CVD --- Disease-Specific (Cardiovascular Disease)","2016-05-04","2016-05-04","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000474.v3.p2","Biology and Molecular Analysis of Human Hematopoiesis Genetics","In this study we have performed exome sequencing using the hybrid capture method that has previously been described (Gnirke et al., Nature Biotechnology, 2009) on genomic DNA samples from patients  with the congenital bone marrow failure syndrome that affects the erythroid lineage, specifically, Diamond-Blackfan anemia. This disease is","Not Applicable","Anemia, Dyserythropoietic, Congenital","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 3 molecular datasets, 556 samples sequenced,  SRA, 556 subjects, 556 samples","","NHGRI","DS-BMF --- Disease-Specific (Bone Marrow Failure Conditions)","2016-04-28","2016-04-28","Aase syndrome; Aase-Smith II syndrome; Anemia, Blackfan Diamond; Anemia, Congenital Hypoplastic, Of Blackfan And Diamond; Anemia, Diamond Blackfan; Anemia, Diamond Blackfan Type",""
"phs001057.v1.p1","Population Genetics Analysis Program: Immunity to Vaccines/Infections    (NIAID/NIH)","The study examines the role of candidate human immune response gene polymorphisms (and their receptors, expression and function) and variations in immune response, among 1,000 active duty members of the  military who were recently vaccinated with ACAM2000 or Dryvax Smallpox vaccine. In addition to the phenotype and genotype data available through","Not Applicable","Smallpox Vaccine","Prospective Longitudinal Cohort","HumanOmni2.5-8","SNP Genotypes (Array)","5 phenotype datasets, 17 variables, 1 molecular datasets, 993 subjects, 993 samples","European (656), African (1), East Asian (11), African American (105), Hispanic1 (39), Hispanic2 (142), Other Asian or Pacific Islander (17), South Asian (2), Other (20)","NIAID","GRU-IRB --- General Research Use (IRB)","2016-04-22","2016-04-22","Not Provided",""
"phs001000.v1.p1","MIGen_ExS: U. of Leicester","MI cases were ascertained from two studies: (i) the British Heart Foundation Family Heart Study and (ii) the BRICCS Study. Control subjects were ascertained from the control subjects being recruited  as part of the UK Aneurysm Growth Study (UKAGS). All exome sequencing was performed at the Broad Institute of Harvard and MIT; samples sequence","Not Applicable","Myocardial Infarction","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets, 2322 samples sequenced, 2322 subjects, 2322 samples","","NHLBI","DS-CVD-NPU --- Disease-Specific (Cardiovascular Disease, NPU), GRU-NPU --- General Research Use (NPU)","2016-04-12","2016-04-12","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart",""
"phs001009.v1.p1","Determinants of Asthma Following RSV Bronchiolitis in Early Life","The goal of the RSV Bronchiolitis in Early Life (RBEL) study is to determine how specific genetic, biologic, and immunologic characteristics interact to predispose individuals to develop asthma. Participants were  carefully recruited by selecting a prospective cohort of 206 infants with severe respiratory syncytial virus (RSV) bronchiolitis who were at","Not Applicable","Asthma","Prospective Longitudinal Cohort","GoldenGate_Array","SNP Genotypes (Array)","5 phenotype datasets, 28 variables, 1 molecular datasets, 178 subjects, 178 samples","","NHLBI","DS-AAR-IRB --- Disease-Specific (Allergy, Asthma, and Respiratory, IRB)","2016-04-07","2016-04-07","Bronchiolitis, Viral; Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma",""
"phs001054.v1.p1","Genomic Characterization of Pediatric Low-Grade Gliomas","Pediatric low-grade gliomas (PLGGs) are the most common pediatric brain-tumor, with more than ten histologic subtypes recognized by the World Health Organization. We performed a genomic analysis of 230 PLGGs  of which 73 had whole genome/RNA sequencing performed and show that MYB-QKI fusions define the seizure associated tumor, Angiocentric Glioma (AG).","Not Applicable","Glioma","Case Set","Not Provided","WXS, RNA-Seq, ChIP-Seq, WGS","4 phenotype datasets, 13 variables, 92 samples sequenced,  SRA, 80 subjects, 93 samples","","NCI","GRU --- General Research Use, DS-NTT --- Disease-Specific (Nervous Tissue Tumors)","2016-04-06","2016-04-06","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytoma (excluding glioblastoma); Astrocytomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000822.v1.p1","Genome-Wide Discovery of Novel Breast Cancer Predisposing Mutations","Cancer risk shows clear heritability, but the inherited genetic factors remain largely unknown. This project will seek to identify new genes in which mutations confer hereditary risk for early onset  breast cancer, with important implications for both biological understanding and clinical prediction and prevention. Identifying cancer predisposing","Not Applicable","Breast Neoplasms","Case Set","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 12 variables, 1 molecular datasets, 466 samples sequenced, 466 subjects, 466 samples","","NHGRI","DS-GLCS-GSO --- Disease-Specific (Cancer - Germline genetic susceptibility, GSO)","2016-03-31","2017-03-31","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000806.v1.p1","MIGen_ExS: Ottawa Heart Study","The Ottawa Heart Study is a cross-sectional case-control study designed to identify genes that predispose to angiographically defined coronary artery disease. All exome sequencing was performed at the Broad Institute  of Harvard and MIT; samples sequence capture was performed using Agilent SureSelect Human All Exon Kit v2 and sequencing was performed on an Illumina","Not Applicable","Coronary Artery Disease","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 1968 samples sequenced,  SRA, 1968 subjects, 1968 samples","","NHLBI","GRU --- General Research Use","2016-03-24","2016-03-24","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs000952.v1.p1","Substance Dependence GWAS in European- and African - Americans","This study includes SSADDA (Semi Structured Assessment for Drug Dependence and Alcoholism) assessed subjects (mostly unrelated, but including some affected sibling pairs) recruited in the course of several substance dependence  genetics projects. The sample includes 1,531 self-reported African-American (AA) subjects, 1,339 self-reported European-American (EA) subjects, and 2","Not Applicable","Substance-Related Disorders","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","5 phenotype datasets, 51 variables, 1 molecular datasets, 2872 subjects, 2872 samples","European (1139), African (56), African American (1434), Hispanic1 (187), Hispanic2 (26), Other (29)","NIDA","DS-ADX-IRB-RD --- Disease-Specific (Addictive Disorders, IRB, RD)","2016-03-15","2017-03-15","Alcohol-Related Disorders; Cocaine-Related Disorders; Opioid-Related Disorders; Tobacco Use Disorder; Alcohol Problem; Alcohol Problems",""
"phs001008.v1.p1","GUARDIAN: IRAS FAMILY STUDY (IRASFS)","TThe IRAS Family Study was a family study designed to examine the genetic and epidemiologic basis of glucose homeostasis traits and abdominal adiposity. Briefly, self-reported Mexican pedigrees were recruited in  San Antonio, TX and San Luis Valley, CO. Probands with large families were recruited from the initial non-family-based IRAS Study, which was modestly","Not Applicable","Insulin Resistance","Family/Twin/Trios","HumanOmni1S-8, HumanOmniExpress-12","SNP Genotypes (Array)","5 phenotype datasets, 24 variables, 1 molecular datasets, 1024 subjects, 1024 samples","","NHLBI","DS-DHD-IRB-NPU-MDS-RD --- Disease-Specific (Diabetes and Heart Disease, IRB, NPU, MDS, RD)","2016-03-14","2017-03-14","",""
"phs000934.v1.p1","Antibody Repertoires in CVID","The data consist of the DNA sequences of antibody gene rearrangements from peripheral blood human B cells of subjects with Common Variable Immune Deficiency (CVID) and healthy controls subjects. CVID  subjects were diagnosed on the basis of: 1) reduced serum IgG, IgA, and/or IgM two or more confidence intervals below the normal ranges for age, and","Not Applicable","Common Variable Immunodeficiency","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 11 variables, 1291 samples sequenced,  SRA, 198 subjects, 1291 samples","","NIAID","DS-IR-IRB --- Disease-Specific (Immunological Research, IRB)","2016-03-11","2017-03-11","Acquired Agammaglobulinemia; CVID; CVID - common variable immunodeficiency; Common Variable Hypogammaglobulinemia; Common Variable Hypogammaglobulinemias; Common Variable Immune Deficiency",""
"phs000967.v1.p1","Clear Cell Endometrial Cancer Exome Sequencing Study","The purpose of this study was to identify somatic (tumor-specific) mutations in clear cell endometrial tumor exomes. The dataset was generated at the NIH Intramural Sequencing Center (NISC) and NHGRI  by next generation sequencing the exomes of 16 de-identified primary tumor DNAs and matched non-tumor DNAs. Inclusion criteria: 1. Clear cell","Not Applicable","Endometrial Neoplasms","Case Set","other","WXS, SNV Aggregate (.MAF)","4 phenotype datasets, 17 variables, 1 molecular datasets, 32 samples sequenced,  SRA, 16 subjects, 32 samples","","NHGRI","DS-ECA-COL --- Disease-Specific (Endometrial Cancer, COL)","2016-03-10","2016-03-10","Endometrial Tumor; Endometrial neoplasm; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium",""
"phs000944.v1.p1","eMERGE Clinical Center at Partners HealthCare","The Partners HealthCare Biobank is a large research data and sample repository working within the framework of Partners Personalized Medicine. It provides researchers access to high quality, consented samples to  help foster research, advance understanding of the causes of common diseases, and advance the practice of medicine. The Partners Biobank provides","Not Applicable","Hypercholesterolemia","Cross-Sectional","MEGA_Consortium_Array","SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 2 documents, 1 molecular datasets, 4929 subjects, 4929 samples","European (4210), African (21), East Asian (43), African American (292), Hispanic1 (186), Hispanic2 (73), Other Asian or Pacific Islander (20), South Asian (33), Other (51)","NHGRI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2016-03-07","2016-03-07","Arthritis, Rheumatoid; Asthma; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Coronary Disease; Depression",""
"phs000942.v1.p1","Use of WGS for Diagnosis and Discovery in the Cancer Genetics Clinic","Despite the potential of whole-genome sequencing (WGS) to improve patient diagnosis and care, the empirical value of WGS in the cancer genetics clinic is unknown. We performed WGS on members  of two cohorts of cancer genetics patients: those with BRCA1/2 mutations (n 176) and those without (n 82). Initial analysis of potentially pathogenic","Not Applicable","Neoplasms","Prospective Longitudinal Cohort","WGS_markerset_grc37","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 31 variables, 1 molecular datasets, 235 samples sequenced,  SRA, 258 subjects, 258 samples","European (214), African American (14), Hispanic1 (3), Hispanic2 (17), Other Asian or Pacific Islander (1), South Asian (4), Other (4)","NCI","GRU-PUB-MDS --- General Research Use (PUB, MDS)","2016-03-03","2016-03-03","Adenomatous Polyposis Coli; Bile Duct Neoplasms; Colonic Polyps; Esophageal Neoplasms; Fallopian Tube Neoplasms; Hemangioblastoma",""
"phs001038.v1.p1","DNA Methylation Inhibitors in Immunotherapy","We show that DNA methyltransferase inhibitors (DNMTis) upregulate immune signaling in cancer through the viral defense pathway and re-expression of epigenetically silenced endogenous retrovirus. In melanoma patients treated with an  immune checkpoint therapy, high viral defense signature expression in tumors significantly associates with durable clinical response and DNMTi","Not Applicable","Melanoma","Case Set","RNAseq_probe_set_grc37","RNA Seq (NGS), RNA-Seq","4 phenotype datasets, 38 variables, 1 molecular datasets, 20 samples sequenced,  SRA, 20 subjects, 20 samples","","NCI","HMB-PUB-NPU-MDS --- Health/Medical/Biomedical (PUB, NPU, MDS)","2016-03-02","2016-03-02","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs000153.v9.p8","Framingham SHARe Social Network","Note: Data Use Restrictions: The data must only be used for genetic research projects solely in the area of health-related social-network research. This study compiles detailed information on family and  social ties linked to participants in the offspring cohort of the Framingham Heart Study. The investigators took computerized information from","Not Applicable","Social Behavior","Prospective Longitudinal Cohort","Not Provided","Not Provided","4 phenotype datasets, 49 variables, 4 documents, 15172 subjects","","NHLBI","DS-SN-IRB-MDS --- Disease-Specific (Social Network, IRB, MDS), DS-SN-IRB-NPU-MDS --- Disease-Specific (Social Network, IRB, NPU, MDS)","2016-03-02","2010-06-26","Depression; Diabetes Mellitus",""
"phs001014.v1.p1","GUARDIAN: IRAS (IRAS Classic)","The Insulin Resistance Atherosclerosis Study (IRAS) was an epidemiologic cohort study designed to examine the relationship between insulin resistance and carotid atherosclerosis across a range of glucose tolerance. Individuals of  self-reported Mexican-American ethnicity were recruited in San Antonio, TX and San Luis Valley, CO. Recruitment was balanced across age and glucose","Not Applicable","Insulin Resistance","Prospective Longitudinal Cohort","HumanOmni1S-8, HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 173 subjects, 173 samples","","NHLBI","DS-DHD-IRB-NPU-MDS-RD --- Disease-Specific (Diabetes and Heart Disease, IRB, NPU, MDS, RD)","2016-03-01","2017-03-01","",""
"phs000536.v2.p1","Retrotransposition in Colorectal Cancer","The purpose of this study is to ascertain the locations of somatic LINE-1 retrotransposition events in human colon tumor samples by pooling multiple tumor samples from different patients and performing  a targeted resequencing assay (Ewing and Kazazian, Genome Research 2010) to sequence the 3' flanking regions of all insertions in the pooled sample.","Not Applicable","Colonic Neoplasms","Case-Control","Not Provided","AMPLICON","5 phenotype datasets, 29 variables, 17 samples sequenced,  SRA, 92 subjects, 17 samples","","NIGMS","GRU --- General Research Use","2016-02-25","2012-11-27","COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic; Cancers, Colon","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs001058.v1.p1","MIGen_ExS: BioImage Study","The BioImage Study (BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population, NCT00738725), is a prospective, observational study aimed at characterizing subclinical atherosclerosis in U.S.  adults (55 to 80 years old) at risk for clinical atherosclerotic cardiovascular disease (PMID: 25790876). All exome sequencing was performed at the","Not Applicable","Myocardial Infarction","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 503 samples sequenced, 503 subjects, 503 samples","","NHLBI","DS-CVD --- Disease-Specific (Cardiovascular Disease)","2016-02-19","2016-02-19","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000909.v1.p1","Neuroendocrine Prostate Cancer (Trento/Cornell/Broad 2015)","A subset of advanced prostate cancers can progress from an androgen receptor (AR)-driven state to AR independence, often associated with low or absent AR expression and extensive neuroendocrine differentiation. Once  neuroendocrine prostate cancer (NEPC) develops, patients typically demonstrate an aggressive clinical course and poor overall survival. Early","Not Applicable","Adenocarcinoma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, Bisulfite-Seq, WXS","4 phenotype datasets, 14 variables, 300 samples sequenced,  SRA, 94 subjects, 300 samples","","NHGRI","GRU --- General Research Use","2016-02-19","2016-02-19","Neuroendocrine Tumors; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma",""
"phs001067.v1.p1","Metagenomic Deep Sequencing in Meningitis and Encephalitis","This is a prospective observational study seeking to identify pathogens in cases of unexplained neurological disease, particularly those in which there is a presumed infectious cause. This next generation analytical  approach will hopefully allow for rapid identification of foreign genomic material, and through a sophisticated bioinformatics pipeline developed in","Not Applicable","Encephalitis","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 6 samples sequenced, 3 subjects, 6 samples","","NIAID","DS-NDR-IRB --- Disease-Specific (Neurological Disorders Research, IRB)","2016-02-17","2016-02-17","Meningitis; Myelitis; Brain Inflammation; Brain Inflammations; Inflammation, Brain; Pachymeningitides",""
"phs001059.v1.p1","Maternal Folate and Newborn DNA Methylation Meta-Analysis","Folic acid is routinely recommended for women trying to conceive to ensure proper fetal development. Mechanisms whereby periconceptional folate influences normal development and disease are poorly understood: epigenetics may be  involved. This data represents meta-analysis results from a large epigenomics study to examine the association between maternal plasma folate during","Not Applicable","Embryonic and Fetal Development","Prospective Longitudinal Cohort","HumanMethylation450","Not Provided","1 molecular datasets","","NIEHS","GRU --- General Research Use","2016-02-10","2016-02-10","Gestation; Pregnancy, function",""
"phs000949.v1.p1","Genetic Analysis of Normal Human Facial Variation","The purpose of this project is to identify genes associated with normal human quantitative facial variation. The motivation for this project stems from the fact that very little is known  about how variation in specific genes relates to the diversity of facial forms commonly observed in humans. Viable candidates for these morphogenes","Not Applicable","Anthropometry","Control Set","HumanOmniExpressExome-8_plus, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 88 variables, 2 molecular datasets, 3186 subjects, 3328 samples","European (2967), African (11), East Asian (1), African American (18), Hispanic1 (9), Hispanic2 (164), South Asian (1), Other (15)","NIDCR","DS-CFR --- Disease-Specific (Craniofacial Research)","2016-02-09","2016-02-09","Not Provided",""
"phs001021.v1.p1","Center for Health Discovery and Well Being (CHDWB)","In order to evaluate whether rare regulatory variants in the vicinity of promoters are likely to impact gene expression, we conducted a novel burden test for rare variants at the  extreme of expression. After targeted sequencing of 2kb promoter regions of 472 genes in 410 healthy adults, burden tests were performed by","Not Applicable","Fitness Centers","Prospective Longitudinal Cohort","Not Provided","OTHER","4 phenotype datasets, 20 variables, 410 samples sequenced,  SRA, 410 subjects, 410 samples","","NIGMS","HMB --- Health/Medical/Biomedical","2016-02-02","2016-02-02","Biological Aging; Metabolic Syndrome X; Aging, Biological; Cardiometabolic Syndrome; Cardiovascular Syndrome, Metabolic; Cardiovascular Syndromes, Metabolic",""
"phs000332.v3.p2","GWAS of Preterm Birth","Preterm birth (PTB, born before 37 weeks of gestation) is a leading cause of neonatal mortality and post-natal morbidity. PTB affects one in nine all live births in the U.S.  Notably, the highest rate of PTB occurs among African Americans (one in six). PTB is a complex trait, likely determined by multiple environmental and","Not Applicable","Infant, Premature","Case-Control","imputation_panel, HumanOmni2.5-8, HumanOmni2.5-4","SNP Genotypes (imputed), SNP Genotypes (Array)","4 phenotype datasets, 47 variables, 2 molecular datasets, 1779 subjects, 1917 samples","European (2), African (297), African American (1467), Hispanic1 (6), Hispanic2 (4), Other Asian or Pacific Islander (1), Other (14)","NICHD","DS-PTB-RD --- Disease-Specific (Preterm Birth, RD)","2016-02-02","2016-07-28","Premature Birth; Neonatal Prematurity; Prematurity, Neonatal; Birth, Premature; Birth, Preterm; Births, Premature",""
"phs000936.v1.p1","NHLBI GO-ESP: Early-Onset Myocardial Infarction Exome Chip (Broad EOMI)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Cardiovascular Diseases","Case-Control","","SNP Genotypes (Array)","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 5870 subjects, 5870 samples","","NHLBI","GRU --- General Research Use, DS-MI --- Disease-Specific (Myocardial Infarction), DS-CVD --- Disease-Specific (Cardiovascular Disease)","2016-02-01","2016-02-01","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs000883.v1.p1","MIGen_ExS: PROCARDIS","The Precocious Coronary Artery Disease (PROCARDIS) study is an international, multicenter case-control study aimed at discovering the genetic contributors to premature coronary artery disease. All exome sequencing was performed at  the Broad Institute of Harvard and MIT; samples sequence capture was performed using Agilent SureSelect Human All Exon Kit v2 and sequencing was","Not Applicable","Coronary Artery Disease","Case-Control","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 10 variables, 1 molecular datasets, 2054 samples sequenced, 2054 subjects, 2054 samples","","NHLBI","DS-HTD --- Disease-Specific (Heart Disease)","2016-01-29","2016-01-29","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs001050.v1.p1","Breast Cancer Genome Guided Therapy Study (BEAUTY)","The Breast Cancer Genome Guided Therapy Study (BEAUTY) is a prospective neoadjuvant clinical study enrolling 140 women with Stage I-III breast cancer. The goals of this study were to 1)  perform comprehensive sequencing of germline and tumor tissues (exome and RNA seq), 2) identify genomic alterations and perturbed pathways associated","Not Applicable","Breast Neoplasms","Case Set","Not Provided","RNA-Seq, WXS","4 phenotype datasets, 33 variables, 354 samples sequenced,  SRA, 118 subjects, 354 samples","","NIGMS","GRU --- General Research Use","2016-01-26","2017-01-26","Carcinoma, Ductal, Breast; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors",""
"phs000917.v1.p1","MIGen_ExS: PROMIS","The Pakistan Risk of Myocardial Infarction (PROMIS) study is a retrospective multicenter case-control cohort study of individuals with and without coronary heart disease from Pakistan. Multiple biological samples have been  collected from the participants including DNA, plasma, serum, and whole blood. The goal of the study is to recruit 20,000 cases and 20,000 controls","Not Applicable","Coronary Artery Disease","Case-Control","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 7298 samples sequenced,  SRA, 7298 subjects, 7298 samples","","NHLBI","GRU --- General Research Use","2016-01-26","2016-01-26","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs000908.v1.p1","Identification of Rare Variants in PD through Whole Exome Sequencing","The focus of this study is to identify a new level of genetic variation, i.e. rare genetic variants with a population frequency less than 5%, usually less than 1%, which  are believed to provide a stronger risk per variant than those studied to date in the large genome wide association studies (GWAS). To do this we are","Not Applicable","Parkinson Disease","Case-Control","target_markerset_grc37","WXS, SNP Genotypes (NGS)","5 phenotype datasets, 22 variables, 1 molecular datasets, 200 samples sequenced,  SRA, 200 subjects, 200 samples","","NINDS","GRU-IRB --- General Research Use (IRB), DS-PD-IRB --- Disease-Specific (Parkinson's Disease, IRB)","2016-01-25","2017-01-25","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs000983.v1.p1","Pharmacogenomics of Rheumatoid Arthritis Therapy","Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis worldwide and affects 1.3 million adults in the USA. It has previously been studied using phenotype algorithms to identify electronic  health records (EHR) case cohorts. Early genetic studies of EHR-linked cohorts of RA patients have been replicated in known associations. Further","Not Applicable","Arthritis, Rheumatoid","Case Set","HumanExome-12","SNP Genotypes (Array)","4 phenotype datasets, 22 variables, 1 molecular datasets, 512 subjects, 512 samples","","NIGMS","GRU --- General Research Use","2016-01-21","2017-01-21","",""
"phs000902.v1.p1","MIGen_ExS: Regicor","The Registre Gironi del Cor (REGICOR) study developed a nested case-control cohort from the Girona province in Spain in order to study genetic factors associated with the development of coronary  heart disease. All exome sequencing was performed at the Broad Institute of Harvard and MIT; samples sequence capture was performed using Agilent","Not Applicable","Coronary Artery Disease","Case-Control","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 10 variables, 1 molecular datasets, 784 samples sequenced, 784 subjects, 784 samples","","NHLBI","DS-CVD --- Disease-Specific (Cardiovascular Disease)","2016-01-21","2016-01-21","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000814.v1.p1","MIGen_ExS: Italian Atherosclerosis Thrombosis and Vascular Biology","Italian Atherosclerosis Thrombosis and Vascular Biology study is a prospective, nationwide, case-control study involving 125 coronary care units in Italy. The cases were patients who were hospitalised for a first  MI before the age of 45 years and underwent coronary angiography. Acute MI was defined as resting chest pain lasting more than 30 minutes,","Not Applicable","Coronary Artery Disease","Case-Control","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 10 variables, 1 molecular datasets, 3592 samples sequenced,  SRA, 3592 subjects, 3592 samples","","NHLBI","GRU --- General Research Use","2016-01-21","2016-01-21","Atherosclerosis; Atherogeneses; Atherogenesis; Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs000824.v1.p1","Genome-Wide Discovery of Novel Colon Cancer Predisposing Mutations","Cancer risk shows clear heritability, but the inherited genetic factors remain largely unknown. This project will seek to identify new genes in which mutations confer hereditary risk for early onset  colorectal cancer, with important implications for both biological understanding and clinical prediction and prevention. Identifying cancer","Not Applicable","Colorectal Neoplasms","Case Set","WGS_markerset_grc37","WXS, SNP Genotypes (NGS)","4 phenotype datasets, 12 variables, 1 molecular datasets, 100 samples sequenced, 100 subjects, 100 samples","","NHGRI","DS-GLCS-GSO --- Disease-Specific (Cancer - Germline genetic susceptibility, GSO)","2016-01-20","2017-01-20","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs000994.v1.p1","The Mutational Landscape of CTCL and Sezary Syndrome.","Sezary syndrome is a leukemic and aggressive form of cutaneous T-cell lymphoma (CTCL) resulting from the malignant transformation of skin-homing central memory CD4+ T cells. To identify new genetic alterations  involved in Sezary syndrome and CTCL transformation we performed whole-exome sequencing of tumor-normal sample pairs from 26 Sezary syndrome and 16","Not Applicable","Sezary Syndrome","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 21 variables, 84 samples sequenced,  SRA, 84 subjects, 84 samples","","NCI","DS-CA-IRB-PUB --- Disease-Specific (Cancer, IRB, PUB)","2016-01-15","2016-01-15","Mycosis Fungoides; CTCL / Sezary syndrome; Erythroderma, Sezary; Lymphoma, Sezary's; SC)zary syndrome; SEZARY SYNDROME, SOMATIC",""
"phs001034.v1.p1","New England-Based Case-Control Study of Ovarian Cancer (NECC)","The case-control data provided to dbGaP were collected under NCI grant number CA54419 which had 3 enrollment phases: I (1992-1997), II (1998-2002) and III (2003-2008). Altogether, CA54419 funded 15 years  of data and specimen collection, resulting in one of the longest running population based case-control studies of ovarian cancer. The study goal was","Not Applicable","Ovarian Neoplasms","Case-Control","Not Provided","Not Provided","2 phenotype datasets, 84 variables, 3 documents, 4141 subjects","","NCI","GRU-NPU --- General Research Use (NPU)","2016-01-14","2016-01-14","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian",""
"phs000928.v1.p1","Effect of LGG Probiotic on Human Whole Blood Transcriptome","Open label study to evaluate the safety of Lactobacillus rhamnosus GG ATCC 53103 (LGG) in elderly subjects. Fifteen healthy elderly volunteers, ages 65-80 were enrolled in a study in which  they received LGG capsules containing 1 x 1010 CFU, twice daily for 28 days and were followed through day 56. The study subjects completed a daily","Not Applicable","Healthy Volunteers","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 20 variables, 2 documents, 32 samples sequenced,  SRA, 11 subjects, 32 samples","","NCCIH","HMB --- Health/Medical/Biomedical","2016-01-14","2016-01-14","Not Provided",""
"phs000459.v1.p1","Genome-Wide Association Study of 24 Hour Urine Composition in the Nurses'    Health Study, Nurses' Health Study II, and the Health Professionals    Follow-Up Study","Building upon our previous linkage and association studies, we will use whole exome sequencing studies of second and third degree affected relatives drawn from multiplex families. Our specific aims are:  1) To conduct whole exome sequencing on affected members (2&#x000b0; and 3&#x000b0; relatives) drawn from multiplex cleft families from a consortium","Not Applicable","Cleft Lip","Family/Twin/Trios","Not Provided","WXS","4 phenotype datasets, 17 variables, 121 samples sequenced,  SRA, 115 subjects, 121 samples","","NIDCR","OC-IRB-COL-GSO-BEATY --- Oral Clefts, IRB, COL, GSO, BeatyT, DS-CFD-GSO --- Disease-Specific (Craniofacial Disorders, GSO), OC-IRB-COL-GSO-BAILEYWILSON --- Oral Clefts, IRB, COL, GSO, Bailey-WilsonJ, OC-IRB-COL-GSO-MANGOLD-NOTHEN --- Oral Clefts, IRB, COL, GSO, MangoldE-NothenM, DS-OFC --- Disease-Specific (Orofacial Cleft)","2016-01-13","2016-01-13","Cleft Palate; Congenital Abnormalities; Stomatognathic System Abnormalities; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip",""
"phs001002.v1.p1","A Genome-Wide Association Study of CALGB 90401: Randomized, Double-Blind,    Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone    with or without Bevacizumab in Men with Metastatic    Castration-Resistant Prostate Cancer","The Cancer and Leukemia Group B (CALGB) 90401 trial compared docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer. A genome-wide association study using clinical  outcomes and toxicities was conducted on the basis of data from CALGB patients who provided consent for pharmacogenomic studies and usable DNA CALGB","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 47 variables, 1 molecular datasets, 761 subjects, 761 samples","European (651), African (3), East Asian (4), African American (73), Hispanic1 (10), Hispanic2 (18), South Asian (2)","NIGMS","HMB --- Health/Medical/Biomedical","2016-01-06","2017-01-06","Neutropenia; NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic",""
"phs000982.v1.p1","Genetic Analysis of Psoriasis and Psoriatic Arthritis","This is a genome-wide study of genetic associations with psoriatic arthritis (PsA), an inflammatory musculoskeletal condition that develops in up to 30% of people who have chronic psoriasis skin lesions.  1,526 cases affected with psoriatic arthritis and 1,508 unaffected controls were recruited and typed on the Illumina HumanOmni1-Quad BeadChip array.","Not Applicable","Arthritis, Psoriatic","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 analyses, 1 molecular datasets, 2847 subjects, 2847 samples","","NIAMS","GRU --- General Research Use","2015-12-11","2015-12-11","Arthritic Psoriasis; Arthropathies, Psoriatic; Arthropathy, Psoriatic; PA (Psoriatic arthritis); PsA (Psoriatic arthritis); Psoriasis Arthropathica","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000970.v1.p1","Mercury and Gut Microbiota","There are few studies that have characterized maternal gut microbiota and fetal methylmercury exposure, yet microbes likely modulate this relationship. The primary objective of our pilot study was to determine  associations between gut microbial taxa and mercury concentrations in multiple biomarkers (stool, hair, and cord blood). Our secondary objective was","Not Applicable","Methylmercury Compounds","Cross-Sectional","Not Provided","AMPLICON, WGS","4 phenotype datasets, 17 variables, 17 samples sequenced,  SRA, 17 subjects, 17 samples","","NIEHS","HMB --- Health/Medical/Biomedical","2015-12-11","2015-12-11","Not Provided",""
"phs001007.v1.p1","The Genetic Landscape of Metastasis and Recurrence in HNSCC","Recurrence and/or metastasis occur in more than half of patients with head and neck squamous cell carcinoma (HNSCC) and pose the greatest threats to long-term survival. The genetic alterations underlying  recurrent/metastatic HNSCC are unknown. This study represents the first whole exome sequencing (WES) cohort study of patient-matched tumor pairs in","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Case Set","Not Provided","WXS","4 phenotype datasets, 26 variables, 65 samples sequenced, 23 subjects, 65 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2015-12-02","2015-12-02","Epidermoid Carcinoma of Hypopharynx; Epidermoid Carcinoma of the Hypopharynx; Hypopharyngeal Conventional Squamous Cell Carcinoma; Hypopharyngeal Epidermoid Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Hypopharynx","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000975.v1.p1","Nurses' Health Study (NHS)","The Nurses' Health Study is an on-going prospective cohort study of women that was initiated in 1976. This specific study was part of a larger study to advance our knowledge  of breast cancer etiology, expand the current knowledge of mammographic density, and clarify the relationship between mammographic density and breast","Not Applicable","Breast Density","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 26 variables, 1 molecular datasets, 794 subjects, 794 samples","","NCI","GRU --- General Research Use","2015-12-02","2015-12-02","Mammographic Density; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000953.v1.p1","Microdissected Pancreatic Cancer Whole Exome Sequencing","109 micro-dissected pancreatic cancer cases and normal control tissue were subjected to whole-exome sequencing. Microdissection enriches tumor cellularity and enhances mutation calling. Inclusion: Diagnosis of pancreatic cancer with sufficient available  tumor tissue and normal control. Principal Investigator: Agnieszka Witkiewicz, University of Texas Southwestern Medical Center, Dallas, TX, USA","Not Applicable","Pancreatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","WXS","3 phenotype datasets, 11 variables, 218 samples sequenced,  SRA, 109 subjects, 218 samples","","NCI","DS-PACA-IRB-NPU-MDS --- Disease-Specific (Pancreatic Cancer, IRB, NPU, MDS)","2015-11-30","2015-11-30","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic",""
"phs000769.v1.p1","NHLBI Lung HIV Microbiome Project (LHMP)","Humans interact with countless microorganisms in multiple environments. The Lung HIV Microbiome Project (LHMP) characterized the microbiome of the lung and respiratory tract. This effort provided initial data to develop  further hypotheses addressing differences between HIV-infected and HIV-uninfected individuals. The project involved multiple studies, either single","Not Applicable","HIV","Metagenomics","Not Provided","AMPLICON","5 phenotype datasets, 37 variables, 642 samples sequenced,  SRA, 141 subjects, 642 samples","","NHLBI","GRU --- General Research Use, DS-HIV --- Disease-Specific (Human Immunodeficiency Virus)","2015-11-20","2016-11-20","Not Provided",""
"phs000980.v1.p1","PD-1 Blockade in Non-Small Cell Lung Cancer","Patients with non-small cell lung cancer were treated with pembrolizumab. Their tumors and matched normal blood were sequenced. Inclusion: non-small cell lung cancer, treated with pembrolizumab Principal Investigators: Timothy Chan,  MD, PhD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA Principal Investigators: Matthew Hellmann, MD,","Not Applicable","Carcinoma, Non-Small-Cell Lung","Tumor vs. Matched-Normal","other","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 36 variables, 1 molecular datasets, 68 samples sequenced,  SRA, 34 subjects, 68 samples","","NCI","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2015-11-19","2022-12-06","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER",""
"phs000957.v1.p1","Geisinger Health System - MyCode, eMERGE III Exome Chip","DNA samples were obtained from participants of the Geisinger MyCode biobank. Phenotype data to determine case or control status for abdominal aortic aneurysm or extreme obesity were derived from Geisinger  electronic medical record data through an enterprise data warehouse. Samples were genotyped using the Illumina Human CoreExome-12 v1.0 Array.","Not Applicable","Aortic Aneurysm, Abdominal","Case-Control","HumanCoreExome-12","SNP Genotypes (Array)","4 phenotype datasets, 84 variables, 1 molecular datasets, 9212 subjects, 9212 samples","European (9102), African (1), East Asian (11), African American (28), Hispanic1 (18), Hispanic2 (26), Other Asian or Pacific Islander (2), South Asian (13), Other (11)","NHGRI","GRU --- General Research Use","2015-11-16","2015-11-16","AAA; AAA - Abdominal aortic aneurysm; ABDOMINAL AORTIC ANEURYSM; ANEURYSM, ABDOMINAL AORTIC; Abdominal Aorta Aneurysm; Abdominal Aorta Aneurysms",""
"phs000730.v1.p1","Genomics of Brain Metastases","Brain metastases are the most frequently occurring intracranial tumors in adults. Median survival after the diagnosis of a brain metastasis is in the order of a few months. Despite its  large burden of disease and devastating clinical sequelae, we continue to have a limited understanding of the molecular mechanisms driving brain","Not Applicable","Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 24 variables, 292 samples sequenced,  SRA, 86 subjects, 292 samples","","NHGRI","GRU --- General Research Use, DS-CRM --- Disease-Specific (Cancer Research and Methods), GRU-NPU --- General Research Use (NPU)","2015-11-16","2015-11-16","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs001016.v1.p1","Fixed Single Cell Study (Radial Glia Cells)","The human neocortex is created from diverse intermixed progenitors in the prenatal germinal zones. These progenitors have been difficult to characterize since progenitors - particularly radial glia (RG) - are  rare, and are defined by a combination of intracellular markers, position and morphology. To circumvent these problems we developed a method called","Not Applicable","Neuroglia","Control Set","RNAseq_probe_set_grc37","RNA-Seq, RNA Seq (NGS)","4 phenotype datasets, 18 variables, 1 molecular datasets, 136 samples sequenced,  SRA, 3 subjects, 136 samples","","NINDS","GRU-NPU --- General Research Use (NPU)","2015-11-06","2016-01-13","growth and development; growth",""
"phs000881.v1.p1","Children's Hospital of Philadelphia GWAS of Conotruncal Cardiac Defects","This is a family-based genome-wide association study of conotruncal and related cardiac malformations (CTDs). Cases with CTDs and their parents were recruited from the Cardiac Center at The Children's Hospital  of Philadelphia between 1992 and 2010. The discovery dataset included 750 CTD case-parent triads. DNA was extracted from blood or saliva samples from","Not Applicable","Heart Defects, Congenital","Family/Twin/Trios","Not Provided","Not Provided","1 analyses","","NHLBI","","2015-11-04","","Double Outlet Right Ventricle; Tetralogy of Fallot; Transposition of Great Vessels; DORV with non-committed subpulmonary VSD; Double Outlet Right Ventricle, Noncommitted VSD; Abnormal heart morphology",""
"phs000712.v1.p1","UIC ACE Exome Sequencing Analysis","Autism spectrum disorder (ASD) is highly heritable with recent sibling recurrence risk estimates of 19% overall and 26% in males. The heritable phenotype of hyperserotonemia, or elevated levels of platelet  serotonin (5HT), in 35% of people with ASD is a well-established biomarker. The efficacy of drugs like risperidone and potent serotonin transporter","Not Applicable","Autistic Disorder","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 194 variables, 1 molecular datasets, 533 samples sequenced,  SRA, 589 subjects, 533 samples","","NICHD","DS-ASD-RD --- Disease-Specific (Autism Spectrum Disorder, RD)","2015-11-03","2016-08-03","Developmental Disabilities; AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile","dbGaP Collection: NIH Autism -omics Studies (phs000764.v1.p1)"
"phs000789.v1.p1","Collaborative Study of Genes, Nutrients and Metabolites (CSGNM)","While many genetic and metabolic studies focus on understanding disease states, this genome wide association study (GWAS) was designed to understand the influence of genetic variants on circulating metabolites and  factors in normal, healthy individuals. Over 2500 healthy, ethnically Irish college students attending Trinity College Dublin completed a health and","Not Applicable","Genome-Wide Association Study","Control Set","HumanOmni1-Quad","SNP Genotypes (Array)","5 phenotype datasets, 76 variables, 1 molecular datasets, 2408 subjects, 2527 samples","","NHGRI","HMB --- Health/Medical/Biomedical","2015-10-29","2016-10-29","Birth Place; Tryptophan; Community; L Tryptophan; L-Tryptophan; Levotryptophan",""
"phs000903.v1.p1","OCD Collaborative Genetic Association Study (OCGAS)","The OCD Collaborative Genetics Association Study Group (OCGAS) was funded by NIMH to conduct a genome-wide association study to identify disease susceptibility loci of early-onset obsessive-compulsive disorder (OCD). Collaborators at  Johns Hopkins, Brown, Columbia, MGH, UCLA, and NIMH evaluated 2,000 individuals with OCD and collected DNA from these individuals and both their","Not Applicable","Obsessive-Compulsive Disorder","Family/Twin/Trios","HumanOmniExpress-12","SNP Genotypes (Array)","5 phenotype datasets, 23 variables, 1 analyses, 1 molecular datasets, 2614 subjects, 2613 samples","European (2504), East Asian (10), African American (5), Hispanic1 (14), Hispanic2 (48), Other Asian or Pacific Islander (7), South Asian (11), Other (14)","NIMH","DS-OCD-OPC --- Disease-Specific (Obsessive Compulsive Disorder and other psychiatric conditions)","2015-10-26","2016-02-01","Anancastic neurosis; Anankastic Personalities; Anankastic Personality; Disorder, Obsessive-Compulsive; Disorders, Obsessive-Compulsive; Neuroses, Obsessive-Compulsive",""
"phs000813.v1.p1","Sequencing of Targeted Genomic Regions Associated with Smoking","This study includes samples from two projects: Collaborative Genetic Study of Nicotine Dependence (COGEND; PI: Laura Bierut) and Genetic Study of Nicotine Dependence in African Americans (AAND; PI: Laura Bierut  and Eric Johnson). The majority of the COGEND subjects included in the current study overlap with the two datasets already available on dbGaP. GWAS","Not Applicable","Tobacco Use Disorder","Case-Control","target_markerset_grc37, other","SNP Genotypes (Array), SNP Genotypes (NGS), WXS","4 phenotype datasets, 131 variables, 27 documents, 1 molecular datasets, 3098 samples sequenced,  SRA, 2969 subjects, 3098 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2015-10-23","2016-10-23","Compulsive tobacco user syndrome; Dependence, Tobacco; Tobacco Dependence","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000958.v1.p1","CSER-MedSeq","Whole genome sequencing (WGS) and whole exome sequencing (WES) services are currently available to and being utilized by physicians and their patients in both research and clinical settings, and recently  to anyone in the general public via direct-to-consumer companies. But the widespread availability and use of WGS and WES in the practice of clinical","Not Applicable","Cardiomyopathies","Case-Control","HumanOmni2.5-8","WGS, SNP Genotypes (Array)","4 phenotype datasets, 22 variables, 3 documents, 2 molecular datasets, 100 samples sequenced,  SRA, 100 subjects, 200 samples","","NHGRI","GRU --- General Research Use","2015-10-21","2015-10-21","Cardiomyopathies, Primary; Cardiomyopathy, Primary; Disease, Primary Myocardial; Diseases, Primary Myocardial; Myocardial Disease, Primary; Myocardial Diseases, Primary",""
"phs000870.v1.p1","Characterization of Human Transcriptome by Computational and HTS    Approaches","We have deeply sequenced total RNA and whole exome of six different post-mortem human snap-frozen tissues (brain, liver, lung, striated muscle, kidney, heart) from three unrelated healthy Caucasian individuals (males,  aged 47-54) with the aim to characterize post-transcriptional events due to alternative splicing and RNA editing. In addition, to facilitate the","Not Applicable","Gene Expression Profiling","Control Set","WGS_markerset_grc37, WES_markerset_grc37","WGS, miRNA-Seq, WXS, SNP/CNV Genotypes (NGS), RNA-Seq","4 phenotype datasets, 19 variables, 1 molecular datasets, 57 samples sequenced,  SRA, 3 subjects, 57 samples","","NHGRI","GRU --- General Research Use","2015-10-19","2016-10-19","Not Provided",""
"phs000969.v1.p1","Whole Exome Sequence of Hearing Loss Family","Our goal is to find genes responsible for non-syndromic sensorineural hearing loss. Blood samples were collected from the JS6 family affected with hearing loss. The family is of Caribbean Hispanic  ethnicity. Family JS6 consisted of two deaf siblings, JS6.001 (Male) and JS6.002 (Female) and healthy parents, JS6.100 (mother) and JS6.200 (father).","Not Applicable","Hearing Loss, Bilateral","Family/Twin/Trios","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 1 molecular datasets, 4 samples sequenced,  SRA, 4 subjects, 4 samples","","NIDCD","GRU-PUB --- General Research Use (PUB)","2015-10-06","2015-11-06","Bilateral Deafness; Bilateral Hearing Loss; Bilateral Hearing Losses; Loss, Bilateral Hearing",""
"phs000947.v1.p1","DNA methylation in SLE-Related Autoantibodies","Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can have debilitating effects on multiple organ systems. In SLE, the pivotal immunologic disturbance is the formation of autoantibodies directed  against nuclear and cellular antigens. These autoantibodies are associated with specific organ manifestations. Our previous work has shown that","Not Applicable","Lupus Erythematosus, Systemic","Case Set","HumanMethylation450","Methylation (CpG)","4 phenotype datasets, 14 variables, 1 molecular datasets, 325 subjects, 325 samples","","NCATS","DS-ADO-IRB --- Disease-Specific (Autoimmune Diseases, IRB)","2015-10-06","2015-10-06","Autoimmune Diseases; Systemic Lupus Erythematosus; Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE",""
"phs000977.v1.p1","Genetic Analysis of Desmoplastic Melanoma","Desmoplastic melanoma is an infrequent variant of melanoma with sarcomatous histology, distinct clinical behavior, and unknown pathogenesis. We performed low-coverage genome and high-coverage exome sequencing of 20 desmoplastic melanomas, followed  by targeted sequencing of 293 genes to validate candidate genes. A high mutation burden (median 62 mutations/Mb) ranked desmoplastic melanoma among","Not Applicable","Melanoma","Tumor vs. Matched-Normal","Not Provided","WGS, WXS","3 phenotype datasets, 12 variables, 140 samples sequenced,  SRA, 62 subjects, 140 samples","","NCI","GRU --- General Research Use, DS-M-MDS --- Disease-Specific (Melanoma, MDS)","2015-10-01","2015-10-01","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000708.v1.p1","Warfarin Pharmacogenetics: Pharmacogenetic Optimization of Anticoagulant    Response (POAT) and Genetic and Environmental Determinants of Warfarin    Response (GEDWR)","Although the efficacy of warfarin in the treatment and prevention of thromboembolic disorders is proven, it is vastly underutilized with difficulties in management and risk of complications being the main  deterrents. Recognition of genetic regulation of warfarin response has fueled efforts to quantify this influence, but the focus has been restricted","Not Applicable","Thromboembolism","Interventional","Human1M-Duo","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 analyses, 1 molecular datasets, 200 subjects, 199 samples","","NHLBI","DS-TH --- Disease-Specific (Thromboembolic disorders and hemorrhage)","2015-10-01","2015-10-01","Atrial Fibrillation; Ischemic Attack, Transient; A-fib; AF; AF - Atrial fibrillation; AFib","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000884.v1.p1","Gut Microbiome Profiles and Risk of Colorectal Cancer","Findings from recent studies suggest that the community of microbes residing in the human body is important in disease etiology; however, it remains unclear whether personal factors modulate human microbial  composition. Studies based on animal models indicate that differences in composition might be attributed to sex-mediated effects. We analyzed the","Not Applicable","Microbiota","Case-Control","Not Provided","POOLCLONE","4 phenotype datasets, 35 variables, 1 documents, 240 samples sequenced,  SRA, 240 subjects, 240 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2015-09-21","2015-09-21","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000941.v1.p1","Phylogenetic Analyses Reveal Complex Patterns of Melanoma Metastasis","Subpopulations of cells in a primary melanoma can disseminate and establish metastases. Still, the precise ancestral relationship between primary tumors and their metastases is not well understood. Using whole-exome sequencing  (for discovery) and targeted sequencing (for validation), we analyzed mutation patterns of primary melanomas and two or more metastases in each of 8","Not Applicable","Melanoma","Tumor vs. Matched-Normal","Not Provided","WXS","3 phenotype datasets, 11 variables, 39 samples sequenced,  SRA, 8 subjects, 39 samples","","NCI","GRU --- General Research Use, DS-M-MDS --- Disease-Specific (Melanoma, MDS)","2015-09-18","2015-09-18","Neoplasm Metastasis; Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000885.v1.p1","Strong Activation of Retroviral LTRs in HCC","The ncRNA transcriptome of human hepatocellular carcinoma (HCC) is largely unexplored. We used CAGE to characterize transcription start sites across different etiologies of human HCCs with emphasis on ncRNAs. Here  we report that retroviral LTR promoters, expressed in healthy tissues such as testis and placenta but not liver, are widely activated in HCC. Despite","Not Applicable","Carcinoma, Hepatocellular","Case-Control","CAGE_RNA_seq_markerset","Expression ncRNA (NGS), RNA-Seq","4 phenotype datasets, 16 variables, 1 molecular datasets, 105 samples sequenced,  SRA, 55 subjects, 105 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2015-09-17","2015-09-17","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000830.v1.p1","XPC and Non-XPC Cutaneous Squamous Cell Carcinoma Mutation Rate Study","Base mutations occur at higher frequencies within heterochromatin and late-replicating DNA. In this study, we show that regional differences in mutation frequency are absent in portions of the genome that  are not transcribed within cutaneous squamous cell carcinomas (cSCCs) with an XPC-\- genetic background. The XPC-\- genetic background predicates a","Not Applicable","Xeroderma Pigmentosum, Complementation Group C","Prospective Longitudinal Cohort","Not Provided","WGS","4 phenotype datasets, 20 variables, 26 samples sequenced,  SRA, 13 subjects, 26 samples","","NCI","DS-SKCA-MDS --- Disease-Specific (Skin Cancer, MDS), DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2015-09-16","2015-09-16","Skin Neoplasms; Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinoma, Squamous Cell; Carcinomas, Epidermoid","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000672.v1.p1","National Institute of Dental and Craniofacial Research (NIDCR) Sj&#x000f6;gren's    International Collaborative Clinical Alliance (SICCA): Center for    Inherited Disease Research (CIDR) Genome-Wide Genotyping","The Sj&#x000f6;gren's International Collaborative Clinical Alliance (SICCA) is a multisite observational cohort study that recruited a large cohort of geographically diverse participants. Enrollment of participants began in late 2004 at  five (one domestic and four international) sites, in which all groups used the same protocol-directed methods to provide uniform evaluations; collect","Not Applicable","Sjogren's Syndrome","Collection","HumanOmni2.5-4, HumanOmni2.5-8, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 118 variables, 2 molecular datasets, 3932 subjects, 4225 samples","European (2439), African (5), East Asian (834), African American (104), Hispanic1 (20), Hispanic2 (305), Other Asian or Pacific Islander (29), South Asian (170), Other (26)","NIDCR","DS-ADO --- Disease-Specific (Autoimmune Diseases)","2015-09-14","2015-09-14","Keratoconjunctivitis Sicca; Xerostomia; Absent salivary secretion; Aptyalia; Aptyalism; Asialia",""
"phs000837.v1.p1","Whole Genome Sequencing of Two 22q11DS Trios","Two subjects with 22q11.2 deletion syndromes (22q11DS) and their parents were recruited for a whole genome sequencing study to identify candidate genetic modifiers of the various phenotypes seen in 22q11DS.  Both probands had a typical 3 megabase deletion on chromosome 22q11.2 but discordant phenotypes. Inclusion criteria: Probands diagnosed with 22q11.2","Not Applicable","Tetralogy of Fallot","Family/Twin/Trios","WGS_markerset_grc37","WGS, SNP Genotypes (NGS)","5 phenotype datasets, 27 variables, 1 molecular datasets, 6 samples sequenced, 6 subjects, 6 samples","","NHGRI","GRU-IRB --- General Research Use (IRB)","2015-09-01","2015-09-01","Arthritis, Juvenile; Psychotic Disorders; Arthritis, Juvenile Systemic; Juvenile Onset Still Disease; Juvenile Onset Stills Disease; Juvenile Systemic Arthritis",""
"phs000948.v1.p1","Genetic Discovery and Application in a Clinical Setting: Continuing a    Partnership (eMERGE Phase II)","The electronic Medical Records and Genomics (eMERGE) Network is a consortium of ten participating sites funded by the NHGRI to investigate the use of electronic medical record systems for genomic  research. The goal of eMERGE is to conduct genome-wide association studies in approximately 19,000 individuals using EMR-derived phenotypes and DNA","Not Applicable","Electronic Health Records","Control Set","HumanExome-12","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 1968 subjects, 1968 samples","","NHGRI","HMB --- Health/Medical/Biomedical","2015-08-28","2015-08-28","Not Provided",""
"phs000626.v1.p1","CD4+ cell transcriptional profiling by RNA sequencing","We use next generation sequencing to investigate the different transcriptomes of closely related CD4+ T-cells from healthy human donors to elucidate the genetic programs that underlie their specialized immune functions.  Six cell types were included: Regulatory T-cells (CD25hiCD127low/neg with 95% FOXP3+ purity), regulatory T-cells activated using PMA/ionomycin,","Not Applicable","Immune System Phenomena","Control Set","Not Provided","RNA-Seq","4 phenotype datasets, 15 variables, 12 samples sequenced,  SRA, 2 subjects, 12 samples","","NIAID","GRU --- General Research Use","2015-08-25","2015-08-25","Not Provided",""
"phs000910.v1.p1","Type 1 Diabetes Genetics Consortium (T1DGC): Copy Number Variant (CNV)    Study","Type 1 Diabetes Genetics Consortium (T1DGC) was formed to address issues of limited sample size and consistency of phenotyping that had limited genetic investigations on risk of type 1 diabetes  (T1D). The T1DGC first collected affected sib pair (ASP) families from four geographic networks (Asia-Pacific, Europe, North America, United","Not Applicable","Diabetes Mellitus, Type 1","Family/Twin/Trios","target_markerset_grc36","CNV Genotypes","5 phenotype datasets, 36 variables, 1 molecular datasets, 8005 subjects, 8005 samples","","NIDDK","DS-T1DR-IRB-RD --- Disease-Specific (Type 1 diabetes, its complications and other autoimmune diseases, IRB, RD)","2015-08-24","2015-08-24","Autoimmune Diseases; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset",""
"phs000831.v1.p1","Sporadic Amyotrophic Lateral Sclerosis (ALS): Sequencing Study","Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects the nerves in the brain and spinal cord, leading to muscle weakening and eventual paralysis and death. Ten percent of  ALS cases are thought to be familial while the majority of cases are sporadic and the causative factors unknown. Dr. Roger Pamphlett of the","Not Applicable","Amyotrophic Lateral Sclerosis","Family/Twin/Trios","Not Provided","WGS, WXS","5 phenotype datasets, 17 variables, 157 samples sequenced,  SRA, 157 subjects, 157 samples","","NHGRI","DS-ALS --- Disease-Specific (Amyotrophic Lateral Sclerosis)","2015-08-21","2015-08-21","ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease; Disease, Lou-Gehrigs",""
"phs000415.v1.p1","Whole Exome and Targeted Sequencing in Tourette Syndrome Multiplex    Families","This study consists of 771 individuals from 15 extended, multi-generational Tourette Syndrome (TS) pedigrees collected by the Tourette Syndrome Association International Consortium for Genetics (TSAICG), 213 of whom are affected  either with TS or its broader, genetically related phenotype, chronic tic disorder (CT). Prior microsatellite linkage analysis, including 624","Not Applicable","Tourette Syndrome","Family/Twin/Trios","HumanOmniExpress-12","WXS, SNP Genotypes (Array), Targeted-Capture","5 phenotype datasets, 26 variables, 1 molecular datasets, 124 samples sequenced,  SRA, 256 subjects, 302 samples","","NINDS","DS-TS-NPU --- Disease-Specific (Tourette Syndrome, NPU), GRU --- General Research Use","2015-08-14","2016-08-14","Tics; Chorea, Habit; Choreas, Habit; Habit Chorea; Habit Choreas; Habit Spasm",""
"phs000913.v1.p1","Genomic Analysis of Mycosis Fungoides and S&#x000e9;zary Syndrome","Mycosis Fungoides (MF) and S&#x000e9;zary Syndrome (Sz) comprise the majority of Cutaneous T-Cell Lymphoma (CTCL) cases and are characterized by clinical heterogeneity. This array of symptoms includes skin patches, plaques  and tumors as well as blood involvement and erythroderma. Because the genetic basis of CTCL is still poorly understood, we performed whole-exome","Not Applicable","Mycosis Fungoides","Tumor vs. Matched-Normal","Affymetrix_WG_Array","SNP Genotypes (Array), WXS","4 phenotype datasets, 17 variables, 1 molecular datasets, 170 samples sequenced,  SRA, 93 subjects, 170 samples","","NCI","HMB --- Health/Medical/Biomedical","2015-08-10","2015-08-10","Sezary Syndrome; CTCL / Sezary syndrome; Erythroderma, Sezary; Lymphoma, Sezary's; SC)zary syndrome; SEZARY SYNDROME, SOMATIC","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000926.v1.p1","Rare Disease Susceptibility Alleles in Children with Crohn Disease","The overall goal of this proposed project is to identify rare genetic variants contributing to childhood onset-Crohn disease. Crohn disease is a chronic inflammatory disorder of the gastrointestinal tract of  unclear etiology and no known cure. Affected children suffer from diarrhea, abdominal pain, growth disturbances, and an impaired quality of life. The","Not Applicable","Crohn Disease","Family/Twin/Trios","WGS_markerset_grc37","SNP Genotypes (NGS)","5 phenotype datasets, 18 variables, 1 molecular datasets, 4 subjects, 4 samples","","NIDDK","DS-IBD-IRB-RD --- Disease-Specific (Inflammatory Bowel Disease, IRB, RD)","2015-08-07","2015-08-07","Rare Diseases; CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's disease of colon",""
"phs000938.v1.p1","Appraisal of Whole Exome Sequencing Methods","Next generation sequencing has aided characterization of genomic variation. While whole genome sequencing may capture all possible mutations, whole exome sequencing is more cost-effective and captures most phenotype-altering mutations. Initial  strategies for exome enrichment utilized a hybridization-based capture approach. Recently, amplicon-based methods were designed to simplify","Not Applicable","Exome Sequencing","Cross-Sectional","target_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 13 variables, 1 molecular datasets, 4 samples sequenced,  SRA, 3 subjects, 4 samples","","NHGRI","GRU-PUB --- General Research Use (PUB)","2015-07-24","2015-07-24","Not Provided",""
"phs000616.v2.p2","CIP: Obesity-Diabetes Familial Risk","The VIVA LA FAMILIA Study was designed to identify genetic variants influencing childhood obesity and its comorbidities in the Hispanic population. Family recruitment and phenotyping were conducted in 2000-2005 in  Houston, TX. All enrolled children (n 1030) and parents gave written informed consent or assent. The protocol was approved by the Institutional","Not Applicable","Obesity","Prospective Longitudinal Cohort","HumanOmni1-Quad, HumanOmni2.5-4","SNP Genotypes (Array), WXS","5 phenotype datasets, 36 variables, 1 molecular datasets, 928 samples sequenced, 935 subjects, 957 samples","","NIDDK","DS-OBS-IRB-RD --- Disease-Specific (Obesity, IRB, RD)","2015-07-17","2013-11-12","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000864.v1.p1","Genomic Predictors of Combat Stress Vulnerability and Resilience","The Genomic Predictors of Combat Stress Vulnerability and Resilience Study was designed to probe the likely hereditary basis for risk or resilience to develop PTSD and other trauma spectrum disorders.  The overall guiding hypothesis was that genomic variation gives rise to risk/susceptibility traits that, when actuated by traumatic environmental","Not Applicable","Stress Disorders, Post-Traumatic","Prospective Longitudinal Cohort","HumanOmniExpressExome-8","SNP Genotypes (Array)","5 phenotype datasets, 23 variables, 1 analyses, 1 molecular datasets, 3992 subjects, 3992 samples","European (2662), African (10), East Asian (55), African American (198), Hispanic1 (102), Hispanic2 (766), Other Asian or Pacific Islander (122), South Asian (5), Other (72)","NIMH","GRU --- General Research Use","2015-07-15","2015-07-15","Combat Neurosis; Neuroses, Post Traumatic; Neuroses, Post-Traumatic; Neuroses, Posttraumatic; PTSD; PTSD - post-traumatic stress disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000564.v2.p1","Rapid Whole Genome Sequencing for Genetic Disease Diagnosis in the NICU","Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease presentations are often undifferentiated at birth. More than 3,500 monogenic diseases have been characterized, but clinical testing is  available for only some of them and many feature clinical and genetic heterogeneity. As such, an immense unmet need exists for improved molecular","Not Applicable","Congenital, Hereditary, and Neonatal Diseases and Abnormalities","Family/Twin/Trios","WGS_markerset_grc37","SNP Genotypes (NGS)","5 phenotype datasets, 19 variables, 2 molecular datasets, 279 subjects, 278 samples","","NICHD","GRU-IRB-PUB-COL-NPU-MDS-GSO --- General Research Use (IRB, PUB, COL, NPU, MDS, GSO)","2015-07-14","2015-07-14","Cerebellar Ataxia; Developmental Disabilities; growth and development; Heterotaxy Syndrome; Macrocephaly; Malformations of Cortical Development",""
"phs000838.v1.p1","Ghana Prostate Study","Participants were recruited through the Ghana Prostate Study-a population-based component, and a clinical component. The population-based component was a probability sample designed using the 2000 Ghana Population and Housing Census  data in an attempt to recruit approximately 1,000 men aged 50-74 years in the Greater Accra region ( 3 million people), which successfully recruited","Not Applicable","Prostatic Neoplasms","Case-Control","HumanOmni5-4","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 932 subjects, 932 samples","","NCI","DS-UC-MDS --- Disease-Specific (Urinary Conditions, MDS)","2015-07-10","2015-07-10","Prostatic Hyperplasia; BEP - Benign enlargement of prostate; BPH; BPH - benign prostatic hyperplasia; Benign Hyperplasia of Prostate; Benign Hyperplasia of the Prostate",""
"phs000901.v1.p1","University of Washington CSF biomarker study for Parkinson disease","There is a clear need to develop biomarkers for Parkinson disease (PD) diagnosis and monitoring disease progression. In this study we evaluated cerebrospinal fluid (CSF) proteins, which are known to  be critically involved in PD or identified in our preliminary profiling studies, aptamers, and RNAs as potential PD biomarkers. Access to subjects","Not Applicable","Parkinson Disease","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 17 variables, 57 samples sequenced,  SRA, 57 subjects, 57 samples","","NINDS","GRU --- General Research Use","2015-07-01","2016-07-01","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000196.v3.p1","Genome-Wide Association Study of Parkinson Disease","Parkinson's disease (PD) is a common, progressive, age-related, movement disorder that affects 1-2% of the people over the age of 65. The NeuroGenetics Research Consortium (NGRC) is the infrastructure of  the study. Study subjects were recruited at NGRC-affiliated movement disorder clinics in Oregon, Washington, Georgia, New York, and Alabama. DNA was","Not Applicable","Parkinson Disease","Case-Control","Not Provided","SNP Genotypes (Array)","4 phenotype datasets, 124 variables, 1 documents, 1 molecular datasets, 4011 subjects, 4271 samples","European (3976), African American (1), Hispanic1 (1), Hispanic2 (4), Other Asian or Pacific Islander (1), Other (3)","NINDS","GRU-IRB --- General Research Use (IRB)","2015-06-30","2016-06-30","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs000634.v1.p1","NCI GWAS of Lung Cancer in Never Smokers","A genomewide study of lung cancer in never smokers Abstract and specific aims In the United States, lung cancer incidence and mortality rates have been steadily declining over the past  decade, following decline in the prevalence of tobacco smoking. However, lung cancer remains the leading cause of cancer death, killing more patients","Not Applicable","Lung Neoplasms","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 26 variables, 4 analyses, 1 molecular datasets, 2320 subjects, 2320 samples","","NCI","GRU-MDS --- General Research Use (MDS), DS-CA --- Disease-Specific (Cancer)","2015-06-29","2015-06-29","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000863.v1.p1","NCI GWAS of Renal Cell Carcinoma in African Americans","The NCI GWAS of renal cell carcinoma (RCC) in African Americans was undertaken to provide insight into genetic loci affecting susceptibility to this malignancy in a racial group known to  be at elevated risk. We genotyped 1,136,723 single-nucleotide polymorphisms (SNPs) among 255 cases and 375 controls of African ancestry from the NCI","Not Applicable","Carcinoma, Renal Cell","Case-Control","Human1M-Duo","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 630 subjects, 650 samples","","NCI","DS-RCC-NPU-MDS --- Disease-Specific (Kidney Cancer, NPU, MDS)","2015-06-24","2015-06-24","ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal Cell",""
"phs000620.v1.p1","Minnesota Center for Twin and Family Research (MCTFR)","This is an epidemiological study of substance abuse and related psychopathology in which the subjects have been drawn from the Minnesota Center for Twin and Family Research (MCTFR). The MCTFR  is a large, ongoing, family-based study. It is in part a longitudinal study of two cohorts of adolescent twins and their parents. It additionally","Not Applicable","Substance-Related Disorders","Prospective Longitudinal Cohort","Human660W-Quad","WGS, SNP Genotypes (Array)","6 phenotype datasets, 29 variables, 1 molecular datasets, 981 samples sequenced,  SRA, 7377 subjects, 6097 samples","","NIDA","GRU --- General Research Use","2015-06-24","2016-06-24","Impulse Control Disorders; Disinhibition; Disorders, Impulse Control; ICD; Impulse Control Disorder; Impulse-Control Disorders","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000335.v3.p2","Genome-Wide associations of Lung Health Study (LHS)","The 'Genome-Wide Associations Environmental Interactions in the Lung Health Study' at Johns Hopkins University aims to test for association between lung function decline as a primary outcome associated with chronic  obstructive pulmonary disease (COPD) using banked DNA and phenotype data on 4,287 European Americans from the longitudinal, multicenter Lung Health","Not Applicable","Pulmonary Disease, Chronic Obstructive","Prospective Longitudinal Cohort","Human660W-Quad","SNP Genotypes (Array), SNP Genotypes (imputed)","6 phenotype datasets, 357 variables, 26 documents, 2 molecular datasets, 4391 subjects, 4361 samples","European (4113), African American (5), Hispanic1 (4), Hispanic2 (19), Other Asian or Pacific Islander (1), South Asian (1), Other (2)","NHLBI","DS-HLB --- Disease-Specific (Heart, Lung, and Blood diseases)","2015-06-24","2016-06-24","COPD; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000718.v1.p1","Trisomy 21 Nondisjunction (T21NDJ)","The overall goal of the project is to identify genetic risk factors associated with chromosome 21 nondisjunction in the oocyte. The dataset derives from multi-site collection of live birth probands  with Down syndrome due to standard trisomy 21 (T21) and their biological parents. The type of nondisjunction error (NDJ)(maternal or paternal) in all","Not Applicable","Nondisjunction, Genetic","Family/Twin/Trios","HumanOmniExpressExome-8, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","5 phenotype datasets, 31 variables, 2 documents, 2 molecular datasets, 2230 subjects, 2289 samples","European (1961), African (3), East Asian (2), African American (48), Hispanic1 (10), Hispanic2 (130), Other Asian or Pacific Islander (9), South Asian (3), Other (20)","NICHD","DS-DS-IRB-RD --- Disease-Specific (Down Syndrome, IRB, RD)","2015-06-23","2016-06-23","Down Syndrome; Trisomy; 47,XX,+21; 47,XY,+21; DS; Down syndrome chromosome region",""
"phs000509.v1.p1","Genome Sequencing of Hepatocellular Carcinoma","Hepatocellular carcinoma (HCC) accounts for 85-90% of primary liver cancers. We have focused on three major HCC etiologies:hepatitis C virus (HCV), hepatitis B virus (HBV), and nonviral causes. The onset  and progression of cancer is driven by extensive rearrangement and mutation of the genome. We combined our capability to capture and enrich exome DNA","Not Applicable","Carcinoma, Hepatocellular","Case Set","WES_markerset_grc37","WXS, SNP Genotypes (NGS)","4 phenotype datasets, 22 variables, 1 molecular datasets, 178 samples sequenced,  SRA, 100 subjects, 178 samples","","NHGRI","GRU --- General Research Use","2015-06-22","2015-12-23","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000869.v1.p1","Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study    (BEAGESS)","BEAGESS is a genome-wide association study (GWAS) which takes advantage of the extensive data collected by investigators in the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON, http://beacon.tlvnet.net), representing many of the  high-quality population-based and other epidemiologic studies of BE and EA in the world. The overall goal of our research is to evaluate the","Not Applicable","Esophageal Neoplasms","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 1 molecular datasets, 6923 subjects, 6929 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2015-06-19","2015-06-19","Barrett Esophagus; BARRETT METAPLASIA; BE; Barret syndrome; Barrett Metaplasias; Barrett Syndrome","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000918.v1.p1","International Parkinson's Disease Genomics Consortium (IPDGC), NeuroX    Dataset","Expanded replication set based on Nalls et al. 2014. Included samples are unrelated cases and controls of European ancestry with high quality genotype data and proper consent. For further details  see PMID: 21292315, PMID: 21738488, PMID: 25444595, and PMID: 25064009. Principal Investigators: Andrew B. Singleton, PhD, National Institute on","Not Applicable","Parkinson Disease","Case-Control","Neuro_Consortium_Array","SNP Genotypes (Array)","4 phenotype datasets, 33 variables, 1 molecular datasets, 11402 subjects, 11402 samples","","NINDS","GRU --- General Research Use","2015-06-15","2015-06-15","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs000545.v1.p1","Predicting Chemotherapy-Induced Mucositis with Genetic and Clinical    Factors","We hypothesized that genetic variability in the enzymes/proteins involved in drug metabolism, inflammation, and immune function is a major underlying contributor to mucositis incidence and progression and that, based on  this variability we can identify variants that influence risk, and develop a mucositis progression prediction model that improves on existing models","Not Applicable","Multiple Myeloma","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 37 variables, 1 molecular datasets, 764 subjects, 764 samples","European (699), African (1), East Asian (2), African American (41), Hispanic1 (5), Hispanic2 (11), South Asian (3), Other (2)","NINR","DS-CIM --- Disease-Specific (Chemotherapy Induced Mucositis)","2015-06-12","2016-06-12","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease",""
"phs000346.v2.p2","Cancer Genetic Markers of Susceptibility for Bladder Cancer (CGEMS    Bladder)","This study funded by the National Cancer Institute (NCI) involves conducting a genome-wide association study of common genetic variants to identify markers of susceptibility to bladder cancer. This bladder GWAS  has led to the discovery of three novel regions in the genome associated with bladder cancer risk. Cases were defined as individuals having","Not Applicable","Urinary Bladder Neoplasms","Case-Control","HumanHap240S, HumanHap300, HumanHap550, Human610-Quad, Human1M-Duo, Human660W-Quad","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 documents, 2 molecular datasets, 11424 subjects, 13060 samples","","NCI","CADM --- Cancer in all age groups, adult diseases, and methods","2015-06-12","2015-06-12","Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant; Epithelioma",""
"phs000912.v1.p1","San Francisco Bay Area Latina Breast Cancer Study","The genome-wide association study (GWAS) includes participants enrolled into two different studies. The first study, the San Francisco Bay Area Cancer Study (SFBCS) is a population-based case-control study of breast  cancer conducted in the San Francisco Bay Area and included women ages 35-79 years from three racial/ethnic groups: Non-Hispanic whites, African","Not Applicable","Breast Neoplasms","Case-Control","imputation_panel, Affymetrix_WG_Array","SNP Genotypes (imputed), SNP Genotypes (Array)","4 phenotype datasets, 23 variables, 2 molecular datasets, 1165 subjects, 1165 samples","European (94), African American (8), Hispanic1 (34), Hispanic2 (977), Other Asian or Pacific Islander (2), South Asian (1), Other (49)","NCI","DS-CABNHD-MDS --- Disease-Specific (Cancer, benign neoplasms, or hematopoietic diseases related to cancer, MDS), GRU-COL --- General Research Use (COL)","2015-06-11","2018-10-25","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000851.v1.p1","African American Breast Cancer GWAS","The GWAS includes African American participants from 9 epidemiological studies of breast cancer, comprising a total of 3,153 cases and 2,831 controls (cases/controls: The Multiethnic Cohort Study (MEC), 734/1,003; The  Los Angeles component of The Women's Contraceptive and Reproductive Experiences (CARE) Study, 380/224; The Women's Circle of Health Study (WCHS),","Not Applicable","Breast Neoplasms","Case-Control","Not Provided","SNP Genotypes (imputed), SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 2 molecular datasets, 5367 subjects, 5367 samples","European (4), African (185), African American (5024), Hispanic1 (116), Hispanic2 (4), South Asian (4), Other (30)","NCI","CHALLENGE --- Up for a Challenge (Publication required), CHALLENGE-NPU --- Up for a Challenge (Not for Profit Use Only, Publication required)","2015-06-11","2015-09-03","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000812.v1.p1","The Breast and Prostate Cancer Cohort Consortium (BPC3) GWAS of    Aggressive Prostate Cancer and ER- Breast Cancer","The Breast and Prostate Cancer Cohort Consortium (BPC3) was established in 2003 to pool data and biospecimens from nine large prospective cohorts to conduct research on gene-environment interactions in cancer  etiology. The BPC3 initially focused on the association of 70 candidate genes in the Steroid Hormone Metabolism and IGF pathways with risk of breast","Not Applicable","Prostatic Neoplasms","Case-Control","imputation_panel, Human610-Quad, HumanHap550, Human660W-Quad","SNP Genotypes (imputed), SNP Genotypes (Array)","5 phenotype datasets, 46 variables, 2 analyses, 4 molecular datasets, 12501 subjects, 12501 samples","European (12484), Hispanic1 (4), Hispanic2 (6), South Asian (1), Other (6)","NCI","GRU-MDS --- General Research Use (MDS), HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS), DS-BOED-MDS --- Disease-Specific (Breast, Ovarian, or Endometrial Disease, MDS), CADM --- Cancer in all age groups, other disease in adults only and methods","2015-06-11","2015-06-11","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000799.v1.p1","Shanghai Breast Cancer Genetics Study (SBCGS)","The Shanghai Breast Cancer Genetics Study (SBCGS) includes data from four population-based studies conducted among Chinese women in urban Shanghai: the Shanghai Breast Cancer Study (SBCS), the Shanghai Breast Cancer  Survival Study (SBCSS), the Shanghai Women's Health Study (SWHS), and the Shanghai Endometrial Cancer Study (SECS, contributing controls only).","Not Applicable","Breast Neoplasms","Case-Control","imputation_panel, Affymetrix_WG_Array","SNP Genotypes (NGS), SNP Genotypes (imputed)","4 phenotype datasets, 17 variables, 2 molecular datasets, 5152 subjects, 5152 samples","","NCI","GRU-PUB-NPU --- General Research Use (PUB, NPU)","2015-06-11","2018-08-28","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000517.v3.p1","Multiethnic Cohort (MEC) Breast Cancer Genetics","The Multiethnic Cohort Study is a population-based prospective cohort study (n 215,251) that was initiated between 1993 and 1996 and includes subjects from various ethnic groups - African Americans and  Latinos primarily from Californian (great Los Angeles area) and Native Hawaiians, Japanese-Americans, and European Americans primarily from Hawaii.","Not Applicable","Breast Neoplasms","Case-Control","Human660W-Quad, Human1M-Duo, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 documents, 2 molecular datasets, 3708 subjects, 3790 samples","European (34), African (21), East Asian (1650), African American (869), Hispanic1 (45), Hispanic2 (992), Other Asian or Pacific Islander (58), Other (39)","NCI","DS-CA --- Disease-Specific (Cancer), GRU-MDS --- General Research Use (MDS), HMB-MDS --- Health/Medical/Biomedical (MDS)","2015-06-11","2014-01-25","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000147.v3.p1","CGEMS Breast Cancer GWAS","The initial stage of the Cancer Genetic Markers of Susceptibility (CGEMS) breast cancer genome-wide association study (GWAS) included genotyping 528,173 SNPs (Illumina HumanHap550) in 1,145 postmenopausal women of European ancestry  with invasive breast cancer and 1,142 controls from the Nurses' Health Study (NHS). Subsequently, incident invasive breast cancer cases from the","Not Applicable","Breast Neoplasms","Case-Control","HumanHap550, imputation_panel","WXS, SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 16 variables, 1 documents, 1 analyses, 3 molecular datasets, 1558 samples sequenced,  SRA, 2576 subjects, 2723 samples","","NCI","GRU --- General Research Use","2015-06-11","2014-02-13","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000868.v1.p1","Transcriptome Sequencing of Pediatric Neuroblastoma","Neuroblastoma is the most common extra-cranial solid tumor in children. It represents 8% to 10% of all childhood cancers. Stage 4 Neuroblastoma is characterized by its clinical heterogeneous outcome. The  special category, stage 4S tumors (2-5% of all NB) are chemo-sensitive, and the patients show spontaneous regression. On the other hand, MYCN","Not Applicable","Neuroblastoma","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 14 variables, 29 samples sequenced,  SRA, 29 subjects, 29 samples","","NCI","GRU --- General Research Use","2015-06-05","2015-06-05","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000180.v3.p2","T1DGC: Genome-Wide Association Study in Type 1 Diabetes, 2008","Cases with Type 1 Diabetes (T1D) in the UK, were part of the Wellcome Trust Case Control Consortium (WTCCC) - http://www.wtccc.org.uk - that first reported in 2007: Wellcome Trust Case  Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-678.","Not Applicable","Diabetes Mellitus, Type 1","Case Set","HumanHap550","SNP Genotypes (Array)","4 phenotype datasets, 28 variables, 14 documents, 1 analyses, 1 molecular datasets, 4069 subjects, 4129 samples","European (4023), African (1), Hispanic1 (9), Other Asian or Pacific Islander (1), South Asian (2), Other (7)","NIDDK","DS-T1DR-IRB --- Disease-Specific (Type 1 diabetes, its complications and other autoimmune diseases, IRB)","2015-05-27","2012-08-03","DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes Mellitus, Sudden Onset",""
"phs000874.v1.p1","Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS)","GERFHS is a population-based, case-control study of hemorrhagic stroke in the Greater Cincinnati/Northern Kentucky region. Cases are recruited from within 50 miles of the University of Cincinnati and population-based controls  are matched to cases by age (+/- 5 years), race and gender from the same population as cases. All study participants are of self-reported","Not Applicable","Cerebral Hemorrhage","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 950 subjects, 950 samples","","NINDS","GRU-PUB --- General Research Use (PUB)","2015-05-22","2015-05-22","Intracerebral Hemorrhage; Bleeding in brain; Brain Hemorrhage, Cerebral; Brain Hemorrhages, Cerebral; Cerebral Brain Hemorrhage; Cerebral Brain Hemorrhages",""
"phs000826.v1.p1","Prediction of Trastuzumab Benefit in Adjuvant Breast Cancer: NSABP B31","Background National Surgical Adjuvant Breast and Bowel Project (NSABP) trial B-31 suggested the efficacy of adjuvant trastuzumab, even in HER2-negative breast cancer. This finding prompted us to develop a predictive  model for degree of benefit from trastuzumab using archived tumor blocks from B-31. Methods Case subjects with tumor blocks were randomly divided","Not Applicable","Breast Neoplasms","Clinical Trial","","miRNA Expression (Array)","4 phenotype datasets, 25 variables, 1 molecular datasets, 1579 subjects, 1579 samples","","NCI","DS-CA-IRB-MDS --- Disease-Specific (Cancer, IRB, MDS)","2015-05-12","2015-05-12","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000787.v1.p1","Immunosenescence: Immunity in the Young and Aged","The study sequenced TCRB gene rearrangements from young versus elderly human subjects. Inclusion: Healthy apheresis platelet donors Aged 20-35 years, or 70-85 years Exclusion: History of autoimmune disease History of  diabetes mellitus History of chemotherapy Co-principal Investigators: Scott D. Boyd, MD, PhD, Stanford University, Stanford, CA, USA Co-principal","Not Applicable","Aging","Prospective Longitudinal Cohort","Not Provided","AMPLICON","4 phenotype datasets, 14 variables, 210 samples sequenced, 9 subjects, 210 samples","","NIAID","HMB-IRB --- Health/Medical/Biomedical (IRB)","2015-05-08","2016-01-08","Aging, Biological; Biological Aging",""
"phs000900.v1.p1","Functionally-defined Therapeutic Targets in DIPG","Diffuse Intrinsic Pontine Glioma (DIPG) is a universally fatal childhood cancer. Here, we performed a chemical screen in patient-derived DIPG cell cultures along with RNAseq expression analysis and integrated computational  modeling to identify potentially effective therapeutic strategies. Panobinostat, among the more promising agents identified, demonstrated efficacy in","Not Applicable","Glioma","Prospective Longitudinal Cohort","Not Provided","RNA-Seq, WXS","3 phenotype datasets, 13 variables, 75 samples sequenced,  SRA, 22 subjects, 75 samples","","NCI","GRU --- General Research Use","2015-05-01","2015-05-01","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000857.v1.p1","Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole","These are tumor biopsies and corresponding normal samples from patients with early stage ER+/HER2- breast cancer who had received the aromatase inhibitor letrozole for 10-21 days prior to surgery. All  patients had early stage ER+/HER2- breast cancer and participated in a clinical trial of neoadjuvant letrozole for 10-21 days prior to surgery.","Not Applicable","Breast Neoplasms","Clinical Trial","Not Provided","RNA-Seq","4 phenotype datasets, 10 variables, 50 samples sequenced,  SRA, 50 subjects, 50 samples","","NHGRI","HMB-PUB-NPU --- Health/Medical/Biomedical (PUB, NPU)","2015-04-29","2015-04-29","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000168.v2.p2","National Institute on Aging - Late Onset Alzheimer's Disease Family    Study: Genome-Wide Association Study for Susceptibility Loci","Alzheimer disease is the most common neurodegenerative disorder of the elderly affecting an estimated five million Americans. Genetic factors contribute to the risk for disease with heritability estimates ranging from  57% to 79%. More than a decade ago, the &#x003b5;4 variant of APOE was identified and remains the most consistently replicated genetic variant","Not Applicable","Alzheimer Disease","Case-Control","Human610-Quad, custom_markerset","SNP Genotypes (Array)","5 phenotype datasets, 80 variables, 1 documents, 1 molecular datasets, 5220 subjects, 5572 samples","European (4445), African (4), East Asian (8), African American (310), Hispanic1 (403), Hispanic2 (39), Other Asian or Pacific Islander (1), Other (10)","NIA","GRU --- General Research Use, NPU --- Non Profit Use, DS-ALZ --- Disease-Specific (Alzheimer Disease), DS-ALZ-NPU --- Disease-Specific (Alzheimer Disease, NPU)","2015-04-28","2010-09-21","Dementia; AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000867.v1.p1","The Finland-United States Investigation of NIDDM Genetics (FUSION) Study","The Finland-United States Investigation of NIDDM Genetics (FUSION) study is a long-term effort to identify genetic variants that predispose to type 2 diabetes (T2D) or that impact the variability of  T2D-related quantitative traits. The initial effort involved linkage analysis of affected-sibling-pair (ASP) families based on over 5,000 individuals","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","HumanHap300","Not Provided","3 phenotype datasets, 28 variables, 2220 samples sequenced,  SRA, 1850 subjects, 3928 samples, 2 substudies","","NIDDK","GRU-IRB --- General Research Use (IRB)","2015-04-24","2015-04-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000702.v1.p1","Sequence Data From Participants in the FUSION Study","This study is part of a re-sequencing project to identify variants associated with metabolic syndrome traits in a Finnish cohort. Metabolic syndrome (MetS) increases the risk of cardiovascular disease and  diabetes, and prevalence is estimated to be as high as 25% in the United States. MetS is characterized via measure of triglycerides (TG),","The Finland-United States Investigation of NIDDM Genetics (FUSION) Study (phs000867.v1.p1)","Diabetes Mellitus, Type 2","Case-Control","Not Provided","WXS, WXS","2 phenotype datasets, 6 variables, 2220 samples sequenced,  SRA, 1825 subjects, 2222 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2015-04-24","2015-04-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000100.v4.p1","The Finland-United States Investigation of NIDDM Genetics (FUSION) - GWAS    Study","The Finland-United States Investigation of NIDDM Genetics (FUSION) study is a long-term effort to identify genetic variants that predispose to type 2 diabetes (T2D) or that impact the variability of  T2D-related quantitative traits. The initial effort involved linkage analysis of affected-sibling-pair (ASP) families based on over 5,000 individuals","The Finland-United States Investigation of NIDDM Genetics (FUSION) Study (phs000867.v1.p1)","Diabetes Mellitus, Type 2","Case-Control","HumanHap300","SNP Genotypes (Array)","2 phenotype datasets, 6 variables, 1 analyses, 1 molecular datasets, 1706 subjects, 1706 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2015-04-24","2015-04-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000873.v1.p1","Exome Sequencing of a Family with Thrombocytopenia and Leukemia","A family with a history of bleeding, variable thrombocytopenia, red cell macrocytosis and two cases of pre B-cell acute lymphoblastic leukemia was studied in a single visit. The family was  assessed for bleeding history using a bleeding questionnaire. Additionally, complete blood counts were measured and whole blood was collected from","Not Applicable","Thrombocytopenia","Family/Twin/Trios","WES_markerset_grc37","WXS, SNP/CNV Genotypes (NGS), RNA-Seq","5 phenotype datasets, 23 variables, 3 documents, 1 molecular datasets, 11 samples sequenced,  SRA, 8 subjects, 11 samples","","NHLBI","GRU --- General Research Use","2015-04-15","2015-04-15","B-Cell Leukemia; B Cell Leukemia; B Lymphocytic Leukemia; B-Cell Leukemias; B-Cell Lymphocytic Leukemia; B-Cell Lymphocytic Leukemias","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs000794.v1.p1","Longitudinal Genome-Wide Analysis of Patients with Chronic Lymphocytic    Leukemia","Samples from two-center prospective phase 2 clinical trail conducted at Ohio State University (Columbus, OH) and Mayo Clinic (Rochester, MN) were analyzed in 12 cases. All patients had progressive CLL  as defined by National Cancer Institute (NCI) Working Group criteria. Patients provided written informed consent for correlative studies according to","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Prospective Longitudinal Cohort","Not Provided","WXS","4 phenotype datasets, 20 variables, 42 samples sequenced,  SRA, 12 subjects, 42 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2015-04-15","2015-04-15","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000855.v1.p1","Resistance studies in Lung Cancer","The purpose of the study was to compare gene expression profiles from a cohort of crizotinib-resistant ALK-rearranged lung tumors and a cohort of treatment-naive ALK-rearranged lung tumors. Expression profiles were  generated by RNA-seq. In parallel, gene expression profiles were obtained from ALK-rearranged lung cancer cell lines in the presence or absence of","Not Applicable","Carcinoma","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 10 variables, 48 samples sequenced,  SRA, 15 subjects, 48 samples","","NHGRI","DS-LCTC-MDS --- Disease-Specific (Lung Cancer and Thoracic Malignancies, MDS)","2015-04-07","2015-04-07","Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant; Epithelioma",""
"phs000832.v1.p1","Sensitivity to the subjective effects of amphetamine","The goal of this study was to identify SNPs associated with subjective, physiological, and behavioral responses to d-amphetamine. The study was double-blind and placebo-controlled. 381 healthy volunteers aged 18-35 years  old received oral doses of d-amphetamine (10 and 20 mg) and placebo over the course of three different phenotyping sessions. A subset of subjects","Not Applicable","Dextroamphetamine","Prospective Longitudinal Cohort","Affymetrix_WG_Array, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","4 phenotype datasets, 770 variables, 2 analyses, 2 molecular datasets, 381 subjects, 381 samples","European (337), African (4), East Asian (9), African American (14), Hispanic2 (12), South Asian (2), Other (3)","NIDA","GRU --- General Research Use","2015-04-02","2015-04-02","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000757.v1.p1","Ataxia Gene Identification by Integrated Genomic Analysis","Ataxias are a group of diseases that result in a lack of coordinated muscle movement. Hereditary ataxias are genetically heterogeneous and it is reported that 40% of suspected genetic ataxias  currently have an unknown cause. We used exome sequencing to detect mutations responsible for ataxia. We sequenced, when available, multiple","Not Applicable","Ataxia","Family/Twin/Trios","Not Provided","WXS","5 phenotype datasets, 17 variables, 54 samples sequenced, 127 subjects, 54 samples","","NINDS","DS-NDR-IRB --- Disease-Specific (Neurological Disorders Research, IRB)","2015-04-01","2015-04-01","Ataxia (loss of muscle coordination); Ataxia,; Ataxias; Ataxy; Cerebellar ataxia; Coordination Impairment",""
"phs000691.v2.p1","CIP: Differential Response to Hydroxyurea and Incidence of Stroke in    Sickle Cell Disease","Sickle cell disease (SCD) is a severe debilitating hematological disorder associated with a high degree of morbidity and mortality. There are approximately 200,000 babies born with sickle cell disease each  year, with the disease predominately affecting individuals in Africa. The overall global burden of the disease is tremendous, with more than 100,000","Not Applicable","Anemia, Sickle Cell","Case-Control","Not Provided","WXS, WGS","4 phenotype datasets, 20 variables, 1 documents, 651 samples sequenced,  SRA, 651 subjects, 651 samples","","NHGRI","GRU --- General Research Use","2015-04-01","2014-07-10","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000766.v1.p1","GEI Studies - Psoriasis","The GEI Studies Project was started as an NIH consortium involving 5 disease groups with funding provided through the Genes, Environment, and Health Initiative (GEI). The objective of the project  was to optimize strategies for identifying rare variants as a follow up to genome-wide association studies (GWAS) using next-generation sequencing","Not Applicable","Psoriasis","Case-Control","Not Provided","WXS","4 phenotype datasets, 15 variables, 4844 samples sequenced,  SRA, 4844 subjects, 4844 samples","","NHGRI","GRU --- General Research Use","2015-03-31","2015-10-01","Arthritic Psoriasis; Arthritis, Psoriatic; Arthropathies, Psoriatic; Arthropathy, Psoriatic; PA (Psoriatic arthritis); PsA (Psoriatic arthritis)","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000761.v1.p1","Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA)","The OPPERA project has two sub-studies investigating effects of genetic, physiological, psychological and clinical factors on the risk of developing painful temporomandibular disorder (TMD). 1. OPPERA I baseline case-control study  of chronic TMJD (dbGaP study accession phs000762). This sub-study uses a case-control study design to investigate characteristics associated with","Not Applicable","Temporomandibular Joint Disorders","Case-Control","target_markerset_grc37","Not Provided","3 phenotype datasets, 21 variables, 1 documents, 3446 subjects, 3035 samples, 2 substudies","","NIDCR","DS-TMJD-RD --- Disease-Specific (Temporomandibular Joint Disorder, RD)","2015-03-27","2015-03-27","Chronic Pain; Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic; Widespread Chronic Pain",""
"phs000850.v1.p1","OPPERA Prospective Cohort Study of First-Onset TMJD","The OPPERA project investigates effects of genetic, physiological, psychological and clinical factors on risk of developing painful temporomandibular disorder. The prospective cohort study evaluated factors at enrollment that predicted subsequent  risk of developing first-onset temporomandibular disorder (TMD). Between May 2006 and November 2008, 3,263 study participants with no significant","Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) (phs000761.v1.p1)","Temporomandibular Joint Disorders","Prospective Longitudinal Cohort","target_markerset_grc37","SNP Genotypes (NGS), SNP Genotypes (NGS)","23 phenotype datasets, 1061 variables, 19 documents, 1 molecular datasets, 3258 subjects, 2866 samples","","NIDCR","DS-TMJD-RD --- Disease-Specific (Temporomandibular Joint Disorder, RD)","2015-03-27","2015-03-27","Chronic Pain; Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic; Widespread Chronic Pain",""
"phs000762.v1.p1","OPPERA baseline case-control study of chronic TMJD","The OPPERA project investigates effects of genetic, physiological, psychological and clinical factors on risk of developing painful temporomandibular disorder. The baseline case-control study evaluated factors associated with chronic temporomandibular disorder  among OPPERA participants who enrolled in the study between May 2006 and November 2008. Inclusion criteria were all three of: 1. Age 18-44 years 2.","Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) (phs000761.v1.p1)","Temporomandibular Joint Disorders","Case-Control","target_markerset_grc37","SNP Genotypes (NGS), SNP Genotypes (NGS)","24 phenotype datasets, 1079 variables, 20 documents, 1 molecular datasets, 1818 subjects, 1608 samples","","NIDCR","DS-TMJD-RD --- Disease-Specific (Temporomandibular Joint Disorder, RD)","2015-03-27","2015-03-27","Chronic Pain; Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic; Widespread Chronic Pain",""
"phs000846.v1.p1","Whole Genome Bisulfite Sequencing of ccf DNA and its Cellular    Contributors","Background: Circulating cell free (ccf) fetal DNA has enabled non-invasive prenatal fetal aneuploidy testing without direct discrimination of the genetically distinct maternal and fetal DNA. Current testing may be improved  by specifically enriching the sample material for fetal DNA. DNA methylation may allow for such a separation of DNA and thus support additional","Not Applicable","DNA Methylation","Cross-Sectional","Not Provided","Bisulfite-Seq","4 phenotype datasets, 17 variables, 27 samples sequenced,  SRA, 27 subjects, 27 samples","","NHGRI","GRU-IRB --- General Research Use (IRB)","2015-03-26","2015-03-26","",""
"phs000687.v1.p1","Bulgarian Schizophrenia Trio Sequencing Study","The primary aim of this study is to whole exome sequence complete Bulgarian trios to identify de novo mutations in schizophrenic probands. We are investigating the rate of de novo  mutations in probands as well as looking for enrichment among previously implicated genes and synaptic gene sets. Probands of this study (N 623),","Not Applicable","Schizophrenia","Family/Twin/Trios","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets, 1819 samples sequenced,  SRA, 1826 subjects, 1826 samples","","NIMH","GRU-NPU --- General Research Use (NPU)","2015-03-26","2015-09-26","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder",""
"phs000726.v1.p1","Genome-Wide Association Study of Myasthenia Gravis","The purpose of this project was to conduct a genome-wide associate study to search for the genetic factors that predispose to myasthenia gravis. The rationale for this study lies in  the fact that, although the immunological and physiological processes affecting the neuromuscular junctions of myasthenia gravis patients are well","Not Applicable","Myasthenia Gravis","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 972 subjects, 972 samples","","NIA","GRU-IRB --- General Research Use (IRB)","2015-03-17","2015-03-17","Generalized Myasthenia Gravis; Myasthenia Gravis, Generalized",""
"phs000733.v1.p1","ICPCG Genome Wide Association Study of Familial Prostate Cancer","Initially, the ICPCG focused largely on high-risk prostate cancer pedigrees using linkage analysis. However, association studies have also been informative to find prostate cancer susceptibility variants in the genome. We  hypothesize that genome-wide (GW) association studies of familial cases of prostate cancer will have the power to identify rarer and perhaps less","Not Applicable","Prostate cancer, familial","Case-Control","HumanOmni5Exome-4, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 2 molecular datasets, 4036 subjects, 4181 samples","European (3930), African (6), East Asian (2), African American (26), Hispanic1 (10), Hispanic2 (5), Other Asian or Pacific Islander (3), South Asian (4), Other (4)","NCI","DS-PC --- Disease-Specific (Prostate Cancer)","2015-03-10","2015-03-10","Familial malignant neoplasm of prostate; Hereditary Prostate Cancer",""
"phs000170.v2.p1","GWAS on Cataract and HDL in the PMRP","The primary goals of this project are to develop and validate electronic phenotyping algorithms, to accurately identify cases and controls while maintaining a positive predictive value (PPV) of 95%, and  to conduct a genome wide association study that advances understanding of two specific yet interrelated disease states, while simultaneously engaging","Not Applicable","Cataract","Case-Control","Human660W-Quad","SNP Genotypes (Array)","7 phenotype datasets, 551 variables, 5 documents, 1 molecular datasets, 11059 subjects, 4048 samples","European (3919), East Asian (8), African American (2), Hispanic1 (2), Hispanic2 (10), Other Asian or Pacific Islander (4), South Asian (1), Other (1)","NHGRI","HMB-GSO --- Health/Medical/Biomedical (GSO)","2015-03-09","2016-03-09","Glaucoma; Hypertension; CRYGS cataract (disease); CTRCT20; Cataract, Membranous; Cataracts, Membranous",""
"phs000678.v1.p1","A Family-Based Study of Genes and Environment in Young-Onset Breast    Cancer","To study environmental and genetic causes of young onset breast cancer, we recruited women who had been young when recently diagnosed (under age 50 and within 4 years of enrollment),  and had been identified as potentially eligible by a sister who was already participating in the ongoing Sister Study. The unaffected sister had","Not Applicable","Breast Neoplasms","Case-Control","HumanOmniExpressExome-8, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","5 phenotype datasets, 30 variables, 2 molecular datasets, 5957 subjects, 3492 samples","European (3055), African (5), East Asian (16), African American (144), Hispanic1 (19), Hispanic2 (85), Other Asian or Pacific Islander (10), South Asian (4), Other (4)","NIEHS","GRU --- General Research Use","2015-02-25","2016-02-25","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000760.v1.p1","Human Responses to Influenza Vaccination","The data consist of the DNA sequences of antibody gene rearrangements from peripheral blood human B cells of subjects vaccinated with trivalent seasonal influenza or monovalent pandemic H1N1 vaccine. Multiple  replicate libraries of immunoglobulin heavy chain gene rearrangements were prepared from each subject for each time point. The seven healthy vaccine","Not Applicable","Influenza Vaccines","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 16 variables, 586 samples sequenced,  SRA, 15 subjects, 586 samples","","NIAID","HMB-IRB --- Health/Medical/Biomedical (IRB)","2015-02-20","2015-02-20","Not Provided",""
"phs000841.v1.p1","Tyrosine Kinase Mutations in Endometrial Cancer","The purpose of the original study was to search for somatic mutations in the tyrosine kinome of serous and clear cell endometrial carcinomas (human). The study was conducted in two  phases. Phase 1: A mutation discovery screen, in which 577 exons encoding the catalytic domains of 86 tyrosine kinases were PCR-amplified and","Not Applicable","Endometrial Neoplasms","Case Set","Not Provided","AMPLICON","4 phenotype datasets, 24 variables, 180 samples sequenced,  SRA, 112 subjects, 180 samples","","NHGRI","DS-EC --- Disease-Specific (Endometrial Carcinoma)","2015-02-13","2016-02-13","Endometrial Tumor; Endometrial neoplasm; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium",""
"phs000817.v1.p1","Responses to Varicella Zoster Virus Vaccination","The study sequenced antibody heavy chain gene rearrangements from 4 identical twin pairs undergoing vaccination with Varicella Zoster viral vaccine. Inclusion: Identical twins Prior history of chicken pox Exclusion: Episode  of shingles within 5 years of the study Prior vaccination with Zostavax Co-principal Investigators: Scott D. Boyd, MD PhD, Stanford University,","Not Applicable","Chickenpox Vaccine","Family/Twin/Trios","Not Provided","AMPLICON","5 phenotype datasets, 18 variables, 255 samples sequenced, 16 subjects, 256 samples","","NIAID","GRU --- General Research Use","2015-02-10","2016-02-10","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000856.v1.p1","Chromothripsis in Patient WHIM-09","We are studying the natural history, pathogenesis and treatment of patients with WHIM syndrome, an immunodeficiency disorder characterized by warts, hypogammaglobulinemia, recurrent infections and neutropenia usually due to autosomal dominant  gain-of-function mutations in chemokine receptor CXCR4. We have identified a patient born with WHIM syndrome and the WHIM mutation CXCR4R334X who has","Not Applicable","WHIM syndrome","Case Set","Not Provided","WGS","4 phenotype datasets, 23 variables, 2 samples sequenced,  SRA, 1 subjects, 2 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2015-02-05","2015-05-05","Severe congenital neutropenia; Warts; Warts, hypogammaglobulinemia, infections, and myelokathexis; Autosomal dominant or sporadic congenital neutropenia; Congenital Agranulocytosis; Congenital Neutropenia",""
"phs000737.v1.p1","NIDDK Genetics of Metabolic Syndrome in an Island Population","The major objective of this study was to conduct a systematic genetic study of metabolic traits involved in metabolic syndrome through collection and analysis of epidemiological, demographic, environmental, and relevant  biological and clinical data from a relatively isolated island population of the eastern Adriatic coast of Croatia. The population was chosen for the","Not Applicable","Metabolic Syndrome","Cross-Sectional","Affymetrix_WG_Array","SNP Genotypes (Array)","5 phenotype datasets, 74 variables, 1 molecular datasets, 2089 subjects, 1315 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-Specific (Type 2 Diabetes, IRB, RD)","2015-02-05","2015-02-05","Coronary Heart Disease; Dyslipidemia; Gout; Hypertension, Essential; Metabolic Syndrome X; CHD - Coronary heart disease",""
"phs000807.v1.p1","Breast Cancer Study","The Cancer and Leukemia Group B (CALGB) 40101 trial compared four and six cycles of AC or single-agent paclitaxel in early breast cancer. The study was a 2X2 factorial design  trial that also examined the effects of AC vs singleagent paclitaxel. CALGB 40101 enrolled over 3000 women with operable primary breast cancer and","Not Applicable","Breast Neoplasms","Prospective Longitudinal Cohort","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 31 variables, 1 molecular datasets, 1914 subjects, 1914 samples","European (1612), African (7), East Asian (16), African American (169), Hispanic1 (21), Hispanic2 (58), Other Asian or Pacific Islander (11), South Asian (5), Other (15)","NIGMS","APTC --- For the use in future research to learn about, prevent or treat cancer","2015-02-03","2016-02-03","Neutropenia; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors",""
"phs000790.v1.p1","Comparative Analysis of Primary and Metastatic Colorectal Cancer","Molecular profiling for somatic mutations that predict response to anti-EGFR therapy in colorectal cancer (CRC) has become standard practice. However, abundant tissue from metastatic lesions is not always available from  patients with metastatic CRC. Concerns involving genetic heterogeneity between primary and metastatic lesions have called into question the","Not Applicable","Colorectal Neoplasms","Prospective Longitudinal Cohort","other","WGS, SNV (.MAF)","3 phenotype datasets, 17 variables, 1 molecular datasets, 12 samples sequenced, 4 subjects, 12 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2015-01-29","2015-01-29","COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic; Cancers, Colon","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000811.v1.p1","Comparison of custom capture for targeted next generation DNA sequencing","Targeted, capture-based DNA sequencing is an economical way to sequence a customized region of the genome. Several targeted sequencing kits are available, but the efficacies of these kits have not  been compared. We appraised four targeted DNA technologies for next generation sequencing, considering on-target sequencing, uniformity, and single","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","target_markerset_grc36","SNP Genotypes (NGS), OTHER","4 phenotype datasets, 13 variables, 1 molecular datasets, 16 samples sequenced,  SRA, 10 subjects, 16 samples","","NHGRI","GRU --- General Research Use","2015-01-09","2015-01-09","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000699.v1.p1","Osteosarcoma Genomics","In this study we attempt to elucidate the genomic characteristics of osteosarcoma. Clinical characteristics 58 tumor / normal pairs from 58 patients were included in the study. Median age at  diagnosis was 12 years. 49% of the patients were male and 47% had metastases at diagnosis. 5 year overall survival was 49% for the entire population,","Not Applicable","Osteosarcoma","Case Set","Somatic_Variant","WXS, WGS, SNV (.MAF), RNA-Seq","4 phenotype datasets, 14 variables, 1 analyses, 1 molecular datasets, 116 samples sequenced,  SRA, 58 subjects, 116 samples","","NCI","DS-CA-NPU-MDS --- Disease-Specific (Cancer, NPU, MDS)","2015-01-07","2015-01-07","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteoblastic osteosarcoma; Osteoblastic sarcoma; Osteochondrosarcoma",""
"phs000622.v1.p1","FaceBase Study of Facial Shape in Tanzania: CIDR","The goals of this project are to identify loci that underlie major genetic determinants of orofacial shape, by means of a GWAS in a cohort of normal African children (from  Tanzania) from whom we have collected 3D digitized facial morphometric scans, and a subsequent replication study of normal children from the same","Not Applicable","Congenital, Hereditary, and Neonatal Diseases and Abnormalities","Clinical Trial","HumanOmni2.5-8, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","6 phenotype datasets, 84 variables, 2 molecular datasets, 3623 subjects, 3739 samples","","NIDCR","DS-CFR --- Disease-Specific (Craniofacial Research)","2014-12-23","2014-12-23","",""
"phs000348.v2.p1","Towards a Genomic Understanding of Myeloma","This project was designed to describe genetic abnormalities in primary samples from patients with multiple myeloma by next generation sequencing. We generated sequence data from multiple myeloma (MM) patients analyzing  DNA both from tumor cells (purified from bone marrow using CD138 selection as a marker of plasma cells) and from normal peripheral blood cells","Not Applicable","Multiple Myeloma","Tumor vs. Matched-Normal","WGS_markerset_grc37, other","SNV Aggregate (.MAF), WXS, WGS","4 phenotype datasets, 32 variables, 2 molecular datasets, 408 samples sequenced,  SRA, 204 subjects, 409 samples","","NCI","GRU-MDS --- General Research Use (MDS), DS-CCRD-MDS --- Disease-Specific (Cancer and Cancer-Related Disorders, MDS)","2014-12-22","2014-12-22","Al amyloidosis; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000486.v1.p1","Integration of Genomics and Transcriptomics in unselected Twins and in    Major Depression","Our goals are to develop a comprehensive understanding of the genomics of transcription in a population based unselected sample and to discover DNA and RNA biomarkers for major depressive disorder  (MDD). This work is essential to developing a more complete understanding of the biological basis of MDD, a common complex trait associated with","Not Applicable","Depressive Disorder, Major","Prospective Longitudinal Cohort","Affymetrix_expression_array, Affymetrix_WG_Array","mRNA Expression (Array), SNP Genotypes (Array)","5 phenotype datasets, 44 variables, 2 molecular datasets, 8257 subjects, 10490 samples","European (4926), African American (3), Hispanic1 (17), Hispanic2 (3), Other Asian or Pacific Islander (27), South Asian (7), Other (78)","NIMH","DS-PD-RSC --- Disease-Specific (Psychiatric Disorders and Related Somatic Conditions)","2014-12-18","2015-12-18","Depression, Involutional; Depressions, Involutional; Involutional melancholia; Melancholia, Involutional; Melancholias, Involutional",""
"phs000018.v2.p1","Search for Susceptibility Genes for Diabetic Nephropathy in Type 1    Diabetes (GoKinD study participants), GAIN","Genetics of Kidneys in Diabetes (GoKinD) study is an initiative aimed at identifying susceptibility genes for diabetic nephropathy in type 1 diabetes. A large number of individuals with type 1  diabetes were screened to identify two subsets, one with clear-cut kidney disease and another with normal renal status despite long-term diabetes.","Not Applicable","Diabetic Nephropathies","Case-Control","Affymetrix_500K","SNP Genotypes (Array)","5 phenotype datasets, 68 variables, 28 documents, 3 analyses, 1 molecular datasets, 3046 subjects, 1829 samples","European (1697), African (1), East Asian (3), African American (46), Hispanic1 (24), Hispanic2 (21), Other Asian or Pacific Islander (4), South Asian (3), Other (8)","NIDDK","DS-T1DCR-IRB --- Disease-Specific (Type 1 Diabetes, Complications, and Related Traits, IRB)","2014-12-18","2008-07-09","DKD; Diabetic Kidney Disease; Diabetic Kidney Diseases; Diabetic nephropathy; Diabetic renal disease; Kidney Disease, Diabetic",""
"phs000848.v1.p1","Autosomal Recessive TPP2 Mutations Cause a New Human Immunodeficiency","To define a genetic syndrome of combined immunodeficiency, severe autoimmunity, and developmental delay, 4 patients from two families who had similar syndromic features were studied. To identify disease-causing mutations, we  performed whole exome sequencing for one patient and her healthy parent from Family 1 and also for one patient from Family 2. Disease segregated with","Not Applicable","Immunologic Deficiency Syndromes","Case-Control","WES_markerset_grc36","SNP Genotypes (NGS)","5 phenotype datasets, 24 variables, 1 molecular datasets, 3 subjects, 3 samples","","NIAID","GRU --- General Research Use","2014-12-16","2015-12-16","Autoimmunity; Developmental Disabilities; Autoimmune condition; Autoimmune disease; Autoimmune disorder; Autoimmunities","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000628.v1.p1","Characterization of a Metastatic Cervical Cancer Using NGS","In this study, we used shallow whole genome, exome, and RNA sequencing to genomically and transcriptomically characterize a cervical squamous carcinoma lesion metastatic to the lung and to detect and  analyze HPV infection in the same sample. Principal Investigator: Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA","Not Applicable","Uterine Cervical Neoplasms","Case Set","WES_markerset_grc37","WXS, SNP Genotypes (NGS), RNA-Seq, WGS","4 phenotype datasets, 16 variables, 1 molecular datasets, 7 samples sequenced,  SRA, 3 subjects, 7 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2014-12-16","2014-12-16","Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant; Epithelioma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000798.v1.p1","Performance Characteristics of Selective Targeted Enrichment in Genetic    Diagnostic Testing","The Nex-StoCT and ACMG recommend that validation of an NGS-based diagnostic test include performance test characteristics for assay accuracy, analytical sensitivity and specificity, reproducibility and repeatability. To measure these parameters  for the GEDi capture and sequencing test, 4 samples (three randomly selected patient samples and the NA12878 HapMap sample) were prepared and","Not Applicable","Genetic Testing","Control Set","HumanOmni2.5-8","SNP Genotypes (Array), WXS","3 phenotype datasets, 17 variables, 1 molecular datasets, 40 samples sequenced,  SRA, 4 subjects, 44 samples","","NEI","GRU-NPU --- General Research Use (NPU)","2014-11-26","2015-05-26","Not Provided",""
"phs000809.v1.p1","Autosomal recessive PGM3 mutations cause a new Congenital Disorder of    Glycosylation","To define a genetic syndrome of severe atopy, elevated serum IgE, immune deficiency, autoimmunity, and motor and neurocognitive impairment, eight patients from two families who had similar syndromic features were  studied. Whole exome sequencing was performed to identify disease-causing mutations. A disease segregated with a novel autosomal recessive mutations","Not Applicable","Congenital Disorders of Glycosylation","Family/Twin/Trios","WES_markerset_grc37","SNP Genotypes (NGS)","5 phenotype datasets, 26 variables, 1 molecular datasets, 8 subjects, 8 samples","","NIAID","GRU --- General Research Use","2014-11-25","2014-11-25","CDG; CDG - Carbohydrate-deficient glycoprotein syndrome; Carbohydrate Deficient Glycoprotein Syndrome; Carbohydrate deficiency glycoprotein syndrome; Carbohydrate-Deficient Glycoprotein Syndrome; Carbohydrate-Deficient Glycoprotein Syndromes","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000792.v1.p1","Oncogenomics of Malignant Peripheral Nerve Sheath Tumors","Malignant peripheral nerve sheath tumors (MPNSTs) are a group of highly aggressive soft tissue sarcomas that may occur sporadically, in association with neurofibromatosis type I (NF1-associated), or after radiotherapy (RT-associated).  We utilized comprehensive genomic approaches and identified recurrent loss-of-function somatic alterations in the Polycomb repressive complex 2","Not Applicable","Neurilemmoma","Case Set","Affymetrix_WG_Array","WXS, SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 14 variables, 1 molecular datasets, 46 samples sequenced, 18 subjects, 46 samples","","NCI","GRU-PUB-MDS --- General Research Use (PUB, MDS)","2014-11-24","2014-11-24","Nerve Sheath Neoplasms; Blastoma; CA; CA - Cancer; Cancer; MT",""
"phs000825.v1.p1","Whole Genome Sequencing of HUES63 and HUES64","In this study we used next generation deep sequencing technologies to analyze the genomes of Harvard University Stem Cell lines 63 and 64. We performed 101-bp paired-end whole genome sequencing  of the two cell lines using Illumina HiSeq platforms. The sequence reads obtained were analyzed for copy number and used for replication timing","Not Applicable","growth & development","Control Set","Not Provided","WGS","3 phenotype datasets, 12 variables, 2 samples sequenced,  SRA, 2 subjects, 2 samples","","NIMH","GRU --- General Research Use","2014-11-20","2014-11-20","growth and development; growth","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000689.v1.p1","Genomic Analysis of Peripheral T-Cell Lymphomas","Peripheral T-cell lymphomas (PTCLs) are a heterogeneous and poorly understood group of non Hodgkin lymphomas. We aim to identify new genetic alterations in PTCL transformation by using a combination of  whole exome sequencing of tumor-normal DNA pairs, RNAseq analysis and targeted deep sequencing of candidate genes. Our data identified highly","Not Applicable","Lymphoma, T-Cell, Peripheral","Case-Control","Not Provided","RNA-Seq, WXS","3 phenotype datasets, 18 variables, 59 samples sequenced,  SRA, 59 subjects, 55 samples","","NCI","DS-CA-PUB-MDS --- Disease-Specific (Cancer, PUB, MDS)","2014-11-18","2014-11-18","Lymphoma, Non-Hodgkin; Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum Cell Sarcomas; Reticulum cell sarcoma morphology",""
"phs000209.v13.p3","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort","MESA The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (disease detected non-invasively before it has produced clinical signs and symptoms) and the  risk factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease. MESA researchers study a","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Affymetrix_WG_Array, HumanExome-12","Not Provided","93 phenotype datasets, 22147 variables, 182 documents, 404 samples sequenced, 8296 subjects, 23922 samples, 3 substudies","","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2014-11-18","2015-11-18","Atherosclerosis; Atherogeneses; Atherogenesis; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000420.v6.p3","NHLBI MESA SHARe","This substudy phs000420 MESA SHARe contains Affy 6.0 genotypes and Infinium HumanExome BeadChip data, produced as part of NHLBI's SNP Health Association Resource (SHARe) project. Summary level phenotypes for the  MESA Cohort study participants can be viewed at the top-level study page phs000209 MESA Cohort. Individual level phenotype data and molecular data","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort (phs000209.v13.p3)","Cardiovascular Diseases","Prospective Longitudinal Cohort","Affymetrix_WG_Array, HumanExome-12","CNV Genotypes, SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 2 molecular datasets, 8388 subjects, 17098 samples","European (2737), African (122), East Asian (773), African American (2648), Hispanic1 (457), Hispanic2 (1354), Other Asian or Pacific Islander (14), South Asian (2), Other (117)","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2014-11-18","2015-11-18","Atherosclerosis; Atherogeneses; Atherogenesis; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs000403.v3.p3","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort (phs000209.v13.p3)","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","WXS, SNP Genotypes (NGS)","2 phenotype datasets, 97 variables, 2 molecular datasets, 404 samples sequenced,  SRA, 404 subjects, 404 samples","","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2014-11-18","2015-11-18","Brain Ischemia; Myocardial Infarction; Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies",""
"phs000283.v7.p3","NHLBI MESA Candidate Gene Association Resource (CARe)","This substudy phs000283 MESA CARe contains 50k genotypes from 2,100 candidate genes across a range of cardiovascular, metabolic, and inflammatory syndromes, produced as part of NHLBI's Candidate Gene Association Resource  (CARe) project. Summary level phenotypes for the MESA Cohort study participants can be viewed at the top-level study page phs000209 MESA Cohort.","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort (phs000209.v13.p3)","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 1 molecular datasets, 6354 subjects, 6420 samples","","NHLBI","HMB --- Health/Medical/Biomedical, HMB-NPU --- Health/Medical/Biomedical (NPU)","2014-11-18","2015-11-18","Atherosclerosis; Atherogeneses; Atherogenesis; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event",""
"phs000821.v1.p1","DNA Methylation Age and Mortality in the Lothian Birth Cohorts","The study examined the association between DNA methylation age and mortality. Methylation age was estimated in 4 cohorts (including the Lothian Birth Cohorts of 1921 and 1936) and related to  subsequent time-to-death. Across all four cohorts there was a strong correlation between predicted methylation age and chronological age. For","Not Applicable","mortality","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 19 variables, 1366 subjects","","NHLBI","HMB --- Health/Medical/Biomedical","2014-11-12","2015-11-12","DNA Methylation","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs000543.v1.p1","Exome Sequencing of Pleuropulmonary Blastoma","Pleuropulmonary blastoma (PPB) is a rare, aggressive pediatric cancer arising from the lung or pleural cavity. In this study, we sequenced and analyzed the exomes of 15 PPB matched tumor  and normal pairs. This study is part of a larger effort to characterize pediatric cancers as part of the Slim Initiative for Genomic Medicine (SIGMA)","Not Applicable","Pleuropulmonary blastoma","Case Set","Somatic_Variant","SNV (.MAF), WXS","4 phenotype datasets, 14 variables, 1 analyses, 1 molecular datasets, 30 samples sequenced,  SRA, 15 subjects, 30 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2014-11-06","2014-11-06","","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000778.v1.p1","NIDDK Gene discovery in VUR","Primary vesicoureteric reflux (PVUR), or non-syndromic VUR, is the most common type of congenital anomaly of the kidney and the urinary tract (CAKUT). PVUR is the single most important risk  factor for pyelonephritis and renal parenchymal scarring in the pediatric age group. Renal parenchymal scarring due to PVUR is referred to as reflux","Not Applicable","Vesico-Ureteral Reflux","Case Set","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 23 variables, 1 molecular datasets, 5 samples sequenced, 5 subjects, 5 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2014-11-05","2014-11-05","Pyelonephritis; Necrotizing Pyelonephritis; Pyelonephritis, Acute Necrotizing; Reflux, Vesico-Ureteral; Reflux, Vesicoureteral; Ureteral reflux",""
"phs000727.v1.p1","miRNA Profiles in Serum and CSF of Parkinson's and Alzheimer's Patients","We profiled the miRNA contents from cerebrospinal fluid and serum (using next generation sequencing) from postmortem patients diagnosed with Alzheimer's or Parkinson's disease, and neurologically normal controls. All biofluids were  cell-free and patient matched, there was one cerebrospinal fluid and one serum sample from each of 70 patients with Alzheimer's disease, 67 patients","Not Applicable","Alzheimer Disease","Case-Control","Not Provided","miRNA-Seq","4 phenotype datasets, 36 variables, 395 samples sequenced,  SRA, 211 subjects, 395 samples","","NINDS","GRU --- General Research Use","2014-11-05","2014-11-05","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000086.v3.p1","DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","The Diabetes Control and Complications Trial (DCCT, 1982-93) and the Epidemiology of Diabetes Interventions and Complications follow-up study (EDIC, 1994-2016) have been ongoing for more than twenty years. After a  mean follow-up of approximately 16 years, the DCCT-EDIC cohort of 1,441 Type 1 diabetics had remained remarkably complete with more than 90% of the","Not Applicable","Diabetes Mellitus, Type 1","Clinical Trial","HumanHap550, Human1M-Duo","SNP Genotypes (Array)","119 phenotype datasets, 13191 variables, 151 documents, 5 analyses, 2 molecular datasets, 1516 subjects, 1447 samples","European (1343), East Asian (3), African American (30), Hispanic1 (5), Hispanic2 (11), Other Asian or Pacific Islander (4), South Asian (1), Other (4)","NIDDK","DS-T1D-IRB --- Disease-Specific (Type 1 Diabetes, IRB), DS-DRC-IRB --- Disease-Specific (Diabetes and Related Complications, IRB)","2014-11-05","2014-11-05","Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Insulin-Dependent Diabetes Mellitus; DKD; Diabetic Kidney Disease",""
"phs000776.v1.p1","Consanguinity and Rare Mutations Outside of MCCC Genes Underlie    Non-Specific Phenotypes of MCC Deficiency","3-Methylcrotonyl-CoA Carboxylase Deficiency (MCCD) is an autosomal recessive disorder of leucine catabolism, which has a highly variable clinical phenotype, ranging from acute metabolic acidosis to non-specific symptoms such as developmental  delay, failure to thrive, hemiparesis, muscular hypotonia, and multiple sclerosis. Implementation of newborn screening for MCCD has resulted in","Not Applicable","Urea Cycle Disorders, Inborn","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 33 samples sequenced,  SRA, 33 subjects, 33 samples","","NICHD","DS-MCCD-IRB-NPU --- Disease-Specific (3-Methylcrotonyl-CoA Carboxylase Deficiency, IRB, NPU)","2014-10-27","2015-10-27","Disorder of urea cycle; Disorder, Urea Cycle; Disorders, Urea Cycle; Inborn Urea Cycle Disorder; UCD; Urea Cycle Disorder",""
"phs000797.v1.p1","CTLA4 haploinsufficiency and immune dysregulation","We identified germline heterozygous mutations in CTLA4 in members of four families with severe immune dysregulation. Human CTLA4 haploinsufficiency caused dysregulation of FoxP3+ regulatory T (Treg) cells and lymphocytic infiltration  of target organs, mimicking Ctla4 homozygous mice. Patients also exhibited a B cell phenotype, with progressive loss of B cells and accumulation of","Not Applicable","Autoimmune enteropathy","Case Set","WES_markerset_grc37","SNP Genotypes (NGS)","5 phenotype datasets, 27 variables, 1 molecular datasets, 5 subjects, 5 samples","","NIAID","DS-ADO-IRB-PUB --- Disease-Specific (Autoimmune Diseases, IRB, PUB)","2014-10-24","2015-10-24","Anemia, Hemolytic, Autoimmune; Autoimmune Thrombocytopenia; Immunodeficiencies, Common Variable; Intracranial Central Nervous System Disorders; Lung Diseases, Interstitial; Anemia, Hemolytic, Idiopathic Acquired",""
"phs000713.v1.p1","GDNF and Anxiety","GDNF gene variants were studied as possible risk factors of depression or anxiety on a young sample. The association study involved eight (rs1981844, rs3812047, rs3096140, rs2973041, rs2910702, rs1549250, rs2973050 and  rs11111) GDNF single nucleotide polymorphisms and anxiety and depression scores measured by the Hospital Anxiety and Depression Scale (HADS) on 708","Not Applicable","Anxiety","Cross-Sectional","SNP-PCR","SNP Genotypes (PCR)","4 phenotype datasets, 42 variables, 1 molecular datasets, 708 subjects, 708 samples","","NIMH","GRU --- General Research Use","2014-10-21","2014-10-21","Depression; Angst; Anxiety disease; Anxiety reaction; Anxiety-related personality traits; Anxiousness","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000376.v1.p1","Whole Exome Sequencing in Familial Parkinson Disease","We have an ongoing study that has recruited families having at least a sibling pair with Parkinson disease (PD). Families have been screened for mutations in known PD causative genes  (LRRK2, parkin, etc). Following review of families without a causative mutation, we selected families for whole exome sequencing that had the","Not Applicable","Parkinson Disease","Family/Twin/Trios","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 46 variables, 1 molecular datasets, 44 samples sequenced,  SRA, 77 subjects, 44 samples","","NINDS","DS-PDND --- Disease-Specific (Parkinson's disease or other neurodegenerative disorders)","2014-10-20","2015-10-20","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs000779.v1.p1","OFCCR SNP-CpG","We profiled the methylation landscape of 2100 DNA samples ( 1100 cases of colorectal cancer and 1000 controls) from the Ontario Familial Colon Cancer Registry (OFCCR) using the HumanMethylation450 array  from Illumina. DNA was extracted from lymphocyte pellets, except for 99 samples for which DNA was extracted from lymphoblastoid cell lines. Samples","Not Applicable","Colorectal Neoplasms","Case-Control","Affymetrix_100K, Affymetrix_500K, HumanMethylation450","Methylation (CpG), SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 2402 subjects, 2902 samples","European (2281), African (1), East Asian (40), African American (10), Hispanic1 (7), Hispanic2 (13), Other Asian or Pacific Islander (5), South Asian (21), Other (19)","NHGRI","DS-CA-IRB --- Disease-Specific (Cancer, IRB)","2014-10-17","2014-10-17","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal",""
"phs000772.v1.p1","Genetic Predictors of Adverse Radiotherapy Effects (Gene-PARE)","The goal of this study was to identify SNPs and CNPs that are associated with development of normal tissue toxicities resulting from radiotherapy for prostate cancer. The study population includes  approximately 1,400 men treated with brachytherapy, external beam radiation therapy, or a combination of the two treatments, and assessed for adverse","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","custom_markerset","SNP Genotypes (Array)","4 phenotype datasets, 39 variables, 1 molecular datasets, 787 subjects, 848 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2014-10-17","2014-10-17","Erectile Dysfunction; Proctitis; Abnormal erection; Dysfunction, Erectile; Erectile abnormalities; Failure of erection","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000717.v1.p1","Genomics of Circulating Tumor Cells","Comprehensive analyses of cancer genomes in clinical settings promise to inform prognoses and guide the deployment of precise cancer treatments. A major barrier, however, is the inaccessibility of adequate metastatic  tissue for accurate genomic analysis in prostate and other cancers. A potential solution is to characterize circulating tumor cells (CTCs), but this","Not Applicable","Prostatic Neoplasms","Case Set","other","WXS, SNV (.MAF)","4 phenotype datasets, 10 variables, 1 molecular datasets, 36 samples sequenced,  SRA, 2 subjects, 48 samples","","NCI","DS-PC-MDS --- Disease-Specific (Prostate Cancer, MDS)","2014-10-17","2014-10-17","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs000629.v1.p1","GWAS of Familial Lung Cancer","Familial lung cancer cases were collected by the Genetic Epidemiology of Lung Cancer Consortium (GELCC) recruitment sites: University of Cincinnati, Karmanos Cancer Institute at Wayne State University, Louisiana State University  Health Sciences Center-New Orleans, Mayo Clinic, and Medical College of Ohio. Familial cases for this study came from three sources: 1) one case each","Not Applicable","Lung Neoplasms","Case-Control","HumanOmniExpressExome-8, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 22 variables, 2 molecular datasets, 1553 subjects, 1620 samples","European (1531), East Asian (4), African American (9), Hispanic1 (3), Hispanic2 (4), Other Asian or Pacific Islander (1), South Asian (1)","NCI","DS-LC-IRB-COL-MDS --- Disease-Specific (Lung Cancer, IRB, COL, MDS)","2014-10-16","2014-10-16","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs000759.v1.p1","Spectrum of Mutations in Myeloid Neoplasms","Patients with myeloid malignancies bearing high-risk cytogenetic abnormalities lack effective therapies and have a poor overall survival. -7/del(7q) is identified in half of high-risk myeloid neoplasms. We recently identified CUX1  to be a haploinsufficient myeloid tumor suppressor gene located within the commonly deleted segment of 7q22. Here we identify the spectrum of somatic","Not Applicable","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","Not Provided","WXS, RNA-Seq","4 phenotype datasets, 21 variables, 25 samples sequenced,  SRA, 18 subjects, 25 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2014-10-08","2014-10-08","Monosomy 7; AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000758.v1.p1","Family Genomics of Congenital Heart Defects","The study identified the causal mutation in a five-generation pedigree harboring a cardiac septal defect. The inheritance pattern is consistent with an autosomal dominant mutation with high penetrance. We performed  whole-genome sequencing (Complete Genomics) on 21 individuals in the pedigree, of which 11 individuals are affected. We identified a single gene,","Not Applicable","Heart Septal Defects","Family/Twin/Trios","other","SNP Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 28 subjects, 21 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2014-10-07","2015-10-07","Cardiac Septal Defect; Cardiac Septal Defects; Congenital cardiac septal defect; Congenital heart defects, septal; Congenital septal defect; Congenital septal defects","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs000753.v1.p1","High Density SNP Association Analysis of Lung Cancer","This research builds upon an extensive resource of a case-control study that has been ongoing at the UT MD Anderson Cancer Center since 1991. To identify risk variants for lung  cancer, we conducted a genome-wide association study. Cases are newly diagnosed, histologically-confirmed patients presenting at MD Anderson Cancer","Not Applicable","Lung Neoplasms","Case-Control","HumanHap300","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 molecular datasets, 2290 subjects, 2290 samples","European (2284), African American (1), Hispanic1 (1), Hispanic2 (2), Other (2)","NCI","GRU-MDS --- General Research Use (MDS)","2014-09-30","2014-09-30","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000438.v1.p1","PGRN-RIKEN: Identification of Genetic Predictors of ACE    Inhibitor-Associated Angioedema","The purpose of this study is to identify genetic predictors of ACE inhibitor-associated angioedema. In addition to preventing the formation of the pressor angiotensin II, ACE inhibitors prevent the carboxyl-terminal  degradation of the vasoactive substances bradykinin and substance P. Angioedema is hypothesized to result from defective amino-terminal degradation","Not Applicable","Angioedema","Case-Control","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 721 subjects, 722 samples","European (437), African (4), African American (217), Hispanic1 (1), Hispanic2 (2), Other (1)","NHLBI","HMB --- Health/Medical/Biomedical","2014-09-30","2015-09-30","Angioneurotic Edema; Angioneurotic Edemas; Angioneurotic oedema; Angiooedema; Edema, Angioneurotic; Edema, Quincke's","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000020.v2.p1","Major Depression: Stage 1 Genomewide Association in Population-Based    Samples","Identification of genomic regions that confer susceptibility to or protection from major depressive disorder (MDD) via genomewide association. Consent groups and participant set Psychiatric and Related Somatic Conditions (PRSC): 3741  (1821 cases, 1822 controls, 98 others) Case selection: MDD cases were recruited through mental health care organizations, general practices and in","Not Applicable","Depressive Disorder, Major","Case-Control","Perlegen_Array","SNP Genotypes (Array)","3 phenotype datasets, 232 variables, 5 documents, 1 analyses, 1 molecular datasets, 3741 subjects, 3741 samples","European (3612), Hispanic1 (5), Hispanic2 (1), Other Asian or Pacific Islander (5), South Asian (3), Other (25)","NIMH","PRSC --- Psychiatric and Related Somatic Conditions","2014-09-30","2008-07-09","Major Depressive Disorder; Depression, Involutional; Depressions, Involutional; Involutional melancholia; Melancholia, Involutional; Melancholias, Involutional",""
"phs000615.v1.p1","NINDS Stroke Genetics Network (SiGN)","The NINDS Stroke Genetics Network (SiGN) is a large international collaboration designed to detect genetic variants that predispose to subtypes of ischemic stroke. The study implements a genome wide association  study (GWAS) methodology with all stroke cases undergoing phenotypic and stroke-subtype classification using the same web-based Causative","Not Applicable","Cerebral Infarction","Case-Control","HumanOmni5Exome-4","SNP Genotypes (Array)","4 phenotype datasets, 31 variables, 1 molecular datasets, 11187 subjects, 11579 samples","European (9187), African (80), East Asian (2), African American (1057), Hispanic1 (176), Hispanic2 (453), Other Asian or Pacific Islander (4), South Asian (7), Other (118)","NINDS","DS-STK-NPU --- Disease-Specific (Stroke, NPU), GRU-NPU --- General Research Use (NPU)","2014-09-29","2015-09-29","CVA - cerebral infarction; Cerebral Infarct; Cerebral Infarctions; Cerebral Infarcts; Cerebral Ischemia; Infarct, Cerebral",""
"phs000254.v2.p1","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis)","The major goal of this project is to apply second generation resequencing technology to identify disease causing variants influencing pediatric and adult lung diseases in a collection of two longitudinal  population cohorts of cystic fibrosis patients that have been well characterized for a comprehensive set of clinical traits. In Phase I, exome","Not Applicable","Cystic Fibrosis","Prospective Longitudinal Cohort","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (NGS), WXS","5 phenotype datasets, 28 variables, 3 molecular datasets, 431 samples sequenced,  SRA, 431 subjects, 431 samples","","NHLBI","DS --- Disease Specific (Cystic Fibrosis and Genetic Variation Discovery Research Related to Cystic Fibrosis), GRU --- General Research Use","2014-09-26","2014-12-26","CF; CF - Cystic fibrosis; Fibrocystic disease; Fibrosis, Cystic; MUCOVISCIDOSIS; cystic fibrosis lung disease, modifier of",""
"phs000019.v1.p1","Collaborative Association Study of Psoriasis","The goal of this collaborative study is to combine the resources and expertise of three groups with long-standing studies of psoriasis genetics in order to identify new genetic susceptibility factors  for psoriasis, a common inflammatory skin disease that affects over 4 million Americans. Consent groups and participant set General research use","Not Applicable","Psoriasis","Case-Control","Affymetrix_expression_array, Perlegen_Array, Affymetrix_WG_Array","SNP Genotypes (Array)","5 phenotype datasets, 35 variables, 5 documents, 1 analyses, 2 molecular datasets, 2875 subjects, 2875 samples","European (2707), African (1), East Asian (1), African American (5), Hispanic1 (7), Hispanic2 (21), Other Asian or Pacific Islander (3), South Asian (1)","NIAMS","GRU --- General Research Use, ADO --- Disease-Specific (Autoimmune Diseases, GSO)","2014-09-19","2008-08-13","Psoriatic Arthritis; Acropustulosis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis",""
"phs000793.v1.p1","Paired AML Epigenetics Study on Clonality","We describe methclone, a novel method to identify epigenetic loci that harbor large changes in the clonality of their epialleles (epigenetic alleles). Methclone efficiently analyzes genome-wide DNA methylation sequencing data.  We quantify the changes using a composition entropy difference calculation and also introduce a new measure of global clonality shift, loci with","Not Applicable","Leukemia, Myeloid, Acute","Collection","Not Provided","Bisulfite-Seq","4 phenotype datasets, 25 variables, 18 samples sequenced,  SRA, 18 subjects, 18 samples","","NINDS","GRU --- General Research Use","2014-09-12","2014-09-12","Leukemia, Biphenotypic, Acute; Acute Biphenotypic Leukemia; Acute Biphenotypic Leukemias; Acute Leukemia, Biphenotypic; Acute Leukemia, Hybrid; Acute Leukemia, Mixed-Lineage","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000016.v2.p2","International Multi-Center ADHD Genetics Project","The goal of the project is to complete a 600,000 tag SNP genome-wide association scan of 958 parent-child trios from the International Multisite ADHD Genetics (IMAGE) project, in order to  assess the association of SNP markers with ADHD, analyze quantitative ADHD phenotypes, complete copy number analyses, assess parent of origin effects","Not Applicable","Attention Deficit Disorder with Hyperactivity","Family/Twin/Trios","Perlegen_Array","SNP Genotypes (Array)","9 phenotype datasets, 442 variables, 14 documents, 1 analyses, 1 molecular datasets, 2758 subjects, 2758 samples","European (2683), Hispanic1 (38), Hispanic2 (3), South Asian (5), Other (13)","NIMH","ADHD --- ADHD","2014-09-12","2008-03-26","ADD; ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorders with Hyperactivity; Attention Deficit Hyperactivity Disorder","dbGaP Collection: Psychiatric Genomics Consortium (PGC) dbGaP Datasets (phs001254.v1.p1)"
"phs000777.v1.p1","NIDDK Gene discovery in FSGS","Focal segmental glomerulosclerosis (FSGS) is a frequent cause of end-stage renal disease. The pathogenesis of FSGS has not been precisely defined and there are no consistently effective treatments. Recent studies  identifying causal genes in rare, inherited FSGS, including our own study, have associated mutations in at least six genes with familial FSGS, and","Not Applicable","Glomerulosclerosis, Focal Segmental","Case Set","WES_markerset_grc37","WXS, SNP Genotypes (NGS)","5 phenotype datasets, 24 variables, 3 documents, 1 molecular datasets, 10 samples sequenced, 10 subjects, 10 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2014-09-04","2014-09-04","Kidney Failure, Chronic; Nephrotic Syndrome; FGS; FGS (focal glomerular sclerosis); FGS - Focal glomerulosclerosis; FSGS",""
"phs000750.v1.p1","Genomic Origins and Admixture in Latinos (GOAL)","The GOAL Study was designed to comprehensively evaluate the genomic architecture of diverse Hispanic/Latino individuals with origins from the Caribbean, Central and South America, and to understand the impact of  this diversity on genetic disease studies. Population structure and admixture are key confounders in genome-wide association and medical resequencing","Not Applicable","Population Groups","Family/Twin/Trios","Affymetrix_WG_Array","SNP Genotypes (Array)","5 phenotype datasets, 20 variables, 4 documents, 1 molecular datasets, 271 subjects, 250 samples","European (40), African American (34), Hispanic1 (62), Hispanic2 (83), Other (31)","NIGMS","GRU --- General Research Use","2014-09-04","2014-09-04","Not Provided",""
"phs000719.v1.p1","Genetic Basis of Pulmonary Non-tuberculous Mycobacterial Infections","This project aims at characterizing the human host susceptibility to pulmonary non-tuberculous mycobacterial (PNTM) infections. PNTM infections occur in patients with chronic lung disease, but also in a distinct group  of elderly women without lung defects but who share a common body morphology: tall and lean with scoliosis, pectus excavatum, and mitral valve","Not Applicable","Mycobacterium avium-intracellulare Infection","Family/Twin/Trios","WGS_markerset_grc37","SNP Genotypes (NGS), WXS","6 phenotype datasets, 23 variables, 1 molecular datasets, 102 samples sequenced,  SRA, 102 subjects, 102 samples","","NIAID","DS-PNTM-IRB --- Disease-Specific (Pulmonary non-tuberculous mycobacterial infection, IRB)","2014-08-19","2015-08-19","DMAC; Infection, Mycobacterium avium intracellulare; Infection, Mycobacterium avium-intracellulare; Infection, Mycobacterium intracellulare; Infections, Mycobacterium avium-intracellulare; Infections, Mycobacterium intracellulare",""
"phs000745.v1.p1","RNAseq analysis of posterior cingulate astrocytes in Alzheimer's disease","In this study, RNA sequencing was performed on astrocytes microdissected from the posterior cingulate cortex of Alzheimer's disease subjects and healthy elderly controls. Alzheimer's subjects had expired ages 65, frequent  plaque densities, Braak scores of at least IV, and intermediate to high criteria met for NIA-R. Healthy elderly controls had expired ages of 65, zero","Not Applicable","Alzheimer Disease","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 21 variables, 20 samples sequenced,  SRA, 20 subjects, 20 samples","","NIA","GRU --- General Research Use","2014-08-15","2015-08-15","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000703.v1.p1","CATHeterization GENetics (CATHGEN)","The CATHGEN biorepository consists of biological samples collected on 9334 sequential consenting individuals undergoing cardiac catheterization at Duke University Medical Center between 2001 and 2010 inclusive. The Institutional Review Board  informed consent allowed for 50 mL of blood to be collected from fasting patients through the femoral arterial sheath during the catheterization","Not Applicable","Coronary Disease","Cross-Sectional","HumanHT-12, HumanOmni1-Quad","Not Provided","2 phenotype datasets, 7 variables, 3304 subjects, 3306 samples, 2 substudies","","NHLBI","DS-CVD-IRB --- Disease-Specific (Cardiovascular Disease, IRB)","2014-07-30","2014-07-30","Diabetes Mellitus; Heart Failure; Hypertension; CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease",""
"phs000705.v1.p1","CATHGEN: Genetic Mediators of Metabolic Cardiovascular Disease Risk","The CATHGEN biorepository consists of biological samples collected on sequential consenting individuals undergoing cardiac catheterization at Duke University Medical Center between 2001 and 2010 inclusive. The Institutional Review Board informed  consent allowed for 50 mL of blood to be collected from fasting patients through the femoral arterial sheath during the catheterization procedure.","CATHeterization GENetics (CATHGEN) (phs000703.v1.p1)","Coronary Disease","Cross-Sectional","HumanHT-12, HumanOmni1-Quad","SNP Genotypes (Array), mRNA Expression (Array), mRNA Expression (Array), SNP Genotypes (Array)","2 phenotype datasets, 19 variables, 2 documents, 2 molecular datasets, 1977 subjects, 1979 samples","European (1391), African (18), East Asian (4), African American (398), Hispanic1 (94), Hispanic2 (11), Other Asian or Pacific Islander (3), South Asian (10), Other (2)","NHLBI","DS-CVD-IRB --- Disease-Specific (Cardiovascular Disease, IRB)","2014-07-30","2014-07-30","Diabetes Mellitus; Hypertension; CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases",""
"phs000704.v1.p1","CATHGEN: Identification of Novel Genetic and Metabolomic CV Phenotypes","The CATHGEN biorepository consists of biological samples collected on sequential consenting individuals undergoing cardiac catheterization at Duke University Medical Center between 2001 and 2010 inclusive. The Institutional Review Board informed  consent allowed for 50 mL of blood to be collected from fasting patients through the femoral arterial sheath during the catheterization procedure.","CATHeterization GENetics (CATHGEN) (phs000703.v1.p1)","Coronary Disease","Cross-Sectional","HumanOmni1-Quad","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 20 variables, 2 documents, 1 molecular datasets, 1327 subjects, 1327 samples","European (944), African (11), East Asian (2), African American (268), Hispanic1 (86), Hispanic2 (6), Other Asian or Pacific Islander (1), South Asian (6), Other (3)","NHLBI","DS-CVD-IRB --- Disease-Specific (Cardiovascular Disease, IRB)","2014-07-30","2014-07-30","Diabetes Mellitus; Hypertension; CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases",""
"phs000775.v1.p1","Joint Genome-Wide Gene Expression and GWAS Mapping in the MGS Dataset","Schizophrenia is a common and severe psychotic disorder. While some common SNPs and rare copy number variants have been identified as being significantly associated with disease risk, the biological mechanisms  remain undefined. To identify gene expression abnormalities in schizophrenia, we generated whole-genome gene expression profiles using microarrays on","Not Applicable","Schizophrenia","Case-Control","HumanHT-12","mRNA Expression (Array)","4 phenotype datasets, 33 variables, 1 molecular datasets, 859 subjects, 859 samples","","NIMH","GRU --- General Research Use, DS-PD-RSC --- Disease-Specific (Psychiatric Disorders and Related Somatic Conditions)","2014-07-25","2014-07-25","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: Open Translational Science in Schizophrenia (OPTICS) (phs000887.v1.p1)"
"phs000714.v1.p1","NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)","We performed genome-wide association studies (GWAS) to study the Spontaneous Preterm birth (SPTB). Maternal and neonatal DNA from 743 SPTB (20 to and less than 34 weeks), and 752 controls  (39 to and less than 42 weeks) who fully consented for public research usage were collected from participants in several clinical centers in Alabama,","Not Applicable","Premature Birth","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 332 variables, 1 molecular datasets, 2928 subjects, 2852 samples","European (1389), African (10), East Asian (10), African American (703), Hispanic1 (93), Hispanic2 (491), Other Asian or Pacific Islander (65), South Asian (14), Other (77)","NICHD","DS-PREG-COM-RD --- Disease-Specific (Pregnancy Complications, RD)","2014-07-22","2015-04-22","Birth, Premature; Birth, Preterm; Births, Premature; Births, Preterm; Premature Births; Premature delivery",""
"phs000767.v1.p1","The UC San Diego Chronic Lymphocytic Leukemia (CLL) Study","The UC San Diego Chronic Lymphocytic Leukemia Study is designed to identify genetic, epigenetic, and transcriptional changes important for CLL. This data release consists of samples collected to 1) identify  genomic changes associated with CLL progression using serially collected tumor samples; 2) characterize the transcriptional consequences of SF3B1","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Tumor vs. Matched-Normal","Not Provided","AMPLICON, RNA-Seq","4 phenotype datasets, 27 variables, 139 samples sequenced,  SRA, 49 subjects, 177 samples","","NCI","DS-CLL --- Disease-Specific (Chronic Lymphocytic Leukemia)","2014-07-11","2014-07-11","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs000496.v1.p1","Columbia University Study of Caribbean Hispanics and Late Onset    Alzheimer's disease","Compared to Caucasians residing in the same community the incidence rate of Alzheimer's disease is approximately twice as high in Caribbean Hispanics. Moreover, Caribbean Hispanics represent a homogenous population with  only a few founders. Replication of genetic associations in other ethnic groups provides supporting evidence that a putative gene is involved in the","Not Applicable","Alzheimer Disease","Case-Control","HumanOmni1-Quad, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","5 phenotype datasets, 53 variables, 2 molecular datasets, 4002 subjects, 3208 samples","European (131), African (7), African American (1029), Hispanic1 (1780), Hispanic2 (110), Other (82)","NIA","GRU-IRB --- General Research Use (IRB)","2014-07-09","2015-07-09","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases",""
"phs000625.v1.p1","Targeted Sequencing of GWAS Loci in Cleft Lip and Palate","Nonsyndromic cleft lip and palate (NSCL/P) is a complex disorder caused by both genetic and environmental factors and has been the focus of an extensive effort to identify genetic risk  factors. A number of candidate gene studies have been performed but have not been widely replicated. To date, four independent genome wide","Not Applicable","Orofacial Cleft 1","Family/Twin/Trios","Not Provided","WXS","5 phenotype datasets, 31 variables, 5512 samples sequenced,  SRA, 6123 subjects, 5512 samples","","NHGRI","DS-CFD --- Disease-Specific (Craniofacial Disorders), DS-OFC --- Disease-Specific (Orofacial Cleft), DS-OC-GSO --- Disease-Specific (Oral Clefts, GSO)","2014-07-03","2015-01-03","Cleft Lip; Cleft Palate; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips",""
"phs000751.v1.p1","GWAS in Fibrosing Interstitial Lung Disease","This study was a case-control genome-wide association study of 1616 non-Hispanic white cases and 4683 controls. Under an additive model for the minor allele at each SNP, we identified 19  SNPs, representing 7 chromosomal locations (5p15, 6p24, 7q22, 11p15, 15q14-15, 17q21, and 19p13), with genome-wide significant (P 5x10-8)","Not Applicable","Lung Diseases, Interstitial","Case-Control","Human660W-Quad","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 analyses, 1 molecular datasets, 1616 subjects, 1616 samples","","NHLBI","DS-LD-IRB-PUB --- Disease-Specific (Lung Disease, IRB, PUB)","2014-06-25","2014-06-25","Idiopathic Interstitial Pneumonias; Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary; FIBROCYSTIC PULMONARY DYSPLASIA; FIBROSING ALVEOLITIS, CRYPTOGENIC",""
"phs000715.v1.p1","NINDS MS and ADEM Deep Sequencing Studies","Deep sequencing allows for a rapid, accurate characterization of microbial DNA and RNA sequences in many types of samples. Deep sequencing (also called next generation sequencing or NGS) is being  developed to assist with the diagnosis of a wide variety of infectious diseases. In this study, seven frozen brain samples (n 7) from deceased","Not Applicable","Multiple Sclerosis, Chronic Progressive","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 23 variables, 35 samples sequenced, 35 subjects, 35 samples","","NINDS","GRU --- General Research Use","2014-06-25","2014-07-25","Encephalitis, Herpes Simplex; Subacute Sclerosing Panencephalitis; Acute Necrotizing Encephalitis, Herpetic; Herpetic Acute Necrotizing Encephalitis; Chronic Progressive Multiple Sclerosis; Multiple sclerosis (MS) progressive","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000729.v1.p1","Follicular Lymphoma 2013 - Malek","A cohort of follicular lymphoma cases had tumor cells purified from tissue samples after informed consent using flow cytometry. DNA was extracted from the cells, and samples were subjected to  solution-based exome capture using the Illumina TruSeq Exome Enrichment Kit and the Illumina HiSeq 2000 platform. Patients were enrolled between 2008","Not Applicable","Lymphoma, Follicular","Case Set","WES_markerset_grc36","SNP Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 18 samples sequenced, 9 subjects, 18 samples","","NCI","DS-LYM-MDS --- Disease-Specific (Lymphoma, MDS)","2014-06-24","2014-06-24","Lymphoma, Non-Hodgkin; Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC",""
"phs000706.v1.p1","RAD50 Hypomorphism as Basis for Response to Chemotherapy","Outlier analyses represent a versatile method to identify predictive biomarkers of response to both targeted agents and chemotherapy. We performed whole genome sequencing (WGS) of tumor and germline blood from  a patient with metastatic small cell carcinoma of the ureter who experienced a durable complete response to a combination of irinotecan plus AZD7762,","Not Applicable","Ureteral Neoplasms","Case Set","Not Provided","OTHER, WGS","4 phenotype datasets, 20 variables, 5 samples sequenced, 1 subjects, 5 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2014-06-19","2014-06-19","Neoplasia of the ureters; Neoplasm of Ureter; Neoplasm of the Ureter; Neoplasm, Ureteral; Neoplasms of Ureter; Neoplasms of the Ureter","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000734.v1.p1","Osteosarcoma Genome-Wide Association Study","This is a genome-wide association study (GWAS) of osteosarcoma, the most common primary bone malignancy. Osteosarcoma typically occurs in adolescents and young adults. It occurs at increased frequency in several  inherited cancer predisposition syndromes but the genetic contribution to sporadic osteosarcoma is largely unexplored. The objective of this study","Not Applicable","Osteosarcoma","Case Set","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 694 subjects, 717 samples","","NCI","GRU --- General Research Use","2014-06-10","2014-06-10","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteoblastic osteosarcoma; Osteoblastic sarcoma; Osteochondrosarcoma","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000660.v1.p1","Chinese Alternating Hemiplegia of Childhood (AHC) Disease Study","AHC is a rare and severe neurological disorder, and characterized by episodic hemiplegia or quadriplegia attacks, accompanied by other paroxysmal symptoms of oculomotor abnormalities, dystonia, seizures and autonomic disturbances; the  age of onset usually occurrs before 18 months of life. Sodium-potassium ATPase alpha3 subunit (ATP1A3) has recently been identified as a causal gene","Not Applicable","Alternating hemiplegia of childhood","Case Set","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 21 variables, 1 molecular datasets, 12 samples sequenced,  SRA, 12 subjects, 12 samples","","NINDS","GRU --- General Research Use","2014-06-06","2015-06-06","AHC; Alternating hemiplegia; Alternating hemiplegia syndrome; adrenal hypoplasia congenita; childhood alternating hemiplegia; congenital adrenal Hypoplasia","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000716.v1.p1","GWAS of Lung Cancer Susceptibility in Never-Smoking Women in Asia","To learn about the etiology of lung cancer among never-smoking women in Asia, we formed the Female Lung Cancer Consortium in Asia (FLCCA), which includes studies of lung cancer in  Eastern Asia and conducted a GWAS. We analyzed a total of 5510 lung cancer cases and 4544 controls and identified 3 novel loci (Lan et al., 2012). Of","Not Applicable","Lung Neoplasms","Case-Control","Human610-Quad, Human660W-Quad","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 3 analyses, 2 molecular datasets, 8881 subjects, 9178 samples","","NCI","DS-LC-MDS --- Disease Specific (LC, MDS)","2014-06-04","2014-06-04","Adenocarcinoma; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma",""
"phs000612.v1.p1","The Mutational Characterization of Adenoid Cystic Carcinoma","Adenoid cystic carcinoma (ACC) typically emanate from the major and minor salivary glands of the head and neck. ACCs have high rates of perineural invasion, locoregional recurrence, and distant metastasis.  Here we report sequencing of 60 tumor/normal pairs and find substantial mutational diversity. On pathway analysis, a significant percentage of","Not Applicable","Neoplasms","Case-Control","Affymetrix_WG_Array","WXS, CNV Genotypes","4 phenotype datasets, 34 variables, 1 molecular datasets, 120 samples sequenced,  SRA, 60 subjects, 127 samples","","NIDCR","DS-CA --- Disease-Specific (Cancer)","2014-06-04","2014-06-04","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs000735.v1.p1","The Placenta Harbors a Unique Microbiome","This study is to investigate placental microbiome through 16S rDNA-based and whole genome shotgun metagenomic sequencing. Identified taxa and their gene carriage patterns were compared to other human body sites  niches. The placental microbiome profiles were most akin to the human oral microbiome. Exclusion Criteria Subjects with fatal fetal anomalies, fetal","Not Applicable","Bacterial Infections","Case Set","Not Provided","WGS","4 phenotype datasets, 15 variables, 48 samples sequenced,  SRA, 48 subjects, 48 samples","","NICHD","GRU --- General Research Use","2014-05-23","2014-05-23","Bacteria caused disease or disorder; Bacteria disease or disorder; Bacteria infectious disease; Bacterial Disease; Bacterial Diseases; Bacterial Disorder",""
"phs000460.v1.p1","Genome wide association study of 24 hour urine composition in the Nurses'    Health Study, Nurses' Health Study II, and the Health Professionals    Follow-Up Study","Genetic and environmental factors play an important role in the etiology of nephrolithiasis. This project will build on and extend our previous efforts (examining environmental risk factors for stone formation)  by allowing us to study the risk of stone formation associated with specific genes and gene-environment interactions. We will take advantage of","Not Applicable","Nephrolithiasis","Prospective Longitudinal Cohort","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 31 variables, 2 documents, 1 molecular datasets, 1682 subjects, 1682 samples","","NIDDK","GRU-IRB --- General Research Use (IRB)","2014-05-23","2014-05-23","Hypercalciuria; Hyperoxaluria; Kidney Calculi; Urolithiasis; Elevated urine calcium levels; Hypercalcinuria",""
"phs000738.v1.p1","Exome Sequencing in Schizophrenia Families","Schizophrenia is a complex neuropsychiatric disorder characterized by marked genetic heterogeneity. Much of the genetic architecture of the disorder has yet to be explained, but de novo mutations appear to  play an important role. We used exome sequencing of parent-offspring quads and trios to detect de novo mutations in persons with schizophrenia.","Not Applicable","Schizophrenia","Family/Twin/Trios","Not Provided","WXS","5 phenotype datasets, 23 variables, 216 samples sequenced,  SRA, 216 subjects, 216 samples","","NIMH","DS-PD-RSC --- Disease-Specific (Psychiatric Disorders and Related Somatic Conditions)","2014-05-12","2014-05-12","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder",""
"phs000709.v1.p1","The Genome and Transcriptome of Fibrolamellar Hepatocellular Carcinoma","Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare liver tumor primarily affecting adolescents and young adults. Little is known of the molecular pathogenesis. To characterize the disease we performed RNA sequencing  and whole genome sequencing on FL-HCC tumors and adjacent normal tissue. The results demonstrate few consistent differences on the chromosomal level","Not Applicable","Fibrolamellar hepatocellular carcinoma","Tumor vs. Matched-Normal","Not Provided","RNA-Seq","3 phenotype datasets, 12 variables, 29 samples sequenced,  SRA, 11 subjects, 29 samples","","NCI","DS-CA-IRB-MDS --- Disease-Specific (Cancer, IRB, MDS)","2014-05-09","2014-05-09","Carcinoma, Hepatocellular; Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells",""
"phs000684.v1.p1","Age-Related Macular Degeneration - MMAP Cohort: Association and    Sequencing Studies","Age-related Macular Degeneration (AMD) is a leading cause of incurable blindness in people over the age of 65. AMD is a late-onset multi-factorial neurodegenerative disease and its pathogenesis involves interaction  of genetic and environmental factors. Several chromosomal regions have been associated with AMD susceptibility through linkage analysis (Swaroop et","Not Applicable","Macular Degeneration","Case-Control","HumanCNV370-Duo, HumanMethylation450","Not Provided","2 phenotype datasets, 13 variables, 2 analyses, 3352 samples sequenced, 5653 subjects, 7229 samples, 4 substudies","","NEI","GRU --- General Research Use, DS-ED --- Disease-Specific (Eye Disease)","2014-05-08","2015-05-08","Degeneration, Macular; Degenerative disorder of macula; Dystrophy, Macular; Macular Degenerations; Macular Dystrophies; Macular Dystrophy",""
"phs000685.v1.p1","Age-Related Macular Degeneration (AMD) Targeted Sequencing Study","Age-related Macular Degeneration (AMD) is a leading cause of incurable blindness in people over the age of 65. AMD is a late-onset multi-factorial neurodegenerative disease and its pathogenesis involves interaction  of genetic and environmental factors. Several chromosomal regions have been associated with AMD susceptibility through linkage analysis (Swaroop et","Age related Macular Degeneration (AMD) - Michigan, Mayo, AREDS, Pennsylvania (MMAP) Cohort Study: Association and Sequencing Studies (phs000684.v1.p1)","Macular Degeneration","Case-Control","Not Provided","WXS, WXS","2 phenotype datasets, 7 variables, 3352 samples sequenced,  SRA, 3337 subjects, 3352 samples","","NEI","GRU --- General Research Use, DS-ED --- Disease-Specific (Eye Disease)","2014-05-08","2015-05-08","Degeneration, Macular; Degenerative disorder of macula; Dystrophy, Macular; Macular Degenerations; Macular Dystrophies; Macular Dystrophy",""
"phs000457.v1.p1","MMAP-Methylation in AMD","This is a case-control study of Age-related Macular Degeneration (AMD). AMD is a progressive disease which results in loss of vision in the central field. In the U.S., AMD affects  over 1.7 million people now, and due to the aging population, that number is predicted to reach 3 million by 2015. Gene expression changes in the","Age related Macular Degeneration (AMD) - Michigan, Mayo, AREDS, Pennsylvania (MMAP) Cohort Study: Association and Sequencing Studies (phs000684.v1.p1)","Macular Degeneration","Case-Control","HumanMethylation450","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 7 variables, 1 molecular datasets, 300 subjects, 300 samples","","NEI","DS-ED --- Disease-Specific (Eye Disease)","2014-05-08","2015-05-08","Macular Degeneration, Age-Related; Degeneration, Macular; Degenerative disorder of macula; Dystrophy, Macular; Macular Degenerations; Macular Dystrophies",""
"phs000246.v2.p1","Fuchs' Corneal Dystrophy GWAS","We sought to identify biological pathways contributing to Fuchs corneal dystrophy (FCD) by performing a genome wide association study (GWAS). We re-coded the ocular phenotypes for a previous GWAS on  age-related macular degeneration that employed an unrelated case-control study design. The recoded cases with FCD were matched to two controls","Age related Macular Degeneration (AMD) - Michigan, Mayo, AREDS, Pennsylvania (MMAP) Cohort Study: Association and Sequencing Studies (phs000684.v1.p1)","Fuchs' Endothelial Dystrophy","Case-Control","Not Provided","Not Provided","1 phenotype datasets, 3 variables, 389 subjects","","NEI","GRU --- General Research Use, DS-ED --- Disease-Specific (Eye Disease)","2014-05-08","2015-05-08","Dystrophy, Fuch's Endothelial; Dystrophy, Fuchs' Endothelial; Endoepithelial corneal dystrophy; Endothelial Dystrophy, Fuch's; Endothelial Dystrophy, Fuchs'; FCED",""
"phs000182.v3.p1","AMD-MMAP Cohort Study: A Joint Genome Wide Association Study","Age-related Macular Degeneration (AMD) is a leading cause of incurable blindness in people over the age of 65. AMD is a late-onset multi-factorial neurodegenerative disease and its pathogenesis involves interaction  of genetic and environmental factors. Several chromosomal regions have been associated with AMD susceptibility through linkage analysis (Swaroop et","Age related Macular Degeneration (AMD) - Michigan, Mayo, AREDS, Pennsylvania (MMAP) Cohort Study: Association and Sequencing Studies (phs000684.v1.p1)","Macular Degeneration","Case-Control","HumanCNV370-Duo","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 2 analyses, 1 molecular datasets, 3340 subjects, 3577 samples","European (3291), African American (5), Hispanic1 (3), Hispanic2 (8), Other (2)","NEI","GRU --- General Research Use, DS-ED --- Disease-Specific (Eye Disease)","2014-05-08","2015-05-08","Degeneration, Macular; Degenerative disorder of macula; Dystrophy, Macular; Macular Degenerations; Macular Dystrophies; Macular Dystrophy",""
"phs000378.v1.p1","Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of    Dementia","In 1991 collaboration between researchers at Indiana University School of Medicine and the University of Ibadan, Ibadan, Nigeria established the Indianapolis-Ibadan Dementia Project. It is a longitudinal, prospective population-based comparative  epidemiological study of the prevalence and incidence rates and risk factors of Alzheimer's disease and other age associated dementias. The project","Not Applicable","Alzheimer Disease","Prospective Longitudinal Cohort","HumanOmni2.5-8, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","5 phenotype datasets, 43 variables, 24 documents, 2 molecular datasets, 1251 subjects, 1302 samples","","NIA","GRU-IRB --- General Research Use (IRB)","2014-05-06","2015-05-06","Cognition Disorders; Dementia; AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia",""
"phs000739.v1.p1","Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas","RNA-seq data from two cases of ameloblastoma was analyzed for candidate gene fusions and point mutations. Recurrent point mutations identified in the RNA-seq data, as well as mutations identified with  limited panel targeted deep sequencing, were validated as somatic. Expanding to a larger cohort of 28, one of two activating mutations was found in","Not Applicable","Ameloblastoma","Case Set","WES_markerset_grc37","AMPLICON, RNA Seq (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 9 samples sequenced,  SRA, 7 subjects, 7 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2014-05-05","2014-05-05","","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000630.v1.p1","Exome Chip Study of NIMH Controls","Here, we report exome chip genotyping results of 1052 samples from the NIMH control set, a collection of healthy controls for general research use. The samples are all unrelated. DNA  quality was assessed by Picogreen quantification. SNP concordance and gender concordance checks were used to confirm that no significant","Not Applicable","Health","Control Set","HumanExome-12","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 1051 subjects, 1051 samples","","NIMH","GRU --- General Research Use","2014-05-02","2014-05-02","Not Provided","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000437.v1.p1","Next Generation Mendelian Genetics: Auriculocondylar Syndrome (ACS)","This project is part of an ongoing project to identify the molecular genetic basis of rare craniofacial disorders. This specific project involved the collection of DNA samples from four probands  with severe manifestations of auriculocondylar syndrome and their parents. Detailed clinical phenotypic data is available on each proband. The sole","Not Applicable","Auriculo-condylar syndrome","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 18 variables, 1 molecular datasets, 12 samples sequenced,  SRA, 12 subjects, 12 samples","","NHGRI","DS-CFD --- Disease-Specific (Craniofacial Disorders)","2014-05-01","2016-02-01","Auriculocondylar syndrome; Cosman ear; Dysgnathia complex; Ears prominent and constricted; QUESTION MARK EARS SYNDROME; Question mark ear",""
"phs000587.v1.p1","NHLBI GO-ESP: Family Studies (Mendelian Lipid Disorders)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Hyperlipoproteinemia Type II","Case Set","WES_markerset_grc37","WXS, SNP Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 29 samples sequenced,  SRA, 29 subjects, 29 samples","","NHLBI","DS-CLA --- Disease-Specific (Cardiovascular disease, lipoprotein metabolism disorders/atherosclerosis)","2014-04-28","2014-07-28","Hypoalphalipoproteinemias; Density Lipoproteinemia, Hyper-Low; Density Lipoproteinemias, Hyper-Low; Essential Hypercholesterolemia; Essential Hypercholesterolemias; Essential familial hypercholesterolemia","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000732.v1.p1","L1-seq and genome-wide SNP genotyping in a multiethnic Asian population","Insertions of the human-specific subfamily of LINE-1 (L1) retrotransposon are highly polymorphic across individuals and can critically influence the human transcriptome. We hypothesized that L1 insertions could represent genetic variants  determining important human phenotypic traits, and performed an integrated analysis of L1 elements and single nucleotide polymorphisms (SNPs) in","Not Applicable","Molecular Structure","Prospective Longitudinal Cohort","Human610-Quad","Tn-Seq, SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 20 samples sequenced,  SRA, 20 subjects, 20 samples","","NHGRI","GRU --- General Research Use","2014-04-24","2014-04-24","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000370.v2.p1","The Mutational Landscape of Head and Neck Squamous Cell Carcinoma","This study was the first-known large-scale effort to uncover the mutational spectrum of head and neck cancers. We analyzed whole-exome sequence from 92 tumor-normal pairs and retained 74 of them  for significance analysis. The majority exhibited a mutational profile consistent with tobacco exposure; human papilloma virus sequence was","Not Applicable","Head and Neck Neoplasms","Case Set","Somatic_Variant","WXS, SNV (.MAF)","4 phenotype datasets, 21 variables, 1 molecular datasets, 184 samples sequenced,  SRA, 92 subjects, 184 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2014-04-17","2014-04-17","Head Neoplasm; Head Neoplasms; Neoplasm, Head; Neoplasms, Head","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000306.v4.p1","A Multiethnic Genome-wide Scan of Prostate Cancer","Multiple GWA studies of prostate cancer conducted in European White populations are ongoing. These studies will continue to have a dramatic impact on our understanding of the contribution of common  genetic variation on inter-individual susceptibility to this common cancer. Important questions that will remain unanswered, however, are whether all","Not Applicable","Prostatic Neoplasms","Case-Control","Human660W-Quad, Human1M-Duo, imputation_panel","SNP Genotypes (imputed), SNP Genotypes (Array)","7 phenotype datasets, 67 variables, 2 documents, 6 molecular datasets,  SRA, 9457 subjects, 11325 samples","European (115), African (185), East Asian (2157), African American (4425), Hispanic1 (112), Hispanic2 (1997), Other Asian or Pacific Islander (56), South Asian (1), Other (81)","NCI","DS-CA-PUB-MDS --- Disease-Specific (Cancer, PUB, MDS), GRU-MDS --- General Research Use (MDS), DS-PC --- Disease-Specific (Prostate Cancer), CHDSADM --- Cancer, Heart Disease, Stroke, Alzheimer Disease, and Diabetes Research and Methods, HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2014-04-17","2013-02-01","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000201.v2.p1","Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes","We performed genome-wide copy number analysis with paired normal and tumor DNA obtained from 86 adult patients with de novo AML using the Affymetrix Genome-Wide Human SNP array 6.0 containing  1.85 million features. Acquired copy number alterations (CNA) were confirmed using an independent, higher resolution, custom array comparative","Not Applicable","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","Affymetrix_WG_Array","SNP Genotypes (Array)","3 phenotype datasets, 47 variables, 1 molecular datasets, 86 subjects, 172 samples","","NCI","DS-HEM-MDS-GSO --- Disease-Specific (Hematologic Disease, MDS, GSO)","2014-04-17","2010-01-12","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs000602.v2.p1","Identification of Targetable FGFR Gene Fusions in Diverse Cancers","In this study, patients with advanced cancer across all histologies were enrolled in our IRB approved clinical sequencing program, called MI-ONCOSEQ, to go through an integrative sequencing which includes whole  exome sequencing of the tumor and matched normal, and transcriptome sequencing. Four index cases were identified which harbor gene rearrangements of","Not Applicable","Neoplasms","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 16 variables, 7 samples sequenced,  SRA, 7 subjects, 6 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2014-04-16","2013-05-21","Mouth Neoplasms; Urinary Bladder Neoplasms; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000418.v2.p1","Temporal Dissection of Tumorigenesis in Primary Cancers","The earliest genetic abnormalities in cancer represent a unique opportunity for timely clinical diagnosis. Classic deep sequencing of tumors identifies many aberrations acquired later in cancer progression. In this study,  data regarding simple mutation and chromosomal aberration were integrated to trace the evolution of cutaneous squamous cell carcinomas and ovarian","Not Applicable","Carcinoma, Squamous Cell","Tumor vs. Matched-Normal","Not Provided","WXS","4 phenotype datasets, 27 variables, 16 samples sequenced,  SRA, 8 subjects, 16 samples","","NCI","DS-CA-IRB-MDS --- Disease-Specific (Cancer, IRB, MDS)","2014-04-16","2012-05-15","Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinomas, Epidermoid; Carcinomas, Planocellular; Carcinomas, Squamous",""
"phs000340.v3.p1","Sequencing of ETP T-ALL","CREST The accurate identification of structural variations using whole-genome DNA sequencing data generated by next-generation sequencing technology is extremely difficult. To address this challenge, we have developed CREST, an algorithm  that uses sequencing reads with partial alignments to the reference human genome (so-called soft-clipped reads) to directly map the breakpoints of","Not Applicable","Leukemia, T-Cell","Tumor vs. Matched-Normal","Affymetrix_WG_Array","SNP Genotypes (Array), RNA-Seq, WXS, WGS","5 phenotype datasets, 33 variables, 1 molecular datasets, 30 samples sequenced,  SRA, 106 subjects, 196 samples","European (68), African American (11), Hispanic1 (2), Hispanic2 (8), Other Asian or Pacific Islander (2)","NCI","GRU-MDS --- General Research Use (MDS)","2014-04-16","2012-01-12","Leukemia, Lymphocytic, T Cell; Leukemia, Lymphocytic, T-Cell; Leukemia, T Cell; Leukemia, T Lymphocytic; Leukemia, T-Cell Lymphocytic; Leukemia, T-Lymphocytic","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000552.v2.p1","Genomic Characterization of Meningiomas","Meningiomas are the most common primary brain tumor in the US. Although the tumor suppressor gene NF2 is disrupted in approximately half of meningiomas, the complete spectrum of genetic changes  in meningiomas remains poorly understood, particularly in the large subset of tumors without NF2 alterations. Therefore we performed whole-genome","Not Applicable","Meningioma","Case Set","WES_markerset_grc37","WGS, WXS, AMPLICON, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 15 variables, 1 documents, 1 analyses, 2 molecular datasets, 130 samples sequenced,  SRA, 65 subjects, 130 samples","","NCI","DS-BDBC-NPU-MDS --- Disease-Specific (Brain Disorders and Brain Cancer, NPU, MDS)","2014-04-15","2013-01-17","Diffuse meningiomatosis; Meningioma, Multiple; Meningiomas, Multiple; Meningiomatoses; Meningiomatosis; Multifocal meningiomata",""
"phs000508.v2.p1","Genomic Sequencing of Pediatric Rhabdoid Cancers","In this study, we sequenced the exomes of 35 rhabdoid tumors, highly aggressive cancers of early childhood. This study is part of a larger effort to characterize pediatric cancers as  part of the Slim Initiative for Genomic Medicine (SIGMA) project. Principal Investigator: Charles Roberts, MD, PhD, Dana Farber Cancer Institute,","Not Applicable","Rhabdoid Tumor","Case-Control","other","WXS, SNV Aggregate (.MAF)","4 phenotype datasets, 14 variables, 1 molecular datasets, 70 samples sequenced,  SRA, 35 subjects, 70 samples","","NCI","PCR --- Pediatric Cancer Research, DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2014-04-15","2014-04-15","","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000487.v2.p1","Functionally Active Copy Number Variants Associated with Prostate Cancer    Risk","Prostate cancer is a leading cause of cancer death in males throughout the world and has the largest estimated effect of heritability among the most common tumor types. Copy Number  Variants (CNVs) are a recently recognized class of human germline polymorphisms (Iafrate AJ, et al. (2004) Nat Genet 36, 949-951; Sebat J, et al.","Not Applicable","Prostatic Neoplasms","Case-Control","Affymetrix_WG_Array","CNV Genotypes","4 phenotype datasets, 22 variables, 2 analyses, 1 molecular datasets, 1903 subjects, 1903 samples","","NCI","DS-PC-NPU-MDS-GSO --- Disease-Specific (Prostate Cancer, NPU, MDS, GSO)","2014-04-15","2014-01-04","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs000682.v1.p1","Genetics of Neuropsychiatric and Neurodevelopmental Disorders","Although schizophrenia is a highly heritable disease, relatively little progress had been made in securely identifying the genetic causes of this disorder, and most instances of schizophrenia in the general  population remain unexplained. One avenue of explanation for the genetic basis of schizophrenia, however, has been effectively closed by recent","Not Applicable","Mental Disorders","Family/Twin/Trios","WGS_markerset_grc37","WGS, SNP Genotypes (NGS)","5 phenotype datasets, 24 variables, 1 molecular datasets, 162 samples sequenced,  SRA, 162 subjects, 162 samples","European (84), African (1), East Asian (1), African American (66), Hispanic1 (8), Hispanic2 (2)","NIMH","GRU --- General Research Use","2014-04-11","2015-04-11","Anxiety; Ataxia; Attention Deficit Hyperactivity Disorder; Bipolar Disorder; Depression; Developmental Disabilities","dbGaP Collection: Open Translational Science in Schizophrenia (OPTICS) (phs000887.v1.p1); Joint Addiction, Aging, and Mental Health Data Access Committee General    Research Use Datasets (GSR Restricted) Collection (phs003421.v1.p1)"
"phs000679.v1.p1","Genome-Wide Association Study of Anorexia Nervosa","Twin studies are consistent with substantial heritability in anorexia nervosa (AN), although detecting and confirming individual risk alleles has been difficult, due to small effects of single alleles and limited  samples in prior studies. Methods: 1105 AN DNA samples obtained in a multisite study and 3733 pediatric patients of normal body weight were genotyped","Not Applicable","Anorexia Nervosa","Case-Control","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 203 variables, 1 molecular datasets, 1001 subjects, 1001 samples","","NIMH","GRU --- General Research Use","2014-04-09","2014-04-09","Bulimia Nervosa; AN - Anorexia nervosa; Anorexia Nervosas; Nervosa, Anorexia; Nervosas, Anorexia","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000350.v1.p1","FHCRC - Whole-Exome Sequencing of Hereditary Prostate Cancer Families","The specific aim of this study is to identify hereditary prostate cancer (HPC) susceptibility genes using a novel study design, whereby whole-exome sequencing will be undertaken on multiple affected relatives  from 19 HPC families, in which &#x02265; 3 affected relatives were diagnosed with clinically aggressive and/or early onset prostate cancer (PC).","Not Applicable","Prostatic Neoplasms","Family/Twin/Trios","Not Provided","WXS","5 phenotype datasets, 26 variables, 1 documents, 95 samples sequenced,  SRA, 94 subjects, 96 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2014-04-01","2014-04-01","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000583.v1.p1","Asian Indian Diabetic Heart Study (AIDHS)","The Punjabi Sikh population is a well-defined, carefully collected homogeneous sample from northern India and the US. It has unique characteristics, which are ideal for genetic studies. Sikhs are strictly  a non-smoking population and about 50% of participants are life-long vegetarians. All subjects included in the genome-wide association studies (GWAS)","Not Applicable","Metabolic Syndrome","Case-Control","Human660W-Quad","SNP Genotypes (Array)","5 phenotype datasets, 25 variables, 1 molecular datasets, 1616 subjects, 1616 samples","","NIDDK","T2DMS --- Type 2 diabetes and metabolic syndrome","2014-03-24","2014-03-24","Metabolic Syndrome X; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset",""
"phs000633.v1.p1","Enrichment of Lung Microbiome Associated with Pulmonary Inflammation","Background: The lung microbiome of healthy individuals frequently harbors oral organisms. Despite evidence that micro-aspiration is commonly associated with smoking-related lung diseases, the effects of lung microbiome enrichment with upper  airway taxa on inflammation has not been studied. We hypothesize that the presence of oral microorganisms in the lung microbiome is associated with","Not Applicable","Pneumonia","Cross-Sectional","Not Provided","AMPLICON","4 phenotype datasets, 17 variables, 103 samples sequenced,  SRA, 29 subjects, 103 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB)","2014-03-21","2014-03-21","Inflammation, Lung; Inflammation, Pulmonary; Inflammations, Lung; Inflammations, Pulmonary; Lung Inflammation; Lung Inflammations",""
"phs000600.v1.p1","Genomic Sequencing of Cervical Cancers","Cervical cancer is responsible for 10-15% of cancer related deaths in women worldwide. The etiological role of infection with high-risk human papilloma viruses (HPV) in carcinomas of the cervix is  well established. In general, the development of cervical carcinomas follows a progression from persistent HPV infection through precancerous lesions","Not Applicable","Uterine Cervical Neoplasms","Case-Control","Somatic_Variant","WXS, SNV (.MAF), RNA-Seq, WGS","4 phenotype datasets, 24 variables, 2 analyses, 1 molecular datasets, 230 samples sequenced,  SRA, 115 subjects, 230 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2014-03-19","2014-03-19","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Tumor; Cervical neoplasm; Cervix Neoplasm; Cervix Neoplasms","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000627.v1.p1","UNC Hepatocellular Carcinoma Study by Exome Sequencing (HCCSES)","Genetic alterations in specific driver genes lead to disruption of cellular pathways and are critical events in the instigation and progression of hepatocellular carcinoma. As a prerequisite for individualized cancer  treatment, we sought to characterize the landscape of recurrent somatic mutations in hepatocellular carcinoma. We performed whole exome sequencing on","Not Applicable","Carcinoma, Hepatocellular","Case Set","WES_markerset_grc37","SNP Genotypes (NGS), WXS","3 phenotype datasets, 18 variables, 1 molecular datasets, 174 samples sequenced,  SRA, 87 subjects, 174 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2014-03-14","2014-03-14","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000410.v1.p1","Whole Exome Sequencing for Colorectal Cancer","This project was designed to use next generation sequencing technology to screen the protein coding regions of the genome for low frequency variants in a panel of high-risk colorectal adenocarcinoma  cases. Blood and cell-line DNA for colorectal cancer patients and a subset of quality control samples that had existing whole exome sequence data","Not Applicable","Colorectal Neoplasms","Case Set","Not Provided","WXS","4 phenotype datasets, 21 variables, 168 samples sequenced,  SRA, 165 subjects, 174 samples","","NCI","GRU-MDS --- General Research Use (MDS), GRU-NPU-MDS --- General Research Use (NPU, MDS)","2014-03-14","2014-03-14","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000519.v1.p1","Study of Melanoma Risk in Australia and the United Kingdom","The results from a small number of melanoma GWAS have been published. Initial studies identified several pigmentation- and nevus-associated loci that mediate an effect on melanoma risk, however, these studies  were somewhat limited in that sample number (hence power) was low, they used first-generation low density SNP arrays, or used pools of DNA samples.","Not Applicable","Melanoma","Case Set","HumanOmniExpressExome-8","SNP Genotypes (Array)","4 phenotype datasets, 353 variables, 1 molecular datasets, 3912 subjects, 4079 samples","","NCI","GRU-MDS --- General Research Use (MDS), DS-M-MDS --- Disease-Specific (Melanoma, MDS)","2014-03-12","2015-03-12","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000436.v1.p1","University of Miami Study on Genetics of Autism and Related Disorders    (AutismDisorders)","Autism spectrum disorders (ASD) are neurodevelopmental in origin and characterized by impairments in reciprocal social interaction and communication accompanied by restricted and repetitive patterns of interest or behavior. With improved  surveillance and a broadening of the diagnostic criteria, the most recent prevalence studies suggest that ASD may affect as many as 1/166 children in","Not Applicable","Autistic Disorder","Family/Twin/Trios","Human1M-Duo","SNP Genotypes (Array)","5 phenotype datasets, 26 variables, 1 molecular datasets, 1205 subjects, 1205 samples","European (1181), African (1), African American (2), Hispanic1 (8), Hispanic2 (6), South Asian (3), Other (1)","NIMH","DS-ASD-RD --- Disease-Specific (Autism Spectrum Disorder, RD)","2014-03-05","2014-03-05","Child Development Disorders, Pervasive; AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile","dbGaP Collection: NIH Autism -omics Studies (phs000764.v1.p1)"
"phs000251.v2.p2","Cutaneous Microbiome in Psoriasis (HMP Demonstration Study)","Psoriasis, a highly prevalent disease of humans of unknown cause, is a chronic inflammatory disorder primarily involving skin, with distinctive clinical characteristics. With the newly developed tools that facilitate microbiome  research, it now is possible to assess whether the cutaneous microbiome plays a role in the pathogenesis of this disorder. Preliminary data from our","Not Applicable","Psoriasis","Case-Control","Not Provided","AMPLICON","4 phenotype datasets, 27 variables, 236 samples sequenced,  SRA, 93 subjects, 236 samples","","NIAMS","HMP --- Human Microbiome Research","2014-03-04","2011-06-16","Acropustulosis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis; Palmoplantar Pustulosis",""
"phs000299.v2.p1","Genentech Lung Cancer Sequencing","Version 1 Whole genome sequencing was applied to tumor and adjacent normal lung tissue in an individual non-small-cell lung cancer patient. We present an analysis of somatic changes identified throughout  the tumor genome, including single-nucleotide variants, copy number variants, and large-scale chromosomal rearrangements. Over 50,000 high-confidence","Not Applicable","Lung Neoplasms","Tumor vs. Matched-Normal","Not Provided","RNA-Seq, WGS","5 phenotype datasets, 24 variables, 25 samples sequenced,  SRA, 21 subjects, 25 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2014-02-28","2010-08-18","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000692.v1.p1","A Pharmcogenetic Study of Bipolar Disorder in a Taiwanese Han Chinese    Population (TWBP)","Objective: To identify genetic variants associated with response to lithium prophylaxis treatment. Materials: 294 bipolar I (BPI) patients receiving lithium treatment, a subset of 1761 bipolar I (BPI) patients recruited  by the Taiwan Bipolar Consortium. Lithium response was assessed based on the Alda Scale. Methods: Responders to lithium treatment were defined if the","Not Applicable","Bipolar Disorder","Case Set","Not Provided","Not Provided","4 analyses","","NIMH","DS-BPD-RD --- Disease-Specific (Bipolar Disorder, RD)","2014-02-27","2014-02-27","Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders; Bipolar Mood Disorder",""
"phs000638.v1.p1","Genome-Wide Association Study of Relapse of Childhood Acute Lymphoblastic    Leukemia","Using risk-directed therapy for childhood acute lymphoblastic leukemia (ALL), outcome has improved dramatically in the last 40 years. However, a substantial portion of patients experience relapse, many of whom have  no known risk factors. Taking a genome-wide approach, we sought to evaluate the relationships between germline SNP genotypes and the risk of relapse","Not Applicable","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Interventional","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 molecular datasets, 2487 subjects, 2487 samples","European (1631), African (5), East Asian (33), African American (243), Hispanic1 (61), Hispanic2 (396), Other Asian or Pacific Islander (41), South Asian (30), Other (47)","NIGMS","HMB --- Health/Medical/Biomedical","2014-02-21","2014-02-21","ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic; Leukemia, Lymphoblastic, Acute, L1",""
"phs000461.v1.p1","GLAUGEN-Methylation in POAG","This is a case-control study of Primary Open Angle Glaucoma (POAG). POAG is a progressive optic neuropathy that eventually leads to blindness. More than 30 million people worldwide have Primary  Open Angle Glaucoma (POAG), of which greater than 3 million are blind. Gene expression changes in the retina have been observed for POAG. Several","Not Applicable","Glaucoma, Open-Angle","Case-Control","HumanMethylation450","Methylation (CpG)","3 phenotype datasets, 9 variables, 1 molecular datasets, 70 subjects, 70 samples","","NEI","GRU --- General Research Use","2014-02-19","2015-02-19","Compensated Glaucoma; Compensative Glaucoma; Glaucoma Simplex; Glaucoma, Compensated; Glaucoma, Compensative; Glaucoma, Open Angle",""
"phs000372.v1.p1","ADGC Genome Wide Association Study","The National Institute on Aging (NIA) Alzheimer's Disease Centers (ADCs) cohort includes subjects ascertained and evaluated by the clinical and neuropathology cores of the 29 NIA-funded ADCs. Data collection is  coordinated by the National Alzheimer's Coordinating Center (NACC). NACC coordinates collection of phenotype data from the 29 ADCs, cleans all data,","Not Applicable","Alzheimer Disease","Case-Control","Human660W-Quad, HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 26 variables, 1 molecular datasets, 6065 subjects, 6065 samples","European (5376), African (15), East Asian (21), African American (434), Hispanic1 (58), Hispanic2 (142), Other Asian or Pacific Islander (2), South Asian (1), Other (16)","NIA","ADR --- Alzheimer's Disease Genetics Consortium","2014-02-19","2015-02-19","Dementia; AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias",""
"phs000248.v1.p1","Genetic Determinants of Viral Clearance in HCV-Infected Populations","The World Health Organization estimates there are 170 million persons with HCV infection worldwide, and an estimated 4 million persons are infected in the United States. Persistent HCV infection can  cause cirrhosis and hepatocellular cancer. Long term disease consequences do not occur in persons who spontaneously recover. It is not known why","Not Applicable","Hepatitis C","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 3434 subjects, 3636 samples","European (2544), African (16), East Asian (12), African American (542), Hispanic1 (124), Hispanic2 (136), Other Asian or Pacific Islander (9), South Asian (17), Other (34)","NIDA","GRU-IRB --- General Research Use (IRB)","2014-02-13","2015-02-13","HCV Infection; Hepatitis C Virus Infection; Hepatitis C virus caused hepatitis; Hepatitis C virus hepatitis; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted; NANBH",""
"phs000666.v1.p1","B and T Cell Determinants of Influenza Vaccine Responses in the Elderly","The study sequenced antibody heavy chain gene rearrangements from human subjects receiving influenza vaccination. Inclusion: Age 18-30, 60-79, or 80-100 years, inclusive at time of initial enrollment General good health  and ambulatory at time of enrollment No acute illness at time of vaccination Willing and able to sign Informed Consent Available for follow-up for","Not Applicable","Influenza Vaccines","Prospective Longitudinal Cohort","Not Provided","AMPLICON","4 phenotype datasets, 15 variables, 2554 samples sequenced, 27 subjects, 2554 samples","","NIAID","DS-IR-IRB --- Disease-Specific (Immunological Research, IRB)","2014-02-05","2015-02-05","Not Provided",""
"phs000690.v1.p1","Whole-genome sequencing in multiplex epilepsy families","Epilepsy is one of the most common neurologic disorders, affecting approximately 4% of individuals at some time in their lives. More than 30% of people with epilepsy continue to have  seizures despite treatment, and improved approaches to treatment and prevention are sorely needed. In the search for new strategies to reduce the","Not Applicable","Epilepsy, Idiopathic Generalized","Family/Twin/Trios","Not Provided","WGS, WXS","5 phenotype datasets, 22 variables, 60 samples sequenced, 60 subjects, 60 samples","","NINDS","GRU --- General Research Use, DS-ESD-GSO --- Disease-Specific (Epilepsy and seizure disorders, GSO)","2014-01-30","2015-01-30","Generalized Epilepsy with Febrile Seizures Plus; Idiopathic Generalized Epilepsy; GEFS+; GEFS+ - genetic epilepsy with febrile seizure plus; Genetic epilepsy with febrile seizures-plus; epilepsy, generalized, with febrile seizures plus","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000658.v1.p1","MDD2000AFFY","Sub-study QI: 941 cases of Major Depressive Disorder (MDD) from the Queensland Institute of Medical Research (QIMR), Australia Sub-study VU: 127 MDD cases from The Netherlands Study of Anxiety and  Depression (NESDA) (http://www.nesda.nl) and The Netherlands Twin Registry (NTR) (http://www.tweelingenregister.org) based at the VU Amsterdam, The","Not Applicable","Depressive Disorder, Major","Case Set","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 50 variables, 2 documents, 1 molecular datasets, 1441 subjects, 1441 samples","","NIMH","NR --- No data use restrictions","2014-01-30","2014-01-30","Major Depressive Disorder; Depression, Involutional; Depressions, Involutional; Involutional melancholia; Melancholia, Involutional; Melancholias, Involutional",""
"phs000632.v1.p1","NHLBI GO-ESP: Family Studies (Hematological Cancers)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Hemic and Lymphatic Diseases","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets, 19 samples sequenced,  SRA, 10 subjects, 19 samples","","NHLBI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2014-01-30","2014-04-30","Blood and Lymphatic System Disorders; Hematopoietic and Lymphoid System Disorder",""
"phs000276.v2.p1","STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966)","The Northern Finland Birth Cohorts program (NFBC) was initiated in the 1960s in the two northernmost provinces of Finland to study risk factors involved in pre-term birth and intrauterine growth  retardation, and the consequences of these early adverse events on subsequent morbidity and mortality. The uniqueness of NBFCs is that the data of","Not Applicable","Metabolic Syndrome","Prospective Longitudinal Cohort","HumanCNV370-Duo","WXS, SNP Genotypes (Array)","4 phenotype datasets, 34 variables, 9 analyses, 1 molecular datasets, 5529 samples sequenced,  SRA, 5415 subjects, 10931 samples","","NHLBI","GRU --- General Research Use","2014-01-24","2014-01-24","Cardiovascular Diseases; Metabolic Syndrome X; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000670.v1.p1","PGRN Antidepressant Medication Pharmacogenomic Study (AMPS)","This pharmacogenomic study focused on the response of patients with MDD to an 8-week course of treatment with citalopram or escitalopram. Briefly, clinical assessments and research assessments were performed at  each study visit as summarized in Table 1. Many patients continued on antidepressant medication after the 8 week study. Table 1: Study timeline and","Not Applicable","Depressive Disorder, Major","Prospective Longitudinal Cohort","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 52 variables, 7 documents, 4 analyses, 1 molecular datasets, 529 subjects, 529 samples","European (500), African (1), East Asian (2), African American (9), Hispanic1 (2), Hispanic2 (7), Other Asian or Pacific Islander (4), South Asian (2), Other (2)","NIGMS","HMB --- Health/Medical/Biomedical","2014-01-22","2015-01-22","Depression, Involutional; Depressions, Involutional; Involutional melancholia; Melancholia, Involutional; Melancholias, Involutional",""
"phs000631.v1.p1","ARDSnet and the iSPAAR Consortium: Genetic Studies","Acute Respiratory Distress Syndrome (ARDS)/ Acute Lung Injury (ALI) is a syndrome defined by the presence of acute hypoxemic respiratory failure, bilateral pulmonary infiltrates on chest radiograph, a known clinical  risk factor (e.g. sepsis, pneumonia, trauma, gastric fluid aspiration, pancreatitis, massive transfusion), and the absence of physiologic or clinical","Not Applicable","Respiration Disorders","Clinical Trial","Human660W-Quad, WES_markerset_grc37, WES_markerset_grc36","Not Provided","3 phenotype datasets, 22 variables, 89 samples sequenced, 3033 subjects, 3772 samples, 2 substudies","","NHLBI","HMB --- Health/Medical/Biomedical","2014-01-15","2015-01-15","Sepsis; Pyaemia; Pyaemias; Pyemia; Pyemias; Pyohemia","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000611.v1.p1","Whole Genome Comparisons of Breast Cancers and their Xenotransplants","Early passage breast cancer xenografts have been proposed as alternatives to cell lines as model systems for studying the basic biology of tumors and for advancing therapy development. This study  explores the relatedness of primary disease genomes to their matched xenotransplants. Using paired-end massively parallel sequencing 17 matched","Not Applicable","Breast Neoplasms","Xenograft","WGS_markerset_grc36","WGS, SNP/CNV Genotypes (NGS), RNA-Seq","4 phenotype datasets, 24 variables, 1 molecular datasets, 67 samples sequenced,  SRA, 16 subjects, 67 samples","","NHGRI","DS-CA --- Disease-Specific (Cancer), DS-CROTx --- Cancer Treatment Research Only","2014-01-15","2014-03-15","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000559.v1.p1","PAGE: Epidemiologic Architecture for Genes Linked to Environment (EAGLE)    - BioVU Cancer Project","As part of Population Architecture using Genomics and Epidemiology PAGE study (Phase I), the Epidemiologic Architecture using Genomics and Epidemiology (EAGLE I) project accessed both epidemiologic- and clinic-based collections. The  epidemiologic-based collection of EAGLE I included the National Health and Nutritional Examination Surveys (NHANES), ascertained between 1991-1994","Not Applicable","Neoplasms","Case-Control","custom_probe_set","SNP Genotypes (Array)","4 phenotype datasets, 68 variables, 1 molecular datasets, 15256 subjects, 15256 samples","","NHGRI","GRU --- General Research Use","2014-01-15","2015-01-15","Lung Neoplasms; Lymphoma, Non-Hodgkin; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor",""
"phs000686.v1.p1","Genetic Risks for ALI in ARDSNet and the iSPAAR Consortium","This GWAS sub-study phs000686 contains genotype and selected phenotype of subjects available from the phs000631 study. Summary level phenotypes for the ""ARDSnet and the iSPAAR Consortium: Genetic Studies"" study participants  can be viewed at the top-level study page phs000631 ARDSNet iSPAAR cohort. Individual level phenotype data and molecular data for all ARDSnet and the","ARDSnet and the iSPAAR Consortium: Genomic Basis of Susceptibility and Outcomes in Patients with the Acute Respiratory Distress Syndrome (ARDS) (phs000631.v1.p1)","Acute Lung Injury","Case-Control","Human660W-Quad","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 2236 subjects, 2236 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2014-01-15","2015-01-15","Sepsis; Pyaemia; Pyaemias; Pyemia; Pyemias; Pyohemia",""
"phs000334.v1.p1","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Acute Lung Injury)","This sub-study phs000334 LungGO ALI contains genotype and selected phenotype of subjects available from the phs000631 study. Summary level phenotypes for the ""ARDSnet and the iSPAAR Consortium: Genetic Studies"" study  participants can be viewed at the top-level study page phs000631 ARDSNet iSPAAR cohort. Individual level phenotype data and molecular data for all","ARDSnet and the iSPAAR Consortium: Genomic Basis of Susceptibility and Outcomes in Patients with the Acute Respiratory Distress Syndrome (ARDS) (phs000631.v1.p1)","Acute Lung Injury","Case-Control","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (Array), SNP Genotypes (Array), SNP Genotypes (NGS), SNP Genotypes (NGS), WXS, WXS","1 phenotype datasets, 5 variables, 3 molecular datasets, 89 samples sequenced,  SRA, 1536 subjects, 1536 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2014-01-15","2015-01-15","Shock, Septic; Endotoxin Shock; Endotoxin Shocks; Gram-negative septic shock; Gram-negative shock; Shock, Endotoxic",""
"phs000677.v1.p1","An APOBEC Cytidine Deaminase Mutagenesis in Human Cancers","Reprinted from Roberts et al. ""An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers"", Nature Genetics, 45:970-976, 2013, with permission of Nature Publishing Group: Recent studies indicate that  a subclass of APOBEC cytidine deaminases, which convert cytosine to uracil during RNA editing and retrovirus or retrotransposon restriction, may","Not Applicable","Neoplasms","Cross-Sectional","WES_markerset_grc36","SNV (.MAF)","3 phenotype datasets, 12 variables, 1 molecular datasets,  SRA, 5427 subjects, 5427 samples","","NCI","GRU --- General Research Use","2013-12-20","2013-12-20","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000662.v1.p1","National Children's Study Vanguard Study Formative Research Study (NCS)","The National Children's Study (NCS) is a multi-year prospective epidemiological study tasked with identifying a nationally representative sample of 100,000 children and following them from pregnancy through age 21 to  study environmental impacts on growth, development, and health. Determination of NCS enrollee ancestry is important for assessing the diversity of","Not Applicable","Population Groups","Prospective Longitudinal Cohort","HumanExome-12","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 2 documents, 1 molecular datasets,  SRA, 641 subjects, 641 samples","","NICHD","HBM --- Health/Biomedical/Medical-IRB","2013-12-20","2014-12-20","Not Provided",""
"phs000647.v1.p1","Study of Adaptation to Hypoxia in Ethiopian Highlanders","Although it has long been proposed that genetic factors contribute to adaptation to high altitude, such factors remain largely unverified. Recent advances in high-throughput sequencing have made it feasible to  analyze genome-wide patterns of genetic variation in human populations. Since traditionally such studies surveyed only a small fraction of the genome","Not Applicable","Cell Hypoxia","Cross-Sectional","WGS_markerset_grc37","SNP Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 13 subjects, 13 samples","","NHLBI","GRU --- General Research Use","2013-12-20","2013-12-20","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs000661.v1.p1","Germline Sequencing for Aggressive Prostate Carcinoma","This study aims to elucidate the genetic determinants of susceptibility to aggressive prostate carcinoma. To this end, germ line whole exome sequence has been generated from patients with aggressive prostate  cancer. Whole genome sequence for a representative subset of tumors from patients whose cancer was resistant to primary therapy is included as well.","Not Applicable","Neoplasms","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 13 variables, 10 samples sequenced,  SRA, 5 subjects, 10 samples","","NHGRI","DS-PC --- Disease-Specific (Prostate Cancer)","2013-12-18","2013-12-18","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs000652.v1.p1","Cohort-Based Genome-Wide Association Study of Glioma (GliomaScan)","We conducted a new independent GWAS of adult glioma using 1,856 cases and 4,955 controls from 14 cohort studies belonging to the Cohort Consortium, 3 case-control studies, and 1 population-based  case only study. Cases were newly diagnosed glioma [ICDO-3 codes 9380-9480 or equivalent], and controls were cancer-free at the time of glioma","Not Applicable","Glioma","Case-Control","HumanHap550, Human610-Quad, Human660W-Quad","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 analyses, 3 molecular datasets, 6811 subjects, 7072 samples","","NCI","DS-GAO-GSO --- Disease-Specific (Glioma in Adults Only, GSO), CADM --- Cancer in all age groups, other diseases in adults only, and methods","2013-12-17","2014-12-17","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia",""
"phs000458.v1.p1","NEIGHBOR-Methylation in POAG","This is a case-control study of Primary Open Angle Glaucoma (POAG). POAG is a progressive optic neuropathy that eventually leads to blindness. More than 30 million people worldwide have Primary  Open Angle Glaucoma (POAG), of which greater than 3 million are blind. Gene expression changes in the retina have been observed for POAG. Several","Not Applicable","Glaucoma, Open-Angle","Case-Control","HumanMethylation450","Methylation (CpG)","3 phenotype datasets, 9 variables, 1 molecular datasets, 122 subjects, 27 samples","","NEI","GRU --- General Research Use, DS-ED --- Disease-Specific (Eye Disease)","2013-12-17","2014-09-17","Compensated Glaucoma; Compensative Glaucoma; Glaucoma Simplex; Glaucoma, Compensated; Glaucoma, Compensative; Glaucoma, Open Angle",""
"phs000608.v1.p1","Whole Genome Profiling to Detect Schizophrenia Methylation Markers","Schizophrenia (SCZ) is a devastating psychiatric disorder. The aim of this study was to detect DNA methylation (5meC) profiles in whole blood associated with SCZ. The sample consisted of schizophrenia  cases and controls selected from national population registers in Sweden. We employed MBD protein-based enrichment of the methylated DNA fraction,","Not Applicable","Schizophrenia","Case-Control","HumanMethylation450","Methylation (CpG)","4 phenotype datasets, 31 variables, 2 documents, 1 molecular datasets, 1459 subjects, 1459 samples","","NIMH","GRU --- General Research Use","2013-12-13","2014-12-13","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder","dbGaP Collection: Open Translational Science in Schizophrenia (OPTICS) (phs000887.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000641.v1.p1","TTC7A Mutations for Combined Immunodeficiency with Intestinal Atresia","Combined Immunodeficiency with Multiple Intestinal Atresias (CID-MIA) is a rare genetic disorder with the cause previously unknown. Symptoms of CID-MIA include atresias in the small and/or large intestine, as well  as immunodeficiency. In this study, we sequenced the whole exome of 5 unrelated CID-MIA patients as well as their healthy family members, and","Not Applicable","Immunologic Deficiency Syndromes","Family/Twin/Trios","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 19 variables, 1 molecular datasets, 15 samples sequenced,  SRA, 15 subjects, 15 samples","","NIAID","GRU-IRB --- General Research Use (IRB)","2013-12-04","2014-12-04","Immunological Deficiency Syndrome; Antibody Deficiency Syndrome; Antibody Deficiency Syndromes; Deficiency Syndrome, Antibody; Deficiency Syndromes, Antibody; Syndrome, Antibody Deficiency",""
"phs000504.v2.p2","Medulloblastoma exome sequence analysis","Medulloblastomas are the most common malignant brain tumors in children. Identifying and understanding the genetic events that drive these tumors is critical for the development of more effective diagnostic, prognostic  and therapeutic strategies. Recently, our group and others described distinct molecular subtypes of medulloblastoma based on transcriptional and copy","Not Applicable","Medulloblastoma","Case-Control","Not Provided","WXS","4 phenotype datasets, 16 variables, 184 samples sequenced,  SRA, 92 subjects, 184 samples","","NHGRI","DS-CA --- Disease-Specific (Cancer)","2013-12-04","2012-07-31","Arachnoidal Cerebellar Sarcoma, Circumscribed; Circumscribed arachnoidal cerebellar sarcoma; Desmoplastic Medulloblastomas; Desmoplastic Nodular Medulloblastoma; Desmoplastic medulloblastoma; Medulloblastoma, Desmoplastic",""
"phs000597.v1.p1","DNA Methylation Analysis of Prostate Cancer","Aberrant DNA methylation changes are known to occur during prostate cancer progression beginning with precursor lesions. Utilizing fifty nanograms of genomic DNA in Methylplex-Next Generation Sequencing (M-NGS) we mapped the  global DNA methylation patterns in prostate tissues (n 17) and cells (n 2). Peaks were located from mapped reads obtained in each sequencing run","Not Applicable","Prostatic Neoplasms","Case-Control","Not Provided","OTHER","4 phenotype datasets, 23 variables, 19 samples sequenced,  SRA, 17 subjects, 19 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2013-11-26","2013-11-26","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000598.v2.p2","Exome Sequencing of Esophageal Adenocarcinoma","The incidence of esophageal adenocarcinoma (EAC) has risen 600% over the last 30 years. When coupled to the five-year survival rate of only 15% for this disease, identification of new  therapeutic targets for EAC is of great importance. Here, we analyze the mutational spectra identified from the whole genome sequencing of 16 EACs","Not Applicable","Esophageal Neoplasms","Case Set","WES_markerset_grc36","WGS, SNV (.MAF), WXS","4 phenotype datasets, 13 variables, 1 molecular datasets, 300 samples sequenced,  SRA, 150 subjects, 300 samples","","NHGRI","DS-HEC --- Disease-Specific (Human Esophageal Cancer), DS-CA --- Disease-Specific (Cancer), DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2013-11-22","2013-11-22","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophageal neoplasm; Esophageal tumour; Esophagus Neoplasm",""
"phs000657.v1.p1","NGS in Advanced Cancers","In this study, we used NGS to identify somatic events in advanced stage cancer patients to demonstrate the feasibility for using this approach to improve patient treatment. Principal Investigator: Glen  Weiss, MD, Translational Genomics Research Institute, Phoenix, AZ, USA Co-Investigator: Winnie Liang, PhD, Translational Genomics Research Institute,","Not Applicable","Carcinoma","Case Set","Not Provided","WXS, WGS, RNA-Seq","4 phenotype datasets, 17 variables, 31 samples sequenced,  SRA, 15 subjects, 31 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2013-11-20","2013-11-20","Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant; Epithelioma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000238.v1.p1","NEIGHBOR Consortium Glaucoma GWAS","This is a case-control study of primary open angle glaucoma (POAG). POAG is an intraocular pressure (IOP) related progressive optic neuropathy that ultimately leads to blindness. For this study we  have formed a collaborative consortium contributing 2170 POAG cases and 2347 controls with a unified definition of POAG (the NEIGHBOR consortium: NEI","Not Applicable","Glaucoma","Case-Control","Human660W-Quad","SNP Genotypes (Array)","3 phenotype datasets, 46 variables, 1 molecular datasets, 5073 subjects, 5416 samples","European (4591), African (10), East Asian (4), African American (72), Hispanic1 (46), Hispanic2 (304), Other Asian or Pacific Islander (4), South Asian (9), Other (33)","NEI","GRU --- General Research Use, DS-ED --- Disease-Specific (Eye Disease)","2013-11-20","2014-08-20","",""
"phs000664.v1.p1","Genome Variations Among the Aboriginals in Malaysia","Copy number variation (CNV) has been recognized as a major contributor to human genome diversity. It plays an important role in determining phenotypes and has been associated with a number  of common and complex diseases. However the CNV data from diverse populations is rather limited. Here we report the first investigation of copy","Not Applicable","Population Groups","Cross-Sectional","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 34 subjects, 34 samples","","NHGRI","GRU --- General Research Use","2013-11-15","2014-02-15","Not Provided","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000364.v2.p1","Genome-Wide Analysis of Chronic Lymphocytic Leukemia","Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation The pathogenesis of chronic lymphocytic leukemia (CLL), the most common leukemia in adults, is still largely unknown  since the full spectrum of genetic lesions that are present in the CLL genome, and therefore the number and identity of dysregulated cellular","Not Applicable","Leukemia, Lymphocytic, Chronic, B-Cell","Tumor vs. Matched-Normal","Affymetrix_WG_Array","WXS, SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 2 molecular datasets, 49 samples sequenced,  SRA, 43 subjects, 61 samples","","NCI","DS-CA-PUB-MDS --- Disease-Specific (Cancer, PUB, MDS)","2013-11-15","2013-11-15","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Cell Malignancy, Low Grade; B Lymphocytic Leukemia, Chronic",""
"phs000671.v1.p1","Somatic Mutations in Variant and IGHV4-34 Expressing Hairy Cell Leukemia","To understand the genetic mechanisms driving variant and IGHV4-34 expressing hairy-cell leukemia, we performed whole exome sequencing of tumor/normal pairs from ten patients. All patients have either IGHV4-34 expressing classic  hairy cell leukemia, IGHV4-34 expressing variant hairy-cell leukemia, or IGHV4-34 non-expressing variant hairy-cell leukemia. Principal Investigator:","Not Applicable","Leukemia, Hairy Cell","Case Set","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 20 samples sequenced,  SRA, 10 subjects, 20 samples","","NCI","HMB-MDS --- Health/Medical/Biomedical (MDS)","2013-11-14","2013-11-14","HCL; HCL - Hairy cell leukemia; HCL-C; Hairy Cell Leukemias; LRE - Leukemic reticuloendotheliosis; Leukemias, Hairy Cell","NCI's Collection of Datasets for Health, Medical, and Biomedical Research    Purposes (phs003044.v1.p1)"
"phs000579.v1.p1","Small Intestine Neuroendocrine Tumors (Carcinoid Tumors)","The diagnosed incidence of small bowel neuroendocrine tumors (NETs) is increasing. While patients with localized disease can be treated surgically, those with metastatic disease currently have few treatment options. The  success of biologically targeted therapies in other malignancies has led to interest in the molecular alterations underlying the pathogenesis of","Not Applicable","Intestinal Neoplasms","Case Set","Somatic_Variant","WGS, SNV (.MAF), WXS","4 phenotype datasets, 20 variables, 1 analyses, 1 molecular datasets, 105 samples sequenced,  SRA, 51 subjects, 105 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS), DS-GI-MDS --- Disease-Specific (Gastrointestinal Illness, MDS), GRU-MDS --- General Research Use (MDS)","2013-11-06","2013-11-22","Intestinal Tumor; Intestinal Tumors; Intestines Neoplasm; Intestines Neoplasms; Neoplasm of Intestines; Neoplasm of intestine","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1); NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000160.v1.p1","Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR    Project)","Multiplex Family Study The purpose of the NIA Genetics Initiative: Multiplex Family Study is to identify families with multiple members diagnosed with late-onset Alzheimer's Disease. Families will be characterized clinically  and blood samples will be collected to establish cell lines. If a blood sample is not available, autopsy samples will be collected for DNA extraction","Not Applicable","Alzheimer Disease","Prospective Longitudinal Cohort","linkage_panel","SNP Genotypes (Array)","4 phenotype datasets, 25 variables, 1 documents, 1 molecular datasets, 2398 subjects, 2512 samples","","NIA","GRU --- General Research Use, NPU --- Non-Profit Use, ALZ --- Alzheimer Disease Only, ALZ_NPU --- Alzheimer Disease and Non-Profit Use Only","2013-11-06","2009-04-14","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000659.v1.p1","Mount Sinai Hospital (MSH, Toronto, CANADA) pelvic pouch microbiome study","This study involved evaluation of the tissue associated microbiome of the ileal pouch following surgery for ulcerative colitis (UC) or familial adenomatous polyposis (FAP). Individuals were recruited, with biopsies taken  from the ileal pouch and the pre-pouch ileum, microbial DNA was extracted and sequenced using 454 pyrosequencing. Total bacterial community structure","Not Applicable","Inflammatory Bowel Diseases","Case-Control","Not Provided","POOLCLONE","4 phenotype datasets, 16 variables, 158 samples sequenced,  SRA, 80 subjects, 158 samples","","NIDDK","GRU --- General Research Use","2013-11-01","2013-11-01","Adenomatous Polyposis Coli; Colitis, Ulcerative; Pouchitis; ADENOMATOUS POLYPOSIS OF THE COLON; APC; APC - Adenomatous Polyposis Coli","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000637.v1.p1","Methotrexate Clearance GWAS","We estimated the plasma clearance of methotrexate from 1279 acute lymphoblastic leukemia (ALL) patients treated on the Children Oncology Group 9904 and 9905 trials (http://clinicaltrials.gov/show/NCT00005585 and http://clinicaltrials.gov/show/NCT00005596). Patients received either  a 24-hour infusion of a 1 g/m2 dose or 4-hour infusion of a 2 g/m2 dose). Methotrexate clearance was lower in older children (p 7 x 10-7), females (p","Not Applicable","Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","Clinical Trial","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets, 1267 subjects, 1267 samples","European (823), African (3), East Asian (18), African American (90), Hispanic1 (38), Hispanic2 (225), Other Asian or Pacific Islander (24), South Asian (17), Other (29)","NIGMS","HMB --- Health/Medical/Biomedical","2013-10-29","2013-10-29","Leukemia, Pre B Cell; Leukemia, Pre-B-Cell; Leukemias, Pre-B-Cell; Pre B ALL; Pre B Cell Leukemia; Pre B-ALL",""
"phs000601.v1.p1","Identifying the Genetic Explanation for Heritable Breast Cancer","The project developed a suite of new methods (FAVR) designed to assist the shortlisting of genetic variants under a rare variant-phenotype/disease model. The methods were designed to work with commonly  used massively parallel sequencing analysis pipelines, such as the GATK or ANNOVAR, and have been made publically available as a suite of software","Not Applicable","Breast Neoplasms","Family/Twin/Trios","WES_markerset_grc37","WXS, SNP Genotypes (NGS)","4 phenotype datasets, 19 variables, 1 molecular datasets, 20 samples sequenced,  SRA, 20 subjects, 20 samples","","NCI","DS-CA-MDS --- Disease-Specific (Cancer, MDS)","2013-10-29","2013-10-29","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Studies for General Cancer Research (phs003967.v1.p1)"
"phs000618.v1.p1","Hypertriglyceridemia Study in Mexicans","Coronary artery disease (CAD) is the number one cause of death and mortality world-wide. High levels of serum triglycerides (TGs) and low levels of serum high-density lipoprotein cholesterol (HDL-C) are  major risk factors for CAD. Previous epidemiological studies have shown that these two lipid disturbances are highly common dyslipidemias in","Not Applicable","Hypertriglyceridemia","Case-Control","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 4 analyses, 1 molecular datasets, 4350 subjects, 4350 samples","European (26), Hispanic1 (1), Hispanic2 (2188), Other Asian or Pacific Islander (1), Other (13)","NHLBI","DS-HTG-MDS-RD --- Disease-Specific (Hypertriglyceridemia, MDS, RD)","2013-10-25","2013-10-25","Not Provided",""
"phs000279.v2.p1","NHLBI GO-ESP: Early-Onset Myocardial Infarction (Broad EOMI)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Myocardial Infarction","Prospective Longitudinal Cohort","WES_markerset_grc37, WES_markerset_grc36","SNP/CNV Genotypes (NGS), SNP Genotypes (NGS), WXS","4 phenotype datasets, 30 variables, 2 molecular datasets, 727 samples sequenced,  SRA, 736 subjects, 727 samples","","NHLBI","DS-CVD --- Disease-Specific (Cardiovascular Disease)","2013-10-25","2016-04-12","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000266.v4.p1","Skin Microbiome in Disease States: Atopic Dermatitis and Immunodeficiency","The NIH Intramural Skin Microbiome Consortium (NISMC) is a collaboration of investigators with primary expertise in genomics, bioinformatics, large-scale DNA sequencing, dermatology, immunology, allergy, infectious disease, and clinical microbiology. Atopic  dermatitis (AD, ""eczema"") is a chronic relapsing skin disorder that affects 15% of U.S. children and is associated with $1 billion of medical costs","Not Applicable","Dermatitis, Atopic","Prospective Longitudinal Cohort","Not Provided","AMPLICON","5 phenotype datasets, 29 variables, 2269 samples sequenced,  SRA, 114 subjects, 3211 samples","","NIAMS","HMP --- Human Microbiome Research","2013-10-25","2012-09-13","Job's Syndrome; Wiskott-Aldrich Syndrome; AD - Atopic dermatitis; ATOD; Allergic eczema; Atopic Eczema",""
"phs000354.v1.p1","NHLBI GO-ESP Family Studies: Pulmonary Arterial Hypertension","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Hypertension, Pulmonary","Prospective Longitudinal Cohort","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 23 variables, 1 molecular datasets, 12 samples sequenced,  SRA, 12 subjects, 12 samples","","NHLBI","GRU --- General Research Use","2013-09-27","2013-12-27","","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000215.v2.p1","Genome-Wide Association Analysis of Biomarkers in the InCHIANTI and BLSA","Version 1 The aim of this study was to identify gene(s) associated with serum iron concentrations. This dataset contains the results from a meta-analysis of 1919 subjects from the InCHIANTI  and Baltimore Longitudinal Study of Aging (BLSA). Both studies are population based prospective studies that evaluate the contributors of normal","Not Applicable","Nutritional and Metabolic Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 phenotype datasets, 23 variables, 94 analyses","","NIA","GRU --- General Research Use","2013-09-27","2010-02-05","","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000656.v1.p1","Genetic Measurement of Memory B-cell Recall Using Antibody Repertoire    Sequencing","We developed an improved high throughput sequencing approach to measure the quantities and sequences of the repertoire of antibody heavy chain RNA in a blood sample. Using this approach we  analyzed the antibody repertoire in response to yearly vaccinations with influenza vaccines TIV and LAIV in healthy adults in two subsequent years.","Not Applicable","Influenza Vaccines","Interventional","Not Provided","AMPLICON","4 phenotype datasets, 15 variables, 105 samples sequenced,  SRA, 28 subjects, 105 samples","","NIAID","IRU --- Immunology Research Use","2013-09-26","2013-09-26","Not Provided",""
"phs000646.v1.p1","Breakpoint Detection Using Long Insert Whole Genome Sequencing","In this study, we hypothesize that shallow long insert whole genome sequencing (LI-WGS) increases our power for detecting breakpoints compared to shallow short insert WGS. We performed a priori analyses  to demonstrate the benefits of LI-WGS, developed a long insert library preparation protocol based off Illumina's protocol, and compared LI-WGS","Not Applicable","Chromosome Breakpoints","Case Set","Not Provided","WGS","4 phenotype datasets, 16 variables, 6 samples sequenced, 3 subjects, 6 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2013-09-10","2013-09-10","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000644.v1.p1","The Effect of the Menstrual Cycle on the Normal Human Breast","The Susan G. Komen for the Cure&#x000ae; Tissue Bank at the IU Simon Cancer Center [www.komentissuebank.iu.edu] (KTB) was established expressly for the prospective collection of normal, healthy breast tissue from  volunteer donors. Blood is also obtained from donors at the time of donation and is processed for serum, plasma and peripheral blood leukocyte DNA.","Not Applicable","Menstrual Cycle","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 44 variables, 20 samples sequenced,  SRA, 20 subjects, 20 samples","","NCI","DS-BRCA-PUB-MDS --- Disease-Specific (Breast Cancer, PUB, MDS)","2013-09-10","2013-09-10","Not Provided",""
"phs000619.v1.p1","Epigenetic Marks as Peripheral Biomarkers of Autism","Autism is a common disorder whose causes are poorly understood. Both genetic and environmental influences are thought to act together causing autism. Epigenetics is an area that bridges genetic and  environmental influencing and commonly is studied by examining dynamic methylation changes to the DNA. We have screened a total of 78 autistic boys","Not Applicable","Autistic Disorder","Case-Control","HumanMethylation450","Methylation (CpG)","5 phenotype datasets, 21 variables, 1 molecular datasets, 820 subjects, 820 samples","","NIMH","GRU --- General Research Use","2013-09-05","2013-09-05","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile","dbGaP Collection: NIH Autism -omics Studies (phs000764.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000362.v1.p1","NHLBI GO-ESP: Family Studies: (Familial Atrial Fibrillation)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Atrial Fibrillation","Family/Twin/Trios","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets, 12 samples sequenced,  SRA, 12 subjects, 12 samples","","NHLBI","HMB --- Health/Medical/Biomedical","2013-08-28","2013-11-28","Atrial fibrillation, familial 1; A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for Health / Medical / Biomedical Research    Use (Public Posting of Genomic Summary Results: Allowed) (phs003134.v1.p1)"
"phs000636.v1.p1","Whole Exome Sequencing for Familial Intracranial Aneurysm (FIA I-II)    Study","The goal of this study is to identify the genes underlying the risk of intracranial aneurysm (IA). The FIA Study initially recruited families appropriate for linkage analysis. Therefore, the recruitment  focus was not only on probands with a family history of IA but also required that biological samples be obtained for at least two affected family","Not Applicable","Intracranial Aneurysm","Family/Twin/Trios","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 32 variables, 1 molecular datasets, 45 samples sequenced,  SRA, 45 subjects, 44 samples","","NINDS","GRU --- General Research Use","2013-08-22","2014-01-22","Aneurysm, Middle Cerebral Artery; Middle Cerebral Artery Aneurysm; Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000623.v1.p1","Rare Mendelian Disease in Old Order Amish and Mennonite Patients","The Clinic for Special Children (CSC) has integrated biochemical and molecular methods into a rural pediatric practice serving Old Order Amish and Mennonite (Plain) children. Among the Plain people, we  have used single nucleotide polymorphism (SNP) microarrays to genetically map recessive disorders to large autozygous haplotype blocks (mean 4.4 Mb)","Not Applicable","Developmental Disabilities","Case Set","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 106 samples sequenced,  SRA, 106 subjects, 106 samples","","NHGRI","GRU --- General Research Use","2013-08-22","2013-08-22","Metabolic Diseases; Child Development Disorder; Child Development Disorders; Development Disorder, Child; Development Disorders, Child; Developmental Disability","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000604.v1.p1","Mapping Genes for Mammographic Density","We recruited 1,521 women from the Old Order Amish (OOA) population of Lancaster County, Pennsylvania, with the primary goal of identifying genetic factors that influence mammographic density. All women were  between the ages of 40 and 88 years, with a mean of 54 years. Additional study design details, including eligibility criteria, are described","Not Applicable","Neoplasms","Collection","Not Provided","Not Provided","3 analyses","","NCI","GRU-MDS --- General Research Use (MDS)","2013-08-22","","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000285.v3.p2","CARDIA Cohort","CARDIA is a study examining the etiology and natural history of cardiovascular disease beginning in young adulthood. In 1985-1986, a cohort of 5115 healthy black and white men and women  aged 18-30 years were selected to have approximately the same number of people in subgroups of age (18-24 and 25-30), sex, race, and education (high","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","iSelect_BeadChip, Affymetrix_WG_Array, imputation_panel, WES_markerset_grc37, custom_PCR_marker_set, WES_markerset_grc36","Not Provided","322 phenotype datasets, 9364 variables, 115 documents, 165 samples sequenced,  SRA, 3622 subjects, 13539 samples, 4 substudies","European (148), African (9), African American (555), Hispanic1 (6), Hispanic2 (1), Other Asian or Pacific Islander (2), Other (4)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2013-08-22","2014-08-22","Atherosclerosis; Diabetes Mellitus; Hypertension; Atherogeneses; Atherogenesis; Adverse Cardiac Event",""
"phs000613.v1.p2","NHLBI CARDIA Candidate Gene Association Resource (CARe)","This sub-study phs000613 CARDIA_CARe contains genotype of subjects available from the phs000613 study. Summary level phenotypes for the NHLBI CARDIA Cohort study participants can be viewed at the top-level study  page phs000285 CARDIA_v3 Cohort. Individual level phenotype data and molecular data for all CARDIA Cohort top-level study and sub-study are available","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","Cardiovascular Diseases","Prospective Longitudinal Cohort","iSelect_BeadChip, Affymetrix_WG_Array","SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 2 molecular datasets, 3299 subjects, 4754 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2013-08-22","2014-08-22","Atherosclerosis; Diabetes Mellitus; Hypertension; Atherogeneses; Atherogenesis; Adverse Cardiac Event",""
"phs000399.v1.p2","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)","This sub-study phs000399 GO-ESP HeartGO_CARDIA contains genotype derived from sequence data and selected phenotype of subjects available from the phs000399 study. Summary level phenotypes for the NHLBI CARDIA Cohort study  participants can be viewed at the top-level study page phs000285 CARDIA Cohort. Individual level phenotype data and molecular data for all CARDIA","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","Cardiovascular Diseases","Prospective Longitudinal Cohort","WES_markerset_grc37, WES_markerset_grc36","SNP/CNV Genotypes (NGS), SNP Genotypes (NGS), WXS","2 phenotype datasets, 86 variables, 2 molecular datasets, 165 samples sequenced,  SRA, 199 subjects, 199 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2013-08-22","2014-08-22","Brain Ischemia; Myocardial Infarction; Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies",""
"phs000309.v3.p2","The CARDIA-GENEVA Study","This sub-study phs000309 GENEVA CARDIA contains genotype and selected phenotype of subjects available from the phs000309 study. Summary level phenotypes for the NHLBI CARDIA Cohort study participants can be viewed  at the top-level study page phs000285 CARDIA Cohort. Individual level phenotype data and molecular data for all CARDIA Cohort top-level study and","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","Cardiovascular Diseases","Prospective Longitudinal Cohort","Affymetrix_WG_Array, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed), SNP Genotypes (Array), SNP Genotypes (imputed)","2 phenotype datasets, 155 variables, 59 documents, 2 molecular datasets, 1926 subjects, 4991 samples","European (1644), East Asian (1), African American (1), Hispanic1 (5), Hispanic2 (12), Other Asian or Pacific Islander (7), Other (5)","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2013-08-22","2014-08-22","Atherosclerosis; Diabetes Mellitus; Hypertension; Atherogeneses; Atherogenesis; Adverse Cardiac Event",""
"phs000236.v2.p2","PAGE: CALiCo: Coronary Artery Risk Development in Young Adults(CARDIA)","This sub-study phs000236 PAGE CALiCo CARDIA contains genotype derived from sequence data and selected phenotype of subjects available from the phs000236 study. Summary level phenotypes for the NHLBI CARDIA Cohort  study participants can be viewed at the top-level study page phs000285 CARDIA Cohort. Individual level phenotype data and molecular data for all","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","Cardiovascular Diseases","Prospective Longitudinal Cohort","custom_PCR_marker_set","SNP Genotypes (PCR)","1 phenotype datasets, 3 variables, 83 documents, 4 analyses, 1 molecular datasets, 3595 subjects, 3595 samples","","NHLBI","HMB-IRB --- Health/Medical/Biomedical (IRB), HMB-IRB-NPU --- Health/Medical/Biomedical (IRB, NPU)","2013-08-22","2014-08-22","Coronary Disease; Gout; Hypertension; Myocardial Infarction; Respiratory Tract Diseases; Adverse Cardiac Event",""
"phs000367.v1.p1","Genome Wide Association Study in Familial Crohn's Disease","The National Institute of Diabetes and Digestive and Kidney Diseases Inflammatory Bowel Disease Genetics Consortium (NIDDK - IBDGC) conducted a genome wide association study (GWAS) using the Human Omni2.5-Quad beadchip  from Illumina to identify disease variants associated with familial Crohn's disease. This study includes a subset of individuals from an original","Not Applicable","Crohn Disease","Family/Twin/Trios","HumanOmni2.5-8","SNP Genotypes (Array)","5 phenotype datasets, 25 variables, 1 molecular datasets, 704 subjects, 730 samples","European (684), African American (8), Hispanic1 (4), South Asian (1), Other (2)","NIDDK","DS-IBD-IRB --- Disease-Specific (Inflammatory Bowel Disease, IRB)","2013-08-12","2013-08-12","Colitis, Ulcerative; Inflammatory Bowel Diseases; Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type",""
"phs000505.v2.p1","Gene Fusion Discovery through RNA Sequencing of Human Glioblastoma Stem    Cell Lines","We used massively parallel, paired-end sequencing of expressed transcripts (RNA-seq) to detect novel gene fusions in short-term cultures of glioma stem-like cells freshly isolated from nine patients carrying primary glioblastoma  multiforme (GBM). The culture of primary GBM tumors under serum-free conditions selects cells that retain phenotypes and genotypes closely mirroring","Not Applicable","Glioblastoma","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 10 variables, 24 samples sequenced,  SRA, 24 subjects, 24 samples","","NCI","GRU-MDS --- General Research Use (MDS)","2013-07-31","2012-10-31","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000293.v1.p1","The Familial Intracranial Aneurysm Linkage Study (FIA)","Our long-term objective is to identify susceptibility genes that are related to the formation of intracranial aneurysms (IA). Rupture of IAs occurs in 16,000 to 17,000 persons in the U.S.  annually and nearly half of affected persons are dead within the first 30 days. An additional 6,000 to 7,000 persons with unruptured IAs are","Not Applicable","Intracranial Aneurysm","Family/Twin/Trios","linkage_panel","SNP Genotypes (Array)","5 phenotype datasets, 28 variables, 16 documents, 1 molecular datasets, 2507 subjects, 2073 samples","","NINDS","GRU --- General Research Use","2013-07-26","2014-07-26","Aortic Aneurysm, Abdominal; AAA; AAA - Abdominal aortic aneurysm; ABDOMINAL AORTIC ANEURYSM; ANEURYSM, ABDOMINAL AORTIC; Abdominal Aorta Aneurysm","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000614.v1.p1","Genomic Analysis of Pediatric Low Grade Gliomas","Pediatric low-grade gliomas (PLGGs) are among the most common solid tumors in children but, apart from mutations or duplications in the BRAF kinase in specific subclasses, few genetic driver events  are known. Diffuse PLGGs compose a set of uncommon subtypes that exhibit invasive growth and are therefore especially challenging clinically. These","Not Applicable","Astrocytoma","Tumor vs. Matched-Normal","HumanOmni2.5-8, WGS_markerset_grc37","SNP Genotypes (NGS), WGS","5 phenotype datasets, 17 variables, 1 molecular datasets, 2 samples sequenced,  SRA, 1 subjects, 2 samples","","NCI","DS-PBDPBC-NPU-MDS --- Disease-Specific (Pediatric Brain Disorders and Pediatric Brain Cancer, NPU, MDS)","2013-07-22","2013-07-22","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytoma (excluding glioblastoma); Astrocytomas",""
"phs000556.v1.p1","NHLBI GO-ESP: Family Studies (Atypical Cystic Fibrosis)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Cystic Fibrosis","Case-Control","WES_markerset_grc37","Not Provided","5 phenotype datasets, 25 variables, 1 molecular datasets, 6 samples sequenced,  SRA, 12 subjects","","NHLBI","DS-CF --- Disease-Specific (Cystic Fibrosis)","2013-07-10","2013-10-10","CF; CF - Cystic fibrosis; Fibrocystic disease; Fibrosis, Cystic; MUCOVISCIDOSIS; cystic fibrosis lung disease, modifier of",""
"phs000548.v1.p1","Aspirin Pharmacogenomics","The study protocol for both cohorts has been previously described (Journal of Thrombosis and Thrombolysis 2012:1-12). HV1 cohort: Briefly 50 healthy volunteers were exposed to two weeks of 325mg/day aspirin  after which whole blood RNA was collected in PAXgene tubes and profiled by microarray before and after aspirin exposure. The pre-aspirin samples were","Not Applicable","Aspirin","Interventional","Affymetrix_expression_array","mRNA Expression (Array)","5 phenotype datasets, 14 variables, 1 molecular datasets, 104 subjects, 201 samples","","NIGMS","ASP --- Aspirin-Related Research","2013-07-10","2014-07-10","Not Provided",""
"phs000546.v1.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ISGS)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Stroke","Case-Control","WES_markerset_grc37, WES_markerset_grc36","WXS, SNP Genotypes (NGS), SNP/CNV Genotypes (NGS)","4 phenotype datasets, 36 variables, 2 molecular datasets, 75 samples sequenced, 75 subjects, 75 samples","","NHLBI","DS-STK-IRB-RD --- Disease-Specific (Stroke, IRB, RD)","2013-07-10","2013-10-10","Brain Ischemia; Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy",""
"phs000347.v1.p1","NHLBI GO-ESP: Family Studies (Aortic Disease)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Aortic Diseases","Family/Twin/Trios","WES_markerset_grc37","WXS, SNP Genotypes (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets, 29 samples sequenced,  SRA, 29 subjects, 29 samples","","NHLBI","GRU-IRB --- General Research Use (IRB)","2013-07-10","2013-10-10","Aortic Disease; Disease of the aorta; Disease, Aortic; Diseases, Aortic; aorta disease; aorta disease or disorder",""
"phs000553.v1.p1","Familial Exome Sequencing in Rare Pediatric Phenotypes","To discover novel candidate genes associated with rare Mendelian phenotypes, we will conduct individual genomic and phenotypic characterization using genome-wide array, pedigree exome sequencing, candidate genotyping, and pertinent clinical testing  to define phenotype. Pedigrees included in this submission will have a variety of clinical pathological phenotypes. Probands in these studies will be","Not Applicable","Mendelian Randomization Analysis","Family/Twin/Trios","Affymetrix_WG_Array","SNP Genotypes (Array), WXS","5 phenotype datasets, 30 variables, 2 documents, 1 molecular datasets, 7 samples sequenced,  SRA, 6 subjects, 7 samples","","NHLBI","GRU-MDS --- General Research Use (MDS)","2013-06-27","2014-06-27","Microcephaly; Isolated Non-compaction of the Ventricular Myocardium; Isolated Noncompaction of the Ventricular Myocardium; Congenital Microcephalies, Severe; Congenital Microcephaly, Severe; Microcephalies, Severe Congenital","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000621.v1.p1","Genome Wide Association Studies in ECOG 2997 Trial","The ECOG 2997 trial was a randomized controlled trial for patients with previously untreated CLL comparing fludarabine monotherapy to the combination of fludarabine and cyclophosphamide. The initial clinical findings of  this study were published in the Journal of Clinical Oncology in 2007 (JCO 25:793-8). Additional laboratory studies have also published (JCO","Not Applicable","Leukemia, Lymphoid","Clinical Trial","HumanHap550","SNP Genotypes (Array)","4 phenotype datasets, 33 variables, 1 molecular datasets, 215 subjects, 215 samples","East Asian (1), Hispanic2 (1), European (177), African American (31), Hispanic1 (1), African (2), South Asian (2)","NCI","HMB-PUB-MDS --- Health/Medical/Biomedical (PUB, MDS)","2013-06-26","2013-06-26","Leukemia, Lymphocytic; Leukemias, Lymphocytic; Leukemias, Lymphoid; Lymphatic leukemia; Lymphocytic Leukemia; Lymphocytic Leukemias",""
"phs000609.v1.p1","RNA-Seq Studies of Gene Expression in Cells and Networks in FI and ACC in    Autism","RNA-Seq studies of Gene Expression in Cells and Networks in FI (fronto-insular) and AC (anterior cingulate) cortex in Autism. We seek to understand the cellular bases of autism by using  a new technology, RNA-Seq, to determine differences in gene expression in autopsy brains of subjects with well described autism versus age and sex","Not Applicable","Autistic Disorder","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 18 variables, 43 samples sequenced,  SRA, 27 subjects, 43 samples","","NIMH","GRU --- General Research Use","2013-06-20","2013-06-20","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile; Autism, Infantile","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NIH Autism -omics Studies (phs000764.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000549.v1.p1","Clonal Evolution of Pre-Leukemic HSC Precedes Human AML","Acute myeloid leukemia is an aggressive clonal malignancy of the bone marrow that is the direct result of sequential acquisition of mutations in a single lineage of cells. In this  study, we investigate a model in which this mutational acquisition occurs serially in long-lived self-renewing hematopoietic stem cells eventually","Not Applicable","Leukemia, Myeloid, Acute","Case Set","Not Provided","WXS","4 phenotype datasets, 16 variables, 12 samples sequenced,  SRA, 6 subjects, 12 samples","","NHLBI","DS-BD-MDS --- Disease-specific (Blood Disorders, MDS)","2013-06-13","2013-06-13","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs000580.v1.p1","PAGE: CALiCo: Strong Heart Study (SHS)","The SHS is a study of cardiovascular disease and its risk factors among American Indian men and women. Using standardized methodology, it was designed to estimate cardiovascular disease mortality and  morbidity and the prevalence of known and suspected cardiovascular disease risk factors and to assess the significance of these risk factors in a","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","2 analyses","","NHGRI","HMB --- Health/Medical/Biomedical","2013-06-12","","Coronary Disease; Gout; Kidney Disease; Myocardial Infarction; Adverse Cardiac Event; Adverse Cardiac Events","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000581.v1.p1","NHLBI GO-ESP: Family Studies (Dilated Cardiomyopathy)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Cardiomyopathy, Dilated","Case Set","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 23 variables, 1 molecular datasets, 48 samples sequenced,  SRA, 49 subjects, 48 samples","","NHLBI","DS-FDC --- Disease Specific (Familial Dilated Cardiomyopathy)","2013-06-11","2013-09-11","familial dilated cardiomyopathy; Idiopathic dilation cardiomyopathy; CARDIOMYOPATHY, FAMILIAL IDIOPATHIC; Cardiomyopathies, Familial Idiopathic; Cardiomyopathies, Idiopathic Dilated; Cardiomyopathy, Dilated, Autosomal Recessive","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000341.v2.p1","The Genetic Basis of Hypodiploid ALL","The genetic basis of hypodiploid acute lymphoblastic leukemia (ALL), a subtype of ALL characterized by aneuploidy and poor outcome, is unknown. Genomic profiling of 124 hypodiploid ALL cases, including whole-genome  and exome sequencing of 40 cases, identified two subtypes that differ in the severity of aneuploidy, transcriptional profiles and submicroscopic","Not Applicable","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Tumor vs. Matched-Normal","Affymetrix_WG_Array","SNP Genotypes (Array), RNA-Seq, WGS, WXS","5 phenotype datasets, 33 variables, 2 molecular datasets, 83 samples sequenced,  SRA, 241 subjects, 379 samples","Other (7), Hispanic2 (16), Other Asian or Pacific Islander (4), European (78), African American (15), Hispanic1 (4), South Asian (1)","NCI","GRU --- General Research Use","2013-06-11","2013-06-11","ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic; Leukemia, Lymphoblastic, Acute, L1","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000421.v1.p1","A Genome-Wide Association Study of Fuchs' Endothelial Corneal Dystrophy    (FECD)","Fuchs' Endothelial Corneal Dystrophy (FECD) is a common disease that results in loss of vision associated with progressive corneal edema and loss of corneal transparency. In the initial stages of  the disease, excrescences on Descemet's membrane with the appearance of an abnormal posterior collagenous layer, result in the clinical and","Not Applicable","Fuchs' Endothelial Dystrophy","Case-Control","HumanOmni2.5-4, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 89 variables, 2 molecular datasets, 4592 subjects, 4782 samples","Other (1), Hispanic2 (5), Other Asian or Pacific Islander (1), European (4576), African American (9)","NEI","FECD --- FECD Studies Only, GRU --- General Research Use, EDO --- Eye Disease Research Only","2013-05-31","2014-03-03","Dystrophy, Fuch's Endothelial; Dystrophy, Fuchs' Endothelial; Endoepithelial corneal dystrophy; Endothelial Dystrophy, Fuch's; Endothelial Dystrophy, Fuchs'; FCED",""
"phs000582.v1.p1","NHLBI GO-ESP: Family Studies (Familial Interstitial Pneumonia)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Idiopathic Pulmonary Fibrosis","Family/Twin/Trios","WES_markerset_grc37","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 18 variables, 1 molecular datasets, 12 samples sequenced,  SRA, 12 subjects, 12 samples","","NHLBI","DS-LD --- Disease Specific (Lung Diseases)","2013-05-16","2013-08-16","Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary; FIBROCYSTIC PULMONARY DYSPLASIA; FIBROSING ALVEOLITIS, CRYPTOGENIC; Fibrocystic Pulmonary Dysplasias",""
"phs000422.v1.p1","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Asthma","Case Set","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 27 variables, 2 molecular datasets, 191 samples sequenced,  SRA, 191 subjects, 191 samples","","NHLBI","GRU --- General Research Use","2013-05-16","2013-08-16","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000479.v1.p1","NHLBI Exome Sequencing in SCID","Analysis of the molecular etiologies of severe combined immunodeficiency (SCID) has led to important insights into the control of immune cell development. Most cases of SCID result from either X-linked  or autosomal recessive inheritance of mutations in a known causative gene. However, in some cases, the molecular etiology remains unclear. To","Not Applicable","Severe Combined Immunodeficiency","Family/Twin/Trios","Not Provided","WXS","6 phenotype datasets, 36 variables, 1 documents, 3 samples sequenced,  SRA, 3 subjects, 3 samples","","NHLBI","GRU --- General Research Use","2013-04-25","2014-04-25","Combined Immunodeficiencies, Severe; Combined Immunodeficiency, Severe; Combined T-cell and B-cell immunodeficiency; Immunodeficiencies, Severe Combined; Immunodeficiency Syndrome, Severe Combined; Immunodeficiency, Severe Combined","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000145.v4.p2","POPRES: Population Reference Sample","POPRES version 1 and 2 Technological and scientific advances, stemming in large part from the Human Genome and HapMap projects, have made large-scale, genome-wide investigations feasible and cost-effective. These advances  have the potential to dramatically impact drug discovery and development by identifying genetic factors that contribute to variation in disease risk","Not Applicable","Health","Case-Control","Affymetrix_500K, Affymetrix_WG_Array","SNP Genotypes (Array), SNP Genotypes (NGS)","6 phenotype datasets, 47 variables, 2 molecular datasets, 8012 subjects, 8012 samples","Other (15), East Asian (73), Hispanic2 (114), European (3175), African American (321), Hispanic1 (11), African (8), South Asian (360)","NHGRI","GRU --- General Research Use","2013-04-18","2012-10-22","Not Provided",""
"phs000092.v1.p1","Study of Addiction: Genetics and Environment (SAGE)","This study is part of the Gene Environment Association Studies initiative (GENEVA) funded by the National Human Genome Research Institute. The overarching goal is to identify novel genetic factors that  contribute to addiction through a large-scale genome-wide association study of DSM-IV alcohol dependent (and frequently illicit drug dependent) cases","Not Applicable","Alcoholism","Case-Control","Human1M-Duo, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 140 variables, 108 documents, 3 analyses, 2 molecular datasets, 4121 subjects, 8485 samples","Other (17), East Asian (1), Hispanic2 (57), Other Asian or Pacific Islander (3), European (2671), African American (1324), Hispanic1 (39), African (9)","NHGRI","HR --- Health Research, ARC --- Alcoholism and Related Conditions","2013-04-12","2009-09-23","Alcohol Dependence; Drug Dependence; Nicotine Dependence; ALCOHOL DEPENDENCE, PROTECTION AGAINST; Addiction, Alcohol; Addictive alcohol use","dbGaP Collection: Psychiatric Genomics Consortium (PGC) dbGaP Datasets (phs001254.v1.p1)"
"phs000573.v1.p1","Genetic Heterogeneity of Diffuse Large B Cell Lymphoma","We sequenced exomes of 94 DLBCL tumors and cell lines. 34 of the tumors had paired normal tissue. Our work elucidates commonly occurring gene-coding mutations in DLBCL. Principal Investigator: Sandeep  Dave, MD, Duke University, Durham, NC, USA Funding Source: R21CA156168, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA","Not Applicable","Lymphoma, Large B-Cell, Diffuse","Case-Control","target_markerset_grc36","SNP Genotypes (NGS), WXS","5 phenotype datasets, 16 variables, 1 molecular datasets, 128 samples sequenced,  SRA, 94 subjects, 128 samples","","NCI","GRU --- General Research Use","2013-04-02","2013-04-02","Lymphoma, Non-Hodgkin; Centroblastic diffuse large B-cell malignant lymphoma; Centroblastic diffuse malignant lymphoma; Centroblastic malignant lymphoma; DLBCL; DLBCL - diffuse large B cell lymphoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000525.v1.p1","Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers","In this study, we describe a systematic analysis of pseudogene 'transcription' from an RNA-Seq resource of 293 samples, from 13 cancer and normal tissue types. We observed a highly prevalent,  genome-wide expression of pseudogenes that could be categorized as universally expressed or lineage- and/or cancer-specific. We also explored disease","Not Applicable","Neoplasms","Cross-Sectional","Not Provided","RNA-Seq","3 phenotype datasets, 15 variables, 293 samples sequenced,  SRA, 293 subjects, 293 samples","","NCI","CRGM --- Cancer Research and General Methods","2013-03-29","2013-03-29","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs000541.v1.p1","Next Generation Mendelian Genetics: Muscle Hypertrophy","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. Samples were collected from a single, multi-generational family with the same phenotype of  exaggerated muscular development (muscular hypertrophy) and strength characterized by reduced fat pad thickness under the skin. All family members","Not Applicable","Hypertrophy","Mendelian","WES_markerset_grc37, target_markerset_grc37","SNP Genotypes (Array), SNP Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 4 samples sequenced,  SRA, 7 subjects, 7 samples","","NHGRI","MDD --- Muscle Development Disorders","2013-03-28","2013-03-28","",""
"phs000339.v2.p1","MitoExome Sequencing of Mitochondrial OXPHOS Diseases (MGH)","Human disorders of mitochondrial oxidative phosphorylation (OXPHOS) represent a devastating collection of inherited diseases. These disorders impact at least 1:5000 live births, and are characterized by multi-organ system involvement. They  are characterized by remarkable locus heterogeneity, with mutations in the mtDNA as well as in over 77 nuclear genes identified to date. It is","Not Applicable","Mitochondrial Diseases","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 1 molecular datasets, 134 samples sequenced,  SRA, 134 subjects, 134 samples","","NHGRI","GRU --- General Research Use (NPU)","2013-03-28","2012-08-31","Depletion of mitochondrial deoxyribonucleic acid; Mitochondrial DNA Depletion Syndromes; Mitochondrial DNA depletions; mitochondrial DNA depletion; mtDNA depletion syndrome",""
"phs000327.v1.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (SWISS)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Stroke","Family/Twin/Trios","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (NGS), WXS","5 phenotype datasets, 44 variables, 2 molecular datasets, 94 samples sequenced,  SRA, 94 subjects, 94 samples","","NHLBI","DS-STK-IRB-RD --- Disease Specific (Stroke and Related Disorders)","2013-03-25","2013-06-25","Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents; CEREBROVASCULAR ACCIDENT; CVA",""
"phs000493.v1.p1","Genetic Association Studies in the Solomon Islanders","The goal of this study was to determine the genetics underlying blond hair in the Solomon Islands, which has the highest prevalence of blondism outside of Europe. Participants in the  study were of self-reported Solomon Islands ancestry and were 6-36 years of age at enrollment. Individuals with blond (N 43) and dark hair (N 42)","Not Applicable","Hair","Case-Control","Not Provided","Not Provided","1 analyses","","NHGRI","NPR --- Non-profit Research","2013-02-22","","Not Provided",""
"phs000430.v1.p1","Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)","Reprinted from http://www.haltctrial.org/ Purpose The Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial is a randomized controlled trial designed to evaluate the safety and efficacy of long-term use of  pegylated interferon for the treatment of chronic hepatitis C in patients who failed to respond to previous interferon therapy. The HALT-C Trial was","Not Applicable","Hepatitis C","Clinical Trial","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 47 variables, 1 molecular datasets, 966 subjects, 966 samples","Other (5), East Asian (14), Hispanic2 (70), Other Asian or Pacific Islander (2), European (710), African American (137), Hispanic1 (19), African (3), South Asian (6)","NIMH","GRU --- General Research Use","2013-02-12","2014-02-12","Liver Cirrhosis; Liver Disease; HCV Infection; Hepatitis C Virus Infection; Hepatitis C virus caused hepatitis; Hepatitis C virus hepatitis","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000500.v1.p1","Non-Invasive Whole Genome Sequencing of a Human Fetus","The overall purpose of this study was to demonstrate the feasibility of producing haplotype-phased whole genome sequence data from a fetus using free fetal DNA isolated from maternal plasma collected  during the first half of gestation. Trios: Maternal plasma sample, from pregnancy of male fetus, collected during first trimester. Paternal and","Not Applicable","Prenatal Care","Family/Twin/Trios","Not Provided","POOLCLONE, WGS","4 phenotype datasets, 19 variables, 8 samples sequenced,  SRA, 6 subjects, 8 samples","","NHGRI","GRU --- General Research Use","2013-01-30","2013-01-30","Not Provided",""
"phs000562.v1.p1","The Genetic Landscape of Mutations in Burkitt Lymphoma","Burkitt lymphoma (BL) is characterized by deregulation of MYC, but the contribution of other genetic mutations to the disease is largely unknown. We sequenced exomes of 59 BL tumors, 14  of which had paired normal tissue. Our work elucidates commonly occurring gene-coding mutations in Burkitt lymphoma and implicates ID3 as a novel","Not Applicable","Burkitt Lymphoma","Tumor vs. Matched-Normal","Not Provided","WXS","4 phenotype datasets, 14 variables, 72 samples sequenced,  SRA, 59 subjects, 72 samples","","NCI","GRU --- General Research Use","2013-01-29","2013-01-29","Lymphoma, Non-Hodgkin; BL; BL - Burkitt's lymphoma; Burkitt Tumor; Burkitt lymphoma/leukemia; Burkitt's Lymphoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000550.v1.p1","Characterization of Pancreatic Adenocarcinoma Patients Using NGS","In this study, we whole genome sequenced tumor/normal pairs from three pancreatic adenocarcinoma patients to separately characterize each patient with respect to somatic alterations. For 2 patients for whom tumor  RNA was available, we also performed RNA sequencing to evaluate gene expression changes. While additional sequencing is needed to improve our","Not Applicable","Pancreatic Neoplasms","Case Set","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 19 variables, 9 samples sequenced,  SRA, 4 subjects, 9 samples","","NCI","GRU --- General Research Use","2013-01-29","2013-01-29","Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant; Epithelioma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000522.v1.p1","Hyperdiploid Acute Lymphoblastic Leukemia RNA-Seq","Few genetic drivers of children with hyperdiploid precursor B-cell acute lymphoblastic leukemia (ALL) have been identified to date. In an effort to detect novel genomic rearrangements that could be promoting  leukemogenesis in this subset of patients, we sequenced ribosomal RNA-depleted transcriptomes isolated from 5 hyperdiploid acute lymphoblastic","Not Applicable","Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","Case Set","Not Provided","RNA-Seq","3 phenotype datasets, 10 variables, 5 samples sequenced,  SRA, 5 subjects, 5 samples","","NCI","PCRGM --- Pediatric Cancer Research and General Methods","2013-01-16","2014-01-16","Leukemia, Pre B Cell; Leukemia, Pre-B-Cell; Leukemias, Pre-B-Cell; Pre B ALL; Pre B Cell Leukemia; Pre B-ALL",""
"phs000567.v1.p1","NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative    Sequencing","Transcriptome sequencing of solitary fibrous tumors / hemangiopericytomas from a variety of anatomic sites revealed recurrent gene fusions between two genes, NAB2 and STAT6. All SFTs examined exhibited an in-frame  fusion transcript encoding a fusion protein containing the EGR1 interaction domain of NAB2 with the transcriptional activation domain of STAT6.","Not Applicable","Solitary Fibrous Tumors","Case Set","Not Provided","RNA-Seq","4 phenotype datasets, 20 variables, 26 samples sequenced,  SRA, 26 subjects, 26 samples","","NCI","CRM --- Cancer Research and Methods","2013-01-11","2014-01-11","Neoplasms, Connective and Soft Tissue",""
"phs000568.v1.p1","Genomic Sequencing of Solitary Fibrous Tumors","Solitary fibrous tumors (SFTs) are rare mesenchymal tumors that can be benign or malignant. In this study, we sequenced and analyzed the exomes of 17 SFT matched tumor and normal  pairs. This study appertains to a large endeavor to characterize cancers as part of the Slim Initiative for Genomic Medicine in the Americas (SIGMA)","Not Applicable","Sarcoma","Case Set","WES_markerset_grc36","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 23 variables, 1 molecular datasets, 34 samples sequenced,  SRA, 17 subjects, 34 samples","","NCI","GRU --- General Research Use","2013-01-10","2013-01-10","Solitary Fibrous Tumors; Sarcoma, Spindle Cell; Sarcomas, Spindle Cell; Spindle Cell Sarcomas; spindle cell sarcoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000547.v1.p1","A Genome-Wide Association Study in Breast Cancer Patients from the    SUCCESS Trial","The SUCCESS-A Study (http://www.success-studie.de) is a randomized Phase III study of response to treatment of early primary breast cancer with adjuvant therapy after surgical resection. The primary outcome is disease-free  survival and secondary outcomes are overall survival and toxicity. The study design includes comparison of two pairs of treatment regimes performed","Not Applicable","Breast Neoplasms","Interventional","HumanOmniExpress-12, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 41 variables, 4 documents, 2 molecular datasets, 3596 subjects, 3440 samples","Other (22), East Asian (5), Hispanic2 (4), Other Asian or Pacific Islander (3), European (3274), African American (2), Hispanic1 (11), South Asian (1)","NHGRI","BCETC --- Breast cancer, study drug efficacy and toxicity, and covariates","2012-12-19","2013-12-19","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000565.v1.p1","Copy Number Variation in Congenital Kidney Malformations","We report a study of large rare, copy number variants (CNVs) in 192 patients with renal hypodysplasia (RHD). Congenital malformations of the kidney and urinary tract are present in 3  to 7 per 1,000 births, accounting for 16% of birth defects. These malformations account for 40-50% of pediatric and 7% of adult end-stage renal","Not Applicable","Congenital Abnormalities","Case Set","Human660W-Quad, Human610-Quad","CNV Genotypes","4 phenotype datasets, 12 variables, 1 molecular datasets, 192 subjects, 192 samples","","NIDDK","GRU --- General Research Use","2012-12-14","2012-12-14","Chromosome Disorders; Kidney Diseases; Urologic Diseases; Anomaly of chromosome; Chromosomal Disorder; Chromosomal Disorders",""
"phs000383.v1.p1","GWAS of Breast Cancer in the African Diaspora","The paucity of data on the genetic epidemiology of breast cancer for racial/ethnic groups other than those of European ancestry hinders the development of innovative interventions to reduce health disparities.  Women in the African Diaspora experience a disproportionate burden of pre-menopausal breast cancer in comparison to all other races for reasons that","Not Applicable","Breast Neoplasms","Case-Control","HumanOmni2.5-8, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 34 variables, 2 molecular datasets, 3766 subjects, 4001 samples","Other (7), Other Asian or Pacific Islander (1), European (20), African American (2234), Hispanic1 (21), African (1481), South Asian (2)","NCI","HRGM --- Health Research and General Methods","2012-12-14","2013-12-14","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000391.v1.p1","Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study","CHD is the leading cause of death in the United States. One of the most common ways to prevent CHD is to take an anti-platelet agent, which lessens platelet aggregation.  Two of the most common anti-platelet agents are aspirin and clopidogrel. However, up to 25% to 30% of people do not respond to these medications.","Not Applicable","Blood Platelets","Interventional","Not Provided","Not Provided","3 phenotype datasets, 36 variables, 19 documents, 15 analyses, 666 subjects, 666 samples","","NHLBI","GRU --- General Research Use","2012-12-11","2013-12-11","Not Provided","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000539.v1.p1","Next Generation Mendelian Genetics: Congenital Hyperinsulinism","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. Congenital Hyperinsulinism (CHI) is the most common cause of hypoglycemia in the newborn  and it is due to mutations in 8 different genes (ABCC8, KCNJ11, GLUD1, GCK, HADH, SLC16A1, HNF4A and UCP2). It is a heterogeneous disease with","Not Applicable","Congenital Hyperinsulinism","Mendelian","target_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 8 samples sequenced,  SRA, 8 subjects, 8 samples","","NHGRI","GRU --- General Research Use","2012-12-04","2012-12-04","Hyperinsulinism, Congenital; Persistent Hyperinsulinemia Hypoglycemia of Infancy; ABCC8 hyperinsulinemic hypoglycemia (disease); ABCC8-Related Hyperinsulinism; Familial Hyperinsulinemic Hypoglycemia 1; HHF1",""
"phs000540.v1.p1","Next Generation Mendelian Genetics: Ehlers-Danlos Syndrome Type VIII","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. Ehlers-Danlos syndrome Type VIII is a dominantly inherited connective tissue disorder that is  distinguished from other forms of EDS by significant early-onset periodontal disease. Although the clinical phenotype is well delineated, the","Not Applicable","Ehlers-Danlos Syndrome","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 21 variables, 1 molecular datasets, 8 samples sequenced,  SRA, 8 subjects, 8 samples","","NHGRI","DCT --- Disorders of Connective Tissues","2012-11-30","2012-11-30","Cutis Elastica; Cutis hyperelastica; Cutis hyperelastica dermatorrhexis; Danlos Disease, Ehlers; Danlos disease; Disease, Ehlers Danlos",""
"phs000542.v1.p1","Next Generation Mendelian Genetics: Neonatal Diabetes","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. Neonatal diabetes mellitus (ND) is a rare form of monogenic diabetes (90,000-260,000 live  births) that is diagnosed in the first 6 months of life. The disease has been classified as transient or permanent and although it can be inherited,","Not Applicable","Pancreatic beta cell agenesis with neonatal diabetes mellitus","Mendelian","target_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 4 samples sequenced,  SRA, 4 subjects, 4 samples","","NHGRI","GRU --- General Research Use","2012-11-28","2012-11-28","Congenital absence of insulin-producing beta cells with diabetes mellitus; diabetes mellitus, insulin-dependent, neonatal",""
"phs000538.v1.p1","Next Generation Mendelian Genetics: Familial Combined Hyperlipidemia","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. The research study procedures included the collection of a fasting blood sample, 2  medical history/life style questionnaires and a measurement of subjects' waist circumference that were completed many years ago. Blood samples were","Not Applicable","Hyperlipidemia, Familial Combined","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 6 samples sequenced,  SRA, 6 subjects, 6 samples","","NHGRI","HD --- Heart Disease","2012-11-28","2012-11-28","Combined Hyperlipidemia, Familial; Combined Hyperlipidemias, Familial; FAMILIAL COMBINED HYPERLIPIDEMIA; FCHL; FCHL3; Familial Combined Hyperlipidemias",""
"phs000537.v1.p1","Next Generation Mendelian Genetics: Familial Hemophagocytic    Lymphohistiocytosis","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. Familial hemophagocytic lymphohistiocytosis (fHLH) is a serious immune disorder that results from defective  cytotoxic lymphocyte function. Autosomal recessive mutations in PFP1, UNC13D, STX11, STBP2, or RAB27, and hemizygous mutations in SH2D1A or BIRC4,","Not Applicable","Lymphohistiocytosis, Hemophagocytic","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 18 variables, 1 molecular datasets, 4 samples sequenced,  SRA, 4 subjects, 4 samples","","NHGRI","GRU --- General Research Use","2012-11-26","2012-11-26","Hemophagocytic Syndrome, Infection Associated; Hemophagocytic Syndrome, Infection-Associated; Hemophagocytic Syndrome, Reactive; Hemophagocytic syndrome due to infection; IAHS; Infection-Associated Hemophagocytic Syndrome",""
"phs000413.v2.p1","Transcriptome Sequencing of Pediatric AML FAB-M7","High resolution analysis of DNA copy number abnormalities and loss-of-heterozygosity on acute myeloblastic leukemia samples utilizing SNP arrays has demonstrated that in contrast to pediatric ALL, de novo AML is  characterized by a very low burden of genomic alterations (Radtke, et al., PNAS, 2009). Samples for this study represented a cross-section of the","Not Applicable","Leukemia, Megakaryoblastic, Acute","Case Set","Not Provided","SNP Genotypes (Array), RNA-Seq, WGS, WXS","5 phenotype datasets, 32 variables, 1 molecular datasets, 47 samples sequenced,  SRA, 15 subjects, 85 samples","","NCI","GRU --- General Research Use","2012-11-20","2013-08-20","AMKL; AML M7; AMegL; Acute M7 Myeloid Leukemia; Acute Megakaryoblastic Leukemia (FAB Type M7); Acute Megakaryoblastic Leukemias","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000405.v1.p1","Next Generation Mendelian Genetics: Malignant Hyperthermia","Malignant hyperthermia (MH) is a genetic disorder that causes a profound metabolic derangement following exposure to certain anesthetics. While approximately half of all cases are associated with ryanodine receptor-1 gene  (RYR1) mutations, many cases have an unknown genetic cause. We sought to identify rare variants in novel MH candidate genes by sequencing the","Not Applicable","Malignant Hyperthermia","Case Set","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 18 variables, 1 molecular datasets, 13 samples sequenced,  SRA, 13 subjects, 13 samples","","NHGRI","GRU --- General Research Use","2012-11-20","2012-11-20","Anesthesia Hyperthermia; Anesthesia Related Hyperthermia; Anesthesic-triggered malignant hyperthermia; HYPERTHERMIA OF ANESTHESIA; Hyperpyrexia, Malignant; Hyperthermia, Anesthesia Related",""
"phs000551.v1.p1","Gene expression in CAD","Case control cohort: The details have been previously published: American Heart Journal. 2010;160:371-379 e372. Briefly, a nested case:control cohort of CATHGEN participants who had experienced death or MI (n 250)  after their index catheterization and age-, sex-, and race-matched controls (n 250) who were free of death/MI 2 years after cardiac catheterization","Not Applicable","Cardiovascular Diseases","Case-Control","Affymetrix_expression_array","mRNA Expression (Array)","4 phenotype datasets, 22 variables, 1 molecular datasets, 594 subjects, 638 samples","","NIGMS","DS-CVD-IRB --- Disease-Specific (Cardiovascular Disease, IRB)","2012-11-19","2013-05-19","Myocardial Infarction; Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events",""
"phs000561.v1.p1","Metabolism and Genetics of Hypobetalipoproteinemia","Hypobetalipoproteinemia is characterized by extremely low levels of low-density lipoprotein cholesterol. Familial hypobetalipoproteinemia (FHBL) is a monogenic form of hypobetalipoproteinemia caused by mutations in the APOB gene. There are cases  of hypobetalipoproteinemia not caused by mutations in APOB, however. The purpose of this study is to identify novel genetic causes of","Not Applicable","Hypobetalipoproteinemias","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 11 samples sequenced,  SRA, 11 subjects, 11 samples","","NHGRI","HPBLM --- Metabolism and Genetics of Hypobetalipoproteinemia: Population Screen","2012-11-14","2012-11-14","FHBL; Familial Hypobetalipoproteinemia; HYPOBETALIPOPROTEINEMIA, FAMILIAL; Hypo beta Lipoproteinemia; Hypo beta Lipoproteinemias; Hypobetalipoproteinemia",""
"phs000535.v1.p1","Genome and Targeted Sequencing of Bladder Cancer","One primary bladder cancer and paired peripheral blood sample were subjected to whole genome sequencing on an Illumina HiSeq 2000 platform. This technology was utilized to investigate the genetic basis  of a durable remission of metastatic bladder cancer in a patient treated with everolimus, a drug that inhibits the mTOR (mammalian target of","Not Applicable","Urinary Bladder Neoplasms","Clinical Trial","Not Provided","OTHER, WGS","4 phenotype datasets, 18 variables, 16 samples sequenced,  SRA, 14 subjects, 16 samples","","NCI","GRU --- General Research Use","2012-11-02","2012-11-02","Bladder Cancer; Bladder Cancers; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder; Cancer, Urinary Bladder","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000514.v1.p1","Identification of Genes Involved in Familial Coronary Artery Disease","Studying families with multiple cases of coronary artery disease (CAD) or with early onset CAD in order to identify new genes involved in CAD in an autosomal dominant manner. After  identifying these genes in families that pass on CAD in Mendelian inheritance, we want to pursue their role in the pathogenesis of CAD and their","Not Applicable","Coronary Artery Disease","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 19 samples sequenced,  SRA, 19 subjects, 19 samples","","NHGRI","GRU --- General Research Use","2012-10-25","2012-10-25","Atherosclerosis; Heart Diseases; Atherogeneses; Atherogenesis; Arterioscleroses, Coronary; Arteriosclerosis, Coronary",""
"phs000512.v1.p1","Genetics of High HDL Cholesterol","We have assembled what we believe to be the largest cohort in the world ascertained specifically based on the phenotypes of extremely low or high HDL-Cholesterol (HDL-C). Several years ago,  we initiated a protocol at the University of Pennsylvania to recruit subjects with extremely low or high levels of HDL-C with the primary goal of","Not Applicable","Lipoproteins, HDL","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 97 samples sequenced,  SRA, 97 subjects, 97 samples","","NHGRI","CD --- Cardiovascular Disease","2012-10-19","2012-10-19","Hyperlipidemias; Hypoalphalipoproteinemias; Elevated lipids in blood; HLD - Hyperlipidemia; Hyperlipemia; Hyperlipemias",""
"phs000445.v1.p1","HIV-Resistant People with Hemophilia","Rare individuals are highly resistant to infection with human immunodeficiency virus (HIV). Studies of candidate genes resulted in the discovery of a 32bp deletion in the CC-chemokine receptor 5 gene  (CCR5&#x00394;32), which rendered this critical co-receptor for primary HIV infection to be non-functional. Pharmacologic and vaccine-induced","Not Applicable","HIV","Case-Control","Not Provided","OTHER, WGS","4 phenotype datasets, 14 variables, 11 samples sequenced,  SRA, 20 subjects, 21 samples","","NCI","HVI --- Hemophilia and Viral Infections","2012-10-16","2012-10-16","Hemophilia A; AHG deficiency disease; AUTOSOMAL HEMOPHILIA A; Classic Hemophilia; Classic Hemophilias; Classical hemophilia",""
"phs000518.v1.p1","NHLBI GO-ESP Family Studies: Idiopathic Bronchiectasis","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Bronchiectasis","Prospective Longitudinal Cohort","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 1 molecular datasets, 24 samples sequenced,  SRA, 24 subjects, 24 samples","","NHLBI","GRU --- General Research Use","2012-10-12","2013-01-12","Bronchiectases; Permanent enlargement of the airways of the lungs; Polynesian bronchiectasis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000491.v1.p1","Whole-Genome and Exome Sequencing in Clear-Cell Renal Cell Carcinoma","Study to evaluate the molecular genetics of ccRCC through integrative analyses of tumors and tumorgrafts using multiple platforms in clinically annotated samples. Genome and exome data for patients giving consent  to have the information available on a public, secure, database is being submitted. Principal Investigator: James Brugarolas, MD, PhD, UT","Not Applicable","Carcinoma, Renal Cell","Case-Control","Not Provided","WXS","5 phenotype datasets, 30 variables, 5 samples sequenced,  SRA, 3 subjects, 7 samples","","NCI","GRU --- General Research Use","2012-10-05","2013-01-05","Urogenital Neoplasms; Urologic Diseases; ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000490.v1.p1","A Study of the Genetic Causes of Complex Pediatric Disorders","The Center for Applied Genomics (CAG) at the Children's Hospital of Philadelphia (CHOP) is a high-throughput, highly automated genotyping and sequencing facility equipped with state-of-the-art genotyping and sequencing platforms. Children  who are treated at the Children's Hospital Healthcare Network and their parents may be eligible to take part in a major initiative to collect more","Not Applicable","Child Health","Case-Control","HumanHap550, Human610-Quad","SNP Genotypes (Array)","9 phenotype datasets, 174 variables, 1 molecular datasets, 7431 subjects, 7430 samples","Other (94), East Asian (93), Hispanic2 (68), Other Asian or Pacific Islander (63), European (3322), African American (2862), Hispanic1 (198), African (47), South Asian (45)","NHGRI","GRU --- General Research Use","2012-10-02","2013-10-02","Asthma; Attention Deficit Disorder with Hyperactivity; Dermatitis, Atopic; Gastroesophageal Reflux; Airway hyperreactivity; Asthma, Bronchial",""
"phs000275.v1.p1","BWH MS Genetic Collection","The main objective of this GWA study is to identify Multiple Sclerosis (MS) susceptibility loci. Whole-genome association analysis was performed on 924 individuals genotyped on the Affymetrix 6.0 Genechip. The  cohort consisted of 860 clinically diagnosed MS patients and 64 control subjects. Diagnosis of multiple sclerosis (McDonald criteria), age 18.","Not Applicable","Multiple Sclerosis","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","3 phenotype datasets, 13 variables, 1 molecular datasets, 924 subjects, 924 samples","","NINDS","MSRD --- MS and Related Disorders","2012-10-02","2013-10-02","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple",""
"phs000511.v1.p1","Treatment of Genetic Screening of Hypertriglyceridemia type I, III, and V    - HTG Amsterdam","This is a cohort of patients with extreme hypertriglyceridemia. Patients have been screened for loss of function mutations in LPL, GPIHBP1, APOC2, APOA5 and LMF1. Inclusion: See Surendran RP et  al., J Inte Med, 2012 TG 10 mmol/l Exclusion: ApoE2E2 Alcohol abuse Uncontrolled diabetes Principal Investigator: E.S.G.Stroes, Prof. Dr, AMC,","Not Applicable","Hypertriglyceridemia","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 48 samples sequenced,  SRA, 48 subjects, 48 samples","","NHGRI","HTG --- Hypertriglyceridemia type I, III, and V","2012-10-01","2012-10-01","Not Provided",""
"phs000125.v1.p1","CIDR: Collaborative Study on the Genetics of Alcoholism (COGA)","This is a case-control study of alcoholism, in which the subjects have been drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), a large, ongoing family-based study that  includes subjects from seven sites around the US. COGA has gathered detailed, standardized data on study participants, including diagnostic and","Not Applicable","Alcoholism","Case-Control","Human1M-Duo","SNP Genotypes (Array)","5 phenotype datasets, 428 variables, 49 documents, 3 analyses, 1 molecular datasets, 1945 subjects, 1957 samples","Other (14), East Asian (4), Hispanic2 (63), Other Asian or Pacific Islander (8), European (1295), African American (473), Hispanic1 (39), African (13), South Asian (4)","NIAAA","HR --- Health Research, ARC --- Alcoholism and Related Conditions","2012-09-27","2009-10-06","ALCOHOL DEPENDENCE, PROTECTION AGAINST; Addiction, Alcohol; Addictive alcohol use; Alcohol Addiction; Alcohol Dependence; Alcohol dependence syndrome",""
"phs000297.v1.p1","eMERGE Network Study of Resistant Hypertension","The electronic Medical Records and Genomics (eMERGE) Network is a consortium of five participating sites (Group Health Seattle, Marshfield Clinic, Mayo Clinic, Northwestern University, and Vanderbilt University) funded by the  NHGRI to investigate the use of electronic medical record systems for genomic research. The goal of eMERGE is to conduct genome-wide association","Not Applicable","Hypertension","Case-Control","Human1M-Duo, Human660W-Quad","SNP Genotypes (Array)","4 phenotype datasets, 29 variables, 1 molecular datasets, 5281 subjects, 5491 samples","Other (7), East Asian (19), Hispanic2 (24), Other Asian or Pacific Islander (9), European (4097), African American (1057), Hispanic1 (25), African (26), South Asian (8)","NHGRI","HR_GHS --- Health Research - Northwestern U, AGING_GHS --- Dementia or Aging - Group Health Seattle, HR_MC --- Health Research - Marshfield Clinic, HR_VU --- Health Research - Northwestern U, HR_MYO --- Health Research - Northwestern U, HR_NWU --- Health Research - Northwestern U","2012-09-26","2013-09-26","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; HBP - High blood pressure",""
"phs000523.v1.p1","Cebu Longitudinal Health and Nutrition Survey (CLHNS)","Conducted by a team of researchers from the United States and the Philippines, the Cebu Longitudinal Health and Nutrition Survey is part of an ongoing study of a cohort of  Filipino women who gave birth between May 1, 1983, and April 30, 1984. The cohort of children born during that period, their mothers, other","Not Applicable","Maternal Nutritional Physiological Phenomena","Prospective Longitudinal Cohort","Affymetrix_WG_Array","SNP Genotypes (Array)","3 phenotype datasets, 29 variables, 1 molecular datasets, 1799 subjects, 1799 samples","","NIDDK","GRU --- General Research Use","2012-09-17","2012-09-17","Not Provided",""
"phs000513.v1.p1","MAST Kinase and Notch Gene Families in Breast Cancer","Paired-end transcriptome sequencing was performed on a panel of breast cancer cell lines and tissues and a set of benign cell line and tissue controls. Analyses of the paired end  sequences were performed and chimeric transcripts derived from gene rearrangement events were identified. Sequencing was performed on Illumina GAII","Not Applicable","Breast Neoplasms","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 19 variables, 89 samples sequenced,  SRA, 89 subjects, 89 samples","","NCI","CRGM --- Cancer Research and General Methods","2012-09-14","2012-09-14","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000506.v1.p1","NIAID Multicenter AIDS Cohort Study (MACS)","The Multicenter AIDS Cohort Study (MACS) is an ongoing prospective study of the natural and treated histories of HIV-1 infection in homosexual and bisexual men conducted by sites located in  Baltimore, Chicago, Pittsburgh and Los Angeles. A total of 6,972 men have been enrolled. From April 1984 through March 1985, 4954 men were enrolled;","Not Applicable","Acquired Immunodeficiency Syndrome","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","NIAID","","2012-09-13","","AIDS-Related Opportunistic Infections; HIV Infections; AIDS Related Opportunistic Infections; AIDS, Opportunistic Infection; AIDS-Related Opportunistic Infection; HIV Related Opportunistic Infections",""
"phs000451.v1.p1","NHLBI and NIA The New England Centenarian Study (NECS)","Supercentenarians (age 110+ years old) generally delay or escape age-related diseases and disability well beyond the age one hundred and this exceptional survival is likely to be influenced by a  genetic predisposition that includes both common and rare genetic variants. In this report, we describe the complete genomic sequences of male and","Not Applicable","Centenarians","Case-Control","WGS_markerset_grc36","CNV Genotypes, SNP Genotypes (NGS), WGS","3 phenotype datasets, 12 variables, 1 molecular datasets, 2 samples sequenced,  SRA, 2 subjects, 2 samples","","NIA","GRU --- General Research Use","2012-09-13","2012-09-13","Aging; Aging, Biological; Biological Aging",""
"phs000434.v1.p1","Next Generation Mendelian Genetics: Atypical Werner Syndrome","Werner syndrome (WS) is an adult-onset progeroid syndrome characterized by accelerated aging. The International Registry of Werner Syndrome in the Department of Pathology, University of Washington, collects WS cases from  all over the world. Classical WS is caused by WRN mutations. Those who do not carry WRN are categorized as ""atypical Werner syndrome."" A small subset","Not Applicable","Werner Syndrome","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets, 8 samples sequenced,  SRA, 8 subjects, 8 samples","","NHGRI","AAS --- Accelerated Aging Syndromes","2012-09-12","2012-09-12","Adult Premature Aging Syndrome; Adult Progeria; Pangeria; Progeria of the adult; Progeria, Adult; Syndrome, Werner",""
"phs000482.v1.p1","Sporadic Autism Exomes Reveal a Highly Interconnected Protein Network of    De Novo Mutations","It is well established that autism spectrum disorders (ASD) have a strong genetic component; however, for at least 70% of cases, the underlying genetic cause is unknown. Under the hypothesis  that de novo mutations underlie a substantial fraction of the risk for developing ASD in families with no previous history of ASD or related","Not Applicable","Autistic Disorder","Family/Twin/Trios","Not Provided","WXS","4 phenotype datasets, 19 variables, 616 samples sequenced,  SRA, 617 subjects, 617 samples","","NIMH","DS-ASD-RD --- Disease-Specific (Autism Spectrum Disorder, RD)","2012-09-07","2012-09-07","Child Development Disorders, Pervasive; AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism, Early Infantile","dbGaP Collection: NIH Autism -omics Studies (phs000764.v1.p1)"
"phs000439.v1.p1","PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation","The goal of this study was to identify genetic predictors of response to rate control therapy in patients with AF. We conducted a genome-wide association study (GWAS) focusing on subjects  with a history of atrial fibrillation. Rate control therapy for AF uses a range of drugs (beta-adrenergic receptor blockers, calcium channel","Not Applicable","Atrial Fibrillation","Case-Control","Human610-Quad","SNP Genotypes (Array)","3 phenotype datasets, 17 variables, 1 molecular datasets, 1888 subjects, 1888 samples","Other (2), East Asian (3), Hispanic2 (9), Other Asian or Pacific Islander (3), European (1743), African American (110), Hispanic1 (10), African (5), South Asian (3)","NHLBI","HMB --- Health/Medical/Biomedical","2012-09-05","2013-09-05","A-fib; AF; AF - Atrial fibrillation; AFib; Atrial Fibrillations; Auricular Fibrillation","dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000448.v1.p1","Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort","Schizophrenia is characterized by high heritability ( 80%), yet the identification of susceptibility genes has proven extremely challenging. The Ashkenazi Jewish population, derived from a limited number of founders, may  be enriched for a subset of susceptibility alleles, which may also have higher odds ratios than those detected by previous studies. GWAS was","Not Applicable","Schizophrenia","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 documents, 1 molecular datasets, 3096 subjects, 3096 samples","Other (18), Hispanic2 (10), European (3063), Hispanic1 (4), South Asian (1)","NIMH","GRU --- General Research Use","2012-09-04","2013-09-04","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder","dbGaP Collection: Open Translational Science in Schizophrenia (OPTICS) (phs000887.v1.p1); Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000359.v1.p1","KIF1A Hereditary Spastic Paraparesis","The study involves a single consanguineous Palestinian family with Hereditary Spastic Paraparesis (HSP). The affected individuals suffer from spasticity of the lower limbs and abnormal gait. Using exome sequencing and  homozygosity mapping, our analysis implicated the causative mutation in the motor domain of KIF1A, a gene that functions in anterograde axonal","Not Applicable","Spastic Paraplegia, Hereditary","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array), CLONEEND, WXS","3 phenotype datasets, 8 variables, 1 molecular datasets, 4 samples sequenced,  SRA, 4 subjects, 5 samples","","NINDS","MDNS --- Diseases of Muscle and the Nervous System","2012-08-31","2012-10-01","Hereditary Spastic Paraplegias; Spastic Paraplegia Hypertrophic Motor Sensory Neuropathy; FSP; Familial spastic paraparesis; Familial spastic paraplegia; Familial spastic paraplegia syndrome",""
"phs000495.v1.p1","The Gene Partnership (TGP) - eMERGE Data","The Gene Partnership (TGP) is a prospective longitudinal registry at Boston Children's Hospital (BCH) to study the genetic and environmental contributions to childhood health and disease, collect genetic information on  a large number of children who have been phenotyped, and implement the Informed Cohort and the Informed Cohort Oversight Board (ICOB). The term ""The","Not Applicable","Family Health","Prospective Longitudinal Cohort","Axiom_GW_EUR","SNP Genotypes (Array)","4 phenotype datasets, 55 variables, 1 molecular datasets, 1024 subjects, 1077 samples","Other (26), East Asian (17), Hispanic2 (15), Other Asian or Pacific Islander (20), European (738), African American (128), Hispanic1 (73), South Asian (7)","NHGRI","HR_CHB --- Health Research - Children's Hospital Boston","2012-08-30","2013-08-30","Arrhythmias, Cardiac; Asthma; Attention Deficit Disorders; Autoimmune Diseases; Chromosome Aberrations; Congenital Abnormalities",""
"phs000433.v1.p1","The Sea Islands Genetic Network (SIGNET)","Recent genome-wide association studies (GWAS) have successfully identified genetic variants that influence diabetes risk in European populations, however most do not have a major impact on diabetes risk in populations  of African descent. The African American (AA) population from the Sea Islands of coastal South Carolina and Georgia has high rates of type 2","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","5 phenotype datasets, 74 variables, 1 molecular datasets, 4291 subjects, 4358 samples","Other (1), European (18), African American (3215), Hispanic1 (29), African (1028)","NIDDK","GRU --- General Research Use, LGRU --- General Research Use except HIV/AIDS, SR --- Stroke and Risk factors for stroke","2012-08-17","2012-08-17","Dyslipidemia; Dyslipidemias; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II",""
"phs000449.v2.p1","Genetic Variation and Signatures of Natural Selection in Diverse Africans","Our study identified candidate regions of genome involved in adaptation and identified regions associated with selected phenotypes. We included unrelated individuals living in Cameroon and Ethiopia. Principal Investigator: Dr. Sarah  A. Tishkoff, PhD, Departments of Genetics and Biology, University of Pennsylvania, Philadelphia, PA USA Funding Source: NIH Pioneer Award DP1OD0644S,","Not Applicable","Population Control","Case-Control","Human1M-Duo","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 2 molecular datasets, 172 subjects, 172 samples","","NIEHS","NPU --- Non-Profit Use","2012-08-08","2012-08-08","Not Provided",""
"phs000502.v1.p1","Genome-Wide Analysis of Splenic Marginal Zone Lymphoma","Splenic Marginal Zone Lymphoma (SMZL) is a B-cell malignancy of unknown pathogenesis and thus orphan of targeted therapies. By integrating whole-exome sequencing and copy-number analysis of 8 paired tumor-normal DNAs  from patients with SMZL, we show that the typical SMZL exome carries 30 genetic alterations. Targeted resequencing of selected candidates in an","Not Applicable","Lymphoma, Non-Hodgkin","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array), WXS","3 phenotype datasets, 10 variables, 1 molecular datasets, 16 samples sequenced,  SRA, 8 subjects, 16 samples","","NCI","CRGM_PUB --- Cancer Research and General Methods with Publication Statement","2012-08-02","2013-08-02","Lymphoma, B-Cell; Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum Cell Sarcomas; Reticulum cell sarcoma morphology",""
"phs000384.v1.p1","Genentech Whole Genome Sequencing of Four Hepatocellular Carcinoma    Patients","Hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC). In this study we sequenced the whole genome ( 80X) and transcriptome of tumor and non-tumor  samples from four HCC patients and identified over two hundred HBV integration sites. We found significant clonal expansion of HBV-integrated","Not Applicable","Carcinoma, Hepatocellular","Case-Control","Not Provided","RNA-Seq, WGS","4 phenotype datasets, 20 variables, 16 samples sequenced,  SRA, 4 subjects, 18 samples","","NCI","GRU --- General Research Use","2012-07-30","2012-07-30","Hepatitis B; Hepatocellular Carcinomas; HBV infection; Hepatitis B Virus Infection; Hepatitis B infection; Hepatitis B virus caused hepatitis","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000494.v1.p1","CCHMC - eMERGE Data","This submission includes genotyping data from 6 separate cohorts (named A-E here), each is described in separate paragraphs below. Cohort A) Autism is a neurodevelopmental disorder that affects 1.5 million  people in the United States, at an estimated lifetime cost of $4 million. It is part of Pervasive Developmental Disorder characterized by impairments","Not Applicable","Child Health","Prospective Longitudinal Cohort","Human610-Quad, Human660W-Quad, HumanOmni5-4, Affymetrix_WG_Array, HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 4562 subjects, 4562 samples","Other (37), East Asian (21), Hispanic2 (77), Other Asian or Pacific Islander (23), European (3786), African American (473), Hispanic1 (111), African (7), South Asian (26)","NHGRI","HR_CCHMC --- Health/Medical/Biomedical","2012-07-23","2013-07-23","Arthritis, Juvenile Rheumatoid; Developmental Disabilities; Eosinophilic Esophagitis; Epilepsy, Absence; Hypoplastic Left Heart Syndrome; Arthritis, Juvenile Systemic",""
"phs000395.v1.p1","CPMCRI Breast Health Cohort","Description of Cohort: The California Pacific Medical Center (CPMC) Breast Health Cohort is a cohort study based at CPMC and is linked to the San Francisco Mammography Registry, one of  the sites of the NCI-funded Breast Cancer Screening Consortium (U01CA063740). CPMC is a community hospital in San Francisco, which has one of the","Not Applicable","Breast Neoplasms","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","4 phenotype datasets, 30 variables, 1 documents, 1 molecular datasets, 982 subjects, 1014 samples","","NCI","GRU --- General Research Use","2012-07-20","2012-07-20","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000476.v1.p1","Molecular Defects in Pseudohypoparathyroidism or Related Disorders","Maintaining calcium levels within a narrow normal range is of critical importance for numerous different cellular functions. One of the most important regulators of blood calcium levels is parathyroid hormone  (PTH), which mediates its actions through the PTH/PTHrP receptor, a G&#x003b1;s-coupled receptor. Few inherited disorders are characterized by","Not Applicable","Pseudohypoparathyroidism","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets, 20 samples sequenced,  SRA, 20 subjects, 20 samples","","NHGRI","PHPH --- Pseudohypoparathyroidism or Related Disorders","2012-07-17","2012-07-17","Hypoparathyroidism familial isolated; PHD Ib; PHD1b; PHP IB; PHP1B; Php 1B",""
"phs000314.v1.p1","Genetic Associations in Idiopathic Talipes Equinovarus (GAIT)","Isolated clubfoot or idiopathic talipes equinovarus (ITEV) is one of the five most common birth defects, affecting approximately 4,000 newborns each year in the US. While the orthopedic care of  these children has improved, long-term problems persist and the health care costs are significant. Studies suggest that clubfoot is a complex","Not Applicable","Clubfoot","Family/Twin/Trios","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 50 variables, 2 documents, 1 molecular datasets, 1903 subjects, 1832 samples","Other (21), East Asian (1), Hispanic2 (802), Other Asian or Pacific Islander (2), European (885), African American (1), Hispanic1 (4)","NICHD","GRU --- General Research Use","2012-07-17","2013-07-17","CCF; CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; Club feet; Club foot; Clubbed Foot; Clubbing of feet",""
"phs000455.v1.p1","Dobyns DBD","Study 1 2R01-NS050375 (PI: DOBYNS, William B.) The genetic basis of mid-hindbrain malformations Our general goal for this project is to advance our understanding of human developmental disorders that involve  the brainstem and cerebellum - brain structures derived from the embryonic midbrain and hindbrain - that affect a minimum of 2.4 per 1000 resident","Not Applicable","Brain Diseases","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS), WXS","5 phenotype datasets, 29 variables, 1 molecular datasets, 10 samples sequenced,  SRA, 10 subjects, 10 samples","","NINDS","GRU --- General Research Use","2012-06-22","2012-07-22","Agenesis of Corpus Callosum; Dysplasia, Septooptic; Focal Cortical Dysplasia; Holoprosencephaly; Megalencephaly cutis marmorata telangiectatica congenita; Microcephaly","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000394.v1.p1","Autopsy-Confirmed Parkinson Disease GWAS Consortium (APDGC)","The APDGC was formed to conduct a genome-wide association study in individuals with neuropathologically confirmed Parkinson Disease (PD) and neuropathologically normal controls. The rationale for the study is that including  only cases and controls with neuropathologically confirmed disease status will reduce diagnostic misclassification and increase power to detect novel","Not Applicable","Parkinson Disease","Case-Control","HumanOmni1-Quad, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 19 variables, 2 molecular datasets, 977 subjects, 1044 samples","East Asian (7), Hispanic2 (7), European (932), African American (24), Hispanic1 (5), African (2)","NINDS","ARU --- Academic Research Use","2012-06-22","2013-06-22","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs000485.v1.p1","Gene Mutation and Rescue in Congenital Diaphragmatic Hernia","Congenital Diaphragmatic Hernia (CDH) is a common and life-threatening malformation. The most common phenotype is left-sided posterolateral (Bochdalek-type) hernia accompanied by pulmonary hypoplasia. Due to the high mortality, most of  the cases have no family history for CDH. The rare presumed Mendelian instances of CDH have the potential to be extremely informative about the","Not Applicable","Hernias, Diaphragmatic, Congenital","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 4 samples sequenced,  SRA, 4 subjects, 4 samples","","NHGRI","CDH --- Congenital Diaphragmatic Hernia and Related Disorders","2012-06-08","2012-06-08","Agenesis of Hemidiaphragm; CDH; CDH - Congenital diaphragmatic hernia; Congenital Diaphragmatic Defect; Congenital Diaphragmatic Defects; Congenital Diaphragmatic Hernia",""
"phs000475.v1.p1","The Molecular Basis of Inherited Reproductive Disorders","The purpose of this study is to discover genetic mutations in patients who have GnRH deficient states. This includes individuals with variant forms of hypogonadotropic hypogonadism, including individuals who have  somatic anomalies involving mid-line facial defects, renal agenesis, synkinesia, and ataxia, amongst others. Participants must undergo and physical","Not Applicable","Hypogonadism","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 1 samples sequenced,  SRA, 1 subjects, 1 samples","","NHGRI","GRU --- General Research Use","2012-06-08","2012-06-08","Kallmann Syndrome; Hypergonadotrophic hypogonadism; Hypergonadotropic Hypogonadism; Hypogonadism, Hypergonadotropic; Primary Gonadal Failure; Primary hypogonadism",""
"phs000484.v1.p1","Molecular Genetic Analysis of Inherited Kidney Dysfunction","Samples were chosen for sequencing from a set of probands from pedigrees with apparently inherited forms of focal segmental glomerulosclerosis (FSGS). Several genes have been identified which when mutated cause  FSGS under both recessive and dominant inheritance patterns. These known genes are estimated to explain less than 50% of inherited FSGS. We chose","Not Applicable","Glomerulosclerosis, Focal Segmental","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 7 samples sequenced,  SRA, 7 subjects, 7 samples","","NHGRI","IKD --- Kidney diseases","2012-06-06","2012-06-06","Nephrotic Syndrome; FGS; FGS (focal glomerular sclerosis); FGS - Focal glomerulosclerosis; FSGS; FSGS - Focal Segmental Glomerulosclerosis",""
"phs000477.v1.p1","Genetic Defects in Familial Renal Disorders","1. Several different genes cause, when mutated, increased urinary phosphate excretion and hypophosphatemia leading to rickets/osteomalacia; however, the majority of phosphate-wasting disorders has not yet been defined at the molecular  level. Identification of phosphate-regulating genes has provided important novel insights into the mechanism contributing to phosphate homeostasis,","Not Applicable","Hypophosphatemia, Familial","Mendelian","Cardio-Metabo_Chip","SNP Genotypes (NGS), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets, 31 samples sequenced,  SRA, 21 subjects, 31 samples","","NHGRI","FRD --- Genetic Defects in familial renal disorders","2012-06-06","2012-06-06","Hajdu-Cheney Syndrome; Vesico-Ureteral Reflux; ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE; ARTHRODENTOOSTEODYSPLASIA; Acroosteolysis dominant type; Arthro-dento-osteo dysplasia",""
"phs000414.v1.p1","Whole Genome Sequencing of CBF-Leukemia","Pediatric de novo acute myeloid leukemia (AML) is a heterogeneous disease that can be divided into clinically distinct subtypes based on the presence of specific chromosomal abnormalities or gene alterations.  One of the best characterized subtypes of AML involves leukemias with alterations of the core-binding factor (CBF)-complex, which comprises the FAB","Not Applicable","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","Not Provided","WGS","3 phenotype datasets, 16 variables, 34 samples sequenced,  SRA, 17 subjects, 34 samples","","NCI","GRU --- General Research Use","2012-05-30","2013-03-02","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000409.v1.p1","Sequencing of Medulloblastoma","Medulloblastoma is a heterogenous disease made up of at least four distinct subtypes of disease which appear to exploit and disrupt naturally occurring developmental pathways of cellular growth and hindbrain  development. To better understand the driver mutations of this disease, we performed whole genome sequencing of 37 medulloblastomas and the","Not Applicable","Medulloblastoma","Tumor vs. Matched-Normal","Affymetrix_WG_Array","SNP Genotypes (Array), RNA-Seq, WGS","5 phenotype datasets, 33 variables, 1 molecular datasets, 78 samples sequenced,  SRA, 93 subjects, 306 samples","Other (5), East Asian (2), Hispanic2 (8), Other Asian or Pacific Islander (4), European (45), African American (6), Hispanic1 (3), South Asian (3)","NCI","GRU --- General Research Use","2012-05-30","2012-05-30","Arachnoidal Cerebellar Sarcoma, Circumscribed; Circumscribed arachnoidal cerebellar sarcoma; Desmoplastic Medulloblastomas; Desmoplastic Nodular Medulloblastoma; Desmoplastic medulloblastoma; Medulloblastoma, Desmoplastic","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000291.v2.p1","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Lung Health Study of    Chronic Obstructive Pulmonary Disease)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Pulmonary Disease, Chronic Obstructive","Prospective Longitudinal Cohort","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (NGS), WXS","5 phenotype datasets, 44 variables, 2 molecular datasets, 337 samples sequenced,  SRA, 337 subjects, 337 samples","","NHLBI","GRU --- General Research Use","2012-05-21","2012-08-21","CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD; COLD - Chronic obstructive lung disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000096.v4.p1","HAPO Maternal Glycemia and Birthweight GEI Study","Low and high birth weight are not only major causes of neonatal morbidity and mortality, but epidemiological data have established an association between birth weight and later life risk of  adult metabolic diseases. Fetal growth is determined by complex interactions between fetal genes and the maternal uterine environment. Subtle or","Not Applicable","Pregnancy Complications","Prospective Longitudinal Cohort","Human1M-Duo, Human610-Quad, imputation_panel, HumanOmni1-Quad","SNP Genotypes (Array), SNP Genotypes (imputed)","9 phenotype datasets, 270 variables, 44 documents, 11 molecular datasets, 9987 subjects, 9339 samples","Other (123), East Asian (165), Hispanic2 (1427), Other Asian or Pacific Islander (2277), European (2751), African American (2073), Hispanic1 (26), African (158), South Asian (17)","NHGRI","T2DMBIRTHWT --- GWA mapping: Maternal Metabolism-Birth Weight Interactions","2012-05-16","2012-12-02","Gestation; Pregnancy, function; Adverse Birth Outcome; Adverse Birth Outcomes; Birth Outcome, Adverse; Outcome, Adverse Birth",""
"phs000456.v1.p1","Risk Assessment of Cerebrovascular Events (RACE) Study","This study includes 1,220 cases with young onset stroke (stroke before age 60 years) who are participants of the larger RACE study. Risk Assessment of Cerebrovascular Events (RACE) is an  on-going existing case-control study of stroke now involving over 5000 imaging confirmed cases of stroke and 5000 controls, recruited from seven","Not Applicable","Stroke","Case-Control","Human660W-Quad, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","6 phenotype datasets, 39 variables, 3 documents, 2 molecular datasets, 2627 subjects, 2632 samples","Other (42), Other Asian or Pacific Islander (2), European (4), African American (4), Hispanic1 (14), South Asian (2427)","NHGRI","GRU --- General Research Use (GSO)","2012-05-08","2013-05-08","Brain Infarction; Anterior Cerebral Circulation Infarction; Infarction, Anterior Cerebral Circulation; Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident",""
"phs000443.v1.p1","Molecular Profiling of Cancer","Noncoding RNAs (ncRNAs) are emerging as key molecules in human cancer, with the potential to serve as novel markers of disease and to reveal uncharacterized aspects of tumor biology. Here  we discover 121 unannotated prostate cancer-associated ncRNA transcripts (PCATs) by ab initio assembly of high-throughput sequencing of polyA+ RNA","Not Applicable","Prostatic Neoplasms","Case-Control","Not Provided","RNA-Seq","4 phenotype datasets, 22 variables, 144 samples sequenced,  SRA, 72 subjects, 144 samples","","NCI","CRGM --- Cancer Research and General Methods","2012-05-08","2012-05-08","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs000478.v1.p1","Strabismus, CCDD and Other Anomalies","Strabismus is one of the most common ophthalmological diseases affecting our population. It has many detrimental effects for affected individuals, including functional visual loss from amblyopia, secondary psychosocial difficulties, and  limited employment opportunities. Strabismus also imposes a significant economical burden on society from the cost of screening programs, surgical","Not Applicable","Strabismus","Mendelian","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets, 13 samples sequenced,  SRA, 13 subjects, 13 samples","","NHGRI","CCDD --- Strabismus, cranial nerve abnormalities and associated disorders","2012-05-07","2012-05-07","Blepharoptosis; Facial Paralysis; Blepharoptoses; Drooping eyelid; Drooping upper eyelid; Droopy eyelid",""
"phs000407.v1.p1","IMAGE II Genome-Wide Association","This sample represents a collection of cases across a range of sites. All of these samples were ascertained for ADHD with most meeting criteria for combined type ADHD. The collection  sites span Europe and America. Further details on the source and inclusion and exclusion information can be found in Neale et al. ""Case-Control","Not Applicable","Attention Deficit Disorder with Hyperactivity","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 923 subjects, 923 samples","Other (4), Hispanic2 (2), European (880), African American (18), Hispanic1 (19)","NIMH","ADHD --- Attention Deficit Hyperactivity Disorder","2012-05-02","2012-05-02","Attention Deficit and Disruptive Behavior Disorders; ADD; ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorders with Hyperactivity","dbGaP Collection: Psychiatric Genomics Consortium (PGC) dbGaP Datasets (phs001254.v1.p1)"
"phs000345.v1.p1","NIDDK IBD Genetics Consortium Ulcerative Colitis Genome-Wide Association    Study","This dataset contains data for 1,028 white, non-Hispanic, European ancestry individuals with ulcerative colitis who were included in a genome-wide association study published by Silverberg et al. (2009). These individuals  were ascertained in North America and selected to have either left-sided or extensive disease (i.e., individuals with proctitis only were excluded).","Not Applicable","Colitis, Ulcerative","Case-Control","HumanHap550, HumanHap300","SNP Genotypes (Array)","3 phenotype datasets, 67 variables, 2 documents, 1 molecular datasets, 1028 subjects, 1028 samples","Other (2), Hispanic2 (2), European (1021), Hispanic1 (1), African (1), South Asian (1)","NIDDK","GRU --- General Research Use, IBDO --- Inflammatory Bowel Disease Only","2012-05-02","2012-05-02","Inflammatory Bowel Diseases; Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - ulcerative colitis",""
"phs000447.v1.p1","Prostate Cancer Genome Sequencing Project","Prostate cancer is a prevalent cause of cancer morbidity and mortality in men. In order to characterize the full range of somatic mutations in protein-coding genes that may drive the  growth of prostate cancer, we sequenced the exonic regions of genomic and tumor DNA from over 100 patients with high-risk primary prostate cancer.","Not Applicable","Prostatic Neoplasms","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array), WGS, WXS","4 phenotype datasets, 27 variables, 1 molecular datasets, 330 samples sequenced,  SRA, 149 subjects, 624 samples","","NHGRI","GRU --- General Research Use, CRO --- Cancer Research Only","2012-04-26","2012-04-26","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000390.v1.p1","Genomic Wide Scans for Female Osteoporosis Genes","Osteoporosis is a condition of excessive skeletal fragility which results in high risk to low trauma fractures. It is the most prevalent metabolic bone disease and is a major public  health problem which may result in devastating morbidity and mortality. The most powerful, measurable determinant of fracture risk is bone mineral","Not Applicable","Osteoporosis","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 28 variables, 2 documents, 1 molecular datasets, 1617 subjects, 1617 samples","Other (4), Hispanic2 (6), Other Asian or Pacific Islander (2), European (1598), African American (3), Hispanic1 (4)","NIAMS","OSTEO --- Osteoporosis","2012-04-26","2013-04-26","Age Related Osteoporosis; Age-Related Bone Loss; Age-Related Bone Losses; Age-Related Osteoporoses; Age-Related Osteoporosis; Bone Loss, Age Related",""
"phs000444.v1.p1","Italian PBC Study","A Genome-wide association study of primary biliary cirrhosis (PBC) with an Italian cohort and loci meeting suggestive criteria were confirmed using a replication dataset from a previous Canadian study. The  results confirmed associations for IL12A, IL12RB2, and HLA (peak between DQA1 and DQB1) and identified novel associations with IKZF3/ORMDL3 on","Not Applicable","Liver Cirrhosis, Biliary","Case-Control","HumanHap550","SNP Genotypes (Array)","3 phenotype datasets, 18 variables, 1 documents, 1 analyses, 1 molecular datasets, 1389 subjects, 1389 samples","","NIDDK","PBCRC --- Primary Biliary Cirrhosis and Related Conditions","2012-04-20","2012-04-20","Biliary Cholangitides, Primary; Biliary Cholangitis, Primary; Biliary Cirrhosis, Primary; Cholangitides, Primary Biliary; Cholangitis, Chronic Nonsuppurative Destructive; Cholangitis, Primary Biliary",""
"phs000369.v1.p1","Sequence Analysis of Mutations and Translocations Across Breast Cancer    Subtypes","This study combined whole exome (103 samples) and whole genome (22 samples) sequencing over a total of 108 breast tumors and matched normal DNA to identify novel mutations and translocations.  Samples were subjected to paired-end Illumina sequencing with goal of 30x coverage of tumor/normal for whole genomes and 100x tumor/normal coverage","Not Applicable","Carcinoma, Ductal, Breast","Case Set","Affymetrix_expression_array, Affymetrix_WG_Array","SNP Genotypes (Array), mRNA Expression (Array), WGS, WXS","4 phenotype datasets, 23 variables, 2 molecular datasets, 216 samples sequenced,  SRA, 108 subjects, 216 samples","","NCI","GRU --- General Research Use, CRGM --- Cancer Research and General Methods","2012-04-19","2012-04-19","BREAST CANCER, INVASIVE DUCTAL; Carcinoma, Infiltrating Duct; Carcinoma, Invasive Ductal, Breast; Carcinomas, Infiltrating Duct; Infiltrating Ductal Adenocarcinoma; Infiltrating Ductal Breast Carcinoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000442.v1.p1","Drug Resistant Hypertension in African Americans' Exome","Resistant hypertension is defined as blood pressure that remains above goal in spite of the concurrent use of 3 antihypertensive agents of different classes or the concurrent use of 4  or more antihypertensive agents regardless of control. Its diagnosis is important for the identification of patients who are at high risk of having","Not Applicable","Hypertension","Case-Control","WES_markerset_grc37","SNP Genotypes (NGS), WXS","4 phenotype datasets, 27 variables, 1 molecular datasets, 91 samples sequenced,  SRA, 91 subjects, 91 samples","","NHLBI","GRU --- General Research Use","2012-04-12","2013-04-12","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; HBP - High blood pressure","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000001.v3.p1","NEI Age-Related Eye Disease Study (AREDS)","The Age-Related Eye Disease Study (AREDS) was initially designed as a long-term multi-center, prospective study of the clinical course of age-related macular degeneration (AMD) and age-related cataract. In addition to  collecting natural history data, AREDS included a clinical trial of high-dose vitamin and mineral supplements for AMD and a clinical trial of","Not Applicable","Cataract","Case-Control","HumanHap100, Affymetrix_100K, HumanOmni2.5-4","Not Provided","16 phenotype datasets, 635 variables, 48 documents, 3 analyses, 2 molecular datasets, 279973 images, 4757 subjects, 6962 samples, 1 substudies","Other (3), European (575), African American (11), Hispanic1 (2), South Asian (2)","NEI","EDO --- Eye Disease Research Only, GRU --- General Research Purposes","2012-04-05","2016-02-11","CRYGS cataract (disease); CTRCT20; Cataract, Membranous; Cataracts, Membranous; Membranous Cataract; Membranous Cataracts","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000429.v1.p1","NEI Age-Related Eye Disease Study (AREDS) - Genetic Variation in    Refractive Error Substudy","A genome-wide association study of refractive error using the Illumina 2.5M chip was performed using a subset of the control group from the original AREDS study. These control individuals are  all Caucasian, do not have age-related macular degeneration (AMD) and were further screened to also exclude individuals with cataracts, retinitis","National Eye Institute (NEI) Age-Related Eye Disease Study (AREDS) (phs000001.v3.p1)","Refractive Errors","Case-Control","HumanOmni2.5-4","SNP Genotypes (Array)","1 phenotype datasets, 15 variables, 1 molecular datasets, 2000 subjects, 3877 samples","","NEI","EDO --- Eye Disease Research Only, GRU --- General Research Purposes","2012-04-05","2016-02-11","Astigmatism; Hyperopia; Myopia; Refractive Error; Abnormal curving of the cornea or lens of the eye; astigmatism (disease)",""
"phs000440.v1.p1","CCDG: Dental Caries and CL/P in Guatemala","This study provides an opportunity to investigate the genetics of both dental caries and orofacial clefts (OFCs) in one set of families ascertained in Guatemala. This study is part of  the Gene Environment Association Studies initiative (GENEVA, http://www.genevastudy.org), which was developed through the trans-NIH Genes,","Not Applicable","Dental Caries","Case-Control","Human610-Quad, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 119 variables, 21 documents, 2 molecular datasets, 1304 subjects, 968 samples","","NIDCR","OH --- Oral Health","2012-03-20","2013-03-20","Cleft Lip; Cleft Palate; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips",""
"phs000425.v1.p1","Alcohol Dependence GWAS in European- and African Americans","This study includes SSADDA (Semi Structured Assessment for Drug Dependence and Alcoholism) assessed subjects (mostly unrelated, but including some affected sibling pairs) recruited in the course of several substance dependence  genetics projects. The sample includes 1889 African-American (AA) subjects and 1020 European-American (EA) subjects. Among the AAs, 1397 meet DSM-IV","Not Applicable","Alcoholism","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","3 phenotype datasets, 45 variables, 1 molecular datasets, 2909 subjects, 3050 samples","Other (21), Hispanic2 (16), European (831), African American (1802), Hispanic1 (139), African (100)","NIAAA","ARC --- Alcohol Related Conditions","2012-03-09","2013-03-09","Cocaine Dependence; Nicotine Dependence; Opiate Dependence; ALCOHOL DEPENDENCE, PROTECTION AGAINST; Addiction, Alcohol; Addictive alcohol use",""
"phs000423.v1.p1","GWAS for Early Onset Coronary Disease (ADVANCE)","ADVANCE (Atherosclerotic Disease, VAscular functioN, and genetiC Epidemiology) is a large epidemiological study of genetic and non-genetic determinants of coronary artery disease (CAD) that started in 2000 as a collaborative  effort between researchers at Stanford University and Kaiser Permanente of Northern California. The overarching goal of the study is to improve our","Not Applicable","Coronary Disease","Case-Control","Not Provided","Not Provided","1 analyses","","NHLBI","NPU --- Non Profit Research Use","2012-03-09","","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart",""
"phs000375.v1.p1","Genome-Wide Association of Platelet Phenotypes","The goal of this study was to identify genetic variants in a genome-wide association study (GWAS) that are associated with previously obtained platelet function phenotypes measured in each individual under  baseline conditions and following 2 weeks of low dose aspirin (ASA). During this study we performed a high density 1 million-SNP genome scan on","Not Applicable","Platelet Aggregation","Prospective Longitudinal Cohort","Not Provided","Not Provided","1 documents, 410 analyses","","NHLBI","NPU --- Non Profit Research Use","2012-02-07","","Not Provided",""
"phs000419.v1.p1","A Novel Recurrent Mutation in MITF Predisposes to Familial and Sporadic    Melanoma","We conducted whole-genome sequencing of probands from several melanoma families, identifying one individual carrying a novel germline variant (c.G1075A, NM_000248.3; p.E318K, NP_000239.1; rs149617956) in the melanoma lineage-specific oncogene MITF. While  the variant cosegregated with melanoma in some, but not all cases in the family, linkage analysis of 31 families subsequently identified to carry the","Not Applicable","Melanoma","Case-Control","Not Provided","WGS","4 phenotype datasets, 15 variables, 1 samples sequenced,  SRA, 1 subjects, 1 samples","","NCI","CRO --- Cancer Research Only","2012-02-03","2012-02-03","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs000417.v2.p1","BrainCloud: Data from Human Postmortem Brain Across the Lifespan","This study explores the temporal dynamics and genetic control of transcription and DNA methylation in the human dorsolateral prefrontal cortex in postmortem tissue. This study examines 269 subjects for gene  expression (version 1) and 108 subjects for DNA methylation (version 2). The subjects are normal controls without neuropathological and","Not Applicable","Aging","Case-Control","Human1M-Duo, HumanHap650Y","SNP Genotypes (Array)","5 phenotype datasets, 21 variables, 2 molecular datasets, 270 subjects, 270 samples","East Asian (3), Hispanic2 (5), Other Asian or Pacific Islander (1), European (110), African American (148), Hispanic1 (1), South Asian (2)","NIMH","GRU --- General Research Use","2012-02-02","2012-02-02","growth and development; Aging, Biological; Biological Aging; growth","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000352.v1.p1","Sequencing of Retinoblastoma","Retinoblastoma is a pediatric cancer of the developing retina. All retinoblastomas are believed to initiate with biallelic inactivation of the RB1 gene. To identify subsequent genetic lesions in retinoblastoma, we  performed whole genome sequencing of tumor and normal DNA of 4 children with retinoblastoma and one matched orthotopic xenograft. Both alleles of RB1","Not Applicable","Retinoblastoma","Tumor vs. Matched-Normal","Affymetrix_WG_Array","SNP Genotypes (Array), RNA-Seq, WGS","5 phenotype datasets, 34 variables, 1 molecular datasets, 9 samples sequenced,  SRA, 46 subjects, 93 samples","Other (1), Hispanic2 (7), European (22), African American (13), Hispanic1 (1), South Asian (1)","NCI","GRU --- General Research Use","2012-01-19","2012-01-19","Cancer, Retinoblastoma Eye; Cancers, Retinoblastoma Eye; Eye Cancer, Retinoblastoma; Eye Cancers, Retinoblastoma; RB; RB - retinoblastoma","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000393.v1.p1","Summary Level Data: deCODE Genetics Study on Genes Contributing to    Nicotine Dependence in Humans","A genome-wide association study on smoking behavior and nicotine dependence in Icelandic smokers, assessed by the number of cigarettes smoked per day, smoking initiation and degree of dependence on nicotine.  The number of cigarettes smoked per day was ascertained through questionnaires given to individuals participating in multiple disease projects at","Not Applicable","Tobacco Use Disorder","Case-Control","Not Provided","Not Provided","1 phenotype datasets, 5 variables, 3 analyses","","NIDA","GRU --- General Research Use","2012-01-18","","Compulsive tobacco user syndrome; Dependence, Tobacco; Tobacco Dependence","Joint Addiction, Aging, and Mental Health (JAAMH) Data Access Committee    General Research Use Datasets (phs003202.v1.p1)"
"phs000380.v1.p1","eMERGE Genome-Wide Association Studies of Obesity (Metabochip)","The Geisinger eMERGE Genome Wide Association Studies of Obesity (Metabochip) Project is a genetic study of a cohort of primarily Caucasian patients with extreme obesity who have undergone bariatric surgery.  Roux-en-Y gastric bypass (RYGB) surgery, in which intestinal anatomy is altered, dramatically ameliorates and/or eliminates Type 2 diabetes mellitus","Not Applicable","Obesity","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 36 variables, 1 molecular datasets, 982 subjects, 982 samples","","NHGRI","HR_GC_NASH --- Health/Medical/Biomedical","2012-01-17","2013-01-17","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000387.v1.p1","Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP)","A large research cohort of Geisinger Abdominal Aortic Aneurysm (AAA) patients was created by enrolling and consenting patients of the Geisinger Department of Vascular Surgery. Consented patients provide blood, serum  and DNA samples for research and authorize use of data in their medical record for research. They also complete a data questionnaire that asks","Not Applicable","Aortic Aneurysm, Abdominal","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 28 variables, 1 molecular datasets, 910 subjects, 943 samples","","NHGRI","HR_GC_AAA --- Health/Medical/Biomedical","2011-12-19","2012-12-19","Abdominal Aortic Aneurysms; AAA; AAA - Abdominal aortic aneurysm; ABDOMINAL AORTIC ANEURYSM; ANEURYSM, ABDOMINAL AORTIC; Abdominal Aorta Aneurysm",""
"phs000381.v1.p1","Geisinger eMERGE - MyCode Project","A research cohort of adult Geisinger Clinic patients was enrolled from community-based primary care clinics of the Geisinger Health System. Patients were eligible for enrollment if they were a primary  care patient of a Geisinger Clinic physician and were scheduled for a non-emergent clinic visit. All participants provided written informed consent","Not Applicable","Health","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 29 variables, 2 documents, 1 molecular datasets, 1231 subjects, 1264 samples","","NHGRI","HR_GC_MYCODE --- Health/Medical/Biomedical","2011-12-19","2012-12-19","Not Provided",""
"phs000404.v1.p1","The Genetic Architecture of Smoking and Smoking Cessation","This study includes samples from two projects: Collaborative Genetic Study of Nicotine Dependence (COGEND; PI: Laura Bierut) and University of Wisconsin Transdisciplinary Tobacco Use Research Center (UW-TTURC; PI: Timothy Baker).  Data are available for an additional 1420 COGEND subjects through the Study of Addiction: Genetics and Environment (SAGE), dbGaP study accession","Not Applicable","Smoking Cessation","Case-Control","HumanOmni2.5-4, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 189 variables, 15 documents, 2 molecular datasets, 3499 subjects, 3564 samples","Other (17), East Asian (8), Hispanic2 (45), Other Asian or Pacific Islander (12), European (2545), African American (751), Hispanic1 (25), African (4), South Asian (6)","NIDA","GRU --- General Research Use, NAR --- Nicotine Addiction Research","2011-12-14","2012-12-14","Nicotine Dependence; Compulsive tobacco user syndrome; Dependence, Tobacco; Tobacco Dependence","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000426.v1.p1","SLCO1B1 Variants and Methotrexate Clearance","Methotrexate plasma concentration is related to its clinical effects. To identify the genetic basis of interindividual variability in methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia (ALL), we  performed a genome-wide analysis (GWAS) of 500,568 germline single-nucleotide polymorphisms (SNPs) in 434 children with ALL who received 3,014","Not Applicable","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Prospective Longitudinal Cohort","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 673 subjects, 673 samples","Other (6), East Asian (7), Hispanic2 (70), Other Asian or Pacific Islander (2), European (459), African American (111), Hispanic1 (12), African (2), South Asian (4)","NIGMS","BRU --- Biomedical Research Use","2011-12-13","2011-12-13","Acute Lymphoblastic Leukemia; ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic",""
"phs000408.v1.p1","eMERGE Genome-Wide Association Studies of Obesity","The Geisinger eMERGE Genome-Wide Association Studies of Obesity Project is a genetic study of a cohort of primarily Caucasian patients with extreme obesity who have undergone bariatric surgery. Roux-en-Y gastric  bypass (RYGB) surgery, in which intestinal anatomy is altered, dramatically ameliorates and/or eliminates Type 2 diabetes mellitus (T2D) in 50-80% of","Not Applicable","Obesity","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","4 phenotype datasets, 37 variables, 1 molecular datasets, 962 subjects, 1006 samples","","NHGRI","HR_GC_NASH --- Health/Medical/Biomedical","2011-12-06","2012-12-06","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000368.v1.p1","POLYGEN","PCOS is a complex genetic disease reflecting the interplay of susceptibility genes and environmental factors. The cardinal reproductive feature of the syndrome, hyperandrogenemia, appears to play a direct role in  the pathogenesis of the associated metabolic abnormalities. Male as well as female first-degree relatives have reproductive and metabolic phenotypes","Not Applicable","Polycystic Ovary Syndrome","Case-Control","HumanOmniExpress-12","SNP Genotypes (Array)","5 phenotype datasets, 28 variables, 11 documents, 1 molecular datasets, 4151 subjects, 8286 samples","Other (5), Hispanic2 (11), Other Asian or Pacific Islander (2), European (4052), African American (13), Hispanic1 (15), South Asian (1)","NICHD","PCOS --- Genetic Analysis of Polycystic Ovary Syndrome, NUGENE --- NUgene Biorepository","2011-11-30","2012-11-30","HYPERANDROGENEMIA; Multicystic ovaries; Ovarian Degeneration, Sclerocystic; Ovarian Syndrome, Polycystic; Ovary Syndrome, Polycystic; PCO",""
"phs000274.v1.p1","Genome-Wide Association Study of Celiac Disease","Celiac disease (gluten-sensitive enteropathy, celiac sprue) is a common disease with significant morbidity and mortality. It is caused by sensitivity to the dietary protein gluten, resulting in a chronic enteropathy  in the small intestine. Celiac disease is now recognized to be a common disease, with reports that the disease frequency is 1:133 in the United","Not Applicable","Celiac Disease","Case-Control","Human660W-Quad","SNP Genotypes (Array)","3 phenotype datasets, 14 variables, 1 molecular datasets, 2300 subjects, 2394 samples","Other (3), East Asian (1), Hispanic2 (21), Other Asian or Pacific Islander (2), European (2203), African American (2), Hispanic1 (7), African (2), South Asian (5)","NIDDK","GRU --- General Research Use","2011-11-30","2012-11-30","Dermatitis Herpetiformis; CD; CD - Celiac disease; CS - Celiac sprue; Celiac Sprue; Celiac syndrome","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000385.v1.p1","Epigenetic Profiling of Human Colorectal Cancer","DNA methylation, together with chromatin modifications, constitute the epigenome that functions to regulate gene expression and genome integrity. DNA methylation alterations are ubiquitous in human cancers, as many genes acquire  DNA methylation in a cancer-specific manner. DNA methylation at these sites in the genome of cancer cells not only serves as a marker for tumor","Not Applicable","Colorectal Neoplasms","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array), Bisulfite-Seq","5 phenotype datasets, 42 variables, 1 documents, 1 molecular datasets, 2 samples sequenced,  SRA, 100 subjects, 104 samples","","NCI","GRU --- General Research Use","2011-11-29","2011-11-29","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000374.v1.p1","Genomic Sequencing of Colorectal Adenocarcinomas","This study was the first-known effort to complete the complete genome sequencing of primary colorectal adenocarcinomas and the matched germline genome. Nine colorectal adenocarcinomas selected on the basis of having  chromosomal instability were subjected to 'shotgun' Illumina sequencing with 101-bp paired end reads to an approximate goal of 30x coverage of tumor","Not Applicable","Colonic Neoplasms","Tumor vs. Matched-Normal","Affymetrix_WG_Array","SNP Genotypes (Array), WGS","4 phenotype datasets, 25 variables, 1 molecular datasets, 18 samples sequenced,  SRA, 9 subjects, 18 samples","","NHGRI","GRU --- General Research Use","2011-11-08","2011-11-08","Adenocarcinoma; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma",""
"phs000389.v1.p1","GENIE UK-ROI Diabetic Nephropathy GWAS","Diabetic kidney disease, or diabetic nephropathy (DN), is one of the leading causes of end-stage renal disease in the United States and worldwide. DN is a common complication of long-standing  type 1 and type 2 diabetes. The clinical course is characterized by development of proteinuria and gradual loss of kidney function. Although existing","Not Applicable","Diabetes Mellitus, Type 1","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","3 phenotype datasets, 22 variables, 1 molecular datasets, 1801 subjects, 1822 samples","","NIDDK","GRU --- General Research Use","2011-11-04","2011-11-04","Albuminuria; Diabetes Complications; Diabetic Nephropathy; Kidney Failure, Chronic; Diabetes Mellitus Complication; Diabetes Mellitus Complications",""
"phs000355.v1.p1","Genome Wide Association for Asthma and Lung Function","The SNP Typing for Association with Multiple Phenotypes from Existing Epidemiologic (STAMPEED) asthma project includes subjects with asthma and controls from the Chicago Asthma Genetics Study (CAG), NHLBI multicenter Severe  Asthma Research Program (SARP) and NHLBI Collaborative Studies on the Genetics of Asthma CSGA (Wake Forest). All studies included European American","Not Applicable","Asthma","Case-Control","Not Provided","Not Provided","2 analyses","","NHLBI","GRU --- General Research Use","2011-10-28","","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000303.v1.p1","Genetic Epidemiology of Refractive Error in the KORA Study","KORA (""Kooperative Gesundheitsforschung in der Region Augsburg"" which translates as ""Cooperative Health Research in the Region of Augsburg"") is a population based study of adults randomly selected from 430,000 inhabitants  living in Augsburg and 16 surrounding counties in Germany. The collection was done in 4 separate groups from 1984-2001 (S1-S4). One of the KORA","Not Applicable","Population Control","Prospective Longitudinal Cohort","HumanOmni2.5-4","SNP Genotypes (Array)","3 phenotype datasets, 24 variables, 4 documents, 1 molecular datasets, 1980 subjects, 1956 samples","","NEI","GRU --- General Research Use","2011-10-28","2012-07-28","Astigmatism; Hyperopia; Myopia; Refractive Errors; Abnormal curving of the cornea or lens of the eye; astigmatism (disease)",""
"phs000333.v1.p1","Family Investigation of Nephropathy and Diabetes (FIND) Study","The Family Investigation of Nephropathy and Diabetes (FIND) is a multicenter study designed to identify genetic determinants of diabetic kidney disease. Study subjects were recruited from eleven centers and in  many ethnic groups throughout the United States. A genome-wide association study (GWAS) was conducted with the Affymetrix 6.0 chip. Subjects (index","Not Applicable","Diabetes Mellitus","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","5 phenotype datasets, 56 variables, 6 documents, 1 molecular datasets, 2622 subjects, 2622 samples","Other (15), Hispanic2 (979), Other Asian or Pacific Islander (1), European (753), African American (818), Hispanic1 (13), African (43)","NIDDK","DNAR --- diabetes, kidney disease, retinopathy and/or related diseases","2011-10-25","2011-10-25","Diabetic Nephropathies; Kidney Diseases; DKD; Diabetic Kidney Disease; Diabetic Kidney Diseases; Diabetic nephropathy",""
"phs000392.v1.p1","Exome Sequencing of arPEO","Progressive external ophthalmoplegia (PEO) is an inherited mitochondrial disease that follows either autosomal dominant or recessive forms of inheritance (adPEO or arPEO). AdPEO is a genetically heterogeneous disease and several  genes including POLG1 and C10orf2/Twinkle have been identified as responsible genes. On the other hand, POLG1 was the only established gene causing","Not Applicable","Ophthalmoplegia, Chronic Progressive External","Case-Control","Not Provided","WXS","4 phenotype datasets, 13 variables, 1 samples sequenced,  SRA, 1 subjects, 1 samples","","NHGRI","GRU --- General Research Use","2011-10-20","2011-10-20","CPEO; CPEO - chronic progressive external ophthalmoplegia; Chronic Progressive External Ophthalmoplegia; Chronic progressive ophthalmoplegia; Disease, Graefe; Dystrophy, Ocular Muscular",""
"phs000265.v3.p1","The Human Gut Microbiome and Recurrent Abdominal Pain in Children","This project explores the nature of the human intestinal microbiome in healthy children and children with recurrent abdominal pain. The overall goal is to obtain a robust knowledge-base of the  intestinal microbiome in children without evidence of pain or gastrointestinal disease, children with functional abdominal pain, and children with","Not Applicable","Irritable Bowel Syndrome","Metagenomics","Not Provided","AMPLICON","4 phenotype datasets, 43 variables, 5 documents, 91 samples sequenced,  SRA, 69 subjects, 127 samples","","NIDDK","HMP --- Microbiome","2011-10-17","2011-06-07","Abdominal Pain; Digestive System Diseases; Digestive System Disease; Digestive System Disorder; Gastrointestinal and digestive disorder; System Disorders, Digestive",""
"phs000379.v1.p1","Genetic Epidemiology Network of Arteriopathy (GENOA)","The Genetic Epidemiology Network of Arteriopathy (GENOA): GENOA is one of four research networks that form the NHLBI Family Blood Pressure Program (FBPP). From its inception in 1995, GENOA's long-term  objective was to elucidate the genetics of hypertension and its arteriosclerotic target-organ damage, including both atherosclerotic (macrovascular)","Not Applicable","Peripheral Arterial Disease","Family/Twin/Trios","Not Provided","Not Provided","1 documents, 19 analyses","","NHLBI","GRU --- General Research Use","2011-10-05","","Kidney Diseases; Leukoaraiosis; Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000388.v1.p1","IPM BioBank GWAS","The Institute for Personalized Medicine (IPM) Biobank Project is a consented, EMR-linked medical care setting biorepository of the Mount Sinai Medical Center (MSMC) drawing from a population of over 70,000  inpatients and 800,000 outpatient visits annually. MSMC serves diverse local communities of upper Manhattan, including Central Harlem (86% African","Not Applicable","Metabolic Syndrome","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","3 phenotype datasets, 13 variables, 6 documents, 1 molecular datasets, 2867 subjects, 2867 samples","Other (147), East Asian (1), Hispanic2 (152), Other Asian or Pacific Islander (2), European (700), African American (1038), Hispanic1 (704), African (102), South Asian (21)","NHGRI","HR_MSSM --- Health/Medical/Biomedical (GSO)","2011-09-21","2012-09-21","Chronic Kidney Failure; Dyslipidemias; Hypertension; Metabolic Syndrome X; CRF - Chronic Renal Failure; Chronic Renal Disease",""
"phs000358.v1.p1","PGC: the PUWMa GWAS of ADHD","The PUWMa GWAS of ADHD is a multi-site collaboration initiated to conduct a family-based association study from existing research samples. The source sample of ADHD families was ascertained at Massachusetts  General Hospital (MGH, N 309 trios), Washington University at St. Louis (WASH-U, N 272 trios), and University of California at Los Angeles (UCLA, N","Not Applicable","Attention Deficit Disorder with Hyperactivity","Family/Twin/Trios","Human1M-Duo","SNP Genotypes (Array)","4 phenotype datasets, 38 variables, 1 documents, 1 molecular datasets, 1383 subjects, 1383 samples","Other (6), East Asian (5), Hispanic2 (47), Other Asian or Pacific Islander (2), European (1284), African American (23), Hispanic1 (13), African (3)","NIMH","ADHD_RD --- ADHD and Related Disorders","2011-09-15","2011-12-15","Attention Deficit Hyperactivity Disorder; ADD; ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorders with Hyperactivity","dbGaP Collection: Psychiatric Genomics Consortium (PGC) dbGaP Datasets (phs001254.v1.p1)"
"phs000290.v1.p1","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Pulmonary Arterial    Hypertension)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the human  genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public health and","Not Applicable","Hypertension, Pulmonary","Case-Control","WES_markerset_grc37, WES_markerset_grc36","SNP Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 2 molecular datasets, 78 samples sequenced,  SRA, 96 subjects, 94 samples","","NHLBI","GRU --- General Research Use","2011-09-06","2011-12-06","Scleroderma, Systemic; Diffuse Scleroderma; Diffuse Sclerosis; PSS (progressive systemic sclerosis); SS - Systemic sclerosis; SSc","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs000302.v1.p1","Genetic Study on Nephropathy in Type-2 Diabetes","A collection of patients with type-2 diabetes was collected at the Joslin Diabetes Center. Patients were categorized to a group of cases with diabetic nephropathy, and a group of controls  with normoalbuminuria. From these groups, 173 cases and 177 controls were randomly selected for a genome-wide association study. Inclusion as","Not Applicable","Diabetic Nephropathies","Case-Control","HumanCNV370-Duo","SNP Genotypes (Array)","3 phenotype datasets, 15 variables, 3 documents, 1 molecular datasets, 350 subjects, 350 samples","East Asian (2), Hispanic2 (3), European (326), African American (11), Hispanic1 (6), African (1), South Asian (1)","NIDDK","DIABCOMP --- diabetes and complications","2011-08-19","2012-08-19","DKD; Diabetic Kidney Disease; Diabetic Kidney Diseases; Diabetic nephropathy; Diabetic renal disease; Kidney Disease, Diabetic",""
"phs000365.v1.p1","Genetic Basis of XMEN Disease","The etiologies of primary immunodeficiencies often yield novel insights about the immune system. Although a genetic etiology has been suspected for patients with abnormally low CD4+ T cells in the  absence of HIV infection or any known causes of lymphopenia, no genetic mutation has been described to date for any case of primary CD4 lymphopenia.","Not Applicable","Immune System Diseases","Case-Control","Not Provided","WXS","5 phenotype datasets, 27 variables, 6 samples sequenced,  SRA, 3 subjects, 6 samples","","NIAID","DIS --- Diseases of the Immune System","2011-08-16","2012-05-16","Disease, Immune; Disease, Immune System; Disease, Immunologic; Disease, Immunological; Diseases of Immune System; Disorder, Immune System",""
"phs000353.v1.p1","GENEVA Study of Preterm Delivery (African-American)","Preterm delivery resulting in the birth of a premature infant is a complex problem with a devastating impact on individuals, families and society. The prevalence of preterm birth has increased  steadily in developed countries over the last 20 years and more than three million children die of preterm birth worldwide each year. Despite the","Not Applicable","Premature Birth","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array), SNP Genotypes (imputed)","10 phenotype datasets, 290 variables, 52 documents, 2 molecular datasets, 3478 subjects, 2203 samples","Other (27), East Asian (2), Hispanic2 (160), Other Asian or Pacific Islander (6), European (200), African American (1676), Hispanic1 (38), African (25), South Asian (7)","NHGRI","PTB --- Preterm Birth and its Complications","2011-08-16","2012-08-16","Birth, Premature; Birth, Preterm; Births, Premature; Births, Preterm; Premature Births; Premature delivery",""
"phs000240.v1.p1","NEI Ocular Hypertension Treatment Study (OHTS)","The Ocular Hypertension Treatment Study (OHTS) is an National Eye Institute-sponsored multi-center, randomized, prospective treatment trial designed to determine whether lowering intraocular pressure (IOP) in individuals with ocular hypertension delays  or prevents the development of primary open angle glaucoma (POAG). A total of 1,636 individuals with ocular hypertension between 40 and 80 years old","Not Applicable","Glaucoma, Open-Angle","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array)","3 phenotype datasets, 20 variables, 4 documents, 1 molecular datasets, 1063 subjects, 1131 samples","Other (8), East Asian (7), Hispanic2 (17), Other Asian or Pacific Islander (2), European (756), African American (242), Hispanic1 (14), African (9), South Asian (2)","NEI","GRC --- Glaucoma and related conditions","2011-08-03","2012-08-03","Ocular Hypertension; Compensated Glaucoma; Compensative Glaucoma; Glaucoma Simplex; Glaucoma, Compensated; Glaucoma, Compensative",""
"phs000366.v1.p1","NHLBI: Cooperative Study of Sickle Cell Disease (CSSCD)","Phenotypic heterogeneity is characteristic of sickle cell anemia, a Mendelian disorder caused by homozygosity for the sickle HBB gene (glu6val). Patients have different rates of hemolysis/vasculopathy and viscosity/vasoocclusion-related complications. These  complications account for a substantial reduction in life expectancy. In 1994, the median life expectancy for men and women with sickle cell anemia","Not Applicable","Anemia, Sickle Cell","Prospective Longitudinal Cohort","Not Provided","Not Provided","1 analyses","","NHLBI","GRU --- General Research Use","2011-08-02","","Sickle Cell Anemia; Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000273.v1.p1","High-Throughput Retrotransposon Discovery in Humans","The aim of this study is to discover LINE-1 (L1) insertion sites present in humans that are absent from the reference genome sequence. We use the distinguishing nucleotide characteristics of  human-specific L1 elements to resequence the L1 3' flanking regions thus locating the L1 insertion sites whether or not they are present in the","Not Applicable","Health","Cross-Sectional","Not Provided","AMPLICON, CLONE","3 phenotype datasets, 14 variables, 1 documents, 25 samples sequenced,  SRA, 25 subjects, 25 samples","","NIGMS","GRU --- General Research Use","2011-07-12","","Not Provided",""
"phs000250.v1.p1","CALGB 80303: Genome-Wide Association Study of Advanced Pancreatic Cancer    Patients","CALGB 80303 was a randomized, phase III study in advanced pancreatic cancer patients treated with Gemcitabine plus either Bevacizumab or placebo. No difference in overall survival (OS) was observed between  the two arms. We prospectively collected germline DNA and conducted a genome-wide association study (GWAS). 1. No documented invasion of adjacent","Not Applicable","Pancreatic Neoplasms","Case-Control","HumanHap550","SNP Genotypes (Array)","3 phenotype datasets, 32 variables, 1 molecular datasets, 351 subjects, 351 samples","Other (1), East Asian (4), Hispanic2 (6), Other Asian or Pacific Islander (1), European (307), African American (27), Hispanic1 (3), African (1), South Asian (1)","NIGMS","APTC --- For use in future research to learn about, prevent or treat cancer","2011-07-08","2012-07-08","Cancer of the pancreas; Neoplasia of the pancreas; Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic",""
"phs000344.v1.p1","Genome-Wide Association Study of Amyotrophic Lateral Sclerosis in Finland","The genetic etiology of amyotrophic lateral sclerosis (ALS) is not well understood. Finland has one of the highest incidence of ALS in the world, making it an ideal population for  study. To identify genetic risk factors for this fatal neurodegenerative disease, we undertook a genome-wide association study of 405 Finnish","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","HumanCNV370-Quad, HumanCNV370-Duo, Human1M-Duo","SNP Genotypes (Array)","3 phenotype datasets, 18 variables, 1 molecular datasets, 896 subjects, 896 samples","","NINDS","GRU --- General Research Use","2011-06-30","2011-06-30","ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease; Disease, Lou-Gehrigs","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000289.v2.p1","NHGRI Genome-Wide Association Study of Venous Thromboembolism (GWAS of    VTE)","Overview: Our overall long-term goal is to determine risk factors for the complex (multifactorial) disease, venous thromboembolism (VTE), that will allow physicians to stratify individual patient risk and target VTE  prophylaxis to those who would benefit most. In this genome-wide association case-control study (1300 cases and 1300 controls) we hope to identify","Not Applicable","Venous Thrombosis","Case-Control","Human660W-Quad","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 53 variables, 4 documents, 2 molecular datasets, 2597 subjects, 2760 samples","Other (2), East Asian (1), Hispanic2 (22), Other Asian or Pacific Islander (1), European (2555), African American (1), Hispanic1 (11), South Asian (1)","NHGRI","GRU --- General Research Use","2011-06-28","2011-09-20","Pulmonary Embolism; Thrombophlebitis; Blood clot in vein; Phlebothromboses; Phlebothrombosis; Thromboses, Venous",""
"phs000361.v1.p1","Genome-Wide Association Studies in Upper Gastrointestinal Cancers (Asian)","This project aims to conduct genome-wide association studies (GWAS) in two anatomically different upper gastrointestinal (UGI) cancer sites in two populations with distinctly different disease rates and genetic profiles. One  population has very high rates for both esophageal squamous cell carcinomas (ESCCs) and gastric cancers (GCs) and is comprised of Asians (the ""Asian","Not Applicable","Intestinal Neoplasms","Case-Control","Human660W-Quad","SNP Genotypes (Array)","3 phenotype datasets, 10 variables, 1 documents, 2 analyses, 1 molecular datasets, 5623 subjects, 5754 samples","","NCI","CODA --- Cancer and other important diseases in adults, EGA --- Esophageal and gastric cancer in adults","2011-06-21","2011-06-21","Esophageal Cancer; Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophageal neoplasm; Esophageal tumour",""
"phs000221.v1.p1","NHLBI Family Heart Study (FamHS)","The Family Heart Study (FamHS) was funded by the National Heart, Lung, and Blood Institute (NHLBI). It was begun in 1992 with the ascertainment of 1,200 families, half randomly sampled,  and half selected because of an excess of coronary heart disease (CHD) or risk factor abnormalities as compared with age- and sex-specific population","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","99 analyses","","NHLBI","GRU --- General Research Use","2011-06-21","2011-06-21","Atherosclerosis; Coronary Heart Diseases; Atherogeneses; Atherogenesis; Adverse Cardiac Event; Adverse Cardiac Events","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1)"
"phs000336.v1.p1","DCEG Lung Cancer Study","Three genetic loci for lung cancer risk have been identified by genome-wide association studies (GWAS), but inherited susceptibility to specific histologic types of lung cancer is not well established. We  conducted a GWAS of lung cancer and its major histologic types genotyping 515,922 single nucleotide polymorphisms (SNPs) in 5,739 incident lung","Not Applicable","Lung Neoplasms","Prospective Longitudinal Cohort","Human1M-Duo, Human610-Quad, HumanHap240S, HumanHap300, HumanHap550","SNP Genotypes (Array)","3 phenotype datasets, 14 variables, 1 documents, 1 molecular datasets, 11517 subjects, 13073 samples","","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods, SLD --- Research related to lung disease or smoking","2011-05-27","2011-05-27","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs000351.v1.p1","NCI Genome-Wide Association Study of Renal Cell Carcinoma","The National Cancer Institute (NCI) genome-wide association study (GWAS) of renal cell carcinoma (RCC) was conducted to investigate common genetic variants associated with RCC risk. The GWAS includes 1,453 RCC  cases and 3,531 controls of European background from 4 studies (3 cohort, 1 case-control), scanned using the Illumina InfiniumHumanHap 550, 610 and","Not Applicable","Carcinoma, Renal Cell","Case-Control","HumanHap550, Human610-Quad, Human660W-Quad","SNP Genotypes (Array)","3 phenotype datasets, 9 variables, 1 documents, 1 molecular datasets, 4735 subjects, 4909 samples","","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods","2011-05-17","2011-05-17","Kidney Neoplasms; ADENOCARCINOMA OF KIDNEY; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell",""
"phs000396.v1.p1","DCEG Imputation Reference Dataset","We have built a new resource for imputation of SNPs for existing and future genome-wide association studies (GWAS), known as the Division of Cancer Epidemiology and Genetics (DCEG) Reference Set.  The first build of the data set includes 728 cancer-free individuals of European descent from three large prospectively sampled studies, 98","Not Applicable","National Program of Cancer Registries","Clinical Trial","imputation_panel","SNP Genotypes (imputed)","2 phenotype datasets, 4 variables, 1 molecular datasets, 1249 subjects, 1249 samples","","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods, EGC --- Esophageal and stomach cancer","2011-05-07","2011-05-07","Not Provided",""
"phs000349.v1.p1","SNPs and Extent of Atherosclerosis (SEA) Study","The SEA study is a genome-wide association study to identify genetic variants associated with premature atherosclerosis in subjects included in the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) repository -  a unique NHLBI resource including data, DNA and arterial specimens from over 3000 multi-ethnic subjects 15-34 years of age who died of","Not Applicable","Atherosclerosis","Case-Control","Perlegen_Array","SNP Genotypes (Array)","3 phenotype datasets, 21 variables, 1 documents, 1 molecular datasets, 1068 subjects, 1068 samples","","NHLBI","GRU --- General Research Use","2011-05-05","2011-05-05","Atherogeneses; Atherogenesis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000311.v1.p1","FusionSeq: Finding Fusions with Paired-End RNA-Seq","We have developed FusionSeq to identify fusion transcripts from paired-end RNA-sequencing. FusionSeq includes filters to remove spurious candidate fusions with artifacts such as misalignments or random pairing of transcript fragments  and it ranks candidates according to several statistics. It also has a module to identify exact sequences at breakpoint junctions. FusionSeq detected","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 27 variables, 8 samples sequenced,  SRA, 8 subjects, 8 samples","","NHGRI","PPC --- Health/Medical/Biomedical (NPU)","2011-05-03","2011-05-03","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs000310.v1.p1","Discovery of Non-ETS Gene Fusions using RNA Sequencing","Half of prostate cancers harbor gene fusions between TMPRSS2 and members of the ETS transcription factor family. To date little is known about the presence of non-ETS fusion events in  prostate cancer. We employed next-generation transcriptome sequencing (RNA-Seq) in order to explore the whole transcriptome of 25 human prostate","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","RNA-Seq","4 phenotype datasets, 30 variables, 28 samples sequenced,  SRA, 28 subjects, 28 samples","","NHGRI","PPC --- Health/Medical/Biomedical (NPU)","2011-05-02","2011-05-02","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs000338.v1.p1","National Institute on Aging (NIA) SardiNIA Study","Sardinia is the second largest island in the Mediterranean and constitutes a genetically isolated founder population. This population has aided in the identification of genes involved in several Mendelian disorders  and is attractive for genetic studies due to its organization in long-established settlements that developed from an initial group of founder","Not Applicable","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Provided","98 analyses","","NIA","GRU --- General Research Use","2011-04-26","","Adverse Cardiac Event; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events; Cardiac Events, Adverse",""
"phs000237.v1.p1","Northwestern NUgene Project: Type 2 Diabetes","The ability to correlate genetic variation with disease susceptibility and response to drug therapy depends on genotype or sequence analysis of large numbers of richly characterized DNA samples. Eight years  agoWe are a part of NHGRI's electronic Medical Records and Genomics (eMERGE) Network, whose goal is to conduct genome-wide association studies in","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","Human660W-Quad, Human1M-Duo","SNP Genotypes (Array)","4 phenotype datasets, 41 variables, 3 documents, 2 molecular datasets, 3563 subjects, 3539 samples","Other (14), East Asian (3), Hispanic2 (27), Other Asian or Pacific Islander (8), European (1738), African American (1586), Hispanic1 (25), African (35), South Asian (1)","NHGRI","HR_VU --- Health/Medical/Biomedical (GSO), HR_NWU --- Health Research - Northwestern U","2011-04-22","2012-04-22","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000258.v2.p1","Human Gut Microbiome in Amish Obesity","Emerging evidence that the gut microbiota may contribute in important ways to human health and disease has led us and others to hypothesize that both symbiotic and pathological relationships between  gut microbes and their host may be key contributors to obesity and the metabolic complications of obesity. Our ""Thrifty Microbiome Hypothesis"" poses","Not Applicable","Obesity","Metagenomics","Not Provided","AMPLICON","3 phenotype datasets, 21 variables, 20 documents, 321 samples sequenced,  SRA, 404 subjects, 599 samples","","NIDDK","HMP --- Human Microbiome Research","2011-04-15","2011-06-23","Obesity, Morbid; Morbid Obesities; Morbid Obesity; OBESITY, SEVERE; Obesities, Morbid; Obesities, Severe",""
"phs000264.v2.p1","The Human Virome and Febrile Illness in Children","Definition of the human microbiome is an important scientific priority. This study will expand the scope of the investigation to include viruses, which account for a substantial proportion of infectious  disease morbidity and mortality, especially in children. The long-term goal of this project is to describe the human virome in children and to","Not Applicable","Virus Diseases","Metagenomics","Not Provided","FL-cDNA","4 phenotype datasets, 35 variables, 2 documents, 228 samples sequenced,  SRA, 183 subjects, 249 samples","","NIAID","HMP --- Human Microbiome Research","2011-03-22","2011-06-23","Fever of Unknown Origin; Disease caused by virus; Disease due to virus; Disease, Viral; Disease, Virus; Diseases, Viral",""
"phs000252.v2.p1","Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease","We investigate the hypothesis that consistent changes in the human gut microbiome are associated with Crohn's disease, a form of inflammatory bowel disease, and that altered microbiota contributes to pathogenesis.  Analysis of this problem is greatly complicated by the fact that multiple factors influence the composition of the gut microbiota, including diet,","Not Applicable","Crohn Disease","Prospective Longitudinal Cohort","Not Provided","AMPLICON, WGS","5 phenotype datasets, 421 variables, 534 samples sequenced,  SRA, 128 subjects, 596 samples","","NIDDK","HMP --- Human Microbiome Research","2011-03-16","2011-06-28","CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's disease of colon; Crohn's disease of large bowel",""
"phs000259.v2.p1","Urethral Microbiome of Adolescent Males","Urethral microbiome of adolescent males is designed to characterize the microbial communities resident in the urethra of young men, to identify differences in these communities as a function of race/ethnicity,  circumcision status, sexual exposures, and uro-genital symptoms. We collect detailed sexual behavior and symptoms data using cellular telephones with","Not Applicable","Urethritis","Metagenomics","Not Provided","AMPLICON, WGS","6 phenotype datasets, 46 variables, 142 samples sequenced,  SRA, 55 subjects, 144 samples","","NIAID","HMP --- Human Microbiome Research","2011-03-10","2010-06-07","Dysuria; Prostatitis; Sexually Transmitted Diseases, Bacterial; Acute Bacterial Prostatitides; Acute Bacterial Prostatitis; Acute inflammation of prostate caused by bacteria",""
"phs000268.v1.p1","Genotyping NIGMS CEPH Samples from the United States, Venezuela, and    France","The Human Genetic Cell Repository (HGCR) is sponsored by the National Institute of General Medical Sciences (NIGMS) with the mission of supplying scientists with the materials for accelerating disease gene  discovery and functional studies. The resources available include highly-characterized, contaminant-free fibroblast cell lines, transformed","Not Applicable","Cell Line","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 181 subjects, 184 samples","","NIGMS","GRU --- General Research Use","2011-02-25","2011-02-25","Not Provided",""
"phs000330.v1.p1","The Genomic Complexity of Primary Human Prostate Cancer","Seven primary prostate cancers and their paired normal counterparts were DNA-sequenced on a massively parallel sequencing platform. This approach was taken to investigate the genomes for mutations and genomic alterations  that would be undetectable by lower-resolution methods. As result, tumors containing chains of balanced rearrangements that occurred within or","Not Applicable","Prostatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","WGS","4 phenotype datasets, 34 variables, 1 documents, 14 samples sequenced,  SRA, 7 subjects, 14 samples","","NHGRI","HMB-NPU --- Health/Medical/Biomedical (NPU)","2011-02-10","2011-02-10","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs000308.v1.p1","The Glaucoma Genes and Environment (GLAUGEN) Study","Background Information: Primary open-angle glaucoma (POAG) is an age-related, intraocular pressure (IOP)-dependent progressive optic neuropathy that ultimately leads to irreversible blindness. Vision loss from POAG is a condition of public  health significance. Current evidence suggests that POAG is a polygenetic disease modified by environmental influences. Despite the fact that a","Not Applicable","Glaucoma, Open-Angle","Case-Control","Human660W-Quad, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 59 variables, 21 documents, 2 molecular datasets, 2289 subjects, 2243 samples","Other (2), Hispanic2 (12), Other Asian or Pacific Islander (2), European (2148), African American (2), Hispanic1 (18), African (1)","NEI","MEEI --- Massachusetts Eye and Ear Infirmary, GRU --- General Research Use","2010-12-21","2011-12-21","Low Tension Glaucoma; Compensated Glaucoma; Compensative Glaucoma; Glaucoma Simplex; Glaucoma, Compensated; Glaucoma, Compensative",""
"phs000305.v1.p1","PGRN-RIKEN NSABP Prevention Study","The primary aim of this study is to identify genes related to the occurrence of breast events, defined as occurrence of invasive breast cancer or ductal carcinoma in situ (DCIS),  in women at high risk of developing breast cancer who have received a Selective Estrogen Receptor Modulator (SERM - tamoxifen or raloxifene) on the","Not Applicable","Breast Neoplasms","Case-Control","Human610-Quad","SNP Genotypes (Array)","3 phenotype datasets, 55 variables, 2 documents, 1 molecular datasets, 1763 subjects, 1763 samples","","NIGMS","APTC --- For use in the future research to learn about, prevent or treat cancer","2010-11-16","2011-11-16","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000203.v1.p1","A Genome-Wide Association Study of Peripheral Arterial Disease","The Electronic Medical Record Phenotypes and Community-engaged Genomic Association Study aims to identify genetic variants mediating susceptibility to peripheral arterial disease (PAD). The study leverages a biorepository of blood samples  of 1688 PAD cases and 1649 controls, and the electronic medical record (EMR) to annotate the biorepository. PAD cases were identified from the","Not Applicable","Peripheral Vascular Diseases","Case-Control","Human660W-Quad","SNP Genotypes (Array)","4 phenotype datasets, 44 variables, 3 documents, 1 molecular datasets, 3337 subjects, 3432 samples","Other (1), East Asian (2), Hispanic2 (13), European (3298), African American (14), Hispanic1 (1), African (2), South Asian (6)","NHGRI","HR_MYO --- Health/Medical/Biomedical (PUB, GSO)","2010-11-05","2011-11-05","Angiopathies, Peripheral; Angiopathy, Peripheral; Disease, Peripheral Vascular; Diseases, Peripheral Vascular; PVD - peripheral vascular disease; Peripheral Angiopathies",""
"phs000021.v3.p2","Genome-Wide Association Study of Schizophrenia","The goal of the study is to find susceptibility genes for schizophrenia. Dataset versioning Version 1: European-American (EA) ancestry only Version 2: Version 1 plus African-American (AA) ancestry Consent groups  and participant set General research use (GRU): 4591 cases and controls (1217 EA cases, 1442 EA controls, 953 AA cases, 979 AA controls) This consent","Not Applicable","Schizophrenia","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","8 phenotype datasets, 824 variables, 29 documents, 2 analyses, 2 molecular datasets, 5064 subjects, 5064 samples","Other (4), Hispanic2 (5), European (2718), African American (2072), Hispanic1 (20), African (44)","NIMH","GRU --- General Research Use, SARC --- Schizophrenia and Related Conditions","2010-10-28","2008-12-03","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCZD; Schizophrenias; Schizophrenic Disorder","dbGaP Collection: Open Translational Science in Schizophrenia (OPTICS) (phs000887.v1.p1); dbGaP Collection: Psychiatric Genomics Consortium (PGC) dbGaP Datasets (phs001254.v1.p1)"
"phs000245.v1.p1","Whole Genome Sequencing of Triple Negative Breast Cancer","Breast Cancer Subject Participant ID 700064 (Source Sample names: 6888 and 206). We used massively parallel DNA sequencing technologies to screen entire genomes, in an unbiased manner, for genetic changes  associated with tumor growth and metastasis. We describe the complete genome sequence analysis of four DNA samples from a 44-year old","Not Applicable","Breast Neoplasms","Tumor vs. Matched-Normal","Not Provided","WGS","4 phenotype datasets, 21 variables, 4 samples sequenced,  SRA, 1 subjects, 4 samples","","NHGRI","CR --- Cancer Research","2010-10-08","2010-10-08","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000188.v1.p1","Vanderbilt Genome-Electronic Records (VGER) Project: QRS Duration","An important potential enabling resource for Personalized Medicine is the combination of a DNA repository with Electronic Medical Record (EMR) systems sufficiently robust to provide excellence in clinical care and  to serve as resources for analysis of disease susceptibility and therapeutic outcomes across patient populations. The Vanderbilt EMR is a state of","Not Applicable","Heart Conduction System","Case Set","Human660W-Quad, Human1M-Duo","SNP Genotypes (Array)","5 phenotype datasets, 36 variables, 1 molecular datasets, 3021 subjects, 3203 samples","Other (7), East Asian (4), Hispanic2 (9), Other Asian or Pacific Islander (7), European (2501), African American (469), Hispanic1 (12), African (8), South Asian (4)","NHGRI","HR_VU --- Health Research - Northwestern U, HR_NWU --- Health Research - Northwestern U","2010-10-08","2011-10-08","Not Provided",""
"phs000103.v1.p1","GENEVA Study of Preterm Delivery (DNBC/Iowa)","Preterm labor resulting in the delivery of a premature child is a complex problem with an enormous impact on individuals, families and society. An estimated 500,000 children are born prematurely  in the U.S. each year, and 5 million worldwide die annually of prematurity and its complications. Prematurity is also the single largest contributor","Not Applicable","Premature Birth","Case-Control","Human660W-Quad","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 63 variables, 10 documents, 2 molecular datasets, 4136 subjects, 3945 samples","Other (2), Hispanic2 (2), Other Asian or Pacific Islander (3), European (3830), Hispanic1 (1)","NHGRI","GRU --- General Research Use","2010-10-08","2011-10-08","Birth, Premature; Birth, Preterm; Births, Premature; Births, Preterm; Premature Births; Premature delivery",""
"phs000225.v1.p1","Expression QTL (eQTL) Analysis in Human Primary Cells","The common genetic variants associated with complex traits typically lie in non-coding DNA and may alter gene regulation in a cell type-specific manner. Consequently, the choice of tissue or cell  model in the dissection of disease associations is important. We carried out an expression quantitative trait loci (eQTL) study of primary human","Not Applicable","Osteoporosis","Case-Control","Not Provided","Not Provided","Not Provided","","NIAMS","GRU --- General Research Use","2010-10-01","2010-10-01","Age Related Osteoporosis; Age-Related Bone Loss; Age-Related Bone Losses; Age-Related Osteoporoses; Age-Related Osteoporosis; Bone Loss, Age Related",""
"phs000272.v1.p1","Genome-Wide Association Study of Beh&#x000e7;et's Disease (Turkish)","Introduction Beh&#x000e7;et's disease (BD) is a genetically complex multisystem disease of unknown etiology, characterized by recurrent inflammatory attacks affecting orogenital mucosa, eyes, skin, joints, blood vessels, and less frequently, the  central nervous system and gastrointestinal tract. Family studies suggest a genetically complex contribution to BD. With the exception of HLA-B51,","Not Applicable","Behcet Syndrome","Case-Control","HumanCNV370-Duo","SNP Genotypes (Array)","3 phenotype datasets, 7 variables, 1 analyses, 1 molecular datasets, 2493 subjects, 2493 samples","","NIAMS","GRU --- General Research Use","2010-09-27","2011-09-27","Adamantiades Behcet Disease; Adamantiades-Behcet Disease; Adamantiades-Behcet Diseases; BD; BEHCET DISEASE; Bechet syndrome",""
"phs000127.v2.p1","Study of Irish Amyotrophic Lateral Sclerosis (SIALS)","Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by loss of motor neurons. Epidemiological studies indicate that 2-5% of cases are familial, usually with an autosomal dominant pattern  of inheritance. For a portion of these, causative genes have been identified. The remaining 95% of ALS cases are described as sporadic, and believed","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","HumanHap550","SNP Genotypes (Array), WGS","4 phenotype datasets, 17 variables, 1 analyses, 1 molecular datasets, 1 samples sequenced,  SRA, 432 subjects, 432 samples","","NINDS","NPU --- Non-profit_use","2010-09-07","2008-10-06","Motor Neuron Disease; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease; Charcot Disease",""
"phs000294.v1.p1","STAMPEED: Myocardial Infarction Genetics Consortium (MIGen)","Myocardial infarction (MI) is a common complex disease and the leading cause of death and disability worldwide. The genetic basis of this disease is largely unknown. It has been thought  that early-onset MI events would have a substantially greater heritability, thus making DNA collections with younger individuals desirable. More","Not Applicable","Myocardial Infarction","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 29 variables, 1 molecular datasets, 6042 subjects, 6042 samples","Other (20), Hispanic2 (20), Other Asian or Pacific Islander (3), European (5943), African American (35), Hispanic1 (9), African (3), South Asian (9)","NHLBI","GRU --- General Research Use","2010-08-24","2010-08-24","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Allowed) (phs003132.v1.p1)"
"phs000244.v1.p1","Genetic Analysis of Limb Malformation Disorders: Miller Syndrome    Sequencing Study (LMD-MS)","The overall goal of this project is to investigate the etiology and pathogenesis of malformations (i.e., birth defects) of the limb, concentrating on abnormalities of limb patterning such as limb  deficiency/duplications and multiple congenital contractures. The exome sequences of two siblings and two unrelated individuals were obtained by","Not Applicable","Genee-Wiedemann syndrome","Mendelian","Not Provided","WGS, WXS","3 phenotype datasets, 14 variables, 8 samples sequenced,  SRA, 6 subjects, 8 samples","","NHLBI","GRU --- Miller Syndrome Exome - General Research Use","2010-08-19","2010-08-19","Ciliary Motility Disorders; Mandibulofacial Dysostosis; Ciliary Dyskinesia; Ciliary Dyskinesias; Ciliary Motility Disorder; Dextrocardia bronchiectasis and sinusitis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs000204.v1.p1","Genetic Analysis of Limb Malformation Disorders: Freeman Sheldon Syndrome    Exome Sequencing Study (LMD-FSS)","The overall goal of this project is to investigate the etiology and pathogenesis of malformations (i.e., birth defects) of the limb, concentrating on abnormalities of limb patterning such as limb  deficiency/duplications and multiple congenital contractures. The exome sequences of four unrelated individuals were obtained by massively parallel","Not Applicable","Freeman-Sheldon syndrome","Mendelian","Not Provided","WXS","2 phenotype datasets, 9 variables, 3 samples sequenced,  SRA, 3 subjects, 3 samples","","NHLBI","GRU --- Freeman Sheldon Syndrome Exome - General Research Use","2010-08-19","2010-08-19","Contracture; AMC; AMC - arthrogryposis multiplex congenita; Amyoplasia Congenita; Arthrogryposes; Arthrogryposes, Congenital Multiple","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1); dbGaP Collection: NHLBI Heart Failure Related dbGaP Data (No IRB    requirement) (phs001991.v1.p1); NHLBI's Collection of Datasets for General Research Use (Public Posting    of Genomic Summary Results: Not Allowed) (phs003131.v1.p1)"
"phs000269.v1.p1","Genotyping NIGMS Chromosomal Aberration and Inherited Disorder Samples","As part of an effort to correlate molecular copy number variation determinations with state of the art karyotype analyses, 716 samples derived from 697 individuals from the Chromosomal Aberrations and  Inherited Disorders collections of the NIGMS Human Genetic Cell Repository were genotyped and analyzed for CNV determination by the Microarray Center","Not Applicable","Chromosome Disorders","Cross-Sectional","Affymetrix_WG_Array","SNP Genotypes (Array)","3 phenotype datasets, 13 variables, 1 molecular datasets, 697 subjects, 716 samples","Other (9), East Asian (7), Hispanic2 (37), Other Asian or Pacific Islander (7), European (527), African American (67), Hispanic1 (25), African (8), South Asian (10)","NIGMS","GRU --- General Research Use","2010-08-10","2010-08-11","Anomaly of chromosome; Chromosomal Disorder; Chromosomal Disorders; Chromosomal abnormality syndrome; Chromosomal anomaly; Chromosomal hereditary disorder",""
"phs000292.v1.p1","GENEVA Genetics of Early Onset Stroke (GEOS) Study","The Genetics of Early Onset Stroke (GEOS) Study is a population-based case-control study designed to identify genes associated with early-onset ischemic stroke and to characterize interactions of identified stroke genes  and/or SNPs with environmental risk factors such as smoking and oral contraceptive use. The GEOS study consists of 921 ischemic stroke cases with age","Not Applicable","Stroke","Case-Control","HumanOmni1-Quad, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 33 variables, 4 documents, 3 molecular datasets, 1862 subjects, 1949 samples","Other (16), East Asian (9), Hispanic2 (13), Other Asian or Pacific Islander (6), European (990), African American (723), Hispanic1 (10), African (34), South Asian (16)","NHGRI","STROKE --- Genetic Studies of Stroke, MEDCOND --- Studies of Genes for Medical Conditions","2010-08-06","2011-08-06","Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents; CEREBROVASCULAR ACCIDENT; CVA",""
"phs000128.v3.p3","GAW16 Framingham and Simulated Data","Important links to apply for individual-level data 1. Genetic Analysis Workshop 2. Instructions to Request Authorized Access 3. Data Use Certification Requirements (DUC) 4. Apply here for controlled access to  individual level data 5. Research Use Statement Questions regarding GAW16 should be directed to Vanessa Olmo at vanessa@business-endeavors.com.","Not Applicable","Coronary Disease","Prospective Longitudinal Cohort","Affymetrix_50K, Affymetrix_WG_Array","Not Provided","207 phenotype datasets, 6582 variables, 6 documents, 2 molecular datasets, 14275 subjects, 7096 samples","","NHLBI","HMB-IRB-MDS --- Health/Medical/Biomedical (IRB, MDS)","2010-07-28","2008-10-19","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart",""
"phs000239.v2.p1","Genome, Epigenome and RNA Sequences of MZ Twins Discordant for MS","Monozygotic (MZ) twins have been widely employed for dissection of the relative contributions of genetics and environment in disease. In multiple sclerosis (MS), an autoimmune demyelinating disease that commonly causes  neurodegeneration and disability in young adults, disease discordance in MZ twins has been interpreted to indicate environmental importance in","Not Applicable","Multiple Sclerosis","Family/Twin/Trios","Not Provided","Bisulfite-Seq, FL-cDNA, WGS","5 phenotype datasets, 17 variables, 16 samples sequenced,  SRA, 6 subjects, 16 samples","","NINDS","GRU --- General Research Use","2010-07-27","2011-05-19","Lung Neoplasms; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors",""
"phs000138.v2.p1","GWAS for Genetic Determinants of Bone Fragility","Osteoporotic fractures are largely due to an increased propensity to fall with aging and a reduction in bone strength. Although skeletal architecture contributes to fracture risk, bone mineral density (BMD)  is the most important determinant of bone strength and fracture risk. Between 60 and 80% of the variance of BMD of adult Caucasian women is due to","Not Applicable","Osteoporosis","Case-Control","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 52 variables, 2 molecular datasets, 1493 subjects, 1590 samples","","NIA","GRU --- General Research Use","2010-07-01","2010-08-04","Osteoporosis, Postmenopausal; Age Related Osteoporosis; Age-Related Bone Loss; Age-Related Bone Losses; Age-Related Osteoporoses; Age-Related Osteoporosis","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000263.v1.p1","Metagenomic Study of the Human Skin Microbiome Associated with Acne","Acne vulgaris affects 17 million Americans, more than 80% of the people of age 12-24. The goal of this study is to investigate the relationship between acne pathogenesis and the  skin microbiota residing in the microcomedones. This study will enroll approximately 100 healthy individuals and acne patients, both male and female","Not Applicable","Acne Vulgaris","Metagenomics","Not Provided","Not Provided","5 phenotype datasets, 25 variables,  SRA, 94 subjects, 165 samples","","NIAMS","HMP --- Human Microbiome Research","2010-06-22","2011-06-22","",""
"phs000255.v1.p1","Effect of Crohn's Disease Risk Alleles on Enteric Microbiota","This UH2/UH3 demonstration project entitled ""Effects of Crohn's disease risk alleles on enteric microbiota"" is focused on characterizing intestinal associated microbiota in patients with ileal Crohn's disease (ileal CD), ulcerative  colitis (UC) and control patients without inflammatory bowel diseases (non-IBD). We hypothesize that genetic factors that affect Paneth cell","Not Applicable","Crohn Disease","Metagenomics","Not Provided","AMPLICON","6 phenotype datasets, 23 variables, 157 samples sequenced,  SRA, 228 subjects, 293 samples","","NIDDK","HMP --- Human Microbiome Research, BSDO --- Bacterial Sequence Data Only","2010-06-08","2011-06-08","Colitis, Ulcerative; Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - ulcerative colitis",""
"phs000187.v1.p1","High Density SNP Association Analysis of Melanoma","This research builds upon an extensive resource of melanoma cases and hospital based controls collected over several years at the U.T. M.D. Anderson Cancer Center. The goal of this research  is to identify novel susceptibility and outcome-related genes for melanoma using a systematic genome-wide association-based approach. Our goal is to","Not Applicable","Melanoma","Case-Control","HumanOmni1-Quad","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 38 variables, 7 documents, 3 molecular datasets, 3115 subjects, 3311 samples","","NCI","GRU --- General Research Use","2010-05-18","2011-05-18","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas","NCI's Collection of Datasets for General Research Use (phs003014.v1.p1)"
"phs000094.v1.p1","International Consortium to Identify Genes and Interactions Controlling    Oral Clefts","Oral clefts represent the most common group of craniofacial birth defects in humans, and include cleft lip with or without cleft palate (CL/P) and cleft palate (CP). Oral clefts have  a complex and heterogeneous etiology, with strong evidence for both genetic and environmental causal factors. Candidate gene studies and genome wide","Not Applicable","Cleft Palate","Family/Twin/Trios","Human610-Quad, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 39 variables, 29 documents, 2 molecular datasets, 7507 subjects, 7567 samples","Other (43), East Asian (3395), Hispanic2 (101), Other Asian or Pacific Islander (366), European (3094), African American (46), Hispanic1 (11), African (3), South Asian (30)","NIDCR","CFA --- Craniofacial Anomalies","2010-04-22","2011-04-22","Cleft Lips; CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lip; Cleft of upper lip",""
"phs000216.v1.p1","International Consortium on the Genetics of Systemic Lupus Erythematosus    (SLEGEN)","The genetic makeup of an individual strongly influences the risk of developing systemic lupus erythematosus (SLE). The identification of genes that predispose an individual to SLE will lead to earlier  and better diagnosis, better treatments, and possibly prevention. To this end, the International Consortium on the Genetics of Systemic Lupus","Not Applicable","Lupus Erythematosus, Systemic","Case-Control","Not Provided","Not Provided","1 analyses","","NIAMS","GRU --- General Research Use","2010-03-25","2010-03-25","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus",""
"phs000122.v1.p1","Whole Genome Association Study of Systemic Lupus Erythematosus","The goal of this collaborative study was to identify new genetic risk factors for Systemic Lupus Erythematosus (SLE). To do this we conducted a genome-wide scan by combining the resources  and expertise from a number of SLE researchers to establish a large sample set comprising 1311 SLE cases and 3340 controls. The SLE case samples were","Not Applicable","Lupus Erythematosus, Systemic","Case-Control","Not Provided","Not Provided","2 phenotype datasets, 19 variables, 1 analyses, 4651 subjects","","NIAMS","GRU --- General Research Use","2010-03-25","2010-03-25","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus",""
"phs000202.v1.p1","OMRF SLEGEN GWAS Data from European-American Women with Lupus","""Systemic lupus erythematosus (SLE) is a common systemic autoimmune disease with complex etiology but strong clustering in families (lambda(S) approximately 30). We performed a genome-wide association scan using 317,501 SNPs  in 720 women of European ancestry with SLE and in 2,337 controls, and we genotyped consistently associated SNPs in two additional independent sample","Not Applicable","Lupus Erythematosus, Systemic","Case-Control","HumanHap300","SNP Genotypes (Array)","3 phenotype datasets, 14 variables, 1 analyses, 1 molecular datasets, 297 subjects, 297 samples","","NIAMS","LRR --- Lupus Related Research","2010-03-24","2011-03-24","Disseminated lupus erythematosus; Lupus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus",""
"phs000219.v1.p1","GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)","GenADA is a multi-site collaborative study, involving GlaxoSmithKline Inc and nine medical centres in Canada, to develop a dataset containing 1000 Alzheimer's disease patients and 1000 ethnically-matched controls in order  to associate DNA sequence (allelic) variations in candidate genes with Alzheimer's disease phenotypes. The study consists of both retrospective and","Not Applicable","Alzheimer Disease","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","59 phenotype datasets, 1558 variables, 10 documents, 1 analyses, 1 molecular datasets, 1718 subjects, 1588 samples","","NIMH","GBA --- Genetic Basis of Alzheimer's","2010-01-21","2010-07-21","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Diseases",""
"phs000169.v1.p1","Whole Genome Association Study of Visceral Adiposity in the HABC Study","The Health Aging and Body Composition (Health ABC) Study is a NIA-sponsored cohort study of the factors that contribute to incident disability and the decline in function of healthier older  persons, with a particular emphasis on changes in body composition in old age. Between 4/15/97 and 6/5/98 the Health ABC study has recruited 3,075","Not Applicable","Obesity","Prospective Longitudinal Cohort","Human1M-Duo","SNP Genotypes (Array)","3 phenotype datasets, 17 variables, 2 documents, 1 molecular datasets, 2802 subjects, 2991 samples","Other (3), East Asian (1), Hispanic2 (2), European (1654), African American (1080), Hispanic1 (22), African (40)","NIA","GRU --- General Research Use","2010-01-15","2011-01-15","Cardiovascular Diseases; Diabetes Mellitus; Inflammation; Metabolic Syndrome X; Adverse Cardiac Event; Adverse Cardiac Events","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000207.v1.p1","CGEMS Prostate Cancer GWAS - Stage 1 - PLCO","The Cancer Genetic Markers of Susceptibility (CGEMS) prostate cancer genome-wide association study (GWAS) included genotyping approximately 550,000 SNPs (Phase 1A with HumanHap300 and Phase 1B HumanHap240, both from Illumina, San  Diego, CA) in 1,172 prostate cancer patients and 1,157 controls of European ancestry from the Prostate, Lung, Colon and Ovarian (PLCO,","Not Applicable","Prostatic Neoplasms","Case-Control","HumanHap240S, HumanHap300","SNP Genotypes (Array)","3 phenotype datasets, 10 variables, 2 analyses, 1 molecular datasets, 2252 subjects, 2300 samples","","NCI","CADM --- Research related to adult diseases and methods","2009-12-22","2009-12-22","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs000211.v1.p1","Genotyping 400 Samples from the NIGMS Human Variation Panels","The Human Genetic Cell Repository is sponsored by the National Institute of General Medical Sciences (NIGMS) with the mission of supplying scientists with the materials for accelerating disease gene discovery  and functional studies. The resources available include highly-characterized, contaminant-free cell cultures and high quality, well-characterized DNA","Not Applicable","Health","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","3 phenotype datasets, 11 variables, 1 molecular datasets, 400 subjects, 400 samples","","NIGMS","GRU --- General research use","2009-11-10","2009-11-10","Not Provided",""
"phs000181.v1.p1","Alcohol Research using Australian twins and their families (OZ-ALC)","The Australian twin-family study of alcohol use disorder (OZALC study) derives from telephone diagnostic interview studies of two general population volunteer cohorts of Australian twins (cohort 1, mostly born 1940-1964;  cohort 2, born 1964-71) and the spouses of the former cohort - a total of over 11,000 families. Three coordinated studies, using a shared assessment","Not Applicable","Alcohol-Related Disorders","Family/Twin/Trios","HumanCNV370-Duo, HumanCNV370-Quad","SNP Genotypes (Array)","4 phenotype datasets, 44 variables, 2 documents, 1 molecular datasets, 6775 subjects, 7084 samples","Other (29), East Asian (2), Other Asian or Pacific Islander (22), European (6629), Hispanic1 (2), South Asian (10)","NIAAA","RATRP --- Research on Alcohol and Tobacco Related Phenotypes","2009-11-10","2010-05-10","Tobacco Use Disorder; Alcohol Problem; Alcohol Problems; Depression; Depression Disorder; Depressive Disorder",""
"phs000199.v1.p1","CHOP Control CNV Study","We present a database of copy number variations (CNVs) detected in 2,026 disease-free individuals, using high-density, SNP-based oligonucleotide microarrays. This large cohort analyzed for CNVs in a single study using  a uniform array platform and computational tools, comprises mainly of Caucasians (65.2%) and African-Americans (34.2%), We have catalogued and","Not Applicable","Health","Case-Control","HumanHap550","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 molecular datasets, 2026 subjects, 2026 samples","","NIGMS","GRU --- General research use","2009-10-27","2009-10-27","Not Provided",""
"phs000093.v2.p2","A Genome Wide Scan of Lung Cancer and Smoking","The majority of cases of lung cancer are the culmination of a dynamic process that begins with smoking initiation, proceeds through dependency and smoking persistence, continues with lung cancer development  and ends with progression to disseminated disease or response to therapy and survival. We are conducting a whole genome study of lung cancer and","Not Applicable","Lung Neoplasms","Case-Control","HumanHap550, imputation_panel","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 34 variables, 33 documents, 3 molecular datasets, 5566 subjects, 11337 samples","","NCI","CADM --- Research related to adult diseases and methods, SLD --- Research related to smoking or lung disease","2009-10-22","2010-01-08","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs000210.v1.p1","PGRN-RIKEN MA.27 Mayo Aromatase Inhibitor Musculoskeletal Adverse Events    Study","Source of Patients The source of the patients for this genome-wide case control study was MA.27, which was conducted as a multi-cooperative group effort under the auspices of the NCI  Breast Cancer Intergroup of North America. The NCIC Clinical Trials Group (CTG) serves as the coordinating group, with participation by the","Not Applicable","Breast Neoplasms","Case-Control","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 27 variables, 1 documents, 1 molecular datasets, 879 subjects, 878 samples","","NIGMS","HR --- Health Research","2009-10-14","2010-10-14","Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors; Cancer breast",""
"phs000166.v2.p1","SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)","SNP Health Association Resource (SHARe) Asthma Resource project (SHARP) is conducting a genome-wide analysis in adults and children who have participated in National Heart, Lung, and Blood Institute's clinical research  trials on asthma. This includes 1041 children with asthma who participated in the Childhood Asthma Management Program (CAMP), 994 children who","Not Applicable","Asthma","Cross-Sectional","Affymetrix_WG_Array","SNP Genotypes (Array)","9 phenotype datasets, 348 variables, 39 documents, 1 molecular datasets, 4046 subjects, 4046 samples","","NHLBI","ARR --- Asthma-Related Research","2009-09-09","2009-12-11","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease",""
"phs000142.v1.p1","Whole Genome Association Twin Study of Myopia and Glaucoma Risk Factors","Myopia and glaucoma are highly prevalent ophthalmic disorders worldwide and contribute significantly to ocular morbidity. There is substantial evidence that genetic factors play a significant role in the development of  non-syndromic myopia and glaucoma. We propose to perform mapping studies for well-characterized twin populations in the United Kingdom and Australia","Not Applicable","Eye Diseases","Family/Twin/Trios","Human610-Quad","SNP Genotypes (Array)","4 phenotype datasets, 49 variables, 10 documents, 1 molecular datasets, 2928 subjects, 3124 samples","Other (9), East Asian (10), Hispanic2 (1), Other Asian or Pacific Islander (12), European (2870), African American (14), Hispanic1 (2), African (4), South Asian (6)","NEI","GRU --- General Research Use","2009-08-27","2009-10-27","Glaucoma; Myopia; Refractive Errors; Disease of eyeball; Disorder of eye proper; Disorder of eyeball",""
"phs000091.v2.p1","GENEVA Diabetes Study (NHS/HPFS)","Type 2 diabetes mellitus (T2D) affects approximately 21 million individuals in the U.S., or almost 10% of the U.S. adult population. Because diabetes is determined by both genetic and environmental  factors, a better understanding of the etiology of diabetes requires a careful investigation of gene-environment interactions. The Nurses' Health","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 37 variables, 24 documents, 3 molecular datasets, 6033 subjects, 6088 samples","Other (4), East Asian (34), Hispanic2 (29), Other Asian or Pacific Islander (6), European (5822), African American (48), Hispanic1 (12), African (2), South Asian (4)","NHGRI","NPU --- Non-Profit Use Only","2009-07-31","2010-07-31","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
"phs000167.v1.p1","Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)","This study is part of the Molecular Genetics of Schizophrenia (MGS) genome wide association study (GWAS) of 3,972 cases (2,686 EA and 1,286 AA) and 3,629 controls (2,656 EA and  973 AA) (analyzed sample remaining after quality control exclusions), comprised of European ancestry (EA) and African American (AA) samples. We","Not Applicable","Schizophrenia","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","6 phenotype datasets, 432 variables, 27 documents, 1 molecular datasets, 3029 subjects, 3061 samples","Other (11), Hispanic2 (11), Other Asian or Pacific Islander (1), European (2816), African American (113), Hispanic1 (13), African (3), South Asian (1)","NIMH","GRU --- General Research Use, SARC --- Schizophrenia and Related Conditions","2009-05-13","2010-02-13","Psychotic Disorders; Brief Reactive Psychoses; Brief psychotic disorder; Brief psychotic episodes; Brief reactive psychosis; Psychoses, Brief Reactive","dbGaP Collection: Open Translational Science in Schizophrenia (OPTICS) (phs000887.v1.p1)"
"phs000171.v1.p1","Genetic Multiple Sclerosis Associations - GeneMSA","This is a multi-centre, case-controlled study to develop a dataset containing 1000 MS cases and 1000 matched controls and to associate DNA sequence (allelic) variations with MS phenotypes. Study subjects  were enrolled through a prospective effort initiated in 2003. Three MS clinical centres were involved in subject recruitment and biological specimen","Not Applicable","Multiple Sclerosis","Case-Control","HumanHap550","SNP Genotypes (Array)","40 phenotype datasets, 740 variables, 5 documents, 1 analyses, 1 molecular datasets, 1920 subjects, 2054 samples","Other (17), Hispanic2 (44), Other Asian or Pacific Islander (2), European (1818), African American (1), Hispanic1 (9)","NINDS","MSG --- Multiple Sclerosis Genetics research","2009-05-12","2009-05-12","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple",""
"phs000144.v1.p1","NHGRI Tumor Sequencing Project (Lung Adenocarcinoma)","The Tumor Sequencing Project (TSP) Consortium is a collaboration among participants at the Baylor College of Medicine Human Genome Sequencing Center, the Broad Institute Genome Sequencing Platform, the Dana Farber  Cancer Institute, the Memorial Sloan-Kettering Cancer Center, the Genome Sequencing Center and Siteman Cancer Center at Washington University, the","Not Applicable","Neoplasms","Tumor vs. Matched-Normal","Affymetrix_WG_Array","SNP Genotypes (Array)","7 phenotype datasets, 48 variables, 1 molecular datasets, 384 subjects, 768 samples","","NHGRI","GRU --- General Research Use","2009-02-27","2009-02-27","Adenocarcinoma; Lung Neoplasms; ADNOS; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000017.v3.p1","Whole Genome Association Study of Bipolar Disorder","The goal of the project is to identify genes that make individuals more susceptible to bipolar disorder (manic depressive illness) and to better understand the brain pathways involved in the  disease. Dataset versioning Version 1: European-American (EA) ancestry only Version 2: Version 1 plus African-American (AA) ancestry Version 3: EA","Not Applicable","Bipolar Disorder","Case-Control","Affymetrix_WG_Array","SNP Genotypes (Array)","17 phenotype datasets, 8678 variables, 89 documents, 2 analyses, 2 molecular datasets, 3261 subjects, 3261 samples","","NIMH","GRU --- General Research Use, BARD --- Bipolar and related disorders, BDO --- Bipolar disorder only","2008-11-24","2008-12-01","Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders; Bipolar Mood Disorder","dbGaP Collection: Psychiatric Genomics Consortium (PGC) dbGaP Datasets (phs001254.v1.p1)"
"phs000088.v1.p1","Search for Susceptibility Genes for Diabetic Nephropathy in Type 1    Diabetes (GoKinD study participants and parents), NIDDK","Genetics of Kidneys in Diabetes (GoKinD) study is an initiative aimed at identifying susceptibility genes for diabetic nephropathy in type 1 diabetes. A large number of individuals with type 1  diabetes were screened to identify two subsets, one with clear-cut kidney disease and another with normal renal status despite long-term diabetes.","Not Applicable","Diabetic Nephropathies","Case-Control","Affymetrix_500K","SNP Genotypes (Array)","4 phenotype datasets, 64 variables, 26 documents, 1 analyses, 1 molecular datasets, 1206 subjects, 1220 samples","Other (2), East Asian (2), Hispanic2 (12), Other Asian or Pacific Islander (3), European (1132), African American (7), Hispanic1 (11), South Asian (4)","NIDDK","T1DC --- T1 Diabetes and complications (T1DC)","2008-11-20","2008-11-20","DKD; Diabetic Kidney Disease; Diabetic Kidney Diseases; Diabetic nephropathy; Diabetic renal disease; Kidney Disease, Diabetic",""
"phs000139.v1.p1","IMSGC Genome Wide Association Study of Multiple Sclerosis","The goal of this study is to perform a comprehensive allelic and genotypic association analysis of the entire human genome in multiple sclerosis. The recent definitive linkage genome screen demonstrated  that there is no other MS risk gene with an effect size anywhere near that of the MHC. However, linkage analysis is significantly hampered by reduced","Not Applicable","Multiple Sclerosis","Family/Twin/Trios","Affymetrix_WG_Array","SNP Genotypes (Array)","4 phenotype datasets, 34 variables, 2 documents, 1 analyses, 1 molecular datasets, 3002 subjects, 3002 samples","Other (2), East Asian (1), Hispanic2 (40), Other Asian or Pacific Islander (1), European (2947), Hispanic1 (11)","NINDS","MSRD --- Multiple Sclerosis and Related disorders, MS --- Multiple Sclerosis, NPU --- Non-Profit Use Only","2008-11-06","2008-11-06","Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis",""
"phs000130.v1.p1","NIDDK IBDGC Crohn's Disease Genome-Wide Association Study","This dataset contains data from a genome-wide association study performed with 968 Inflammatory Bowel Disease (IBD) affected cases and 995 unrelated controls using the Illumina HumanHap300 Genotyping BeadChip. Cases were  selected to have Crohn's disease with ileal involvement, and controls were matched to cases based on sex and year of birth. Subjects were drawn from","Not Applicable","Crohn Disease","Case-Control","HumanHap300","SNP Genotypes (Array)","3 phenotype datasets, 82 variables, 2 documents, 1 analyses, 1 molecular datasets, 1963 subjects, 1963 samples","Other (6), East Asian (1), Other Asian or Pacific Islander (1), European (1740), African American (2), Hispanic1 (10)","NIDDK","GRU --- General Research Use, IBDO --- Inflammatory Bowel Disease Only","2008-11-06","2008-11-06","Colitis, Ulcerative; Inflammatory Bowel Diseases; Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type",""
"phs000102.v1.p1","Ischemic Stroke Genetics Study (ISGS)","The third leading cause of death in the United States, stroke is an acute neurological event leading to death of neural tissues. Although the majority of strokes are ischemic strokes,  meaning there is oxygen deprivation to the brain, almost 20% of strokes are hemorrhagic, resulting from bleeding into the brain. Stroke is a complex","Not Applicable","Cerebrovascular Disorders","Case-Control","HumanHap100, HumanHap300, HumanHap550","SNP Genotypes (Array)","2 phenotype datasets, 74 variables, 5 documents, 1 analyses, 1 molecular datasets, 485 subjects, 485 samples","","NINDS","GRU --- General research use, SARD --- Stroke and Related Disorders","2008-06-26","2008-06-26","Brain Ischemia; Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs000006.v1.p1","NINDS Repository Motor Neuron Disease/ALS Study","The National Institute of Neurological Disorders and Stroke (NINDS) Human Genetics Resource Center: DNA and Cell Line Repository (the NINDS Repository), banks phenotypic data and biological samples, including from individuals  with motor neuron disease, in order to facilitate gene discovery in neurological disorders. Those samples are used in a number of studies, and","Not Applicable","Amyotrophic Lateral Sclerosis","Case-Control","Not Provided","Not Provided","1 phenotype datasets, 59 variables, 3 documents, 1790 subjects","","NINDS","GRU --- NULL","2008-06-26","2008-06-26","Bulbar Palsy, Progressive; Motor Neuron Disease; ALS; ALS - Amyotrophic Lateral Sclerosis; ALS Amyotrophic Lateral Sclerosis; Bulbar motor neuron disease",""
"phs000048.v1.p1","Mayo-Perlegen LEAPS (Linked Efforts to Accelerate Parkinson's Solutions)    Collaboration","We performed a two-tiered, whole-genome association study of Parkinson disease (PD). For tier 1, we individually genotyped 198,345 uniformly spaced and informative single-nucleotide polymorphisms (SNPs) in 443 sibling pairs discordant  for PD. For tier 2a, we individually genotyped 1,793 PD-associated SNPs (P .01 in tier 1) and 300 genomic control SNPs in 332 matched case-unrelated","Not Applicable","Parkinson Disease","Case-Control","Perlegen_Array","SNP Genotypes (Array)","2 phenotype datasets, 12 variables, 6 documents, 3 analyses, 1 molecular datasets, 1550 subjects, 1550 samples","","NHGRI","HR --- Health/Medical/Biomedical (GSO)","2008-03-03","2008-03-03","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE",""
"phs004408.v1.p1","Single Nucleus and Spatial Transcriptomic Analyses of Pulmonary Fibrosis    from the &#x0201c;Lung Transplant&#x0201d; and &#x0201c;Lung Tissue&#x0201d; Biorepositories","Interstitial lung disease (ILD) is characterized by a progressive destruction of the lung parenchyma driven by complex interactions between epithelial, stromal and immune cells. To understand the cellular programs and  interactions involved in ILD, we performed single nucleus and spatial transcriptomic analyses of lung tissues from ILD patients or comparators. The","Not Applicable","Lung Diseases, Interstitial","Case-Control","Not Provided","RNA-Seq","6 phenotype datasets, 38 variables, 102 samples sequenced, 29 subjects, 102 samples","","NHLBI","GRU --- General Research Use, HMB --- Health/Medical/Biomedical","2026-01-13","2026-01-13","Pulmonary Fibrosis; Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary; FIBROCYSTIC PULMONARY DYSPLASIA; FIBROSING ALVEOLITIS, CRYPTOGENIC","dbGaP Collection: Compilation of Individual-Level Genomic Data for    General Research Use (phs000688.v1.p1)"
"phs004377.v1.p1","Healthy Donor Controls for Immune Evaluation","Bioenergetic dysfunction is an archetypical finding in critical illness, particularly among patients with sepsis. A central feature of sepsis is the shift towards pathologic immunosuppression predisposing to secondary infections and  ineffectual organ recovery. However, the extent to which metabolic abnormalities contribute to immune cell dysregulation in critically ill patients","Not Applicable","Healthy Volunteers","Control Set","Not Provided","Not Provided","Not Provided","","NIGMS","","","","Not Provided",""
"phs004346.v1.p1","Assessing the Readiness of Oxford Nanopore Sequencing for Clinical    Genomics Applications","This study evaluates the readiness of Oxford Nanopore Technologies (ONT) long-read sequencing (LRS) for clinical genomics by benchmarking it against Illumina and MGI short-read sequencing (SRS) platforms. The goal was  to assess ONT's performance across multiple variant classes, including those that are typically challenging for SRS. A total of 17 Coriell reference","Not Applicable","Genomics","Methods","Not Provided","Not Provided","Not Provided","","NHGRI","","","","Disease, Genetic; Disease, Hereditary; Diseases, Genetic; Diseases, Hereditary; Disorder, Genetic; Disorders, Genetic",""
"phs004258.v1.p1","The Sepsis ClinicAl Resource And Biorepository (SCARAB) Project","Bioenergetic dysfunction is an archetypical finding in critical illness, particularly among patients with sepsis. A central feature of sepsis is the shift towards pathologic immunosuppression predisposing to secondary infections and  ineffectual organ recovery. However, the extent to which metabolic abnormalities contribute to immune cell dysregulation in critically ill patients","Not Applicable","Critical Illness","Case Set","Not Provided","Not Provided","Not Provided","","NIGMS","","","","Sepsis; Critical Illnesses; Critically Ill; Illness, Critical; Illnesses, Critical; Pyaemia",""
"phs004189.v1.p1","BTC GBM TeamLab Trial 1: Longitudinal Tissue Profiling of Recurrent    Malignant Glioma During Repeat Dosing of Oncolytic Viral Immunotherapy    (NCT03152318)","The data in this repository is generated from the work of the GBM TeamLab as part of Break Through Cancer (BTC) (https://breakthroughcancer.org/). The TeamLab's goal is to evaluate the feasibility,  safety, and value of performing serial brain biopsies to obtain biological readouts during the assessment of novel glibolastoma (GBM) therapeutics.","Not Applicable","Glioblastoma","Interventional","Not Provided","AMPLICON, RNA-Seq","21 samples sequenced, 27 samples","","NCI","","","","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs004188.v1.p1","DeepSomatic: Accurate Somatic Small Variant Discovery for Multiple    Sequencing Technologies","This study introduces DeepSomatic, a deep learning-based tool for detecting somatic SNVs and indels from tumor-normal short-read and long-read sequencing data. To train and benchmark the model, the researchers generated  the Cancer Standards Long-read Evaluation (CASTLE) dataset, comprising six matched tumor-normal cancer cell lines sequenced with Illumina, PacBio","Not Applicable","Glioblastoma","Tumor vs. Matched-Normal","Not Provided","WGS","2 samples sequenced, 1 subjects, 2 samples","","NCI","","","","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme",""
"phs004104.v1.p1","DNA Termini Correlate with Methylation at CpG Sites in Hair, Urine and    Blood Plasma Cell-Free DNA","The aim of this study was to reconstruct the age of individuals from cell-free DNA (cfDNA) present in rootless hair and urine samples using epigenetic clock methods. Hair was chosen  as a noninvasive source for biological age estimation and a sample type which is relevant in forensic science. Samples were obtained from anonymous","Not Applicable","Aging","Collection","Not Provided","Not Provided","Not Provided","","NHGRI","","","","DNA Methylation; Aging, Biological; Biological Aging",""
"phs004038.v1.p1","High-Resolution Single Cell Profiling of SARS-CoV-2 Vaccine    Responsiveness in Healthy Adults","mRNA vaccines, administered in two doses, have been highly effective against SARS-CoV-2 and are now being explored for broader applications. However, how human immune cells respond to these platforms, particularly  differences between primary and booster responses, remains incompletely understood. Here, we longitudinally profiled plasma and peripheral blood","Not Applicable","SARS-CoV-2","Prospective Longitudinal Cohort","Not Provided","OTHER","9 samples sequenced, 41 subjects, 87 samples","","NIAID","","","","Not Provided",""
"phs003940.v1.p1","The Primate-Specific Nedd4-1(NE) Localizes to Late Endosomes in Response    to Amino Acids to Suppress Autophagy","We report a patient with lymphangiectasia and protein-losing enteropathy who carries a homozygous variant located in the NE region of Nedd4-1(NE), E70Q. Exome sequencing were used to identify the missense  variants in the patient. The pathogenic variant leads to reduced VPS16B ubiquitination by Nedd4-1(NE). This work uncovered an mTORC1-independent,","Not Applicable","Protein-Losing Enteropathies","Family/Twin/Trios","Not Provided","CNV Genotypes","3 subjects, 3 samples","","NIAID","","","","Lymphangiectasis, Intestinal; Intestinal Lymphangiectases; Intestinal Lymphangiectasis; Intestinal lymphangiectasia; Lymphangiectases, Intestinal; Lymphangiectasia, Intestinal",""
"phs003849.v1.p1","Functional Genomics and Tumor Microenvironment Analysis Reveal Prognostic    Biological Subtypes in Mantle Cell Lymphoma","Mantle cell lymphoma (MCL) is a genetically and clinically heterogeneous B-cell malignancy. We studied two MCL cohorts with differing treatment patterns: one enriched for immunochemotherapy, the other for chemotherapy alone.  TP53 alterations are consistently associated with poor prognosis, whereas ATM mutations correlate with improved outcomes following rituximab-based","Not Applicable","Lymphoma, Mantle-Cell","Case Set","Not Provided","Targeted-Capture, WXS","265 samples sequenced, 267 subjects, 267 samples","","NCI","","","","Mantle Cell Lymphoma; Lymphoma, Lymphocytic, Intermediate",""
"phs003836.v1.p1","A Non-Invasive, Multi-Dimensional Study of Early Detection of Prostate    Cancer with Urine","Prostate biopsy is the gold standard for prostate cancer diagnostics and is an invasive procedure. Overbiopsy is a serious health issue caused by the low specificity of PSA. A urine  tumor DNA multidimensional bioinformatic algorithm, utLIFE, was developed for urine signal detection. This study (ChiCTR2300071837) was designed to","Not Applicable","Early Detection of Cancer","Case-Control","Not Provided","Not Provided","580 subjects, 580 samples","","NHGRI","","","","Not Provided",""
"phs003728.v1.p1","Multiomic Profiling of Adult Acute Myeloid Leukemia Patients","We performed whole exome and transcriptome sequencing on ancestry diverse patients with acute myeloid leukemia (AML) focusing on underexplored populations. We aim to improve risk stratification and treatments for minority  AML patients. Our study found that 7% of Black AML patients harbor an unreported PHIP alteration and that Black patients with myelodysplasia-related","Not Applicable","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","Not Provided","Not Provided","Not Provided","","NCI","","","","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML - acute myeloid leukaemia; AML adult; ANLL",""
"phs003588.v1.p1","The CHK1 Inhibitor Prexasertib in BRCA Wild-Type Platinum-Resistant    Recurrent High-Grade Serous Ovarian Carcinoma: a Phase 2 Trial","Ovarian carcinoma, especially high-grade serous ovarian carcinoma (HGSOC), is the deadliest gynecologic malignancy in the USA. Despite initial treatment with surgery and platinum-based chemotherapy, around 80% of HGSOC patients experience  relapse. This is particularly challenging in platinum-resistant recurrent HGSOC, especially in cases where BRCA1/BRCA2 genes are wild-type (BRCAwt),","Not Applicable","Ovarian Neoplasms","Clinical Trial","Not Provided","WXS","18 samples sequenced, 18 subjects, 18 samples","","NCI","","","","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian",""
"phs003580.v1.p1","Sebaceous Neoplasm Tissue Study, 20190101","Sebaceous carcinoma, a rare but aggressive skin cancer, often shares clinicopathologic features with benign sebaceous neoplasms, complicating accurate diagnosis. This study aimed to identify molecular biomarkers to improve classification and  treatment strategies by analyzing the genomic and transcriptomic profiles of sebaceous neoplasms from multiple U.S. healthcare facilities.","Not Applicable","Sebaceous Gland Neoplasms","Case Set","Not Provided","Not Provided","27 subjects, 47 samples","","NCI","","","","",""
"phs003500.v1.p1","Circulating Tumor DNA Analyses of Breast Cancer Patients Paired and Over    Time","Blood-based 'liquid biopsy' is increasingly utilized in clinical care of cancer patients and the fraction of tumor-derived DNA in circulation ('tumor fraction', TFx) has demonstrated clinical utility across multiple cancer  types. To determine TFx, shallow whole genome sequencing of cell-free DNA can be performed from a single blood sample, using an established","Not Applicable","Neoplasms","Case Set","Not Provided","Not Provided","33 subjects, 109 samples","","NCI","","","","Neoplasm Metastasis; Metastase; Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize",""
"phs003420.v1.p1","Patient-Derived Models of Prostate Cancer for Personalized Medicine","The aim of this study was to develop a molecular dataset that reflects the heterogeneity of prostate cancer using patient-derived xenografts (PDX) grown in the subcutaneous flank of SCID (CB17/Icr-Prkdcscid/IcrIcoCrl)  mice. Whole-genome, targeted sequencing, and RNA sequencing were performed on tumors from 44 PDXs derived from 38 patients. The cohort included","Not Applicable","Prostatic Neoplasms","Xenograft","Not Provided","Not Provided","38 subjects, 44 samples","","NCI","","","","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate",""
"phs003329.v1.p1","Genetic Determinants of Antidepressant Response","Treatment-resistant depression (TRD) is a severe form of major depressive disorder (MDD) with substantial public health impact and poor treatment outcome. Treatment outcome in MDD is significantly heritable, but genome-wide  association studies have failed to identify replicable common marker alleles, suggesting a potential role for uncommon variants. Here we investigated","Not Applicable","Depressive Disorder, Major","Case-Control","Not Provided","Not Provided","156 subjects, 156 samples","","NIMH","","","","Depressive Disorder, Treatment-Resistant; Depression, Involutional; Depressions, Involutional; Involutional melancholia; Melancholia, Involutional; Melancholias, Involutional",""
"phs003285.v1.p1","Establishment of a Human, Age-Specific Model for Axon Growth and    Regeneration Studies","Injury to mammalian central nervous system (CNS) axons results in limited regeneration. Rodent studies have revealed a developmental switch in CNS axon regenerative abilities, yet whether this is conserved in  humans is unknown. Using 11 different lines of human fibroblasts from 8 gestational weeks to 72 years-old, we performed direct reprogramming to","Not Applicable","Neuronal Outgrowth","Case Set","Not Provided","RNA-Seq","48 samples sequenced, 11 subjects, 48 samples","","NINDS","","","","Not Provided",""
"phs003211.v1.p1","The Natural History of Lymph Node Metastases in Head and Neck Cancer","The metastatic trajectory of head and neck squamous cell cancers (HNSCC) is poorly characterized despite a long-held view of sequential dissemination through the lymph nodes from higher to lower echelon  nodal stations. It is not known whether tumour dissemination is more heavily influenced by this anatomical structure of lymphatic drainage or by","Not Applicable","Squamous Cell Carcinoma of Head and Neck","Tumor vs. Matched-Normal","Not Provided","SNP/CNV Genotypes (NGS), WGS","59 samples sequenced, 14 subjects, 59 samples","","NCI","","","","Clonal Evolution; Neoplasm Metastasis; Evolution, Clonal; Metastase; Metastases, Neoplasm; Metastasis",""
"phs003055.v1.p1","Rare Variants and HLA Haplotypes Associated in Serbian Patients with    Neuromyelitis Optica Spectrum Disorders","Neuromyelitis optica spectrum disorders (NMOSD) are rare, debilitating, antibody-mediated autoimmune diseases of the central nervous system. Prior studies show associations of NMOSD with individual Human Leukocyte Antigen (HLA) alleles and  the complement pathway. HLA allele associations with NMOSD are inconsistent between populations, suggesting complex relationships between the","Not Applicable","Neuromyelitis Optica","Case Set","Not Provided","Not Provided","78 subjects, 78 samples","","NIAID","","","","Devic Disease; Devic Neuromyelitis Optica; Devic Neuromyelitis Opticas; Devic Syndrome; Devic's Disease; Devic's Neuromyelitis Optica",""
"phs002951.v1.p1","Whole Transcriptome Analysis of Melanoma PDX Models","This study reports bulk total RNA sequencing from melanoma patient-derived xenograft (PDX) tumors. The goal is to determine transcriptomic differences across melanomas of distinct subtypes including cutaneous, acral, mucosal, and  unknown primary. Fresh surgical specimens used for deriving PDX models were obtained from the University of Colorado Skin Cancer Biorepository under","Not Applicable","Melanoma","Xenograft","Not Provided","Not Provided","65 subjects, 65 samples","","NCI","","","","Cancer of skin pigment cells; MM - malignant melanoma; Malignant Melanoma; Malignant Melanomas; Melanoma, Malignant; Melanomas",""
"phs002712.v1.p1","Genomic, Transcriptomic, and Single-Cell Sequencing of Pancreatic Cancer","Clinically relevant RNA expression states exist in pancreatic ductal adenocarcinoma (PDAC), but our understanding of their drivers, stability, and relationship to therapeutic response is limited. To examine these attributes systematically,  we profiled metastatic biopsies and matched organoid models with single-cell RNA-sequencing. We also analyzed a cohort of patient-derived PDAC","Not Applicable","Carcinoma, Pancreatic Ductal","Case Set","Not Provided","Not Provided","Not Provided","","NCI","","","","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas",""
"phs002693.v1.p1","Molecular and Cellular Characterization of the Development and Physiology    of the Pancreas","This study contains an atlas of gene expression and chromatin accessibility in developing human fetal pancreatic tissue, at single-cell resolution. The study included samples from 8 independent biological samples that  were profiled using single cell RNA sequencing, and one tissue sample was subjected to single cell ATAC sequencing. This dataset represents a","Not Applicable","Human Development","Collection","Not Provided","ATAC-seq, RNA-Seq","15 samples sequenced, 9 subjects, 15 samples","","NIDDK","","","","Not Provided",""
"phs002577.v1.p1","The Collaboration to Assess Risk and Identify LoNG-term outcomes for    Children with COVID (CARING for Children with COVID) -    NICHD-2019-POP02: Pharmacokinetics, Pharmacodynamics, and Safety    Profile of Understudied Drugs Administered to Children per Standard of    Care","The goals of the NIH's Collaboration to Assess Risk and Identify LoNG-term outcomes for Children with COVID (CARING for Children with COVID) effort are to foster collaborative and accelerated pediatric  COVID research to understand the spectrum of pediatric SARS-CoV-2 infection and pediatric COVID-19, and identify MIS-C risk factors and long term","Not Applicable","COVID-19","Case Set","Not Provided","Not Provided","1 documents","","NICHD","","","","2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019 nCoV Disease; 2019 nCoV Infection; 2019 novel coronavirus; 2019-nCoV",""
"phs002359.v1.p1","Genomic Architecture of LGL Leukemia","LGL leukemia results from a clonal expansion of cytotoxic T lymphocytes with a terminal effector memory (TEMRA) phenotype. LGL leukemia patients have multiple clinical phenotypes including chronic neutropenia, pure red  cell aplasia, and rheumatoid arthritis. The major focus of this project is to identify and understand how genomic changes contribute to the","Not Applicable","Leukemia, Large Granular Lymphocytic","Case Set","Not Provided","Not Provided","7 subjects, 20 samples","","NCI","","","","Anemia; Neutropenia; Aggressive NK Cell Leukemia; Aggressive Natural Killer Cell Leukemia; LGL Leukemia; LGL Leukemias",""
"phs002223.v1.p1","National Cancer Institute Familial Burkitt Lymphoma in Shirati (FBiS)","In 1980, Dr. Glen Brubaker and colleagues reported 5 familial cases of Burkitt Lymphoma (BL) in Shirati in Tanzania and began collecting cryopreserved lymphocytes from affected and non-affected family members  to study the potential genetic basis of familial BL occurring in the malaria belt in Africa. This area is settled by the Luo tribe (85% of the","Not Applicable","Burkitt Lymphoma","Case-Control","Not Provided","Not Provided","Not Provided","","NCI","","","","Epstein-Barr Virus Infections; BL; BL - Burkitt's lymphoma; Burkitt Tumor; Burkitt lymphoma/leukemia; Burkitt's Lymphoma",""
"phs001773.v1.p1","Linked-Read Sequencing to Resolve Complex Structural Variants","Large structural variants (SVs) are important contributors to disease yet remain one of the most difficult types of variation to accurately ascertain, in part because they cluster in duplicated/repetitive regions,  but also because the signals for these events can be challenging to detect with short reads. Clinically, array comparative genome hybridization and","Not Applicable","Genomic Structural Variation","Case Set","Not Provided","Not Provided","23 subjects, 23 samples","","NHGRI","","","","Not Provided",""
"phs001697.v2.p1","Integrative Analysis of Lung Cancers in Never Smokers (The Sherlock-Lung    Study)","We performed whole-genome sequencing of lung cancers from never smoker subjects as part of the Sherlock-Lung study to understand etiology, novel mutational processes, tumor progression trajectories, and risk factors in  people who have never smoked. Lung cancer in never smokers Principal Investigator: Maria Teresa Landi, MD, PhD, National Institutes of Health,","Not Applicable","Lung Neoplasms","Tumor vs. Matched-Normal","Not Provided","WGS","1720 samples sequenced, 860 subjects, 1720 samples","","NCI","","","","Lung Tumor; Lung cancer; Lung neoplasm; Lung tumour; Neoplasm of Lung; Neoplasm of the Lung",""
"phs000780.v1.p1","Exome Sequencing of Childhood Wilms Tumor","Wilms tumor is the most common kidney cancer of children. To define the mutation spectrum of Wilms tumor, we performed whole-exome sequencing on matched tumor-normal pairs. A further set of  tumor samples underwent whole exome sequencing without accompanying normal tissue. Exome data for patients giving consent to have the information","Not Applicable","Wilms Tumor","Case Set","Not Provided","Not Provided","5 subjects, 8 samples","","NIDDK","","","","Blastoma; CA; CA - Cancer; Cancer; MT; Malignancies",""
"phs000696.v1.p1","Exome Sequencing of Craniopharyngiomas","Craniopharyngiomas are epithelial tumors of the brain that form in the suprasellar region. Patients experience a broad range of sequelae from growth of the tumors and from therapeutic interventions. We  used whole exome sequencing to investigate the genetic aberrations in both adamantinomatous and papillary craniopharyngiomas. We found mutations in","Not Applicable","Craniopharyngioma","Case Set","Not Provided","Not Provided","Not Provided","","NCI","","","","Adamantinomatous tumor; Adamantinomatous tumour; Craniopharyngeal duct tumor; Craniopharyngioma (WHO Grade 1); Craniopharyngioma (WHO Grade I); Craniopharyngiomas",""
"phs000329.v1.p1","Evolution of Human BCR-ABL1 Lymphoblastic Leukemia-Initiating Cells","Many tumour types are composed of genetically diverse cells, however little is known of how diversity evolves or the impact diversity has on functional properties. Here, using xenografting and DNA  copy number alteration (CNA) profiling of human BCR-ABL1 lymphoblastic leukaemia, we demonstrate that genetic diversity occurs in functionally","Not Applicable","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Xenograft","Not Provided","Not Provided","Not Provided","","NCI","","","","Acute Lymphoblastic Leukemia; ALL, Childhood; Childhood ALL; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic",""
"phs000124.v3.p1","Neuroblastoma Genome-Wide Association Study (NBL-GWAS)","Neuroblastoma is a malignancy of the developing sympathetic nervous system that most commonly affects young children and is often lethal. The etiology of this embryonal cancer is not fully understood.  We therefore initiated a genome-wide association study (GWAS) in 2007 focused on neuroblastoma patients identified through the Children's Oncology","Not Applicable","Neuroblastoma","Case-Control","Not Provided","Not Provided","2 analyses","","NCI","","","","Not Provided",""
"phs000050.v1.p1","Genotyping the 270 HapMap Samples for GAIN by Perlegen","For the GAIN studies, Perlegen Sciences uses a high-density oligonucleotide array-based platform to analyze 600,000 SNPs in large numbers of individuals. The SNP set was selected on the basis of  linkage disequilibrium analysis of the HapMap data, and includes tag SNPs for all CEU bins. The arrays consist of DNA probes (short segments of DNA)","Not Applicable","Health","Family/Twin/Trios","Not Provided","SNP Genotypes (Array)","270 samples","East Asian (85), Other Asian or Pacific Islander (5), European (90), African American (3), African (87)","NHGRI","","","","Not Provided",""
"phs000049.v1.p1","Genotyping the 270 HapMap Samples for GAIN by Broad","The Broad Institute Center for Genotyping and Analysis is an NCRR-funded fee-for-service SNP genotyping facility based at MIT (www.broad.mit.edu/genotyping). For the GAIN studies, Broad uses the Affymetrix GeneChip genotyping platform.  The first set of studies is being analyzed on the soon-to-be-publicly-released ""Human Mapping 500K Array 2.0"", which detects 500,000 SNPs, as well as","Not Applicable","Health","Family/Twin/Trios","Not Provided","SNP Genotypes (Array)","277 samples","","NHGRI","","","","Not Provided",""
"phs000683.v1.p1","SIGMA Type 2 Diabetes Consortium","Diabetes in Mexico Study (DMS): Individuals were enrolled in the study, recruited from two tertiary level institutions (IMSS and ISSSTE) located in Mexico City. The diagnosis of T2D was made  based on ADA criteria. 811 unrelated healthy subjects older than 45 years and with fasting glucose levels below 100 mg/dL were classified as","Not Applicable","Diabetes Mellitus, Type 2","Case-Control","Not Provided","Not Provided","Not Provided","","NIDDK","","","","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NONINSULIN-DEPENDENT; DIABETES MELLITUS, TYPE II; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Adult-Onset",""
